PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cantrell, KA; Sutton, S; Gaur, AH				Cantrell, Kathryn A.; Sutton, Sylvia; Gaur, Aditya H.			Pause, Listen, Share	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NARRATIVE MEDICINE; ILLNESS NARRATIVES		[Cantrell, Kathryn A.] Univ Massachusetts, Dept Counseling, Boston, MA 02125 USA; [Cantrell, Kathryn A.] Univ Massachusetts, Sch Psychol, Boston, MA 02125 USA; [Sutton, Sylvia; Gaur, Aditya H.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston; St Jude Children's Research Hospital	Gaur, AH (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	aditya.gaur@stjude.org	Gaur, Aditya H/N-8057-2018	Gaur, Aditya H/0000-0002-6639-5231; Cantrell, Kathryn/0000-0001-7198-3807	NCI NIH HHS [CA 21765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Charon R, 2001, JAMA-J AM MED ASSOC, V286, P1897, DOI 10.1001/jama.286.15.1897; DasGupta S, 2007, PEDIATRICS, V119, pE1384, DOI 10.1542/peds.2006-2619; Ezzy D, 2000, SOC SCI MED, V50, P605, DOI 10.1016/S0277-9536(99)00306-8; Frank A., 2010, WOUNDED STORYTELLER; Frank A.W., 1998, FAM SYST HEALTH, V16, P197, DOI [https://doi.org/10.1037/h0089849, DOI 10.1037/H0089849, 10.1037/h0089849]; Kleinman A., 1988, ILLNESS NARRATIVES; Nowaczyk MJM, 2013, AM J MED GENET A, V161, P2117, DOI 10.1002/ajmg.a.36114	7	2	2	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					345	346		10.1001/jama.2014.6201	http://dx.doi.org/10.1001/jama.2014.6201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038350				2022-12-28	WOS:000339257800018
J	Chamberlain, PI				Chamberlain, Paul Ivor			An assisted dying law might save me from a lingering and unpleasant death Paul Ivor Chamberlain has motor neurone disease and explains why he backs Lord Falconer's bill	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												paul.chamberlain@sky.com						Dyer C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4739	1	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2014	349								g4784	10.1136/bmj.g4784	http://dx.doi.org/10.1136/bmj.g4784			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VN	25052048				2022-12-28	WOS:000339565700015
J	Coles, CH; Bradke, F				Coles, Charlotte H.; Bradke, Frank			Microtubule Self-Organization via Protein-RNA Network Crosstalk	CELL			English	Editorial Material							AXONS	Microtubule plus-end tracking proteins are crucial for the regulation of microtubule dynamics. Preitner et al. report that one such protein, adenomatous polyposis coli (APC), also binds RNA and identify mRNAs encoding tubulin subunits within the brain APC-RNA interactome, suggesting a new mode of microtubule self-regulation.	[Coles, Charlotte H.; Bradke, Frank] German Ctr Neurodegenerat Dis DZNE, Lab Axon Growth & Regenerat, D-53175 Bonn, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Coles, CH (corresponding author), German Ctr Neurodegenerat Dis DZNE, Lab Axon Growth & Regenerat, Ludwig Erhard Allee 2, D-53175 Bonn, Germany.	charlotte.coles@dzne.de; frank.bradke@dzne.de		Coles, Charlotte/0000-0003-4525-7144; Bradke, Frank/0000-0002-0345-3772				Bahi-Buisson N, 2014, BRAIN, V137, P1676, DOI 10.1093/brain/awu082; Breitsprecher D, 2012, SCIENCE, V336, P1164, DOI 10.1126/science.1218062; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Hoerndli FJ, 2013, NEURON, V80, P1421, DOI 10.1016/j.neuron.2013.10.050; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Preitner N, 2014, CELL, V158, P368, DOI 10.1016/j.cell.2014.05.042; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Wang L, 2002, CURR BIOL, V12, P1496, DOI 10.1016/S0960-9822(02)01078-3	12	0	0	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					245	247		10.1016/j.cell.2014.06.044	http://dx.doi.org/10.1016/j.cell.2014.06.044			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036626	Bronze			2022-12-28	WOS:000340943600005
J	Yuen, TJ; Silbereis, JC; Griveau, A; Chang, SM; Daneman, R; Fancy, SPJ; Zahed, H; Maltepe, E; Rowitch, DH				Yuen, Tracy J.; Silbereis, John C.; Griveau, Amelie; Chang, Sandra M.; Daneman, Richard; Fancy, Stephen P. J.; Zahed, Hengameh; Maltepe, Emin; Rowitch, David H.			Oligodendrocyte-Encoded HIF Function Couples Postnatal Myelination and White Matter Angiogenesis	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; NUCLEAR TRANSLOCATOR ARNT; HYPOXIA-INDUCIBLE FACTORS; BETA-CATENIN; MULTIPLE-SCLEROSIS; ENDOTHELIAL-CELLS; AXONAL INTEGRITY; PROGENITOR CELLS; CEREBRAL-PALSY	Myelin sheaths provide critical functional and trophic support for axons in white matter tracts of the brain. Oligodendrocyte precursor cells (OPCs) have extraordinary metabolic requirements during development as they differentiate to produce multiple myelin segments, implying that they must first secure adequate access to blood supply. However, mechanisms that coordinate myelination and angiogenesis are unclear. Here, we show that oxygen tension, mediated by OPC-encoded hypoxia-inducible factor (HIF) function, is an essential regulator of postnatal myelination. Constitutive HIF1/2 alpha stabilization resulted in OPC maturation arrest through autocrine activation of canonical Wnt7 alpha/7 beta. Surprisingly, such OPCs also show paracrine activity that induces excessive postnatal white matter angiogenesis in vivo and directly stimulates endothelial cell proliferation in vitro. Conversely, OPC-specific HIF1/2 alpha loss of function leads to insufficient angiogenesis in corpus callosum and catastrophic axon loss. These findings indicate that OPC-intrinsic HIF signaling couples postnatal white matter angiogenesis, axon integrity, and the onset of myelination in mammalian forebrain.	[Yuen, Tracy J.; Silbereis, John C.; Griveau, Amelie; Chang, Sandra M.; Fancy, Stephen P. J.; Zahed, Hengameh; Rowitch, David H.] Univ Calif San Francisco, Eli & Edythe Broad Inst Stem Cell Res & Regenerat, Dept Pediat, San Francisco, CA 94143 USA; [Yuen, Tracy J.; Silbereis, John C.; Griveau, Amelie; Chang, Sandra M.; Fancy, Stephen P. J.; Zahed, Hengameh; Rowitch, David H.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Silbereis, John C.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Daneman, Richard] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Zahed, Hengameh] Univ Calif San Francisco, Med Sci Training Program, San Francisco, CA 94143 USA; [Maltepe, Emin; Rowitch, David H.] Univ Calif San Francisco, Div Neonatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rowitch, DH (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Inst Stem Cell Res & Regenerat, Dept Pediat, 513 Parnassus Ave, San Francisco, CA 94143 USA.	rowitchd@peds.ucsf.edu		Yuen, Tracy/0000-0002-3451-9279; Rowitch, David/0000-0002-0079-0060	National Multiple Sclerosis Society (NMSS); NIGMS [T32 GM007449-36]; Ruth Kirschstein NRSA fellowship from NINDS [F31 NS076254-03]; NICHD [HD072544]; NINDS [NS040511, P01NS083513]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076254, R01NS040511, P01NS083513] Funding Source: NIH RePORTER	National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ruth Kirschstein NRSA fellowship from NINDS; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Emily Harrington and April Tenney for expert technical help and Matt Rasband, Nenad Sestan, and Klaus Nave for discussions. We thank Andrew McMahon (USC) for genomic sequence information for Wnt7a and 7b loci, William Kaelin (Dana-Farber Cancer Institute) for floxed VHL transgenic mice, and William Richardson (UCL) for Sox10-cre transgenic mice. We also thank Nina Bauer, who drew all illustrations. T.J.Y. acknowledges a postdoctoral fellowship from the National Multiple Sclerosis Society (NMSS). J.C.S. acknowledges support from training grant T32 GM007449-36 from NIGMS and the Ruth Kirschstein NRSA fellowship F31 NS076254-03 from NINDS. This work was made possible by grants from NICHD (HD072544 to E.M.), NMSS (to D.H.R.) and NINDS (NS040511 and P01NS083513 to D.H.R.). D.H.R. is a HHMI Investigator.	Aboul-Enein F, 2003, J NEUROPATH EXP NEUR, V62, P25, DOI 10.1093/jnen/62.1.25; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Baron W, 2010, FEBS LETT, V584, P1760, DOI 10.1016/j.febslet.2009.10.085; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CAMMERMEYER J, 1960, AM J ANAT, V106, P197, DOI 10.1002/aja.1001060303; Cayre M, 2013, DEVELOPMENT, V140, P3107, DOI 10.1242/dev.092999; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Chrast R, 2011, J LIPID RES, V52, P419, DOI 10.1194/jlr.R009761; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Davies AL, 2013, ANN NEUROL, V74, P815, DOI 10.1002/ana.24006; del Rio-Hortega P, 2012, CLIN NEUROPATHOL, V31, P460, DOI 10.5414/NP301000; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Dugas-Ford J, 2012, P NATL ACAD SCI USA, V109, P16974, DOI 10.1073/pnas.1204773109; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Emery Ben, 2013, Cold Spring Harb Protoc, V2013, P854, DOI 10.1101/pdb.prot073973; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Franceschini MA, 2007, PEDIATR RES, V61, P546, DOI 10.1203/pdr.0b013e318045be99; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Harb R, 2013, J CEREBR BLOOD F MET, V33, P146, DOI 10.1038/jcbfm.2012.152; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; Hirose K, 1996, MOL CELL BIOL, V16, P1706; Hu FH, 2004, SEMIN PERINATOL, V28, P371, DOI 10.1053/j.semperi.2004.10.001; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Jiang LD, 2011, TRANSL STROKE RES, V2, P366, DOI 10.1007/s12975-011-0078-0; Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Lee H, 2006, MOL CELLS, V21, P1; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Ment LR, 1998, DEV BRAIN RES, V111, P197, DOI 10.1016/S0165-3806(98)00139-4; Miller DJ, 2012, P NATL ACAD SCI USA, V109, P16480, DOI 10.1073/pnas.1117943109; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Pham LDD, 2012, GLIA, V60, P875, DOI 10.1002/glia.22320; Porfiri E, 1997, ONCOGENE, V15, P2833, DOI 10.1038/sj.onc.1201462; Rankin EB, 2005, MOL CELL BIOL, V25, P3163, DOI 10.1128/MCB.25.8.3163-3172.2005; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Rosenstein JM, 2010, ORGANOGENESIS, V6, P107, DOI 10.4161/org.6.2.11687; Ryan HE, 2000, CANCER RES, V60, P4010; Sapieha P, 2012, BLOOD, V120, P2182, DOI 10.1182/blood-2012-04-396846; Sawamiphak S, 2010, NAT PROTOC, V5, P1659, DOI 10.1038/nprot.2010.130; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Silbereis JC, 2010, DIS MODEL MECH, V3, P678, DOI 10.1242/dmm.002915; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Tan S, 2005, J CHILD NEUROL, V20, P972, DOI 10.1177/08830738050200120801; Tanaka K, 2001, NEUROREPORT, V12, P2169, DOI 10.1097/00001756-200107200-00025; TESSITORE C, 1988, DEV BRAIN RES, V43, P139, DOI 10.1016/0165-3806(88)90159-9; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Weiss J, 2004, EXP NEUROL, V189, P141, DOI 10.1016/j.expneurol.2004.05.018; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Yuen TJ, 2013, BRAIN, V136, P1035, DOI 10.1093/brain/awt024	76	237	245	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					383	396		10.1016/j.cell.2014.04.052	http://dx.doi.org/10.1016/j.cell.2014.04.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25018103	Green Accepted, Bronze			2022-12-28	WOS:000340943600017
J	Narain, C				Narain, Charvy			GENETICS Complex expressions	NATURE			English	Editorial Material																		Glasscock E, 2007, NAT NEUROSCI, V10, P1554, DOI 10.1038/nn1999; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Lerche H, 2013, J PHYSIOL-LONDON, V591, P753, DOI 10.1113/jphysiol.2012.240606; Thomas EA, 2010, EPILEPSIA, V51, P136, DOI 10.1111/j.1528-1167.2009.02202.x	4	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S8	S9		10.1038/511S8a	http://dx.doi.org/10.1038/511S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25019127				2022-12-28	WOS:000338649800004
J	Deng, L; Ignacio-Espinoza, JC; Gregory, AC; Poulos, BT; Weitz, JS; Hugenholtz, P; Sullivan, MB				Deng, Li; Ignacio-Espinoza, J. Cesar; Gregory, Ann C.; Poulos, Bonnie T.; Weitz, Joshua S.; Hugenholtz, Philip; Sullivan, Matthew B.			Viral tagging reveals discrete populations in Synechococcus viral genome sequence space	NATURE			English	Article							MARINE VIRUSES; GENE-TRANSFER; CYANOPHAGES; EVOLUTION; DIVERSITY; BACTERIOPHAGE; COMMUNITIES; PROPHAGES; ABUNDANCE; BACTERIAL	Microbes and their viruses drive myriad processes across ecosystems ranging from oceans and soils to bioreactors and humans(1-4). Despite this importance, microbial diversity is only now being mapped at scales relevant to nature(5), while the viral diversity associated with any particular host remains little researched. Here we quantify host-associated viral diversity using viral-tagged metagenomics, which links viruses to specific host cells for high-throughput screening and sequencing. In a single experiment, we screened 10(7) Pacific Ocean viruses against a single strain of Synechococcus and found that naturally occurring cyanophage genome sequence space is statistically clustered into discrete populations. These population-based, host-linked viral ecological data suggest that, for this single host and seawater sample alone, there are at least 26 double-stranded DNA viral populations with estimated relative abundances ranging from 0.06 to 18.2%. These populations include previously cultivated cyanophage and new viral types missed by decades of isolate-based studies. Nucleotide identities of homologous genes mostly varied by less than 1% within populations, even in hypervariable genome regions, and by 42-71% between populations, which provides benchmarks for viral metagenomics and genome-based viral species definitions. Together these findings showcase a new approach to viral ecology that quantitatively links objectively defined environmental viral populations, and their genomes, to their hosts.	[Deng, Li; Gregory, Ann C.; Poulos, Bonnie T.; Sullivan, Matthew B.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85719 USA; [Ignacio-Espinoza, J. Cesar; Sullivan, Matthew B.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85719 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Hugenholtz, Philip] Univ Queensland, Australian Ctr Ecogen, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Hugenholtz, Philip] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Arizona; University of Arizona; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of Queensland; University of Queensland	Sullivan, MB (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85719 USA.	mbsulli@email.arizona.edu	Hugenholtz, Philip/AAD-9138-2019; Deng, Li/A-7233-2015; Sullivan, Matthew B/H-3256-2011	Hugenholtz, Philip/0000-0001-5386-7925; Deng, Li/0000-0003-0225-0663; Sullivan, Matthew B/0000-0003-4040-9831; Ignacio Espinoza, J. Cesar/0000-0001-9303-7504	US Department of Energy (DOE) Joint Genome Institute (JGI) Community Sequencing Program; Biosphere 2; BIO5; US National Science Foundation (NSF) [OCE0940390]; Gordon and Betty Moore Foundation grants; NSF [OCE1233760]; Burroughs Wellcome Fund grants; University Information Technology Services Research Computing Group; ARL Biotechnology Computing for high-performance computing clusters (HPCC); DOE JGI Community Sequencing Program under the Office of Science of the US DOE [DE-AC02-05CH11231]; Division Of Physics [1205878] Funding Source: National Science Foundation	US Department of Energy (DOE) Joint Genome Institute (JGI) Community Sequencing Program(United States Department of Energy (DOE)); Biosphere 2; BIO5; US National Science Foundation (NSF)(National Science Foundation (NSF)); Gordon and Betty Moore Foundation grants(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); Burroughs Wellcome Fund grants(Burroughs Wellcome Fund); University Information Technology Services Research Computing Group; ARL Biotechnology Computing for high-performance computing clusters (HPCC); DOE JGI Community Sequencing Program under the Office of Science of the US DOE(United States Department of Energy (DOE)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Funding was provided by the US Department of Energy (DOE) Joint Genome Institute (JGI) Community Sequencing Program, Biosphere 2, BIO5, US National Science Foundation (NSF) OCE0940390, and Gordon and Betty Moore Foundation grants to M.B.S., as well as NSF OCE1233760 and Burroughs Wellcome Fund grants to J.S.W. We thank J. Fuhrman for suggesting stable-isotope-labelled host DNA; A. Z. Warden and the CANON Initiative for the cruise opportunity; Warden laboratory members; the captain and crew of the R/V Western Flyer for operational/sampling support; J. B. Waterbury, S. W. Chisholm and A. Wichels for strains; the Tucson Marine Phage laboratory; Institute of Groundwater Ecology of Helmholtz Munich; and N. Pace, M. Young, S. W. Chisholm and S. Yilmaz for technical/analytical support and manuscript comments. We acknowledge the University of Arizona Genetics Core for viral-tagging metagenomic sequencing; iCyt and the Arizona Cancer Center and Arizona Research Laboratories (ARL) Division of Biotechnology Cytometry Core Facility for cytometry support; the University Information Technology Services Research Computing Group and the ARL Biotechnology Computing for high-performance computing clusters (HPCC) access and support. Community metagenomic sequencing was provided by the DOE JGI Community Sequencing Program under the Office of Science of the US DOE contract no. DE-AC02-05CH11231.	Akhter S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks406; Angly F, 2009, ENVIRON MICROBIOL, V11, P2863, DOI 10.1111/j.1462-2920.2009.02021.x; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Ceyssens PJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-134; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chen F, 2002, APPL ENVIRON MICROB, V68, P2589, DOI 10.1128/AEM.68.5.2589-2594.2002; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Deng L, 2008, FRESHWATER BIOL, V53, P1240, DOI 10.1111/j.1365-2427.2007.01947.x; Deng L, 2012, MBIO, V3, DOI 10.1128/mBio.00373-12; Duhaime MB, 2012, ENVIRON MICROBIOL, V14, P2526, DOI 10.1111/j.1462-2920.2012.02791.x; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Fuller NJ, 1998, APPL ENVIRON MICROB, V64, P2051; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Holmfeldt K, 2013, P NATL ACAD SCI USA, V110, P12798, DOI 10.1073/pnas.1305956110; Holmfeldt K, 2012, APPL ENVIRON MICROB, V78, P892, DOI 10.1128/AEM.06580-11; Hurwitz BL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r123; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ignacio-Espinoza JC, 2012, ENVIRON MICROBIOL, V14, P2113, DOI 10.1111/j.1462-2920.2012.02704.x; John SG, 2011, ENV MICROBIOL REP, V3, P195, DOI 10.1111/j.1758-2229.2010.00208.x; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kuznetsov YG, 2012, MICRON, V43, P1336, DOI 10.1016/j.micron.2012.02.013; Labonte JM, 2013, ISME J, V7, P2169, DOI 10.1038/ismej.2013.110; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Lawrence JG, 2002, J BACTERIOL, V184, P4891, DOI 10.1128/JB.184.17.4891-4905.2002; Lu J, 2001, APPL ENVIRON MICROB, V67, P3285, DOI 10.1128/AEM.67.7.3285-3290.2001; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marston MF, 2009, ENVIRON MICROBIOL, V11, P2893, DOI 10.1111/j.1462-2920.2009.02037.x; Marston MF, 2003, APPL ENVIRON MICROB, V69, P4639, DOI 10.1128/AEM.69.8.4639-4647.2003; Millard AD, 2009, ENVIRON MICROBIOL, V11, P2370, DOI 10.1111/j.1462-2920.2009.01966.x; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Sharon I, 2011, ISME J, V5, P1178, DOI 10.1038/ismej.2011.2; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Solonenko SA, 2013, METHOD ENZYMOL, V531, P143, DOI 10.1016/B978-0-12-407863-5.00008-3; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; SUTTLE CA, 1993, MAR ECOL PROG SER, V92, P99, DOI 10.3354/meps092099; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Wang K, 2008, ENVIRON MICROBIOL, V10, P300, DOI 10.1111/j.1462-2920.2007.01452.x; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; Waterbury JB, 1986, CAN B FISH AQUAT SCI, V214, P71; Weitz JS, 2013, TRENDS MICROBIOL, V21, P82, DOI 10.1016/j.tim.2012.11.003; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; WILSON WH, 1993, APPL ENVIRON MICROB, V59, P3736, DOI 10.1128/AEM.59.11.3736-3743.1993; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	58	125	125	2	108	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					242	+		10.1038/nature13459	http://dx.doi.org/10.1038/nature13459			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043051				2022-12-28	WOS:000341362800052
J	Kupitz, C; Basu, S; Grotjohann, I; Fromme, R; Zatsepin, NA; Rendek, KN; Hunter, MS; Shoeman, RL; White, TA; Wang, DJ; James, D; Yang, JH; Cobb, DE; Reeder, B; Sierra, RG; Liu, HG; Barty, A; Aquila, AL; Deponte, D; Kirian, RA; Bari, S; Bergkamp, JJ; Beyerlein, KR; Bogan, MJ; Caleman, C; Chao, TC; Conrad, CE; Davis, KM; Fleckenstein, H; Galli, L; Hau-Riege, SP; Kassemeyer, S; Laksmono, H; Liang, MN; Lomb, L; Marchesini, S; Martin, AV; Messerschmidt, M; Milathianaki, D; Nass, K; Ros, A; Roy-Chowdhury, S; Schmidt, K; Seibert, M; Steinbrener, J; Stellato, F; Yan, LF; Yoon, C; Moore, TA; Moore, AL; Pushkar, Y; Williams, GJ; Boutet, S; Doak, RB; Weierstall, U; Frank, M; Chapman, HN; Spence, JCH; Fromme, P				Kupitz, Christopher; Basu, Shibom; Grotjohann, Ingo; Fromme, Raimund; Zatsepin, Nadia A.; Rendek, Kimberly N.; Hunter, Mark S.; Shoeman, Robert L.; White, Thomas A.; Wang, Dingjie; James, Daniel; Yang, Jay-How; Cobb, Danielle E.; Reeder, Brenda; Sierra, Raymond G.; Liu, Haiguang; Barty, Anton; Aquila, Andrew L.; Deponte, Daniel; Kirian, Richard A.; Bari, Sadia; Bergkamp, Jesse J.; Beyerlein, Kenneth R.; Bogan, Michael J.; Caleman, Carl; Chao, Tzu-Chiao; Conrad, Chelsie E.; Davis, Katherine M.; Fleckenstein, Holger; Galli, Lorenzo; Hau-Riege, Stefan P.; Kassemeyer, Stephan; Laksmono, Hartawan; Liang, Mengning; Lomb, Lukas; Marchesini, Stefano; Martin, Andrew V.; Messerschmidt, Marc; Milathianaki, Despina; Nass, Karol; Ros, Alexandra; Roy-Chowdhury, Shatabdi; Schmidt, Kevin; Seibert, Marvin; Steinbrener, Jan; Stellato, Francesco; Yan, Lifen; Yoon, Chunhong; Moore, Thomas A.; Moore, Ana L.; Pushkar, Yulia; Williams, Garth J.; Boutet, Sebastien; Doak, R. Bruce; Weierstall, Uwe; Frank, Matthias; Chapman, Henry N.; Spence, John C. H.; Fromme, Petra			Serial time-resolved crystallography of photosystem II using a femtosecond X-ray laser	NATURE			English	Article							OXYGEN-EVOLVING COMPLEX; FREE-ELECTRON LASER; WATER OXIDATION; PROTEIN NANOCRYSTALLOGRAPHY; MN4CA CLUSTER; STRUCTURAL MODELS; CRYSTAL-STRUCTURE; D1 POLYPEPTIDE; S-3 STATES; OMIT MAPS	Photosynthesis, a process catalysed by plants, algae and cyanobacteria converts sunlight to energy thus sustaining all higher life on Earth. Two large membrane protein complexes, photosystem I and II (PSI and PSII), act in series to catalyse the light-driven reactions in photosynthesis. PSII catalyses the light-driven water splitting process, which maintains the Earth's oxygenic atmosphere(1). In this process, the oxygen-evolving complex (OEC) of PSII cycles through five states, S-0 to S-4, in which four electrons are sequentially extracted from the OEC in four light-driven charge-separation events. Here we describe time resolved experiments on PSII nano/microcrystals from Thermosynechococcus elongatus performed with the recently developed(2) technique of serial femtosecond crystallography. Structures have been determined from PSII in the dark S-1 state and after double laser excitation (putative S-3 state) at 5 and 5.5 angstrom resolution, respectively. The results provide evidence that PSII undergoes significant conformational changes at the electron acceptor side and at the Mn4CaO5 core of the OEC. These include an elongation of the metal cluster, accompanied by changes in the protein environment, which could allow for binding of the second substrate water molecule between the more distant protruding Mn (referred to as the 'dangler' Mn) and the Mn3CaOx cubane in the S-2 to S-3 transition, as predicted by spectroscopic and computational studies(3,4). This work shows the great potential for time-resolved serial femtosecond crystallography for investigation of catalytic processes in biomolecules.	[Kupitz, Christopher; Basu, Shibom; Grotjohann, Ingo; Fromme, Raimund; Rendek, Kimberly N.; Hunter, Mark S.; Yang, Jay-How; Cobb, Danielle E.; Reeder, Brenda; Bergkamp, Jesse J.; Chao, Tzu-Chiao; Conrad, Chelsie E.; Ros, Alexandra; Roy-Chowdhury, Shatabdi; Moore, Thomas A.; Moore, Ana L.; Fromme, Petra] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Zatsepin, Nadia A.; Wang, Dingjie; James, Daniel; Liu, Haiguang; Kirian, Richard A.; Schmidt, Kevin; Doak, R. Bruce; Weierstall, Uwe; Spence, John C. H.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Hunter, Mark S.; Hau-Riege, Stefan P.; Frank, Matthias] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Shoeman, Robert L.; Kassemeyer, Stephan; Lomb, Lukas; Nass, Karol; Steinbrener, Jan] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [White, Thomas A.; Barty, Anton; Aquila, Andrew L.; Deponte, Daniel; Kirian, Richard A.; Beyerlein, Kenneth R.; Caleman, Carl; Fleckenstein, Holger; Galli, Lorenzo; Liang, Mengning; Martin, Andrew V.; Nass, Karol; Stellato, Francesco; Yoon, Chunhong; Chapman, Henry N.] Ctr Free Elect Laser Sci, DESY, D-22607 Hamburg, Germany; [Sierra, Raymond G.; Bogan, Michael J.; Laksmono, Hartawan] SLAC Natl Accelerator Lab, Stanford PULSE Inst, Menlo Pk, CA 94025 USA; [Aquila, Andrew L.; Yoon, Chunhong] European XFEL GmbH, D-22607 Hamburg, Germany; [Deponte, Daniel; Messerschmidt, Marc; Milathianaki, Despina; Seibert, Marvin; Williams, Garth J.; Boutet, Sebastien] Natl Accelerator Lab, Stanford Linear Accelerator Ctr SLAC, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Bari, Sadia; Kassemeyer, Stephan] Ctr Free Elect Laser Sci CFEL, Max Planck Adv Study Grp, D-22607 Hamburg, Germany; [Bari, Sadia] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Caleman, Carl] Uppsala Univ, Dept Phys & Astron, SE-75237 Uppsala, Sweden; [Chao, Tzu-Chiao] Univ Regina, Regina, SK S4S 0A2, Canada; [Davis, Katherine M.; Yan, Lifen; Pushkar, Yulia] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Galli, Lorenzo; Nass, Karol; Chapman, Henry N.] Univ Hamburg, D-22761 Hamburg, Germany; [Marchesini, Stefano] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Martin, Andrew V.] Univ Melbourne, Dept Phys, Ctr Excellence Coherent Xray Sci, Dept ARC, Melbourne, Vic 3010, Australia; [Seibert, Marvin] Uppsala Univ, S-75312 Uppsala, Sweden; [Chapman, Henry N.] Ctr Ultrafast Imaging, D-22761 Hamburg, Germany	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Max Planck Society; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; European XFEL; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Max Planck Society; Max Planck Society; Uppsala University; University of Regina; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Hamburg; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Melbourne; Uppsala University	Fromme, P (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.	pfromme@asu.edu	Yan, Lifen/P-3920-2018; Milathianaki, Despina/AAG-5381-2021; Zatsepin, Nadia/AAF-2451-2019; Beyerlein, Kenneth/ABB-9823-2020; Bari, Sadia/E-6216-2015; Chao, Tzu-Chiao/A-6400-2013; Frank, Matthias/O-9055-2014; Basu, Shibom/GLU-3308-2022; Fromme, Raimund/W-5838-2019; Marchesini, Stefano/A-6795-2009; Nass, Karol/K-1970-2012; Fromme, Raimund/AAG-6578-2019; Fromme, Raimund/C-8885-2012; Stellato, Francesco/AAZ-4379-2020; Messerschmidt, Marc/Y-8929-2019; Messerschmidt, Marc/F-3796-2010; FRS, Henry N Chapman/G-2153-2010; Barty, Anton/K-5137-2014; Marchesini, Stefano/GYR-1409-2022	Beyerlein, Kenneth/0000-0002-7701-4369; Bari, Sadia/0000-0003-3985-2051; Basu, Shibom/0000-0001-6484-8236; Fromme, Raimund/0000-0003-4835-1080; Marchesini, Stefano/0000-0002-6798-2913; Nass, Karol/0000-0001-8843-1566; Fromme, Raimund/0000-0003-4835-1080; Messerschmidt, Marc/0000-0002-8641-3302; Messerschmidt, Marc/0000-0002-8641-3302; FRS, Henry N Chapman/0000-0002-4655-1743; Barty, Anton/0000-0003-4751-2727; Seibert, Mark Marvin/0000-0003-0251-0744; Bergkamp, Jesse/0000-0003-3443-0255; Fromme, Petra/0000-0003-0953-4909; Davis, Katherine/0000-0002-0258-8907; White, Thomas/0000-0002-8407-0270; Frank, Matthias/0000-0002-5244-0791; liu, haiguang/0000-0001-7324-6632; Zatsepin, Nadia/0000-0003-1757-0205; MARTIN, ANDREW/0000-0003-3704-1829; Schmidt, Kevin/0000-0002-1597-9835; Aquila, Andrew/0000-0003-0358-2774	Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center - DOE, Office of Basic Energy Sciences [DE-SC0001016]; National Institutes of Health [1R01GM095583]; US National Science Foundation [MCB-1021557, MCB-1120997]; DFG Clusters of Excellence 'Inflammation at Interfaces' [EXC 306]; DFG Clusters of Excellence 'Center for Ultrafast Imaging'; Max Planck Society, the Atomic, Molecular and Optical Sciences Program; Deutsche Forschungsgemeinschaft (DFG); Chemical Sciences Geosciences and Biosciences Division, DOE OBES; SLAC LDRD program; US DOE through Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; UCOP Lab Fee Program [118036]; LLNL LDRD program [12-ERD-031]; Hamburg Ministry of Science and Research; Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research; U.S. Department of Energy (DOE), Office of Basic Energy Sciences [DE-FG02-12ER16340]; National Science Foundation Graduate Research Fellowship [0833366]; National Science Foundation through the BioFEL Science Technology Center [1231306]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095583] Funding Source: NIH RePORTER	Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center - DOE, Office of Basic Energy Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); DFG Clusters of Excellence 'Inflammation at Interfaces'; DFG Clusters of Excellence 'Center for Ultrafast Imaging'; Max Planck Society, the Atomic, Molecular and Optical Sciences Program; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Chemical Sciences Geosciences and Biosciences Division, DOE OBES; SLAC LDRD program; US DOE through Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); UCOP Lab Fee Program; LLNL LDRD program; Hamburg Ministry of Science and Research; Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research; U.S. Department of Energy (DOE), Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation through the BioFEL Science Technology Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Experiments were carried out at the Linac Coherent Light Source (LCLS), a national user facility operated by Stanford University on behalf of the US Department of Energy (DOE), Office of Basic Energy Sciences (OBES). This work was supported by the following agencies: the Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center funded by the DOE, Office of Basic Energy Sciences (award DE-SC0001016), the National Institutes of Health (award 1R01GM095583), the US National Science Foundation (award MCB-1021557 and MCB-1120997), the DFG Clusters of Excellence 'Inflammation at Interfaces' (EXC 306) and the 'Center for Ultrafast Imaging'; the Deutsche Forschungsgemeinschaft (DFG); the Max Planck Society, the Atomic, Molecular and Optical Sciences Program; Chemical Sciences Geosciences and Biosciences Division, DOE OBES (M.J.B.) and the SLAC LDRD program (M.J.B., H.L.); the US DOE through Lawrence Livermore National Laboratory under the contract DE-AC52-07NA27344 and supported by the UCOP Lab Fee Program (award no. 118036) and the LLNL LDRD program (12-ERD-031); the Hamburg Ministry of Science and Research and Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research. The research at Purdue University was supported by the U.S. Department of Energy (DOE), Office of Basic Energy Sciences DE-FG02-12ER16340 (Y.P.) and the National Science Foundation Graduate Research Fellowship under Grant 0833366 (K.M.D.). We also want to thank the National Science Foundation for providing funding for the publication of this work through the BioFEL Science Technology Center (award 1231306). We thank H. Isobe, M. Shoji, S. Yamanaka, Y. Umena, K. Kawakami, N. Kamiya, J. R. Shen and K. Yamaguchi for permission to show a section of Fig. 6 of their publication ref. 4 in Fig. 3d of this publication. We thank R. Neutze and his team for support and discussions during joint beamtime for the PSII project and his projects on time-resolved wide-angle scattering studies. We thank A. T. Brunger for discussions concerning data analysis. We thank T. Terwilliger for support with parameter setting of phenix.autobuild program for the SA-omit maps. We also wish to thank R. Burnap for discussions concerning interpretation of results of ligand mutagenesis. We thank J. D. Zook for his contributions concerning plastoquinone quantification. We thank M. Zhu for helping to create high resolution figures for this publication. We thank Raytheon for support of our studies by providing night-vision devices.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ames W, 2011, J AM CHEM SOC, V133, P19743, DOI 10.1021/ja2041805; Aquila A, 2012, OPT EXPRESS, V20, P2706, DOI 10.1364/OE.20.002706; Barty A, 2014, J APPL CRYSTALLOGR, V47, P1118, DOI 10.1107/S1600576714007626; Barty A, 2012, NAT PHOTONICS, V6, P35, DOI [10.1038/nphoton.2011.297, 10.1038/NPHOTON.2011.297]; BHAT TN, 1988, J APPL CRYSTALLOGR, V21, P279, DOI 10.1107/S0021889887012755; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Boutet S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035024; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; CHU HA, 1995, BIOCHEMISTRY-US, V34, P5839, DOI 10.1021/bi00017a016; Cox N, 2013, ACCOUNTS CHEM RES, V46, P1588, DOI 10.1021/ar3003249; Dau H, 2012, CURR OPIN CHEM BIOL, V16, P3, DOI 10.1016/j.cbpa.2012.02.011; Davis KM, 2013, J PHYS CHEM B, V117, P9161, DOI 10.1021/jp403654n; de Wijn R, 2001, BIOCHEMISTRY-US, V40, P11912, DOI 10.1021/bi010852r; Debus RJ, 2005, BIOCHEMISTRY-US, V44, P1367, DOI 10.1021/bi047558u; DEKKER JP, 1984, BIOCHIM BIOPHYS ACTA, V767, P176, DOI 10.1016/0005-2728(84)90093-8; DePonte DP, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/195505; Dilbeck PL, 2012, BIOCHEMISTRY-US, V51, P1079, DOI 10.1021/bi201659f; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grundmeier A, 2012, BBA-BIOENERGETICS, V1817, P88, DOI 10.1016/j.bbabio.2011.07.004; Han GY, 2008, BBA-BIOENERGETICS, V1777, P496, DOI 10.1016/j.bbabio.2008.03.007; Han GY, 2012, J BIOL CHEM, V287, P13422, DOI 10.1074/jbc.M112.342543; Herrmann S, 2013, NUCL INSTRUM METH A, V718, P550, DOI 10.1016/j.nima.2013.01.057; HODEL A, 1992, ACTA CRYSTALLOGR A, V48, P851, DOI 10.1107/S0108767392006044; Hundelt M, 1998, BIOCHEMISTRY-US, V37, P14450, DOI 10.1021/bi981164j; Isobe H, 2012, DALTON T, V41, P13727, DOI 10.1039/c2dt31420g; Kanady JS, 2011, SCIENCE, V333, P733, DOI 10.1126/science.1206036; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Kirian RA, 2010, OPT EXPRESS, V18, P5713, DOI 10.1364/OE.18.005713; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Lomb L, 2012, J APPL CRYSTALLOGR, V45, P674, DOI 10.1107/S0021889812024557; Luber S, 2011, BIOCHEMISTRY-US, V50, P6308, DOI 10.1021/bi200681q; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Navarro MP, 2013, P NATL ACAD SCI USA, V110, P15561, DOI 10.1073/pnas.1304334110; Neutze R, 2012, CURR OPIN STRUC BIOL, V22, P651, DOI 10.1016/j.sbi.2012.08.006; Philipp HT, 2011, NUCL INSTRUM METH A, V649, P67, DOI 10.1016/j.nima.2010.11.189; Pushkar YL, 2008, P NATL ACAD SCI USA, V105, P1879, DOI 10.1073/pnas.0707092105; Read RJ, 2003, ACTA CRYSTALLOGR D, V59, P1891, DOI 10.1107/S0907444903017918; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Renger G, 2012, BBA-BIOENERGETICS, V1817, P1164, DOI 10.1016/j.bbabio.2012.02.005; Rivalta I, 2012, CURR OPIN CHEM BIOL, V16, P11, DOI 10.1016/j.cbpa.2012.03.003; Sauter NK, 2013, ACTA CRYSTALLOGR D, V69, P1274, DOI 10.1107/S0907444913000863; Siegbahn PEM, 2013, BBA-BIOENERGETICS, V1827, P1003, DOI 10.1016/j.bbabio.2012.10.006; Siegbahn PEM, 2013, J AM CHEM SOC, V135, P9442, DOI 10.1021/ja401517e; Spence JCH, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/102601; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vellieux FMD, 1997, J APPL CRYSTALLOGR, V30, P396, DOI 10.1107/S0021889896012551; Wampler RD, 2008, J AM CHEM SOC, V130, P14076, DOI 10.1021/ja805983b; Weierstall U, 2008, EXP FLUIDS, V44, P675, DOI 10.1007/s00348-007-0426-8; Weierstall U, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3693040; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; Yamaguchi K, 2013, INT J QUANTUM CHEM, V113, P453, DOI 10.1002/qua.24280; Yano J, 2008, INORG CHEM, V47, P1711, DOI 10.1021/ic7016837; Yano J, 2007, PHOTOSYNTH RES, V92, P289, DOI 10.1007/s11120-007-9153-5; Zouni A, 2000, BBA-BIOENERGETICS, V1457, P103, DOI 10.1016/S0005-2728(00)00100-6; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	59	335	361	5	414	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					261	+		10.1038/nature13453	http://dx.doi.org/10.1038/nature13453			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043005	Green Accepted			2022-12-28	WOS:000341362800056
J	Saha, SK; Parachoniak, CA; Ghanta, KS; Fitamant, J; Ross, KN; Najem, MS; Gurumurthy, S; Akbay, EA; Sia, D; Cornella, H; Miltiadous, O; Walesky, C; Deshpande, V; Zhu, AX; Hezel, AF; Yen, KE; Straley, KS; Travins, J; Popovici-Muller, J; Gliser, C; Ferrone, CR; Apte, U; Llovet, JM; Wong, KK; Ramaswamy, S; Bardeesy, N				Saha, Supriya K.; Parachoniak, Christine A.; Ghanta, Krishna S.; Fitamant, Julien; Ross, Kenneth N.; Najem, Mortada S.; Gurumurthy, Sushma; Akbay, Esra A.; Sia, Daniela; Cornella, Helena; Miltiadous, Oriana; Walesky, Chad; Deshpande, Vikram; Zhu, Andrew X.; Hezel, Aram F.; Yen, Katharine E.; Straley, Kimberly S.; Travins, Jeremy; Popovici-Muller, Janeta; Gliser, Camelia; Ferrone, Cristina R.; Apte, Udayan; Llovet, Josep M.; Wong, Kwok-Kin; Ramaswamy, Sridhar; Bardeesy, Nabeel			Mutant IDH inhibits HNF-4 alpha to block hepatocyte differentiation and promote biliary cancer	NATURE			English	Article							INTRAHEPATIC CHOLANGIOCARCINOMA; LIVER-REGENERATION; MUTATION; GROWTH; MICE; PROLIFERATION; PROGENITORS; HOMEOSTASIS; EXPRESSION	Mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 are among the most common genetic alterations in intrahepatic cholangiocarcinoma (IHCC), a deadly liver cancer(1-5). Mutant IDH proteins in IHCC and other malignancies acquire an abnormal enzymatic activity allowing themto convert alpha-ketoglutarate (alpha KG) to 2-hydroxyglutarate (2HG), which inhibits the activity of multiple alpha KG-dependent dioxygenases, and results in alterations in cell differentiation, survival, and extracellular matrix maturation(6-10). However, the molecular pathways by which IDH mutations lead to tumour formation remain unclear. Here we show that mutant IDH blocks liver progenitor cells from undergoing hepatocyte differentiation through the production of 2HG and suppression of HNF-4 alpha, a master regulator of hepatocyte identity and quiescence. Correspondingly, genetically engineered mouse models expressing mutant IDH in the adult liver show an aberrant response to hepatic injury, characterized by HNF-4 alpha silencing, impaired hepatocyte differentiation, and markedly elevated levels of cell proliferation. Moreover, IDH and Kras mutations, genetic alterations that co-exist in a subset of human IHCCs4,5, cooperate to drive the expansion of liver progenitor cells, development of premalignant biliary lesions, and progression to metastatic IHCC. These studies provide a functional link between IDH mutations, hepatic cell fate, and IHCC pathogenesis, and present a novel genetically engineered mouse model of IDH-driven malignancy.	[Saha, Supriya K.; Parachoniak, Christine A.; Ghanta, Krishna S.; Fitamant, Julien; Ross, Kenneth N.; Najem, Mortada S.; Gurumurthy, Sushma; Deshpande, Vikram; Zhu, Andrew X.; Ferrone, Cristina R.; Ramaswamy, Sridhar; Bardeesy, Nabeel] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA; [Akbay, Esra A.; Wong, Kwok-Kin] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Dept Med, Boston, MA 02115 USA; [Sia, Daniela; Cornella, Helena; Llovet, Josep M.] Univ Barcelona, Hosp Clin, Barcelona Clin Liver Canc Grp, HCC Translat Res Lab,IDIBAPS,Liver Unit, Catalonia 08036, Spain; [Sia, Daniela; Miltiadous, Oriana; Llovet, Josep M.] Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, Mt Sinai Liver Canc Program, New York, NY 10029 USA; [Sia, Daniela] Natl Canc Inst, Gastrointestinal Surg & Liver Transplantat Unit, I-20133 Milan, Italy; [Sia, Daniela] Dept Expt Oncol, I-20133 Milan, Italy; [Walesky, Chad; Apte, Udayan] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Hezel, Aram F.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Yen, Katharine E.; Straley, Kimberly S.; Travins, Jeremy; Popovici-Muller, Janeta; Gliser, Camelia] Agios Pharmaceut, Cambridge, MA 02139 USA; [Llovet, Josep M.] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Catalonia, Spain; [Llovet, Josep M.] Univ Barcelona, Catalonia 08036, Spain; [Ramaswamy, Sridhar] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Icahn School of Medicine at Mount Sinai; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Kansas; University of Kansas Medical Center; University of Rochester; Agios Pharmaceuticals; ICREA; University of Barcelona; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bardeesy, N (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA.	Bardeesy.Nabeel@mgh.harvard.edu	Saha, Supriya/AAC-5365-2019; Ghanta, Krishna S./M-1307-2019; Llovet, Josep M/D-4340-2014; Llovet, Josep M/ABB-6264-2021	Ghanta, Krishna S./0000-0001-7502-3141; Llovet, Josep M/0000-0003-0547-2667; Llovet, Josep M/0000-0003-0547-2667; wong, kwok kin/0000-0001-6323-235X; Sia, Daniela/0000-0002-9000-611X; Miltiadous, Oriana/0000-0002-1571-3893; Akbay, Esra/0000-0002-4149-2529	TargetCancer Foundation; National Institutes of Health [R01CA136567-02, P50CA1270003]; Cholangiocarcinoma Foundation/Conquer Cancer Foundation of ASCO Young Investigator Award; American Cancer Society Postdoctoral Fellowship [PF-13-294-01-TBG]; Canadian Institutes of Health Research postdoctoral fellowship; Asociacion Espanola para el Estudio del Cancer; NATIONAL CANCER INSTITUTE [R01CA136567, P50CA127003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007792, R01DK098414] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	TargetCancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cholangiocarcinoma Foundation/Conquer Cancer Foundation of ASCO Young Investigator Award; American Cancer Society Postdoctoral Fellowship(American Cancer Society); Canadian Institutes of Health Research postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); Asociacion Espanola para el Estudio del Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ICREA(ICREA)	We thank R. Mostoslavsky, L. Ellisen, A. Kimmelman, and members of the Bardeesy laboratory for valuable input. We also thank S. Thorgeirsson and J. Andersen for sharing unpublished data sets. This work was supported by grants from TargetCancer Foundation and the National Institutes of Health (R01CA136567-02 and P50CA1270003) to N.B. N.B. holds the Gallagher Endowed Chair in Gastrointestinal Cancer Research at Massachusetts General Hospital. S. K. S. is the recipient of a Cholangiocarcinoma Foundation/Conquer Cancer Foundation of ASCO Young Investigator Award, and an American Cancer Society Postdoctoral Fellowship (PF-13-294-01-TBG). C. A. P. is the recipient of a Canadian Institutes of Health Research postdoctoral fellowship. N.B., J. M. L. and D. S are members of the Samuel Waxman Cancer Research Foundation Institute Without Walls. J. M. L. and D. S. are supported by the Asociacion Espanola para el Estudio del Cancer.	Avruch J, 2011, BRIT J CANCER, V104, P24, DOI 10.1038/sj.bjc.6606011; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Bluteau O, 2002, NAT GENET, V32, P312, DOI 10.1038/ng1001; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davis MI, 2014, J BIOL CHEM, V289, P13717, DOI 10.1074/jbc.M113.511030; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Hezel AF, 2010, J CLIN ONCOL, V28, P3531, DOI 10.1200/JCO.2009.27.4787; Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Michalopoulos GK, 2013, COMPR PHYSIOL, V3, P485, DOI 10.1002/cphy.c120014; O'Dell MR, 2012, CANCER RES, V72, P1557, DOI 10.1158/0008-5472.CAN-11-3596; Oishi N, 2012, HEPATOLOGY, V56, P1792, DOI 10.1002/hep.25890; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Preisegger KH, 1999, LAB INVEST, V79, P103; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Sia D, 2013, GASTROENTEROLOGY, V144, P829, DOI 10.1053/j.gastro.2013.01.001; Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123; Tefferi A, 2010, LEUKEMIA, V24, P1302, DOI 10.1038/leu.2010.113; Torres-Padilla ME, 2001, MECH DEVELOP, V109, P183, DOI 10.1016/S0925-4773(01)00521-4; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; Voss JS, 2013, HUM PATHOL, V44, P1216, DOI 10.1016/j.humpath.2012.11.006; Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251; Wang P, 2013, ONCOGENE, V32, P3091, DOI 10.1038/onc.2012.315; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112	38	293	305	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					110	+		10.1038/nature13441	http://dx.doi.org/10.1038/nature13441			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25043045	Green Accepted			2022-12-28	WOS:000341174800040
J	Ishimura, R; Nagy, G; Dotu, I; Zhou, HH; Yang, XL; Schimmel, P; Senju, S; Nishimura, Y; Chuang, JH; Ackerman, SL				Ishimura, Ryuta; Nagy, Gabor; Dotu, Ivan; Zhou, Huihao; Yang, Xiang-Lei; Schimmel, Paul; Senju, Satoru; Nishimura, Yasuharu; Chuang, Jeffrey H.; Ackerman, Susan L.			Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration	SCIENCE			English	Article							MESSENGER-RNA; IN-VIVO; TRANSLATION; MOUSE; DISSOCIATION; REVEALS; FAMILY; GTPBP2	In higher eukaryotes, transfer RNAs (tRNAs) with the same anticodon are encoded by multiple nuclear genes, and little is known about how mutations in these genes affect translation and cellular homeostasis. Similarly, the surveillance systems that respond to such defects in higher eukaryotes are not clear. Here, we discover that loss of GTPBP2, a novel binding partner of the ribosome recycling protein Pelota, in mice with a mutation in a tRNA gene that is specifically expressed in the central nervous system causes ribosome stalling and widespread neurodegeneration. Our results not only define GTPBP2 as a ribosome rescue factor but also unmask the disease potential of mutations in nuclear-encoded tRNA genes.	[Ishimura, Ryuta; Nagy, Gabor; Ackerman, Susan L.] Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; [Ishimura, Ryuta; Nagy, Gabor; Ackerman, Susan L.] Jackson Lab, Bar Harbor, ME 04609 USA; [Dotu, Ivan; Chuang, Jeffrey H.] Jackson Lab Genom Med, Farmington, CT 06030 USA; [Zhou, Huihao; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Senju, Satoru; Nishimura, Yasuharu] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Chuo Ku, Kumamoto 8608556, Japan	Howard Hughes Medical Institute; Jackson Laboratory; Jackson Laboratory; Scripps Research Institute; Kumamoto University	Ackerman, SL (corresponding author), Howard Hughes Med Inst, 600 Main St, Bar Harbor, ME 04609 USA.	susan.ackerman@jax.org	Yang, Xiang-Lei/AAR-7107-2020; ZHOU, HUIHAO/L-6133-2016	ZHOU, HUIHAO/0000-0002-9675-5007; Yang, Xiang-Lei/0000-0003-2554-084X; Chuang, Jeffrey/0000-0002-3298-2358; Nagy, Gabor/0000-0001-7452-5174; Dotu, Ivan/0000-0002-0438-9557	CORE grant [CA34196]; National Science Foundation [0850155]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS096600, R01NS085092] Funding Source: NIH RePORTER	CORE grant; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Data were deposited in GenBank (GSE56127). We thank The Jackson Laboratory sequencing, histology, microinjection, and multimedia services for their assistance. We also thank K. Brown for mouse husbandry assistance and W. Frankel for comments on the manuscript. This work was supported in part by an institutional CORE grant CA34196 (JAX) and a National Science Foundation Award 0850155 to J.H.C. as part of the American Recovery and Reinvestment Act. S. L. A. is an investigator of the Howard Hughes Medical Institute.	Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Goldowitz D, 2004, MOL BRAIN RES, V132, P105, DOI 10.1016/j.molbrainres.2004.09.016; Goodenbour JM, 2006, NUCLEIC ACIDS RES, V34, P6137, DOI 10.1093/nar/gkl725; Guydosh NR, 2014, CELL, V156, P950, DOI 10.1016/j.cell.2014.02.006; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kudo H, 2000, BIOCHEM BIOPH RES CO, V272, P456, DOI 10.1006/bbrc.2000.2763; LEVINGER L, 1995, J BIOL CHEM, V270, P18903, DOI 10.1074/jbc.270.32.18903; Levinger L, 2012, RNA BIOL, V9, P283, DOI 10.4161/rna.19025; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Rooijers K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3886; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Watanabe M, 2000, GENE, V256, P51, DOI 10.1016/S0378-1119(00)00346-2; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142	17	249	252	4	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					455	459		10.1126/science.1249749	http://dx.doi.org/10.1126/science.1249749			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061210	Green Accepted			2022-12-28	WOS:000339655100044
J	Gunthard, HF; Aberg, JA; Eron, JJ; Hoy, JF; Telenti, A; Benson, CA; Burger, DM; Cahn, P; Gallant, JE; Glesby, MJ; Reiss, P; Saag, MS; Thomas, DL; Jacobsen, DM; Volberding, PA				Guenthard, Huldrych F.; Aberg, Judith A.; Eron, Joseph J.; Hoy, Jennifer F.; Telenti, Amalio; Benson, Constance A.; Burger, David M.; Cahn, Pedro; Gallant, Joel E.; Glesby, Marshall J.; Reiss, Peter; Saag, Michael S.; Thomas, David L.; Jacobsen, Donna M.; Volberding, Paul A.			Antiretroviral Treatment of Adult HIV Infection 2014 Recommendations of the International Antiviral Society-USA Panel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BOOSTED PROTEASE INHIBITOR; REVERSE-TRANSCRIPTASE INHIBITORS; TREATMENT-EXPERIENCED PATIENTS; TWICE-DAILY RALTEGRAVIR; LOW-LEVEL VIREMIA; ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE; CO-FORMULATED ELVITEGRAVIR; GLOMERULAR-FILTRATION-RATE; ONCE-DAILY DOLUTEGRAVIR; DOUBLE-BLIND	IMPORTANCE New data and antiretroviral regimens expand treatment choices in resource-rich settings and warrant an update of recommendations to treat adults infected with human immunodeficiency virus (HIV). OBJECTIVE To provide updated treatment recommendations for adults with HIV, emphasizing when to start treatment; what treatment to start; the use of laboratory monitoring tools; and managing treatment failure, switches, and simplification. DATA SOURCES, STUDY SELECTION, AND DATA SYNTHESIS An International Antiviral Society-USA panel of experts in HIV research and patient care considered previous data and reviewed new data since the 2012 update with literature searches in PubMed and EMBASE through June 2014. Recommendations and ratings were based on the quality of evidence and consensus. RESULTS Antiretroviral therapy is recommended for all adults with HIV infection. Evidence for benefits of treatment and quality of available data increase at lower CD4 cell counts. Recommended initial regimens include 2 nucleoside reverse transcriptase inhibitors (NRTIs; abacavir/lamivudine or tenofovir disoproxil furnarate/emtricitabine) and a third single or boosted drug, which should be an integrase strand transfer inhibitor (dolutegravir, elvitegravir, or raltegravir), a nonnucleoside reverse transcriptase inhibitor (efavirenz or rilpivirine) or a boosted protease inhibitor (darurlavir or atazanavir). Alternative regimens are available. Boosted protease inhibitor monotherapy is generally not recommended, but NRTI-sparing approaches may be considered. New guidance for optimal timing of monitoring of laboratory parameters is provided. Suspected treatment failure warrants rapid confirmation, performance of resistance testing while the patient is receiving the failing regimen, and evaluation of reasons for failure before consideration of switching therapy. Regimen switches for adverse effects, convenience, or to reduce costs should not jeopardize antiretroviral potency. CONCLUSIONS AND RELEVANCE After confirmed diagnosis of HIV infection, antiretroviral therapy should be initiated in all individuals who are willing and ready to start treatment. Regimens should be selected or changed based on resistance test results with consideration of dosing frequency, pill burden, adverse toxic effect profiles, comorbidities, and drug interactions.	[Guenthard, Huldrych F.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Aberg, Judith A.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Eron, Joseph J.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Hoy, Jennifer F.] Alfred Hosp, Melbourne, Vic, Australia; [Hoy, Jennifer F.] Monash Univ, Melbourne, Vic 3004, Australia; [Telenti, Amalio] Univ Lausanne Hosp, Lausanne, Switzerland; [Benson, Constance A.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Burger, David M.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Cahn, Pedro] Univ Buenos Aires, Hosp Juan Fernandez, Sch Med, Buenos Aires, DF, Argentina; [Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [Gallant, Joel E.] Southwest CARE Ctr, Santa Fe, NM USA; [Glesby, Marshall J.] Weill Cornell Med Coll, New York, NY USA; [Reiss, Peter] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Saag, Michael S.] Univ Alabama Birmingham, Birmingham, AL USA; [Thomas, David L.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Jacobsen, Donna M.] Int Antiviral Soc USA, San Francisco, CA USA; [Volberding, Paul A.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Zurich; University Zurich Hospital; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Florey Institute of Neuroscience & Mental Health; Monash University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of California System; University of California San Diego; Radboud University Nijmegen; University of Buenos Aires; Cornell University; University of Amsterdam; Academic Medical Center Amsterdam; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; University of California System; University of California San Francisco	Gunthard, HF (corresponding author), Univ Zurich Hosp, Ramistr 100, CH-8091 Zurich, Switzerland.	huldrych.guenthard@usz.ch	Hoy, Jennifer/AAK-7968-2020; Burger, David/C-9929-2013; Telenti, Amalio/AAY-1674-2021; gunthard, huldrych f/F-1724-2011	gunthard, huldrych f/0000-0002-1142-6723; Hoy, Jennifer/0000-0002-6948-7086	International Antiviral Society-USA, a mission-based, nonmembership, 501(c)(3) not-for-profit organization; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	International Antiviral Society-USA, a mission-based, nonmembership, 501(c)(3) not-for-profit organization; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding/Support: This work was supported and funded by the International Antiviral Society-USA, a mission-based, nonmembership, 501(c)(3) not-for-profit organization. No private sector or government funding was used to support the effort. Panel members are not compensated for participation.	AASLD, REC TEST MAN TREAT H; Abdool Karim S, 2011, 18 C RETR OPP INF FE; Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Ajose O, 2012, AIDS, V26, P929, DOI 10.1097/QAD.0b013e328351f5b2; [Anonymous], 2012, STRIB ELV COB EMTR T; Antiretroviral Pregnancy Registry, ANT PREGN REG INT RE; Archin NM, 2012, P NATL ACAD SCI USA, V109, P9523, DOI 10.1073/pnas.1120248109; Arribas JR, 2014, LANCET INFECT DIS, V14, P581, DOI 10.1016/S1473-3099(14)70782-0; Avila D, 2014, JAIDS-J ACQ IMM DEF, V65, pE8, DOI 10.1097/QAI.0b013e3182a39979; Bedimo RJ, 2011, CLIN INFECT DIS, V53, P84, DOI 10.1093/cid/cir269; Benson C, 2014, TOP ANTIVIR MED, V22, P425; Bisson GP, 2013, CLIN INFECT DIS, V56, P1165, DOI 10.1093/cid/cit019; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Boufassa F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085516; Boulanger C, 2009, CLIN INFECT DIS, V49, P1305, DOI 10.1086/606056; Boulle A, 2008, JAMA-J AM MED ASSOC, V300, P530, DOI 10.1001/jama.300.5.530; Boulware DR, 2014, NEW ENGL J MED, V370, P2487, DOI 10.1056/NEJMoa1312884; Boyd MA, 2013, LANCET, V381, P2091, DOI 10.1016/S0140-6736(13)61164-2; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brown T, 2014, TOP ANTIVIR MED, V22, P401; Buscher A, 2013, AIDS PATIENT CARE ST, V27, P459, DOI 10.1089/apc.2013.0105; Cahn P, 2014, LANCET INFECT DIS, V14, P572, DOI 10.1016/S1473-3099(14)70736-4; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Castagna A, 2014, J INFECT DIS, V210, P354, DOI 10.1093/infdis/jiu051; Charania MR, 2014, AIDS BEHAV, V18, P646, DOI 10.1007/s10461-013-0594-x; Charpentier C, 2012, J ANTIMICROB CHEMOTH, V67, P2231, DOI 10.1093/jac/dks191; Chen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082461; Chen RY, 2006, CLIN INFECT DIS, V42, P1003, DOI 10.1086/500453; Cheung C, 2014, TOP ANTIVIR MED, V22, P271; Chun TW, 2013, J INFECT DIS, V208, P1443, DOI 10.1093/infdis/jit306; Clotet B, 2014, LANCET; Clumeck N, 2014, JAIDS-J ACQ IMM DEF, V65, pE121, DOI 10.1097/QAI.0000000000000089; Cohan D, 2014, TOP ANTIVIR MED, V22, P34; Cohen C, 2014, AIDS, V28, P989, DOI 10.1097/QAD.0000000000000169; Cohen CJ, 2013, AIDS, V27, P939, DOI 10.1097/QAD.0b013e32835cee6e; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Colbers A, 2013, CURR OPIN INFECT DIS, V26, P575, DOI 10.1097/QCO.0000000000000017; Curran A, 2012, AIDS, V26, P475, DOI 10.1097/QAD.0b013e32834f3507; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; DeJesus E, 2012, LANCET, V379, P2429, DOI 10.1016/S0140-6736(12)60918-0; Delaugerre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036673; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Ding X, 2012, JAIDS-J ACQ IMM DEF, V61, P441, DOI 10.1097/QAI.0b013e31826f993c; Dooley KE, 2013, JAIDS-J ACQ IMM DEF, V62, P21, DOI 10.1097/QAI.0b013e318276cda9; Drescher SM, 2014, CLIN INFECT DIS, V58, P285, DOI 10.1093/cid/cit694; Elzi L, 2012, ARCH INTERN MED, V172, P1313, DOI 10.1001/archinternmed.2012.3216; Eron JJ, 2013, J INFECT DIS, V207, P740, DOI 10.1093/infdis/jis750; Eron JJ, 2010, LANCET, V375, P396, DOI 10.1016/S0140-6736(09)62041-9; Fayet-Mello A, 2013, ANTIVIR THER, V18, P171, DOI 10.3851/IMP2328; Feinberg J, 2013, 53 INT C ANT AG CHEM; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Friedland G, 2006, J ANTIMICROB CHEMOTH, V58, P1299, DOI 10.1093/jac/dkl399; Gale HB, 2013, CLIN INFECT DIS, V56, P1340, DOI 10.1093/cid/cit004; Gallant JE, 2013, J INFECT DIS, V208, P32, DOI 10.1093/infdis/jit122; German P, 2012, JAIDS-J ACQ IMM DEF, V61, P32, DOI 10.1097/QAI.0b013e3182645648; Ghosn J, 2013, J MED VIROL, V85, P8, DOI 10.1002/jmv.23404; Gonzalez-Serna A, 2014, CLIN INFECT DIS, V58, P1165, DOI 10.1093/cid/ciu019; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P459, DOI 10.1016/S1473-3099(14)70711-X; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Guiguet M, 2012, AIDS, V26, P2345, DOI 10.1097/QAD.0b013e32835646e0; Gutmann C, 2010, AIDS, V24, P2347, DOI 10.1097/QAD.0b013e32833db9a1; Hamada Y, 2012, CLIN INFECT DIS, V55, P1262, DOI 10.1093/cid/cis621; Hardy WD, 2010, JAIDS-J ACQ IMM DEF, V55, P558, DOI 10.1097/QAI.0b013e3181ee3d82; Hatano H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003691; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Hicks CB, 2006, LANCET, V368, P466, DOI 10.1016/S0140-6736(06)69154-X; Hill A, 2013, J INFECT DIS, V207, pS78, DOI 10.1093/infdis/jit112; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Hocqueloux L, 2013, J ANTIMICROB CHEMOTH, V68, P1169, DOI 10.1093/jac/dks533; Hyle EP, 2013, JAMA INTERN MED, V173, P1746, DOI 10.1001/jamainternmed.2013.9329; Jarvis JN, 2014, CLIN INFECT DIS, V58, P736, DOI 10.1093/cid/cit794; Jenny-Avital ER, 2009, CLIN INFECT DIS, V48, P1471, DOI 10.1086/598336; Jereb John A., 2011, Morbidity and Mortality Weekly Report, V60, P1650; Karageorgopoulos DE, 2014, CURR OPIN INFECT DIS, V27, P36, DOI 10.1097/QCO.0000000000000034; Katlama C, 2009, AIDS, V23, P2289, DOI 10.1097/QAD.0b013e3283316a5e; Koenig SP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001095; Kovari H, 2013, CLIN INFECT DIS, V56, P870, DOI 10.1093/cid/cis919; Kulkarni R, 2014, TOP ANTIVIR MED, V22, P288; Lambert-Niclot S, 2011, J INFECT DIS, V204, P1211, DOI 10.1093/infdis/jir518; Landovitz RJ, 2014, TOP ANTIVIR MED, V22, P42; Laprise C, 2013, CLIN INFECT DIS, V57, P1489, DOI 10.1093/cid/cit529; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Li JZ, 2014, AIDS, V28, P181, DOI 10.1097/QAD.0000000000000123; Li JZ, 2012, ANTIMICROB AGENTS CH, V56, P5998, DOI 10.1128/AAC.01217-12; Liverpool HIV and Hepatitis Pharmacology Group, DRUG INT CHART; Luetkemeyer AF, 2013, CLIN INFECT DIS, V57, P586, DOI 10.1093/cid/cit246; Lundgren JD, 2008, AIDS, V22, pF17, DOI 10.1097/QAD.0b013e32830fe35e; Maggiolo F, 2012, JAIDS-J ACQ IMM DEF, V60, P473, DOI 10.1097/QAI.0b013e3182567a57; Martinez E, 2012, AIDS, V26, P2315, DOI 10.1097/QAD.0b013e328359f29c; Masia M, 2013, J ANTIMICROB CHEMOTH, V68, P409, DOI 10.1093/jac/dks412; Mathis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022003; Mauskopf J, 2005, JAIDS-J ACQ IMM DEF, V39, P562; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; Miller V, 2012, CURR OPIN HIV AIDS, V7, P299, DOI 10.1097/COH.0b013e328354d8e7; Mills A, 2014, HIV CLIN TRIALS, V15, P51, DOI 10.1310/hct1502-51; Mills AM, 2013, HIV CLIN TRIALS, V14, P216, DOI 10.1310/hct1405-216; Mocroft A, 2013, CLIN INFECT DIS, V57, P1038, DOI 10.1093/cid/cit423; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Molina JM, 2012, LANCET INFECT DIS, V12, P27, DOI 10.1016/S1473-3099(11)70249-3; Mollan KR, 2014, ANN INTERN MED, V161, P1, DOI 10.7326/M14-0293; Monforte AD, 2013, AIDS, V27, P407, DOI 10.1097/QAD.0b013e32835b2ef1; Morlat P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066223; Naiker S, 2011, 18 C RETR OPP INF FE; Napoli A, 2014, TOP ANTIVIR MED, V22, P419; Njei B., 2013, COCHRANE DB SYST REV, V2; Ofotokun I, 2014, TOP ANTIVIR MED, V22, P381; Overton ET, 2014, TOP ANTIVIR MED, V22, P66; Palella FJ, 2014, AIDS, V28, P335, DOI 10.1097/QAD.0000000000000087; Paton N, 2014, TOP ANTIVIR MED, V22, P266; Paton N, 2013, 7 IAS C HIV PATH TRE; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Podany AT, 2014, TOP ANTIVIR MED, V22, P54; Pozniak A, 2014, LANCET INFECT DIS, V14, P590, DOI 10.1016/S1473-3099(14)70796-0; Pugliese P, 2013, HIV MED, V14, P509, DOI 10.1111/hiv.12041; Puls RL, 2014, LANCET, V383, P1474, DOI 10.1016/S0140-6736(13)62187-X; Raffi F, 2014, TOP ANTIVIR MED, V22, P41; Raffi F, 2013, LANCET INFECT DIS, V13, P927, DOI 10.1016/S1473-3099(13)70257-3; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Rakhmanina N, 2012, PEDIATR CLIN N AM, V59, P1093, DOI 10.1016/j.pcl.2012.07.009; Rakotondravelo S, 2012, CLIN INFECT DIS, V55, P1270, DOI 10.1093/cid/cis620; Reina E, 2012, INT J CLIN PHARM-NET, V34, P911, DOI 10.1007/s11096-012-9692-5; Reynes J, 2013, AIDS RES HUM RETROV, V29, P256, DOI [10.1089/aid.2011.0275, 10.1089/AID.2011.0275]; Rieder P, 2010, AIDS, V24, P1177, DOI 10.1097/QAD.0b013e328338e4de; Rimsky L, 2012, JAIDS-J ACQ IMM DEF, V59, P39, DOI 10.1097/QAI.0b013e31823df4da; Rockstroh J, 2012, J INT AIDS SOC S4, V15, P3; Rockstroh JK, 2013, JAIDS-J ACQ IMM DEF, V63, P77, DOI 10.1097/QAI.0b013e31828ace69; Rodger A BT, 2014, TOP ANTIVIR MED, V22, P24; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Ruelle J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-100; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Sabin C, 2014, TOP ANTIVIR MED, V22, P382; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Sax PE, 2013, CLIN INFECT DIS, V56, P1344, DOI 10.1093/cid/cit008; Sax PE, 2012, LANCET, V379, P2439, DOI 10.1016/S0140-6736(12)60917-9; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Schackman BR, 2002, ARCH INTERN MED, V162, P2478, DOI 10.1001/archinte.162.21.2478; Scherrer AU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050307; Schoenenberger JA, 2013, THER DRUG MONIT, V35, P71, DOI 10.1097/FTD.0b013e3182791f8c; Sension M, 2013, HIV MED, V14, P437, DOI 10.1111/hiv.12024; Siberry GK, 2014, TOP ANTIVIR MED, V22, P34; Soliman EZ, 2011, AIDS, V25, P367, DOI 10.1097/QAD.0b013e328341dcc0; Swenson LC, 2014, AIDS; Swenson LC, 2014, J CLIN MICROBIOL, V52, P517, DOI 10.1128/JCM.02461-13; Taiwo B, 2013, AIDS, V27, P1593, DOI 10.1097/QAD.0b013e3283601115; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tashima K, 2013, 20 C RETR OPP INF MA; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Trottier B, 2010, HIV CLIN TRIALS, V11, P175, DOI 10.1310/hct1104-175; Vandenhende MA, 2014, TOP ANTIVIR MED, V22, P535; Vingerhoets J, 2010, AIDS, V24, P503, DOI 10.1097/QAD.0b013e32833677ac; Vinikoor MJ, 2013, JAIDS-J ACQ IMM DEF, V62, P505, DOI 10.1097/QAI.0b013e318285cd33; Volz EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001568; von Wyl V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027463; Wada N, 2014, AIDS, V28, P257, DOI 10.1097/QAD.0000000000000078; Walensky RP, 2013, ANN INTERN MED, V158, P84, DOI 10.7326/0003-4819-158-2-201301150-00002; Walmsley S, 2014, TOPICS ANTIVIRAL MED, V22, P261; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541; Whitlock GG, 2013, CLIN INFECT DIS, V57, P327, DOI 10.1093/cid/cit203; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Wohl DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096187; Wohl DA, 2014, JAIDS-J ACQ IMM DEF, V65, pE118, DOI 10.1097/QAI.0000000000000057; World Health Organization, STRAT US ANT HELP EN; World Health Organization (WHO), 2014, SUPPL 2013 CONS  MAR; Zolopa A, 2013, JAIDS-J ACQ IMM DEF, V63, P96, DOI 10.1097/QAI.0b013e318289545c; Zolopa AR, 2010, J INFECT DIS, V201, P814, DOI 10.1086/650698; Zorrilla CD, 2014, HIV MED, V15, P50, DOI 10.1111/hiv.12047; 1979, CAN MED ASS J, V121, P1193	171	363	375	3	89	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					410	425		10.1001/jama.2014.8722	http://dx.doi.org/10.1001/jama.2014.8722			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038359	Bronze			2022-12-28	WOS:000339257800027
J	Moore, TJ; Cohen, MR; Mattison, DR				Moore, Thomas J.; Cohen, Michael R.; Mattison, Donald R.			Dabigatran, bleeding, and the regulators	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MECHANICAL HEART-VALVES; ATRIAL-FIBRILLATION; WARFARIN; ETEXILATE; SAFETY		[Moore, Thomas J.; Cohen, Michael R.] Inst Safe Medicat Practices, Horsham, PA 19044 USA; [Mattison, Donald R.] Risk Sci Int, Ottawa, ON, Canada; [Mattison, Donald R.] Univ Ottawa, Ottawa, ON, Canada	University of Ottawa	Moore, TJ (corresponding author), Inst Safe Medicat Practices, 200 Lakeside Dr,Suite 200, Horsham, PA 19044 USA.	tmoore@ismp.org	; Mattison, Donald/L-4661-2013	Moore, Thomas/0000-0003-0994-836X; Mattison, Donald/0000-0001-5623-0874				Advisory Committee Briefing Document, 2010, DRUG SUBST DAB ET; [Anonymous], 2012, MIN ANSW CHMP HOC AD; [Anonymous], 2011, CHMP ASSESSMENT REPO; [Anonymous], 2014, PRESCR INF XARELTO R; [Anonymous], 2014, FDA STUDY MEDICARE P; [Anonymous], 2014, PRESCR INF PRADAXA D; [Anonymous], 2012, CHMP ASSESSMENT REPO; [Anonymous], 2008, CHMP ASSESSMENT REPO; [Anonymous], 2012, U12107201; [Anonymous], 2012, BIPIPRA0028572360KLI; [Anonymous], 2014, PRESCR INF ELIZUIS A; [Anonymous], 2012, CV SCIENT ADV GROUP; Avorn J, 2013, CIRCULATION, V128, P745, DOI 10.1161/CIRCULATIONAHA.113.003419; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Cardiovascular and Renal Drugs Advisory Committee, 2010, M MOND SEP 20 2010 F; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615; Eikelboom JW, 2013, J AM COLL CARDIOL, V62, P900, DOI 10.1016/j.jacc.2013.05.042; FDA Drug Safety Communication, 2012, UPD RISK SER BLEED E; FDA Drug Safety Communication, SAF REV POST MARK RE; Larsen TB, 2013, J AM COLL CARDIOL, V61, P2264, DOI 10.1016/j.jacc.2013.03.020; Luik S, 2010, BIPIPRA006011738; Moore T. J., 2012, QUARTERWATCH; Moore TJ, 2011, QUARTERWATCH; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Schulman S, 2010, J THROMB HAEMOST, V8, P202, DOI 10.1111/j.1538-7836.2009.03678.x; Southworth MR, 2013, NEW ENGL J MED, V368, P1272, DOI 10.1056/NEJMp1302834; Stangier J, 2012, BLOOD COAGUL FIBRIN, V23, P138, DOI 10.1097/MBC.0b013e32834f1b0c; ten Cate H, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-8; Unger EF, 2010, SUMMARY REVIEW DEPUT; Van de Werf F, 2012, AM HEART J, V163, P931, DOI 10.1016/j.ahj.2012.03.011	32	59	59	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2014	349								g4517	10.1136/bmj.g4517	http://dx.doi.org/10.1136/bmj.g4517			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VP	25056265				2022-12-28	WOS:000339565900002
J	Chong, SS; Chen, CY; Ge, H; Xie, XS				Chong, Shasha; Chen, Chongyi; Ge, Hao; Xie, X. Sunney			Mechanism of Transcriptional Bursting in Bacteria	CELL			English	Article							STOCHASTIC GENE-EXPRESSION; RNA-POLYMERASE MOLECULES; REAL-TIME OBSERVATION; SINGLE-MOLECULE; ESCHERICHIA-COLI; DNA GYRASE; FLUCTUATING ENVIRONMENTS; TOPOISOMERASE-I; OXOLINIC ACID; CENTRAL DOGMA	Transcription of highly expressed genes has been shown to occur in stochastic bursts. But the origin of such ubiquitous phenomenon has not been understood. Here, we present the mechanism in bacteria. We developed a high-throughput, in vitro, single-molecule assay to follow transcription on individual DNA templates in real time. We showed that positive supercoiling buildup on a DNA segment by transcription slows down transcription elongation and eventually stops transcription initiation. Transcription can be resumed upon gyrase binding to the DNA segment. Furthermore, using single-cell mRNA counting fluorescence in situ hybridization (FISH), we found that duty cycles of transcriptional bursting depend on the intracellular gyrase concentration. Together, these findings prove that transcriptional bursting of highly expressed genes in bacteria is primarily caused by reversible gyrase dissociation from and rebinding to a DNA segment, changing the supercoiling level of the segment.	[Chong, Shasha; Chen, Chongyi; Xie, X. Sunney] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Chen, Chongyi] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ge, Hao; Xie, X. Sunney] Peking Univ, Biodynam Opt Imaging Ctr BIOPIC, Beijing 100871, Peoples R China; [Ge, Hao] Peking Univ, BICMR, Beijing 100871, Peoples R China	Harvard University; Harvard University; Peking University; Peking University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Chen, Chongyi/D-4178-2015	Chen, Chongyi/0000-0002-0504-5369; Chong, Shasha/0000-0002-5372-311X	NIH [1DP1OD000277, 5R01GM096450-02]; National Science Foundation of China [21373021]; Foundation for the Author of National Excellent Doctoral Dissertation of China [201119]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096450] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Xiaowei Zhuang for the collaboration on bacterial chromosomal structure study, which prompted us to conduct the current study; N. Patrick Higgins for providing the plasmid containing strong gyrase site sequence; Gene-Wei Li for development of FISH protocol; Minbiao Ji for help with microscope construction; Rahul Roy for advice on data analysis; and James Wang, Long Cai, Gene-Wei Li, and Paul Choi for critical reading of the manuscript. This work was supported by NIH Pioneer Award (1DP1OD000277; to X.S.X.), NIH grant TR01 (5R01GM096450-02; to X.S.X.), National Science Foundation of China (21373021; to H.G.), and the Foundation for the Author of National Excellent Doctoral Dissertation of China (201119; to H.G.).	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Bai L, 2006, ANNU REV BIOPH BIOM, V35, P343, DOI 10.1146/annurev.biophys.35.010406.150153; BAKER TA, 1987, J BIOL CHEM, V262, P6877; Billingsley DJ, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/2/021001; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bustamante C, 2011, CELL, V144, P480, DOI 10.1016/j.cell.2011.01.033; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Deng S, 2004, P NATL ACAD SCI USA, V101, P3398, DOI 10.1073/pnas.0307550101; Deng S, 2005, MOL MICROBIOL, V57, P1511, DOI 10.1111/j.1365-2958.2005.04796.x; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; Efron B., 1994, MONOGRAPHS STAT APPL; El Hanafi D, 2000, MOL MICROBIOL, V37, P583; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; FRANCO RJ, 1988, J MOL BIOL, V201, P229, DOI 10.1016/0022-2836(88)90449-4; Friedman LJ, 2012, CELL, V148, P679, DOI 10.1016/j.cell.2012.01.018; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Gore J, 2006, NATURE, V439, P100, DOI 10.1038/nature04319; Guptasarma P, 1996, BIOESSAYS, V18, P325, DOI 10.1002/bies.950180411; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; Hebenstreit D, 2013, TRENDS GENET, V29, P333, DOI 10.1016/j.tig.2013.04.001; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; HIGGINS NP, 1982, NUCLEIC ACIDS RES, V10, P6833, DOI 10.1093/nar/10.21.6833; Hocine S, 2013, NAT METHODS, V10, P119, DOI 10.1038/nmeth.2305; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Leng FF, 2011, P NATL ACAD SCI USA, V108, P19973, DOI 10.1073/pnas.1109854108; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Lim HM, 2003, BIOCHEMISTRY-US, V42, P10718, DOI 10.1021/bi030110t; Lionberger TA, 2010, BIOPHYS J, V99, P1139, DOI 10.1016/j.bpj.2010.04.074; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LYNCH AS, 1993, J BACTERIOL, V175, P1645, DOI 10.1128/JB.175.6.1645-1655.1993; Ma J, 2013, SCIENCE, V340, P1580, DOI 10.1126/science.1235441; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; MAXWELL A, 1984, J BIOL CHEM, V259, P4472; Mitarai N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000109; MORRISON A, 1981, P NATL ACAD SCI-BIOL, V78, P1416, DOI 10.1073/pnas.78.3.1416; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Muramoto T, 2012, P NATL ACAD SCI USA, V109, P7350, DOI 10.1073/pnas.1117603109; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; RAU DC, 1987, J MOL BIOL, V193, P555, DOI 10.1016/0022-2836(87)90266-X; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Revyakin A, 2012, GENE DEV, V26, P1691, DOI 10.1101/gad.194936.112; Rovinskiy N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002845; Samul R, 2007, J MOL BIOL, V374, P925, DOI 10.1016/j.jmb.2007.10.011; Shundrovsky A, 2004, BIOPHYS J, V87, P3945, DOI 10.1529/biophysj.104.044081; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; Skinner GM, 2004, J BIOL CHEM, V279, P3239, DOI 10.1074/jbc.M310471200; SNYDER M, 1979, J MOL BIOL, V131, P287, DOI 10.1016/0022-2836(79)90077-9; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; TENHEGGELERBORDIER B, 1992, EMBO J, V11, P667, DOI 10.1002/j.1460-2075.1992.tb05098.x; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; TSAO YP, 1989, CELL, V56, P111, DOI 10.1016/0092-8674(89)90989-6; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020; WILLMOTT CJR, 1994, J MOL BIOL, V242, P351, DOI 10.1006/jmbi.1994.1586; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; Zhang ZJ, 2014, ELIFE, V3, DOI 10.7554/eLife.01775; Zong CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.96	81	220	223	2	112	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					314	326		10.1016/j.cell.2014.05.038	http://dx.doi.org/10.1016/j.cell.2014.05.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036631	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000340943600012
J	Koton, S; Schneider, ALC; Rosamond, WD; Shahar, E; Sang, YY; Gottesman, RF; Coresh, J				Koton, Silvia; Schneider, Andrea L. C.; Rosamond, Wayne D.; Shahar, Eyal; Sang, Yingying; Gottesman, Rebecca F.; Coresh, Josef			Stroke Incidence and Mortality Trends in US Communities, 1987 to 2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; ISCHEMIC-STROKE; CARDIOVASCULAR-DISEASE; IMPROVED SURVIVAL; TEMPORAL TRENDS; INCIDENCE RATES; POPULATION; ATHEROSCLEROSIS; SEVERITY; AUCKLAND	IMPORTANCE Prior studies have shown decreases in stroke mortality over time, but data on validated stroke incidence and long-term trends by race are limited. OBJECTIVE To study trends in stroke incidence and subsequent mortality among black and white adults in the Atherosclerosis Risk in Communities (ARIC) cohort from 1987 to 2011. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study of 14 357 participants (282 097 person-years) free of stroke at baseline was facilitated in 4 different US communities. Participants were recruited for the purpose of studying all stroke hospitalizations and deaths and for collection of baseline information on cardiovascular risk factors (via interviews and physical examinations) in 1987-1989. Participants were followed up (via examinations, annual phone interviews, active surveillance of discharges from local hospitals, and linkage with the National Death Index) through December 31, 2011. The study physician reviewers adjudicated all possible strokes and classified them as definite or probable ischemic or hemorrhagic events. MAIN OUTCOMES AND MEASURES Trends in rates of first-ever stroke per 10 years of calendar time were estimated using Poisson regression incidence rate ratios (IRRs), with subsequent mortality analyzed using Cox proportional hazards regression models and hazard ratios (HRs) overall and by race, sex, and age divided at 65 years. RESULTS Among 1051 (7%) participants with incident stroke, there were 929 with incident ischemic stroke and 140 with incident hemorrhagic stroke (18 participants had both during the study period). Crude incidence rates were 3.73 (95% CI, 3.51-3.96) per 1000 person-years for total stroke, 3.29 (95% CI, 3.08-3.50) per 1000 person-years for ischemic stroke, and 0.49 (95% CI, 0.41-0.57) per 1000 person-years for hemorrhagic stroke. Stroke incidence decreased over time in white and black participants (age-adjusted IRRs per 10-year period, 0.76 [95% CI, 0.66-0.87]; absolute decrease of 0.93 per 1000 person-years overall). The decrease in age-adjusted incidence was evident in participants age 65 years and older (age-adjusted IRR per 10-year period, 0.69 [95% CI, 0.59-0.81]; absolute decrease of 1.35 per 1000 person-years) but not evident in participants younger than 65 years (age-adjusted IRR per 10-year period, 0.97 [95% CI, 0.76-1.25]; absolute decrease of 0.09 per 1000 person-years) (P =.02 for interaction). The decrease in incidence was similar by sex. Of participants with incident stroke, 614 (58%) died through 2011. The mortality rate was higher for hemorrhagic stroke (68%) than for ischemic stroke (57%). Overall, mortality after stroke decreased over time (hazard ratio [HR], 0.80 [95% CI, 0.66-0.98]; absolute decrease of 8.09 per 100 strokes after 10 years [per 10-year period]). The decrease in mortality was mostly accounted for by the decrease at younger than age 65 years (HR, 0.65 [95% CI, 0.46-0.93]; absolute decrease of 14.19 per 100 strokes after 10 years [per 10-year period]), but was similar across race and sex. CONCLUSIONS AND RELEVANCE In a multicenter cohort of black and white adults in US communities, stroke incidence and mortality rates decreased from 1987 to 2011. The decreases varied across age groups, but were similar across sex and race, showing that improvements in stroke incidence and outcome continued to 2011. Copyright 2014 American Medical Association. All rights reserved.	[Koton, Silvia] Tel Aviv Univ, Sackler Fac Med, Stanley Steyer Sch Hlth Profess, IL-69978 Tel Aviv, Israel; [Koton, Silvia; Schneider, Andrea L. C.; Sang, Yingying; Gottesman, Rebecca F.; Coresh, Josef] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA; [Rosamond, Wayne D.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Shahar, Eyal] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Div Epidemiol & Biostat, Tucson, AZ USA; [Gottesman, Rebecca F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA	Tel Aviv University; Sackler Faculty of Medicine; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of Arizona; Johns Hopkins University	Coresh, J (corresponding author), Johns Hopkins Univ, Dept Epidemiol, 2024 E Monument,Ste 2-630, Baltimore, MD 21287 USA.	coresh@jhu.edu	Gottesman, Rebecca/ABA-8468-2020	Christman Schneider, Andrea Lauren/0000-0003-0026-5052; KOTON, SILVIA/0000-0002-9327-7505	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; National Institutes of Health (NIH)/NHLBI [T32 HL007024]; NIH/NHLBI [R01 AG040282];  [U01 HL096812];  [HL096814];  [HL096899];  [HL096902];  [HL096917];  [R01-HL70825]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070825, U01HL096812, U01HL096902, U01HL096917, U01HL096899, U01HL096814, T32HL007024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040282] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH)/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Atherosclerosis Risk in Communities (ARIC) study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute (NHLBI) contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C) with neurocognitive studies supported by U01 HL096812, HL096814, HL096899, HL096902, HL096917, and with previous brain magnetic resonance imaging examinations funded by R01-HL70825. Dr Schneider reports receipt of grant support from the National Institutes of Health (NIH)/NHLBI T32 HL007024. Dr Gottesman reports receit of grant support from NIH/NHLBI R01 AG040282.	Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Anderson CS, 2005, STROKE, V36, P2087, DOI 10.1161/01.STR.0000181079.42690.bf; BRODERICK JP, 1989, STROKE, V20, P577, DOI 10.1161/01.STR.20.5.577; Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Carter KN, 2007, CEREBROVASC DIS, V23, P162, DOI 10.1159/000097054; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Centers for Disease Control and Prevention National Center for Health Statistics, 2012, COMPL COMPR MORT FIL, V20; Chroinin DN, 2013, STROKE, V44, P448, DOI 10.1161/STROKEAHA.112.668277; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hata J, 2013, CIRCULATION, V128, P1198, DOI 10.1161/CIRCULATIONAHA.113.002424; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Islam SM, 2008, STROKE, V39, P776, DOI 10.1161/STROKEAHA.107.493643; Kelly AG, 2012, NEUROLOGY, V79, P941, DOI 10.1212/WNL.0b013e318266fc40; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Kleindorfer DO, 2010, STROKE, V41, P1326, DOI 10.1161/STROKEAHA.109.575043; Koton S, 2010, NEUROEPIDEMIOLOGY, V34, P90, DOI 10.1159/000264826; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; MAY DS, 1994, STROKE, V25, P2343, DOI 10.1161/01.STR.25.12.2343; Medin J, 2004, STROKE, V35, P1047, DOI 10.1161/01.STR.0000125866.78674.96; Numminen H, 1996, STROKE, V27, P1487, DOI 10.1161/01.STR.27.9.1487; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Rosengren A, 2013, STROKE, V44, P2388, DOI 10.1161/STROKEAHA.113.001170; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Schmidt M, 2014, NEUROLOGY, V82, P340, DOI 10.1212/WNL.0000000000000062; SHAHAR E, 1995, STROKE, V26, P1; Shahar E, 1997, STROKE, V28, P275, DOI 10.1161/01.STR.28.2.275; Sivenius J, 2004, STROKE, V35, P420, DOI 10.1161/01.STR.0000110220.63212.59; Thorvaldsen P, 1999, STROKE, V30, P2529, DOI 10.1161/01.STR.30.12.2529; Wieberdink RG, 2012, EUR J EPIDEMIOL, V27, P287, DOI 10.1007/s10654-012-9673-y; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	31	332	336	2	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					259	268		10.1001/jama.2014.7692	http://dx.doi.org/10.1001/jama.2014.7692			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	25027141	Bronze			2022-12-28	WOS:000338940300023
J	Casadei, CM; Gumiero, A; Metcalfe, CL; Murphy, EJ; Basran, J; Concilio, MG; Teixeira, SCM; Schrader, TE; Fielding, AJ; Ostermann, A; Blakeley, MP; Raven, EL; Moody, PCE				Casadei, Cecilia M.; Gumiero, Andrea; Metcalfe, Clive L.; Murphy, Emma J.; Basran, Jaswir; Concilio, Maria Grazia; Teixeira, Susana C. M.; Schrader, Tobias E.; Fielding, Alistair J.; Ostermann, Andreas; Blakeley, Matthew P.; Raven, Emma L.; Moody, Peter C. E.			Neutron cryo-crystallography captures the protonation state of ferryl heme in a peroxidase	SCIENCE			English	Article							CYTOCHROME-C PEROXIDASE; COMPOUND-I FORMATION; H BOND ACTIVATION; HORSERADISH-PEROXIDASE; CATALYTIC PATHWAY; CRYSTAL-STRUCTURE; ES; INTERMEDIATE; MECHANISM; RESONANCE	Heme enzymes activate oxygen through formation of transient iron-oxo (ferryl) intermediates of the heme iron. A long-standing question has been the nature of the iron-oxygen bond and, in particular, the protonation state. We present neutron structures of the ferric derivative of cytochrome c peroxidase and its ferryl intermediate; these allow direct visualization of protonation states. We demonstrate that the ferryl heme is an Fe(IV)=O species and is not protonated. Comparison of the structures shows that the distal histidine becomes protonated on formation of the ferryl intermediate, which has implications for the understanding of O-O bond cleavage in heme enzymes. The structures highlight the advantages of neutron cryo-crystallography in probing reaction mechanisms and visualizing protonation states in enzyme intermediates.	[Casadei, Cecilia M.; Basran, Jaswir; Moody, Peter C. E.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Casadei, Cecilia M.; Basran, Jaswir; Moody, Peter C. E.] Univ Leicester, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England; [Casadei, Cecilia M.; Teixeira, Susana C. M.; Blakeley, Matthew P.] Inst Max Von Laue Paul Langevin, F-38000 Grenoble, France; [Gumiero, Andrea; Metcalfe, Clive L.; Murphy, Emma J.; Raven, Emma L.] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; [Concilio, Maria Grazia; Fielding, Alistair J.] Univ Manchester, Photon Sci Inst, Manchester M13 9PL, Lancs, England; [Teixeira, Susana C. M.] Keele Univ, EPSAM, Keele ST5 5BG, Staffs, England; [Schrader, Tobias E.] Forschungszentrum Julich, JCNS, Outstn MLZ, D-85747 Garching, Germany; [Ostermann, Andreas] Tech Univ Munich, Heinz Maier Leibnitz Zentrum MLZ, D-85748 Garching, Germany	University of Leicester; University of Leicester; Institut Laue-Langevin (ILL); University of Leicester; University of Manchester; Keele University; Helmholtz Association; Research Center Julich; Technical University of Munich	Raven, EL (corresponding author), Univ Leicester, Dept Chem, Univ Rd, Leicester LE1 7RH, Leics, England.	emma.raven@le.ac.uk; peter.moody@le.ac.uk	Teixeira, Susana C. M./H-2205-2016; Concilio, Maria Grazia/GRX-4452-2022; Moody, Peter/A-6832-2008; Teixeira, Susana/H-2824-2013; Blakeley, Matthew Paul/G-7984-2015; Fielding, Alistair J./AAR-3101-2021	Teixeira, Susana C. M./0000-0002-6603-7936; Concilio, Maria Grazia/0000-0002-6534-4838; Moody, Peter/0000-0003-1762-9238; Teixeira, Susana/0000-0002-1967-0026; Blakeley, Matthew Paul/0000-0002-6412-4358; Fielding, Alistair J./0000-0002-4437-9791; Raven, Emma/0000-0002-1643-8694; Metcalfe, Clive/0000-0002-7856-8574; Schrader, Tobias Erich/0000-0001-5159-0846; Murphy, Emma/0000-0003-4551-8068	Leverhulme Trust [F/00 212/Q]; Biotechnology and Biological Sciences Research Council [BB/C001184/1]; Wellcome Trust, an Institut Laue-Langevin studentship [WT094104MA]; EU [283883]; Bruker UK; Biotechnology and Biological Sciences Research Council [BB/K015656/1] Funding Source: researchfish; BBSRC [BB/K015656/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust, an Institut Laue-Langevin studentship; EU(European Commission); Bruker UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. Collison for assistance with EPR, P. Ortiz de Montellano for discussions on the mechanisms, S. Fisher for assistance with the joint x-ray/neutron refinement, and the University of Leicester BioMedical Workshop for custom building of microspectrophotometry equipment, and J. Devos and the D-lab for experimental support. Atomic coordinates have been deposited in the Protein Data Bank under accession codes 4CVI for ferric CcP and 4CVJ for compound I. This work was supported by The Leverhulme Trust (grant F/00 212/Q to E.L.R./P.C.E.M.), Biotechnology and Biological Sciences Research Council (grant BB/C001184/1 to E.L.R./P.C.E.M., and a studentship to E. J. M.), The Wellcome Trust (grant WT094104MA to P.C.E.M./E.L.R.), an Institut Laue-Langevin studentship (to C. M. C.) and beam time at LADI-III and BIODIFF (EU FP7 NMI3-II grant 283883), Bruker UK (Sponsorship of A.J.F. and M. G. C.), and beam time at LADI-III and BIODIFF. P. C. E. M., M. P. B., and E. L. R. designed the research; C. M. C., A. G., M. P. B., A.O., S. C. M. T, T. E. S., C. L. M., E.J.M., and P. C. E. M. performed crystallographic experiments; C. M. C., A. G., M. P. B., S. C. M. T., A.O., T. E. S., E. L. R., and P. C. E. M. analyzed crystallographic data; C. M. C., A.J.F., M. G. C., J.B., and P. C. E. M. performed spectroscopic experiments; C. M. C., A. G., A.J.F., M. G. C., E. L. R., and P. C. E. M. analyzed spectra; and E. L. R., M. P. B., and P. C. E. M. wrote the paper, with contributions from all authors.	Behan RK, 2006, J INORG BIOCHEM, V100, P448, DOI 10.1016/j.jinorgbio.2005.12.019; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Blakeley MP, 2009, CRYSTALLOGR REV, V15, P157, DOI 10.1080/08893110902965003; Blakeley MP, 2004, P NATL ACAD SCI USA, V101, P16405, DOI 10.1073/pnas.0405109101; Davidson VL, 2011, NAT CHEM, V3, P662, DOI 10.1038/nchem.1122; Derat E, 2006, J PHYS CHEM B, V110, P10526, DOI 10.1021/jp055412e; Dunford H. B., 2010, PEROXIDASES CATALASE; Dunford H. B., 1999, HEME PEROXIDASES; EDWARDS SL, 1987, BIOCHEMISTRY-US, V26, P1503, DOI 10.1021/bi00380a002; Efimov I, 2011, J AM CHEM SOC, V133, P15376, DOI 10.1021/ja2007017; ERMAN JE, 1992, J AM CHEM SOC, V114, P6592, DOI 10.1021/ja00042a068; ERMAN JE, 1975, BIOCHIM BIOPHYS ACTA, V393, P350, DOI 10.1016/0005-2795(75)90061-6; Groves JT, 2014, NAT CHEM, V6, P89, DOI 10.1038/nchem.1855; Gumiero A, 2011, J BIOL CHEM, V286, P1260, DOI 10.1074/jbc.M110.183483; HORI H, 1985, J BIOL CHEM, V260, P349; HUYETT JE, 1995, J AM CHEM SOC, V117, P9033, DOI 10.1021/ja00140a021; Karlin KD, 2010, NATURE, V463, P168, DOI 10.1038/463168a; Kellner DG, 2002, J BIOL CHEM, V277, P9641, DOI 10.1074/jbc.C100745200; McDonald AR, 2011, NAT CHEM, V3, P761, DOI 10.1038/nchem.1153; Meharenna YT, 2010, BIOCHEMISTRY-US, V49, P2984, DOI 10.1021/bi100238r; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Pond AE, 1998, INORG CHIM ACTA, V276, P250; POULOS TL, 1980, J BIOL CHEM, V255, P8199; POULOS TL, 1980, J BIOL CHEM, V255, P575; Que L, 2008, NATURE, V455, P333, DOI 10.1038/nature07371; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Shaik S, 2005, CHEM REV, V105, P2279, DOI 10.1021/cr030722j; SITTER AJ, 1985, J BIOL CHEM, V260, P7515; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Sligar SG, 2010, SCIENCE, V330, P924, DOI 10.1126/science.1197881; Terner J, 2006, J INORG BIOCHEM, V100, P480, DOI 10.1016/j.jinorgbio.2006.01.008; Vidossich P, 2010, J PHYS CHEM B, V114, P5161, DOI 10.1021/jp911170b; Yosca TH, 2013, SCIENCE, V342, P825, DOI 10.1126/science.1244373	34	117	117	0	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					193	197		10.1126/science.1254398	http://dx.doi.org/10.1126/science.1254398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013070	Green Accepted, Green Submitted			2022-12-28	WOS:000339409900048
J	Groves, JT; Boaz, NC				Groves, John T.; Boaz, Nicholas C.			Fishing for peroxidase protons	SCIENCE			English	Editorial Material							COMPOUND I FORMATION; LIGATION; NEUTRON; WATER		[Groves, John T.; Boaz, Nicholas C.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University	Groves, JT (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	jtgroves@princeton.edu	Groves, John T./GPP-7588-2022	Groves, John T./0000-0002-9944-5899; Boaz, Nicholas/0000-0002-4562-0233	Division Of Chemistry [1148597] Funding Source: National Science Foundation; NIGMS NIH HHS [R01 GM036298, R37 GM036298] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036298, R37GM036298] Funding Source: NIH RePORTER	Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Casadei CM, 2014, SCIENCE, V345, P193, DOI 10.1126/science.1254398; Cuypers MG, 2013, ANGEW CHEM INT EDIT, V52, P1022, DOI 10.1002/anie.201207071; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; PENNERHAHN JE, 1986, J AM CHEM SOC, V108, P7819, DOI 10.1021/ja00284a054; Poulos TL, 2014, CHEM REV, V114, P3919, DOI 10.1021/cr400415k; Sen K, 2014, J PHYS CHEM B, V118, P2810, DOI 10.1021/jp411272h; Tomanicek SJ, 2013, J BIOL CHEM, V288, P4715, DOI 10.1074/jbc.M112.436238; Vidossich P, 2010, J PHYS CHEM B, V114, P5161, DOI 10.1021/jp911170b; Wang XS, 2012, J AM CHEM SOC, V134, P12897, DOI 10.1021/ja3049223; Yosca TH, 2013, SCIENCE, V342, P825, DOI 10.1126/science.1244373	10	18	19	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					142	143		10.1126/science.1256754	http://dx.doi.org/10.1126/science.1256754			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013049	Green Accepted			2022-12-28	WOS:000339409900024
J	Zolla-Pazner, S				Zolla-Pazner, Susan			A critical question for HIV vaccine development: Which antibodies to induce?	SCIENCE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; POTENT NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; HIV-1-INFECTED INDIVIDUALS; V3 LOOP; CONFORMATIONAL EPITOPE; EFFICACY TRIAL; CD4 BINDING; BROAD; SUPERINFECTION	A vaccine against HIV-1 must prevent infection against genetically diverse virus strains. Two approaches are currently being pursued to elicit antibody-mediated protection: vaccines that induce potent and broadly reactive neutralizing antibodies (bnAbs) or vaccines that induce "conventional antibodies," which are less potent and broadly neutralizing in comparison. Although bnAbs may provide the greatest level of protection, their structural and genetic characteristics make their elicitation through vaccination a major challenge. In contrast, conventional HIV-1 antibodies have been induced by vaccination and correlated with reduced HIV-1 infection in a phase III vaccine trial. Here, I present evidence that both approaches should be pursued with equal vigor.	[Zolla-Pazner, Susan] New York Vet Affairs Harbor Healthcare Syst, New York, NY 10010 USA; [Zolla-Pazner, Susan] NYU, Sch Med, New York, NY 10016 USA	New York University	Zolla-Pazner, S (corresponding author), New York Vet Affairs Harbor Healthcare Syst, New York, NY 10010 USA.	zollas01@med.nyu.edu	Zolla-Pazner, Susan/S-1864-2019	Zolla-Pazner, Susan/0000-0002-0750-2666	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100151] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL059725, R01 HL59725] Funding Source: Medline; NIAID NIH HHS [P01 AI100151, P01 AI 100151] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrus L, 1998, J INFECT DIS, V177, P889, DOI 10.1086/515251; Bar KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002721; Basu D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-76; Bhattacharyya S, 2013, J BIOL CHEM, V288, P9815, DOI 10.1074/jbc.M112.425959; Blish CA, 2008, J VIROL, V82, P12094, DOI 10.1128/JVI.01730-08; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Delany I, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012476; EMINI EA, 1990, J VIROL, V64, P3674, DOI 10.1128/JVI.64.8.3674-3678.1990; Forthal DN, 2013, JAIDS-J ACQ IMM DEF, V63, P31, DOI 10.1097/QAI.0b013e3182874d41; Georgiev IS, 2014, J IMMUNOL, V192, P1100, DOI 10.4049/jimmunol.1302515; Gorny MK, 2012, VIROLOGY, V427, P198, DOI 10.1016/j.virol.2012.02.003; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Haynes BF, 2014, SCIENCE, V344, P588, DOI 10.1126/science.1254990; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Israel ZR, 1997, AIDS, V11, P128; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lambert JS, 1997, J INFECT DIS, V175, P283, DOI 10.1093/infdis/175.2.283; Li LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039534; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; Moore PL, 2013, J VIROL, V87, P4882, DOI 10.1128/JVI.03424-12; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Pollara J, 2014, J VIROL, V88, P7715, DOI 10.1128/JVI.00156-14; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; ROBBINS JB, 1995, J INFECT DIS, V171, P1387, DOI 10.1093/infdis/171.6.1387; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Ronen K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003593; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Smith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Totrov M, 2010, VIROLOGY, V405, P513, DOI 10.1016/j.virol.2010.06.027; Vaine M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013916; Verrier F, 2001, J VIROL, V75, P9177, DOI 10.1128/JVI.75.19.9177-9186.2001; VijhWarrier S, 1996, J VIROL, V70, P4466, DOI 10.1128/JVI.70.7.4466-4473.1996; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Watkins JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018207; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner Susan, 2005, Human Antibodies, V14, P69; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629; Zolla-Pazner S, 2011, J VIROL, V85, P9887, DOI 10.1128/JVI.05086-11	67	27	35	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					167	168		10.1126/science.1256526	http://dx.doi.org/10.1126/science.1256526			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013066	Green Accepted			2022-12-28	WOS:000339409900040
J	Gravitz, L				Gravitz, Lauren			SOCIOLOGY Shedding the shame	NATURE			English	Editorial Material							EPILEPSY											Ekenze OS, 2013, EPILEPSY BEHAV, V26, P87, DOI 10.1016/j.yebeh.2012.10.016; Kale R, 1997, BRIT MED J, V315, P2, DOI 10.1136/bmj.315.7099.2; Meador KJ, 2011, NEUROLOGY, V77, P1305, DOI 10.1212/WNL.0b013e318230a18f	3	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S10	S11		10.1038/511S10a	http://dx.doi.org/10.1038/511S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8AP	25019128	Bronze			2022-12-28	WOS:000338649800005
J	Jurcevic, P; Lanyon, BP; Hauke, P; Hempel, C; Zoller, P; Blatt, R; Roos, CF				Jurcevic, P.; Lanyon, B. P.; Hauke, P.; Hempel, C.; Zoller, P.; Blatt, R.; Roos, C. F.			Quasiparticle engineering and entanglement propagation in a quantum many-body system	NATURE			English	Article							LIEB-ROBINSON BOUNDS; STATES; COMPUTATION; EMERGENCE	The key to explaining and controlling a range of quantum phenomena is to study how information propagates around many-body systems. Quantum dynamics can be described by particle-like carriers of information that emerge in the collective behaviour of the underlying system, the so-called quasiparticles(1). These elementary excitations are predicted to distribute quantum information in a fashion determined by the system's interactions(2). Here we report quasiparticle dynamics observed in a quantum many-body system of trapped atomic ions(3,4). First, we observe the entanglement distributed by quasiparticles as they trace out light-cone-like wavefronts(5-11). Second, using the ability to tune the interaction range in our system, we observe information propagation in an experimental regime where the effective-light-cone picture does not apply(7,12). Our results will enable experimental studies of a range of quantum phenomena, including transport(13,14), thermalization(15), localization(16) and entanglement growth(17), and represent a first step towards a newquantum-optic regime of engineered quasiparticles with tunable nonlinear interactions.	[Jurcevic, P.; Lanyon, B. P.; Hauke, P.; Hempel, C.; Zoller, P.; Blatt, R.; Roos, C. F.] Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria; [Jurcevic, P.; Lanyon, B. P.; Hempel, C.; Blatt, R.; Roos, C. F.] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; [Hauke, P.; Zoller, P.] Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria	Austrian Academy of Sciences; University of Innsbruck; University of Innsbruck	Roos, CF (corresponding author), Austrian Acad Sci, Inst Quantenopt & Quanteninformat, Technikerstr 21a, A-6020 Innsbruck, Austria.	christian.roos@uibk.ac.at	Hauke, Philipp/H-5304-2015; Chown, Steven L/H-3347-2011; Roos, Christian F/D-8475-2011; Blatt, Rainer/H-9527-2014; Jurcevic, Petar/O-4268-2014; Zoller, Peter/O-1639-2014; Hempel, Cornelius/I-2388-2013	Hauke, Philipp/0000-0002-0414-1754; Chown, Steven L/0000-0001-6069-5105; Roos, Christian F/0000-0001-7121-8259; Jurcevic, Petar/0000-0003-1234-6386; Zoller, Peter/0000-0003-4014-1505; Hempel, Cornelius/0000-0002-4053-722X; lanyon, benjamin/0000-0002-7379-4572	Austrian Science Fund (FWF) [P25354-N20]; European Commission via the integrated project SIQS; Institut fur Quanteninformation; European Research Council through the CRYTERION Project [227959]; Austrian Science Fund (FWF) [P 25354] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Commission via the integrated project SIQS; Institut fur Quanteninformation; European Research Council through the CRYTERION Project; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We acknowledge discussions with L. Tagliacozzo, M. Heyl, A. Gorshkov and S. Bose. This work was supported by the Austrian Science Fund (FWF) under grant number P25354-N20, and by the European Commission via the integrated project SIQS and by the Institut fur Quanteninformation. We also acknowledge support from the European Research Council through the CRYTERION Project (number 227959).	Bose S, 2007, CONTEMP PHYS, V48, P13, DOI 10.1080/00107510701342313; Bravyi S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050401; Britton JW, 2012, NATURE, V484, P489, DOI 10.1038/nature10981; Cheneau M, 2012, NATURE, V481, P484, DOI 10.1038/nature10748; Cramer M, 2008, CRM SER, V8, P51; Friedenauer A, 2008, NAT PHYS, V4, P757, DOI 10.1038/nphys1032; Fukuhara T, 2013, NATURE, V502, P76, DOI 10.1038/nature12541; Gong ZX, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/11/113051; Haffner H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.143602; Hastings M. B., 2010, LECT NOTES LES HOUCH, V95; Hastings MB, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.104431; Hauke P, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.207202; Holstein T, 1940, PHYS REV, V58, P1098, DOI 10.1103/PhysRev.58.1098; Islam R, 2013, SCIENCE, V340, P583, DOI 10.1126/science.1232296; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; Junemann J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.230404; Kim K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.120502; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Langen T, 2013, NAT PHYS, V9, P639, DOI 10.1038/NPHYS2739; LIEB EH, 1972, COMMUN MATH PHYS, V28, P251, DOI 10.1007/BF01645779; Nachtergaele B., 2010, IAMP NEWS B      OCT, V4, P22; Nachtergaele B, 2006, COMMUN MATH PHYS, V265, P119, DOI 10.1007/s00220-006-1556-1; Plenio MB, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/11/113019; Porras D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207901; Rebentrost P, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033003; Rigol M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.050405; Roos CF, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.220402; Sachdev S, 2000, SCIENCE, V288, P475, DOI 10.1126/science.288.5465.475; Schachenmayer J, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.031015; Schindler P, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/12/123012; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245; Yao N. Y., 2014, MANY BODY LOCALIZATI	36	534	538	0	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					202	+		10.1038/nature13461	http://dx.doi.org/10.1038/nature13461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008526	Green Submitted			2022-12-28	WOS:000338649800039
J	Pallotta, M; Schnurbusch, T; Hayes, J; Hay, A; Baumann, U; Paull, J; Langridge, P; Sutton, T				Pallotta, Margaret; Schnurbusch, Thorsten; Hayes, Julie; Hay, Alison; Baumann, Ute; Paull, Jeff; Langridge, Peter; Sutton, Tim			Molecular basis of adaptation to high soil boron in wheat landraces and elite cultivars	NATURE			English	Article							TRITICUM-AESTIVUM L.; TOXICITY TOLERANCE; AEGILOPS-TAUSCHII; DRAFT GENOME; BARLEY; GENES; IDENTIFICATION; EXPRESSION; EVOLUTION; SOFTWARE	Environmental constraints severely restrict crop yields inmost production environments, and expanding the use of variation will underpin future progress in breeding. In semi-arid environments boron toxicity constrains productivity, and genetic improvement is the only effective strategy for addressing the problem(1). Wheat breeders have sought and used available genetic diversity from landraces to maintain yield in these environments; however, the identity of the genes at the major tolerance loci was unknown. Here we describe the identification of near-identical, root-specific boron transporter genes underlying the two major-effect quantitative trait loci for boron tolerance in wheat, Bo1 and Bo4 (ref. 2). We show that tolerance to a high concentration of boron is associated with multiple genomic changes including tetraploid introgression, dispersed gene duplication, and variation in gene structure and transcript level. An allelic series was identified from a panel of bread and durum wheat cultivars and landraces originating from diverse agronomic zones. Our results demonstrate that, during selection, breeders have matched functionally different boron tolerance alleles to specific environments. The characterization of boron tolerance in wheat illustrates the power of the new wheat genomic resources to define key adaptive processes that have underpinned crop improvement.	[Pallotta, Margaret; Schnurbusch, Thorsten; Hayes, Julie; Hay, Alison; Baumann, Ute; Langridge, Peter; Sutton, Tim] Univ Adelaide, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Urrbrae, SA 5064, Australia; [Schnurbusch, Thorsten] Leibniz Inst Plant Genet & Crop Plant Res IPK, Genebank Dept, D-06466 Gatersleben, Germany; [Paull, Jeff] Univ Adelaide, Sch Agr Food & Wine, Urrbrae, SA 5064, Australia	University of Adelaide; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Adelaide	Sutton, T (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Waite Campus, Urrbrae, SA 5064, Australia.	tim.sutton@acpfg.com.au	Langridge, Peter/G-5864-2010; Sutton, Tim/ABC-8454-2020; Schnurbusch, Thorsten/B-2249-2009	Langridge, Peter/0000-0001-9494-400X; Schnurbusch, Thorsten/0000-0002-5267-0677; Sutton, Timothy/0000-0002-9059-0774; Pallotta, Margaret/0000-0002-1642-5623; Hayes, Julie/0000-0001-8716-5024	Australian Research Council; Grains Research and Development Corporation; South Australian Government	Australian Research Council(Australian Research Council); Grains Research and Development Corporation(Grains R&D Corp); South Australian Government	We thank N. Collins, J. Dvorjak, H. Kuchel, D. Mares, S. Wu, the John Innes Centre, the Biotechnology and Biological Sciences Research Council, the Institut National de la Recherche Agronomique and the International Wheat Genome Sequencing Consortium for resources, and J. Tiong, T. Oz and A. Pohlen for assistance. The authors are supported by grants from the Australian Research Council, the Grains Research and Development Corporation and the South Australian Government.	Akhunov ED, 2007, MOL BIOL EVOL, V24, P539, DOI 10.1093/molbev/msl183; Allouis S, 2003, CEREAL RES COMMUN, V31, P331; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Chantachume Y, 1995, PLANT SOIL, V177, P249, DOI 10.1007/BF00010131; Chantachume Y., 1995, THESIS U ADELAIDE; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Jamjod S., 1996, THESIS U ADELAIDE; Jefferies SP, 1999, THEOR APPL GENET, V98, P1293, DOI 10.1007/s001220051195; Jefferies SP, 2000, THEOR APPL GENET, V101, P767, DOI 10.1007/s001220051542; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Lai KT, 2012, PLANT CELL PHYSIOL, V53, DOI 10.1093/pcp/pcr141; Leaungthitikanchana S, 2013, PLANT CELL PHYSIOL, V54, P1056, DOI 10.1093/pcp/pct059; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Mares D, 2008, J CEREAL SCI, V47, P6, DOI 10.1016/j.jcs.2007.01.005; Mathews KL, 2011, CROP PASTURE SCI, V62, P313, DOI 10.1071/CP10318; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; McDonald GK, 2012, CROP PASTURE SCI, V63, P1043, DOI 10.1071/CP12244; McIntosh R., 2008, P 11 INT WHEAT GEN S; Miwa K, 2010, ANN BOT-LONDON, V105, P1103, DOI 10.1093/aob/mcq044; Nable RO, 1997, PLANT SOIL, V193, P181, DOI 10.1023/A:1004272227886; Pallotta MA, 2000, THEOR APPL GENET, V101, P1100, DOI 10.1007/s001220051585; Pallotta MA, 2003, PROC INT WHEAT GENET, V2, P789; PAULL JG, 1991, EUPHYTICA, V55, P217, DOI 10.1007/BF00021242; PAULL JG, 1992, PLANT SOIL, V146, P251, DOI 10.1007/BF00012019; Paull JG, 1993, P 8 INT WHEAT GEN S, V2, P1065; Preuss CP, 2010, PLANT PHYSIOL, V152, P1431, DOI 10.1104/pp.109.152009; Reid R, 2007, PLANT CELL PHYSIOL, V48, P1673, DOI 10.1093/pcp/pcm159; Rerkasem B, 1997, EUPHYTICA, V96, P257, DOI 10.1023/A:1003093532561; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Schnurbusch T, 2008, GENOME, V51, P963, DOI 10.1139/G08-084; Schnurbusch T, 2007, THEOR APPL GENET, V115, P451, DOI 10.1007/s00122-007-0579-0; Schnurbusch T, 2010, PLANT PHYSIOL, V153, P1706, DOI 10.1104/pp.110.158832; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Yau SK, 2008, CROP SCI, V48, P854, DOI 10.2135/cropsci2007.10.0539	40	69	69	4	129	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					88	+		10.1038/nature13538	http://dx.doi.org/10.1038/nature13538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25043042				2022-12-28	WOS:000342420800041
J	Li, B; Qiu, B; Lee, DSM; Walton, ZE; Ochocki, JD; Mathew, LK; Mancuso, A; Gade, TPF; Keith, B; Nissim, I; Simon, MC				Li, Bo; Qiu, Bo; Lee, David S. M.; Walton, Zandra E.; Ochocki, Joshua D.; Mathew, Lijoy K.; Mancuso, Anthony; Gade, Terence P. F.; Keith, Brian; Nissim, Itzhak; Simon, M. Celeste			Fructose-1,6-bisphosphatase opposes renal carcinoma progression	NATURE			English	Article							CELL CARCINOMA; IDENTIFICATION; METABOLISM; INACTIVATION; DISEASE	Clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer(1), is characterized by elevated glycogen levels and fat deposition(2). These consistent metabolic alterations are associated with normoxic stabilization of hypoxia-inducible factors (HIFs)3 secondary to von Hippel-Lindau (VHL) mutations that occur in over 90% of ccRCC tumours(4). However, kidney-specific VHL deletion in mice fails to elicit ccRCC-specific metabolic phenotypes and tumour formation(5), suggesting that additional mechanisms are essential. Recent large-scale sequencing analyses revealed the loss of several chromatin remodelling enzymes in a subset of ccRCC (these included polybromo-1, SET domain containing 2 and BRCA1 -associated protein-1, among others)(6-9), indicating that epigenetic perturbations are probably important contributors to the natural history of this disease. Here we used an integrative approach comprising pan-metabolomic profiling and metabolic gene set analysis and determined that the gluconeogenic enzyme fructose-1,6-bisphosphatase 1 (FBP1)(10) is uniformly depleted in over six hundred ccRCC tumours examined. Notably, the human FBP1 locus resides on chromosome 9q22, the loss of which is associated with poor prognosis for ccRCC patients". Our data further indicate that FBP1 inhibits ccRCC progression through two distinct mechanisms. First, FBP1 antagonizes glycolytic flux in renal tubular epithelial cells, the presumptive ccRCC cell of origin(12), thereby inhibiting a potential Warburg effect(13,14). Second, in pVHL (the protein encoded by the VHL gene)-deficient ccRCC cells, FBP1 restrains cell proliferation, glycolysis and the pentose phosphate pathway in a catalyticactivity-independent manner, by inhibiting nuclear HIF function via direct interaction with the HIF inhibitory domain. This unique dual function of the FBP1 protein explains its ubiquitous loss in ccRCC, distinguishing FBP1 from previously identified tumour suppressors that are not consistently mutated in all tumours(6,7,15).	[Li, Bo; Qiu, Bo; Lee, David S. M.; Walton, Zandra E.; Ochocki, Joshua D.; Mathew, Lijoy K.; Mancuso, Anthony; Keith, Brian; Simon, M. Celeste] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Lee, David S. M.; Mathew, Lijoy K.; Simon, M. Celeste] Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Walton, Zandra E.; Mancuso, Anthony; Keith, Brian] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Mancuso, Anthony; Gade, Terence P. F.] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Nissim, Itzhak] Univ Penn, Dept Pediat,Biochem & Biophys, Philadelphia, PA 19104 USA; [Nissim, Itzhak] Childrens Hosp Philadelphia, Div Child Dev & Metab Dis, Philadelphia, PA 19104 USA; [Simon, M. Celeste] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Simon, MC (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	celeste2@mail.med.upenn.edu	Lorkiewicz, Pawel/A-2126-2011; Li, Bo/O-7127-2019; Li, Bo/Y-2835-2019; Simon, Celeste/AAG-3941-2021; Li, Bo/M-2192-2013	Lorkiewicz, Pawel/0000-0002-1755-9826; Li, Bo/0000-0002-7979-8339; Li, Bo/0000-0002-7979-8339; Walton, Zandra/0000-0002-0465-0153; Lee, David/0000-0002-8821-9028; Qiu, Bo/0000-0003-4199-1659	Howard Hughes Medical Institute, NIH Grant [CA104838, DK053761]; NATIONAL CANCER INSTITUTE [P30CA016520, F32CA192758, F30CA177106, P01CA104838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053761, R56DK053761] Funding Source: NIH RePORTER	Howard Hughes Medical Institute, NIH Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y. Daikhin, O. Horyn and Ilana Nissim for assistance with the isotopomer enrichment analysis in the Metabolomic Core facility, Children's Hospital of Philadelphia. We also thank J. Tobias for help with processing the TCGA RNA-sequencing data. This work was supported by the Howard Hughes Medical Institute, NIH Grant CA104838 to M.C.S. and DK053761 to I.N. M.C.S. is an Investigator of the Howard Hughes Medical Institute.	Asberg C, 2010, J INHERIT METAB DIS, V33, pS113, DOI 10.1007/s10545-009-9034-5; Choe JY, 2000, BIOCHEMISTRY-US, V39, P8565, DOI 10.1021/bi000574g; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Dondeti VR, 2012, CANCER RES, V72, P112, DOI 10.1158/0008-5472.CAN-11-1698; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Moore LE, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.14; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Nissim I, 2012, BIOCHEM J, V444, P537, DOI 10.1042/BJ20120163; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Salway JG, 2004, METABOLISM GLANCE; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; TEJWANI GA, 1983, ADV ENZYMOL RAMB, V54, P121; Valera VA, 2011, NAT REV UROL, V8, P321, DOI 10.1038/nrurol.2011.64; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2	30	334	347	2	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					251	+		10.1038/nature13557	http://dx.doi.org/10.1038/nature13557			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043030	Green Accepted			2022-12-28	WOS:000341362800054
J	Desai, SA; Miller, LH				Desai, Sanjay A.; Miller, Louis H.			MALARIA Protein-export pathway illuminated	NATURE			English	Editorial Material							PLASMODIUM-FALCIPARUM; HOST ERYTHROCYTES; VIRULENCE; PARASITES; MEMBRANE; REVEALS; CHANNEL; PTEX		[Desai, Sanjay A.; Miller, Louis H.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Desai, SA (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	sdesai@niaid.nih.gov; lmiller@niaid.nih.gov		Desai, Sanjay/0000-0003-2150-2483	Intramural NIH HHS [ZIA AI000882-13] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000882, ZIAAI000241] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Gehde N, 2009, MOL MICROBIOL, V71, P613, DOI 10.1111/j.1365-2958.2008.06552.x; Goldberg DE, 2010, NAT REV MICROBIOL, V8, P617, DOI 10.1038/nrmicro2420; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; Kulzer S, 2012, CELL MICROBIOL, V14, P1784, DOI 10.1111/j.1462-5822.2012.01840.x; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Papakrivos J, 2005, MOL MICROBIOL, V55, P1272, DOI 10.1111/j.1365-2958.2004.04468.x; Pesce E.-R., 2014, PARASITOLOGY; Pillai AD, 2012, MOL PHARMACOL, V82, P1104, DOI 10.1124/mol.112.081224; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084	16	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					541	542		10.1038/nature13646	http://dx.doi.org/10.1038/nature13646			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043009	Green Accepted			2022-12-28	WOS:000339566300023
J	Seddon, PJ; Griffiths, CJ; Soorae, PS; Armstrong, DP				Seddon, Philip J.; Griffiths, Christine J.; Soorae, Pritpal S.; Armstrong, Doug P.			Reversing defaunation: Restoring species in a changing world	SCIENCE			English	Review							CLIMATE-CHANGE; ASSISTED COLONIZATION; GLOBAL BIODIVERSITY; TRANSLOCATION; RESTORATION; DIVERSITY; EXTINCTION; MEGAFAUNA; MIGRATION; TORTOISES	The rate of biodiversity loss is not slowing despite global commitments, and the depletion of animal species can reduce the stability of ecological communities. Despite this continued loss, some substantial progress in reversing defaunation is being achieved through the intentional movement of animals to restore populations. We review the full spectrum of conservation translocations, from reinforcement and reintroduction to controversial conservation introductions that seek to restore populations outside their indigenous range or to introduce ecological replacements for extinct forms. We place the popular, but misunderstood, concept of rewilding within this framework and consider the future role of new technical developments such as de-extinction.	[Seddon, Philip J.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Griffiths, Christine J.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Soorae, Pritpal S.] Environm Agcy, Abu Dhabi, U Arab Emirates; [Armstrong, Doug P.] Massey Univ, Inst Nat Resources, Palmerston North, New Zealand	University of Otago; University of Bristol; Massey University	Seddon, PJ (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	philip.seddon@otago.ac.nz	Seddon, Philip/G-8659-2011	Seddon, Philip/0000-0001-9076-9566				Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Boitani L., 2014, REWILDING EUROPEAN L; Bowman D, 2012, NATURE, V482, P30, DOI 10.1038/482030a; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Champagnon J, 2012, J NAT CONSERV, V20, P231, DOI 10.1016/j.jnc.2012.02.002; Chauvenet ALM, 2013, J APPL ECOL, V50, P1330, DOI 10.1111/1365-2664.12150; Corlett RT, 2013, BIOL CONSERV, V163, P13, DOI 10.1016/j.biocon.2012.11.012; Deinet S., 2013, WILDLIFE COMEBACK EU; Deredec A, 2007, ECOSCIENCE, V14, P440, DOI 10.2980/1195-6860(2007)14[440:IOTAEF]2.0.CO;2; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Donlan J, 2005, NATURE, V436, P913, DOI 10.1038/436913a; Ewen JG, 2012, REINTRODUCTION BIOL; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Germano JM, 2009, CONSERV BIOL, V23, P7, DOI 10.1111/j.1523-1739.2008.01123.x; Giacomini HC, 2013, BIOL CONSERV, V163, P33, DOI 10.1016/j.biocon.2013.04.007; Gibbs JP, 2008, RESTOR ECOL, V16, P88, DOI 10.1111/j.1526-100X.2007.00265.x; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Griffiths CJ, 2013, CONSERV BIOL, V27, P690, DOI 10.1111/cobi.12087; Griffiths CJ, 2011, CURR BIOL, V21, P762, DOI 10.1016/j.cub.2011.03.042; Griffiths CJ, 2010, RESTOR ECOL, V18, P1, DOI 10.1111/j.1526-100X.2009.00612.x; Groombridge Jim J., 2012, P395; Guimaraes Paulo R. Jr, 2008, PLoS ONE, V3, pUnpaginated, DOI 10.1371/journal.pone.0001745; Hansen DM, 2010, ECOGRAPHY, V33, P272, DOI 10.1111/j.1600-0587.2010.06305.x; Hansen DM, 2009, SCIENCE, V324, P42, DOI 10.1126/science.1172393; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hewitt N, 2011, BIOL CONSERV, V144, P2560, DOI 10.1016/j.biocon.2011.04.031; Hobbs Richard J., 2013, NOVEL ECOSYSTEMS INT; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Hunter ML, 2007, CONSERV BIOL, V21, P1356, DOI 10.1111/j.1523-1739.2007.00780.x; Huntley B, 2010, ECOGRAPHY, V33, P621, DOI 10.1111/j.1600-0587.2009.06023.x; IUCN, 2013, GUID REINTR OTH CONS; Jackson ST, 2009, SCIENCE, V325, P567, DOI 10.1126/science.1172977; Jamieson Ian G., 2012, P441; Keedwell RJ, 2002, BIOL CONSERV, V105, P369, DOI 10.1016/S0006-3207(01)00220-8; Keller L.K., 2012, REINTRODUCTION BIOL, P360, DOI DOI 10.1002/9781444355833.CH11; Larson BMH, 2013, ETHICS POLICY ENV, V16, P16, DOI 10.1080/21550085.2013.768381; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Lorimer J, 2014, T I BRIT GEOGR, V39, P169, DOI 10.1111/tran.12030; Loss SR, 2011, BIOL CONSERV, V144, P92, DOI 10.1016/j.biocon.2010.11.016; Lunt ID, 2013, BIOL CONSERV, V157, P172, DOI 10.1016/j.biocon.2012.08.034; MacDougall AS, 2013, NATURE, V494, P86, DOI 10.1038/nature11869; McDonald-Madden E, 2011, NAT CLIM CHANGE, V1, P261, DOI 10.1038/NCLIMATE1170; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; Mitchell Nicola, 2013, Biology - Basel, V2, P1, DOI 10.3390/biology2010001; Nogardy B., 2013, ECOS, V25, P13036; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pedrono M, 2013, BIOL CONSERV, V159, P501, DOI 10.1016/j.biocon.2012.11.027; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; PETERS RL, 1985, BIOSCIENCE, V35, P707, DOI 10.2307/1310052; Reardon S, 2014, NEW SCI, V221, P40, DOI 10.1016/S0262-4079(14)60432-2; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Sandom C., 2013, KEY TOPICS CONSERVAT, V2, P430, DOI DOI 10.1002/9781118520178.ch23; Schwartz MW, 2013, ANN NY ACAD SCI, V1286, P15, DOI 10.1111/nyas.12050; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Seddon PJ, 2014, TRENDS ECOL EVOL, V29, P140, DOI 10.1016/j.tree.2014.01.007; Seddon PJ, 2005, ANIM CONSERV, V8, P51, DOI 10.1017/S1367943004001799; Soule M., 1998, WILD EARTH, p[1, 1998]; Soulu M., 2001, CONSERVATION BIOL RE; Sutherland WJ, 2010, CONSERV LETT, V3, P229, DOI 10.1111/j.1755-263X.2010.00113.x; Thomas CD, 2011, TRENDS ECOL EVOL, V26, P216, DOI 10.1016/j.tree.2011.02.006; Thorpe AS, 2011, J APPL ECOL, V48, P275, DOI 10.1111/j.1365-2664.2011.01972.x; Tracy LN, 2011, ANIM CONSERV, V14, P439, DOI 10.1111/j.1469-1795.2011.00448.x; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Vera F. W. M., 2009, WILDLIFE S, V20, P28; Willis Stephen G., 2009, Conservation Letters, V2, P46, DOI 10.1111/j.1755-263X.2008.00043.x; Wolf CM, 1998, BIOL CONSERV, V86, P243	70	369	380	37	1103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					406	412		10.1126/science.1251818	http://dx.doi.org/10.1126/science.1251818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061203				2022-12-28	WOS:000339655100032
J	Marx, V				Marx, Vivien			STOP THE MICROBIAL CHATTER	NATURE			English	Editorial Material							IDENTIFICATION; BACTERIA											Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Hastings JW, 1999, J BACTERIOL, V181, P2667, DOI 10.1128/JB.181.9.2667-2668.1999; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100	8	13	14	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					493	497		10.1038/511493a	http://dx.doi.org/10.1038/511493a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25056065	Bronze			2022-12-28	WOS:000339335700052
J	Schulte, JM; Rothaus, CS; Adler, JN				Schulte, Joann M.; Rothaus, Carla S.; Adler, Jonathan N.			Starting Statins - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		DAGOSTINO RB, 2014, NEW ENGL J MED, V370, P1652	1	6	6	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4							e6	10.1056/NEJMclde1407177	http://dx.doi.org/10.1056/NEJMclde1407177			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL7TY	25054734				2022-12-28	WOS:000339339800002
J	Paszek, MJ; DuFort, CC; Rossier, O; Bainer, R; Mouw, JK; Godula, K; Hudak, JE; Lakins, JN; Wijekoon, AC; Cassereau, L; Rubashkin, MG; Magbanua, MJ; Thorn, KS; Davidson, MW; Rugo, HS; Park, JW; Hammer, DA; Giannone, G; Bertozzi, CR; Weaver, VM				Paszek, Matthew J.; DuFort, Christopher C.; Rossier, Olivier; Bainer, Russell; Mouw, Janna K.; Godula, Kamil; Hudak, Jason E.; Lakins, Jonathon N.; Wijekoon, Amanda C.; Cassereau, Luke; Rubashkin, Matthew G.; Magbanua, Mark J.; Thorn, Kurt S.; Davidson, Michael W.; Rugo, Hope S.; Park, John W.; Hammer, Daniel A.; Giannone, Gregory; Bertozzi, Carolyn R.; Weaver, Valerie M.			The cancer glycocalyx mechanically primes integrin-mediated growth and survival	NATURE			English	Article							CELL-ADHESION; X-RAY; MICROSCOPY; RECEPTOR; GLYCOPOLYMERS; HYALURONAN; SCATTERING; NANOSCALE; DYNAMICS; TENSION	Malignartcy is associated with altered expression of glycans and glycoprotems that contribute the cellular glycocalyx. We constructed a glycoprotein expression signature, which revealed that metastatic tumours upregulate expression of bulky glycoproteins. A computational model predicted that these glycoproteins would influence transmembrane receptor spatial organization and function. We tested this prediction by investigating whether bulky glycoproteins in the glycocalyx promote a tumour phenotype in human cells by increasing integrin adhesion and signalling. Our data revealed that a bulky glycocalyx facilitates integrin clustering by funnelling active integrins into adhesions and altering integrin state by applying tension to matrix-bound integrins, independent of actomyosin contractility. Expression of large tumour-associated glycoproteins in non-transformed mammary cells promoted focal adhesion assembly and facilitated integrin dependent growth factor signalling to support cell growth and survival. Clinical studies revealed that large glycoproteins are abundantly expressed on circulating tumour cells from patients with advanced disease. Thus, a bulky glycocalyx is a feature of tumour cells that could foster metastasis by mechanically enhancing cell-surface receptor function.	[Paszek, Matthew J.; DuFort, Christopher C.; Bainer, Russell; Mouw, Janna K.; Lakins, Jonathon N.; Wijekoon, Amanda C.; Cassereau, Luke; Rubashkin, Matthew G.; Weaver, Valerie M.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Paszek, Matthew J.; DuFort, Christopher C.; Bainer, Russell; Mouw, Janna K.; Lakins, Jonathon N.; Wijekoon, Amanda C.; Cassereau, Luke; Rubashkin, Matthew G.; Weaver, Valerie M.] Univ Calif San Francisco, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA; [Paszek, Matthew J.; DuFort, Christopher C.; Bainer, Russell; Wijekoon, Amanda C.; Cassereau, Luke; Rubashkin, Matthew G.; Weaver, Valerie M.] Univ Calif Berkeley, Bay Area Phys Sci Oncol Program, Berkeley, CA 94720 USA; [Paszek, Matthew J.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Paszek, Matthew J.] Cornell Univ, Cornell Nanoscale Sci, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Paszek, Matthew J.] Cornell Univ, Cornell Nanoscale Sci, Kavli Inst, Ithaca, NY 14853 USA; [Rossier, Olivier; Giannone, Gregory] Univ Bordeaux, UMR 5297, Interdisciplinary Inst Neurosci, F-33000 Bordeaux, France; [Rossier, Olivier; Giannone, Gregory] Univ Bordeaux, CNRS, Interdisciplinary Inst Neurosci, UMR 5297, F-33000 Bordeaux, France; [Godula, Kamil; Hudak, Jason E.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Godula, Kamil] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Magbanua, Mark J.; Rugo, Hope S.; Park, John W.; Weaver, Valerie M.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Magbanua, Mark J.; Rugo, Hope S.; Park, John W.] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA; [Thorn, Kurt S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32310 USA; [Hammer, Daniel A.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Hammer, Daniel A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Mol Biol, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Cornell University; Cornell University; Cornell University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of Pennsylvania; University of Pennsylvania; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weaver, VM (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.	Valerie.Weaver@ucsfmedctr.org	Rossier, Olivier M/I-6569-2013	Rossier, Olivier M/0000-0002-6932-931X; Mouw, Janna K/0000-0002-9846-8466; Weaver, Valerie marie/0000-0003-4786-6752; Thorn, Kurt/0000-0001-9310-288X; Giannone, Gregory/0000-0002-0932-1690	Kavli Institute; UCSF Program for Biomedical Breakthrough postdoctoral fellowships; DoD NDSEG Fellowship; NIH Pathway to Independence Award [K99 EB013446-02]; French Ministry of Research; CNRS; ANR grant Nanomotility; INSERM; Fondation ARC pour la Recherche sur le Cancer; Conseil Regional Aquitaine; NIH [AI082292-03A1, 2R01GM059907-13, GM59907]; Breast Cancer Research Foundation; BCRP DOD Era of Hope Scholar Expansion grant [BC122990]; NIH NCI [U54CA163155-01, U54CA143836-01, 1U01 E5019458-01, CA138818-01A1]; France BioImaging [ANR-10-INBS-04-01]; NATIONAL CANCER INSTITUTE [U01CA151925, R01CA138818, U54CA143836, U54CA163155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K99EB013446, R00EB013446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698, R01GM059907] Funding Source: NIH RePORTER	Kavli Institute; UCSF Program for Biomedical Breakthrough postdoctoral fellowships; DoD NDSEG Fellowship; NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Ministry of Research(Ministry of Research, FranceEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR grant Nanomotility(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Conseil Regional Aquitaine(Region Nouvelle-Aquitaine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; BCRP DOD Era of Hope Scholar Expansion grant; NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); France BioImaging(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Gendler, J. Goedhart and M. McMahon for cDNAs, as indicated in the Methods section. We thank A. Walker for bioinformatics support, L. Hauranieh for assistance in CTC analysis, H. Aaron for assistance with FLIM, J. B. Sibarita and M. Lagardere for support in sptPALM analysis, B. Hoffman in design of the FRET sensor, and T. Wittmann in assistance with pbFRET measurements. Image acquisition was partly performed at the Nikon Imaging Center and Biological Imaging Development Center at UCSF and the Berkeley Molecular Imaging Center. This work was supported by the Kavli Institute and UCSF Program for Biomedical Breakthrough postdoctoral fellowships to M.J.P.; DoD NDSEG Fellowship to M.G.R.; NIH GM59907 to C.R.B.; NIH Pathway to Independence Award K99 EB013446-02 to K.G.; French Ministry of Research, CNRS,ANR grant Nanomotility, INSERM, Fondation ARC pour la Recherche sur le Cancer, France BioImaging ANR-10-INBS-04-01, and Conseil Regional Aquitaine to O.R. and G.G.; NIH AI082292-03A1 to D.A.H.; The Breast Cancer Research Foundation to M.J.M., H.S.R. and J.W.P.; NIH 2R01GM059907-13 to C.R.B. and V.M.W.; and BCRP DOD Era of Hope Scholar Expansion grant BC122990, and NIH NCI grants U54CA163155-01, U54CA143836-01, 1U01 E5019458-01, and CA138818-01A1 to V.M.W.	Bono P, 2001, MOL BIOL CELL, V12, P891, DOI 10.1091/mbc.12.4.891; Bruns N, 2009, ANGEW CHEM INT EDIT, V48, P5666, DOI 10.1002/anie.200900554; Chen W, 2012, J CELL BIOL, V199, P497, DOI 10.1083/jcb.201201091; Comoletti D, 2007, STRUCTURE, V15, P693, DOI 10.1016/j.str.2007.04.010; Coombs D, 2004, BIOPHYS J, V86, P1408, DOI 10.1016/S0006-3495(04)74211-3; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dustin ML, 2012, J CLIN INVEST, V122, P1149, DOI 10.1172/JCI58705; Eng ET, 2011, J BIOL CHEM, V286, P35218, DOI 10.1074/jbc.M111.275107; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Friedrichs J, 2010, NAT PROTOC, V5, P1353, DOI 10.1038/nprot.2010.89; Godula K, 2009, J AM CHEM SOC, V131, P10263, DOI 10.1021/ja903114g; Godula K, 2009, ANGEW CHEM INT EDIT, V48, P4973, DOI 10.1002/anie.200805756; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Groves JT, 2007, ANNU REV PHYS CHEM, V58, P697, DOI 10.1146/annurev.physchem.56.092503.141216; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lakins Johnathon N, 2012, Methods Mol Biol, V916, P317, DOI 10.1007/978-1-61779-980-8_24; Lanctot PM, 2007, CURR OPIN CHEM BIOL, V11, P373, DOI 10.1016/j.cbpa.2007.05.032; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lundmark R, 2010, SEMIN CELL DEV BIOL, V21, P363, DOI 10.1016/j.semcdb.2009.11.014; Magbanua MJM, 2013, CANCER RES, V73, P30, DOI 10.1158/0008-5472.CAN-11-3017; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Pankov Roumen, 2009, V522, P261, DOI 10.1007/978-1-59745-413-1_18; Paszek MJ, 2012, NAT METHODS, V9, DOI [10.1038/nmeth.2077, 10.1038/NMETH.2077]; Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Varki A., 2009, ESSENTIALS GLYCOBIOL; Walker JL, 2005, CYTOKINE GROWTH F R, V16, P395, DOI 10.1016/j.cytogfr.2005.03.003	35	427	430	14	268	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					319	+		10.1038/nature13535	http://dx.doi.org/10.1038/nature13535			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030168	Green Accepted			2022-12-28	WOS:000338992200029
J	Fleurence, RL; Forsythe, LP; Lauer, M; Rotter, J; Ioannidis, JPA; Beal, A; Frank, L; Selby, JV				Fleurence, Rachael L.; Forsythe, Laura P.; Lauer, Michael; Rotter, Jason; Ioannidis, John P. A.; Beal, Anne; Frank, Lori; Selby, Joseph V.			Engaging Patients and Stakeholders in Research Proposal Review: The Patient-Centered Outcomes Research Institute	ANNALS OF INTERNAL MEDICINE			English	Article							BREAST-CANCER RESEARCH	The inaugural round of merit review for the Patient-Centered Outcomes Research Institute (PCORI) in November 2012 included patients and other stakeholders, as well as scientists. This article examines relationships among scores of the 3 reviewer types, changes in scoring after in-person discussion, and the effect of inclusion of patient and stakeholder reviewers on the review process. In the first phase, 363 scientists scored 480 applications. In the second phase, 59 scientists, 21 patients, and 31 stakeholders provided a "prediscussion" score and a final "postdiscussion" score after an in-person meeting for applications. Bland-Altman plots were used to characterize levels of agreement among and within reviewer types before and after discussion. Before discussion, there was little agreement among average scores given by the 4 lead scientific reviewers and patient and stakeholder reviewers. After discussion, the 4 primary reviewers showed mild convergence in their scores, and the 21-member panel came to a much stronger agreement. Of the 25 awards with the best (and lowest) scores after phase 2, only 13 had ranked in the top 25 after the phase 1 review by scientists. Five percent of the 480 proposals submitted were funded. The authors conclude that patient and stakeholder reviewers brought different perspectives to the review process but that in-person discussion led to closer agreement among reviewer types. It is not yet known whether these conclusions are generalizable to future rounds of peer review. Future work would benefit from additional data collection for evaluation purposes and from long-term evaluation of the effect on the funded research.	[Fleurence, Rachael L.] Patient Ctr Outcomes Res Inst, Washington, DC 20036 USA; NHLBI, NIH, Bethesda, MD 20892 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Stanford University	Fleurence, RL (corresponding author), Patient Ctr Outcomes Res Inst, 1828 L St,Suite 900, Washington, DC 20036 USA.	rfleurence@pcori.org	Ioannidis, John P. A./G-9836-2011					Andejeski Y, 2002, J WOMEN HEALTH GEN-B, V11, P119, DOI 10.1089/152460902753645263; Andejeski Y, 2002, J WOMEN HEALTH GEN-B, V11, P379, DOI 10.1089/152460902317586010; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boudreau K, 2012, 13053 HBS; Kotchen TAS, 2012, PEER REV RES PRIORIT; National Institutes of Health, 2008, 2007 2008 P IN PRESS; Nicholson JM, 2012, NATURE, V492, P34, DOI 10.1038/492034a; Patient-Centered Outcomes Research Institute Methodology Committee, 2013, PCORI METH REP; Rich I M, 1998, Breast Dis, V10, P33; Statacorp, 2011, STAT 12 BAS REF MAN; StataCorp, 2011, STAT STAT SOFTW REL; Washington A Eugene, 2011, N Engl J Med, V365, pe31, DOI 10.1056/NEJMp1109407	13	46	46	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2					122	+		10.7326/M13-2412	http://dx.doi.org/10.7326/M13-2412			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023251				2022-12-28	WOS:000339764600021
J	Hoffman, RM				Hoffman, Richard M.			In persons at average risk, stool DNA tests had higher sensitivity than FIT for detecting colorectal cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ New Mexico, Albuquerque, NM 87131 USA	University of New Mexico	Hoffman, RM (corresponding author), Univ New Mexico, Albuquerque, NM 87131 USA.			Hoffman, Richard/0000-0002-4714-7726				Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Ouyang DL, 2005, AM J GASTROENTEROL, V100, P1393, DOI 10.1111/j.1572-0241.2005.41427.x; Pickhardt PJ, 2011, RADIOLOGY, V259, P393, DOI 10.1148/radiol.11101887	3	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2							JC10	10.7326/0003-4819-161-2-201407150-02010	http://dx.doi.org/10.7326/0003-4819-161-2-201407150-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023264				2022-12-28	WOS:000339764600013
J	Tollanes, MC; Wilcox, AJ; Lie, RT; Moster, D				Tollanes, Mette C.; Wilcox, Allen J.; Lie, Rolv T.; Moster, Dag			Familial risk of cerebral palsy: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GESTATIONAL-AGE; BIRTHS; ASSOCIATIONS; SURVEILLANCE; AGGREGATION; RECURRENCE; NORWAY	Objective To investigate risks of recurrence of cerebral palsy in family members with various degrees of relatedness to elucidate patterns of hereditability. Design Population based cohort study. Setting Data from the Medical Birth Registry of Norway, linked to the Norwegian social insurance scheme to identify cases of cerebral palsy and to databases of Statistics Norway to identify relatives. Participants 2 036 741 Norwegians born during 1967-2002, 3649 of whom had a diagnosis of cerebral palsy; 22 558 pairs of twins, 1 851 144 pairs of first degree relatives, 1 699 856 pairs of second degree relatives, and 5 165 968 pairs of third degree relatives were identified. Main outcome measure Cerebral palsy. Results If one twin had cerebral palsy, the relative risk of recurrence of cerebral palsy was 15.6 (95% confidence interval 9.8 to 25) in the other twin. In families with an affected singleton child, risk was increased 9.2 (6.4 to 13)-fold in a subsequent full sibling and 3.0 (1.1 to 8.6)-fold in a half sibling. Affected parents were also at increased risk of having an affected child (6.5 (1.6 to 26)-fold). No evidence was found of differential transmission through mothers or fathers, although the study had limited power to detect such differences. For people with an affected first cousin, only weak evidence existed for an increased risk (1.5 (0.9 to 2.7)-fold). Risks in siblings or cousins were independent of sex of the index case. After exclusion of preterm births (an important risk factor for cerebral palsy), familial risks remained and were often stronger. Conclusions People born into families in which someone already has cerebral palsy are themselves at elevated risk, depending on their degree of relatedness. Elevated risk may extend even to third degree relatives (first cousins). The patterns of risk suggest multifactorial inheritance, in which multiple genes interact with each other and with environmental factors. These data offer additional evidence that the underlying causes of cerebral palsy extend beyond the clinical management of delivery.	[Tollanes, Mette C.; Lie, Rolv T.; Moster, Dag] Univ Bergen, Dept Global Publ Hlth & Primary Care, N-5020 Bergen, Norway; [Wilcox, Allen J.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Lie, Rolv T.; Moster, Dag] Natl Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway; [Moster, Dag] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway	University of Bergen; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Bergen; Haukeland University Hospital	Tollanes, MC (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, PB 7804, N-5020 Bergen, Norway.	mette.tollanes@igs.uib.no	Wilcox, Allen J/C-7723-2019	Wilcox, Allen J/0000-0002-3376-1311	University of Bergen; Western Norway Regional Health Authority; National Institute of Environmental Health Sciences, National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049027, ZIAES044003] Funding Source: NIH RePORTER	University of Bergen; Western Norway Regional Health Authority; National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study has been supported by grants from the University of Bergen and the Western Norway Regional Health Authority and by the Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health. The authors' institutions had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.	Andersen GL, 2008, EUR J PAEDIATR NEURO, V12, P4, DOI 10.1016/j.ejpn.2007.05.001; Blair E, 2006, SEMIN FETAL NEONAT M, V11, P117, DOI 10.1016/j.siny.2005.10.010; Braun KV, 2005, PAEDIATR PERINAT EP, V19, P69, DOI 10.1111/j.1365-3016.2004.00597.x; Cans C, 2002, DEV MED CHILD NEUROL, V44, P633; FOLEY J, 1992, DEV MED CHILD NEUROL, V34, P972; GRETHER JK, 1993, PEDIATRICS, V92, P854; Guo SW, 2000, AM J EPIDEMIOL, V151, P1121, DOI 10.1093/oxfordjournals.aje.a010156; GUSTAVSON KH, 1969, ACTA PAEDIATR SCAND, V58, P330, DOI 10.1111/j.1651-2227.1969.tb04729.x; Hammer H, 2002, TIDSSKR NOR LEGEFORE, V122, P1; Hemminki K, 2007, PAEDIATR PERINAT EP, V21, P235, DOI 10.1111/j.1365-3016.2007.00798.x; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; KHOURY MJ, 1988, AM J EPIDEMIOL, V127, P674, DOI 10.1093/oxfordjournals.aje.a114842; Liu JM, 2000, INT J EPIDEMIOL, V29, P292, DOI 10.1093/ije/29.2.292; MCGUE M, 1992, SCHIZOPHRENIA BULL, V18, P171, DOI 10.1093/schbul/18.2.171; McIntyre S, 2013, DEV MED CHILD NEUROL, V55, P499, DOI 10.1111/dmcn.12017; Melve KK, 1999, AM J EPIDEMIOL, V150, P756; Moster D, 2001, J PEDIATR-US, V138, P798, DOI 10.1067/mpd.2001.114694; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Nelson KB, 2008, CLIN OBSTET GYNECOL, V51, P749, DOI 10.1097/GRF.0b013e318187087c; O'Callaghan ME, 2009, HUM GENET, V126, P149, DOI 10.1007/s00439-009-0638-5; O'Callaghan ME, 2013, J PAEDIATR CHILD H, V49, P575, DOI 10.1111/jpc.12279; O'Callaghan ME, 2012, PEDIATRICS, V129, pE414, DOI 10.1542/peds.2011-0739; O'Callaghan ME, 2011, OBSTET GYNECOL, V118, P576, DOI 10.1097/AOG.0b013e31822ad2dc; Paneth N, 2008, CLIN OBSTET GYNECOL, V51, P742, DOI 10.1097/GRF.0b013e318187081a; PETTERSON B, 1993, BRIT MED J, V307, P1239, DOI 10.1136/bmj.307.6914.1239; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Stanley F, 2000, CLIN DEV MED; Tan SS, 2014, DEV MED CHILD NEUROL, V56, P370, DOI 10.1111/dmcn.12343; Tissot R, HUMAN GENETICS 1 YEA	30	31	34	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2014	349								g4294	10.1136/bmj.g4294	http://dx.doi.org/10.1136/bmj.g4294			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7OZ	25028249	Green Published, hybrid			2022-12-28	WOS:000339325400002
J	Decker, MR; Crago, AL; Chu, SKH; Sherman, SG; Seshu, MS; Buthelezi, K; Dhaliwal, M; Beyrer, C				Decker, Michele R.; Crago, Anna-Louise; Chu, Sandra K. H.; Sherman, Susan G.; Seshu, Meena S.; Buthelezi, Kholi; Dhaliwal, Mandeep; Beyrer, Chris			Human rights violations against sex workers: burden and effect on HIV	LANCET			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; INJECTION-DRUG USE; ANDHRA-PRADESH; HEALTH-CARE; ANTIRETROVIRAL PROPHYLAXIS; SELLING SEX; CONDOM USE; FEMALE; VIOLENCE; RISK	We reviewed evidence from more than 800 studies and reports on the burden and HIV implications of human rights violations against sex workers. Published research documents widespread abuses of human rights perpetrated by both state and non-state actors. Such violations directly and indirectly increase HIV susceptibility, and undermine effective HIV-prevention and intervention efforts. Violations include homicide; physical and sexual violence, from law enforcement, clients, and intimate partners; unlawful arrest and detention; discrimination in accessing health services; and forced HIV testing. Abuses occur across all policy regimes, although most profoundly where sex work is criminalised through punitive law. Protection of sex workers is essential to respect, protect, and meet their human rights, and to improve their health and wellbeing. Research findings affirm the value of rights-based HIV responses for sex workers, and underscore the obligation of states to uphold the rights of this marginalised population.	[Decker, Michele R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21212 USA; [Decker, Michele R.; Sherman, Susan G.; Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21212 USA; [Sherman, Susan G.; Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21212 USA; [Crago, Anna-Louise] Univ Toronto, Toronto, ON, Canada; [Chu, Sandra K. H.] Canadian HIV AIDS Legal Network, Toronto, ON, Canada; [Seshu, Meena S.] Sampada Grameen Mahila Sanstha SANGRAM, Sangli, India; [Buthelezi, Kholi] Sex Workers Educ & Advocacy Taskforce SWEAT, Sisonke Sex Workers Movement, Cape Town, South Africa; [Dhaliwal, Mandeep] Div HIV Hlth & Dev Practice UNDP, New York, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Toronto	Decker, MR (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Womens Hlth & Rights Program, Ctr Publ Hlth & Human Rights, Baltimore, MD 21212 USA.	mdecker@jhu.edu		Decker, Michele/0000-0002-7085-7080	Bill & Melinda Gates Foundation; UN Population Fund; Johns Hopkins University Center for AIDS Research, a programme - National Institute of Health [1P30AI094189]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UN Population Fund; Johns Hopkins University Center for AIDS Research, a programme - National Institute of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This Review and The Lancet Series on HIV and sex work were supported by grants to the Center for Public Health and Human Rights at Johns Hopkins Bloomberg School of Public Health from The Bill & Melinda Gates Foundation, The UN Population Fund, and the Johns Hopkins University Center for AIDS Research, a programme funded by the National Institute of Health (1P30AI094189) supported by the following NIH co-funding and participating institutes and centres: National Institutes of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), National Institute for Child Health and Development (NICHD), National Heart, Lung, and Blood Institute (NHLBI), National Institute for Drug Abuse (NIDA), National Institute of Mental Health (NIMH), National Institute on Aging (NIA), Fogarty International Center (FIC), and Offi ce of AIDS Research (OAR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. We thank Swathi Manchikanti and Jennifer Parsons for their assistance in the literature review and abstraction, and Claire Twose for advising on our literature search strategy.	Arnott J, 2009, RIGHTS NOT RESCUE RE; Asia Catalyst, 2013, CUST ED ARB DET FEM; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baral SD, 2014, LANCET; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Beattie TSH, 2012, J EPIDEMIOL COMMUN H, V66, pII42, DOI 10.1136/jech-2011-200475; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Beletsky L, 2013, J URBAN HEALTH, V90, P284, DOI 10.1007/s11524-012-9741-3; Braunstein SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024321; Brown, 2021, PEOPLE MANAGEMENT; Bruckert C., 2013, PIMPS PROCURERS PARA; Canadian H., 2005, SEX WORK RIGHTS REF; Chakrapani V, 2009, AIDS PATIENT CARE ST, V23, P973, DOI 10.1089/apc.2009.0035; Chen NE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1000; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen J., 2007, PUBLIC HLTH HUMAN RI, P362; Cohen MH, 2004, AM J PUBLIC HEALTH, V94, P1147, DOI 10.2105/AJPH.94.7.1147; Collins SP, 2013, AIDS CARE, V25, P459, DOI 10.1080/09540121.2012.720361; Committee on the Eliminaion of Discrimination against Women, 2013, COMM ITS 54 SESS; Crago A., 2009, ARREST VIOLENCE HUMA; Crago A. L., 2008, OUR LIVES MATTER SEX; Crago AL, 2014, SIGNS, V39, P365, DOI 10.1086/673087; Csete J, 2010, J LAW MED ETHICS, V38, P816, DOI 10.1111/j.1748-720X.2010.00535.x; Darling KEA, 2013, POSTGRAD MED J, V89, P371, DOI 10.1136/postgradmedj-2012-131001; Decker MR, 2014, AIDS BEHAV, V18, P562, DOI 10.1007/s10461-013-0577-y; Decker MR, 2012, SEX TRANSM INFECT, V88, P278, DOI 10.1136/sextrans-2011-050171; Decker MR, 2011, J EPIDEMIOL COMMUN H, V65, P334, DOI 10.1136/jech.2009.096834; Decker MR, 2009, INT J GYNECOL OBSTET, V107, P151, DOI 10.1016/j.ijgo.2009.06.002; Deering KN, 2013, SEX TRANSM DIS, V40, P168, DOI 10.1097/OLQ.0b013e31827df174; Devine A, 2010, AIDS CARE, V22, P228, DOI 10.1080/09540120903039869; Dimitrov S, 2008, SWAN NEWS, V21; Dyna C, 2010, RES SEX WORK, V12, P27; Empower Foundation, 2012, HIT RUN IMP ANT POL; Erausquin JT, 2011, J INFECT DIS, V204, pS1223, DOI 10.1093/infdis/jir539; George A, 2013, INT J GYNECOL OBSTET, V120, P119, DOI 10.1016/j.ijgo.2012.08.019; Ghahfarokhi SM, 2010, RETROVIROLOGY, V7, P54, DOI 10.1186/1742-4690-7-S1-P130; Ghimire L, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-42; Global Network of Sex Work Projects (NSWP), 2011, CRIM CLIENTS BRIEF P; Goldenberg SM, 2013, JAIDS-J ACQ IMM DEF, V63, P639, DOI 10.1097/QAI.0b013e318296de71; Goldenberg SM, 2012, AIDS BEHAV, V16, P969, DOI 10.1007/s10461-011-0063-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gupta J, 2011, INT J GYNECOL OBSTET, V114, P101, DOI 10.1016/j.ijgo.2011.03.005; Harcourt C, 2010, AUST NZ J PUBL HEAL, V34, P482, DOI 10.1111/j.1753-6405.2010.00594.x; Hawkes S, 2009, SEX TRANSM INFECT, V85, P8, DOI 10.1136/sti.2008.033910; Hosseinkhah M, 2012, EXECUTION WOMEN IRAN; Human Rights Watch, 2010, STREETS ARB DET OTH; Human Rights Watch, 2013, SWEPT AW AB SEX WORK; Infante C, 2009, CULT HEALTH SEX, V11, P125, DOI 10.1080/13691050802431314; International Committee of the Rights of Sex Workers in Europe (ICRSE), EUR C SEX WORK HUM R; International Committee on the Rights of Sex Workers in Europe, 2005, EUR C SEX WORK HUM R; Jamel J, 2011, INT J SEX HEALTH, V23, P63, DOI 10.1080/19317611.2011.537958; Jana S, 2014, J PUBLIC HEALTH-UK, V36, P622, DOI 10.1093/pubmed/fdt095; Jeffreys E., 2012, WORLD J AIDS, V2, DOI [DOI 10.4236/WJA.2012.23026, https://doi.org/10.4236/wja.2012.23026]; Kenya FIDA, 2008, DOC HUM RIGHTS VIOL; Kerrigan D, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9774-9; Kerrigan D, 2014, LANCET; Kerrigan DL, 2013, AIDS BEHAV, V17, P1926, DOI 10.1007/s10461-013-0458-4; Kurtz SP, 2005, J HEALTH CARE POOR U, V16, P345, DOI 10.1353/hpu.2005.0038; Lautz TB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040816; Lazarus L, 2011, SOC SCI MED, V73, P1600, DOI 10.1016/j.socscimed.2011.09.015; Lazarus L, 2012, CULT HEALTH SEX, V14, P139, DOI 10.1080/13691058.2011.628411; Levy J., 2011, BRIT SOC CRIM ANN C; Lowman J, 2011, BEIJING LAW REV, V2, P33, DOI DOI 10.4236/BLR.2011.22005; Magar V, 2012, SIGNS, V37, P619, DOI 10.1086/662698; Maher L, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-30; Makyao N, 2011, SEX TRANSM INFECT, V87, pA40, DOI 10.1136/sextrans-2011-050109.43; Mann Jonathan M, 1994, Health Hum Rights, V1, P6; Mayhew S, 2009, SEX TRANSM INFECT, V85, P31, DOI 10.1136/sti.2008.033670; McLemore M., 2012, SEX WORKERS RISK CON; Mgbako C., 2011, FORDHAM INT LAW J, V33, P1178; Mtetwa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-698; Mugavero MJ, 2009, PSYCHOSOM MED, V71, P920, DOI 10.1097/PSY.0b013e3181bfe8d2; Nemoto T, 2011, AM J PUBLIC HEALTH, V101, P1980, DOI 10.2105/AJPH.2010.197285; Office of the United Nations High Commissioner for Human Rights, 2006, INT GUID HIV AIDS HU; Okal J, 2011, AIDS CARE, V23, P612, DOI 10.1080/09540121.2010.525605; Okanlawon K, 2013, CULT HEALTH SEX, V15, P22, DOI 10.1080/13691058.2012.754053; Oppal WallyT., 2012, FORSAKEN REPORT MISS; OSF, 2013, BRING JUST HLTH IMP; OSF Sexual Health and Rights Project, 2012, CRIM COND; Overs C, 2008, CAUGHT TIGER CROCODI; Overs C, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S3-S6; Pando MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054147; Pavlos S, 2013, LANCET INFECT DIS, V13, P649, DOI 10.1016/S1473-3099(13)70186-5; Poteat T, 2014, LANCET; Potterat JJ, 2004, AM J EPIDEMIOL, V159, P778, DOI 10.1093/aje/kwh110; Punyam S, 2012, J EPIDEMIOL COMMUN H, V66, pII87, DOI 10.1136/jech-2011-200478; Renzaho A. M. N., 2009, Open Tropical Medicine Journal, V2, P27, DOI 10.2174/1874315300902010027; Reza-Paul S, 2012, INDIAN J MED RES, V135, P98, DOI 10.4103/0971-5916.93431; Rhodes T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a811; Richter M, 2014, J IMMIGR MINOR HEALT, V16, P7, DOI 10.1007/s10903-012-9758-4; Saggurti N, 2011, J BIOSOC SCI, V43, P535, DOI 10.1017/S0021932011000277; Sarkar K, 2008, J HEALTH POPUL NUTR, V26, P223; Scorgie F, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-33; Scorgie F, 2013, CULT HEALTH SEX, V15, P450, DOI 10.1080/13691058.2012.763187; Sex-Worker Forum of Vienna Austria, 2013, SHAD REP PERS SYST V; Shahmanesh M, 2009, JAIDS-J ACQ IMM DEF, V52, P253, DOI 10.1097/QAI.0b013e3181ab6d75; Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858; Silverman JG, 2011, J INFECT DIS; Simic M, 2009, SOCIOL HEALTH ILL, V31, P1, DOI 10.1111/j.1467-9566.2008.01112.x; Sirotin N, 2010, PUBLIC HEALTH REP, V125, P101, DOI 10.1177/00333549101250S414; Sorfleet A, 2005, EUR C SEX WORK HUM R; Strathdee SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019048; Surratt HL, 2012, AIDS CARE, V24, P553, DOI 10.1080/09540121.2011.630342; SZEXE Association of Hungarian Sex Workers, 2013, REP VIOL DISCR FEM S; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Ulibarri MD, 2011, AIDS BEHAV, V15, P179, DOI 10.1007/s10461-009-9595-1; UNAIDS, 2010, MAK LAW WORK HIV RES; UNAIDS, 2012, UNAIDS GUID NOT HIV; United Nations General Assembly, 2001, REP SPEC RAPP QUEST; United Nations General Assembly, 2010, AHRC1420 UN GEN ASS; Unlu H, 2011, TURK KLIN TIP BILIM, V31, P1167, DOI 10.5336/medsci.2010-21228; Wilson E, 2011, CULT HEALTH SEX, V13, P253, DOI 10.1080/13691058.2010.524247; Wilson E, 2010, RETROVIROLOGY, V7, P52, DOI 10.1186/1742-4690-7-S1-P122; Wong WCW, 2011, SOCIOL HEALTH ILL, V33, P50, DOI 10.1111/j.1467-9566.2010.01276.x; Yi HS, 2012, GLOB PUBLIC HEALTH, V7, P840, DOI 10.1080/17441692.2012.662991; Zhang C, 2013, AIDS CARE, V25, P503, DOI 10.1080/09540121.2012.726345	116	203	203	1	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2015	385	9963					186	199		10.1016/S0140-6736(14)60800-X	http://dx.doi.org/10.1016/S0140-6736(14)60800-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY7BI	25059943	Green Accepted			2022-12-28	WOS:000347715900026
J	Fridman, O; Goldberg, A; Ronin, I; Shoresh, N; Balaban, NQ				Fridman, Ofer; Goldberg, Amir; Ronin, Irine; Shoresh, Noam; Balaban, Nathalie Q.			Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations	NATURE			English	Article							ESCHERICHIA-COLI; PERSISTENCE; AMPICILLIN; RESISTANCE; EVOLUTION	The great therapeutic achievements of antibiotics have been dramatically undercut by the evolution of bacterial strategies that overcome antibiotic stress(1),(2). These strategies fall into two classes. 'Resistance' makes it possible for a microorganism to grow in the constant presence of the antibiotic, provided that the concentration of the antibiotic is not too high. 'Tolerance' allows a microorganism to survive antibiotic treatment, even at high antibiotic concentrations, as long as the duration of the treatment is limited. Although both resistance and tolerance are important reasons for the failure of antibiotic treatments(3-6), the evolution of resistance(7-9) is much better understood than that of tolerance. Here we followed the evolution of bacterial populations under intermittent exposure to the high concentrations of antibiotics used in the clinic and characterized the evolved strains in terms of both resistance and tolerance. We found that all strains adapted by specific genetic mutations, which became fixed in the evolved populations. By monitoring the phenotypic changes at the population and single-cell levels, we found that the first adaptive change to antibiotic stress was the development of tolerance through a major adjustment in the single-cell lag-time distribution, without a change in resistance. Strikingly, we found that the lag time of bacteria before regrowth was optimized to match the duration of the antibiotic-exposure interval. Whole genome sequencing of the evolved strains and restoration of the wild-type alleles allowed us to identify target genes involved in this antibiotic-driven phenotype: 'tolerance by lag' (tbl). Better understanding of lag-time evolution as a key determinant of the survival of bacterial populations under high antibiotic concentrations could lead to new approaches to impeding the evolution of antibiotic resistance.	[Fridman, Ofer; Goldberg, Amir; Ronin, Irine; Balaban, Nathalie Q.] Hebrew Univ Jerusalem, Sudarsky Ctr Computat Biol, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Fridman, Ofer; Goldberg, Amir; Ronin, Irine; Balaban, Nathalie Q.] Hebrew Univ Jerusalem, Ctr NanoSci, IL-91904 Jerusalem, Israel; [Shoresh, Noam] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Balaban, NQ (corresponding author), Hebrew Univ Jerusalem, Sudarsky Ctr Computat Biol, Racah Inst Phys, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	nathalieqb@phys.huji.ac.il	Balaban, Nathalie/AAH-1004-2019; Balaban, Nathalie/AGI-1487-2022	Balaban, Nathalie/0000-0001-8018-0766; Balaban, Nathalie/0000-0001-8018-0766	European Research Council [260871]; Israel Science Foundation [592/10]; Levtzion Fellowship	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Levtzion Fellowship	We thank I. Levin-Riesman for discussions and technical help with the ScanLag system, S. Belkin for strains, and the National BioResource Project and National Institute of Genetics, Japan, for the Keio collection deletion mutants. The work was supported by the European Research Council (Starting Grant no. 260871) and the Israel Science Foundation (no. 592/10). O.F. acknowledges support from the Levtzion Fellowship.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Baranyi J, 2002, INT J FOOD MICROBIOL, V73, P203, DOI 10.1016/S0168-1605(01)00650-X; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; BLACK DS, 1991, J BACTERIOL, V173, P5732, DOI 10.1128/jb.173.18.5732-5739.1991; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Cohen NR, 2013, CELL HOST MICROBE, V13, P632, DOI 10.1016/j.chom.2013.05.009; Collignon PJ, 2002, MED J AUSTRALIA, V177, P325, DOI 10.5694/j.1326-5377.2002.tb04794.x; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Germain E, 2013, MOL CELL, V52, P248, DOI 10.1016/j.molcel.2013.08.045; GILBERT P, 1990, ANTIMICROB AGENTS CH, V34, P1865, DOI 10.1128/AAC.34.10.1865; Girgis HS, 2012, P NATL ACAD SCI USA, V109, P12740, DOI 10.1073/pnas.1205124109; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Kaspy I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4001; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Levin-Reisman I, 2010, NAT METHODS, V7, P737, DOI 10.1038/nmeth.1485; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Nahata MC, 1999, ANTIMICROB AGENTS CH, V43, P1225, DOI 10.1128/AAC.43.5.1225; OLSSON O, 1983, P NATL ACAD SCI-BIOL, V80, P7556, DOI 10.1073/pnas.80.24.7556; Oxman E, 2008, EVOLUTION, V62, P1547, DOI 10.1111/j.1558-5646.2008.00397.x; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; WOLFSON JS, 1990, ANTIMICROB AGENTS CH, V34, P1938, DOI 10.1128/AAC.34.10.1938	30	314	324	18	241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					418	+		10.1038/nature13469	http://dx.doi.org/10.1038/nature13469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043002				2022-12-28	WOS:000341814900060
J	Huerta-Sanchez, E; Jin, X; Asan; Bianba, Z; Peter, BM; Vinckenbosch, N; Liang, Y; Yi, X; He, MZ; Somel, M; Ni, PX; Wang, B; Ou, XH; Huasang; Luosang, JB; Cuo, ZXP; Li, K; Gao, GY; Yin, Y; Wang, W; Zhang, XQ; Xu, X; Yang, HM; Li, YR; Wang, J; Wang, J; Nielsen, R				Huerta-Sanchez, Emilia; Jin, Xin; Asan; Bianba, Zhuoma; Peter, Benjamin M.; Vinckenbosch, Nicolas; Liang, Yu; Yi, Xin; He, Mingze; Somel, Mehmet; Ni, Peixiang; Wang, Bo; Ou, Xiaohua; Huasang; Luosang, Jiangbai; Cuo, Zha Xi Ping; Li, Kui; Gao, Guoyi; Yin, Ye; Wang, Wei; Zhang, Xiuqing; Xu, Xun; Yang, Huanming; Li, Yingrui; Wang, Jian; Wang, Jun; Nielsen, Rasmus			Altitude adaptation in Tibetans caused by introgression of Denisovan-like DNA	NATURE			English	Article							HEMOGLOBIN CONCENTRATION; POSITIVE SELECTION; GENOME SEQUENCE; RECOMBINATION; SAMPLES; PIGMENTATION; PREGNANCY; ANCESTRY; SIGNALS	As modern humans migrated out of Africa, they encountered many new environmental conditions, including greater temperature extremes, different pathogens and higher altitudes. These diverse environments are likely to have acted as agents of natural selection and to have led to local adaptations. One of the most celebrated examples in humans is the adaptation of Tibetans to the hypoxic environment of the high-altitude Tibetan plateau(1-3). A hypoxia pathway gene, EPAS1, was previously identified as having the most extreme signature of positive selection in Tibetans(4-10), and was shown to be associated with differences in haemoglobin concentration at high altitude. Re-sequencing the region around EPAS1 in 40 Tibetan and 40 Han individuals, we find that this gene has a highly unusual haplotype structure that can only be convincingly explained by introgression of DNA from Denisovan or Denisovan-related individuals into humans. Scanning a larger set of worldwide populations, we find that the selected haplotype is only found in Denisovans and in Tibetans, and at very low frequency among Han Chinese. Furthermore, the length of the haplotype, and the fact that it is not found in any other populations, makes it unlikely that the haplotype sharing between Tibetans and Denisovans was caused by incomplete ancestral lineage sorting rather than introgression. Our findings illustrate that admixture with other hominin species has provided genetic variation that helped humans to adapt to new environments.	[Huerta-Sanchez, Emilia; Jin, Xin; Asan; Liang, Yu; Yi, Xin; He, Mingze; Somel, Mehmet; Ni, Peixiang; Wang, Bo; Ou, Xiaohua; Huasang; Luosang, Jiangbai; Yin, Ye; Wang, Wei; Zhang, Xiuqing; Xu, Xun; Yang, Huanming; Li, Yingrui; Wang, Jian; Wang, Jun; Nielsen, Rasmus] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Huerta-Sanchez, Emilia; Peter, Benjamin M.; Vinckenbosch, Nicolas; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Huerta-Sanchez, Emilia] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA; [Jin, Xin] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Asan; Liang, Yu; Yi, Xin] BGI Tianjin, Binhai Genom Inst, Tianjin 300308, Peoples R China; [Asan; Liang, Yu; Yi, Xin] BGI Tianjin, Tianjin Translat Genom Ctr, Tianjin 300308, Peoples R China; [Bianba, Zhuoma] Peoples Hosp Lhasa, Lhasa 850000, Peoples R China; [He, Mingze] Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA 50011 USA; [Somel, Mehmet] Middle E Tech Univ, Dept Biol Sci, TR-06800 Ankara, Turkey; [Cuo, Zha Xi Ping] Second Peoples Hosp Tibet Autonomous Reg, Lhasa 850000, Peoples R China; [Li, Kui] Peoples Hosp Tibet Autonomous Reg, Lhasa 850000, Peoples R China; [Gao, Guoyi] Hosp XiShuangBanNa Dai Nationalities, Autonomous Jinghong 666100, Yunnan, Peoples R China; [Zhang, Xiuqing] BGI Shenzhen, Guangdong Enterprise Key Lab Human Dis Genom, Shenzhen 518083, Peoples R China; [Zhang, Xiuqing] BGI Shenzhen, Shenzhen Key Lab Trans Biotechnol, Shenzhen 518083, Peoples R China; [Yang, Huanming; Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah 21589, Saudi Arabia; [Yang, Huanming; Wang, Jian] James D Watson Inst Genome Sci, Hangzhou 310008, Zhejiang, Peoples R China; [Wang, Jun; Nielsen, Rasmus] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] Macau Univ Sci & Technol, Taipa 999078, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong 999077, Hong Kong, Peoples R China; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	Beijing Genomics Institute (BGI); University of California System; University of California Berkeley; University of California System; University of California Merced; South China University of Technology; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Iowa State University; Middle East Technical University; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); King Abdulaziz University; University of Copenhagen; Macau University of Science & Technology; University of Hong Kong; University of California System; University of California Berkeley	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	wangjian@genomics.cn; wangj@genomics.cn; rasmus_nielsen@berkeley.edu	Jin, Xin/ABF-1329-2020; Xu, Xun/AAI-6763-2020; Li, Yingrui/K-1064-2015; Somel, Mehmet/B-1471-2016; Wang, Jun/C-8434-2016; Nielsen, Rasmus/D-4405-2009; Wang, Jun/B-9503-2016	Jin, Xin/0000-0001-7554-4975; Xu, Xun/0000-0002-5338-5173; He, Mingze/0000-0002-8164-2480; Wang, Jun/0000-0002-8540-8931; Nielsen, Rasmus/0000-0003-0513-6591; Somel, Mehmet/0000-0002-3138-1307; Wang, Jun/0000-0002-2113-5874	973 Program [2011CB809203, 2012CB518201, 2011CB809201, 2011CB809202]; State Key Development Program for Basic Research of China; China National GeneBank-Shenzhen; Shenzhen Key Laboratory of Transomics Biotechnologies [CXB201108250096A]; US NIH [R01HG003229, R01HG003229-08S2]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	973 Program(National Basic Research Program of China); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); China National GeneBank-Shenzhen; Shenzhen Key Laboratory of Transomics Biotechnologies; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was funded by the State Key Development Program for Basic Research of China, 973 Program (2011CB809203, 2012CB518201, 2011CB809201, 2011CB809202), China National GeneBank-Shenzhen and Shenzhen Key Laboratory of Transomics Biotechnologies (no. CXB201108250096A). This work was also supported by research grants from the US NIH; R01HG003229 to R.N. and R01HG003229-08S2 to E.H.S. We thank F. Jay, M. Liang and F. Casey for useful discussions.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Mendez FL, 2012, AM J HUM GENET, V91, P265, DOI 10.1016/j.ajhg.2012.06.015; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Moore LG, 2004, PLACENTA, V25, pS60, DOI 10.1016/j.placenta.2004.01.008; Moore LG, 2001, AM J HUM BIOL, V13, P635, DOI 10.1002/ajhb.1102; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Niermeyer S, 2009, ARCH DIS CHILD, V94, P806, DOI 10.1136/adc.2008.141838; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; REYNOLDS J, 1983, GENETICS, V105, P767; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sankararaman S, 2014, NATURE; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; Soejima M, 2007, INT J LEGAL MED, V121, P36, DOI 10.1007/s00414-006-0112-z; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Teshima KM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-166; Vargas EE, 2006, HIGH ALT MED BIOL, V7, P138, DOI 10.1089/ham.2006.7.138; Vernot B., 2014, SCIENCE; Wang BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017002; Wu TY, 2005, J APPL PHYSIOL, V98, P598, DOI 10.1152/japplphysiol.01034.2002; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yip R, 2000, AM J CLIN NUTR, V72, p272S, DOI 10.1093/ajcn/72.1.272S	43	551	577	32	492	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					194	+		10.1038/nature13408	http://dx.doi.org/10.1038/nature13408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043035	Green Submitted, Green Accepted			2022-12-28	WOS:000340200700032
J	Whitney, JB; Hill, AL; Sanisetty, S; Penaloza-MacMaster, P; Liu, JY; Shetty, M; Parenteau, L; Cabral, C; Shields, J; Blackmore, S; Smith, JY; Brinkman, AL; Peter, LE; Mathew, SI; Smith, KM; Borducchi, EN; Rosenbloom, DIS; Lewis, MG; Hattersley, J; Li, B; Hesselgesser, J; Geleziunas, R; Robb, ML; Kim, JH; Michael, NL; Barouch, DH				Whitney, James B.; Hill, Alison L.; Sanisetty, Srisowmya; Penaloza-MacMaster, Pablo; Liu, Jinyan; Shetty, Mayuri; Parenteau, Lily; Cabral, Crystal; Shields, Jennifer; Blackmore, Stephen; Smith, Jeffrey Y.; Brinkman, Amanda L.; Peter, Lauren E.; Mathew, Sheeba I.; Smith, Kaitlin M.; Borducchi, Erica N.; Rosenbloom, Daniel I. S.; Lewis, Mark G.; Hattersley, Jillian; Li, Bei; Hesselgesser, Joseph; Geleziunas, Romas; Robb, Merlin L.; Kim, Jerome H.; Michael, Nelson L.; Barouch, Dan H.			Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys	NATURE			English	Article							ANTIRETROVIRAL THERAPY; LATENT RESERVOIR; HIV-1 INFECTION; REPLICATION; VACCINE; PREVENTION; INITIATION; DYNAMICS; DEPENDS; ASSAY	The viral reservoir represents a critical challenge for human immunodeficiency virus type 1 (HIV-1) eradication strategies(1-5). However, it remains unclear when and where the viral reservoir is seeded during acute infection and the extent to which it is susceptible to early anti-retroviral therapy (ART). Here we show that the viral reservoir is seeded rapidly after mucosal simian immunodeficiency virus (SIV) infection of rhesus monkeys and before systemic viraemia. We initiated suppressive ART in groups of monkeys on days 3, 7, 10 and 14 after intrarectal SIVMAC251 infection. Treatment with ART on day 3 blocked the emergence of viral RNA and proviral DNA in peripheral blood and also substantially reduced levels of proviral DNA in lymph nodes and gastrointestinal mucosa as compared with treatment at later time points. In addition, treatment on day 3 abrogated the induction of SIV-specific humoral and cellular immune responses. Nevertheless, after discontinuation of ART following 24 weeks of fully suppressive therapy, virus rebounded in all animals, although the monkeys that were treated on day 3 exhibited a delayed viral rebound as compared with those treated on days 7, 10 and 14. The time to viral rebound correlated with total viraemia during acute infection and with proviral DNA at the time of ART discontinuation. These data demonstrate that the viral reservoir is seeded rapidly after intrarectal SIV infection of rhesus monkeys, during the 'eclipse' phase, and before detectable viraemia. This strikingly early seeding of the refractory viral reservoir raises important new challenges for HIV-1 eradication strategies.	[Whitney, James B.; Sanisetty, Srisowmya; Penaloza-MacMaster, Pablo; Liu, Jinyan; Shetty, Mayuri; Parenteau, Lily; Cabral, Crystal; Shields, Jennifer; Blackmore, Stephen; Smith, Jeffrey Y.; Brinkman, Amanda L.; Peter, Lauren E.; Mathew, Sheeba I.; Smith, Kaitlin M.; Borducchi, Erica N.; Barouch, Dan H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Whitney, James B.; Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Hill, Alison L.; Rosenbloom, Daniel I. S.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA; [Hattersley, Jillian; Li, Bei; Hesselgesser, Joseph; Geleziunas, Romas] Gilead Sci Inc, Foster City, CA 94404 USA; [Robb, Merlin L.; Kim, Jerome H.; Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; BIOQUAL Inc.; Gilead Sciences; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Barouch, DH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019; Hill, Alison Lynn/W-7839-2019	Hill, Alison Lynn/0000-0002-6583-3623; Peter, Lauren/0000-0002-2105-7503; Brinkman, Amanda/0000-0002-2845-6494	US Army Medical Research and Material Command; US Military HIV Research Program; Henry M. Jackson Foundation for the Advancement of Military Medicine [W81XWH-07-2-0067, W81XWH-11-2-0174]; NIH [AI060354, AI078526, AI084794, AI095985, AI096040, AI100645]; Ragon Institute of MGH, MIT and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084794, U19AI095985, UM1AI100645, T32AI007245, P30AI060354, UM1AI100663, U19AI096040, R56AI091514, U19AI078526] Funding Source: NIH RePORTER	US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); US Military HIV Research Program; Henry M. Jackson Foundation for the Advancement of Military Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of MGH, MIT and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Pensiero, M. Marovich, C. Dieffenbach, W. Wagner, C. Gittens, J. Yalley-Ogunro, M. Nowak, R. Siliciano, D. Persaud, S. Deeks, N. Chomont, J. Ananworanich, L. Picker, F. Stephens, R. Hamel, K. Kelly and L. Dunne for advice, assistance and reagents. The SIV<INF>MAC239</INF> peptides were obtained from the National Institutes of Health (NIH) AIDS Research and Reference Reagent Program. We acknowledge support from the US Army Medical Research and Material Command and the US Military HIV Research Program through its cooperative agreement with the Henry M. Jackson Foundation for the Advancement of Military Medicine (W81XWH-07-2-0067, W81XWH-11-2-0174); the NIH (AI060354, AI078526, AI084794, AI095985, AI096040, AI100645); and the Ragon Institute of MGH, MIT and Harvard. The views expressed in this manuscript are those of the authors and do not represent the official views of the Department of the Army or the Department of Defense.	Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Archin NM, 2012, P NATL ACAD SCI USA, V109, P9523, DOI 10.1073/pnas.1120248109; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cline AN, 2005, J MED PRIMATOL, V34, P303; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hocqueloux L, 2013, J ANTIMICROB CHEMOTH, V68, P1169, DOI 10.1093/jac/dks533; Liu JY, 2012, J VIROL, V86, P7829, DOI 10.1128/JVI.00512-12; Liu JY, 2010, J VIROL, V84, P10406, DOI 10.1128/JVI.01155-10; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Nowak MA, 1997, J VIROL, V71, P7518, DOI 10.1128/JVI.71.10.7518-7525.1997; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Persaud D, 2003, J VIROL, V77, P1659, DOI 10.1128/JVI.77.3.1659-1665.2003; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Rosenberg ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010555; Rosenbloom DIS, 2012, NAT MED, V18, P1378, DOI 10.1038/nm.2892; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Steingrover R, 2008, AIDS, V22, P1583, DOI 10.1097/QAD.0b013e328305bd77; Stohr W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078287; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; von Wyl V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027463; Whitney JB, 2009, J VIROL, V83, P10840, DOI 10.1128/JVI.01202-09; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	28	393	406	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					74	+		10.1038/nature13594	http://dx.doi.org/10.1038/nature13594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25042999	Green Submitted, Green Accepted			2022-12-28	WOS:000339908000034
J	Fontana, L; Kennedy, BK; Longo, VD				Fontana, Luigi; Kennedy, Brian K.; Longo, Valter D.			Prepare for human testing	NATURE			English	Editorial Material									[Fontana, Luigi] Washington Univ, St Louis, MO 63130 USA; [Fontana, Luigi] Univ Brescia, I-25121 Brescia, Italy; [Kennedy, Brian K.] Buck Inst Res Aging, Novato, CA USA; [Longo, Valter D.] Univ So Calif, Longev Inst, Los Angeles, CA USA	Washington University (WUSTL); University of Brescia; Buck Institute for Research on Aging; University of Southern California	Fontana, L (corresponding author), Washington Univ, St Louis, MO 63130 USA.	fontana.luigi@gmail.com		Fontana, Luigi/0000-0001-8500-5537; Kennedy, Brian/0000-0002-5754-1874					0	158	168	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					405	406		10.1038/511405a	http://dx.doi.org/10.1038/511405a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL7SO	25056047	Bronze			2022-12-28	WOS:000339335700021
J	Northcott, PA; Lee, C; Zichner, T; Stutz, AM; Erkek, S; Kawauchi, D; Shih, DJH; Hovestadt, V; Zapatka, M; Sturm, D; Jones, DTW; Kool, M; Remke, M; Cavalli, FMG; Zuyderduyn, S; Bader, GD; VandenBerg, S; Esparza, LA; Ryzhova, M; Wang, W; Wittmann, A; Stark, S; Sieber, L; Seker-Cin, H; Linke, L; Kratochwil, F; Jager, N; Buchhalter, I; Imbusch, CD; Zipprich, G; Raeder, B; Schmidt, S; Diessl, N; Wolf, S; Wiemann, S; Brors, B; Lawerenz, C; Eils, J; Warnatz, HJ; Risch, T; Yaspo, ML; Weber, UD; Bartholomae, CC; von Kalle, C; Turanyi, E; Hauser, P; Sanden, E; Darabi, A; Siesjo, P; Sterba, J; Zitterbart, K; Sumerauer, D; van Sluis, P; Versteeg, R; Volckmann, R; Koster, J; Schuhmann, MU; Ebinger, M; Grimes, HL; Robinson, GW; Gajjar, A; Mynarek, M; von Hoff, K; Rutkowski, S; Pietsch, T; Scheurlen, W; Felsberg, J; Reifenberger, G; Kulozik, AE; von Deimling, A; Witt, O; Eils, R; Gilbertson, RJ; Korshunov, A; Taylor, MD; Lichter, P; Korbel, JO; Wechsler-Reya, RJ; Pfister, SM				Northcott, Paul A.; Lee, Catherine; Zichner, Thomas; Stuetz, Adrian M.; Erkek, Serap; Kawauchi, Daisuke; Shih, David J. H.; Hovestadt, Volker; Zapatka, Marc; Sturm, Dominik; Jones, David T. W.; Kool, Marcel; Remke, Marc; Cavalli, Florence M. G.; Zuyderduyn, Scott; Bader, Gary D.; VandenBerg, Scott; Esparza, Lourdes Adriana; Ryzhova, Marina; Wang, Wei; Wittmann, Andrea; Stark, Sebastian; Sieber, Laura; Seker-Cin, Huriye; Linke, Linda; Kratochwil, Fabian; Jaeger, Natalie; Buchhalter, Ivo; Imbusch, Charles D.; Zipprich, Gideon; Raeder, Benjamin; Schmidt, Sabine; Diessl, Nicolle; Wolf, Stephan; Wiemann, Stefan; Brors, Benedikt; Lawerenz, Chris; Eils, Juergen; Warnatz, Hans-Joerg; Risch, Thomas; Yaspo, Marie-Laure; Weber, Ursula D.; Bartholomae, Cynthia C.; von Kalle, Christof; Turanyi, Eszter; Hauser, Peter; Sanden, Emma; Darabi, Anna; Siesjoe, Peter; Sterba, Jaroslav; Zitterbart, Karel; Sumerauer, David; van Sluis, Peter; Versteeg, Rogier; Volckmann, Richard; Koster, Jan; Schuhmann, Martin U.; Ebinger, Martin; Grimes, H. Leighton; Robinson, Giles W.; Gajjar, Amar; Mynarek, Martin; von Hoff, Katja; Rutkowski, Stefan; Pietsch, Torsten; Scheurlen, Wolfram; Felsberg, Joerg; Reifenberger, Guido; Kulozik, Andreas E.; von Deimling, Andreas; Witt, Olaf; Eils, Roland; Gilbertson, Richard J.; Korshunov, Andrey; Taylor, Michael D.; Lichter, Peter; Korbel, Jan O.; Wechsler-Reya, Robert J.; Pfister, Stefan M.			Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma	NATURE			English	Article							FINGER PROTEIN GFI-1; SUPER-ENHANCERS; CELL IDENTITY; GENOME; GENE; MYC; MUTATIONS; SUBGROUP; MODEL; PIM-1	Medulloblastoma is a highly malignant paediatric brain tumour currently treated with a combination of surgery, radiation and chemotherapy, posing a considerable burden of toxicity to the developing child. Genomics has illuminated the extensive intertumoral heterogeneity of medulloblastoma, identifying four distinct molecular subgroups. Group 3 and group 4 subgroup medulloblastomas account for most paediatric cases; yet, oncogenic drivers for these subtypes remain largely unidentified. Here we describe a series of prevalent, highly disparate genomic structural variants, restricted to groups 3 and 4, resulting in specific and mutually exclusive activation of the growth factor independent 1 family proto-oncogenes, GFI1 and GFI1B. Somatic structural variants juxtapose GFI1 or GFI1B coding sequences proximal to active enhancer elements, including super-enhancers, instigating oncogenic activity. Our results, supported by evidence from mouse models, identify GFI1 and GFI1B as prominent medulloblastoma oncogenes and implicate 'enhancer hijacking' as an efficient mechanism driving oncogene activation in a childhood cancer.	[Northcott, Paul A.; Erkek, Serap; Kawauchi, Daisuke; Sturm, Dominik; Jones, David T. W.; Kool, Marcel; Wittmann, Andrea; Stark, Sebastian; Sieber, Laura; Seker-Cin, Huriye; Linke, Linda; Kratochwil, Fabian; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Lee, Catherine] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Lee, Catherine; Esparza, Lourdes Adriana; Wechsler-Reya, Robert J.] Sanford Burnham Med Res Inst, Tumor Initiat & Maintenance Program, La Jolla, CA 92037 USA; [Zichner, Thomas; Stuetz, Adrian M.; Erkek, Serap; Raeder, Benjamin; Korbel, Jan O.] European Mol Biol Lab EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany; [Shih, David J. H.; Remke, Marc; Cavalli, Florence M. G.; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON M5G 1X8, Canada; [Hovestadt, Volker; Zapatka, Marc; Wang, Wei; Weber, Ursula D.; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Zuyderduyn, Scott; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [VandenBerg, Scott] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Ryzhova, Marina] NN Burdenko Inst Neurosurg, Dept Neuropathol, Moscow 125047, Russia; [Jaeger, Natalie; Buchhalter, Ivo; Brors, Benedikt; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Imbusch, Charles D.; Zipprich, Gideon; Lawerenz, Chris; Eils, Juergen] German Canc Res Ctr, Data Management Facil, D-69120 Heidelberg, Germany; [Schmidt, Sabine; Diessl, Nicolle; Wolf, Stephan; Wiemann, Stefan] German Canc Res Ctr, Genom & Prote Core Facil, D-69120 Heidelberg, Germany; [Warnatz, Hans-Joerg; Risch, Thomas; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Bartholomae, Cynthia C.; von Kalle, Christof] German Canc Res Ctr, Div Translat Oncol, D-69120 Heidelberg, Germany; [Bartholomae, Cynthia C.; von Kalle, Christof] Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany; [von Kalle, Christof; Eils, Roland; Lichter, Peter] Heidelberg Ctr Personalised Oncol DKFZ HIPO, D-69120 Heidelberg, Germany; [Turanyi, Eszter] Semmelweis Univ SE, Dept Pathol & Expt Canc Res 1, H-1094 Budapest, Hungary; [Hauser, Peter] Semmelweis Univ, Dept Pediat 2, H-1094 Budapest, Hungary; [Sanden, Emma; Darabi, Anna; Siesjoe, Peter] Lund Univ, Div Neurosurg, Glioma Immunotherapy Grp, S-22100 Lund, Sweden; [Sanden, Emma; Darabi, Anna; Siesjoe, Peter] Lund Univ, Dept Clin Sci, S-22100 Lund, Sweden; [Sterba, Jaroslav; Zitterbart, Karel] Masaryk Univ, Dept Pediat Oncol, Brno 61300, Czech Republic; [Sterba, Jaroslav; Zitterbart, Karel] Univ Hosp, Brno 61300, Czech Republic; [Sumerauer, David] Charles Univ Prague, Dept Pediat Hematol & Oncol, Fac Med 2, Prague 15006, Czech Republic; [Sumerauer, David] Univ Hosp Motol, Prague 15006, Czech Republic; [van Sluis, Peter; Versteeg, Rogier; Volckmann, Richard; Koster, Jan] Univ Amsterdam, AMC, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Schuhmann, Martin U.; Ebinger, Martin] Tubingen Univ Hosp, Dept Neurosurg, D-72076 Tubingen, Germany; [Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Program Hematol Malignancies, Program Canc Pathol, Div Immunobiol,Div Expt Hematol & Pathol,Canc & B, Cincinnati, OH 45229 USA; [Robinson, Giles W.; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Robinson, Giles W.; Gajjar, Amar; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; Univ Med Ctr Hamburg Eppendorf, Dept Paediat Haematol & Oncol, D-20246 Hamburg, Germany; [Pietsch, Torsten] Univ Bonn, Dept Neuropathol, D-53105 Bonn, Germany; [Scheurlen, Wolfram] Nurnberg Childrens Hosp, Cnopfsche Kinderklin, D-90419 Nurnberg, Germany; [Felsberg, Joerg; Reifenberger, Guido] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Kulozik, Andreas E.; Witt, Olaf; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [von Deimling, Andreas; Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, D-69120 Heidelberg, Germany; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Korbel, Jan O.] European Bioinformat Inst EMBL EBI, EMBL, Saffron Walden CB10 1SD, Essex, England	Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; European Molecular Biology Laboratory (EMBL); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; University of California System; University of California San Diego; Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Semmelweis University; Semmelweis University; Lund University; Lund University; Masaryk University Brno; University Hospital Brno; Charles University Prague; Motol University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn; Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); European Molecular Biology Laboratory (EMBL)	Northcott, PA (corresponding author), German Canc Res Ctr, Div Pediat Neurooncol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	m.macleod@dkfz-heidelberg.de; korbel@embl.de; rwreya@sanfordburnham.org; s.pfister@dkfz-heidelberg.de	Pfister, Stefan M/F-6860-2013; Kulozik, Andreas/AAO-2432-2020; Kool, Marcel/H-2541-2013; Wiemann, Stefan/E-4424-2013; Bader, Gary/C-1176-2009; von Deimling, Andreas/F-7774-2013; Erkek, Serap/AAV-5549-2020; Zapatka, Marc/G-9896-2013; Sturm, Dominik/AAL-3689-2020; Shih, David J. H./AAE-8726-2019; Versteeg, Rogier/AAQ-1765-2020; Ryzhova, Marina/G-4178-2014; Reifenberger, Guido/AAE-3599-2019; Gajjar, Amar/N-8059-2018; Jones, David T. W./Z-1963-2019; Sterba, Jaroslav/N-6156-2016; Koster, Jan/C-5934-2008; Robinson, Giles W/N-8095-2018; Eils, Roland/B-6121-2009; Jones, David TW/G-9588-2013; Northcott, Paul A/N-4022-2018; Shih, David J H/H-3186-2011; Brors, Benedikt/E-5620-2013; Gilbertson, Richard James/ABE-1346-2021; Ebinger, Martin/O-4936-2016; Kawauchi, Daisuke/ABE-9133-2021; Korbel, Jan O/G-6470-2012; Mynarek, Martin/AAY-6129-2020	Pfister, Stefan M/0000-0002-5447-5322; Wiemann, Stefan/0000-0003-4683-3174; Bader, Gary/0000-0003-0185-8861; von Deimling, Andreas/0000-0002-5863-540X; Zapatka, Marc/0000-0001-8287-5967; Sturm, Dominik/0000-0003-0250-1696; Shih, David J. H./0000-0002-9802-4937; Ryzhova, Marina/0000-0001-7206-6365; Koster, Jan/0000-0002-0890-7585; Robinson, Giles W/0000-0001-7441-9486; Eils, Roland/0000-0002-0034-4036; Jones, David TW/0000-0002-2036-5141; Northcott, Paul A/0000-0002-1220-5252; Shih, David J H/0000-0002-9802-4937; Brors, Benedikt/0000-0001-5940-3101; Gilbertson, Richard James/0000-0001-7539-9472; Ebinger, Martin/0000-0002-4229-8058; Korbel, Jan O/0000-0002-2798-3794; Darabi, Anna/0000-0003-4326-8149; Hovestadt, Volker/0000-0002-3480-6649; von Hoff, Katja/0000-0002-5669-8546; Zichner, Thomas/0000-0001-9848-7598; Jaeger, Natalie/0000-0002-9589-7580; Erkek, Serap/0000-0003-4439-5203; Taylor, Michael/0000-0001-7009-3466; Remke, Marc/0000-0002-9404-9993; Versteeg, Rogier/0000-0001-7172-0388; Raeder, Benjamin/0000-0002-9494-8884; Korshunov, Andrey/0000-0002-5257-3623; Buchhalter, Ivo/0000-0003-0764-5832; Sterba, Jaroslav/0000-0002-8482-8352; Lee, Catherine/0000-0002-3105-3557; Grimes, H. Leighton/0000-0001-8162-6758; Stuetz, Adrian/0000-0001-7650-3470; Mynarek, Martin/0000-0003-3302-2719; Warnatz, Hans-Jorg/0000-0002-0327-9209; Cavalli, Florence M. G./0000-0002-4409-9642	PedBrain Tumor Project - German Cancer Aid [109252]; German Federal Ministry of Education and Research (BMBF) [01KU1201A, MedSys 0315416C, NGFNplus 01GS0883]; German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); EMBL International PhD Programme; Dutch Cancer Foundation KWF [2010-4713]; Dutch Cancer Foundation KIKA; US National Institutes of Health, National Center for Research Resources [P41 GM103504]; CancerSys grant MYC-NET (German Federal Ministry of Education and Research, BMBF) [0316076A]; European Commission [Health-F2-2010-260791]; Helmholtz Alliance PCCC [HA-305]; Hertie Foundation; DKFZ; California Institute for Regenerative Medicine [CIRM LA1-01747]; National Cancer Institute [5P30CA030199, R01 CA159859]; CureSearch for Children's Cancer Foundation; NATIONAL CANCER INSTITUTE [P01CA096832, R01CA129541, R01CA159859, P30CA030199] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER	PedBrain Tumor Project - German Cancer Aid; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); EMBL International PhD Programme; Dutch Cancer Foundation KWF(KWF Kankerbestrijding); Dutch Cancer Foundation KIKA; US National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); CancerSys grant MYC-NET (German Federal Ministry of Education and Research, BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Helmholtz Alliance PCCC; Hertie Foundation; DKFZ(Helmholtz Association); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CureSearch for Children's Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	For technical support and expertise we thank: the DKFZ Genomics and Proteomics Core Facility; B. Haase, D. Pavlinic and B. Baying (EMBL Genomics Core Facility); M. Knopf (NCT Heidelberg); the Sanford-Burnham Animal Facility and Cell Imaging, Tissue & Histopathology Shared Resource; and the UCSD Flow Cytometry Core Facility. We also thank Active Motif for the preparation of histone ChIP libraries. This work was principally supported by the PedBrain Tumor Project contributing to the International Cancer Genome Consortium, funded by the German Cancer Aid (109252) and by the German Federal Ministry of Education and Research (BMBF, grants 01KU1201A, MedSys 0315416C and NGFNplus 01GS0883). Additional support came from the German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO), the EMBL International PhD Programme (T.Z.), Dutch Cancer Foundations KWF (2010-4713) and KIKA (M.Ko.), the US National Institutes of Health, National Center for Research Resources (P41 GM103504; G.D.B.), the CancerSys grant MYC-NET (German Federal Ministry of Education and Research, BMBF, 0316076A), the European Commission (Health-F2-2010-260791), and the Helmholtz Alliance PCCC (grant number HA-305). PAN is a Roman Herzog Postdoctoral Fellow funded by the Hertie Foundation and the DKFZ. R.J.W.-R. is the recipient of a Research Leadership Award from the California Institute for Regenerative Medicine (CIRM LA1-01747) and obtained additional support from the National Cancer Institute (5P30CA030199 and R01 CA159859), and the CureSearch for Children's Cancer Foundation.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bhatia B, 2009, CANCER RES, V69, P7224, DOI 10.1158/0008-5472.CAN-09-1299; Boutros PC, 2010, CANCER INFORM, V9, P197; Cairns J, 2011, BIOINFORMATICS, V27, P713, DOI 10.1093/bioinformatics/btq685; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Hovestadt V, 2013, ACTA NEUROPATHOL, V125, P913, DOI 10.1007/s00401-013-1126-5; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kim TM, 2013, GENOME RES, V23, P217, DOI 10.1101/gr.140301.112; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2012, ACTA NEUROPATHOL, V123, P615, DOI 10.1007/s00401-011-0899-7; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Scheijen B, 1997, J VIROL, V71, P9, DOI 10.1128/JVI.71.1.9-16.1997; Schmidt T, 1998, ONCOGENE, V17, P2661, DOI 10.1038/sj.onc.1202191; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977; Zhukova N, 2013, J CLIN ONCOL, V31, P2927, DOI 10.1200/JCO.2012.48.5052; Zornig M, 1996, ONCOGENE, V12, P1789	46	378	387	1	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					428	+		10.1038/nature13379	http://dx.doi.org/10.1038/nature13379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043047	Green Accepted, Green Published			2022-12-28	WOS:000339335700038
J	Barnabas, RV; Celum, C				Barnabas, Ruanne V.; Celum, Connie			Bending the curve: maximising impact with focused HIV prevention	LANCET			English	Editorial Material							COST		[Barnabas, Ruanne V.; Celum, Connie] Univ Washington, Int Clin Res Ctr, Dept Global Hlth, Seattle, WA 98104 USA; [Barnabas, Ruanne V.; Celum, Connie] Univ Washington, Int Clin Res Ctr, Dept Med, Seattle, WA 98104 USA; [Barnabas, Ruanne V.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Celum, Connie] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Barnabas, RV (corresponding author), Univ Washington, Int Clin Res Ctr, Dept Global Hlth, Seattle, WA 98104 USA.	rbarnaba@uw.edu						Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; Jones A, 2014, LANCET; Kenya National STI and AIDS Control Programme (NASCOP) Kenya National AIDS Control Council (NACC), 2014, KEN HIV PRE IN PRESS; Scott KW, 2014, NEW ENGL J MED, V371, P3, DOI 10.1056/NEJMp1402157; Shrestha RK, 2011, AIDS EDUC PREV, V23, P49, DOI 10.1521/aeap.2011.23.3_supp.49; Shrestha RK, 2010, J PUBLIC HEALTH MAN, V16, P457, DOI 10.1097/PHH.0b013e3181cb433b; Stover J, 2014, JAIDS-J ACQ IMM DEF, V66, pS170, DOI 10.1097/QAI.0000000000000174; van Rooyen H, 2010, HIV AIDS S AFRICA 25, P165	8	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					216	217		10.1016/S0140-6736(14)61182-X	http://dx.doi.org/10.1016/S0140-6736(14)61182-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL8JI	25042222				2022-12-28	WOS:000339384100008
J	Smith, RF; Eggert, JH; Jeanloz, R; Duffy, TS; Braun, DG; Patterson, JR; Rudd, RE; Biener, J; Lazicki, AE; Hamza, AV; Wang, J; Braun, T; Benedict, LX; Celliers, PM; Collins, GW				Smith, R. F.; Eggert, J. H.; Jeanloz, R.; Duffy, T. S.; Braun, D. G.; Patterson, J. R.; Rudd, R. E.; Biener, J.; Lazicki, A. E.; Hamza, A. V.; Wang, J.; Braun, T.; Benedict, L. X.; Celliers, P. M.; Collins, G. W.			Ramp compression of diamond to five terapascals	NATURE			English	Article							MASS-RADIUS RELATIONSHIPS; DUCTILE POROUS MATERIALS; LASER-SHOCK COMPRESSION; EQUATION-OF-STATE; HIGH-PRESSURE; ISENTROPIC COMPRESSION; SOLID EXOPLANETS; INTERIOR; HYDROGEN; MODELS	The recent discovery of more than a thousand planets outside our Solar System(1,2), together with the significant push to achieve inertially confined fusion in the laboratory(3), has prompted a renewed interest in how dense matter behaves at millions to billions of atmospheres of pressure. The theoretical description of such electron-degenerate matter has matured since the early quantum statistical model of Thomas and Fermi(4-10), and now suggests that new complexities can emerge at pressures where core electrons (not only valence electrons) influence the structure and bonding of matter(11). Recent developments in shock-free dynamic (ramp) compression now allow laboratory access to this dense matter regime. Here we describe ramp-compression measurements for diamond, achieving 3.7-fold compression at a peak pressure of 5 terapascals (equivalent to 50 million atmospheres). These equation-of-state data can now be compared to first-principles density functional calculations(12) and theories long used to describe matter present in the interiors of giant planets, in stars, and in inertial-confinement fusion experiments. Our data also provide new constraints on mass-radius relationships for carbon-rich planets.	[Smith, R. F.; Eggert, J. H.; Braun, D. G.; Patterson, J. R.; Rudd, R. E.; Biener, J.; Lazicki, A. E.; Hamza, A. V.; Braun, T.; Benedict, L. X.; Celliers, P. M.; Collins, G. W.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Jeanloz, R.; Wang, J.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Dept Astron, Berkeley, CA 94720 USA; [Jeanloz, R.; Wang, J.] Univ Calif Berkeley, Miller Inst Basic Res Sci, Berkeley, CA 94720 USA; [Duffy, T. S.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Princeton University	Collins, GW (corresponding author), Lawrence Livermore Natl Lab, POB 808, Livermore, CA 94550 USA.	collins7@llnl.gov	Braun, Tom/H-4521-2011; Duffy, Thomas S/C-9140-2017; Collins, Gilbert/ABH-2158-2020	Braun, Tom/0000-0002-4633-5311; Duffy, Thomas S/0000-0002-5357-1259; Rudd, Robert/0000-0002-6632-2681; Eggert, Jon/0000-0001-5730-7108; Celliers, Peter/0000-0001-7600-1227	US Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Department of Energy; University of California; Miller Institute for Basic Research in Science	US Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); University of California(University of California System); Miller Institute for Basic Research in Science	We thank the NIF staff, B. Goldstein, Ed Moses, C. Keane, the Science Use of NIF programme, C. Wild (Fraunhofer Institute for Applied Solid-State Physics, Freiburg, Germany) for preparation of the diamond targets, D. Hicks for his analysis work, and M. Millot for reanalysing published diamond Hugoniot data. This work was performed under the auspices of the US Department of Energy by Lawrence Livermore National Laboratory under contract number DE-AC52-07NA27344, with additional support from the Department of Energy, the University of California, and the Miller Institute for Basic Research in Science.	ABRAHAMS AM, 1990, PHYS REV A, V42, P2530, DOI 10.1103/PhysRevA.42.2530; AIDUN JB, 1991, J APPL PHYS, V69, P6998, DOI 10.1063/1.347639; Atzeni S, 2004, PHYS INERTIAL FUSION; Bailes M, 2011, SCIENCE, V333, P1717, DOI 10.1126/science.1208890; Benedict L. X., 2013, MULTIPHASE EQUATION; BIRCH F, 1947, PHYS REV, V71, P809, DOI 10.1103/PhysRev.71.809; Bradley DK, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.075503; Brygoo S, 2007, NAT MATER, V6, P274, DOI 10.1038/nmat1863; CARROLL MM, 1972, J APPL PHYS, V43, P1626, DOI 10.1063/1.1661372; Celliers PM, 2004, REV SCI INSTRUM, V75, P4916, DOI 10.1063/1.1807008; Celliers PM, 2005, J APPL PHYS, V98, DOI 10.1063/1.2140077; Coppari F, 2013, NAT GEOSCI, V6, P926, DOI [10.1038/NGEO1948, 10.1038/ngeo1948]; Correa AA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.024101; Dawedeit C, 2013, DIAM RELAT MATER, V40, P75, DOI 10.1016/j.diamond.2013.10.001; Dewaele A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.094106; Dirac PAM, 1930, P CAMB PHILOS SOC, V26, P376; Dubrovinsky L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2160; Edwards MJ, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4816115; Eggert JH, 2010, NAT PHYS, V6, P40, DOI 10.1038/NPHYS1438; Eremets MI, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2061853; FEYNMAN RP, 1949, PHYS REV, V75, P1561, DOI 10.1103/PhysRev.75.1561; HERRMANN W, 1969, J APPL PHYS, V40, P2490, DOI 10.1063/1.1658021; Hicks DG, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.174102; Hicks DG, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2009528; HOLZAPFEL WB, 1991, EUROPHYS LETT, V16, P67, DOI 10.1209/0295-5075/16/1/012; Knudson MD, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.184107; Knudson MD, 2008, SCIENCE, V322, P1822, DOI 10.1126/science.1165278; LAI D, 1991, ASTROPHYS J, V377, P612, DOI 10.1086/170389; Martinez-Canales M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.045704; McQueen R.G., 1970, HIGH VELOCITY IMPACT, P293; McWilliams RS, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.014111; Nagao H, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2205194; Neaton JB, 1999, NATURE, V400, P141, DOI 10.1038/22067; Nettelmann N, 2008, ASTROPHYS J, V683, P1217, DOI 10.1086/589806; Occelli F, 2003, NAT MATER, V2, P151, DOI 10.1038/nmat831; Reichart P, 2004, SCIENCE, V306, P1537, DOI 10.1126/science.1102910; Reisman DB, 2003, J APPL PHYS, V93, P8952, DOI 10.1063/1.1571969; Rothman SD, 2005, J PHYS D APPL PHYS, V38, P733, DOI 10.1088/0022-3727/38/5/011; SALPETER EE, 1967, PHYS REV, V158, P876, DOI 10.1103/PhysRev.158.876; Schneider J, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116713; Seager S, 2007, ASTROPHYS J, V669, P1279, DOI 10.1086/521346; Smith RF, 2013, J APPL PHYS, V114, DOI 10.1063/1.4839655; Sun J, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3139060; Swift DC, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/59; Thomas LH, 1927, P CAMB PHILOS SOC, V23, P542, DOI 10.1017/S0305004100011683; VINET P, 1987, J GEOPHYS RES-SOLID, V92, P9319, DOI 10.1029/JB092iB09p09319; Wagner FW, 2011, ICARUS, V214, P366, DOI 10.1016/j.icarus.2011.05.027; Zeldovich YB, 2002, DOVER BOOKS PHYS	49	155	162	1	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					330	+		10.1038/nature13526	http://dx.doi.org/10.1038/nature13526			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030170				2022-12-28	WOS:000338992200031
J	Garabedian, LF; Chu, P; Toh, S; Zaslavsky, AM; Soumerai, SB				Garabedian, Laura Faden; Chu, Paula; Toh, Sengwee; Zaslavsky, Alan M.; Soumerai, Stephen B.			Potential Bias of Instrumental Variable Analyses for Observational Comparative Effectiveness Research	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; VOLUME-OUTCOME-RELATIONSHIP; NONMETROPOLITAN MORTALITY PENALTY; UNITED-STATES; CAUSAL INFERENCE; MEDICARE BENEFICIARIES; GEOGRAPHIC-VARIATION; REDUCE MORTALITY; HEART-FAILURE; CARE	Instrumental variable analysis is an increasingly popular method in comparative effectiveness research (CER). In theory, the instrument controls for unobserved and observed patient characteristics that affect the outcome. However, the results of instrumental variable analyses in observational settings may be biased if the instrument and outcome are related through an unadjusted third variable: an "instrument-outcome confounder." The authors identified published CER studies that used instrumental variable analysis and searched the literature for potential confounders of the most common instrument-outcome pairs. Of the 187 studies identified, 114 used 1 or more of the 4 most common instrument categories: distance to facility, regional variation, facility variation, and physician variation. Of these, 65 used mortality as an outcome. Potential unadjusted instrument-outcome confounders were observed in all studies, including patient race, socioeconomic status, clinical risk factors, health status, and urban or rural residency; facility and procedure volume; and co-occurring treatments. Only 4 (6%) instrumental variable CER studies considered potential instrument-outcome confounders outside the study data. Many effect estimates may be biased by the failure to adjust for instrument-outcome confounding. The authors caution against overreliance on instrumental variable studies for CER.	[Garabedian, Laura Faden] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School	Garabedian, LF (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	laura.garabedian@post.harvard.edu	Toh, Sengwee/D-7567-2017	Toh, Sengwee/0000-0002-5160-0810	Brigham and Women's Hospital DEcIDE Method Center from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [290-05-0016I]	Brigham and Women's Hospital DEcIDE Method Center from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services	This work was supported as a subcontract from the Brigham and Women's Hospital DEcIDE Method Center under contract 290-05-0016I from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program. Dr. Soumerai received grant support from the Centers for Disease Control and Prevention's Natural Experiments for Translation in Diabetes.	Abrams TE, 2011, ANN INTERN MED, V155, P80, DOI 10.7326/0003-4819-155-2-201107190-00003; Ambardekar AV, 2010, AM J CARDIOL, V105, P139, DOI 10.1016/j.amjcard.2009.09.003; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Angrist JD, 2001, J ECON PERSPECT, V15, P69, DOI 10.1257/jep.15.4.69; Ayanian JZ, 2002, MILBANK Q, V80, P569, DOI 10.1111/1468-0009.00023; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Beck CA, 2003, HEALTH SERV RES, V38, P1423, DOI 10.1111/j.1475-6773.2003.00186.x; Billingsley KG, 2007, ARCH SURG-CHICAGO, V142, P23, DOI 10.1001/archsurg.142.1.23; Brookhart MA, 2007, MED CARE, V45, pS116, DOI 10.1097/MLR.0b013e318070c057; Brookhart MA, 2010, PHARMACOEPIDEM DR S, V19, P537, DOI 10.1002/pds.1908; Brookhart M Alan, 2007, Int J Biostat, V3, P14; Brooks JM, 2000, INQUIRY-J HEALTH CAR, V37, P75; Carroll CJ, 2006, MEASUREMENT ERROR IN; Chen J, 2010, ARCH INTERN MED, V170, P433, DOI 10.1001/archinternmed.2009.538; Chen Y, 2011, J CLIN EPIDEMIOL, V64, P687, DOI 10.1016/j.jclinepi.2010.09.006; Cosby AG, 2008, AM J PUBLIC HEALTH, V98, P1470, DOI 10.2105/AJPH.2007.123778; Cossman JS, 2010, AM J PUBLIC HEALTH, V100, P1417, DOI 10.2105/AJPH.2009.174185; Cutler DM, 2007, J HEALTH ECON, V26, P1081, DOI 10.1016/j.jhealeco.2007.09.003; Davies NM, 2013, EPIDEMIOLOGY, V24, P363, DOI 10.1097/EDE.0b013e31828abafb; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Epstein AJ, 2012, MED CARE, V50, P10, DOI 10.1097/MLR.0b013e3182293510; Fischer MA, 2007, HEALTH AFFAIR, V26, P800, DOI 10.1377/hlthaff.26.3.800; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Galandiuk S, 2006, SURGERY, V140, P589, DOI 10.1016/j.surg.2006.07.010; Garber AM, 2011, HEALTH AFFAIR, V30, P2243, DOI 10.1377/hlthaff.2010.0255; Geronimus AT, 2011, AM J PUBLIC HEALTH, V101, P720, DOI 10.2105/AJPH.2010.195537; Gillum LA, 2008, J HOSP MED, V3, P184, DOI 10.1002/jhm.313; Glickman ME, 2000, STAT SINICA, V10, P517; Glymour MM, 2006, METHODS SOCIAL EPIDE, V1, P429; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Groenwold RHH, 2010, VALUE HEALTH, V13, P132, DOI 10.1111/j.1524-4733.2009.00584.x; Grootendorst P, 2007, HEALTH SERV OUTCOME, V7, P159, DOI 10.1007/s10742-007-0023-6; Hayanga AJ, 2010, ARCH SURG-CHICAGO, V145, P346, DOI 10.1001/archsurg.2010.24; Hu Y, 2008, ECONOMETRICA, V76, P195, DOI 10.1111/j.0012-9682.2008.00823.x; Hutt E, 2011, J AM MED DIR ASSOC, V12, P595, DOI 10.1016/j.jamda.2010.08.008; Institute of Medicine, 2009, INITIAL NATIONAL PRI; Johnson ML, 2009, VALUE HEALTH, V12, P1062, DOI 10.1111/j.1524-4733.2009.00602.x; Khan JA, 2011, PREV CHRONIC DIS, V8; LANDRUM MB, 2001, HLTH SERV OUTCOMES R, V2, P221, DOI DOI 10.1023/A:1020367111374; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; Lorch SA, 2009, HEALTH SERV RES, V44, P519, DOI 10.1111/j.1475-6773.2008.00940.x; Martens EP, 2006, EPIDEMIOLOGY, V17, P260, DOI 10.1097/01.ede.0000215160.88317.cb; Maybury RS, 2011, J AM COLL SURGEONS, V212, P1061, DOI 10.1016/j.jamcollsurg.2011.02.021; McClellan M, 1996, P NATL ACAD SCI USA, V93, P12701, DOI 10.1073/pnas.93.23.12701; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Parsons C, 2012, DRUG AGING, V29, P143, DOI 10.2165/11598560-000000000-00000; Patient-Centered Outcomes Research Institute, 2013, PCORI METHODOLOGY ST; Pilote L, 2008, AM HEART J, V155, P42, DOI 10.1016/j.ahj.2007.09.016; Rosenbaum PR, 2010, SPRINGER SER STAT, P113, DOI 10.1007/978-1-4419-1213-8_5; Shadish W., 2002, EXPT QUASIEXPERIMENT, P33; Shahinian VB, 2010, NEW ENGL J MED, V363, P1822, DOI 10.1056/NEJMsa0910784; Southern WN, 2011, AM J MED, V124, P868, DOI 10.1016/j.amjmed.2011.04.011; Sundmacher L, 2011, HEALTH POLICY, V103, P53, DOI 10.1016/j.healthpol.2011.08.004; Swanson SA, 2013, EPIDEMIOLOGY, V24, P370, DOI 10.1097/EDE.0b013e31828d0590; Tsai AC, 2006, HEALTH SERV RES, V41, P252, DOI 10.1111/j.1475-6773.2005.00461.x; Tunis SR, 2010, STAT MED, V29, P1963, DOI 10.1002/sim.3818; Vukmir RB, 2006, RESUSCITATION, V69, P229, DOI 10.1016/j.resuscitation.2005.08.014; Weiner BJ, 2006, HEALTH SERV RES, V41, P307, DOI 10.1111/j.1475-6773.2005.00483.x; Weissman J, 2011, GEN HOSP PSYCHIAT, V33, P587, DOI 10.1016/j.genhosppsych.2011.07.006; Welch HG, 2011, JAMA-J AM MED ASSOC, V305, P1113, DOI 10.1001/jama.2011.307; Willison DJ, 2000, MED CARE, V38, P1092, DOI 10.1097/00005650-200011000-00004; Wooldridge J, 2006, INTRO ECONOMETRICS M; Zaslavsky AM, 2012, HEALTH SERV RES, V47, P1300, DOI 10.1111/j.1475-6773.2012.01411.x	67	76	77	1	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2					131	+		10.7326/M13-1887	http://dx.doi.org/10.7326/M13-1887			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM3PJ	25023252				2022-12-28	WOS:000339764600022
J	Neuman, MD; Rosenbaum, PR; Ludwig, JM; Zubizarreta, JR; Silber, JH				Neuman, Mark D.; Rosenbaum, Paul R.; Ludwig, Justin M.; Zubizarreta, Jose R.; Silber, Jeffrey H.			Anesthesia Technique, Mortality, and Length of Stay After Hip Fracture Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENERAL-ANESTHESIA; ELDERLY-PATIENTS; POSTOPERATIVE DELIRIUM; CONFIDENCE-INTERVALS; SENSITIVITY-ANALYSIS; BIAS REDUCTION; OUTCOMES; CARE; ASSOCIATION; INSTRUMENT	IMPORTANCE More than 300 000 hip fractures occur each year in the United States. Recent practice guidelines have advocated greater use of regional anesthesia for hip fracture surgery. OBJECTIVE To test the association of regional (ie, spinal or epidural) anesthesia vs general anesthesia with 30-day mortality and hospital length of stay after hip fracture. DESIGN, SETTING, AND PATIENTS We conducted a matched retrospective cohort study involving patients 50 years or older who were undergoing surgery for hip fracture at general acute care hospitals in New York State between July 1, 2004, and December 31, 2011. Our main analysis was a near-far instrumental variable match that paired patients who lived at different distances from hospitals that specialized in regional or general anesthesia. Supplementary analyses included a within-hospital match that paired patients within the same hospital and an across-hospital match that paired patients at different hospitals. EXPOSURES Spinal or epidural anesthesia; general anesthesia. MAIN OUTCOMES AND MEASURES Thirty-day mortality and hospital length of stay. Because the distribution of length of stay had long tails, we characterized this outcome using the Huber M estimate with Huber weights, a robust estimator similar to a trimmed mean. RESULTS Of 56 729 patients, 15 904 (28%) received regional anesthesia and 40 825 (72%) received general anesthesia. Overall, 3032 patients (5.3%) died. The M estimate of the length of stay was 6.2 days (95% CI, 6.2 to 6.2). The near-far matched analysis showed no significant difference in 30-day mortality by anesthesia type among the 21 514 patients included in this match: 583 of 10 757 matched patients (5.4%) who lived near a regional anesthesia-specialized hospital died vs 629 of 10 757 matched patients (5.8%) who lived near a general anesthesia-specialized hospital (instrumental variable estimate of risk difference, -1.1%; 95% CI, -2.8 to 0.5; P = .20). Supplementary analyses of within and across hospital patient matches yielded mortality findings to be similar to the main analysis. In the near-far match, regional anesthesia was associated with a 0.6-day shorter length of stay than general anesthesia (95% CI, -0.8 to -0.4, P < .001). Supplementary analyses also showed regional anesthesia to be associated with shorter length of stay, although the observed association was smaller in magnitude than in the main analysis. CONCLUSIONS AND RELEVANCE Among adults in acute care hospitals in New York State undergoing hip repair, the use of regional anesthesia compared with general anesthesia was not associated with lower 30-day mortality but was associated with a modestly shorter length of stay. These findings do not support a mortality benefit for regional anesthesia in this setting.	[Neuman, Mark D.; Silber, Jeffrey H.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Neuman, Mark D.; Rosenbaum, Paul R.; Silber, Jeffrey H.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Rosenbaum, Paul R.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Ludwig, Justin M.; Silber, Jeffrey H.] Childrens Hosp Philadelphia, Ctr Outcomes Res, Philadelphia, PA USA; [Zubizarreta, Jose R.] Columbia Business Sch, Div Decis Risk & Operat, New York, NY USA; [Zubizarreta, Jose R.] Columbia Univ, Dept Stat, New York, NY USA; [Silber, Jeffrey H.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Columbia University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Neuman, MD (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, 1119 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	neumanm@mail.med.upenn.edu	Rosenbaum, Paul R/H-8687-2012		Foundation for Anesthesia Education and Research; National Institute on Aging [1K08AG043548]; National Science Foundation [1260782]; NATIONAL INSTITUTE ON AGING [K08AG043548] Funding Source: NIH RePORTER	Foundation for Anesthesia Education and Research; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants to MDN from the Foundation for Anesthesia Education and Research and 1K08AG043548 from the National Institute on Aging (Dr Neuman) and by grant 1260782 the from the National Science Foundation, (Dr Rosenbaum).	Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Baiocchi M, 2012, HEALTH SERV OUTCOME, V12, P237, DOI 10.1007/s10742-012-0091-0; Baiocchi M, 2010, J AM STAT ASSOC, V105, P1285, DOI 10.1198/jasa.2010.ap09490; BERGGREN D, 1987, ANESTH ANALG, V66, P497; Blackman D K, 1999, MMWR CDC Surveill Summ, V48, P1; Boulton C, 2014, NATL HIP FRACTURE DA; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; COCHRAN WG, 1973, SANKHYA SER A, V35, P417; DAVIS FM, 1987, BRIT J ANAESTH, V59, P561, DOI 10.1093/bja/59.5.561; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Foss NB, 2005, ANESTHESIOLOGY, V102, P1197, DOI 10.1097/00000542-200506000-00020; Griffiths R, 2012, ANAESTHESIA, V67, P85, DOI 10.1111/j.1365-2044.2011.06957.x; Horlocker TT, 2010, REGION ANESTH PAIN M, V35, P64, DOI 10.1097/AAP.0b013e3181c15c70; Huber P. H., 1981, ROBUST STAT; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Imbens GW, 2005, J ROY STAT SOC A STA, V168, P109, DOI 10.1111/j.1467-985X.2004.00339.x; Lee HB, 2011, J AM GERIATR SOC, V59, P2306, DOI 10.1111/j.1532-5415.2011.03725.x; Magaziner J, 2000, J GERONTOL A-BIOL, V55, pM498, DOI 10.1093/gerona/55.9.M498; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Maritz J. S., 1995, DISTRIBUTION FREE ST, V2nd; Neuman MD, 2012, ANESTHESIOLOGY, V117, P72, DOI 10.1097/ALN.0b013e3182545e7c; Neuman MD, 2010, MED CARE, V48, P314, DOI 10.1097/MLR.0b013e3181ca4126; O'Hara DA, 2000, ANESTHESIOLOGY, V92, P947, DOI 10.1097/00000542-200004000-00011; Parker MJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000521.PUB2; Polsky D, 2008, HEALTH SERV RES, V43, P1388, DOI 10.1111/j.1475-6773.2008.00837.x; Radcliff TA, 2008, J BONE JOINT SURG AM, V90A, P34, DOI 10.2106/JBJS.G.00065; Regan EA, 2013, COPD, V10, P11, DOI 10.3109/15412555.2012.723072; Rosenbaum PR, 2007, BIOMETRICS, V63, P456, DOI 10.1111/j.1541-0420.2006.00717.x; Rosenbaum PR, 2007, J AM STAT ASSOC, V102, P75, DOI 10.1198/016214506000001059; Rosenbaum PR, 2012, J COMPUT GRAPH STAT, V21, P57, DOI 10.1198/jcgs.2011.09219; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; RUBIN DB, 1980, BIOMETRICS, V36, P293, DOI 10.2307/2529981; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; Scheinin H, 2000, ACTA ANAESTH SCAND, V44, P1061, DOI 10.1034/j.1399-6576.2000.440905.x; Scottish Intercollegiate Guidelines Network, 2009, MAN HIP FRACT OLD PE; Sheffield KM, 2013, JAMA-J AM MED ASSOC, V310, P812, DOI 10.1001/jama.2013.276205; Sieber FE, 2010, J CLIN ANESTH, V22, P179, DOI 10.1016/j.jclinane.2009.06.005; Sieber FE, 2010, MAYO CLIN PROC, V85, P18, DOI 10.4065/mcp.2009.0469; Silber JH, 2007, MED CARE, V45, P918, DOI 10.1097/MLR.0b013e31812e01cc; Silber JH, 2001, MED CARE, V39, P1048, DOI 10.1097/00005650-200110000-00003; Small DS, 2008, J AM STAT ASSOC, V103, P924, DOI 10.1198/016214507000001247; UK National Clinical Guideline Centre, 2011, MAN HIP FRACT AD; VALENTIN N, 1986, BRIT J ANAESTH, V58, P284, DOI 10.1093/bja/58.3.284; White SM, 2014, ANAESTHESIA, V69, P224, DOI 10.1111/anae.12542; White SM, 2010, ANAESTHESIA, V65, P243, DOI 10.1111/j.1365-2044.2009.06208.x; Zubizarreta JR, 2012, J AM STAT ASSOC, V107, P1360, DOI 10.1080/01621459.2012.703874	49	178	191	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2508	2517		10.1001/jama.2014.6499	http://dx.doi.org/10.1001/jama.2014.6499			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	25058085	Green Accepted, Green Published			2022-12-28	WOS:000337757000024
J	McClure, C; Chandler, C; Bissell, S				McClure, Craig; Chandler, Caitlin; Bissell, Susan			Responses to HIV in sexually exploited children or adolescents who sell sex	LANCET			English	Editorial Material							INFECTION; WORKERS; INDIA; AGE		[McClure, Craig] UNICEF, New York, NY 10017 USA; HIV Young Leaders Fund, New York, NY USA	UNICEF	McClure, C (corresponding author), UNICEF, New York, NY 10017 USA.	cmcclure@unicef.org						[Anonymous], 2014, UN IATT TEC IN PRESS; Conner B, 2014, SEXUAL REPR IN PRESS; Goldenberg SM, 2012, AIDS BEHAV, V16, P969, DOI 10.1007/s10461-011-0063-3; Gupta J, 2009, INT J GYNECOL OBSTET, V107, P30, DOI 10.1016/j.ijgo.2009.06.009; Moscicki AB, 2001, J INFECT DIS, V183, P865, DOI 10.1086/319261; Sarkar K, 2008, J HEALTH POPUL NUTR, V26, P223; Sarkar K, 2006, J INFECTION, V53, P255, DOI 10.1016/j.jinf.2005.11.009; Silverman JG, 2011, ARCH DIS CHILD, V96, P478, DOI 10.1136/adc.2009.178715; Strode A, 2009, S AFR J HIV MED, P8; UNAIDS, 2013, REP GLOB AIDS EP; UNICEF, 2010, BLAM BAN UND HIV EP; WHO, 2014, POL BRIEF Y IN PRESS	12	18	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2015	385	9963					97	99		10.1016/S0140-6736(14)60979-X	http://dx.doi.org/10.1016/S0140-6736(14)60979-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY7BI	25059951				2022-12-28	WOS:000347715900007
J	Williams, CM; Maher, CG; Latimer, J; McLachlan, AJ; Hancock, MJ; Day, RO; Lin, CWC				Williams, Christopher M.; Maher, Christopher G.; Latimer, Jane; McLachlan, Andrew J.; Hancock, Mark J.; Day, Richard O.; Lin, Chung-Wei Christine			Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial	LANCET			English	Article							GUIDELINES; DISABILITY; DIAGNOSIS; PROGNOSIS; THERAPY; HEALTH; CARE	Background Regular paracetamol is the recommended first-line analgesic for acute low-back pain; however, no high-quality evidence supports this recommendation. We aimed to assess the efficacy of paracetamol taken regularly or as-needed to improve time to recovery from pain, compared with placebo, in patients with low-back pain. Methods We did a multicentre, double-dummy, randomised, placebo controlled trial across 235 primary care centres in Sydney, Australia, from Nov 11, 2009, to March 5, 2013. We randomly allocated patients with acute low-back pain in a 1: 1: 1 ratio to receive up to 4 weeks of regular doses of paracetamol (three times per day; equivalent to 3990 mg paracetamol per day), as-needed doses of paracetamol (taken when needed for pain relief; maximum 4000 mg paracetamol per day), or placebo. Randomisation was done according to a centralised randomisation schedule prepared by a researcher who was not involved in patient recruitment or data collection. Patients and staff at all sites were masked to treatment allocation. All participants received best-evidence advice and were followed up for 3 months. The primary outcome was time until recovery from low-back pain, with recovery defined as a pain score of 0 or 1 (on a 0-10 pain scale) sustained for 7 consecutive days. All data were analysed by intention to treat. This study is registered with the Australian and New Zealand Clinical Trial Registry, number ACTN 12609000966291. Findings 550 participants were assigned to the regular group (550 analysed), 549 were assigned to the as-needed group (546 analysed), and 553 were assigned to the placebo group (547 analysed). Median time to recovery was 17 days (95% CI 14-19) in the regular group, 17 days (15-20) in the as-needed group, and 16 days (14-20) in the placebo group (regular vs placebo hazard ratio 0.99, 95% CI 0.87-1.14; as-needed vs placebo 1.05, 0 .92-1.19; regular vs as-needed 1.05, 0.92-1.20). We recorded no difference between treatment groups for time to recovery (adjusted p= 0 .79). Adherence to regular tablets (median tablets consumed per participant per day of maximum 6; 4.0[IQR1.6-5.7] in the regular group, 3.9 [1.5-5.6] in the as-needed group, and 4.0 [1.5-5.7] in the placebo group), and number of participants reporting adverse events (99 [18.5%] in the regular group, 99 [18.7%] in the as-needed group, and 98 [18.5%] in the placebo group) were similar between groups. Interpretation Our findings suggest that regular or as-needed dosing with paracetamol does not affect recovery time compared with placebo in low-back pain, and question the universal endorsement of paracetamol in this patient group.	[Williams, Christopher M.; Maher, Christopher G.; Latimer, Jane; Lin, Chung-Wei Christine] Univ Sydney, Sydney Med Sch, George Inst Global Hlth, Camperdown, NSW, Australia; [McLachlan, Andrew J.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [McLachlan, Andrew J.] Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW 2006, Australia; [Hancock, Mark J.] Macquarie Univ, Fac Human Sci, Sydney, NSW 2109, Australia; [Day, Richard O.] Univ New S Wales, Darlinghurst, NSW, Australia; [Day, Richard O.] St Vincents Hosp, Darlinghurst, NSW 2010, Australia; [Williams, Christopher M.] Hunter Med Res Inst, Callaghan, NSW, Australia; [Williams, Christopher M.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia	George Institute for Global Health; University of Sydney; University of Sydney; University of Sydney; Macquarie University; University of New South Wales Sydney; St Vincents Hospital Sydney; Hunter Medical Research Institute; University of Newcastle; University of Newcastle	Williams, CM (corresponding author), Hunter Med Res Inst, Longworth Ave, Wallsend, NSW 2287, Australia.	cwilliams@georgeinstitute.org.au	Williams, Christopher M/AAU-7946-2021; Maher, Christopher/AAC-6267-2019; Williams, Christopher M/A-2395-2011; Day, Richard/D-8699-2011; Lin, Chung-Wei Christine/S-8840-2019	Williams, Christopher M/0000-0001-8896-0978; Maher, Christopher/0000-0002-1628-7857; Williams, Christopher M/0000-0001-8896-0978; Day, Richard/0000-0002-6045-6937; Lin, Chung-Wei Christine/0000-0001-6192-7238; Hancock, Mark/0000-0002-9277-5377; McLachlan, Andrew/0000-0003-4674-0242	National Health and Medical Research Council of Australia; GlaxoSmithKline Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); GlaxoSmithKline Australia(GlaxoSmithKline)	National Health and Medical Research Council of Australia and GlaxoSmithKline Australia.	Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Buckley N, 2013, AUSTR MED HDB 2013; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; Davies RA, 2008, EUR SPINE J, V17, P1423, DOI 10.1007/s00586-008-0783-x; Hancock MJ, 2007, LANCET, V370, P1638, DOI 10.1016/S0140-6736(07)61686-9; Hayden JA, 2010, BEST PRACT RES CL RH, V24, P167, DOI 10.1016/j.berh.2009.12.005; Henschke N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a171; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Costa LDM, 2012, CAN MED ASSOC J, V184, pE613, DOI 10.1503/cmaj.111271; MILGROM C, 1993, J SPINAL DISORD, V6, P187, DOI 10.1097/00002517-199306030-00001; Ong CKS, 2007, CLIN MED RES, V5, P17, DOI 10.3121/cmr.2007.698; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pahor M, 1999, AM J PUBLIC HEALTH, V89, P930, DOI 10.2105/AJPH.89.6.930; Pengel LHM, 2004, SPINE, V29, P879, DOI 10.1097/00007632-200404150-00011; Proschan MA, 2000, CONTROL CLIN TRIALS, V21, P527, DOI 10.1016/S0197-2456(00)00106-9; Roelofs PDDM, 2008, COCHRANE DB SYST REV, V1; Smeets RJEM, 2008, CLIN J PAIN, V24, P305, DOI 10.1097/AJP.0b013e318164aa75; Temple AR, 2006, CLIN THER, V28, P222, DOI 10.1016/j.clinthera.2006.02.004; Toms L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004602.pub2; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Weil K, 2007, COCHRANE DB SYST REV, V3; Williams CM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-248; Williams CM, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-169; Williams CM, 2010, ARCH INTERN MED, V170, P271, DOI 10.1001/archinternmed.2009.507; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	28	167	178	0	79	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2014	384	9954					1586	1596		10.1016/S0140-6736(14)60805-9	http://dx.doi.org/10.1016/S0140-6736(14)60805-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9NK	25064594				2022-12-28	WOS:000343901700027
J	Cong, PY; Ma, XY; Hou, XG; Edgecombe, GD; Strausfeld, NJ				Cong, Peiyun; Ma, Xiaoya; Hou, Xianguang; Edgecombe, Gregory D.; Strausfeld, Nicholas J.			Brain structure resolves the segmental affinity of anomalocaridid appendages	NATURE			English	Article							BURGESS SHALE; ARTHROPOD; EVOLUTION; ONYCHOPHORA; ORIGIN; PERIPATOPSIDAE; ORGANIZATION; MORPHOLOGY; SUGGESTS; LABRUM	Despite being among the most celebrated taxa from Cambrian biotas, anomalocaridids (order Radiodonta) have provoked intense debate about their affinities within the moulting-animal clade that includes Arthropoda. Current alternatives identify anomalocaridids as either stem-group euarthropods(1-3), crown-group euarthropods near the ancestry of chelicerates(4), or a segmented ecdysozoan lineage with convergent similarity to arthropods in appendage construction(5). Determining unambiguous affinities has been impeded by uncertainties about the segmental affiliation of anomalocaridid frontal appendages. These structures are variably homologized with jointed appendages of the second (deutocerebral) head segment, including antennae and 'great appendages' of Cambrian arthropods, or with the paired antenniform frontal appendages of living Onychophora and some Cambrian lobopodians. Here we describe Lyrarapax unguis-pinus, a new anomalocaridid from the early Cambrian Chengjiang biota, southwest China, nearly complete specimens of which preserve traces of muscles, digestive tract and brain. The traces of brain provide the first direct evidence for the segmental composition of the anomalocaridid head and its appendicular organization. Carbon-rich areas in the head resolve paired pre-protocerebral ganglia at the origin of paired frontal appendages. The ganglia connect to areas indicative of a bilateral pre-oral brain that receives projections from the eyestalk neuropils and compound retina. The dorsal, segmented brain of L. unguispinus reinforces an alliance between anomalocaridids and arthropods rather than cycloneuralians. Correspondences in brain organization between anomalocaridids and Onychophora resolve pre-protocerebral ganglia, associated with pre-ocular frontal appendages, as characters of the last common ancestor of euarthropods and onychophorans. A position of Radiodonta on the euarthropod stem-lineage implies the transformation of frontal appendages to another structure in crown-group euarthropods, with gene expression and neuroanatomy providing strong evidence that the paired, pre-oral labrum is the remnant of paired frontal appendages(1).	[Cong, Peiyun; Ma, Xiaoya; Hou, Xianguang] Yunnan Univ, Yunnan Key Lab Palaeobiol, Kunming 650091, Peoples R China; [Ma, Xiaoya; Edgecombe, Gregory D.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Strausfeld, Nicholas J.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Strausfeld, Nicholas J.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA	Yunnan University; Natural History Museum London; University of Arizona; University of Arizona	Hou, XG (corresponding author), Yunnan Univ, Yunnan Key Lab Palaeobiol, Kunming 650091, Peoples R China.	xghou@ynu.edu.cn; flybrain@neurobio.arizona.edu	Cong, Pei-yun/D-2537-2009; Strausfeld, Nicholas James/AAF-4566-2021	Cong, Pei-yun/0000-0001-9910-6478; Strausfeld, Nicholas James/0000-0002-1115-1774; Edgecombe, Gregory/0000-0002-9591-8011	National Natural Science Foundation of China [U1302232, 41372031, 40962001]; Leverhulme Trust [F/00 696/T]; Center for Insect Science, University of Arizona; Air Force Research Laboratory [FA86511010001]; Natural Environment Research Council [NE/L011751/1] Funding Source: researchfish; NERC [NE/L011751/1] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leverhulme Trust(Leverhulme Trust); Center for Insect Science, University of Arizona; Air Force Research Laboratory; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the National Natural Science Foundation of China (U1302232, 41372031 and 40962001), a Leverhulme Trust Research Project Grant (F/00 696/T), by the Center for Insect Science, University of Arizona, and by a grant from the Air Force Research Laboratory (FA86511010001) to N.J.S. We thank T. Goral for assistance with energy dispersive X-ray spectroscopy. We acknowledge A. Daley's advice about anomalocaridid anatomy.	Boxshall GA, 2004, BIOL REV, V79, P253, DOI 10.1017/S1464793103006274; Boyan GS, 2002, ARTHROPOD STRUCT DEV, V31, P65, DOI 10.1016/S1467-8039(02)00016-6; Browne WE, 2005, GENESIS, V42, P124, DOI 10.1002/gene.20145; Budd GE, 1998, LETHAIA, V31, P197, DOI 10.1111/j.1502-3931.1998.tb00508.x; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Daley AC, 2014, J PALEONTOL, V88, P68, DOI 10.1666/13-067; Daley AC, 2012, NATURWISSENSCHAFTEN, V99, P501, DOI 10.1007/s00114-012-0910-8; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Eriksson BJ, 2009, DEV GENES EVOL, V219, P249, DOI 10.1007/s00427-009-0287-7; Haas MS, 2001, DEV GENES EVOL, V211, P96, DOI 10.1007/s004270000129; Haug JT, 2012, PALAEONTOLOGY, V55, P369, DOI 10.1111/j.1475-4983.2011.01124.x; Hou Xiang, 2006, P139; Legg DA, 2013, LETHAIA, V46, P540, DOI 10.1111/let.12032; Legg DA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3485; Ma XY, 2012, NATURE, V490, P258, DOI 10.1038/nature11495; Mayer G, 2008, J COMP NEUROL, V507, P1196, DOI 10.1002/cne.21603; Mayer G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-255; Mayer G, 2009, DEV BIOL, V335, P263, DOI 10.1016/j.ydbio.2009.08.011; Paterson JR, 2011, NATURE, V480, P237, DOI 10.1038/nature10689; Scholtz G, 2006, DEV GENES EVOL, V216, P395, DOI 10.1007/s00427-006-0085-4; Schurmann F.-W., 1987, P159; Stein M, 2010, ZOOL J LINN SOC-LOND, V158, P477, DOI 10.1111/j.1096-3642.2009.00562.x; Strausfeld N. J., 2012, ARTHROPOD BRAINS EVO, P427; Strausfeld NJ, 2006, ARTHROPOD STRUCT DEV, V35, P169, DOI 10.1016/j.asd.2006.06.002; Strausfeld NJ, 2006, P ROY SOC B-BIOL SCI, V273, P1857, DOI 10.1098/rspb.2006.3536; Tanaka G, 2013, NATURE, V502, P364, DOI 10.1038/nature12520; Vinther J, 2014, NATURE, V507, P496, DOI 10.1038/nature13010; WIGGLESWORTH VB, 1957, PROC R SOC SER B-BIO, V147, P185, DOI 10.1098/rspb.1957.0043	28	117	120	5	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					538	+		10.1038/nature13486	http://dx.doi.org/10.1038/nature13486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25043032				2022-12-28	WOS:000342075800038
J	Wright, JD; Tergas, AI; Burke, WM; Cui, RR; Ananth, CV; Chen, L; Hershman, DL				Wright, Jason D.; Tergas, Ana I.; Burke, William M.; Cui, Rosa R.; Ananth, Cande V.; Chen, Ling; Hershman, Dawn L.			Uterine Pathology in Women Undergoing Minimally Invasive Hysterectomy Using Morcellation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Wright, Jason D.; Tergas, Ana I.; Burke, William M.; Cui, Rosa R.; Ananth, Cande V.; Chen, Ling] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA; [Hershman, Dawn L.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University	Wright, JD (corresponding author), Columbia Univ Coll Phys & Surg, Div Gynecol Oncol, Dept Obstet & Gynecol, 161 Ft Washington Ave,Eighth Floor, New York, NY 10032 USA.	jw2459@columbia.edu	Hershman, Dawn/AAG-2114-2020		NCI NIH HHS [R25 CA094061-11, R01 CA134964, R25 CA094061, R01 CA169121, R01CA134964, R01CA169121-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA169121, R01CA134964, R25CA094061] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2014, LANCET ONCOL, V15, P123; Hagemann IS, 2011, INT J GYNECOL PATHOL, V30, P476, DOI 10.1097/PGP.0b013e3182107ecf; Kho KA, 2014, JAMA-J AM MED ASSOC, V311, P905, DOI 10.1001/jama.2014.1093; Oduyebo T, 2014, GYNECOL ONCOL, V132, P360, DOI 10.1016/j.ygyno.2013.11.024; Seidman MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050058; Wright JD, 2013, JAMA-J AM MED ASSOC, V309, P689, DOI 10.1001/jama.2013.186	6	111	113	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2014	312	12					1253	1255		10.1001/jama.2014.9005	http://dx.doi.org/10.1001/jama.2014.9005			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP3QA	25051495	Green Accepted, Bronze			2022-12-28	WOS:000341990600027
J	Robert, C; Ribas, A; Wolchok, JD; Hodi, FS; Hamid, O; Kefford, R; Weber, JS; Joshua, AM; Hwu, WJ; Gangadhar, TC; Patnaik, A; Dronca, R; Zarour, H; Joseph, RW; Boasberg, P; Chmielowski, B; Mateus, C; Postow, MA; Gergich, K; Elassaiss-Schaap, J; Li, XN; Iannone, R; Ebbinghaus, SW; Kang, SP; Daud, A				Robert, Caroline; Ribas, Antoni; Wolchok, Jedd D.; Hodi, F. Stephen; Hamid, Omid; Kefford, Richard; Weber, Jeffrey S.; Joshua, Anthony M.; Hwu, Wen-Jen; Gangadhar, Tara C.; Patnaik, Amita; Dronca, Roxana; Zarour, Hassane; Joseph, Richard W.; Boasberg, Peter; Chmielowski, Bartosz; Mateus, Christine; Postow, Michael A.; Gergich, Kevin; Elassaiss-Schaap, Jeroen; Li, Xiaoyun Nicole; Iannone, Robert; Ebbinghaus, Scot W.; Kang, S. Peter; Daud, Adil			Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial	LANCET			English	Article							METASTATIC MELANOMA; RESPONSE CRITERIA; IMPROVED SURVIVAL; BRAF INHIBITORS; MEK INHIBITION; OPEN-LABEL; SAFETY; MUTATION; PD-1; IMMUNOTHERAPY	Background The anti-programmed-death-receptor-1 (PD-1) antibody pembrolizumab has shown potent antitumour activity at different doses and schedules in patients with melanoma. We compared the efficacy and safety of pembrolizumab at doses of 2 mg/kg and 10 mg/kg every 3 weeks in patients with ipilimumab-refractory advanced melanoma. Methods In an open-label, international, multicentre expansion cohort of a phase 1 trial, patients (aged >= 18 years) with advanced melanoma whose disease had progressed after at least two ipilimumab doses were randomly assigned with a computer-generated allocation schedule (1:1 final ratio) to intravenous pembrolizumab at 2 mg/kg every 3 weeks or 10 mg/kg every 3 weeks until disease progression, intolerable toxicity, or consent withdrawal. Primary endpoint was overall response rate (ORR) assessed with the Response Evaluation Criteria In Solid Tumors (RECIST, version 1.1) by independent central review. Analysis was done on the full-analysis set (all treated patients with measurable disease at baseline). This study is registered with ClinicalTrials.gov, number NCT01295827. Findings 173 patients received pembrolizumab 2 mg/kg (n=89) or 10 mg/kg (n=84). Median follow-up duration was 8 months. ORR was 26% at both doses-21 of 81 patients in the 2 mg/kg group and 20 of 76 in the 10 mg/kg group (difference 0%, 95% CI -14 to 13; p=0.96). Treatment was well tolerated, with similar safety profiles in the 2 mg/kg and 10 mg/kg groups and no drug-related deaths. The most common drug-related adverse events of any grade in the 2 mg/kg and 10 mg/kg groups were fatigue (29 [33%] vs 31 [37%]), pruritus (23 [26%] vs 16 [19%]), and rash (16 [18%] vs 15 [18%]). Grade 3 fatigue, reported in five (3%) patients in the 2 mg/kg pembrolizumab group, was the only drug-related grade 3 to 4 adverse event reported in more than one patient. Interpretation The results suggest that pembrolizumab at a dose of 2 mg/kg or 10 mg/kg every 3 weeks might be an effective treatment in patients for whom there are few effective treatment options.	[Robert, Caroline; Mateus, Christine] Gustave Roussy, Paris, France; [Robert, Caroline; Mateus, Christine] INSERM, U981, Paris, France; [Ribas, Antoni; Chmielowski, Bartosz] Univ Calif Los Angeles, Los Angeles, CA USA; [Wolchok, Jedd D.; Postow, Michael A.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Hodi, F. Stephen] Dana Farber Canc Inst, Boston, MA 02115 USA; [Hamid, Omid; Boasberg, Peter] Angeles Clin & Res Inst, Los Angeles, CA USA; [Kefford, Richard] Westmead Hosp, Crown Princess Mary Canc Ctr, Westmead, NSW 2145, Australia; [Kefford, Richard] Melanoma Inst Australia, Westmead, NSW 2145, Australia; [Kefford, Richard] Univ Sydney, Sydney, NSW 2006, Australia; [Weber, Jeffrey S.] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Joshua, Anthony M.] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Hwu, Wen-Jen] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Gangadhar, Tara C.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Patnaik, Amita] South Texas Accelerated Res Therapeut, San Antonio, TX USA; [Dronca, Roxana] Mayo Clin, Rochester, MN USA; [Zarour, Hassane] Univ Pittsburgh, Pittsburgh, PA USA; [Joseph, Richard W.] Mayo Clin, Jacksonville, FL 32224 USA; [Gergich, Kevin; Elassaiss-Schaap, Jeroen; Li, Xiaoyun Nicole; Iannone, Robert; Ebbinghaus, Scot W.; Kang, S. Peter] Merck, Whitehouse Stn, NJ USA; [Daud, Adil] Univ Calif San Francisco, San Francisco, CA 94143 USA	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Los Angeles; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Angeles Clinic & Research Institute; University of Sydney; Melanoma Institute Australia; University of Sydney; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Texas System; UTMD Anderson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic; Merck & Company; University of California System; University of California San Francisco	Robert, C (corresponding author), Inst Gustave Roussy, 114 Rue Edouard Vaillant, F-94805 Villejuif Paris Sud, France.	caroline.robert@gustaveroussy.fr	Li, Xiaoyun/P-8265-2014; Elassaiss-Schaap, Jeroen/Q-5451-2016; Robert, Caroline/G-6157-2018; Daud, Adil/T-3079-2019	Robert, Caroline/0000-0002-9493-0238; Daud, Adil/0000-0002-6617-8421; Weber, Jeffrey/0000-0002-4962-2957; Kefford, Richard/0000-0001-9251-9229; Joshua, Anthony/0000-0001-5159-4580; Joseph, Richard/0000-0001-6102-4661; Chmielowski, Bartosz/0000-0002-2374-3320	Merck Sharp and Dohme; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Merck Sharp and Dohme(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Merck Sharp and Dohme.	Ackerman A, 2014, CANCER-AM CANCER SOC, V120, P1695, DOI 10.1002/cncr.28620; Ascierto PA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-85; Ascierto PA, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-61; Beal S, 1989, NONMEM USERS GUIDES; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; EFRON B, 1977, J AM STAT ASSOC, V72, P557, DOI 10.2307/2286217; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Hamid O, 2013, J CLIN ONCOL, V31; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; McArthur GA, 2014, LANCET ONCOL, V15, P323, DOI 10.1016/S1470-2045(14)70012-9; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Nishino M, 2013, CLIN CANCER RES, V19, P3936, DOI 10.1158/1078-0432.CCR-13-0895; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Robert C, 2013, PIGM CELL MELANOMA R, V26, P993; Shahabi V, 2012, CANCER IMMUNOL IMMUN, V61, P733, DOI 10.1007/s00262-012-1227-3; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Weber JS, 2013, J CLIN ONCOL, V31, P4311, DOI 10.1200/JCO.2013.51.4802; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	32	1335	1400	7	163	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					1109	1117		10.1016/S0140-6736(14)60958-2	http://dx.doi.org/10.1016/S0140-6736(14)60958-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PU	25034862				2022-12-28	WOS:000342630600031
J	Henrich, TJ; Hanhauser, E; Marty, FM; Sirignano, MN; Keating, S; Lee, TH; Robles, YP; Davis, BT; Li, JZ; Heisey, A; Hill, AL; Busch, MP; Armand, P; Soiffer, RJ; Altfeld, M; Kuritzkes, DR				Henrich, Timothy J.; Hanhauser, Emily; Marty, Francisco M.; Sirignano, Michael N.; Keating, Sheila; Lee, Tzong-Hae; Robles, Yvonne P.; Davis, Benjamin T.; Li, Jonathan Z.; Heisey, Andrea; Hill, Alison L.; Busch, Michael P.; Armand, Philippe; Soiffer, Robert J.; Altfeld, Marcus; Kuritzkes, Daniel R.			Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation Report of 2 Cases	ANNALS OF INTERNAL MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; STRUCTURED TREATMENT INTERRUPTIONS; VIRUS TYPE-1 INFECTION; POSITIVE PATIENTS; PCR ASSAY; THERAPY; VIREMIA; RNA; PLASMA; BLOOD	Background: It is unknown whether the reduction in HIV-1 reservoirs seen after allogeneic hematopoietic stem cell transplantation (HSCT) with susceptible donor cells is sufficient to achieve sustained HIV-1 remission. Objective: To characterize HIV-1 reservoirs in blood and tissues and perform analytic antiretroviral treatment interruptions to determine the potential for allogeneic HSCT to lead to sustained, antiretroviral-free HIV-1 remission. Design: Case report with characterization of HIV-1 reservoirs and immunity before and after antiretroviral interruption. Setting: Tertiary care center. Patients: Two men with HIV with undetectable HIV-1 after allogeneic HSCT for hematologic tumors. Measurements: Quantification of HIV-1 in various tissues after HSCT and the duration of antiretroviral-free HIV-1 remission after treatment interruption. Results: No HIV-1 was detected from peripheral blood or rectal mucosa before analytic treatment interruption. Plasma HIV-1 RNA and cell-associated HIV-1 DNA remained undetectable until 12 and 32 weeks after antiretroviral cessation. Both patients experienced rebound viremia within 2 weeks of the most recent negative viral load measurement and developed symptoms consistent with the acute retroviral syndrome. One patient developed new efavirenz resistance after reinitiation of antiretroviral therapy. Reinitiation of active therapy led to viral decay and resolution of symptoms in both patients. Limitation: The study involved only 2 patients. Conclusion: Allogeneic HSCT may lead to loss of detectable HIV-1 from blood and gut tissue and variable periods of antiretroviral-free HIV-1 remission, but viral rebound can occur despite a minimum 3-log10 reduction in reservoir size. Long-lived tissue reservoirs may have contributed to viral persistence. The definition of the nature and half-life of such reservoirs is essential to achieve durable antiretroviral-free HIV-1 remission.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; Blood Syst Res Inst, San Francisco, CA 94118 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; MIT, Ragon Inst Massachusetts Gen Hosp, Cambridge, MA 02139 USA; Harvard Univ, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Heinrich Pette Institute; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Henrich, TJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Infect Dis, 65 Landsdowne St, Cambridge, MA 02139 USA.	thenrich@partners.org	Marty, Francisco M./H-7088-2019; Hill, Alison Lynn/W-7839-2019; Altfeld, Marcus/AAE-7306-2019	Marty, Francisco M./0000-0002-3708-8734; Hill, Alison Lynn/0000-0002-6583-3623; Altfeld, Marcus/0000-0001-5972-2997; Keating, Sheila/0000-0002-8324-3694	Foundation for AIDS Research; National Institute of Allergy and Infectious Diseases; Foundation for AIDS Research (amfAR Research Consortium on HIV Eradication grant); National Institute of Allergy and Infectious Disease, National Institutes of Health [1K23AI098480-01A1]; AIDS Clinical Trials Group Virology Support Laboratory [UM1 AI068636]; Harvard University Center for AIDS Research Therapeutics Program [P30 AI060354]; Delaney AIDS Research Enterprise Collaboratory [U19 AI096109]; Ragon Institute of Massachusetts General Hospital; Massachusetts Institute of Technology; Harvard University; Bill & Melinda Gates Foundation (Global Health grant) [OPP1017716]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068636, P30AI027763, UM1AI106701, P30AI060354, K23AI098480, U19AI096109] Funding Source: NIH RePORTER	Foundation for AIDS Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Foundation for AIDS Research (amfAR Research Consortium on HIV Eradication grant); National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AIDS Clinical Trials Group Virology Support Laboratory; Harvard University Center for AIDS Research Therapeutics Program; Delaney AIDS Research Enterprise Collaboratory; Ragon Institute of Massachusetts General Hospital; Massachusetts Institute of Technology; Harvard University; Bill & Melinda Gates Foundation (Global Health grant); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Foundation for AIDS Research and National Institute of Allergy and Infectious Diseases.; By the Foundation for AIDS Research (amfAR Research Consortium on HIV Eradication grant); National Institute of Allergy and Infectious Disease, National Institutes of Health (1K23AI098480-01A1); AIDS Clinical Trials Group Virology Support Laboratory (UM1 AI068636); Harvard University Center for AIDS Research Therapeutics Program (P30 AI060354); Delaney AIDS Research Enterprise Collaboratory (U19 AI096109); and Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University. This article is also based on research funded in part by the Bill & Melinda Gates Foundation (Global Health grant OPP1017716).	Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Altfeld MA, 2000, J VIROL, V74, P8541, DOI 10.1128/JVI.74.18.8541-8549.2000; Avettand-Fenoel V, 2007, AIDS, V21, P776, DOI 10.1097/QAD.0b013e3280b01836; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; CONTU L, 1993, BONE MARROW TRANSPL, V12, P669; DAAR ES, 1991, NEW ENGL J MED, V324, P961, DOI 10.1056/NEJM199104043241405; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fischer M, 2003, AIDS, V17, P195, DOI 10.1097/00002030-200301240-00009; Frost SDW, 2002, J VIROL, V76, P968, DOI 10.1128/JVI.76.3.968-979.2002; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; Gandhi RT, 2010, J INFECT DIS, V201, P293, DOI 10.1086/649569; Harrigan PR, 1999, AIDS, V13, pF59, DOI 10.1097/00002030-199905280-00001; Henrich TJ, 2013, J INFECT DIS, V207, P1694, DOI 10.1093/infdis/jit086; Henrich TJ, 2012, J VIROL METHODS, V186, P68, DOI 10.1016/j.jviromet.2012.08.019; HOLLAND HK, 1989, ANN INTERN MED, V111, P973, DOI 10.7326/0003-4819-111-12-973; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Huzicka I, 1999, MED HYPOTHESES, V52, P247, DOI 10.1054/mehy.1997.0638; Kaufmann DE, 2004, PLOS MED, V1, P137, DOI 10.1371/journal.pmed.0010036; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Lee TH, 2005, TRANSFUSION, V45, P1280, DOI 10.1111/j.1537-2995.2005.00201.x; Lee TH, 2006, TRANSFUSION, V46, P1870, DOI 10.1111/j.1537-2995.2006.00992.x; Li JZ, 2012, ANTIMICROB AGENTS CH, V56, P5998, DOI 10.1128/AAC.01217-12; Malnati MS, 2008, NAT PROTOC, V3, P1240, DOI 10.1038/nprot.2008.108; Murphy WJ, 2012, BIOL BLOOD MARROW TR, V18, pS2, DOI 10.1016/j.bbmt.2011.10.033; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Ruiz L, 2000, AIDS, V14, P397, DOI 10.1097/00002030-200003100-00013; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Siliciano Janet D, 2005, Methods Mol Biol, V304, P3; Siliciano Robert F, 2010, Top HIV Med, V18, P104; Taylor S, 2007, AIDS, V21, P1673, DOI 10.1097/QAD.0b013e3281c61394; van Besien K, 2013, HEMATOL-AM SOC HEMAT, P56, DOI 10.1182/asheducation-2013.1.56; Woolfrey AE, 2008, BLOOD, V112, P3484, DOI 10.1182/blood-2008-05-157511; Yukl SA, 2013, J INFECT DIS, V208, P1212, DOI 10.1093/infdis/jit308; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722	39	312	318	3	40	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2014	161	5					319	+		10.7326/M14-1027	http://dx.doi.org/10.7326/M14-1027			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO7VT	25047577	Green Accepted			2022-12-28	WOS:000341561400002
J	Hwang, WL; Deindl, S; Harada, BT; Zhuang, XW				Hwang, William L.; Deindl, Sebastian; Harada, Bryan T.; Zhuang, Xiaowei			Histone H4 tail mediates allosteric regulation of nucleosome remodelling by linker DNA	NATURE			English	Article							SINGLE-MOLECULE; CORE PARTICLE; CHROMATIN; ISWI; ACF; COMPLEXES; RESOLUTION; CONTAINS; DYNAMICS; SUBUNITS	Imitation switch (ISWI)-family remodelling enzymes regulate access to genomic DNA by mobilizing nucleosomes(1). These ATP-dependent chromatin remodellers promote heterochromatin formation and transcriptional silencing(1) by generating regularly spaced nucleosome arrays(2-5). The nucleosome-spacing activity arises from the dependence of nucleosome translocation on the length of extranucleosomal linker DNA(6-10), but the underlying mechanism remains unclear. Here we study nucleosome remodelling by human ATP-dependent chromatin assembly and remodelling factor (ACF), an ISWI enzyme comprising a catalytic subunit, Snf2h, and an accessory subunit, Acf1 (refs 2, 11-13). We find that ACF senses linker DNA length through an interplay between its accessory and catalytic subunits mediated by the histone H4 tail of the nucleosome. Mutation of AutoN, an auto-inhibitory domain within Snf2h that bears sequence homology to the H4 tail(14), abolishes the linker-length sensitivity in remodelling. Addition of exogenous H4-tail peptide or deletion of the nucleosomal H4 tail also diminishes the linker-length sensitivity. Moreover, Acf1 binds both the H4-tail peptide and DNA in an amino (N)-terminal domain dependent manner, and in the ACF-bound nucleosome, lengthening the linker DNA reduces the Acf1-H4 tail proximity. Deletion of the N-terminal portion of Acf1 (or itshomologue in yeast) abolishes linker-length sensitivity in remodelling and leads to severe growth defects in vivo. Taken together, our results suggest a mechanism for nucleosome spacing where linker DNA sensing by Acf1 is allosterically transmitted to Snf2h through the H4 tail of the nucleosome. For nucleosomes with short linker DNA, Acf1 preferentially binds to the H4 tail, allowing AutoN to inhibit the ATPase activity of Snf2h. As the linker DNA lengthens, Acf1 shifts its binding preference to the linker DNA, freeing the H4 tail to compete Auto N off the ATPase and thereby activating ACF.	[Hwang, William L.; Deindl, Sebastian; Harada, Bryan T.; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Hwang, William L.; Harada, Bryan T.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Hwang, William L.] Harvard Univ, Sch Med, Harvard MIT MD PhD Program, Boston, MA 02115 USA; [Deindl, Sebastian; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Harada, Bryan T/AAW-3169-2020	Harada, Bryan T/0000-0002-9683-782X; Deindl, Sebastian/0000-0001-6807-8654	National Institutes of Health [GM105637, T32G007753]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM105637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Narlikar, T. Tsukiyama, J. Vaughan, J. Moffitt and E. Sun for discussions, S. Mukherji for assistance in designing the yeast experiments, S. Trauger, K. L. Hwang, R. Magnusson, G. Hilinski and J. McGee for assistance with protein characterization and biochemistry, and G. Narlikar for providing Snf2h and Acf1 expression vectors and purification protocols. This work was supported in part by the National Institutes of Health (GM105637 to X.Z.). W.L.H. acknowledges support from the National Institutes of Health T32G007753 Training Grant. S.D. was a Merck Fellow of the Jane Coffin Childs Foundation. X.Z. is a Howard Hughes Medical Investigator.	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Blosser TR, 2009, NATURE, V462, P1022, DOI 10.1038/nature08627; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Dang WW, 2006, MOL CELL BIOL, V26, P7388, DOI 10.1128/MCB.01159-06; Deindl S, 2013, CELL, V152, P442, DOI 10.1016/j.cell.2012.12.040; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Fyodorov DV, 2002, MOL CELL BIOL, V22, P6344, DOI 10.1128/MCB.22.18.6344-6353.2002; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; He X, 2008, BIOCHEMISTRY-US, V47, P7025, DOI 10.1021/bi702304p; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Killian JL, 2012, CURR OPIN STRUC BIOL, V22, P80, DOI 10.1016/j.sbi.2011.11.003; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; LeRoy G, 2000, J BIOL CHEM, V275, P14787, DOI 10.1074/jbc.C000093200; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P82, DOI 10.1038/nsmb.2457; Narlikar GJ, 2010, CURR OPIN CHEM BIOL, V14, P660, DOI 10.1016/j.cbpa.2010.08.001; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170	36	60	60	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					213	+		10.1038/nature13380	http://dx.doi.org/10.1038/nature13380			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043036	Green Accepted, Green Submitted			2022-12-28	WOS:000340200700036
J	Campbell, P; Grayson, M				Campbell, Philip; Grayson, Michelle			Assessing science	NATURE			English	Editorial Material																			0	5	5	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					S49	S49		10.1038/511S49a	http://dx.doi.org/10.1038/511S49a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25054850	Bronze			2022-12-28	WOS:000339335700001
J	Caricchi, L; Simpson, G; Schaltegger, U				Caricchi, Luca; Simpson, Guy; Schaltegger, Urs			Zircons reveal magma fluxes in the Earth's crust	NATURE			English	Article							IGNEOUS ROCK SERIES; TORRES-DEL-PAINE; ADAMELLO BATHOLITH; WALLOWA-BATHOLITH; VOLCANIC FIELD; PLUTON; CRYSTALLIZATION; EMPLACEMENT; SYSTEMS; RATES	Magma fluxes regulate the planetary thermal budget, the growth of continents and the frequency and magnitude of volcanic eruptions, and play a part in the genesis and size of magmatic ore deposits(1-4). However, because a large fraction of the magma produced on the Earth does not erupt at the surface(2,5), determinations of magma fluxes are rare and this compromises our ability to establish a link between global heat transfer and large-scale geological processes. Here we show that age distributions of zircons, a mineral often present in crustal magmatic rocks(6), in combination with thermal modelling, provide an accurate means of retrieving magma fluxes. The characteristics of zircon age populations vary significantly and systematically as a function of the flux and total volume of magma accumulated in the Earth's crust. Our approach produces results that are consistent with independent determinations of magma fluxes and volumes of magmatic systems. Analysis of existing age population data sets using our method suggests that porphyry-type deposits, plutons and large eruptions each require magma input over different timescales at different characteristic average fluxes. We anticipate that more extensive and complete magma flux data sets will serve to clarify the control that the global heat flux exerts on the frequency of geological events such as volcanic eruptions, and to determine the main factors controlling the distribution of resources on our planet.	[Caricchi, Luca; Simpson, Guy; Schaltegger, Urs] Univ Geneva, Sect Earth & Environm Sci, CH-1205 Geneva, Switzerland	University of Geneva	Caricchi, L (corresponding author), Univ Geneva, Sect Earth & Environm Sci, Rue Maraichers 13, CH-1205 Geneva, Switzerland.	luca.caricchi@unige.ch		Schaltegger, Urs/0000-0003-4404-8607	University of Geneva; Swiss National Science Foundation	University of Geneva; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank C. Miller for the comments provided on the manuscript. The suggestions of J. Blundy on an early version of this manuscript are appreciated. Discussions with J. Wotzlaw, C. Chelle-Michou and M. Chiaradia helped to structure the study. All authors acknowledge the funding support of the University of Geneva and the Swiss National Science Foundation.	Annen C, 2009, EARTH PLANET SC LETT, V284, P409, DOI 10.1016/j.epsl.2009.05.006; Boehnke P, 2013, CHEM GEOL, V351, P324, DOI 10.1016/j.chemgeo.2013.05.028; Caricchi L, 2014, NAT GEOSCI, V7, P126, DOI [10.1038/NGEO2041, 10.1038/ngeo2041]; Caricchi L, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009325; Chelle-Michou C, 2014, LITHOS, V198, P129, DOI 10.1016/j.lithos.2014.03.017; CRISP JA, 1984, J VOLCANOL GEOTH RES, V20, P177, DOI 10.1016/0377-0273(84)90039-8; de Saint Blanquat M., 2011, TECTONOPHYSICS, V500, P20, DOI DOI 10.1016/J.TECTO.2009.12.009; Glazner A.F., 2004, GSA TODAY, V14, P4, DOI [10.1130/1052-5173(2004)0142.0.CO;2, DOI 10.1130/1052-5173(2004)014<0004:APA0M0>2.0.C0;2, DOI 10.1130/1052-5173(2004)0142.0.CO;2]; Gregg PM, 2012, J VOLCANOL GEOTH RES, V241, P1, DOI 10.1016/j.jvolgeores.2012.06.009; Hanchar JM, 2003, REV MINERAL GEOCHEM, V53, P89, DOI 10.2113/0530089; Harrison TM, 2007, GEOLOGY, V35, P635, DOI 10.1130/G23505A.1; JAEGER JC, 1964, REV GEOPHYS, V2, P443, DOI 10.1029/RG002i003p00443; Jellinek AM, 2003, B VOLCANOL, V65, P363, DOI 10.1007/s00445-003-0277-y; JOHN BE, 1993, GEOL SOC AM BULL, V105, P1517, DOI 10.1130/0016-7606(1993)105<1517:ERDOGM>2.3.CO;2; Leuthold J, 2012, EARTH PLANET SC LETT, V325, P85, DOI 10.1016/j.epsl.2012.01.032; Lipman PW, 2007, GEOSPHERE, V3, P42, DOI 10.1130/GES00061.1; Lipman PW, 1996, GEOL SOC AM BULL, V108, P1039, DOI 10.1130/0016-7606(1996)108<1039:REASAT>2.3.CO;2; Lissenberg CJ, 2009, SCIENCE, V323, P1048, DOI 10.1126/science.1167330; Longo AA, 2010, ECON GEOL, V105, P1191, DOI 10.2113/econgeo.105.7.1191; MARSH BD, 1981, CONTRIB MINERAL PETR, V78, P85, DOI 10.1007/BF00371146; Michaut C, 2006, EARTH PLANET SC LETT, V250, P38, DOI 10.1016/j.epsl.2006.07.019; Michel J, 2008, GEOLOGY, V36, P459, DOI 10.1130/G24546A.1; PIWINSKII AJ, 1968, J GEOL, V76, P205, DOI 10.1086/627323; PIWINSKII AJ, 1970, J GEOL, V78, P52, DOI 10.1086/627488; Schaltegger U, 2009, EARTH PLANET SC LETT, V286, P208, DOI 10.1016/j.epsl.2009.06.028; Schoene B, 2012, EARTH PLANET SC LETT, V355, P162, DOI 10.1016/j.epsl.2012.08.019; Steinberger I, 2013, ECON GEOL, V108, P605, DOI 10.2113/econgeo.108.4.605; von Quadt A, 2011, GEOLOGY, V39, P731, DOI 10.1130/G31966.1; WATSON EB, 1983, EARTH PLANET SC LETT, V64, P295, DOI 10.1016/0012-821X(83)90211-X; White SM, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001002; Wilson CJN, 2009, J PETROL, V50, P875, DOI 10.1093/petrology/egp023; Wotzlaw JF, 2013, GEOLOGY, V41, P867, DOI 10.1130/G34366.1	32	62	62	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					457	+		10.1038/nature13532	http://dx.doi.org/10.1038/nature13532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25056063				2022-12-28	WOS:000339335700044
J	Forcada, J; Hoffman, JI				Forcada, Jaume; Hoffman, Joseph Ivan			Climate change selects for heterozygosity in a declining fur seal population	NATURE			English	Article							INBREEDING DEPRESSION; ARCTOCEPHALUS-GAZELLA; ADAPTATION; RESPONSES; GENETICS; SUCCESS; STRESS; MODEL; SIZE; LONG	Global environmental change is expected to alter selection pressures in many biological systems(1-3), but the long-term molecular and life history data required to quantify changes in selection are rare(4). An unusual opportunity is afforded by three decades of individual-based data collected from a declining population of Antarctic fur seals in the South Atlantic. Here, climate change has reduced prey availability and caused a significant decline in seal birth weight. However, the mean age and size of females recruiting into the breeding population are increasing. We show that such females have significantly higher heterozygosity (a measure of within-individual genetic variation) than their non-recruiting siblings and their own mothers. Thus, breeding female heterozygosity has increased by 8.5% per generation over the last two decades. Nonetheless, as heterozygosity is not inherited from mothers to daughters, substantial heterozygote advantage is not transmitted from one generation to the next and the decreasing viability of homozygous individuals causes the population to decline. Our results provide compelling evidence that selection due to climate change is intensifying, with far-reaching consequences for demography as well as phenotypic and genetic variation.	[Forcada, Jaume] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Hoffman, Joseph Ivan] Univ Bielefeld, Dept Anim Behav, D-33501 Bielefeld, Germany	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Bielefeld	Forcada, J (corresponding author), British Antarctic Survey, Nat Environm Res Council, Madingley Rd, Cambridge CB3 0ET, England.	jfor@bas.ac.uk	Forcada, Jaume/GYU-0677-2022; Hoffman, Joseph i/K-7725-2012	Hoffman, Joseph i/0000-0001-5895-8949	Marie Curie FP7-Reintegration-Grant within the 7th European Community Framework Programme [PCIG-GA-2011-303618]; Deutsche Forschungsgemeinschaft standard grant [HO 5122/3-1]	Marie Curie FP7-Reintegration-Grant within the 7th European Community Framework Programme; Deutsche Forschungsgemeinschaft standard grant	The authors thank the many fieldworkers who have contributed to data collection over the years. We are also grateful to W. Amos, J. Bascompte, M. Boerner, K. Dasmahapatra, O. Kruger and I. Staniland for advice and feedback on the manuscript, together with T. Coulson for helpful referee comments. This work contributes to the Long Term Monitoring and Survey project and Ecosystems project of the British Antarctic Survey, Natural Environment Research Council, part of the Polar Science for Planet Earth programme. The genetic work was supported by a Marie Curie FP7-Reintegration-Grant within the 7th European Community Framework Programme (PCIG-GA-2011-303618) and a Deutsche Forschungsgemeinschaft standard grant (HO 5122/3-1) awarded to J.I.H.	Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Caswell, 2000, MATRIX POPULATION MO; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Coulson T, 2010, J ANIM ECOL, V79, P1226, DOI 10.1111/j.1365-2656.2010.01734.x; Di Fonzo MMI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019667; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Eberhardt LL, 2002, ECOLOGY, V83, P2841, DOI 10.2307/3072020; Forcada J, 2005, ECOLOGY, V86, P2408, DOI 10.1890/04-1153; Forcada J, 2008, GLOBAL CHANGE BIOL, V14, P2473, DOI 10.1111/j.1365-2486.2008.01678.x; Franks SJ, 2012, ANNU REV GENET, V46, P185, DOI 10.1146/annurev-genet-110711-155511; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Hoffman JI, 2007, NATURE, V445, P912, DOI 10.1038/nature05558; Hoffman JI, 2012, MOL ECOL RESOUR, V12, P861, DOI 10.1111/j.1755-0998.2012.03158.x; Hoffman JI, 2004, EVOLUTION, V58, P2087; Hoffman JI, 2014, P NATL ACAD SCI USA, V111, P3775, DOI 10.1073/pnas.1318945111; Hoffman JI, 2010, J HERED, V101, P527, DOI 10.1093/jhered/esq045; Hoffmann AA, 2000, BIOSCIENCE, V50, P217, DOI 10.1641/0006-3568(2000)050[0217:ESAAEF]2.3.CO;2; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Meredith MP, 2008, DEEP-SEA RES PT II, V55, P2007, DOI 10.1016/j.dsr2.2008.05.020; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; MITTON JB, 1993, HEREDITY, V71, P59, DOI 10.1038/hdy.1993.107; Murphy EJ, 2007, P ROY SOC B-BIOL SCI, V274, P3057, DOI 10.1098/rspb.2007.1180; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; SAMOLLOW PB, 1983, EVOLUTION, V37, P646, DOI 10.1111/j.1558-5646.1983.tb05584.x; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x	26	99	104	1	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					462	+		10.1038/nature13542	http://dx.doi.org/10.1038/nature13542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25056064				2022-12-28	WOS:000339335700045
J	McGilvray, A				McGilvray, Annabel			RESEARCH ASSESSMENT The limits of excellence	NATURE			English	Editorial Material																		[Anonymous], 2013, PERF BAS RES FUND EV; Australian Research Council, 2012, EXC RES AUSTR 2012 N; Cinlar N., 2008, STAFFING PERFORMANCE	3	3	3	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					S64	S66		10.1038/511S64a	http://dx.doi.org/10.1038/511S64a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL7SO	25054853	Bronze			2022-12-28	WOS:000339335700004
J	Chi, BH; Thirumurthy, H; Stringer, JSA				Chi, Benjamin H.; Thirumurthy, Harsha; Stringer, Jeffrey S. A.			Maximizing Benefits of New Strategies to Prevent Mother-to-Child HIV Transmission Without Harming Existing Services	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AFRICA		[Chi, Benjamin H.; Thirumurthy, Harsha; Stringer, Jeffrey S. A.] Univ N Carolina, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Chi, BH (corresponding author), POB 34681,5032 Great North Rd, Lusaka, Zambia.	bchi@med.unc.edu	Stringer, Jeffrey S. A./AAU-2342-2021	Thirumurthy, Harsha/0000-0002-3308-7603; Stringer, Jeffrey/0000-0002-9590-7216	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075131, K01HD061605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI050410] Funding Source: Medline; NICHD NIH HHS [P2C HD050924, K01 HD061605, R01 HD075131] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Duber HC, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-21; Goodson JL, 2013, JAIDS-J ACQ IMM DEF, V63, pE9, DOI 10.1097/QAI.0b013e31828a3e3f; Grepin KA, 2012, HEALTH AFFAIR, V31, P1406, DOI 10.1377/hlthaff.2012.0279; Nelson LJ, 2014, AIDS, V28, pS217, DOI 10.1097/QAD.0000000000000239; Rasschaert Freya, 2011, J Int AIDS Soc, V14 Suppl 1, pS3, DOI 10.1186/1758-2652-14-S1-S3; Shiffman J, 2008, HEALTH POLICY PLANN, V23, P95, DOI 10.1093/heapol/czm045; Topp SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011522	8	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					341	342		10.1001/jama.2014.6929	http://dx.doi.org/10.1001/jama.2014.6929			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038348	Green Accepted			2022-12-28	WOS:000339257800016
J	Sandler, VM; Lis, R; Liu, Y; Kedem, A; James, D; Elemento, O; Butler, JM; Scandura, JM; Rafii, S				Sandler, Vladislav M.; Lis, Raphael; Liu, Ying; Kedem, Alon; James, Daylon; Elemento, Olivier; Butler, Jason M.; Scandura, Joseph M.; Rafii, Shahin			Reprogramming human endothelial cells to haematopoietic cells requires vascular induction	NATURE			English	Article							STEM-CELLS; HAEMOGENIC ENDOTHELIUM; ANGIOCRINE SIGNALS; PROGENITOR CELLS; SELF-RENEWAL; CORD BLOOD; B-CELLS; DIFFERENTIATION; REGENERATION; NICHE	Generating engraftable human haematopoietic cells from autologous tissues is a potential route to new therapies for blood diseases. However, directed differentiation of pluripotent stem cells yields haematopoietic cells that engraft poorly. Here, we have devised a method to phenocopy the vascular-niche microenvironment of haemogenic cells, thereby enabling reprogramming of human endothelial cells into engraftable haematopoietic cells without transition through a pluripotent intermediate. Highly purifiednon-haemogenic human umbilical vein endothelial cells or adult dermalmicrovascular endothelial cells were transduced with the transcription factors FOSB, GFI1, RUNX1 and SPI1 (hereafter referred to as FGRS), and then propagated on serum-free instructive vascular niche monolayers to induce outgrowth of haematopoietic colonies containing cells with functional and immunophenotypic features of multipotent progenitor cells (MPPs). These endothelial cells that have been reprogrammed into human MPPs (rEC-hMPPs) acquire colony-forming-cell potential and durably engraft into immune-deficient mice after primary and secondary transplantation, producing long-term rEC-hMPP-derived myeloid (granulocytic/monocytic, erythroid, megakaryocytic) and lymphoid (natural killer and B cell) progenies. Conditional expression of FGRS transgenes, combined with vascular induction, activates endogenous FGRS genes, endowing rEC-hMPPs with a transcriptional and functional profile similar to that of self-renewing MPPs. Our approach underscores the role of inductive cues from the vascular niche in coordinating and sustaining haematopoietic specification and may prove useful for engineering autologous haematopoietic grafts to treat inherited and acquired blood disorders.	[Sandler, Vladislav M.; Lis, Raphael; Liu, Ying; Kedem, Alon; James, Daylon; Butler, Jason M.; Rafii, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, Dept Med Genet, New York, NY 10065 USA; [Sandler, Vladislav M.; Lis, Raphael; Liu, Ying; Kedem, Alon; James, Daylon; Butler, Jason M.; Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY 10065 USA; [Lis, Raphael; Kedem, Alon; James, Daylon] Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Elemento, Olivier] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10065 USA; [Scandura, Joseph M.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Scandura, Joseph M.] New York Presbyterian Hosp, New York, NY 10065 USA	Cornell University; Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University; Cornell University; NewYork-Presbyterian Hospital	Rafii, S (corresponding author), Weill Cornell Med Coll, Ansary Stem Cell Inst, Dept Med Genet, New York, NY 10065 USA.	srafii@med.cornell.edu		Rafii, Shahin/0000-0001-5605-1067; Scandura, Joseph/0000-0002-9525-143X	Empire State Stem Cell Board (ESSCB); New York State Department of Health [NYSDH C026878]; Ansary Stem Cell Institute (ASCI); HHMI; ESSCB/NYSDH [C024180, C026438, C026878, C028117]; NHLBI [R01HL097797, R01HL119872, U01 HL099997, HL119872, HL055748, U01-HL099997]; NIDDK [R01DK095039]; NCI [U54CA163167, CA159175, CA163167]; Qatar National Priorities Research Foundation [NPRP08-663-3-140]; Qatar Foundation BioMedical Research Program; Starr Foundation and a Leukemia & Lymphoma Society Scholar award; American Society of Hematology Scholar Award; Angiocrine Bioscience; ASCI; NATIONAL CANCER INSTITUTE [R21CA159175, U54CA163167] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099997, R01HL055748, R01HL119872, R01HL115128, R01HL097797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095039] Funding Source: NIH RePORTER	Empire State Stem Cell Board (ESSCB); New York State Department of Health; Ansary Stem Cell Institute (ASCI); HHMI(Howard Hughes Medical Institute); ESSCB/NYSDH; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Qatar National Priorities Research Foundation; Qatar Foundation BioMedical Research Program(Qatar National Research Fund (QNRF)); Starr Foundation and a Leukemia & Lymphoma Society Scholar award; American Society of Hematology Scholar Award; Angiocrine Bioscience; ASCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	V.M.S. is supported by Empire State Stem Cell Board (ESSCB) and New York State Department of Health (NYSDH C026878). S. R. is supported by Ansary Stem Cell Institute (ASCI), HHMI, ESSCB/NYSDH (C024180, C026438, C026878, C028117), NHLBI (R01HL097797, R01HL119872, U01 HL099997), NIDDK (R01DK095039), NCI (U54CA163167), Qatar National Priorities Research Foundation grant NPRP08-663-3-140 and the Qatar Foundation BioMedical Research Program. J.M.S. is supported by grants from NCI (CA159175 and CA163167), NHLBI (HL119872 and HL055748), Starr Foundation and a Leukemia & Lymphoma Society Scholar award. J.M.B. is supported by an American Society of Hematology Scholar Award, NHLBI U01-HL099997 and Angiocrine Bioscience and ASCI. We acknowledge the contribution of J. Z. Xiang and Agnes J. Viale for enabling and executing molecular profiling, and E. Gars for technical support. We appreciate W. Schachterle for recommendations and edits of the manuscript.	Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Butler JM, 2012, BLOOD, V120, P1344, DOI 10.1182/blood-2011-12-398115; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Chen MJ, 2011, CELL STEM CELL, V9, P541, DOI 10.1016/j.stem.2011.10.003; Choi KD, 2012, CELL REP, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Doan PL, 2013, STEM CELLS, V31, P327, DOI 10.1002/stem.1275; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; Gordon-Keylock S, 2013, BLOOD, V122, P2338, DOI 10.1182/blood-2012-12-470971; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Lancrin C, 2012, BLOOD, V120, P314, DOI 10.1182/blood-2011-10-386094; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Marcelo KL, 2013, DEV CELL, V27, P504, DOI 10.1016/j.devcel.2013.11.004; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Poulos MG, 2013, CELL REP, V4, P1022, DOI 10.1016/j.celrep.2013.07.048; RAFII S, 1994, BLOOD, V84, P10; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Rafii S, 2013, BLOOD, V121, P770, DOI 10.1182/blood-2012-07-444208; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Sandler VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018265; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Sturgeon CM, 2013, NAT BIOTECHNOL, V31, P416, DOI 10.1038/nbt.2571; Swiers G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3924; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Wu X, 2007, STEM CELLS, V25, P2770, DOI 10.1634/stemcells.2006-0783; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yoshimoto M, 2008, CELL STEM CELL, V3, P583, DOI 10.1016/j.stem.2008.11.002; Zou GM, 2005, P NATL ACAD SCI USA, V102, P13236, DOI 10.1073/pnas.0506218102; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	43	156	166	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					312	+		10.1038/nature13547	http://dx.doi.org/10.1038/nature13547			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030167	Green Accepted			2022-12-28	WOS:000338992200028
J	Li, J; Zheng, HY				Li, Jun; Zheng, Heyi			Erosive Plaque on Scrotum	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BASAL-CELL CARCINOMA		[Li, Jun; Zheng, Heyi] Beijing Union Med Coll Hosp, Dept Dermatol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Li, J (corresponding author), Beijing Union Med Coll Hosp, Dept Dermatol, 1 Shuaifuyuan Wangfujing Dongcheng Dist, Beijing 100730, Peoples R China.	lijun35@hotmail.com						Dai B, 2012, DERMATOL SURG, V38, P783, DOI 10.1111/j.1524-4725.2012.02356.x; Gibson GE, 2001, J AM ACAD DERMATOL, V45, P68, DOI 10.1067/mjd.2001.114588; Handa Y, 2005, EUR J DERMATOL, V15, P186; NAHASS GT, 1992, J AM ACAD DERMATOL, V26, P574, DOI 10.1016/0190-9622(92)70083-R; Ouchi T, 2008, J DERMATOL, V35, P804, DOI 10.1111/j.1346-8138.2008.00576.x; Rosen T, 2003, JAMA-J AM MED ASSOC, V290, P1001, DOI 10.1001/jama.290.8.1001; Wang JW, 2012, INT J DERMATOL, V51, P752, DOI 10.1111/j.1365-4632.2010.04637.x; Wright JL, 2008, UROLOGY, V72, P1139, DOI 10.1016/j.urology.2008.06.043	8	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					288	289		10.1001/jama.2013.286242	http://dx.doi.org/10.1001/jama.2013.286242			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	25027145				2022-12-28	WOS:000338940300027
J	Dyer, C				Dyer, Clare			Who is paying your doctor?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												claredyer4@gmail.com						General Medical Council, 2013, FINANCIAL AND COMMER; Lo B, 2009, CONFLICTS OF INTERES; Omstein C, 2014, PROPUBLICA; Thomas K., 2013, NEW YORK TIMES	4	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2014	349								g4601	10.1136/bmj.g4601	http://dx.doi.org/10.1136/bmj.g4601			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7OZ	25027054				2022-12-28	WOS:000339325400013
J	Armbrust, EV				Armbrust, E. Virginia			Taking the pulse of ocean microbes	SCIENCE			English	Editorial Material							DIEL VARIATIONS; PROCHLOROCOCCUS; BACTERIOPLANKTON; SEA		Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Armbrust, EV (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	armbrust@uw.edu						Bertilsson S, 2005, VIE MILIEU, V55, P225; DeLong EF, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000359; FUHRMAN JA, 1985, MAR ECOL PROG SER, V27, P9, DOI 10.3354/meps027009; Gasol JM, 1998, MAR ECOL PROG SER, V164, P107, DOI 10.3354/meps164107; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Ottesen EA, 2014, SCIENCE, V345, P207, DOI 10.1126/science.1252476; Ottesen EA, 2013, P NATL ACAD SCI USA, V110, pE488, DOI 10.1073/pnas.1222099110; Swan BK, 2013, P NATL ACAD SCI USA, V110, P11463, DOI 10.1073/pnas.1304246110; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135	12	3	4	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					134	135		10.1126/science.1256578	http://dx.doi.org/10.1126/science.1256578			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013043				2022-12-28	WOS:000339409900018
J	Eisenstein, M				Eisenstein, Michael			NEUROBIOLOGY Unrestrained excitement	NATURE			English	Editorial Material																		Christian CA, 2013, P NATL ACAD SCI USA, V110, P20278, DOI 10.1073/pnas.1318031110; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Schevon CA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2056; Wykes RC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004190	4	5	5	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S4	S6		10.1038/511S4a	http://dx.doi.org/10.1038/511S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25019125	Bronze			2022-12-28	WOS:000338649800002
J	Venkatesh, B; Lee, AP; Swann, JB; Ohta, Y; Flajnik, MF; Kasahara, M; Boehm, T; Warren, WC				Venkatesh, Byrappa; Lee, Alison P.; Swann, Jeremy B.; Ohta, Yuko; Flajnik, Martin F.; Kasahara, Masanori; Boehm, Thomas; Warren, Wesley C.			T(H)2 and T-reg candidate genes in elephant shark Reply	NATURE			English	Letter							GENOMES		[Venkatesh, Byrappa; Lee, Alison P.] ASTAR, Inst Mol & Cell Biol, Comparat Genom Lab, Singapore 138673, Singapore; [Venkatesh, Byrappa] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 119228, Singapore; [Swann, Jeremy B.; Boehm, Thomas] Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, D-79108 Freiburg, Germany; [Ohta, Yuko; Flajnik, Martin F.] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Kasahara, Masanori] Hokkaido Univ, Dept Pathol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [Warren, Wesley C.] Washington Univ, Genome Inst, St Louis, MO 63108 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Max Planck Society; University System of Maryland; University of Maryland Baltimore; Hokkaido University; Washington University (WUSTL)	Venkatesh, B (corresponding author), ASTAR, Inst Mol & Cell Biol, Comparat Genom Lab, Singapore 138673, Singapore.	mcbbv@imcb.a-star.edu.sg; wwarren@genome.wustl.edu	Lee, Alison/HCH-1286-2022; Kasahara, Masanori/G-7651-2011	Lee, Alison/0000-0002-3773-1021; Venkatesh, Byrappa/0000-0003-3620-0277; Flajnik, Martin Francis/0000-0002-2792-5084	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NHGRI NIH HHS [U54 HG003079] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Andersen KG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00113; Dijkstra JM, 2014, NATURE, V511, pE7, DOI 10.1038/nature13446; Dijkstra JM, 2014, IMMUNOGENETICS, V66, P93, DOI 10.1007/s00251-013-0747-0; Dijkstra JM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-260; Liu MY, 2004, TRENDS GENET, V20, P399, DOI 10.1016/j.tig.2004.06.013; Ohtani M, 2008, IMMUNOGENETICS, V60, P383, DOI 10.1007/s00251-008-0299-x; Takizawa F, 2011, MOL IMMUNOL, V48, P1360, DOI 10.1016/j.molimm.2011.02.014; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826	9	6	6	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					E9	E10		10.1038/nature13447	http://dx.doi.org/10.1038/nature13447			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SP	25008535				2022-12-28	WOS:000349549100002
J	Taylor, RW; Pyle, A; Griffin, H; Blakely, EL; Duff, J; He, LP; Smertenko, T; Alston, CL; Neeve, VC; Best, A; Yarham, JW; Kirschner, J; Schara, U; Talim, B; Topaloglu, H; Baric, I; Holinski-Feder, E; Abicht, A; Czermin, B; Kleinle, S; Morris, AAM; Vassallo, G; Gorman, GS; Ramesh, V; Turnbull, DM; Santibanez-Koref, M; McFarland, R; Horvath, R; Chinnery, PF				Taylor, Robert W.; Pyle, Angela; Griffin, Helen; Blakely, Emma L.; Duff, Jennifer; He, Langping; Smertenko, Tania; Alston, Charlotte L.; Neeve, Vivienne C.; Best, Andrew; Yarham, John W.; Kirschner, Janbernd; Schara, Ulrike; Talim, Beril; Topaloglu, Haluk; Baric, Ivo; Holinski-Feder, Elke; Abicht, Angela; Czermin, Birgit; Kleinle, Stephanie; Morris, Andrew A. M.; Vassallo, Grace; Gorman, Grainne S.; Ramesh, Venkateswaran; Turnbull, Douglass M.; Santibanez-Koref, Mauro; McFarland, Robert; Horvath, Rita; Chinnery, Patrick F.			Use of Whole-Exome Sequencing to Determine the Genetic Basis of Multiple Mitochondrial Respiratory Chain Complex Deficiencies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRANSFER-RNA SYNTHETASE; SIDEROBLASTIC ANEMIA-MLASA; HYPERTROPHIC CARDIOMYOPATHY; LACTIC-ACIDOSIS; I DEFICIENCY; TRANSLATION DEFECT; HIGH-THROUGHPUT; RMND1 MUTATION; DISORDERS; DISEASE	IMPORTANCE Mitochondrial disorders have emerged as a common cause of inherited disease, but their diagnosis remains challenging. Multiple respiratory chain complex defects are particularly difficult to diagnose at the molecular level because of the massive number of nuclear genes potentially involved in intramitochondrial protein synthesis, with many not yet linked to human disease. OBJECTIVE To determine the molecular basis of multiple respiratory chain complex deficiencies. DESIGN, SETTING, AND PARTICIPANTS We studied 53 patients referred to 2 national centers in the United Kingdom and Germany between 2005 and 2012. All had biochemical evidence of multiple respiratory chain complex defects but no primary pathogenic mitochondrial DNA mutation. Whole-exome sequencing was performed using 62-Mb exome enrichment, followed by variant prioritization using bioinformatic prediction tools, variant validation by Sanger sequencing, and segregation of the variant with the disease phenotype in the family. RESULTS Presumptive causal variants were identified in 28 patients (53%; 95% CI, 39%-67%) and possible causal variants were identified in 4 (8%; 95% CI, 2%-18%). Together these accounted for 32 patients (60% 95% CI, 46%-74%) and involved 18 different genes. These included recurrent mutations in RMND1, AARS2, and MTO1, each on a haplotype background consistent with a shared founder allele, and potential novel mutations in 4 possible mitochondrial disease genes (VARS2, GARS, FLAD1, and PTCD1). Distinguishing clinical features included deafness and renal involvement associated with RMND1 and cardiomyopathy with AARS2 and MTO1. However, atypical clinical features were present in some patients, including normal liver function and Leigh syndrome (subacute necrotizing encephalomyelopathy) seen in association with TRMU mutations and no cardiomyopathy with founder SCO2 mutations. It was not possible to confidently identify the underlying genetic basis in 21 patients (40%; 95% CI, 26%-54%). CONCLUSIONS AND RELEVANCE Exome sequencing enhances the ability to identify potential nuclear gene mutations in patients with biochemically defined defects affecting multiple mitochondrial respiratory chain complexes. Additional study is required in independent patient populations to determine the utility of this approach in comparison with traditional diagnostic methods.	[Taylor, Robert W.; Blakely, Emma L.; He, Langping; Alston, Charlotte L.; Yarham, John W.; Gorman, Grainne S.; Turnbull, Douglass M.; McFarland, Robert] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Pyle, Angela; Griffin, Helen; Duff, Jennifer; Smertenko, Tania; Neeve, Vivienne C.; Best, Andrew; Santibanez-Koref, Mauro; Horvath, Rita; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Kirschner, Janbernd] Univ Med Ctr Freiburg, Div Neuropediat & Muscle Disorders, Freiburg, Germany; [Schara, Ulrike] Univ Essen Gesamthsch, Dept Neuropediat, Essen, Germany; [Talim, Beril; Topaloglu, Haluk] Hacettepe Univ, Dept Pediat, Ankara, Turkey; [Baric, Ivo] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Dept Paediat, Zagreb 41001, Croatia; [Holinski-Feder, Elke; Abicht, Angela; Czermin, Birgit; Kleinle, Stephanie] Ctr Med Genet, Munich, Germany; [Morris, Andrew A. M.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, Willink Biochem Genet Unit, Manchester, Lancs, England; [Vassallo, Grace] Cent Manchester Univ Hosp NHS Fdn Trust, Dept Paediat Neurol, Manchester, Lancs, England; [Ramesh, Venkateswaran; McFarland, Robert] Newcastle Upon Tyne Hosp NHS Trust, Dept Paediat Neurol, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; University of Freiburg; University of Duisburg Essen; Hacettepe University; University of Zagreb; University of Manchester; University of Manchester; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Chinnery, PF (corresponding author), Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Cent Pkwy, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	patrick.chinnery@ncl.ac.uk	Horvath, Rita/AAY-7042-2020; Alston, Charlotte/ABG-9602-2020; Kirschner, Janbernd/Q-1493-2019; TOPALOGLU, HALUK AYDIN/I-9318-2013; Kirschner, Janbernd/H-7418-2016	Alston, Charlotte/0000-0003-2095-5464; Kirschner, Janbernd/0000-0003-1618-7386; Kirschner, Janbernd/0000-0003-1618-7386; Gorman, Grainne/0000-0002-7585-3409; Griffin, Helen R/0000-0002-5288-3322; Chinnery, Patrick/0000-0002-7065-6617; Turnbull, Doug/0000-0002-8878-9901; McFarland, Robert/0000-0002-8833-2688; Horvath, Rita/0000-0002-9841-170X	Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; UK Medical Research Council Centre for Translational Muscle Diseases [G0601943]; Mitochondrial Disease Patient Cohort [G0800674]; UK Medical Research Council [G1000848]; European Research Council [309548]; Wellcome Trust Senior Fellow in Clinical Science [101876/Z/13/Z]; EU FP7 TIRCON; NIHR Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust; Newcastle University; MRC [G0601943, MR/K006312/1, G0800674, G1000848, MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K006312/1, G1000848, MR/K000608/1, G0601943, G0800674] Funding Source: researchfish; National Institute for Health Research [NIHR-HCS-D12-03-04] Funding Source: researchfish; NIHR Newcastle Biomedical Research Centre [BH111030] Funding Source: researchfish	Wellcome Trust Centre for Mitochondrial Research(Wellcome Trust); UK Medical Research Council Centre for Translational Muscle Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Mitochondrial Disease Patient Cohort; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust Senior Fellow in Clinical Science(Wellcome Trust); EU FP7 TIRCON; NIHR Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust; Newcastle University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR Newcastle Biomedical Research Centre	Drs Taylor, Turnbull, and Chinnery receive support from the Wellcome Trust Centre for Mitochondrial Research (grant 096919Z/11/Z). Drs Taylor, Gorman, Turnbull, McFarland, Horvath, and Chinnery receive support from the UK Medical Research Council Centre for Translational Muscle Diseases (grant G0601943) and Mitochondrial Disease Patient Cohort (grant G0800674). Dr Horvath was supported by the UK Medical Research Council (grant G1000848) and the European Research Council (grant 309548). Dr Chinnery is a Wellcome Trust Senior Fellow in Clinical Science (grant 101876/Z/13/Z), is a UK National Institute for Health Research (NIHR) senior investigator, and receives additional support from EU FP7 TIRCON and the NIHR Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004; Baruffini E, 2013, HUM MUTAT, V34, P1501, DOI 10.1002/humu.22393; Brizio C, 2006, BIOCHEM BIOPH RES CO, V344, P1008, DOI 10.1016/j.bbrc.2006.04.003; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Garcia-Diaz B, 2012, AM J HUM GENET, V91, P729, DOI 10.1016/j.ajhg.2012.08.019; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Gotz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006; Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577; Janer A, 2012, AM J HUM GENET, V91, P737, DOI 10.1016/j.ajhg.2012.08.020; Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40; McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2; McMillan HJ, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-36; Papadopoulou LC, 1999, NAT GENET, V23, P333; Rackham O, 2009, NUCLEIC ACIDS RES, V37, P5859, DOI 10.1093/nar/gkp627; Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001; Rotig A, 2010, DIABETES METAB, V36, P97, DOI 10.1016/j.diabet.2009.11.002; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Skladal D, 2000, J INHERIT METAB DIS, V23, P513, DOI 10.1023/A:1005620515996; Steenweg ME, 2012, ARCH NEUROL-CHICAGO, V69, P718, DOI 10.1001/archneurol.2011.1048; Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070; Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547; Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004	38	229	233	5	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					68	77		10.1001/jama.2014.7184	http://dx.doi.org/10.1001/jama.2014.7184			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	25058219	Green Accepted			2022-12-28	WOS:000338131100022
J	Konerman, MA; Lok, AS				Konerman, Monica A.; Lok, Anna S.			Diagnostic Challenges of Hepatitis C	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VIRUS-INFECTION; UPDATE		[Konerman, Monica A.; Lok, Anna S.] Univ Michigan Hlth Syst, Div Gastroenterol, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Konerman, MA (corresponding author), Univ Michigan Hlth Syst, Div Gastroenterol, Dept Internal Med, Taubman Ctr 3912, 1500 E Med Ctr Dr,SPC 5362, Ann Arbor, MI 48109 USA.	konerman@med.umich.edu	Tincopa, Monica/AAK-7187-2021		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK062708] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK062708, T32DK062708] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2013, OLYSIO SIMEPREVIR FU; Getchell JP, 2013, MMWR-MORBID MORTAL W, V62, P362; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Scott JD, 2007, JAMA-J AM MED ASSOC, V297, P724, DOI 10.1001/jama.297.7.724; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Stramer SL, 2013, TRANSFUSION, V53, P1497, DOI 10.1111/j.1537-2995.2012.03955.x	9	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2536	2537		10.1001/jama.2014.306	http://dx.doi.org/10.1001/jama.2014.306			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	25058088	Green Accepted			2022-12-28	WOS:000337757000028
J	Taylor, HR; Burton, MJ; Haddad, D; West, S; Wright, H				Taylor, Hugh R.; Burton, Matthew J.; Haddad, Danny; West, Sheila; Wright, Heathcote			Trachoma	LANCET			English	Article							MASS ANTIBIOTIC-TREATMENT; COMMUNITY RANDOMIZED-TRIAL; SINGLE-DOSE AZITHROMYCIN; CHLAMYDIA-TRACHOMATIS; OCULAR CHLAMYDIA; RISK-FACTORS; TRICHIASIS SURGERY; IMMUNE-RESPONSES; ACTIVE TRACHOMA; CONJUNCTIVAL TRANSCRIPTOME	Trachoma is the most common infectious cause of blindness. Repeated episodes of infection with Chlamydia trachomatis in childhood lead to severe conjunctival inflammation, scarring, and potentially blinding inturned eyelashes (trichiasis or entropion) in later life. Trachoma occurs in resource-poor areas with inadequate hygiene, where children with unclean faces share infected ocular secretions. Much has been learnt about the epidemiology and pathophysiology of trachoma. Integrated control programmes are implementing the SAFE Strategy: surgery for trichiasis, mass distribution of antibiotics, promotion of facial cleanliness, and environmental improvement. This strategy has successfully eliminated trachoma in several countries and global efforts are underway to eliminate blinding trachoma worldwide by 2020.	[Taylor, Hugh R.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Carlton, Vic 3053, Australia; [Burton, Matthew J.] London Sch Hyg & Trop Med, Dept Clin Res, Int Ctr Eye Hlth, London WC1, England; [Haddad, Danny] Emory Univ, Sch Med, Emory Eye Ctr, Global Vis Initiat, Atlanta, GA USA; [West, Sheila] Johns Hopkins Univ Hosp, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Wright, Heathcote] Univ Melbourne, Ctr Eye Res Australia, East Melbourne, Vic, Australia	University of Melbourne; University of London; London School of Hygiene & Tropical Medicine; Emory University; Johns Hopkins University; Johns Hopkins Medicine; Centre for Eye Research Australia; University of Melbourne	Taylor, HR (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Carlton, Vic 3053, Australia.	h.taylor@unimelb.edu.au		Haddad, Danny/0000-0002-6299-1984; Burton, Matthew/0000-0003-1872-9169; Taylor, Hugh/0000-0002-9437-784X	Wellcome Trust [098481/Z12/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	MB is supported by the Wellcome Trust (grant number 098481/Z12/Z).	Abdou A, 2010, TROP MED INT HEALTH, V15, P98, DOI 10.1111/j.1365-3156.2009.02429.x; Abu El-Asrar AM, 1998, EYE, V12, P453, DOI 10.1038/eye.1998.104; Abu el-Asrar AM, 1998, EYE, V12, P735, DOI DOI 10.1038/EYE.1998.179; ABUELASRAR AM, 1989, BRIT J OPHTHALMOL, V73, P276, DOI 10.1136/bjo.73.4.276; al Arab GE, 2001, BRIT J OPHTHALMOL, V85, P1406, DOI 10.1136/bjo.85.12.1406; Alemayehu W, 2004, OPHTHALMOLOGY, V111, P578, DOI 10.1016/j.ophtha.2003.06.030; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P161; [Anonymous], 2006, CHLAMYDIAL INFECT; Atik B, 2006, JAMA-J AM MED ASSOC, V296, P1488, DOI 10.1001/jama.296.12.1488; BAILEY R, 1989, INT J EPIDEMIOL, V18, P944, DOI 10.1093/ije/18.4.944; Bailey RL, 2009, DRUG TODAY, V45, P45; Baltussen RMRM, 2005, OPHTHAL EPIDEMIOL, V12, P91, DOI 10.1080/09286580590932761; Biebesheimer JB, 2009, OPHTHALMOLOGY, V116, P2047, DOI 10.1016/j.ophtha.2009.04.041; Blake IM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000862; Blake IM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000401; Bobo LD, 1997, J INFECT DIS, V176, P1524, DOI 10.1086/514151; Bowman RJC, 2000, TROP MED INT HEALTH, V5, P528, DOI 10.1046/j.1365-3156.2000.00605.x; Bowman RJC, 2002, BRIT J OPHTHALMOL, V86, P339, DOI 10.1136/bjo.86.3.339; Bowman RJC, 2001, OPHTHALMOLOGY, V108, P2219, DOI 10.1016/S0161-6420(01)00645-5; Broman AT, 2006, INVEST OPHTH VIS SCI, V47, P99, DOI 10.1167/iovs.05-0326; Burton MJ, 2011, INFECT IMMUN, V79, P4977, DOI 10.1128/IAI.05718-11; Burton MJ, 2011, INFECT IMMUN, V79, P499, DOI 10.1128/IAI.00888-10; Burton MJ, 2005, BRIT J OPHTHALMOL, V89, P1282, DOI 10.1136/bjo.2004.062489; Burton MJ, 2005, BRIT J OPHTHALMOL, V89, P575, DOI 10.1136/bjo.2004.055996; Burton MJ, 2005, LANCET, V365, P1321, DOI 10.1016/S0140-6736(05)61029-X; Burton MJ, 2004, INFECT IMMUN, V72, P7352, DOI 10.1128/IAI.72.12.7352-7356.2004; Burton MJ, 2010, PLOS NEGLECT TROP D, V4, P1; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; Chidambaram JD, 2006, JAMA-J AM MED ASSOC, V295, P1142, DOI 10.1001/jama.295.10.1142; Clarke IN, 2011, ANN NY ACAD SCI, V1230, pE11, DOI 10.1111/j.1749-6632.2011.06194.x; Coles CL, 2011, AM J TROP MED HYG, V85, P691, DOI 10.4269/ajtmh.2011.11-0046; CONGDON N, 1993, AM J EPIDEMIOL, V137, P366, DOI 10.1093/oxfordjournals.aje.a116683; COURTRIGHT P, 1991, BRIT J OPHTHALMOL, V75, P322, DOI 10.1136/bjo.75.6.322; COURTRIGHT P, 1989, BRIT J OPHTHALMOL, V73, P536, DOI 10.1136/bjo.73.7.536; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Dembele M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001574; Dhaliwal U, 2006, OPHTHAL EPIDEMIOL, V13, P59, DOI 10.1080/09286580500473803; Emerson PM, 2000, T ROY SOC TROP MED H, V94, P28, DOI 10.1016/S0035-9203(00)90427-9; Emerson PM, 2004, LANCET, V363, P1093, DOI 10.1016/S0140-6736(04)15891-1; Evans JR, 2011, COCHRANE DB SYST REV, V3; Frick KD, 2001, ARCH OPHTHALMOL-CHIC, V119, P1839, DOI 10.1001/archopht.119.12.1839; Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414; Gall A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00010; Gebre T, 2012, LANCET, V379, P143, DOI 10.1016/S0140-6736(11)61515-8; Grassly NC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000341; Habte D, 2008, OPHTHAL EPIDEMIOL, V15, P328, DOI 10.1080/09286580801974897; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Haug S, 2010, CLIN INFECT DIS, V51, P571, DOI 10.1086/655697; HOLLAND MJ, 1993, J INFECT DIS, V168, P1528, DOI 10.1093/infdis/168.6.1528; Hong KC, 2009, EMERG INFECT DIS, V15, P1088, DOI 10.3201/eid1507.081563; Hotez PJ, 2009, CLIN PHARMACOL THER, V85, P659, DOI 10.1038/clpt.2009.16; House JI, 2009, LANCET, V373, P1111, DOI 10.1016/S0140-6736(09)60323-8; Hsieh YH, 2000, AM J EPIDEMIOL, V152, P204, DOI 10.1093/aje/152.3.204; Hu VH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002020; Hu VH, 2011, OPHTHALMOLOGY, V118, P2138, DOI 10.1016/j.ophtha.2011.04.014; Hu VH, 2011, INVEST OPHTH VIS SCI, V52, P2181, DOI 10.1167/iovs.10-5829; International Coalition for Trachoma Control, 2011, END SIGHT 2020 INSIG; International Coalition for Trachoma Control, 2013, GLOB TRACH MAPP PROJ; Keenan JD, 2012, INVEST OPHTH VIS SCI, V53, P235, DOI 10.1167/iovs.11-8493; Keenan JD, 2012, CLIN INFECT DIS, V54, P253, DOI 10.1093/cid/cir791; Keenan JD, 2011, ARCH OPHTHALMOL-CHIC, V129, P512, DOI 10.1001/archophthalmol.2011.46; Keenan JD, 2011, CLIN INFECT DIS, V52, P883, DOI 10.1093/cid/cir069; Khandekar R, 2001, Ophthalmic Epidemiol, V8, P155, DOI 10.1076/opep.8.2.155.4165; Khandekar R, 2007, OPHTHAL EPIDEMIOL, V14, P267, DOI 10.1080/09286580601160622; Khandekar R, 2006, AM J OPHTHALMOL, V141, P1087, DOI 10.1016/j.ajo.2006.01.024; Lakew T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000376; Lee S, 2007, AM J TROP MED HYG, V76, P129; Lietman T, 1999, NAT MED, V5, P572, DOI 10.1038/8451; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; MCCAULEY AP, 1990, SOC SCI MED, V31, P1233, DOI 10.1016/0277-9536(90)90129-G; Merbs SL, 2005, OPHTHALMOLOGY, V112, P705, DOI 10.1016/j.ophtha.2004.10.037; Michel CEC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000986; Miller K, 2004, BRIT J OPHTHALMOL, V88, P750, DOI 10.1136/bjo.2003.038661; Montgomery MA, 2010, B WORLD HEALTH ORGAN, V88, P82, DOI 10.2471/BLT.09.075424; Munoz B, 1999, INT J EPIDEMIOL, V28, P1167, DOI 10.1093/ije/28.6.1167; Munoz B, 2011, INVEST OPHTH VIS SCI, V52, P8806, DOI 10.1167/iovs.11-8074; Myatt M, 2003, B WORLD HEALTH ORGAN, V81, P877; Natividad A, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-40; Natividad A, 2010, INFECT IMMUN, V78, P4895, DOI 10.1128/IAI.00844-10; Natividad A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-138; Negrel A., 2001, GUIDELINES RAPID ASS; Ngondi J, 2005, B WORLD HEALTH ORGAN, V83, P904; Ngondi J, 2006, PLOS MED, V3, P2424, DOI 10.1371/journal.pmed.0030478; Ngondi J, 2006, LANCET, V368, P589, DOI 10.1016/S0140-6736(06)69202-7; Ngondi J, 2009, T ROY SOC TROP MED H, V103, P1001, DOI 10.1016/j.trstmh.2008.11.023; Ngondi J, 2009, B WORLD HEALTH ORGAN, V87, P143, DOI 10.2471/BLT.07.046326; Peeling RW, 1998, J INFECT DIS, V177, P256, DOI 10.1086/517367; Rabiu M M, 2001, Ophthalmic Epidemiol, V8, P181, DOI 10.1076/opep.8.2.181.4167; Rajak SN, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001766; Rajak SN, 2012, SURV OPHTHALMOL, V57, P105, DOI 10.1016/j.survophthal.2011.08.002; Rajak SN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001137; Rajak SN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001136; Rajak SN, 2012, OPHTHALMOLOGY, V119, P84, DOI 10.1016/j.ophtha.2011.06.045; Rajak SN, 2010, INVEST OPHTH VIS SCI, V51, P4996, DOI 10.1167/iovs.10-5169; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; REACHER MH, 1991, OPHTHALMOLOGY, V98, P334; REACHER MH, 1992, ARCH OPHTHALMOL-CHIC, V110, P667, DOI 10.1001/archopht.1992.01080170089030; REACHER MH, 1993, TRICHIASIS SURG TRAC; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; Schemann JF, 2002, INT J EPIDEMIOL, V31, P194, DOI 10.1093/ije/31.1.194; See CW, 2011, INVEST OPHTH VIS SCI, V52, P6133, DOI 10.1167/iovs.11-7419; Smith A, 2001, Ophthalmic Epidemiol, V8, P127, DOI 10.1076/opep.8.2.127.4164; Solomon AW, 2008, NEW ENGL J MED, V358, P1870, DOI 10.1056/NEJMc0706263; Solomon AW, 2004, NEW ENGL J MED, V351, P1962, DOI 10.1056/NEJMoa040979; Solomon AW, 2003, LANCET, V362, P198, DOI 10.1016/S0140-6736(03)13909-8; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Stephens S, 2002, P 10 INT S HUM CHLAM, V6, P3; Tabbara K F, 1997, Ophthalmic Epidemiol, V4, P127; Taylor H. R., 2008, TRACHOMA BLINDING SC; TAYLOR HR, 1987, J IMMUNOL, V138, P3023; TAYLOR HR, 1990, AM J TROP MED HYG, V42, P358, DOI 10.4269/ajtmh.1990.42.358; TAYLOR HR, 1989, INVEST OPHTH VIS SCI, V30, P1823; TAYLOR HR, 1991, J CLIN MICROBIOL, V29, P1593, DOI 10.1128/JCM.29.8.1593-1595.1991; Thanh TTK, 2004, BRIT J OPHTHALMOL, V88, P1114, DOI 10.1136/bjo.2003.039834; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; WARD M, 1990, SCAND J INFECT DIS, P137; West ES, 2006, BRIT J OPHTHALMOL, V90, P171, DOI 10.1136/bjo.2005.075390; West ES, 2005, INVEST OPHTH VIS SCI, V46, P447, DOI 10.1167/iovs.04-0600; WEST S, 1989, B WORLD HEALTH ORGAN, V67, P71; WEST S, 1994, INT OPHTHALMOL, V18, P105, DOI 10.1007/BF00919249; WEST S, 1995, LANCET, V345, P155, DOI 10.1016/S0140-6736(95)90167-1; West S K, 2001, Ophthalmic Epidemiol, V8, P137, DOI 10.1076/opep.8.2.137.4158; West SK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002415; West SK, 2011, J INFECT DIS, V204, P268, DOI 10.1093/infdis/jir257; West SK, 2006, ARCH OPHTHALMOL-CHIC, V124, P309, DOI 10.1001/archopht.124.3.309; West SK, 2005, LANCET, V366, P1296, DOI 10.1016/S0140-6736(05)67529-0; West SK, 1996, AM J EPIDEMIOL, V143, P73, DOI 10.1093/oxfordjournals.aje.a008659; WEST SK, 1991, INT J EPIDEMIOL, V20, P1088, DOI 10.1093/ije/20.4.1088; WHO, 2010, 3 GLOB SCI M TRACH E; *WHO, 2008, 12 M WHO ALL GLOB EL; Wolle MA, 2009, OPHTHALMOLOGY, V116, P243, DOI 10.1016/j.ophtha.2008.09.011; Woreta TA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1505, DOI 10.1001/archophthalmol.2009.278; World Health Organisation (WHO), TRACH STAT END BLIND; World Health Organization, 2013, Weekly Epidemiological Record, V88, P242; Yang JL, 2007, BRIT J OPHTHALMOL, V91, P293, DOI 10.1136/bjo.2006.099150; Yohannan J, 2013, JAMA OPHTHALMOL, V131, P431, DOI 10.1001/jamaophthalmol.2013.2356; Zhang H, 2006, BRIT J OPHTHALMOL, V90, P943, DOI 10.1136/bjo.2006.093104; Zhang H, 2004, ARCH OPHTHALMOL-CHIC, V122, P511, DOI 10.1001/archopht.122.4.511	138	189	192	1	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2014	384	9960					2142	2152		10.1016/S0140-6736(13)62182-0	http://dx.doi.org/10.1016/S0140-6736(13)62182-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BK	25043452				2022-12-28	WOS:000346354300031
J	Elsworth, B; Matthews, K; Nie, CQ; Kalanon, M; Charnaud, SC; Sanders, PR; Chisholm, SA; Counihan, NA; Shaw, PJ; Pino, P; Chan, JA; Azevedo, MF; Rogerson, SJ; Beeson, JG; Crabb, BS; Gilson, PR; de Koning-Ward, TF				Elsworth, Brendan; Matthews, Kathryn; Nie, Catherine Q.; Kalanon, Ming; Charnaud, Sarah C.; Sanders, Paul R.; Chisholm, Scott A.; Counihan, Natalie A.; Shaw, Philip J.; Pino, Paco; Chan, Jo-Anne; Azevedo, Mauro F.; Rogerson, Stephen J.; Beeson, James G.; Crabb, Brendan S.; Gilson, Paul R.; de Koning-Ward, Tania F.			PTEX is an essential nexus for protein export in malaria parasites	NATURE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; PARASITOPHOROUS VACUOLE; CHONDROITIN SULFATE; PLACENTAL MALARIA; SURFACE; VIRULENCE; INVASION; ANTIBODIES; ANTIGEN	During the blood stages of malaria, several hundred parasite-encoded proteins are exported beyond the double-membrane barrier that separates the parasite from the host cell cytosol(1-6). These proteins have a variety of roles that are essential to virulence or parasite growth(7). There is keen interest in understanding how proteins are exported and whether common machineries are involved in trafficking the different classes of exported proteins(8,9). One potential trafficking machine is a protein complex known as the Plasmodium translocon of exported proteins (PTEX)(10). Although PTEX has been linked to the export of one class of exported proteins(10,11), there has been no direct evidence for its role and scope in protein translocation. Here we show, through the generation of two parasite lines defective for essential PTEX components (HSP101 or PTEX150), and analysis of a line lacking the non-essential component TRX2 (ref. 12), greatly reduced trafficking of all classes of exported proteins beyond the double membrane barrier enveloping the parasite. This includes proteins containing the PEXEL motif (RxLxE/Q/D)(1,2) and PEXEL-negative exported proteins (PNEPs)(6). Moreover, the export of proteins destined for expression on the infected erythrocyte surface, including the major virulence factor PfEMP1 in Plasmodium falciparum, was significantly reduced in PTEX knockdown parasites. PTEX function was also essential for blood-stage growth, because even a modest knockdown of PTEX components had a strong effect on the parasite's capacity to complete the erythrocytic cycle both in vitro and in vivo. Hence, as the only known nexus for protein export in Plasmodium parasites, and an essential enzymic machine, PTEX is a prime drug target.	[Elsworth, Brendan; Nie, Catherine Q.; Charnaud, Sarah C.; Sanders, Paul R.; Chan, Jo-Anne; Azevedo, Mauro F.; Beeson, James G.; Crabb, Brendan S.; Gilson, Paul R.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia; [Elsworth, Brendan; Charnaud, Sarah C.; Beeson, James G.; Crabb, Brendan S.; Gilson, Paul R.] Monash Univ, Clayton, Vic 3800, Australia; [Matthews, Kathryn; Kalanon, Ming; Chisholm, Scott A.; Counihan, Natalie A.; de Koning-Ward, Tania F.] Deakin Univ, Waurn Ponds, Vic 3216, Australia; [Shaw, Philip J.] Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani 12120, Thailand; [Pino, Paco] Univ Geneva, CH-1211 Geneva 4, Switzerland; [Rogerson, Stephen J.; Beeson, James G.; Crabb, Brendan S.] Univ Melbourne, Parkville, Vic 3010, Australia	Burnet Institute; Monash University; Deakin University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of Geneva; University of Melbourne	de Koning-Ward, TF (corresponding author), Deakin Univ, Waurn Ponds, Vic 3216, Australia.	crabb@burnet.edu.au; gilson@burnet.edu.au; taniad@deakin.edu.au	de Koning-Ward, Tania F/N-3572-2017; Chisholm, Scott/K-2661-2019; Azevedo, Mauro/H-6180-2012	de Koning-Ward, Tania F/0000-0001-5810-8063; Chisholm, Scott/0000-0002-3833-8854; Azevedo, Mauro/0000-0002-5233-2037; Charnaud, Sarah/0000-0002-9029-9696; Rogerson, Stephen/0000-0003-4287-1982	National Health and Medical Research Council (NHMRC) of Australia [1021560, 1025665, 637406]; Victorian State Government; Australian Postgraduate Awards	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government; Australian Postgraduate Awards(Australian Government)	We thank T. Templeton, B. Franke-Fayard, C. Janse, A. Cowman, J. Boddey, B. Cooke, M. Duffy, L. Tilley, R. Anders, F. Fowkes, A. McLean and D. Bursac for reagents and/or other assistance with aspects of this study; D. Stanisic, F. Baiwog and I. Mueller for contributions to clinical studies of pregnant women; and P. Siba. We also thank the Australian Red Cross Blood Bank for the provision of human blood and serum. This work was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia (1021560, 1025665 and 637406) and the Victorian State Government Operational Infrastructure Support Scheme. T.F.d.K.-W. is an NHMRC Career Development Fellow, and J.G.B. is a NHMRC Senior Research Fellow. B.E. and K.M. are the recipients of Australian Postgraduate Awards.	Avril M, 2010, INFECT IMMUN, V78, P2248, DOI 10.1128/IAI.00410-09; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Beeson JG, 2004, J INFECT DIS, V189, P540, DOI 10.1086/381186; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Boddey JA, 2013, ANNU REV MICROBIOL, V67, P243, DOI 10.1146/annurev-micro-092412-155730; Boddey JA, 2013, TRAFFIC, V14, P532, DOI 10.1111/tra.12053; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; Bullen HE, 2012, J BIOL CHEM, V287, P7871, DOI 10.1074/jbc.M111.328591; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; Cooke BM, 1996, BLOOD, V88, P4040, DOI 10.1182/blood.V88.10.4040.bloodjournal88104040; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; CULVENOR JG, 1991, INFECT IMMUN, V59, P1183, DOI 10.1128/IAI.59.3.1183-1187.1991; de Koning-Ward TF, 2008, MOL BIOCHEM PARASIT, V159, P69, DOI 10.1016/j.molbiopara.2008.01.005; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; de Koning-Ward TF, 2003, J EXP MED, V198, P869, DOI 10.1084/jem.20030085; Drew DR, 2005, INFECT IMMUN, V73, P3912, DOI 10.1128/IAI.73.7.3912-3922.2005; Elsworth B, 2014, CELL MICROBIOL, V16, P355, DOI 10.1111/cmi.12261; Haase S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061482; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Matthews K, 2013, MOL MICROBIOL, V89, P1167, DOI 10.1111/mmi.12334; Matz JM, 2013, MOL BIOCHEM PARASIT, V191, P44, DOI 10.1016/j.molbiopara.2013.09.003; Pasini EM, 2013, MOL CELL PROTEOMICS, V12, P426, DOI 10.1074/mcp.M112.021238; Pino P, 2012, CELL HOST MICROBE, V12, P824, DOI 10.1016/j.chom.2012.10.016; POLOGE LG, 1986, NATURE, V322, P474, DOI 10.1038/322474a0; Prommana P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073783; Riglar DT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2449; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Sleebs BE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001897; Umbers AJ, 2011, J INFECT DIS, V203, P561, DOI 10.1093/infdis/jiq080; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084	42	168	171	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					587	+		10.1038/nature13555	http://dx.doi.org/10.1038/nature13555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043043				2022-12-28	WOS:000339566300034
J	Ball, SJ; Pereira, G; Jacoby, P; de Klerk, N; Stanley, FJ				Ball, Stephen J.; Pereira, Gavin; Jacoby, Peter; de Klerk, Nicholas; Stanley, Fiona J.			Re-evaluation of link between interpregnancy interval and adverse birth outcomes: retrospective cohort study matching two intervals per mother	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRETERM BIRTH; PREGNANCY INTERVAL; PERINATAL OUTCOMES; HEALTH; CHILD; RISK; ASSOCIATION; WEIGHT; INFANT	Objective To re-evaluate the causal effect of interpregnancy interval on adverse birth outcomes, on the basis that previous studies relying on between mother comparisons may have inadequately adjusted for confounding by maternal risk factors. Design Retrospective cohort study using conditional logistic regression (matching two intervals per mother so each mother acts as her own control) to model the incidence of adverse birth outcomes as a function of interpregnancy interval; additional unconditional logistic regression with adjustment for confounders enabled comparison with the unmatched design of previous studies. Setting Perth, Western Australia, 1980-2010. Participants 40 441 mothers who each delivered three liveborn singleton neonates. Main outcome measures Preterm birth (< 37 weeks), small for gestational age birth (< 10th centile of birth weight by sex and gestational age), and low birth weight (< 2500 g). Results Within mother analysis of interpregnancy intervals indicated a much weaker effect of short intervals on the odds of preterm birth and low birth weight compared with estimates generated using a traditional between mother analysis. The traditional unmatched design estimated an adjusted odds ratio for an interpregnancy interval of 0-5 months (relative to the reference category of 18-23 months) of 1.41 (95% confidence interval 1.31 to 1.51) for preterm birth, 1.26 (1.15 to 1.37) for low birth weight, and 0.98 (0.92 to 1.06) for small for gestational age birth. In comparison, the matched design showed a much weaker effect of short interpregnancy interval on preterm birth (odds ratio 1.07, 0.86 to 1.34) and low birth weight (1.03, 0.79 to 1.34), and the effect for small for gestational age birth remained small (1.08, 0.87 to 1.34). Both the unmatched and matched models estimated a high odds of small for gestational age birth and low birth weight for long interpregnancy intervals (longer than 59 months), but the estimated effect of long interpregnancy intervals on the odds of preterm birth was much weaker in the matched model than in the unmatched model. Conclusion This study questions the causal effect of short interpregnancy intervals on adverse birth outcomes and points to the possibility of unmeasured or inadequately specified maternal factors in previous studies.	[Ball, Stephen J.; Pereira, Gavin; Jacoby, Peter; de Klerk, Nicholas; Stanley, Fiona J.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6872, Australia; [Pereira, Gavin] Yale Univ, Yale Ctr Perinatal Pediat & Environm Epidemiol, New Haven, CT 06510 USA	Telethon Kids Institute; University of Western Australia; Yale University	Ball, SJ (corresponding author), Univ Western Australia, Telethon Kids Inst, POB 855, Perth, WA 6872, Australia.	stephen.ball@telethonkids.org.au	de Klerk, Nicholas H/D-8388-2016; Pereira, Gavin/D-7136-2014	de Klerk, Nicholas H/0000-0001-9223-0767; Pereira, Gavin/0000-0003-3740-8117	Australian National Health and Medical Research Council [572742, 1052236]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this research was received from the Australian National Health and Medical Research Council as a program grant (572742) and early career fellowship (1052236 to GP). The authors maintained full control over the design and conduct of the study; the collection, management, analysis, and interpretation of the data; and the preparation, review, and approval of the manuscript.	Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Cheslack-Postava K, 2011, PEDIATRICS, V127, P246; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Conde-Agudelo A, 2005, OBSTET GYNECOL, V106, P359, DOI 10.1097/01.AOG.0000171118.79529.a3; Conde-Agudelo A, 2012, STUD FAMILY PLANN, V43, P93, DOI 10.1111/j.1728-4465.2012.00308.x; Dobbins TA, 2012, MED J AUSTRALIA, V197, P291, DOI 10.5694/mja11.11331; ERICKSON JD, 1978, J EPIDEMIOL COMMUN H, V32, P124, DOI 10.1136/jech.32.2.124; Gee V, 1994, VALIDATION STUDY WES; Grisaru-Granovsky S, 2009, CONTRACEPTION, V80, P512, DOI 10.1016/j.contraception.2009.06.006; Gunawardana L, 2011, BRIT J PSYCHIAT, V199, P338, DOI 10.1192/bjp.bp.111.092916; Howard EJ, 2013, MATERN CHILD HLTH J, V17, P933, DOI 10.1007/s10995-012-1073-0; Huynh M, 2006, PAEDIATR PERINAT EP, V20, P454, DOI 10.1111/j.1365-3016.2006.00759.x; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Klebanoff MA, 1999, NEW ENGL J MED, V340, P643, DOI 10.1056/NEJM199902253400809; Kwon S, 2012, J PERINATOL, V32, P45, DOI 10.1038/jp.2011.49; Lindblad F, 2010, NICOTINE TOB RES, V12, P408, DOI 10.1093/ntr/ntq017; Lindstrom K, 2011, PEDIATRICS, V127, P858, DOI 10.1542/peds.2010-1279; Marston C., 2005, REPORT WHO TECHNICAL; McClennan W., 1996, 20390 AUSTR BUR STAT; MILLER JE, 1991, FAM PLANN PERSPECT, V23, P62, DOI 10.2307/2135451; Read A W, 1993, Paediatr Perinat Epidemiol, V7, P177, DOI 10.1111/j.1365-3016.1993.tb00392.x; Ritsmitchai S, 1997, J OCCUP HEALTH, V39, P217, DOI 10.1539/joh.39.217; Rousso D, 2002, EUR J OBSTET GYN R B, V105, P4, DOI 10.1016/S0301-2115(02)00077-5; Shachar BZ, 2012, OBSTET GYNECOL SURV, V67, P584, DOI 10.1097/OGX.0b013e31826b2c3e; Wendt A, 2012, PAEDIATR PERINAT EP, V26, P239, DOI 10.1111/j.1365-3016.2012.01285.x; WINIKOFF B, 1983, STUD FAMILY PLANN, V14, P231, DOI 10.2307/1965748; Zhu Bao-Ping, 2003, Matern Child Health J, V7, P169, DOI 10.1023/A:1025184304391; Zhu BP, 2005, INT J GYNECOL OBSTET, V89, pS25, DOI 10.1016/j.ijgo.2004.08.002; Zhu BP, 1999, NEW ENGL J MED, V340, P589, DOI 10.1056/NEJM199902253400801	29	116	121	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2014	349								g4333	10.1136/bmj.g4333	http://dx.doi.org/10.1136/bmj.g4333			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM0VP	25056260	Green Published, hybrid			2022-12-28	WOS:000339565900001
J	Mugo, NR; Hong, T; Celum, C; Donnell, D; Bukusi, EA; John-Stewart, G; Wangisi, J; Were, E; Heffron, R; Matthews, LT; Morrison, S; Ngure, K; Baeten, JM				Mugo, Nelly R.; Hong, Ting; Celum, Connie; Donnell, Deborah; Bukusi, Elizabeth A.; John-Stewart, Grace; Wangisi, Jonathan; Were, Edwin; Heffron, Renee; Matthews, Lynn T.; Morrison, Susan; Ngure, Kenneth; Baeten, Jared M.		Partners PrEP Study Team	Pregnancy Incidence and Outcomes Among Women Receiving Preexposure Prophylaxis for HIV Prevention A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TENOFOVIR DISOPROXIL FUMARATE; SERO-DISCORDANT COUPLES; ANTIRETROVIRAL PROPHYLAXIS; CONTRACEPTIVE USE; GROWTH OUTCOMES; DOUBLE-BLIND; INFECTION; EFFICACY; SAFETY; TRANSMISSION	IMPORTANCE Antiretroviral preexposure prophylaxis (PrEP), using tenofovir disoproxil fumarate (TDF) and combination emtricitabine/tenofovir disoproxil fumarate (FTC+TDF), is efficacious for prevention of human immunodeficiency virus (HIV) acquisition. PrEP could reduce periconception HIV risk, but the effect on pregnancy outcomes is not well defined. OBJECTIVE To assess pregnancy incidence and outcomes among women using PrEP during the periconception period. DESIGN, SETTING, AND PARTICIPAPITS Randomized trial among 1785 HIV-serodiscordant heterosexual couples (the Partners PrEP Study) in which the female partner was HIV uninfected that demonstrated that PrEP was efficacious for HIV prevention, conducted between July 2008 and June 2013 at 9 sites in Kenya and Uganda. INTERVENTIONS Daily oral TDF (n = 598), combination FTC+TDF = 566), or Placebo (n = 621) through July 2011, when PrEP demonstrated efficacy for HIV prevention. Thereafter, participants continued receiving active PrEP without placebo. Pregnancy testing occurred monthly and study medication was discontinued when pregnancy was detected. MAIN OUTCOMES AND MEASURES Pregnancy incidence, birth outcomes (live births, pregnancy loss, preterm birth, congenital anomalies), and infant growth. RESULTS A total of 431 pregnancies occurred. Pregnancy incidence was 10.0 Per 100 person-years among women assigned placebo, 11.9 among those assigned TDF (incidence difference, 1.9; 95% Cl, -1.1 to 4.9 [P = .22 vs placebo]), and 8.8 among those assigned FTC+TDF (incidence difference, -1.3; 95% Cl, -4.1 to 1.5 [P = .39 vs placebo]). Before discontinuation of the placebo treatment group in July 2011, the occurrence of pregnancy loss (96 of 288 pregnancies) was 42.5% for women receiving FTC+TDF compared with 32.3% for those receiving placebo (difference for FTC+TDF vs placebo, 10.2%; 95% Cl, -5.3% to 25.7%; P = .16) and was 27.7% for those receiving TDF alone (difference vs placebo, -4.6%; 95% Cl, -18.1% to 8.9%; P = .46). After July 2011, the frequency of Pregnancy loss (52 of 143 Pregnancies) was 37.5% for FTC+TDF and 36.7% for TDF alone (difference, 0.8%; 95% Cl, -16.8% to 18.5%; P = .92). Occurrence of preterm birth, congenital anomalies, and growth throughout the first year of life did not differ significantly for infants born to women who received PrEP vs placebo. CONCLUSIONS AND RELEVANCE Among HIV-serodiscordant heterosexual African couples, differences in pregnancy incidence, birth outcomes, and infant growth were not statistically different for women receiving PrEP with TDF alone or combination FTC+TDF compared with placebo at conception. Given that PrEP was discontinued when pregnancy was detected and that Cls for the birth outcomes were wide, definitive statements about the safety of PrEP in the periconception period cannot be made. These results should be discussed with HIV-uninfected women receiving PrEP who are considering becoming pregnant.	[Mugo, Nelly R.; Hong, Ting; Celum, Connie; Donnell, Deborah; Bukusi, Elizabeth A.; John-Stewart, Grace; Heffron, Renee; Morrison, Susan; Baeten, Jared M.] Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA; [Mugo, Nelly R.] Kenya Govt Med Res Ctr, Clin Res Ctr, Nairobi, Kenya; [Mugo, Nelly R.] Kenyatta Natl Hosp, Dept Obstet & Gynaecol, Nairobi, Kenya; [Celum, Connie; John-Stewart, Grace; Baeten, Jared M.] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Celum, Connie; John-Stewart, Grace; Baeten, Jared M.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Bukusi, Elizabeth A.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98104 USA; [Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [John-Stewart, Grace] Univ Washington, Dept Pediat, Seattle, WA 98104 USA; [Wangisi, Jonathan] AIDS Support Org TASO, Kampala, Uganda; [Were, Edwin] Moi Univ, Dept Reprod Hlth, Eldoret, Kenya; [Matthews, Lynn T.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Matthews, Lynn T.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Ngure, Kenneth] Jomo Kenyatta Univ Agr & Technol, Nairobi, Kenya	University of Washington; University of Washington Seattle; Kenya Medical Research Institute; Kenyatta National Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Kenya Medical Research Institute; University of Washington; University of Washington Seattle; Moi University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Jomo Kenyatta University of Agriculture & Technology	Baeten, JM (corresponding author), Univ Washington, Dept Global Hlth, 325 Ninth Ave,Box 359927, Seattle, WA 98104 USA.	jbaeten@uw.edu	John-Stewart, Grace/L-3650-2019; John-Stewart, Grace/U-3351-2019; Heffron, Renee/AAG-5002-2020; Hendrix, Craig W/G-4182-2014	Hendrix, Craig W/0000-0002-5696-8665; Were, Edwin/0000-0002-4783-0795; Donnell, Deborah/0000-0002-0587-7480; John-Stewart, Grace/0000-0002-4301-1573	Bill and Melinda Gates Foundation [OPP47674]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD054314] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding/Support: The Partners PrEP Study was funded by The Bill and Melinda Gates Foundation (grant OPP47674). Study medication was donated by Gilead Sciences (Foster City).	[Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2006, WHO CHILD GROWTH STA; Antiretroviral Pregnancy Registry, ANT PREGN REG INT RE; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Beyeza-Kashesya J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-247; Beyeza-Kashesya J, 2009, AFR HEALTH SCI, V9, P2; Centers for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI; Cherutich P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036797; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Fenton Tanis R, 2003, BMC Pediatr, V3, P13; Food and Drug Administration, FDA APPR 1 DRUGS RED; Gibb DM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001217; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission-A Working Group of the Office of AIDS Research Advisory Council (OARAC), REC US ANT DRUGS PRE; Kakaire O, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-27; Matthews LT, J ACQUIR IMMUNE DEFI; Matthews LT, 2010, AIDS, V24, P1975, DOI 10.1097/QAD.0b013e32833bedeb; McComsey GA, 2010, CLIN INFECT DIS, V51, P937, DOI 10.1086/656412; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Mujugira A, 2013, JAIDS-J ACQ IMM DEF, V63, pE33, DOI 10.1097/QAI.0b013e318288bb32; Mujugira A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025828; Murnane PM, 2013, AIDS, V27, P2155, DOI 10.1097/QAD.0b013e3283629037; Ndase P, 2014, JAIDS-J ACQ IMM DEF, V66, P206, DOI 10.1097/QAI.0000000000000141; Ngure K, 2012, AIDS CARE, V24, P509, DOI 10.1080/09540121.2011.613911; Ngure K, 2012, AIDS, V26, P513, DOI 10.1097/QAD.0b013e32834f981c; Odutola A, 2012, SEX TRANSM INFECT, V88, P436, DOI 10.1136/sextrans-2011-050412; Pan CQ, 2012, DIGEST DIS SCI, V57, P2423, DOI 10.1007/s10620-012-2187-3; Ransom CE, 2013, JAIDS-J ACQ IMM DEF, V64, P374, DOI 10.1097/QAI.0b013e3182a7adb2; Reid SE, 2010, JAIDS-J ACQ IMM DEF, V53, P606, DOI 10.1097/QAI.0b013e3181bc4869; Siberry GK, 2012, AIDS, V26, P1151, DOI 10.1097/QAD.0b013e328352d135; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; UNAIDS, 2011, GOOD PART PRACT GUID; *UNAIDS WHO, 2007, ETH CONS BIOM HIV PR; Wang LM, 2013, CLIN INFECT DIS, V57, P1773, DOI 10.1093/cid/cit601; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401	38	85	88	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					362	371		10.1001/jama.2014.8735	http://dx.doi.org/10.1001/jama.2014.8735			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038355	Bronze, Green Accepted			2022-12-28	WOS:000339257800023
J	McKenney, RJ; Huynh, W; Tanenbaum, ME; Bhabha, G; Vale, RD				McKenney, Richard J.; Huynh, Walter; Tanenbaum, Marvin E.; Bhabha, Gira; Vale, Ronald D.			Activation of cytoplasmic dynein motility by dynactin-cargo adapter complexes	SCIENCE			English	Article							MICROTUBULE-BINDING; PROCESSIVITY; TRANSPORT; MOTOR; PROTEIN; LIS1; INCREASES; DOMAIN	Cytoplasmic dynein is a molecular motor that transports a large variety of cargoes (e. g., organelles, messenger RNAs, and viruses) along microtubules over long intracellular distances. The dynactin protein complex is important for dynein activity in vivo, but its precise role has been unclear. Here, we found that purified mammalian dynein did not move processively on microtubules in vitro. However, when dynein formed a complex with dynactin and one of four different cargo-specific adapter proteins, the motor became ultraprocessive, moving for distances similar to those of native cargoes in living cells. Thus, we propose that dynein is largely inactive in the cytoplasm and that a variety of adapter proteins activate processive motility by linking dynactin to dynein only when the motor is bound to its proper cargo.	[Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	vale@ucsf.edu			NIH [F32GM096484, R01GM097312]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096484, R01GM097312] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Ori-McKenney for helpful discussions and analysis. This work was supported by NIH F32 postdoctoral grant F32GM096484 (to R.J.M.) and R01GM097312 (to R.D.V.). G. B. is the Merck Fellow of the Damon Runyon Cancer Research Foundation (DRG-2136-12).	Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Bielska E, 2014, J CELL BIOL, V204, P989, DOI 10.1083/jcb.201309022; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Kim H, 2007, J CELL BIOL, V176, P641, DOI 10.1083/jcb.200608128; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Lazarus JE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001611; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Miura M, 2010, FEBS LETT, V584, P2351, DOI 10.1016/j.febslet.2010.04.016; Moughamian AJ, 2012, NEURON, V74, P331, DOI 10.1016/j.neuron.2012.02.025; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Soundararajan HC, 2014, ELIFE, V3, DOI 10.7554/eLife.01596; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Stuurman N, 1999, EUR J CELL BIOL, V78, P278, DOI 10.1016/S0171-9335(99)80061-2; Tanenbaum ME, 2013, ELIFE, V2, DOI 10.7554/eLife.00943; Tokito MK, 1996, MOL BIOL CELL, V7, P1167, DOI 10.1091/mbc.7.8.1167; Trokter M, 2012, P NATL ACAD SCI USA, V109, P20895, DOI 10.1073/pnas.1210573110; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Wang ZH, 1995, BIOPHYS J, V69, P2011, DOI 10.1016/S0006-3495(95)80071-8; Zhang J, 2014, J CELL BIOL, V204, P1009, DOI 10.1083/jcb.201308009	30	303	307	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					337	341		10.1126/science.1254198	http://dx.doi.org/10.1126/science.1254198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035494	Green Accepted			2022-12-28	WOS:000339400700054
J	Nachtsheim, BJ				Nachtsheim, Boris J.			Creating antioxidants by oxidation catalysis	SCIENCE			English	Editorial Material							VITAMIN-E		Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Nachtsheim, BJ (corresponding author), Univ Tubingen, Inst Organ Chem, Morgenstelle 18, D-72076 Tubingen, Germany.	boris.nachtsheim@uni-tuebingen.de		Nachtsheim, Boris Johannes/0000-0002-3759-2770				French AN, 2010, SCIENCE, V328, P1365, DOI 10.1126/science.1191408; Netscher T, 2007, VITAM HORM, V76, P155, DOI 10.1016/S0083-6729(07)76007-7; Schneider C, 2005, MOL NUTR FOOD RES, V49, P7, DOI 10.1002/mnfr.200400049; Shen HC, 2009, TETRAHEDRON, V65, P3931, DOI 10.1016/j.tet.2009.02.002; Tanaka S, 2009, ANGEW CHEM INT EDIT, V48, P8948, DOI 10.1002/anie.200904671; Tietze LF, 2005, ANGEW CHEM INT EDIT, V44, P257, DOI 10.1002/anie.200461629; Trost BM, 2004, J AM CHEM SOC, V126, P11966, DOI 10.1021/ja048078t; Uyanik M, 2014, SCIENCE, V345, P291, DOI 10.1126/science.1254976; Uyanik M, 2012, CHEMCATCHEM, V4, P177, DOI 10.1002/cctc.201100352; Uyanik M, 2010, SCIENCE, V328, P1376, DOI 10.1126/science.1188217	10	8	8	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					270	271		10.1126/science.1257347	http://dx.doi.org/10.1126/science.1257347			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035475				2022-12-28	WOS:000339400700029
J	McKinley, KL; Cheeseman, IM				McKinley, Kara L.; Cheeseman, Iain M.			Polo-like Kinase 1 Licenses CENP-A Deposition at Centromeres	CELL			English	Article							CYTOKINESIS; RECRUITMENT; REVEALS; PLK1; MAINTENANCE; INHIBITOR; BI-2536; M18BP1; HJURP	To ensure the stable transmission of the genome during vertebrate cell division, the mitotic spindle must attach to a single locus on each chromosome, termed the centromere. The fundamental requirement for faithful centromere inheritance is the controlled deposition of the centromere-specifying histone, CENP-A. However, the regulatory mechanisms that ensure the precise control of CENP-A deposition have proven elusive. Here, we identify polo-like kinase 1 (Plk1) as a centromere-localized regulator required to initiate CENP-A deposition in human cells. We demonstrate that faithful CENP-A deposition requires integrated signals from Plk1 and cyclin-dependent kinase (CDK), with Plk1 promoting the localization of the key CENP-A deposition factor, the Mis18 complex, and CDK inhibiting Mis18 complex assembly. By bypassing these regulated steps, we uncoupled CENP-A deposition from cell-cycle progression, resulting in mitotic defects. Thus, CENP-A deposition is controlled by a two-step regulatory paradigm comprised of Plk1 and CDK that is crucial for genomic integrity.	[McKinley, Kara L.; Cheeseman, Iain M.] MIT, Cambridge Ctr 9, Whitehead Inst, Cambridge, MA 02142 USA; [McKinley, Kara L.; Cheeseman, Iain M.] MIT, Cambridge Ctr 9, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Cheeseman, IM (corresponding author), MIT, Cambridge Ctr 9, Whitehead Inst, Cambridge, MA 02142 USA.	icheese@wi.mit.edu		McKinley, Kara/0000-0001-6283-9168; Cheeseman, Iain/0000-0002-3829-5612	Scholar Award from the Leukemia & Lymphoma Society; NIH/National Institute of General Medical Sciences [GM088313]; American Cancer Society [121776]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287, R01GM088313] Funding Source: NIH RePORTER	Scholar Award from the Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the I.M.C. laboratory, Defne Yarar, David Sabatini, Peter Reddien, Steve Bell, Frank Solomon, Terry Orr-Weaver, and Rick Young for discussions and critical reading of the manuscript. We are grateful to Daniel Lim and Michael Yaffe (MIT) for providing the GST-Plk1-PBD and advice on working with Plk1. We thank Aaron Straight (Stanford University) for the CENP-A-SNAP cell line, Prasad Jallepalli (Sloan Kettering) for the Rpe1-Plk1<SUP>as</SUP> cell line, and Lars Jansen (Gulbenkian Institute) for the M18BP1 cDNA and CENP-A-SNAP plasmids. We thank Paul Fields and Laurie Boyer (MIT) and Chikdu Shivalila and Rudolf Jaenisch (Whitehead Institute and MIT) for advice and reagents for CRISPR/Cas9-mediated genome editing. This work was supported by a Scholar Award from the Leukemia & Lymphoma Society, a grant from the NIH/National Institute of General Medical Sciences (GM088313), and a Research Scholar Grant (121776) from the American Cancer Society to I.M. C.I.M.C. is a Thomas D. and Virginia W. Cabot Career Development Professor of Biology.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Arnaud L, 1998, CHROMOSOMA, V107, P424, DOI 10.1007/s004120050326; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Black BE, 2010, COLD SH Q B, V75, P403, DOI 10.1101/sqb.2010.75.038; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Cheeseman I. M., 2005, SCI STKE, V266, P1; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dambacher S, 2012, NUCLEUS-PHILA, V3, P101, DOI 10.4161/nucl.18955; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fachinetti D, 2013, NAT CELL BIOL, V15, P1056, DOI 10.1038/ncb2805; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Gascoigne KE, 2013, CHROMOSOME RES, V21, P407, DOI 10.1007/s10577-013-9368-6; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Gomez-Rodriguez M, 2013, CURR OPIN GENET DEV, V23, P219, DOI 10.1016/j.gde.2012.11.002; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Lagana A, 2010, NAT CELL BIOL, V12, P1186, DOI 10.1038/ncb2129; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Moree B, 2011, J CELL BIOL, V194, P855, DOI 10.1083/jcb.201106079; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Shiromizu T, 2013, J PROTEOME RES, V12, P2414, DOI 10.1021/pr300825v; Silva MCC, 2012, DEV CELL, V22, P52, DOI 10.1016/j.devcel.2011.10.014; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Wang H, 2013, CELL, V153; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110	37	97	97	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					397	411		10.1016/j.cell.2014.06.016	http://dx.doi.org/10.1016/j.cell.2014.06.016			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036634	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000340943600018
J	Rechavi, O; Houri-Ze'evi, L; Anava, S; Goh, WSS; Kerk, SY; Hannon, GJ; Hobert, O				Rechavi, Oded; Houri-Ze'evi, Leah; Anava, Sarit; Goh, Wee Siong Sho; Kerk, Sze Yen; Hannon, Gregory J.; Hobert, Oliver			Starvation-Induced Transgenerational Inheritance of Small RNAs in C. elegans	CELL			English	Article							GERMLINE GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; EPIGENETIC INHERITANCE; NUTRITIONAL CONTROL; PRENATAL EXPOSURE; MEMORY; PIRNAS; AMPLIFICATION; INTERFERENCE; LONGEVITY	Evidence from animal studies and human famines suggests that starvation may affect the health of the progeny of famished individuals. However, it is not clear whether starvation affects only immediate offspring or has lasting effects; it is also unclear how such epigenetic information is inherited. Small RNA-induced gene silencing can persist over several generations via transgenerationally inherited small RNA molecules in C. elegans, but all known transgenerational silencing responses are directed against foreign DNA introduced into the organism. We found that starvation-induced developmental arrest, a natural and drastic environmental change, leads to the generation of small RNAs that are inherited through at least three consecutive generations. These small, endogenous, transgenerationally transmitted RNAs target genes with roles in nutrition. We defined genes that are essential for this multigenerational effect. Moreover, we show that the F3 offspring of starved animals show an increased lifespan, corroborating the notion of a transgenerational memory of past conditions.	[Rechavi, Oded; Houri-Ze'evi, Leah; Anava, Sarit] Tel Aviv Univ, Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Rechavi, Oded; Houri-Ze'evi, Leah; Anava, Sarit] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Rechavi, Oded; Kerk, Sze Yen; Hobert, Oliver] Columbia Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Goh, Wee Siong Sho; Hannon, Gregory J.] Watson Sch Biol Sci, Howard Hughes Med Inst, Cold Spring Harbor Lab, New York, NY 11724 USA	Tel Aviv University; Tel Aviv University; Columbia University; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Rechavi, O (corresponding author), Tel Aviv Univ, Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	odedrechavi@gmail.com	Hannon, Gregory/AAB-3568-2019; Houri-Zeevi, Leah/AAR-2327-2021; Goh, Sho/AAG-6762-2021	Goh, Sho/0000-0003-4355-3927; Hobert, Oliver/0000-0002-7634-2854; Kerk, Sze Yen/0000-0003-2358-9674	Alon fellowship; Bikura fellowship; Yad Hanadiv fellowship; CBRC grant; Teva NNE grant; ISF grant; ERC grant; Howard Hughes Medical Institute; Cancer Research UK [21143] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062534] Funding Source: NIH RePORTER	Alon fellowship; Bikura fellowship; Yad Hanadiv fellowship; CBRC grant; Teva NNE grant(Teva Pharmaceutical Industries); ISF grant; ERC grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Yoav Benjamini for help with the statistical methods. We thank Scott Kennedy for providing the hrde-1 strain. We also thank Assaf Gordon, Michal lineal, Shelly Mahlab, and all members of the Rechavi and Hobert lab for their helpful comments. Oded Rechavi, Leah Houri-Ze'evi, and Sarit Anava were supported by funds from the Alon, Bikura, and Yad Hanadiv fellowships, and by the CBRC, Teva NNE, ISF, and ERC grants. This work was supported by the Howard Hughes Medical Institute.	Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Baugh LR, 2013, GENETICS, V194, P539, DOI 10.1534/genetics.113.150847; Billi AC, 2012, PLOS GENET, V8, P84, DOI 10.1371/journal.pgen.1002617; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Bygren LO, 2001, ACTA BIOTHEOR, V49, P53, DOI 10.1023/A:1010241825519; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Conine CC, 2013, CELL, V155, P1532, DOI 10.1016/j.cell.2013.11.032; DePina Ana S., 2011, BMC Physiology, V11, P11, DOI 10.1186/1472-6793-11-11; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fischer S. E. J., 2014, C ELEGANS RES COMMUN; Fischer SEJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002369; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Grishok A, 2013, ADV GENET, V83, P1, DOI 10.1016/B978-0-12-407675-4.00001-8; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Hall SE, 2013, RNA, V19, P306, DOI 10.1261/rna.036418.112; Han T, 2009, P NATL ACAD SCI USA, V106, P18674, DOI 10.1073/pnas.0906378106; Harvey SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025840; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hellwig S, 2008, P NATL ACAD SCI USA, V105, P12897, DOI 10.1073/pnas.0805118105; Jablonka E, 2008, GENET MOL BIOL, V31, P389, DOI 10.1590/S1415-47572008000300001; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Kamminga LM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002702; Koonin EV, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-42; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Mansisidor AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002299; Maxwell CS, 2012, GENOME RES, V22, P1920, DOI 10.1101/gr.133587.111; Meloche S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003163; Montgomery TA, 2012, PLOS GENET, V8, P72, DOI 10.1371/journal.pgen.1002616; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Rechavi O, 2014, TRENDS CELL BIOL, V24, P212, DOI 10.1016/j.tcb.2013.10.003; Rechavi O, 2011, CELL, V147, P1248, DOI 10.1016/j.cell.2011.10.042; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Remy JJ, 2010, CURR BIOL, V20, pR877, DOI 10.1016/j.cub.2010.08.013; Remy JJ, 2005, SCIENCE, V309, P787, DOI 10.1126/science.1114209; Seth M, 2013, DEV CELL, V27, P656, DOI 10.1016/j.devcel.2013.11.014; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; SIMPSON VJ, 1986, NUCLEIC ACIDS RES, V14, P6711, DOI 10.1093/nar/14.16.6711; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Song SG, 2009, SOC SCI MED, V68, P1315, DOI 10.1016/j.socscimed.2009.01.027; Stanner SA, 1997, BMJ-BRIT MED J, V315, P1342, DOI 10.1136/bmj.315.7119.1342; Sterken MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089760; Vasale JJ, 2010, P NATL ACAD SCI USA, V107, P3582, DOI 10.1073/pnas.0911908107; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Wedeles CJ, 2013, DEV CELL, V27, P664, DOI 10.1016/j.devcel.2013.11.016; Zhang XC, 2011, P NATL ACAD SCI USA, V108, P17997, DOI 10.1073/pnas.1105982108	53	286	296	3	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					277	287		10.1016/j.cell.2014.06.020	http://dx.doi.org/10.1016/j.cell.2014.06.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25018105	Bronze, Green Accepted			2022-12-28	WOS:000340943600009
J	Lane, R				Lane, Richard			Karen Sliwa: cardiology from the heart of South Africa	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					123	123		10.1016/S0140-6736(14)61151-X	http://dx.doi.org/10.1016/S0140-6736(14)61151-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1YC	25016986	Bronze			2022-12-28	WOS:000338921500019
J	Lee, CH; Lu, W; Michel, JC; Goehring, A; Du, J; Song, XQ; Gouaux, E				Lee, Chia-Hsueh; Lu, Wei; Michel, Jennifer Carlisle; Goehring, April; Du, Juan; Song, Xianqiang; Gouaux, Eric			NMDA receptor structures reveal subunit arrangement and pore architecture	NATURE			English	Article							AMINO-TERMINAL DOMAIN; SIZE-EXCLUSION CHROMATOGRAPHY; LIGAND-BINDING DOMAIN; HIGH-LEVEL EXPRESSION; D-ASPARTATE RECEPTORS; GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURE; ALLOSTERIC INHIBITION; MOLECULAR-BASIS; CENTRAL NEURONS	N-methyl-D-aspartate (NMDA) receptors are Hebbian-like coincidence detectors, requiring binding of glycine and glutamate in combination with the relief of voltage-dependent magnesium block to open an ion conductive pore across the membrane bilayer. Despite the importance of the NMDA receptor in the development and function of the brain, a molecular structure of an intact receptor has remained elusive. Here we present X-ray crystal structures of the Xenopus laevis GluN1-GluN2B NMDA receptor with the allosteric inhibitor, Ro25-6981, partial agonists and the ion channel blocker, MK-801. Receptor subunits are arranged in a 1-2-1-2 fashion, demonstrating extensive interactions between the amino-terminal and ligand-binding domains. The transmembrane domains harbour a closed-blocked ion channel, a pyramidal central vestibule lined by residues implicated in binding ion channel blockers and magnesium, and a twofold symmetric arrangement of ion channel pore loops. These structures provide new insights into the architecture, allosteric coupling and ion channel function of NMDA receptors.	[Lee, Chia-Hsueh; Lu, Wei; Michel, Jennifer Carlisle; Goehring, April; Du, Juan; Song, Xianqiang; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Michel, Jennifer Carlisle; Goehring, April; Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Song, Xianqiang/B-9768-2017	Gouaux, Eric/0000-0002-8549-2360; Song, Xianqiang/0000-0002-5637-3119	Oregon Brain Institute Graduate Student Fellowship; NIH; Vollum Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS038631] Funding Source: NIH RePORTER	Oregon Brain Institute Graduate Student Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vollum Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All members of the Gouaux laboratory are gratefully acknowledged for their support and assistance, especially L. Chen, K. Duerr and K. Wang. We thank L. Vaskalis for assistance with the figures, G. Westbrook and C. Jahr for comments on the manuscript, H. Owen for proofreading and I. Baconguis for making the animation. E. G. acknowledges the generous support of R. LaCroute, B. LaCroute and J. LaCroute. This work was also supported by an Oregon Brain Institute Graduate Student Fellowship (C. H. L.), the NIH (E. G.) and the Vollum Institute (E. G.). E. G. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALLAN RD, 1990, J MED CHEM, V33, P2905, DOI 10.1021/jm00172a036; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delano W.L, 2002, PYMOL USERS MANUAL; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Erreger K, 2007, MOL PHARMACOL, V72, P907, DOI 10.1124/mol.107.037333; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Gourdon P, 2011, CRYST GROWTH DES, V11, P2098, DOI 10.1021/cg101360d; Hansen KB, 2012, J NEUROSCI, V32, P6197, DOI 10.1523/JNEUROSCI.5757-11.2012; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; HART HE, 1979, MOL IMMUNOL, V16, P265, DOI 10.1016/0161-5890(79)90065-8; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kashiwagi K, 2002, MOL PHARMACOL, V61, P533, DOI 10.1124/mol.61.3.533; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Lee CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019180; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mony L, 2011, EMBO J, V30, P3134, DOI 10.1038/emboj.2011.203; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Peery HE, 2012, AUTOIMMUN REV, V11, P863, DOI 10.1016/j.autrev.2012.03.001; Pohlsgaard J, 2011, NEUROPHARMACOLOGY, V60, P135, DOI 10.1016/j.neuropharm.2010.08.004; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; REICHLING DB, 1991, J PHYSIOL-LONDON, V441, P199, DOI 10.1113/jphysiol.1991.sp018746; Riou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035134; Salussolia CL, 2011, J NEUROSCI, V31, P11295, DOI 10.1523/JNEUROSCI.5612-10.2011; SHERRY AD, 1975, BIOCHEMISTRY-US, V14, P2191, DOI 10.1021/bi00681a023; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Soto David, 2014, Commun Integr Biol, V7, pe27887, DOI 10.4161/cib.27887; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tovar KR, 2013, J NEUROSCI, V33, P9150, DOI 10.1523/JNEUROSCI.0829-13.2013; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; WATSON GB, 1990, NEUROPHARMACOLOGY, V29, P727, DOI 10.1016/0028-3908(90)90125-B; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Zhu SJ, 2013, NAT STRUCT MOL BIOL, V20, P477, DOI 10.1038/nsmb.2522	68	340	349	4	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					191	+		10.1038/nature13548	http://dx.doi.org/10.1038/nature13548			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008524	Green Accepted			2022-12-28	WOS:000338649800037
J	Wiebe, S				Wiebe, Samuel			PERSPECTIVE The surgical solution	NATURE			English	Editorial Material							TEMPORAL-LOBE EPILEPSY; SURGERY; TRIAL		Univ Calgary, Calgary, AB T2N 1N4, Canada	University of Calgary	Wiebe, S (corresponding author), Univ Calgary, Calgary, AB T2N 1N4, Canada.							Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Fiest KM, 2014, EPILEPSIA; Jette N, 2012, NEUROLOGY, V79, P1084, DOI 10.1212/WNL.0b013e3182698c4c; Schmidt D, 2009, EPILEPSIA, V50, P1301, DOI 10.1111/j.1528-1167.2008.01997.x; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wiebe S, 2012, NAT REV NEUROL, V8, P669, DOI 10.1038/nrneurol.2012.181	7	4	4	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S7	S7		10.1038/511S7a	http://dx.doi.org/10.1038/511S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25019126	Bronze			2022-12-28	WOS:000338649800003
J	Cappola, AR				Cappola, Anne R.			Levothyroxine Prescription Not as Simple as It Seems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SUBCLINICAL HYPOTHYROIDISM; THYROTROPIN	IMPORTANCE Rates of thyroid hormone prescribing in the United States and the United Kingdom have increased substantially. If some of the increase is due to lowering the thyrotropin threshold for treatment, this may result in less benefit and greater harm. OBJECTIVE To define trends in thyrotropin levels at the initiation of levothyroxine sodium therapy and the risk of developing a suppressed thyrotropin level following treatment. DESIGN, SETTING, PARTICIPANTS, AND EXPOSURE Retrospective cohort study using data from the United Kingdom Clinical Practice Research Datalink. Among 52 298 individuals who received a prescription for levothyroxine between January 1, 2001, and October 30, 2009, we extracted data about the thyrotropin level before levothyroxine therapy initiation, clinical symptoms, and thyrotropin levels up to 5 years after levothyroxine was initiated. We excluded persons who had a history of hyperthyroidism, pituitary disease, or thyroid surgery; those who were taking thyroid-altering medication or if the levothyroxine prescription was related to pregnancy; and those who did not have a thyrotropin level measured within 3 months before the initiation of levothyroxine. MAIN OUTCOMES AND MEASURES The median thyrotropin level at the time of the index levothyroxine prescription, the odds of initiation of levothyroxine therapy at thyrotropin levels of 10.0 mIU/L or less, and the age-stratified odds of developing a low or suppressed thyrotropin level after levothyroxine therapy. RESULTS Between 2001 and 2009, the median thyrotropin level at the initiation of levothyroxine therapy fell from 8.7 to 7.9 mIU/L. The odds ratio for prescribing levothyroxine at thyrotropin levels of 10.0 mIU/L or less in 2009 compared with 2001 (adjusted for changes in population demographics) was 1.30 (95% CI, 1.19-1.42; P < .001). Older individuals and individuals with cardiac risk factors had higher odds of initiation of levothyroxine therapy with a thyrotropin level 10.0 mIU/L or less. At 5 years after levothyroxine initiation, 5.8% of individuals had a thyrotropin level of < 0.1 mIU/L. Individuals with depression or tiredness at baseline had increased odds of developing a suppressed thyrotropin level, whereas individuals with cardiac risk factors (eg, atrial fibrillation, diabetes mellitus, hypertension, and raised lipid levels) did not. CONCLUSIONS AND RELEVANCE We observed a trend toward levothyroxine treatment of more marginal degrees of hypothyroidism and a substantial risk of developing a suppressed thyrotropin level following therapy. Large-scale prospective studies are required to assess the risk-benefit ratio of current practice.	[Cappola, Anne R.] Univ Penn, Div Endocrinol Diabet & Metab, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Cappola, AR (corresponding author), Univ Penn, Div Endocrinol Diabet & Metab, Perelman Sch Med, 3400 Civ Ctr Blvd,12th Floor,TRC Room 136, Philadelphia, PA 19104 USA.	acappola@mail.med.upenn.edu						Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; Surks MI, 2007, J CLIN ENDOCR METAB, V92, P4575, DOI 10.1210/jc.2007-1499; Taylor PN, 2014, JAMA INTERN MED, V174, P32, DOI 10.1001/jamainternmed.2013.11312; Waring AC, 2012, J CLIN ENDOCR METAB, V97, P3944, DOI 10.1210/jc.2012-2481	4	3	3	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2532	2533		10.1001/jama.2014.3808	http://dx.doi.org/10.1001/jama.2014.3808			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	25058086				2022-12-28	WOS:000337757000026
J	Steen, R; Jana, S; Reza-Paul, S; Richter, M				Steen, Richard; Jana, Smarajit; Reza-Paul, Sushena; Richter, Marlise			Trafficking, sex work, and HIV: efforts to resolve conflicts	LANCET			English	Editorial Material							HARM REDUCTION; PREVENTION; PROSTITUTION; POLICY		[Steen, Richard] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 Rotterdam, Netherlands; [Steen, Richard; Jana, Smarajit] Durbar Mahila Samanwaya Comm, Kolkata, W Bengal, India; [Reza-Paul, Sushena] Univ Manitoba, Community Hlth Serv, Winnipeg, MB R3T 2N2, Canada; [Reza-Paul, Sushena] Ashodaya Samithi, Mysore, Karnataka, India; [Richter, Marlise] Univ Witwatersrand, African Ctr Migrat & Soc, Johannesburg, South Africa; [Richter, Marlise] Sonke Gender Justice, Cape Town, South Africa; [Richter, Marlise] Univ Cape Town, Dept Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa	Erasmus University Rotterdam; Erasmus MC; University of Manitoba; University of Witwatersrand; University of Cape Town	Steen, R (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 Rotterdam, Netherlands.	steenr7@gmail.com						Brandt Allan M., 1987, NO MAGIC BULLET SOCI; Busza J, 2006, HEALTH POLICY PLANN, V21, P329, DOI 10.1093/heapol/czl016; Busza Joanna, 2004, HLTH HUMAN RIGHTS, V7, P231, DOI DOI 10.2307/4065357; Butcher K, 2003, LANCET, V361, P1983, DOI 10.1016/S0140-6736(03)13596-9; Decker MR, 2014, LANCET; Ditmore MH, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17354; Jana S, 2006, LANCET, V367, P814, DOI 10.1016/S0140-6736(06)68331-1; Jana S, 2013, J PUBLIC HLTH OXF; Pearshouse Richard, 2008, HIV AIDS Policy Law Rev, V13, P21; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Reza-Paul S, 2012, INDIAN J MED RES, V135, P98, DOI 10.4103/0971-5916.93431; Richter M, 2014, J IMMIGR MINOR HEALT, V16, P7, DOI 10.1007/s10903-012-9758-4; Richter ML, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-1; Shahmanesh M, 2009, SOC SCI MED, V69, P604, DOI 10.1016/j.socscimed.2009.06.020; Thomson N, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-31; Weitzer R, 2014, ANN AM ACAD POLIT SS, V653, P6, DOI 10.1177/0002716214521562	16	15	15	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2015	385	9963					94	96		10.1016/S0140-6736(14)60966-1	http://dx.doi.org/10.1016/S0140-6736(14)60966-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY7BI	25059945				2022-12-28	WOS:000347715900006
J	Lipstein, SH; Dunagan, WC				Lipstein, Steven H.; Dunagan, W. Claiborne			The Risks of Not Adjusting Performance Measures for Sociodemographic Factors	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							READMISSIONS		[Lipstein, Steven H.; Dunagan, W. Claiborne] BJC HealthCare, St Louis, MO 63108 USA		Lipstein, SH (corresponding author), BJC HealthCare, 4901 Forest Pk Ave,Suite 1200, St Louis, MO 63108 USA.	notestosteve@bjc.org						Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Council of Economic Advisers, 2014, MISS OPP CONS STAT D; Hu JH, 2014, HEALTH AFFAIR, V33, P778, DOI 10.1377/hlthaff.2013.0816; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; Nagasako EM, 2014, HEALTH AFFAIR, V33, P786, DOI 10.1377/hlthaff.2013.1148; National Quality Forum, 2014, RISK ADJ SOC FACT; Neuhausen K, 2014, HEALTH AFFAIR, V33, P988, DOI 10.1377/hlthaff.2013.1222; Pear Robert, 2014, NY TIMES, pA13; Thomas L., 2014, MILWAUKEE J SENTINEL	9	28	28	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8					594	U94		10.7326/M14-1601	http://dx.doi.org/10.7326/M14-1601			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25048401				2022-12-28	WOS:000343906800021
J	Gostin, LO				Gostin, Lawrence O.			The ACA's Contraceptive Mandate Religious Freedom, Women's Health, and Corporate Personhood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], NONCONTRACEPTIVE BEN; Cohen IG, 2014, NEW ENGL J MED, V371, P596, DOI 10.1056/NEJMp1407965; Gemzell-Danielsson K, 2013, CONTRACEPTION, V87, P300, DOI 10.1016/j.contraception.2012.08.021; Gossett DR, 2013, JAMA-J AM MED ASSOC, V309, P1997, DOI 10.1001/jama.2013.4262; LIPTAK A, 2013, NY TIMES, pA1; Wiley Lindsay F., 2016, PUBL HLTH LAW POW, V3rd	6	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2014	312	8					785	786		10.1001/jama.2014.9455	http://dx.doi.org/10.1001/jama.2014.9455			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7NX	25014562				2022-12-28	WOS:000340788500015
J	Belew, AT; Meskauskas, A; Musalgaonkar, S; Advani, VM; Sulima, SO; Kasprzak, WK; Shapiro, BA; Dinman, JD				Belew, Ashton Trey; Meskauskas, Arturas; Musalgaonkar, Sharmishtha; Advani, Vivek M.; Sulima, Sergey O.; Kasprzak, Wojciech K.; Shapiro, Bruce A.; Dinman, Jonathan D.			Ribosomal frameshifting in the CCR5 mRNA is regulated by miRNAs and the NMD pathway	NATURE			English	Article							TRANSLATIONAL FIDELITY; SEQUENCE ALIGNMENT; GENE; MODEL; EFFICIENCY; DATABASE; BINDING; VERSION; SIGNAL; CELLS	Programmed -1 ribosomal frameshift (-1 PRF) signals redirect translating ribosomes to slip back one base on messenger RNAs. Although well characterizedin viruses, how these elements may regulate cellular gene expression is not understood. Here we describe a -1 PRF signal in the human mRNA encoding CCR5, the HIV-1 co-receptor. CCR5 mRNA-mediated -1 PRF is directed by an mRNA pseudoknot, and is stimulated by at least two microRNAs. Mapping the mRNA-miRNA interaction suggests that formation of a triplex RNA structure stimulates -1 PRF. A -1 PRF event on the CCR5 mRNA directs translating ribosomes to a premature termination codon, destabilizing it through the nonsense-mediated mRNA decay pathway. At least one additional mRNA decay pathway is also involved. Functional -1 PRF signals that seem to be regulated by miRNAs are also demonstrated in mRNAs encoding six other cytokine receptors, suggesting a novel mode through which immune responses may be fine-tuned in mammalian cells.	[Belew, Ashton Trey; Meskauskas, Arturas; Musalgaonkar, Sharmishtha; Advani, Vivek M.; Sulima, Sergey O.; Dinman, Jonathan D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Meskauskas, Arturas] Vilnius State Univ, Dept Biotechnol & Microbiol, LT-03101 Vilnius, Lithuania; [Kasprzak, Wojciech K.] Leidos Biomed Res Inc, Basic Sci Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Shapiro, Bruce A.] NCI, Basic Res Lab, Frederick, MD 21702 USA	University System of Maryland; University of Maryland College Park; Vilnius University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dinman, JD (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	dinman@umd.edu	Advani, Vivek/L-1827-2019	Advani, Vivek/0000-0002-0584-8989; Dinman, Jonathan/0000-0002-2402-9698	National Institutes of Health [5 R01GM058859, R21GM068123]; National Science Foundation [MCB-0084559]; University of Maryland College of CMNS Hockmeyer Fellowship; NIH/NIGMS [T32GM080201]; Frederick National Laboratory for Cancer Research, NIH [HHSN261200800001E]; Intramural Research Program of the National Institutes of Health, Center for Cancer Research;  [NIH/NIAIDT32AI051967]; NATIONAL CANCER INSTITUTE [ZIABC008382] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI051967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080201, R01GM117177, R01GM058859, R21GM068123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of Maryland College of CMNS Hockmeyer Fellowship; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Frederick National Laboratory for Cancer Research, NIH; Intramural Research Program of the National Institutes of Health, Center for Cancer Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to J.D.D. from the National Institutes of Health (5 R01GM058859, R21GM068123) and from the National Science Foundation(MCB-0084559). A. T. B. was supported by NIH/NIAID T32AI051967, and a University of Maryland College of CMNS Hockmeyer Fellowship. S.O.S. was supported by NIH/NIGMS T32GM080201. This publication has also been funded in part with federal funds from the Frederick National Laboratory for Cancer Research, NIH, under Contract HHSN261200800001E to W. K. K. This research was supported in part by the Intramural Research Program of the National Institutes of Health, Center for Cancer Research to B. A. S. The content of this publication does not necessarily reflect the views or policies of the DHHS, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Advani VM, 2013, TRANSLATION, V1, DOI 10.4161/trla.24418; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Belew AT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-339; Belew AT, 2011, NUCLEIC ACIDS RES, V39, P2799, DOI 10.1093/nar/gkq1220; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Case DA, 2012, AMBER 12; Clark MB, 2007, J BIOL CHEM, V282, P37359, DOI 10.1074/jbc.M705676200; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; de Messieres M, 2014, BIOPHYS J, V106, P244, DOI 10.1016/j.bpj.2013.09.036; DINMAN JD, 1992, J VIROL, V66, P3669, DOI 10.1128/JVI.66.6.3669-3676.1992; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Dinman JD, 2010, NUCLEIC ACIDS MOL BI, V24, P321, DOI 10.1007/978-0-387-89382-2_15; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grentzmann G, 1998, RNA, V4, P479; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hekman KE, 2012, HUM MOL GENET, V21, P5472, DOI 10.1093/hmg/dds392; Houck-Loomis B, 2011, NATURE, V480, P561, DOI 10.1038/nature10657; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; HU JC, 1983, NUCLEIC ACIDS RES, V11, P4823, DOI 10.1093/nar/11.14.4823; Jack K, 2011, MOL CELL, V44, P660, DOI 10.1016/j.molcel.2011.09.017; Jacobs JL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh157; Jin H, 2009, MOL CELL BIOL, V29, P5789, DOI 10.1128/MCB.00653-09; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Manktelow E, 2005, NUCLEIC ACIDS RES, V33, P1553, DOI 10.1093/nar/gki299; Martinez HM, 2008, J BIOMOL STRUCT DYN, V25, P669, DOI 10.1080/07391102.2008.10531240; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Orom UA, 2007, METHODS, V43, P162, DOI 10.1016/j.ymeth.2007.04.007; PEATTIE DA, 1980, P NATL ACAD SCI-BIOL, V77, P4679, DOI 10.1073/pnas.77.8.4679; Plant EP, 2005, NUCLEIC ACIDS RES, V33, P1825, DOI 10.1093/nar/gki329; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Popenda M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks339; Popenda M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-231; Ritchie DB, 2012, P NATL ACAD SCI USA, V109, P16167, DOI 10.1073/pnas.1204114109; Staple DW, 2005, J MOL BIOL, V349, P1011, DOI 10.1016/j.jmb.2005.03.038; Sulima SO, 2014, P NATL ACAD SCI USA, V111, P5640, DOI 10.1073/pnas.1400247111; Temple G, 2009, GENOME RES, V19, P2324, DOI 10.1101/gr.095976.109; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wills NM, 2006, J BIOL CHEM, V281, P7082, DOI 10.1074/jbc.M511629200; Ysla RM, 2008, METHOD ENZYMOL, V449, P47, DOI 10.1016/S0076-6879(08)02403-8; Zhang YW, 1999, MOL BIOL EVOL, V16, P1145, DOI 10.1093/oxfordjournals.molbev.a026205	48	103	106	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					265	+		10.1038/nature13429	http://dx.doi.org/10.1038/nature13429			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25043019	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000340508200025
J	Dore, AS; Okrasa, K; Patel, JC; Serrano-Vega, M; Bennett, K; Cooke, RM; Errey, JC; Jazayeri, A; Khan, S; Tehan, B; Weir, M; Wiggin, GR; Marshall, FH				Dore, Andrew S.; Okrasa, Krzysztof; Patel, Jayesh C.; Serrano-Vega, Maria; Bennett, Kirstie; Cooke, Robert M.; Errey, James C.; Jazayeri, Ali; Khan, Samir; Tehan, Ben; Weir, Malcolm; Wiggin, Giselle R.; Marshall, Fiona H.			Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; ALLOSTERIC MODULATORS; HEPTAHELICAL DOMAIN; CRYSTAL-STRUCTURE; BINDING POCKETS; ACTIVATION; FAMILY; THERMOSTABILIZATION; ANTAGONISTS; MUTATIONS	Metabotropic glutamate receptors are class C G-protein-coupled receptors which respond to the neurotransmitter glutamate. Structural studies have been restricted to the amino-terminal extracellular domain, providing little understanding of the membrane-spanning signal transduction domain. Metabotropic glutamate receptor 5 is of considerable interest as a drug target in the treatment of fragile X syndrome, autism, depression, anxiety, addiction and movement disorders. Here we report the crystal structure of the transmembrane domain of the human receptor in complex with the negative allosteric modulator, mavoglurant. The structure provides detailed insight into the architecture of the transmembrane domain of class C receptors including the precise location of the allosteric binding site within the transmem-branedomain and key micro-switches which regulate receptor signalling. This structure also provides a model for all class CG-protein-coupled receptors and may aid in the design of new small-molecule drugs for the treatment of brain disorders.	[Dore, Andrew S.; Okrasa, Krzysztof; Patel, Jayesh C.; Serrano-Vega, Maria; Bennett, Kirstie; Cooke, Robert M.; Errey, James C.; Jazayeri, Ali; Khan, Samir; Tehan, Ben; Weir, Malcolm; Wiggin, Giselle R.; Marshall, Fiona H.] Heptares Therapeut Ltd, Welwyn Garden City AL7 3AX, Herts, England	Heptares Therapeutics Ltd.	Marshall, FH (corresponding author), Heptares Therapeut Ltd, BioPk,Broadwater Rd, Welwyn Garden City AL7 3AX, Herts, England.	fiona.marshall@heptares.com	Marshall, Fiona/AAZ-9626-2020	Wiggin, Giselle/0000-0003-4436-9208; Marshall, Fiona/0000-0002-8681-005X				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Beqollari D, 2009, MOL PHARMACOL, V76, P992, DOI 10.1124/mol.109.058628; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chang WH, 2000, J BIOL CHEM, V275, P19955, DOI 10.1074/jbc.M909613199; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gasparini F, 2002, BIOORG MED CHEM LETT, V12, P407, DOI 10.1016/S0960-894X(01)00767-3; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Gregory KJ, 2013, MOL PHARMACOL, V83, P991, DOI 10.1124/mol.112.083949; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Hu JX, 2007, J CELL MOL MED, V11, P908, DOI 10.1111/j.1582-4934.2007.00096.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lebon G, 2011, J MOL BIOL, V409, P298, DOI 10.1016/j.jmb.2011.03.075; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Levenga J, 2011, NEUROBIOL DIS, V42, P311, DOI 10.1016/j.nbd.2011.01.022; Li GY, 2013, PHARM PAT ANAL, V2, P767, DOI [10.4155/PPA.13.58, 10.4155/ppa.13.58]; Malherbe P, 2003, MOL PHARMACOL, V64, P823, DOI 10.1124/mol.64.4.823; Malherbe P, 2006, J NEUROCHEM, V98, P601, DOI 10.1111/j.1471-4159.2006.03886.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; O'Brien JA, 2003, MOL PHARMACOL, V64, P731, DOI 10.1124/mol.64.3.731; Pagano A, 2000, J BIOL CHEM, V275, P33750, DOI 10.1074/jbc.M006230200; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Robertson N, 2011, NEUROPHARMACOLOGY, V60, P36, DOI 10.1016/j.neuropharm.2010.07.001; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; SHIGEMOTO R, 1993, NEUROSCI LETT, V163, P53, DOI 10.1016/0304-3940(93)90227-C; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stauffer SR, 2011, ACS CHEM NEUROSCI, V2, P450, DOI 10.1021/cn2000519; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489	50	315	327	5	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					557	+		10.1038/nature13396	http://dx.doi.org/10.1038/nature13396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25042998				2022-12-28	WOS:000339566300027
J	Kelly, BT; Graham, SC; Liska, N; Dannhauser, PN; Honing, S; Ungewickell, EJ; Owen, DJ				Kelly, Bernard T.; Graham, Stephen C.; Liska, Nicole; Dannhauser, Philip N.; Hoening, Stefan; Ungewickell, Ernst J.; Owen, David J.			AP2 controls clathrin polymerization with a membrane-activated switch	SCIENCE			English	Article							ADAPTER COMPLEX; COATED VESICLES; PROTEINS; CARGO; RECRUITMENT; PIT; ENDOCYTOSIS; DYNAMIN	Clathrin-mediated endocytosis (CME) is vital for the internalization of most cell-surface proteins. In CME, plasma membrane-binding clathrin adaptors recruit and polymerize clathrin to form clathrin-coated pits into which cargo is sorted. Assembly polypeptide 2 (AP2) is the most abundant adaptor and is pivotal to CME. Here, we determined a structure of AP2 that includes the clathrin-binding beta 2 hinge and developed an AP2-dependent budding assay. Our findings suggest that an autoinhibitory mechanism prevents clathrin recruitment by cytosolic AP2. A large-scale conformational change driven by the plasma membrane phosphoinositide phosphatidylinositol 4,5-bisphosphate and cargo relieves this autoinhibition, triggering clathrin recruitment and hence clathrin-coated bud formation. This molecular switching mechanism can couple AP2's membrane recruitment to its key functions of cargo and clathrin binding.	[Kelly, Bernard T.; Liska, Nicole; Owen, David J.] Univ Cambridge, CIMR, Dept Clin Biochem, Cambridge CB2 0XY, England; [Graham, Stephen C.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Dannhauser, Philip N.; Ungewickell, Ernst J.] Hannover Med Sch, Dept Cell Biol, Ctr Anat, D-30625 Hannover, Germany; [Hoening, Stefan] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Hoening, Stefan] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	University of Cambridge; University of Cambridge; Hannover Medical School; University of Cologne; University of Cologne	Kelly, BT (corresponding author), Univ Cambridge, CIMR, Dept Clin Biochem, Hills Rd, Cambridge CB2 0XY, England.	btk1000@cam.ac.uk; djo30@cam.ac.uk	Dannhauser, Philip/A-5675-2018	Dannhauser, Philip/0000-0002-6749-7678; Graham, Stephen/0000-0003-4547-4034	Wellcome Trust [090909/Z/09/Z, 079895]; German Science Foundation [SFB 635, TP A3]; Royal Society [098406/Z/12/Z]	Wellcome Trust(Wellcome Trust); German Science Foundation(German Research Foundation (DFG)); Royal Society(Royal Society of London)	We would like to thank the I02, I03, and I04-1 beamline staff at the Diamond Lightsource; A. McCoy and P. Evans for crystallographic advice; C. Oubridge for advice and assistance with SeMet mapping of the hinge residues; N. Bright, C. Savva, and S. Miller for advice and assistance with EM; C. Smith for reagents; and H. B ning and H. Ungewickell for expert technical assistance. D.J.O. and B. T. K. are supported by a Wellcome Trust Principal Research fellowship (090909/Z/09/Z). S. H. is supported by a grant of the German Science Foundation (SFB 635, TP A3). S. C. G. is supported by a Sir Henry Dale fellowship from the Wellcome Trust and the Royal Society (098406/Z/12/Z). CIMR is supported by a Wellcome Trust Strategic Award (079895). Coordinates have been deposited in the Protein Data Bank with PDB ID 4uqi.	Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Borner GHH, 2012, J CELL BIOL, V197, P141, DOI 10.1083/jcb.201111049; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Dannhauser PN, 2012, NAT CELL BIOL, V14, P634, DOI 10.1038/ncb2478; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Hirst J, 2013, MOL BIOL CELL, V24, P2558, DOI 10.1091/mbc.E13-03-0170; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; LINDNER R, 1992, J BIOL CHEM, V267, P16567; Liu AP, 2010, J CELL BIOL, V191, P1381, DOI 10.1083/jcb.201008117; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Traub LM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001037; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; ZAREMBA S, 1983, J CELL BIOL, V97, P1339, DOI 10.1083/jcb.97.5.1339	24	138	139	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					459	463		10.1126/science.1254836	http://dx.doi.org/10.1126/science.1254836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061211	Green Accepted			2022-12-28	WOS:000339655100045
J	Coulson, T; Clegg, S				Coulson, Tim; Clegg, Sonya			POPULATION BIOLOGY Fur seals signal their own decline	NATURE			English	Editorial Material							HETEROZYGOSITY-FITNESS CORRELATIONS		[Coulson, Tim; Clegg, Sonya] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Clegg, Sonya] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [Clegg, Sonya] Griffith Univ, Environm Futures Res Inst, Nathan, Qld 4111, Australia	University of Oxford; Griffith University; Griffith University	Coulson, T (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	timothy.coulson@zoo.ox.ac.uk; sonya.clegg@zoo.ox.ac.uk	Coulson, Tim/AAL-8148-2021	Coulson, Tim/0000-0001-9371-9003	NERC [NE/H007148/2, NE/G004390/2, NE/I023783/2, NE/I023783/1, NE/I023791/2, NE/E015921/1, NE/I023791/1, NE/G004390/1, NE/K014218/1] Funding Source: UKRI; Natural Environment Research Council [NE/G004390/1, NE/I023791/2, NE/I023791/1, 1136795, NE/H007148/1, NE/E015921/1, NE/G004390/2, NE/I023783/1, NE/I023783/2, 1221700, NE/K014218/1, NE/H007148/2] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Forcada J, 2014, NATURE, V511, P462, DOI 10.1038/nature13542; Magera AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077908; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; Thelen GC, 2001, EVOLUTION, V55, P1180, DOI 10.1111/j.0014-3820.2001.tb00637.x	6	2	2	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					414	415		10.1038/511414a	http://dx.doi.org/10.1038/511414a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25056058				2022-12-28	WOS:000339335700033
J	Fauci, AS; Marston, HD; Folkers, GK				Fauci, Anthony S.; Marston, Hilary D.; Folkers, Gregory K.			An HIV Cure Feasibility, Discovery, and Implementation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CCR5		[Fauci, Anthony S.; Marston, Hilary D.; Folkers, Gregory K.] NIAID, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						Balazs AB, 2014, NAT MED, V20, P296, DOI 10.1038/nm.3471; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; UN Joint Programme on HIV/AIDS (UNAIDS), GLOB REP UN REP GLOB; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052	8	25	25	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					335	336		10.1001/jama.2014.4754	http://dx.doi.org/10.1001/jama.2014.4754			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038345				2022-12-28	WOS:000339257800013
J	Levine, M				Levine, Michael			Walter Gehring (1939-2014)	SCIENCE			English	Biographical-Item									Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Levine, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, 229 Stanley Hall, Berkeley, CA 94720 USA.	mlevine@berkeley.edu		Levine, Michael/0000-0001-7629-0081					0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					277	277		10.1126/science.1258143	http://dx.doi.org/10.1126/science.1258143			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035479				2022-12-28	WOS:000339400700033
J	Hunt, LP; Ben-Shlomo, Y; Clark, EM; Dieppe, P; Judge, A; MacGregor, AJ; Tobias, JH; Vernon, K; Blom, AW				Hunt, Linda P.; Ben-Shlomo, Yoav; Clark, Emma M.; Dieppe, Paul; Judge, Andrew; MacGregor, Alex J.; Tobias, Jon H.; Vernon, Kelly; Blom, Ashley W.		Natl Joint Registry England Wales	45-day mortality after 467 779 knee replacements for osteoarthritis from the National Joint Registry for England and Wales: an observational study	LANCET			English	Article							EARLY POSTOPERATIVE MORTALITY; RANDOMIZED CONTROLLED-TRIAL; IN-HOSPITAL COMPLICATIONS; TOTAL HIP; RETROSPECTIVE ANALYSIS; 90-DAY MORTALITY; RISK-FACTORS; ARTHROPLASTY; MORBIDITY; PROGNOSIS	Background Understanding the risk factors for early death after knee replacement could help to reduce the risk of mortality after this procedure. We assessed secular trends in death within 45 days of knee replacement for osteoarthritis in England and Wales, with the aim of investigating whether any change that we recorded could be explained by alterations in modifiable perioperative factors. Methods We took data for knee replacements done for osteoarthritis in England and Wales between April 1, 2003, and Dec 31, 2011, from the National Joint Registry for England and Wales. Patient identifiers were used to link these data to the national mortality database and the Hospital Episode Statistics database to obtain details of death, sociodemographics, and comorbidity. We assessed mortality within 45 days by Kaplan-Meier analysis and assessed the role of patient and treatment factors by Cox proportional hazards models. Findings 467 779 primary knee replacements were done to treat osteoarthritis during 9 years. 1183 patients died within 45 days of surgery, with a substantial secular decrease in mortality from 0.37% in 2003 to 0.20% in 2011, even after adjustment for age, sex, and comorbidity. The use of unicompartmental knee replacement was associated with substantially lower mortality than was total knee replacement (hazard ratio [HR] 0.32, 95% CI 0.19-0. 54, p<0.0005). Several comorbidities were associated with increased mortality: myocardial infarction (HR 3.46, 95% CI 2.81-4.14, p<0.0005), cerebrovascular disease (3.35, 2.7-4. 14, p<0.0005), moderate/severe liver disease (7.2, 3.93-13.21, p<0.0005), and renal disease (2.18, 1.76-2.69, p<0.0005). Modifiable perioperative risk factors, including surgical approach and thromboprophylaxis were not associated with mortality. Interpretation Postoperative mortality after knee replacement has fallen substantially between 2003 and 2011. Efforts to further reduce mortality should concentrate more on older patients, those who are male and those with specific comorbidities, such as myocardial infarction, cerebrovascular disease, liver disease, and renal disease.	[Hunt, Linda P.; Clark, Emma M.; Tobias, Jon H.; Vernon, Kelly; Blom, Ashley W.] Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Bristol BS10 5NB, Avon, England; [Ben-Shlomo, Yoav] Univ Bristol, Bristol BS10 5NB, Avon, England; [Dieppe, Paul] Univ Exeter, Sch Med, Exeter, Devon, England; [Judge, Andrew] Univ Oxford, NIHR Musculoskeletal Biomed Res Unit, Oxford, England; [Judge, Andrew] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England; [MacGregor, Alex J.] Norwich Med Sch, Norwich, Norfolk, England	University of Bristol; University of Bristol; University of Exeter; University of Oxford; University of Southampton; University of East Anglia	Blom, AW (corresponding author), Univ Bristol, Southmead Hosp, Bristol BS10 5NB, Avon, England.	ashley.blom@nbt.nhs.uk	Ben-Shlomo, Yoav/ABD-2004-2021; Tobias, Jon/E-2832-2014	Ben-Shlomo, Yoav/0000-0001-6648-3007; MacGregor, Alex/0000-0003-2163-2325; Judge, Andrew/0000-0003-3015-0432; Tobias, Jon/0000-0002-7475-3932; Blom, Ashley/0000-0002-9940-1095	National Joint Registry for England and Wales	National Joint Registry for England and Wales	Funding National Joint Registry for England and Wales.	[Anonymous], 2007, INDICES DEPRIVATION; Aylin P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2424; Baker PN, 2012, J BONE JOINT SURG BR, V94B, P919, DOI 10.1302/0301-620X.94B7.28436; Beard D, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-292; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Gomez-Outes A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3675; Goodfellow JW, 2010, J BONE JOINT SURG BR, V92B, P1628, DOI 10.1302/0301-620X.92B12.25193; Greenberg JA, 2013, AM J CLIN NUTR, V97, P1195, DOI 10.3945/ajcn.112.045815; Hamer M, 2013, PREV MED, V57, P12, DOI 10.1016/j.ypmed.2013.02.012; Hunt LP, 2013, LANCET, V382, P1097, DOI 10.1016/S0140-6736(13)61749-3; Jamsen E, 2013, ACTA ORTHOP, V84, P44, DOI 10.3109/17453674.2012.752691; Kirksey M, 2012, ANESTH ANALG, V115, P321, DOI 10.1213/ANE.0b013e31825b6824; Lie SA, 2010, J BONE JOINT SURG AM, V92A, P58, DOI 10.2106/JBJS.H.01882; Memtsoudis SG, 2008, CLIN ORTHOP RELAT R, V466, P2617, DOI 10.1007/s11999-008-0402-5; Memtsoudis SG, 2012, J ORTHOP RES, V30, P1811, DOI 10.1002/jor.22139; Memtsoudis SG, 2010, J ARTHROPLASTY, V25, P19, DOI 10.1016/j.arth.2008.11.010; Memtsoudis SG, 2009, J ARTHROPLASTY, V24, P518, DOI 10.1016/j.arth.2008.01.307; Morris MJ, 2013, KNEE, V20, P218, DOI 10.1016/j.knee.2012.10.019; National Collaborating Centre for Acute and Chronic Conditions, 2010, VEN THROMB RED RISK, V92; National Joint Registry for England and Wales, 2013, 10 ANN REP NAT JOINT; Newman J, 2009, J BONE JOINT SURG BR, V91B, P52, DOI 10.1302/0301-620X.91B1.20899; Parry MC, 2011, J BONE JOINT SURG AM, V93A, P948, DOI 10.2106/JBJS.J.00425; Parvizi J, 2001, J BONE JOINT SURG AM, V83A, P1157, DOI 10.2106/00004623-200108000-00004; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Robertsson O, 2007, J BONE JOINT SURG BR, V89B, P599, DOI 10.1302/0301-620X.89B5.18355; Santaguida PL, 2008, CAN J SURG, V51, P428; Singh JA, 2013, ARTHRIT CARE RES, V65, P1095, DOI 10.1002/acr.21953; Singh JA, 2012, J ARTHROPLASTY, V27, P1417, DOI 10.1016/j.arth.2012.03.008; Singh JA, 2011, J RHEUMATOL, V38, P1507, DOI 10.3899/jrheum.110280; Wu Christopher L, 2008, Am J Orthop (Belle Mead NJ), V37, P524; Wylde V, 2011, J BONE JOINT SURG BR, V93B, P569, DOI 10.1302/0301-620X.93B5.26687	31	128	132	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2014	384	9952					1429	1436		10.1016/S0140-6736(14)60540-7	http://dx.doi.org/10.1016/S0140-6736(14)60540-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ8TV	25012118				2022-12-28	WOS:000343107000023
J	Dungan, KM; Povedano, ST; Forst, T; Gonzalez, JGG; Atisso, C; Sealls, W; Fahrbach, JL				Dungan, Kathleen M.; Tofe Povedano, Santiago; Forst, Thomas; Gonzalez Gonzalez, Jose G.; Atisso, Charles; Sealls, Whitney; Fahrbach, Jessie L.			Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial	LANCET			English	Article							PEPTIDE-1 RECEPTOR AGONISTS; PHYSICAL-ACTIVITIES; GLYCEMIC CONTROL; PARALLEL-GROUP; EXENATIDE; EFFICACY; SAFETY; ANALOG; LY2189265; TWICE	Background Dulaglutide and liraglutide, both glucagon-like peptide-1 (GLP-1) receptor agonists, improve glycaemic control and reduce weight in patients with type 2 diabetes. In a head-to-head trial, we compared the safety and efficacy of once-weekly dulaglutide with that of once-daily liraglutide in metformin-treated patients with uncontrolled type 2 diabetes. Methods We did a phase 3, randomised, open-label, parallel-group study at 62 sites in nine countries between June 20, 2012, and Nov 25, 2013. Patients with inadequately controlled type 2 diabetes receiving metformin (>= 1500 mg/day), aged 18 years or older, with glycated haemoglobin (HbA(1c)) 7.0% or greater (>= 53 mmol/mol) and 10.0% or lower (<= 86 mmol/mol), and body-mass index 45 kg/m(2) or lower were randomly assigned to receive once-weekly dulaglutide (1.5 mg) or once-daily liraglutide (1.mg). Randomisation was done according to a computer-generated random sequence with an interactive voice response system. Participants and investigators were not masked to treatment allocation. The primary outcome was non-inferiority (margin 0.4%) of dulaglutide compared with liraglutide for change in HbA(1c) (least-squares mean change from baseline) at 26 weeks. Safety data were collected for a further 4 weeks' follow-up. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT01624259. Findings We randomly assigned 599 patients to receive once-weekly dulaglutide (299 patients) or once-daily liraglutide (300 patients). 269 participants in each group completed treatment at week 26. Least-squares mean reduction in HbA(1c) was -1.42% (SE 0.05) in the dulaglutide group and -1.36% (0.05) in the liraglutide group. Mean treatment difference in HbA(1c) was -0.06% (95% CI -0.19 to 0.07, Pnon-inferiority<0.0001) between the two groups. The most common gastrointestinal adverse events were nausea (61 [20%] in dulaglutide group vs 54 [18%] in liraglutide group), diarrhoea (36 [12%] vs 36 [12%]), dyspepsia (24 [8%] vs 18 [6%]), and vomiting (21 [7%] vs 25 [8%]), with similar rates of study or study drug discontinuation because of adverse events between the two groups (18 [6%] in each group). The hypoglycaemia rate was 0.34 (SE 1.44) and 0.52 (3.01) events per patient per year, respectively, and no severe hypoglycaemia was reported. Interpretation Once-weekly dulaglutide is non-inferior to once-daily liraglutide for least-squares mean reduction in HbA(1c), with a similar safety and tolerability profile.	[Dungan, Kathleen M.] Ohio State Univ, Columbus, OH 43210 USA; [Tofe Povedano, Santiago] Clin Juaneda, Palma de Mallorca, Spain; [Forst, Thomas] Profil Mainz GmbH & Co KG, Mainz, Germany; [Gonzalez Gonzalez, Jose G.] Univ Autonoma Nuevo Leon, Monterrey, NL, Mexico; [Atisso, Charles; Sealls, Whitney; Fahrbach, Jessie L.] Eli Lilly & Co, Lilly Diabet, Indianapolis, IN 46285 USA	University System of Ohio; Ohio State University; Profil; Universidad Autonoma de Nuevo Leon; Eli Lilly	Dungan, KM (corresponding author), Ohio State Univ, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA.	kathleen.dungan@osumc.edu	Dungan, Kathleen/E-2999-2011	Gonzalez-Gonzalez, Jose Gerardo/0000-0002-6609-9483; TOFE, SANTIAGO/0000-0003-3034-4667	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	Eli Lilly and Company.	[Anonymous], 1997, JAMA-J AM MED ASSOC, V277, P925; Baggio LL, 2004, DIABETES, V53, P2492, DOI 10.2337/diabetes.53.9.2492; Barrington P, 2011, DIABETES OBES METAB, V13, P426, DOI 10.1111/j.1463-1326.2011.01364.x; Blevins T, 2011, J CLIN ENDOCR METAB, V96, P1301, DOI 10.1210/jc.2010-2081; Bolli GB, 2014, DIABETIC MED, V31, P176, DOI 10.1111/dme.12328; Brooks R., 2003, MEASUREMENT VALUATIO; Buse JB, 2013, LANCET, V381, P117, DOI 10.1016/S0140-6736(12)61267-7; Buse JB, 2011, ANN INTERN MED, V154, P103, DOI 10.7326/0003-4819-154-2-201101180-00300; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Childs BP, 2005, DIABETES CARE, V28, P1245; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; DeVries JH, 2012, DIABETES CARE, V35, P1446, DOI 10.2337/dc11-1928; Dmitrienko A, 2008, BIOMETRICAL J, V50, P667, DOI 10.1002/bimj.200710464; Dmitrienko A, 2006, BIOMETRICAL J, V48, P984, DOI 10.1002/bimj.200610274; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Ferdinand K, 2012, J CLIN HYPERTENS, V14, P488; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Garber AJ, 2014, LANCET DIABETES ENDO, V2, P266, DOI 10.1016/S2213-8587(14)70014-2; Glaesner W, 2010, DIABETES-METAB RES, V26, P287, DOI 10.1002/dmrr.1080; Hayes RP, 2012, DIABETES TECHNOL THE, V14, P1118, DOI 10.1089/dia.2012.0123; Hayes RP, 2011, DIABETES TECHNOL THE, V13, P705, DOI 10.1089/dia.2011.0027; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Lund A, 2014, EUR J INTERN MED, V25, P407, DOI 10.1016/j.ejim.2014.03.005; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Nauck M, 2014, DIABETES CARE, V37, P2149, DOI 10.2337/dc13-2761; Pratley RE, 2014, LANCET DIABETES ENDO, V2, P289, DOI 10.1016/S2213-8587(13)70214-6; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Steinberg W, 2012, GASTROENTEROLOGY, V142, pS850; Umpierrez G, 2014, DIABETES CARE, V37, P2168, DOI 10.2337/dc13-2759; Wysham C, 2014, DIABETES CARE, V37, P2159, DOI [10.2337/dc13-2760, 10.2337/dc15-er07b]; Zinman B, 2009, DIABETES CARE, V32, P1224, DOI 10.2337/dc08-2124	33	323	336	2	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2014	384	9951					1349	1357		10.1016/S0140-6736(14)60976-4	http://dx.doi.org/10.1016/S0140-6736(14)60976-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NH	25018121				2022-12-28	WOS:000343004000024
J	Deng, K; Siliciano, RF				Deng, Kai; Siliciano, Robert F.			Early treatment may not be early enough	NATURE			English	Editorial Material							ACTIVE ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; PRIMARY HIV-1 INFECTION; LATENT RESERVOIR; CESSATION		[Deng, Kai; Siliciano, Robert F.] Johns Hopkins Univ Sch Med, Dept Med, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Deng, K (corresponding author), Johns Hopkins Univ Sch Med, Dept Med, Baltimore, MD 21205 USA.		Deng, Kai/AAK-4404-2020	Deng, Kai/0000-0002-9973-8130				Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hill AL, 2014, P NATL ACAD SCI US; Hocqueloux L, 2013, J ANTIMICROB CHEMOTH, V68, P1169, DOI 10.1093/jac/dks533; Ledford H., 2014, NATURE; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Salgado M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-97; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594	16	15	15	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					35	36		10.1038/nature13647	http://dx.doi.org/10.1038/nature13647			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043038				2022-12-28	WOS:000339908000024
J	Gupta, S; Chai, J; Cheng, J; D'Mello, R; Chance, MR; Fu, D				Gupta, Sayan; Chai, Jin; Cheng, Jie; D'Mello, Rhijuta; Chance, Mark R.; Fu, Dax			Visualizing the kinetic power stroke that drives proton-coupled zinc(II) transport	NATURE			English	Article							MASS-SPECTROMETRY; METAL-BINDING; YIIP; SPECIFICITY; SELECTIVITY; MECHANISM; DYNAMICS; VESICLES; FAMILY; FIEF	The proton gradient is a principal energy source for respiration-dependent active transport, but the structural mechanisms of proton-coupled transport processes are poorly understood. YiiP is a proton-coupled zinc transporter found in the cytoplasmic membrane of Escherichia coli. Its transport site receives protons from water molecules that gain access to its hydrophobic environment and transduces the energy of an inward proton gradient to drive Zn(II) efflux(1,2). This membrane protein is a well characterized member3- 7 of the family of cation diffusion facilitators that occurs at all phylogenetic levels(8-10). Here we show, using X-ray-mediated hydroxyl radical labelling of YiiP and mass spectrometry, that Zn( II) binding triggers a highly localized, all-or-nothing change of water accessibility to the transport site and an adjacent hydrophobic gate. Milli-secondtime-resolved dynamics reveal a concerted and reciprocal pattern of accessibility changes along a trans membrane helix, suggesting a rigid-body helical re-orientation linked to Zn( II) binding that triggers the closing of the hydrophobic gate. The gated water access to the transport site enables a stationary proton gradient to facilitate the conversion of zinc-binding energy to the kinetic power stroke of a vectorial zinc transport. The kinetic details provide energetic insights intoaproton-coupled active-transport reaction.	[Gupta, Sayan; Cheng, Jie; D'Mello, Rhijuta] Case Western Reserve Univ, Ctr Synchrotron Biosci, Cleveland, OH 44109 USA; [Gupta, Sayan; D'Mello, Rhijuta; Chance, Mark R.] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44109 USA; [Chai, Jin; Fu, Dax] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Cheng, Jie; Fu, Dax] Johns Hopkins Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Case Western Reserve University; Case Western Reserve University; United States Department of Energy (DOE); Brookhaven National Laboratory; Johns Hopkins University; Johns Hopkins Medicine	Fu, D (corresponding author), Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.	mrc16@case.edu; dfu3@jhmi.edu		chai, jin/0000-0002-4760-5811; Fu, Dax/0000-0002-2663-1316	National Institutes of Health [R01GM065137]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DOE) [DE-AC02-98CH10886]; Physical Biosciences Program, Office of Basic Energy Sciences of the DOE; National Institute for Biomedical Imaging and Bioengineering [P30-EB-09998, R01-EB-09688]; DOE [DE-AC02-98CH10886]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998, R01EB009688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DOE)(United States Department of Energy (DOE)); Physical Biosciences Program, Office of Basic Energy Sciences of the DOE; National Institute for Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this work to the memory of Peter C. Maloney, who read and commented on a version of the manuscript. This work was supported in part by the National Institutes of Health under grant R01GM065137(to D.F.), the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DOE) under contract DE-AC02-98CH10886 (to D.F.); D.F. is primarily supported by the Physical Biosciences Program, Office of Basic Energy Sciences of the DOE and the National Institute for Biomedical Imaging and Bioengineering under grants P30-EB-09998 and R01-EB-09688 (to M.R.C.). The National Synchrotron Light Source at Brookhaven National Laboratory is supported by the DOE under contract DE-AC02-98CH10886.	Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Chao Y, 2004, J BIOL CHEM, V279, P17173, DOI 10.1074/jbc.M400208200; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Gupta S, 2007, J SYNCHROTRON RADIAT, V14, P233, DOI 10.1107/S0909049507013118; Gupta S, 2012, P NATL ACAD SCI USA, V109, P14882, DOI 10.1073/pnas.1209060109; Gupta S, 2010, STRUCTURE, V18, P839, DOI 10.1016/j.str.2010.04.012; Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048; Hoch E, 2012, P NATL ACAD SCI USA, V109, P7202, DOI 10.1073/pnas.1200362109; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kaur P, 2009, ANAL CHEM, V81, P8141, DOI 10.1021/ac9013644; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lin HL, 2009, BIOCHEM J, V422, P273, DOI 10.1042/BJ20090853; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Podar D, 2012, J BIOL CHEM, V287, P3185, DOI 10.1074/jbc.M111.305649; Ralston CY, 2000, METHOD ENZYMOL, V317, P353; RAMOS S, 1976, P NATL ACAD SCI USA, V73, P1892, DOI 10.1073/pnas.73.6.1892; Takamoto K, 2006, ANNU REV BIOPH BIOM, V35, P251, DOI 10.1146/annurev.biophys.35.040405.102050; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047	27	89	91	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					101	+		10.1038/nature13382	http://dx.doi.org/10.1038/nature13382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043033	Green Accepted			2022-12-28	WOS:000339908000040
J	Lloyd-Jones, GC; Ball, LT				Lloyd-Jones, Guy C.; Ball, Liam T.			Self-control tames the coupling of reactive radicals	SCIENCE			English	Editorial Material									[Lloyd-Jones, Guy C.; Ball, Liam T.] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	University of Edinburgh	Lloyd-Jones, GC (corresponding author), Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland.	guy.lloyd-jones@ed.ac.uk; liam.ball@ed.ac.uk		Ball, Liam/0000-0003-3849-9006; Lloyd-Jones, Guy/0000-0003-2128-6864				Cordier CJ, 2013, J AM CHEM SOC, V135, P10946, DOI 10.1021/ja4054114; Evans LA, 2012, ANGEW CHEM INT EDIT, V51, P1526, DOI 10.1002/anie.201106836; Jana R, 2011, CHEM REV, V111, P1417, DOI 10.1021/cr100327p; Lennox AJJ, 2012, J AM CHEM SOC, V134, P7431, DOI 10.1021/ja300236k; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176; Tellis JC, 2014, SCIENCE, V345, P433, DOI 10.1126/science.1253647; Zuo ZW, 2014, SCIENCE, V345, P437, DOI 10.1126/science.1255525	9	12	12	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					381	382		10.1126/science.1256755	http://dx.doi.org/10.1126/science.1256755			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061190	Green Accepted			2022-12-28	WOS:000339655100017
J	Smith, DR				Smith, David R.			A cloaking coating for murky media	SCIENCE			English	Editorial Material									[Smith, David R.] Duke Univ, Ctr Metamat & Integrated Plasmon, Durham, NC 27708 USA; [Smith, David R.] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA	Duke University; Duke University	Smith, DR (corresponding author), Duke Univ, Ctr Metamat & Integrated Plasmon, Durham, NC 27708 USA.	drsmith@ee.duke.edu	Smith, David R/E-4710-2012					Alu A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016623; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Schittny R, 2014, SCIENCE, V345, P427, DOI 10.1126/science.1254524; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Xu HY, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.054301; Zigoneanu L, 2014, NAT MATER, V13, P352, DOI [10.1038/NMAT3901, 10.1038/nmat3901]	6	15	15	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					384	385		10.1126/science.1256753	http://dx.doi.org/10.1126/science.1256753			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061192				2022-12-28	WOS:000339655100019
J	Canaud, G; Bienaime, F; Tabarin, F; Bataillon, G; Seilhean, D; Noel, LH; Dragon-Durey, MA; Snanoudj, R; Friedlander, G; Halbwachs-Mecarelli, L; Legendre, C; Terzi, F				Canaud, Guillaume; Bienaime, Frank; Tabarin, Fanny; Bataillon, Guillaume; Seilhean, Danielle; Noel, Laure-Helene; Dragon-Durey, Marie-Agnes; Snanoudj, Renaud; Friedlander, Gerard; Halbwachs-Mecarelli, Lise; Legendre, Christophe; Terzi, Fabiola			Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIBODY-MEDIATED REJECTION; POLYCYSTIC KIDNEY-DISEASE; SMOOTH-MUSCLE-CELLS; ANTI-BETA(2)-GLYCOPROTEIN-I ANTIBODIES; SYNDROME NEPHROPATHY; RAPAMYCIN; VASCULOPATHY; BETA(2)-GLYCOPROTEIN-I; ANGIOPLASTY	BACKGROUND Although thrombosis is considered the cardinal feature of the antiphospholipid syndrome, chronic vascular lesions are common, particularly in patients with life-threatening complications. In patients who require transplantation, vascular lesions often recur. The molecular pathways involved in the vasculopathy of the antiphospholipid syndrome are unknown, and adequate therapies are lacking. METHODS We used double immunostaining to evaluate pathway activation in the mammalian target of rapamycin complex (mTORC) and the nature of cell proliferation in the vessels of patients with primary or secondary antiphospholipid syndrome nephropathy. We also evaluated autopsy specimens from persons who had catastrophic antiphospholipid syndrome. The molecular pathways through which antiphospholipid antibodies modulate the mTORC pathway were evaluated in vitro, and potential pharmacologic inhibitors were also tested in vitro. Finally, we studied the effect of sirolimus in kidney-transplant recipients with the antiphospholipid syndrome. RESULTS The vascular endothelium of proliferating intrarenal vessels from patients with antiphospholipid syndrome nephropathy showed indications of activation of the mTORC pathway. In cultured vascular endothelial cells, IgG antibodies from patients with the antiphospholipid syndrome stimulated mTORC through the phosphatidy-l-inositol 3-kinase (PI3K)-AKT pathway. Patients with antiphospholipid syndrome nephropathy who required transplantation and were receiving sirolimus had no recurrence of vascular lesions and had decreased vascular proliferation on biopsy as compared with patients with antiphospholipid antibodies who were not receiving sirolimus. Among 10 patients treated with sirolimus, 7 (70%) had a functioning renal allograft 144 months after transplantation versus 3 of 27 untreated patients (11%). Activation of mTORC was also found in the vessels of autopsy specimens from patients with catastrophic antiphospholipid syndrome. CONCLUSIONS Our results suggest that the mTORC pathway is involved in the vascular lesions associated with the antiphospholipid syndrome.	[Canaud, Guillaume; Bienaime, Frank; Tabarin, Fanny; Friedlander, Gerard; Halbwachs-Mecarelli, Lise; Legendre, Christophe; Terzi, Fabiola] Univ Paris 05, INSERM, U1151, Inst Necker Enfants Malad,Sorbone Paris Cite, Paris, France; [Canaud, Guillaume; Snanoudj, Renaud; Legendre, Christophe] Hop Necker Enfants Malad, Serv Nephrol Transplantat Adultes, F-75015 Paris, France; [Bienaime, Frank; Friedlander, Gerard] Hop Necker Enfants Malad, Serv Explorat Fonct, F-75015 Paris, France; [Noel, Laure-Helene] Hop Necker Enfants Malad, Serv Anat & Cytol Pathol, F-75015 Paris, France; [Dragon-Durey, Marie-Agnes] Hop Necker Enfants Malad, Serv Immunol Biol, F-75015 Paris, France; [Bataillon, Guillaume; Seilhean, Danielle] Univ Paris 06, Hop Europeen Georges Pompidou, Hop Pitie Salpetriere, AP HP, Paris, France; [Bataillon, Guillaume; Seilhean, Danielle] Univ Paris 06, Neuropathol Lab, Hop Pitie Salpetriere, AP HP, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Terzi, F (corresponding author), Hop Necker Enfants Malad, INSERM, U1151, 6eme Etage,149 Rue Sevres, F-75015 Paris, France.	fabiola.terzi@inserm.fr	, Dragon-Durey/AGM-3653-2022; Snanoudj, Renaud/AAK-1294-2020; seilhean, danielle/O-6899-2018	Snanoudj, Renaud/0000-0002-6657-6235; Friedlander, Gerard/0000-0002-6854-4261; Bienaime, Frank/0000-0002-8666-2042; Dragon-Durey, Marie-Agnes/0000-0002-5809-8122; seilhean, danielle/0000-0003-3498-4602	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Funded by INSERM and others.	ALARCONSEGOVIA D, 1989, J RHEUMATOL, V16, P762; Allen KL, 2012, BLOOD, V119, P884, DOI 10.1182/blood-2011-03-344671; Basu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023919; Bayliss J, 2008, TRANSPLANTATION, V86, P991, DOI 10.1097/TP.0b013e318186d734; Canaud G, 2013, AM J TRANSPLANT, V13, P2179, DOI 10.1111/ajt.12319; Canaud G, 2010, AM J TRANSPLANT, V10, P1701, DOI 10.1111/j.1600-6143.2010.03152.x; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Daugas E, 2002, J AM SOC NEPHROL, V13, P42, DOI 10.1681/ASN.V13142; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; Eisen HJ, 2003, NEW ENGL J MED, V349, P847, DOI 10.1056/NEJMoa022171; Espinosa G, 2009, CURR OPIN PULM MED, V15, P413, DOI 10.1097/MCP.0b013e32832d0463; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Gallo R, 1999, CIRCULATION, V99, P2164, DOI 10.1161/01.CIR.99.16.2164; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Heydarkhan-Hagvall S, 2003, J CELL BIOCHEM, V89, P1250, DOI 10.1002/jcb.10583; HUGHSON MD, 1995, HUM PATHOL, V26, P716, DOI 10.1016/0046-8177(95)90218-X; Ivey ME, 2008, ATHEROSCLEROSIS, V199, P237, DOI 10.1016/j.atherosclerosis.2008.03.006; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lepin EJ, 2006, AM J TRANSPLANT, V6, P1560, DOI 10.1111/j.1600-6143.2006.01355.x; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Long BR, 2008, HEMATOL ONCOL CLIN N, V22, P79, DOI 10.1016/j.hoc.2007.10.002; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nochy D, 1999, J AM SOC NEPHROL, V10, P507; Poulton K, 2012, SEMIN ARTHRITIS RHEU, V41, P720, DOI 10.1016/j.semarthrit.2011.09.004; Qi YX, 2011, P NATL ACAD SCI USA, V108, P1908, DOI 10.1073/pnas.1019219108; Ramesh S, 2011, J CLIN INVEST, V121, P120, DOI 10.1172/JCI39828; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shi T, 2006, ARTHRITIS RHEUM-US, V54, P2558, DOI 10.1002/art.21968; Sousa JE, 2001, CIRCULATION, V104, P2007, DOI 10.1161/hc4201.098056; Stylianou K, 2011, NEPHROL DIAL TRANSPL, V26, P498, DOI 10.1093/ndt/gfq496; Tektonidou MG, 2004, ARTHRITIS RHEUM-US, V50, P2569, DOI 10.1002/art.20433; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WARNER LM, 1994, ARTHRITIS RHEUM, V37, P289, DOI 10.1002/art.1780370219; Zhang X, 2009, AM J TRANSPLANT, V9, P2459, DOI 10.1111/j.1600-6143.2009.02819.x	37	193	204	2	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					303	312		10.1056/NEJMoa1312890	http://dx.doi.org/10.1056/NEJMoa1312890			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7TY	25054716				2022-12-28	WOS:000339339800007
J	Cortez, NG; Cohen, IG; Kesselheim, AS				Cortez, Nathan G.; Cohen, I. Glenn; Kesselheim, Aaron S.			FDA Regulation of Mobile Health Technologies	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Cortez, Nathan G.] So Methodist Univ, Dedman Sch Law, Dallas, TX 75275 USA; [Cohen, I. Glenn] Harvard Univ, Sch Law, Cambridge, MA 02138 USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Program Regulat Therapeut & Law, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA	Southern Methodist University; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Cortez, NG (corresponding author), So Methodist Univ, Dedman Sch Law, Dallas, TX 75275 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Cortez, Nathan/0000-0002-2536-1297				A. Ohne Autor Fd, 2002, GEN PRINCIPLES SOFTW, V2.0; Abroms LC, 2011, AM J PREV MED, V40, P279, DOI 10.1016/j.amepre.2010.10.032; AgaMatrix, 2013, 510 K SUMM IBGSTAR B; Airstrip Technologies LP, 2009, 510 K SUMM AIRSTRIP; AliveCor, 2013, 510 K CLEAR LETT ALI; [Anonymous], CYB; [Anonymous], 2012, FCC CHAIRM JUL GEN P; [Anonymous], 2013, EX MMAS FDA HAS CLEA; Bilton N., 2010, NY TIMES; Blackburn M, 2012, COMMUNICATION; Carpenter D, 2010, REGUL GOV, V4, P383, DOI 10.1111/j.1748-5991.2010.01091.x; Cortez N., 2014, UC DAVIS LAW REV, V47, P101; Department of Health and Human Services, MHEALTH IN; Department of Veterans Affairs, MOB APP PTSD COACH; Dolan B., 2013, MOBIHEALTHNEWS  1126; FDA, 2005, GUID CONT PREM SUBM; FDA, MAUDE MAN US FAC DEV; Food and Drug Administration, 2011, PUBL WORKSH MOB MED; House Committee on Small Business, 2019, MOB MED APP ENTR CHA, P343; Kahn JG, 2010, HEALTH AFFAIR, V29, P254, DOI 10.1377/hlthaff.2009.0965; Kharif Olga, 2011, BLOOMBERG BUSIN 0929; Klonoff David C, 2013, J Diabetes Sci Technol, V7, P749; Micromedical Industries, 2002, 510 K SUMM POCKETVIE; Miller Claire Cain, 2013, NY TIMES; Mital M, 2013, COMMUNICATION; National Institutes of Health, BMI CALC; Nundy S, 2014, HEALTH AFFAIR, V33, P265, DOI 10.1377/hlthaff.2013.0589; Offit P.A, 2013, SENSE NONSENSE ALTER; Pfizer UK, 2011, DEAR DOCTOR LETT PFI; Pocket App Ltd, POCK DOCT LIT ITUNES; Research2Guidance, 2013, MOB HLTH MARK REP 20, V3; Rosser BA, 2011, J TELEMED TELECARE, V17, P308, DOI 10.1258/jtt.2011.101102; Senior K, 2011, LANCET ONCOL, V12, P429, DOI 10.1016/S1470-2045(11)70116-4; Sharp R., 2012, LACKING REGULATION M; Silver Spring, 2014, FDASIA HLTH IT REP P; Software MIM, 2011, 510 K SUMM SAF EFF M; Steinhubl SR, 2013, JAMA-J AM MED ASSOC, V310, P2395, DOI 10.1001/jama.2013.281078; Thompson BM, 2013, FDA REGULATION MOBIL; Topol EJ, 2012, CREATIVE DESTRUCTION; Wolf JA, 2013, JAMA DERMATOL, V149, P422, DOI 10.1001/jamadermatol.2013.2382; Yang YT, 2014, HEALTH AFFAIR, V33, P222, DOI 10.1377/hlthaff.2013.0958; Yu H, BMJ INNOV, V7, P637, DOI [10.1136/bmjinnov-2021-000713, DOI 10.1136/BMJINNOV-2021-000713]	42	145	148	2	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					372	379		10.1056/NEJMhle1403384	http://dx.doi.org/10.1056/NEJMhle1403384			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL7TY	25054722				2022-12-28	WOS:000339339800016
J	Reilly, BM				Reilly, Brendan M.			Don't Learn on Me - Are Teaching Hospitals Patient-Centered?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NATIONAL-SURVEY		Geisel Sch Med Dartmouth, Hanover, NH 03755 USA	Dartmouth College	Reilly, BM (corresponding author), Geisel Sch Med Dartmouth, Hanover, NH 03755 USA.							Berwick DM, 2009, HEALTH AFFAIR, V28, pW555, DOI 10.1377/hlthaff.28.4.w555; Drolet BC, 2012, NEW ENGL J MED, V366, DOI 10.1056/NEJMp1202848; Drolet BC, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMp1011413; Reilly BM, 2007, LANCET, V370, P705, DOI 10.1016/S0140-6736(07)61347-6; Shahian DM, 2012, ACAD MED, V87, P701, DOI 10.1097/ACM.0b013e318253676a	5	12	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					293	295		10.1056/NEJMp1405709	http://dx.doi.org/10.1056/NEJMp1405709			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL7TY	25054715				2022-12-28	WOS:000339339800003
J	Smith, JM				Smith, Jeanette M.			Woman With Child	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					320	321		10.1001/jama.2013.279629	http://dx.doi.org/10.1001/jama.2013.279629			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038331				2022-12-28	WOS:000339257800001
J	Choulet, F; Alberti, A; Theil, S; Glover, N; Barbe, V; Daron, J; Pingault, L; Sourdille, P; Couloux, A; Paux, E; Leroy, P; Mangenot, S; Guilhot, N; Le Gouis, J; Balfourier, F; Alaux, M; Jamilloux, V; Poulain, J; Durand, C; Bellec, A; Gaspin, C; Safar, J; Dolezel, J; Rogers, J; Vandepoele, K; Aury, JM; Mayer, K; Berges, H; Quesneville, H; Wincker, P; Feuillet, C				Choulet, Frederic; Alberti, Adriana; Theil, Sebastien; Glover, Natasha; Barbe, Valerie; Daron, Josquin; Pingault, Lise; Sourdille, Pierre; Couloux, Arnaud; Paux, Etienne; Leroy, Philippe; Mangenot, Sophie; Guilhot, Nicolas; Le Gouis, Jacques; Balfourier, Francois; Alaux, Michael; Jamilloux, Veronique; Poulain, Julie; Durand, Celine; Bellec, Arnaud; Gaspin, Christine; Safar, Jan; Dolezel, Jaroslav; Rogers, Jane; Vandepoele, Klaas; Aury, Jean-Marc; Mayer, Klaus; Berges, Helene; Quesneville, Hadi; Wincker, Patrick; Feuillet, Catherine			Structural and functional partitioning of bread wheat chromosome 3B	SCIENCE			English	Article							TRANSPOSABLE ELEMENTS; GENE DUPLICATION; GENOME SEQUENCE; COMPLEX GENOMES; DRAFT GENOME; EVOLUTION; RECOMBINATION; DIVERSITY; MAP; KARYOTYPE	We produced a reference sequence of the 1-gigabase chromosome 3B of hexaploid bread wheat. By sequencing 8452 bacterial artificial chromosomes in pools, we assembled a sequence of 774 megabases carrying 5326 protein-coding genes, 1938 pseudogenes, and 85% of transposable elements. The distribution of structural and functional features along the chromosome revealed partitioning correlated with meiotic recombination. Comparative analyses indicated high wheat-specific inter-and intrachromosomal gene duplication activities that are potential sources of variability for adaption. In addition to providing a better understanding of the organization, function, and evolution of a large and polyploid genome, the availability of a high-quality sequence anchored to genetic maps will accelerate the identification of genes underlying important agronomic traits.	[Choulet, Frederic; Theil, Sebastien; Glover, Natasha; Daron, Josquin; Pingault, Lise; Sourdille, Pierre; Paux, Etienne; Leroy, Philippe; Guilhot, Nicolas; Le Gouis, Jacques; Balfourier, Francois; Feuillet, Catherine] INRA, UMR1095, 5 Chemin Beaulieu, F-63039 Clermont Ferrand, France; [Choulet, Frederic; Theil, Sebastien; Glover, Natasha; Daron, Josquin; Pingault, Lise; Sourdille, Pierre; Paux, Etienne; Leroy, Philippe; Guilhot, Nicolas; Le Gouis, Jacques; Balfourier, Francois; Feuillet, Catherine] Univ Blaise Pascal, UMR1095, F-63039 Clermont Ferrand, France; [Alberti, Adriana; Barbe, Valerie; Couloux, Arnaud; Mangenot, Sophie; Poulain, Julie; Durand, Celine; Aury, Jean-Marc; Wincker, Patrick] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Genom, F-91000 Evry, France; [Alaux, Michael; Jamilloux, Veronique; Quesneville, Hadi] INRA Versailles, Res Unit Genom Info, UR1164, INRA, F-78026 Versailles, France; [Bellec, Arnaud; Berges, Helene] INRA, UPR 1258, Ctr Natl Ressources Genom Vegetales, F-31326 Castanet Tolosan, France; [Gaspin, Christine] INRA, Biometrie & Intelligence Artificielle, F-31326 Castanet Tolosan, France; [Safar, Jan; Dolezel, Jaroslav] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, CZ-78371 Olomouc, Czech Republic; [Rogers, Jane] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Vandepoele, Klaas] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Vandepoele, Klaas] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Mayer, Klaus] Helmholtz Zentrum Muenchen, Inst Bioinformat & Syst Biol, Munich Informat Ctr Prot Sequences, D-85764 Neuherberg, Germany; [Wincker, Patrick] CNRS, UMR 8030, F-91000 Evry, France; [Wincker, Patrick] Univ Evry, CP5706 Evry, Evry, France	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); CEA; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; The Genome Analysis Centre (TGAC); Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Choulet, F (corresponding author), INRA, UMR1095, 5 Chemin Beaulieu, F-63039 Clermont Ferrand, France.	frederic.choulet@clermont.inra.fr	Dolezel, Jaroslav/B-7716-2008; Quesneville, Hadi/AAG-1048-2020; Aury, Jean-Marc/N-1621-2019; Gaspin, Christine/B-6756-2015; Mayer, Klaus FX/M-7941-2015; Pingault, Lise/AAQ-8602-2020; Safar, Jan/G-1038-2014; Vandepoele, Klaas/E-7514-2010; Sourdille, Pierre/CAF-2780-2022; Alberti, Adriana/AAZ-2013-2021; Alberti, Adriana/E-7142-2017	Dolezel, Jaroslav/0000-0002-6263-0492; Quesneville, Hadi/0000-0003-3001-4908; Aury, Jean-Marc/0000-0003-1718-3010; Mayer, Klaus FX/0000-0001-6484-1077; Pingault, Lise/0000-0002-6149-1267; Vandepoele, Klaas/0000-0003-4790-2725; Alberti, Adriana/0000-0003-3372-9423; Alberti, Adriana/0000-0003-3372-9423; Poulain, Julie/0000-0002-8744-3116; BERGES, Helene/0000-0002-5492-1062; Couloux, Arnaud/0000-0003-2356-0062; Choulet, Frederic/0000-0003-1788-7288; Daron, Josquin/0000-0003-3914-5998; Paux, Etienne/0000-0002-3094-7129; Sourdille, Pierre/0000-0002-1027-2224; Jamilloux, Veronique/0000-0002-6898-4910; Alaux, Michael/0000-0001-9356-4072	French National Research Agency [ANR-09-GENM-025 3BSEQ]; France Agrimer; INRA BAP Biologie et Amelioration des Plantes division; European Commission research training program Marie-Curie Actions (FP7-MC-IIF-NoncollinearGenes); French Ministry of Research; Region Auvergne; Ghent University Multidisciplinary Research Partnership ["Bioinformatics: From nucleotides to networks"] [01MR0310W]; Czech Science Foundation [P501/12/G090]; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish; BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI	French National Research Agency(French National Research Agency (ANR)); France Agrimer; INRA BAP Biologie et Amelioration des Plantes division; European Commission research training program Marie-Curie Actions (FP7-MC-IIF-NoncollinearGenes); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Region Auvergne(Region Auvergne-Rhone-Alpes); Ghent University Multidisciplinary Research Partnership ["Bioinformatics: From nucleotides to networks"](Ghent University); Czech Science Foundation(Grant Agency of the Czech Republic); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the scientific advisory board (P. Schnable, S. Rounsley, D. Ware, J. Rogers, and K. Eversole) of the 3BSEQ project for fruitful discussions; K. Eversole for critical reading and editing of the manuscript; H. Rimbert, N. Cubizolles, and E. Rey for SNP marker discovery and genotyping; M. Kubalakova and J. Vrana for assistance with the preparation of DNA amplified from flow-sorted chromosome 3B; L. Couderc, A. Keliet, and S. Reboux for their support in database and system administration; and C. Poncet and the "Plateforme GENTYANE" for SNP genotyping. This work was supported by a grant from the French National Research Agency (ANR-09-GENM-025 3BSEQ), a grant from France Agrimer, and a grant (project DL-BLE) from the INRA BAP Biologie et Amelioration des Plantes division. N. G. is funded by a grant from the European Commission research training program Marie-Curie Actions (FP7-MC-IIF-NoncollinearGenes). J. Daron is funded by a grant from the French Ministry of Research. L. P. is funded by a grant from the Region Auvergne. K. V. is supported by the Ghent University Multidisciplinary Research Partnership ["Bioinformatics: From nucleotides to networks" (Project 01MR0310W)]. J. Dolezel is supported by the Czech Science Foundation (award no. P501/12/G090). The chromosome 3B BAC library and the pools of the MTP BAC clones are available upon request under a materials transfer agreement at the French Plant Genomic Center, INRA-Centre National de Ressources Genomiques Vegetales. Annotation data and browser are available at https://urgi.versailles.inra.fr/gb2/gbrowse/wheat_annot_3B. Sequences and annotations of the reference pseudomolecule and unassigned scaffolds have been deposited in ENA (project PRJEB4376) under accession numbers HG670306 and CBUC010000001 to CBUC010001450, respectively. RNA-Seq data were deposited under accession number ERP004714.	Akhunov ED, 2003, P NATL ACAD SCI USA, V100, P10836, DOI 10.1073/pnas.1934431100; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Baucom RS, 2009, GENOME RES, V19, P243, DOI 10.1101/gr.083360.108; Bhat PR, 2007, NUCLEIC ACIDS RES, V35, P2936, DOI 10.1093/nar/gkm148; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Charles M, 2008, GENETICS, V180, P1071, DOI 10.1534/genetics.108.092304; Chen J., 2012, PARAMETRIC STATISTIC; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Evans J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079192; Feuillet C, 2011, TRENDS PLANT SCI, V16, P77, DOI 10.1016/j.tplants.2010.10.005; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; Goffinet B, 2000, GENETICS, V155, P463; Gottlieb A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054101; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Leroy P, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00005; Li BC, 2013, PLANT J, V73, P952, DOI 10.1111/tpj.12086; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Lu C, 2012, MOL BIOL EVOL, V29, P1005, DOI 10.1093/molbev/msr282; LUKASZEWSKI AJ, 1993, THEOR APPL GENET, V86, P121, DOI 10.1007/BF00223816; Marx V, 2013, NATURE, V501, P263, DOI 10.1038/501261a; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Murat F, 2010, GENOME RES, V20, P1545, DOI 10.1101/gr.109744.110; Pan QC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052777; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Paux E, 2010, PLANT BIOTECHNOL J, V8, P196, DOI 10.1111/j.1467-7652.2009.00477.x; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Rustenholz C, 2011, PLANT PHYSIOL, V157, P1596, DOI 10.1104/pp.111.183921; Safar J, 2004, PLANT J, V39, P960, DOI 10.1111/j.1365-313X.2004.02179.x; Saintenac C, 2009, GENETICS, V181, P393, DOI 10.1534/genetics.108.097469; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sekhon RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061005; Sergeeva EM, 2010, MOL GENET GENOMICS, V284, P11, DOI 10.1007/s00438-010-0544-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Wicker T, 2010, GENOME RES, V20, P1229, DOI 10.1101/gr.107284.110; Wilson ID, 2004, PLANT BIOTECHNOL J, V2, P495, DOI 10.1111/j.1467-7652.2004.00096.x; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yan HH, 2008, PLOS BIOL, V6, P2563, DOI 10.1371/journal.pbio.0060286; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang H, 2012, CHROMOSOME RES, V20, P403, DOI 10.1007/s10577-012-9284-1; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	56	388	408	1	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194			SI				1249721	10.1126/science.1249721	http://dx.doi.org/10.1126/science.1249721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR2MB	25035497	Green Submitted			2022-12-28	WOS:000343420300001
J	Lucas, D; Frenette, PS				Lucas, Daniel; Frenette, Paul S.			STEM CELLS Reprogramming finds its niche	NATURE			English	Editorial Material							BLOOD		[Lucas, Daniel] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA	University of Michigan System; University of Michigan; Yeshiva University; Albert Einstein College of Medicine	Lucas, D (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	paul.frenette@einstein.yu.edu	Frenette, Paul S/J-8272-2012; Lucas, Daniel/ABB-6893-2021	Frenette, Paul S/0000-0003-0862-9922; Lucas, Daniel/0000-0002-0147-5425	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438, R01HL097819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL097819, R01 HL069438] Funding Source: Medline; NIDDK NIH HHS [R01 DK056638] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Butler JM, 2012, BLOOD, V120, P1344, DOI 10.1182/blood-2011-12-398115; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Pfaff N, 2013, CELL STEM CELL, V13, P131, DOI 10.1016/j.stem.2013.07.007; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Sandler VM, 2014, NATURE, V511, P312, DOI 10.1038/nature13547; Sturgeon CM, 2013, NAT BIOTECHNOL, V31, P416, DOI 10.1038/nbt.2571; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	7	4	6	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					301	302		10.1038/nature13516	http://dx.doi.org/10.1038/nature13516			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030164	Green Accepted			2022-12-28	WOS:000338992200025
J	Meyer, M				Meyer, Michelle			Misjudgements will drive social trials underground	NATURE			English	Editorial Material									Icahn Sch Med Mt Sinai, Union Grad Coll, Bioeth Program, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Union College	Meyer, M (corresponding author), Icahn Sch Med Mt Sinai, Union Grad Coll, Bioeth Program, New York, NY 10029 USA.	michellenmeyer@gmail.com							0	14	14	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					265	265		10.1038/511265a	http://dx.doi.org/10.1038/511265a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL2YR	25030132	Bronze			2022-12-28	WOS:000338992200004
J	Kroenke, K; Krebs, EE; Wu, JW; Yu, ZS; Chumbler, NR; Bair, MJ				Kroenke, Kurt; Krebs, Erin E.; Wu, Jingwei; Yu, Zhangsheng; Chumbler, Neale R.; Bair, Matthew J.			Telecare Collaborative Management of Chronic Pain in Primary Care A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MUSCULOSKELETAL PAIN; COMPARATIVE RESPONSIVENESS; DEPRESSION; THERAPY; CANCER	IMPORTANCE Chronic musculoskeletal pain is among the most prevalent, costly, and disabling medical disorders. However, few clinical trials have examined interventions to improve chronic pain in primary care. OBJECTIVE To determine the effectiveness of a telecare intervention for chronic pain. DESIGN, SETTING, AND PARTICIPANTS The Stepped Care to Optimize Pain Care Effectiveness (SCOPE) study was a randomized trial comparing a telephone-delivered collaborative care management intervention vs usual care in 250 patients with chronic (>= 3 months) musculoskeletal pain of at least moderate intensity (Brief Pain Inventory [BPI] score >= 5). Patients were enrolled from 5 primary care clinics in a single Veterans Affairs medical center from June 2010 through May 2012, with 12-month follow-up completed by June 2013. INTERVENTIONS Patients were randomized either to an intervention group (n = 124) or to a usual care group whose members received all pain care as usual from their primary care physicians (n = 126). The intervention group received 12 months of telecare management that coupled automated symptom monitoring with an algorithm-guided stepped care approach to optimizing analgesics. MAIN OUTCOMES AND MEASURES Primary outcome was the BPI total score, which ranges from 0 ("no pain") to 10 ("pain as bad as you can imagine") and for which a 1-point change is considered clinically important. Secondary pain outcomes included BPI interference and severity, global pain improvement, treatment satisfaction, and use of opioids and other analgesics. RESULTS Overall, mean (SD) baseline BPI scores in the intervention and control groups were 5.31 (1.81) and 5.12 (1.80), respectively. Compared with usual care, the intervention group had a 1.02-point lower (95% CI, -1.58 to -0.47) BPI score at 12 months (3.57 vs 4.59). Patients in the intervention group were nearly twice as likely to report at least a 30% improvement in their pain score by 12 months (51.7% vs 27.1%; relative risk, 1.9 [95% CI, 1.4 to 2.7]), with a number needed to treat of 4.1 (95% CI, 3.0 to 6.4) for a 30% improvement. Secondary pain outcomes also improved. Few patients in either group required opioid initiation or dose escalation. CONCLUSIONS AND RELEVANCE Telecare collaborative management increased the proportion of primary care patients with improved chronic musculoskeletal pain. This was accomplished by optimizing nonopioid analgesic medications using a stepped care algorithm and monitoring. Copyright 2014 American Medical Association. All rights reserved.	[Kroenke, Kurt; Bair, Matthew J.] Roudebush VA Med Ctr, VA HSR&D Ctr Hlth Informat & Commun, Indianapolis, IN USA; [Kroenke, Kurt; Bair, Matthew J.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Kroenke, Kurt; Bair, Matthew J.] Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA; [Krebs, Erin E.] Minneapolis VA Hlth Care Syst, VA HSR&D Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Krebs, Erin E.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Wu, Jingwei; Yu, Zhangsheng] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Chumbler, Neale R.] Univ Georgia, Coll Publ Hlth, Dept Hlth Policy & Management, Athens, GA 30602 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Indiana University System; Indiana University Bloomington; University System of Georgia; University of Georgia	Kroenke, K (corresponding author), Regenstrief Inst Hlth Care, 1050 Wishard Blvd,Fifth Floor, Indianapolis, IN 46202 USA.	kkroenke@regenstrief.org	Wu, Jing/GZK-5063-2022	Krebs, Erin/0000-0003-0843-7410; Kroenke, Kurt/0000-0002-0114-4669	Department of Veterans Affairs (VA) Health Services Research and Development (VA HSR&D) Merit Review award [IIR 07-119]; VA Career Development Award [CDA 07-215]	Department of Veterans Affairs (VA) Health Services Research and Development (VA HSR&D) Merit Review award; VA Career Development Award	This work was supported by a Department of Veterans Affairs (VA) Health Services Research and Development (VA HSR&D) Merit Review award to Dr Kroenke (IIR 07-119) and a VA Career Development Award to Dr Krebs (CDA 07-215).	Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Curatolo M, 2001, CLIN J PAIN, V17, P25, DOI 10.1097/00002508-200103000-00005; Dobscha SK, 2009, JAMA-J AM MED ASSOC, V301, P1242, DOI 10.1001/jama.2009.377; Dowell D, 2013, JAMA-J AM MED ASSOC, V309, P2219, DOI 10.1001/jama.2013.5794; Du SZ, 2011, PATIENT EDUC COUNS, V85, pE299, DOI 10.1016/j.pec.2011.02.021; Dunn KM, 2008, PAIN, V135, P48, DOI 10.1016/j.pain.2007.05.001; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Gilbody S, 2008, CAN MED ASSOC J, V178, P997, DOI 10.1503/cmaj.070281; Jackson JL, 2006, CNS SPECTRUMS, V11, P212, DOI 10.1017/S1092852900014383; Joint Commission on Accreditation of Healthcare Organizations, 2000, PAIN ASS MAN ORG APP; Kamaleri Y, 2009, PAIN, V141, P25, DOI 10.1016/j.pain.2008.09.013; Katon W, 2010, GEN HOSP PSYCHIAT, V32, P456, DOI 10.1016/j.genhosppsych.2010.04.001; Krebs EE, 2010, MED CARE, V48, P1007, DOI 10.1097/MLR.0b013e3181eaf835; Krebs EE, 2009, J GEN INTERN MED, V24, P733, DOI 10.1007/s11606-009-0981-1; Kroenke K, 2003, INT J METH PSYCH RES, V12, P34, DOI 10.1002/mpr.140; Kroenke K, 2013, CONTEMP CLIN TRIALS, V34, P270, DOI 10.1016/j.cct.2012.11.008; Kroenke K, 2012, J PAIN, V13, P764, DOI 10.1016/j.jpain.2012.05.004; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Kroenke K, 2010, JAMA-J AM MED ASSOC, V304, P163, DOI 10.1001/jama.2010.944; Kroenke K, 2009, GEN HOSP PSYCHIAT, V31, P206, DOI 10.1016/j.genhosppsych.2008.12.006; Kroenke K, 2009, JAMA-J AM MED ASSOC, V301, P2099, DOI 10.1001/jama.2009.723; Mallinckrodt CH, 2001, DRUG INF J, V35, P1215, DOI 10.1177/009286150103500418; McGeary DD, 2012, PAIN PRACT, V12, P570, DOI 10.1111/j.1533-2500.2012.00534.x; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Panel on Musculoskeletal Disorders and the Workplace Institute of Medicine, 2000, MUSC DIS WORKPL LOW; Schappert S M, 1992, Vital Health Stat 13, P1; Smith BH, 2001, FAM PRACT, V18, P292, DOI 10.1093/fampra/18.3.292; Tan G, 2007, J REHABIL RES DEV, V44, P195, DOI 10.1682/JRRD.2006.06.0063; Trivedi MH, 2009, J CLIN PSYCHIAT, V70, P26, DOI 10.4088/JCP.8133su1c.04; Turk DC, 2002, CLIN J PAIN, V18, P355, DOI 10.1097/00002508-200211000-00003; Von Korff M, 2011, ANN INTERN MED, V155, P325, DOI 10.7326/0003-4819-155-5-201109060-00011	31	109	110	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					240	248		10.1001/jama.2014.7689	http://dx.doi.org/10.1001/jama.2014.7689			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL2FC	25027139	Bronze			2022-12-28	WOS:000338940300021
J	Peul, WC; Bredenoord, AL; Jacobs, WCH				Peul, Wilco C.; Bredenoord, Annelien L.; Jacobs, Wilco C. H.			CHANGE PAGE Avoid surgery as first line treatment for non-specific low back pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT; FUSION; TRENDS; DISC		[Peul, Wilco C.; Jacobs, Wilco C. H.] Leiden Univ, Med Ctr, Dept Neurosurg, NL-2300 RC Leiden, Netherlands; [Peul, Wilco C.] Med Ctr Haaglanden, Dept Neurosurg, NL-2501 CK The Hague, Netherlands; [Bredenoord, Annelien L.] Univ Med Ctr Utrecht, Julius Ctr, Dept Med Humanities, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haaglanden Medical Center; Utrecht University; Utrecht University Medical Center	Peul, WC (corresponding author), Leiden Univ, Med Ctr, Dept Neurosurg, POB 9600, NL-2300 RC Leiden, Netherlands.	w.c.peul@lumc.nl						Boos N, 1995, SPINE, V20, P2613, DOI 10.1097/00007632-199512150-00002; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Chou R, 2009, SPINE, V34, P1094, DOI 10.1097/BRS.0b013e3181a105fc; Deyo RA, 2006, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000198726.62514.75; GALBRAITH S, 1978, J MED ETHICS, V4, P61, DOI 10.1136/jme.4.2.61; Helm S, 2012, PAIN PHYSICIAN, V15, pE279; Jacobs W., 2012, COCHRANE DB SYST REV, V9; Jacobs WCH, 2006, EUR SPINE J, V15, P391, DOI 10.1007/s00586-005-1021-4; Jacobs WCH, 2011, EUR SPINE J, V20, P513, DOI 10.1007/s00586-010-1603-7; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kovacs FM, 2011, SPINE, V36, pE1335, DOI 10.1097/BRS.0b013e31820c97b1; London AJ, 2013, ETHICAL GUIDELIBES I; May S, 2013, PHYSIOTHERAPY, V99, P12, DOI 10.1016/j.physio.2011.12.004; Moojen WA, 2011, EUR SPINE J, V20, P1596, DOI 10.1007/s00586-011-1873-8; Pumberger M, 2012, J BONE JOINT SURG BR, V94B, P359, DOI 10.1302/0301-620X.94B3.27825; Rajaee SS, 2012, SPINE, V37, P67, DOI 10.1097/BRS.0b013e31820cccfb; Savigny P, 2009, NATL COLLABORATION C; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2	19	6	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 16	2014	349								g4214	10.1136/bmj.g4214	http://dx.doi.org/10.1136/bmj.g4214			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7PE	25030631				2022-12-28	WOS:000339326000001
J	Wood, E; Kerr, T; Rowell, G; Montaner, JSG; Phillips, P; Korthuis, PT; Simel, DL				Wood, Evan; Kerr, Thomas; Rowell, Greg; Montaner, Julio S. G.; Phillips, Peter; Korthuis, P. Todd; Simel, David L.			Does This Adult Patient Have Early HIV Infection? The Rational Clinical Examination Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; SEROCONVERSION ILLNESS; PRIMARY-CARE; RISK; LYMPHADENOPATHY; TRANSMISSION; PREVALENCE; SYMPTOMS; MEN; RECOMMENDATIONS	IMPORTANCE Timely identification of human immunodeficiency virus (HIV) infection in adults can contribute to reduced mortality and likelihood of further HIV transmission. During the first 6 months after infection, known as early HIV infection, patients often report a well-described constellation of symptoms and signs. However, the literature examining utility of the clinical examination in identifying early infection has not been systematically assessed. OBJECTIVE To assess the accuracy of symptoms and signs in identifying early HIV infection among adults. DATA SOURCES We searched MEDLINE and EMBASE (1981-May, 2014) for articles investigating symptoms and signs of early HIV infection in adults and searched reference lists of retrieved articles. STUDY SELECTION We retained original studies that compared symptoms and signs among patients with early HIV infection in comparison to HIV-negative individuals. DATA EXTRACTION AND SYNTHESIS Datawere extracted and used to calculate sensitivity, specificity, and likelihood ratios (LRs), and meta-analysis was used to calculate summary LRs. RESULTS Of 1356 studies, 16 studies included data that were eligible formeta-analysis and included a total of 24 745 patients and 1253 cases of early HIV infection. Symptoms that increased the likelihood of early HIV infection the most included genital ulcers (LR, 5.4; 95% CI, 2.5-12), weight loss (LR, 4.7; 95% CI, 2.1-7.2), vomiting (LR, 4.6; 95% CI, 2.5-8.0), and swollen lymph nodes (LR, 4.6; 95% CI, 1.3-8.0). No symptoms had an LR that was 0.5 or lower, but the absence of recent fever (LR, 0.74; 95% CI, 0.64-0.84) slightly decreased the likelihood of early HIV infection. The presence of lymphadenopathy on physical examination was the most useful sign (LR, 3.1; 95% CI, 1.0-5.2). No sign had an LR of 0.5 or less, but the absence of lymphadenopathy slightly decreased the likelihood of early HIV infection (LR, 0.70, 95% CI, 0.49-0.92). Using data from studies that considered combinations of findings (range of possible findings, 4-17), the summary LR for individuals with 0 findings was 0.47 (95% CI, 0.38-0.58). CONCLUSIONS AND RELEVANCE The limited utility of the clinical examination to detect or rule out early HIV infection highlights the importance of routine testing for HIV infection among adults. Copyright 2014 American Medical Association. All rights reserved.	[Wood, Evan; Kerr, Thomas; Montaner, Julio S. G.; Phillips, Peter] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Wood, Evan; Kerr, Thomas; Montaner, Julio S. G.; Phillips, Peter] Univ British Columbia, Dept Med, Vancouver, BC V6Z 1Y6, Canada; [Rowell, Greg] Fraser Hlth Author, Clin Policy Off, Vancouver, BC, Canada; [Korthuis, P. Todd] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Korthuis, P. Todd] Oregon Hlth & Sci Univ, Dept Publ Hlth Prevent Med, Portland, OR 97201 USA; [Simel, David L.] Durham Vet Affairs Med Ctr, Durham, NC USA; [Simel, David L.] Duke Univ, Med Ctr, Durham, NC USA	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Wood, E (corresponding author), Univ British Columbia, Div Aids, Canada Res Chair Inner City Med, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	uhri-ew@cfenet.ubc.ca		Korthuis, Philip/0000-0001-5556-3597	Canadian Institutes of Health Research New Investigator Award; Michael Smith Foundation for Health Research Scholar Award; Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine - National Institutes of Health [R01DA021525]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021525] Funding Source: NIH RePORTER	Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research Scholar Award(Michael Smith Foundation for Health Research); Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine - National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr Kerr is supported by a Canadian Institutes of Health Research New Investigator Award and by a Michael Smith Foundation for Health Research Scholar Award. This research was undertaken, in part, thanks to funding from the Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine, which supports Dr Wood, who also was supported by grant R01DA021525 from the National Institutes of Health.	[Anonymous], DIAGN HIV INF US DEP; Bollinger RC, 1997, JAMA-J AM MED ASSOC, V278, P2085, DOI 10.1001/jama.278.23.2085; Borenstein M., 2009, INTROD MAGN MAT, P277, DOI [DOI 10.1002/9780470743386.CH30, 10.1002/9780470743386.ch30, DOI 10.1002/9780470386323.FMATTER]; BOYKO WJ, 1987, CAN MED ASSOC J, V137, P109; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Caponetti G, 2008, ENT-EAR NOSE THROAT, V87, P374, DOI 10.1177/014556130808700706; Centers for Disease Control and Prevention, 2012, HIV SURVEILLANCE S, V17; Centers for Disease Control and Prevention, 2013, HIV US GLANC; Centers for Disease Control and Prevention, 2012, HIV SURVEILLANCE S A, V17; COATES RA, 1988, J CLIN EPIDEMIOL, V41, P267, DOI 10.1016/0895-4356(88)90131-X; Coco A, 2005, ANN FAM MED, V3, P400, DOI 10.1370/afm.376; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Daar ES, 2008, CURR OPIN HIV AIDS, V3, P10, DOI 10.1097/COH.0b013e3282f2e295; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dombrowski JC, 2013, SEX TRANSM DIS, V40, P41, DOI 10.1097/OLQ.0b013e3182753327; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Ellis S, 2012, CLIN MED, V12, P430, DOI 10.7861/clinmedicine.12-5-430; Fontaine A, 1999, J PAIN SYMPTOM MANAG, V18, P263, DOI 10.1016/S0885-3924(99)00078-0; Fox PA, 1999, SEX TRANSM INFECT, V75, P133; FOX R, 1987, AIDS, V1, P35; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Haynes RB, 2005, BMJ-BRIT MED J, V330, P1179, DOI 10.1136/bmj.38446.498542.8F; Herrin J, 2013, PUBLIC HEALTH REP, V128, P161, DOI 10.1177/003335491312800306; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hofer CB, 2000, J ACQ IMMUN DEF SYND, V25, P188, DOI 10.1097/00126334-200010010-00014; Hsu DTS, 2013, HIV MED, V14, P60, DOI 10.1111/j.1468-1293.2012.01023.x; Jia ZW, 2013, LANCET, V382, P1195, DOI 10.1016/S0140-6736(12)61898-4; Joint United Nations Programme on HIV/AIDS, GLOB REP UNAIDS REP; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; KRAMER A, 1992, AM J EPIDEMIOL, V136, P71; Lavreys L, 2000, CLIN INFECT DIS, V30, P486, DOI 10.1086/313718; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Marmor M, 1996, J ACQ IMMUN DEF SYND, V12, P514, DOI 10.1097/00042560-199608150-00012; McKellar MS, 2013, AIDS RES HUM RETROV, V29, P121, DOI [10.1089/aid.2012.0064, 10.1089/AID.2012.0064]; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MIENTJES GHC, 1993, BRIT MED J, V306, P371, DOI 10.1136/bmj.306.6874.371; Mlisana K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062928; Morgan D, 2001, AIDS, V15, P1575, DOI 10.1097/00002030-200108170-00016; Morrison CS, 2013, J INT ASS PROVID AID; Motyckova G, 2012, HEMATOL ONCOL CLIN N, V26, P395, DOI 10.1016/j.hoc.2012.02.005; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; PAAUW DS, 1995, JAMA-J AM MED ASSOC, V274, P1380, DOI 10.1001/jama.274.17.1380; PHILLIPS AN, 1992, JAMA-J AM MED ASSOC, V268, P2662, DOI 10.1001/jama.268.19.2662; Pilcher CD, 2004, AIDS, V18, P517, DOI 10.1097/00002030-200402200-00019; Pilcher CD, 2002, JAMA-J AM MED ASSOC, V288, P216, DOI 10.1001/jama.288.2.216; Pincus JM, 2003, CLIN INFECT DIS, V37, P1699, DOI 10.1086/379772; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Richey LE, 2013, AM J MED SCI, V345, P136, DOI 10.1097/MAJ.0b013e31825d4b88; Sanchez J, 2009, JAIDS-J ACQ IMM DEF, V51, pS47, DOI 10.1097/QAI.0b013e3181a2671d; SCHMID GP, 1990, MED CLIN N AM, V74, P1559, DOI 10.1016/S0025-7125(16)30495-3; Sharghi N, 2005, JAIDS-J ACQ IMM DEF, V40, P472, DOI 10.1097/01.qai.0000164246.49098.47; Simel DL, 2013, J CLIN EPIDEMIOL, V66, P458, DOI 10.1016/j.jclinepi.2012.07.014; Simel DL, 2009, J CLIN EPIDEMIOL, V62, P1292, DOI 10.1016/j.jclinepi.2009.02.007; Simel DL, 2008, RATIONAL CLIN EXAMIN, P9; Sullivan PS, 2012, AIDS, V26, P175, DOI 10.1097/QAD.0b013e32834ed8c8; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; United Nations Program on HIV/AIDS (UNAIDS), 2012, REP GLOB HIV AIDS EP; Vanhems P, 2002, JAIDS-J ACQ IMM DEF, V31, P318, DOI 10.1097/00126334-200211010-00007; Vanhems P, 1997, CLIN INFECT DIS, V24, P965, DOI 10.1093/clinids/24.5.965; Vanhems P, 1998, CLIN INFECT DIS, V26, P323, DOI 10.1086/516289; Wahome E, 2013, AIDS, V27, P2163, DOI 10.1097/QAD.0b013e3283629095; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; Wood Evan, 2009, BMJ, V338, pb1649, DOI 10.1136/bmj.b1649; World Health Organization, DAT SIZ HIV AIDS EP; Yerly S, 2012, EXPERT REV ANTI-INFE, V10, P31, DOI [10.1586/eri.11.154, 10.1586/ERI.11.154]; Zetola NM, 2008, PUBLIC HEALTH REP, V123, P41, DOI 10.1177/00333549081230S306; Zetola NM, 2009, JAIDS-J ACQ IMM DEF, V50, P546, DOI 10.1097/QAI.0b013e318195bd2b	71	26	28	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					278	285		10.1001/jama.2014.5954	http://dx.doi.org/10.1001/jama.2014.5954			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	25027143				2022-12-28	WOS:000338940300025
J	Thompson, KM				Thompson, Kimberly M.			Polio endgame management: focusing on performance with or without inactivated poliovirus vaccine	LANCET			English	Editorial Material							IMMUNITY		Univ Cent Florida, Coll Med, Orlando, FL 32827 USA	State University System of Florida; University of Central Florida	Thompson, KM (corresponding author), Univ Cent Florida, Coll Med, Orlando, FL 32827 USA.	kimt@kidrisk.org		Thompson, Kimberly/0000-0002-0849-9147				Anis E, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.38.20586; [Anonymous], 2014, DET POL SEW; Duintjer Tebbens RJ, 2014, J INFECT DI IN PRESS; Estivariz CF, 2012, LANCET INFECT DIS, V12, P128, DOI 10.1016/S1473-3099(11)70190-6; Independent Monitoring Board of the Global Polio Eradication Initiative, 2014, 9 GLOB POL ER IN IND; John J, 2014, LANCET; Kalkowska D, 2014, J INFECT DI IN PRESS; Tebbens RJD, 2013, RISK ANAL, V33, P544, DOI 10.1111/j.1539-6924.2012.01864.x; Tebbens RJD, 2013, RISK ANAL, V33, P703, DOI 10.1111/risa.12044; The Global Polio Eradication Initiative, 2013, YEAR TYP 3 COULT TYP; Thompson KM, 2014, EXPERT REV VACCINES, V13, P221, DOI 10.1586/14760584.2014.864563; Thompson KM, 2013, RISK ANAL, V33, P647, DOI 10.1111/j.1539-6924.2012.01891.x; Thompson KM, 2013, RISK ANAL, V33, P516, DOI 10.1111/risa.12019	13	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2014	384	9953					1480	1482		10.1016/S0140-6736(14)60983-1	http://dx.doi.org/10.1016/S0140-6736(14)60983-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9MO	25018123				2022-12-28	WOS:000343899600005
J	Cobb, JP				Cobb, Justin P.			Patient safety after partial and total knee replacement	LANCET			English	Editorial Material							JOINT REGISTRY; ARTHROPLASTY; SURVIVAL; REVISION; TRIAL; GAIT		[Cobb, Justin P.] Univ London Imperial Coll Sci Technol & Med, Sect Orthopaed, London W6 8RP, England; [Cobb, Justin P.] Univ London Imperial Coll Sci Technol & Med, MSk Lab, London W6 8RP, England	Imperial College London; Imperial College London	Cobb, JP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sect Orthopaed, Charing Cross Campus, London W6 8RP, England.	j.cobb@imperial.ac.uk		cobb, justin/0000-0002-6095-8822				Andrews BA, 2014, AM AC ORTH SURG 2014; Baker PN, 2012, J BONE JOINT SURG BR, V94B, P919, DOI 10.1302/0301-620X.94B7.28436; Baker Paul N, 2012, J Bone Joint Surg Am, V94, pe126; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Felson DT, 2008, J RHEUMATOL, V35, P2047; FISHER B, 1985, NEW ENGL J MED, V312, P674, DOI 10.1056/NEJM198503143121102; Goodfellow JW, 2010, J BONE JOINT SURG BR, V92B, P1628, DOI 10.1302/0301-620X.92B12.25193; Hunt LP, 2014, LANCET; Hunt LP, 2013, LANCET; KNUTSON K, 1994, ACTA ORTHOP SCAND, V65, P375, DOI 10.3109/17453679408995475; Liddle AD, 2014, LANCET; National Joint Registry for England and Wales, 2013, 10 NJR; Newman J, 2009, J BONE JOINT SURG BR, V91B, P52, DOI 10.1302/0301-620X.91B1.20899; Noble PC, 2005, CLIN ORTHOP RELAT R, P157, DOI 10.1097/01.blo.0000150130.03519.fb; Pearse AJ, 2010, J BONE JOINT SURG BR, V92B, P508, DOI 10.1302/0301-620X.92B4.22659; Price AJ, 2011, CLIN ORTHOP RELAT RE; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; W-Dahl A, 2010, ACTA ORTHOP, V81, P90, DOI 10.3109/17453671003587150; Wiik AV, 2013, J ARTHROPLASTY, V28, P176, DOI 10.1016/j.arth.2013.07.036; Willis-Owen CA, 2009, KNEE, V16, P473, DOI 10.1016/j.knee.2009.04.006	20	12	12	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2014	384	9952					1405	1407		10.1016/S0140-6736(14)60885-0	http://dx.doi.org/10.1016/S0140-6736(14)60885-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ8TV	25012117	Green Submitted			2022-12-28	WOS:000343107000005
J	Zhang, QF; Siegel, TN; Martins, RM; Wang, F; Cao, J; Gao, Q; Cheng, X; Jiang, LB; Hon, CC; Scheidig-Benatar, C; Sakamoto, H; Turner, L; Jensen, ATR; Claes, A; Guizetti, J; Malmquist, NA; Scherf, A				Zhang, Qingfeng; Siegel, T. Nicolai; Martins, Rafael M.; Wang, Fei; Cao, Jun; Gao, Qi; Cheng, Xiu; Jiang, Lubin; Hon, Chung-Chau; Scheidig-Benatar, Christine; Sakamoto, Hiroshi; Turner, Louise; Jensen, Anja T. R.; Claes, Aurelie; Guizetti, Julien; Malmquist, Nicholas A.; Scherf, Artur			Exonuclease-mediated degradation of nascent RNA silences genes linked to severe malaria	NATURE			English	Article							MUTUALLY EXCLUSIVE EXPRESSION; ANTIGENIC VARIATION; VIRULENCE GENES; PLASMODIUM; EXORIBONUCLEASE; TRANSCRIPTION; DOMAINS; BINDING; SUBSET; SHOWS	Antigenic variation of the Plasmodium falciparum multicopy vargene family enables parasite evasion of immune destruction by host antibodies(1),(2). Expression of a particularvar subgroup, termed upsA, is linked to the obstruction of blood vessels in the brain and to the pathogenesis of human cerebralmalaria(3-6). The mechanism determining upsA activation remains unknown. Here we show that an entirely new type of gene silencing mechanism involving an exonuclease-mediated degradation of nascent RNA controls the silencing of genes linked to severe malaria. We identify a novel chromatin-associated exoribonuclease, termed PfR Nase II, that controls the silencing of upsA var genes by marking their transcription start site and intron-promoter regions leading to short-lived cryptic RNA. Parasites carrying a deficient PfRNase II gene produce full-lengthups Avar transcripts and intron-derived antisense longnon-coding RNA. The presence of stable upsA var transcripts overcomes monoallelic expression, resulting in the simultaneous expression of both upsA and upsC type PfEMP1 proteins on the surface of individual infected red blood cells. In addition, we observe an inverse relationship between transcript levels of PfRNase II andupsA-type var genes in parasites from severe malaria patients, implying a crucial role of PfRNase II in severe malaria. Our results uncover a previously unknown type of post-transcriptional gene silencing mechanism in malaria parasites with repercussions for other organisms. Additionally, the identification of RNase II as a parasite protein controlling the expression of virulence genes involved in pathogenesis in patients with severe malaria may provide new strategies for reducing malaria mortality.	[Zhang, Qingfeng; Wang, Fei] Tongji Univ Sch Med, Shanghai East Hosp, Res Ctr Translat Med, Shanghai 200120, Peoples R China; [Zhang, Qingfeng; Wang, Fei] Tongji Univ Sch Med, Inst Infect Dis & Vaccine Dev, Shanghai 200120, Peoples R China; [Zhang, Qingfeng; Siegel, T. Nicolai; Martins, Rafael M.; Scheidig-Benatar, Christine; Sakamoto, Hiroshi; Claes, Aurelie; Guizetti, Julien; Malmquist, Nicholas A.; Scherf, Artur] Inst Pasteur, Unite Biol Interact Hote Paras, F-75724 Paris, France; [Zhang, Qingfeng; Siegel, T. Nicolai; Martins, Rafael M.; Scheidig-Benatar, Christine; Sakamoto, Hiroshi; Claes, Aurelie; Guizetti, Julien; Malmquist, Nicholas A.; Scherf, Artur] CNRS, URA 2581, F-75724 Paris, France; [Cao, Jun; Gao, Qi] Jiangsu Inst Parasit Dis, Key Lab Parasit Dis Control & Prevent, Minist Hlth, Wuxi 214064, Peoples R China; [Cao, Jun; Gao, Qi] Jiangsu Prov Key Lab Parasite Mol Biol, Wuxi 214064, Peoples R China; [Cheng, Xiu; Jiang, Lubin] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China; [Hon, Chung-Chau] Inst Pasteur, Cell Biol Parasitism Unit, F-75724 Paris, France; [Hon, Chung-Chau] Inst Pasteur, INSERM, U786, F-75724 Paris, France; [Turner, Louise; Jensen, Anja T. R.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Turner, Louise; Jensen, Anja T. R.] Rigshosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark	Tongji University; Tongji University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Copenhagen; Rigshospitalet; University of Copenhagen	Scherf, A (corresponding author), Inst Pasteur, Unite Biol Interact Hote Paras, F-75724 Paris, France.	qfzhangsh@aliyun.com; artur.scherf@pasteur.fr	Jensen, Anja Ramstedt/AAL-3119-2021; Guizetti, Julien/AAF-3793-2020; Jensen, Anja Tatiana TR Ramstedt/T-3583-2017; Cao, Jun/AAR-7268-2020; Siegel, Tim Nicolai/F-2502-2013	Jensen, Anja Ramstedt/0000-0002-4004-7554; Guizetti, Julien/0000-0002-8762-4259; Jensen, Anja Tatiana TR Ramstedt/0000-0002-4004-7554; Cao, Jun/0000-0001-5298-9234; Siegel, Tim Nicolai/0000-0002-1715-7907; Malmquist, Nicholas/0000-0003-2822-8245; ZHANG, Qingfeng/0000-0002-8759-9102; Hon, Chung-Chau/0000-0002-3741-7577; Guizetti, Julien/0000-0002-7735-4689; miyazawa martins, rafael/0000-0001-7449-0696; Turner, Louise/0000-0003-4494-2289; Scherf, Artur/0000-0003-2411-3328; Sakamoto, Hiroshi/0000-0002-8767-2111	European Research Council [250320]; French Parasitology consortium ParaFrap [ANR-11-LABX0024]; National Natural Science Foundation of China (NSFC) [31271388]; French National Research Agency-NSFC [13-ISV3-0003-01, 81361130411]; Fundamental Research Funds for the Central Universities of China [20123283]; Human Frontier Science Program; European Molecular Biology Organization long-term fellowship; NSFC [81271870]; Novo Nordisk Fonden [NNF13OC0006249] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); French Parasitology consortium ParaFrap; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); French National Research Agency-NSFC(French National Research Agency (ANR)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Human Frontier Science Program(Human Frontier Science Program); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); NSFC(National Natural Science Foundation of China (NSFC)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank T. Wandless for providing Shld1 compound. This work was supported by a European Research Council Advanced Grant (PlasmoEscape 250320), the French Parasitology consortium ParaFrap (ANR-11-LABX0024), the National Natural Science Foundation of China (NSFC; no. 31271388), the French National Research Agency (13-ISV3-0003-01)-NSFC (no. 81361130411) International Collaboration Project, and the Fundamental Research Funds for the Central Universities of China (20123283). T.N.S. was supported by the Human Frontier Science Program and a European Molecular Biology Organization long-term fellowship. J.C. was supported by the NSFC (no. 81271870). J.G. was supported by the Human Frontier Science Program.	Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Deitsch KW, 2012, P NATL ACAD SCI USA, V109, P10130, DOI 10.1073/pnas.1207174109; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Epp C, 2009, RNA, V15, P116, DOI 10.1261/rna.1080109; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Frank M, 2007, MOL MICROBIOL, V64, P1486, DOI 10.1111/j.1365-2958.2007.05736.x; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gudipati RK, 2012, EMBO J, V31, P2427, DOI 10.1038/emboj.2012.81; Horrocks P, 2004, P NATL ACAD SCI USA, V101, P11129, DOI 10.1073/pnas.0402347101; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Kiss DL, 2011, RNA, V17, P1, DOI 10.1261/rna.2364811; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Kyes SA, 2003, MOL MICROBIOL, V48, P1339, DOI 10.1046/j.1365-2958.2003.03505.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mancio-Silva Liliana, 2013, Methods Mol Biol, V923, P335; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mourier T, 2008, GENOME RES, V18, P281, DOI 10.1101/gr.6836108; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Ralph SA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r93; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Scherf A, 2008, CELL, V134, P190, DOI 10.1016/j.cell.2008.06.042; Staals RHJ, 2010, EMBO J, V29, P2358, DOI 10.1038/emboj.2010.122; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Zhang QF, 2011, CELL HOST MICROBE, V10, P451, DOI 10.1016/j.chom.2011.09.013	39	52	55	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					431	+		10.1038/nature13468	http://dx.doi.org/10.1038/nature13468			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043062				2022-12-28	WOS:000341814900063
J	Atun, R				Atun, Rifat			Time for a revolution in reporting of global health data	LANCET			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Atun, R (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	ratun@hsph.harvard.edu	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983				[Anonymous], 2013, MILL DEV GOALS REP 2; Ataya N, 2014, LANCET; Atun R, 2012, LANCET, V380, P2044, DOI 10.1016/S0140-6736(12)61460-3; Equator Network, ENH QUAL TRANSP HLTH; Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI 10.2471/BLT.11.087510; Horton R, 2014, LANCET, V383, P1620, DOI 10.1016/S0140-6736(14)60769-8; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lopez A, 2013, LANCET, V381, P1275, DOI 10.1016/S0140-6736(13)60838-7; McCoy D, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001522; Murray CJ, 2014, LANCET; UNAIDS, 2013, METH UND HIV EST; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	13	8	8	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2014	384	9947					937	938		10.1016/S0140-6736(14)61062-X	http://dx.doi.org/10.1016/S0140-6736(14)61062-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO9ML	25059946				2022-12-28	WOS:000341679700007
J	Murray, CJL; Ortblad, KF; Guinovart, C; Lim, SS; Wolock, TM; Roberts, DA; Dansereau, EA; Graetz, N; Barber, RM; Brown, JC; Wang, HD; Duber, HC; Naghavi, M; Dicker, D; Dandona, L; Salomon, JA; Heuton, KR; Foreman, K; Phillips, DE; Fleming, TD; Flaxman, AD; Phillips, BK; Johnson, EK; Coggeshall, MS; Abd-Allah, F; Abera, SF; Abraham, JP; Abubakar, I; Abu-Raddad, LJ; Abu-Rmeileh, NM; Achoki, T; Adeyemo, AO; Adou, AK; Adsuar, JC; Agardh, EE; Akena, D; Al Kahbouri, MJ; Alasfoor, D; Albittar, MI; Alcala-Cerra, G; Alegretti, MA; Alemu, ZA; Alfonso-Cristancho, R; Alhabib, S; Ali, R; Alla, F; Allen, PJ; Alsharif, U; Alvarez, E; Alvis-Guzman, N; Amankwaa, AA; Amare, AT; Amini, H; Ammar, W; Anderson, BO; Antonio, CAT; Anwari, P; Arnlov, J; Arsenijevic, VSA; Artaman, A; Asghar, RJ; Assadi, R; Atkins, LS; Badawi, A; Balakrishnan, K; Banerjee, A; Basu, S; Beardsley, J; Bekele, T; Bell, ML; Bernabe, E; Beyene, TJ; Bhala, N; Bhalla, A; Bhutta, ZA; Bin Abdulhak, A; Binagwaho, A; Blore, JD; Basara, BB; Bose, D; Brainin, M; Breitborde, N; Castaneda-Orjuela, CA; Catala-Lopez, F; Chadha, VK; Chang, JC; Chiang, PPC; Chuang, TW; Colomar, M; Cooper, LT; Cooper, C; Courville, KJ; Cowie, BC; Criqui, MH; Dandona, R; Dayama, A; De Leo, D; Degenhardt, L; Del Pozo-Cruz, B; Deribe, K; Des Jarlais, DC; Dessalegn, M; Dharmaratne, SD; Dilmen, U; Ding, EL; Driscoll, TR; Durrani, AM; Ellenbogen, RG; Ermakov, SP; Esteghamati, A; Faraon, EJA; Farzadfar, F; Fereshtehnejad, SM; Fijabi, DO; Forouzanfar, MH; Paleo, UF; Gaffikin, L; Gamkrelidze, A; Gankpe, FG; Geleijnse, JM; Gessner, BD; Gibney, KB; Ginawi, IAM; Glaser, EL; Gona, P; Goto, A; Gouda, HN; Gugnani, HC; Gupta, R; Gupta, R; Hafezi-Nejad, N; Hamadeh, RR; Hammami, M; Hankey, GJ; Harb, HL; Haro, JM; Havmoeller, R; Hay, SI; Hedayati, MT; Pi, IBH; Hoek, HW; Hornberger, JC; Hosgood, HD; Hotez, PJ; Hoy, DG; Huang, JJ; Iburg, KM; Idrisov, BT; Innos, K; Jacobsen, KH; Jeemon, P; Jensen, PN; Jha, V; Jiang, GH; Jonas, JB; Juel, K; Kan, HD; Kankindi, I; Karam, NE; Karch, A; Karema, CK; Kaul, A; Kawakami, N; Kazi, DS; Kemp, AH; Kengne, AP; Keren, A; Kereselidze, M; Khader, YS; Khalifa, SEAH; Khan, EA; Khang, YH; Khonelidze, I; Kinfu, Y; Kinge, JM; Knibbs, L; Kokubo, Y; Kosen, S; Defo, BK; Kulkarni, VS; Kulkarni, C; Kumar, K; Kumar, RB; Kumar, GA; Kwan, GF; Lai, T; Balaji, AL; Lam, H; Lan, Q; Lansingh, VC; Larson, HJ; Larsson, A; Lee, JT; Leigh, J; Leinsalu, M; Leung, R; Li, YC; Li, YM; De Lima, GMF; Lin, HH; Lipshultz, SE; Liu, SW; Liu, Y; Lloyd, BK; Lotufo, PA; Machado, VMP; Maclachlan, JH; Magis-Rodriguez, C; Majdan, M; Mapoma, CC; Marcenes, W; Marzan, MB; Masci, JR; Mashal, MT; Mason-Jones, AJ; Mayosi, BM; Mazorodze, TT; Mckay, AC; Meaney, PA; Mehndiratta, MM; Mejia-Rodriguez, F; Melaku, YA; Memish, ZA; Mendoza, W; Miller, TR; Mills, EJ; Mohammad, KA; Mokdad, AH; Mola, GL; Monasta, L; Montico, M; Moore, AR; Mori, R; Moturi, WN; Mukaigawara, M; Murthy, KS; Naheed, A; Naidoo, KS; Naldi, L; Nangia, V; Narayan, KMV; Nash, D; Nejjari, C; Nelson, RG; Neupane, SP; Newton, CR; Ng, M; Nisar, MI; Nolte, S; Norheim, OF; Nowaseb, V; Nyakarahuka, L; Oh, IH; Ohkubo, T; Olusanya, BO; Omer, SB; Opio, JN; Orisakwe, OE; Pandian, JD; Papachristou, C; Caicedo, AJP; Patten, SB; Paul, VK; Pavlin, BI; Pearce, N; Pereira, DM; Pervaiz, A; Pesudovs, K; Petzold, M; Pourmalek, F; Qato, D; Quezada, AD; Quistberg, DA; Rafay, A; Rahimi, K; Rahimi-Movaghar, V; Rahman, SU; Raju, M; Rana, SM; Razavi, H; Reilly, RQ; Remuzzi, G; Richardus, JH; Ronfani, L; Roy, N; Sabin, N; Saeedi, MY; Sahraian, MA; Samonte, GMJ; Sawhney, M; Schneider, IJC; Schwebel, DC; Seedat, S; Sepanlou, SG; Servan-Mori, EE; Sheikhbahaei, S; Shibuya, K; Shin, HH; Shiue, I; Shivakoti, R; Sigfusdottir, ID; Silberberg, DH; Silva, AP; Simard, EP; Singh, JA; Skirbekk, V; Sliwa, K; Soneji, S; Soshnikov, SS; Sreeramareddy, CT; Stathopoulou, VK; Stroumpoulis, K; Swaminathan, S; Sykes, BL; Tabb, KM; Talongwa, RT; Tenkorang, EY; Terkawi, AS; Thomson, AJ; Thorne-Lyman, AL; Towbin, JA; Traebert, J; Tran, BX; Dimbuene, ZT; Tsilimbaris, M; Uchendu, US; Ukwaja, KN; Uzun, SB; Vallely, AJ; Vasankari, TJ; Venketasubramanian, N; Violante, FS; Vlassov, VV; Vollset, SE; Waller, S; Wallin, MT; Wang, LH; Wang, XR; Wang, YP; Weichenthal, S; Weiderpass, E; Weintraub, RG; Westerman, R; White, RA; Wilkinson, JD; Williams, TN; Woldeyohannes, SM; Wong, JQ; Xu, GL; Yang, YC; Yano, Y; Yentur, GK; Yip, P; Yonemoto, N; Yoon, SJ; Younis, M; Yu, CH; Jin, KY; Zaki, ME; Zhao, Y; Zheng, YF; Zhou, MG; Zhu, J; Zou, XN; Lopez, AD; Vos, T				Murray, Christopher J. L.; Ortblad, Katrina F.; Guinovart, Caterina; Lim, Stephen S.; Wolock, Timothy M.; Roberts, D. Allen; Dansereau, Emily A.; Graetz, Nicholas; Barber, Ryan M.; Brown, Jonathan C.; Wang, Haidong; Duber, Herbert C.; Naghavi, Mohsen; Dicker, Daniel; Dandona, Lalit; Salomon, Joshua A.; Heuton, Kyle R.; Foreman, Kyle; Phillips, David E.; Fleming, Thomas D.; Flaxman, Abraham D.; Phillips, Bryan K.; Johnson, Elizabeth K.; Coggeshall, Megan S.; Abd-Allah, Foad; Abera, Semaw Ferede; Abraham, Jerry P.; Abubakar, Ibrahim; Abu-Raddad, Laith J.; Abu-Rmeileh, Niveen Me; Achoki, Tom; Adeyemo, Austine Olufemi; Adou, Arsene Kouablan; Adsuar, Jose C.; Agardh, Emilie Elisabet; Akena, Dickens; Al Kahbouri, Mazin J.; Alasfoor, Deena; Albittar, Mohammed I.; Alcala-Cerra, Gabriel; Angel Alegretti, Miguel; Alemu, Zewdie Aderaw; Alfonso-Cristancho, Rafael; Alhabib, Samia; Ali, Raghib; Alla, Francois; Allen, Peter J.; Alsharif, Ubai; Alvarez, Elena; Alvis-Guzman, Nelson; Amankwaa, Adansi A.; Amare, Azmeraw T.; Amini, Hassan; Ammar, Walid; Anderson, Benjamin O.; Antonio, Carl Abelardo T.; Anwari, Palwasha; Arnlov, Johan; Arsenijevic, Valentina S. Arsic; Artaman, Ali; Asghar, Rana J.; Assadi, Reza; Atkins, Lydia S.; Badawi, Alaa; Balakrishnan, Kalpana; Banerjee, Amitava; Basu, Sanjay; Beardsley, Justin; Bekele, Tolesa; Bell, Michelle L.; Bernabe, Eduardo; Beyene, Tariku Jibat; Bhala, Neeraj; Bhalla, Ashish; Bhutta, Zulfiqar A.; Bin Abdulhak, Aref; Binagwaho, Agnes; Blore, Jed D.; Basara, Berrak Bora; Bose, Dipan; Brainin, Michael; Breitborde, Nicholas; Castaneda-Orjuela, Carlos A.; Catala-Lopez, Ferran; Chadha, Vineet K.; Chang, Jung-Chen; Chiang, Peggy Pei-Chia; Chuang, Ting-Wu; Colomar, Mercedes; Cooper, Leslie Trumbull; Cooper, Cyrus; Courville, Karen J.; Cowie, Benjamin C.; Criqui, Michael H.; Dandona, Rakhi; Dayama, Anand; De Leo, Diego; Degenhardt, Louisa; Del Pozo-Cruz, Borja; Deribe, Kebede; Des Jarlais, Don C.; Dessalegn, Muluken; Dharmaratne, Samath D.; Dilmen, Ugur; Ding, Eric L.; Driscoll, Tim R.; Durrani, Adnan M.; Ellenbogen, Richard G.; Ermakov, Sergey Petrovich; Esteghamati, Alireza; Faraon, Emerito Jose A.; Farzadfar, Farshad; Fereshtehnejad, Seyed-Mohammad; Fijabi, Daniel Obadare; Forouzanfar, Mohammad H.; Paleo, Urbano Fra; Gaffikin, Lynne; Gamkrelidze, Amiran; Gankpe, Fortune Gbetoho; Geleijnse, Johanna M.; Gessner, Bradford D.; Gibney, Katherine B.; Ginawi, Ibrahim Abdelmageem Mohamed; Glaser, Elizabeth L.; Gona, Philimon; Goto, Atsushi; Gouda, Hebe N.; Gugnani, Harish Chander; Gupta, Rajeev; Gupta, Rahul; Hafezi-Nejad, Nima; Hamadeh, Randah Ribhi; Hammami, Mouhanad; Hankey, Graeme J.; Harb, Hilda L.; Maria Haro, Josep; Havmoeller, Rasmus; Hay, Simon I.; Hedayati, Mohammad T.; Heredia Pi, Ileana B.; Hoek, Hans W.; Hornberger, John C.; Hosgood, H. Dean; Hotez, Peter J.; Hoy, Damian G.; Huang, John J.; Iburg, Kim M.; Idrisov, Bulat T.; Innos, Kaire; Jacobsen, Kathryn H.; Jeemon, Panniyammakal; Jensen, Paul N.; Jha, Vivekanand; Jiang, Guohong; Jonas, Jost B.; Juel, Knud; Kan, Haidong; Kankindi, Ida; Karam, Nadim E.; Karch, Andre; Karema, Corine Kakizi; Kaul, Anil; Kawakami, Norito; Kazi, Dhruv S.; Kemp, Andrew H.; Kengne, Andre Pascal; Keren, Andre; Kereselidze, Maia; Khader, Yousef Saleh; Khalifa, Shams Eldin Ali Hassan; Khan, Ejaz Ahmed; Khang, Young-Ho; Khonelidze, Irma; Kinfu, Yohannes; Kinge, Jonas M.; Knibbs, Luke; Kokubo, Yoshihiro; Kosen, S.; Defo, Barthelemy Kuate; Kulkarni, Veena S.; Kulkarni, Chanda; Kumar, Kaushalendra; Kumar, Ravi B.; Kumar, G. Anil; Kwan, Gene F.; Lai, Taavi; Balaji, Arjun Lakshmana; Lam, Hilton; Lan, Qing; Lansingh, Van C.; Larson, Heidi J.; Larsson, Anders; Lee, Jong-Tae; Leigh, James; Leinsalu, Mall; Leung, Ricky; Li, Yichong; Li, Yongmei; Ferreira De Lima, Graca Maria; Lin, Hsien-Ho; Lipshultz, Steven E.; Liu, Shiwei; Liu, Yang; Lloyd, Belinda K.; Lotufo, Paulo A.; Pedro Machado, Vasco Manuel; Maclachlan, Jennifer H.; Magis-Rodriguez, Carlos; Majdan, Marek; Mapoma, Christopher Chabila; Marcenes, Wagner; Barrieotos Marzan, Melvin; Masci, Joseph R.; Mashal, Mohammad Taufiq; Mason-Jones, Amanda J.; Mayosi, Bongani M.; Mazorodze, Tasara T.; Mckay, Abigail Cecilia; Meaney, Peter A.; Mehndiratta, Man Mohan; Mejia-Rodriguez, Fabiola; Melaku, Yohannes Adama; Memish, Ziad A.; Mendoza, Walter; Miller, Ted R.; Mills, Edward J.; Mohammad, Karzan Abdulmuhsin; Mokdad, Ali H.; Mola, Glen Liddell; Monasta, Lorenzo; Montico, Marcella; Moore, Ami R.; Mori, Rintaro; Moturi, Wilkister Nyaora; Mukaigawara, Mitsuru; Murthy, Kinnari S.; Naheed, Aliya; Naidoo, Kovin S.; Naldi, Luigi; Nangia, Vinay; Narayan, K. M. Venkat; Nash, Denis; Nejjari, Chakib; Nelson, Robert G.; Neupane, Sudan Prasad; Newton, Charles R.; Ng, Marie; Nisar, Muhammad Imran; Nolte, Sandra; Norheim, Ole F.; Nowaseb, Vincent; Nyakarahuka, Luke; Oh, In-Hwan; Ohkubo, Takayoshi; Olusanya, Bolajoko O.; Omer, Saad B.; Opio, John Nelson; Orisakwe, Orish Ebere; Pandian, Jeyaraj D.; Papachristou, Christina; Paternina Caicedo, Angel J.; Patten, Scott B.; Paul, Vinod K.; Pavlin, Boris Igor; Pearce, Neil; Pereira, David M.; Pervaiz, Aslam; Pesudovs, Konrad; Petzold, Max; Pourmalek, Farshad; Qato, Dima; Quezada, Amado D.; Quistberg, D. Alex; Rafay, Anwar; Rahimi, Kazem; Rahimi-Movaghar, Vafa; Rahman, Sajjad Ur; Raju, Murugesan; Rana, Saleem M.; Razavi, Homie; Reilly, Robert Quentin; Remuzzi, Giuseppe; Richardus, Jan Hendrik; Ronfani, Luca; Roy, Nobhojit; Sabin, Nsanzimana; Saeedi, Mohammad Yahya; Sahraian, Mohammad Ali; Samonte, Genesis May J.; Sawhney, Monika; Schneider, Ione J. C.; Schwebel, David C.; Seedat, Soraya; Sepanlou, Sadaf G.; Servan-Mori, Edson E.; Sheikhbahaei, Sara; Shibuya, Kenji; Shin, Hwashin Hyun; Shiue, Ivy; Shivakoti, Rupak; Sigfusdottir, Inga Dora; Silberberg, Donald H.; Silva, Andrea P.; Simard, Edgar P.; Singh, Jasvinder A.; Skirbekk, Vegard; Sliwa, Karen; Soneji, Samir; Soshnikov, Sergey S.; Sreeramareddy, Chandrashekhar T.; Stathopoulou, Vasiliki Kalliopi; Stroumpoulis, Konstantinos; Swaminathan, Soumya; Sykes, Bryan L.; Tabb, Karen M.; Talongwa, Roberto Tchio; Tenkorang, Eric Yeboah; Terkawi, Abdullah Sulieman; Thomson, Alan J.; Thorne-Lyman, Andrew L.; Towbin, Jeffrey A.; Traebert, Jefferson; Tran, Bach X.; Dimbuene, Zacharie Tsala; Tsilimbaris, Miltiadis; Uchendu, Uche S.; Ukwaja, Kingsley N.; Uzun, Selen Begum; Vallely, Andrew J.; Vasankari, Tommi J.; Venketasubramanian, N.; Violante, Francesco S.; Vlassov, Vasiliy Victorovich; Vollset, Stein Emil; Waller, Stephen; Wallin, Mitchell T.; Wang, Linhong; Wang, XiaoRong; Wang, Yanping; Weichenthal, Scott; Weiderpass, Elisabete; Weintraub, Robert G.; Westerman, Ronny; White, Richard A.; Wilkinson, James D.; Williams, Thomas Neil; Woldeyohannes, Solomon Meseret; Wong, John Q.; Xu, Gelin; Yang, Yong C.; Yano, Yuichiro; Yentur, Gokalp Kadri; Yip, Paul; Yonemoto, Naohiro; Yoon, Seok-Jun; Younis, Mustafa; Yu, Chuanhua; Jin, Kim Yun; Zaki, Maysaa El Sayed; Zhao, Yong; Zheng, Yingfeng; Zhou, Maigeng; Zhu, Jun; Zou, Xiao Nong; Lopez, Alan D.; Vos, Theo			Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; FEMALE SEX WORKERS; PLASMODIUM-FALCIPARUM MALARIA; MILLENNIUM DEVELOPMENT GOALS; SEVERE FEBRILE ILLNESS; ANTIRETROVIRAL THERAPY; VERBAL AUTOPSY; INJECT DRUGS; PROJECTION PACKAGE; COST-EFFECTIVENESS	Background The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration. Methods To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010-13) of incidence, drug resistance, and coverage of insecticide-treated bednets. Findings Globally in 2013, there were 1.8 million new HIV infections (95% uncertainty interval 1.7 million to 2.1 million), 29.2 million prevalent HIV cases (28.1 to 31.7), and 1.3 million HIV deaths (1.3 to 1.5). At the peak of the epidemic in 2005, HIV caused 1.7 million deaths (1.6 million to 1.9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19.1 million life-years (16.6 million to 21.5 million) have been saved, 70.3% (65.4 to 76.1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7.5 million (7.4 million to 7.7 million), prevalence was 11.9 million (11.6 million to 12.2 million), and number of deaths was 1.4 million (1.3 million to 1.5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7.1 million (6.9 million to 7.3 million), prevalence was 11.2 million (10.8 million to 11.6 million), and number of deaths was 1.3 million (1.2 million to 1.4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64.0% of cases (63.6 to 64.3) and 64.7% of deaths (60.8 to 70.3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1.2 million deaths (1.1 million to 1.4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31.5% (15.7 to 44.1). Outside of Africa, malaria mortality has been steadily decreasing since 1990. Interpretation Our estimates of the number of people living with HIV are 18.7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. The number of people living with HIV, tuberculosis, or malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action.	[Murray, Christopher J. L.; Ortblad, Katrina F.; Guinovart, Caterina; Wolock, Timothy M.; Roberts, D. Allen; Dansereau, Emily A.; Graetz, Nicholas; Barber, Ryan M.; Brown, Jonathan C.; Wang, Haidong; Duber, Herbert C.; Naghavi, Mohsen; Dicker, Daniel; Dandona, Lalit; Heuton, Kyle R.; Phillips, David E.; Fleming, Thomas D.; Flaxman, Abraham D.; Phillips, Bryan K.; Johnson, Elizabeth K.; Coggeshall, Megan S.; Forouzanfar, Mohammad H.; Mokdad, Ali H.; Ng, Marie; Vos, Theo] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Ellenbogen, Richard G.] Harborview, Seattle, WA USA; [Ellenbogen, Richard G.] Univ Washington Med, Seattle, WA USA; [Alfonso-Cristancho, Rafael; Anderson, Benjamin O.; Jensen, Paul N.; Quistberg, D. Alex] Univ Washington, Seattle, WA 98195 USA; [Dandona, Lalit; Dandona, Rakhi; Kumar, G. Anil; Murthy, Kinnari S.] Publ Hlth Fdn India, New Delhi, India; [Foreman, Kyle; Williams, Thomas Neil] Univ London Imperial Coll Sci Technol & Med, London, England; [Ding, Eric L.] Harvard Univ, Harvard Sch Publ Hlth, Cambridge, MA 02138 USA; [Salomon, Joshua A.] Harvard Univ, Cambridge, MA 02138 USA; [Abd-Allah, Foad] Cairo Univ, Fac Med, Cairo, Egypt; [Abera, Semaw Ferede] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Mekelle, Ethiopia; [Melaku, Yohannes Adama] Mekelle Univ, Mekelle, Ethiopia; [Abraham, Jerry P.] Univ Texas San Antonio, Sch Med, San Antonio, TX USA; [Abubakar, Ibrahim] UCL, London, England; [Abu-Raddad, Laith J.] Weill Cornell Med Coll Qatar, Doha, Qatar; [Abu-Rmeileh, Niveen Me] Birzeti Univ, Inst Community & Publ Hlth, Ramallah, West Bank, Palestine; [Achoki, Tom] Minist Hlth, Gaborone, Botswana; [Adeyemo, Austine Olufemi] Evidence Act MamaYe, Freetown, Western Area, Sierra Leone; [Adou, Arsene Kouablan] Assoc Ivoirienne Bien Etre Familial, Abidjan, Cote Ivoire; [Adsuar, Jose C.; Paleo, Urbano Fra] Univ Extremadura, Caceres, Spain; [Agardh, Emilie Elisabet] Inst Publ Hlth Sci, Stockholm, Sweden; [Akena, Dickens; Nyakarahuka, Luke] Makerere Univ, Kampala, Uganda; [Al Kahbouri, Mazin J.; Alasfoor, Deena] Minist Hlth, Muscat, Oman; [Albittar, Mohammed I.] Independent, Damascus, Syria; [Alcala-Cerra, Gabriel] Grp Invest Ciencias Salud & Neurociencias CISNEUR, Cartagena de Indias, Colombia; [Angel Alegretti, Miguel] Univ Republica, Fac Med, Dept Prevent & Social Med, Montevideo, Uruguay; [Alemu, Zewdie Aderaw] Debre Markos Univ, Debre Markos, Ethiopia; [Alhabib, Samia] Natl Guard Hlth Affairs, Riyadh, Saudi Arabia; [Ali, Raghib; Hay, Simon I.; Rahimi, Kazem] Univ Oxford, Oxford, England; [Alla, Francois] Univ Lorraine, Sch Publ Hlth, Nancy, France; [Allen, Peter J.] Minist Hlth, Belmopan, Cayo, Belize; [Alsharif, Ubai; Nolte, Sandra; Papachristou, Christina] Charite, D-13353 Berlin, Germany; [Alvarez, Elena] Govt, Madrid, Spain; [Alvis-Guzman, Nelson; Paternina Caicedo, Angel J.] Univ Cartagena, Cartagena de Indias, Colombia; [Amankwaa, Adansi A.] Albany State Univ, Albany, GA 31705 USA; [Amare, Azmeraw T.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Amare, Azmeraw T.] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Amini, Hassan] Kurdistan Univ Med Sci, Kurdistan Environm Hlth Res Ctr, Sanandaj, Kurdistan, Iran; [Ammar, Walid; Harb, Hilda L.] Minist Publ Hlth, Beirut, Lebanon; [Antonio, Carl Abelardo T.; Faraon, Emerito Jose A.] Univ Philippines, Coll Publ Hlth, Manila, Philippines; [Anwari, Palwasha] UNFPA, Kabul, Afghanistan; [Arnlov, Johan; Larsson, Anders] Uppsala Univ, Uppsala, Sweden; [Karema, Corine Kakizi] Malaria & Other Parasit Dis Div, Kigali, Rwanda; [Binagwaho, Agnes; Kankindi, Ida] Minist Hlth, Kigali, Rwanda; [Arsenijevic, Valentina S. Arsic] Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Belgrade, Serbia; [Artaman, Ali] Median Inc, Windsor, ON, Canada; [Asghar, Rana J.] Asian Publ Hlth Forum, Islamabad, Pakistan; [Assadi, Reza] Mashhad Univ Med Sci, Mashhad, Iran; [Atkins, Lydia S.] Minist Hlth Wellness Human Serv & Gender Relat, Castries, St Lucia; [Badawi, Alaa] Publ Hlth Agcy Canada, Toronto, ON, Canada; [Balakrishnan, Kalpana] Sri Ramachandra Univ, Chennai, Tamil Nadu, India; [Banerjee, Amitava] Univ Birmingham, Birmingham, W Midlands, England; [Gaffikin, Lynne] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Basu, Sanjay] Stanford Univ, Stanford, CA 94305 USA; [Beardsley, Justin] Univ Oxford, Ho Chi Minh City, Vietnam; [Bekele, Tolesa] Madawalabu Univ, Bale, Goba, Ethiopia; [Bell, Michelle L.; Huang, John J.] Yale Univ, New Haven, CT USA; [Bernabe, Eduardo] Kings Coll London, London WC2R 2LS, England; [Beyene, Tariku Jibat; Deribe, Kebede] Univ Addis Ababa, Addis Ababa, Ethiopia; [Bhala, Neeraj] Wellington Hosp, Wellington, New Zealand; [Bhalla, Ashish; Jha, Vivekanand] Postgrad Inst Med Educ & Res, Chandigarh, India; [Bhutta, Zulfiqar A.] Aga Khan Univ, Med Ctr, Nairobi, Kenya; [Bin Abdulhak, Aref] Univ Missouri, Kansas City, MO 64110 USA; [Chiang, Peggy Pei-Chia] Univ Melbourne, Gen Practice & Primary Hlth Care Acad Ctr, Melbourne, Vic, Australia; [Blore, Jed D.; Balaji, Arjun Lakshmana; Weintraub, Robert G.; Lopez, Alan D.] Univ Melbourne, Melbourne, Vic, Australia; [Weintraub, Robert G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Basara, Berrak Bora; Yentur, Gokalp Kadri] Gen Directorate Hlth Res, Ankara, Turkey; [Dilmen, Ugur; Uzun, Selen Begum] Minist Hlth, Ankara, Turkey; [Bose, Dipan] World Bank, Washington, DC 20433 USA; [Brainin, Michael] Danube Univ Krems, Krems, Austria; [Breitborde, Nicholas] Univ Arizona, Tucson, AZ USA; [Castaneda-Orjuela, Carlos A.] Inst Nacl Salud, Colombian Natl Hlth Observ, Bogota, Colombia; [Catala-Lopez, Ferran] Spanish Med & Healthcare Prod Agcy AEMPS, Div Pharmacoepidemiol & Pharmacovigilance, Minist Hlth, Madrid, Spain; [Chadha, Vineet K.] Natl TB Inst, Bangalore, Karnataka, India; [Lin, Hsien-Ho] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chang, Jung-Chen] Natl Taiwan Univ, Taipei 10764, Taiwan; [Chuang, Ting-Wu] Taipei Med Univ, Coll Med, Dept Parasitol, Taipei, Taiwan; [Chuang, Ting-Wu] Taipei Med Univ, Coll Med, Ctr Int Trop Med, Taipei, Taiwan; [Colomar, Mercedes] UNICEM, Montevideo, Uruguay; [Cooper, Leslie Trumbull] Mayo Clin, Rochester, MN USA; [Cooper, Cyrus] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Courville, Karen J.] Hosp Dr Gustavo N Collado, Chitre, Herrera, Panama; [Cowie, Benjamin C.; Maclachlan, Jennifer H.] Victorian Infect Dis Reference Lab, North Melbourne, Vic, Australia; [Criqui, Michael H.] Univ Calif San Diego, San Diego, CA 92103 USA; [Dayama, Anand] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Liu, Yang; Narayan, K. M. Venkat; Omer, Saad B.] Emory Univ, Atlanta, GA 30322 USA; [De Leo, Diego] Griffith Univ, Brisbane, Qld 4111, Australia; [Vallely, Andrew J.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Degenhardt, Louisa] Univ New S Wales, Sydney, NSW, Australia; [Del Pozo-Cruz, Borja] Univ Auckland, Auckland 1, New Zealand; [Des Jarlais, Don C.] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Dessalegn, Muluken] Africa Med & Res Fdn Ethiopia, Addis Ababa, Ethiopia; [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka; [Driscoll, Tim R.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Leigh, James] Univ Sydney, Sydney, NSW 2006, Australia; [Durrani, Adnan M.] NIH, Montgomery, MD USA; [Ermakov, Sergey Petrovich] Russian Acad Sci, Inst Social & Econ Studies Populat, Moscow, Russia; [Farzadfar, Farshad] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Tehran, Iran; [Esteghamati, Alireza; Hafezi-Nejad, Nima; Sheikhbahaei, Sara] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran; [Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Sahraian, Mohammad Ali] Univ Tehran Med Sci, MS Res Ctr, Tehran, Iran; [Sepanlou, Sadaf G.] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran; [Fereshtehnejad, Seyed-Mohammad] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Havmoeller, Rasmus] Karolinska Inst, Stockholm, Sweden; [Fijabi, Daniel Obadare] Brandeis Univ, Heller Grad Sch, Waltham, MA USA; [Glaser, Elizabeth L.] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA; [Idrisov, Bulat T.] Brandeis Univ, Waltham, MA USA; [Gamkrelidze, Amiran; Kereselidze, Maia; Khonelidze, Irma] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Gankpe, Fortune Gbetoho] Clin Cooperat Parakou, Parakou, Borgou, Benin; [Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Gessner, Bradford D.] Agence Med Prevent, Paris, France; [Lloyd, Belinda K.] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic 3004, Australia; [Gibney, Katherine B.] Monash Univ, Melbourne, Vic 3004, Australia; [Lloyd, Belinda K.] Eastern Hlth, Turning Point, Fitzroy, Vic, Australia; [Ginawi, Ibrahim Abdelmageem Mohamed] Univ Hail, Coll Med, Hail, Saudi Arabia; [Gona, Philimon] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Goto, Atsushi] Natl Ctr Global Hlth & Med, Dept Diabet Res, Tokyo, Japan; [Hoy, Damian G.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Gouda, Hebe N.; Knibbs, Luke] Univ Queensland, Brisbane, Qld, Australia; [Hoy, Damian G.] Secretariat Pacific Community, Publ Hlth Div, Noumea, New Caledonia; [Gugnani, Harish Chander] St James Sch Med, Kralendijk, Bonaire, Netherlands; [Gupta, Rajeev] Fortis Escorts Hosp, Jaipur, Rajasthan, India; [Gupta, Rahul] Kanawha Charleston Hlth Dept, Charleston, WV USA; [Hamadeh, Randah Ribhi] Arabian Gulf Univ, Manama, Bahrain; [Hammami, Mouhanad] Wayne Cty Dept Hlth & Human Serv, Detroit, MI USA; [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Maria Haro, Josep] Univ Barcelona, CIBERSAM, Parc Sanitari Sant Joan de Deu, Barcelona, Spain; [Hedayati, Mohammad T.] Mazandaran Univ Med Sci, Sari, Mazandaran, Iran; [Heredia Pi, Ileana B.; Mejia-Rodriguez, Fabiola; Quezada, Amado D.; Servan-Mori, Edson E.] Natl Inst Publ Hlth Mexico, Cuernavaca, Morelos, Mexico; [Hoek, Hans W.] Parnassia Psychiat Inst, The Hague, Netherlands; [Hornberger, John C.] Cedar Associates, Menlo Pk, CA USA; [Hosgood, H. Dean] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Hotez, Peter J.] Baylor Coll Med, Houston, TX 77030 USA; [Iburg, Kim M.] Aarhus Univ, Aarhus, Denmark; [Innos, Kaire; Leinsalu, Mall] Natl Inst Hlth Dev, Tallinn, Estonia; [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA 22030 USA; [Jeemon, Panniyammakal] Ctr Chron Dis Control, New Delhi, India; [Jiang, Guohong] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Juel, Knud] Natl Inst Publ Hlth, Copenhagen, Denmark; [Kan, Haidong] Fudan Univ, Shanghai 200433, Peoples R China; [Karam, Nadim E.] Univ Balamand, Beirut, Lebanon; [Karch, Andre] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Karch, Andre] German Ctr Infect Res DZIF, Hannover, Germany; [Kaul, Anil] Oklahoma State Univ, Tulsa, OK USA; [Kawakami, Norito] Univ Tokyo, Sch Publ Hlth, Tokyo, Japan; [Shibuya, Kenji] Univ Tokyo, Tokyo, Japan; [Kazi, Dhruv S.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kemp, Andrew H.; Lotufo, Paulo A.] Univ Sao Paulo, Sao Paulo, Brazil; [Kengne, Andre Pascal] South African Med Res Council, Cape Town, Western Cape, South Africa; [Keren, Andre] Hadassah Ein Kerem Univ Hosp, Jerusalem, Israel; [Khader, Yousef Saleh] Jordan Univ Sci & Technol, Al Ramtha, Jordan; [Khalifa, Shams Eldin Ali Hassan] Supreme Council Hlth, Doha, Qatar; [Khan, Ejaz Ahmed] Hlth Serv Acad, Islamabad, Punjab, Pakistan; [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Inst Hlth Policy & Management, Seoul, South Korea; [Kinfu, Yohannes] Univ Canberra, Canberra, ACT 2601, Australia; [White, Richard A.] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Div Infect Dis Control, Oslo, Norway; [White, Richard A.] Norwegian Inst Publ Hlth, Dept Hlth Stat, Div Epidemiol, Oslo, Norway; [Kinge, Jonas M.; Skirbekk, Vegard; Vollset, Stein Emil] Norwegian Inst Publ Hlth, Oslo, Norway; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Dept Prevent Cardiol, Suita, Osaka, Japan; [Kosen, S.] NIHRD, Ctr Community Empowerment Hlth Policy & Humanitie, Jakarta, Indonesia; [Defo, Barthelemy Kuate] Univ Montreal, Montreal, PQ, Canada; [Kulkarni, Veena S.] Arkansas State Univ, Jonesboro, AR USA; [Kulkarni, Chanda] Rajrajeshwari Med Coll & Hosp, Bangalore, Karnataka, India; [Kumar, Kaushalendra] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Kumar, Ravi B.] Publ Hlth Fdn India, Indian Inst Publ Hlth, Gurgaon, Haryana, India; [Kwan, Gene F.] Boston Med Ctr, Boston, MA USA; [Lai, Taavi] Fourth View Consulting, Tallinn, Estonia; [Lam, Hilton] Natl Inst Hlth, Inst Hlth Policy & Dev Studies, Manila, Philippines; [Lan, Qing] Natl Canc Inst, Rockville, MD USA; [Lansingh, Van C.] IAPB & Vis 2020 LA, Weston, FL USA; [Larson, Heidi J.; Pearce, Neil] London Sch Hyg & Trop Med, Bloomsbury, England; [Lee, Jong-Tae; Yoon, Seok-Jun] Korea Univ, Seoul, South Korea; [Leung, Ricky] SUNY Albany, Rensselaer, NY 12222 USA; [Li, Yichong; Liu, Shiwei; Wang, Linhong; Zhou, Maigeng] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [Li, Yongmei] Genentech Inc, San Francisco, CA USA; [Ferreira De Lima, Graca Maria] Dept Publ Hlth, Unidade Local Saude Matosinhos, Oporto, Portugal; [Pedro Machado, Vasco Manuel] Dept Publ Hlth, Northern Reg Hlth Adm, Oporto, Portugal; [Lipshultz, Steven E.] Wayne State Univ, Miami, FL USA; [Magis-Rodriguez, Carlos] Ctr Nacl Prevenc & Control VIH SIDA, Mexico City, DF, Mexico; [Majdan, Marek] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Trnava, Slovakia; [Mapoma, Christopher Chabila] Univ Zambia, Lusaka, Zambia; [Marcenes, Wagner] Univ London, London, England; [Barrieotos Marzan, Melvin] Univ East Ramon, Magsaysay Med Ctr, Quezon City, Philippines; [Masci, Joseph R.] Elmhurst Hosp Ctr, Mt Sinai Serv, Elmhurst, NY USA; [Mashal, Mohammad Taufiq] Minist Publ Hlth, Kabul, Afghanistan; [Mason-Jones, Amanda J.] Univ York, York YO10 5DD, N Yorkshire, England; [Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Hatter Inst Cardiovasc Res Africa, ZA-7925 Cape Town, Western Cape, South Africa; [Mayosi, Bongani M.] Univ Cape Town, ZA-7925 Cape Town, Western Cape, South Africa; [Mazorodze, Tasara T.] AIDC EC, Port Elizabeth, South Africa; [Mckay, Abigail Cecilia] EmergentCorp, Belize City, Belize; [Meaney, Peter A.] Univ Penn, Pereleman Sch Med, Philadelphia, PA 19104 USA; [Silberberg, Donald H.] Univ Penn, Philadelphia, PA 19104 USA; [Mehndiratta, Man Mohan] Janakpuri Superspecialty Hosp, New Delhi, India; [Memish, Ziad A.; Saeedi, Mohammad Yahya] Minist Hlth, Riyadh, Saudi Arabia; [Mendoza, Walter] UNFPA, Lima, Peru; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Miller, Ted R.] Curtin Univ, Ctr Populat Hlth Res, Perth, WA 6845, Australia; [Mills, Edward J.] Univ Ottawa, Ottawa, ON, Canada; [Mohammad, Karzan Abdulmuhsin] Univ Salahaddin, Erbil, Iraq; [Mola, Glen Liddell] Univ Papua New Guinea, Port Moresby, NCD, Papua N Guinea; [Monasta, Lorenzo; Montico, Marcella; Ronfani, Luca] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy; [Moore, Ami R.] Univ N Texas, Denton, TX 76203 USA; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Tokyo, Tokyo, Japan; [Moturi, Wilkister Nyaora] Egerton Univ, Egerton, Rift Valley, Kenya; [Mukaigawara, Mitsuru] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo, Japan; [Naheed, Aliya] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Naidoo, Kovin S.] Univ KwaZulu Natal, Durban, KwaZulu Natal, South Africa; [Naldi, Luigi] Azienda Osped Papa Giovanni XXIII, Bergamo, Italy; [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India; [Nash, Denis] CUNY, Sch Publ Hlth, New York, NY 10021 USA; [Nejjari, Chakib] Fac Med, Fes, Morocco; [Nelson, Robert G.] NIDDK, Phoenix, AZ USA; [Neupane, Sudan Prasad] Univ Oslo, Norwegian Ctr Addict Res SERAF, Oslo, Norway; [Newton, Charles R.] Kenya Med Res Inst Wellcome Trust Programme, Kilifi, Kenya; [Nisar, Muhammad Imran] Aga Khan Univ, Karachi, Pakistan; [Norheim, Ole F.; Vollset, Stein Emil] Univ Bergen, Bergen, Norway; [Nowaseb, Vincent] Polytech Namibia, Windhoek, Namibia; [Oh, In-Hwan] Kyung Hee Univ, Seoul, South Korea; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Tokyo 173, Japan; [Olusanya, Bolajoko O.] Ctr Hlth Start Initiat, Lagos, Nigeria; [Opio, John Nelson] Lira Dist Local Govt, Lira Municipal Council, Northern Uganda, Uganda; [Orisakwe, Orish Ebere] Univ Port Harcourt, Fac Pharm, Toxicol Unit, Port Harcourt, Rivers State, Nigeria; [Pandian, Jeyaraj D.] Christian Med Coll Ludhiana, Ludhiana, Punjab, India; [Patten, Scott B.] Univ Calgary, Calgary, AB, Canada; [Paul, Vinod K.] AIIMS, New Delhi, India; [Pavlin, Boris Igor] Independent, Waigani, NCD, Papua N Guinea; [Pereira, David M.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, Braga, Portugal; [Pereira, David M.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Pervaiz, Aslam] Postgrad Med Inst, Lahore, Punjab, Pakistan; [Pesudovs, Konrad] Flinders Univ S Australia, Adelaide, SA, Australia; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat, Gothenburg, Sweden; [Pourmalek, Farshad] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Qato, Dima] Univ Illinois, Coll Pharm, Chicago, IL USA; [Rafay, Anwar] Contech Intl, Lahore, Punjab, Pakistan; [Rahman, Sajjad Ur] Hamad Med Corp, Doha, Qatar; [Raju, Murugesan] Univ Missouri, Columbia, MO USA; [Rana, Saleem M.] Univ Punjab, Dept Publ Hlth, Lahore, Punjab, Pakistan; [Razavi, Homie] Ctr Dis Anal, Louisville, CO USA; [Reilly, Robert Quentin] Private Consultant, Cairns, Qld, Australia; [Remuzzi, Giuseppe] Ctr Anna Maria Astori, IRCCS Mario Negri Inst Pharmacol Res, Bergamo, Italy; [Richardus, Jan Hendrik] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands; [Roy, Nobhojit] BARC Hosp, Mumbai, Maharashtra, India; [Sabin, Nsanzimana] Rwanda Biomed Ctr, Kigali, Rwanda; [Samonte, Genesis May J.] Natl Epidemiol Ctr, Dept Hlth, Natl HIV AIDS & STI Surveillance & Strateg Inform, Manila, National Capita, Philippines; [Sawhney, Monika] Marshall Univ, Huntington, WV USA; [Schneider, Ione J. C.] Univ Fed Santa Catarina, Florianopolis, SC, Brazil; [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA; [Seedat, Soraya] Univ Stellenbosch, Cape Town, South Africa; [Shin, Hwashin Hyun; Weichenthal, Scott] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Shiue, Ivy] Heriot Watt Univ, Edinburgh, Midlothian, Scotland; [Shivakoti, Rupak] Johns Hopkins Univ, Ctr Clin Global Hlth Educ, Baltimore, MD USA; [Tran, Bach X.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Sigfusdottir, Inga Dora] Reykjavik Univ, Reykjavik, Iceland; [Silva, Andrea P.] Inst Nacl Epidemiol Dr Juan H Jara, Mar Del Plata, Buenos Aires, Argentina; [Simard, Edgar P.] Surveillance & Hlth Serv Res Program Amer Canc So, Atlanta, GA USA; [Soneji, Samir] Dartmouth Coll, Lebanon, NH 03756 USA; [Soshnikov, Sergey S.] Fed Res Inst Hlth Org, Moscow, Russia; [Soshnikov, Sergey S.] Informat Minist Hlth Russian Federat, Moscow, Russia; [Sreeramareddy, Chandrashekhar T.] Univ Tunku Abdul Rahman, Fac Med & Hlth Sci, Kajang, Selangor, Malaysia; [Stathopoulou, Vasiliki Kalliopi] Ctr Hosp Nord Deux Sevres, Bressuire, France; [Stroumpoulis, Konstantinos] Alexandra Gen Hosp Athens, KEELPNO Ctr Dis Control, Athens, Greece; [Swaminathan, Soumya] Natl Inst Res TB, Chennai, Tamil Nadu, India; [Sykes, Bryan L.] Univ Calif Irvine, Dept Criminol Law & Soc, Chicago, IL USA; [Sykes, Bryan L.] Univ Calif Irvine, Dept Sociol, Chicago, IL USA; [Tabb, Karen M.] Univ Illinois, Champaign, IL 61820 USA; [Talongwa, Roberto Tchio] Minist Hlth MINSANTE, Yaounde, Cameroon; [Tenkorang, Eric Yeboah] Mem Univ, St John, NF, Canada; [Terkawi, Abdullah Sulieman] Univ Virginia, Dept Anesthesiol, Charlottesville, VA USA; [Terkawi, Abdullah Sulieman] King Fahad Med City, Dept Anesthesiol, Riyadh, Saudi Arabia; [Thomson, Alan J.] Adapt Knowledge Management, Victoria, BC, Canada; [Thorne-Lyman, Andrew L.] Columbia Univ, Earth Inst, New York, NY USA; [Towbin, Jeffrey A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Traebert, Jefferson] Univ Southern Santa Catarina, Palhoca, SC, Brazil; [Dimbuene, Zacharie Tsala] Univ Kinshasa, Fac Econ & Management, Dept Populat Sci & Dev, Kinshasa, DEM REP CONGO; [Tsilimbaris, Miltiadis] Univ Crete, Dept Med, Iraklion, Greece; [Uchendu, Uche S.] Dept Vet Affairs, Washington, DC USA; [Ukwaja, Kingsley N.] Fed Teaching Hosp Abakaliki, Dept Internal Med, Abakailiki, Ebonyi State, Nigeria; [Vasankari, Tommi J.] UKK Inst Hlth Promot Res, Tampere, Finland; [Venketasubramanian, N.] Raffles Hosp, Ctr Neurosci, Singapore, Singapore; [Violante, Francesco S.] Univ Bologna, Bologna, Italy; [Vlassov, Vasiliy Victorovich] Higher Sch Econ, Moscow, Russia; [Waller, Stephen] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Wallin, Mitchell T.] VA Med Ctr, Washington, DC USA; [Wallin, Mitchell T.] Georgetown Univ, Dept Neurol, Washington, DC USA; [Wang, XiaoRong] Shandong Univ, Jinan Cent Hosp, Jinan 250100, Peoples R China; [Wang, Yanping; Zhu, Jun] Natl Off Maternal & Child Hlth Surveillance, Chengdu, Peoples R China; [Westerman, Ronny] Univ Marburg, Marburg, Germany; [Wilkinson, James D.] Univ Miami, Miami, FL USA; [Woldeyohannes, Solomon Meseret] Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia; [Wong, John Q.] Ateneo Sch Med & Publ Hlth, Pasig, Metro Manila, Philippines; [Xu, Gelin] Nanjing Univ, Jinling Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Yang, Yong C.] Univ N Carolina, Chapel Hill, NC USA; [Yano, Yuichiro] Jichi Med Univ, Sch Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Yip, Paul] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Younis, Mustafa] Jackson State Univ, Jackson, MS USA; [Yu, Chuanhua] Wuhan Univ, Sch Publ Hlth & Global Hlth Inst, Dept Epidemiol & Biostat, Wuhan, Peoples R China; [Jin, Kim Yun] TCM MEDICAL TK SDN BHD, Nusajaya, Johor Bahru, Malaysia; [Zaki, Maysaa El Sayed] Mansoura Fac Med, Mansoura, Egypt; [Zhao, Yong] Chongqing Med Univ, Chongqing, Peoples R China; [Zheng, Yingfeng] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zou, Xiao Nong] Chinese Acad Med Sci, Canc Inst Hosp, Beijing 100730, Peoples R China	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Public Health Foundation of India; Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Egyptian Knowledge Bank (EKB); Cairo University; Mekelle University; Mekelle University; University of Texas System; University of Texas at San Antonio (UTSA); University of London; University College London; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Universidad de Extremadura; Makerere University; Universidad de la Republica, Uruguay; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Ministry of National Guard - Health Affairs; National Guard Health Affairs - Saudi Arabia; University of Oxford; Universite de Lorraine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universidad de Cartagena; University System of Georgia; Albany State University; University of Groningen; Bahir Dar University; Kurdistan University of Medical Sciences; University of the Philippines System; University of the Philippines Manila; Uppsala University; University of Belgrade; Mashhad University Medical Science; Public Health Agency of Canada; Sri Ramachandra Institute of Higher Education & Research; University of Birmingham; Stanford University; Stanford University; University of Oxford; Yale University; University of London; King's College London; Addis Ababa University; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Aga Khan University; University of Missouri System; University of Missouri Kansas City; University of Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Ministry of Health - Turkey; The World Bank; Danube University Krems; University of Arizona; Instituto Nacional de Salud (Colombia); National Taiwan University; National Taiwan University; Taipei Medical University; Taipei Medical University; Mayo Clinic; University of Southampton; Victorian Infectious Diseases Reference Laboratory; University of California System; University of California San Diego; Emory University; Emory University; Griffith University; University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; University of Auckland; Harvard University; Beth Israel Deaconess Medical Center; African Medical & Research Foundation (AMREF); University of Peradeniya; University of Sydney; University of Sydney; National Institutes of Health (NIH) - USA; Russian Academy of Sciences; Federal Center of Theoretical & Applied Sociology - FCTAS; Institute of Social & Economic Studies of Population; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Brandeis University; Brandeis University; Brandeis University; National Center for Disease Control & Public Health - Georgia; Wageningen University & Research; Agence de Medecine Preventive; Monash University; Monash University; Turning Point Alcohol & Drug Centre - Australia; University Ha'il; University of Massachusetts System; University of Massachusetts Worcester; National Center for Global Health & Medicine - Japan; University of Queensland; University of Queensland; Fortis Escorts Hospital; Arabian Gulf University; University of Western Australia; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Mazandaran University Medical Sciences; Instituto Nacional de Salud Publica; Parnassia Psychiatric Institute; Yeshiva University; Albert Einstein College of Medicine; Baylor College of Medicine; Aarhus University; National Institute for Health Development - Estonia; George Mason University; Tianjin Center for Disease Control & Prevention; Ruprecht Karls University Heidelberg; Fudan University; University Balamand; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research; University of Tokyo; University of Tokyo; University of California System; University of California San Francisco; Universidade de Sao Paulo; South African Medical Research Council; Hebrew University of Jerusalem; Hadassah University Medical Center; Jordan University of Science & Technology; Health Services Academy; Seoul National University (SNU); University of Canberra; Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); National Cerebral & Cardiovascular Center - Japan; National Institute of Health Research & Development (NIHRD); Universite de Montreal; Arkansas State University; International Institute for Population Sciences; Public Health Foundation of India; Boston Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; London School of Hygiene & Tropical Medicine; Korea University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Roche Holding; Genentech; University of Trnava; University of Zambia; University of London; UERM Memorial Medical Center; Icahn School of Medicine at Mount Sinai; University of York - UK; University of Cape Town; University of Cape Town; University of Pennsylvania; University of Pennsylvania; Ministry of Health - Saudi Arabia; Pacific Institute for Research & Evaluation (PIRE); Curtin University; University of Ottawa; Salahaddin University; University of Papua New Guinea; IRCCS Burlo Garofolo; University of North Texas System; University of North Texas Denton; National Center for Child Health & Development - Japan; Egerton University; Tokyo Medical & Dental University (TMDU); International Centre for Diarrhoeal Disease Research (ICDDR); University of Kwazulu Natal; ASST Papa Giovanni XXIII; Suraj Eye Institute; City University of New York (CUNY) System; Mohammed First University of Oujda; Sidi Mohamed Ben Abdellah University of Fez; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Oslo; Kenya Medical Research Institute; Aga Khan University; University of Bergen; Namibia University of Science & Technology; Kyung Hee University; Teikyo University; University of Port Harcourt; University of Calgary; All India Institute of Medical Sciences (AIIMS) New Delhi; Universidade do Minho; Flinders University South Australia; University of Gothenburg; University of British Columbia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Hamad Medical Corporation; University of Missouri System; University of Missouri Columbia; University of Punjab; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Erasmus University Rotterdam; Erasmus MC; Bhabha Atomic Research Center (BARC); Rwanda Biomedical Center; Philippine Department Health; Marshall University; Universidade Federal de Santa Catarina (UFSC); University of Alabama System; University of Alabama Birmingham; Stellenbosch University; Health Canada; Heriot Watt University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Reykjavik University; Dartmouth College; Ministry of Health of the Russian Federation; Universiti Tunku Abdul Rahman (UTAR); Alexandra Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); University of California System; University of California Irvine; University of California System; University of California Irvine; University of Illinois System; University of Illinois Urbana-Champaign; Memorial University Newfoundland; University of Virginia; King Fahad Medical City; Columbia University; Cincinnati Children's Hospital Medical Center; Universidade do Sul de Santa Catarina; Universite de Kinshasa; University of Crete; UKK Institute; Raffles Hospital; University of Bologna; HSE University (National Research University Higher School of Economics); Uniformed Services University of the Health Sciences - USA; Georgetown University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Philipps University Marburg; University of Miami; University of Gondar; Nanjing University; University of North Carolina; University of North Carolina Chapel Hill; Jichi Medical University; University of Hong Kong; National Center for Neurology & Psychiatry - Japan; Jackson State University; Wuhan University; Egyptian Knowledge Bank (EKB); Mansoura University; Chongqing Medical University; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.		Newton, Charles RJC/B-7578-2014; Castañeda-Orjuela, Carlos/N-2601-2017; Memish, Ziad Ahmed/AEJ-9424-2022; Lotufo, Paulo/A-9843-2008; Lopez, Alan/AAA-2734-2022; Ortblad, Katrina/ABF-9070-2020; Mason-Jones, Amanda/ABF-1565-2020; Liu, Yang/AAA-7224-2019; Zheng, Yingfeng/CAE-9225-2022; Defo, Barthelemy Kuate/I-4818-2017; Kaul, Anil/B-2075-2016; Kengne, Andre Pascal/ABB-3696-2020; Mapoma, Christopher Chabila/AAX-3368-2020; Rahimi, Kazem/AAA-4250-2022; A, Naheed/AHB-2940-2022; Melaku, Yohannes Adama/S-2451-2019; Patten, Scott/B-4434-2011; Waller, Stephen/AAI-1787-2020; assadi, reza/AAI-1124-2021; Abu-Raddad, Laith J/AAY-1441-2020; Fra.Paleo, Urbano/B-8088-2016; Juel, Knud/C-8916-2013; Alvis-Guzman, Nelson/D-4913-2013; Quistberg, D Alex/P-3538-2019; Mukaigawara, Mitsuru/L-2144-2016; ORISAKWE, ORISH EBERE/X-5852-2019; wang, lin/GSE-3040-2022; Nyakarahuka, Luke/AGH-2432-2022; Gona, Philimon/K-1477-2019; Oh, In Hwan/AAI-9070-2020; Geleijnse, Johanna Marianna M/B-5749-2012; Norheim, Ole Frithjof/AAC-8771-2020; Knibbs, Luke/C-7865-2012; Rahimi-Movaghar, Vafa/L-6339-2019; Guinovart, Caterina/ABH-2981-2020; Olusanya, Bolajoko O./F-4504-2012; Weiderpass, Elisabete/M-4029-2016; Sepanlou, Sadaf G/H-9343-2016; Ärnlöv, Johan/AAF-2746-2019; Degenhardt, Louisa J/D-4515-2012; SHIN, HS/AAE-5381-2022; Zaki, Maysaa El Sayed/C-1522-2013; Antonio, Carl Abelardo/AAP-4280-2020; Monasta, Lorenzo/B-1388-2012; Cowie, Benjamin/HFZ-9941-2022; Soshnikov, Sergey/AAV-8566-2020; Papachristou, Christina/AAR-2187-2021; Bin Abdulhak, Aref/AAM-9492-2020; Ding, Eric L./K-1118-2019; Li, Yichong/A-3559-2019; Pourmalek, Farshad/A-8188-2010; Hamadeh, Randah R./AAE-9720-2020; A, Naheed/AHB-2941-2022; Khader, Yousef/AAE-9620-2019; GANKPE, GBETOHO FORTUNE/GLT-4476-2022; Nolte, Sandra/B-7498-2008; Lopez, Alan D/F-1487-2010; Deribe, Kebede/I-5422-2019; Ukwaja, Kingsley N./A-7794-2013; Khan, Prof Dr Ejaz/GNP-1245-2022; Paternina-Caicedo, Angel/N-4496-2015; Newton, Charles/V-7872-2019; Naidoo, Kovin Shunmugam/AAF-5914-2020; Rahimi, Kazem/Q-1279-2015; Weiderpass, Elisabete/AAP-2747-2021; Montico, Marcella/B-5290-2013; Wallin, Mitchell T./J-8190-2019; alla, francois/D-2295-2014; Zhao, Yong/Z-3231-2019; Zhou, Maigeng/HCH-7703-2022; Banerjee, Amitava/D-4381-2014; Amare, Azmeraw T./B-9487-2018; Soshnikov, Sergey/AAG-9739-2020; Boothapati, Anil Kumar/HHS-1813-2022; Kan, Haidong/AGU-0328-2022; Deribe, Kebede/K-7055-2019; wang, lin/HHM-2225-2022; CT, Sreeramareddy/I-1203-2019; Neupane, Sudan Prasad/C-8056-2011; Rana, Saleem M/Y-9791-2018; Singh, Jasvinder/R-6172-2019; Dimbuene, Zacharie Tsala/H-3029-2019; Traebert, Jefferson/R-8699-2016; wang, YA XING/K-9671-2016; Bin Abdulhak, Aref/AAK-4348-2020; Alsharif, Ubai/C-6527-2017; Bell, Michelle/Y-4608-2018; Mokdad, Ali H./AAD-1232-2022; Alsharif, Ubai/AAK-2088-2021; Pandian, Jeyaraj Durai/AAV-5591-2020; Amini, Heresh/B-3076-2010; Woldeyohannes, Solomon Meseret/E-5783-2012; Balakrishnan, Kalpana/B-6653-2015; Naohiro, Yonemoto/Y-3761-2019; Asghar, Rana Jawad/AAF-7634-2021; Schwebel, David/GXH-9944-2022; Schneider, Ione J.C./J-8762-2013; Catalá-López, Ferrán/N-6018-2018; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020; Zheng, Yingfeng/AAE-2983-2022; Bernabe, Eduardo/R-3441-2017; Pesudovs, Konrad/T-9403-2019; Bose, Dipan/GRS-0467-2022; Lee, Jong-Tae/AAF-5746-2020; Beyene, Tariku Jibat/A-6875-2017; Khan, Ejaz A/B-9340-2016; Pereira, David/M-9286-2013; Ermakov, Sergey/G-1709-2016; Alvarez, Elena/S-1068-2019; Towbin, Jeffrey A./J-5595-2019; Marzan, Melvin/AAP-8443-2020; Salomon, Joshua/S-1929-2019; Hay, Simon Iain/F-8967-2015; KUMAR, ANIL/ACD-8340-2022; Jacobsen, Kathryn H./B-5857-2008; Courville, Karen/AAW-1462-2021; wang, xiao/HGB-7081-2022; Nyakarahuka, Luke/W-8164-2019; Leung, Ricky/P-3702-2015; Soshnikov, Sergey/R-7352-2016; Venketasubramanian, Narayanaswamy/GPP-5948-2022; Narayan, K.M. Venkat/J-9819-2012; Majdan, Marek/K-5017-2012; assadi, reza/AAT-6629-2020; Leinsalu, Mall/I-3768-2018; Salomon, Joshua A/D-3898-2009; Violante, Francesco S/A-6934-2009; Ginawi, Ibrahim Abdelmageed Mohamed/H-3260-2012; Adsuar, Jose C/C-6558-2008; Richardus, Jan Hendrik/AAE-1278-2021; Naldi, Luigi/AFM-8982-2022; Nash, Denis/AFI-7485-2022; Terkawi, Abdullah Suleiman/AAC-1113-2019; Idrisov, Bulat/A-8271-2018; Abu-Rmeileh, Niveen ME/H-7135-2019; Hankey, Graeme J/H-4968-2014; Karch, André/D-6973-2017; wang, lili/HDL-7210-2022; Kemp, Andrew Haddon/C-7984-2012; Badawi, Alaa/ABC-1300-2021; Heredia-Pi, Ileana Beatriz/L-4247-2019; Zaki, Maysaa El Sayed/H-3049-2019; Hedayati, Mohammad T./E-2304-2017; Naldi, Luigi/K-6343-2016; Hornberger, John/M-4932-2019; Ronfani, Luca/B-6668-2013; Kinfu, Yohannes/AAC-8054-2020; Haro, Josep Maria/D-1423-2011; Remuzzi, Giuseppe/V-9766-2017; Lansingh, Van/C-8672-2018; Shivakoti, Rupak/HIU-0448-2022; Larson, Heidi J./N-1018-2017; Vlassov, Vasiliy/B-4036-2014	Newton, Charles RJC/0000-0002-6999-5507; Castañeda-Orjuela, Carlos/0000-0002-8735-6223; Memish, Ziad Ahmed/0000-0002-5099-0714; Lotufo, Paulo/0000-0002-4856-8450; Ortblad, Katrina/0000-0002-5675-8836; Mason-Jones, Amanda/0000-0002-4292-3183; Liu, Yang/0000-0001-5477-2186; Zheng, Yingfeng/0000-0002-0914-7864; Defo, Barthelemy Kuate/0000-0002-6589-0564; Mapoma, Christopher Chabila/0000-0001-9233-5462; A, Naheed/0000-0002-6016-5603; Melaku, Yohannes Adama/0000-0002-3051-7313; Patten, Scott/0000-0001-9871-4041; Abu-Raddad, Laith J/0000-0003-0790-0506; Fra.Paleo, Urbano/0000-0001-6192-7684; Alvis-Guzman, Nelson/0000-0001-9458-864X; Quistberg, D Alex/0000-0001-9730-2686; Mukaigawara, Mitsuru/0000-0001-6530-2083; ORISAKWE, ORISH EBERE/0000-0002-5806-9858; Nyakarahuka, Luke/0000-0002-2944-9157; Oh, In Hwan/0000-0002-5450-9887; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Norheim, Ole Frithjof/0000-0002-5748-5956; Olusanya, Bolajoko O./0000-0002-3826-0583; Weiderpass, Elisabete/0000-0003-2237-0128; Sepanlou, Sadaf G/0000-0002-3669-5129; Ärnlöv, Johan/0000-0002-6933-4637; Degenhardt, Louisa J/0000-0002-8513-2218; SHIN, HS/0000-0002-7263-6257; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Antonio, Carl Abelardo/0000-0001-7476-0553; Monasta, Lorenzo/0000-0001-7774-548X; Cowie, Benjamin/0000-0002-7087-5895; Bin Abdulhak, Aref/0000-0001-9988-8609; Ding, Eric L./0000-0002-5881-8097; Li, Yichong/0000-0003-3842-475X; Pourmalek, Farshad/0000-0002-2134-0771; Hamadeh, Randah R./0000-0002-4205-1354; A, Naheed/0000-0002-6016-5603; Khader, Yousef/0000-0002-7830-6857; GANKPE, GBETOHO FORTUNE/0000-0002-1242-9686; Nolte, Sandra/0000-0001-6185-9423; Lopez, Alan D/0000-0001-5818-6512; Deribe, Kebede/0000-0002-8526-6996; Ukwaja, Kingsley N./0000-0002-1974-8735; Khan, Prof Dr Ejaz/0000-0002-7072-8035; Paternina-Caicedo, Angel/0000-0002-6332-5174; Newton, Charles/0000-0002-6999-5507; Rahimi, Kazem/0000-0002-4807-4610; Weiderpass, Elisabete/0000-0003-2237-0128; Montico, Marcella/0000-0003-0377-8232; Wallin, Mitchell T./0000-0003-1061-5714; Zhao, Yong/0000-0001-9290-109X; Banerjee, Amitava/0000-0001-8741-3411; Amare, Azmeraw T./0000-0002-7940-0335; Soshnikov, Sergey/0000-0002-6983-7066; CT, Sreeramareddy/0000-0002-5693-7631; Rana, Saleem M/0000-0001-6479-9235; Singh, Jasvinder/0000-0003-3485-0006; Dimbuene, Zacharie Tsala/0000-0002-7977-1689; wang, YA XING/0000-0003-2749-7793; Alsharif, Ubai/0000-0002-4024-3950; Bell, Michelle/0000-0002-3965-1359; Mokdad, Ali H./0000-0002-4994-3339; Alsharif, Ubai/0000-0002-4024-3950; Amini, Heresh/0000-0002-4825-1322; Balakrishnan, Kalpana/0000-0002-5905-1801; Schneider, Ione J.C./0000-0001-6339-7832; Catalá-López, Ferrán/0000-0002-3833-9312; Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; Bernabe, Eduardo/0000-0002-1858-3713; Pesudovs, Konrad/0000-0002-6322-9369; Lee, Jong-Tae/0000-0002-8510-3054; Beyene, Tariku Jibat/0000-0002-7474-1966; Khan, Ejaz A/0000-0002-7072-8035; Pereira, David/0000-0003-0384-7592; Ermakov, Sergey/0000-0003-1072-1162; Alvarez, Elena/0000-0002-9679-2721; Towbin, Jeffrey A./0000-0002-6585-714X; Marzan, Melvin/0000-0003-2696-7335; Salomon, Joshua/0000-0003-3929-5515; Hay, Simon Iain/0000-0002-0611-7272; Jacobsen, Kathryn H./0000-0002-4198-6246; Courville, Karen/0000-0002-4182-6736; wang, xiao/0000-0002-4088-3341; Nyakarahuka, Luke/0000-0002-2944-9157; Leung, Ricky/0000-0002-2852-6771; Soshnikov, Sergey/0000-0002-6983-7066; Narayan, K.M. Venkat/0000-0001-8621-5405; Majdan, Marek/0000-0001-8037-742X; Leinsalu, Mall/0000-0003-4453-4760; Salomon, Joshua A/0000-0003-3929-5515; Violante, Francesco S/0000-0003-4084-2782; Ginawi, Ibrahim Abdelmageed Mohamed/0000-0001-8628-1840; Adsuar, Jose C/0000-0001-7203-3168; Richardus, Jan Hendrik/0000-0003-0564-6313; Naldi, Luigi/0000-0002-3160-2835; Terkawi, Abdullah Suleiman/0000-0001-8734-2748; Hankey, Graeme J/0000-0002-6044-7328; Karch, André/0000-0003-3014-8543; Kemp, Andrew Haddon/0000-0003-1146-3791; Heredia-Pi, Ileana Beatriz/0000-0002-9998-9239; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Hedayati, Mohammad T./0000-0001-6415-4648; Naldi, Luigi/0000-0002-3160-2835; Ronfani, Luca/0000-0001-5710-3914; Kinfu, Yohannes/0000-0001-9607-6891; Haro, Josep Maria/0000-0002-3984-277X; Mori, Rintaro/0000-0001-7656-6156; Roberts, Allen/0000-0003-3660-6330; Seedat, Soraya/0000-0002-5118-786X; Ohkubo, Takayoshi/0000-0002-3283-8196; Neupane, Sudan Prasad/0000-0002-7389-4178; Servan-Mori, Edson/0000-0001-9820-8325; Moturi, Wilkister Nyaora/0000-0001-6620-4856; CHANG, JUNG-CHEN/0000-0001-8651-2602; Razavi, Homie/0000-0002-2658-6930; Jha, Vivekanand/0000-0002-8015-9470; Jeemon, Panniyammakal/0000-0003-4172-4307; Liu, Zhi-Hong/0000-0001-6093-0726; Knibbs, Luke/0000-0002-0399-2370; Kwan, Gene/0000-0002-0929-6800; Cooper, Leslie/0000-0003-1002-3313; Abubakar, Ibrahim/0000-0002-0370-1430; Remuzzi, Giuseppe/0000-0002-6194-3446; Goto, Atsushi/0000-0003-0669-654X; Yoon, Seok-Jun/0000-0003-3297-0071; Meaney, Peter/0000-0001-9898-6928; MacLachlan, Jennifer/0000-0002-7654-4536; Farzadfar, Farshad/0000-0001-8288-4046; LIN, HSIEN-HO/0000-0002-7481-6016; Idrisov, Bulat/0000-0002-1971-2572; Miller, Ted/0000-0002-0958-2639; Esteghamati, Alireza/0000-0001-5114-3982; Duber, Herbert/0000-0002-5077-3170; Nisar, Muhammad Imran/0000-0002-2378-4720; WILKINSON, JAMES/0000-0003-1945-5622; Abd-Allah, Foad/0000-0001-8308-5756; Stroumpoulis, Konstantinos/0000-0003-3234-3772; Nash, Denis/0000-0002-3280-5386; Lansingh, Van/0000-0002-0090-4195; Mayosi, Bongani/0000-0001-6641-8950; Shivakoti, Rupak/0000-0002-2773-9310; Pandian, Jeyaraj/0000-0003-0028-1968; Al Asfoor, Deena/0000-0002-7973-1935; Shibuya, Kenji/0000-0003-2528-7530; Juel, Knud/0000-0002-4134-1173; Woldeyohannes, Solomon/0000-0003-2431-2730; Vallely, Andrew/0000-0003-1558-4822; FARAON, EMERITO JOSE A./0000-0001-6157-5930; Pearce, Neil/0000-0002-9938-7852; Tsilimbaris, Miltiadis/0000-0002-0130-1150; Hoek, Hans/0000-0001-6353-5465; Innos, Kaire/0000-0003-0120-2213; Bhala, Neeraj/0000-0003-2502-1177; Qato, Dima/0000-0001-5411-6998; Assadi, Reza/0000-0002-5016-2994; , Borja/0000-0003-3944-2212; Roy, Nobhojit/0000-0003-2022-7416; Kengne, Andre Pascal/0000-0002-5183-131X; Larson, Heidi J./0000-0002-8477-7583; Vlassov, Vasiliy/0000-0001-5203-549X; Achoki, Tom/0000-0001-6309-8904; Khang, Young-Ho/0000-0002-9585-8266; Tabb Dina, Karen/0000-0002-4722-9502; Shiue, Ivy/0000-0003-1788-3009; Hotez, Peter/0000-0001-8770-1042; Gibney, Katherine/0000-0001-5851-5339; Quezada-Sanchez, Amado D./0000-0003-3258-8198; Dandona, Rakhi/0000-0003-0926-788X; Tenkorang, Eric/0000-0001-6127-3799; del Pozo Cruz, Borja/0000-0002-9728-1317; Glaser, Elizabeth/0000-0002-1918-057X; alla, francois/0000-0002-5793-7190; Xu, Gelin/0000-0002-6194-0341; Magis-Rodriguez, Carlos/0000-0001-5481-1253; Sahraian, Mohammad Ali/0000-0002-3224-8807	UK National Institute for Health Research; MRC; Qatar National Research Fund [NPRP 04-924-3-251]; Health Sciences and Neurosciences (CI SNEURO) Research Group; Australian National Health and Medical Research Council Principal Research Fellowship [1041742]; NIH [DA R01 003574]; Welcome Trust Fellowship in Public Health and Tropical Medicine [099876]; International Society of Nephrology (ISN); Agency for Health Quality and Research Center for Education and Research on Therapeutics (AHRQ CERTs) [U19 HS021110]; National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS) [P50 AR060772, U34 AR062891]; National Institute of Aging (NIA) [U01 AG018947]; National Cancer Institute (NCI) [U10 CA149950]; Patient Centered Outcomes Research Institute (PCORI) [CE-1304-6631]; VA Medical Center at Birmingham, Alabama, USA; National Center for Advancing Translational Sciences [KL2TR001088]; National Health and Medical Research Council (NHMRC), Australia; Nature Science Foundation of China (NSFC) [81070922]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS021110] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U10CA149950] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001086, KL2TR001088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U34AR062891, P50AR060772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG018947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003574] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12011/1, MC_UP_A620_1014, G1100684, MC_U147585824, U1475000001] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082, NF-SI-0513-10085, CDF-2013-06-012] Funding Source: researchfish; MRC [G1100684] Funding Source: UKRI	UK National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Qatar National Research Fund(Qatar National Research Fund (QNRF)); Health Sciences and Neurosciences (CI SNEURO) Research Group; Australian National Health and Medical Research Council Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welcome Trust Fellowship in Public Health and Tropical Medicine; International Society of Nephrology (ISN); Agency for Health Quality and Research Center for Education and Research on Therapeutics (AHRQ CERTs); National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Patient Centered Outcomes Research Institute (PCORI)(Patient-Centered Outcomes Research Institute - PCORI); VA Medical Center at Birmingham, Alabama, USA; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the countless individuals who have contributed to the Global Burden of Disease Study 2013 in various capacities. We would like to acknowledge the extensive support from all staff members at the Institute for Health Metrics and Evaluation and specifically thank: Michael F MacIntyre, Peter Speyer, and Summer Lockett Ohno for their management of the Global Burden of Disease Study 2013; Kelsey Pierce for her valuable assistance; Peter Speyer, James Bullard, Serkan Yalcin, Edgar Sioson, Evan Laurie, Charles Atkinson, and Andrew Ernst for their tireless support of the computational infrastructure necessary to produce the results; Linda A Ettinger for her expert administrative support; Peter Speyer, Abigail McLain, James Hancock, Marissa Iannarone, and Eden Stork for their persistent and invaluable work to gain access to and catalogue as much data as possible to inform the estimates; Stan Biryukov for his assistance with the tuberculosis database; Henry Apfel and Madeline Moyer for data extraction and processing; Christopher Margono, Michelle Subart, Lavanya Singh and Margaret Lind for assistance with galleys; Matthew M Coates, Carly E Levitz, Chelsea A Lidell, Meghan D Mooney, and Austin E Schumaker for production of all-cause mortality estimates; Amelia Bertozzi-Villa for review of Python coding of the Spectrum model. We would also like to acknowledge Mary Mahy, Keith Sabin and John Stover for sharing the UNAIDS EPP files with us and especially John Stover for responding to multiple queries regarding Spectrum. Additionally, Ibrahim Abubakar would like to acknowledge the UK National Institute for Health Research and MRC for funding. Laith J Abu-Raddad would like to acknowledge the support of Qatar National Research Fund (NPRP 04-924-3-251) who provided the main funding for generating the data provided to the GBD-IH ME effort. Gabriel Alcala-Cerra would like to acknowledge institutional support from Health Sciences and Neurosciences (CI SNEURO) Research Group. Louisa Degenhardt is supported by an Australian National Health and Medical Research Council Principal Research Fellowship (#1041742). Dr. Des Jarlais would like to acknowledge funding from NIH Grant DA R01 003574. KD is supported by a Welcome Trust Fellowship in Public Health and Tropical Medicine [grant number 099876]. Prof. Giuseppe Remuzzi would like to acknowledge the International Society of Nephrology (ISN) for their support of his involvement in the GBD 2013. JAS is supported by grants from the Agency for Health Quality and Research Center for Education and Research on Therapeutics (AHRQ CERTs) U19 HS021110, National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS) P50 AR060772 and U34 AR062891, National Institute of Aging (NIA) U01 AG018947, National Cancer Institute (NCI) U10 CA149950, and research contract CE-1304-6631 from the Patient Centered Outcomes Research Institute (PCORI). JAS is also supported by the resources and the use of facilities at the VA Medical Center at Birmingham, Alabama, USA. Dr. Soneji was supported by the National Center for Advancing Translational Sciences grant number KL2TR001088. Karen M Tabb would like to acknowledge her current support: Lemann Institute Faculty Research Grant, University of Illinois. Andrew J Vallely is supported by a Training Fellowship from the National Health and Medical Research Council (NHMRC), Australia. Gelin Xu is currently funded by the Nature Science Foundation of China (NSFC, 81070922). No individuals acknowledged received additional compensation for their efforts.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; ALLEN S, 1992, AM REV RESPIR DIS, V146, P1439, DOI 10.1164/ajrccm/146.6.1439; Alleyne G, 2013, LANCET, V381, P566, DOI 10.1016/S0140-6736(12)61806-6; Alliance NCD, 2014, TACKL NONC DIS ENH S; ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; [Anonymous], 2013, MEDICC REV, V15, P3, DOI 10.37757/MR2013V15.N3.1; [Anonymous], 2013, MILL DEV GOALS REP 2; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Atun R, 2010, LANCET, V376, P940, DOI 10.1016/S0140-6736(10)61428-6; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bates M, 2012, LANCET, V380, P560, DOI 10.1016/S0140-6736(12)61323-3; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Bautista-Arredondo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072616; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Birnbaum JK, 2011, B WORLD HEALTH ORGAN, V89, P278, DOI 10.2471/BLT.11.086280; BRAUN MM, 1991, AM REV RESPIR DIS, V143, P501, DOI 10.1164/ajrccm/143.3.501; Brown T, 2006, SEX TRANSM INFECT, V82, pIII34, DOI 10.1136/sti.2006.020230; Byass P, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001477; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Chambers RG, 2012, LANCET, V379, P707, DOI 10.1016/S0140-6736(12)60280-3; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Clemens MA, 2007, WORLD DEV, V35, P735, DOI 10.1016/j.worlddev.2006.08.003; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Dabis F, 2005, AIDS, V19, P309; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Darby SC, 1996, LANCET, V347, P1573, DOI 10.1016/S0140-6736(96)91073-9; Decker MR, 2014, AIDS BEHAV, V18, P562, DOI 10.1007/s10461-013-0577-y; Degenhardt L, 2014, INT J DRUG POLICY, V25, P53, DOI 10.1016/j.drugpo.2013.08.004; Department for International Development. UKAID, 2011, ZER INF UKS POS PAP; Dieleman JL, 2014, HEALTH AFFAIR, V33, P878, DOI 10.1377/hlthaff.2013.1432; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Espinal MA, 2003, TUBERCULOSIS, V83, P44, DOI 10.1016/S1472-9792(02)00058-6; Fehling M, 2013, GLOB PUBLIC HEALTH, V8, P1109, DOI 10.1080/17441692.2013.845676; Ferreira MMC, 1996, J ACQ IMMUN DEF SYND, V13, P177, DOI 10.1097/00042560-199610010-00009; Flateau C, 2011, LANCET INFECT DIS, V11, P541, DOI 10.1016/S1473-3099(11)70031-7; Floyd K, 2013, LANCET GLOB HEALTH, V1, pE105, DOI 10.1016/S2214-109X(13)70032-9; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Freguja R, 2012, NEW MICROBIOL, V35, P249; Freguja R, 2012, AIDS, V26, P765, DOI 10.1097/QAD.0b013e3283514350; Futures Institute, AIM COMP PROGR MAK H; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Ghys PD, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010199; Ghys PD, 2007, AIDS, V21, pS1, DOI 10.1097/01.aids.0000299404.99033.bf; GIGLIOLI G, 1972, B WORLD HEALTH ORGAN, V46, P181; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; GRAY RH, 1974, POP STUD-J DEMOG, V28, P205, DOI 10.2307/2173955; Hallett TB, 2008, PLOS MED, V5, P611, DOI 10.1371/journal.pmed.0050080; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hecht R, 2010, LANCET, V376, P1254, DOI 10.1016/S0140-6736(10)61255-X; Herbeck JT, 2010, J INFECT DIS, V201, P618, DOI 10.1086/649842; Hewitt K, 2006, AIDS, V20, P1993, DOI 10.1097/01.aids.0000247572.95880.92; Houben RMGJ, 2012, AIDS, V26, P2233, DOI 10.1097/QAD.0b013e32835958ed; Institute for Health Metrics and Evaluation, 2013, FIN GLOB HLTH 2013 T; Jackson DJ, 2007, AIDS, V21, P509, DOI 10.1097/QAD.0b013e32801424d2; Keizer ST, 2000, J EPIDEMIOL COMMUN H, V54, P64, DOI 10.1136/jech.54.1.64; Ki-Moon Ban, 2011, SECRETARY GEN MESSAG; Korenromp EL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-18; LEROY V, 1995, J ACQ IMMUN DEF SYND, V9, P415; Li DM, 2014, CHINESE MED J-PEKING, V127, P707, DOI 10.3760/cma.j.issn.0366-6999.20131502; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lomazzi M, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23695; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lynch M, 2012, LANCET, V380, P559, DOI 10.1016/S0140-6736(12)61320-8; Makani J, 2003, QJM-INT J MED, V96, P355, DOI 10.1093/qjmed/hcg059; Malaria Roll Back, 2010, MAL FUND RES UT 1 DE; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Mason K, 2013, AIDS RES HUM RETROV, V29, P1547, DOI [10.1089/AID.2013.0092, 10.1089/aid.2013.0092]; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; McGowan CC, 2007, INT J EPIDEMIOL, V36, P969, DOI 10.1093/ije/dym073; Mehra M, 2013, INT J TUBERC LUNG D, V17, P1186, DOI 10.5588/ijtld.12.0959; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Miller WM, 2013, SALUD PUBLICA MEXICO, V55, pS65; Mpimbaza A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026892; Murray CJL, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-5; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2055, DOI 10.1016/S0140-6736(12)62134-5; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nadjm B, 2012, T ROY SOC TROP MED H, V106, P688, DOI 10.1016/j.trstmh.2012.08.006; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0; Nykanen M, 1995, E AFR MED J, V72, P731; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Papworth E, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18751; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pretorius C, 2014, AIDS, V28, pS25, DOI 10.1097/QAD.0000000000000085; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Ruan Yuhua, 2013, Southeast Asian J Trop Med Public Health, V44, P842; Sajadi L, 2013, SEX TRANSM INFECT, V89, P37, DOI 10.1136/sextrans-2013-051028; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; Shah NK, 2011, LANCET, V377, P991, DOI 10.1016/S0140-6736(11)60378-4; Shah NK, 2012, LANCET, V380, P560, DOI 10.1016/S0140-6736(12)61322-1; Shah NK, 2012, INDIAN J MED RES, V135, P270; Shanks GD, 2008, LANCET INFECT DIS, V8, P564, DOI 10.1016/S1473-3099(08)70130-0; Shiffman J, 2008, HEALTH POLICY PLANN, V23, P95, DOI 10.1093/heapol/czm045; Simbayi L, 2014, S AFRICAN NATL HIV P; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Snow RW, 2010, LANCET, V376, P1409, DOI 10.1016/S0140-6736(10)61340-2; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; Snow RW, 2004, AM J TROP MED HYG, V71, P16, DOI 10.4269/ajtmh.2004.71.16; Snow RW, 2003, 11 DCPP, P75; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; South Africa Info Reporter, 2012, S AFR HIV AIDS BATTL; Steketee RW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-299; Stop TB, 2012, PARTN NO MOR CRYING; Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; The GBD 2013 Collaboration, 2013, GLOB REG NAT B UNPUB; TODD JE, 1994, ANN TROP PAEDIATR, V14, P31, DOI 10.1080/02724936.1994.11747689; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; Treatment Action Group, 2012, ZER DECL; Umunyana J, 2014, INCIDENCE MALARIA HI; UNAIDS, 2013, METH UND HIV EST; UNAIDS, 2013, GLOBAL REPORT UNAIDS; *UNAIDS, 2007, 2007 AIDS EP UPD; UNAIDS, 2010, 2011 2015 STRAT GETT; UNAIDS. WHO, 2005, GUID MEAS NAT HIV PR; Vandemoortele J, 2010, IDS BULL-I DEV STUD, V41, P60, DOI 10.1111/j.1759-5436.2010.00105.x; Vassall A, 2013, LANCET GLOB HEALTH, V1, pE62, DOI 10.1016/S2214-109X(13)70044-5; Verguet S, 2013, J INFECT DIS, V207, P72, DOI 10.1093/infdis/jis635; Vitoria M, 2009, AM J CLIN PATHOL, V131, P844, DOI 10.1309/AJCP5XHDB1PNAEYT; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Waage J, 2010, LANCET, V376, P991, DOI 10.1016/S0140-6736(10)61196-8; Waddington C, 2005, TRENDS INT FUNDING M; Wagstaff A, 2004, MILLENNIUM DEV GOALS; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; WEF Harvard School of Public Health, GLOBAL EC BURDEN NON; White NJ, 2012, LANCET, V380, P559, DOI 10.1016/S0140-6736(12)61321-X; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, GLOB TUB CONTR 2010; WHO, 2012, Q A MAL MORT EST; WHO, 2004, CAS STUD EST HIV INF; WHO Global Task Force on TB Impact Measurement, 2014, NAT TB PREV SURV; World Health Organization,, 2011, TUB PREV SURV HDB, V2nd; World Health Organization (WHO), 2013, ROADM CHILDH TUB; World Health Organization (WHO), 2011, BURD BEST BUYS RED E; WORLDHEALTH ORGANIZATION (WHO), 2008, WORLD MAL REP 2008; Yang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030198; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	158	591	612	6	504	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2014	384	9947					1005	1070		10.1016/S0140-6736(14)60844-8	http://dx.doi.org/10.1016/S0140-6736(14)60844-8			66	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO9ML	25059949	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000341679700032
J	Matsunaga, R; Tsuji, N; Fujita, H; Sugioka, A; Makise, K; Uzawa, Y; Terai, H; Wang, Z; Aoki, H; Shimano, R				Matsunaga, Ryusuke; Tsuji, Naoto; Fujita, Hiroyuki; Sugioka, Arata; Makise, Kazumasa; Uzawa, Yoshinori; Terai, Hirotaka; Wang, Zhen; Aoki, Hideo; Shimano, Ryo			Light-induced collective pseudospin precession resonating with Higgs mode in a superconductor	SCIENCE			English	Article							CHARGE-DENSITY WAVES; GENERATION; RELAXATION; EXCITATION; PARTICLES; MATTER; GAP	Superconductors host collective modes that can be manipulated with light. We show that a strong terahertz light field can induce oscillations of the superconducting order parameter in NbN with twice the frequency of the terahertz field. The result can be captured as a collective precession of Anderson's pseudospins in ac driving fields. A resonance between the field and the Higgs amplitudemode of the superconductor then results in large terahertz third-harmonic generation. The method we present here paves a way toward nonlinear quantum optics in superconductors with driving the pseudospins collectively and can be potentially extended to exotic superconductors for shedding light on the character of order parameters and their coupling to other degrees of freedom.	[Matsunaga, Ryusuke; Tsuji, Naoto; Fujita, Hiroyuki; Sugioka, Arata; Aoki, Hideo; Shimano, Ryo] Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; [Makise, Kazumasa; Terai, Hirotaka; Wang, Zhen] Natl Inst Informat & Commun Technol, Kobe Adv Res Ctr, Kobe, Hyogo 6512492, Japan; [Uzawa, Yoshinori] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Aoki, Hideo] High Energy Accelerator Res Org KEK, Tsukuba, Ibaraki 3050801, Japan; [Shimano, Ryo] Univ Tokyo, Cryogen Res Ctr, Tokyo 1130032, Japan	University of Tokyo; National Institute of Information & Communications Technology (NICT) - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); High Energy Accelerator Research Organization (KEK); University of Tokyo	Matsunaga, R (corresponding author), Univ Tokyo, Dept Phys, Tokyo 1130033, Japan.	matsunaga@thz.phys.s.u-tokyo.ac.jp; shimano@phys.s.u-tokyo.ac.jp	Matsunaga, Ryusuke/C-4742-2011; Makise, Kazumasa/AAF-7564-2020; Aoki, Hideo/A-2525-2009; Shimano, Ryo/H-6337-2013	Makise, Kazumasa/0000-0002-2429-319X; Aoki, Hideo/0000-0002-7332-9355; 	Advanced Photon Science Alliance by the Photon Frontier Network Program from Ministry of Education, Culture, Sports, Science, and Technology;  [25800175];  [22244036];  [20110005];  [25104709];  [25800192];  [26247057]	Advanced Photon Science Alliance by the Photon Frontier Network Program from Ministry of Education, Culture, Sports, Science, and Technology; ; ; ; ; ; 	This work was supported by a Grant-in-Aid for Scientific Research (grant nos. 25800175, 22244036, 20110005, 25104709, 25800192, and 26247057) and Advanced Photon Science Alliance by the Photon Frontier Network Program from Ministry of Education, Culture, Sports, Science, and Technology.	AMATO JC, 1976, PHYS REV LETT, V37, P930, DOI 10.1103/PhysRevLett.37.930; ANDERSON PW, 1963, PHYS REV, V130, P439, DOI 10.1103/PhysRev.130.439; ANDERSON PW, 1958, PHYS REV, V112, P1900, DOI 10.1103/PhysRev.112.1900; Barankov RA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.160401; Barlas Y, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.054503; Carlson P. V., 1975, PHYS REV LETT, V34, P11; ENTINWOHLMAN O, 1978, PHYS REV B, V18, P4762, DOI 10.1103/PhysRevB.18.4762; GORKOV LP, 1968, SOV PHYS JETP-USSR, V27, P328; Halperin W. P., 1990, HELIUM 3 MODERN PROB; Hebling J, 2008, J OPT SOC AM B, V25, pB6, DOI 10.1364/JOSAB.25.0000B6; HIGGS PW, 1964, PHYS LETT, V12, P132, DOI 10.1016/0031-9163(64)91136-9; Junginger F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.147403; Kampfrath T, 2013, NAT PHOTONICS, V7, P680, DOI [10.1038/nphoton.2013.184, 10.1038/NPHOTON.2013.184]; Kawakami A, 2004, PHYSICA C, V412, P1455, DOI 10.1016/j.physc.2004.01.161; Krauser JS, 2014, SCIENCE, V343, P157, DOI 10.1126/science.1244059; LEGGETT AJ, 1975, REV MOD PHYS, V47, P331, DOI 10.1103/RevModPhys.47.331; LITTLEWOOD PB, 1981, PHYS REV LETT, V47, P811, DOI 10.1103/PhysRevLett.47.811; Makise K, 2011, IEEE T APPL SUPERCON, V21, P139, DOI 10.1109/TASC.2010.2088350; Mansart B, 2013, P NATL ACAD SCI USA, V110, P4539, DOI 10.1073/pnas.1218742110; Matsunaga R, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.187002; NAMBU Y, 1960, PHYS REV LETT, V4, P380, DOI 10.1103/PhysRevLett.4.380; Schaefer H, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.045106; Shimano R, 2012, J INFRARED MILLIM TE, V33, P861, DOI 10.1007/s10762-012-9914-x; Sidorenkov LA, 2013, NATURE, V498, P78, DOI 10.1038/nature12136; SOORYAKUMAR R, 1980, PHYS REV LETT, V45, P660, DOI 10.1103/PhysRevLett.45.660; Tsuji N, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.136404; Varma CM, 2002, J LOW TEMP PHYS, V126, P901, DOI 10.1023/A:1013890507658; VOLKOV AF, 1973, ZH EKSP TEOR FIZ+, V65, P2038; Volovik GE, 2014, J LOW TEMP PHYS, V175, P486, DOI 10.1007/s10909-013-0905-7; Yuzbashyan EA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.230404; ZIMMERMANN W, 1991, PHYSICA C, V183, P99, DOI 10.1016/0921-4534(91)90771-P	33	290	293	8	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1145	1149		10.1126/science.1254697	http://dx.doi.org/10.1126/science.1254697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25011555				2022-12-28	WOS:000341179800038
J	Wang, F; Chan, C; Weir, NR; Denic, V				Wang, Fei; Chan, Charlene; Weir, Nicholas R.; Denic, Vladimir			The Get1/2 transmembrane complex is an endoplasmic-reticulum membrane protein insertase	NATURE			English	Article							ER MEMBRANE; TAIL; MECHANISM; BIOGENESIS	Hundreds of tail-anchored proteins, including soluble N-ethylmaleimide-sensitive factor attachment receptors (SNAREs) involved in vesicle fusion, are inserted post-translationally into the endoplasmic reticulum membrane by a dedicated protein-targeting pathway(1-4). Before insertion, the carboxy-terminal transmembrane domains of tail-anchored proteins are shielded in the cytosol by the conserved targeting factor Get3 (in yeast; TRC40 inmammals)(5-7). The Get3 endoplasmic-reticulum receptor comprises the cytosolic domains of the Get1/2 (WRB/CAML) transmembrane complex, which interact individually with the targeting factor to drive a conformational change that enables substrate release and, as a consequence, insertion(8-11). Because tail-anchored protein insertion is not associated with significant translocation of hydrophilic protein sequences across the membrane, it remains possible that Get1/2 cytosolic domains are sufficient to place Get3 in proximity with the endoplasmic-reticulum lipid bilayer and permit spontaneous insertion to occur(12,13). Here we use cell reporters and biochemical reconstitution to define mutations in the Get1/2 transmembrane domain that disrupt tail-anchored protein insertion without interfering with Get1/2 cytosolic domain function. These mutations reveal a novel Get1/2 insertase function, in the absence of which substrates stay bound to Get3 despite their proximity to the lipid bilayer; as a consequence, the notion of spontaneous transmembrane domain insertion is a non sequitur. Instead, the Get1/2 transmembrane domain helps to release substrates from Get3 by capturing their transmembrane domains, and these transmembrane interactions define a bona fide pre-integrated intermediate along a facilitated route for tail-anchor entry into the lipid bilayer. Our work sheds light on the fundamental point of convergence between co-translational and post-translational endoplasmic-reticulum membrane protein targeting and insertion: a mechanism for reducing the ability of a targeting factor to shield its substrates enables substrate handover to a transmembrane-domain-docking site embedded in the endoplasmic-reticulum membrane.	[Wang, Fei; Chan, Charlene; Weir, Nicholas R.; Denic, Vladimir] Harvard Univ, Dept Mol & Cellular Biol, Northwest Labs, Cambridge, MA 02138 USA	Harvard University	Denic, V (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Northwest Labs, Cambridge, MA 02138 USA.	vdenic@mcb.harvard.edu		Chan, Charlene/0000-0002-0479-3373	National Institutes of Health [RO1GM0999943-01]; Sara Elizabeth O'Brien Trust Postdoctoral Fellowship Program, Bank of America; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sara Elizabeth O'Brien Trust Postdoctoral Fellowship Program, Bank of America; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Brandman and R. Hegde for reagents, members of the Denic laboratory for scientific advice, and J. Weissman, A. Murray, B. Stern and C. Patil for comments on the manuscript. This work was supported by the National Institutes of Health (RO1GM0999943-01) and a postdoctoral fellowship from the Sara Elizabeth O'Brien Trust Postdoctoral Fellowship Program, Bank of America, Co-Trustee (to F.W.).	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Brachmann CB, 1998, YEAST, V14, P115; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Chartron JW, 2012, CURR OPIN STRUC BIOL, V22, P217, DOI 10.1016/j.sbi.2012.03.001; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Denic V, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013334; Denic V, 2012, TRENDS BIOCHEM SCI, V37, P411, DOI 10.1016/j.tibs.2012.07.004; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Joglekar AP, 2008, METHOD CELL BIOL, V85, P127, DOI 10.1016/S0091-679X(08)85007-8; Kubota K, 2012, J MOL BIOL, V422, P366, DOI 10.1016/j.jmb.2012.05.045; Leznicki P, 2011, BIOCHEM J, V436, P719, DOI 10.1042/BJ20101737; Li J, 2002, P NATL ACAD SCI USA, V99, P11605, DOI 10.1073/pnas.192439299; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; RICHARDS FM, 1959, J BIOL CHEM, V234, P1459; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038	24	76	76	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					441	U486		10.1038/nature13471	http://dx.doi.org/10.1038/nature13471			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25043001	Green Accepted			2022-12-28	WOS:000340840600036
J	Thirumurthy, H; Masters, SH; Rao, S; Bronson, MA; Lanham, M; Omanga, E; Evens, E; Agot, K				Thirumurthy, Harsha; Masters, Samuel H.; Rao, Samwel; Bronson, Megan A.; Lanham, Michele; Omanga, Eunice; Evens, Emily; Agot, Kawango			Effect of Providing Conditional Economic Compensation on Uptake of Voluntary Medical Male Circumcision in Kenya A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIV PREVENTION; INCENTIVES; RISK; PROGRAM; DEMAND; MEN	IMPORTANCE Novel strategies are needed to increase the uptake of voluntary medical male circumcision (VMMC) in sub-Saharan Africa and enhance the effectiveness of male circumcision as an HIV prevention strategy. OBJECTIVE To determine whether small economic incentives could increase circumcision prevalence by addressing reported economic barriers to VMMC and behavioral factors such as present-biased decision making. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial conducted between June 22, 2013, and February 4, 2014, among 1504 uncircumcised men aged 25 to 49 years in Nyanza region, Kenya. VMMC services were provided free of charge and participants were randomized to 1 of 3 intervention groups or a control group. INTERVENTIONS Participants in the 3 intervention groups received varying amounts of compensation conditional on undergoing circumcision at 1 of 9 study clinics within 2 months of enrollment. Compensation took the form of food vouchers worth 200 Kenya shillings (approximate to US $2.50), 700 Kenya shillings (approximate to US $8.75), or 1200 Kenya shillings (approximate to US $15.00), which reflected a portion of transportation costs and lost wages associated with getting circumcised. The control group received no compensation. MAIN OUTCOMES AND MEASURES VMMC uptake within 2 months. RESULTS Analysis of data for 1502 participants with complete data showed that VMMC uptake within 2 months was higher in the US $8.75 group (6.6%; 95% CI, 4.3%-9.5% [25 of 381]) and the US $15.00 group (9.0%; 95% CI, 6.3%-12.4% [34 of 377]) than in the US $2.50 group (1.9%; 95% CI, 0.8%-3.8% [7 of 374]) and the control group (1.6%; 95% CI, 0.6%-3.5% [6 of 370]). In logistic regression analysis, the US $8.75 group had significantly higher VMMC uptake than the control group (adjusted odds ratio [AOR] 4.3; 95% CI, 1.7-10.7), as did the US $15.00 group (AOR 6.2; 95% CI, 2.6-15.0). Effect sizes for the US $8.75 and US $15.00 groups did not differ significantly (P = .20). CONCLUSIONS AND RELEVANCE Among uncircumcised men in Kenya, compensation in the form of food vouchers worth approximately US $8.75 or US $15.00, compared with lesser or no compensation, resulted in a modest increase in the prevalence of circumcision after 2 months. The effects of more intense promotion or longer implementation require further investigation.	[Thirumurthy, Harsha; Masters, Samuel H.] Univ N Carolina, Dept Hlth Policy & Management, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Thirumurthy, Harsha; Bronson, Megan A.] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27599 USA; [Rao, Samwel; Omanga, Eunice; Agot, Kawango] Impact Res & Dev Org, Kisumu, Kenya; [Lanham, Michele; Evens, Emily] FHI360, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Thirumurthy, H (corresponding author), Univ N Carolina, Dept Hlth Policy & Management, Gillings Sch Global Publ Hlth, 135 Dauer Dr,Campus Box 7411, Chapel Hill, NC 27599 USA.	harsha@unc.edu	Omanga, Eunice/H-2336-2011	Masters, Samuel/0000-0001-7581-8219; Lanham, Michele/0000-0003-3012-5683; , Eunice/0000-0003-2579-4014; Thirumurthy, Harsha/0000-0002-3308-7603	Bill and Melinda Gates Foundation [OPP1069673]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [KO1HD061605]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD061605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by the Bill and Melinda Gates Foundation (grant OPP1069673). Dr Thirumurthy reports receipt of support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (grant KO1HD061605).	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002679; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Banerjee AV, 2010, BMJ-BRIT MED J, V340, pc2220; Bjorkman-Nyqvist M, 2013, P 7 IAS C HIV PATH T; Chinkhumba J, 2014, AM ECON J-APPL ECON, V6, P152, DOI 10.1257/app.6.2.152; de Walque D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000747; Evens E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098221; Galbraith JS, 2014, JAIDS-J ACQ IMM DEF, V66, pS37, DOI 10.1097/QAI.0000000000000121; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2013, SEX TRANSM INFECT, V89, P345, DOI 10.1136/sextrans-2012-050595; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Hatzold K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085051; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019814; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lee R, 2014, AIDS BEHAV, V18, P905, DOI 10.1007/s10461-013-0588-8; Levy S, 2006, PROGRESS AGAINST POVERTY: SUSTAINING MEXICO'S PROGRESA-OPORTUNIDADES PROGRAM, P1; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Macintyre K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083998; National AIDS and STI Control Programme, 2013, KEN AIDS IND SURV 20; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; O'Donoghue T, 1999, AM ECON REV, V89, P103, DOI 10.1257/aer.89.1.103; Operario D, 2013, HEALTH PSYCHOL, V32, P932, DOI 10.1037/a0032760; Schultz TP, 2004, J DEV ECON, V74, P199, DOI 10.1016/j.jdeveco.2003.12.009; Sgaier SK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001641; Sindelar JL, 2008, HEALTH ECON, V17, P449, DOI 10.1002/hec.1350; Thornton RL, 2008, AM ECON REV, V98, P1829, DOI 10.1257/aer.98.5.1829; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P2631, DOI 10.1001/jama.2008.804; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; WHO & UNAIDS, 2011, JOINT STRAT ACT FRAM; World Health Organization Joint United Nations Program on HIV / AIDS, 2007, NEW DAT MAL CIRC HIV	34	88	88	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					703	711		10.1001/jama.2014.9087	http://dx.doi.org/10.1001/jama.2014.9087			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN2TR	25042290	Green Accepted, Bronze			2022-12-28	WOS:000340438700018
J	Oye, KA; Esvelt, K; Appleton, E; Catteruccia, F; Church, G; Kuiken, T; Lightfoot, SBY; McNamara, J; Smidler, A; Collins, JP				Oye, Kenneth A.; Esvelt, Kevin; Appleton, Evan; Catteruccia, Flaminia; Church, George; Kuiken, Todd; Lightfoot, Shlomiya Bar-Yam; McNamara, Julie; Smidler, Andrea; Collins, James P.			BIOTECHNOLOGY Regulating gene drives	SCIENCE			English	Editorial Material									[Oye, Kenneth A.] MIT, Polit Sci Dept, Cambridge, MA 02139 USA; [Oye, Kenneth A.; Lightfoot, Shlomiya Bar-Yam; McNamara, Julie] MIT, Engn Syst Div, Cambridge, MA 02139 USA; [Esvelt, Kevin; Church, George] Harvard Univ, Wyss Inst, Cambridge, MA 02138 USA; [Appleton, Evan] Boston Univ, Boston, MA 02215 USA; [Catteruccia, Flaminia; Smidler, Andrea] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; [Catteruccia, Flaminia] Univ Perugia, I-06100 Perugia, Italy; [Kuiken, Todd] Woodrow Wilson Int Ctr Scholars, Washington, DC USA; [Smidler, Andrea] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Collins, James P.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; University of Perugia; Harvard University; Arizona State University; Arizona State University-Tempe	Oye, KA (corresponding author), MIT, Polit Sci Dept, Cambridge, MA 02139 USA.	oye@mit.edu	Kuiken, Todd/U-3476-2019; Kuiken, Todd/A-3784-2016	Kuiken, Todd/0000-0001-7851-6232; Kuiken, Todd/0000-0001-7851-6232; Esvelt, Kevin/0000-0001-8797-3945; Catteruccia, Flaminia/0000-0003-3295-6683; Smidler, Andrea/0000-0002-3281-1161; church, george/0000-0001-6232-9969	Direct For Biological Sciences [1337431] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		[Anonymous], 1972, PROD STOCKP BACT BIO; Australia Group, 2012, GUID TRANSF SENS CHE; Bar Yam S., 2012, REGULATION SYNTHETIC; Benedict M, 2008, VECTOR-BORNE ZOONOT, V8, P127, DOI 10.1089/vbz.2007.0273; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Center for Veterinary Medicine (CVM) Food and Drug Administration U. S. Department of Health and Human Services, 2009, REG GEN ENG AN CONT; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Drinkwater K, 2014, CREATING RES AGENDA; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Kuiken T., 2014, J ENVIRON STUD SCI, V4, P191, DOI [10.1007/s13412-014-0171-2, DOI 10.1007/S13412-014-0171-2]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Reeves RG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001502; U. S. Science and Technology Office, 2013, US GOV POL I OV LIF; United Nations, 2003, CART PROT BIOS CONV; United Nations, 1925, 1925 GEN PROT; World Health Organization, 2009, PROGR PROSP US GEN M	16	212	223	0	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					626	628		10.1126/science.1254287	http://dx.doi.org/10.1126/science.1254287			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25035410				2022-12-28	WOS:000339962800022
J	Morgan, B				Morgan, Branwen			RESEARCH IMPACT Income for outcome	NATURE			English	Editorial Material													Morgan, Branwen/ABG-1328-2021	Morgan, Branwen/0000-0001-5318-1675					0	17	18	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					S72	S75		10.1038/511S72a	http://dx.doi.org/10.1038/511S72a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL7SO	25054855	Bronze			2022-12-28	WOS:000339335700006
J	Wang, S; Wang, W; Dong, XY; Peng, J				Wang, Shuang; Wang, Wen; Dong, Xiao-yuan; Peng, Jun			PICTURE QUIZ A woman with pain and weakness in both legs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXTRAMEDULLARY PLASMACYTOMA; MENINGIOMA		[Wang, Shuang; Wang, Wen; Dong, Xiao-yuan; Peng, Jun] Shandong Univ, Qilu Hosp, Dept Haematol, Jinan 250012, Peoples R China	Shandong University	Peng, J (corresponding author), Shandong Univ, Qilu Hosp, Dept Haematol, Jinan 250012, Peoples R China.	junpeng88@sina.com.cn						Chao MW, 2005, INTERN MED J, V35, P211, DOI 10.1111/j.1445-5994.2005.00804.x; Galieni P, 2000, HAEMATOLOGICA, V85, P47; GUPTA RK, 1994, NEURORADIOLOGY, V36, P39, DOI 10.1007/BF00599194; Jurisic V, 2010, ONKOLOGIE, V33, P113, DOI 10.1159/000278713; MAYR NA, 1990, RADIOTHER ONCOL, V17, P293, DOI 10.1016/0167-8140(90)90003-F; MIRIMANOFF RO, 1985, J NEUROSURG, V62, P18, DOI 10.3171/jns.1985.62.1.0018; Naderi S, 2001, CLIN NEUROL NEUROSUR, V103, P247, DOI 10.1016/S0303-8467(01)00157-3; Ozdemir S, 2013, J CRANIO MAXILL SURG, V41, P140, DOI 10.1016/j.jcms.2012.06.006; Palmer MV, 2007, VET PATHOL, V44, P863, DOI 10.1354/vp.44-6-863; Reed V, 2011, CANCER-AM CANCER SOC, V117, P4468, DOI 10.1002/cncr.26031; Suzer T, 1998, Eur Spine J, V7, P168, DOI 10.1007/s005860050050; Wallace EW, 2004, RADIOLOGY, V233, P56, DOI 10.1148/radiol.2331021332; Wang XQ, 2014, J COMPUT ASSIST TOMO, V38, P200, DOI 10.1097/RCT.0000000000000018	13	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2014	349								g4721	10.1136/bmj.g4721	http://dx.doi.org/10.1136/bmj.g4721			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VP	25056336				2022-12-28	WOS:000339565900007
J	Marcussen, T; Sandve, SR; Heier, L; Spannagl, M; Pfeifer, M; Jakobsen, KS; Wulff, BBH; Steuernagel, B; Mayer, KFX; Olsen, OA; Rogers, J; Dolezel, J; Pozniak, C; Eversole, K; Feuillet, C; Gill, B; Friebe, B; Lukaszewski, AJ; Sourdille, P; Endo, TR; Kubalakova, M; Cihalikova, J; Dubska, Z; Vrana, J; Sperkova, R; Simkova, H; Febrer, M; Clissold, L; Mclay, K; Singh, K; Chhuneja, P; Singh, NK; Khurana, J; Akhunov, E; Choulet, F; Alberti, A; Barbe, V; Wincker, P; Kanamori, H; Kobayashi, F; Itoh, T; Matsumoto, T; Sakai, H; Tanaka, T; Wu, JZ; Ogihara, Y; Handa, H; Maclachlan, PR; Sharpe, A; Klassen, D; Edwards, D; Batley, J; Lien, S; Caccamo, M; Ayling, S; Ramirez-Gonzalez, RH; Clavijo, BJ; Wright, J; Martis, MM; Mascher, M; Chapman, J; Poland, JA; Scholz, U; Barry, K; Waugh, R; Rokhsar, DS; Muehlbauer, GJ; Stein, N; Gundlach, H; Zytnicki, M; Jamilloux, V; Quesneville, H; Wicker, T; Faccioli, P; Colaiacovo, M; Stanca, AM; Budak, H; Cattivelli, L; Glover, N; Pingault, L; Paux, E; Sharma, S; Appels, R; Bellgard, M; Chapman, B; Nussbaumer, T; Bader, KC; Rimbert, H; Wang, SC; Knox, R; Kilian, A; Alaux, M; Alfama, F; Couderc, L; Guilhot, N; Viseux, C; Loaec, M; Keller, B; Praud, S				Marcussen, Thomas; Sandve, Simen R.; Heier, Lise; Spannagl, Manuel; Pfeifer, Matthias; Jakobsen, Kjetill S.; Wulff, Brande B. H.; Steuernagel, Burkhard; Mayer, Klaus F. X.; Olsen, Odd-Arne; Rogers, Jane; Dolezel, Jaroslav; Pozniak, Curtis; Eversole, Kellye; Feuillet, Catherine; Gill, Bikram; Friebe, Bernd; Lukaszewski, Adam J.; Sourdille, Pierre; Endo, Takashi R.; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana; Febrer, Melanie; Clissold, Leah; McLay, Kirsten; Singh, Kuldeep; Chhuneja, Parveen; Singh, Nagendra K.; Khurana, Jitendra; Akhunov, Eduard; Choulet, Frederic; Alberti, Adriana; Barbe, Valerie; Wincker, Patrick; Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Ogihara, Yasunari; Handa, Hirokazu; Maclachlan, P. Ron; Sharpe, Andrew; Klassen, Darrin; Edwards, David; Batley, Jacqueline; Lien, Sigbjorn; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Wright, Jonathan; Martis, Mihaela M.; Mascher, Martin; Chapman, Jarrod; Poland, Jesse A.; Scholz, Uwe; Barry, Kerrie; Waugh, Robbie; Rokhsar, Daniel S.; Muehlbauer, Gary J.; Stein, Nils; Gundlach, Heidrun; Zytnicki, Matthias; Jamilloux, Veronique; Quesneville, Hadi; Wicker, Thomas; Faccioli, Primetta; Colaiacovo, Moreno; Stanca, Antonio Michele; Budak, Hikmet; Cattivelli, Luigi; Glover, Natasha; Pingault, Lise; Paux, Etienne; Sharma, Sapna; Appels, Rudi; Bellgard, Matthew; Chapman, Brett; Nussbaumer, Thomas; Bader, Kai Christian; Rimbert, Helene; Wang, Shichen; Knox, Ron; Kilian, Andrzej; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Guilhot, Nicolas; Viseux, Claire; Loaec, Mikael; Keller, Beat; Praud, Sebastien		Int Wheat Genome Sequencing	Ancient hybridizations among the ancestral genomes of bread wheat	SCIENCE			English	Article							AEGILOPS-TAUSCHII; DRAFT GENOME; A-GENOME; EVOLUTION; TRITICUM; DOMESTICATION; ALIGNMENT; PACKAGE; GENES	The allohexaploid bread wheat genome consists of three closely related subgenomes (A, B, and D), but a clear understanding of their phylogenetic history has been lacking. We used genome assemblies of bread wheat and five diploid relatives to analyze genome-wide samples of gene trees, as well as to estimate evolutionary relatedness and divergence times. We show that the A and B genomes diverged from a common ancestor similar to 7 million years ago and that these genomes gave rise to the D genome through homoploid hybrid speciation 1 to 2 million years later. Our findings imply that the present-day bread wheat genome is a product of multiple rounds of hybrid speciation (homoploid and polyploid) and lay the foundation for a new framework for understanding the wheat genome as a multilevel phylogenetic mosaic.	[Marcussen, Thomas; Sandve, Simen R.; Olsen, Odd-Arne] Norwegian Univ Life Sci, Dept Plant Sci, N-1432 As, Norway; [Spannagl, Manuel; Pfeifer, Matthias; Mayer, Klaus F. X.] Helmholtz Ctr Munich, D-85764 Neuherberg, Germany; [Jakobsen, Kjetill S.] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway; [Wulff, Brande B. H.; Steuernagel, Burkhard] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Spannagl, Manuel; Pfeifer, Matthias; Mayer, Klaus F. X.; Martis, Mihaela M.; Gundlach, Heidrun; Sharma, Sapna; Nussbaumer, Thomas; Bader, Kai Christian] Helmholtz Zentrum Munich, Plant Genome & Syst Biol, Ingolstadter Landstrasse 1, D-85764 Neuherberg, Germany; [Rogers, Jane; Eversole, Kellye] Eversole Associates, IWGSC, 5207 Wyoming Rd, Bethesda 20816, MD USA; [Dolezel, Jaroslav; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana] Inst Expt Bot, Ctr Plant Struct & Funct Genom, Slechtitelu 31, Olomouc 78371, Czech Republic; [Pozniak, Curtis; Maclachlan, P. Ron] Univ Saskatchewan, Coll Agr & Bioresources, Dept Plant Sci, Ctr Crop Dev, 51 Campus Dr, Saskatoon, SK, Canada; [Feuillet, Catherine] Bayer Crop Sci, 3500 Paramount Pkwy, Morrisville, NC 27560 USA; [Gill, Bikram; Friebe, Bernd; Akhunov, Eduard; Wang, Shichen] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA; [Lukaszewski, Adam J.] Univ Calif, Coll Nat & Agr Sci Bot & Plant Sci, Riverside, CA 92521 USA; [Endo, Takashi R.] Kyoto Univ, Grad Sch Agr, Lab Plant Genet, Kyoto 6068502, Japan; [Febrer, Melanie] Univ Dundee, Genom Sequenc Unit, Dow St, Dundee DD1 5EH, Scotland; [Clissold, Leah; McLay, Kirsten; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Wright, Jonathan] Genome Anal Ctr, Res Pk, Norwich NR4 7UH, Norfolk, England; [Singh, Kuldeep; Chhuneja, Parveen] Punjab Agr Univ, Sch Agrictural Biotechnol, Ludhiana 141004, Punjab, India; [Singh, Nagendra K.] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Khurana, Jitendra] Univ Delhi, Dept Plant Mol, Interdisciplinary Ctr Plant Genom, South Campus, New Delhi 110021, India; [Sourdille, Pierre; Choulet, Frederic; Glover, Natasha; Pingault, Lise; Paux, Etienne; Guilhot, Nicolas] INRA Univers Blaise Pascal UMR1095 Genet, Div & Ecophysiol Cereals, 5 Chemin Beaulieu, F-63039 Clermont Ferrand, France; [Alberti, Adriana; Barbe, Valerie; Wincker, Patrick] Ctr Natl Sequencage, Commissariat IEnergie Atom Genoscope, 2 rue Gaston Cremieux, F-91057 Evry, France; [Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Handa, Hirokazu] Natl Inst Agrobiol Sci, Plant Genome Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan; [Ogihara, Yasunari] Yokohama City Univ, Kihara Inst Biol Res, Maioka cho 641-12 Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; [Sharpe, Andrew; Klassen, Darrin] Natl Res Council Canada, 110 Gymnasium Pl, Saskatoon, SK S7N 0W9, Canada; [Edwards, David; Batley, Jacqueline] Univ Queensland, Sch Agr & Food Sci, Australian Ctr Plant Funct Genom, St Lucia, Qld 4072, Australia; [Edwards, David; Batley, Jacqueline] Univ Western Australia, Sch Plant Biol, Nedlands, WA 6009, Australia; [Sandve, Simen R.; Olsen, Odd-Arne] Norwegian Univ Life Sci, Dept Plant Sci, Ctr Integrat Genet CIGENE, N-1432 As, Norway; [Olsen, Odd-Arne] Hedmark Univ Coll, Dept Nat Sci & Technol, N-2318 Oslo, Norway; [Wulff, Brande B. H.; Steuernagel, Burkhard] Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Mascher, Martin; Scholz, Uwe] Leibniz Inst Plant Genet & Crop Plant Res IPK, Bioinformat & Informat Technol, D-06466 Seeland OT Gatersleben, Germany; [Chapman, Jarrod; Barry, Kerrie; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA; [Poland, Jesse A.] Kansas State Univ, Dept Agron, USDA ARS Hard Winter Wheat Genet Res Unit, Manhattan, KS 66506 USA; [Waugh, Robbie] James Hutton Inst, Invergowrie, Dundee DD2 5DA, Scotland; [Muehlbauer, Gary J.] Univ Minnesota, Dept Agron & Plant Genet, Dept Plant Biol, St Paul, MN 55108 USA; [Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK, Genome Div, D-06466 Seeland OT Gatersleben, Germany; [Jamilloux, Veronique; Quesneville, Hadi; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Viseux, Claire; Loaec, Mikael] INRA Versailles, UR1164 URGI Research Unit Genom Info, INRA, Route Saint Cyr, F-78026 Versailles, France; [Wicker, Thomas; Keller, Beat] Univ Zurich, Inst Plant Biol, Zollikerstrasse 107, CH-8008 Zurich, Switzerland; [Faccioli, Primetta; Colaiacovo, Moreno; Stanca, Antonio Michele; Cattivelli, Luigi] Consiglio Ric Sperimentazione Agricoltura Gen Res, Via San Protaso 302, I-29017 Fjorenzuola dArda, Italy; [Budak, Hikmet] Sabanci Univ, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey; [Appels, Rudi; Bellgard, Matthew; Chapman, Brett] Murdoch Univ, Ctr Comparat Genom, Perth, WA 6150, Australia; [Knox, Ron] Semiarid Prairie Agr Res Ctr, Post Off Box 1030, Swift Current, SK S9H 3X2, Canada; [Kilian, Andrzej] Div Arrays Technol Pty Ltd, 1 Wilf Crane Crescent, Yarralumla ACT2600, Australia; [Rimbert, Helene] Ctr Rech Chappes, Biogemma, Route dEnnezat, F-63720 Chappes, France; [Lien, Sigbjorn] Norwegian Univ Life Sci, Dept Anim & Aquicultural Sci, CIGENE, Arboretvelen 6, N-1432 As, Norway	Norwegian University of Life Sciences; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Oslo; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Saskatchewan; Bayer AG; Bayer CropScience; Kansas State University; University of California System; University of California Riverside; Kyoto University; University of Dundee; The Genome Analysis Centre (TGAC); Punjab Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); University of Delhi; INRAE; UDICE-French Research Universities; Universite Paris Saclay; National Institute of Agrobiological Sciences - Japan; Yokohama City University; National Research Council Canada; University of Queensland; University of Western Australia; Norwegian University of Life Sciences; Inland Norway University of Applied Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Kansas State University; James Hutton Institute; University of Minnesota System; University of Minnesota Twin Cities; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Zurich; Sabanci University; Murdoch University; Norwegian University of Life Sciences	Sandve, SR (corresponding author), Norwegian Univ Life Sci, Dept Plant Sci, N-1432 As, Norway.	simen.sandve@nmbu.no	Budak, Hikmet/S-5835-2017; Wicker, Thomas/Z-1978-2019; Sourdille, Pierre/CAF-2780-2022; Simkova, Hana/F-7734-2014; Wu, Jian/AAU-5221-2020; Wulff, Brande BH/C-7465-2013; Dolezel, Jaroslav/B-7716-2008; Quesneville, Hadi/AAG-1048-2020; Mayer, Klaus FX/M-7941-2015; Eversole, Kellye/AAN-6141-2020; Wulff, Brande B/N-4273-2013; Edwards, David/H-3710-2015; cattivelli, luigi/AAE-7046-2020; Batley, Jacqueline/A-5723-2008; Sharma, Sapna/N-6357-2017; Budak, Hikmet/U-8517-2019; Kubaláková, Marie/F-8269-2014; Pingault, Lise/AAQ-8602-2020; Marcussen, Thomas/I-7768-2019; Pfeifer, Matthias/GRJ-4579-2022; Stein, Nils/F-7507-2017; Barry, Kerrie Whitelaw/AAA-5500-2020; Wang, Shichen/E-6213-2012; Ramírez, Ricardo/H-4808-2019; Wu, Jian/AAU-5221-2020	Budak, Hikmet/0000-0002-2556-2478; Simkova, Hana/0000-0003-4159-7619; Wu, Jian/0000-0001-9933-7364; Wulff, Brande BH/0000-0003-4044-4346; Dolezel, Jaroslav/0000-0002-6263-0492; Quesneville, Hadi/0000-0003-3001-4908; Mayer, Klaus FX/0000-0001-6484-1077; Eversole, Kellye/0000-0002-8784-4913; Edwards, David/0000-0001-7599-6760; cattivelli, luigi/0000-0002-6067-4600; Batley, Jacqueline/0000-0002-5391-5824; Budak, Hikmet/0000-0002-2556-2478; Pingault, Lise/0000-0002-6149-1267; Stein, Nils/0000-0003-3011-8731; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Wang, Shichen/0000-0003-1441-2252; Ramírez, Ricardo/0000-0001-5745-7085; Gundlach, Heidrun/0000-0002-6757-0943; Singh, Kuldeep/0000-0001-5239-6586; Martis, Mihaela-Maria/0000-0001-7509-2446; Alaux, Michael/0000-0001-9356-4072; Jamilloux, Veronique/0000-0002-6898-4910; Colaiacovo, Moreno/0000-0003-1320-0506; Steuernagel, Burkhard/0000-0002-8284-7728; Bellgard, Matthew/0000-0002-6303-9469; Spannagl, Manuel/0000-0003-0701-7035; , Thomas/0000-0002-6777-7135; Kilian, Andrzej/0000-0002-2730-7462; Keller, Beat/0000-0003-2379-9225; Marcussen, Thomas/0000-0002-1960-9508; Wu, Jian/0000-0002-3394-1507; Sourdille, Pierre/0000-0002-1027-2224; Scholz, Uwe/0000-0001-6113-3518	Norwegian Research Council [199387]; BBSRC [BB/J003166/1, BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BB/J003166/1] Funding Source: researchfish; Division Of Computer and Network Systems [1126709] Funding Source: National Science Foundation	Norwegian Research Council(Research Council of NorwayEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was financed by Norwegian Research Council grant 199387 to Norwegian University of Life Sciences and Graminor AS to O.-A.O. The phylogenetic analyses were run, in part, on the Bioportal supercomputing facility at the University of Oslo. We thank C.-P. Antoine and two anonymous reviewers for valuable comments on the manuscript and S. Saebo for help on implementation of the OpenBUGS analyses in R. Ortholog alignments, gene trees, and the OpenBUGS model used for multispecies coalescent modeling can be downloaded from Dryad (data available from the Dryad Digital Repository: http://doi.org/10.5061/dryad.f6c34).	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Akhunov ED, 2005, THEOR APPL GENET, V111, P1617, DOI 10.1007/s00122-005-0093-1; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Doyle JJ, 2010, NEW PHYTOL, V186, P73, DOI 10.1111/j.1469-8137.2009.03118.x; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dvorak J, 2005, GENETICS, V171, P323, DOI 10.1534/genetics.105.041632; Eroukhmanoff F, 2013, CURR ZOOL, V59, P667, DOI 10.1093/czoolo/59.5.667; Escobar JS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-181; Fan X, 2013, BIOCHEM SYST ECOL, V50, P346, DOI 10.1016/j.bse.2013.05.010; Heun M, 1997, SCIENCE, V278, P1312, DOI 10.1126/science.278.5341.1312; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Lev-Yadun S, 2000, SCIENCE, V288, P1602, DOI 10.1126/science.288.5471.1602; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lotsy J. P., 1916, EVOLUTION BY MEANS O; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; MCFADDEN ES, 1946, J HERED, V37, P81, DOI 10.1093/oxfordjournals.jhered.a105590; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Pfeifer M, 2014, SCIENCE, V345, DOI 10.1126/science.1250091; Riehl S, 2013, SCIENCE, V341, P65, DOI 10.1126/science.1236743; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Stromberg CAE, 2011, ANNU REV EARTH PL SC, V39, P517, DOI 10.1146/annurev-earth-040809-152402; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Than C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-322; Vigeland MD, 2013, NEW PHYTOL, V199, P1060, DOI 10.1111/nph.12337; Yu Y, 2013, SYST BIOL, V62, P738, DOI 10.1093/sysbio/syt037	35	418	445	17	268	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194			SI				1250092	10.1126/science.1250092	http://dx.doi.org/10.1126/science.1250092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR2MB	25035499				2022-12-28	WOS:000343420300003
J	Dyer, C				Dyer, Clare			BRIEFING Scottish health in a post-independence world	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London, England		Dyer, C (corresponding author), BMJ, London, England.	claredyer4@gmail.com						Anderson Strathern Solicitors, NOT U SCOTL RES REQ; Carrell S, 2014, GUARDIAN; HM Government, 2013, SCOTT AN SCI RES; Law Society of Scotland, 2013, SCOTL CONST FUT VIEW; National Audit Office, 2012, HEALTHC UK COMP NHS; Scottish Government, 2013, SCOTL FUT YOUR GUID; Simpson R., 2014, HLTH SCOTLAND    MAR	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2014	349								g4456	10.1136/bmj.g4456	http://dx.doi.org/10.1136/bmj.g4456			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7PI	25034036				2022-12-28	WOS:000339326400005
J	Gorgolas, M; Cuadros, J				Gorgolas, Miguel; Cuadros, Juan			Video Photomicroscopy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gorgolas, Miguel] Fdn Jimenez Diaz, E-28040 Madrid, Spain; [Cuadros, Juan] Hosp Univ Principe Asturias, Madrid, Spain	Prince of Asturias University Hospital	Gorgolas, M (corresponding author), Fdn Jimenez Diaz, E-28040 Madrid, Spain.	mgorgolas@fjd.es	Gonzalez, Juan Cuadros/E-8697-2015	Gonzalez, Juan Cuadros/0000-0003-4098-4377					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2014	371	3					261	261	e4	10.1056/NEJMicm1105786	http://dx.doi.org/10.1056/NEJMicm1105786			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL3BK	25014709				2022-12-28	WOS:000338999800010
J	Bekker, LG; Johnson, L; Cowan, F; Overs, C; Besada, D; Hillier, S; Cates, W				Bekker, Linda-Gail; Johnson, Leigh; Cowan, Frances; Overs, Cheryl; Besada, Donela; Hillier, Sharon; Cates, Willard, Jr.			Combination HIV prevention for female sex workers: what is the evidence?	LANCET			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL THERAPY; HIGH-RISK; POPULATION-LEVEL; CONDOM USE; HETEROSEXUAL MEN; HIV/STI RISK; DOUBLE-BLIND; VIRAL LOAD	Sex work occurs in many forms and sex workers of all genders have been affected by HIV epidemics worldwide. The determinants of HIV risk associated with sex work occur at several levels, including individual biological and behavioural, dyadic and network, and community and social environmental levels. Evidence indicates that effective HIV prevention packages for sex workers should include combinations of biomedical, behavioural, and structural interventions tailored to local contexts, and be led and implemented by sex worker communities. A model simulation based on the South African heterosexual epidemic suggests that condom promotion and distribution programmes in South Africa have already reduced HIV incidence in sex workers and their clients by more than 70%. Under optimistic model assumptions, oral pre-exposure prophylaxis together with test and treat programmes could further reduce HIV incidence in South African sex workers and their clients by up to 40% over a 10-year period. Combining these biomedical approaches with a prevention package, including behavioural and structural components as part of a community-driven approach, will help to reduce HIV infection in sex workers in different settings worldwide.	[Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7705 Observatory, South Africa; [Johnson, Leigh] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7705 Observatory, South Africa; [Cowan, Frances] UCL, Res Dept Infect & Populat Hlth, London, England; [Cowan, Frances] Ctr Sexual Hlth & HIV AIDS Res CeSHHAR Zimbabwe, Harare, Zimbabwe; [Overs, Cheryl] Michael Kirby Ctr Publ Hlth & Human Rights, Melbourne, Vic, Australia; [Besada, Donela] Desmond Tutu HIV Fdn, Cape Town, South Africa; [Hillier, Sharon] Unvers Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Cates, Willard, Jr.] FHI 360, Durham, NC USA	University of Cape Town; University of Cape Town; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; FHI 360	Bekker, LG (corresponding author), Univ Cape Town, Fac Hlth Sci, Desmond Tutu HIV Ctr, Anzio Rd, ZA-7705 Observatory, South Africa.	Linda-Gail.Bekker@hiv-research.org.za	Bekker, Linda-Gail/AAZ-8929-2020	Cowan, Frances/0000-0003-3087-4422; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Besada, Donela/0000-0002-2020-5244	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); UCT CTU grant [2UM1AI069519-08]; NIH [1R01AI094586-01]; Hasso Plattner Foundation; NIAID; Microbicide Trials Network [1UM1AI068633]; USAID Preventive Technologies [GHO-A-00-09-00016-00]; NIH HIV Prevention Trials Network [1U01A1068619-01]; Center for Public Health and Human Rights at Johns Hopkins Bloomberg School of Public Health; Bill & Melinda Gates Foundation; United Nations Family Planning Association (UNFPA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069519, UM1AI068633, R01AI094586] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCT CTU grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hasso Plattner Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Microbicide Trials Network; USAID Preventive Technologies(United States Agency for International Development (USAID)); NIH HIV Prevention Trials Network; Center for Public Health and Human Rights at Johns Hopkins Bloomberg School of Public Health; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); United Nations Family Planning Association (UNFPA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	L-GB is supported in part by National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), UCT CTU grant 2UM1AI069519-08. LJ received support from NIH (1R01AI094586-01) and Hasso Plattner Foundation. SH received support from NIAID, Microbicide Trials Network (1UM1AI068633). WC received support from USAID Preventive Technologies Agreement (GHO-A-00-09-00016-00) and NIAID, NIH HIV Prevention Trials Network (1U01A1068619-01). This article and The Lancet Series on HIV and sex workers was supported by grants to the Center for Public Health and Human Rights at Johns Hopkins Bloomberg School of Public Health from The Bill & Melinda Gates Foundation and from The United Nations Family Planning Association (UNFPA).	Abdool Karim Quarraisha, 2010, Science, V329, P1168, DOI 10.1126/science.1193748; Ainsworth M, 2003, HEALTH POLICY, V64, P13, DOI 10.1016/S0168-8510(02)00079-9; Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; [Anonymous], 2008, OPEN DEMOGRAPHY J, DOI [DOI 10.2174/1874918600801010001, 10.2174/1874918600801010001]; [Anonymous], 2013, 20 C RETR OPP INF AT, DOI DOI 10.1056/NEJM0A1402269; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2013, JAIDS-J ACQ IMM DEF, V63, pS122, DOI 10.1097/QAI.0b013e3182986f69; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Baral SD, 2015, LANCET, V385, P260, DOI 10.1016/S0140-6736(14)60801-1; Baral SD, 2013, LANCET INFECT DIS, V13, P13, DOI 10.1016/S1473-3099(12)70319-5; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; Beyrer C, 2015, LANCET, V385, P287, DOI 10.1016/S0140-6736(14)60933-8; Birungi J, 2012, J INT AIDS SOC, V15, P144; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Boily MC, 2013, AIDS, V27, P1449, DOI 10.1097/QAD.0b013e32835fba81; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Braunstein SL, 2011, JAIDS-J ACQ IMM DEF, V57, pE70, DOI 10.1097/QAI.0b013e3182170fd3; Brown, 2021, PEOPLE MANAGEMENT; Brown B, 2012, SEX WORKERS INTRO MA; Buzdugan R, 2009, TROP MED INT HEALTH, V14, P673, DOI 10.1111/j.1365-3156.2009.02278.x; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Centers for Disease Control and Prevention, 2021, PREEXP PROPH PREV HI; Chersich MF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17980; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cornman H, 2012, 1 USAID AIDSTARONE; Cowan FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077080; de Walque D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000747; Delva W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028363; Diabate S, 2011, WORLD J AIDS, V1, P94, DOI [10.4236/wja.2011.13014, DOI 10.4236/WJA.2011.13014]; Dickinson C, 2009, B WORLD HEALTH ORGAN, V87, P846, DOI 10.2471/BLT.08.059279; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dunkle KL, 2005, INT J STD AIDS, V16, P256, DOI 10.1258/0956462053420220; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; FACTS Consortium, FACTS 001 STUD DES; Folch C, 2009, MED CLIN-BARCELONA, V132, P385, DOI 10.1016/j.medcli.2008.05.019; Foss AM, 2003, AIDS, V17, P1227, DOI 10.1097/00002030-200305230-00015; French PP, 2003, SEX TRANSM DIS, V30, P433, DOI 10.1097/00007435-200305000-00010; Galarraga O, EUR J HLTH EC, V15, P41; Ghose T, 2011, QUAL HEALTH RES, V21, P587, DOI 10.1177/1049732310395328; Gomez GB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001401; GOSTIN LO, 1994, JAMA-J AM MED ASSOC, V271, P1436, DOI 10.1001/jama.271.18.1436; Gouws E, 2012, SEX TRANSM INFECT, V88, pI76, DOI 10.1136/sextrans-2012-050719; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; GROSSKURTH H, 1995, AIDS, V9, P927, DOI 10.1097/00002030-199508000-00015; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; Guest PP BJ, 2007, SURVEY SEXUAL REPROD; Hallett TB, 2008, INT J EPIDEMIOL, V37, P77, DOI 10.1093/ije/dym232; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; Harcourt C, 2010, AUST NZ J PUBL HEAL, V34, P482, DOI 10.1111/j.1753-6405.2010.00594.x; Hargreaves J, 2013, 17 ICASA C CAP TOWN; Heffron R, 2012, JAIDS-J ACQ IMM DEF, V61, P116, DOI 10.1097/QAI.0b013e31825da73f; Heise L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18615; Holmes K, 2007, LANCET INFECT DIS, V7, P516; Hong Y, 2008, SEX TRANSM DIS, V35, P662, DOI 10.1097/OLQ.0b013e31816b322c; Hong Y, 2012, AIDS BEHAV, V16, P44, DOI 10.1007/s10461-011-9960-8; Huet Charlotte, 2011, BMC Public Health, V11, P700, DOI 10.1186/1471-2458-11-700; Human Rights Watch, 2003, FANN FLAM HUM RIGHTS; Illife J., 2006, AFRICAN AIDS EPIDEMI; Izulla P, 2013, JAIDS-J ACQ IMM DEF, V62, P220, DOI 10.1097/QAI.0b013e318278ba1b; Jana S, 2006, LANCET, V367, P814, DOI 10.1016/S0140-6736(06)68331-1; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Jia ZW, 2013, LANCET, V382, P1195, DOI 10.1016/S0140-6736(12)61898-4; Johnson LFD, 2021, THEMBISA VERSION 4 4; Jones A, 2014, LANCET, V384, P272, DOI 10.1016/S0140-6736(13)62230-8; Kahle EM, 2013, JAIDS-J ACQ IMM DEF, V62, P339, DOI 10.1097/QAI.0b013e31827e622d; KARIM QA, 1995, AM J PUBLIC HEALTH, V85, P1521, DOI 10.2105/AJPH.85.11.1521; Karim QA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-67; Karmon E, 2003, JAIDS-J ACQ IMM DEF, V34, P71, DOI 10.1097/00126334-200309010-00011; Kaul R, 2004, JAMA-J AM MED ASSOC, V291, P2555, DOI 10.1001/jama.291.21.2555; Kayigamba FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036792; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; Kerrigan D, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9774-9; Kerrigan D., 2001, Culture, Health & Sexuality, V3, P221, DOI 10.1080/136910501750153049; Kerrigan D, 2014, LANCET; Kerrigan DL, 2013, AIDS BEHAV, V17, P1926, DOI 10.1007/s10461-013-0458-4; Kriitmaa K, 2010, AIDS, V24, pS61, DOI 10.1097/01.aids.0000386735.87177.2a; Kulkarni Prasad S., 2003, AIDS Reviews, V5, P87; Labbe AC, 2003, 15 BIENN C INT SOC S, P27; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Lippman SA, 2010, AM J PUBLIC HEALTH, V100, pS216, DOI 10.2105/AJPH.2008.147462; Lowndes CM, 2003, SEX TRANSM DIS, V30, P46, DOI 10.1097/00007435-200301000-00010; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; Mamaev T., 2007, MIKROBIOL EPIDEMIOL, V3, P72; Manhart LE, 2005, J INFECT DIS, V191, pS7, DOI 10.1086/425275; Marum E, 2012, JAIDS-J ACQ IMM DEF, V60, pS63, DOI 10.1097/QAI.0b013e31825f313b; McClelland RS, 2010, AIDS, V24, P891, DOI 10.1097/QAD.0b013e32833616c7; Michael M, 2013, HEALTH TECHNOL SOC, P1, DOI 10.1057/9781137316677; MILLS E.J., 2005, BMC INT HEALTH HUM R, V5, P1; Morar NS, 1998, S AFR MED J, V88, P470; Mugwanya KK, 2013, LANCET INFECT DIS, V13, P1021, DOI 10.1016/S1473-3099(13)70226-3; Munoz J, 2010, SAHARA J-J SOC ASP H, V7, P52, DOI 10.1080/17290376.2010.9724957; Murnane PM, 2013, AIDS, V27, P2155, DOI 10.1097/QAD.0b013e3283629037; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Nel AM, 2011, J WOMENS HEALTH, V20, P1207, DOI 10.1089/jwh.2010.2476; Ng M, 2011, LANCET, V378, P1643, DOI 10.1016/S0140-6736(11)61390-1; Ngo AD, 2007, AIDS CARE, V19, P878, DOI 10.1080/09540120601163078; Ngugi EN BE, 1999, PREVENTING HIV DEV C, P205; Nnorom J, 2008, W AFRICA HIV AIDS EP; Overs C, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18459; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; Pathfinder International, 2004, COMB PREV HIV TECHN; Pickles M, 2013, LANCET GLOB HEALTH, V1, pE289, DOI 10.1016/S2214-109X(13)70083-4; Pleaner M, 2009, RHRU SUPPORT SEX WOR; Population Council, COMM APPR GOV POL RE; Poteat T, 2015, LANCET, V385, P274, DOI 10.1016/S0140-6736(14)60833-3; Pretorius C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013646; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ramjee G, 1998, SEX TRANSM DIS, V25, P346, DOI 10.1097/00007435-199808000-00004; Roberts L, 2011, 18 C RETR OPP INF FE; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; Rou KM, 2010, INT J EPIDEMIOL, V39, pII38, DOI 10.1093/ije/dyq211; Rustomjee R, 1999, AIDS, V13, P1511, DOI 10.1097/00002030-199908200-00011; Scambler G, 2008, SOC SCI MED, V66, P1848, DOI 10.1016/j.socscimed.2008.01.002; Scheibe A, 2012, SAHARA J-J SOC ASP H, V9, P167, DOI 10.1080/17290376.2012.743809; Scorgie F, 2011, I EXPECT ABUSED I HA; Sex Workers Education and Advocacy Taskforce, SEX WORK S AFR RAP P; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Shannon K, 2005, J URBAN HEALTH, V82, P488, DOI 10.1093/jurban/jti076; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090; Sibongile Mtetwa FMC, SISTERS VOICE; Simoni JM, 2011, AIDS BEHAV, V15, P376, DOI 10.1007/s10461-010-9836-3; Singh JA, 2005, PLOS MED, V2, P824, DOI 10.1371/journal.pmed.0020234; Steen R, 2012, AIDS, V26, P437, DOI 10.1097/QAD.0b013e32834ed991; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Strathdee SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065812; SWEAT, 2004, WORK WIS SEX WORK HD; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tucker JD, 2013, CURR OPIN INFECT DIS, V26, P73, DOI 10.1097/QCO.0b013e32835c21b0; Ulibarri MD, 2010, PSYCHOL TRAUMA-US, V2, P318, DOI 10.1037/a0017500; UNAIDS, 2006, RISK NEGL 4 KEY POP; UNAIDS, 2012, GLOB REP GLOB AIDS E; UNAIDS, 2013, GLOB HIV AIDS REP; UNAIDS, 2010, REP GLOB AIDS EP; UNAIDS A, 2007, GOOD PART PRACT GUID; UNAIDS World Bank, 2009, GLOB EC CRIS PREV TR; Underhill K, 2010, JAIDS-J ACQ IMM DEF, V55, P8, DOI 10.1097/QAI.0b013e3181e8efe4; UNFPA, 2010, HIV SEX WORK PREV HI; USAID, 2013, DHS COMP REPORTS, V30; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2012, AIDS BEHAV, V16, P1775, DOI 10.1007/s10461-012-0215-0; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Varga C A, 1997, Afr J Reprod Health, V1, P74, DOI 10.2307/3583277; Verma R, 2010, SEX TRANSM INFECT, V86, pI76, DOI 10.1136/sti.2009.039115; Vickerman P, 2006, SEX TRANSM DIS, V33, P397, DOI 10.1097/01.olq.0000218974.77208.cc; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; Wang Y, 2009, AIDS BEHAV, V13, P866, DOI 10.1007/s10461-008-9446-5; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Watts C, 2010, SEX TRANSM INFECT, V86, P85, DOI 10.1136/sti.2010.044602; Weeks MR, 2004, SEX TRANSM DIS, V31, P682, DOI 10.1097/01.olq.0000143113.04524.a5; WELLER SC, 1993, SOC SCI MED, V36, P1635, DOI 10.1016/0277-9536(93)90352-5; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; WHO (World Health Organization), 2005, VIOL WOM HIV AIDS CR; Wirtz AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088047; Witte SS, 1999, INT J STD AIDS, V10, P162, DOI 10.1258/0956462991913826; World Health Organization, 2012, GU OR PRE PROPHYL PR; World Health Organization, 2011, PREV HIV SEX WORK SU; World Health Organization, 2013, PREP DEM PROJ FRAM C; Yam EA, 2013, SEX TRANSM DIS, V40, P406, DOI 10.1097/OLQ.0b013e318283c16d; Yao XD, 2014, MUCOSAL IMMUNOL, V7, P268, DOI 10.1038/mi.2013.44	173	148	153	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					72	87		10.1016/S0140-6736(14)60974-0	http://dx.doi.org/10.1016/S0140-6736(14)60974-0			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX8IW	25059942				2022-12-28	WOS:000347154200029
J	Bhatia, S; Thompson, JA				Bhatia, Shailender; Thompson, John A.			Melanoma: immune checkpoint blockade story gets better	LANCET			English	Editorial Material							METASTATIC MELANOMA; IMPROVED SURVIVAL; MEK INHIBITION; SAFETY; BRAF; ANTI-PD-1		[Thompson, John A.] Univ Washington, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Seattle Cancer Care Alliance	Thompson, JA (corresponding author), Univ Washington, Seattle, WA 98195 USA.	jat@uw.edu	Thompson, John A/T-7985-2019	Thompson, John A/0000-0002-0872-7306				Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bhatia S, 2012, J NATL COMPR CANC NE, V10, P403, DOI 10.6004/jnccn.2012.0037; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Robert C, 2014, LANCET; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690	11	9	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					1078	1079		10.1016/S0140-6736(14)61140-5	http://dx.doi.org/10.1016/S0140-6736(14)61140-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PU	25034863				2022-12-28	WOS:000342630600011
J	Behjati, S; Huch, M; van Boxtel, R; Karthaus, W; Wedge, DC; Tamuri, AU; Martincorena, I; Petljak, M; Alexandrov, LB; Gundem, G; Tarpey, PS; Roerink, S; Blokker, J; Maddison, M; Mudie, L; Robinson, B; Nik-Zainal, S; Campbell, P; Goldman, N; van de Wetering, M; Cuppen, E; Clevers, H; Stratton, MR				Behjati, Sam; Huch, Meritxell; van Boxtel, Ruben; Karthaus, Wouter; Wedge, David C.; Tamuri, Asif U.; Martincorena, Inigo; Petljak, Mia; Alexandrov, Ludmil B.; Gundem, Gunes; Tarpey, Patrick S.; Roerink, Sophie; Blokker, Joyce; Maddison, Mark; Mudie, Laura; Robinson, Ben; Nik-Zainal, Serena; Campbell, Peter; Goldman, Nick; van de Wetering, Marc; Cuppen, Edwin; Clevers, Hans; Stratton, Michael R.			Genome sequencing of normal cells reveals developmental lineages and mutational processes	NATURE			English	Article							LGR5(+VE) STEM-CELLS; 21 BREAST CANCERS; SOMATIC MUTATIONS; SMALL-INTESTINE; SELF-RENEWAL; IN-VITRO; LGR5; COLON; FATE; HOMEOSTASIS	The somatic mutations present in the genome of a cell accumulate over the lifetime of a multicellular organism. These mutations can provide insights into the developmental lineage tree(1), the number of divisions that each cell has undergone and the mutational processes that have been operative(2). Here we describe whole genomes of clonal lines(3) derived from multiple tissues of healthy mice. Using somatic base substitutions, we reconstructed the early cell divisions of each animal, demonstrating the contributions of embryonic cells to adult tissues. Differences were observed between tissues in the numbers and types of mutations accumulated by each cell, which likely reflect differences in the number of cell divisions they have undergone and varying contributions of different mutational processes. If somatic mutation rates are similar to those in mice, the results indicate that precise insights into development and mutagenesis of normal human cells will be possible.	[Behjati, Sam; Wedge, David C.; Martincorena, Inigo; Petljak, Mia; Alexandrov, Ludmil B.; Gundem, Gunes; Tarpey, Patrick S.; Roerink, Sophie; Maddison, Mark; Mudie, Laura; Robinson, Ben; Nik-Zainal, Serena; Campbell, Peter; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, Cambs, England; [Behjati, Sam] Univ Cambridge, Dept Paediat, Cambridge CB2 2XY, England; [Huch, Meritxell; van Boxtel, Ruben; Karthaus, Wouter; Blokker, Joyce; van de Wetering, Marc; Cuppen, Edwin; Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, CancerGenom Nl, NL-3584 CT Utrecht, Netherlands; [Huch, Meritxell; van Boxtel, Ruben; Karthaus, Wouter; Blokker, Joyce; van de Wetering, Marc; Cuppen, Edwin; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Goldman, Nick] European Bioinformat Inst, European Mol Biol Lab, Hinxton CB10 1SA, Cambs, England; [Nik-Zainal, Serena] Cambridge Univ Hosp NHS Fdn Trust, East Anglian Med Genet Serv, Cambridge CB2 0QQ, England	Wellcome Trust Sanger Institute; University of Cambridge; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; European Molecular Biology Laboratory (EMBL); University of Cambridge	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	mrs@sanger.ac.uk	Cuppen, Edwin/H-2389-2016; Nik-Zainal, Serena/ABD-4437-2020; Alexandrov, Ludmil/AAS-1454-2021; Cuppen, Edwin/F-5696-2011; Wedge, David/AAC-4977-2021	Cuppen, Edwin/0000-0002-0400-9542; Alexandrov, Ludmil/0000-0003-3596-4515; Cuppen, Edwin/0000-0002-0400-9542; van Boxtel, Ruben/0000-0003-1285-2836; Nik-Zainal, Serena/0000-0001-5054-1727; Behjati, Sam/0000-0002-6600-7665; Goldman, Nick/0000-0001-8486-2211; Wedge, David/0000-0002-7572-3196; Martincorena, Inigo/0000-0003-1122-4416; Tamuri, Asif/0000-0001-6633-3789; Karthaus, Wouter R./0000-0002-9234-9044	Wellcome Trust [077012/Z/05/Z]; Kadoorie Charitable Foundation; Louis-Jeantet Foundation; Marie Curie IEF fellowship [EU/236954]; ERC [232814]; Netherlands Genomics Initiative [935.12.003]; Centre for Biomedical Genetics, Utrecht; EMBO Long Term Fellowship [ALTF-1287-2012]; Wellcome Trust Intermediate Clinical Fellowship [WT100183MA]; Wellcome-Beit Prize Fellowship; Wellcome Trust Research Training Fellowship for Clinicians; Wellcome Trust Senior Research Fellowship in Clinical Science	Wellcome Trust(Wellcome TrustEuropean Commission); Kadoorie Charitable Foundation; Louis-Jeantet Foundation; Marie Curie IEF fellowship(European Commission); ERC(European Research Council (ERC)European Commission); Netherlands Genomics Initiative; Centre for Biomedical Genetics, Utrecht; EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); Wellcome-Beit Prize Fellowship; Wellcome Trust Research Training Fellowship for Clinicians; Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust)	We thank M. Zernicka-Goetz and the Goldman group for discussion of our findings. This work was supported by funding from the Wellcome Trust (grant reference 077012/Z/05/Z), the Kadoorie Charitable Foundation and the Louis-Jeantet Foundation. Individual authors were supported as follows: M. H., Marie Curie IEF fellowship (EU/236954) and ERC grant (232814); R. B. and E. C., Zenith grant of the Netherlands Genomics Initiative (935.12.003); W. K., Centre for Biomedical Genetics, Utrecht; I. M., EMBO Long Term Fellowship (ALTF-1287-2012); S.N.Z., Wellcome Trust Intermediate Clinical Fellowship (WT100183MA) and Wellcome-Beit Prize Fellowship 2013; S. B., Wellcome Trust Research Training Fellowship for Clinicians; and P. C., Wellcome Trust Senior Research Fellowship in Clinical Science.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Barker N, 2008, COLD SH Q B, V73, P351, DOI 10.1101/sqb.2008.72.003; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bruce AW, 2010, CURR OPIN GENET DEV, V20, P485, DOI 10.1016/j.gde.2010.05.006; Carlson CA, 2012, NAT METHODS, V9, P78, DOI [10.1038/nmeth.1781, 10.1038/NMETH.1781]; De S, 2011, TRENDS GENET, V27, P217, DOI 10.1016/j.tig.2011.03.002; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Kennedy SR, 2012, MECH AGEING DEV, V133, P118, DOI 10.1016/j.mad.2011.10.009; Lasken RS, 2013, NAT BIOTECHNOL, V31, P211, DOI 10.1038/nbt.2523; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leushacke M, 2013, CELL REP, V5, P349, DOI 10.1016/j.celrep.2013.09.025; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Plusa B, 2005, NATURE, V434, P391, DOI 10.1038/nature03388; Salipante SJ, 2006, P NATL ACAD SCI USA, V103, P5448, DOI 10.1073/pnas.0601265103; Salipante SJ, 2007, CURR TOP DEV BIOL, V79, P157, DOI 10.1016/S0070-2153(06)79006-8; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Shibata D, 2006, CELL CYCLE, V5, P610, DOI 10.4161/cc.5.6.2570; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; Wasserstrom A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001939; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186; Zhou WY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-39	30	222	226	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					422	+		10.1038/nature13448	http://dx.doi.org/10.1038/nature13448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043003	Green Accepted			2022-12-28	WOS:000341814900061
J	Palmer, J; Boyce, N				Palmer, Joanna; Boyce, Niall			The Wakley Essay Prize 2014: the best of both worlds	LANCET			English	Editorial Material									[Palmer, Joanna] The Lancet, London NW1 7BY, England; [Boyce, Niall] Lancet Psychiat, London NW1 7BY, England		Palmer, J (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2014	384	9940					290	291		10.1016/S0140-6736(14)61189-2	http://dx.doi.org/10.1016/S0140-6736(14)61189-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM3AE	25066149				2022-12-28	WOS:000339722400008
J	Godefroit, P; Sinitsa, SM; Dhouailly, D; Bolotsky, YL; Sizov, AV; McNamara, ME; Benton, MJ; Spagna, P				Godefroit, Pascal; Sinitsa, Sofia M.; Dhouailly, Danielle; Bolotsky, Yuri L.; Sizov, Alexander V.; McNamara, Maria E.; Benton, Michael J.; Spagna, Paul			A Jurassic ornithischian dinosaur from Siberia with both feathers and scales	SCIENCE			English	Article							INTEGUMENTARY STRUCTURES; CHINA; THEROPOD; ORIGIN; EVOLUTION; PLUMAGE; FOSSILS; COLOR; BIRDS	Middle Jurassic to Early Cretaceous deposits from northeastern China have yielded varied theropod dinosaurs bearing feathers. Filamentous integumentary structures have also been described in ornithischian dinosaurs, but whether these filaments can be regarded as part of the evolutionary lineage toward feathers remains controversial. Here we describe a new basal neornithischian dinosaur from the Jurassic of Siberia with small scales around the distal hindlimb, larger imbricated scales around the tail, monofilaments around the head and the thorax, and more complex featherlike structures around the humerus, the femur, and the tibia. The discovery of these branched integumentary structures outside theropods suggests that featherlike structures coexisted with scales and were potentially widespread among the entire dinosaur clade; feathers may thus have been present in the earliest dinosaurs.	[Godefroit, Pascal; Spagna, Paul] Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, B-1000 Brussels, Belgium; [Sinitsa, Sofia M.] Inst Nat Resources Ecol & Cryol, Chita 672014, Russia; [Dhouailly, Danielle] Univ Grenoble 1, AGIM, UJF CNRS FRE 3405, F-38706 La Tronche, France; [Bolotsky, Yuri L.] FEB RAS, Inst Geol & Nat Management, Blagoveshchensk, Russia; [Sizov, Alexander V.] SB RAS, Inst Earth Crust, Irkutsk, Russia; [McNamara, Maria E.] Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland; [McNamara, Maria E.; Benton, Michael J.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England	Royal Belgian Institute of Natural Sciences; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institute of Geology & Nature Management FEB RAS; Irkutsk Science Centre of the Russian Academy of Sciences; Institute of Earth's Crust of Siberian Branch of the Russian Academy of Sciences; Russian Academy of Sciences; University College Cork; University of Bristol	Godefroit, P (corresponding author), Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, Rue Vautier 29, B-1000 Brussels, Belgium.	pascal.godefroit@naturalsciences.be	Benton, Michael J/A-5639-2008; Sinitsa, Sofia/J-3201-2018; Sizov, Alexander/ABH-9485-2020; McNamara, Maria E/C-8431-2014	Benton, Michael J/0000-0002-4323-1824; Sinitsa, Sofia/0000-0002-5074-787X; Sizov, Alexander/0000-0002-3029-9686; McNamara, Maria E/0000-0003-0968-4624	Belgian Science Policy [BL/36/62]; Natural Environment Research Council [NE/I027630/1]; NERC [NE/I027630/1] Funding Source: UKRI	Belgian Science Policy(Belgian Federal Science Policy Office); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank A. B. Ptitsyn for making fossils available for study; Ph. Claeys, J.-M. Baele, and I. Y. Bolosky for help and comments on the manuscript; and P. Golinvaux, J. Dos Remedios Esteves, C. Desmedt, and A. Vandersypen for the drawings and reconstructions. This study was supported by Belgian Science Policy grant BL/36/62 to P. G. and by Natural Environment Research Council Standard Grant NE/I027630/1 awarded to M.J.B.	Bell PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031295; Brusatte SL, 2010, EARTH-SCI REV, V101, P68, DOI 10.1016/j.earscirev.2010.04.001; Buchwitz M, 2012, PALAEONTOL Z, V86, P313, DOI 10.1007/s12542-012-0135-3; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Currie PJ, 2001, CAN J EARTH SCI, V38, P1705, DOI 10.1139/e01-050; Dhouailly D, 2009, J ANAT, V214, P587, DOI 10.1111/j.1469-7580.2008.01041.x; Godefroit P, 2013, NATURE, V498, P359, DOI 10.1038/nature12168; Godefroit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2389; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Lingham-Soliar T, 2008, P ROY SOC B-BIOL SCI, V275, P775, DOI 10.1098/rspb.2007.1342; Lingham-Soliar T, 2007, P ROY SOC B-BIOL SCI, V274, P1823, DOI 10.1098/rspb.2007.0352; Lucas A., 1972, AVIAN ANATOMY INTEGU; Mayr G, 2002, NATURWISSENSCHAFTEN, V89, P361, DOI 10.1007/s00114-002-0339-6; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Prin F, 2004, INT J DEV BIOL, V48, P137, DOI 10.1387/ijdb.15272378; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Vickaryous MK, 2004, DINOSAURIA, 2ND EDITION, P363; Wang XL, 2002, CHINESE SCI BULL, V47, P226, DOI 10.1360/02tb9054; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zhang FC, 2006, GEOL J, V41, P395, DOI 10.1002/gj.1057; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740; Zheng XT, 2009, NATURE, V458, P333, DOI 10.1038/nature07856; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753	27	76	78	1	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					451	455		10.1126/science.1253351	http://dx.doi.org/10.1126/science.1253351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061209	Green Submitted			2022-12-28	WOS:000339655100043
J	Nissim, R; Pejkic, A; Myslivets, E; Kuo, BP; Alic, N; Radic, S				Nissim, R.; Pejkic, A.; Myslivets, E.; Kuo, B. P.; Alic, N.; Radic, S.			Ultrafast optical control by few photons in engineered fiber	SCIENCE			English	Article							WAVE	Fast control of a strong optical beam by a few photons is an outstanding challenge that limits the performance of quantum sensors and optical processing devices. We report that a fast and efficient optical gate can be realized in an optical fiber that has been engineered with molecular-scale accuracy. Highly efficient, distributed phase-matched photon-photon interaction was achieved in the fiber with locally controlled, nanometer-scale core variations. A three-photon input was used to manipulate a Watt-scale beam at a speed exceeding 500 gigahertz. In addition to very fast beam control, the results provide a path to developing a new class of sensitive receivers capable of operating at very high rates.	[Nissim, R.; Pejkic, A.; Myslivets, E.; Kuo, B. P.; Alic, N.; Radic, S.] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Radic, S (corresponding author), Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.	sradic@ucsd.edu	Nissim, Ron Reuven/P-6203-2019; Nissim, Ron/P-7928-2014	Nissim, Ron Reuven/0000-0003-2973-0819; Nissim, Ron/0000-0003-2973-0819	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA)	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA)	This research is based on work supported by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA).	Andrekson PA, 2008, OPT EXPRESS, V16, P10956, DOI 10.1364/OE.16.010956; Bajcsy M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.203902; Birnbaum KM, 2005, NATURE, V436, P87, DOI 10.1038/nature03804; Braje DA, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.041801; Dawes AMC, 2005, SCIENCE, V308, P672, DOI 10.1126/science.1110151; Dayan B, 2009, NAT PHOTONICS, V3, P429, DOI 10.1038/nphoton.2009.125; Ferain I, 2011, NATURE, V479, P310, DOI 10.1038/nature10676; Hirano M, 2009, IEEE J SEL TOP QUANT, V15, P103, DOI 10.1109/JSTQE.2008.2010241; Hwang J, 2009, NATURE, V460, P76, DOI 10.1038/nature08134; Kuo BPP, 2012, OPT EXPRESS, V20, P18611, DOI 10.1364/OE.20.018611; Kuo BPP, 2012, OPT EXPRESS, V20, P18422, DOI 10.1364/OE.20.018422; Marhic ME, 2006, ELECTRON LETT, V42, P519, DOI 10.1049/el:20064303; Marhic M. E., 2008, FOPAS OSCILLATORS RE; Matsuda N, 2009, NAT PHOTONICS, V3, P95, DOI 10.1038/NPHOTON.2008.292; MOZZI RL, 1969, J APPL CRYSTALLOGR, V2, P164, DOI 10.1107/S0021889869006868; Myslivets E, 2010, J LIGHTWAVE TECHNOL, V28, P3478, DOI 10.1109/JLT.2010.2080312; Myslivets Evgeny, 2009, IEEE Photonics Technology Letters, V21, P1807, DOI 10.1109/LPT.2009.2033462; Radic S, 2012, IEEE J SEL TOP QUANT, V18, P670, DOI 10.1109/JSTQE.2011.2121896; Raybon G., 2002, P OPT FIB COMM C 17; STEGEMAN GI, 1989, J OPT SOC AM B, V6, P652, DOI 10.1364/JOSAB.6.000652; STOLEN RH, 1973, APPL PHYS LETT, V22, P294, DOI 10.1063/1.1654644	21	16	16	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					417	419		10.1126/science.1253125	http://dx.doi.org/10.1126/science.1253125			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061204				2022-12-28	WOS:000339655100033
J	Ronnow, TF; Wang, ZH; Job, J; Boixo, S; Isakov, SV; Wecker, D; Martinis, JM; Lidar, DA; Troyer, M				Ronnow, Troels F.; Wang, Zhihui; Job, Joshua; Boixo, Sergio; Isakov, Sergei V.; Wecker, David; Martinis, John M.; Lidar, Daniel A.; Troyer, Matthias			Defining and detecting quantum speedup	SCIENCE			English	Article							ISING SPIN-GLASS; QUBITS	The development of small-scale quantum devices raises the question of how to fairly assess and detect quantum speedup. Here, we show how to define and measure quantum speedup and how to avoid pitfalls that might mask or fake such a speedup. We illustrate our discussion with data from tests run on a D-Wave Two device with up to 503 qubits. By using random spin glass instances as a benchmark, we found no evidence of quantum speedup when the entire data set is considered and obtained inconclusive results when comparing subsets of instances on an instance-by-instance basis. Our results do not rule out the possibility of speedup for other classes of problems and illustrate the subtle nature of the quantum speedup question.	[Ronnow, Troels F.; Troyer, Matthias] ETH, CH-8093 Zurich, Switzerland; [Wang, Zhihui; Lidar, Daniel A.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Wang, Zhihui; Job, Joshua; Lidar, Daniel A.] Univ So Calif, Ctr Quantum Informat Sci & Technol, Los Angeles, CA 90089 USA; [Job, Joshua; Lidar, Daniel A.] Univ So Calif, Dept Phys, Los Angeles, CA 90089 USA; [Boixo, Sergio] Google, Venice Beach, CA 90291 USA; [Boixo, Sergio; Lidar, Daniel A.] Univ So Calif, Inst Informat Sci, Los Angeles, CA 90089 USA; [Isakov, Sergei V.] Google, CH-8002 Zurich, Switzerland; [Wecker, David] Microsoft Res, Quantum Architectures & Computat Grp, Redmond, WA 98052 USA; [Martinis, John M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Lidar, Daniel A.] Univ So Calif, Dept Elect Engn, Los Angeles, CA 90089 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Southern California; University of Southern California; University of Southern California; Google Incorporated; University of Southern California; Google Incorporated; Microsoft; University of California System; University of California Santa Barbara; University of Southern California	Troyer, M (corresponding author), ETH, CH-8093 Zurich, Switzerland.	troyer@phys.ethz.ch	Troyer, Matthias/B-7826-2008; Lidar, Daniel/A-5871-2008	Troyer, Matthias/0000-0002-1469-9444; Lidar, Daniel/0000-0002-1671-1515	Swiss National Science Foundation through the National Center of Competence in Research Quantum Science and Technology; Army Research Office (ARO) Multidisciplinary University Research Initiative (MURI) [W911NF11-1-0268]; ARO [W911NF-12-1-0523]; Lockheed Martin Corporation; Microsoft Research; NSF [PHY-1066293]	Swiss National Science Foundation through the National Center of Competence in Research Quantum Science and Technology; Army Research Office (ARO) Multidisciplinary University Research Initiative (MURI); ARO; Lockheed Martin Corporation; Microsoft Research(Microsoft); NSF(National Science Foundation (NSF))	We thank N. Allen, M. Amin, E. Farhi, M. Mohseni, H. Neven, and C. McGeoch for useful discussions and comments and I. Zintchenko for providing the an_ss_ge_nf_bp simulated annealing code before publication of the code with (30). This project was supported by the Swiss National Science Foundation through the National Center of Competence in Research Quantum Science and Technology, the Army Research Office (ARO) Multidisciplinary University Research Initiative (MURI) grant no. W911NF11-1-0268, ARO grant no. W911NF-12-1-0523, the Lockheed Martin Corporation, and Microsoft Research. Simulations were performed on clusters at Microsoft Research and ETH Zurich an on supercomputers of the Swiss Center for Scientific Computing. We acknowledge hospitality of the Aspen Center for Physics, supported by NSF grant PHY-1066293.	BARAHONA F, 1982, J PHYS A-MATH GEN, V15, P3241, DOI 10.1088/0305-4470/15/10/028; Bennett CH, 1997, SIAM J COMPUT, V26, P1510, DOI 10.1137/S0097539796300933; Berkley AJ, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/10/105014; Boixo S, 2014, NAT PHYS, V10, P218, DOI [10.1038/nphys2900, 10.1038/NPHYS2900]; Brooke J, 1999, SCIENCE, V284, P779, DOI 10.1126/science.284.5415.779; Choi V, 2011, QUANTUM INF PROCESS, V10, P343, DOI 10.1007/s11128-010-0200-3; Farhi E, 2001, SCIENCE, V292, P472, DOI 10.1126/science.1057726; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Harris R, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.024511; Johnson MW, 2011, NATURE, V473, P194, DOI 10.1038/nature10012; Johnson MW, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/6/065004; Kadowaki T, 1998, PHYS REV E, V58, P5355, DOI 10.1103/PhysRevE.58.5355; Katzgraber HG, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021008; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Martonak R, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.094203; Papageorgiou A, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.022316; Parberry I., 1986, SIGACT News, V18, P54, DOI 10.1145/8312.8317; Pudenz KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4243; Santoro GE, 2002, SCIENCE, V295, P2427, DOI 10.1126/science.1068774; Shor P. W., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P124, DOI 10.1109/SFCS.1994.365700; Somma RD, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.050501	23	314	316	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					420	424		10.1126/science.1252319	http://dx.doi.org/10.1126/science.1252319			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061205	Green Submitted			2022-12-28	WOS:000339655100034
J	Anders, AM				Anders, Alison M.			EARTH SCIENCE Rain on the parade	NATURE			English	Editorial Material									Univ Illinois, Dept Geol, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign	Anders, AM (corresponding author), Univ Illinois, Dept Geol, Champaign, IL 61820 USA.	amanders@illinois.edu	Anders, Alison/I-3635-2016	Anders, Alison/0000-0002-7597-5465				Barke R, 2006, EARTH PLANET SC LETT, V249, P350, DOI 10.1016/j.epsl.2006.07.012; Gasparini N. M., 2014, LITHOSPHERE; Marshak S., 2004, THRUST TECTONICS HYD, V82, P131, DOI DOI 10.1306/M82813C9; Nesbitt SW, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038026; Thomson SN, 2010, NATURE, V467, P313, DOI 10.1038/nature09365; Whipple K. X., 2014, LITHOSPHERE; Wobus CW, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000406	7	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					413	414		10.1038/511413a	http://dx.doi.org/10.1038/511413a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25056057				2022-12-28	WOS:000339335700032
J	Sobek, S				Sobek, Sebastian			CLIMATE SCIENCE Cold carbon storage	NATURE			English	Editorial Material							PERMAFROST; LAKES; THAW		Uppsala Univ, Dept Ecol & Genet, S-75236 Uppsala, Sweden	Uppsala University	Sobek, S (corresponding author), Uppsala Univ, Dept Ecol & Genet, S-75236 Uppsala, Sweden.	sebastian.sobek@ebc.uu.se						Bastviken D, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002238; Ciais P, 2008, BIOGEOSCIENCES, V5, P1259, DOI 10.5194/bg-5-1259-2008; Knoblauch C, 2013, GLOBAL CHANGE BIOL, V19, P1160, DOI 10.1111/gcb.12116; Mendonca R, 2012, NAT GEOSCI, V5, P838, DOI 10.1038/ngeo1653; Rantakari M, 2005, GLOBAL CHANGE BIOL, V11, P1368, DOI 10.1111/j.1365-2486.2005.00982.x; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Vonk JE, 2013, GEOPHYS RES LETT, V40, P2689, DOI 10.1002/grl.50348; Walter KM, 2007, SCIENCE, V318, P633, DOI 10.1126/science.1142924; Walter KM, 2006, NATURE, V443, P71, DOI 10.1038/nature05040; Zimov SA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027484	11	1	1	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					415	417		10.1038/nature13643	http://dx.doi.org/10.1038/nature13643			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043037	Green Submitted			2022-12-28	WOS:000339335700034
J	Sun, L; Petrenko, A; Leghtas, Z; Vlastakis, B; Kirchmair, G; Sliwa, KM; Narla, A; Hatridge, M; Shankar, S; Blumoff, J; Frunzio, L; Mirrahimi, M; Devoret, MH; Schoelkopf, RJ				Sun, L.; Petrenko, A.; Leghtas, Z.; Vlastakis, B.; Kirchmair, G.; Sliwa, K. M.; Narla, A.; Hatridge, M.; Shankar, S.; Blumoff, J.; Frunzio, L.; Mirrahimi, M.; Devoret, M. H.; Schoelkopf, R. J.			Tracking photon jumps with repeated quantum non-demolition parity measurements	NATURE			English	Article							SCHRODINGER CAT STATES; NUMBER STATES; CAVITY; SPIN; AMPLIFICATION; DECOHERENCE; INFORMATION; FEEDBACK; COLLAPSE; LIMIT	Quantum error correction is required for a practical quantum computer because of the fragile nature of quantum information. In quantum error correction, information is redundantly stored in a large quantum state space and one or more observables must be monitored to reveal the occurrence of an error, without disturbing the information encoded in an unknown quantum state. Such observables, typically multi-quantum-bit parities, must correspond to a special symmetry property inherent in the encoding scheme. Measurements of these observables, or error syndromes, must also be performed in a quantum non-demolition way (projecting without further perturbing the state) and more quickly than errors occur. Previously, quantum non-demolition measurements of quantum jumps between states of well-defined energy have been performed in systems such as trapped ions(1-3), electrons(4), cavity quantum electrodynamics(5,6), nitrogen-vacancy centres(7-9) and superconducting quantum bits(10,11). So far, however, no fast and repeated monitoring of an error syndrome has been achieved. Here we track the quantum jumps of a possible error syndrome, namely the photon number parity of a microwave cavity, by mapping this property onto an ancilla quantum bit, whose only role is to facilitate quantum state manipulation and measurement. This quantity is just the error syndrome required in a recently proposed scheme for a hardware efficient protected quantum memory using Schrodinger cat states (quantum superpositions of different coherent states of light) in a harmonic oscillator(12). We demonstrate the projective nature of this measurement onto a region of state space with well-defined parity by observing the collapse of a coherent state onto even or odd cat states. The measurement is fast compared with the cavity lifetime, has a high single-shot fidelity and has a 99.8 per cent probability per single measurement of leaving the parity unchanged. In combination with the deterministic encoding of quantum information in cat states realized earlier(13,14), the quantum non-demolition parity tracking that we demonstrate represents an important step towards implementing an active system that extends the lifetime of a quantum bit.	[Sun, L.; Petrenko, A.; Leghtas, Z.; Vlastakis, B.; Kirchmair, G.; Sliwa, K. M.; Narla, A.; Hatridge, M.; Shankar, S.; Blumoff, J.; Frunzio, L.; Mirrahimi, M.; Devoret, M. H.; Schoelkopf, R. J.] Yale Univ, Dept Appl Phys, New Haven, CT 06511 USA; [Sun, L.; Petrenko, A.; Leghtas, Z.; Vlastakis, B.; Kirchmair, G.; Sliwa, K. M.; Narla, A.; Hatridge, M.; Shankar, S.; Blumoff, J.; Frunzio, L.; Mirrahimi, M.; Devoret, M. H.; Schoelkopf, R. J.] Yale Univ, Dept Phys, New Haven, CT 06511 USA; [Mirrahimi, M.] INRIA Paris Rocquencourt, F-78153 Le Chesnay, France	Yale University; Yale University	Sun, L (corresponding author), Tsinghua Univ, Inst Interdisciplinary Informat Sci, Ctr Quantum Informat, Beijing 100084, Peoples R China.	luyansun@mail.tsinghua.edu.cn; robert.schoelkopf@yale.edu	Shankar, Shyam/K-5127-2013; Schoelkopf, Robert J/J-8178-2012; Kirchmair, Gerhard/J-5218-2013; Frunzio, Luigi/O-1573-2019; Narla, Anirudh/AAG-2987-2019	Shankar, Shyam/0000-0002-1311-9508; Kirchmair, Gerhard/0000-0003-4286-8839; Frunzio, Luigi/0000-0002-0272-5481; Narla, Anirudh/0000-0002-1498-8641; Sun, Luyan/0000-0003-4419-5674; Leghtas, Zaki/0000-0002-9172-1537; Mirrahimi, Mazyar/0000-0001-9471-6031	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office [W911NF-09-1-0369]; US Army Research Office [W911NF-09-1-0514]; Agence National de Recherche [EPOQ2, ANR-09-JCJC-0070]; NSF [PHY-1309996]; Direct For Mathematical & Physical Scien [1309996] Funding Source: National Science Foundation	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office; US Army Research Office; Agence National de Recherche(French National Research Agency (ANR)); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank L. Jiang and S. M. Girvin for discussions. Facilities use was supported by the Yale Institute for Nanoscience and Quantum Engineering and the US NSF MRSEC DMR 1119826. This research was supported in part by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office (W911NF-09-1-0369) and in part by the US Army Research Office (W911NF-09-1-0514). All statements of fact, opinion or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of IARPA, the ODNI or the US government. M.M. acknowledges partial support from the Agence National de Recherche under the project EPOQ2, ANR-09-JCJC-0070. B.V. acknowledges partial support from NSF under the project PHY-1309996.	BELAVKIN VP, 1992, J MULTIVARIATE ANAL, V42, P171, DOI 10.1016/0047-259X(92)90042-E; Bergeal N, 2010, NATURE, V465, P64, DOI 10.1038/nature09035; BERGQUIST JC, 1986, PHYS REV LETT, V57, P1699, DOI 10.1103/PhysRevLett.57.1699; Bertet P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.200402; Bouten L, 2007, SIAM J CONTROL OPTIM, V46, P2199, DOI 10.1137/060651239; Brune M, 1996, PHYS REV LETT, V77, P4887, DOI 10.1103/PhysRevLett.77.4887; BRUNE M, 1992, PHYS REV A, V45, P5193, DOI 10.1103/PhysRevA.45.5193; Castellanos-Beltran MA, 2008, NAT PHYS, V4, P929, DOI 10.1038/nphys1090; Deleglise S, 2008, NATURE, V455, P510, DOI 10.1038/nature07288; Devoret MH, 2013, SCIENCE, V339, P1169, DOI 10.1126/science.1231930; Gleyzes S, 2007, NATURE, V446, P297, DOI 10.1038/nature05589; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; Haroche S., 2006, EXPLORING QUANTUM; Hatridge M, 2013, SCIENCE, V339, P178, DOI 10.1126/science.1226897; Jelezko F, 2002, APPL PHYS LETT, V81, P2160, DOI 10.1063/1.1507838; Kamal A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.184301; Kirchmair G, 2013, NATURE, V495, P205, DOI 10.1038/nature11902; Leghtas Z, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.120501; Leghtas Z, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.042315; Murch KW, 2013, NATURE, V502, P211, DOI 10.1038/nature12539; NAGOURNEY W, 1986, PHYS REV LETT, V56, P2797, DOI 10.1103/PhysRevLett.56.2797; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Peil S, 1999, PHYS REV LETT, V83, P1287, DOI 10.1103/PhysRevLett.83.1287; Reagor M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807015; Riste D, 2013, NATURE, V502, P350, DOI 10.1038/nature12513; Robledo L, 2011, NATURE, V477, P574, DOI 10.1038/nature10401; SAUTER T, 1986, PHYS REV LETT, V57, P1696, DOI 10.1103/PhysRevLett.57.1696; Sayrin C, 2011, NATURE, V477, P73, DOI 10.1038/nature10376; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Siddiqi I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.027005; Vijay R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.110502; Vijay R, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3224703; Vlastakis B, 2013, SCIENCE, V342, P607, DOI 10.1126/science.1243289	35	162	167	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					444	+		10.1038/nature13436	http://dx.doi.org/10.1038/nature13436			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043007	Green Submitted			2022-12-28	WOS:000339335700041
J	Yamey, G				Yamey, Gavin			FEATURE The bias busters	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PUBLICATION		Univ Calif San Francisco, Global Hlth Grp, Evidence Policy Initiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Yamey, G (corresponding author), Univ Calif San Francisco, Global Hlth Grp, Evidence Policy Initiat, San Francisco, CA 94143 USA.	YameyG@globalhealth.ucsf.edu						Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Gordon D, 2013, NEW ENGL J MED, V369, P1926, DOI 10.1056/NEJMsa1300237; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Shaywitz DA., 2006, BOSTON GLOBE	9	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2014	349								g4748	10.1136/bmj.g4748	http://dx.doi.org/10.1136/bmj.g4748			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VP	25056305				2022-12-28	WOS:000339565900010
J	Deeks, SG; Hunt, PW				Deeks, Steven G.; Hunt, Peter W.			Antiretroviral therapy: stubborn limitations persist	LANCET			English	Editorial Material							HIV-INFECTION		[Deeks, Steven G.; Hunt, Peter W.] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, San Francisco, CA 94110 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Deeks, SG (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, San Francisco, CA 94110 USA.	sdeeks@php.ucsf.edu	Hunt, Peter W./P-2976-2017	Hunt, Peter W./0000-0002-4571-4870				Baker JV, 2014, AIDS, V28, P831, DOI 10.1097/QAD.0000000000000145; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Hunt PW, 2014, J INFECT DIS, V210, P1228, DOI 10.1093/infdis/jiu238; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8	10	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					214	216		10.1016/S0140-6736(14)60848-5	http://dx.doi.org/10.1016/S0140-6736(14)60848-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL8JI	25042221				2022-12-28	WOS:000339384100007
J	Lewin, SR; Deeks, SG; Barre-Sinoussi, F				Lewin, Sharon R.; Deeks, Steven G.; Barre-Sinoussi, Francoise			Towards a cure for HIV-are we making progress?	LANCET			English	Editorial Material							LATENCY		[Lewin, Sharon R.] Alfred Hlth, Dept Infect Dis, Melbourne, Vic 3004, Australia; [Lewin, Sharon R.] Monash Univ, Melbourne, Vic 3004, Australia; [Lewin, Sharon R.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Deeks, Steven G.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA; [Barre-Sinoussi, Francoise] INSERM, Paris, France; [Barre-Sinoussi, Francoise] Inst Pasteur, Dept Virol, Unit Regulat Retroviral Infect, Paris, France	Monash University; Burnet Institute; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lewin, SR (corresponding author), Alfred Hlth, Dept Infect Dis, Melbourne, Vic 3004, Australia.	sharon.lewin@monash.edu	Lewin, Sharon/Z-3297-2019	Lewin, Sharon Ruth/0000-0002-0330-8241				Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Henrich TJ, 2013, J INFECT DIS, V207, P1694, DOI 10.1093/infdis/jit086; Henrich TJ, 2014, C RETR OPP INF CROI; Maartens G, 2014, LANCET; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Sogaard OS, 2014, 20 INT AIDS C MELB A; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662	14	23	23	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					209	211		10.1016/S0140-6736(14)61181-8	http://dx.doi.org/10.1016/S0140-6736(14)61181-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL8JI	25042220				2022-12-28	WOS:000339384100004
J	Hadders, MA; Lens, SMA				Hadders, Michael A.; Lens, Susanne M. A.			Mind the midzone	SCIENCE			English	Editorial Material							AURORA-B; CHROMOSOME COMPACTION; ANAPHASE; PHOSPHORYLATION; ASSOCIATION; SPINDLE; KINASE		[Hadders, Michael A.; Lens, Susanne M. A.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Mol Canc Res, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Hadders, MA (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Dept Mol Canc Res, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	s.m.a.lens@umcutrecht.nl						Afonso O, 2014, SCIENCE, V345, P332, DOI 10.1126/science.1251121; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Bouchoux C, 2011, CELL, V147, P803, DOI 10.1016/j.cell.2011.09.047; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Neurohr G, 2011, SCIENCE, V332, P465, DOI 10.1126/science.1201578; Tada K, 2011, NATURE, V474, P477, DOI 10.1038/nature10179; van der Waal MS, 2012, EXP CELL RES, V318, P1407, DOI 10.1016/j.yexcr.2012.03.015	14	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					265	266		10.1126/science.1257267	http://dx.doi.org/10.1126/science.1257267			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035472				2022-12-28	WOS:000339400700026
J	Holmes, EA; Craske, MG; Graybiel, AM				Holmes, Emily A.; Craske, Michelle G.; Graybiel, Ann M.			A call for mental-health science	NATURE			English	Editorial Material							OBSESSIVE-COMPULSIVE DISORDER; THERAPY; CLOMIPRAMINE; STIMULATION; PREVENTION; EXPOSURE; TRIAL		[Holmes, Emily A.] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Holmes, Emily A.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Craske, Michelle G.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Craske, Michelle G.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Graybiel, Ann M.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Karolinska Institutet; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT)	Holmes, EA (corresponding author), MRC, Cognit & Brain Sci Unit, Cambridge, England.	emily.holmes@mrc-cbu.cam.ac.uk	Holmes, Emily/ABD-4367-2020	Holmes, Emily/0000-0001-7319-3112; Graybiel, Ann/0000-0002-4326-7720	MRC [MC_UP_0901/1] Funding Source: UKRI; Medical Research Council [MC_UP_0901/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmari SE, 2013, SCIENCE, V340, P1234, DOI 10.1126/science.1234733; Browning M, 2010, BIOL PSYCHIAT, V67, P919, DOI 10.1016/j.biopsych.2009.10.031; Burguiere E, 2013, SCIENCE, V340, P1243, DOI 10.1126/science.1232380; Fairburn CG, 2009, AM J PSYCHIAT, V166, P311, DOI 10.1176/appi.ajp.2008.08040608; Foa EB, 2005, AM J PSYCHIAT, V162, P151, DOI 10.1176/appi.ajp.162.1.151; Hollon SD, 2005, ARCH GEN PSYCHIAT, V62, P417, DOI 10.1001/archpsyc.62.4.417; MacLeod C, 2012, ANNU REV CLIN PSYCHO, V8, P189, DOI 10.1146/annurev-clinpsy-032511-143052; Otto MW, 2010, BIOL PSYCHIAT, V67, P365, DOI 10.1016/j.biopsych.2009.07.036; Simpson HB, 2004, DEPRESS ANXIETY, V19, P225, DOI 10.1002/da.20003; Vervliet B, 2013, ANNU REV CLIN PSYCHO, V9, P215, DOI 10.1146/annurev-clinpsy-050212-185542	10	139	143	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					287	289		10.1038/511287a	http://dx.doi.org/10.1038/511287a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL2YR	25030152	Bronze			2022-12-28	WOS:000338992200013
J	Bhutta, ZA; Crane, J				Bhutta, Zulfiqar A.; Crane, Julian			Should research fraud be a crime?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada; [Crane, Julian] Univ Otago Wellington, Dept Med, Wellington Asthma Res Grp, Wellington 6242, New Zealand	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Otago	Bhutta, ZA (corresponding author), Hosp Sick Children, Ctr Global Child Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	zulfiqar.bhutta@sickkids.ca; julian.crane@otago.ac.nz						[Anonymous], 2013, NATURE, V504, P7; [Anonymous], 2012, LANCET, V380, P2; Deer B, SOLVED RIDDLE MMR; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Fang FC, 2012, P NATL ACAD SCI USA, V109, P17028, DOI 10.1073/pnas.1212247109; Fenning TM, 2004, NATURE, V427, P393, DOI 10.1038/427393a; Fujii Jolley D., 2012, ANAESTHESIA RES FRAU; Gammon Elizabeth, 2013, J Health Care Finance, V40, P75; Gee J, 2014, FINANCIAL COST HLTH; Glenn David, 2005, Chron High Educ, V52, P35; Grieneisen ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044118; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Kay M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3536; Maisonneuve H, 2012, PRESSE MED, V41, P827, DOI 10.1016/j.lpm.2012.03.022; Markey ML, 2007, J HLTH LIFE SCI LAW, V63, P65; Maslen G., 2013, U WORLD NEWS; Nimmo W, 2000, P R COLL PHYS EDI S7, V30, P2; Nosengo N, 2012, NATURE          1022, DOI [10.1038/nature.2012.11640, DOI 10.1038/NATURE.2012.11640]; OBOKATA H, 2014, NATURE, V511, P112; ONeill Onora., 2002, TELEGRAPH; Roehr B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4568; Sarwar U, 2012, J RES MED SCI, V17, P1077; Smith R, 2013, BMJ BLOGS       1203; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0	24	13	14	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2014	349								g4532	10.1136/bmj.g4532	http://dx.doi.org/10.1136/bmj.g4532			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7OZ	25027665	Green Published			2022-12-28	WOS:000339325400008
J	Tsai, AC; Lucas, M; Sania, A; Kim, D; Kawachi, I				Tsai, Alexander C.; Lucas, Michel; Sania, Ayesha; Kim, Daniel; Kawachi, Ichiro			Social Integration and Suicide Mortality Among Men: 24-Year Cohort Study of US Health Professionals	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVASCULAR-DISEASE; RISK; NETWORKS; ENGAGEMENT; DURKHEIM; OUTCOMES; SUPPORT; DEATH; TIES; QUESTIONNAIRE	Background: Suicide is a major public health problem. Current thinking about suicide emphasizes the study of psychiatric, psychological, or biological determinants. Previous work in this area has largely relied on surrogate outcomes or samples enriched for psychiatric morbidity. Objective: To evaluate the relationship between social integration and suicide mortality. Design: Prospective cohort study initiated in 1988. Setting: United States. Participants: 34 901 men aged 40 to 75 years. Measurements: Social integration was measured with a 7-item index that included marital status, social network size, frequency of contact, religious participation, and participation in other social groups. Vital status of study participants was ascertained through 1 February 2012. The primary outcome of interest was suicide mortality, defined as deaths classified with codes E950 to E959 from the International Classification of Diseases, Ninth Revision. Results: Over 708 945 person-years of follow-up, there were 147 suicides. The incidence of suicide decreased with increasing social integration. In a multivariable Cox proportional hazards regression model, the relative hazard of suicide was lowest among participants in the highest (adjusted hazard ratio [AHR], 0.41 [95% CI, 0.24 to 0.69]) and second-highest (AHR, 0.52 [CI, 0.30 to 0.91]) categories of social integration. Three components (marital status, social network size, and religious service attendance) showed the strongest protective associations. Social integration was also inversely associated with all-cause and cardiovascular-related mortality, but accounting for competing causes of death did not substantively alter the findings. Limitations: The study lacked information on participants' mental well-being. Some suicides could have been misclassified as accidental deaths. Conclusion: Men who were socially well-integrated had a more than 2-fold reduced risk for suicide over 24 years of follow-up.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Sch Publ Hlth, Boston, MA 02115 USA; Northeastern Univ, Bouve Coll Hlth Sci, Boston, MA 02115 USA; Mbarara Univ Sci & Technol, Mbarara, Uganda; Univ Laval, Ctr Rech, Ctr Hosp Univ Quebec, Quebec City, PQ G1V 2M2, Canada	Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Massachusetts General Hospital; Northeastern University; Mbarara University of Science & Technology; Laval University	Tsai, AC (corresponding author), Massachusetts Gen Hosp, Ctr Global Hlth, Room 1529-E3,100 Cambridge St,15th Floor, Boston, MA 02114 USA.	actsai@partners.org	Tsai, Alexander C./F-4247-2015	Tsai, Alexander C./0000-0001-6397-7917; Kim, Daniel/0000-0001-8907-6420; Sania, Ayesha/0000-0002-6445-9481	NIH [P01CA055075, K23MH096620, R00HL089459]; Robert Wood Johnson Foundation Health and Society Scholars Program; NATIONAL CANCER INSTITUTE [P01CA055075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL089459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH096620] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation Health and Society Scholars Program(Robert Wood Johnson Foundation (RWJF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	By the NIH (P01CA055075). Dr. Tsai was supported by NIH K23MH096620 and, with Dr. Kawachi, by a seed grant from the Robert Wood Johnson Foundation Health and Society Scholars Program. Dr. Kim was supported by NIH R00HL089459.	Bearman PS, 2004, AM J PUBLIC HEALTH, V94, P89, DOI 10.2105/AJPH.94.1.89; BERKMAN L, 1983, HLTH WAYS LIVING; Berkman L. F., 1977, THESIS U CALIFORNIA; BERKMAN LF, 1984, ANNU REV PUBL HEALTH, V5, P413, DOI 10.1146/annurev.pu.05.050184.002213; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; BERKMAN LF, 1986, AM J EPIDEMIOL, V123, P559, DOI 10.1093/oxfordjournals.aje.a114276; BREAULT KD, 1986, AM J SOCIOL, V92, P628, DOI 10.1086/228544; Breiding M J, 2006, Inj Prev, V12 Suppl 2, pii49, DOI 10.1136/ip.2006.012591; Brissette I, 2000, SOCIAL SUPPORT MEASU, P53, DOI DOI 10.1093/MED:PSYCH/9780195126709.003.0003; Cantor CH., 1995, J FAMILY STUDIES, V1, P91, DOI [10.5172/jfs.1.2.91, DOI 10.5172/JFS.1.2.91]; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P321; CERHAN JR, 1993, AM J EPIDEMIOL, V137, P870, DOI 10.1093/oxfordjournals.aje.a116748; Cerhan JR, 1997, EPIDEMIOLOGY, V8, P475, DOI 10.1097/00001648-199709000-00001; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; CHERLIN A, 1990, ANN AM ACAD POLIT SS, V510, P145, DOI 10.1177/0002716290510001011; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Cornwell B, 2013, SOC SCI MED; Cornwell B, 2009, SOC NETWORKS, V31, P92, DOI 10.1016/j.socnet.2008.10.005; Corso PS, 2007, AM J PREV MED, V32, P474, DOI 10.1016/j.amepre.2007.02.010; Cox D. R., 1984, ANAL SURVIVAL DATA; COYNE JC, 1976, J ABNORM PSYCHOL, V85, P186, DOI 10.1037/0021-843X.85.2.186; COYNE JC, 1976, PSYCHIATRY, V39, P28, DOI 10.1080/00332747.1976.11023874; DEAN K, 1994, J EPIDEMIOL COMMUN H, V48, P201, DOI 10.1136/jech.48.2.201; DECATANZARO D, 1980, BEHAV BRAIN SCI, V3, P283, DOI 10.1017/S0140525X00004908; Druss B, 2000, ARCH INTERN MED, V160, P1522, DOI 10.1001/archinte.160.10.1522; Durkheim E., 1967, SUICIDE ETUDE SOCIOL; Eng PM, 2002, AM J EPIDEMIOL, V155, P700, DOI 10.1093/aje/155.8.700; Ertel KA, 2009, J SOC PERS RELAT, V26, P73, DOI 10.1177/0265407509105523; Fang F, 2012, NEW ENGL J MED, V366, P1310, DOI 10.1056/NEJMoa1110307; Feld SL, 2007, FIELD METHOD, V19, P218, DOI 10.1177/1525822X06299134; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Giordano GN, 2010, SOC SCI MED, V70, P700, DOI 10.1016/j.socscimed.2009.10.044; Goldsmith SK, 2001, REDUCING SUICIDE NAT, pix; Goldstein JR, 1999, DEMOGRAPHY, V36, P409, DOI 10.2307/2648063; Goldstein JR, 2001, AM SOCIOL REV, V66, P506, DOI 10.2307/3088920; GOODENOW C, 1990, HEALTH PSYCHOL, V9, P266, DOI 10.1037/0278-6133.9.3.266; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; GROBBEE DE, 1990, NEW ENGL J MED, V323, P1026, DOI 10.1056/NEJM199010113231504; Hawton K, 2011, J AFFECT DISORDERS, V134, P320, DOI 10.1016/j.jad.2011.05.044; Heron Melonie, 2012, Natl Vital Stat Rep, V61, P1; Hirschfield RMA, 1997, JAMA-J AM MED ASSOC, V277, P333, DOI 10.1001/jama.277.4.333; Holma KM, 2010, AM J PSYCHIAT, V167, P801, DOI 10.1176/appi.ajp.2010.09050627; Ikeda A, 2011, HANDBOOK OF BEHAVIORAL MEDICINE: METHODS AND APPLICATIONS, P237, DOI 10.1007/978-0-387-09488-5_18; Kawachi I, 1996, ARCH INTERN MED, V156, P521, DOI 10.1001/archinte.156.5.521; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kawachi I, 1996, J EPIDEMIOL COMMUN H, V50, P245, DOI 10.1136/jech.50.3.245; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Knox KL, 2003, BMJ-BRIT MED J, V327, P1376, DOI 10.1136/bmj.327.7428.1376; Koenig HG, 2012, HDB RELIG HLTH; Kposowa AJ, 2000, J EPIDEMIOL COMMUN H, V54, P254, DOI 10.1136/jech.54.4.254; Larsen KK, 2010, CIRCULATION, V122, P2388, DOI 10.1161/CIRCULATIONAHA.110.956136; Lewis G, 1998, BMJ-BRIT MED J, V317, P1283, DOI 10.1136/bmj.317.7168.1283; Lindqvist P, 2002, FORENSIC SCI INT, V128, P136, DOI 10.1016/S0379-0738(02)00188-3; Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; MEEHL PE, 1962, AM PSYCHOL, V17, P827, DOI 10.1037/h0041029; Miller AS, 1996, J SCI STUD RELIG, V35, P275, DOI 10.2307/1386559; Miller M, 2000, AM J PUBLIC HEALTH, V90, P768, DOI 10.2105/AJPH.90.5.768; Minino Arialdi M, 2006, Natl Vital Stat Rep, V54, P1; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Mukamal KJ, 2007, ARCH INTERN MED, V167, P468, DOI 10.1001/archinte.167.5.468; Mukamal KJ, 2007, SOC PSYCH PSYCH EPID, V42, P153, DOI 10.1007/s00127-006-0144-1; Nock MK, 2010, MOL PSYCHIATR, V15, P868, DOI 10.1038/mp.2009.29; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; Peplau L.A., 1979, LOVE ATTRACTION INT, P99, DOI DOI 10.1016/B978-0-08-022234-9.50020-0; Perlis RH, 2011, AM J PSYCHIAT, V168, P1009, DOI 10.1176/appi.ajp.2011.11081250; PESCOSOLIDO BA, 1986, AM SOCIOL REV, V51, P80, DOI 10.2307/2095479; PHILLIPS DP, 1993, SUICIDE LIFE-THREAT, V23, P307; PLATT S, 1988, SOC PSYCH PSYCH EPID, V23, P217, DOI 10.1007/BF01787820; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1990, AM J EPIDEMIOL, V131, P1068, DOI 10.1093/oxfordjournals.aje.a115598; Roberts SE, 2013, PSYCHOL MED, V43, P1231, DOI 10.1017/S0033291712002024; Rockett Ian R H, 2012, Am J Public Health, V102, pe84, DOI 10.2105/AJPH.2012.300960; Rockett IRH, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-35; SCHAEFER C, 1981, Journal of Behavioral Medicine, V4, P381, DOI 10.1007/BF00846149; Schafer MH, 2013, RES AGING, V35, P348, DOI 10.1177/0164027512441612; Seeman TE, 2011, J GERONTOL B-PSYCHOL, V66, P141, DOI 10.1093/geronb/gbq091; Shenassa ED, 2003, J EPIDEMIOL COMMUN H, V57, P120, DOI 10.1136/jech.57.2.120; Spicer RS, 2000, AM J PUBLIC HEALTH, V90, P1885, DOI 10.2105/AJPH.90.12.1885; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Stenager EN, 1998, BRIT MED J, V316, P1206, DOI 10.1136/bmj.316.7139.1206; Therneau TM, 2000, MODELING SURVIVAL DA; Thomas PA, 2012, J AGING HEALTH, V24, P547, DOI 10.1177/0898264311432310; Thomas PA, 2011, J HEALTH SOC BEHAV, V52, P430, DOI 10.1177/0022146511411922; Thomas PA, 2011, SOC SCI MED, V73, P1428, DOI 10.1016/j.socscimed.2011.07.035; Thorlindsson T, 1998, AM SOCIOL REV, V63, P94, DOI 10.2307/2657479; Thornton A, 2001, J MARRIAGE FAM, V63, P1009, DOI 10.1111/j.1741-3737.2001.01009.x; Wray M, 2011, ANNU REV SOCIOL, V37, P505, DOI 10.1146/annurev-soc-081309-150058	94	58	58	3	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2					85	+		10.7326/M13-1291	http://dx.doi.org/10.7326/M13-1291			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM3PJ	25023247	Green Accepted			2022-12-28	WOS:000339764600017
J	Snyder, A				Snyder, Alison			Nephrologist and longtime Editor-in-Chief of The New England Journal of Medicine Obituary	LANCET			English	Biographical-Item																		RELMAN AS, PUBLICATION LIST	1	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					126	126		10.1016/S0140-6736(14)61153-3	http://dx.doi.org/10.1016/S0140-6736(14)61153-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1YC	25025104				2022-12-28	WOS:000338921500021
J	Sham, LT; Butler, EK; Lebar, MD; Kahne, D; Bernhardt, TG; Ruiz, N				Sham, Lok-To; Butler, Emily K.; Lebar, Matthew D.; Kahne, Daniel; Bernhardt, Thomas G.; Ruiz, Natividad			MurJ is the flippase of lipid-linked precursors for peptidoglycan biogenesis	SCIENCE			English	Article							ESCHERICHIA-COLI; MUREIN SYNTHESIS; IDENTIFICATION; RODA; MVIN; GENE; FTSW	Peptidoglycan (PG) is a polysaccharide matrix that protects bacteria from osmotic lysis. Inhibition of its biogenesis is a proven strategy for killing bacteria with antibiotics. The assembly of PG requires disaccharide-pentapeptide building blocks attached to a polyisoprene lipid carrier called lipid II. Although the stages of lipid II synthesis are known, the identity of the essential flippase that translocates it across the cytoplasmic membrane for PG polymerization is unclear. We developed an assay for lipid II flippase activity and used a chemical genetic strategy to rapidly and specifically block flippase function. We combined these approaches to demonstrate that MurJ is the lipid II flippase in Escherichia coli.	[Sham, Lok-To; Bernhardt, Thomas G.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Butler, Emily K.; Ruiz, Natividad] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Lebar, Matthew D.; Kahne, Daniel] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kahne, Daniel] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; Harvard University; Harvard University; Harvard Medical School	Bernhardt, TG (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	thomas_bernhardt@hms.harvard.edu; ruiz.82@osu.edu	Sham, Lok To/L-8149-2016	Ruiz, Natividad/0000-0002-6369-2206; Butler, Emily K./0000-0003-2906-0595; Lebar, Matthew/0000-0003-4910-1438; Sham, Lok To/0000-0001-9047-0310	American Heart Association; National Institutes of Health (NIH) [F32GM103056, R01GM100951, R01AI099144, R01GM76710]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100951, F32GM103056, R01GM076710] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Mengin-Lecreulx for the generous gift of plasmids for ColM production and H. Joseph and R. M. Davis for their technical assistance. Research was supported by funds from the American Heart Association (L.S.) and the National Institutes of Health (NIH) under award numbers F32GM103056 (M.D.L.), R01GM100951 (N.R.), R01AI099144 (T.G.B.), and R01GM76710 (D.K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH. For additional data, see the supplementary materials.	Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Butler EK, 2013, J BACTERIOL, V195, P4639, DOI 10.1128/JB.00731-13; de Pedro MA, 2001, J BACTERIOL, V183, P4115, DOI 10.1128/JB.183.14.4115-4126.2001; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; HEPPEL LA, 1967, SCIENCE, V156, P1451, DOI 10.1126/science.156.3781.1451; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Inoue A, 2008, J BACTERIOL, V190, P7298, DOI 10.1128/JB.00551-08; KHATTAR MM, 1994, J BACTERIOL, V176, P7140, DOI 10.1128/JB.176.23.7140-7147.1994; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P15553, DOI 10.1073/pnas.0808352105; Touze T, 2012, BIOCHEM SOC T, V40, P1522, DOI 10.1042/BST20120189; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677	13	188	193	2	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					220	222		10.1126/science.1254522	http://dx.doi.org/10.1126/science.1254522			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013077	Green Accepted			2022-12-28	WOS:000339409900055
J	Wang, DS; Song, CM; Shen, HW; Barabasi, AL				Wang, Dashun; Song, Chaoming; Shen, Hua-Wei; Barabasi, Albert-Laszlo			Response to Comment on "Quantifying long-term scientific impact"	SCIENCE			English	Editorial Material								Wang, Mei, and Hicks claim that they observed large mean prediction errors when using our model. We find that their claims are a simple consequence of overfitting, which can be avoided by standard regularization methods. Here, we show that our model provides an effective means to identify papers that may be subject to overfitting, and the model, with or without prior treatment, outperforms the proposed naive approach.	[Wang, Dashun] IBM Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Song, Chaoming] Univ Miami, Dept Phys, Coral Gables, FL 33146 USA; [Shen, Hua-Wei; Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Shen, Hua-Wei; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Shen, Hua-Wei; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Comp Sci, Boston, MA 02115 USA; [Shen, Hua-Wei; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Shen, Hua-Wei] Chinese Acad Sci, Inst Comp Technol, Beijing 100190, Peoples R China	International Business Machines (IBM); University of Miami; Northeastern University; Northeastern University; Northeastern University; Northeastern University; Chinese Academy of Sciences; Institute of Computing Technology, CAS	Barabasi, AL (corresponding author), Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA.	alb@neu.edu	Barabasi, Albert-Laszlo/S-6474-2017; Shen, Hua-Wei/E-8028-2010	Shen, Hua-Wei/0000-0002-1081-8119; Barabasi, Albert/0000-0002-4028-3522				Bishop C.M., 2006, PATTERN RECOGN; Shen H., 2014, 28 AAAI C ART INT QU; Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825; Wang J, 2014, SCIENCE, V345, DOI 10.1126/science.1248770	4	3	3	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193								10.1126/science.1248961	http://dx.doi.org/10.1126/science.1248961			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8SS	25013056				2022-12-28	WOS:000339409900033
J	Brooks-Pollock, E; Roberts, GO; Keeling, MJ				Brooks-Pollock, Ellen; Roberts, Gareth O.; Keeling, Matt J.			A dynamic model of bovine tuberculosis spread and control in Great Britain	NATURE			English	Article							MOUTH EPIDEMIC; CATTLE; TRANSMISSION; ENGLAND; FOOT	Bovine tuberculosis (TB) is one of the most complex, persistent and controversial problems facing the British cattle industry, costing the country an estimated 100 pound million per year(1). The low sensitivity of the standard diagnostic test leads to considerable ambiguity in determining the main transmission routes of infection, which exacerbates the continuing scientific debate(2-6). In turn this uncertainty fuels the fierce public and political disputes on the necessity of controlling badgers to limit the spread of infection. Here we present a dynamic stochastic spatial model for bovine TB in Great Britain that combines within-farm and between-farm transmission. At the farmscale the model incorporates stochastic transmission of infection, maintenance of infection in the environment and a testing protocol that mimics historical government policy. Between-farm transmission has a short-range environmental component and is explicitly driven by movements of individual cattle between farms, as recorded in the Cattle Tracing System(2). The resultant model replicates the observed annual increase of infection over time as well as the spread of infection into new areas. Given that our model is mechanistic, it can ascribe transmission pathways to each new case; the majority of newly detected cases involve several transmission routes with moving infected cattle, reinfection from an environmental reservoir and poor sensitivity of the diagnostic test all having substantive roles. This underpins our findings on the implications of control measures. Very few of the control options tested have the potential to reverse the observed annual increase, with only intensive strategies such as whole-herd culling or additional national testing proving highly effective, whereas controls focused on a single transmission route are unlikely to be highly effective.	[Brooks-Pollock, Ellen] Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge CB3 0ES, England; [Brooks-Pollock, Ellen; Keeling, Matt J.] Univ Warwick, Math Inst, WIDER Ctr, Coventry CV4 7AL, W Midlands, England; [Brooks-Pollock, Ellen; Keeling, Matt J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Roberts, Gareth O.] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England	University of Cambridge; University of Warwick; University of Warwick; University of Warwick	Keeling, MJ (corresponding author), Univ Warwick, Math Inst, WIDER Ctr, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	M.J.Keeling@warwick.ac.uk	Keeling, Matt J/J-9280-2012	Keeling, Matt J/0000-0003-4639-4765; Brooks-Pollock, Ellen/0000-0002-5984-4932	BBSRC; Wellcome Trust; EPSRC; Biotechnology and Biological Sciences Research Council [BB/H00811X/1, BB/I013482/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H027270/1, EP/D002060/1] Funding Source: researchfish; BBSRC [BB/I013482/1, BB/H00811X/1] Funding Source: UKRI; EPSRC [EP/H027270/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by BBSRC, the Wellcome Trust and EPSRC. We would like to thank G. Medley, L. Green, O. Courtenay, A. Ramirez-Villaescusa, J. Wood and L. Danon for helpful discussions on bovine TB dynamics. Thanks to A. Conlan and T. J. McKinley for advice on implementing SMC-ABC and to A. Conlan to setting up the Marx Bros cluster. The breakdown and reactor data was supplied by the AHVLA team (particularly A. Mitchell and R. Blackwell), the RADAR team and DEFRA.	Barlow ND, 1997, PREV VET MED, V32, P57, DOI 10.1016/S0167-5877(97)00002-0; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Brooks-Pollock E, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-97; Conlan AJK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002730; Cox DR, 2005, P NATL ACAD SCI USA, V102, P17588, DOI 10.1073/pnas.0509003102; Department for Environment Food and Rural Affairs, 2013, BOV TUB EV PLAN; Department for Environment Food and Rural Affairs, 2011, BOV TB ER PROGR ENGL; Donnelly C. A., 2010, STAT COMMUN INFECT D, V2, P1; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Fischer EAJ, 2005, PREV VET MED, V67, P283, DOI 10.1016/j.prevetmed.2004.12.002; Godfray HCJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1634; Gopal R, 2006, VET REC, V159, P265, DOI 10.1136/vr.159.9.265; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; Green LE, 2005, PREV VET MED, V70, P293, DOI 10.1016/j.prevetmed.2005.05.005; Independent Scientific Group on Cattle TB, 2007, BOV TB SCI EV; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Krebs J., 1997, PB3423 HMSO; MONAGHAN ML, 1994, VET MICROBIOL, V40, P111, DOI 10.1016/0378-1135(94)90050-7; National Audit Office, 2003, ID TRACK LIV ENGL; O'Hare A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0248; Pollock JM, 2001, TUBERCULOSIS, V81, P103, DOI 10.1054/tube.2000.0258; Reynolds D, 2006, VET MICROBIOL, V112, P119, DOI 10.1016/j.vetmic.2005.11.042; Sisson SA, 2007, P NATL ACAD SCI USA, V104, P1760, DOI 10.1073/pnas.0607208104; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Waddington K, 2004, MED HIST, V48, P29, DOI 10.1017/S0025727300007043; Woolhouse MEJ, 2005, BIOL LETTERS, V1, P350, DOI 10.1098/rsbl.2005.0331	26	147	149	1	185	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					228	+		10.1038/nature13529	http://dx.doi.org/10.1038/nature13529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008532				2022-12-28	WOS:000338649800045
J	Pinal-Fernandez, I; Callejas-Moraga, EL; Roade-Tato, ML; Simeon-Aznar, CP				Pinal-Fernandez, Iago; Luis Callejas-Moraga, Eduardo; Luisa Roade-Tato, Maria; Pilar Simeon-Aznar, Carmen			Groove sign in eosinophilic fasciitis	LANCET			English	Editorial Material									[Pinal-Fernandez, Iago; Luis Callejas-Moraga, Eduardo; Luisa Roade-Tato, Maria; Pilar Simeon-Aznar, Carmen] Vall dHebron Univ Hosp, Dept Internal Med, System Autoimmune Dis Unit, Barcelona, Spain	Hospital Universitari Vall d'Hebron	Pinal-Fernandez, I (corresponding author), Hosp Valle De Hebron, Dept Internal Med, P Vall dHebron 119-139, Barcelona 08035, Spain.	ipinal@vhebron.net	Pinal-Fernandez, Iago/G-6335-2014	Pinal-Fernandez, Iago/0000-0001-6338-9218; Roade, Luisa/0000-0002-8160-9613; Simeon-Aznar, Carmen Pilar/0000-0003-3390-9029					0	9	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1774	1774		10.1016/S0140-6736(14)60526-2	http://dx.doi.org/10.1016/S0140-6736(14)60526-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KX	25043386	Bronze			2022-12-28	WOS:000345116400028
J	Chang, LF; Zhang, ZG; Yang, J; McLaughlin, SH; Barford, D				Chang, Leifu; Zhang, Ziguo; Yang, Jing; McLaughlin, Stephen H.; Barford, David			Molecular architecture and mechanism of the anaphase-promoting complex	NATURE			English	Article							MITOTIC CHECKPOINT COMPLEX; UBIQUITIN CHAIN ELONGATION; EM STRUCTURE DETERMINATION; CULLIN-RING LIGASES; CRYSTAL-STRUCTURE; ELECTRON-MICROSCOPY; CRYOELECTRON MICROSCOPY; STRUCTURAL INSIGHTS; DEGRON RECOGNITION; SUBSTRATE-BINDING	The ubiquitination of cell cycle regulatory proteins by the anaphase-promoting complex/cyclosome(APC/C) controls sister chromatid segregation, cytokinesis and the establishment of the G1 phase of the cell cycle. The APC/C is an unusually large multimeric cullin-RING ligase. Its activity is strictly dependent on regulatory coactivator subunits that promote APC/C-substrate interactions and stimulate its catalytic reaction. Because the structures of many APC/C subunits and their organization within the assembly are unknown, the molecular basis for these processes is poorly understood. Here, from a cryo-electron microscopy reconstruction of a human APC/C-coactivator-substrate complex at 7.4 angstrom resolution, we have determined the complete secondary structural architecture of the complex. With this information we identified protein folds for structurally uncharacterized subunits, and the definitive location of all 20 APC/C subunits within the 1.2 MDa assembly. Comparison with apo APC/C shows that the coactivator promotes a profound allosteric transition involving displacement of the cullin-RING catalytic subunits relative to the degron-recognition module of coactivator and APC10. This transition is accompanied by increased flexibility of the cullin-RING subunits and enhanced affinity for UBCH10-ubiquitin, changes which may contribute to coactivator-mediated stimulation of APC/C E3 ligase activity.	[Chang, Leifu; Zhang, Ziguo; Yang, Jing; Barford, David] Inst Canc Res, Div Struct Biol, London SW3 6JB, England; [Chang, Leifu; Zhang, Ziguo; Yang, Jing; McLaughlin, Stephen H.; Barford, David] MRC Lab Mol Biol, Cambridge CB2 0QH, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; MRC Laboratory Molecular Biology	Barford, D (corresponding author), MRC Lab Mol Biol, Cambridge CB2 0QH, England.	dbarford@mrc-lmb.cam.ac.uk		McLaughlin, Stephen/0000-0001-9135-6253; Barford, David/0000-0001-8810-950X; Yang, Jing/0000-0002-8984-4503; Zhang, Ziguo/0000-0002-7268-9631	Cancer Research UK; MRC [MC_UP_1201/6] Funding Source: UKRI; Cancer Research UK [14109] Funding Source: researchfish; Medical Research Council [MC_UP_1201/6] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank P. da Fonseca for her guidance preparing cryo electron microscopy grids and X. Bai and S. Scheres for help with the use of RELION and A. Plechanovova for advice in preparing stable UBCH10-Ub conjugates. We thank D. Morgan and W. Chao for their comments on the manuscript and D. Morgan for communicating data before publication. This work was funded by a Cancer Research UK grant to D.B.	Au SWN, 2002, J MOL BIOL, V316, P955, DOI 10.1006/jmbi.2002.5399; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Buschhorn BA, 2011, NAT STRUCT MOL BIOL, V18, P6, DOI 10.1038/nsmb.1979; Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzgerald DJ, 2007, STRUCTURE, V15, P275, DOI 10.1016/j.str.2007.01.016; Frye JJ, 2013, NAT STRUCT MOL BIOL, V20, P827, DOI 10.1038/nsmb.2593; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Han D, 2009, J BIOL CHEM, V284, P15137, DOI 10.1074/jbc.M804887200; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; He J, 2012, STRUCTURE, V20, P513, DOI 10.1016/j.str.2011.12.015; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Li YF, 2012, PROTEIN EXPRES PURIF, V82, P162, DOI 10.1016/j.pep.2011.12.008; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Pfleger CM, 2000, GENE DEV, V14, P655; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Tian W, 2012, P NATL ACAD SCI USA, V109, P18419, DOI 10.1073/pnas.1213438109; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Uzunova K, 2012, NAT STRUCT MOL BIOL, V19, P1116, DOI 10.1038/nsmb.2412; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wang J, 2009, NAT STRUCT MOL BIOL, V16, P987, DOI 10.1038/nsmb.1645; Wang WP, 2013, NAT CELL BIOL, V15, P797, DOI 10.1038/ncb2755; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Zhang ZG, 2013, J MOL BIOL, V425, P4236, DOI 10.1016/j.jmb.2013.04.004; Zhang ZG, 2013, BIOCHEM J, V449, P365, DOI 10.1042/BJ20121374; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247; Zhang ZG, 2010, J MOL BIOL, V397, P1316, DOI 10.1016/j.jmb.2010.02.045; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	68	149	166	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					388	+		10.1038/nature13543	http://dx.doi.org/10.1038/nature13543			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043029	Green Accepted			2022-12-28	WOS:000341814900053
J	Schumacher, T; Bunse, L; Pusch, S; Sahm, F; Wiestler, B; Quandt, J; Menn, O; Osswald, M; Oezen, I; Ott, M; Keil, M; Balss, J; Rauschenbach, K; Grabowska, AK; Vogler, I; Diekmann, J; Trautwein, N; Eichmuller, SB; Okun, J; Stevanovic, S; Riemer, AB; Sahin, U; Friese, MA; Beckhove, P; von Deimling, A; Wick, W; Platten, M				Schumacher, Theresa; Bunse, Lukas; Pusch, Stefan; Sahm, Felix; Wiestler, Benedikt; Quandt, Jasmin; Menn, Oliver; Osswald, Matthias; Oezen, Iris; Ott, Martina; Keil, Melanie; Balss, Joerg; Rauschenbach, Katharina; Grabowska, Agnieszka K.; Vogler, Isabel; Diekmann, Jan; Trautwein, Nico; Eichmueller, Stefan B.; Okun, Juergen; Stevanovic, Stefan; Riemer, Angelika B.; Sahin, Ugur; Friese, Manuel A.; Beckhove, Philipp; von Deimling, Andreas; Wick, Wolfgang; Platten, Michael			A vaccine targeting mutant IDH1 induces antitumour immunity	NATURE			English	Article							BRAIN-TUMORS; MUTATIONS; CELLS; DIFFERENTIATION; PHENOTYPE; MELANOMA; GLIOMAS; MICE	Monoallelic point mutations of isocitrate dehydrogenase type 1 (IDH1) are an early and defining event in the development of a subgroup of gliomas(1-3) and other types of tumour(4-6). They almost uniformly occur in the critical arginine residue (Arg 132) in the catalytic pocket, resulting in a neomorphic enzymatic function, production of the oncometabolite 2-hydroxyglutarate (2-HG)(7,8), genomic hypermethylation9-11, genetic instability and malignant transformation(12). More than 70% of diffuse grade II and grade III gliomas carry the most frequent mutation, IDH1(R132H) (ref. 3). From an immunological perspective, IDH1(R132H) represents a potential target for immunotherapy as it is a tumour-specific potential neoantigen with high uniformity and penetrance expressed in all tumour cells(13,14). Here we demonstrate that IDH1(R132H) contains an immunogenic epitope suitable formutation-specific vaccination. Peptides encompassing the mutated region are presented on major histocompatibility complexes (MHC) class II and induce mutation-specific CD4(+) T-helper-1 (TH1) responses. CD41 TH1 cells and antibodies spontaneously occurring in patients with IDH1(R132H)-mutated gliomas specifically recognize IDH1(R132H). Peptide vaccination of mice devoid of mouse MHC and transgenic for human MHC class I and II with IDH1(R132H) p123-142 results in an effective MHC class II-restrictedmutation-specific antitumourimmune response and control of pre-established syngeneic IDH1(R132H)-expressing tumours in a CD4(+)T-cell-dependent manner. As IDH1(R132H) is present in all tumour cells of these slow-growing gliomas(15), a mutation-specific anti-IDH1(R132H) vaccine may represent a viable novel therapeutic strategy for IDH1(R132H)-mutated tumours.	[Schumacher, Theresa; Bunse, Lukas; Wiestler, Benedikt; Menn, Oliver; Osswald, Matthias; Oezen, Iris; Ott, Martina; Keil, Melanie; Rauschenbach, Katharina; Wick, Wolfgang; Platten, Michael] Univ Heidelberg Hosp, Dept Neurooncol, D-69120 Heidelberg, Germany; [Schumacher, Theresa; Bunse, Lukas; Wiestler, Benedikt; Menn, Oliver; Osswald, Matthias; Oezen, Iris; Ott, Martina; Keil, Melanie; Rauschenbach, Katharina; Wick, Wolfgang; Platten, Michael] Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Schumacher, Theresa; Bunse, Lukas; Oezen, Iris; Ott, Martina; Keil, Melanie; Balss, Joerg; Rauschenbach, Katharina; Platten, Michael] German Canc Res Ctr, German Canc Consortium DKTK Clin Cooperat Unit Ne, D-69120 Heidelberg, Germany; [Pusch, Stefan; Sahm, Felix; von Deimling, Andreas] Univ Heidelberg Hosp, Dept Neuropathol, D-69120 Heidelberg, Germany; [Pusch, Stefan; Sahm, Felix; von Deimling, Andreas] Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Pusch, Stefan; Sahm, Felix; Balss, Joerg; von Deimling, Andreas] German Canc Res Ctr, German Canc Consortium DKTK Clin Cooperat Unit Ne, D-69120 Heidelberg, Germany; [Wiestler, Benedikt; Osswald, Matthias; Wick, Wolfgang] German Canc Res Ctr, German Canc Consortium DKTK Clin Cooperat Unit Ne, D-69120 Heidelberg, Germany; [Quandt, Jasmin; Eichmueller, Stefan B.; Beckhove, Philipp] German Canc Res Ctr, Dept Translat Immunol, D-69120 Heidelberg, Germany; [Grabowska, Agnieszka K.; Riemer, Angelika B.] German Canc Res Ctr, Dept Immunotherapy & Prevent Grp, D-69120 Heidelberg, Germany; [Vogler, Isabel] Ribological GmbH, D-55131 Mainz, Germany; [Diekmann, Jan; Sahin, Ugur] Translat Oncol, D-55131 Mainz, Germany; [Trautwein, Nico; Stevanovic, Stefan] Univ Tubingen, Dept Immunol, D-72076 Tubingen, Germany; [Okun, Juergen] Univ Childrens Hosp, Metab Ctr Heidelberg, D-69120 Heidelberg, Germany; [Friese, Manuel A.] Univ Med Ctr, Ctr Mol Neurobiol, D-20251 Hamburg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Platten, M (corresponding author), Univ Heidelberg Hosp, Dept Neurooncol, D-69120 Heidelberg, Germany.	m.platten@dkfz.de	Eichmüller, Stefan B/A-5053-2008; Bunse, Theresa/AAD-1719-2019; Bunse, Lukas/L-2975-2016; Platten, Michael/F-2902-2013; Sahin, Ugur/L-4818-2017; von Deimling, Andreas/F-7774-2013; Wick, Wolfgang/AAA-2545-2020; Sahm, Felix/GQY-8202-2022; Pusch, Stefan/H-3152-2019	Eichmüller, Stefan B/0000-0002-3497-6904; Bunse, Lukas/0000-0002-4490-7574; Platten, Michael/0000-0002-4746-887X; Sahin, Ugur/0000-0003-0363-1564; von Deimling, Andreas/0000-0002-5863-540X; Wick, Wolfgang/0000-0002-6171-634X; Sahm, Felix/0000-0001-5441-1962; Pusch, Stefan/0000-0002-3407-4249; Wiestler, Benedikt/0000-0002-2963-7772; Riemer, Angelika/0000-0002-5865-0714; Friese, Manuel A./0000-0001-6380-2420	DKFZ Light Microscopy and Genomics and Proteomics Facilities; NIH; Interdisciplinary Research Program of the National Center for Tumor Diseases Heidelberg [IFP III/2]; Wilhelm Sander Foundation [2012.118.1]; Helmholtz Foundation [VH-NG-306]; Andreas Zimprich Foundation; German Research Foundation [SFB938]; Helmholtz International Graduate School; Heinrich F. C. Behr Foundation; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology MD/PhD program, University Heidelberg; University Hospital Heidelberg	DKFZ Light Microscopy and Genomics and Proteomics Facilities; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interdisciplinary Research Program of the National Center for Tumor Diseases Heidelberg; Wilhelm Sander Foundation; Helmholtz Foundation(Helmholtz Association); Andreas Zimprich Foundation; German Research Foundation(German Research Foundation (DFG)); Helmholtz International Graduate School; Heinrich F. C. Behr Foundation; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology MD/PhD program, University Heidelberg; University Hospital Heidelberg	We are indebted to the patients and their relatives who agreed to participate in this study. We thank A. Gardyan, T. Lanz and W. Osen for technical advice, T. Lanz and A. Hertenstein for providing patient blood samples, S. Hundt for cloning, A. Habel and D. Krunic for technical support, W. Nicklas for pathological analysis, and J. Jung for graphics design. We acknowledge the support by the DKFZ Light Microscopy and Genomics and Proteomics Facilities. HLA-DRB1*01:01 MHC class II tetramer bound to IDH1(R132H) p123-142 was provided by NIH tetramer core facility. A2.DR1 mice were provided by Institut Pasteur. This work was supported by the Interdisciplinary Research Program of the National Center for Tumor Diseases Heidelberg (IFP III/2) to M. P. and A. V. D., the Wilhelm Sander Foundation (2012.118.1) to M. P and A. V. D., the Helmholtz Foundation (VH-NG-306) and the Andreas Zimprich Foundation to M. P. and the German Research Foundation (SFB938 TPK) to M. P. and W. W. T. S. and M. K. were supported by the Helmholtz International Graduate School, and L. B. was supported by the Heinrich F. C. Behr Foundation and the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology MD/PhD program, University Heidelberg. F.S. was supported by a postdoctoral fellowship of the University Hospital Heidelberg.	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Balss J, 2012, ACTA NEUROPATHOL, V124, P883, DOI 10.1007/s00401-012-1060-y; Cairns RA, 2013, CANCER DISCOV, V3, P730, DOI 10.1158/2159-8290.CD-13-0083; Capper D, 2010, BRAIN PATHOL, V20, P245, DOI 10.1111/j.1750-3639.2009.00352.x; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Ito K, 1996, J EXP MED, V183, P2635, DOI 10.1084/jem.183.6.2635; Jansen M, 2010, LANCET NEUROL, V9, P717, DOI 10.1016/S1474-4422(10)70105-8; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Pajot A, 2004, EUR J IMMUNOL, V34, P3060, DOI 10.1002/eji.200425463; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	26	458	479	3	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					324	+		10.1038/nature13387	http://dx.doi.org/10.1038/nature13387			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25043048				2022-12-28	WOS:000340508200038
J	Schleich, S; Strassburger, K; Janiesch, PC; Koledachkina, T; Miller, KK; Haneke, K; Cheng, YS; Kuchler, K; Stoecklin, G; Duncan, KE; Teleman, AA				Schleich, Sibylle; Strassburger, Katrin; Janiesch, Philipp Christoph; Koledachkina, Tatyana; Miller, Katharine K.; Haneke, Katharina; Cheng, Yong-Sheng; Kuechler, Katrin; Stoecklin, Georg; Duncan, Kent E.; Teleman, Aurelio A.			DENR-MCT-1 promotes translation re-initiation downstream of uORFs to control tissue growth	NATURE			English	Article							MSL-2 MESSENGER-RNA; OPEN READING FRAMES; CANDIDATE ONCOGENE; INSULIN-RECEPTOR; GENE-EXPRESSION; SEX-LETHAL; DROSOPHILA; MECHANISM; PROTEIN; MCT-1	During cap-dependent eukaryotic translation initiation, ribosomes scan messenger RNA from the 5' end to the first AUG start codon with favourable sequence context(1,2). For many mRNAs this AUG belongs to a short upstream open reading frame (uORF)(3), and translation of the main downstream ORF requires re-initiation, an incompletely understood process(1,4-6). Re-initiation is thought to involve the same factors as standard initiation(1,5,7). It is unknown whether any factors specifically affect translation re-initiation without affecting standard cap-dependent translation. Here we uncover the non-canonical initiation factors density regulated protein (DENR) and multiple copies in T-cell lymphoma-1(MCT-1; also called MCTS1 inhumans) as the first selective regulators of eukaryotic re-initiation. mRNAs containing upstream ORFs with strong Kozak sequences selectively require DENR-MCT-1 for their proper translation, yielding a novel class of mRNAs that can be co-regulated and that is enriched for regulatory proteins such as oncogenic kinases. Collectively, our data reveal that cells have a previously unappreciated translational control system with a key role in supporting proliferation and tissue growth.	[Schleich, Sibylle; Strassburger, Katrin; Haneke, Katharina; Cheng, Yong-Sheng; Stoecklin, Georg; Teleman, Aurelio A.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Schleich, Sibylle; Janiesch, Philipp Christoph; Koledachkina, Tatyana; Miller, Katharine K.; Kuechler, Katrin; Duncan, Kent E.] Univ Med Ctr Hamburg Eppendorf UKE, Ctr Mol Neurobiol ZMNH, D-20251 Hamburg, Germany; [Haneke, Katharina; Stoecklin, Georg] Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Duncan, KE (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Ctr Mol Neurobiol ZMNH, Falkenried 94, D-20251 Hamburg, Germany.	kent.duncan@zmnh.uni-hamburg.de; a.teleman@dkfz.de	kuchler, karl/AAL-6937-2020; Teleman, Aurelio A/E-6864-2013; Teleman, Aurelio/V-8470-2019; Miller, Katharine K/O-6804-2015	kuchler, karl/0000-0003-2719-5955; Teleman, Aurelio A/0000-0002-4237-9368; Teleman, Aurelio/0000-0002-4237-9368; Miller, Katharine K/0000-0002-0690-7426; Duncan, Kent/0000-0003-4290-2670; Cheng, Yong-Sheng/0000-0002-4586-8116; Stoecklin, Georg/0000-0001-9284-9834; Hoerth, Katharina/0000-0002-6676-3583	Hans und Ilse Breuer Foundation; Fritz Thyssen Foundation; Deutsche Forschungsgemeinschaft (DFG); ERC	Hans und Ilse Breuer Foundation; Fritz Thyssen Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	We thank B. Bukau, R. Green and P. Soba for suggestions on the manuscript, V. Benes and T. Bahr-Ivacevic (EMBL Genomics Core Facility) for assistance with microarray experiments, S. Abmayr for anti-Mbc antibody, T. Hsu for anti-Awd antibody, C. Strein and M. Hentze for Drosophila DENR antibodies, P. Jakob for help with testing conditions for S2 in vitro translation extracts, L. Schibalski and J. Grawe for help with cloning, S. Hofmann for help with polysome analysis, and S. Lerch, A. Haffner and M. Schroder for technical assistance. K.K.M. is the recipient of an Alzheimer's Research Scholarship from the Hans und Ilse Breuer Foundation. P.C.J. is supported in part by a grant from the Fritz Thyssen Foundation to K.E.D. This work was supported in part by a Deutsche Forschungsgemeinschaft (DFG) grant and ERC Starting Grant to A.A.T.	Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Dierov J, 1999, J CELL BIOCHEM, V74, P544, DOI 10.1002/(SICI)1097-4644(19990915)74:4<544::AID-JCB4>3.3.CO;2-W; Dmitriev SE, 2010, J BIOL CHEM, V285, P26779, DOI 10.1074/jbc.M110.119693; Duncan K, 2006, GENE DEV, V20, P368, DOI 10.1101/gad.371406; Duncan KE, 2009, MOL CELL, V36, P571, DOI 10.1016/j.molcel.2009.09.042; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; HAYASHI S, 1993, DEVELOPMENT, V118, P105; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang J, 2008, GENETICS, V180, P703, DOI 10.1534/genetics.108.090563; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jackson RJ, 2012, ADV PROTEIN CHEM STR, V86, P45, DOI [10.1016/B978-0-12-386497-0.00002-5, 10.1016/B978-0-12.386497.000002-5]; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kong J, 2012, NAT REV GENET, V13, P383, DOI 10.1038/nrg3184; KONGSUWAN K, 1985, NATURE, V317, P555, DOI 10.1038/317555a0; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Mazan-Mamczarz K, 2009, LEUKEMIA RES, V33, P474, DOI 10.1016/j.leukres.2008.08.012; Nandi S, 2007, ONCOGENE, V26, P2283, DOI 10.1038/sj.onc.1210030; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Prosniak M, 1998, CANCER RES, V58, P4233; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Skabkin MA, 2013, MOL CELL, V51, P249, DOI 10.1016/j.molcel.2013.05.026; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Somers J, 2013, INT J BIOCHEM CELL B, V45, P1690, DOI 10.1016/j.biocel.2013.04.020; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Valasek LS, 2012, CURR PROTEIN PEPT SC, V13, P305; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wilson TG, 2006, GENETICS, V172, P253, DOI 10.1534/genetics.105.046631; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	104	107	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					208	+		10.1038/nature13401	http://dx.doi.org/10.1038/nature13401			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043021	Green Accepted			2022-12-28	WOS:000340200700035
J	Ghavi-Helm, Y; Klein, FA; Pakozdi, T; Ciglar, L; Noordermeer, D; Huber, W; Furlong, EEM				Ghavi-Helm, Yad; Klein, Felix A.; Pakozdi, Tibor; Ciglar, Lucia; Noordermeer, Daan; Huber, Wolfgang; Furlong, Eileen E. M.			Enhancer loops appear stable during development and are associated with paused polymerase	NATURE			English	Article							GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; ABDOMINAL-B; TRANSCRIPTION; ORGANIZATION; BINDING; RANGE; TRANSFORMATION; CONSERVATION; ELEMENTS	Developmental enhancers initiate transcription and are fundamental to our understanding of developmental networks, evolution and disease. Despite their importance, the properties governing enhancer-promoter interactions and their dynamics during embryogenesis remain unclear. At the beta-globin locus, enhancer-promoter interactions appear dynamic and cell-type specific(1,2), whereas at the HoxD locus they are stable and ubiquitous, being present in tissues where the target genes are not expressed(3,4). The extent to which preformed enhancer-promoter conformations exist at other, more typical, loci and how transcription is eventually triggered is unclear. Here we generated a high-resolution map of enhancer three-dimensional contacts during Drosophila embryogenesis, covering two developmental stages and tissue contexts, at unprecedented resolution. Although local regulatory interactions are common, long-range interactions are highly prevalent within the compact Drosophila genome. Each enhancer contacts multiple enhancers, and promoters with similar expression, suggesting a role in their co-regulation. Notably, most interactions appear unchanged between tissue context and across development, arising before gene activation, and are frequently associated with paused RNA polymerase. Our results indicate that the general topology governing enhancer contacts is conserved from flies to humans and suggest that transcription initiates from preformed enhancer-promoter loops through release of paused polymerase.	[Ghavi-Helm, Yad; Klein, Felix A.; Pakozdi, Tibor; Ciglar, Lucia; Huber, Wolfgang; Furlong, Eileen E. M.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Noordermeer, Daan] Swiss Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland	European Molecular Biology Laboratory (EMBL); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Furlong, EEM (corresponding author), European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany.	furlong@embl.de	Noordermeer, Daan/F-3306-2011	Noordermeer, Daan/0000-0002-9296-7002; Huber, Wolfgang/0000-0002-0474-2218; Pakozdi, Tibor/0000-0002-7633-7529; Ghavi-Helm, Yad/0000-0003-2397-9576; Furlong, Eileen/0000-0002-9544-8339	DFG [FU 750]; EMBO; EC	DFG(German Research Foundation (DFG)); EMBO(European Molecular Biology Organization (EMBO)); EC(European CommissionEuropean Commission Joint Research Centre)	This work was technically supported by the EMBL Genomics Core and FACS core facilities. We thank all members of the Furlong laboratory for discussions and comments, in particular D. Garfield, J. Reddington and I. Schor for important suggestions. Embryo images in Fig. 3c were used with permission from Development<SUP>27</SUP> and Nature Publishing Group<SUP>26</SUP> as these fly strains no longer exist. This work was supported by a DFG (FU 750) grant to E.E.M.F., an EMBO post-doctoral fellowship to Y.G.-H., and the EC FP7 project 'Radiant' grant to F.A.K. and W.H.	Albrecht S, 2011, DEV BIOL, V350, P89, DOI 10.1016/j.ydbio.2010.11.016; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Bonn S, 2012, NAT PROTOC, V7, P978, DOI 10.1038/nprot.2012.049; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; BUSTURIA A, 1993, EMBO J, V12, P1415, DOI 10.1002/j.1460-2075.1993.tb05785.x; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Capovilla M, 2001, DEVELOPMENT, V128, P1221; Chen K, 2013, ELIFE, V2, DOI 10.7554/eLife.00861; Chopra VS, 2009, GENE DEV, V23, P1505, DOI 10.1101/gad.1807309; Cleard F, 2006, NAT GENET, V38, P931, DOI 10.1038/ng1833; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Fanucchi S, 2013, CELL, V155, P606, DOI 10.1016/j.cell.2013.09.051; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Gaertner B, 2012, CELL REP, V2, P1670, DOI 10.1016/j.celrep.2012.11.024; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Lai WKM, 2012, BIOINFORMATICS, V28, P1021, DOI 10.1093/bioinformatics/bts063; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Saunders A, 2013, GENE DEV, V27, P1146, DOI 10.1101/gad.215459.113; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Scuderi A, 2006, DEV BIOL, V291, P110, DOI 10.1016/j.ydbio.2005.12.014; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Thomas S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r43; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tolhuis B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001343; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wilczynski B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002798; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Zhou JM, 1999, DEVELOPMENT, V126, P3057; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	55	323	324	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					96	+		10.1038/nature13417	http://dx.doi.org/10.1038/nature13417			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043061				2022-12-28	WOS:000339908000039
J	Tseng, YY; Moriarity, BS; Gong, WM; Akiyama, R; Tiwari, A; Kawakami, H; Ronning, P; Reuland, B; Guenther, K; Beadnell, TC; Essig, J; Otto, GM; O'Sullivan, MG; Largaespada, DA; Schwertfeger, KL; Marahrens, Y; Kawakami, Y; Bagchi, A				Tseng, Yuen-Yi; Moriarity, Branden S.; Gong, Wuming; Akiyama, Ryutaro; Tiwari, Ashutosh; Kawakami, Hiroko; Ronning, Peter; Reuland, Brian; Guenther, Kacey; Beadnell, Thomas C.; Essig, Jaclyn; Otto, George M.; O'Sullivan, M. Gerard; Largaespada, David A.; Schwertfeger, Kathryn L.; Marahrens, York; Kawakami, Yasuhiko; Bagchi, Anindya			PVT1 dependence in cancer with MYC copy-number increase	NATURE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; BREAST-CANCER; C-MYC; TRANSCRIPTION FACTORS; MAMMARY-GLAND; CHROMOSOME 8Q; CELL-LINES; EXPRESSION; AMPLIFICATION; MICE	'Gain' of supernumerary copies of the 8q24.21 chromosomal region has been shown to be common in many human cancers(1-13) and is associated with poor prognosis(7,10,14). The well-characterized myelocytomatosis (MYC) oncogene resides in the 8q24.21 region and is consistently co-gained with an adjacent 'gene desert' of approximately 2 megabases that contains the long non-coding RNA gene PVT1, the CCDC26 gene candidate and the GSDMC gene. Whether low copy-number gain of one or more of these genes drives neoplasia is not known. Here we use chromosome engineering in mice to show that a single extra copy of either the Myc gene or the region encompassing Pvt1, Ccdc26 and Gsdmc fails to advance cancer measurably, whereas a single supernumerary segment encompassing all four genes successfully promotes cancer. Gain of PVT1 long non-coding RNA expression was required for high MYC protein levels in 8q24-amplified human cancer cells. PVT1 RNA and MYC protein expression correlated in primary human tumours, and copy number of PVT1 was co-increased in more than 98% of MYC-copy-increase cancers. Ablation of PVT1 from MYC-driven colon cancer line HCT116 diminished its tumorigenic potency. As MYC protein has been refractory to small-molecule inhibition, the dependence of high MYC protein levels on PVT1 long non-coding RNA provides a much needed therapeutic target.	[Tseng, Yuen-Yi; Gong, Wuming; Akiyama, Ryutaro; Kawakami, Hiroko; Ronning, Peter; Reuland, Brian; Guenther, Kacey; Essig, Jaclyn; Largaespada, David A.; Marahrens, York; Kawakami, Yasuhiko; Bagchi, Anindya] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Moriarity, Branden S.; Gong, Wuming; Tiwari, Ashutosh; Otto, George M.; O'Sullivan, M. Gerard; Largaespada, David A.; Schwertfeger, Kathryn L.; Bagchi, Anindya] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Akiyama, Ryutaro; Kawakami, Hiroko; Kawakami, Yasuhiko] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Beadnell, Thomas C.; Schwertfeger, Kathryn L.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bagchi, A (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	bagch005@umn.edu	Tseng, Yuen-Yi/C-2148-2015; Tiwari, Ashutosh/ABG-9394-2020; Gong, Wuming/GQH-1435-2022; Gong, Wuming/GQH-9157-2022	Tseng, Yuen-Yi/0000-0002-8757-4087; Gong, Wuming/0000-0002-3147-4028; Kawakami, Yasuhiko/0000-0002-0043-9705; Tiwari, Ashutosh/0000-0003-3404-8881	Masonic Cancer Center Laboratory; Institute of Prostate and Urologic Cancer, University of Minnesota; American Cancer Society [118198-IRG-58-001-52-IRG92]; Indo-US fellowship from the Indo-US Science and Technology Forum; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064195] Funding Source: NIH RePORTER	Masonic Cancer Center Laboratory; Institute of Prostate and Urologic Cancer, University of Minnesota; American Cancer Society(American Cancer Society); Indo-US fellowship from the Indo-US Science and Technology Forum; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. T. Vogel for writing statistical analysis scripts; Research Animal Resources, University of Minnesota, for maintaining the mouse colony; S. Horn and L. Oseth for embryonic stem cell blastocyst injection and FISH analysis respectively. This work was supported by Masonic Cancer Center Laboratory start-up funds (to A.B.), and by grants from the Masonic Scholar Award (to A.B.), the Karen Wyckoff Rein in Sarcoma Fund (to A.B.), Translational Workgroup Pilot Project Awards by the Institute of Prostate and Urologic Cancer, University of Minnesota (to A.B.) and an American Cancer Society Institutional Research Grant (award 118198-IRG-58-001-52-IRG92, to A.B.). A.T. was supported by an Indo-US fellowship from the Indo-US Science and Technology Forum.	Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; BORG A, 1992, INT J CANCER, V51, P687, DOI 10.1002/ijc.2910510504; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Douglas EJ, 2004, CANCER RES, V64, P4817, DOI 10.1158/0008-5472.CAN-04-0328; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Huppi Konrad, 2012, Frontiers in Genetics, V3, P69, DOI 10.3389/fgene.2012.00069; Itou J, 2012, DEVELOPMENT, V139, P4133, DOI 10.1242/dev.079756; Jain AN, 2001, P NATL ACAD SCI USA, V98, P7952, DOI 10.1073/pnas.151241198; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Le Beau MM, 2002, BLOOD, V99, P2985, DOI 10.1182/blood.V99.8.2985; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023356; Moriarity BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096114; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Park K, 2005, HUM PATHOL, V36, P634, DOI 10.1016/j.humpath.2005.04.016; Rahrmann EP, 2013, NAT GENET, V45, P756, DOI 10.1038/ng.2641; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Reed JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045877; Saji S, 2000, P NATL ACAD SCI USA, V97, P337, DOI 10.1073/pnas.97.1.337; Sato K, 1999, JNCI-J NATL CANCER I, V91, P1574, DOI 10.1093/jnci/91.18.1574; Schwertfeger KL, 2006, CANCER RES, V66, P5676, DOI 10.1158/0008-5472.CAN-05-3781; van Duin M, 2007, CYTOGENET GENOME RES, V118, P130, DOI 10.1159/000108293; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Yamada T, 2000, CANCER GENET CYTOGEN, V120, P11, DOI 10.1016/S0165-4608(99)00240-X; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P2790, DOI 10.1073/pnas.1100764108; Zitterbart K, 2011, J NEURO-ONCOL, V102, P25, DOI 10.1007/s11060-010-0289-3	37	519	543	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					82	+		10.1038/nature13311	http://dx.doi.org/10.1038/nature13311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043044	Green Accepted			2022-12-28	WOS:000339908000036
J	Arany, ZP; Walker, CM; Wang, L				Arany, Zoltan P.; Walker, Christopher M.; Wang, Lin			Case 22-2014: A 40-Year-Old Woman with Postpartum Dyspnea and Hypoxemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERIPARTUM CARDIOMYOPATHY; UNITED-STATES; PREGNANCY; PREECLAMPSIA; OUTCOMES; DISEASE; WOMEN; TERM		[Arany, Zoltan P.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Walker, Christopher M.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Wang, Lin] Massachusetts Gen Hosp, Dept Cardiol, Boston, MA 02114 USA; [Arany, Zoltan P.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Walker, Christopher M.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Wang, Lin] Harvard Univ, Sch Med, Dept Cardiol, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Arany, ZP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.							[Anonymous], 2012, N ENGL J MED, V367, P2528; Bello N, 2013, J AM COLL CARDIOL, V62, P1715, DOI 10.1016/j.jacc.2013.08.717; Berg CJ, 2010, OBSTET GYNECOL, V116, P1302, DOI 10.1097/AOG.0b013e3181fdfb11; Brito V, 2011, CLIN CHEST MED, V32, P121, DOI 10.1016/j.ccm.2010.10.004; Conde-Agudelo A, 2009, AM J OBSTET GYNECOL, V201; DEMAKIS JG, 1971, CIRCULATION, V44, P964, DOI 10.1161/01.CIR.44.5.964; Elkayam U, 2001, NEW ENGL J MED, V344, P1567, DOI 10.1056/NEJM200105243442101; Goland S, 2009, J CARD FAIL, V15, P645, DOI 10.1016/j.cardfail.2009.03.008; Halkein J, 2013, J CLIN INVEST, V123, P2143, DOI 10.1172/JCI64365; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; James AH, 2006, CIRCULATION, V113, P1564, DOI 10.1161/CIRCULATIONAHA.105.576751; Koul AK, 2001, CATHETER CARDIO INTE, V52, P88, DOI 10.1002/1522-726X(200101)52:1<88::AID-CCD1022>3.0.CO;2-P; Marik PE, 2008, NEW ENGL J MED, V359, P2025, DOI 10.1056/NEJMra0707993; Melchiorre K, 2011, HYPERTENSION, V57, P85, DOI 10.1161/HYPERTENSIONAHA.110.162321; Ouzounian JG, 2012, CARDIOL CLIN, V30, P317, DOI 10.1016/j.ccl.2012.05.004; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Rasmusson KD, 2007, J HEART LUNG TRANSPL, V26, P1097, DOI 10.1016/j.healun.2007.08.002; ROBSON SC, 1989, AM J PHYSIOL, V256, pH1060, DOI 10.1152/ajpheart.1989.256.4.H1060; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Sciscione AC, 2003, OBSTET GYNECOL, V101, P511, DOI 10.1016/S0029-7844(02)02733-3; Sliwa K, 2010, EUR J HEART FAIL, V12, P767, DOI 10.1093/eurjhf/hfq120; Sliwa K, 2010, CIRCULATION, V121, P1465, DOI 10.1161/CIRCULATIONAHA.109.901496; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6	26	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2014	371	3					261	269		10.1056/NEJMcpc1304163	http://dx.doi.org/10.1056/NEJMcpc1304163			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL3BK	25014691				2022-12-28	WOS:000338999800011
J	Ewald, AJ; Egeblad, M				Ewald, Andrew J.; Egeblad, Mikala			CANCER Sugar-coated cell signalling	NATURE			English	Editorial Material									[Ewald, Andrew J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA; [Ewald, Andrew J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21218 USA; [Egeblad, Mikala] Cold Spring Harbor Lab, Ctr Canc, Cold Spring Harbor, NY 11724 USA	Johns Hopkins University; Johns Hopkins University; Cold Spring Harbor Laboratory	Ewald, AJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA.	egeblad@cshl.edu	Egeblad, Mikala/GNP-0620-2022	Egeblad, Mikala/0000-0002-3371-1445				Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Hakomori S, 1996, CANCER RES, V56, P5309; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Horm TM, 2013, CELL ADHES MIGR, V7, P187, DOI 10.4161/cam.23131; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604	8	9	9	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					298	299		10.1038/nature13506	http://dx.doi.org/10.1038/nature13506			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030162				2022-12-28	WOS:000338992200023
J	Goodrich, JK; Di Rienzi, SC; Poole, AC; Koren, O; Walters, WA; Caporaso, JG; Knight, R; Ley, RE				Goodrich, Julia K.; Di Rienzi, Sara C.; Poole, Angela C.; Koren, Omry; Walters, William A.; Caporaso, J. Gregory; Knight, Rob; Ley, Ruth E.			Conducting a Microbiome Study	CELL			English	Article							HUMAN GUT MICROBIOTA; INTESTINAL MICROBIOTA; BACTERIAL; HOST; CLASSIFICATION; IMPACT; MICE; IDENTIFICATION; AMPLIFICATION; DIVERSITY	Human microbiome research is an actively developing area of inquiry, with ramifications for our lifestyles, our interactions with microbes, and how we treat disease. Advances depend on carefully executed, controlled, and reproducible studies. Here, we provide a Primer for researchers from diverse disciplines interested in conducting microbiome research. We discuss factors to be considered in the design, execution, and data analysis of microbiome studies. These recommendations should help researchers to enter and contribute to this rapidly developing field.	[Goodrich, Julia K.; Di Rienzi, Sara C.; Poole, Angela C.; Koren, Omry; Ley, Ruth E.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Goodrich, Julia K.; Di Rienzi, Sara C.; Poole, Angela C.; Koren, Omry; Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Walters, William A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Walters, William A.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Caporaso, J. Gregory] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Cornell University; Cornell University; University of Colorado System; University of Colorado Boulder; Northern Arizona University; United States Department of Energy (DOE); Argonne National Laboratory; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Ley, RE (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	rel222@cornell.edu	Ley, Ruth E/M-8542-2014; Di Rienzi, Sara C./U-1035-2019; Knight, Rob/D-1299-2010; Koren, Omry/A-5222-2016; Goodrich, Julia/ABD-8368-2021	Ley, Ruth E/0000-0002-9087-1672; Di Rienzi, Sara C./0000-0002-6188-663X; Koren, Omry/0000-0002-7738-1337; Caporaso, Greg/0000-0002-8865-1670; Poole, Angela/0000-0003-0278-7655; Knight, Rob/0000-0002-0975-9019	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD011389] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG004872] Funding Source: Medline; NIDDK NIH HHS [P01 DK078669] Funding Source: Medline; NIGMS NIH HHS [T32 GM008759, T32 GM142607] Funding Source: Medline; NIMHD NIH HHS [R01 MD011389] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bai GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036934; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016900; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Chassaing B, 2012, ADV IMMUNOL, V116, P93, DOI 10.1016/B978-0-12-394300-2.00003-X; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Di Rienzi SC, 2013, ELIFE, V2, DOI 10.7554/eLife.01102; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goff SA, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00034; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jack PJM, 2009, VET MICROBIOL, V133, P145, DOI 10.1016/j.vetmic.2008.05.030; Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844; Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sergeant MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038094; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Smith Birgitte, 2011, Open Microbiol J, V5, P14, DOI 10.2174/1874285801105010014; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Tanner MA, 1998, APPL ENVIRON MICROB, V64, P3110; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	98	425	435	2	179	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					250	262		10.1016/j.cell.2014.06.037	http://dx.doi.org/10.1016/j.cell.2014.06.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036628	Green Accepted, Bronze			2022-12-28	WOS:000340943600007
J	Hallmann, CA; Foppen, RPB; van Turnhout, CAM; de Kroon, H; Jongejans, E				Hallmann, Caspar A.; Foppen, Ruud P. B.; van Turnhout, Chris A. M.; de Kroon, Hans; Jongejans, Eelke			Declines in insectivorous birds are associated with high neonicotinoid concentrations	NATURE			English	Article							FARMLAND BIRDS; INSECTICIDES; PESTICIDES; SCALE; BEES	Recent studies have shown that neonicotinoid insecticides have adverse effects on non-target invertebrate species(1-6). Invertebrates constitute a substantial part of the diet of many bird species during the breeding season and are indispensable for raising offspring(7). We investigated the hypothesis that the most widely used neonicotinoid insecticide, imidacloprid, has a negative impact on insectivorous bird populations. Here we show that, in the Netherlands, local population trends were significantly more negative in areas with higher surface-water concentrations of imidacloprid. At imidacloprid concentrations of more than 20 nanograms per litre, bird populations tended to decline by 3.5 per cent on average annually. Additional analyses revealed that this spatial pattern of decline appeared only after the introduction of imidacloprid to the Netherlands, in the mid-1990s. We further show that the recent negative relationship remains after correcting for spatial differences in land-use changes that are known to affect bird populations in farmland. Our results suggest that the impact of neonicotinoids on the natural environment is even more substantial than has recently been reported and is reminiscent of the effects of persistent insecticides in the past. Future legislation should take into account the potential cascading effects of neonicotinoidson ecosystems.	[Hallmann, Caspar A.; de Kroon, Hans; Jongejans, Eelke] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Expt Plant Ecol, NL-6500 GL Nijmegen, Netherlands; [Hallmann, Caspar A.; de Kroon, Hans; Jongejans, Eelke] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Ecol & Ecophysiol, NL-6500 GL Nijmegen, Netherlands; [Hallmann, Caspar A.; Foppen, Ruud P. B.; van Turnhout, Chris A. M.] Dutch Ctr Field Ornithol, Sovon, NL-6503 GA Nijmegen, Netherlands; [Foppen, Ruud P. B.] Birdlife Netherlands, NL-3700 AX Zeist, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Hallmann, CA (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Expt Plant Ecol, POB 9100 Mail Box 31, NL-6500 GL Nijmegen, Netherlands.	c.hallmann@science.ru.nl	de Kroon, Hans/B-3359-2009; Serrano, Jose/A-2854-2009; Jongejans, Eelke/B-4832-2008	de Kroon, Hans/0000-0001-6151-3561; Serrano, Jose/0000-0002-1565-5216; Jongejans, Eelke/0000-0003-1148-7419	Dutch Ministry of EZ; NWO [840.11.001, 841.11.007]	Dutch Ministry of EZ; NWO(Netherlands Organization for Scientific Research (NWO))	We thank A. J. van Dijk, H. Sierdsema and D. Zoetebier for processing the bird data sets and J. P. van der Sluijs for sharing the database with imidacloprid concentration measurements. The Breeding Bird Monitoring Program is organised in close collaboration with Statistics Netherlands and provinces and is funded by the Dutch Ministry of EZ. We thank Sovon volunteers for their efforts in the field. The study was supported by NWO grants 840.11.001 and 841.11.007 and was the result of a collaboration within the Center for Avian Population Studies.	[Anonymous], 2011, FINE CHEM IND BUSINE, DOI DOI 10.1002/9780470946404; Bibby CJ, 1992, BIRD CENSUS TECHNIQU; Boatman ND, 2004, IBIS, V146, P131, DOI 10.1111/j.1474-919X.2004.00347.x; Chamberlain DE, 2000, AGR ECOSYST ENVIRON, V78, P1, DOI 10.1016/S0167-8809(99)00105-X; Cramp S., 1994, BIRDS W PALEARCTIC; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Easton AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054819; Fuller RJ, 2000, ECOLOGY AND CONSERVATION OF LOWLAND FARMLAND BIRDS, P5; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Institute of Environmental Sciences Leiden University and Rijkswaterstaat-Water Services, 2009, DUTCH PEST ATL; Kampichler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035272; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Mineau P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057457; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Newton I., 1998, POPULATION LIMITATIO; Poulin B, 2010, J APPL ECOL, V47, P884, DOI 10.1111/j.1365-2664.2010.01821.x; Roessink I, 2013, ENVIRON TOXICOL CHEM, V32, P1096, DOI 10.1002/etc.2201; Statistics Netherlands, 2013, STATLINE DAT; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Van Turnhout CAM, 2007, BIOL CONSERV, V134, P505, DOI 10.1016/j.biocon.2006.09.011; Van Turnhout CAM, 2010, BIOL CONSERV, V143, P173, DOI 10.1016/j.biocon.2009.09.023; VANDIJK AJ, 2004, HANDLEIDING BROEDVOG; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	28	547	590	35	772	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					341	+		10.1038/nature13531	http://dx.doi.org/10.1038/nature13531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030173				2022-12-28	WOS:000338992200034
J	Harden, WD; Prochazka, AV				Harden, Wesley D.; Prochazka, Allan V.			Review: Preoperative behavioral interventions increase smoking cessation and reduce postoperative complications	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Harden, Wesley D.; Prochazka, Allan V.] Denver VA Med Ctr, Denver, CO 80220 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Harden, WD (corresponding author), Denver VA Med Ctr, Denver, CO 80220 USA.							Myers K, 2011, ARCH INTERN MED, V171, P983, DOI 10.1001/archinternmed.2011.97; Stead LF, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009670.pub4, 10.1002/14651858.CD002850.pub3]; Tobacco Use and Dependence Guideline Panel, 2008, TREATING TOBACCO USE	3	3	3	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2							JC2	10.7326/0003-4819-161-2-201407150-02002	http://dx.doi.org/10.7326/0003-4819-161-2-201407150-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023268				2022-12-28	WOS:000339764600001
J	Yudkin, JS; Montori, VM				Yudkin, John S.; Montori, Victor M.			The epidemic of pre-diabetes: the medicine and the politics	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTIONS; DIABETES PREVENTION; HEMOGLOBIN A1C; FOLLOW-UP; DEFINITIONS; PROGRESSION; PREVALENCE; REDUCTION; HBA(1C)		[Yudkin, John S.] UCL, Div Med, London, England; [Montori, Victor M.] Mayo Clin, Dept Med, Div Endocrinol & Diabet, Knowledge & Evaluat Res Unit, Rochester, MN USA; [Montori, Victor M.] Mayo Clin, Dept Hlth Sci Res, Div Endocrinol & Diabet, Knowledge & Evaluat Res Unit, Rochester, MN USA	University of London; University College London; Mayo Clinic; Mayo Clinic	Yudkin, JS (corresponding author), UCL, Div Med, London, England.	j.yudkin@ucl.ac.uk	Yudkin, John S/C-1988-2008	Montori, Victor/0000-0003-0595-2898	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000135] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Dunkley AJ, 2014, DIABETES CARE, V37, P922, DOI 10.2337/dc13-2195; Edelman D, 2004, J GEN INTERN MED, V19, P1175, DOI 10.1111/j.1525-1497.2004.40178.x; Gale EAM, 2013, HEART, V99, P824, DOI 10.1136/heartjnl-2012-302763; Gavin JR, 1997, DIABETES CARE, V20, P1183; Genuth S, 2003, DIABETES CARE, V26, P3160; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gong Q, 2011, DIABETOLOGIA, V54, P300, DOI 10.1007/s00125-010-1948-9; HARRIS M, 1979, DIABETES, V28, P1039; Holman RR, 2011, DIABETES CARE, V34, P1265, DOI 10.2337/dc10-1567; Hopper I, 2011, EUR J CARDIOV PREV R, V18, P813, DOI 10.1177/1741826711421687; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; James C, 2011, DIABETES CARE, V34, P387, DOI 10.2337/dc10-1314; Kahn R, 2014, DIABETES CARE, V37, P943, DOI 10.2337/dc13-1954; Knowler WC, 2003, DIABETES CARE, V26, P977; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Montori V, 2007, BMJ-BRIT MED J, V334, P882, DOI 10.1136/bmj.39169.447488.94; Morris DH, 2013, DIABETOLOGIA, V56, P1489, DOI 10.1007/s00125-013-2902-4; Moynihan RN, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001500; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Institute for Health and Care Excellence, 2012, PREV TYP 2 DIAB RISK; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Pradhan AD, 2007, AM J MED, V120, P720, DOI 10.1016/j.amjmed.2007.03.022; Selvin E, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-5-201103010-00004; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Uusitupa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005656; W.H. Organization, 1999, DEFINITION DIAGNOSIS; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organization, 2006, DEF DIAGN DIAB MELL; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yudkin JS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7995; Yudkin JS, 2011, LANCET, V377, P1220, DOI 10.1016/S0140-6736(10)61112-9; YUDKIN JS, 1990, BRIT MED J, V301, P397, DOI 10.1136/bmj.301.6749.397; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	44	49	49	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2014	349								g4485	10.1136/bmj.g4485	http://dx.doi.org/10.1136/bmj.g4485			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7OZ	25028385	Green Published			2022-12-28	WOS:000339325400004
J	Carlson, JM; Schaefer, M; Monaco, DC; Batorsky, R; Claiborne, DT; Prince, J; Deymier, MJ; Ende, ZS; Klatt, NR; DeZiel, CE; Lin, TH; Peng, J; Seese, AM; Shapiro, R; Frater, J; Ndung'u, T; Tang, JM; Goepfert, P; Gilmour, J; Price, MA; Kilembe, W; Heckerman, D; Goulder, PJR; Allen, TM; Allen, S; Hunter, E				Carlson, Jonathan M.; Schaefer, Malinda; Monaco, Daniela C.; Batorsky, Rebecca; Claiborne, Daniel T.; Prince, Jessica; Deymier, Martin J.; Ende, Zachary S.; Klatt, Nichole R.; DeZiel, Charles E.; Lin, Tien-Ho; Peng, Jian; Seese, Aaron M.; Shapiro, Roger; Frater, John; Ndung'u, Thumbi; Tang, Jianming; Goepfert, Paul; Gilmour, Jill; Price, Matt A.; Kilembe, William; Heckerman, David; Goulder, Philip J. R.; Allen, Todd M.; Allen, Susan; Hunter, Eric			Selection bias at the heterosexual HIV-1 transmission bottleneck	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CLASS-I ALLELES; REPLICATION CAPACITY; DISCORDANT COUPLES; ESCAPE MUTATIONS; VIRAL-LOAD; SEXUAL TRANSMISSION; CHRONIC INFECTION; IMMUNE CONTROL; SH3 DOMAIN	Heterosexual transmission of HIV-1 typically results in one genetic variant establishing systemic infection. We compared, for 137 linked transmission pairs, the amino acid sequences encoded by non-envelope genes of viruses in both partners and demonstrate a selection bias for transmission of residues that are predicted to confer increased in vivo fitness on viruses in the newly infected, immunologically naive recipient. Although tempered by transmission risk factors, such as donor viral load, genital inflammation, and recipient gender, this selection bias provides an overall transmission advantage for viral quasispecies that are dominated by viruses with high in vivo fitness. Thus, preventative or therapeutic approaches that even marginally reduce viral fitness may lower the overall transmission rates and offer long-term benefits even upon successful transmission.	[Carlson, Jonathan M.; DeZiel, Charles E.; Lin, Tien-Ho; Peng, Jian] Microsoft Res, Redmond, WA 98052 USA; [Schaefer, Malinda; Monaco, Daniela C.; Claiborne, Daniel T.; Prince, Jessica; Deymier, Martin J.; Ende, Zachary S.; Klatt, Nichole R.; Hunter, Eric] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Batorsky, Rebecca; Seese, Aaron M.; Ndung'u, Thumbi; Allen, Todd M.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02114 USA; [Shapiro, Roger] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Frater, John] Univ Oxford, Nuffield Dept Clin Med, Oxford OX1 7BN, England; [Frater, John] Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford OX3 7LE, England; [Frater, John] Univ Oxford, Oxford Martin Sch, Oxford OX1 3BD, England; [Ndung'u, Thumbi; Goulder, Philip J. R.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, ZA-4013 Durban, South Africa; [Ndung'u, Thumbi] Max Planck Inst Infekt Biol, D-10117 Berlin, Germany; [Tang, Jianming; Goepfert, Paul] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Gilmour, Jill] Int AIDS Vaccine Initiat, London SW10 9NH, England; [Gilmour, Jill] Univ London Imperial Coll Sci Technol & Med, London SW10 9NH, England; [Price, Matt A.] Int AIDS Vaccine Initiat, San Francisco, CA 94105 USA; [Price, Matt A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94105 USA; [Kilembe, William; Allen, Susan; Hunter, Eric] Zambia Emory HIV Res Project, Rwanda Zambia HIV Res Grp, Lusaka, Zambia; [Heckerman, David] Microsoft Res, Los Angeles, CA USA; [Goulder, Philip J. R.] Univ Oxford, Dept Paediat, Oxford OX1 3SY, England; [Allen, Susan; Hunter, Eric] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Allen, Susan] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA	Microsoft; Emory University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Beth Israel Deaconess Medical Center; University of Oxford; University of Oxford; University of Oxford; University of Kwazulu Natal; Max Planck Society; University of Alabama System; University of Alabama Birmingham; International AIDS Vaccine Initiative; Imperial College London; International AIDS Vaccine Initiative; University of California System; University of California San Francisco; Microsoft; University of Oxford; Emory University; Emory University; Rollins School Public Health	Carlson, JM (corresponding author), Univ Washington, Washington Natl Primate Res Ctr, Dept Pharmaceut, Seattle, WA 98121 USA.	carlson@microsoft.com; ehunte4@emory.edu	Ende, Zachary/AAD-3800-2019; Allen, Todd/F-5473-2011; Price, Matt/AAK-6881-2021; Tang, Jianming "James"/O-4980-2019	Allen, Todd/0000-0002-6609-1318; Price, Matt/0000-0002-2918-1373; Tang, Jianming "James"/0000-0003-0137-7486; Frater, John/0000-0001-7163-7277; Peng, Jian/0000-0002-1736-2978; Ndung'u, Thumbi/0000-0003-2962-3992	International AIDS Vaccine Initiative; American people through the U.S. Agency for International Development (USAID); Virology Core at the Emory Center for AIDS Research [P30 AI050409]; Yerkes National Primate Research Center through the National Center for Research Resources [2P51RR000165-51, P51RR165]; Office of Research Infrastructure Programs/OD [P51OD11132]; NIAID [P01-AI074415, U01 AI 66454]; Multidisciplinary AIDS Training Grant NIH [T32-AI007387]; Action Cycling Fellowships; South African Department of Science and Technology; National Research Foundation through the South Africa Research Chairs Initiative; Howard Hughes Medical Institute; Victor Daitz Foundation;  [R01 AI64060];  [R37 AI51231]; MRC [G108/626] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, R01AI064060, U01AI066454, R01AI046995, T32AI007387, R37AI051231, P01AI074415] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132, P51OD010425] Funding Source: NIH RePORTER; Medical Research Council [G108/626] Funding Source: researchfish	International AIDS Vaccine Initiative; American people through the U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Virology Core at the Emory Center for AIDS Research; Yerkes National Primate Research Center through the National Center for Research Resources; Office of Research Infrastructure Programs/OD; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Multidisciplinary AIDS Training Grant NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Action Cycling Fellowships; South African Department of Science and Technology; National Research Foundation through the South Africa Research Chairs Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Victor Daitz Foundation; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all the volunteers in Zambia who participated in this study and all the staff at the Zambia Emory HIV Research Project in Lusaka who made this study possible. We would like to thank J. Allen and M. Hurlston for technical assistance and sample management; P. Farmer, Ph.D., for database design and management; and I. Brill, K. Wall, X. Li, C. Lippert, N. Fusi, J. Listgarten, and Z. Brumme for helpful discussions. This study was funded by R01 AI64060 and R37 AI51231 (E. H.) and the International AIDS Vaccine Initiative (to S. A.), and made possible in part by the support of the American people through the U.S. Agency for International Development (USAID). The contents are the responsibility of the study authors and do not necessarily reflect the views of USAID or the U.S. government. This work was also supported, in part, by the Virology Core at the Emory Center for AIDS Research (grant P30 AI050409); the Yerkes National Primate Research Center base grant (2P51RR000165-51) through the National Center for Research Resources P51RR165 and by the Office of Research Infrastructure Programs/OD P51OD11132; NIAID grants P01-AI074415 (T. M. A.) and U01 AI 66454 (R. S.); and Multidisciplinary AIDS Training Grant NIH T32-AI007387 (R. B.). J. P., D. T. C., and M. S. were supported in part by Action Cycling Fellowships. T. N. was supported by the International AIDS Vaccine Initiative, the South African Department of Science and Technology and the National Research Foundation through the South Africa Research Chairs Initiative, by an International Early Career Scientist award from the Howard Hughes Medical Institute, and by the Victor Daitz Foundation. E. H. is a Georgia Eminent Scholar. All viral sequences not previously published have been submitted to GenBank-accession numbers JN014076-JN014465, JQ219842, and KM048382-KM050767. The data reported in this paper are tabulated in the supplementary online material.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Bates D., 2013, LME4 LINEAR MIXED EF; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Boutwell CL, 2013, J VIROL, V87, P3952, DOI 10.1128/JVI.03233-12; Boutwell CL, 2009, J VIROL, V83, P2460, DOI 10.1128/JVI.01970-08; Brockman MA, 2010, J VIROL, V84, P11937, DOI 10.1128/JVI.01086-10; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Carlson JM, 2012, J VIROL, V86, P13202, DOI 10.1128/JVI.01998-12; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Cicala C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S2; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Cotton LA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004295; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; DEVINCENZI I, 1992, BRIT MED J, V304, P809; Efron B., 1981, CANADIAN J STATISTIC, V9, P139, DOI [10.1093/jtm/taab016, DOI 10.1093/jtm/taab016]; Etemad B, 2009, J VIROL, V83, P9694, DOI 10.1128/JVI.00925-09; Fenton-May AE, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-146; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Frater AJ, 2006, J VIROL, V80, P7226, DOI 10.1128/JVI.02014-05; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hecht FM, 2010, AIDS, V24, P941, DOI 10.1097/QAD.0b013e328337b12e; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Herbeck JT, 2006, J VIROL, V80, P1637, DOI 10.1128/JVI.80.4.1637-1644.2006; Hollingsworth TD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000876; Hsiou Y, 1996, STRUCTURE, V4, P853, DOI 10.1016/S0969-2126(96)00091-3; Huang KHG, 2009, ANTIVIR THER, V14, P975, DOI 10.3851/IMP1416; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kelly BN, 2006, BIOCHEMISTRY-US, V45, P11257, DOI 10.1021/bi060927x; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Listgarten J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000016; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; Matthews PC, 2011, J IMMUNOL, V186, P5675, DOI 10.4049/jimmunol.1003711; McKenna SL, 1997, AIDS, V11, pS103; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; PIGUET V, 1999, HUMAN RETROVIRUSES A, P448; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Prince JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003041; Robbins AH, 2010, ACTA CRYSTALLOGR D, V66, P233, DOI 10.1107/S0907444909054298; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Sagar M, 2009, J INFECT DIS, V199, P580, DOI 10.1086/596557; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Shaw GM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006965; Song W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023469; Tang JM, 2008, J IMMUNOL, V181, P2626, DOI 10.4049/jimmunol.181.4.2626; Tang JM, 2002, J VIROL, V76, P8276, DOI 10.1128/JVI.76.16.8276-8284.2002; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WONG GY, 1985, J AM STAT ASSOC, V80, P513, DOI 10.2307/2288464; Wright JK, 2011, J VIROL, V85, P3996, DOI 10.1128/JVI.02520-10; Wright JK, 2010, J VIROL, V84, P10820, DOI 10.1128/JVI.01084-10; Yang X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475; Yue L, 2013, J VIROL, V87, P708, DOI 10.1128/JVI.02118-12	72	170	176	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193							1254031	10.1126/science.1254031	http://dx.doi.org/10.1126/science.1254031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013080	Green Accepted			2022-12-28	WOS:000339409900043
J	Gelman, M; Kariv, S; Shapiro, MD; Silverman, D; Tadelis, S				Gelman, Michael; Kariv, Shachar; Shapiro, Matthew D.; Silverman, Dan; Tadelis, Steven			Harnessing naturally occurring data to measure the response of spending to income	SCIENCE			English	Article							HOUSEHOLD CONSUMPTION	This paper presents a new data infrastructure for measuring economic activity. The infrastructure records transactions and account balances, yielding measurements with scope and accuracy that have little precedent in economics. The data are drawn from a diverse population that overrepresents males and younger adults but contains large numbers of underrepresented groups. The data infrastructure permits evaluation of a benchmark theory in economics that predicts that individuals should use a combination of cash management, saving, and borrowing to make the timing of income irrelevant for the timing of spending. As in previous studies and in contrast to the predictions of the theory, there is a response of spending to the arrival of anticipated income. The data also show, however, that this apparent excess sensitivity of spending results largely from the coincident timing of regular income and regular spending. The remaining excess sensitivity is concentrated among individuals with less liquidity.	[Gelman, Michael; Shapiro, Matthew D.] Univ Michigan, Dept Econ, Ann Arbor, MI 48109 USA; [Kariv, Shachar] Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA; [Shapiro, Matthew D.; Silverman, Dan; Tadelis, Steven] NBER, Cambridge, MA 02138 USA; [Silverman, Dan] Arizona State Univ, Dept Econ, Tempe, AZ 85287 USA; [Tadelis, Steven] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA	University of Michigan System; University of Michigan; University of California System; University of California Berkeley; National Bureau of Economic Research; Arizona State University; Arizona State University-Tempe; University of California System; University of California Berkeley	Shapiro, MD (corresponding author), Univ Michigan, Dept Econ, Ann Arbor, MI 48109 USA.	shapiro@umich.edu			Alfred P. Sloan Foundation; Michigan node of the NSF-Census Research Network (NSF) [SES 1131500]; NATIONAL INSTITUTE ON AGING [P30AG012839] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Michigan node of the NSF-Census Research Network (NSF); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a grant from the Alfred P. Sloan Foundation. M. D. S. acknowledges additional support through the Michigan node of the NSF-Census Research Network (NSF grant SES 1131500). This paper has benefited from suggestions by the participants of the NBER Summer Institute, the Conference on Economic Decisionmaking ( Aspen, Colorado), and several seminars. A data set for replicating the results of this paper is available through the University of California Berkeley Econometrics Lab (EML) at https://eml.berkeley.edu/cgi-bin/HarnessingDataScience2014.cgi. To access the data, users must register with EML and agree to terms of use. The data set contains no personal or account identifiers. The data are aggregated and transformed so that they reveal no personally identifying information.	Agarwal S, 2007, J POLIT ECON, V115, P986, DOI 10.1086/528721; Broda C., 2014, EC STIMULUS PA UNPUB; Congressional Budget Office, 2008, OPT RESP SHORT TERM; Congressional Budget Office, 2010, EST IMP AM REC REINV; Hsieh CT, 2003, AM ECON REV, V93, P397, DOI 10.1257/000282803321455377; Intuit, 2013, INT CONS SPEND IND; Kuchler T., 2013, STICKING YOUR UNPUB; Parker JA, 1999, AM ECON REV, V89, P959, DOI 10.1257/aer.89.4.959; Souleles NS, 1999, AM ECON REV, V89, P947, DOI 10.1257/aer.89.4.947; Stephens M, 2003, AM ECON REV, V93, P406, DOI 10.1257/000282803321455386; Stephens M, 2006, ECON J, V116, P680, DOI 10.1111/j.1468-0297.2006.01106.x	13	52	52	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					212	215		10.1126/science.1247727	http://dx.doi.org/10.1126/science.1247727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8SS	25013075	Green Submitted, Green Accepted			2022-12-28	WOS:000339409900053
J	Steele, C; Conlon, N; Edgar, JD				Steele, Cathal; Conlon, Niall; Edgar, J. David			RATIONAL TESTING Diagnosis of immediate food allergy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GUIDELINES; MANAGEMENT; IGE		[Steele, Cathal; Conlon, Niall; Edgar, J. David] Royal Hosp, Belfast Trust Reg Immunol Serv, Belfast BT12 6BA, Antrim, North Ireland; [Conlon, Niall; Edgar, J. David] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland	Queens University Belfast	Steele, C (corresponding author), Royal Hosp, Belfast Trust Reg Immunol Serv, Belfast BT12 6BA, Antrim, North Ireland.	cathal.steele@belfasttrust.hscni.net		Edgar, John David Moore/0000-0003-2969-4475				Ando H, 2008, J ALLERGY CLIN IMMUN, V122, P583, DOI 10.1016/j.jaci.2008.06.016; ASCIA (Australasian Society of Clinical Immunology and Allergy), SKIN PRICK TEST DIAG; Clark AT, 2010, CLIN EXP ALLERGY, V40, P1116, DOI 10.1111/j.1365-2222.2010.03557.x; DAVID TJ, 1984, ARCH DIS CHILD, V59, P983, DOI 10.1136/adc.59.10.983; Heinzerling Lucie, 2013, Clin Transl Allergy, V3, P3, DOI 10.1186/2045-7022-3-3; Keet CA, 2012, J ALLERGY CLIN IMMUN, V130, P1207, DOI 10.1016/j.jaci.2012.07.020; Muraro A, 2007, ALLERGY, V62, P857, DOI 10.1111/j.1398-9995.2007.01421.x; Nowak-Wegrzyn A, 2009, J ALLERGY CLIN IMMUN, V123, pS365, DOI 10.1016/j.jaci.2009.03.042; Sackeyfio A, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d747; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020	10	1	1	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 11	2014	349								g3695	10.1136/bmj.g3695	http://dx.doi.org/10.1136/bmj.g3695			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZH	25015095				2022-12-28	WOS:000338993900001
J	Mingote, LR; Namutamba, D; Apina, F; Barnabas, N; Contreras, C; Elnour, T; Frick, MW; Lee, C; Seaworth, B; Shelly, D; Skipper, N; dos Santos, ET				Mingote, Laia Ruiz; Namutamba, Dorothy; Apina, Francis; Barnabas, Nomampondo; Contreras, Carmen; Elnour, Taharqa; Frick, Mike Watson; Lee, Cynthia; Seaworth, Barbara; Shelly, Debra; Skipper, Natalie; dos Santos Filho, Ezio Tavora			The use of bedaquiline in regimens to treat drug-resistant and drug-susceptible tuberculosis: a perspective from tuberculosis-affected communities	LANCET			English	Editorial Material							OUTCOMES		[Mingote, Laia Ruiz; Namutamba, Dorothy; Apina, Francis; Barnabas, Nomampondo; Contreras, Carmen; Elnour, Taharqa; Lee, Cynthia; Seaworth, Barbara; Shelly, Debra; Skipper, Natalie; dos Santos Filho, Ezio Tavora] Community Res Advisors Grp, New York, NY USA; [Frick, Mike Watson] Treatment Act Grp, New York, NY 10016 USA		Frick, MW (corresponding author), Treatment Act Grp, 261 5th Ave Suite 2110, New York, NY 10016 USA.	mike.frick@treatmentactiongroup.org						Diacon A, 2014, 2014 C RETR OPP INF; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Edney A., 2012, BLOOMBERG NEWS; FDA. Division of Anti-Infective Products. Office of Antimicrobial Products, 2012, FDA ANT DRUGS ADV CO; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Lessem E., 2013, ACTIVISTS GUIDE BEDA; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6; World Health Organization (WHO), 2013, WHONMHNHDEPG131	9	13	14	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					477	479		10.1016/S0140-6736(14)60523-7	http://dx.doi.org/10.1016/S0140-6736(14)60523-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	25018118				2022-12-28	WOS:000348509900035
J	Krzeszinski, JY; Wei, W; Huynh, H; Jin, ZX; Wang, XD; Chang, TC; Xie, XJ; He, L; Mangala, LS; Lopez-Berestein, G; Sood, AK; Mendell, JT; Wan, YH				Krzeszinski, Jing Y.; Wei, Wei; HoangDinh Huynh; Jin, Zixue; Wang, Xunde; Chang, Tsung-Cheng; Xie, Xian-Jin; He, Lin; Mangala, Lingegowda S.; Lopez-Berestein, Gabriel; Sood, Anil K.; Mendell, Joshua T.; Wan, Yihong			RETRACTED: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 (Retracted article. See vol. 582, pg. 134, 2020)	NATURE			English	Article; Retracted Publication							MICRORNAS; RECEPTOR; DIFFERENTIATION; REPRESSION; MOUSE	Bone-resorbing osteoclasts significantly contribute to osteoporosis and bone metastases of cancer(1-3). MicroRNAs play important roles in physiology and disease(4,5), and present tremendous therapeutic potential(6). Nonetheless, how microRNAs regulate skeletal biology is underexplored. Here we identify miR-34a as a novel and critical suppressor of osteoclastogenesis, bone resorption and the bone metastatic niche. miR-34a is downregulated during osteoclast differentiation. Osteoclastic miR-34a-overexpressing transgenic mice exhibit lower bone resorption and higher bone mass. Conversely, miR-34a knockout and heterozygous mice exhibit elevated bone resorption and reduced bone mass. Consequently, ovariectomy-induced osteoporosis, as well as bone metastasis of breast and skin cancers, are diminished in osteoclastic miR-34a transgenic mice, and can be effectively attenuated by miR-34a nanoparticle treatment. Mechanistically, we identify transforming growth factor-beta-induced factor 2 (Tgif2) as an essential direct miR-34a target that is pro-osteoclastogenic. Tgif2 deletion reduces bone resorption and abolishes miR-34a regulation. Together, using mouse genetic, pharmacological and disease models, we reveal miR-34a as a key osteoclast suppressor and a potential therapeutic strategy to confer skeletal protection and ameliorate bone metastasis of cancers.	[Krzeszinski, Jing Y.; Wei, Wei; HoangDinh Huynh; Jin, Zixue; Wang, Xunde; Wan, Yihong] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Chang, Tsung-Cheng; Mendell, Joshua T.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Xie, Xian-Jin; Mendell, Joshua T.; Wan, Yihong] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA; [Xie, Xian-Jin] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [He, Lin] Univ Calif Berkeley, Mol & Cell Biol Dept, Div Cellular & Dev Biol, Berkeley, CA 94705 USA; [Mangala, Lingegowda S.; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; [Mangala, Lingegowda S.; Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Berkeley; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wan, YH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	yihong.wan@utsouthwestern.edu	Sood, Anoop Kumar/A-7344-2013	Sood, Anoop Kumar/0000-0001-5702-4108	CPRIT [RP130145, R1008]; DOD [BC122877]; National Institutes of Health [R01 DK089113, R01 CA120185, P01 CA134292, U54 CA151668, UH2 TR000943, R01 CA139067]; Welch Foundation [I-1751]; University of Texas Southwestern Endowed Scholar Startup Fund; Harold C. Simmons Cancer Center through an NCI Cancer Center Support Grant [1P30 CA142543]; Department of Radiology; National Institutes of Health American Recovery and Reinvestment Act stimulus funds [1S10RR02564801]; NATIONAL CANCER INSTITUTE [U54CA151668, P01CA134292, P30CA142543, R01CA120185, R01CA139067] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000943] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024757, S10RR025648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089113] Funding Source: NIH RePORTER	CPRIT; DOD(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); University of Texas Southwestern Endowed Scholar Startup Fund; Harold C. Simmons Cancer Center through an NCI Cancer Center Support Grant; Department of Radiology; National Institutes of Health American Recovery and Reinvestment Act stimulus funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank University of Texas Southwestern transgenic core and small animal imaging core for their assistance in our studies; P. Dechow, J. Feng and C. Qin for assistance with micro-computed tomography, histomorphometry and X-ray analysis; A. Ventura for miR-34abc triple knockout mice; D. Wotton for Tgif2-KO mice; H. Kronenberg for Osx-CreER mice; Y. Mishina for CAG-Z-EGFP vector. Y. Wan is a Virginia Murchison Linthicum Scholar in Medical Research. This work was in part supported by CPRIT (RP130145, Y.W.; R1008, J.M.), DOD (BC122877, Y.W.), National Institutes of Health (R01 DK089113, Y.W.; R01 CA120185 and P01 CA134292, J.M.; U54 CA151668 and UH2 TR000943, AS.; R01 CA139067, L.H.), The Welch Foundation (I-1751, Y.W.) and a University of Texas Southwestern Endowed Scholar Startup Fund (Y.W.). The University of Texas Southwestern Small Animal Imaging Resource is supported in part by the Harold C. Simmons Cancer Center through an NCI Cancer Center Support Grant (1P30 CA142543) and The Department of Radiology. The VisualSonics Vevo 770 was purchased with National Institutes of Health American Recovery and Reinvestment Act stimulus funds 1S10RR02564801.	Bae YJ, 2012, HUM MOL GENET, V21, P2991, DOI 10.1093/hmg/dds129; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chivukula RR, 2008, TRENDS BIOCHEM SCI, V33, P474, DOI 10.1016/j.tibs.2008.06.008; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coleman RE, 2012, NAT REV CLIN ONCOL, V9, P76, DOI 10.1038/nrclinonc.2011.198; Concepcion CP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002797; Ell B, 2013, CANCER CELL, V24, P542, DOI 10.1016/j.ccr.2013.09.008; Ell B, 2012, CELL, V151, DOI 10.1016/j.cell.2012.10.005; Fukuda T, 2006, GENESIS, V44, P159, DOI 10.1002/dvg.20201; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Lefort K, 2013, EMBO J, V32, P2248, DOI 10.1038/emboj.2013.156; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Powers SE, 2010, DEVELOPMENT, V137, P249, DOI 10.1242/dev.040782; Uluckan O, 2008, J CELL BIOCHEM, V104, P1311, DOI 10.1002/jcb.21709; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057; Wei W, 2011, MOL CELL BIOL, V31, P4692, DOI 10.1128/MCB.05979-11; Wei W, 2011, MOL CELL BIOL, V31, P4706, DOI 10.1128/MCB.05980-11; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105	31	272	292	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					431	U460		10.1038/nature13375	http://dx.doi.org/10.1038/nature13375			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25043055	Green Accepted			2022-12-28	WOS:000340840600034
J	Radford, EJ; Ito, M; Shi, H; Corish, JA; Yamazawa, K; Isganaitis, E; Seisenberger, S; Hore, TA; Reik, W; Erkek, S; Peters, AHFM; Patti, ME; Ferguson-Smith, AC				Radford, Elizabeth J.; Ito, Mitsuteru; Shi, Hui; Corish, Jennifer A.; Yamazawa, Kazuki; Isganaitis, Elvira; Seisenberger, Stefanie; Hore, Timothy A.; Reik, Wolf; Erkek, Serap; Peters, Antoine H. F. M.; Patti, Mary-Elizabeth; Ferguson-Smith, Anne C.			In utero undernourishment perturbs the adult sperm methylome and intergenerational metabolism	SCIENCE			English	Article							LOW-BIRTH-WEIGHT; PROMOTER DNA METHYLATION; EMBRYONIC STEM-CELLS; TRANSGENERATIONAL INHERITANCE; ACTIVATING MUTATIONS; EPIGENETIC MEMORY; GENE-EXPRESSION; C. ELEGANS; MOUSE; GENOME	Adverse prenatal environments can promote metabolic disease in offspring and subsequent generations. Animal models and epidemiological data implicate epigenetic inheritance, but the mechanisms remain unknown. In an intergenerational developmental programming model affecting F-2 mouse metabolism, we demonstrate that the in utero nutritional environment of F-1 embryos alters the germline DNA methylome of F-1 adult males in a locus-specific manner. Differentially methylated regions are hypomethylated and enriched in nucleosome-retaining regions. A substantial fraction is resistant to early embryo methylation reprogramming, which may have an impact on F-2 development. Differential methylation is not maintained in F-2 tissues, yet locus-specific expression is perturbed. Thus, in utero nutritional exposures during critical windows of germ cell development can impact the male germline methylome, associated with metabolic disease in offspring.	[Radford, Elizabeth J.; Ito, Mitsuteru; Shi, Hui; Corish, Jennifer A.; Yamazawa, Kazuki; Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Isganaitis, Elvira; Patti, Mary-Elizabeth] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Isganaitis, Elvira; Patti, Mary-Elizabeth] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Seisenberger, Stefanie; Hore, Timothy A.; Reik, Wolf] Babraham Inst, Cambridge, England; [Seisenberger, Stefanie; Hore, Timothy A.; Reik, Wolf] Wellcome Trust Sanger Inst, Cambridge, England; [Erkek, Serap; Peters, Antoine H. F. M.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Erkek, Serap; Peters, Antoine H. F. M.] Univ Basel, Fac Sci, Basel, Switzerland; [Erkek, Serap] Swiss Inst Bioinformat, Basel, Switzerland	University of Cambridge; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Wellcome Trust Sanger Institute; Friedrich Miescher Institute for Biomedical Research; University of Basel; Swiss Institute of Bioinformatics	Patti, ME (corresponding author), Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	mary.elizabeth.patti@joslin.harvard.edu; afsmith@mole.bio.cam.ac.uk	Peters, Antoine/ABA-6283-2020; Shi, Hui/Z-1004-2019; Erkek, Serap/AAV-5549-2020; Reik, Wolf/I-6794-2012	Shi, Hui/0000-0001-9126-4607; Reik, Wolf/0000-0003-0216-9881; Radford, Elizabeth/0000-0002-7829-5422; Erkek, Serap/0000-0003-4439-5203; Isganaitis, Elvira/0000-0003-3477-0305; Yamazawa, Kazuki/0000-0003-4895-2759; Ferguson-Smith, Anne/0000-0002-7608-5894; Peters, Antoine/0000-0002-0311-1887; Hore, Timothy/0000-0002-6735-225X	U.K. Medical Research Council; Wellcome Trust; European Commission FP7, EpiGeneSys; European Commission FP7, EpiHealth; Pediatric Endocrine Society; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; American Diabetes Association; Graetz Foundation; NIH [P30DK036836]; Novartis Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD064793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0402, BBS/E/B/0000S266] Funding Source: researchfish; Medical Research Council [MR/J001597/1] Funding Source: researchfish; Grants-in-Aid for Scientific Research [25713040] Funding Source: KAKEN; BBSRC [BBS/E/B/0000S266, BBS/E/B/000C0402] Funding Source: UKRI; MRC [MR/J001597/1] Funding Source: UKRI	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission FP7, EpiGeneSys; European Commission FP7, EpiHealth; Pediatric Endocrine Society; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Diabetes Association(American Diabetes Association); Graetz Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to members of the Ferguson-Smith and Patti labs for useful discussions of this work and to K. Tabbada and D. Oxley for expert technical assistance with Illumina sequencing and mass spectrometry. Work was supported by grants from the U.K. Medical Research Council; Wellcome Trust; and European Commission FP7, EpiGeneSys and EpiHealth (to A.C.F.-S.), from the Pediatric Endocrine Society and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH (to E.I.), and from the American Diabetes Association, the Graetz Foundation, and NIH P30DK036836 (to M.-E.P.). W.R. is a consultant for Cambridge Epigenetix. The MeDIP-Seq data sets have been deposited in GEO with accession number GSE58747. A.H.F.M.P. and S.E. are funded by the Novartis Research Foundation.	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; BRUNO JF, 1994, ENDOCRINOLOGY, V135, P1787, DOI 10.1210/en.135.5.1787; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Drake AJ, 2004, J ENDOCRINOL, V180, P1, DOI 10.1677/joe.0.1800001; Erkek S, 2013, NAT STRUCT MOL BIOL, V20, P868, DOI 10.1038/nsmb.2599; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Isganaitis E, 2009, DIABETES, V58, P1192, DOI 10.2337/db08-1266; Iwanaga T, 2011, BIOMED RES-TOKYO, V32, P73, DOI 10.2220/biomedres.32.73; Jimenez-Chillaron JC, 2005, DIABETES, V54, P702, DOI 10.2337/diabetes.54.3.702; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Laukkanen O, 2004, J CLIN ENDOCR METAB, V89, P6286, DOI 10.1210/jc.2004-1204; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Taiwo O, 2012, NAT PROTOC, V7, P617, DOI 10.1038/nprot.2012.012; Takeuchi T, 2011, ANAL CELL PATHOL, V34, P113, DOI [10.1155/2011/578097, 10.3233/ACP-2011-009]; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wei YC, 2014, P NATL ACAD SCI USA, V111, P1873, DOI 10.1073/pnas.1321195111; Woo M, 2011, STEM CELLS DEV, V20, P1763, DOI 10.1089/scd.2010.0349; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	42	424	437	7	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					785	+	1255903	10.1126/science.1255903	http://dx.doi.org/10.1126/science.1255903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6ZT	25011554	Green Accepted			2022-12-28	WOS:000349776300001
J	Wagner, TA; McLaughlin, S; Garg, K; Cheung, CYK; Larsen, BB; Styrchak, S; Huang, HC; Edlefsen, PT; Mullins, JI; Frenkel, LM				Wagner, Thor A.; McLaughlin, Sherry; Garg, Kavita; Cheung, Charles Y. K.; Larsen, Brendan B.; Styrchak, Sheila; Huang, Hannah C.; Edlefsen, Paul T.; Mullins, James I.; Frenkel, Lisa M.			Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GENOME-WIDE ANALYSIS; ANTIRETROVIRAL THERAPY; LATENT RESERVOIR; T-CELLS; REPLICATION; EXPRESSION; MUTATIONS; LANDSCAPE; SELECTION	Antiretroviral treatment (ART) of HIV infection suppresses viral replication. Yet if ART is stopped, virus reemerges because of the persistence of infected cells. We evaluated the contribution of infected-cell proliferation and sites of proviral integration to HIV persistence. A total of 534 HIV integration sites (IS) and 63 adjacent HIV env sequences were derived from three study participants over 11.3 to 12.7 years of ART. Each participant had identical viral sequences integrated at the same position in multiple cells, demonstrating infected-cell proliferation. Integrations were overrepresented in genes associated with cancer and favored in 12 genes across multiple participants. Over time on ART, a greater proportion of persisting proviruses were in proliferating cells. HIV integration into specific genes may promote proliferation of HIV-infected cells, slowing viral decay during ART.	[Wagner, Thor A.; McLaughlin, Sherry; Styrchak, Sheila; Huang, Hannah C.; Frenkel, Lisa M.] Seattle Childrens Res Inst, Seattle, WA 98101 USA; [Wagner, Thor A.; McLaughlin, Sherry; Larsen, Brendan B.; Edlefsen, Paul T.; Mullins, James I.; Frenkel, Lisa M.] Univ Washington, Seattle, WA 98195 USA; [Garg, Kavita; Cheung, Charles Y. K.; Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Frenkel, LM (corresponding author), Seattle Childrens Res Inst, 1900 9th Ave, Seattle, WA 98101 USA.	lfrenkel@uw.edu			Molecular Profiling and Computational Biology Core of the University of Washington's Center for AIDS Research [P30 AI027757]; Canadian Institutes of Health (HIV/AIDS Research Initiative award) [201311CVI-322424-244686];  [R01AI091550];  [K23AI077357];  [R01 AI111806]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, R01AI091550, R01AI111806, K23AI077357, P01AI057005] Funding Source: NIH RePORTER	Molecular Profiling and Computational Biology Core of the University of Washington's Center for AIDS Research; Canadian Institutes of Health (HIV/AIDS Research Initiative award); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to express gratitude to the study participants who donated their time and provided specimens, and to N. H. Tobin, A. J. Melvin, and K. M. Mohan for their contributions to this study. Additionally, we thank Y. C. Ho, R. and J. Siliciano, H. Imamichi and C. Lane, and N. Malani and F. Bushman for providing their HIV integration site data. HIV env sequences generated from specific integration sites were deposited in GenBank under accession numbers (KM025062 to KM025124 and KM201287 to KM201295). Additional HIV env sequences were deposited in GenBank under accession numbers AY075701 to AY077450 (44), AY483287 to AY484389 (2), and KC314011 to KC315287 (8). Sequences of HIV-3'-LTR and adjacent chromosome integration sites are available in table S3. Other data are tabulated in the main paper and in the supplementary materials. Integration site sequences and HIV sequence alignments are available for download at http://mullinslab.microbiol.washington.edu/publications/supplemental.html. These studies were funded by R01AI091550 (L. M. F.), K23AI077357 (T. A. W.), R01 AI111806 (J. I. M.), the Molecular Profiling and Computational Biology Core of the University of Washington's Center for AIDS Research (P30 AI027757), and the Canadian Institutes of Health (HIV/AIDS Research Initiative award 201311CVI-322424-244686) (C. Y. K. C.). We wish to thank A. Embry and D. Lawrence at the National Institutes of Health for their support. The authors report no conflicts of interest related to this research.	Anderson JA, 2011, J VIROL, V85, P5220, DOI 10.1128/JVI.00284-11; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Eipers PG, 2011, VIROLOGY, V410, P151, DOI 10.1016/j.virol.2010.11.001; Fan H, 2011, VIRUSES-BASEL, V3, P398, DOI 10.3390/v3040398; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Frenkel LM, 2003, J VIROL, V77, P5721, DOI 10.1128/JVI.77.10.5721-5730.2003; Friedman J, 2011, J VIROL, V85, P9078, DOI 10.1128/JVI.00836-11; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Ikeda T, 2007, J INFECT DIS, V195, P716, DOI 10.1086/510915; Imai K, 2010, J BIOL CHEM, V285, P16538, DOI 10.1074/jbc.M110.103531; Imamichi H., 2014, AIDS, V1; Josefsson L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003432; Soto MJ, 2011, AIDS RES HUM RETROV, V27, P547, DOI 10.1089/aid.2010.0182; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kuwahara M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4555; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Liu JH, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-2; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Mok HP, 2007, GENE THER, V14, P741, DOI 10.1038/sj.gt.3302923; Persaud D, 2004, J VIROL, V78, P968, DOI 10.1128/JVI.78.2.968-979.2004; Plaisier CL, 2012, GENOME RES, V22, P2302, DOI 10.1101/gr.133991.111; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Sherrill-Mix S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-90; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Swaminathan S, 2013, NAT MED, V19, P1014, DOI 10.1038/nm.3247; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Tsukumo S, 2013, P NATL ACAD SCI USA, V110, P10735, DOI 10.1073/pnas.1306691110; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wagner TA, 2013, J VIROL, V87, P1770, DOI 10.1128/JVI.01985-12; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937	45	427	433	5	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					570	573		10.1126/science.1256304	http://dx.doi.org/10.1126/science.1256304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25011556	Green Accepted			2022-12-28	WOS:000339651300047
J	Chemla, YR; Ha, T				Chemla, Yann R.; Ha, Taekjip			Ultraslow relaxation of confined DNA	SCIENCE			English	Editorial Material							PACKAGING MOTOR; BACTERIOPHAGE; CONFORMATION; MOLECULE; DYNAMICS		[Chemla, Yann R.; Ha, Taekjip] Univ Illinois, Dept Phys, Ctr Phys Living Cells, Urbana, IL 61820 USA; [Chemla, Yann R.; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Inst Genom Biol, Urbana, IL 61820 USA; [Ha, Taekjip] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Chemla, YR (corresponding author), Univ Illinois, Dept Phys, Ctr Phys Living Cells, Urbana, IL 61820 USA.	ychemla@illinois.edu; tjha@illinois.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Chemla, Yann/0000-0001-9167-0234	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Berndsen ZT, 2014, P NATL ACAD SCI USA, V111, P8345, DOI 10.1073/pnas.1405109111; Cerritelli ME, 1997, CELL, V91, P271, DOI 10.1016/S0092-8674(00)80409-2; Chemla YR, 2012, ADV EXP MED BIOL, V726, P549, DOI 10.1007/978-1-4614-0980-9_24; Comolli LR, 2008, VIROLOGY, V371, P267, DOI 10.1016/j.virol.2007.07.035; Evilevitch A, 2003, P NATL ACAD SCI USA, V100, P9292, DOI 10.1073/pnas.1233721100; Keller N, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.248101; Kottadiel VI, 2012, P NATL ACAD SCI USA, V109, P20000, DOI 10.1073/pnas.1209214109; Liu SX, 2014, CELL, V157, P702, DOI 10.1016/j.cell.2014.02.034; PERKINS TT, 1994, SCIENCE, V264, P822, DOI 10.1126/science.8171336; Purohit PK, 2005, BIOPHYS J, V88, P851, DOI 10.1529/biophysj.104.047134; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Reisner W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196101; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Tang J, 2010, MACROMOLECULES, V43, P7368, DOI 10.1021/ma101157x	14	7	7	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					380	381		10.1126/science.1256359	http://dx.doi.org/10.1126/science.1256359			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061189				2022-12-28	WOS:000339655100016
J	Senko, C; Smith, J; Richerme, P; Lee, A; Campbell, WC; Monroe, C				Senko, C.; Smith, J.; Richerme, P.; Lee, A.; Campbell, W. C.; Monroe, C.			Coherent imaging spectroscopy of a quantum many-body spin system	SCIENCE			English	Article							TRAPPED IONS; SIMULATOR	Quantum simulators, in which well-controlled quantum systems are used to reproduce the dynamics of less understood ones, have the potential to explore physics inaccessible to modeling with classical computers. However, checking the results of such simulations also becomes classically intractable as system sizes increase. Here, we introduce and implement a coherent imaging spectroscopic technique, akin to magnetic resonance imaging, to validate a quantum simulation. We use this method to determine the energy levels and interaction strengths of a fully connected quantum many-body system. Additionally, we directly measure the critical energy gap near a quantum phase transition. We expect this general technique to become a verification tool for quantum simulators once experiments advance beyond proof-of-principle demonstrations and exceed the resources of conventional computers.	[Senko, C.; Smith, J.; Richerme, P.; Lee, A.; Monroe, C.] Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA; [Senko, C.; Smith, J.; Richerme, P.; Lee, A.; Monroe, C.] NIST, College Pk, MD 20742 USA; [Campbell, W. C.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA; University of California System; University of California Los Angeles	Senko, C (corresponding author), Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA.	csenko@umd.edu	Monroe, Christopher R/G-8105-2011	Campbell, Wesley/0000-0003-1578-906X	U.S. Army Research Office (ARO) from the Defense Advanced Research Projects Agency Optical Lattice Emulator Program [W911NF0710576]; ARO from the Intelligence Advanced Research Projects Activity Multi-Qubit Coherent Operations Program [W911NF0410234]; NSF Physics Frontier Center at the Joint Quantum Institute; Direct For Mathematical & Physical Scien [0822671] Funding Source: National Science Foundation; Division Of Physics [1430094] Funding Source: National Science Foundation	U.S. Army Research Office (ARO) from the Defense Advanced Research Projects Agency Optical Lattice Emulator Program; ARO from the Intelligence Advanced Research Projects Activity Multi-Qubit Coherent Operations Program; NSF Physics Frontier Center at the Joint Quantum Institute; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank J. Freericks, B. Yoshimura, E. Edwards, S. Will, Z.-X. Gong, M. Foss-Feig, and A. Gorshkov for helpful discussions. This work is supported by the U.S. Army Research Office (ARO) award no. W911NF0710576 with funds from the Defense Advanced Research Projects Agency Optical Lattice Emulator Program, ARO award no. W911NF0410234 with funds from the Intelligence Advanced Research Projects Activity Multi-Qubit Coherent Operations Program, and the NSF Physics Frontier Center at the Joint Quantum Institute.	[Anonymous], 2012, NATURE PHYS, V8, P264; Aspuru-Guzik A, 2012, NAT PHYS, V8, P285, DOI [10.1038/NPHYS2253, 10.1038/nphys2253]; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Britton JW, 2012, NATURE, V484, P489, DOI 10.1038/nature10981; Cipra B. A., 2000, SIAM NEWS, V33, P654; Cirac JI, 2012, NAT PHYS, V8, P264, DOI 10.1038/nphys2275; Diep HT, 2005, FRUSTRATED SPIN SYSTEMS, P1, DOI 10.1142/9789812567819; Edwards EE, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.060412; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Gong ZX, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/11/113051; Hauke P, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.207202; Hauke P, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/8/082401; Islam R, 2013, SCIENCE, V340, P583, DOI 10.1126/science.1232296; Islam R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1374; Jurcevic P, 2014, NATURE, V511, P202, DOI 10.1038/nature13461; Khromova A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.220502; Kim K, 2010, NATURE, V465, P590, DOI 10.1038/nature09071; Kim K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.120502; Knap M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.147205; Liu S, 2010, 48 ANN ALL C COMM CO, P570; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Olmschenk S, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.052314; Porras D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207901; Richerme P, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.012334; Schachenmayer J, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.031015; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Toth G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.250405; van den Worm M, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/083007	30	62	62	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					430	433		10.1126/science.1251422	http://dx.doi.org/10.1126/science.1251422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061207	Green Submitted			2022-12-28	WOS:000339655100037
J	Flint, J; Munafo, M				Flint, Jonathan; Munafo, Marcus			SCHIZOPHRENIA Genesis of a complex disease	NATURE			English	Editorial Material							ASSOCIATION; VARIANTS; SMOKING; LOCUS; RISK		[Flint, Jonathan] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Munafo, Marcus] Univ Bristol, Sch Expt Psychol, Bristol BS8 1TU, Avon, England	University of Oxford; Wellcome Centre for Human Genetics; University of Bristol	Flint, J (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	jf@well.ox.ac.uk	Munafo, Marcus/AAE-2306-2020	Munafo, Marcus/0000-0002-4049-993X; Flint, Jonathan/0000-0002-9427-4429	MRC [MC_UU_12013/6] Funding Source: UKRI; Medical Research Council [MC_UU_12013/6] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BEBBINGTON P, 1988, SCHIZOPHRENIA MAJOR; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; HUGHES JR, 1986, AM J PSYCHIAT, V143, P993; Levinson DF, 2002, SCIENCE, V296, P739, DOI 10.1126/science.1069914; MCGUFFIN P, 1979, PSYCHOL MED, V9, P721, DOI 10.1017/S0033291700034036; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; SEEMAN P, 1976, NATURE, V261, P717, DOI 10.1038/261717a0; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Torrey EF, 2010, SCHIZOPHRENIA BULL, V36, P26, DOI 10.1093/schbul/sbp097; Ware JJ, 2011, NICOTINE TOB RES, V13, P1167, DOI 10.1093/ntr/ntr118	15	34	37	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					412	+		10.1038/nature13645	http://dx.doi.org/10.1038/nature13645			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25056056	Bronze			2022-12-28	WOS:000339335700031
J	Sabo, A; Kress, TR; Pelizzola, M; de Pretis, S; Gorski, MM; Tesi, A; Morelli, MJ; Bora, P; Doni, M; Verrecchia, A; Tonelli, C; Faga, G; Bianchi, V; Ronchi, A; Low, D; Muller, H; Guccione, E; Campaner, S; Amati, B				Sabo, Arianna; Kress, Theresia R.; Pelizzola, Mattia; de Pretis, Stefano; Gorski, Marcin M.; Tesi, Alessandra; Morelli, Marco J.; Bora, Pranami; Doni, Mirko; Verrecchia, Alessandro; Tonelli, Claudia; Faga, Giovanni; Bianchi, Valerio; Ronchi, Alberto; Low, Diana; Mueller, Heiko; Guccione, Ernesto; Campaner, Stefano; Amati, Bruno			Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis	NATURE			English	Article							C-MYC; IN-VIVO; EXPRESSION ANALYSIS; MAMMALIAN GENOMES; PROTEIN-SYNTHESIS; GLOBAL REGULATION; GENE-EXPRESSION; RNA-SEQ; CHROMATIN; CELLS	The c-myc proto-oncogene product, Myc, is a transcription factor that binds thousands of genomic loci(1). Recent work suggested that rather than up-and downregulating selected groups of genes(1-3), Myc targets all active promoters and enhancers in the genome (a phenomenon termed 'invasion') and acts as a general amplifier of transcription(4,5). However, the available data did not readily discriminate between direct and indirect effects of Myc on RNA biogenesis. We addressed this issue with genome-wide chromatin immunoprecipitation and RNA expression profiles during B-cell lymphomagenesis in mice, in cultured B cells and fibroblasts. Consistent with long-standing observations(6), we detected general increases in total RNA or messenger RNA copies per cell (hereby termed 'amplification')(4,5) when comparing actively proliferating cells with control quiescent cells: this was true whether cells were stimulated by mitogens (requiring endogenous Myc for a proliferative response)(7,8) or by deregulated, oncogenic Myc activity. RNA amplification and promoter/enhancer invasion by Myc were separable phenomena that could occur without one another. Moreover, whether or not associated with RNA amplification, Myc drove the differential expression of distinct subsets of target genes. Hence, although having the potential to interact with all active or poised regulatory elements in the genome(4,5,9-11), Myc does not directly act as a global transcriptional amplifier(4,5). Instead, our results indicate that Myc activates and represses transcription of discrete gene sets, leading to changes in cellular state that can in turn feed back on global RNA production and turnover.	[Sabo, Arianna; Kress, Theresia R.; Pelizzola, Mattia; de Pretis, Stefano; Tesi, Alessandra; Morelli, Marco J.; Bora, Pranami; Bianchi, Valerio; Ronchi, Alberto; Mueller, Heiko; Campaner, Stefano; Amati, Bruno] Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, I-20139 Milan, Italy; [Sabo, Arianna; Kress, Theresia R.; Gorski, Marcin M.; Doni, Mirko; Verrecchia, Alessandro; Tonelli, Claudia; Faga, Giovanni; Amati, Bruno] European Inst Oncol IEO, Dept Expt Oncol, I-20139 Milan, Italy; [Low, Diana; Guccione, Ernesto] Inst Mol & Cell Biol, Singapore 138673, Singapore	Istituto Italiano di Tecnologia - IIT; IRCCS European Institute of Oncology (IEO); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Amati, B (corresponding author), Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, Via Adamello 16, I-20139 Milan, Italy.	bruno.amati@iit.it	Doni, Mirko/AAN-6027-2020; de Pretis, Stefano/T-9728-2019; Doni, Mirko/ABA-9174-2021; Verrecchia, Alessandro/AAQ-6454-2020; Sabò, Arianna/J-9531-2018; Faga, Giovanni/AAB-5540-2021; Amati, Bruno/AAM-3418-2020; Morelli, Marco/AAN-1879-2020	Doni, Mirko/0000-0001-7099-2701; Verrecchia, Alessandro/0000-0002-8596-6650; Sabò, Arianna/0000-0002-9542-0045; Morelli, Marco/0000-0003-1862-667X; CAMPANER, Stefano/0000-0003-4547-6849; Muller, Heiko/0000-0001-9873-3146; Gorski, Marcin M./0000-0002-8276-3866; Low, Diana/0000-0002-6054-8524; Tonelli, Claudia/0000-0002-5626-3403; de Pretis, Stefano/0000-0003-1103-7688; Bianchi, Valerio/0000-0001-9025-7923; Pelizzola, Mattia/0000-0001-6672-9636; Amati, Bruno/0000-0002-2958-1799	European School of Molecular Medicine; European Community [305626, 200720, 259743]; European Research Council; Association for International Cancer Research (AICR); Italian Health Ministry; Fondazione Cariplo; Italian Association for Cancer Research (AIRC); Worldwide Cancer Research [10-0245] Funding Source: researchfish	European School of Molecular Medicine; European Community; European Research Council(European Research Council (ERC)European Commission); Association for International Cancer Research (AICR); Italian Health Ministry; Fondazione Cariplo(Fondazione Cariplo); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Worldwide Cancer Research	We thank A. Piontini, P. Nicoli, A. Gobbi and M. Capillo for their help with the management of mouse colonies; S. Bianchi, L. Rotta and T. Capra for assistance with the Illumina HiSeq and NanoString platforms; S. Barozzi, A. Oldani and D. Parazzoli for assistance with imaging technologies; S. Bonifacio and G. Diaferia for discussions about DNase I sequencing; and G. Natoli for comments on the manuscript. We are grateful to C.-L. Wei and collaborators (Genome Institute of Singapore) for the sequencing of ChIP-seq samples in a preliminary phase of this study. T.R.K. was supported by the Structured International Post Doc program of the European School of Molecular Medicine. This work was supported by funding from the European Community's Seventh Framework Programme (FP7/2007-2013), project RADIANT (grant agreement no. 305626) to M.P. and projects EuroSystem (grant agreement no. 200720) and MODHEP (grant agreement no. 259743) to B.A., as well as grants from the European Research Council, the Association for International Cancer Research (AICR), the Italian Health Ministry, Fondazione Cariplo and the Italian Association for Cancer Research (AIRC) to B.A.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; DARZYNKIEWICZ Z, 1980, CYTOMETRY, V1, P98, DOI 10.1002/cyto.990010203; das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Ehrensberger AH, 2013, CELL, V154, P713, DOI 10.1016/j.cell.2013.07.032; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fan JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009691; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerondakis S, 2007, IMMUNOL CELL BIOL, V85, P471, DOI 10.1038/sj.icb.7100097; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guertin MJ, 2013, CURR OPIN GENET DEV, V23, P116, DOI 10.1016/j.gde.2012.11.008; He HSHS, 2012, GENOME RES, V22, P1015, DOI 10.1101/gr.133280.111; Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Marguerat S, 2012, TRENDS GENET, V28, P560, DOI 10.1016/j.tig.2012.07.003; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murn J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-323; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Perna D, 2012, ONCOGENE, V31, P1695, DOI 10.1038/onc.2011.359; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rounbehler RJ, 2012, CELL, V150, P563, DOI 10.1016/j.cell.2012.06.033; Sabo A, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014191; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Yustein JT, 2010, P NATL ACAD SCI USA, V107, P3534, DOI 10.1073/pnas.0901230107; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	56	307	316	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					488	+		10.1038/nature13537	http://dx.doi.org/10.1038/nature13537			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043028	Green Accepted			2022-12-28	WOS:000339335700051
J	Schmidt, B				Schmidt, Brian			PERSPECTIVE If not funding then teaching	NATURE			English	Editorial Material									Australian Natl Univ, Res Sch Astron & Astrophys, Weston, ACT, Australia	Australian National University	Schmidt, B (corresponding author), Australian Natl Univ, Res Sch Astron & Astrophys, Weston, ACT, Australia.	brian@mso.anu.edu.au		Schmidt, Brian/0000-0001-6589-1287					0	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					S81	S81		10.1038/511S81a	http://dx.doi.org/10.1038/511S81a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL7SO	25054857	Bronze			2022-12-28	WOS:000339335700008
J	Marrazzo, JM; del Rio, C; Holtgrave, DR; Cohen, MS; Kalichman, SC; Mayer, KH; Montaner, JSG; Wheeler, DP; Grant, RM; Grinsztejn, B; Kumarasamy, N; Shoptaw, S; Walensky, RP; Dabis, F; Sugarman, J; Benson, CA				Marrazzo, Jeanne M.; del Rio, Carlos; Holtgrave, David R.; Cohen, Myron S.; Kalichman, Seth C.; Mayer, Kenneth H.; Montaner, Julio S. G.; Wheeler, Darrell P.; Grant, Robert M.; Grinsztejn, Beatriz; Kumarasamy, N.; Shoptaw, Steven; Walensky, Rochelle P.; Dabis, Francois; Sugarman, Jeremy; Benson, Constance A.			HIV Prevention in Clinical Care Settings 2014 Recommendations of the International Antiviral Society-USA Panel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; SEXUAL RISK BEHAVIOR; NONOCCUPATIONAL POSTEXPOSURE PROPHYLAXIS; HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL MEDICATION ADHERENCE; TRANSMITTED-DISEASE PREVENTION; NATIONAL HIV/AIDS STRATEGY; UNITED-STATES; COST-EFFECTIVENESS; MALE CIRCUMCISION	IMPORTANCE Emerging data warrant the integration of biomedical and behavioral recommendations for human immunodeficiency virus (HIV) prevention in clinical care settings. OBJECTIVE To provide current recommendations for the prevention of HIV infection in adults and adolescents for integration in clinical care settings. DATA SOURCES, STUDY SELECTION, AND DATA SYNTHESIS Data published or presented as abstracts at scientific conferences (past 17 years) were systematically searched and reviewed by the International Antiviral (formerly AIDS) Society USA HIV Prevention Recommendations Panel. Panel members supplied additional relevant publications, reviewed available data, and formed recommendations by full-panel consensus. RESULTS Testing for HIV is recommended at least once for all adults and adolescents, with repeated testing for those at increased risk of acquiring HIV. Clinicians should be alert to the possibility of acute HIV infection and promptly pursue diagnostic testing if suspected. At diagnosis of HIV, all individuals should be linked to care for timely initiation of antiretroviral therapy (ART). Support for adherence and retention in care, individualized risk assessment and counseling, assistance with partner notification, and periodic screening for common sexually transmitted infections (STIs) is recommended for HIV-infected individuals as part of care. In HIV-uninfected patients, those persons at high risk of HIV infection should be prioritized for delivery of interventions such as preexposure prophylaxis and individualized counseling on risk reduction. Daily emtricitabine/tenofovir disoproxil fumarate is recommended as preexposure prophylaxis for persons at high risk for HIV based on background incidence or recent diagnosis of incident STIs, use of injection drugs or shared needles, or recent use of nonoccupational postexposure prophylaxis; ongoing use of preexposure prophylaxis should be guided by regular risk assessment. For persons who inject drugs, harm reduction services should be provided (needle and syringe exchange programs, supervised injection, and available medically assisted therapies, including opioid agonists and antagonists); low-threshold detoxification and drug cessation programs should be made available. Postexposure prophylaxis is recommended for all persons who have sustained a mucosal or parenteral exposure to HIV from a known infected source and should be initiated as soon as possible. CONCLUSIONS AND RELEVANCE Data support the integration of biomedical and behavioral approaches for prevention of HIV infection in clinical care settings. A concerted effort to implement combination strategies for HIV prevention is needed to realize the goal of an AIDS-free generation.	[Marrazzo, Jeanne M.] Univ Washington, Seattle, WA 98104 USA; [del Rio, Carlos] Emory Univ, Atlanta, GA 30322 USA; [Holtgrave, David R.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Cohen, Myron S.] Univ N Carolina, Chapel Hill, NC USA; [Kalichman, Seth C.] Univ Connecticut, Storrs, CT USA; [Mayer, Kenneth H.] Harvard Univ, Sch Med, Boston, MA USA; [Montaner, Julio S. G.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Wheeler, Darrell P.] Loyola Univ, Chicago, IL 60611 USA; [Grant, Robert M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grinsztejn, Beatriz] Fiocruz MS, Evandro Chagas Clin Res Inst IPEC, BR-21045900 Rio De Janeiro, Brazil; [Kumarasamy, N.] YR Gaitonde Ctr AIDS Res & Educ, Chennai, Tamil Nadu, India; [Shoptaw, Steven] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Walensky, Rochelle P.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Dabis, Francois] Univ Bordeaux, Bordeaux, France; [Sugarman, Jeremy] Johns Hopkins Univ, Baltimore, MD USA; [Benson, Constance A.] Univ Calif San Diego, La Jolla, CA 92093 USA	University of Washington; University of Washington Seattle; Emory University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of Connecticut; Harvard University; Harvard Medical School; University of British Columbia; Loyola University Chicago; University of California System; University of California San Francisco; Fundacao Oswaldo Cruz; University of California System; University of California Los Angeles; Harvard University; Massachusetts General Hospital; UDICE-French Research Universities; Universite de Bordeaux; Johns Hopkins University; University of California System; University of California San Diego	Marrazzo, JM (corresponding author), Univ Washington, Harborview Med Ctr, Box 359932,325 9th Ave, Seattle, WA 98104 USA.	jmm2@uw.edu	DABIS, FRANCOIS/S-9298-2019; Kumarasasmy, Nagalingeswaran/AAB-7348-2021; del Rio, Carlos/B-3763-2012	DABIS, FRANCOIS/0000-0002-1614-8857; del Rio, Carlos/0000-0002-0153-3517; Grant, Robert/0000-0002-0851-7085; Shoptaw, Steven/0000-0002-3583-0026; Sugarman, Jeremy/0000-0001-7022-8332; Walensky, Rochelle P./0000-0002-8795-379X; Holtgrave, David/0000-0002-4321-7395; Marrazzo, Jeanne/0000-0002-9277-7364	International Antiviral Society-USA (IAS-USA), a mission-based, nonmembership, not-for-profit organization [501(c)(3)]; IAS-USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069432] Funding Source: NIH RePORTER	International Antiviral Society-USA (IAS-USA), a mission-based, nonmembership, not-for-profit organization; IAS-USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported and funded by the International Antiviral (formerly AIDS) Society-USA (IAS-USA), a mission-based, nonmembership, 501(c)(3) not-for-profit organization. The IAS-USA appointed members to the IAS-USA HIV Prevention Recommendations Panel to develop the recommendations and provided staff support. In the last 5 years, IAS-USA has received commercial support (grants) for selected continuing medical education (CME) activities that are pooled (ie, no single company supports any single effort) from Abbott Laboratories, AbbVie, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Janssen Therapeutics, Merck & Co, Mylan, Pfizer, Salix Pharmaceuticals, Tibotec Therapeutics, Vertex Pharmaceuticals, and ViiV Healthcare. The designation of selected CME activities refers to the IAS-USA structure of accepting commercial support only if there are enough companies with competing products to meet the criteria for independence and only on programs appropriate for support by commercial sources (eg, recommendations are not supported by industry grants). No private sector funding was used to support the effort. Panel members are not compensated for participation in the effort.	Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Amorosa V, 2005, JAIDS-J ACQ IMM DEF, V39, P557; Andersen M, 2003, AM J DRUG ALCOHOL AB, V29, P847, DOI 10.1081/ADA-120026264; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; [Anonymous], 2013, MMWR-MORBID MORTAL W, V62, P489; [Anonymous], HIGH IMP HIV PREV CD; [Anonymous], MON SEL NAT HIV PREV; Archin NM, 2012, P NATL ACAD SCI USA, V109, P9523, DOI 10.1073/pnas.1120248109; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001509; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bailey RC, 2002, AIDS CARE, V14, P27, DOI 10.1080/09540120220097919; Bassett IV, 2004, CLIN INFECT DIS, V39, P395, DOI 10.1086/422459; Berg KM, 2011, DRUG ALCOHOL DEPEN, V113, P192, DOI 10.1016/j.drugalcdep.2010.07.025; Binford MC, 2012, CURR HIV-AIDS REP, V9, P287, DOI 10.1007/s11904-012-0134-8; Birungi J, 2012, 19 INT AIDS C IAS JU; Blank S, 2012, PEDIATRICS, V130, pE756, DOI 10.1542/peds.2012-1990; Blankenship KM, 2000, AIDS, V14, pS11, DOI 10.1097/00002030-200006001-00003; Blish CA, 2012, JAIDS-J ACQ IMM DEF, V61, P436, DOI 10.1097/QAI.0b013e31826c2edd; Bocour A, 2013, AIDS, V27, P2961, DOI 10.1097/QAD.0000000000000031; Bolu OO, 2004, SEX TRANSM DIS, V31, P469, DOI 10.1097/01.olq.0000135987.12346.f2; Bonolo P. de F., 2005, AIDS, V19, pS5, DOI 10.1097/01.aids.0000191484.84661.2b; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Branson BM, 2012, J INFECT DIS, V205, P521, DOI 10.1093/infdis/jir793; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Butler AR, 2013, AIDS, V27, P105, DOI 10.1097/QAD.0b013e32835a5a52; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; Centers for Disease Control and Prevention, PREEXP PROPH PREV HI; Centers for Disease Control and Prevention, 2011, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention (CDC), QUADR HUM PAP VACC R; Centers for Disease Control and Prevention (CDC), STAT HIV LAWS; Centers for Disease Control and Prevention (CDC), HIV SPEC CRIM LAWS; Centers for Disease Control and Prevention (CDC), LIST ALL RISK RED IN; Chibo D, 2012, AIDS RES HUM RETROV, V28, P460, DOI [10.1089/AID.2011.0137, 10.1089/aid.2011.0137]; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Coffin PO, 2014, AIDS BEHAV, V18, P1390, DOI 10.1007/s10461-014-0712-4; Cohen MS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001232; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Colfax GN, 2011, ARCH GEN PSYCHIAT, V68, P1168, DOI 10.1001/archgenpsychiatry.2011.124; Cornett JK, 2013, CLIN INFECT DIS, V57, P712, DOI 10.1093/cid/cit281; Craw JA, 2008, JAIDS-J ACQ IMM DEF, V47, P597, DOI 10.1097/QAI.0b013e3181684c51; Crepaz N, 2014, AIDS, V28, P633, DOI 10.1097/QAD.0000000000000108; Crosby R, 2009, AM J PUBLIC HEALTH, V99, pS96, DOI 10.2105/AJPH.2007.123893; Diaz-Brito V, 2012, ANTIVIR THER, V17, P337, DOI 10.3851/IMP1955; Dilley JW, 2007, JAIDS-J ACQ IMM DEF, V44, P569, DOI 10.1097/QAI.0b013e318033ffbd; Dilley JW, 2002, J ACQ IMMUN DEF SYND, V30, P177, DOI [10.1097/01.QAI.0000016823.19906.41, 10.1097/00042560-200206010-00006]; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Eaton Lisa A, 2012, Am J Public Health, V102, pe34, DOI 10.2105/AJPH.2012.300968; Eaton LA, 2013, AIDS CARE, V25, P805, DOI 10.1080/09540121.2012.748870; El-Bassel N, 2010, ARCH INTERN MED, V170, P1594, DOI 10.1001/archinternmed.2010.261; Farber S, 2013, AIDS BEHAV, V17, P2293, DOI 10.1007/s10461-013-0416-1; Fauci AS, 2013, NAT IMMUNOL, V14, P1104, DOI 10.1038/ni.2735; Fisher JD, 2006, JAIDS-J ACQ IMM DEF, V41, P44, DOI 10.1097/01.qai.0000192000.15777.5c; Food and Drug Administration (FDA), COMPL LIST DON SCREE; Ford N, 2012, AIDS, V26, P559, DOI 10.1097/QAD.0b013e32834f3264; Fu TC, 2012, AIDS, V26, P2383, DOI 10.1097/QAD.0b013e32835ad438; Fuchs J, 2007, JAIDS-J ACQ IMM DEF, V46, P362, DOI 10.1097/QAI.0b013e3181565dcb; Garcia-Lerma JG, 2012, CURR OPIN HIV AIDS, V7, P505, DOI 10.1097/COH.0b013e328358e484; Garcia-Lerma JG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000391; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Gardner LI, 2014, CLIN INFECT DIS, V59, P725, DOI 10.1093/cid/ciu357; Gardner LI, 2012, CLIN INFECT DIS, V55, P1124, DOI 10.1093/cid/cis623; Garg S, 2013, CLIN INFECT DIS, V56, P1480, DOI 10.1093/cid/cit054; Gebremedhin Samson, 2010, East Afr J Public Health, V7, P295; Gilbert P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001988; Golden MR, 2009, AIDS, V23, P133, DOI 10.1097/QAD.0b013e32831fb52f; Golden MR, 2004, JAIDS-J ACQ IMM DEF, V36, P734, DOI 10.1097/00126334-200406010-00011; Golin CE, 2012, AIDS BEHAV, V16, P1182, DOI 10.1007/s10461-011-0025-9; Golin CE, 2010, AIDS PATIENT CARE ST, V24, P237, DOI 10.1089/apc.2009.0252; Golin CE, 2006, JAIDS-J ACQ IMM DEF, V42, P42, DOI 10.1097/01.qai.0000219771.97303.0a; Gopalappa C, 2012, JAIDS-J ACQ IMM DEF, V61, P99, DOI 10.1097/QAI.0b013e31825bd862; Gowing L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Gross R, 2013, JAMA INTERN MED, V173, P300, DOI 10.1001/jamainternmed.2013.2152; Hall HI, 2013, AIDS BEHAV, V17, P1632, DOI 10.1007/s10461-013-0426-z; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Hallett TB, 2011, SEX TRANSM INFECT, V87, P88, DOI 10.1136/sti.2010.043372; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; Hightow-Weidman LB, 2011, AIDS PATIENT CARE ST, V25, pS31, DOI 10.1089/apc.2011.9878; Hightow-Weidman LB, 2011, AIDS PATIENT CARE ST, V25, P37, DOI 10.1089/apc.2010.0192; Hill S, 2012, AIDS CARE, V24, P583, DOI 10.1080/09540121.2011.630354; Himelhoch S, 2013, AIDS BEHAV, V17, P2756, DOI 10.1007/s10461-013-0465-5; Holtgrave D, 2007, CLIN INFECT DIS, V45, pS240, DOI 10.1086/522544; Holtgrave DR, 2014, JAIDS-J ACQ IMM DEF, V65, pE125, DOI 10.1097/QAI.0b013e3182a8ef0e; Holtgrave DR, 2012, AIDS BEHAV, V16, P1365, DOI 10.1007/s10461-012-0207-0; Holtgrave DR, 2012, AIDS BEHAV, V16, P1085, DOI 10.1007/s10461-012-0186-1; Holtgrave DR, 2010, JAIDS-J ACQ IMM DEF, V55, P139, DOI 10.1097/QAI.0b013e3181f4107a; Hoover KW, 2010, SEX TRANSM DIS, V37, P771, DOI 10.1097/OLQ.0b013e3181e50058; Horvath KJ, 2013, AIDS BEHAV, V17, P2031, DOI 10.1007/s10461-013-0469-1; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; James NJ, 1998, AIDS, V12, P1235, DOI 10.1097/00002030-199810000-00016; Jemmott LS, 2007, AM J PUBLIC HEALTH, V97, P1034, DOI 10.2105/AJPH.2003.020271; Jin FY, 2010, JAIDS-J ACQ IMM DEF, V53, P144, DOI 10.1097/QAI.0b013e3181b48f33; Johnson BT, 2009, JAIDS-J ACQ IMM DEF, V51, P492, DOI 10.1097/QAI.0b013e3181a28121; Johnson MO, 2011, ANN BEHAV MED, V41, P83, DOI 10.1007/s12160-010-9230-4; Justman J, 2013, JAIDS-J ACQ IMM DEF, V63, pS140, DOI 10.1097/QAI.0b013e31829875cc; Juusola JL, 2012, ANN INTERN MED, V156, P541, DOI [10.7326/0003-4819-156-8-201204170-00004, 10.7326/0003-4819-156-8-201204170-00001]; Kahn JA, 2013, CLIN INFECT DIS, V57, P735, DOI 10.1093/cid/cit319; Kalichman SC, 2005, J ASSOC NURSE AIDS C, V16, P3, DOI 10.1016/j.jana.2005.07.001; Kalichman SC, 2005, HEALTH PSYCHOL, V24, P198, DOI 10.1037/0278-6133.24.2.198; Kalichman SC, 2001, AM J PREV MED, V21, P84, DOI 10.1016/S0749-3797(01)00324-5; Kalichman SC, 2013, JAIDS-J ACQ IMM DEF, V63, P42, DOI 10.1097/QAI.0b013e318286ce49; Kalichman SC, 2011, AIDS PATIENT CARE ST, V25, P303, DOI 10.1089/apc.2010.0367; Kalichman SC, 2011, AM J PUBLIC HEALTH, V101, P531, DOI 10.2105/AJPH.2010.197608; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Kuhar DT, 2013, INFECT CONT HOSP EP, V34, P1238, DOI 10.1086/673726; Kuhar DT, 2013, INFECT CONT HOSP EP, V34, P875, DOI 10.1086/672271; Landovitz RJ, 2009, NEW ENGL J MED, V361, P1768, DOI 10.1056/NEJMcp0904189; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Lee MB, 2005, AIDS EDUC PREV, V17, P105, DOI 10.1521/aeap.17.3.105.62906; Letourneau EJ, 2013, AIDS CARE, V25, P507, DOI 10.1080/09540121.2012.715134; Li JH, 2012, AIDS, V26, P2069, DOI 10.1097/QAD.0b013e3283574e54; Lightfoot M, 2007, BEHAV MODIF, V31, P345, DOI 10.1177/0145445506293787; Lissouba P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000309; Long EF, 2013, J GEN INTERN MED, V28, P1294, DOI 10.1007/s11606-013-2417-1; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Lucas GM, 2010, ANN INTERN MED, V152, P704, DOI 10.7326/0003-4819-152-11-201006010-00003; Marrazzo JM, 2013, 20 C RETR OPP INF CR; Marshall BDL, 2009, SEX TRANSM INFECT, V85, P121, DOI 10.1136/sti.2008.032524; Marshall BDL, 2010, AIDS, V24, P2271, DOI 10.1097/QAD.0b013e32833dd101; Mathes T, 2013, HIV MED, V14, P583, DOI 10.1111/hiv.12051; Mausbach BT, 2007, DRUG ALCOHOL DEPEN, V87, P249, DOI 10.1016/j.drugalcdep.2006.08.026; Mavhu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032475; Mayer KH, 2008, JAIDS-J ACQ IMM DEF, V47, P494, DOI 10.1097/QAI.0b013e318162afcb; Mayer KH, 2012, JAIDS-J ACQ IMM DEF, V59, P354, DOI 10.1097/QAI.0b013e31824a03b8; Mayer KH, 2012, SEX TRANSM DIS, V39, P1, DOI 10.1097/OLQ.0b013e31823b1922; McCoy SI, 2013, J ACQ IMMUN DEF SYND, V63, P56; McKirnan DJ, 2010, J CONSULT CLIN PSYCH, V78, P952, DOI 10.1037/a0020759; Mehta SD, 2013, AIDS, V27, P2899, DOI 10.1097/01.aids.0000432444.30308.2d; Metcalf CA, 2005, SEX TRANSM DIS, V32, P130, DOI 10.1097/01.olq.0000151421.97004.c0; Metcalf CA, 2005, SEX TRANSM DIS, V32, P123, DOI 10.1097/01.olq.0000151420.92624.c0; Metsch LR, 2008, CLIN INFECT DIS, V47, P577, DOI 10.1086/590153; Metsch LR, 2013, JAMA-J AM MED ASSOC, V310, P1701, DOI 10.1001/jama.2013.280034; Metsch LR, 2012, AM J PUBLIC HEALTH, V102, P1160, DOI 10.2105/AJPH.2011.300460; Miller WC, 2009, AIDS, V23, P835, DOI 10.1097/QAD.0b013e328326f55e; Milloy MJS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003351; Milloy MJ, 2012, CURR OPIN HIV AIDS, V7, P332, DOI 10.1097/COH.0b013e328354bcc8; Mizuno Y, 2014, AIDS, V28, P407, DOI 10.1097/QAD.0000000000000057; Montaner J, 2011, JAIDS-J ACQ IMM DEF, V56, pE101, DOI 10.1097/QAI.0b013e318202e41d; Montaner JSG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087872; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Morin SF, 2007, JAIDS-J ACQ IMM DEF, V44, P213, DOI 10.1097/QAI.0b013e31802c0cae; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Murphy Debra A, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P113, DOI 10.1177/1545109707301243; Naar-King S, 2012, CURR HIV-AIDS REP, V9, P335, DOI 10.1007/s11904-012-0132-x; Naar-King S, 2009, AIDS CARE, V21, P868, DOI 10.1080/09540120802612824; Nagelkerke NJD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-16; Napper LE, 2010, AIDS BEHAV, V14, P152, DOI 10.1007/s10461-009-9575-5; National Network of STDHIV Prevention Training Centers, ASK SCREEN INT INC H; Neaigus A, 2008, J URBAN HEALTH, V85, P309, DOI 10.1007/s11524-008-9271-1; Noar SM, 2008, AIDS BEHAV, V12, P335, DOI 10.1007/s10461-007-9313-9; Noguchi LM, 2014, TOP ANTIVIR MED, V22, P441; Nosyk B, 2012, CAN MED ASSOC J, V184, pE317, DOI 10.1503/cmaj.110669; Oviedo-Joekes E, 2009, NEW ENGL J MED, V361, P777, DOI 10.1056/NEJMoa0810635; Palepu A, 2011, J URBAN HEALTH, V88, P545, DOI 10.1007/s11524-011-9562-9; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2012, ANN INTERN MED, V157, P744, DOI 10.7326/0003-4819-157-10-201211200-00545; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Parsons JT, 2005, AIDS PATIENT CARE ST, V19, P31, DOI 10.1089/apc.2005.19.31; Pathela P, 2013, CLIN INFECT DIS, V57, P1203, DOI 10.1093/cid/cit437; Pati R, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18490; Patterson TL, 2008, AM J PUBLIC HEALTH, V98, P2051, DOI 10.2105/AJPH.2007.130096; Patton ME, 2014, CLIN INFECT DIS, V58, P1564, DOI 10.1093/cid/ciu184; Patton ME, 2014, MMWR-MORBID MORTAL W, V63, P402; Pettifor A, 2011, AIDS BEHAV, V15, P1243, DOI 10.1007/s10461-010-9839-0; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Phillips SJ, 2013, AIDS, V27, P787, DOI 10.1097/QAD.0b013e32835bb672; Polis CB, 2013, LANCET INFECT DIS, V13, P797, DOI 10.1016/S1473-3099(13)70155-5; Polis CB, 2013, AIDS, V27, P493, DOI 10.1097/QAD.0b013e32835ad539; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Poynten IM, 2009, AIDS, V23, P1119, DOI 10.1097/QAD.0b013e32832c1776; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Reynolds NR, 2008, JAIDS-J ACQ IMM DEF, V47, P62, DOI 10.1097/QAI.0b013e3181582d54; Reznick OG, 2013, J CORRECT HEALTH CAR, V19, P178, DOI 10.1177/1078345813486442; Richardson JL, 2004, AIDS, V18, P1179, DOI 10.1097/00002030-200405210-00011; Rodger A, 2014, 2014 C RETR OPP INF; Roland ME, 2005, CLIN INFECT DIS, V41, P1507, DOI 10.1086/497268; Rotheram-Borus MJ, 2009, AIDS BEHAV, V13, P387, DOI 10.1007/s10461-009-9531-4; Rotheram-Borus MJ, 2004, JAIDS-J ACQ IMM DEF, V37, pS68, DOI 10.1097/01.qai.0000140604.57478.67; Rotheram-Borus MJ, 2002, AP PRA H PS, P15; Rotheram-Borus MJ, 2001, AM J PUBLIC HEALTH, V91, P400, DOI 10.2105/AJPH.91.3.400; Safren SA, 2009, HEALTH PSYCHOL, V28, P1, DOI 10.1037/a0012715; Sanchez J, 2011, AIDS, V25, P519, DOI 10.1097/QAD.0b013e328340fd81; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schechter M, 2004, JAIDS-J ACQ IMM DEF, V35, P519, DOI 10.1097/00126334-200404150-00010; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; Scott-Sheldon LAJ, 2011, JAIDS-J ACQ IMM DEF, V58, P489, DOI 10.1097/QAI.0b013e31823554d7; Scott-Sheldon LAJ, 2010, ANN BEHAV MED, V40, P191, DOI 10.1007/s12160-010-9202-8; Semaan S, 2010, DRUG ALCOHOL DEPEN, V106, P7, DOI 10.1016/j.drugalcdep.2009.07.015; Shrier LA, 2001, ARCH PEDIAT ADOL MED, V155, P73, DOI 10.1001/archpedi.155.1.73; Sikkema KJ, 2008, JAIDS-J ACQ IMM DEF, V47, P506, DOI 10.1097/QAI.0b013e318160d727; Simoni JM, 2007, HEALTH PSYCHOL, V26, P488, DOI 10.1037/0278-6133.26.4.488; Simoni JM, 2013, AIDS BEHAV, V17, P2816, DOI 10.1007/s10461-013-0538-5; Simoni JM, 2011, AIDS BEHAV, V15, P919, DOI 10.1007/s10461-010-9828-3; Smith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1; Soorapanth S, 2013, P 2010 WINT SIM C BA; Spreen W, 2013, 7 IAS C HIV PATH TRE; Steward WT, 2009, AIDS BEHAV, V13, P1054, DOI 10.1007/s10461-009-9582-6; Stoltz JA, 2007, J PUBLIC HEALTH, V29, P35, DOI 10.1093/pubmed/fdl090; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Sullivan Patrick S, 2014, J Int Assoc Provid AIDS Care, V13, P135, DOI 10.1177/2325957413500534; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Taylor MM, 2010, SEX TRANSM DIS, V37, P767, DOI 10.1097/OLQ.0b013e3181e65e8b; Tepper Naomi K., 2012, Morbidity and Mortality Weekly Report, V61, P449; The Well Project, DISCL HIV; The White House Office of National AIDS Policy (ONAP). National HIV/AIDS Strategy for the United States. ONAP, NAT HIV AIDS STRAT U; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Tobian AAR, 2011, LANCET INFECT DIS, V11, P604, DOI 10.1016/S1473-3099(11)70038-X; Tobian AAR, 2009, AIDS, V23, P1589, DOI 10.1097/QAD.0b013e32832d4042; Townsend L, 2013, PREV SCI, V14, P88, DOI 10.1007/s11121-012-0300-7; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; Uhlmann S, 2010, ADDICTION, V105, P907, DOI 10.1111/j.1360-0443.2010.02905.x; United Nations Office on Drugs and Crime (UNODC), COERC COH TREAT DRUG; US Department of Health and Human Services and Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUIDELINES USE ANTIR; US Department of State, PEPFAR BLUEPR CREAT; US Preventive Services Task Force (USPSTF), BEH COUNS PREV SEX T; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Wagner GA, 2014, J INFECT DIS, V209, P1032, DOI 10.1093/infdis/jit633; Walensky RP, 2013, NEW ENGL J MED, V369, P1715, DOI 10.1056/NEJMsa1214720; Walensky RP, 2005, MED DECIS MAKING, V25, P321, DOI 10.1177/0272989X05276955; Wandeler G, 2012, CLIN INFECT DIS, V55, P1408, DOI 10.1093/cid/cis694; Wang L, 2010, JAIDS-J ACQ IMM DEF, V55, P232, DOI 10.1097/QAI.0b013e3181e9b6b7; Warner L, 2008, PLOS MED, V5, P919, DOI 10.1371/journal.pmed.0050135; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; Weintrob AC, 2003, ARCH INTERN MED, V163, P2097, DOI 10.1001/archinte.163.17.2097; Wilkin T, 2010, J INFECT DIS, V202, P1246, DOI 10.1086/656320; Wingood GM, 2004, JAIDS-J ACQ IMM DEF, V37, pS58, DOI 10.1097/01.qai.0000140603.57478.a9; Wohl AR, 2011, AIDS CARE, V23, P988, DOI 10.1080/09540121.2010.542125; Wolitski RJ, 2005, AIDS, V19, pS99, DOI 10.1097/01.aids.0000167356.94664.59; Wood E, 2006, NEW ENGL J MED, V354, P2512, DOI 10.1056/NEJMc052939; Wood E, 2006, SUBST ABUSE TREAT PR, V1, DOI 10.1186/1747-597X-1-13; Wood E, 2006, CAN MED ASSOC J, V175, P1399, DOI 10.1503/cmaj.060863; Workowski Kimberly A., 2010, Morbidity and Mortality Weekly Report, V59, P1; Workowski Kimberly A., 2011, Morbidity and Mortality Weekly Report, V60, P18; World Health Organization, HORM CONTR HIV TECHN; World Health Organization, 2012, UNODC UNAIDS TECHN G; World Health Organization, GUID COUPL HIV TEST; World Health Organization, CONS GUID US ANT DRU; World Health Organization (WHO) and Joint United Nations Programme on HIV/AIDS. (UNAIDS), GUID HIV TEST COUNS; Young MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047395; 1979, CAN MED ASS J, V121, P1193	251	90	94	1	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					390	409		10.1001/jama.2014.7999	http://dx.doi.org/10.1001/jama.2014.7999			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL6QN	25038358	Green Accepted, Bronze			2022-12-28	WOS:000339257800026
J	Weiss, SH; Goedert, JJ; Sarngadharan, MG; Bodner, AJ; Gallo, RC; Blattner, WA				Weiss, Stanley H.; Goedert, James J.; Sarngadharan, M. G.; Bodner, Anne J.; Gallo, Robert C.; Blattner, William A.			Screening Test for HTLV-III (AIDS Agent) Antibodies (Reprinted from vol 253, pg 221, 1985)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							ACQUIRED-IMMUNODEFICIENCY-SYNDROME							Weiss, Stanley/0000-0002-5485-551X				EYSTER ME, 1983, NEW ENGL J MED, V309, P583, DOI 10.1056/NEJM198309083091003; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Griner P F, 1981, Ann Intern Med, V94, P557; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; SAFAI B, 1984, LANCET, V1, P1438, DOI 10.1016/S0140-6736(84)91933-0; SARNGADHARAN MG, 1984, SCIENCE, V224, P506, DOI 10.1126/science.6324345; SCHUPBACH J, 1984, SCIENCE, V224, P503, DOI 10.1126/science.6200937; WEISS SH, 1985, JAMA-J AM MED ASSOC, V253, P221, DOI 10.1001/jama.253.2.221	8	0	1	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					442	442		10.1001/jama.2013.279636	http://dx.doi.org/10.1001/jama.2013.279636			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038372				2022-12-28	WOS:000339257800039
J	Lancaster, MA; Knoblich, JA				Lancaster, Madeline A.; Knoblich, Juergen A.			Organogenesis in a dish: Modeling development and disease using organoid technologies	SCIENCE			English	Review							EMBRYONIC STEM-CELLS; IN-VITRO DIFFERENTIATION; EPITHELIAL-CELLS; DIRECTED DIFFERENTIATION; SPINDLE ORIENTATION; SELF-FORMATION; NEURAL RETINA; GENERATION; VIVO; PROGENITORS	Classical experiments performed half a century ago demonstrated the immense self-organizing capacity of vertebrate cells. Even after complete dissociation, cells can reaggregate and reconstruct the original architecture of an organ. More recently, this outstanding feature was used to rebuild organ parts or even complete organs from tissue or embryonic stem cells. Such stem cell-derived three-dimensional cultures are called organoids. Because organoids can be grown from human stem cells and from patient-derived induced pluripotent stem cells, they have the potential to model human development and disease. Furthermore, they have potential for drug testing and even future organ replacement strategies. Here, we summarize this rapidly evolving field and outline the potential of organoid technology for future biomedical research.	[Lancaster, Madeline A.; Knoblich, Juergen A.] Austrian Acad Sci, IMBA Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Knoblich, JA (corresponding author), Austrian Acad Sci, IMBA Inst Mol Biotechnol, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015	Knoblich, Juergen A/0000-0002-6751-3404; Lancaster, Madeline/0000-0003-2324-8853	European Molecular Biology Organization (EMBO); Helen Hay Whitney Foundation; Marie Curie post-doctoral fellowship; Austrian Academy of Sciences; Austrian Science Fund (FWF) [Z153-B09, I552-B19]; European Research Council; Austrian Science Fund (FWF) [Z 153] Funding Source: researchfish	European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Helen Hay Whitney Foundation; Marie Curie post-doctoral fellowship(European Commission); Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to N. Corsini and M. Renner for critical feedback as well as other members of the Knoblich lab for discussions. M. A. L. received funding from the European Molecular Biology Organization (EMBO), the Helen Hay Whitney Foundation, and a Marie Curie post-doctoral fellowship. Work in J.A.K.'s laboratory is supported by the Austrian Academy of Sciences, the Austrian Science Fund (FWF) (projects Z153-B09 and I552-B19), and an advanced grant from the European Research Council.	Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Antonica F, 2012, NATURE, V491, P66, DOI 10.1038/nature11525; ARMSTRONG PB, 1989, CRIT REV BIOCHEM MOL, V24, P119, DOI 10.3109/10409238909086396; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; BERNFIELD MR, 1967, P NATL ACAD SCI USA, V58, P2227, DOI 10.1073/pnas.58.6.2227; Bielby RC, 2004, TISSUE ENG, V10, P1518, DOI 10.1089/ten.2004.10.1518; Bigorgne AE, 2014, J CLIN INVEST, V124, P328, DOI 10.1172/JCI71471; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Buttery LDK, 2001, TISSUE ENG, V7, P89, DOI 10.1089/107632700300003323; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; Castellanos-Gonzalez A, 2013, INFECT IMMUN, V81, P1996, DOI 10.1128/IAI.01131-12; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Coraux C, 2003, CURR BIOL, V13, P849, DOI 10.1016/S0960-9822(03)00296-3; Cyranoski D, 2012, NATURE, V488, P444, DOI 10.1038/488444a; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Dessimoz J, 2006, MECH DEVELOP, V123, P42, DOI 10.1016/j.mod.2005.10.001; DETRICK RJ, 1990, NEURON, V4, P493, DOI 10.1016/0896-6273(90)90108-R; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; EVANS M, 1981, J REPROD FERTIL, V62, P625; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; Finkbeiner SR, 2012, MBIO, V3, DOI 10.1128/mBio.00159-12; Fischman D. A., 1971, CARDIAC HYPERTROPHY, P125; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Foty RA, 1996, DEVELOPMENT, V122, P1611; FUJIMORI T, 1990, DEVELOPMENT, V110, P97; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gilbert S.F., 2000, DEV BIOL; Greggio C, 2013, DEVELOPMENT, V140, P4452, DOI 10.1242/dev.096628; GROVER JW, 1961, DEV BIOL, V3, P555, DOI 10.1016/0012-1606(61)90032-X; HACHITANDA Y, 1994, HUM PATHOL, V25, P67, DOI 10.1016/0046-8177(94)90173-2; Hagios C, 1998, PHILOS T R SOC B, V353, P857, DOI 10.1098/rstb.1998.0250; HALBERT SP, 1971, J EXP MED, V133, P677, DOI 10.1084/jem.133.4.677; Heath JK, 2010, CURR TOP DEV BIOL, V90, P159, DOI 10.1016/S0070-2153(10)90004-5; Heavner W, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008391; HILFER SP, 1968, Z ZELLFORSCH MIK ANA, V92, P256, DOI 10.1007/BF00335651; Hisha H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03224; Holtfreter Johannes, 1944, REV CANADIENNE BIOL, V3, P220; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Humphreys BD, 2014, NAT CELL BIOL, V16, P19, DOI 10.1038/ncb2904; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; ISHII K, 1966, CYTOLOGIA, V31, P89, DOI 10.1508/cytologia.31.89; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Kale S, 2000, NAT BIOTECHNOL, V18, P954, DOI 10.1038/79439; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Koehler KR, 2013, NATURE, V500, P217, DOI 10.1038/nature12298; KONIGSBERG IR, 1963, SCIENCE, V140, P1273, DOI 10.1126/science.140.3573.1273; Kuno N, 2004, BIRTH DEFECTS RES A, V70, P40, DOI 10.1002/bdra.10133; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lancaster MA, 2012, CURR OPIN NEUROBIOL, V22, P737, DOI 10.1016/j.conb.2012.04.003; Lanza R, 2009, ESSENTIALS OF STEM CELL BIOLOGY, 2ND EDITION, pXV, DOI 10.1016/B978-0-12-374729-7.00073-1; Layer PG, 2002, TRENDS NEUROSCI, V25, P131, DOI 10.1016/S0166-2236(00)02036-1; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; Lehtinen MK, 2011, ANNU REV CELL DEV BI, V27, P653, DOI 10.1146/annurev-cellbio-092910-154026; Levy Emile, 2009, Methods Mol Biol, V550, P205, DOI 10.1007/978-1-60327-009-0_13; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; LI ML, 1987, P NATL ACAD SCI USA, V84, P136, DOI 10.1073/pnas.84.1.136; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Luni C, 2014, CURR OPIN BIOTECH, V25, P45, DOI 10.1016/j.copbio.2013.08.015; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; MALLETTE JM, 1966, EXP CELL RES, V41, P642, DOI 10.1016/S0014-4827(66)80115-5; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; MONTGOMERY RK, 1983, DEV BIOL, V100, P181, DOI 10.1016/0012-1606(83)90209-9; MOSCONA A, 1952, J ANAT, V86, P287; MOSCONA A, 1961, EXP CELL RES, V22, P455, DOI 10.1016/0014-4827(61)90122-7; MOSCONA AA, 1962, J CELL COMPAR PHYSL, V60, P65, DOI 10.1002/jcp.1030600407; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Muguruma K, 2010, NAT NEUROSCI, V13, P1171, DOI 10.1038/nn.2638; Nakagawa S, 2003, DEV BIOL, V260, P414, DOI 10.1016/S0012-1606(03)00320-8; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Nishikawa M, 2012, BIOCHEM BIOPH RES CO, V417, P897, DOI 10.1016/j.bbrc.2011.12.071; Onuma K, 2013, P NATL ACAD SCI USA, V110, P11127, DOI 10.1073/pnas.1221926110; ORR MF, 1968, DEV BIOL, V17, P39, DOI 10.1016/0012-1606(68)90088-2; Petros TJ, 2011, FRONT MOL NEUROSCI, V4, DOI [10.3389/fnmo1.2011.00030, 10.3389/fnmol.2011.00030]; PIERCE GB, 1961, CANCER, V14, P1017, DOI 10.1002/1097-0142(196109/10)14:5<1017::AID-CNCR2820140516>3.0.CO;2-P; Prop F., 1973, TISSUE CULTURE METHO, P21; Ramsden CM, 2013, DEVELOPMENT, V140, P2576, DOI 10.1242/dev.092270; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rothermel A, 1997, P ROY SOC B-BIOL SCI, V264, P1293, DOI 10.1098/rspb.1997.0179; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sergi C, 1999, PEDIATR DEVEL PATHOL, V2, P50, DOI 10.1007/s100249900089; SHANNON JM, 1987, BIOCHIM BIOPHYS ACTA, V931, P143, DOI 10.1016/0167-4889(87)90200-X; Shirahashi H, 2004, CELL TRANSPLANT, V13, P197, DOI 10.3727/000000004783984016; SOBEL H, 1958, J EMBRYOL EXP MORPH, V6, P518; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; Stefanelli A., 1961, ACTA EMBRYOL MORPHOL, V4, P47; Steinberg MS., 1964, CELLULAR MEMBRANES D, P321; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Su HL, 2006, DEV BIOL, V290, P287, DOI 10.1016/j.ydbio.2005.11.010; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tedesco FS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003541; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; URASE K, 1993, DEV GROWTH DIFFER, V35, P33; van der Schaft DWJ, 2013, JOVE-J VIS EXP, DOI 10.3791/4267; VOLLMER G, 1986, NEUROSCI LETT, V63, P91, DOI 10.1016/0304-3940(86)90019-4; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; WEISS P, 1960, P NATL ACAD SCI USA, V46, P1177, DOI 10.1073/pnas.46.9.1177; Weitzer G, 2006, HANDB EXP PHARM, V174, P21; Wilson HV, 1907, SCIENCE, V25, P912, DOI 10.1126/science.25.649.912; Wolpert L, 2007, PRINCIPLES DEV; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872; Xinaris C, 2012, J AM SOC NEPHROL, V23, P1857, DOI 10.1681/ASN.2012050505; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030; ZIMMERMANN B, 1987, DIFFERENTIATION, V36, P86, DOI 10.1111/j.1432-0436.1987.tb00183.x	126	1366	1451	100	857	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194							1247125	10.1126/science.1247125	http://dx.doi.org/10.1126/science.1247125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035496				2022-12-28	WOS:000339400700038
J	Servick, K				Servick, Kelly			Top heart lab comes under fire	SCIENCE			English	Editorial Material																			0	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					254	254		10.1126/science.345.6194.254	http://dx.doi.org/10.1126/science.345.6194.254			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035470				2022-12-28	WOS:000339400700016
J	Conway, TM; John, SG				Conway, Tim M.; John, Seth G.			Quantification of dissolved iron sources to the North Atlantic Ocean	NATURE			English	Article							CONTINENTAL-SHELF; AEROSOL IRON; ISOTOPES; SEAWATER; DUST; FE; CONSTRAINTS; CYCLE; FLUX	Dissolved iron is an essential micronutrient for marine phytoplankton, and its availability controls patterns of primary productivity and carbon cycling throughout the oceans(1,2). The relative importance of different sources of iron to the oceans is not well known, however, and flux estimates from atmospheric dust, hydrothermal vents and oceanic sediments vary by orders of magnitude. Here we present a high-resolution transect of dissolved stable iron isotope ratios (delta Fe-56) and iron concentrations ([Fe]) along a section of the North Atlantic Ocean. The different iron sources can be identified by their unique delta Fe-56 signatures, which persist throughout the water column. This allows us to calculate the relative contribution from dust, hydrothermal venting and reductive and non-reductive sedimentary release to the dissolved phase. We find that Saharan dust aerosol is the dominant source of dissolved iron along the section, contributing 71-87 per cent of dissolved iron. Additional sources of iron are non-reductive release from oxygenated sediments on the North American margin (10-19 per cent), reductive sedimentary dissolution on the African margin (1-4 per cent) and hydrothermal venting at the Mid-Atlantic Ridge (2-6 per cent). Our data also indicate that hydrothermal vents in the North Atlantic are a source of isotopically light iron, which travels thousands of kilometres from vent sites, potentially influencing surface productivity. Changes in the relative importance of the different iron sources through time may affect interactions between the carbon cycle and climate.	[Conway, Tim M.; John, Seth G.] Univ S Carolina, Dept Earth & Ocean Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Conway, TM (corresponding author), ETH, Inst Geochem & Petrol, NWD81-4,Clausiusstr 25, CH-8092 Zurich, Switzerland.	conway.tm@gmail.com		John, Seth/0000-0002-8257-626X	National Science Foundation [OCE-1131387]	National Science Foundation(National Science Foundation (NSF))	We thank the Captain, crew and GEOTRACES sampling team on RV Knorr on both USGT10 and USGT11; A. Rosenberg for technical assistance; J. Wu, R. Middag, K. Bruland and P. Sedwick for supplying concentration data that informed double-spike calculations; and C. Hayes for calibrating transmissometry data. We thank W. Jenkins, W. Smethie, E. Boyle and G. Cutter for water mass observations. The Ocean Data Facility supplied temperature, PSS-78 salinity, fluorescence, transmissometry, dissolved oxygen and nutrient data from both cruises. Figures were created with Matlab and Adobe Illustrator. This study was funded by National Science Foundation grant OCE-1131387.	Beard BL, 2003, GEOLOGY, V31, P629, DOI 10.1130/0091-7613(2003)031<0629:IICOFC>2.0.CO;2; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Carazzo G, 2013, EARTH PLANET SC LETT, V382, P66, DOI 10.1016/j.epsl.2013.09.008; Conway TM, 2013, ANAL CHIM ACTA, V793, P44, DOI 10.1016/j.aca.2013.07.025; Elrod VA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020216; Fitzsimmons JN, 2013, MAR CHEM, V154, P87, DOI 10.1016/j.marchem.2013.05.009; Homoky WB, 2009, GEOLOGY, V37, P751, DOI 10.1130/G25731A.1; Homoky WB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3143; Ilina SM, 2013, GEOCHIM COSMOCHIM AC, V101, P96, DOI 10.1016/j.gca.2012.10.023; Jeandel C., 2011, EOS, V92, P217, DOI DOI 10.1029/2011E0260001; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; John SG, 2012, GEOCHIM COSMOCHIM AC, V93, P14, DOI 10.1016/j.gca.2012.06.003; John SG, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004043; John SG, 2010, MAR CHEM, V119, P65, DOI 10.1016/j.marchem.2010.01.001; Kohfeld KE, 2009, GEOPHYS MONOGR SER, V187, P251, DOI 10.1029/2008GM000845; Lacan F, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035841; Lacan F, 2010, ANAL CHEM, V82, P7103, DOI 10.1021/ac1002504; Mahowald NM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002402; Mead C, 2013, GEOPHYS RES LETT, V40, P5722, DOI 10.1002/2013GL057713; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; Palter JB, 2005, NATURE, V437, P687, DOI 10.1038/nature03969; Radic A, 2011, EARTH PLANET SC LETT, V306, P1, DOI 10.1016/j.epsl.2011.03.015; Saito MA, 2013, NAT GEOSCI, V6, P775, DOI [10.1038/ngeo1893, 10.1038/NGEO1893]; Severmann S, 2004, EARTH PLANET SC LETT, V225, P63, DOI 10.1016/j.epsl.2004.06.001; Tagliabue A, 2010, NAT GEOSCI, V3, P252, DOI 10.1038/NGEO818; Toner BM, 2012, OCEANOGRAPHY, V25, P209, DOI 10.5670/oceanog.2012.19; Toner BM, 2009, NAT GEOSCI, V2, P197, DOI 10.1038/NGEO433; Waeles M, 2007, ENVIRON CHEM, V4, P233, DOI 10.1071/EN07013	28	240	256	22	300	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					212	+		10.1038/nature13482	http://dx.doi.org/10.1038/nature13482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008528				2022-12-28	WOS:000338649800041
J	Kothari, K				Kothari, Komal			The Case for Social Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kothari, K (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	komal_kothari@hms.harvard.edu						[Anonymous], 2012, SURVEY AM PHYS PRACT; Krupa C., 2012, AMERICAN MEDICAL NEW	2	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2483	2484		10.1001/jama.2014.5240	http://dx.doi.org/10.1001/jama.2014.5240			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	25058080				2022-12-28	WOS:000337757000019
J	Beyrer, C; Crago, AL; Bekker, LG; Butler, J; Shannon, K; Kerrigan, D; Decker, MR; Baral, SD; Poteat, T; Wirtz, AL; Weir, BW; Barre-Sinoussi, F; Kazatchkine, M; Sidibe, M; Dehne, KL; Boily, MC; Strathdee, SA				Beyrer, Chris; Crago, Anna-Louise; Bekker, Linda-Gail; Butler, Jenny; Shannon, Kate; Kerrigan, Deanna; Decker, Michele R.; Baral, Stefan D.; Poteat, Tonia; Wirtz, Andrea L.; Weir, Brian W.; Barre-Sinoussi, Francoise; Kazatchkine, Michel; Sidibe, Michel; Dehne, Karl-Lorenz; Boily, Marie-Claude; Strathdee, Steffanie A.			An action agenda for HIV and sex workers	LANCET			English	Article							DRUG-NAIVE INDIVIDUALS; COST-EFFECTIVENESS; PREEXPOSURE PROPHYLAXIS; MOLECULAR EPIDEMIOLOGY; ANTIRETROVIRAL THERAPY; TYPE-1 INFECTION; FEMALE CONDOM; PREVENTION; IMPACT; INTERVENTION	The women, men, and transgender people who sell sex globally have disproportionate risks and burdens of HIV in countries of low, middle, and high income, and in concentrated and generalised epidemic contexts. The greatest HIV burdens continue to be in African female sex workers. Worldwide, sex workers still face reduced access to needed HIV prevention, treatment, and care services. Legal environments, policies, police practices, absence of funding for research and HIV programmes, human rights violations, and stigma and discrimination continue to challenge sex workers' abilities to protect themselves, their families, and their sexual partners from HIV. These realities must change to realise the benefits of advances in HIV prevention and treatment and to achieve global control of the HIV pandemic. Effective combination prevention and treatment approaches are feasible, can be tailored for cultural competence, can be cost-saving, and can help to address the unmet needs of sex workers and their communities in ways that uphold their human rights. To address HIV in sex workers will need sustained community engagement and empowerment, continued research, political will, structural and policy reform, and innovative programmes. But such actions can and must be achieved for sex worker communities everywhere.	[Beyrer, Chris; Kerrigan, Deanna; Decker, Michele R.; Baral, Stefan D.; Poteat, Tonia; Wirtz, Andrea L.; Weir, Brian W.] Johns Hopkins Univ, Ctr Publ Hlth & Human Rights, Baltimore, MD USA; [Wirtz, Andrea L.] Johns Hopkins Univ, Dept Emergency Med, Baltimore, MD USA; [Crago, Anna-Louise] Univ Toronto, Toronto, ON, Canada; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Res Ctr, ZA-7925 Cape Town, South Africa; [Butler, Jenny] United Nations Populat Fund, New York, NY USA; [Shannon, Kate] Univ British Columbia, BC Ctr Excellence HIV AIDS, Vancouver, BC V5Z 1M9, Canada; [Kerrigan, Deanna] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA; [Barre-Sinoussi, Francoise] Inst Pasteur, Paris, France; [Kazatchkine, Michel] UN Special Envoy HIV Eastern Europe & Cent Asia, Geneva, Switzerland; [Sidibe, Michel; Dehne, Karl-Lorenz] UNAIDS, Geneva, Switzerland; [Boily, Marie-Claude] Univ London Imperial Coll Sci Technol & Med, London, England; [Strathdee, Steffanie A.] Univ Calif San Diego, San Diego, CA 92103 USA	Johns Hopkins University; Johns Hopkins University; University of Toronto; University of Cape Town; United Nations Population Fund; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UNAIDS; Imperial College London; University of California System; University of California San Diego	Beyrer, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	cbeyrer@jhu.edu	Baral, Stefan/AAG-4818-2020; Bekker, Linda-Gail/AAZ-8929-2020; Strathdee, Steffanie A/B-9042-2009	Baral, Stefan/0000-0002-5482-2419; Weir, Brian/0000-0003-1634-218X; Decker, Michele/0000-0002-7085-7080; Poteat, Tonia/0000-0001-6541-3787; Boily, Marie-Claude/0000-0003-3919-006X; Strathdee, Steffanie/0000-0002-7724-691X; BEKKER, LINDA-GAIL/0000-0002-0755-4386	Bill & Melinda Gates Foundation; UN Population Fund; Johns Hopkins University Center for AIDS Research, a National Institute of Health (NIH) [1P30AI094189]; National Institutes of Allergy and Infectious Diseases (NIAID); National Cancer Institute (NCI); National Institute for Child Health and Development (NICHD); National Heart, Lung, and Blood Institute (NHLBI); National Institute of Mental Health (NIMH); National Institute for Drug Abuse (NIDA); Fogarty International Center (FIC); Office of AIDS Research (OAR); Johns Hopkins HIV Epidemiology and Prevention Sciences Training Programme [1T32AI102623-01AI]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI102623, P30AI094189] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UN Population Fund; Johns Hopkins University Center for AIDS Research, a National Institute of Health (NIH); National Institutes of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute for Child Health and Development (NICHD); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute for Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of AIDS Research (OAR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins HIV Epidemiology and Prevention Sciences Training Programme; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This review and The Lancet Series on HIV and sex work were supported by: grants to the Center for Public Health and Human Rights at Johns Hopkins Bloomberg School of Public Health from The Bill & Melinda Gates Foundation; The UN Population Fund; the Johns Hopkins University Center for AIDS Research, a National Institute of Health (NIH)-funded programme (1P30AI094189) supported by: National Institutes of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), National Institute for Child Health and Development (NICHD), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Mental Health (NIMH), National Institute for Drug Abuse (NIDA), Fogarty International Center (FIC), and Office of AIDS Research (OAR); and the Johns Hopkins HIV Epidemiology and Prevention Sciences Training Programme (1T32AI102623-01AI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. We thank Aleksandra Mihailovic and Hae-Young Kim, research assistants at the Johns Hopkins School of Public Health, Department of Epidemiology, for their contributions to the search and data abstraction for the analysis of the global prevalence of HIV in sex workers; Mandeep Dhaliwal of UNDP for panel 2 (Global Commission on HIV and the law); and the Conference Coordinating Committee of the 20th International AIDS Conference for the Melbourne 2014 Declaration (panel 3). We would like to thank Harold van Gelder from the Human Trafficking and Prostitution Unit, Amsterdam Police, and Sally Hendriks from Aids Fonds/Soa Aids Nederland for panel 5.	Abel G., 2007, IMPACT PROSTITUTION; Aguayo N, 2008, REV SOC BRAS MED TRO, V41, P225, DOI 10.1590/S0037-86822008000300001; [Anonymous], 2017, 2013 UNAIDS REP GLOB; Baeten JM, 2013, JAIDS-J ACQ IMM DEF, V63, pS122, DOI 10.1097/QAI.0b013e3182986f69; Baral SD, 2014, LANCET; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Beyrer C, 1999, J INFECT DIS, V179, P59, DOI 10.1086/314556; Beyrer C, 1997, J ACQ IMMUN DEF SYND, V15, P304, DOI 10.1097/00042560-199708010-00009; Biradavolu MR, 2009, SOC SCI MED, V68, P1541, DOI 10.1016/j.socscimed.2009.01.040; Carobene M, 2014, J MED VIROL, V86, P64, DOI 10.1002/jmv.23805; Chamberland A, 2012, SEX TRANSM INFECT, V88, P179, DOI 10.1136/sextrans-2011-050209; Chege D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043670; Christenson K, 2011, 4 GAME CHANGING HIV; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Decker MR, 2013, AM J REPROD IMMUNOL, V69, P122, DOI 10.1111/aji.12063; Decker MR, 2014, LANCET; Ditmore MH, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17354; Fung ICH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-195; Gelmon L, 2009, KENYA HIV PREVENTION; Ghoshal N, 2013, TREAT US LIKE HUMAN; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Havlir D, 2012, NEW ENGL J MED, V367, P685, DOI 10.1056/NEJMp1207138; Hellinger FJ, 2013, PHARMACOECONOMICS, V31, P1091, DOI 10.1007/s40273-013-0111-0; Hernan L, 2008, SMARTER PROGRAMMING; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; Jana S, 2006, LANCET, V367, P814, DOI 10.1016/S0140-6736(06)68331-1; Jennes W, 2006, CLIN EXP IMMUNOL, V143, P435, DOI 10.1111/j.1365-2249.2006.03017.x; Jung M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033579; Kato M, 2013, JAIDS-J ACQ IMM DEF, V63, pE142, DOI 10.1097/QAI.0b013e31829b535b; Kerrigan D, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9774-9; Kerrigan D, 2014, LANCET; Kerrigan DL, 2013, AIDS BEHAV, V17, P1926, DOI 10.1007/s10461-013-0458-4; Lajoie J, 2012, MUCOSAL IMMUNOL, V5, P277, DOI 10.1038/mi.2012.7; Land AM, 2008, AIDS RES HUM RETROV, V24, P1455, DOI 10.1089/aid.2008.0179; Marseille E, 2001, SOC SCI MED, V52, P135, DOI 10.1016/S0277-9536(00)00282-3; Mas de Xaxas M, 2008, M COMMUNITY NEEDS HI; Masenior NF, 2007, PLOS MED, V4, P1158, DOI 10.1371/journal.pmed.0040207; McNairy ML, 2013, JAIDS-J ACQ IMM DEF, V63, pS200, DOI 10.1097/QAI.0b013e3182986fc6; Medley A, 2009, AIDS EDUC PREV, V21, P181, DOI 10.1521/aeap.2009.21.3.181; Mehta SR, 2010, AIDS RES HUM RETROV, V26, P1273, DOI 10.1089/aid.2010.0021; Merati TP, 2012, SEX HEALTH, V9, P414, DOI 10.1071/SH11121; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Mills Edward, 2005, BMC Int Health Hum Rights, V5, P6, DOI 10.1186/1472-698X-5-6; Mugavero M, 2006, AIDS PATIENT CARE ST, V20, P418, DOI 10.1089/apc.2006.20.418; Mugavero MJ, 2009, PSYCHOSOM MED, V71, P920, DOI 10.1097/PSY.0b013e3181bfe8d2; Overs S, 2014, LANCET; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Pando MA, 2011, AIDS RES HUM RETROV, V27, P17, DOI 10.1089/aid.2010.0013; Poteat T, 2014, LANCET; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Rojanapithayalkorn W, 2006, REPROD HEALTH MATTER, V14, P41, DOI 10.1016/S0968-8080(06)28270-3; Schafer KR, 2012, AIDS PATIENT CARE ST, V26, P356, DOI 10.1089/apc.2011.0409; Scorgie F, 2013, CULT HEALTH SEX, V15, P450, DOI 10.1080/13691058.2012.763187; Shannon K., 2014, LANCET; Singh JP, 2007, REV POLICY RES, V24, P155, DOI DOI 10.1111/J.1541-1338.2007.00274.X; Ssemwanga D, 2012, AIDS RES HUM RETROV, V28, P1784, DOI [10.1089/aid.2012.0090, 10.1089/AID.2012.0090]; Steen R, 2014, AIDS, V28, P891, DOI 10.1097/QAD.0000000000000176; Steen R, 2013, EXPERT REV ANTI-INFE, V11, P999, DOI 10.1586/14787210.2013.824717; Sweat M, 2006, J HEALTH COMMUN, V11, P123, DOI 10.1080/10810730600974829; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Thomsen SC, 2006, SEX TRANSM INFECT, V82, P397, DOI 10.1136/sti.2006.019992; UNAIDS, 2006, NEW HIV INF MOD TRAN; UNAIDS, 2012, UNAIDS GUID NOT HIV; Vickerman P, 2006, SEX TRANSM DIS, V33, P397, DOI 10.1097/01.olq.0000218974.77208.cc; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; Tran VT, 2012, AIDS RES HUM RETROV, V28, P1349, DOI 10.1089/aid.2012.0006; Wabwire-Mangen F, 2009, UGANDA AIDS COMMISSI; Walensky RP, 2012, CLIN INFECT DIS, V54, P1504, DOI 10.1093/cid/cis225; Williams BG, 2011, JAIDS-J ACQ IMM DEF, V58, P207, DOI 10.1097/QAI.0b013e3182253c19; Wirtz AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088047; World Health Organization, 2013, IMPL COMPR HIV STI P; World Health Organization, 2001, MACR HLTH INV HLTH E; Yao XD, 2014, MUCOSAL IMMUNOL, V7, P268, DOI 10.1038/mi.2013.44	75	148	152	2	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					287	301		10.1016/S0140-6736(14)60933-8	http://dx.doi.org/10.1016/S0140-6736(14)60933-8			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ2DL	25059950	Green Accepted			2022-12-28	WOS:000348044800032
J	John, J; Giri, S; Karthikeyan, AS; Iturriza-Gomara, M; Muliyil, J; Abraham, A; Grassly, NC; Kang, G				John, Jacob; Giri, Sidhartha; Karthikeyan, Arun S.; Iturriza-Gomara, Miren; Muliyil, Jayaprakash; Abraham, Asha; Grassly, Nicholas C.; Kang, Gagandeep			Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial	LANCET			English	Article							SILENT CIRCULATION; MUCOSAL IMMUNITY; WILD-TYPE; IMMUNIZATION; IMMUNOGENICITY; RESPONSES; INDIA; INFECTION; OUTBREAKS	Background Intestinal immunity induced by oral poliovirus vaccine (OPV) is imperfect and wanes with time, permitting transmission of infection by immunised children. Inactivated poliovirus vaccine (IPV) does not induce an intestinal mucosal immune response, but could boost protection in children who are mucosally primed through previous exposure to OPV. We aimed to assess the effect of IPV on intestinal immunity in children previously vaccinated with OPV. Methods We did an open-label, randomised controlled trial in children aged 1-4 years from Chinnallapuram, Vellore, India, who were healthy, had not received IPV before, and had had their last dose of OPV at least 6 months before enrolment. Children were randomly assigned (1: 1) to receive 0.5 mL IPV intramuscularly (containing 40, 8, and 32 D antigen units for serotypes 1, 2, and 3) or no vaccine. The randomisation sequence was computer generated with a blocked randomisation procedure with block sizes of ten by an independent statistician. The laboratory staff did blinded assessments. The primary outcome was the proportion of children shedding poliovirus 7 days after a challenge dose of serotype 1 and 3 bivalent OPV (bOPV). A second dose of bOPV was given to children in the no vaccine group to assess intestinal immunity resulting from the first dose. A per-protocol analysis was planned for all children who provided a stool sample at 7 days after bOPV challenge. This trial is registered with Clinical Trials Registry of India, number CTRI/2012/09/003005. Findings Between Aug 19, 2013, and Sept 13, 2013, 450 children were enrolled and randomly assigned into study groups. 225 children received IPV and 225 no vaccine. 222 children in the no vaccine group and 224 children in the IPV group had stool samples available for primary analysis 7 days after bOPV challenge. In the IPV group, 27 (12%) children shed serotype 1 poliovirus and 17 (8%) shed serotype 3 poliovirus compared with 43 (19%) and 57 (26%) in the no vaccine group (risk ratio 0.62, 95% CI 0.40-0.97, p=0.0375; 0.30, 0.18-0.49, p<0.0001). No adverse events were related to the study interventions. Interpretation The substantial boost in intestinal immunity conferred by a supplementary dose of IPV given to children younger than 5 years who had previously received OPV shows a potential role for this vaccine in immunisation activities to accelerate eradication and prevent outbreaks of poliomyelitis.	[John, Jacob; Giri, Sidhartha; Iturriza-Gomara, Miren; Muliyil, Jayaprakash; Abraham, Asha; Grassly, Nicholas C.; Kang, Gagandeep] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Iturriza-Gomara, Miren] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Grassly, Nicholas C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England	Christian Medical College & Hospital (CMCH) Vellore; University of Liverpool; Imperial College London	Grassly, NC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England.	n.grassly@imperial.ac.uk	Grassly, Nicholas C/C-6381-2008; John, Jacob/M-3563-2019; Giri, Sidhartha/Y-9516-2018; John, Jacob/K-7093-2012; Gomara, Miren Iturriza/B-4351-2013	Grassly, Nicholas C/0000-0001-6067-4507; John, Jacob/0000-0003-3654-5099; Giri, Sidhartha/0000-0003-3927-7392; John, Jacob/0000-0003-3654-5099; Gomara, Miren Iturriza/0000-0001-5816-6423; Abraham, Asha/0000-0002-0736-1445; Karthikeyan Suseeladevi, Arun/0000-0003-0065-0217	Bill & Melinda Gates Foundation; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Bill & Melinda Gates Foundation.	Chen ZC, 2013, P NATL ACAD SCI USA, V110, P20242, DOI 10.1073/pnas.1320041110; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; du Chatelet IP, 2003, VACCINE, V21, P1710, DOI 10.1016/S0264-410X(02)00523-6; Estivariz CF, 2012, LANCET INFECT DIS, V12, P128, DOI 10.1016/S1473-3099(11)70190-6; FADEN H, 1992, AM J DIS CHILD, V146, P1320, DOI 10.1001/archpedi.1992.02160230078023; Global Polio Eradication Initiative, POLIO ERADICATION AN; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Grassly NC, 2012, J INFECT DIS, V205, P1554, DOI 10.1093/infdis/jis241; Grassly NC, 2010, J INFECT DIS, V201, P1535, DOI 10.1086/651952; Greenwood BM, 1997, J INFECT DIS, V175, pS215; Herremans T, 2002, CLIN INFECT DIS, V34, P1067, DOI 10.1086/339489; Herremans TMPT, 1999, J IMMUNOL, V162, P5011; Hird TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002599; KATRAK K, 1991, J GEN VIROL, V72, P1093, DOI 10.1099/0022-1317-72-5-1093; Kidd S, 2011, VACCINE, V29, P3760, DOI 10.1016/j.vaccine.2011.03.034; Kilpatrick DR, 2009, J CLIN MICROBIOL, V47, P1939, DOI 10.1128/JCM.00702-09; Kojouharova M, 2003, B WORLD HEALTH ORGAN, V81, P476; Krieg C, 2004, J GEN VIROL, V85, P1571, DOI 10.1099/vir.0.79919-0; Mach O, 2009, J INFECT DIS IN PRES; Mangal TD, 2013, AM J EPIDEMIOL, V178, P1579, DOI 10.1093/aje/kwt203; Manor Y, 2014, EUROSURVEILLANCE, V19, P31, DOI 10.2807/1560-7917.ES2014.19.7.20710; Modlin JF, 1997, J INFECT DIS, V175, pS228, DOI 10.1093/infdis/175.Supplement_1.S228; MORINIERE BJ, 1993, LANCET, V341, P1545, DOI 10.1016/0140-6736(93)90693-B; Newcombe RG., 2012, CONFIDENCE INTERVALS; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Sutter RW, 2000, NEW ENGL J MED, V343, P767, DOI 10.1056/NEJM200009143431103; Vidor E, 1997, PEDIATR INFECT DIS J, V16, P312, DOI 10.1097/00006454-199703000-00011; WHO, 1997, MANUAL OF LABORATORY; World Health Organization, 2004, POLIO LABORATORY MAN	29	74	74	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2014	384	9953					1505	1512		10.1016/S0140-6736(14)60934-X	http://dx.doi.org/10.1016/S0140-6736(14)60934-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9MO	25018120				2022-12-28	WOS:000343899600024
J	Sommers, BD; Musco, T; Finegold, K; Gunja, MZ; Burke, A; McDowell, AM				Sommers, Benjamin D.; Musco, Thomas; Finegold, Kenneth; Gunja, Munira Z.; Burke, Amy; McDowell, Audrey M.			Health Reform and Changes in Health Insurance Coverage in 2014	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AFFORDABLE CARE ACT; YOUNG-ADULTS; MEDICAID; ACCESS		[Sommers, Benjamin D.; Musco, Thomas; Finegold, Kenneth; Gunja, Munira Z.; Burke, Amy; McDowell, Audrey M.] Dept Hlth & Human Serv, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA; [Sommers, Benjamin D.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Sommers, Benjamin D.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Sommers, BD (corresponding author), Dept Hlth & Human Serv, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA.							[Anonymous], 2012, ASS REPRE PUBL OP SU; [Anonymous], 2014, 2012 NAT POP PRED DO; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Blendon RJ, 2013, NEW ENGL J MED, V369, P1066, DOI 10.1056/NEJMsr1307622; Blendon RJ, 2012, NEW ENGL J MED, V367, P2443, DOI 10.1056/NEJMsr1213905; Blumenthal D, 2014, NEW ENGL J MED, V371, P275, DOI 10.1056/NEJMhpr1405667; Cantor JC, 2012, HEALTH SERV RES, V47, P1773, DOI 10.1111/j.1475-6773.2012.01458.x; Carman KG, 2014, CHANGES HLTH INSURAN; Centers for Medicare & Medicaid Services, 2014, STAT MED CHIP INC EL; Chua KP, 2014, JAMA-J AM MED ASSOC, V311, P2437, DOI 10.1001/jama.2014.2202; Clemans-Cope L, 2014, INCREASE MEDICAID AC; Department of Health and Human Services, 2014, HLTH INS MARK SUMM E; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Holbrook AL, 2008, ADVANCES IN TELEPHONE SURVEY METHODOLOGY, P499; Kenney GM, 2011, HEALTH AFFAIR, V30, P2371, DOI 10.1377/hlthaff.2011.0899; Levy J, 2014, US UNISURED RATE DRO; Levy Jenna, 2014, US UNINSURED RATE LO; Long SK, 2014, HEALTH AFFAIR, V33, P161, DOI 10.1377/hlthaff.2013.0934; Long Sharon K., 2014, QUICKTAKE NUMBER UNI; Long SK, 2005, HEALTH SERV RES, V40, P39, DOI 10.1111/j.1475-6773.2005.00341.x; Mendes E, 2011, US SIGNIFICANTLY FEW; Mulcahy A, 2013, NEW ENGL J MED, V368, P2105, DOI 10.1056/NEJMsa1212779; Skopec L, 2014, HEALTHCARE, V2, P113, DOI 10.1016/j.hjdsi.2014.03.001; Sommers BD, 2014, HEALTH AFFAIR, V33, P887, DOI 10.1377/hlthaff.2014.0005; Sommers BD, 2014, ANN INTERN MED, V160, P585, DOI 10.7326/M13-2275; Sommers BD, 2014, HEALTH AFFAIR, V33, P78, DOI 10.1377/hlthaff.2013.1087; Sommers BD, 2013, HEALTH AFFAIR, V32, P165, DOI 10.1377/hlthaff.2012.0552; Sommers BD, 2012, JAMA-J AM MED ASSOC, V307, P913, DOI 10.1001/jama.307.9.913; Sommers BD, 2011, NEW ENGL J MED, V365, P100, DOI 10.1056/NEJMp1104948	29	110	110	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2014	371	9					867	874		10.1056/NEJMsr1406753	http://dx.doi.org/10.1056/NEJMsr1406753			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7ZN	25054609	Green Published, Green Submitted			2022-12-28	WOS:000340819800015
J	Brennan, T; Shrank, W				Brennan, Troyen; Shrank, William			New Expensive Treatments for Hepatitis C Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VIRUS-INFECTION; HCV		[Brennan, Troyen; Shrank, William] CVS Caremark, Woonsocket, RI USA		Brennan, T (corresponding author), CVS Caremark, 1 CVS Dr, Woonsocket, RI USA.	troyen.brennan@cvscaremark.com						[Anonymous], SUPP PATH SOV; [Anonymous], 2014, MED MAST DRUG DAT BA; California Technology Assessment Forum, 2014, COMP CLIN EFF VAL SI; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Gounder C., 2013, NEW YORKER; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Ozaras R, 2013, NEW ENGL J MED, V369, P679, DOI 10.1056/NEJMc1307589; Staton T., 2014, EXPRESS SCRIPTS ASSE	9	82	83	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					593	594		10.1001/jama.2014.8897	http://dx.doi.org/10.1001/jama.2014.8897			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM8OU	25038617				2022-12-28	WOS:000340136400013
J	Sokol, DK				Sokol, Daniel K.			The exam scam	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												daniel.sokol@talk21.com							0	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2014	349								g4808	10.1136/bmj.g4808	http://dx.doi.org/10.1136/bmj.g4808			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NA	25069656				2022-12-28	WOS:000339905300003
J	Hawkes, N				Hawkes, Nigel			Mixed messages on progress against HIV	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4614; Mills E, 2008, HIV MED, V9, P332, DOI 10.1111/j.1468-1293.2008.00596.x	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 25	2014	349								g4763	10.1136/bmj.g4763	http://dx.doi.org/10.1136/bmj.g4763			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VU	25062743				2022-12-28	WOS:000339566400006
J	Strobel, H; Muessel, W; Linnemann, D; Zibold, T; Hume, DB; Pezze, L; Smerzi, A; Oberthaler, MK				Strobel, Helmut; Muessel, Wolfgang; Linnemann, Daniel; Zibold, Tilman; Hume, David B.; Pezze, Luca; Smerzi, Augusto; Oberthaler, Markus K.			Fisher information and entanglement of non-Gaussian spin states	SCIENCE			English	Article							STATISTICAL DISTANCE; QUANTUM METROLOGY; LIMIT; INTERFEROMETER	Entanglement is the key quantum resource for improving measurement sensitivity beyond classical limits. However, the production of entanglement in mesoscopic atomic systems has been limited to squeezed states, described by Gaussian statistics. Here, we report on the creation and characterization of non-Gaussian many-body entangled states. We develop a general method to extract the Fisher information, which reveals that the quantum dynamics of a classically unstable system creates quantum states that are not spin squeezed but nevertheless entangled. The extracted Fisher information quantifies metrologically useful entanglement, which we confirm by Bayesian phase estimation with sub-shot-noise sensitivity. These methods are scalable to large particle numbers and applicable directly to other quantum systems.	[Strobel, Helmut; Muessel, Wolfgang; Linnemann, Daniel; Zibold, Tilman; Hume, David B.; Oberthaler, Markus K.] Heidelberg Univ, Kirchhoff Inst Phys, D-69120 Heidelberg, Germany; [Pezze, Luca; Smerzi, Augusto] CNR, INO, QSTAR Quantum Sci & Technol Arcetri, I-50125 Florence, Italy; [Pezze, Luca; Smerzi, Augusto] LENS European Lab Nonlinear Spect, I-50125 Florence, Italy	Ruprecht Karls University Heidelberg; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); Istituto Nazionale Astrofisica (INAF)	Strobel, H (corresponding author), Heidelberg Univ, Kirchhoff Inst Phys, Neuenheimer Feld 227, D-69120 Heidelberg, Germany.	fisherinformation@matterwave.de	PEZZE, LUCA/D-5967-2014	PEZZE, LUCA/0000-0003-0325-9555; Zibold, Tilman/0000-0003-0266-6650	Forschergruppe FOR760; Deutsche Forschungsgemeinschaft; Heidelberg Center for Quantum Dynamics; European Commission [284584]; Studienstiftung des deutschen Volkes; Alexander von Humboldt Foundation; Ministero dell'Istruzione, dell'Universit e della Ricerca through Fondo per gli Investimenti della Ricerca di Base [RBFR08H058]	Forschergruppe FOR760; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heidelberg Center for Quantum Dynamics; European Commission(European CommissionEuropean Commission Joint Research Centre); Studienstiftung des deutschen Volkes; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Ministero dell'Istruzione, dell'Universit e della Ricerca through Fondo per gli Investimenti della Ricerca di Base	We thank J. Tomkovic, E. Nicklas, and I. Stroescu for technical help and discussions. This work was supported by the Forschergruppe FOR760, the Deutsche Forschungsgemeinschaft, the Heidelberg Center for Quantum Dynamics, and the European Commission small or medium-scale focused research project QIBEC (Quantum Interferometry with Bose-Einstein condensates, contract no. 284584). W. M. acknowledges support by the Studienstiftung des deutschen Volkes. D. B. H. acknowledges support from the Alexander von Humboldt Foundation. L. P. acknowledges financial support by Ministero dell'Istruzione, dell'Universit e della Ricerca through Fondo per gli Investimenti della Ricerca di Base project no. RBFR08H058. QSTAR is the Max Planck Institute of Quantum Optics, LENS, Istituto Italiano di Tecnologia, Universit degli Studi di Firenze Joint Center for Quantum Science and Technology in Arcetri.	Appel J, 2009, P NATL ACAD SCI USA, V106, P10960, DOI 10.1073/pnas.0901550106; Berrada T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3077; Blatt R, 2008, NATURE, V453, P1008, DOI 10.1038/nature07125; BRAUNSTEIN SL, 1994, PHYS REV LETT, V72, P3439, DOI 10.1103/PhysRevLett.72.3439; Chen ZL, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.133601; Cirac JI, 1998, PHYS REV A, V57, P1208, DOI 10.1103/PhysRevA.57.1208; Esteve J, 2008, NATURE, V455, P1216, DOI 10.1038/nature07332; Fisher RA, 1925, P CAMB PHILOS SOC, V22, P700, DOI 10.1017/S0305004100009580; Giovannetti V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.010401; Gross C, 2010, NATURE, V464, P1165, DOI 10.1038/nature08919; Hamley CD, 2012, NAT PHYS, V8, P305, DOI [10.1038/nphys2245, 10.1038/NPHYS2245]; Helstrom CW, 1976, QUANTUM DETECTION ES; Krischek R, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.080504; Leroux ID, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.250801; Lucke B, 2011, SCIENCE, V334, P773, DOI 10.1126/science.1208798; Micheli A, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.013607; Muessel W, 2013, APPL PHYS B-LASERS O, V113, P69, DOI 10.1007/s00340-013-5553-8; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Ockeloen CF, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.143001; Pan JW, 2012, REV MOD PHYS, V84, DOI 10.1103/RevModPhys.84.777; Pezze L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.100401; Riedel MF, 2010, NATURE, V464, P1170, DOI 10.1038/nature08988; Schnabel R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1122; Sewell RJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.253605; Smerzi A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.150410; Sorensen A, 2001, NATURE, V409, P63, DOI 10.1038/35051038; Vlastakis B, 2013, SCIENCE, V342, P607, DOI 10.1126/science.1243289; WINELAND DJ, 1994, PHYS REV A, V50, P67, DOI 10.1103/PhysRevA.50.67; WOOTTERS WK, 1981, PHYS REV D, V23, P357, DOI 10.1103/PhysRevD.23.357; Zanardi P, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.042105; Zibold T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.204101	31	262	264	3	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					424	427		10.1126/science.1250147	http://dx.doi.org/10.1126/science.1250147			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061206	Green Submitted			2022-12-28	WOS:000339655100035
J	Farel, CE				Farel, Claire E.			Water, Water, Everywhere	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									UNC Inst Global Hlth & Infect Dis, Chapel Hill, NC 27599 USA		Farel, CE (corresponding author), UNC Inst Global Hlth & Infect Dis, Chapel Hill, NC 27599 USA.	cfarel@med.unc.edu		Farel, Claire/0000-0002-4678-7713	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI050410] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					343	344		10.1001/jama.2014.2646	http://dx.doi.org/10.1001/jama.2014.2646			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038349				2022-12-28	WOS:000339257800017
J	Eversole, K; Feuillet, C; Mayer, KFX; Rogers, J				Eversole, Kellye; Feuillet, Catherine; Mayer, Klaus F. X.; Rogers, Jane			SLICING THE Wheat genome	SCIENCE			English	Editorial Material									[Eversole, Kellye; Feuillet, Catherine; Rogers, Jane] Int Wheat Genome Sequencing Consortium, Bethesda, MD 20816 USA; [Feuillet, Catherine] Bayer CropSci, Innovat Ctr, Morrisville, NC 27560 USA; [Mayer, Klaus F. X.] Helmholtz Zentrum Munich, D-85764 Neuherberg, Germany	Bayer AG; Bayer CropScience; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Eversole, K (corresponding author), Int Wheat Genome Sequencing Consortium, 5207 Wyoming Rd, Bethesda, MD 20816 USA.		Eversole, Kellye/AAN-6141-2020; Mayer, Klaus FX/M-7941-2015	Eversole, Kellye/0000-0002-8784-4913; Mayer, Klaus FX/0000-0001-6484-1077				Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847	1	30	36	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					285	285		10.1126/science.1257983	http://dx.doi.org/10.1126/science.1257983			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035484				2022-12-28	WOS:000339400700039
J	Pfeifer, M; Kugler, KG; Sandve, SR; Zhan, BJ; Rudi, H; Hvidsten, TR; Mayer, KFX; Olsen, OA; Rogers, J; Dolezel, J; Pozniak, C; Eversole, K; Feuillet, C; Gill, B; Friebe, B; Lukaszewski, AJ; Sourdille, P; Endo, TR; Kubalakova, M; Cihalikova, J; Dubska, Z; Vrana, J; Sperkova, R; Simkova, H; Febrer, M; Clissold, L; Mclay, K; Singh, K; Chhuneja, P; Singh, NK; Khurana, J; Akhunov, E; Choulet, F; Alberti, A; Barbe, V; Wincker, P; Kanamori, H; Kobayashi, F; Itoh, T; Matsumoto, T; Sakai, H; Tanaka, T; Wu, JZ; Ogihara, Y; Handa, H; Maclachlan, PR; Sharpe, A; Klassen, D; Edwards, D; Batley, J; Lien, S; Steuernagel, B; Wulff, B; Caccamo, M; Ayling, S; Ramirez-Gonzalez, RH; Clavijo, BJ; Wright, J; Spannagl, M; Martis, MM; Mascher, M; Chapman, J; Poland, JA; Scholz, U; Barry, K; Waugh, R; Rokhsar, DS; Muehlbauer, GJ; Stein, N; Gundlach, H; Zytnicki, M; Jamilloux, V; Quesneville, H; Wicker, T; Faccioli, P; Colaiacovo, M; Stanca, AM; Budak, H; Cattivelli, L; Glover, N; Pingault, L; Paux, E; Sharma, S; Appels, R; Bellgard, M; Chapman, B; Nussbaumer, T; Bader, KC; Rimbert, H; Wang, SC; Knox, R; Kilian, A; Alaux, M; Alfama, F; Couderc, L; Guilhot, N; Viseux, C; Loaec, M; Keller, B; Praud, S				Pfeifer, Matthias; Kugler, Karl G.; Sandve, Simen R.; Zhan, Bujie; Rudi, Heidi; Hvidsten, Torgeir R.; Mayer, Klaus F. X.; Olsen, Odd-Arne; Rogers, Jane; Dolezel, Jaroslav; Pozniak, Curtis; Eversole, Kellye; Feuillet, Catherine; Gill, Bikram; Friebe, Bernd; Lukaszewski, Adam J.; Sourdille, Pierre; Endo, Takashi R.; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana; Febrer, Melanie; Clissold, Leah; McLay, Kirsten; Singh, Kuldeep; Chhuneja, Parveen; Singh, Nagendra K.; Khurana, Jitendra; Akhunov, Eduard; Choulet, Frederic; Alberti, Adriana; Barbe, Valerie; Wincker, Patrick; Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Ogihara, Yasunari; Handa, Hirokazu; Maclachlan, P. Ron; Sharpe, Andrew; Klassen, Darrin; Edwards, David; Batley, Jacqueline; Lien, Sigbjorn; Steuernagel, Burkhard; Wulff, Brande; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Wright, Jonathan; Spannagl, Manuel; Martis, Mihaela M.; Mascher, Martin; Chapman, Jarrod; Poland, Jesse A.; Scholz, Uwe; Barry, Kerrie; Waugh, Robbie; Rokhsar, Daniel S.; Muehlbauer, Gary J.; Stein, Nils; Gundlach, Heidrun; Zytnicki, Matthias; Jamilloux, Veronique; Quesneville, Hadi; Wicker, Thomas; Faccioli, Primetta; Colaiacovo, Moreno; Stanca, Antonio Michele; Budak, Hikmet; Cattivelli, Luigi; Glover, Natasha; Pingault, Lise; Paux, Etienne; Sharma, Sapna; Appels, Rudi; Bellgard, Matthew; Chapman, Brett; Nussbaumer, Thomas; Bader, Kai Christian; Rimbert, Helene; Wang, Shichen; Knox, Ron; Kilian, Andrzej; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Guilhot, Nicolas; Viseux, Claire; Loaec, Mikael; Keller, Beat; Praud, Sebastien		Int Wheat Genome Sequencing	Genome interplay in the grain transcriptome of hexaploid bread wheat	SCIENCE			English	Article							STARCHY ENDOSPERM; GENE-EXPRESSION; RNA; PROTEIN; IDENTIFICATION; GERMINATION; ALIGNMENT; PROFILES; TRITICUM; REVEALS	Allohexaploid bread wheat (Triticum aestivum L.) provides approximately 20% of calories consumed by humans. Lack of genome sequence for the three homeologous and highly similar bread wheat genomes (A, B, and D) has impeded expression analysis of the grain transcriptome. We used previously unknown genome information to analyze the cell type-specific expression of homeologous genes in the developing wheat grain and identified distinct co-expression clusters reflecting the spatiotemporal progression during endosperm development. We observed no global but cell type-and stage-dependent genome dominance, organization of the wheat genome into transcriptionally active chromosomal regions, and asymmetric expression in gene families related to baking quality. Our findings give insight into the transcriptional dynamics and genome interplay among individual grain cell types in a polyploid cereal genome.	[Pfeifer, Matthias; Kugler, Karl G.; Mayer, Klaus F. X.] Helmholtz Ctr Munich, D-85764 Neuherberg, Germany; [Sandve, Simen R.; Zhan, Bujie; Rudi, Heidi; Olsen, Odd-Arne] Norwegian Univ Life Sci NMBU, Ctr Integrat Genet, Dept Plant Sci, N-1432 As, Norway; [Hvidsten, Torgeir R.] NMBU, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Pfeifer, Matthias; Mayer, Klaus F. X.; Spannagl, Manuel; Martis, Mihaela M.; Gundlach, Heidrun; Sharma, Sapna; Nussbaumer, Thomas; Bader, Kai Christian] Helmholtz Zentrum Munich, Plant Genome & Syst Biol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Rogers, Jane; Eversole, Kellye] Eversole Associates, IWGSC, 5207 Wyoming Rd, Bethesda, MD 20816 USA; [Dolezel, Jaroslav; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana] Inst Expt Bot, Ctr Plant Struct & Funct Genom, Slechtitelu 31, Olomouc 78371, Czech Republic; [Pozniak, Curtis; Maclachlan, P. Ron] Univ Saskatchewan, Dept Plant Sci, Coll Agr & Bioresources, Ctr Crop Dev, 51 Campus Dr, Saskatoon, SK, Canada; [Feuillet, Catherine] Bayer Crop Sci, 3500 Paramount Pkwy, Morrisville, NC 27560 USA; [Gill, Bikram; Friebe, Bernd; Akhunov, Eduard; Wang, Shichen] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA; [Lukaszewski, Adam J.] Univ Calif Riverside, Coll Nat & Agr Sci, Bot & Plant Sci, Riverside, CA 92521 USA; [Endo, Takashi R.] Kyoto Univ, Grad Sch Agr, Lab Plant Genet, Kyoto 6068502, Japan; [Febrer, Melanie] Univ Dundee, Genom Sequencing Unit, Dow St, Dundee DD1 5EH, Scotland; [Clissold, Leah; McLay, Kirsten; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Wright, Jonathan] Norwich Res Pk, Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Singh, Kuldeep] Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana 141004, Punjab, India; [Singh, Nagendra K.] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Khurana, Jitendra] Univ Delhi, Interdisciplinary Ctr Plant Genom, South Campus, New Delhi 110021, India; [Khurana, Jitendra] Univ Delhi, Dept Plant Mol Biol, South Campus, New Delhi 110021, India; [Sourdille, Pierre; Choulet, Frederic; Glover, Natasha; Pingault, Lise; Paux, Etienne; Guilhot, Nicolas] Univ Blaise Pascal, INRA, UMR Genet Divers & Ecophysiol Cereals 1095, 5 Chemin Beaulieu, F-63039 Clermont Ferrand, France; [Alberti, Adriana; Barbe, Valerie; Wincker, Patrick] Commissariat Energie Atom Genoscope, Ctr Natl Sequencage, 2 Rue Gaston Cremieux, F-91057 Evry, France; [Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Handa, Hirokazu] Natl Inst Agrobiol Sci, Plant Genome Res Unit, 2-1-2 Kan Non Dai, Tsukuba, Ibaraki 3058602, Japan; [Ogihara, Yasunari] Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, Maioka Cho 641-12, Yokohama, Kanagawa 2440813, Japan; [Sharpe, Andrew; Klassen, Darrin] Natl Res Council Canada, 110 Gymnasium Pl, Saskatoon, SK S7N 0W9, Canada; [Edwards, David; Batley, Jacqueline] Univ Queensland, Australian Ctr Plant Funct Genom, Sch Agr & Food Sci, St Lucia, Qld 4072, Australia; [Edwards, David; Batley, Jacqueline] Univ Western Australia, Sch Plant Biol, Nedlands, WA 6009, Australia; [Sandve, Simen R.; Olsen, Odd-Arne] Norwegian Univ Life Sci, Dept Plant Sci, Ctr Integrat Genet CIGENE, N-1432 As, Norway; [Olsen, Odd-Arne] Hedmark Univ Coll, Dept Nat Sci & Technol, N-2318 Elverum, Norway; [Steuernagel, Burkhard; Wulff, Brande] Norwich Res Pk, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Mascher, Martin; Scholz, Uwe] Leibniz Inst Plant Genet & Crop Plant Res IPK, Bioinformat & Informat Technol, D-06466 Seeland Ot Gatersleben, Germany; [Chapman, Jarrod; Barry, Kerrie; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA; [Poland, Jesse A.] USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS 66506 USA; [Poland, Jesse A.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Waugh, Robbie] James Hutton Inst, Dundee DD2 5DA, Scotland; [Muehlbauer, Gary J.] Univ Minnesota, Dept Agron & Plant Genet, Dept Plant Biol, St Paul, MN 55108 USA; [Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK, Genome Divers, D-06466 Seeland Ot Gatersleben, Germany; [Zytnicki, Matthias; Jamilloux, Veronique; Quesneville, Hadi; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Viseux, Claire; Loaec, Mikael] INRA Versailles, URGI Res Unit Genom Info UR1164, Route St Cyr, F-78026 Versailles, France; [Wicker, Thomas; Keller, Beat] Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland; [Faccioli, Primetta; Colaiacovo, Moreno; Stanca, Antonio Michele; Cattivelli, Luigi] Consiglio Ric Sperimentaz Agr, Genom Res Ctr, Via San Protaso 302, I-29017 Fjorenzuola Darda, Italy; [Budak, Hikmet] Sabanci Univ, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey; [Appels, Rudi; Bellgard, Matthew; Chapman, Brett] Murdoch Univ, Ctr Comparat Genom, Perth, WA 6150, Australia; [Knox, Ron] Semiarid Prairie Agr Res Ctr, POB 1030, Swift Current, SK S9H 3X2, Canada; [Kilian, Andrzej] Divers Arrays Technol Pty Ltd, 1 Wilf Crane Crescent, Yarralumla, ACT 2600, Australia; [Rimbert, Helene; Praud, Sebastien] Biogemma, Ctr Rech Chappes, Route Ennezat, F-63720 Chappes, France; [Lien, Sigbjorn] Norwegian Univ Life Sci, Dept Anim & Aquicultural Sci, CIGENE, Arboretvelen 6, N-1432 As, Norway	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Norwegian University of Life Sciences; Norwegian University of Life Sciences; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Saskatchewan; Bayer AG; Bayer CropScience; Kansas State University; University of California System; University of California Riverside; Kyoto University; University of Dundee; The Genome Analysis Centre (TGAC); Punjab Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); University of Delhi; University of Delhi; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Clermont Auvergne (UCA); UDICE-French Research Universities; Universite Paris Saclay; National Institute of Agrobiological Sciences - Japan; Yokohama City University; National Research Council Canada; University of Queensland; University of Western Australia; Norwegian University of Life Sciences; Inland Norway University of Applied Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Agriculture (USDA); Kansas State University; James Hutton Institute; University of Minnesota System; University of Minnesota Twin Cities; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; INRAE; University of Zurich; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Sabanci University; Murdoch University; Norwegian University of Life Sciences	Olsen, OA (corresponding author), Norwegian Univ Life Sci NMBU, Ctr Integrat Genet, Dept Plant Sci, N-1432 As, Norway.	odd-arne.olsen@nmbu.no	Mayer, Klaus FX/M-7941-2015; Edwards, David/H-3710-2015; Pfeifer, Matthias/GRJ-4579-2022; Sourdille, Pierre/CAF-2780-2022; Batley, Jacqueline/A-5723-2008; Dolezel, Jaroslav/B-7716-2008; Quesneville, Hadi/AAG-1048-2020; Simkova, Hana/F-7734-2014; Wicker, Thomas/Z-1978-2019; Wang, Shichen/E-6213-2012; Budak, Hikmet/U-8517-2019; Kugler, Karl G/B-8406-2015; Kubaláková, Marie/F-8269-2014; Budak, Hikmet/S-5835-2017; Hvidsten, Torgeir R./A-3409-2009; Ramírez, Ricardo/H-4808-2019; Pingault, Lise/AAQ-8602-2020; Barry, Kerrie Whitelaw/AAA-5500-2020; Eversole, Kellye/AAN-6141-2020; Wu, Jian/AAU-5221-2020; Stein, Nils/F-7507-2017; cattivelli, luigi/AAE-7046-2020; Wu, Jian/AAU-5221-2020	Mayer, Klaus FX/0000-0001-6484-1077; Edwards, David/0000-0001-7599-6760; Batley, Jacqueline/0000-0002-5391-5824; Dolezel, Jaroslav/0000-0002-6263-0492; Quesneville, Hadi/0000-0003-3001-4908; Simkova, Hana/0000-0003-4159-7619; Wang, Shichen/0000-0003-1441-2252; Budak, Hikmet/0000-0002-2556-2478; Kugler, Karl G/0000-0003-2342-7472; Budak, Hikmet/0000-0002-2556-2478; Hvidsten, Torgeir R./0000-0001-6097-2539; Ramírez, Ricardo/0000-0001-5745-7085; Pingault, Lise/0000-0002-6149-1267; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Eversole, Kellye/0000-0002-8784-4913; Wu, Jian/0000-0001-9933-7364; Stein, Nils/0000-0003-3011-8731; cattivelli, luigi/0000-0002-6067-4600; Singh, Kuldeep/0000-0001-5239-6586; Colaiacovo, Moreno/0000-0003-1320-0506; Jamilloux, Veronique/0000-0002-6898-4910; Wu, Jian/0000-0002-3394-1507; Spannagl, Manuel/0000-0003-0701-7035; Kilian, Andrzej/0000-0002-2730-7462; Keller, Beat/0000-0003-2379-9225; Martis, Mihaela-Maria/0000-0001-7509-2446; , Thomas/0000-0002-6777-7135; Bellgard, Matthew/0000-0002-6303-9469; Gundlach, Heidrun/0000-0002-6757-0943; Paux, Etienne/0000-0002-3094-7129; Scholz, Uwe/0000-0001-6113-3518; Alaux, Michael/0000-0001-9356-4072	Norwegian Research Council [199387]; Deutsche Forschungsgemeinschaft (DFG) [SFB924]; German Federal Ministry of Education and Research (BMBF); European Commission's 7th Framework Program	Norwegian Research Council(Research Council of NorwayEuropean Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission's 7th Framework Program	This work was supported by research grant 199387 from the Norwegian Research Council to the Norwegian University of Life Sciences and Graminor AS to O.A.O. K. F. X. M. acknowledges generous funding by the Deutsche Forschungsgemeinschaft (DFG) to project SFB924 "Molecular mechanisms regulating yield and yield stability in plants," the German Federal Ministry of Education and Research (BMBF) in frame of the Synbreed project, and the European Commission's 7th Framework Program in frame of the TransPLANT project. The data reported in this paper are tabulated in the supplementary materials and archived at the ArrayExpress database www.ebi.ac.uk/arrayexpress, accession no. E-MTAB-2137. No conflict of interest is known for the authors of this manuscript regarding data reported herein. S. I. Chi, E. I. Ako, A. Maharajan, and O. Jorgensen are thankfully acknowledged for grain dissection and plant cultivation. We thank P. Langridge, P. Shewry, B. Keller, and two anonymous reviewers for helpful suggestions on the manuscript. The RNA-seq was carried out at the Norwegian Sequencing Centre of University of Oslo. Graminor AS is acknowledged for generous support throughout this work.	Akhunova AR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-505; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anderson OD, 2013, FUNCT INTEGR GENOMIC, V13, P261, DOI 10.1007/s10142-013-0321-8; Anderson OD, 2009, FUNCT INTEGR GENOMIC, V9, P397, DOI 10.1007/s10142-009-0122-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Belmonte MF, 2013, P NATL ACAD SCI USA, V110, pE435, DOI 10.1073/pnas.1222061110; Bolot S, 2009, CURR OPIN PLANT BIOL, V12, P119, DOI 10.1016/j.pbi.2008.10.011; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; Drea S, 2005, PLANT CELL, V17, P2172, DOI 10.1105/tpc.105.034058; Dupont FM, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-10; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Feldman M, 2012, J EXP BOT, V63, P5045, DOI 10.1093/jxb/ers192; Finnegan EJ, 2004, CURR BIOL, V14, P911, DOI 10.1016/j.cub.2004.04.045; Gillies SA, 2012, PLANT BIOTECHNOL J, V10, P668, DOI 10.1111/j.1467-7652.2012.00705.x; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hu ZR, 2013, NEW PHYTOL, V197, P1344, DOI 10.1111/nph.12131; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Marcussen T, 2014, SCIENCE, V345, DOI 10.1126/science.1250092; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; MOORE G, 1995, TRENDS GENET, V11, P81, DOI 10.1016/S0168-9525(00)89005-8; Morris CF, 2002, PLANT MOL BIOL, V48, P633, DOI 10.1023/A:1014837431178; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Olsen OA, 2004, PLANT CELL, V16, pS214, DOI 10.1105/tpc.017111; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Payne P. I., 1983, Cereal Research Communications, V11, P29; Pellny TK, 2012, PLANT PHYSIOL, V158, P612, DOI 10.1104/pp.111.189191; Ravel C, 2009, PLANT PHYSIOL, V151, P2133, DOI 10.1104/pp.109.146076; Rustenholz C, 2011, PLANT PHYSIOL, V157, P1596, DOI 10.1104/pp.111.183921; Serna A, 2001, PLANT J, V25, P687, DOI 10.1046/j.1365-313x.2001.01004.x; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Shitsukawa N, 2007, PLANT CELL, V19, P1723, DOI 10.1105/tpc.107.051813; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; THOMPSON RD, 1983, THEOR APPL GENET, V67, P87, DOI 10.1007/BF00303930; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vensel WH, 2005, PROTEOMICS, V5, P1594, DOI 10.1002/pmic.200401034; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wilkinson M, 2008, J CEREAL SCI, V48, P722, DOI 10.1016/j.jcs.2008.03.007; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	53	228	239	7	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194			SI				1250091	10.1126/science.1250091	http://dx.doi.org/10.1126/science.1250091			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR2MB	25035498	Green Published			2022-12-28	WOS:000343420300002
J	Spiegelhalter, DJ				Spiegelhalter, D. J.			STATISTICS The future lies in uncertainty	SCIENCE			English	Editorial Material									Univ Cambridge, Stat Lab, Ctr Math Sci, Cambridge CB3 0WB, England	University of Cambridge	Spiegelhalter, DJ (corresponding author), Univ Cambridge, Stat Lab, Ctr Math Sci, Cambridge CB3 0WB, England.	david@statslab.cam.ac.uk						Aalen OO, 2012, J R STAT SOC A STAT, V175, P831, DOI 10.1111/j.1467-985X.2011.01030.x; Aberdein J, 2013, SIGNIFICANCE, V10, P46; Andrieu C, 2010, J R STAT SOC B, V72, P269, DOI 10.1111/j.1467-9868.2009.00736.x; Aydin B, 2009, ANN APPL STAT, V3, P1597, DOI 10.1214/09-AOAS263; Berry CC, 2014, BIOINFORMATICS, V30, P1493, DOI 10.1093/bioinformatics/btu035; Davidian M, 2013, J AM STAT ASSOC, V108, P1141, DOI 10.1080/01621459.2013.844019; Efron B, 2013, SCIENCE, V340, P1177, DOI 10.1126/science.1236536; Gaydos B, 2009, DRUG INF J, V43, P539, DOI 10.1177/009286150904300503; Li B, 2012, J AM STAT ASSOC, V107, P152, DOI 10.1080/01621459.2011.644498; Macilwain C, 2014, SCIENCE, V344, P1221, DOI 10.1126/science.344.6189.1221; National Academy of Sciences, 2013, FRONT MASS DAT AN	12	24	25	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					264	265		10.1126/science.1251122	http://dx.doi.org/10.1126/science.1251122			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035471				2022-12-28	WOS:000339400700025
J	West, PC; Gerber, JS; Engstrom, PM; Mueller, ND; Brauman, KA; Carlson, KM; Cassidy, ES; Johnston, M; MacDonald, GK; Ray, DK; Siebert, S				West, Paul C.; Gerber, James S.; Engstrom, Peder M.; Mueller, Nathaniel D.; Brauman, Kate A.; Carlson, Kimberly M.; Cassidy, Emily S.; Johnston, Matt; MacDonald, Graham K.; Ray, Deepak K.; Siebert, Stefan			Leverage points for improving global food security and the environment	SCIENCE			English	Article							CLIMATE-CHANGE; DEFORESTATION; EMISSIONS; DEMAND; YIELD	Achieving sustainable global food security is one of humanity's contemporary challenges. Here we present an analysis identifying key "global leverage points" that offer the best opportunities to improve both global food security and environmental sustainability. We find that a relatively small set of places and actions could provide enough new calories to meet the basic needs for more than 3 billion people, address many environmental impacts with global consequences, and focus food waste reduction on the commodities with the greatest impact on food security. These leverage points in the global food system can help guide how nongovernmental organizations, foundations, governments, citizens' groups, and businesses prioritize actions.	[West, Paul C.; Gerber, James S.; Engstrom, Peder M.; Brauman, Kate A.; Carlson, Kimberly M.; Johnston, Matt; MacDonald, Graham K.; Ray, Deepak K.] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [Mueller, Nathaniel D.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA; [Cassidy, Emily S.] Environm Working Grp, Washington, DC 20009 USA; [Siebert, Stefan] Univ Bonn, Inst Crop Sci & Resource Conservat, D-53115 Bonn, Germany	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; University of Bonn	West, PC (corresponding author), Univ Minnesota, Inst Environm, St Paul, MN 55108 USA.	pcwest@umn.edu	Ray, Deepak K/F-7720-2012; Mueller, Nathan D/E-5864-2010; West, Paul C./J-1665-2015; Brauman, Kate A/ABD-5349-2021; Siebert, Stefan/B-8621-2009; MacDonald, Graham/L-5648-2019	Mueller, Nathan D/0000-0003-1857-5104; West, Paul C./0000-0001-9024-1657; Brauman, Kate A/0000-0002-8099-285X; Siebert, Stefan/0000-0002-9998-0672; MacDonald, Graham/0000-0002-7120-1366; Gerber, James/0000-0002-6890-0481; Cassidy, Emily/0000-0003-4405-0264; Ray, Deepak/0000-0002-2856-9608	Gordon and Betty Moore Foundation; Institute on the Environment; NASA's Interdisciplinary Earth Science program; Laurel Salton Clark Memorial Fellowship; McKnight Foundation; Grantham Foundation; World Wildlife Fund; Nature Conservancy; Stanford University; NSF; The Natural Sciences and Engineering Research Council of Canada	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Institute on the Environment; NASA's Interdisciplinary Earth Science program; Laurel Salton Clark Memorial Fellowship; McKnight Foundation; Grantham Foundation; World Wildlife Fund; Nature Conservancy; Stanford University(Stanford University); NSF(National Science Foundation (NSF)); The Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research greatly benefited from discussions with J. Foley. S. Carpenter, and E. Bennett, and three anonymous reviewers provided critical feedback that strengthened this paper. Research support was primarily provided by the Gordon and Betty Moore Foundation. Additional research support was from the Institute on the Environment, NASA's Interdisciplinary Earth Science program and Laurel Salton Clark Memorial Fellowship, the McKnight Foundation, the Grantham Foundation, the World Wildlife Fund, the Nature Conservancy, and Stanford University. NSF provided support for N.D.M. The Natural Sciences and Engineering Research Council of Canada provided support for G. K. M. Contributions by General Mills, Mosaic, Cargill, Pentair, Google, Kellogg's, Mars, and PepsiCo supported stakeholder outreach and public engagement. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional data and method details are provided in the supplementary materials.	[Anonymous], 2009, WORLDS WATER 2008 20; Brauman KA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024030; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Cassidy ES, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034015; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]; De Klein C., 2006, 2006 IPCC GUIDELINES, pV4; FAO, 2011, FOOD BAL SHEETS; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gustavsson J., 2011, Global food losses and food waste: extent, causes and prevention; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; International Assessment of Agricultural Knowledge Science and Technology for Development, 2009, AGR CROSSROADS; Kastner T, 2012, P NATL ACAD SCI USA, V109, P6868, DOI 10.1073/pnas.1117054109; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Macedo MN, 2012, P NATL ACAD SCI USA, V109, P1341, DOI 10.1073/pnas.1111374109; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Royal Society, 2009, REAP BEN SCI SUST IN; Siebert S, 2010, J HYDROL, V384, P198, DOI 10.1016/j.jhydrol.2009.07.031; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Venterea RT, 2012, FRONT ECOL ENVIRON, V10, P562, DOI 10.1890/120062; Vermeulen SJ, 2012, ANNU REV ENV RESOUR, V37, P195, DOI 10.1146/annurev-environ-020411-130608; West PC, 2010, P NATL ACAD SCI USA, V107, P19645, DOI 10.1073/pnas.1011078107; Yan XY, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003299; Zhang WF, 2013, P NATL ACAD SCI USA, V110, P8375, DOI 10.1073/pnas.1210447110	30	420	435	35	546	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					325	328		10.1126/science.1246067	http://dx.doi.org/10.1126/science.1246067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035492	Green Submitted			2022-12-28	WOS:000339400700051
J	Asfar, P; Meziani, F; Hamel, JF				Asfar, P.; Meziani, F.; Hamel, J. F.		SEPSISPAM Investigators	In septic shock, MAP targets of 80 to 85 mm Hg vs 65 to 70 mm Hg did not differ for 28-day mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Asfar, P.] Univ Hosp Angers, Angers, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Asfar, P (corresponding author), Univ Hosp Angers, Angers, France.	piasfar@chu-angers.fr	Asfar, Pierre/K-1402-2015						0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2							JC7	10.7326/0003-4819-161-2-201407150-02007	http://dx.doi.org/10.7326/0003-4819-161-2-201407150-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023273				2022-12-28	WOS:000339764600008
J	Kesselheim, AS; Bykov, K; Avorn, J; Tong, A; Doherty, M; Choudhry, NK				Kesselheim, Aaron S.; Bykov, Katsiaryna; Avorn, Jerry; Tong, Angela; Doherty, Michael; Choudhry, Niteesh K.			Burden of Changes in Pill Appearance for Patients Receiving Generic Cardiovascular Medications After Myocardial Infarction Cohort and Nested Case-Control Studies	ANNALS OF INTERNAL MEDICINE			English	Article							BRAND-NAME DRUGS; STATIN THERAPY; ADHERENCE; NONADHERENCE; EQUIVALENCE; PREVENTION; MORTALITY; DISEASE; RISK	Background: Generic prescription drugs made by different manufacturers may vary in color or shape, and switching among these drug products may interrupt medication use. Objective: To determine whether nonpersistent use of generic drugs among patients with cardiovascular disease after myocardial infarction (MI) is associated with inconsistent appearance of their medications. Design: Cohort and nested case-control studies. Setting: Claims from a commercial health insurance database in the United States. Patients: Patients discharged after hospitalization for MI between 2006 and 2011 who initiated treatment with a generic beta-blocker, angiotensin-converting enzyme inhibitor, angiotensin II-receptor blocker, or statin. Case patients discontinued their index medication for at least 1 month; control patients continued treatment. Control patients were matched to case patients on therapeutic class, number of dispensings before nonpersistence, sex, and age. Measurements: Rates of changes in pill color and shape during the year after MI were calculated. Next, 2 refills preceding nonpersistence were evaluated to determine whether pill color or shape had changed. Odds of discordance among case and control patients were compared using conditional logistic regression. Results: A total of 29% of patients (3286 of 11 513) had a change in pill shape or color during the study. Statins had the most changes in appearance, whereas beta-blockers had the fewest. A total of 4573 episodes of nonpersistence was matched to 19 881 control episodes. The odds of nonpersistence in case patients increased by 34% after a change in pill color (adjusted odds ratio, 1.34 [95% CI, 1.12 to 1.59]) and 66% after a change in pill shape (adjusted odds ratio, 1.66 [CI, 1.43 to 1.94]). Limitation: Only 3 categories of drugs indicated after MI were evaluated, and clinical outcomes were not addressed. Conclusion: Variation in the appearance of generic pills is associated with nonpersistent use of these essential drugs after MI among patients with cardiovascular disease.	Brigham & Womens Hosp, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Bykov, Katsiaryna/0000-0003-3336-5412	Agency for Healthcare Research and Quality [K08HS18465-01]; Greenwall Faculty Scholars Program in Bioethics; Harvard Program in Therapeutic Science; Robert Wood Johnson Foundation Investigator Award in Health Policy Research; FDA Office of Generic Drugs; CVS Caremark; Commonwealth Fund; Robert Wood Johnson Foundation; Aetna	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Greenwall Faculty Scholars Program in Bioethics; Harvard Program in Therapeutic Science; Robert Wood Johnson Foundation Investigator Award in Health Policy Research(Robert Wood Johnson Foundation (RWJF)); FDA Office of Generic Drugs; CVS Caremark; Commonwealth Fund; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Aetna	Dr. Kesselheim was supported by a career development award from the Agency for Healthcare Research and Quality (K08HS18465-01), the Greenwall Faculty Scholars Program in Bioethics, the Harvard Program in Therapeutic Science, and a Robert Wood Johnson Foundation Investigator Award in Health Policy Research. Dr. Kesselheim and Dr. Avorn receive research support from the FDA Office of Generic Drugs. Dr. Choudhry was supported by unrestricted research grants from CVS Caremark, Aetna, The Commonwealth Fund, and the Robert Wood Johnson Foundation.	Akincigil A, 2008, J GEN INTERN MED, V23, P115, DOI 10.1007/s11606-007-0351-9; [Anonymous], 2010, CBS NEWS; [Anonymous], 2003, ADHERENCE LONG TERM; [Anonymous], 2011, CLOS LOOK PRESCR BOT; BIRON P, 1974, CAN MED ASSOC J, V110, P1346; Boh M, 2011, INT ANGIOL, V30, P366; Brookhart MA, 2007, ARCH INTERN MED, V167, P847, DOI 10.1001/archinte.167.8.847; Center for Drug Evaluation and Research, 2013, GUID IND SI IN PRESS; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Choudhry NK, 2011, ARCH INTERN MED, V171, P814, DOI 10.1001/archinternmed.2010.495; Cohen M, 2011, PHILLY COM      0808; Colivicchi F, 2007, STROKE, V38, P2652, DOI 10.1161/STROKEAHA.107.487017; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Cutler C, 2011, BIOL BLOOD MARROW TR, V17, P285, DOI 10.1016/j.bbmt.2010.11.006; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; Dicken JE, 2012, GAO12371R; Engelberg AB, 2011, J MANAGE CARE PHARM, V17, P321, DOI 10.18553/jmcp.2011.17.4.321; Faasse K, 2013, PSYCHOSOM MED, V75, P90, DOI 10.1097/PSY.0b013e3182738826; Fischer MA, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2011.05.028; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Green JB, 2013, JAMA INTERN MED, V173, P229, DOI 10.1001/jamainternmed.2013.1529; Greene JA, 2011, NEW ENGL J MED, V365, P83, DOI 10.1056/NEJMhle1101722; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; Ho P Michael, 2006, BMC Cardiovasc Disord, V6, P48, DOI 10.1186/1471-2261-6-48; Kenagy JW, 2001, AM J HEALTH-SYST PH, V58, P2033, DOI 10.1093/ajhp/58.21.2033; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Kesselheim AS, 2013, JAMA INTERN MED, V173, P202, DOI 10.1001/2013.jamainternmed.997; Kronish IM, 2013, PROG CARDIOVASC DIS, V55, P590, DOI 10.1016/j.pcad.2013.02.001; Nightingale SL, 1998, THERAPEUTIC EQUIVALE; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177; Roullet B, 2005, ADV CONSUM RES, V32, P164; Shah ND, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2008.12.021; Shrank WH, 2011, HEALTH AFFAIR, V30, P1351, DOI 10.1377/hlthaff.2010.0431; Smith DH, 2008, ARCH INTERN MED, V168, P477, DOI 10.1001/archinternmed.2007.132; Sundar RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038819; Yu LX, 2013, JAMA INTERN MED, V173, P208, DOI 10.1001/jamainternmed.2013.2283; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	41	63	63	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2					96	+		10.7326/M13-2381	http://dx.doi.org/10.7326/M13-2381			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023248				2022-12-28	WOS:000339764600018
J	Tsai, TC; Jha, AK				Tsai, Thomas C.; Jha, Ashish K.			Hospital Consolidation, Competition, and Quality Is Bigger Necessarily Better?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Tsai, Thomas C.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Tsai, Thomas C.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Jha, Ashish K.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Jha, Ashish K.] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu			NCI NIH HHS [R25CA92203, R25 CA092203] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R25CA092203] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chandra A, 2013, WORKING PAPER SERIES, V19200; Cutler DM, 2013, JAMA-J AM MED ASSOC, V310, P1964, DOI 10.1001/jama.2013.281675; Dafny L, 2014, NEW ENGL J MED, V370, P198, DOI 10.1056/NEJMp1313948; DesRoches CM, 2013, HEALTH AFFAIR, V32, P1478, DOI 10.1377/hlthaff.2013.0308; Gaynor M, 2012, THE IMPACT OF HOSPIT; Guerin-Calvert MM, 2014, HOSPITAL REALIGNMENT; Livingston EH, 2010, JAMA-J AM MED ASSOC, V304, P95, DOI 10.1001/jama.2010.905	7	59	59	2	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					29	30		10.1001/jama.2014.4692	http://dx.doi.org/10.1001/jama.2014.4692			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	25058212				2022-12-28	WOS:000338131100015
J	Butler, M; Ratner, E; McCreedy, E; Shippee, N; Kane, RL				Butler, Mary; Ratner, Edward; McCreedy, Ellen; Shippee, Nathan; Kane, Robert L.			Decision Aids for Advance Care Planning: An Overview of the State of the Science	ANNALS OF INTERNAL MEDICINE			English	Review							END; DIRECTIVES; LIFE; SUPPORT; CANCER; PREFERENCES; INFORMATION	Advance care planning honors patients' goals and preferences for future care by creating a plan for when illness or injury impedes the ability to think or communicate about health decisions. Fewer than 50% of severely or terminally ill patients have an advance directive in their medical record, and physicians are accurate only about 65% of the time when predicting patient preferences for intensive care. Decision aids can support the advance care planning process by providing a structured approach to informing patients about care options and prompting them to document and communicate their preferences. This review, commissioned as a technical brief by the Agency for Healthcare Research and Quality Effective Health Care Program, provides a broad overview of current use of and research related to decision aids for adult advance care planning. Using interviews of key informants and a search of the gray and published literature from January 1990 to May 2014, the authors found that many decision aids are widely available but are not assessed in the empirical literature. The 16 published studies testing decision aids as interventions for adult advance care planning found that most are proprietary or not publicly available. Some are constructed for the general population, whereas others address disease-specific conditions that have more predictable end-of-life scenarios and, therefore, more discrete choices. New decision aids should be designed that are responsive to diverse philosophical perspectives and flexible enough to change as patients gain experience with their personal illness courses. Future efforts should include further research, training of advance care planning facilitators, dissemination and access, and tapping potential opportunities in social media or other technologies.	[Butler, Mary] Univ Minnesota, Sch Publ Hlth, Minnesota Evidence Based Practice Ctr, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Butler, M (corresponding author), Univ Minnesota, Sch Publ Hlth, Minnesota Evidence Based Practice Ctr, 420 Delaware St SE,MMC 197, Minneapolis, MN 55455 USA.	butl0092@umn.edu		Shippee, Nathan/0000-0002-9885-3663	Minnesota EPC [HHSA 290 2012 00016 1]	Minnesota EPC	This project was conducted by the Minnesota EPC under contract HHSA 290 2012 00016 1 to AHRQ.	Allen RS, 2008, J AM GERIATR SOC, V56, P1904, DOI 10.1111/j.1532-5415.2008.01929.x; Balboni TA, 2013, JAMA INTERN MED, V173, P1109, DOI 10.1001/jamainternmed.2013.903; Bradley EH, 1999, J HEALTH POLIT POLIC, V24, P239, DOI 10.1215/03616878-24-2-239; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Coppola KM, 2001, ARCH INTERN MED, V161, P431, DOI 10.1001/archinte.161.3.431; Daaleman TP, 2000, JAMA-J AM MED ASSOC, V284, P2514, DOI 10.1001/jama.284.19.2514; Deep KS, 2010, PATIENT EDUC COUNS, V81, P229, DOI 10.1016/j.pec.2010.02.004; Ditto PH, 2001, ARCH INTERN MED, V161, P421, DOI 10.1001/archinte.161.3.421; Dolan P, 2013, EXPERT REV PHARM OUT, V13, P1, DOI [10.1586/ERP.12.90, 10.1586/erp.12.90]; Elwyn G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004705; Emanuel L, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-57; Green MJ, 2011, J CANCER EDUC, V26, P82, DOI 10.1007/s13187-010-0146-2; Green MJ, 2009, HEALTH EXPECT, V12, P60, DOI 10.1111/j.1369-7625.2008.00517.x; Hakim RB, 1996, ANN INTERN MED, V125, P284, DOI 10.7326/0003-4819-125-4-199608150-00005; Heyland DK, 2006, CAN MED ASSOC J, V174, P627, DOI 10.1503/cmaj.050626; Hossler C, 2011, AMYOTROPH LATERAL SC, V12, P172, DOI 10.3109/17482968.2010.509865; Kaldjian LC, 2008, AM J HOSP PALLIAT ME, V25, P501, DOI 10.1177/1049909108328256; Kass-Bartelmes BL, 2003, ADV CARE PLANNING PR; Levi Benjamin H, 2011, J Clin Ethics, V22, P223; Matlock DD, 2014, HEALTH EXPECT, V17, P49, DOI 10.1111/j.1369-7625.2011.00732.x; Montori VM, 2006, HEALTH EXPECT, V9, P25, DOI 10.1111/j.1369-7625.2006.00359.x; Murphy CP, 2000, J PROF NURS, V16, P21, DOI 10.1016/S8755-7223(00)80008-3; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; O'Connor AM, 2007, MED DECIS MAKING, V27, P554, DOI 10.1177/0272989x07307319; OConnor AM, 2004, DECISION AIDS PEOPLE; Smith Thomas J, 2011, J Support Oncol, V9, P79; Song MK, 2005, MED CARE, V43, P1049, DOI 10.1097/01.mlr.0000178192.10283.b4; Teno J, 1997, J AM GERIATR SOC, V45, P500, DOI 10.1111/j.1532-5415.1997.tb05178.x; Teno JM, 1997, J AM GERIATR SOC, V45, P508, DOI 10.1111/j.1532-5415.1997.tb05179.x; VIRMANI J, 1994, ARCH INTERN MED, V154, P909, DOI 10.1001/archinte.154.8.909; Vogel RI, 2013, GYNECOL ONCOL, V131, P430, DOI 10.1016/j.ygyno.2013.08.017; Volandes AE, 2012, CANCER-AM CANCER SOC, V118, P4331, DOI 10.1002/cncr.27423; Volandes AE, 2011, J PALLIAT MED, V14, P169, DOI 10.1089/jpm.2010.0299; Volandes AE, 2009, J AM MED DIR ASSOC, V10, P575, DOI 10.1016/j.jamda.2009.05.006; Volandes AE, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2159; Wilkinson A., 2007, LIT REV ADV DIRECTIV	36	103	104	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6					408	U69		10.7326/M14-0644	http://dx.doi.org/10.7326/M14-0644			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9LF	25069709				2022-12-28	WOS:000343894400016
J	Goodarzi, H; Zhang, S; Buss, CG; Fish, L; Tavazoie, S; Tavazoie, SF				Goodarzi, Hani; Zhang, Steven; Buss, Colin G.; Fish, Lisa; Tavazoie, Saeed; Tavazoie, Sohail F.			Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins	NATURE			English	Article							BREAST-CANCER METASTASIS; GENE-EXPRESSION; REGULATORY ELEMENTS; PROTEIN; SEQ; STABILITY; DISCOVERY; INVASION; DISEASE; COMPLEX	Aberrant regulation of RNA stability has an important role in many disease states(1,2). Deregulated post-transcriptional modulation, such as that governed by microRNAs targeting linear sequence elements in messenger RNAs, has been implicated in the progression of many cancer types(3-7). A defining feature of RNA is its ability to fold into structures. However, the roles of structural mRNA elements in cancer progression remain unexplored. Here we performed an unbiased search for post-transcriptional modulators of mRNA stability in breast cancer by conducting whole-genome transcript stability measurements in poorly and highly metastatic isogenic human breast cancer lines. Using a computational framework that searches RNA sequence and structure space(8), we discovered a family of GC-rich structural cis-regulatory RNA elements, termed sRSEs for structural RNA stability elements, which are significantly overrepresented in transcripts displaying reduced stability in highly metastatic cells. By integrating computational and biochemical approaches, we identified TARBP2, a double-stranded RNA-binding protein implicated in microRNA processing, as the trans factor that binds the sRSE family and similar structural elements collectively termed TARBP2-binding structural elements (TBSEs) in transcripts. TARBP2 is overexpressed in metastatic cells and metastatic human breast tumours and destabilizes transcripts containing TBSEs. Endogenous TARBP2 promotes metastatic cell invasion and colonization by destabilizing amyloid precursor protein (APP) and ZNF395 transcripts, two genes previously associated with Alzheimer's and Huntington's disease, respectively. We reveal these genes to be novel metastasis suppressor genes in breast cancer. The cleavage product of APP, extracellular alpha-myloida peptide, directly suppresses invasion while ZNF395 transcriptionally represses a pro-metastatic gene expression program. The expression levels of TARBP2, APP and ZNF395 in human breast carcinomas support their experimentally uncovered roles in metastasis. Our findings establish a non-canonical and direct role for TARBP2 in mammalian gene expression regulation and reveal that regulated RNA destabilization through protein-mediated binding of mRNA structural elements can govern cancer progression.	[Goodarzi, Hani; Zhang, Steven; Buss, Colin G.; Fish, Lisa; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA; [Tavazoie, Saeed] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Tavazoie, Saeed] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA	Rockefeller University; Columbia University; Columbia University	Tavazoie, S (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	st2744@columbia.edu; stavazoie@rockefeller.edu	Buss, Colin/I-5326-2014	Buss, Colin/0000-0001-7771-1685; Goodarzi, Hani/0000-0002-9648-8949; Fish, Lisa/0000-0001-9184-0512	Department of Defense Era of Hope Scholar; Department of Defense Breast Cancer Collaborative Scholars and Innovators Award; National Human Genome Research Institute [R01 HG003219]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003219] Funding Source: NIH RePORTER	Department of Defense Era of Hope Scholar(United States Department of Defense); Department of Defense Breast Cancer Collaborative Scholars and Innovators Award; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank C. Alarcon, N. Halberg, N. Pencheva, P. Furlow and A. Nguyen for technical assistance and comments on previous versions of this manuscript. We thank H. Lee for her help with orthotopic injections. We thank P. Oikonomou for providing the reporter constructs. We thank the Darnell laboratory for their input on the HITS-CLIP methodology. We are also grateful to M. McManus and Z. Mourelatos for providing Dicer-null cells. We thank C. Zhao, W. Zhang and S. Dewell of the Rockefeller Genomics Resource Center for assistance with next-generation RNA-sequencing and microarray profiling. H.G. is an Anderson Cancer Center Fellow at Rockefeller University. S.F.T. is a Department of Defense Era of Hope Scholar and a Department of Defense Breast Cancer Collaborative Scholars and Innovators Award recipient. S.T. was supported by the National Human Genome Research Institute (R01 HG003219). We also acknowledge the efforts of Expression Project for Oncology (ExpO) and International Genomics Consortium (IGC) in providing public access to breast cancer gene expression profiles and annotations.	Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cutroneo KR, 2006, CRIT REV EUKAR GENE, V16, P23; De Vito C, 2012, CANCER CELL, V21, P807, DOI 10.1016/j.ccr.2012.04.023; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; Foat BC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.24; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Manley James L, 2013, Cold Spring Harb Protoc, V2013, P156, DOI 10.1101/pdb.prot072934; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Oikonomou P, 2014, CELL REP, V7, P281, DOI 10.1016/j.celrep.2014.03.001; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Singh B, 2007, ONCOGENE, V26, P3789, DOI 10.1038/sj.onc.1210154; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Soria G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-130; STRIETER RM, 1992, AM J PATHOL, V141, P1279; Tanaka K, 2004, J BIOL CHEM, V279, P7275, DOI 10.1074/jbc.M310726200; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	47	60	63	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					256	+		10.1038/nature13466	http://dx.doi.org/10.1038/nature13466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043050	Green Accepted			2022-12-28	WOS:000341362800055
J	Steinbrook, R				Steinbrook, Robert			Interstate Medical Licensure Major Reform of Licensing to Encourage Medical Practice in Multiple States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	Yale University	Steinbrook, R (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,1-456 SHM,POB 208008, New Haven, CT 06520 USA.	robert.steinbrook@yale.edu						Allison Bill, 2013, NY TIMES; DeJong C, 2014, JAMA-J AM MED ASSOC, V311, P1287, DOI 10.1001/jama.2014.1026; Young Aaron, 2013, J MED REGUL, V99, P11, DOI [10.30770/2572-1852-99.2.11, DOI 10.30770/2572-1852-99.2.11]	3	14	14	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					695	696		10.1001/jama.2014.9809	http://dx.doi.org/10.1001/jama.2014.9809			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN2TR	25068568				2022-12-28	WOS:000340438700014
J	Anthony, KMW; Zimov, SA; Grosse, G; Jones, MC; Anthony, PM; Chapin, FS; Finlay, JC; Mack, MC; Davydov, S; Frenzel, P; Frolking, S				Anthony, K. M. Walter; Zimov, S. A.; Grosse, G.; Jones, M. C.; Anthony, P. M.; Chapin, F. S., III; Finlay, J. C.; Mack, M. C.; Davydov, S.; Frenzel, P.; Frolking, S.			A shift of thermokarst lakes from carbon sources to sinks during the Holocene epoch	NATURE			English	Article							PERMAFROST; PEATLANDS; DISTURBANCE; LANDSCAPES; VEGETATION; EVOLUTION; LOWLAND; HISTORY; CLIMATE; SIBERIA	Thermokarst lakes formed across vast regions of Siberia and Alaska during the last deglaciation and are thought to be a net source of atmospheric methane and carbon dioxide during the Holocene epoch(1-4). However, the same thermokarst lakes can also sequester carbon(5), and it remains uncertain whether carbon uptake by thermokarst lakes can offset their greenhouse gas emissions. Here we use field observations of Siberian permafrost exposures, radiocarbon dating and spatial analyses to quantify Holocene carbon stocks and fluxes in lake sediments overlying thawed Pleistocene-aged permafrost. We find that carbon accumulation in deep thermokarst-lake sediments since the last deglaciation is about 1.6 times larger than the mass of Pleistocene-aged permafrost carbon released as greenhouse gases when the lakes first formed. Although methane and carbon dioxide emissions following thaw lead to immediate radiative warming, carbon uptake in peat-rich sediments occurs over millennial timescales. We assess thermokarst-lake carbon feedbacks to climate with an atmospheric perturbation model and find that thermokarst basins switched from a net radiative warming to a net cooling climate effect about 5,000 years ago. High rates of Holocene carbon accumulation in 20 lake sediments (47 +/- 10 grams of carbon per square metre per year; mean +/- standard error) were driven by thermokarst erosion and deposition of terrestrial organic matter, by nutrient release from thawing permafrost that stimulated lake productivity and by slow decomposition in cold, anoxic lake bottoms. When lakes eventually drained, permafrost formation rapidly sequestered sediment carbon. Our estimate of about 160 petagrams of Holocene organic carbon in deep lake basins of Siberia and Alaska increases the circumpolar peat carbon pool estimate for permafrost regions by over 50 per cent (ref. 6). The carbon in perennially frozen drained lake sediments may become vulnerable to mineralization as permafrost disappears(7-9), potentially negating the climate stabilization provided by thermokarst lakes during the late Holocene.	[Anthony, K. M. Walter; Jones, M. C.; Anthony, P. M.] Univ Alaska, Water & Environm Res Ctr, Fairbanks, AK 99775 USA; [Zimov, S. A.; Davydov, S.] Russian Acad Sci, Far East Branch, Northeast Sci Stn, Pacific Inst Geog, Cherskii 678830, Russia; [Grosse, G.] Univ Alaska, Inst Geophys, Fairbanks, AK 99775 USA; [Jones, M. C.] US Geol Survey, Reston, VA 20192 USA; [Chapin, F. S., III] Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Finlay, J. C.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Mack, M. C.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Frenzel, P.] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Frolking, S.] Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA	University of Alaska System; University of Alaska Fairbanks; Pacific Geographical Institute of the Far Eastern Branch of the Russian Academy of Sciences; Russian Academy of Sciences; University of Alaska System; University of Alaska Fairbanks; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; University of Florida; Max Planck Society; University System Of New Hampshire; University of New Hampshire	Anthony, KMW (corresponding author), Univ Alaska, Water & Environm Res Ctr, Fairbanks, AK 99775 USA.	kmwalteranthony@alaska.edu	Finlay, Jacques/B-6081-2011; Grosse, Guido/F-5018-2011; Davydov, Sergei P./S-9906-2018; Zimov, Sergey/K-3009-2018; Chapin, F Stuart/AAZ-3931-2020; Frolking, Steve/ABF-9046-2021	Finlay, Jacques/0000-0002-7968-7030; Grosse, Guido/0000-0001-5895-2141; Chapin, F Stuart/0000-0002-2558-9910; Frolking, Steve/0000-0001-6414-5004; Zimov, Sergey/0000-0002-0053-6599; Davydov, Sergei/0000-0003-0820-9426	NSF [OPP-0099113, OPP-0732735, ARC-1304823]; NASA [NNX08AJ37G]; NSF projects [OPP-1107892, OPP-6737545, PLR-1303940]; USGS; DOE [DE-SC0010580]; ERC [338335]; Direct For Biological Sciences [1026415] Funding Source: National Science Foundation; Directorate For Geosciences [1107892] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1303940] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NSF projects; USGS(United States Geological Survey); DOE(United States Department of Energy (DOE)); ERC(European Research Council (ERC)European Commission); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank L. Brosius, K. Davies, L. Farquharson, J. Neff and N. Zimov for assistance with field and laboratory work; G. Kling for p<INF>CO2</INF> and DOC data sets for Lake N1 (Alaska); and E. A. G. Schuur, B. Gaglioti, C. Bernhardt and S. Neuzil for constructive comments on the manuscript. Research funding was provided by the NSF (OPP-0099113, OPP-0732735 and ARC-1304823) and NASA (NNX08AJ37G). Additional support was received from other NSF projects (OPP-1107892, OPP-6737545, PLR-1303940), the USGS, the DOE(DE-SC0010580) and ERC number 338335.	Anderson NJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1278; Andreev AA, 2009, BOREAS, V38, P72, DOI 10.1111/j.1502-3885.2008.00039.x; Avis CA, 2011, NAT GEOSCI, V4, P444, DOI [10.1038/NGEO1160, 10.1038/ngeo1160]; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; BOWDEN WB, 1994, FRESHWATER BIOL, V32, P445, DOI 10.1111/j.1365-2427.1994.tb01138.x; Brosius LS, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001810; Brouchkov A, 2004, PERMAFROST PERIGLAC, V15, P81, DOI 10.1002/ppp.473; BUNDY LG, 1972, SOIL SCI SOC AM PRO, V36, P273, DOI 10.2136/sssaj1972.03615995003600020021x; Czudek T., 1970, QUATERNARY RES, V1, P103, DOI [10.1016/0033-5894(70)90013-X, DOI 10.1016/0033-5894(70)90013-X]; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Ehhalt D, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P239; Engstrom DR, 2013, J PALEOLIMNOL, V49, P333, DOI 10.1007/s10933-012-9675-5; Ferland ME, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004241; Frolking S, 2007, GLOBAL CHANGE BIOL, V13, P1079, DOI 10.1111/j.1365-2486.2007.01339.x; Giblin A., 2009, PHYS CHEM DATA VARIO; Grosse G, 2006, POLAR RES, V25, P51, DOI 10.1111/j.1751-8369.2006.tb00150.x; Grosse G, 2005, PERMAFROST PERIGLAC, V16, P163, DOI 10.1002/ppp.509; Grosse G., 2013, 20131078 USGS; HERSHEY AE, 1985, ECOLOGY, V66, P1131, DOI 10.2307/1939165; Hopkins DM, 1988, P 5 INT C PERM, V1, P790; Houser JN, 2006, CAN J FISH AQUAT SCI, V63, P2447, DOI 10.1139/F06-131; Hugelius G, 2013, EARTH SYST SCI DATA, V5, P3, DOI 10.5194/essd-5-3-2013; Jones BM, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001666; Jones MC, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001766; Joos F, 1996, TELLUS B, V48, P397, DOI 10.1034/j.1600-0889.1996.t01-2-00006.x; Kanevskiy M., 2011, QUAT RES; Kastowski M, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003874; Kessler MA, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001796; Kholodov A. L., 2003, EARTH CRYOSPHERA, V7, P3; Lantz TC, 2009, GLOBAL CHANGE BIOL, V15, P1664, DOI 10.1111/j.1365-2486.2009.01917.x; Lyons W.B., 2008, POLAR LAKES RIVERS L, P137; MALTBY E, 1993, CHEMOSPHERE, V27, P999, DOI 10.1016/0045-6535(93)90065-D; Marchenko S., 2008, P 9 INT C PERM, P121; Mesquita PS, 2010, FRESHWATER BIOL, V55, P2347, DOI 10.1111/j.1365-2427.2010.02450.x; Morgenstern A, 2011, CRYOSPHERE, V5, P849, DOI 10.5194/tc-5-849-2011; Morgenstern A., 2012, THESIS POTSDAM U; Nikolaev V. I., 2010, ICE SNOW, V4, P79; Petrenko VV, 2009, SCIENCE, V324, P506, DOI 10.1126/science.1168909; PEWE TL, 1977, QUATERNARY RES, V8, P51, DOI 10.1016/0033-5894(77)90056-4; R Core Team, 2020, R LANG ENV STAT COMP; Ramaswamy V., 2001, CLIMATE CHANGE 2001, P350; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Riis T, 2010, ARCTIC, V63, P100; Romanovskii N. N., 1993, FUNDAMENTALS CRYOGEN; Romanovsky VE, 2010, PERMAFROST PERIGLAC, V21, P136, DOI 10.1002/ppp.683; Schirrmeister L, 2002, INT J EARTH SCI, V91, P154, DOI 10.1007/s005310100205; Schirrmeister L, 2008, POLAR RES, V27, P249, DOI 10.1111/j.1751-8369.2008.00067.x; Schirrmeister L, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001647; Schneider J, 2009, REMOTE SENS ENVIRON, V113, P380, DOI 10.1016/j.rse.2008.10.013; Sher A. V., 1979, 14 PAC SCI C TOUR GU, P1; Slater AG, 2013, J CLIMATE, V26, P5608, DOI 10.1175/JCLI-D-12-00341.1; Smith LC, 2007, PERMAFROST PERIGLAC, V18, P201, DOI 10.1002/ppp.581; Smith LC, 2004, SCIENCE, V303, P353, DOI 10.1126/science.1090553; Soloviev P. A., 1973, B PERYGLACJALNY, V23, P135; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Strauss J, 2013, GEOPHYS RES LETT, V40, P6165, DOI 10.1002/2013GL058088; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Tomirdiaro S. V., 1980, LOESS ICE FORMATION; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Vaks A, 2013, SCIENCE, V340, P183, DOI 10.1126/science.1228729; Vasil'cuk Y. K., 1992, OXYGEN ISOTOPE COMPO, V2; Vasil'cuk Y. K., 1992, OXYGEN ISOTOPE COMPO, V1; Veremeeva A, 2009, PERMAFROST PERIGLAC, V20, P399, DOI 10.1002/ppp.674; Vtyurin B. I., 1975, UNDERGROUND ICES USS, P1; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; WALKER DA, 1991, ECOL MONOGR, V61, P437, DOI 10.2307/2937050; Walter Anthony K. M., 2013, J GEOPHYS RES, V118; Walter KM, 2007, SCIENCE, V318, P633, DOI 10.1126/science.1142924; Walter KM, 2006, NATURE, V443, P71, DOI 10.1038/nature05040; Weintraub MN, 2011, SOIL BIOL, V26, P295, DOI 10.1007/978-3-642-15271-9_12; WELCH HE, 1974, J FISH RES BOARD CAN, V31, P609, DOI 10.1139/f74-093; Wetzel R. G., 2000, LIMNOLOGICAL ANAL, P1; Yu ZC, 2009, GEOPHYS MONOGR SER, V184, P55, DOI 10.1029/2008GM000822; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908	74	187	195	21	288	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					452	+		10.1038/nature13560	http://dx.doi.org/10.1038/nature13560			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043014	Green Submitted			2022-12-28	WOS:000339335700043
J	Kim, JV				Kim, Joo-Von			SOLID-STATE PHYSICS Siphoning spins	NATURE			English	Editorial Material							TOPOLOGICAL INSULATORS; TORQUE		[Kim, Joo-Von] Univ Paris 11, Inst Elect Fondamentale, CNRS, F-91405 Orsay, France; [Kim, Joo-Von] Univ Paris 11, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Kim, JV (corresponding author), Univ Paris 11, Inst Elect Fondamentale, CNRS, F-91405 Orsay, France.	joo-von.kim@u-psud.fr	Kim, Joo-Von/B-3672-2008	Kim, Joo-Von/0000-0002-3849-649X				Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Fan YB, 2014, NAT MATER, V13, P699, DOI [10.1038/NMAT3973, 10.1038/nmat3973]; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Liu LQ, 2012, SCIENCE, V336, P555, DOI 10.1126/science.1218197; Mellnik AR, 2014, NATURE, V511, P449, DOI 10.1038/nature13534; Moore JE, 2010, NATURE, V464, P194, DOI 10.1038/nature08916; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5	8	3	3	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					418	419		10.1038/511418a	http://dx.doi.org/10.1038/511418a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25056060				2022-12-28	WOS:000339335700036
J	Lo, WS; Gardiner, E; Xu, ZW; Lau, CF; Wang, F; Zhou, JJ; Mendlein, JD; Nangle, LA; Chiang, KP; Yang, XL; Au, KF; Wong, WH; Guo, M; Zhang, MJ; Schimmel, P				Lo, Wing-Sze; Gardiner, Elisabeth; Xu, Zhiwen; Lau, Ching-Fun; Wang, Feng; Zhou, Jie J.; Mendlein, John D.; Nangle, Leslie A.; Chiang, Kyle P.; Yang, Xiang-Lei; Au, Kin-Fai; Wong, Wing Hung; Guo, Min; Zhang, Mingjie; Schimmel, Paul			Human tRNA synthetase catalytic nulls with diverse functions	SCIENCE			English	Article							PRETRANSFER; EXPRESSION; VARIANTS; PRESSURE; DOMAIN	Genetic efficiency in higher organisms depends on mechanisms to create multiple functions from single genes. To investigate this question for an enzyme family, we chose aminoacyl tRNA synthetases (AARSs). They are exceptional in their progressive and accretive proliferation of noncatalytic domains as the Tree of Life is ascended. Here we report discovery of a large number of natural catalytic nulls (CNs) for each human AARS. Splicing events retain noncatalytic domains while ablating the catalytic domain to create CNs with diverse functions. Each synthetase is converted into several new signaling proteins with biological activities "orthogonal" to that of the catalytic parent. We suggest that splice variants with nonenzymatic functions may be more general, as evidenced by recent findings of other catalytically inactive splice-variant enzymes.	[Lo, Wing-Sze; Xu, Zhiwen; Lau, Ching-Fun; Wang, Feng; Zhou, Jie J.; Yang, Xiang-Lei; Zhang, Mingjie; Schimmel, Paul] Hong Kong Univ Sci & Technol, Inst Adv Study, IAS HKUST Scripps R&D Lab, Kowloon, Hong Kong, Peoples R China; [Lo, Wing-Sze; Xu, Zhiwen; Lau, Ching-Fun; Wang, Feng; Zhou, Jie J.] Pangu Biopharma, Hong Kong, Hong Kong, Peoples R China; [Gardiner, Elisabeth; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Scripps Labs tRNA Synthetase Res, La Jolla, CA 92037 USA; [Gardiner, Elisabeth; Mendlein, John D.; Nangle, Leslie A.; Chiang, Kyle P.] aTyr Pharma, San Diego, CA 92121 USA; [Au, Kin-Fai] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Wong, Wing Hung] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Guo, Min; Schimmel, Paul] Scripps Florida, Scripps Labs tRNA Synthetase Res, Jupiter, FL 33458 USA; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Scripps Research Institute; University of Iowa; Stanford University; State University System of Florida; University of Florida; Hong Kong University of Science & Technology	Schimmel, P (corresponding author), Hong Kong Univ Sci & Technol, Inst Adv Study, IAS HKUST Scripps R&D Lab, Kowloon, Hong Kong, Peoples R China.	schimmel@scripps.edu	Yang, Xiang-Lei/AAR-7107-2020; Lo, Cario Wing Sze/DGZ-8810-2022	Yang, Xiang-Lei/0000-0003-2554-084X; Zhang, Mingjie/0000-0001-9404-0190	Innovation and Technology Fund from the Hong Kong Government [UIM181, UIM192, UIM199]; National Foundation for Cancer Research; NIH [R01CA92577, R01GM088278, R01NS085092, R01HG005717, R01GM100136]; NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088278, R01GM100136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085092] Funding Source: NIH RePORTER	Innovation and Technology Fund from the Hong Kong Government; National Foundation for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Innovation and Technology Fund from the Hong Kong Government (UIM181, UIM192, and UIM199); by a fellowship from the National Foundation for Cancer Research; and by NIH grants R01CA92577, R01GM088278, R01NS085092, R01HG005717, and R01GM100136. We thank K. Piehl and J. Li (aTyr Pharma) for help with splice variant cloning and protein expression. We also thank A. Cubitt (aTyr Pharma) for assistance on the transcriptional profiling, V. Trinh and J. Zhao (both formerly of aTyr Pharma) for assistance with cell profiling of recombinant tRNA synthetase fragments, and B. Cravatt (Scripps Research Institute) for help with interpretation of the PROTOMAP data. P. S. is a cofounder and member of the Board of Directors of aTyr Pharma, W. H. W. is a member of the aTyr Pharma Scientific Advisory Board, and X.-L.Y is a scientific cofounder and a member of the Scientific Advisory Board of aTyr Pharma. E. G. has no financial interest with aTyr Pharma. Clones of catalytic nulls are available for research purposes under a Material Transfer Agreement with aTyr Pharma. W.-S. L, L.A.N, and K. P. C. are inventors on patent applications filed by aTyr Pharma Inc. and Pangu Biopharma Ltd. that cover the splice variants described in this work.	Anamika K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-622; Arif A, 2011, P NATL ACAD SCI USA, V108, P1415, DOI 10.1073/pnas.1011275108; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Giege R, 2003, NAT STRUCT BIOL, V10, P414, DOI 10.1038/nsb0603-414; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Kawahara A, 2009, TRENDS CARDIOVAS MED, V19, P179, DOI 10.1016/j.tcm.2009.11.001; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; LUDMERER SW, 1987, J BIOL CHEM, V262, P10807; Miyanokoshi M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03477; Nakanishi K, 2005, NAT STRUCT MOL BIOL, V12, P931, DOI 10.1038/nsmb988; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Rack JGM, 2014, J MOL BIOL, V426, P1677, DOI 10.1016/j.jmb.2013.10.027; Schwenzer H, 2014, BIOCHIMIE, V100, P18, DOI 10.1016/j.biochi.2013.09.027; Takeda J, 2006, NUCLEIC ACIDS RES, V34, P3917, DOI 10.1093/nar/gkl507; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; Tzima E, 2005, J BIOL CHEM, V280, P2405, DOI 10.1074/jbc.C400431200; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wang F, 2013, J BIOL CHEM, V288, P29223, DOI 10.1074/jbc.C113.490599; Xu XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1686; Xu ZW, 2012, STRUCTURE, V20, P1470, DOI 10.1016/j.str.2012.08.001; Yadavalli SS, 2008, P NATL ACAD SCI USA, V105, P19031, DOI 10.1073/pnas.0810781106; Zhou QS, 2010, NAT STRUCT MOL BIOL, V17, P57, DOI 10.1038/nsmb.1706	34	80	84	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					328	332		10.1126/science.1252943	http://dx.doi.org/10.1126/science.1252943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035493	Green Accepted, Green Submitted			2022-12-28	WOS:000339400700052
J	Munshi, NV; Olson, EN				Munshi, Nikhil V.; Olson, Eric N.			Improving cardiac rhythm with a biological pacemaker	SCIENCE			English	Editorial Material							MESENCHYMAL STEM-CELLS; CARDIOMYOCYTES; FIBROBLASTS; INTEGRATION; DEVICES; FATE		[Munshi, Nikhil V.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [Munshi, Nikhil V.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Munshi, Nikhil V.; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Munshi, NV (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA.	nikhil.munshi@utsouthwestern.edu; eric.olson@utsouthwestern.edu			NHLBI NIH HHS [R01 HL077439, U01 HL100401, R01 HL111665] Funding Source: Medline; NIDDK NIH HHS [R01 DK099653] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077439, U01HL100401, R01HL111665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099653] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baddour LM, 2012, NEW ENGL J MED, V367, P842, DOI 10.1056/NEJMcp1107675; Bakker ML, 2012, CARDIOVASC RES, V94, P439, DOI 10.1093/cvr/cvs120; Chambers SM, 2011, CELL, V145, P827, DOI 10.1016/j.cell.2011.05.036; Cho HC, 2007, CIRC RES, V100, P1112, DOI 10.1161/01.RES.0000265845.04439.78; Cho HC, 2010, CIRC RES, V106, P674, DOI 10.1161/CIRCRESAHA.109.212936; Hu YF, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008681; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kapoor N, 2013, NAT BIOTECHNOL, V31, P54, DOI 10.1038/nbt.2465; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Lampert R, 2013, CIRCULATION, V128, P1576, DOI 10.1161/CIRCULATIONAHA.113.001555; Miake J, 2002, NATURE, V419, P132, DOI 10.1038/419132b; Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110; Plotnikov AN, 2007, CIRCULATION, V116, P706, DOI 10.1161/CIRCULATIONAHA.107.703231; Potapova I, 2004, CIRC RES, V94, P952, DOI 10.1161/01.RES.0000123827.60210.72; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2	15	16	16	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					268	269		10.1126/science.1257976	http://dx.doi.org/10.1126/science.1257976			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035474	Green Accepted			2022-12-28	WOS:000339400700028
J	Uyanik, M; Hayashi, H; Ishihara, K				Uyanik, Muhammet; Hayashi, Hiroki; Ishihara, Kazuaki			High-turnover hypoiodite catalysis for asymmetric synthesis of tocopherols	SCIENCE			English	Article							VITAMIN-E; ALCOHOLS	The diverse biological activities of tocopherols and their analogs have inspired considerable interest in the development of routes for their efficient asymmetric synthesis. Here, we report that chiral ammonium hypoiodite salts catalyze highly chemo-and enantioselective oxidative cyclization of gamma-(2-hydroxyphenyl) ketones to 2-acyl chromans bearing a quaternary stereocenter, which serve as productive synthetic intermediates for tocopherols. Raman spectroscopic analysis of a solution of tetrabutylammonium iodide and tert-butyl hydroperoxide revealed the in situ generation of the hypoiodite salt as an unstable catalytic active species and triiodide salt as a stable inert species. A high-performance catalytic oxidation system (turnover number of similar to 200) has been achieved through reversible equilibration between hypoiodite and triiodide in the presence of potassium carbonate base. We anticipate that these findings will open further prospects for the development of high-turnover redox organocatalysis.	[Uyanik, Muhammet; Hayashi, Hiroki; Ishihara, Kazuaki] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Ishihara, Kazuaki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Ishihara, K (corresponding author), Nagoya Univ, Grad Sch Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	ishihara@cc.nagoya-u.ac.jp	Uyanik, Muhammet/E-1533-2011	Uyanik, Muhammet/0000-0002-9751-1952; Hayashi, Hiroki/0000-0003-2081-6886	Japan Society for the Promotion of Science [24245020, 22750087, 25105722]; Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences," Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [25105722] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences," Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this project was partially provided by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (KAKENHI) (24245020, 22750087, and 25105722), and Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences," Ministry of Education, Culture, Sports, Science and Technology, Japan. Metrical parameters for the structure of compound 2h are available free of charge from the Cambridge Crystallographic Data Centre under reference number CCDC 996935. M. U. and K. I. developed the concept and conceived the experiments. H. H. performed the experiments. H. H. and M. U. analyzed the data. M. U. and K. I. prepared the manuscript, with assistance from H.H.	Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Blatt DH, 2004, J NUTR BIOCHEM, V15, P380, DOI 10.1016/j.jnutbio.2003.12.011; CADLE RD, 1950, J PHYS COLLOID CHEM, V54, P1191, DOI 10.1021/j150482a011; Chenevert R, 2006, BIOORGAN MED CHEM, V14, P5389, DOI 10.1016/j.bmc.2006.03.035; Chia Y., 1958, THESIS U CALIFORNIA; Chougnet A, 2010, CHIMIA, V64, P303, DOI 10.2533/chimia.2010.303; Evans DA, 2007, J AM CHEM SOC, V129, P10029, DOI 10.1021/ja072976i; Howard AC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1594; Huang PH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003816; Ida A., 2011, U.S. Patent, Patent No. [8,080,676, 8080676]; Koyama H, 2004, J MED CHEM, V47, P3255, DOI 10.1021/jm030621d; List B., 2012, SCI SYNTHESIS ASYMME; Lopez GV, 2005, BIOORGAN MED CHEM, V13, P5787, DOI 10.1016/j.bmc.2005.05.060; Magdziak D, 2004, CHEM REV, V104, P1383, DOI 10.1021/cr0306900; Morimura Y., 2013, Japan patent, Patent No. 5212969; Netscher T, 2007, VITAM HORM, V76, P155, DOI 10.1016/S0083-6729(07)76007-7; Nozawa M, 2000, CHEM PHARM BULL, V48, P272; Ooi T, 2007, ANGEW CHEM INT EDIT, V46, P4222, DOI 10.1002/anie.200601737; PACKER JE, 1979, NATURE, V278, P737, DOI 10.1038/278737a0; Sekimoto M, 2010, BIOORG MED CHEM LETT, V20, P1063, DOI 10.1016/j.bmcl.2009.12.034; Shen HC, 2009, TETRAHEDRON, V65, P3931, DOI 10.1016/j.tet.2009.02.002; Tanaka S, 2009, ANGEW CHEM INT EDIT, V48, P8948, DOI 10.1002/anie.200904671; Tietze LF, 2005, ANGEW CHEM INT EDIT, V44, P257, DOI 10.1002/anie.200461629; Tokunou S, 2012, HETEROCYCLES, V84, P1045, DOI 10.3987/COM-11-S(P)82; Tomasetti M, 2007, VITAM HORM, V76, P463, DOI 10.1016/S0083-6729(07)76018-1; Trost BM, 2004, J AM CHEM SOC, V126, P11966, DOI 10.1021/ja048078t; Uyanik M, 2012, CHEMCATCHEM, V4, P177, DOI 10.1002/cctc.201100352; Uyanik M, 2010, SCIENCE, V328, P1376, DOI 10.1126/science.1188217; WALTHER W, 1992, J MICROCOLUMN SEP, V4, P45, DOI 10.1002/mcs.1220040109; WREN JC, 1986, CAN J CHEM, V64, P2284, DOI 10.1139/v86-375; YODA H, 1989, CHEM LETT, P465, DOI 10.1246/cl.1989.465	31	138	138	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					291	294		10.1126/science.1254976	http://dx.doi.org/10.1126/science.1254976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035486				2022-12-28	WOS:000339400700042
J	Ouyang, H; Xue, YC; Lin, Y; Zhang, XH; Xi, L; Patel, S; Cai, HM; Luo, J; Zhang, MX; Zhang, M; Yang, Y; Li, G; Li, HR; Jiang, W; Yeh, E; Lin, J; Pei, M; Zhu, J; Cao, GQ; Zhang, LF; Yu, B; Chen, SC; Fu, XD; Liu, YZ; Zhang, K				Ouyang, Hong; Xue, Yuanchao; Lin, Ying; Zhang, Xiaohui; Xi, Lei; Patel, Sherrina; Cai, Huimin; Luo, Jing; Zhang, Meixia; Zhang, Ming; Yang, Yang; Li, Gen; Li, Hairi; Jiang, Wei; Yeh, Emily; Lin, Jonathan; Pei, Michelle; Zhu, Jin; Cao, Guiqun; Zhang, Liangfang; Yu, Benjamin; Chen, Shaochen; Fu, Xiang-Dong; Liu, Yizhi; Zhang, Kang			WNT7A and PAX6 define corneal epithelium homeostasis and pathogenesis	NATURE			English	Article							STEM-CELLS; P63; MORPHOGENESIS; PATHWAY; DIFFERENTIATION; EXPRESSION; KERATINS; LIMB; SKIN	The surface of the cornea consists of a unique type of non-keratinized epithelial cells arranged in an orderly fashion, and this is essential for vision by maintaining transparency for light transmission. Cornea epithelial cells (CECs) undergo continuous renewal from limbal stem or progenitor cells (LSCs)(1,2), and deficiency in LSCs or corneal epithelium-which turns cornea into a non-transparent, keratinized skin-like epithelium-causes corneal surface disease that leads to blindness in millions of people worldwide(3). How LSCs are maintained and differentiated into corneal epithelium in healthy individuals and which key molecular events are defective in patients have been largely unknown. Here we report establishment of an in vitro feeder-cell-free LSC expansion and three-dimensional corneal differentiation protocol in which we found that the transcription factors p63 (tumour protein 63) and PAX6 (paired box protein PAX6) act together to specify LSCs, and WNT7A controls corneal epithelium differentiation through PAX6. Loss of WNT7A or PAX6 induces LSCs into skin-like epithelium, a critical defect tightly linked to common human corneal diseases. Notably, transduction of PAX6 in skin epithelial stem cells is sufficient to convert them to LSC-like cells, and upon transplantation onto eyes in a rabbit corneal injury model, these reprogrammed cells are able to replenish CECs and repair damaged corneal surface. These findings suggest a central role of the WNT7A-PAX6 axis in corneal epithelial cell fate determination, and point to a new strategy for treating corneal surface diseases.	[Ouyang, Hong; Lin, Ying; Xi, Lei; Liu, Yizhi; Zhang, Kang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; [Ouyang, Hong; Lin, Ying; Zhang, Xiaohui; Xi, Lei; Patel, Sherrina; Luo, Jing; Yang, Yang; Yeh, Emily; Lin, Jonathan; Pei, Michelle; Zhu, Jin; Zhang, Liangfang; Chen, Shaochen; Fu, Xiang-Dong; Zhang, Kang] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Ouyang, Hong; Lin, Ying; Zhang, Xiaohui; Xi, Lei; Patel, Sherrina; Luo, Jing; Yang, Yang; Yeh, Emily; Lin, Jonathan; Pei, Michelle; Zhu, Jin; Zhang, Liangfang; Chen, Shaochen; Fu, Xiang-Dong; Zhang, Kang] Univ Calif San Diego, Biomat & Tissue Engn Ctr, Inst Engn Med, La Jolla, CA 92093 USA; [Xue, Yuanchao; Li, Hairi; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Cai, Huimin; Zhang, Meixia; Zhang, Ming; Li, Gen; Jiang, Wei; Cao, Guiqun; Zhang, Kang] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China; [Cai, Huimin] Guangzhou KangRui Biol Pharmaceut Technol Co Ltd, Guangzhou 510005, Guangdong, Peoples R China; [Zhang, Liangfang; Chen, Shaochen] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA; [Yu, Benjamin] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Yu, Benjamin; Fu, Xiang-Dong; Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Zhang, Kang] Vet Adm Healthcare Syst, San Diego, CA 92093 USA	Sun Yat Sen University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sichuan University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhang, K (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China.	xdfu@ucsd.edu; yzliu62@yahoo.com; kangzhang@ucsd.edu	Zhang, Kang/Y-2740-2019; liu, yi/GXE-9662-2022	Zhang, Kang/0000-0002-4549-1697; XUE, YUANCHAO/0000-0002-8113-2333; Luo, Jing/0000-0002-8905-9388; Zhang, Ming/0000-0003-0151-7813; Yu, Benjamin/0000-0001-6663-6616; Ouyang, Hong/0000-0002-7622-7733; Lin, Jonathan/0000-0002-7438-6941	973 program [2013CB967504, 2014CB964900]; Project of Fundamental Research Funds [2012KF03]; State Key laboratory of Ophthalmology; NIH [GM049369]; KACST-UCSD Center of Excellence in Nanomedicine; NIH Director's Transformative R01 Program [R01 EY021374]; CIRM; NATIONAL EYE INSTITUTE [R01EY021374, R01EY020846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049369] Funding Source: NIH RePORTER	973 program(National Basic Research Program of China); Project of Fundamental Research Funds; State Key laboratory of Ophthalmology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KACST-UCSD Center of Excellence in Nanomedicine; NIH Director's Transformative R01 Program; CIRM(California Institute for Regenerative Medicine); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported in part by the 973 program (2013CB967504 and 2014CB964900), Project of Fundamental Research Funds (no.2012KF03), State Key laboratory of Ophthalmology, NIH (GM049369), KACST-UCSD Center of Excellence in Nanomedicine, NIH Director's Transformative R01 Program (R01 EY021374) and CIRM.	Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; EICHNER R, 1984, J CELL BIOL, V98, P1388, DOI 10.1083/jcb.98.4.1388; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fox-Walsh K, 2011, GENOMICS, V98, P266, DOI 10.1016/j.ygeno.2011.04.003; KOPAN R, 1989, GENE DEV, V3, P1, DOI 10.1101/gad.3.1.1; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; LAUWERYNS B, 1993, INVEST OPHTH VIS SCI, V34, P1991; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037	22	157	170	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					358	+		10.1038/nature13465	http://dx.doi.org/10.1038/nature13465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030175	Green Accepted			2022-12-28	WOS:000338992200038
J	Ottesen, EA; Young, CR; Gifford, SM; Eppley, JM; Marin, R; Schuster, SC; Scholin, CA; DeLong, EF				Ottesen, Elizabeth A.; Young, Curtis R.; Gifford, Scott M.; Eppley, John M.; Marin, Roman, III; Schuster, Stephan C.; Scholin, Christopher A.; DeLong, Edward F.			Multispecies diel transcriptional oscillations in open ocean heterotrophic bacterial assemblages	SCIENCE			English	Article							BACTERIOPLANKTON; POPULATIONS; EXPRESSION; PATTERNS; SEA	Oscillating diurnal rhythms of gene transcription, metabolic activity, and behavior are found in all three domains of life. However, diel cycles in naturally occurring heterotrophic bacteria and archaea have rarely been observed. Here, we report time-resolved whole-genome transcriptome profiles of multiple, naturally occurring oceanic bacterial populations sampled in situ over 3 days. As anticipated, the cyanobacterial transcriptome exhibited pronounced diel periodicity. Unexpectedly, several different heterotrophic bacterioplankton groups also displayed diel cycling in many of their gene transcripts. Furthermore, diel oscillations in different heterotrophic bacterial groups suggested population-specific timing of peak transcript expression in a variety of metabolic gene suites. These staggered multispecies waves of diel gene transcription may influence both the tempo and the mode of matter and energy transformation in the sea.	[Ottesen, Elizabeth A.; Young, Curtis R.; Gifford, Scott M.; Eppley, John M.; DeLong, Edward F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Ottesen, Elizabeth A.; Young, Curtis R.; Gifford, Scott M.; Eppley, John M.; DeLong, Edward F.] Univ Hawaii, C MORE, Honolulu, HI 96822 USA; [Ottesen, Elizabeth A.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Marin, Roman, III; Scholin, Christopher A.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Schuster, Stephan C.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore; [DeLong, Edward F.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of Hawaii System; University System of Georgia; University of Georgia; Monterey Bay Aquarium Research Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Massachusetts Institute of Technology (MIT)	DeLong, EF (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	edelong@hawaii.edu			Gordon and Betty Moore Foundation GBMF [492.01, 3777]; NSF [EF0424599, OCE-0314222]; NASA [NNG06GB34G, NNX09AB78G]; Gordon and Betty Moore Foundation [731, 2728]; David and Lucile Packard Foundation	Gordon and Betty Moore Foundation GBMF(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	We thank the officers and crew of the Kilo Moana, J. Robidart, S. Wilson, and the ESP engineering and science team (J. Ryan, J. Birch, C. Preston, G. Massion, S. Jensen, and B. Roman) for all of the able assistance. This work was supported by grants from the Gordon and Betty Moore Foundation GBMF nos. 492.01 and 3777 (E.F.D.) and NSF grant EF0424599 (E.F.D.). Development of the ESP was supported by NSF grant OCE-0314222 (to C.A.S.), NASA Astrobiology grants NNG06GB34G and NNX09AB78G (to C.A.S.), the Gordon and Betty Moore Foundation nos. 731 and 2728 (C.A.S.), and the David and Lucile Packard Foundation. This work is a contribution of C-MORE. Sequences reported in this paper have been deposited in the GenBank database (accession no. SRP041215). The Monterey Bay Aquarium Research Institute holds rights to C. A. Scholin et al., U.S. Patent 6187530 (2001). C.A.S. is disqualified from receiving any royalties that might arise from licensing agreements. The ESP is available commercially from Spyglass Technologies and MacLane Research Laboratories; C.A.S. has no financial interest in either company and is not compensated in any way for giving advice on ESP technology transfer.	Axmann I. M., 2014, MAR GENOMICS; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Flint JF, 2005, J BACTERIOL, V187, P7460, DOI 10.1128/JB.187.21.7460-7470.2005; Gali M, 2013, GLOBAL BIOGEOCHEM CY, V27, P620, DOI 10.1002/gbc.20047; Gasol JM, 1998, MAR ECOL PROG SER, V164, P107, DOI 10.3354/meps164107; Gifford SM, 2013, ISME J, V7, P281, DOI 10.1038/ismej.2012.96; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Li N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009894; Liu ZQ, 2011, BIOINFORMATICS, V27, P3242, DOI 10.1093/bioinformatics/btr547; Okansen J., 2012, PACKAGE VEGAN COMMUN; Ottesen EA, 2013, P NATL ACAD SCI USA, V110, pE488, DOI 10.1073/pnas.1222099110; Ottesen EA, 2011, ISME J, V5, P1881, DOI 10.1038/ismej.2011.70; Preston CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022522; Steindler L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019725; Tomasch J, 2011, ISME J, V5, P1957, DOI 10.1038/ismej.2011.68; Whitehead K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005485; Wier AM, 2010, P NATL ACAD SCI USA, V107, P2259, DOI 10.1073/pnas.0909712107; Winter C, 2004, AQUAT MICROB ECOL, V35, P207, DOI 10.3354/ame035207; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135	19	152	153	4	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					207	212		10.1126/science.1252476	http://dx.doi.org/10.1126/science.1252476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013074	Green Submitted, Green Accepted			2022-12-28	WOS:000339409900052
J	Wang, J; Mei, YJ; Hicks, D				Wang, Jian; Mei, Yajun; Hicks, Diana			Comment on "Quantifying long-term scientific impact"	SCIENCE			English	Editorial Material								Wang et al. (Reports, 4 October 2013, p. 127) claimed high prediction power for their model of citation dynamics. We replicate their analysis but find discouraging results: 14.75% papers are estimated with unreasonably large m (>5) and l (>10) and correspondingly enormous prediction errors. The prediction power is even worse than simply using short-term citations to approximate long-term citations.	[Wang, Jian] Univ Leuven, Ctr R&D Monitoring ECOOM, B-3000 Leuven, Belgium; [Wang, Jian] Univ Leuven, Dept Managerial Econ Strategy & Innovat, B-3000 Leuven, Belgium; [Wang, Jian] Inst Res Informat & Qual Assurance iFQ, D-10117 Berlin, Germany; [Mei, Yajun] Georgia Inst Technol, H Milton Stewart Sch Ind & Syst Engn, Atlanta, GA 30332 USA; [Hicks, Diana] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA	KU Leuven; KU Leuven; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Wang, J (corresponding author), Univ Leuven, Ctr R&D Monitoring ECOOM, Waaistr 6,Bus 3536, B-3000 Leuven, Belgium.	jian.wang@kuleuven.be	Wang, Jian/E-6080-2011	Wang, Jian/0000-0003-0520-737X				Glanzel W, 2003, SCIENTOMETRICS, V58, P571, DOI 10.1023/B:SCIE.0000006881.30700.ea; Shen H., 2014, 28 AAAI C ART INT QU; Van Noorden R, 2013, NATURE NEWS; van Raan AFJ, 2004, SCIENTOMETRICS, V59, P467, DOI 10.1023/B:SCIE.0000018543.82441.f1; Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825; Wang J, 2013, SCIENTOMETRICS, V94, P851, DOI 10.1007/s11192-012-0775-9	6	18	18	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193								10.1126/science.1248770	http://dx.doi.org/10.1126/science.1248770			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8SS	25013055				2022-12-28	WOS:000339409900032
J	Yu, M; Bardia, A; Aceto, N; Bersani, F; Madden, MW; Donaldson, MC; Desai, R; Zhu, HL; Comaills, V; Zheng, ZL; Wittner, BS; Stojanov, P; Brachtel, E; Sgroi, D; Kapur, R; Shioda, T; Ting, DT; Ramaswamy, S; Getz, G; Iafrate, AJ; Benes, C; Toner, M; Maheswaran, S; Haber, DA				Yu, Min; Bardia, Aditya; Aceto, Nicola; Bersani, Francesca; Madden, Marissa W.; Donaldson, Maria C.; Desai, Rushil; Zhu, Huili; Comaills, Valentine; Zheng, Zongli; Wittner, Ben S.; Stojanov, Petar; Brachtel, Elena; Sgroi, Dennis; Kapur, Ravi; Shioda, Toshihiro; Ting, David T.; Ramaswamy, Sridhar; Getz, Gad; Iafrate, A. John; Benes, Cyril; Toner, Mehmet; Maheswaran, Shyamala; Haber, Daniel A.			Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility	SCIENCE			English	Article							CANCER; INHIBITOR; IDENTIFICATION; MUTATIONS; DISCOVERY; FAMILY; POTENT; DOMAIN; ALPHA	Circulating tumor cells (CTCs) are present at low concentrations in the peripheral blood of patients with solid tumors. It has been proposed that the isolation, ex vivo culture, and characterization of CTCs may provide an opportunity to noninvasively monitor the changing patterns of drug susceptibility in individual patients as their tumors acquire new mutations. In a proof-of-concept study, we established CTC cultures from six patients with estrogen receptor-positive breast cancer. Three of five CTC lines tested were tumorigenic in mice. Genome sequencing of the CTC lines revealed preexisting mutations in the PIK3CA gene and newly acquired mutations in the estrogen receptor gene (ESR1), PIK3CA gene, and fibroblast growth factor receptor gene (FGFR2), among others. Drug sensitivity testing of CTC lines with multiple mutations revealed potential new therapeutic targets. With optimization of CTC culture conditions, this strategy may help identify the best therapies for individual cancer patients over the course of their disease.	[Yu, Min; Bardia, Aditya; Aceto, Nicola; Bersani, Francesca; Madden, Marissa W.; Donaldson, Maria C.; Desai, Rushil; Zhu, Huili; Comaills, Valentine; Zheng, Zongli; Wittner, Ben S.; Sgroi, Dennis; Shioda, Toshihiro; Ting, David T.; Ramaswamy, Sridhar; Getz, Gad; Iafrate, A. John; Benes, Cyril; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Yu, Min; Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Bardia, Aditya; Shioda, Toshihiro; Ting, David T.; Ramaswamy, Sridhar; Benes, Cyril; Haber, Daniel A.] Harvard Univ, Sch Med, Dept Med, Charlestown, MA 02129 USA; [Zheng, Zongli; Brachtel, Elena; Sgroi, Dennis; Getz, Gad; Iafrate, A. John] Harvard Univ, Sch Med, Dept Pathol, Charlestown, MA 02129 USA; [Zheng, Zongli] Karolinska Insitutet, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Stojanov, Petar; Getz, Gad] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Kapur, Ravi; Toner, Mehmet] Harvard Univ, Sch Med, Ctr Bioengn Med, Charlestown, MA 02129 USA; [Toner, Mehmet; Maheswaran, Shyamala] Harvard Univ, Sch Med, Dept Surg, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard University; Karolinska Institutet; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University	Maheswaran, S (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	maheswaran@helix.mgh.harvard.edu; haber@helix.mgh.harvard.edu	Stojanov, Petar/GQI-4462-2022; Sgroi, Dennis/AAV-2487-2021; zheng, zongli/C-7309-2008; zheng, zongli/B-2917-2011; COMAILLS, VALENTINE/AAX-1697-2021; Aceto, Nicola/O-2484-2014; Ting, David/F-4389-2017	Stojanov, Petar/0000-0001-7815-776X; zheng, zongli/0000-0003-4849-4903; COMAILLS, VALENTINE/0000-0001-8857-6976; Donaldson Collier, Maria/0000-0001-6403-6713; Bersani, Francesca/0000-0002-0343-7078; Aceto, Nicola/0000-0001-9579-6918; Yu, Min/0000-0002-3969-8720; Ting, David/0000-0002-3261-2322	Breast Cancer Research Foundation; Stand Up to Cancer; Wellcome TrustNational Foundation for Cancer Research; NIH [CA129933]; NIBIB [EB008047]; Susan G. Komen for the Cure [KG09042]; National Cancer Institute-MGH Proton Federal Share Program; MGH-Johnson and Johnson Center for Excellence in CTCs; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA129933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008047, U01EB012493, P41EB002503] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Stand Up to Cancer; Wellcome TrustNational Foundation for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Cancer Institute-MGH Proton Federal Share Program; MGH-Johnson and Johnson Center for Excellence in CTCs; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We are grateful to all the patients who participated in this study. We thank Dr. Lecia Sequist for coordinating the clinical studies, A. McGovern, C. Hart, and the Massachusetts General Hospital (MGH) clinical research coordinators P. Spuhler, A. Shah, J. Ciciliano, and V. Pai for bioengineering technical support; R. Milano, K. Lynch, H. Robinson, and M. Liebers for technical support; L. Collins (Beth Israel Deaconess Medical Center) for providing pathological specimens; and L. Libby for mouse studies. N. Aceto is a fellow of the Human Frontiers Science Program, the Swiss National Science Foundation, and the Swiss Foundation for Grants in Biology and Medicine. This work was supported by grants from the Breast Cancer Research Foundation (D. A. H), Stand Up to Cancer (D. A. H., M. T., S. M.), the Wellcome Trust (D. A. H., C. B.), National Foundation for Cancer Research (D. A. H.), NIH CA129933 (D. A. H.), NIBIB EB008047 (M. T., D. A. H.), Susan G. Komen for the Cure KG09042 (S. M.), National Cancer Institute-MGH Proton Federal Share Program (S. M.), the MGH-Johnson and Johnson Center for Excellence in CTCs (M. T., S. M.), and the Howard Hughes Medical Institute (M.Y., D. A. H.). A. J. I. holds equity in, and is a paid consultant for, Enzymatics, Inc. M. T., D. A. H., and the Massachusetts General Hospital have filed for patent protection for the CTC-iChip technology. RNA-Seq reads have been deposited into Gene Expression Omnibus: uncultured CTCs (accession no. GSE51827); the six cultured CTC lines (accession no. GSE55807).	Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Furet P, 2013, BIOORG MED CHEM LETT, V23, P3741, DOI 10.1016/j.bmcl.2013.05.007; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Merenbakh-Lamin K, 2013, CANCER RES, V73, P6856, DOI 10.1158/0008-5472.CAN-13-1197; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Wang YS, 2010, CURR OPIN INVEST DR, V11, P1466; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zhang LX, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005109; Zhang QX, 1997, CANCER RES, V57, P1244	26	661	720	9	345	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					216	220		10.1126/science.1253533	http://dx.doi.org/10.1126/science.1253533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013076	Green Submitted, Green Accepted			2022-12-28	WOS:000339409900054
J	Ferry, G				Ferry, Georgina			Fifty years of EMBO	NATURE			English	Editorial Material												mgf@georginaferry.com							0	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					150	151		10.1038/511150a	http://dx.doi.org/10.1038/511150a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8AP	25013879	Bronze			2022-12-28	WOS:000338649800022
J	Federman, DG; Kirsner, RS; Concato, J				Federman, Daniel G.; Kirsner, Robert S.; Concato, John			Sunscreen Counseling by US Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EVIDENCE-BASED MEDICINE; SKIN; RECOMMENDATION; PREVENTION	IMPORTANCE Sunscreen is an important part of sun protection to prevent skin cancer but may not be recommended as often as guidelines dictate. OBJECTIVE To evaluate trends in sunscreen recommendation among physicians to determine whether they are following suggested patient-education guidelines regarding sun protection, and to assess data regarding physician sunscreen recommendations to determine the association with patient demographics, physician specialty, and physician diagnosis. DESIGN, SETTING, AND PARTICIPANTS The National Ambulatory Medical Care Survey was queried to identify patient visits to nonfederal outpatient physician offices at US ambulatory care practices (January 1, 1989-December 26, 2010) during which sunscreen was recommended. MAIN OUTCOMES AND MEASURES Frequency of sunscreen recommendation. RESULTS According to the National Ambulatory Medical Care Survey, there were an estimated 18.30 billion patient visits nationwide. Physicians mentioned sunscreen at approximately 12.83 million visits (0.07%). Mention of sunscreen was reported by physicians at 0.9% of patient visits associated with a diagnosis of skin disease. Dermatologists recorded the mention of sunscreen the most (86.4% of all visits associated with sunscreen). However, dermatologists reported mentioning sunscreen at only 1.6% of all dermatology visits. Sunscreen was mentioned most frequently to white patients, particularly those in their eighth decade of life, and least frequently to children. Actinic keratosis was the most common diagnosis associated with sunscreen recommendation. CONCLUSIONS AND RELEVANCE Despite encouragement to provide patient education regarding sunscreen use and sun-protective behaviors, the rate at which physicians are mentioning sunscreen at patient visits is quite low, even for patients with a history of skin cancer. The high incidence and morbidity of skin cancer can be greatly reduced with the implementation of sun-protective behaviors, which patients should be counseled about at outpatient visits.	[Federman, Daniel G.; Concato, John] VA Connecticut Healthcare Syst, 950 Campbell Ave 11ACSL, West Haven, CT 06516 USA; [Federman, Daniel G.; Concato, John] Yale Univ, Sch Med, West Haven, CT 06516 USA; [Kirsner, Robert S.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; University of Miami	Federman, DG (corresponding author), VA Connecticut Healthcare Syst, 950 Campbell Ave 11ACSL, West Haven, CT 06516 USA.	daniel.federman@va.gov						Akamine KL, 2014, JAMA DERMATOL, V150, P51, DOI 10.1001/jamadermatol.2013.4741; Federman DG, 2009, ARCH DERMATOL, V145, P926, DOI 10.1001/archdermatol.2009.130; Feinstein AR, 1997, AM J MED, V103, P529, DOI 10.1016/S0002-9343(97)00244-1; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; Moyer VA, 2012, ANN INTERN MED, V157, P59, DOI 10.7326/0003-4819-157-1-201207030-00442; Sackett DL, 1997, SEMIN PERINATOL, V21, P3, DOI 10.1016/S0146-0005(97)80013-4; Saraiya M, 2000, ARCH DERMATOL, V136, P633, DOI 10.1001/archderm.136.5.633; van der Pols JC, 2006, CANCER EPIDEM BIOMAR, V15, P2546, DOI 10.1158/1055-9965.EPI-06-0352	8	8	8	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					87	+		10.1001/jama.2014.4320	http://dx.doi.org/10.1001/jama.2014.4320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	25058222				2022-12-28	WOS:000338131100025
J	Gostin, LO; Phelan, A				Gostin, Lawrence O.; Phelan, Alexandra			The Global Health Security Agenda in an Age of Biosecurity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.; Phelan, Alexandra] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Gostin, Lawrence O.] World Hlth Org, Collaborating Ctr Publ Hlth Law & Human Rights, Washington, DC USA	Georgetown University; World Health Organization	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044; Phelan, Alexandra/0000-0002-3084-9158				Division of Budget, 2014, BUDG FISC YEAR 2014; Gostin L.O., 2014, GLOBAL HLTH LAW; Inglesby T, 2014, BIOSECUR BIOTERROR, V12, P63, DOI 10.1089/bsp.2014.3314; Kerry J., 2014, CNN             0212; US Department of Health and Human Services, 2014, GLOB HLTH SEC AG WOR; Wexler A KJ, 2014, US GLOBAL HLTH BUDGE	6	9	9	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					27	28		10.1001/jama.2014.4843	http://dx.doi.org/10.1001/jama.2014.4843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	25058211	Green Published			2022-12-28	WOS:000338131100014
J	Cole, TB				Cole, Thomas B.			Dido, Queen of Carthage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2464	2465		10.1001/jama.2013.279572	http://dx.doi.org/10.1001/jama.2013.279572			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	25058063				2022-12-28	WOS:000337757000001
J	Baral, SD; Friedman, MR; Geibel, S; Rebe, K; Bozhinov, B; Diouf, D; Sabin, K; Holland, CE; Chan, R; Caceres, CF				Baral, Stefan David; Friedman, M. Reuel; Geibel, Scott; Rebe, Kevin; Bozhinov, Borche; Diouf, Daouda; Sabin, Keith; Holland, Claire E.; Chan, Roy; Caceres, Carlos F.			Male sex workers: practices, contexts, and vulnerabilities for HIV acquisition and transmission	LANCET			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; MIDDLE-INCOME COUNTRIES; AT-RISK POPULATIONS; HIGH PREVALENCE; MONEY BOYS; TEL-AVIV; STI RISK; MEN MSM; PREVENTION; BEHAVIORS	Male sex workers who sell or exchange sex for money or goods encompass a very diverse population across and within countries worldwide. Information characterising their practices, contexts where they live, and their needs is limited, because these individuals are generally included as a subset of larger studies focused on gay men and other men who have sex with men (MSM) or even female sex workers. Male sex workers, irrespective of their sexual orientation, mostly off er sex to men and rarely identify as sex workers, using local or international terms instead. Growing evidence indicates a sustained or increasing burden of HIV among some male sex workers within the context of the slowing global HIV pandemic. Several synergistic facilitators could be potentiating HIV acquisition and transmission among male sex workers, including biological, behavioural, and structural determinants. Criminalisation and intersectional stigmas of same-sex practices, commercial sex, and HIV all augment risk for HIV and sexually transmitted infections among male sex workers and reduce the likelihood of these people accessing essential services. These contexts, taken together with complex sexual networks among male sex workers, define this group as a key population underserved by current HIV prevention, treatment, and care services. Dedicated efforts are needed to make those services available for the sake of both public health and human rights. Evidence-based and human rights-affirming services dedicated specifically to male sex workers are needed to improve health outcomes for these men and the people within their sexual networks.	[Baral, Stefan David; Holland, Claire E.] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Friedman, M. Reuel] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Geibel, Scott] Populat Council, Washington, DC USA; [Rebe, Kevin] Health4Men, Anova Hlth Inst, Cape Town, South Africa; [Bozhinov, Borche] STAR STAR, Skopje, Macedonia; [Diouf, Daouda] Enda Sante, Dakar, Senegal; [Sabin, Keith] UNAIDS, Geneva, Switzerland; [Chan, Roy] Natl Skin Ctr, Singapore, Singapore; [Caceres, Carlos F.] Cayetano Heredia Univ, Lima, Peru	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Population Council; UNAIDS; National Skin Centre; Universidad Peruana Cayetano Heredia	Baral, SD (corresponding author), Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Key Populat Program, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA.	sbaral@jhu.edu	Baral, Stefan/AAG-4818-2020	Baral, Stefan/0000-0002-5482-2419; Geibel, Scott/0000-0001-9969-8776; Sabin, Keith/0000-0002-2290-8621; Caceres, Carlos F./0000-0002-8101-0790; Friedman, M. Reuel/0000-0001-6191-9799	Bill & Melinda Gates Foundation; United Nations Population Fund; Johns Hopkins University Center for AIDS Research - National Institutes for Health (NIH) [1P30AI094189]; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099727, P30AI094189] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); United Nations Population Fund; Johns Hopkins University Center for AIDS Research - National Institutes for Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This report and The Lancet's Series on HIV and sex workers was supported by grants to the Center for Public Health and Human Rights at Johns Hopkins Bloomberg School of Public Health from The Bill & Melinda Gates Foundation and The United Nations Population Fund and by the Johns Hopkins University Center for AIDS Research, a programme funded by the National Institutes for Health (NIH; 1P30AI094189), which is supported by NIH cofunding and participating institutes and centres: National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute; National Institute on Drug Abuse; National Institute of Mental Health, National Institute on Aging, Fogarty International Center, and Office of AIDS Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Abdul-Quader A, 2012, USAID BANGLADESH MID; Aggleton P, 1998, MEN WHO SELL SEX INT; Altaf A, 2006, 16 INT AID S C TOR O; amfAR The Foundation for AIDS Research Johns Hopkins Bloomberg School of Public Health, 2012, ACH AIDS FREE GEN GA; Azim T, 2008, INT J STD AIDS, V19, P327, DOI 10.1258/ijsa.2007.007269; Bacon O, 2006, SEX TRANSM DIS, V33, P228, DOI 10.1097/01.olq.0000204914.91923.ad; Ballester-Arnal R, 2014, CURR HIV-AIDS REP, V11, P72, DOI 10.1007/s11904-013-0195-3; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-482; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Bayer A, 2010, 18 INT AIDS C VIENN; Bayer AM, 2013, AM J MENS HLTH; Beyrer C, 2011, DIR DEV, P1, DOI 10.1596/978-0-8213-8726-9; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2011, JAIDS-J ACQ IMM DEF, V57, pS96, DOI 10.1097/QAI.0b013e31821db944; Bilardi JE, 2013, AIDS BEHAV, V17, P2093, DOI 10.1007/s10461-012-0395-7; Bokhari A, 2007, INT J STD AIDS, V18, P486, DOI 10.1258/095646207781147201; Boyce S, 2012, CULT HEALTH SEX, V14, P313, DOI 10.1080/13691058.2011.639393; Brahmam GNV, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000343763.54831.15; Burrell E, 2010, SEX HEALTH, V7, P149, DOI 10.1071/SH09090; Caceres C., 2000, SECRETO VOCES HOMOER; Caceres CF, MEN WHO SEL IN PRESS; Cai WD, 2010, SEX TRANSM INFECT, V86, P15, DOI 10.1136/sti.2009.037440; Centers for Disease Control and Prevention, RESP BRIEF ENH CLIEN; Chow EPF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048025; Clatts MC, 2007, SEX HEALTH, V4, P261, DOI 10.1071/SH07018; Collumbien Martine, 2008, J LGBT Health Res, V4, P71; Creswell J, 2012, SEX TRANSM INFECT, V88, P633, DOI 10.1136/sextrans-2012-050521; Dahoma M, 2011, AIDS BEHAV, V15, P186, DOI 10.1007/s10461-009-9646-7; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Farias MSD, 2011, INT J INFECT DIS, V15, pE635, DOI 10.1016/j.ijid.2011.05.007; Drame FM, 2013, CULT HEALTH SEX, V15, P7, DOI 10.1080/13691058.2012.748935; Estcourt CS, 2000, SEX TRANSM INFECT, V76, P294, DOI 10.1136/sti.76.4.294; Feng Y, 2010, J ACQUIR IMMUNE D S1, V53, P80; Friedman MR, 2014, AIDS BEHAV, V18, P111, DOI 10.1007/s10461-013-0495-z; Friedman MR, 2011, NAT HIB PREV C ATL G; Friedman MR, IS SILK OPEN TONIGHT; Galea JT, 2011, INT J STD AIDS, V22, P256, DOI 10.1258/ijsa.2009.009255; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Geibel S, 2012, SEX TRANSM INFECT, V88, P357, DOI 10.1136/sextrans-2011-050224; Gomez GB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001323; Gorbach PM, 2009, J URBAN HEALTH, V86, pS63, DOI 10.1007/s11524-009-9370-7; Hawkes S, 2009, SEX TRANSM INFECT S2, V85, P16, DOI DOI 10.1136/sti.2008.035444; He Q, 2009, SEX TRANSM INFECT, V85, P383, DOI 10.1136/sti.2009.035808; He Q, 2011, SE ASIAN J TROP MED, V42, P616; Herrick AL, 2013, AM J PUBLIC HEALTH, V103, P79, DOI 10.2105/AJPH.2012.300810; Hiep NV, 2011, SEXUAL RISK BEHAV MA; Hladik W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038143; Human_ Rights_ Watch WASO, 2013, TREAT US LIK HUM BEI; Infante C, 2009, CULT HEALTH SEX, V11, P125, DOI 10.1080/13691050802431314; Jacobson JO, 2014, AIDS BEHAV, V18, P88, DOI 10.1007/s10461-013-0478-0; Katsulis Y, 2012, GLOB PUBLIC HEALTH, V7, P367, DOI 10.1080/17441692.2012.656672; Lama JR, 2006, J INFECT DIS, V194, P1459, DOI 10.1086/508548; Lippman SA, 2010, AM J PUBLIC HEALTH, V100, pS216, DOI 10.2105/AJPH.2008.147462; Liu HJ, 2009, AIDS BEHAV, V13, P652, DOI 10.1007/s10461-008-9475-0; Liu SS, 2012, AIDS BEHAV, V16, P835, DOI 10.1007/s10461-011-9978-y; Liu SS, 2012, AIDS EDUC PREV, V24, P163, DOI 10.1521/aeap.2012.24.2.163; Liu SS, 2012, SEX TRANSM DIS, V39, P251, DOI 10.1097/OLQ.0b013e31824a0903; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Mannava P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052547; Marshall BDL, 2010, JAIDS-J ACQ IMM DEF, V53, P661, DOI 10.1097/QAI.0b013e3181c300d7; Mccamish M, 2000, Cult Health Sex, V2, P167, DOI 10.1080/136910500300787; McKinnon LR, 2014, SEX TRANSM INFECT, V90, P237, DOI 10.1136/sextrans-2013-051310; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Mimiaga MJ, 2009, J URBAN HEALTH, V86, P54, DOI 10.1007/s11524-008-9316-5; Minichiello V, 2013, J SEX RES, V50, P263, DOI 10.1080/00224499.2012.760189; Montano SM, 2005, JAIDS-J ACQ IMM DEF, V40, P57, DOI 10.1097/01.qai.0000159667.72584.8b; Mor Z, 2012, SEX TRANSM INFECT, V88, P574, DOI 10.1136/sextrans-2011-050290; Mor Z, 2012, ISR MED ASSOC J, V14, P147; Mumtaz G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000444; Muraguri N, 2012, 19 INT AIDS C WASH D; Myers T, 2009, INT J INFECT DIS, V13, P730, DOI 10.1016/j.ijid.2008.11.015; Mykhalovskiy E, 2011, SOC SCI MED, V73, P668, DOI 10.1016/j.socscimed.2011.06.051; Narayanan P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1059; Nguyen TA, 2008, AIDS BEHAV, V12, P476, DOI 10.1007/s10461-007-9267-y; Okal J, 2009, CULT HEALTH SEX, V11, P811, DOI 10.1080/13691050902906488; Overs C, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S3-S6; Padilla M, 2008, SOC SCI MED, V67, P380, DOI 10.1016/j.socscimed.2008.03.014; Padilla MS, 2010, AM J PUBLIC HEALTH, V100, P70, DOI 10.2105/AJPH.2009.161968; Parsons JT, 2007, J HOMOSEXUAL, V53, P219, DOI 10.1300/J082v53n01_10; Perlongher NO, 1999, NEGOCIO PROSTITUCION; Pisani E, 2004, SEX TRANSM INFECT, V80, P536, DOI 10.1136/sti.2003.007500; Poteat T, 2014, LANCET; Prestage G, 2010, PLEASURE SEXUAL HLTH; Prestage G, 2014, AIDS BEHAV, V18, P1293, DOI 10.1007/s10461-014-0755-6; Price MA, 2012, JAIDS-J ACQ IMM DEF, V59, P185, DOI 10.1097/QAI.0b013e31823d8693; Pham QD, 2012, SEX TRANSM DIS, V39, P799, DOI 10.1097/OLQ.0b013e318265b180; Reisner Sari L, 2008, J LGBT Health Res, V4, P195; Reza-Paul S, 2012, INDIAN J MED RES, V135, P98, DOI 10.4103/0971-5916.93431; Ruan SM, 2008, AIDS BEHAV, V12, P469, DOI 10.1007/s10461-008-9361-9; Sanders EJ, 2010, SEX TRANSM INFECT, V86, P440, DOI 10.1136/sti.2010.043224; Segura M, 2010, AIDS CARE, V22, P1459, DOI 10.1080/09540121003758556; Semugoma P, 2012, SAHARA J-J SOC ASP H, V9, P173, DOI 10.1080/17290376.2012.744177; Semugoma P, 2012, LANCET, V380, P312, DOI 10.1016/S0140-6736(12)60901-5; Sethi G, 2006, SEX TRANSM INFECT, V82, P359, DOI 10.1136/sti.2005.019257; Sheehy M, 2014, AIDS CARE, V26, P116, DOI 10.1080/09540121.2013.802281; Shinde S, 2009, INDIAN J DERMATOL VE, V75, P41, DOI 10.4103/0378-6323.45219; SIMON PM, 1993, HEALTH EDUC QUART, V20, P261, DOI 10.1177/109019819302000216; Stall R, 2012, 19 INT AIDS C WASH D; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Taylor MM, 2007, CLIN INFECT DIS, V44, P301, DOI 10.1086/510487; Toledo CA, 2010, AIDS EDUC PREV, V22, P299, DOI 10.1521/aeap.2010.22.4.299; Toole MJ, 2006, SEX TRANSM INFECT, V82, P135, DOI 10.1136/sti.2005.016923; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; Trapence G, 2012, LANCET, V380, P400, DOI 10.1016/S0140-6736(12)60834-4; Tun W, 2008, SEX TRANSM INFECT, V84, P455, DOI 10.1136/sti.2008.031336; UNAIDS, 2014, GLOB AIDS RESP PROGR; Valderrama M, 2008, 17 INT AIDS C MEX CI; van der Elst EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005340; Vella A, 2012, INCIDENCE SEXUALLY T; Vu L, 2013, JAIDS-J ACQ IMM DEF, V63, P221, DOI 10.1097/QAI.0b013e31828a3e60; Vuylsteke B, 2012, SEX TRANSM INFECT, V88, P288, DOI 10.1136/sextrans-2011-050276; Weber AE, 2001, INT J EPIDEMIOL, V30, P1449, DOI 10.1093/ije/30.6.1449; Williams ML, 2006, AIDS EDUC PREV, V18, P204, DOI 10.1521/aeap.2006.18.3.204; World Health Organization UNAIDS, 2011, TECHN GUID GLOB FUND; Xiao Y, 2009, SEX TRANSM DIS, V36, P647, DOI 10.1097/OLQ.0b013e3181aac23d; Xu HL, 2013, ASIAN J ANDROL, V15, P545, DOI 10.1038/aja.2013.51; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033748, 10.1371/journal.pone.0037211]; Zhang YQ, 2012, SEX TRANSM INFECT, V88, P444, DOI 10.1136/sextrans-2011-050295; Zhao J, 2012, SEX TRANSM DIS, V39, P942, DOI 10.1097/OLQ.0b013e31826f356f; Zhao J, 2011, AIDS BEHAV, V15, P635, DOI 10.1007/s10461-010-9786-9; Ziersch A, 2000, SEX TRANSM INFECT, V76, P447, DOI 10.1136/sti.76.6.447	124	178	184	0	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					260	273		10.1016/S0140-6736(14)60801-1	http://dx.doi.org/10.1016/S0140-6736(14)60801-1			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ2DL	25059939	Green Accepted			2022-12-28	WOS:000348044800030
J	McIntyre, PB; Clark, TA				McIntyre, Peter B.; Clark, Thomas A.			Pertussis vaccine in pregnancy-first dose for every infant?	LANCET			English	Editorial Material							IMMUNIZATION; DIPHTHERIA; TDAP		[McIntyre, Peter B.] Sydney Childrens Hosp Network, Kids Res Inst, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Sydney, NSW 2145, Australia; [McIntyre, Peter B.] Univ Sydney, Sydney, NSW 2145, Australia; [Clark, Thomas A.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	University of Sydney; University of Sydney; Centers for Disease Control & Prevention - USA	McIntyre, PB (corresponding author), Sydney Childrens Hosp Network, Kids Res Inst, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Sydney, NSW 2145, Australia.	peter.mcintyre@health.nsw.gov.au	McIntyre, Peter/GNM-5277-2022	McIntyre, Peter/0000-0001-5808-7450				Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P1424; [Anonymous], LANCET; ENGLUND JA, 1995, PEDIATRICS, V96, P580; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; Leuridan E, 2013, CLIN INFECT DIS, V57, P471, DOI 10.1093/cid/cit217; McVernon J, 2008, ARCH DIS CHILD, V93, P670, DOI 10.1136/adc.2006.097501; Mooi FR, 2007, LANCET INFECT DIS, V7, P614, DOI 10.1016/s1473-3099(07)70113-5; Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633; Rasmussen SA, 2014, SEMIN FETAL NEONAT M, V19, P161, DOI 10.1016/j.siny.2013.11.014; Steinhoff MC, 2013, VACCINE, V31, pD27, DOI 10.1016/j.vaccine.2013.02.031; Terranella A, 2013, PEDIATRICS, V131, pE1748, DOI 10.1542/peds.2012-3144; Wiley KE, 2013, LANCET RESP MED, V1, P9, DOI 10.1016/S2213-2600(13)70024-9	12	5	5	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2014	384	9953					1484	1486		10.1016/S0140-6736(14)60977-6	http://dx.doi.org/10.1016/S0140-6736(14)60977-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9MO	25037989				2022-12-28	WOS:000343899600007
J	Morens, DM; Fauci, AS				Morens, David M.; Fauci, Anthony S.			Chikungunya at the Door - Deja Vu All Over Again?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PUBLIC-HEALTH; PROSPECTS; SPREAD; VIRUS		[Morens, David M.; Fauci, Anthony S.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Morens, DM (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.							CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243; Morens DM, 2008, JAMA-J AM MED ASSOC, V299, P214, DOI 10.1001/jama.2007.31-a; Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395; Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921; Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/ERV.12.84, 10.1586/erv.12.84]	5	70	75	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2014	371	10					885	887		10.1056/NEJMp1408509	http://dx.doi.org/10.1056/NEJMp1408509			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5NB	25029435	Bronze			2022-12-28	WOS:000341390600003
J	Karasov, TL; Kniskern, JM; Gao, LP; DeYoung, BJ; Ding, J; Dubiella, U; Lastra, RO; Nallu, S; Roux, F; Innes, RW; Barrett, LG; Hudson, RR; Bergelson, J				Karasov, Talia L.; Kniskern, Joel M.; Gao, Liping; DeYoung, Brody J.; Ding, Jing; Dubiella, Ullrich; Lastra, Ruben O.; Nallu, Sumitha; Roux, Fabrice; Innes, Roger W.; Barrett, Luke G.; Hudson, Richard R.; Bergelson, Joy			The long-term maintenance of a resistance polymorphism through diffuse interactions	NATURE			English	Article							DISEASE RESISTANCE; ARABIDOPSIS; COEVOLUTION; SPECIFICITY; EVOLUTION; SELECTION; VARIANCE	Plant resistance (R) genes are a crucial component in plant defence against pathogens(1). Although R genes often fail to provide durable resistance in an agricultural context, they frequently persist as long-lived balanced polymorphisms in nature(2-4). Standard theory explains the maintenance of such polymorphisms through a balance of the costs and benefits of resistance and virulence in a tightly coevolving host-pathogen pair(5,6). However, many plant-pathogen interactions lack such specificity(7). Whether, and how, balanced polymorphisms are maintained in diffusely interacting species(8) is unknown. Here we identify a naturally interacting R gene and effector pair in Arabidopsis thaliana and its facultative plant pathogen, Pseudomonas syringae. The protein encoded by the R gene RPS5 recognizes an AvrPphB homologue (AvrPphB2) and exhibits a balanced polymorphism that has been maintained for over 2 million years (ref. 3). Consistent with the presence of an ancient balanced polymorphism, the R gene confers a benefit when plants are infected with P. syringae carrying avrPphB2 but also incurs a large cost in the absence of infection. RPS5 alleles are maintained at intermediate frequencies in populations globally, suggesting ubiquitous selection for resistance. However, the presence of P. syringae carrying avrPphB is probably insufficient to explain the RPS5 polymorphism. First, avrPphB homologues occur at very low frequencies in P. syringae populations on A. thaliana. Second, AvrPphB only rarely confers a virulence benefit to P. syringae on A. thaliana. Instead, we find evidence that selection for RPS5 involves multiple non-homologous effectors and multiple pathogen species. These results and an associated model suggest that the R gene polymorphism in A. thaliana may not be maintained through a tightly coupled interaction involving a single coevolved R gene and effector pair. More likely, the stable polymorphism is maintained through complex and diffuse community-wide interactions.	[Karasov, Talia L.; Kniskern, Joel M.; Gao, Liping; Ding, Jing; Lastra, Ruben O.; Nallu, Sumitha; Barrett, Luke G.; Hudson, Richard R.; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Karasov, Talia L.] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [DeYoung, Brody J.; Dubiella, Ullrich; Innes, Roger W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Roux, Fabrice] INRA, LIPM, F-31326 Castanet Tolosan, France; [Roux, Fabrice] CNRS, LIPM, F-31326 Castanet Tolosan, France; [Roux, Fabrice] Univ Sci & Technol Lille Lille 1, Lab Genet & Evolut Populat Vegetales, UMR CNRS 8198, F-59655 Villeneuve Dascq, France	University of Chicago; University of Chicago; Indiana University System; Indiana University Bloomington; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Bergelson, J (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	jbergels@uchicago.edu	Nallu, Sumitha/D-5382-2017; Dubiella, Ullrich/AAF-6499-2019; Barrett, Luke G/I-5711-2015	Barrett, Luke G/0000-0001-6530-0731; Karasov, Talia/0000-0002-3592-6597; Innes, Roger/0000-0001-9634-1413; Dubiella, Ullrich/0000-0001-9854-9795; Fabrice, Roux/0000-0001-8059-5638; Bergelson, Joy/0000-0001-7893-7387	Department of Education GAANN fellowship; Dropkin Foundation; National Institutes of Health (NIH) Postbaccalaureate Research Education Program award; Laboratory of Excellence (Labex) TULIP [ANR-10-LABX-41, ANR-11-IDEX-0002-02]; NIH-NIGMS [R01 GM046451, R01 GM057994, R01 GM083068]; NSF [MCB0603515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083068, T32GM007197, R01GM062504, R01GM057994, R01GM046451] Funding Source: NIH RePORTER	Department of Education GAANN fellowship(US Department of Education); Dropkin Foundation; National Institutes of Health (NIH) Postbaccalaureate Research Education Program award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laboratory of Excellence (Labex) TULIP; NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Dwyer, M. Kreitman, L. Merwin, C. Morris and M. Nordborg for discussions, D. Baltrus, D. Dahlbeck, J. Greenberg and B. Vinatzer for supplying plasmids, N. Faure for help collecting the French isolates of P. syringae, C. Gode, J. Higgins and A. Stathos for contributions to genotyping RPS5 presence/absence, G. Sperone for mapping, and T. Morton and the staff of the University of Chicago greenhouse for planting and maintaining A. thaliana. T.L.K. was supported by a Department of Education GAANN fellowship, J.M.K. and L.G.B. were supported by postdoctoral fellowships from the Dropkin Foundation, and R.L. was supported by a National Institutes of Health (NIH) Postbaccalaureate Research Education Program award. F.R. was supported by the Laboratory of Excellence (Labex) TULIP (ANR-10-LABX-41; ANR-11-IDEX-0002-02). This work was supported by grants NIH-NIGMS R01 GM046451 to R.W.I., and grants NSF MCB0603515, NIH-NIGMS R01 GM057994 and NIH-NIGMS R01 GM083068 to J.B.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Barrett LG, 2011, ECOL LETT, V14, P1149, DOI 10.1111/j.1461-0248.2011.01687.x; Barrett LG, 2009, NEW PHYTOL, V183, P513, DOI 10.1111/j.1469-8137.2009.02927.x; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Brown JKM, 2011, ANNU REV PHYTOPATHOL, V49, P345, DOI 10.1146/annurev-phyto-072910-095301; FRANK SA, 1992, TRENDS GENET, V8, P213, DOI 10.1016/0168-9525(92)90236-W; Gao LP, 2009, NEW PHYTOL, V184, P485, DOI 10.1111/j.1469-8137.2009.02959.x; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; HALDANE JBS, 1992, CURR SCI INDIA, V63, P599; Hudson RR, 2007, J MOL EVOL, V64, P702, DOI 10.1007/s00239-006-0261-1; Jakob K, 2002, MOL PLANT MICROBE IN, V15, P1195, DOI 10.1094/MPMI.2002.15.12.1195; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kniskern JM, 2011, EVOLUTION, V65, P818, DOI 10.1111/j.1558-5646.2010.01157.x; Lockett SF, 2001, J ACQ IMMUN DEF SYND, V27, P277, DOI 10.1097/00126334-200107010-00010; Lorang J, 2012, SCIENCE, V338, P659, DOI 10.1126/science.1226743; Morris CE, 2010, MBIO, V1, DOI 10.1128/mBio.00107-10; Paterson S, 1998, P NATL ACAD SCI USA, V95, P3714, DOI 10.1073/pnas.95.7.3714; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Stinchcombe JR, 2001, AM NAT, V158, P376, DOI 10.1086/321990; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Thrall PH, 2012, ECOL LETT, V15, P425, DOI 10.1111/j.1461-0248.2012.01749.x; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Warren RF, 1999, GENETICS, V152, P401	30	111	111	0	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					436	U472		10.1038/nature13439	http://dx.doi.org/10.1038/nature13439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25043057	Green Accepted			2022-12-28	WOS:000340840600035
J	Ducat, L; Philipson, LH; Anderson, BJ				Ducat, Lee; Philipson, Louis H.; Anderson, Barbara J.			The Mental Health Comorbidities of Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ducat, Lee] Mental Hlth Issues Diabet Fdn, Philadelphia, PA USA; [Philipson, Louis H.] Univ Chicago, Chicago, IL 60637 USA; [Anderson, Barbara J.] Baylor Coll Med, Houston, TX 77030 USA	University of Chicago; Baylor College of Medicine	Anderson, BJ (corresponding author), Baylor Coll Med, Dept Pediat, 1102 Bates Ave,Ste 940, Houston, TX 77030 USA.	bja@bcm.edu			NIDDK NIH HHS [T32 DK064582, P30 DK020595] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK064582, P30DK020595] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Anderson B.J., 2007, JOSLINS DIABETES DES, V2nd ed., P641; Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464; Goebel-Fabbri A.E., 2013, TYPE 1 DIABETES SOUR, P180; Gonzalez JS, 2013, TYPE 1 DIABETES SOUR, P169; Katon W., 2010, DEPRESSION DIABETES, P81; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593	7	152	157	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					691	692		10.1001/jama.2014.8040	http://dx.doi.org/10.1001/jama.2014.8040			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN2TR	25010529	Green Accepted			2022-12-28	WOS:000340438700012
J	Deshaies, RJ				Deshaies, Raymond J.			STRUCTURAL BIOLOGY Corralling a protein-degradation regulator	NATURE			English	Editorial Material							COP9 SIGNALOSOME; 26S PROTEASOME; SUBSTRATE; MECHANISM; CLEAVAGE; ACTIVATION; JAB1/CSN5; INSIGHTS; NEDD8; CSN5	The crystal structure of the COP9 signalosome, a large protein complex that regulates intracellular protein degradation, reveals how the complex achieves exquisite specificity for its substrates.	CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Deshaies, RJ (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	deshaies@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	NCI NIH HHS [R01 CA164803] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA164803] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adler AS, 2008, CANCER RES, V68, P506, DOI 10.1158/0008-5472.CAN-07-3060; Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Echalier A, 2013, P NATL ACAD SCI USA, V110, P1273, DOI 10.1073/pnas.1209345110; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Lee YH, 2011, ONCOGENE, V30, P4175, DOI 10.1038/onc.2011.126; Lingaraju GM, 2014, NATURE, V512, P161, DOI 10.1038/nature13566; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Suh GSB, 2002, NEURON, V33, P35, DOI 10.1016/S0896-6273(01)00576-1; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771	17	8	8	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					145	146		10.1038/nature13644	http://dx.doi.org/10.1038/nature13644			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043034	Green Accepted			2022-12-28	WOS:000340200700021
J	Michaletz, ST; Cheng, DL; Kerkhoff, AJ; Enquist, BJ				Michaletz, Sean T.; Cheng, Dongliang; Kerkhoff, Andrew J.; Enquist, Brian J.			Convergence of terrestrial plant production across global climate gradients	NATURE			English	Article							NET PRIMARY PRODUCTION; GENERAL QUANTITATIVE THEORY; TROPICAL FORESTS; TREE SIZE; TEMPERATURE-DEPENDENCE; USE EFFICIENCY; GROWTH; ECOSYSTEM; RESPIRATION; PRECIPITATION	Variation in terrestrial net primary production (NPP) with climate is thought to originate from a direct influence of temperature and precipitation on plant metabolism. However, variation in NPP may also result from an indirect influence of climate by means of plant age, stand biomass, growing season length and local adaptation. To identify the relative importance of direct and indirect climate effects, we extend metabolic scaling theory to link hypothesized climate influences with NPP, and assess hypothesized relationships using a global compilation of ecosystem woody plant biomass and production data. Notably, age and biomass explained most of the variation in production whereas temperature and precipitation explained almost none, suggesting that climate indirectly (not directly) influences production. Furthermore, our theory shows that variation in NPP is characterized by a common scaling relationship, suggesting that global change models can incorporate the mechanisms governing this relationship to improve predictions of future ecosystem function.	[Michaletz, Sean T.; Enquist, Brian J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Cheng, Dongliang] Fujian Normal Univ, Minist Educ, Key Lab Humid Subtrop Ecogeog Proc, Fuzhou 350007, Fujian, Peoples R China; [Kerkhoff, Andrew J.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA; [Enquist, Brian J.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Enquist, Brian J.] The iPlant Collaborat, Tucson, AZ 85721 USA; [Enquist, Brian J.] Aspen Ctr Environm Studies, Aspen, CO 81611 USA	University of Arizona; Fujian Normal University; Kenyon College; The Santa Fe Institute	Enquist, BJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	chengdl@fjnu.edu.cn; benquist@email.arizona.edu	Enquist, Brian J/B-6436-2008; Michaletz, Sean/AAO-8175-2021	Enquist, Brian J/0000-0002-6124-7096; Michaletz, Sean/0000-0003-2158-6525; Kerkhoff, Andrew/0000-0001-9617-8687	NSF [1065861]; Aspen Center for Environmental Studies; National Natural Science Foundation of China [31170374, 31370589]; Fujian Natural Science Funds for Distinguished Young Scholar [2013J06009]; National Science Foundation [1065861]; Emerging Frontiers [1065861] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Aspen Center for Environmental Studies; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Natural Science Funds for Distinguished Young Scholar; National Science Foundation(National Science Foundation (NSF)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	S.T.M. and B.J.E. were supported by an NSF MacroSystems award (1065861) and a fellowship from the Aspen Center for Environmental Studies. D.C. was supported by the National Natural Science Foundation of China (31170374 and 31370589) and Fujian Natural Science Funds for Distinguished Young Scholar (2013J06009). A.J.K. was supported by a sabbatical supplement from Kenyon College, and by a National Science Foundation ROA supplement (1065861) to the NSF MacroSystems award (1065861) to B.J.E.	Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; BONAN GB, 1993, TELLUS B, V45, P397, DOI 10.1034/j.1600-0889.1993.t01-4-00001.x; Brett MT, 2004, OIKOS, V105, P647, DOI 10.1111/j.0030-1299.2004.12777.x; Brooks JR, 2010, NAT GEOSCI, V3, P100, DOI 10.1038/NGEO722; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Campos GEP, 2013, NATURE, V494, P349, DOI 10.1038/nature11836; Cannell MGR, 1982, WORLD FOREST BIOMASS; Chapin FS, 2003, ANN BOT-LONDON, V91, P455, DOI 10.1093/aob/mcg041; Clark DA, 2001, ECOL APPL, V11, P371, DOI 10.1890/1051-0761(2001)011[0371:NPPITF]2.0.CO;2; DeLucia EH, 2007, GLOBAL CHANGE BIOL, V13, P1157, DOI 10.1111/j.1365-2486.2007.01365.x; Enquist B.J., 2012, METAB ECOL SCALING A, P164, DOI [10.1002/, DOI 10.1002/9781119968535.CH14]; Enquist BJ, 2007, NATURE, V449, P218, DOI 10.1038/nature06061; Enquist BJ, 2007, GLOBAL CHANGE BIOL, V13, P591, DOI 10.1111/j.1365-2486.2006.01222.x; Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; FAO/IIASA/ISRIC/ISSCAS/JRC, 2012, HARM WORLD SOIL DAT; Fredlund D. G., 2012, UNSATURATED SOIL MEC; Gates D. M., 1980, BIOPHYSICAL ECOLOGY; Gower ST, 1996, TRENDS ECOL EVOL, V11, P378, DOI 10.1016/0169-5347(96)10042-2; Hasler R, 1999, PHYTON-ANN REI BOT A, V39, P47; Helliker BR, 2008, NATURE, V454, P511, DOI 10.1038/nature07031; Huston MA, 2012, ECOL MONOGR, V82, P277, DOI 10.1890/11-1927.1; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Kempes CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020551; Kerkhoff AJ, 2006, ECOL LETT, V9, P419, DOI 10.1111/j.1461-0248.2006.00888.x; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; Larjavaara M, 2010, FUNCT ECOL, V24, P701, DOI 10.1111/j.1365-2435.2010.01698.x; Lieth H, 1975, PRIMARY PRODUCTIVITY; Luo T. X., 1996, THESIS CHINESE ACAD; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; MONTEITH JL, 1977, PHILOS T ROY SOC B, V281, P277, DOI 10.1098/rstb.1977.0140; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Niklas KJ, 2003, ECOL LETT, V6, P405, DOI 10.1046/j.1461-0248.2003.00440.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; Ryan T., 1997, MODERN REGRESSION ME; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Schuur EAG, 2003, ECOLOGY, V84, P1165, DOI 10.1890/0012-9658(2003)084[1165:PAGCRT]2.0.CO;2; Stegen JC, 2011, GLOBAL ECOL BIOGEOGR, V20, P744, DOI 10.1111/j.1466-8238.2010.00645.x; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Vieira S, 2005, P NATL ACAD SCI USA, V102, P18502, DOI 10.1073/pnas.0505966102; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; West GB, 2009, P NATL ACAD SCI USA, V106, P7040, DOI 10.1073/pnas.0812294106; WHITTAKER RH, 1970, COMMUNITIES ECOSYSTE; Wright IJ, 1999, J ECOL, V87, P85, DOI 10.1046/j.1365-2745.1999.00330.x; Yvon-Durocher G, 2012, NATURE, V487, P472, DOI 10.1038/nature11205	49	204	223	21	318	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					39	+		10.1038/nature13470	http://dx.doi.org/10.1038/nature13470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043056				2022-12-28	WOS:000339908000026
J	Temmerman, M; Khosla, R; Say, L				Temmerman, Marleen; Khosla, Rajat; Say, Lale			Sexual and reproductive health and rights: a global development, health, and human rights priority	LANCET			English	Editorial Material									[Temmerman, Marleen; Khosla, Rajat; Say, Lale] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland	World Health Organization	Khosla, R (corresponding author), WHO, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland.	khoslar@who.int	, lalesay/AAG-1912-2021		World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		The World Bank, 2013, WOM DEL CLOS DEADL G; UN High Level Panel on the post-2015 Development Agenda, 2013, UN HIGH LEV PAN POST; UN Population Division Department of Economic and Social Aff airs, 1994, INT C POP DEV; United Nations, 2014, FRAM ACT FOLL UP PRO; United Nations, 2014, MILL DEV GOALS REP 2; WHO, 2014, PROGR REP SECR; World Health Organization, 2014, HLTH POST 2015 DEV A	7	38	38	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					E30	E31		10.1016/S0140-6736(14)61190-9	http://dx.doi.org/10.1016/S0140-6736(14)61190-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9IV	25043387				2022-12-28	WOS:000340195800001
J	Mawdsley, SE				Mawdsley, Stephen E.			Polio provocation: solving a mystery with the help of history	LANCET			English	Editorial Material									Univ Cambridge, Cambridge CB3 9AL, England	University of Cambridge	Mawdsley, SE (corresponding author), Univ Cambridge, Clare Hall, Cambridge CB3 9AL, England.	sem84@cam.ac.uk		Mawdsley, Stephen/0000-0002-5662-8513					0	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2014	384	9940					300	301		10.1016/S0140-6736(14)61251-4	http://dx.doi.org/10.1016/S0140-6736(14)61251-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM3AE	25072064				2022-12-28	WOS:000339722400015
J	Burdett, TC; Freeman, MR				Burdett, Thomas C.; Freeman, Marc R.			Astrocytes eyeball axonal mitochondria	SCIENCE			English	Editorial Material							TRANSPORT; NEURONS		[Burdett, Thomas C.; Freeman, Marc R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Burdett, TC (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Worcester, MA 01605 USA.	marc.freeman@umassmed.edu		Freeman, Marc/0000-0003-3481-3715; Burdett, Thomas/0000-0001-7069-4122	Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS053538, R37 NS053538] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS053538, R01NS053538] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Court FA, 2012, TRENDS NEUROSCI, V35, P364, DOI 10.1016/j.tins.2012.04.001; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; Morrison BM, 2013, TRENDS CELL BIOL, V23, P644, DOI 10.1016/j.tcb.2013.07.007; Sajic M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001754; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; Smith DH, 2009, PROG NEUROBIOL, V89, P231, DOI 10.1016/j.pneurobio.2009.07.006; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Weaver D, 2014, MOL CELL, V54, P870, DOI 10.1016/j.molcel.2014.03.048; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu DY, 2013, PROG RETIN EYE RES, V36, P217, DOI 10.1016/j.preteyeres.2013.07.001	12	5	7	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					385	386		10.1126/science.1258295	http://dx.doi.org/10.1126/science.1258295			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061193	Green Accepted			2022-12-28	WOS:000339655100020
J	Gould, J				Gould, Julie			FUNDING BY NUMBERS	NATURE			English	Editorial Material																			0	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					S52	S53		10.1038/511S52a	http://dx.doi.org/10.1038/511S52a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL7SO	25054851	Bronze			2022-12-28	WOS:000339335700002
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED "Case finding" in dementia is simply screening with no evidence of benefit	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Andermann A, 2008, B WORLD HEALTH ORGAN, V86, P241; [Anonymous], 2010, UK NSC POLICY ALZHEI; [Anonymous], 2011, GUID INT TUB CAS FIN; Brunet MD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8588; Burns A, RE THERE NO EVIDENCE; Wilson JMG, 1968, PRINCIPLES ORACTICE	6	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2014	349								g4791	10.1136/bmj.g4791	http://dx.doi.org/10.1136/bmj.g4791			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VS	25059715	Green Published, Bronze			2022-12-28	WOS:000339566200006
J	Mellnik, AR; Lee, JS; Richardella, A; Grab, JL; Mintun, PJ; Fischer, MH; Vaezi, A; Manchon, A; Kim, EA; Samarth, N; Ralph, DC				Mellnik, A. R.; Lee, J. S.; Richardella, A.; Grab, J. L.; Mintun, P. J.; Fischer, M. H.; Vaezi, A.; Manchon, A.; Kim, E. -A.; Samarth, N.; Ralph, D. C.			Spin-transfer torque generated by a topological insulator	NATURE			English	Article							MAGNETIZATION DYNAMICS; ORIENTATION; ELECTRONS	Magnetic devices are a leading contender for the implementation of memory and logic technologies that are non-volatile, that can scale to high density and high speed, and that do not wear out. However, widespread application of magnetic memory and logic devices will require the development of efficient mechanisms for reorienting their magnetization using the least possible current and power(1). There has been considerable recent progress in this effort; in particular, it has been discovered that spin-orbit interactions in heavy-metal/ferromagnet bilayers can produce strong current-driven torques on the magnetic layer(2-11), via the spin Hall effect(12,13) in the heavy metal or the Rashba-Edelstein effect(14,15) in the ferromagnet. In the search for materials to provide even more efficient spin-orbit-induced torques, some proposals(16-19) have suggested topological insulators(20,21), which possess a surface state in which the effects of spin-orbit coupling are maximal in the sense that an electron's spin orientation is fixed relative to its propagation direction. Here we report experiments showing that charge current flowing in-plane in a thin film of the topological insulator bismuth selenide (Bi2Se3) at room temperature can indeed exert a strong spin-transfer torque on an adjacent ferromagnetic permalloy (Ni81Fe19) thin film, with a direction consistent with that expected from the topological surface state. We find that the strength of the torque per unit charge current density in Bi2Se3 is greater than for any source of spin-transfer torque measured so far, even for non-ideal topological insulator films in which the surface states coexist with bulk conduction. Our data suggest that topological insulators could enable very efficient electrical manipulation of magnetic materials at room temperature, for memory and logic applications.	[Mellnik, A. R.; Grab, J. L.; Mintun, P. J.; Fischer, M. H.; Vaezi, A.; Kim, E. -A.; Ralph, D. C.] Cornell Univ, Ithaca, NY 14853 USA; [Lee, J. S.; Richardella, A.; Samarth, N.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Fischer, M. H.] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Manchon, A.] King Abdullah Univ Sci & Technol, Phys Sci & Engn Div, Thuwal 239556900, Saudi Arabia; [Ralph, D. C.] Kavli Inst Cornell, Ithaca, NY 14853 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Weizmann Institute of Science; King Abdullah University of Science & Technology	Ralph, DC (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.	dcr14@cornell.edu	Fischer, Mark Hannes/K-2548-2013; Manchon, Aurelien/A-9355-2010; Samarth, Nitin/C-4475-2014; Kim, Eun-Ah/K-6711-2012; Samarth, Nitin/AAV-2322-2020; Lee, Joon Sue/AAC-6295-2020; Fischer, Mark Hannes/ABF-1974-2020	Fischer, Mark Hannes/0000-0003-0810-6064; Manchon, Aurelien/0000-0002-4768-293X; Samarth, Nitin/0000-0003-2599-346X; Kim, Eun-Ah/0000-0002-9554-4443; Samarth, Nitin/0000-0003-2599-346X; Fischer, Mark Hannes/0000-0003-0810-6064; Lee, Joon Sue/0000-0002-1001-1462	DARPA [N66001-11-1-4110]; NSF/MRSEC [DMR-1120296]; Army Research Office [W911NF-08-2-0032]; NSF [DMR-1010768, ECS-0335765]; Office of Naval Research [N00014-12-1-0117]; C-SPIN, one of six centres of STARnet, a Semiconductor Research Corporation program - MARCO; DARPA; Division Of Materials Research [1010768] Funding Source: National Science Foundation	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF/MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Army Research Office; NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); C-SPIN, one of six centres of STARnet, a Semiconductor Research Corporation program - MARCO; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank R. Buhrman, C.-F. Pai, N. Reynolds, J. Gibbons, A. Alemi and M. Bierbaum for discussions and assistance with experiments. Work at Cornell and Penn State was supported by DARPA (N66001-11-1-4110). We acknowledge additional funding for work at Cornell from the NSF/MRSEC-funded Cornell Center for Materials Research (DMR-1120296), the Army Research Office (W911NF-08-2-0032) and the NSF (DMR-1010768), and for work at Penn State from the Office of Naval Research (N00014-12-1-0117). A.R.M. acknowledges a DOE Office of Science graduate fellowship and J.L.G. acknowledges an NSF graduate fellowship. J.S.L. and N.S. acknowledge partial support through C-SPIN, one of six centres of STARnet, a Semiconductor Research Corporation program, sponsored by MARCO and DARPA. This work was performed in part at the Cornell NanoScale Facility and the Penn State Nanofabrication Facility, both nodes of the National Nanotechnology Infrastructure Network (NNIN), which is supported by the NSF (ECS-0335765), and in the facilities of the Cornell Center for Materials Research.	Ando K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.036601; Bahramy MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2162; Burkov AA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.066802; Chernyshov A, 2009, NAT PHYS, V5, P656, DOI 10.1038/NPHYS1362; Culcer D, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.155457; DYAKONOV MI, 1971, PHYS LETT A, VA 35, P459, DOI 10.1016/0375-9601(71)90196-4; EDELSTEIN VM, 1990, SOLID STATE COMMUN, V73, P233, DOI 10.1016/0038-1098(90)90963-C; Emori S, 2013, NAT MATER, V12, P611, DOI [10.1038/NMAT3675, 10.1038/nmat3675]; Fan X, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2709; Fan YB, 2014, NAT MATER, V13, P699, DOI [10.1038/NMAT3973, 10.1038/nmat3973]; Fischer M. H., 2013, PREPRINT; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Garate I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.146802; Garello K, 2013, NAT NANOTECHNOL, V8, P587, DOI [10.1038/NNANO.2013.145, 10.1038/nnano.2013.145]; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Heinrich B, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.066604; Hirsch JE, 1999, PHYS REV LETT, V83, P1834, DOI 10.1103/PhysRevLett.83.1834; Katine JA, 2008, J MAGN MAGN MATER, V320, P1217, DOI 10.1016/j.jmmm.2007.12.013; Kim J, 2013, NAT MATER, V12, P240, DOI [10.1038/nmat3522, 10.1038/NMAT3522]; King PDC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.096802; Liu LQ, 2012, SCIENCE, V336, P555, DOI 10.1126/science.1218197; Liu LQ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.036601; Mahfouzi F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.166602; Manchon A, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.060404; Manchon A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.212405; Miron IM, 2011, NATURE, V476, P189, DOI 10.1038/nature10309; Mosendz O, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214403; Niimi Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.156602; Pai CF, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4753947; Pesin DA, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.014416; Pesin D, 2012, NAT MATER, V11, P409, DOI [10.1038/nmat3305, 10.1038/NMAT3305]; Pi UH, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3502596; Ryu KS, 2013, NAT NANOTECHNOL, V8, P527, DOI [10.1038/nnano.2013.102, 10.1038/NNANO.2013.102]; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Tanaka T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165117; Tserkovnyak Y, 2005, REV MOD PHYS, V77, P1375, DOI 10.1103/RevModPhys.77.1375; Tserkovnyak Y, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.224403; Tserkovnyak Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.187201; Valla T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.117601; Wray LA, 2011, NAT PHYS, V7, P32, DOI 10.1038/NPHYS1838; Yazyev OV, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.266806; Yokoyama T., 2011, PHYS REV B, V81; Yokoyama T, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.113407	44	914	920	34	727	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					449	+		10.1038/nature13534	http://dx.doi.org/10.1038/nature13534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25056062	Green Submitted			2022-12-28	WOS:000339335700042
J	Rubin, LG; Schaffner, W				Rubin, Lorry G.; Schaffner, William			Care of the Asplenic Patient	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SICKLE-CELL-DISEASE; PNEUMOCOCCAL POLYSACCHARIDE VACCINE; CLINICAL-PRACTICE GUIDELINE; INFLUENZAE TYPE-B; TRAUMA PATIENTS; CHILDREN; INFECTION; POSTSPLENECTOMY; SPLENECTOMY; SEPSIS	A 23-year-old man sustained abdominal trauma in a motorcycle accident that required a surgical splenectomy. He received the 23-valent pneumococcal polysaccharide vaccine (PPSV23) after surgery. Six months after his surgery, he calls his primary care provider because he has fever. What is the appropriate management? Are other prophylactic measures available and indicated?	[Rubin, Lorry G.] Steven & Alexandra Cohen Childrens Med Ctr New Yo, Div Infect Dis, Dept Pediat, New Hyde Pk, NY USA; [Rubin, Lorry G.] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA; [Schaffner, William] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37212 USA; [Schaffner, William] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Hofstra University; Northwell Health; Vanderbilt University; Vanderbilt University	Rubin, LG (corresponding author), Cohen Childrens Med Ctr New York, 269-01 76th Ave, New Hyde Pk, NY 11040 USA.	lrubin4@nshs.edu			Dynavax Technologies; Pfizer; Sanofi Pasteur	Dynavax Technologies; Pfizer(Pfizer); Sanofi Pasteur	Dr. Schaffner reports being a member of a data and safety monitoring board for Merck and receiving consulting fees from Dynavax Technologies and Pfizer and lecture fees from Sanofi Pasteur. No other potential conflict of interest relevant to this article was reported.	Adamkiewicz TV, 2008, PEDIATRICS, V121, P562, DOI 10.1542/peds.2007-0018; [Anonymous], 2022, VACC REL BIOL PROD A; Bennett NM, 2013, MMWR-MORBID MORTAL W, V62, P521; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Bisharat N, 2001, J INFECTION, V43, P182, DOI 10.1053/jinf.2001.0904; BISNO AL, 1970, ANN INTERN MED, V72, P389, DOI 10.7326/0003-4819-72-3-389; Briere EC, 2014, MMWR RECOMM REP, V63, P1; BROWN EJ, 1981, J CLIN INVEST, V67, P975, DOI 10.1172/JCI110148; Centers for disease control and prevention, NAT HOSP DISCH SURV; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; Davies JM, 2011, BRIT J HAEMATOL, V155, P308, DOI 10.1111/j.1365-2141.2011.08843.x; Di Sabatino A, 2011, LANCET, V378, P86, DOI 10.1016/S0140-6736(10)61493-6; Ellison AM, 2013, PEDIATR INFECT DIS J, V32, P560, DOI 10.1097/INF.0b013e318286c75b; ERAKLIS AJ, 1967, NEW ENGL J MED, V276, P1225, DOI 10.1056/NEJM196706012762203; EVANS DIK, 1985, J CLIN PATHOL, V38, P309, DOI 10.1136/jcp.38.3.309; FALLETTA JM, 1995, J PEDIATR-US, V127, P685, DOI 10.1016/S0022-3476(95)70154-0; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; Halasa NB, 2007, CLIN INFECT DIS, V44, P1428, DOI 10.1086/516781; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; HOSEA SW, 1981, NEW ENGL J MED, V304, P245, DOI 10.1056/NEJM198101293040501; Katz SC, 2006, AM SURGEON, V72, P565; Konradsen HB, 1997, EPIDEMIOL INFECT, V119, P167, DOI 10.1017/S0950268897007978; Kristinsson SY, 2014, HAEMATOLOGICA, V99, P392, DOI 10.3324/haematol.2013.092460; LATOS DL, 1978, JOHNS HOPKINS MED J, V143, P165; Lesprit P, 2007, AIDS, V21, P2425, DOI 10.1097/QAD.0b013e3282887e91; Lutwick LI, 2010, MANDELL DOUGLAS BENN, P3865; MacNeil JR, 2014, MMWR-MORBID MORTAL W, V63, P527; McCavit TL, 2012, PEDIATR BLOOD CANCER, V58, P945, DOI 10.1002/pbc.23259; Nuorti J Pekka, 2010, MMWR Recomm Rep, V59, P1; PEARSON HA, 1979, BLOOD, V53, P358; Pickering LK, 2012, RED BOOK 2012 REPORT, p[88, 581]; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; RUBIN LG, 1988, INFECT IMMUN, V56, P984, DOI 10.1128/IAI.56.4.984-986.1988; Rubin LG., 2012, PRINCIPLES PRACTICE, P880; Rubin LG, 2014, CLIN INFECT DIS, V58, pE44, DOI [10.1093/cid/cit816, 10.1093/cid/cit684]; SCHWARZMANN SW, 1971, ARCH INTERN MED, V127, P1037, DOI 10.1001/archinte.127.6.1037; Shatz DV, 2002, J TRAUMA, V53, P1037, DOI 10.1097/00005373-200212000-00001; Shatz DV, 1998, J TRAUMA, V44, P760, DOI 10.1097/00005373-199805000-00004; Sickle Cell Association of America, RES SCREEN; Singer D B, 1973, Perspect Pediatr Pathol, V1, P285; STYRT B, 1990, AM J MED, V88, pN33; TORRES J, 1973, AM J MED, V55, P851, DOI 10.1016/0002-9343(73)90268-4; WALDMAN JD, 1977, J PEDIATR-US, V90, P555, DOI 10.1016/S0022-3476(77)80365-X; Wong KK, 2013, PEDIATRICS, V132, P796, DOI 10.1542/peds.2013-1493; Zarrouk V, 2006, MEDICINE, V85, P43, DOI 10.1097/01.md.0000197023.46846.1c	45	127	130	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					349	356		10.1056/NEJMcp1314291	http://dx.doi.org/10.1056/NEJMcp1314291			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7TY	25054718				2022-12-28	WOS:000339339800011
J	Cohen, D				Cohen, Deborah			ANTICOAGULANTS Concerns over data in key dabigatran trial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NONVALVULAR ATRIAL-FIBRILLATION; STROKE PREVENTION; WARFARIN; XIMELAGATRAN; EVENTS					dcohen@bmj.com						Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Albers GW, 2003, LANCET, V362, P1691; [Anonymous], 2011, THERAPEUTICS LETT, V80; Center for Drug Evaluation and Research, 2010, APPL NUMB 22 512; Chatterjee S, 2014, JAMA NEUROL, V71, P371, DOI 10.1001/jamaneurol.2013.6003; Cohen D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4670; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Hohnloser SH, 2012, CIRCULATION, V125, P669, DOI 10.1161/CIRCULATIONAHA.111.055970	9	20	20	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2014	349								g4747	10.1136/bmj.g4747	http://dx.doi.org/10.1136/bmj.g4747			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VP	25055831	Green Published, Bronze			2022-12-28	WOS:000339565900009
J	Muller, PA; Koscso, B; Rajani, GM; Stevanovic, K; Berres, ML; Hashimoto, D; Mortha, A; Leboeuf, M; Li, XM; Mucida, D; Stanley, ER; Dahan, S; Margolis, KG; Gershon, MD; Merad, M; Bogunovic, M				Muller, Paul Andrew; Koscso, Balazs; Rajani, Gaurav Manohar; Stevanovic, Korey; Berres, Marie-Luise; Hashimoto, Daigo; Mortha, Arthur; Leboeuf, Marylene; Li, Xiu-Min; Mucida, Daniel; Stanley, E. Richard; Dahan, Stephanie; Margolis, Kara Gross; Gershon, Michael David; Merad, Miriam; Bogunovic, Milena			Crosstalk between Muscularis Macrophages and Enteric Neurons Regulates Gastrointestinal Motility	CELL			English	Article							IRRITABLE-BOWEL-SYNDROME; INTERSTITIAL-CELLS; SYNAPTIC GROWTH; NERVOUS-SYSTEM; BACTERIAL OVERGROWTH; LANGERHANS CELLS; DENDRITIC CELL; RECEPTOR; MICE; 5-HYDROXYTRYPTAMINE	Intestinal peristalsis is a dynamic physiologic process influenced by dietary and microbial changes. It is tightly regulated by complex cellular interactions; however, our understanding of these controls is incomplete. A distinct population of macrophages is distributed in the intestinal muscularis externa. We demonstrate that, in the steady state, muscularis macrophages regulate peristaltic activity of the colon. They change the pattern of smooth muscle contractions by secreting bone morphogenetic protein 2 (BMP2), which activates BMP receptor (BMPR) expressed by enteric neurons. Enteric neurons, in turn, secrete colony stimulatory factor 1 (CSF1), a growth factor required for macrophage development. Finally, stimuli from microbial commensals regulate BMP2 expression by macrophages and CSF1 expression by enteric neurons. Our findings identify a plastic, microbiotadriven crosstalk between muscularis macrophages and enteric neurons that controls gastrointestinal motility.	[Muller, Paul Andrew; Berres, Marie-Luise; Hashimoto, Daigo; Mortha, Arthur; Leboeuf, Marylene; Merad, Miriam; Bogunovic, Milena] Mt Sinai Hosp, Icahn Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Muller, Paul Andrew; Berres, Marie-Luise; Hashimoto, Daigo; Mortha, Arthur; Leboeuf, Marylene; Merad, Miriam; Bogunovic, Milena] Mt Sinai Hosp, Icahn Sch Med, Tisch Canc Inst, New York, NY 10029 USA; [Muller, Paul Andrew; Berres, Marie-Luise; Hashimoto, Daigo; Mortha, Arthur; Leboeuf, Marylene; Merad, Miriam; Bogunovic, Milena] Mt Sinai Hosp, Icahn Sch Med, Inst Immunol, New York, NY 10029 USA; [Dahan, Stephanie] Mt Sinai Hosp, Icahn Sch Med, Dept Med, Div Clin Immunol, New York, NY 10029 USA; [Li, Xiu-Min] Mt Sinai Hosp, Icahn Sch Med, Dept Pediat, Div Allergy & Immunol, New York, NY 10029 USA; [Li, Xiu-Min] Mt Sinai Hosp, Icahn Sch Med, Jaffe Food Allergy Inst, New York, NY 10029 USA; [Koscso, Balazs; Rajani, Gaurav Manohar; Bogunovic, Milena] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Koscso, Balazs; Rajani, Gaurav Manohar; Bogunovic, Milena] Milton S Hershey Med Ctr, Hershey, PA 17033 USA; [Stevanovic, Korey; Margolis, Kara Gross] Columbia Univ, Morgan Stanley Childrens Hosp, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Gershon, Michael David] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Muller, Paul Andrew; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA; [Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Columbia University; NewYork-Presbyterian Hospital; Morgan Stanley Children's Hospital; Columbia University; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine	Merad, M (corresponding author), Mt Sinai Hosp, Icahn Sch Med, Dept Oncol Sci, New York, NY 10029 USA.	miriam.merad@mssm.edu; mbogunovich@hmc.psu.edu	Mortha, Arthur/ABE-6250-2020; Rajani, Gaurav Manohar/AAX-9919-2021; Stanley, Evan R/J-9154-2013; Hashimoto, Daigo/O-1013-2013; Berres, Marie-Luise/AAN-5351-2021	Stanley, Evan R/0000-0002-2910-2065; Hashimoto, Daigo/0000-0001-9489-9704; Mucida, Daniel/0000-0002-0000-0452; Mortha, Arthur/0000-0003-2673-0485; Stevanovic, Korey/0000-0003-4453-1631; Muller, Paul/0000-0002-1957-4763; Koscso, Balazs/0000-0001-9676-2066	NIH [AI09561, CA173861, AI104848, CA32551, R21-AI105047]; Career Development Award from the CCFA; PCARS from the NIAID; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA032551, R01CA154947, R01CA173861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105047, R01AI104848, U01AI095611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK093786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award from the CCFA; PCARS from the NIAID; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Immgen Project (http://www.immgen.org) for performing a whole-mouse genome microarray and the Penn State Hershey Flow Cytometry Core Facility and the Mount Sinai Flow Cytometry Core for assistance with our experiments. We also thank Frederico Costa Pinta (Rockefeller University, New York, NY, and School of Veterinary Medicine, University of Sao Paulo, Brazil), Hongyan Zou (Icahn School of Medicine at Mount Sinai Hospital, New York, NY), and Florent Ginhoux (Singapore Immunology Network and Agency for Science, Technology and Research, Singapore) for productive discussions regarding the study, and Aron Lukacher (Penn State University College of Medicine, Hershey, PA) for help with the manuscript. This work was supported in part by grants from the NIH (AI09561, CA173861, and AI104848 to M.M.; CA32551 to E.R.S; and R21-AI105047 to D.M.), as well as a Career Development Award from the CCFA and PCARS from the NIAID (M.B.).	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; ABRAMS GD, 1967, P SOC EXP BIOL MED, V126, P301; Anderson L, 2010, AM J PHYSIOL-REG I, V298, pR833, DOI 10.1152/ajpregu.00534.2009; Anitha M, 2012, GASTROENTEROLOGY, V143, P1006, DOI 10.1053/j.gastro.2012.06.034; Boeckxstaens GE, 2009, GUT, V58, P1300, DOI 10.1136/gut.2008.169250; Bogunovic M, 2007, AM J PHYSIOL-GASTR L, V292, pG1770, DOI 10.1152/ajpgi.00249.2006; Bogunovic M, 2012, IMMUNOL RES, V54, P37, DOI 10.1007/s12026-012-8323-5; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; BULBRING E, 1959, J PHYSIOL-LONDON, V146, P29; BULBRING E, 1959, J PHYSIOL-LONDON, V146, P18; Chalazonitis A, 2004, J NEUROSCI, V24, P4266, DOI 10.1523/JNEUROSCI.3688-03.2004; Chalazonitis A, 2008, J COMP NEUROL, V509, P474, DOI 10.1002/cne.21770; Chalazonitis A, 2011, DEV BIOL, V350, P64, DOI 10.1016/j.ydbio.2010.11.017; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Dahan S, 2011, GASTROENTEROLOGY, V140, P550, DOI 10.1053/j.gastro.2010.10.057; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Faure C, 2007, DEV DYNAM, V236, P44, DOI 10.1002/dvdy.20943; Flores-Langarica A, 2005, P NATL ACAD SCI USA, V102, P19039, DOI 10.1073/pnas.0504253102; FRIGO GM, 1970, BRIT J PHARMACOL, V39, P346, DOI 10.1111/j.1476-5381.1970.tb12898.x; Fu M, 2006, DEV BIOL, V299, P137, DOI 10.1016/j.ydbio.2006.07.016; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Goldstein AM, 2005, MECH DEVELOP, V122, P821, DOI 10.1016/j.mod.2005.03.003; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; GUSTAFSSON BE, 1970, SCAND J GASTROENTERO, V5, P309; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Helbing T, 2011, BLOOD, V118, P5040, DOI 10.1182/blood-2011-03-339762; Heredia DJ, 2013, J PHYSIOL-LONDON, V591, P5939, DOI 10.1113/jphysiol.2013.256230; Hoffman SM, 2010, CELL BIOCHEM FUNCT, V28, P686, DOI 10.1002/cbf.1709; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Huynh D, 2009, GASTROENTEROLOGY, V137, P136, DOI 10.1053/j.gastro.2009.03.004; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Li ZS, 2006, J NEUROSCI, V26, P2798, DOI 10.1523/JNEUROSCI.4720-05.2006; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Mikkelsen HB, 2010, J CELL MOL MED, V14, P818, DOI 10.1111/j.1582-4934.2010.01025.x; MIKKELSEN HB, 1985, ANAT REC, V213, P77, DOI 10.1002/ar.1092130111; Mikkelsen HB, 1999, CELL TISSUE RES, V295, P485, DOI 10.1007/s004410051254; MIKKELSEN HB, 1992, CELL TISSUE RES, V270, P273, DOI 10.1007/BF00328013; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Nahm M, 2013, NEURON, V77, P680, DOI 10.1016/j.neuron.2012.12.015; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Peralta S, 2009, WORLD J GASTROENTERO, V15, P2628, DOI 10.3748/wjg.15.2628; Pimentel M, 2003, AM J GASTROENTEROL, V98, P412, DOI 10.1016/S0002-9270(02)05902-6; Pimentel M, 2002, DIGEST DIS SCI, V47, P2639, DOI 10.1023/A:1021039032413; Pimentel M, 2000, AM J GASTROENTEROL, V95, P3503, DOI 10.1111/j.1572-0241.2000.03368.x; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reigstad CS, 2013, NEUROGASTROENT MOTIL, V25, P358, DOI 10.1111/nmo.12134; Rumessen JJ, 2003, INT REV CYTOL, V229, P115, DOI 10.1016/S0074-7696(03)29004-5; Sudo T, 1995, ONCOGENE, V11, P2469; Swapna I, 2012, P NATL ACAD SCI USA, V109, P16336, DOI 10.1073/pnas.1202818109; Tornblom H, 2002, GASTROENTEROLOGY, V123, P1972, DOI 10.1053/gast.2002.37059; Uramatsu M, 2010, MICROBIOL IMMUNOL, V54, P330, DOI 10.1111/j.1348-0421.2010.00217.x; Wang XN, 2007, NAT NEUROSCI, V10, P177, DOI 10.1038/nn1841; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615; Wiktor-Jedrzejczak W., 1991, NATURE, V19, P1049; YEUNG YG, 1987, P NATL ACAD SCI USA, V84, P1268, DOI 10.1073/pnas.84.5.1268; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang HB, 1996, DEVELOPMENT, V122, P2977	65	340	347	5	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					300	313		10.1016/j.cell.2014.04.050	http://dx.doi.org/10.1016/j.cell.2014.04.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036630	Bronze, Green Accepted			2022-12-28	WOS:000340943600011
J	Kirby, T				Kirby, Tony			Profile: NIH's Fogarty International Center	LANCET			English	Editorial Material																			0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					121	121		10.1016/S0140-6736(14)61149-1	http://dx.doi.org/10.1016/S0140-6736(14)61149-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1YC	25025101				2022-12-28	WOS:000338921500017
J	Nibbering, ETJ				Nibbering, Erik T. J.			Low-energy electron diffraction at ultrafast speeds	SCIENCE			English	Editorial Material									Max Born Inst Nichtlineare Opt & Kurzzeitspektros, D-12489 Berlin, Germany	Max Born Institute for Nonlinear Optics & Short Term Spectroscopy	Nibbering, ETJ (corresponding author), Max Born Inst Nichtlineare Opt & Kurzzeitspektros, Max Born Str 2A, D-12489 Berlin, Germany.	nibberin@mbi-berlin.de						Davisson C, 1927, PHYS REV, V30, P705, DOI 10.1103/PhysRev.30.705; Elsaesser T, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4855115; Gulde M, 2014, SCIENCE, V345, P200, DOI 10.1126/science.1250658; Hommelhoff P, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247402; Kirchner FO, 2014, NAT PHOTONICS, V8, P52, DOI [10.1038/NPHOTON.2013.315, 10.1038/nphoton.2013.315]; Miller RJD, 2014, ANNU REV PHYS CHEM, V65, P583, DOI 10.1146/annurev-physchem-040412-110117; Piglosiewicz B, 2014, NAT PHOTONICS, V8, P38, DOI [10.1038/NPHOTON.2013.288, 10.1038/nphoton.2013.288]; Ropers C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.043907; Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135	9	4	4	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					137	138		10.1126/science.1256199	http://dx.doi.org/10.1126/science.1256199			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013045				2022-12-28	WOS:000339409900020
J	Ramasamy, A; Sunthareswaran, R; Warakaulle, D; Dubrey, S				Ramasamy, Anantharaman; Sunthareswaran, Romeshan; Warakaulle, Dinuke; Dubrey, Simon			An elderly woman with postprandial abdominal pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC MESENTERIC ISCHEMIA; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; INTESTINAL ISCHEMIA; FOLLOW-UP; REVASCULARIZATION; EXPERIENCE		[Ramasamy, Anantharaman; Dubrey, Simon] Hillingdon Hosp, Dept Cardiol, Uxbridge UB8 3NN, Middx, England; [Sunthareswaran, Romeshan] Stoke Mandeville Hosp, Dept Surg, Aylesbury HP21 8AL, Bucks, England; [Warakaulle, Dinuke] Stoke Mandeville Hosp, Dept Radiol, Aylesbury HP21 8AL, Bucks, England		Dubrey, S (corresponding author), Hillingdon Hosp, Dept Cardiol, Uxbridge UB8 3NN, Middx, England.	simon.dubrey@thh.nhs.uk						Allen RC, 1996, J VASC SURG, V24, P415, DOI 10.1016/S0741-5214(96)70197-0; Atkins MD, 2007, J VASC SURG, V45, P1162, DOI 10.1016/j.jvs.2007.01.067; Biebl M, 2007, WORLD J SURG, V31, P562, DOI 10.1007/s00268-006-0434-5; Brandt LJ, 2000, GASTROENTEROLOGY, V118, P954, DOI 10.1016/S0016-5085(00)70183-1; Cho JS, 2002, J VASC SURG, V35, P453, DOI 10.1067/mva.2002.118593; MATSUMOTO AH, 1995, J VASC INTERV RADIOL, V6, P165, DOI 10.1016/S1051-0443(95)71087-9; Matsumoto AH, 2002, J AM COLL SURGEONS, V194, pS22, DOI 10.1016/S1072-7515(01)01062-6; Moawad J, 1997, SURG CLIN N AM, V77, P357, DOI 10.1016/S0039-6109(05)70554-5; Park WM, 2002, J VASC SURG, V35, P853, DOI 10.1067/mva.2002.123753; ROSE SC, 1995, J VASC INTERV RADIOL, V6, P339, DOI 10.1016/S1051-0443(95)72819-6	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2014	349								g4509	10.1136/bmj.g4509	http://dx.doi.org/10.1136/bmj.g4509			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZF	25011452				2022-12-28	WOS:000338993700004
J	van Laar, JM; Farge, D; Sont, JK; Naraghi, K; Marjanovic, Z; Larghero, J; Schuerwegh, AJ; Marijt, EWA; Vonk, MC; Schattenberg, AV; Matucci-Cerinic, M; Voskuyl, AE; van de Loosdrecht, AA; Daikeler, T; Kotter, I; Schmalzing, M; Martin, T; Lioure, B; Weiner, SM; Kreuter, A; Deligny, C; Durand, JM; Emery, P; Machold, KR; Sarrot-Reynauld, F; Warnatz, K; Adoue, DFP; Constans, J; Tony, HP; Del Papa, N; Fassas, A; Himsel, A; Launay, D; Lo Monaco, A; Philippe, P; Quere, I; Rich, E; Westhovens, R; Griffiths, B; Saccardi, R; van den Hoogen, FH; Fibbe, WE; Socie, G; Gratwohl, A; Tyndall, A				van Laar, Jacob M.; Farge, Dominique; Sont, Jacob K.; Naraghi, Kamran; Marjanovic, Zora; Larghero, Jerome; Schuerwegh, Annemie J.; Marijt, Erik W. A.; Vonk, Madelon C.; Schattenberg, Anton V.; Matucci-Cerinic, Marco; Voskuyl, Alexandre E.; van de Loosdrecht, Arjan A.; Daikeler, Thomas; Koetter, Ina; Schmalzing, Marc; Martin, Thierry; Lioure, Bruno; Weiner, Stefan M.; Kreuter, Alexander; Deligny, Christophe; Durand, Jean-Marc; Emery, Paul; Machold, Klaus R.; Sarrot-Reynauld, Francoise; Warnatz, Klaus; Adoue, Daniel F. P.; Constans, Joel; Tony, Hans-Peter; Del Papa, Nicoletta; Fassas, Athanasios; Himsel, Andrea; Launay, David; Lo Monaco, Andrea; Philippe, Pierre; Quere, Isabelle; Rich, Eric; Westhovens, Rene; Griffiths, Bridget; Saccardi, Riccardo; van den Hoogen, Frank H.; Fibbe, Willem E.; Socie, Gerard; Gratwohl, Alois; Tyndall, Alan		EBMT EULAR Scleroderma Study Grp	Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TERM-FOLLOW-UP; MARROW-TRANSPLANTATION; AUTOIMMUNE-DISEASES; EUROPEAN GROUP; CIGARETTE-SMOKING; SCLERODERMA; BLOOD; INVOLVEMENT; MORTALITY; PREVALENCE	IMPORTANCE High-dose immunosuppressive therapy and autologous hematopoietic stem cell transplantation (HSCT) have shown efficacy in systemic sclerosis in phase 1 and small phase 2 trials. OBJECTIVE To compare efficacy and safety of HSCT vs 12 successive monthly intravenous pulses of cyclophosphamide. DESIGN, SETTING, AND PARTICIPANTS The Autologous Stem Cell Transplantation International Scleroderma (ASTIS) trial, a phase 3, multicenter, randomized (1:1), open-label, parallel-group, clinical trial conducted in 10 countries at 29 centers with access to a European Group for Blood and Marrow Transplantation-registered transplant facility. From March 2001 to October 2009, 156 patients with early diffuse cutaneous systemic sclerosis were recruited and followed up until October 31, 2013. INTERVENTIONS HSCT vs intravenous pulse cyclophosphamide. MAIN OUTCOMES AND MEASURES The primary end point was event-free survival, defined as time from randomization until the occurrence of death or persistent major organ failure. RESULTS A total of 156 patients were randomly assigned to receive HSCT (n = 79) or cyclophosphamide (n = 77). During a median follow-up of 5.8 years, 53 events occurred: 22 in the HSCT group (19 deaths and 3 irreversible organ failures) and 31 in the control group (23 deaths and 8 irreversible organ failures). During the first year, there were more events in the HSCT group (13 events [16.5%], including 8 treatment-related deaths) than in the control group (8 events [10.4%], with no treatment-related deaths). At 2 years, 14 events (17.7%) had occurred cumulatively in the HSCT group vs 14 events (18.2%) in the control group; at 4 years, 15 events (19%) had occurred cumulatively in the HSCT group vs 20 events (26%) in the control group. Time-varying hazard ratios (modeled with treatment x time interaction) for event-free survival were 0.35 (95% CI, 0.16-0.74) at 2 years and 0.34 (95% CI, 0.16-0.74) at 4 years. CONCLUSIONS AND RELEVANCE Among patients with early diffuse cutaneous systemic sclerosis, HSCT was associated with increased treatment-related mortality in the first year after treatment. However, HCST conferred a significant long-term event-free survival benefit.	[van Laar, Jacob M.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Farge, Dominique] Univ Paris 07, Internal Med & Vasc Dis Unit, AP HP, Hop St Louis, F-75221 Paris 05, France; [Larghero, Jerome] Univ Paris 07, Clin Invest Ctr Biotherapies, AP HP, Hop St Louis, F-75221 Paris 05, France; [Larghero, Jerome] Univ Paris 07, Cell Therapy Unit, AP HP, Hop St Louis, F-75221 Paris 05, France; [Socie, Gerard] Univ Paris 07, AP HP, Hop St Louis, F-75221 Paris 05, France; [Sont, Jacob K.] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands; [Schuerwegh, Annemie J.] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands; [Marijt, Erik W. A.] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands; [Fibbe, Willem E.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Naraghi, Kamran] James Cook Univ Hosp, Dept Rheumatol, Middlesbrough, Cleveland, England; [Marjanovic, Zora] Univ Paris 06, AP HP, Hop St Antoine, Serv Hematol Clin & Therapie Cellulaire, Paris, France; [Vonk, Madelon C.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [Schuerwegh, Annemie J.] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 ED Nijmegen, Netherlands; [Matucci-Cerinic, Marco] Univ Florence, Dept Biomed, Div Rheumatol AOUC, I-50121 Florence, Italy; [Matucci-Cerinic, Marco] Univ Florence, Dept Expt & Clin Med, I-50121 Florence, Italy; [Voskuyl, Alexandre E.] Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, Amsterdam, Netherlands; [van de Loosdrecht, Arjan A.] Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands; [Daikeler, Thomas; Tyndall, Alan] Univ Basel Hosp, Dept Rheumatol, CH-4031 Basel, Switzerland; [Gratwohl, Alois] Univ Basel Hosp, Dept Hematol, CH-4031 Basel, Switzerland; [Koetter, Ina; Schmalzing, Marc] Univ Hosp, Dept Internal Med 2, Tubingen, Germany; [Martin, Thierry] Strasbourg Univ Hosp, Dept Clin Immunol, Strasbourg, France; [Lioure, Bruno] CHU Hautepierre, Unite Greffe Cellules Souches Hermatopoiet, Serv Hematol & Oncol, F-67098 Strasbourg, France; [Weiner, Stefan M.] Krankenhaus Barmherzigen Bruder Trier, Med Abt 2, Trier, Germany; [Kreuter, Alexander] HELIOS St Elisabeth Hosp Oberhausen, Dept Dermatol Venereol & Allergol, Oberhausen, Germany; [Deligny, Christophe] Hop Pierre Zobda Quitman, Serv Med Interne, Fort De France, Martinique, France; [Durand, Jean-Marc] Assistance Publ Hop Marseille, Dept Internal Med CHU Concept, Marseille, France; [Emery, Paul] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Emery, Paul] Leeds Teaching Hosp NHS Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Machold, Klaus R.] Med Univ, Klin Abt Rheumatol, Vienna, Austria; [Sarrot-Reynauld, Francoise] CHU Grenoble, Pole Pluridisciplinaire Med, F-38043 Grenoble, France; [Warnatz, Klaus] Univ Med Ctr Freiburg, Div Rheumatol & Clin Immunol, Freiburg, Germany; [Adoue, Daniel F. P.] Ctr Hosp Univ Toulouse, Serv Med Interne, Toulouse, France; [Constans, Joel] Ctr Hosp Univ Bordeaux, Hop St Andre, Serv Med Interne & Med Vasc, Bordeaux, France; [Tony, Hans-Peter] Univ Wurzburg, Med Ctr, Dept Rheumatol & Clin Immunol, D-97070 Wurzburg, Germany; [Del Papa, Nicoletta] Osped G Pini, Day Hosp Reumatol, Milan, Italy; [Fassas, Athanasios] George Papanicolaou Hosp, Cell & Gene Therapy Ctr, Dept Hematol, Thessaloniki, Greece; [Himsel, Andrea] Univ Hosp Frankfurt, Dept Rheumatol, Frankfurt, Germany; [Launay, David] Hop Claude Huriez, Serv Med Interne, Lille, France; [Lo Monaco, Andrea] Univ Ferrara, Dept Med Sci, Sect & Unit Rheumatol, I-44100 Ferrara, Italy; [Philippe, Pierre] Ctr Hosp Univ Estaing, Serv Med Interne, Clermont Ferrand, France; [Quere, Isabelle] Montpellier Univ Hosp, Dept Internal Med, Montpellier, France; [Rich, Eric] Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Westhovens, Rene] Univ Hosp, Dept Dev & Regenerat KU Leuven, Skeletal Biol & Engn Res Ctr, Leuven, Belgium; [Griffiths, Bridget] Freeman Rd Hosp, Dept Rheumatol, Newcastle Upon Tyne, Tyne & Wear, England; [Saccardi, Riccardo] Careggi Univ Hosp, Dept Hematol, Florence, Italy; [van den Hoogen, Frank H.] Maartensklin, Dept Rheumatol, Nijmegen, Netherlands	Newcastle University - UK; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; James Cook University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Radboud University Nijmegen; Radboud University Nijmegen; University of Florence; University of Florence; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Basel; University of Basel; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; CHU Martinique; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Leeds; Leeds Biomedical Research Centre; University of Leeds; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Freiburg; CHU de Toulouse; CHU Bordeaux; University of Wurzburg; George Papanikolaou General Hospital of Thessaloniki; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Universite de Lille - ISITE; CHU Lille; University of Ferrara; CHU Clermont Ferrand; Universite de Montpellier; CHU de Montpellier; Universite de Montreal; Newcastle Freeman Hospital; Newcastle University - UK; University of Florence; Azienda Ospedaliero Universitaria Careggi; Sint Maartens Clinic	van Laar, JM (corresponding author), Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Room F-02-126,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	j.m.vanlaar@umcutrecht.nl; dominique.farge-bancel@sls.aphp.fr	garban, frederic/M-6130-2014; Monaco, Andrea Lo/D-5774-2015; Quere, Isabelle/AAB-8519-2020; Launay, David/H-1674-2016; Warnatz, Klaus/AAD-3464-2022; Vonk, M.C./L-4726-2015; terriou, louis/S-2830-2018; Koetter, Ina/O-3121-2019; van den Hoogen, Frank/I-7829-2018; Del Papa, Nicoletta/K-8513-2016; Sont, Jacob K/J-8071-2015; CERINIC, marco MATUCCI/AAO-2769-2020; emery, paul/B-3560-2013; Launay, David/A-5270-2018	garban, frederic/0000-0003-3981-0839; Monaco, Andrea Lo/0000-0002-1455-0818; Quere, Isabelle/0000-0002-1492-9764; Launay, David/0000-0003-1840-1817; Vonk, M.C./0000-0002-2266-9907; terriou, louis/0000-0001-5919-9956; Koetter, Ina/0000-0002-9262-005X; van den Hoogen, Frank/0000-0003-1044-015X; Del Papa, Nicoletta/0000-0003-1549-8852; Sont, Jacob K/0000-0002-5840-0651; Launay, David/0000-0003-1840-1817; Sibilia, Jean/0000-0002-1601-4795; Kreuter, Alexander/0000-0003-2275-499X; Saccardi, Riccardo/0000-0002-5763-5467; Machold, Klaus/0000-0002-9551-1975; Voskuyl, Alexandre/0000-0002-9699-1827; Milpied, Noel/0000-0002-5177-014X; Martin, Thierry/0000-0002-2776-2641	French Ministry of Health Programme Hospitalier de Recherche Clinique (Ministere de la Sante-PHRC) [AOM 97030]; National Institute for Health Research (NIHR); NIHR Newcastle Biomedical Research Centre; Imtix-Sangstat; Amgen Europ; National Institute for Health Research [NF-SI-0513-10139] Funding Source: researchfish; Versus Arthritis [18475] Funding Source: researchfish	French Ministry of Health Programme Hospitalier de Recherche Clinique (Ministere de la Sante-PHRC); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Newcastle Biomedical Research Centre; Imtix-Sangstat; Amgen Europ; National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	The European Group for Blood and Marrow Transplantation (EBMT) and European League Against Rheumatism (EULAR) jointly supported the costs of the trial management and operations and approved submission of the manuscript. The Assistance Publique-Hopitaux de Paris (AP-HP), French Ministry of Health Programme Hospitalier de Recherche Clinique (Ministere de la Sante-PHRC AOM 97030), Groupe Francophone de Recherche sur la Sclerodermie supported trial operations in French centres and approved submission of the manuscript. The Association des Sclerodermiques de France contributed to support of the trial in France. The National Institute for Health Research (NIHR) and NIHR Newcastle Biomedical Research Centre financially supported the Study Administration Office. Unrestricted grants were secured from Imtix-Sangstat and Amgen Europ; Miltenyi-Biotec supported the trial through provision of CD34-selection columns at a discount.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Binks M, 2001, ANN RHEUM DIS, V60, P577, DOI 10.1136/ard.60.6.577; Burt RK, 2013, LANCET, V381, P1116, DOI 10.1016/S0140-6736(12)62114-X; Burt RK, 2011, LANCET, V378, P498, DOI 10.1016/S0140-6736(11)60982-3; Chifflot H, 2008, SEMIN ARTHRITIS RHEU, V37, P223, DOI 10.1016/j.semarthrit.2007.05.003; Domsic RT, 2011, ANN RHEUM DIS, V70, P1350, DOI 10.1136/ard.2009.127621corr1; Domsic RT, 2011, ANN RHEUM DIS, V70, P104, DOI 10.1136/ard.2009.127621; Ehlers SL, 2011, BONE MARROW TRANSPL, V46, P285, DOI 10.1038/bmt.2010.113; Farge D, 2005, ARTHRITIS RHEUM, V52, P1555, DOI 10.1002/art.21036; Farge D, 2004, ANN RHEUM DIS, V63, P974, DOI 10.1136/ard.2003.011205; Farge D, 2010, HAEMATOL-HEMATOL J, V95, P284, DOI 10.3324/haematol.2009.013458; Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452; Fox BD, 2013, EUR RESPIR J, V42, P1083, DOI 10.1183/09031936.00091212; Fransen J, 2011, ANN RHEUM DIS, V70, P1788, DOI 10.1136/ard.2010.144360; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Hudson M, 2011, ARTHRITIS RHEUM-US, V63, P230, DOI 10.1002/art.30071; Khanna D, 2006, ANN RHEUM DIS, V65, P1325, DOI 10.1136/ard.2005.050187; Launay D, 2009, J RHEUMATOL, V36, P1460, DOI 10.3899/jrheum.081212; Nash RA, 2007, BLOOD, V110, P1388, DOI 10.1182/blood-2007-02-072389; Pasquini MC, 2012, BIOL BLOOD MARROW TR, V18, P1471, DOI 10.1016/j.bbmt.2012.06.003; Saccardi R, 2004, Bone Marrow Transplant, V34, P877, DOI 10.1038/sj.bmt.1704656; Snowden JA, 2012, BONE MARROW TRANSPL, V47, P770, DOI 10.1038/bmt.2011.185; Tran BT, 2011, BIOL BLOOD MARROW TR, V17, P1004, DOI 10.1016/j.bbmt.2010.10.032; Tyndall A, 1997, LANCET, V349, P254, DOI 10.1016/S0140-6736(05)64864-7; Tyndall A, 1997, BONE MARROW TRANSPL, V19, P643, DOI 10.1038/sj.bmt.1700727; Verrecchia F, 2007, RHEUMATOLOGY, V46, P833, DOI 10.1093/rheumatology/kel451; Vonk MC, 2008, ANN RHEUM DIS, V67, P98, DOI 10.1136/ard.2007.071464	27	443	457	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2490	2498		10.1001/jama.2014.6368	http://dx.doi.org/10.1001/jama.2014.6368			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	25058083	Green Published			2022-12-28	WOS:000337757000022
J	Engineer, CB; Ghassemian, M; Anderson, JC; Peck, SC; Hu, HH; Schroeder, JI				Engineer, Cawas B.; Ghassemian, Majid; Anderson, Jeffrey C.; Peck, Scott C.; Hu, Honghong; Schroeder, Julian I.			Carbonic anhydrases, EPF2 and a novel protease mediate CO2 control of stomatal development	NATURE			English	Article							ASYMMETRIC CELL-DIVISION; SIGNAL-TRANSDUCTION; SECRETORY PEPTIDE; ABSCISIC-ACID; DENSITY; KINASE; DIFFERENTIATION; REVEALS	Environmental stimuli, including elevated carbon dioxide levels, regulate stomatal development(1-3); however, the key mechanisms mediating the perception and relay of the CO2 signal to the stomatal development machinery remain elusive. To adapt CO2 intake to water loss, plants regulate the development of stomatal gas exchange pores in the aerial epidermis. A diverse range of plant species show a decrease in stomatal density in response to the continuing rise in atmospheric CO2 (ref. 4). To date, one mutant that exhibits deregulation of this CO2-controlled stomatal development response, hic (which is defective in cell-wall wax biosynthesis, ref. 5), has been identified. Here we show that recently isolated Arabidopsis thaliana beta-carbonic anhydrase double mutants (cal ca4)(6) exhibit an inversion in their response to elevated CO2, showing increased stomatal development at elevated CO2 levels. We characterized the mechanisms mediating this response and identified an extracellular signalling pathway involved in the regulation of CO2-controlled stomatal development by carbonic anhydrases. RNA-seq analyses of transcripts show that the extracellular pro-peptide-encoding gene EPIDERMAL PATTERNING FACTOR 2 (EPF2)(7,8), but not EPFI (ref. 9), is induced in wild-type leaves but not in cal ca4 mutant leaves at elevated CO2 levels. Moreover, EPF2 is essential for CO2 control of stomatal development. Using cell-wall proteomic analyses and CO2-dependent transcriptomic analyses, we identified a novel CO2-induced extracellular protease, CRSP (CO2 RESPONSE SECRETED PROTEASE), as a mediator of CO2-controlled stomatal development. Our results identify mechanisms and genes that function in the repression of stomatal development in leaves during atmospheric CO2 elevation, including the carbonic-anhydrase-encoding genes CA1 and CA4 and the secreted protease CRSP, which cleaves the pro-peptide EPF2, in turn repressing stomatal development. Elucidation of these mechanisms advances the understanding of how plants perceive and relay the elevated CO2 signal and provides a framework to guide future research into how environmental challenges can modulate gas exchange in plants.	[Engineer, Cawas B.; Hu, Honghong; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Ghassemian, Majid] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Anderson, Jeffrey C.; Peck, Scott C.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Missouri System; University of Missouri Columbia	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	jischroeder@ucsd.edu	Anderson, Jeff/I-1316-2017	Anderson, Jeff/0000-0001-9446-7100	National Science Foundation [MCB0918220, MCB1414339, IOS-1025837]; National Institutes of Health [GM060396-ES010337]; BAYER-UC Discovery grant; seed grant from the UCSD-SDCSB [GM085764]; Systems Biology Center; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-03ER15449]; Direct For Biological Sciences [1414339] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060396, P50GM085764] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BAYER-UC Discovery grant; seed grant from the UCSD-SDCSB; Systems Biology Center; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Knepper for conducting independent CO<INF>2</INF>-dependent stomatal development analyses. We thank A. Ries for help with generating the CA-YFP-fusion complementation lines. We thank D. Bergmann for providing the epfl6 mutant line and DNA constructs for MUTEpro::nucGFP expression; K. Toni for providing DNA constructs for MUTEpro::MUTE-GFP expression, erecta mutants and the oestradiol-inducible EPF constructs; T. Altmann for providing the sdd1-1 mutant; and M. Estelle, Y. Zhao, A. Stephan and M. Facette for comments on the manuscript. This project was funded by grants from the National Science Foundation (MCB0918220 and MCB1414339 to J.I.S. and IOS-1025837 to S.C.P.) and the National Institutes of Health (GM060396-ES010337 to J.I.S.), a BAYER-UC Discovery grant (J.I.S.) and a seed grant from the UCSD-SDCSB (GM085764) Systems Biology Center (C.B.E.). A grant from the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DE-FG02-03ER15449) to J.I.S. funded complementation and localization analyses.	Abrash EB, 2010, DEVELOPMENT, V137, P447, DOI 10.1242/dev.040931; Anderson JC, 2008, PLANT J, V55, P881, DOI 10.1111/j.1365-313X.2008.03550.x; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Berger D, 2000, GENE DEV, V14, P1119; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Gray JE, 2000, NATURE, V408, P713, DOI 10.1038/35047071; Guttman M, 2009, PROTEOMICS, V9, P5016, DOI 10.1002/pmic.200900457; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hu HH, 2010, NAT CELL BIOL, V12, P87, DOI 10.1038/ncb2009; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Kondo T, 2010, PLANT CELL PHYSIOL, V51, P1, DOI 10.1093/pcp/pcp180; Lake JA, 2008, NEW PHYTOL, V179, P397, DOI 10.1111/j.1469-8137.2008.02485.x; Lee JS, 2012, GENE DEV, V26, P126, DOI 10.1101/gad.179895.111; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Niehl A, 2013, J PROTEOME RES, V12, P2491, DOI 10.1021/pr3010698; Ohki S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1520; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Pillitteri LJ, 2012, ANNU REV PLANT BIOL, V63, P591, DOI 10.1146/annurev-arplant-042811-105451; Pillitteri LJ, 2011, PLANT CELL, V23, P3260, DOI 10.1105/tpc.111.088583; Rautengarten C, 2008, PLANT J, V54, P466, DOI 10.1111/j.1365-313X.2008.03437.x; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sellers PJ, 1997, SCIENCE, V275, P502, DOI 10.1126/science.275.5299.502; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Uchida N, 2013, J EXP BOT, V64, P5335, DOI 10.1093/jxb/ert196; Woodward FI, 2002, NEW PHYTOL, V153, P477, DOI 10.1046/j.0028-646X.2001.00338.x; Woodward FI, 2002, CURR OPIN PLANT BIOL, V5, P207, DOI 10.1016/S1369-5266(02)00253-4; WOODWARD FI, 1987, NATURE, V327, P617, DOI 10.1038/327617a0; Xue SW, 2011, EMBO J, V30, P1645, DOI 10.1038/emboj.2011.68; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6	40	144	166	5	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					246	+		10.1038/nature13452	http://dx.doi.org/10.1038/nature13452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043023	Green Accepted			2022-12-28	WOS:000341362800053
J	Rochwerg, B; Alhazzani, W; Sindi, A; Heels-Ansdell, D; Thabane, L; Fox-Robichaud, A; Mbuagbaw, L; Szczeklik, W; Alshamsi, F; Altayyar, S; Ip, WC; Li, GW; Wang, M; Wludarczyk, A; Zhou, Q; Guyatt, GH; Cook, DJ; Jaeschke, R; Annane, D				Rochwerg, Bram; Alhazzani, Waleed; Sindi, Anees; Heels-Ansdell, Diane; Thabane, Lehana; Fox-Robichaud, Alison; Mbuagbaw, Lawrence; Szczeklik, Wojciech; Alshamsi, Fayez; Altayyar, Sultan; Ip, Wang-Chun; Li, Guowei; Wang, Michael; Wludarczyk, Anna; Zhou, Qi; Guyatt, Gordon H.; Cook, Deborah J.; Jaeschke, Roman; Annane, Djillali		Fluids Sepsis Septic Shock Grp	Fluid Resuscitation in Sepsis A Systematic Review and Network Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							HYDROXYETHYL STARCH 130/0.4; ACUTE KIDNEY INJURY; SEPTIC SHOCK; ILL PATIENTS; INTENSIVE-CARE; ALBUMIN; SALINE; MORTALITY; PENTASTARCH; ASSOCIATION	Background: Fluid resuscitation is the cornerstone of sepsis treatment. However, whether balanced or unbalanced crystalloids or natural or synthetic colloids confer a survival advantage is unclear. Purpose: To examine the effect of different resuscitative fluids on mortality in patients with sepsis. Data Sources: MEDLINE, EMBASE, ACP Journal Club, CINAHL, HealthSTAR, the Allied and Complementary Medicine Database, and the Cochrane Central Register of Controlled Trials through March 2014. Study Selection: Randomized trials that evaluated different resuscitative fluids in adult patients with sepsis or septic shock and death. No language restrictions were applied. Data Extraction: Two reviewers extracted data on study characteristics, methods, and outcomes. Risk of bias for individual studies and quality of evidence were assessed. Data Synthesis: 14 studies (18 916 patients) were included with 15 direct comparisons. Network meta-analysis at the 4-node level showed higher mortality with starches than with crystalloids (high confidence) and lower mortality with albumin than with crystalloids (moderate confidence) or starches (moderate confidence). Network meta-analysis at the 6-node level showed lower mortality with albumin than with saline (moderate confidence) and low-molecular-weight starch (low confidence) and with balanced crystalloids than with saline (low confidence) and low-and high-molecular-weight starches (moderate confidence). Limitations: These trials were heterogeneous in case mix, fluids evaluated, duration of fluid exposure, and risk of bias. Imprecise estimates for several comparisons in this network meta-analysis contribute to low confidence in most estimates of effect. Conclusion: Among patients with sepsis, resuscitation with balanced crystalloids or albumin compared with other fluids seems to be associated with reduced mortality.	McMaster Univ, Hamilton, ON L8N 3Z5, Canada; Prince Sultan Mil Med City, Riyadh, Saudi Arabia; King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; Jagiellonian Univ, Coll Med, PL-31066 Krakow, Poland; Univ Versailles St Quentin En Yvelines, F-92380 Garches, France	McMaster University; Prince Sultan Military Medical City; King Abdulaziz University; Jagiellonian University; Collegium Medicum Jagiellonian University; UDICE-French Research Universities; Universite Paris Saclay	Cook, DJ (corresponding author), St Josephs Healthcare, Crit Care Med, Room D176,50 Charlton Ave East, Hamilton, ON L8N 3A5, Canada.	debcook@mcmaster.ca	Wludarczyk, Anna/AAP-4012-2021; Sindi, Anees A/D-6037-2019; Mbuagbaw, Lawrence/D-9381-2015; Li, Guowei/HCH-8923-2022; Rochwerg, Bram/AAE-7606-2020; Annane, Djillali/R-7947-2019; Zhou, Qi/GSM-9583-2022; Alshamsi, Fayez/AAZ-5713-2021; Szczeklik, Wojciech/N-8096-2014	Mbuagbaw, Lawrence/0000-0001-5855-5461; Alshamsi, Fayez/0000-0002-9121-4279; Szczeklik, Wojciech/0000-0002-1349-1123; Sindi, Anees/0000-0002-5854-6298	Hamilton Chapter of the Canadian Intensive Care Foundation; Critical Care Medicine Residency Program; Critical Care Division Alternate Funding Plan at McMaster University; Critical Care Medicine Residency Program at McMaster University; Canadian Institutes of Health Research	Hamilton Chapter of the Canadian Intensive Care Foundation; Critical Care Medicine Residency Program; Critical Care Division Alternate Funding Plan at McMaster University; Critical Care Medicine Residency Program at McMaster University; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The Hamilton Chapter of the Canadian Intensive Care Foundation and the Critical Care Medicine Residency Program and Critical Care Division Alternate Funding Plan at McMaster University.; By the Hamilton Chapter of the Canadian Intensive Care Foundation and the Critical Care Medicine Residency Program and Critical Care Division Alternate Funding Plan, both at McMaster University. Dr. Cook is supported by the Canadian Institutes of Health Research.	Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; [Anonymous], BASES TRIAL BAS STAR; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Bansal M, 2013, CURR DRUG SAF, V8, P236, DOI 10.2174/15748863113089990046; Bellomo R, 2010, CONTRIB NEPHROL, V165, P206, DOI 10.1159/000313760; Bunn F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001319.pub5; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Delaney AP, 2011, CRIT CARE MED, V39, P386, DOI 10.1097/CCM.0b013e3181ffe217; Dubin Arnaldo, 2010, J Crit Care, V25, DOI 10.1016/j.jcrc.2010.04.007; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2011, INTENS CARE MED, V37, P86, DOI 10.1007/s00134-010-2039-6; Gattas DJ, 2012, ANESTH ANALG, V114, P159, DOI 10.1213/ANE.0b013e318236b4d6; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; GUYAT GH, 1993, JAMA-J AM MED ASSOC, V270, P2096, DOI 10.1001/jama.270.17.2096; Guyatt G, 2011, METHODS COMMENTARY R; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Haase N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f839; Haase N, 2013, CURR OPIN CRIT CARE, V19, P321, DOI 10.1097/MCC.0b013e3283632de6; HAUPT MT, 1982, CRIT CARE MED, V10, P159, DOI 10.1097/00003246-198203000-00004; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Jansen JP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-159; Jansen JP, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-152; Jiwaji Z, 2014, EMERG MED J, V31, P1000, DOI 10.1136/emermed-2013-202883; Jones D, 2010, ANAESTH INTENS CARE, V38, P266, DOI 10.1177/0310057X1003800207; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Li Feng, 2008, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V20, P472; Lobo DN, 2012, ANN SURG, V255, P830, DOI 10.1097/SLA.0b013e318250766c; Lv Jie, 2012, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V24, P38; McIntyre LA, 2008, CAN J ANAESTH, V55, P819, DOI 10.1007/BF03034053; Miller DR, 2011, CAN J ANESTH, V58, P777, DOI 10.1007/s12630-011-9558-7; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Morgan TJ, 2013, CURR OPIN CRIT CARE, V19, P299, DOI 10.1097/MCC.0b013e3283632d46; Myburgh JA, 2013, NEW ENGL J MED, V369, P1243, DOI 10.1056/NEJMra1208627; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Perel P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub6; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; RACKOW EC, 1989, CRIT CARE MED, V17, P394, DOI 10.1097/00003246-198905000-00003; Reilly Charles, 2011, Br J Anaesth, V107, P116, DOI 10.1093/bja/aer068; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rochwerg B, 2013, POL ARCH MED WEWN, V123, P603, DOI 10.20452/pamw.1972; U.S. Food and Drug Administration, 2013, FDA SAF COMM BOX WAR; Wilkes MM, 2001, ANN INTERN MED, V135, P149, DOI 10.7326/0003-4819-135-3-200108070-00007; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430	47	178	192	1	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2014	161	5					347	+		10.7326/M14-0178	http://dx.doi.org/10.7326/M14-0178			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO7VT	25047428				2022-12-28	WOS:000341561400005
J	Arranz, L; Sanchez-Aguilera, A; Martin-Perez, D; Isern, J; Langa, X; Tzankov, A; Lundberg, P; Muntion, S; Tzeng, YS; Lai, DM; Schwaller, J; Skoda, RC; Mendez-Ferrer, S				Arranz, Lorena; Sanchez-Aguilera, Abel; Martin-Perez, Daniel; Isern, Joan; Langa, Xavier; Tzankov, Alexandar; Lundberg, Pontus; Muntion, Sandra; Tzeng, Yi-Shiuan; Lai, Dar-Ming; Schwaller, Juerg; Skoda, Radek C.; Mendez-Ferrer, Simon			Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms	NATURE			English	Article							TYROSINE KINASE JAK2; ACTIVATING MUTATION; POLYCYTHEMIA-VERA; BONE; JAK2-V617F	Myeloproliferative neoplasms (MPNs) are diseases caused by mutations in the haematopoietic stem cell (HSC) compartment. Most MPN patients have a common acquired mutation of Janus kinase 2 (JAK2) gene in HSCs1-4 that renders this kinase constitutively active, leading to uncontrolled cell expansion. The bone marrow microenvironment might contribute to the clinical outcomes of this common event. We previously showed that bone marrow nestin(+) mesenchymal stem cells (MSCs) innervated by sympathetic nerve fibres regulate normal HSCs5,6. Here we demonstrate that abrogation of this regulatory circuit is essential for MPN pathogenesis. Sympathetic nerve fibres, supporting Schwann cells and nestin(+) MSCs are consistently reduced in the bone marrow of MPN patients and mice expressing the human JAK2(V617F) mutation in HSCs. Unexpectedly, MSC reduction is not due to differentiation but is caused by bone marrow neural damage and Schwann cell death triggered by interleukin-1 beta produced by mutant HSCs. In turn, in vivo depletion of nestin(+) cells or their production of CXCL12 expanded mutant HSC number and accelerated MPN progression. In contrast, administration of neuroprotective or sympathomimetic drugs prevented mutant HSC expansion. Treatment with beta(3)-adrenergic agonists that restored the sympathetic regulation of nestin(+) MSCs5,6 prevented the loss of these cells and blocked MPN progression by indirectly reducing the number of leukaemic stem cells. Our results demonstrate that mutant-HSC-driven niche damage critically contributes to disease manifestation in MPN and identify niche-forming MSCs and their neural regulation as promising therapeutic targets.	[Arranz, Lorena; Sanchez-Aguilera, Abel; Martin-Perez, Daniel; Isern, Joan; Langa, Xavier; Mendez-Ferrer, Simon] CNIC, Stem Cell Niche Pathophysiol Grp, Madrid 28029, Spain; [Tzankov, Alexandar; Lundberg, Pontus; Schwaller, Juerg; Skoda, Radek C.] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Muntion, Sandra] IBSAL Hosp Univ Salamanca, Dept Haematol, Salamanca 37007, Spain; [Tzeng, Yi-Shiuan; Lai, Dar-Ming] Natl Taiwan Univ, Taipei 10002, Taiwan	Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Basel; National Taiwan University	Mendez-Ferrer, S (corresponding author), CNIC, Stem Cell Niche Pathophysiol Grp, Madrid 28029, Spain.	smendez@cnic.es	Tzankov, Alexandar/H-5656-2019; Martín Pérez, Daniel/AFW-0499-2022; Isern, Joan/C-1250-2017; Méndez-Ferrer, Simón/ABG-8547-2020; Arranz, Lorena/Z-3635-2019; Pérez, Daniel Martín/M-4264-2018; Schwaller, Juerg/A-3044-2016; Méndez-Ferrer, Simón/L-8088-2014	Tzankov, Alexandar/0000-0002-1100-3819; Martín Pérez, Daniel/0000-0001-6125-2955; Isern, Joan/0000-0002-1401-9779; Méndez-Ferrer, Simón/0000-0002-9805-9988; Arranz, Lorena/0000-0002-5896-4238; Pérez, Daniel Martín/0000-0001-6125-2955; Schwaller, Juerg/0000-0001-8616-0096; Méndez-Ferrer, Simón/0000-0002-9805-9988; Muntion Olave, Sandra/0000-0001-7164-0767	Fundacion CNIC; Spanish Ministry of Economy and Competitiveness (TerCel, Spanish Cell Therapy Network) [SAF-2011-30308]; ConSEPOC-Comunidad de Madrid [S2010/BMD-2542]; Ramon y Cajal Program [RYC-2009-04703/2011-09726]; Marie Curie grants [FP7-PEOPLE-2011-RG-294262/294096]; Swiss National Science Foundation [310000-120724/1, 32003BB_135712/1]; Swiss Cancer League [KLS-02398-02-2009]; European Hematology Association; Howard Hughes Medical Institute	Fundacion CNIC; Spanish Ministry of Economy and Competitiveness (TerCel, Spanish Cell Therapy Network); ConSEPOC-Comunidad de Madrid; Ramon y Cajal Program(Spanish Government); Marie Curie grants(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; European Hematology Association; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank S. Martin-Salamanca, A. M. Martin, A. B. Ricote, J. M. Ligos, S. Bartlett and the CNIC Comparative Medicine, Genomics and Bioinformatics Units for assistance; members of S.M.-F. and B. Ibanez groups and M. Garcia-Fernandez for data discussion; G. Enikolopov, G. Fishell and D. Riethmacher for providing mice. This work was supported by Fundacion CNIC, Spanish Ministry of Economy and Competitiveness (TerCel, Spanish Cell Therapy Network; Plan Nacional SAF-2011-30308) and ConSEPOC-Comunidad de Madrid S2010/BMD-2542 grants to S.M.-F.; Ramon y Cajal Program grants RYC-2009-04703/2011-09726 and Marie Curie grants FP7-PEOPLE-2011-RG-294262/294096 to A.S.-A. and S.M.-F.; Swiss National Science Foundation 310000-120724/1, 32003BB_135712/1 and Swiss Cancer League KLS-02398-02-2009 grants to R.C.S.; A.S.-A. received a Research Fellowship from the European Hematology Association. S.M.-F. is supported in part by an International Early Career Scientist grant of the Howard Hughes Medical Institute.	Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Biernaskie JA, 2006, NAT PROTOC, V1, P2803, DOI 10.1038/nprot.2006.422; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Irichishima H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030557; Isern J, 2013, CELL REP, V3, P1714, DOI 10.1016/j.celrep.2013.03.041; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kubovcakova L, 2013, BLOOD, V121, P1188, DOI 10.1182/blood-2012-03-415646; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Pajtler Kristian, 2010, J Vis Exp, DOI 10.3791/2380; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; RAMESHWAR P, 1994, J IMMUNOL, V153, P2819; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053	35	290	299	5	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					78	+		10.1038/nature13383	http://dx.doi.org/10.1038/nature13383			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043017				2022-12-28	WOS:000339908000035
J	Erk, B; Boll, R; Trippel, S; Anielski, D; Foucar, L; Rudek, B; Epp, SW; Coffee, R; Carron, S; Schorb, S; Ferguson, KR; Swiggers, M; Bozek, JD; Simon, M; Marchenko, T; Kupper, J; Schlichting, I; Ullrich, J; Bostedt, C; Rolles, D; Rudenko, A				Erk, Benjamin; Boll, Rebecca; Trippel, Sebastian; Anielski, Denis; Foucar, Lutz; Rudek, Benedikt; Epp, Sascha W.; Coffee, Ryan; Carron, Sebastian; Schorb, Sebastian; Ferguson, Ken R.; Swiggers, Michele; Bozek, John D.; Simon, Marc; Marchenko, Tatiana; Kuepper, Jochen; Schlichting, Ilme; Ullrich, Joachim; Bostedt, Christoph; Rolles, Daniel; Rudenko, Artem			Imaging charge transfer in iodomethane upon x-ray photoabsorption	SCIENCE			English	Article							ELECTRON-TRANSFER; CROSS-SECTIONS; SPECTROSCOPY; COLLISIONS; MOLECULES; DYNAMICS; RATES; IONS	Studies of charge transfer are often hampered by difficulties in determining the charge localization at a given time. Here, we used ultrashort x-ray free-electron laser pulses to image charge rearrangement dynamics within gas-phase iodomethane molecules during dissociation induced by a synchronized near-infrared (NIR) laser pulse. Inner-shell photoionization creates positive charge, which is initially localized on the iodine atom. We map the electron transfer between the methyl and iodine fragments as a function of their interatomic separation set by the NIR-x-ray delay. We observe signatures of electron transfer for distances up to 20 angstroms and show that a realistic estimate of its effective spatial range can be obtained from a classical over-the-barrier model. The presented technique is applicable for spatiotemporal imaging of charge transfer dynamics in a wide range of molecular systems.	[Erk, Benjamin; Boll, Rebecca; Anielski, Denis; Foucar, Lutz; Rudek, Benedikt; Epp, Sascha W.; Schlichting, Ilme; Ullrich, Joachim; Rolles, Daniel; Rudenko, Artem] CFEL, Max Planck Adv Study Grp, D-22607 Hamburg, Germany; [Trippel, Sebastian; Kuepper, Jochen] DESY, Ctr Free Electron Laser Sci CFEL, D-22607 Hamburg, Germany; [Foucar, Lutz; Schlichting, Ilme; Rolles, Daniel] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Rudek, Benedikt; Ullrich, Joachim] Phys Tech Bundesanstalt, D-38116 Braunschweig, Germany; [Coffee, Ryan; Carron, Sebastian; Schorb, Sebastian; Ferguson, Ken R.; Swiggers, Michele; Bozek, John D.; Bostedt, Christoph] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Simon, Marc; Marchenko, Tatiana] Univ Paris 06, Sorbonne Univ, Lab Chim Phys Matiere & Rayonnement, F-75005 Paris, France; [Kuepper, Jochen] Univ Hamburg, Ctr Ultrafast Imaging, D-22761 Hamburg, Germany; [Rudenko, Artem] Kansas State Univ, Dept Phys, JR Macdonald Lab, Manhattan, KS 66506 USA	Max Planck Society; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; Physikalisch-Technische Bundesanstalt (PTB); Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; UDICE-French Research Universities; Sorbonne Universite; University of Hamburg; Kansas State University	Erk, B (corresponding author), Deutsch Elektronen Synchrotron DESY, D-22607 Hamburg, Germany.	benjamin.erk@desy.de; rudenko@phys.ksu.edu	Bozek, John D/E-9260-2010; Boll, Rebecca/AAL-8222-2020; Trippel, Sebastian/J-7825-2015; Rudek, Benedikt/AAX-1278-2021; SIMON, Marc/ABH-1911-2021; Küpper, Jochen/A-5564-2008; Schlichting, Ilme/I-1339-2013; Marchenko, Tatiana/AAB-2225-2019; Rudek, Benedikt/A-5100-2017; Rudenko, Artem/C-7412-2009	Bozek, John D/0000-0001-7486-7238; Boll, Rebecca/0000-0001-6286-4064; Trippel, Sebastian/0000-0002-1895-3868; Rudek, Benedikt/0000-0002-6404-4294; SIMON, Marc/0000-0002-2525-5435; Küpper, Jochen/0000-0003-4395-9345; Marchenko, Tatiana/0000-0002-9015-3339; Rudenko, Artem/0000-0002-9154-8463; Epp, Sascha/0000-0001-6366-9113; Erk, Benjamin/0000-0001-8413-3588	Max Planck Society; Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy; Kansas National Science Foundation Experimental Program to Stimulate Competitive Research (NSF EPSCoR) "First Award"; Helmholtz Gemeinschaft through the Young Investigator Program; excellence cluster "The Hamburg Centre for Ultrafast Imaging - Structure, Dynamics and Control of Matter at the Atomic Scale" of the Deutsche Forschungsgemeinschaft	Max Planck Society(Max Planck Society); Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE)); Kansas National Science Foundation Experimental Program to Stimulate Competitive Research (NSF EPSCoR) "First Award"; Helmholtz Gemeinschaft through the Young Investigator Program; excellence cluster "The Hamburg Centre for Ultrafast Imaging - Structure, Dynamics and Control of Matter at the Atomic Scale" of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Parts of this research were carried out at the Linac Coherent Light Source (LCLS) at the SLAC National Accelerator Laboratory. LCLS is an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. We acknowledge the Max Planck Society for funding the development and operation of the CFEL-ASG-Multi-Purpose (CAMP) instrument within the Advanced Study Group at CFEL. A. R. acknowledges the support from Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy and from Kansas National Science Foundation Experimental Program to Stimulate Competitive Research (NSF EPSCoR) "First Award"; D. R. acknowledges support from the Helmholtz Gemeinschaft through the Young Investigator Program. J. K and S. T. acknowledge support from the excellence cluster "The Hamburg Centre for Ultrafast Imaging - Structure, Dynamics and Control of Matter at the Atomic Scale" of the Deutsche Forschungsgemeinschaft. We are grateful to C. Schmidt for technical support, to M. Cryle for help with sample selection, and to the SLAC staff for their support and hospitality during the beamtime. We thank R. Moshammer, K. Schnorr A. Senftleben, and T. Pfeifer for fruitful discussions and for the idea to adapt the classical over-the-barrier model for the interpretation of the data presented in this manuscript.	Averbukh V, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2126976; Barty A, 2012, NAT PHOTONICS, V6, P35, DOI [10.1038/nphoton.2011.297, 10.1038/NPHOTON.2011.297]; Belshaw L, 2012, J PHYS CHEM LETT, V3, P3751, DOI 10.1021/jz3016028; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Bruhwiler PA, 2002, REV MOD PHYS, V74, P703, DOI 10.1103/RevModPhys.74.703; CLOSS GL, 1988, SCIENCE, V240, P440, DOI 10.1126/science.240.4851.440; Corrales ME, 2012, J PHYS CHEM A, V116, P2669, DOI 10.1021/jp207367a; de la Lande A, 2012, PHYS CHEM CHEM PHYS, V14, P5902, DOI 10.1039/c2cp21823b; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Erk B, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.053003; Hamilton E, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.043402; Huse N, 2011, J PHYS CHEM LETT, V2, P880, DOI 10.1021/jz200168m; Krikunova M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123019; Liu HT, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2424703; Lomb L, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.214111; Lubinski G, 2001, PHYS REV LETT, V86, P616, DOI 10.1103/PhysRevLett.86.616; MARCUS RA, 1993, REV MOD PHYS, V65, P599, DOI 10.1103/RevModPhys.65.599; MATTHEW JAD, 1975, SURF SCI, V53, P716, DOI 10.1016/0039-6028(75)90166-1; Maus M, 1999, J PHYS CHEM A, V103, P3388, DOI 10.1021/jp9905023; May V., 2011, CHARGE AND ENERGY TR; NIEHAUS A, 1986, J PHYS B-AT MOL OPT, V19, P2925, DOI 10.1088/0022-3700/19/18/021; RYUFUKU H, 1980, PHYS REV A, V21, P745, DOI 10.1103/PhysRevA.21.745; SCHANZE KS, 1988, J AM CHEM SOC, V110, P1180, DOI 10.1021/ja00212a029; Spence JCH, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/102601; TARANTELLI F, 1993, PHYS REV LETT, V71, P649, DOI 10.1103/PhysRevLett.71.649; Thomas TD, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.223001; Ullrich J, 2012, ANNU REV PHYS CHEM, V63, P635, DOI [10.1146/annurev-physchem-032511-143720, 10.1146/annurev-physchem-032511-443720]; Weinkauf R, 1996, J PHYS CHEM-US, V100, P18567, DOI 10.1021/jp960926m; YEH JJ, 1985, ATOM DATA NUCL DATA, V32, P1, DOI 10.1016/0092-640X(85)90016-6	29	144	146	1	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					288	291		10.1126/science.1253607	http://dx.doi.org/10.1126/science.1253607			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035485				2022-12-28	WOS:000339400700041
J	Mc Cormack, O; Reynolds, JV				Mc Cormack, Orla; Reynolds, John V.			Intermittent Facial Flushing and Diarrhea	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mc Cormack, Orla; Reynolds, John V.] St James Hosp, Dublin 8, Ireland	Trinity College Dublin	Mc Cormack, O (corresponding author), St James Hosp, Dublin 8, Ireland.	orlamccormack@hotmail.com		Reynolds, John V/0000-0002-5501-9521					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2014	371	3					260	260		10.1056/NEJMicm1314969	http://dx.doi.org/10.1056/NEJMicm1314969			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL3BK	25014690				2022-12-28	WOS:000338999800009
J	Taipale, M; Tucker, G; Peng, J; Krykbaeva, I; Lin, ZY; Larsen, B; Choi, H; Berger, B; Gingras, AC; Lindquist, S				Taipale, Mikko; Tucker, George; Peng, Jian; Krykbaeva, Irina; Lin, Zhen-Yuan; Larsen, Brett; Choi, Hyungwon; Berger, Bonnie; Gingras, Anne-Claude; Lindquist, Susan			A Quantitative Chaperone Interaction Network Reveals the Architecture of Cellular Protein Homeostasis Pathways	CELL			English	Article							E3 UBIQUITIN LIGASE; HSP90 CO-CHAPERONE; KINASE; CANCER; EVOLUTION; COMPLEX; DOMAIN; DEGRADATION; SPECIFICITY; RECOGNITION	Chaperones are abundant cellular proteins that promote the folding and function of their substrate proteins (clients). In vivo, chaperones also associate with a large and diverse set of cofactors (cochaperones) that regulate their specificity and function. However, how these cochaperones regulate protein folding and whether they have chaperone-independent biological functions is largely unknown. We combined mass spectrometry and quantitative high-throughput LUMIER assays to systematically characterize the chaperone-cochaperone-client interaction network in human cells. We uncover hundreds of chaperone clients, delineate their participation in specific cochaperone complexes, and establish a surprisingly distinct network of protein-protein interactions for cochaperones. As a salient example of the power of such analysis, we establish that NUDC family cochaperones specifically associate with structurally related but evolutionarily distinct beta-propeller folds. We provide a framework for deciphering the proteostasis network and its regulation in development and disease and expand the use of chaperones as sensors for drug-target engagement.	[Taipale, Mikko; Krykbaeva, Irina; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02114 USA; [Tucker, George; Peng, Jian; Berger, Bonnie] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Tucker, George; Peng, Jian; Berger, Bonnie] MIT, Dept Math, Cambridge, MA 02139 USA; [Lin, Zhen-Yuan; Larsen, Brett; Gingras, Anne-Claude] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Ctr Syst Biol,Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [Choi, Hyungwon] Natl Univ Singapore, Singapore 117597, Singapore; [Choi, Hyungwon] Natl Univ Hlth Syst, Singapore 117597, Singapore; [Gingras, Anne-Claude] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lindquist, Susan] Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; National University of Singapore; National University of Singapore; University of Toronto; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Gingras, AC (corresponding author), Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Ctr Syst Biol,Dept Mol Genet, Toronto, ON M5G 1X5, Canada.	gingras@lunenfeld.ca; lindquist_admin@wi.mit.edu	Choi, Hyungwon/S-8824-2019; Gingras, Anne-Claude/ABA-8341-2020; Gingras, Anne-Claude/E-9982-2010	Choi, Hyungwon/0000-0002-6687-3088; Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Taipale, Mikko/0000-0003-3811-1761; Krykbaeva, Irina/0000-0003-1380-7607; Peng, Jian/0000-0002-1736-2978	Canadian Institutes of Health Research [MOP-84314]; NIH [5R01GM94231, GM081871]; HFSP; Margaret and Herman Sokol Postdoctoral Award; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871, R01GM094231] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HFSP(Human Frontier Science Program); Margaret and Herman Sokol Postdoctoral Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Freyzon and M. Fischer for technical help, M. Shair for OSW-1, and A. Nesvizhskii and members of S. L. and A.-C.G.'s labs for comments and suggestions. We are grateful to M. Vidal and D. Hill for providing the human ORFeome. The website http://prohits-web.lunenfeld.ca is designed and maintained by J. Zhang and G. Liu. This work was supported by the Canadian Institutes of Health Research (MOP-84314 to A.-C.G.) and the NIH (5R01GM94231 to A.-C.G. and GM081871 to B.B.). M.T. was supported by the HFSP and a Margaret and Herman Sokol Postdoctoral Award. A.-C.G. holds the Canada Chair in Functional Proteomics and the Lea Reichmann Chair in Cancer Proteomics. S.L. is an investigator of the Howard Hughes Medical Institute.	Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Briknarova K, 2002, J BIOL CHEM, V277, P31172, DOI 10.1074/jbc.M202792200; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chadli A, 2008, J BIOL CHEM, V283, P9509, DOI 10.1074/jbc.C800017200; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Echtenkamp FJ, 2012, BBA-MOL CELL RES, V1823, P668, DOI 10.1016/j.bbamcr.2011.08.011; Echtenkamp FJ, 2011, MOL CELL, V43, P229, DOI 10.1016/j.molcel.2011.05.029; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Fuchs M, 2010, BIOCHEM J, V425, P245, DOI 10.1042/BJ20090907; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Hudson Andrew M., 2008, V48, P6, DOI 10.1007/978-0-387-09595-0_2; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Jagannathan M, 2012, J CELL SCI, V125, P133, DOI 10.1242/jcs.089938; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kean MJ, 2012, METHODS, V57, P400, DOI 10.1016/j.ymeth.2012.06.002; Kundrat L, 2010, BIOCHEMISTRY-US, V49, P7428, DOI 10.1021/bi100386w; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lukov GL, 2006, J BIOL CHEM, V281, P22261, DOI 10.1074/jbc.M601590200; Lundin VF, 2010, TRENDS BIOCHEM SCI, V35, P288, DOI 10.1016/j.tibs.2009.12.007; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Scholz GM, 2001, J BIOL CHEM, V276, P30971, DOI 10.1074/jbc.M103889200; Schuyler SC, 2012, J CELL SCI, V125, P4197, DOI 10.1242/jcs.107037; Shao JY, 2003, BIOCHEMISTRY-US, V42, P12577, DOI 10.1021/bi035138j; Taipale M, 2013, NAT BIOTECHNOL, V31, P630, DOI 10.1038/nbt.2620; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsukahara F, 2010, BLOOD, V116, P3582, DOI 10.1182/blood-2009-10-249623; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zheng MY, 2011, J MOL BIOL, V409, P722, DOI 10.1016/j.jmb.2011.04.018	50	254	254	0	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					434	448		10.1016/j.cell.2014.05.039	http://dx.doi.org/10.1016/j.cell.2014.05.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036637	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000340943600021
J	Chowdhury, R; Kunutsor, S; Vitezova, A				Chowdhury, R.; Kunutsor, S.; Vitezova, A.			Review: Vitamin D-3 supplementation may reduce mortality in adults; vitamin D-2 does not	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chowdhury, R.] Univ Cambridge, Cambridge, England	University of Cambridge	Chowdhury, R (corresponding author), Univ Cambridge, Cambridge, England.	rajiv.chowdhury@phpc.cam.ac.uk	Chowdhury, Rajiv/AHB-1253-2022; Tzoulaki, Ioanna/ABE-6269-2020; Kunutsor, Setor K/H-9807-2019	Tzoulaki, Ioanna/0000-0002-4275-9328; Kunutsor, Setor K/0000-0002-2625-0273	British Heart Foundation [RG/08/014/24067] Funding Source: Medline; Medical Research Council [MR/L003120/1] Funding Source: Medline; MRC [MR/L003120/1] Funding Source: UKRI; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))			0	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2							JC5	10.7326/0003-4819-161-2-201407150-02005	http://dx.doi.org/10.7326/0003-4819-161-2-201407150-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023271				2022-12-28	WOS:000339764600004
J	Jain, M; Wernick, R				Jain, Meera; Wernick, Richard			Review: Statins do not increase minor or serious symptomatic adverse events in placebo-controlled trials	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							THERAPY; RISK		[Jain, Meera; Wernick, Richard] Providence Portland Med Ctr, Portland, OR 97213 USA	Providence Portland Medical Center	Jain, M (corresponding author), Providence Portland Med Ctr, Portland, OR 97213 USA.							Lazar LD, 2011, CIRCULATION, V124, P146, DOI 10.1161/CIRCULATIONAHA.110.986349; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Stone NJ, 2014, ANN INTERN MED, V160, P339, DOI 10.7326/M14-0126; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	4	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2							JC3	10.7326/0003-4819-161-2-201407150-02003	http://dx.doi.org/10.7326/0003-4819-161-2-201407150-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023269				2022-12-28	WOS:000339764600002
J	Law, KL; Thompson, RC				Law, Kara Lavender; Thompson, Richard C.			Microplastics in the seas	SCIENCE			English	Editorial Material							MARINE DEBRIS; ACCUMULATION; POLLUTANTS; CHEMICALS; WORMS		[Law, Kara Lavender] Sea Educ Assoc, Dept Oceanog, Woods Hole, MA 02543 USA; [Thompson, Richard C.] Univ Plymouth, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England	University of Plymouth	Law, KL (corresponding author), Sea Educ Assoc, Dept Oceanog, Woods Hole, MA 02543 USA.	klavender@sea.edu	Thompson, Richard C/J-8879-2014	Thompson, Richard/0000-0003-2262-6621; Law, Kara/0000-0002-5298-6751	Division Of Ocean Sciences [1260403] Funding Source: National Science Foundation	Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Bakir A, 2014, ENVIRON POLLUT, V185, P16, DOI 10.1016/j.envpol.2013.10.007; Browne MA, 2008, ENVIRON SCI TECHNOL, V42, P5026, DOI 10.1021/es800249a; Browne MA, 2013, CURR BIOL, V23, P2388, DOI 10.1016/j.cub.2013.10.012; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Collignon A, 2012, MAR POLLUT BULL, V64, P861, DOI 10.1016/j.marpolbul.2012.01.011; Law KL, 2014, ENVIRON SCI TECHNOL, V48, P4732, DOI 10.1021/es4053076; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Maximenko N, 2012, MAR POLLUT BULL, V65, P51, DOI 10.1016/j.marpolbul.2011.04.016; Obbard R. W., 2014, EARTHS FUTURE; Ogata Y, 2009, MAR POLLUT BULL, V58, P1437, DOI 10.1016/j.marpolbul.2009.06.014; Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Wright SL, 2013, CURR BIOL, V23, pR1031, DOI 10.1016/j.cub.2013.10.068; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	15	690	771	80	914	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					144	145		10.1126/science.1254065	http://dx.doi.org/10.1126/science.1254065			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013051				2022-12-28	WOS:000339409900026
J	Suresh, G				Suresh, Gautham			Nominal Competence in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA	Dartmouth College	Suresh, G (corresponding author), Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA.	gautham.suresh@hitchcock.org						Makaryus Amgad N, 2005, J Healthc Qual, V27, P53	1	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					31	32		10.1001/jama.2014.5579	http://dx.doi.org/10.1001/jama.2014.5579			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	25058213				2022-12-28	WOS:000338131100016
J	Zhu, AX; Kudo, M; Assenat, E; Cattan, S; Kang, YK; Lim, HY; Poon, RTP; Blanc, JF; Vogel, A; Chen, CL; Dorval, E; Peck-Radosavljevic, M; Santoro, A; Daniele, B; Furuse, J; Jappe, A; Perraud, K; Anak, O; Sellami, DB; Chen, LT				Zhu, Andrew X.; Kudo, Masatoshi; Assenat, Eric; Cattan, Stephane; Kang, Yoon-Koo; Lim, Ho Yeong; Poon, Ronnie T. P.; Blanc, Jean-Frederic; Vogel, Arndt; Chen, Chao-Long; Dorval, Etienne; Peck-Radosavljevic, Markus; Santoro, Armando; Daniele, Bruno; Furuse, Junji; Jappe, Annette; Perraud, Kevin; Anak, Oezlem; Sellami, Dalila B.; Chen, Li-Tzong			Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib The EVOLVE-1 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MTOR; BRIVANIB	IMPORTANCE Aside from the multikinase inhibitor sorafenib, there are no effective systemic therapies for the treatment of advanced hepatocellular carcinoma. OBJECTIVE To assess the efficacy of everolimus in patients with advanced hepatocellular carcinoma for whom sorafenib treatment failed. DESIGN, SETTING, AND PARTICIPANTS EVOLVE-1 was a randomized, double-blind, phase 3 study conducted among 546 adults with Barcelona Clinic Liver Cancer stage B or C hepatocellular carcinoma and Child-Pugh A liver function whose disease progressed during or after sorafenib or who were intolerant of sorafenib. Patients were enrolled from 17 countries between May 2010 and March 2012. Randomization was stratified by region (Asia vs rest of world) and macrovascular invasion (present vs absent). INTERVENTIONS Everolimus, 7.5 mg/d, or matching placebo, both given in combination with best supportive care and continued until disease progression or intolerable toxicity. Per the 2: 1 randomization scheme, 362 patients were randomized to the everolimus group and 184 patients to the placebo group. MAIN OUTCOMES AND MEASURES The primary end point was overall survival. Secondary end points included time to progression and the disease control rate (the percentage of patients with a best overall response of complete or partial response or stable disease). RESULTS No significant difference in overall survival was seen between treatment groups, with 303 deaths (83.7%) in the everolimus group and 151 deaths (82.1%) in the placebo group (hazard ratio [HR], 1.05; 95% CI, 0.86-1.27; P=.68; median overall survival, 7.6 months with everolimus, 7.3 months with placebo). Median time to progression with everolimus and placebo was 3.0 months and 2.6 months, respectively (HR, 0.93; 95% CI, 0.75-1.15), and disease control rate was 56.1% and 45.1%, respectively (P=.01). The most common grade 3/4 adverse events for everolimus vs placebo were anemia (7.8% vs 3.3%, respectively), asthenia (7.8% vs 5.5%, respectively), and decreased appetite (6.1% vs 0.5%, respectively). No patients experienced hepatitis C viral flare. Based on central laboratory results, hepatitis B viral reactivation was experienced by 39 patients (29 everolimus, 10 placebo); all cases were asymptomatic, but 3 everolimus recipients discontinued therapy. CONCLUSIONS AND RELEVANCE Everolimus did not improve overall survival in patients with advanced hepatocellular carcinoma whose disease progressed during or after receiving sorafenib or who were intolerant of sorafenib.	[Zhu, Andrew X.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Kudo, Masatoshi] Kinki Univ, Sch Med, Osaka 589, Japan; [Assenat, Eric] ICM Val dAurelle, Montpellier, France; [Cattan, Stephane] Univ Nord France, Lille, France; [Kang, Yoon-Koo] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea; [Lim, Ho Yeong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Poon, Ronnie T. P.] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Blanc, Jean-Frederic] Hop St Andre, Bordeaux, France; [Vogel, Arndt] Hannover Med Sch, Hannover, Germany; [Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Dorval, Etienne] CHRU Tours, Tours, France; [Peck-Radosavljevic, Markus] Med Univ Vienna, Vienna, Austria; [Santoro, Armando] Ist Clin Humanitas, Humanitas Canc Ctr, Rozzano, Italy; [Daniele, Bruno] G Rummo Hosp, Benevento, Italy; [Furuse, Junji] Kyorin Univ, Sch Med, Tokyo, Japan; [Jappe, Annette; Perraud, Kevin; Anak, Oezlem] Novartis Pharmaceut, Basel, Switzerland; [Sellami, Dalila B.] Novartis Pharmaceut, E Hanover, NJ USA; [Chen, Li-Tzong] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Chen, Li-Tzong] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan; [Chen, Li-Tzong] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan	Harvard University; Harvard Medical School; Massachusetts General Hospital; Kindai University (Kinki University); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Universite de Lille - ISITE; Universite de Lille; University of Ulsan; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Hong Kong; CHU Bordeaux; Hannover Medical School; Chang Gung Memorial Hospital; CHU Tours; Medical University of Vienna; IRCCS Humanitas Research Hospital; Kyorin University; Novartis; Novartis; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Zhu, AX (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, POB 232,55 Fruit St, Boston, MA 02114 USA.	azhu@mgh.harvard.edu	Kudo, Masatoshi/AAA-9744-2019; Chen, Li-Tzong/D-2071-2010; Santoro, Armando/J-9594-2018; Vogel, Arndt/A-8437-2012	Kudo, Masatoshi/0000-0002-4102-3474; Santoro, Armando/0000-0003-1709-9492; Vogel, Arndt/0000-0003-0560-5538	Novartis Pharmaceuticals	Novartis Pharmaceuticals(Novartis)	This study was sponsored by Novartis Pharmaceuticals. Medical writing and editorial support in the preparation of the manuscript was provided by Melanie Leiby, PhD, and Dolores Matthews, MEd, of ApotheCom (Yardley, Pennsylvania) and was supported by Novartis Pharmaceuticals.	[Anonymous], GUID IND COLL RAC ET; Baba HA, 2009, LIVER INT, V29, P399, DOI 10.1111/j.1478-3231.2008.01798.x; Buitrago-Molina LE, 2009, HEPATOLOGY, V50, P500, DOI 10.1002/hep.23014; Cainap C, 2013, J CLIN ONCOL S, V31, pA249; Cheng AL, 2013, J CLIN ONCOL, V31, P4067, DOI 10.1200/JCO.2012.45.8372; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Frenette C, 2012, WORLD J GASTROENTERO, V18, P498, DOI 10.3748/wjg.v18.i6.498; Goksu SS, 2013, WORLD J HEPATOL, V5, P43, DOI 10.4254/wjh.v5.i1.43; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Huynh H, 2009, J CELL MOL MED, V13, P1371, DOI 10.1111/j.1582-4934.2008.00364.x; Johnson PJ, 2013, J CLIN ONCOL, V31, P3517, DOI 10.1200/JCO.2012.48.4410; Kenerson HL, 2013, GASTROENTEROLOGY, V144, P1055, DOI 10.1053/j.gastro.2013.01.053; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Llovet JM, 2013, J CLIN ONCOL, V31, P3509, DOI 10.1200/JCO.2012.47.3009; Marerro JA, 2013, J CLIN ONCOL S, V31, pA4126; Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Mizuno S, 2013, CLIN J GASTROENTEROL, V6, P188, DOI 10.1007/s12328-013-0371-4; Peveling-Oberhag J, 2013, CLIN THER, V35, P215, DOI 10.1016/j.clinthera.2013.02.007; Sahin F, 2004, CLIN CANCER RES, V10, P8421, DOI 10.1158/1078-0432.CCR-04-0941; Semela D, 2007, J HEPATOL, V46, P840, DOI 10.1016/j.jhep.2006.11.021; Shiah HS, 2013, ALIMENT PHARM THER, V37, P62, DOI 10.1111/apt.12132; Sieghart W, 2007, TRANSPLANTATION, V83, P425, DOI 10.1097/01.tp.0000252780.42104.95; Teplinsky E, 2013, BREAST CANCER RES TR, V141, P167, DOI 10.1007/s10549-013-2681-0; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Zhou LD, 2010, MED ONCOL, V27, P255, DOI 10.1007/s12032-009-9201-4; Zhu AX, 2011, CANCER-AM CANCER SOC, V117, P5094, DOI 10.1002/cncr.26165; Zhu AX, 2012, C EUR SOC MED ONC VI	32	432	445	1	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					57	67		10.1001/jama.2014.7189	http://dx.doi.org/10.1001/jama.2014.7189			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	25058218	Bronze			2022-12-28	WOS:000338131100021
J	Vande Walle, L; Van Opdenbosch, N; Jacques, P; Fossoul, A; Verheugen, E; Vogel, P; Beyaert, R; Elewaut, D; Kanneganti, TD; van Loo, G; Lamkanfi, M				Vande Walle, Lieselotte; Van Opdenbosch, Nina; Jacques, Peggy; Fossoul, Amelie; Verheugen, Eveline; Vogel, Peter; Beyaert, Rudi; Elewaut, Dirk; Kanneganti, Thirumala-Devi; van Loo, Geert; Lamkanfi, Mohamed			Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis	NATURE			English	Article							NF-KAPPA-B; RHEUMATOID-ARTHRITIS; ACTIVATION; INHIBITOR; SUSCEPTIBILITY; ASSOCIATION; CASPASE-1; VARIANTS; RECEPTOR; TNFAIP3	Rheumatoid arthritis is a chronic autoinflammatory disease that affects 1-2% of the world's population and is characterized by widespread joint inflammation. Interleukin-1 is an important mediator of cartilage destruction in rheumatic diseases(1), but our understanding of the upstream mechanisms leading to production of interleukin-1 beta in rheumatoid arthritis is limited by the absence of suitable mouse models of the disease in which inflammasomes contribute to pathology. Myeloid-cell-specific deletion of the rheumatoid arthritis susceptibility gene A20/Tnfaip3 in mice (A20(myel-KO) mice) triggers a spontaneous erosive polyarthritis that resembles rheumatoid arthritis in patients(2). Rheumatoid arthritis in A20(myel-KO) mice is not rescued by deletion of tumour necrosis factor receptor 1 (ref. 2). Here we show, however, that it crucially relies on the Nlrp3 inflammasome and interleukin-1 receptor signalling. Macrophages lacking A 20 have increased basal and lipopolysaccharide-induced expression levels of the inflammasome adaptor Nlrp3 and proIL-beta b. As a result, A 20-deficiency in macrophages significantly enhances Nlrp3 inflammasome- mediated caspase-1 activation, pyroptosis and interleukin-1 beta secretion by soluble and crystalline Nlrp3 stimuli. In contrast, activation of the Nlrc4 and AIM2 inflammasomes is not altered. Importantly, increased Nlrp3 inflammasome activation contributes to the pathology of rheumatoid arthritis in vivo, because deletion of Nlrp3, caspase-1 and the interleukin-1 receptor markedly protects against rheumatoid-arthritis-associated inflammation and cartilage destruction in A20(myel-KO) mice. These results reveal A20 as a novel negative regulator of Nlrp3 inflammasome activation, and describe A(20myel-KO) mice as the first experimental model to study the role of inflammasomes in the pathology of rheumatoid arthritis.	[Vande Walle, Lieselotte; Van Opdenbosch, Nina; Fossoul, Amelie; Lamkanfi, Mohamed] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Vande Walle, Lieselotte; Van Opdenbosch, Nina; Fossoul, Amelie; Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Jacques, Peggy; Verheugen, Eveline; Elewaut, Dirk] Univ Ghent, Dept Rheumatol, B-9000 Ghent, Belgium; [Vogel, Peter; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Beyaert, Rudi; van Loo, Geert] Univ Ghent VIB, Inflammat Res Ctr, B-9052 Ghent, Belgium; [Beyaert, Rudi; van Loo, Geert] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University; St Jude Children's Research Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Lamkanfi, M (corresponding author), Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium.	mohamed.lamkanfi@vib-ugent.be	Vogel, Peter/N-2490-2018; Kanneganti, Thirumala-Devi/Y-2503-2019; Elewaut, Dirk/K-6831-2014; , van Loo Geert/AAD-1220-2019; van Loo, Geert/C-1505-2009; Beyaert, Rudi/B-2589-2009; Kanneganti, Thirumala-Devi/M-9435-2018	Vogel, Peter/0000-0002-7535-0545; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; , van Loo Geert/0000-0002-8427-4775; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Jacques, Peggy/0000-0001-9227-257X; Beyaert, Rudi/0000-0002-5704-582X; Elewaut, Dirk/0000-0002-7468-974X	Ghent University [BOF14/GOA/013]; European Research Council [281600]; FWO [G030212N, 1.2.201.10.N.00, 1.5.122.11.N.00, Odysseus-G091908, G061910N, G016812N]; Queen Elisabeth Medical Foundation; Ghent University Group-ID MRP; National Institutes of Health [AR056296, CA163507, AI101935]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA163507, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101935, R37AI101935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	Ghent University(Ghent University); European Research Council(European Research Council (ERC)European Commission); FWO(FWO); Queen Elisabeth Medical Foundation; Ghent University Group-ID MRP(Ghent University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank R. Flavell and V. Dixit for supplying mutant mice. L.V.W. is a postdoctoral fellow with the Fund for Scientific Research-Flanders (FWO). This work was supported by the Ghent University Concerted Research Actions (grant BOF14/GOA/013) and grants from the European Research Council (Grant 281600) and the FWO (grants G030212N, 1.2.201.10.N.00 and 1.5.122.11.N.00) to M.L., and by FWO research grants (Odysseus-G091908, G061910N and G016812N) and a Queen Elisabeth Medical Foundation grant to G.V.L., and by the Ghent University Group-ID MRP to G.V.L., R.B. and D.E.T.-D.K. is supported by grants from the National Institutes of Health (AR056296, CA163507 and AI101935) and the American Lebanese Syrian Associated Charities.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Ben Hamad M, 2012, INT J IMMUNOGENET, V39, P131, DOI 10.1111/j.1744-313X.2011.01070.x; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Burger D, 2006, BEST PRACT RES CL RH, V20, P879, DOI 10.1016/j.berh.2006.06.004; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dieguez-Gonzalez R, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2650; Fernandes-Alnemri T, 2013, J IMMUNOL, V191, P3995, DOI 10.4049/jimmunol.1301681; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kastbom A, 2008, RHEUMATOLOGY, V47, P415, DOI 10.1093/rheumatology/kem372; Kolly L, 2009, J IMMUNOL, V183, P4003, DOI 10.4049/jimmunol.0802173; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lin KM, 2014, P NATL ACAD SCI USA, V111, P775, DOI 10.1073/pnas.1320294111; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mathews RJ, 2014, ANN RHEUM DIS, V73, P1202, DOI 10.1136/annrheumdis-2013-203276; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Schott WH, 2004, DIABETES, V53, P99, DOI 10.2337/diabetes.53.1.99; Schroder K, 2012, IMMUNOBIOLOGY, V217, P1325, DOI 10.1016/j.imbio.2012.07.020; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	26	320	328	10	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					69	+		10.1038/nature13322	http://dx.doi.org/10.1038/nature13322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043000	Green Accepted			2022-12-28	WOS:000339908000033
J	Kwiatkowski, N; Zhang, TH; Rahl, PB; Abraham, BJ; Reddy, J; Ficarro, SB; Dastur, A; Amzallag, A; Ramaswamy, S; Tesar, B; Jenkins, CE; Hannett, NM; McMillin, D; Sanda, T; Sim, T; Kim, ND; Look, T; Mitsiades, CS; Weng, AP; Brown, JR; Benes, CH; Marto, JA; Young, RA; Gray, NS				Kwiatkowski, Nicholas; Zhang, Tinghu; Rahl, Peter B.; Abraham, Brian J.; Reddy, Jessica; Ficarro, Scott B.; Dastur, Anahita; Amzallag, Arnaud; Ramaswamy, Sridhar; Tesar, Bethany; Jenkins, Catherine E.; Hannett, Nancy M.; McMillin, Douglas; Sanda, Takaomi; Sim, Taebo; Kim, Nam Doo; Look, Thomas; Mitsiades, Constantine S.; Weng, Andrew P.; Brown, Jennifer R.; Benes, Cyril H.; Marto, Jarrod A.; Young, Richard A.; Gray, Nathanael S.			Targeting transcription regulation in cancer with a covalent CDK7 inhibitor	NATURE			English	Article							RNA-POLYMERASE-II; ACTIVATING KINASE; SUPER-ENHANCERS; FACTOR TFIIH; CTD KINASE; PHOSPHORYLATION; ELONGATION; COMPLEX; IDENTIFICATION; DISCOVERY	Tumour oncogenes include transcription factors that co-opt the general transcriptional machinery to sustain the oncogenic state', but direct pharmacological inhibition of transcription factors has so far proven difficult(2). However, the transcriptional machinery contains various enzymatic cofactors that can be targeted for the development of new therapeutic candidates', including cyclin-dependent kinases (CDKs)(4). Here we present the discovery and characterization of a covalent CDK7 inhibitor, THZ1, which has the unprecedented ability to target a remote cysteine residue located outside of the canonical kinase domain, providing an unanticipated means of achieving selectivity for CDK7. Cancer cell-line profiling indicates that a subset of cancer cell lines, including human T-cell acute lymphoblastic leukaemia (T-ALL), have exceptional sensitivity to THZ1. Genome-wide analysis in Jurkat T-ALL cells shows that THZ1 disproportionally affects transcription of RUNXI and suggests that sensitivity to THZ I may be due to vulnerability conferred by the RUNX1 super-enhancer and the key role of RUNXI in the core transcriptional regulatory circuitry of these tumour cells. Pharmacological modulation of CDK7 Ifinase activity may thus provide an approach to identify and treat tumour types that are dependent on transcription for maintenance of the oncogenic state.	[Kwiatkowski, Nicholas; Zhang, Tinghu; Ficarro, Scott B.; Marto, Jarrod A.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Kwiatkowski, Nicholas; Zhang, Tinghu; Ficarro, Scott B.; Marto, Jarrod A.; Gray, Nathanael S.] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Kwiatkowski, Nicholas; Rahl, Peter B.; Abraham, Brian J.; Reddy, Jessica; Hannett, Nancy M.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Reddy, Jessica; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Ficarro, Scott B.; Marto, Jarrod A.] Dana Farber Canc Inst, Blais Prote Ctr, Boston, MA 02115 USA; [Dastur, Anahita; Amzallag, Arnaud; Ramaswamy, Sridhar; Benes, Cyril H.] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Charlestown, MA 02129 USA; [Dastur, Anahita; Amzallag, Arnaud; Ramaswamy, Sridhar; Benes, Cyril H.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Amzallag, Arnaud; Ramaswamy, Sridhar] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Tesar, Bethany; McMillin, Douglas; Mitsiades, Constantine S.; Brown, Jennifer R.] Harvard Univ, Dana Farber Canc Inst, Dept Med Oncol, Sch Med, Boston, MA 02115 USA; [Tesar, Bethany; McMillin, Douglas; Mitsiades, Constantine S.; Brown, Jennifer R.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA; [Jenkins, Catherine E.; Weng, Andrew P.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Sanda, Takaomi; Look, Thomas] Harvard Univ, Dana Farber Canc Inst, Dept Pediat Oncol, Sch Med, Boston, MA 02215 USA; [Sanda, Takaomi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Sim, Taebo] Korea Inst Sci & Technol, Chem Kinom Res Ctr, Seoul 136791, South Korea; [Sim, Taebo] KU KIST Grad Sch Converging Sci & Technol, Seoul 136713, South Korea; [Kim, Nam Doo] Daegu Gyeongbuk Med Innovat Fdn, Taegu 706010, South Korea; [Look, Thomas] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; British Columbia Cancer Agency; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; National University of Singapore; Korea Institute of Science & Technology (KIST); Korea University; Harvard University; Boston Children's Hospital	Gray, NS (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	young@wi.mit.edu; nathanael_gray@dfci.harvard.edu	Abraham, Brian/C-2230-2019; Amzallag, Arnaud/Y-5802-2019; Young, Richard A/F-6495-2012	Abraham, Brian/0000-0001-8085-3027; Amzallag, Arnaud/0000-0001-7467-1227; Young, Richard A/0000-0001-8855-8647	National Institutes of Health [R01 CA130876-04, U54 HG006097-02, CA178860-01, P01 N5047572-10, HG002668, CA109901]; American Cancer Society Postdoctoral Fellowship [120272-PF-11-042-01-DMC]; Translational Research Program of the Leukemia Lymphoma Society; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA179483, R01CA130876, R21CA178860, P01CA109901, P30CA014051] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097, R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Postdoctoral Fellowship(American Cancer Society); Translational Research Program of the Leukemia Lymphoma Society; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Gray and Young laboratories for helpful discussions; D. Orlando, L. Lawton and L. Anders for advice; and C. Thoreen and D. Sabatini, as well as S. Cheng and G. Morin, for reagents. We thank K. Jones and N. Kohl for performing mouse studies and K. Jones and C. Christensen for prepping mouse tissues. We thank S. Riddle for performing LanthaScreen Eu Kinase Assays. This work was supported by the National Institutes of Health (R01 CA130876-04 and U54 HG006097-02 to N.S.G.; CA178860-01 and P01 N5047572-10 to J.A.M.; HG002668 and CA109901 to R.A.Y.), and the American Cancer Society Postdoctoral Fellowship 120272-PF-11-042-01-DMC (P.B.R.). J.R.B. is a Scholar in Clinical Research of the Leukemia Lymphoma Society and is supported by the Translational Research Program of the Leukemia Lymphoma Society and by the American Cancer Society.	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Berg T, 2008, CURR OPIN CHEM BIOL, V12, P464, DOI 10.1016/j.cbpa.2008.07.023; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Lu Q, 2012, J BIOMOL SCREEN, V17, P555, DOI 10.1177/1087057112437763; MAKELA TP, 1994, NATURE, V371, P254, DOI 10.1038/371254a0; Nottingham WT, 2007, BLOOD, V110, P4188, DOI 10.1182/blood-2007-07-100883; O'Neil J, 2007, ONCOGENE, V26, P6838, DOI 10.1038/sj.onc.1210766; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Sanso M, 2013, TRANSCR-AUSTIN, V4, P146, DOI 10.4161/trns.25146; Schachter MM, 2013, MOL CELL, V50, P250, DOI 10.1016/j.molcel.2013.04.003; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; Watanabe Y, 2000, GENES CELLS, V5, P407, DOI 10.1046/j.1365-2443.2000.00336.x; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024	30	520	552	10	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					616	+		10.1038/nature13393	http://dx.doi.org/10.1038/nature13393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043025	Green Accepted, Green Submitted			2022-12-28	WOS:000339566300040
J	Lo, S				Lo, Selina			Sharon Lewin: guiding us towards a cure for HIV	LANCET			English	Biographical-Item																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					223	223		10.1016/S0140-6736(14)61198-3	http://dx.doi.org/10.1016/S0140-6736(14)61198-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL8JI	25042224				2022-12-28	WOS:000339384100012
J	Zhang, ZG; Wang, W; Qiu, B				Zhang, Zhengguang; Wang, Wei; Qiu, Bo			Oceanic mass transport by mesoscale eddies	SCIENCE			English	Article							HEAT; VARIABILITY; CIRCULATION	Oceanic transports of heat, salt, fresh water, dissolved CO2, and other tracers regulate global climate change and the distribution of natural marine resources. The time-mean ocean circulation transports fluid as a conveyor belt, but fluid parcels can also be trapped and transported discretely by migrating mesoscale eddies. By combining available satellite altimetry and Argo profiling float data, we showed that the eddy-induced zonal mass transport can reach a total meridionally integrated value of up to 30 to 40 sverdrups (Sv) (1 Sv = 10(6) cubic meters per second), and it occurs mainly in subtropical regions, where the background flows are weak. This transport is comparable in magnitude to that of the large-scale wind-and thermohaline-driven circulation.	[Zhang, Zhengguang; Wang, Wei] Ocean Univ China, Qingdao Collaborat Innovat Ctr Marine Sci & Techn, Phys Oceanog Lab, Qingdao, Peoples R China; [Qiu, Bo] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA	Ocean University of China; University of Hawaii System; University of Hawaii Manoa	Wang, W (corresponding author), Ocean Univ China, Qingdao Collaborat Innovat Ctr Marine Sci & Techn, Phys Oceanog Lab, Qingdao, Peoples R China.	wei@ouc.edu.cn	Qiu, Bo/D-9569-2017		National Basic Research Priorities Program of China [2013CB430303]; National Natural Science Foundation of China [41276014]; National Global Change Major Research Project of China [2013CB956201]	National Basic Research Priorities Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Global Change Major Research Project of China	We thank the reviewers for their constructive and detailed comments. This research was supported by the National Basic Research Priorities Program of China through grant 2013CB430303, the National Natural Science Foundation of China under grant 41276014, and the National Global Change Major Research Project of China through grant 2013CB956201. The sources of the data used in this paper are contained in the supplementary materials.	BRYDEN HL, 1989, J MAR RES, V47, P55, DOI 10.1357/002224089785076389; Chang YL, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047062; Chelton DB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030812; Chelton DB, 2011, SCIENCE, V334, P328, DOI 10.1126/science.1208897; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; DANABASOGLU G, 1994, SCIENCE, V264, P1123, DOI 10.1126/science.264.5162.1123; de Jong MF, 2014, J PHYS OCEANOGR, V44, P427, DOI 10.1175/JPO-D-13-070.1; Dong CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4294; Early JJ, 2011, J PHYS OCEANOGR, V41, P1535, DOI 10.1175/2011JPO4601.1; FLIERL GR, 1981, GEOPHYS ASTRO FLUID, V18, P39, DOI 10.1080/03091928108208773; Lee MM, 1997, J MAR RES, V55, P483, DOI 10.1357/0022240973224346; LUYTEN JR, 1983, J PHYS OCEANOGR, V13, P292, DOI 10.1175/1520-0485(1983)013<0292:TVT>2.0.CO;2; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; Minobe S, 2008, NATURE, V452, P206, DOI 10.1038/nature06690; Peacock S, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002211; Qiu B, 2000, J PHYS OCEANOGR, V30, P1486, DOI 10.1175/1520-0485(2000)030<1486:IVOTKE>2.0.CO;2; Qiu B, 2003, J PHYS OCEANOGR, V33, P2465, DOI 10.1175/2459.1; Qiu B, 2013, J PHYS OCEANOGR, V43, P344, DOI 10.1175/JPO-D-12-0133.1; RHINES PB, 1982, J FLUID MECH, V122, P347, DOI 10.1017/S0022112082002250; Schmitz Jr W.J., 1996, WHOI9603, V1; Schmitz W.J.J., 1996, WHOI9608, VII; Zhang ZG, 2013, GEOPHYS RES LETT, V40, P3677, DOI 10.1002/grl.50736	24	322	365	22	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					322	324		10.1126/science.1252418	http://dx.doi.org/10.1126/science.1252418			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035491				2022-12-28	WOS:000339400700050
J	Cimermancic, P; Medema, MH; Claesen, J; Kurita, K; Brown, LCW; Mavrommatis, K; Pati, A; Godfrey, PA; Koehrsen, M; Clardy, J; Birren, BW; Takano, E; Sali, A; Linington, RG; Fischbach, MA				Cimermancic, Peter; Medema, Marnix H.; Claesen, Jan; Kurita, Kenji; Brown, Laura C. Wieland; Mavrommatis, Konstantinos; Pati, Amrita; Godfrey, Paul A.; Koehrsen, Michael; Clardy, Jon; Birren, Bruce W.; Takano, Eriko; Sali, Andrej; Linington, Roger G.; Fischbach, Michael A.			Insights into Secondary Metabolism from a Global Analysis of Prokaryotic Biosynthetic Gene Clusters	CELL			English	Article							POLYMERASE EXTENSION CLONING; GENOMICS-DRIVEN DISCOVERY; IN-VITRO RECONSTITUTION; NATURAL-PRODUCT; STAPHYLOCOCCUS-AUREUS; POLYKETIDE; SEQUENCE; IDENTIFICATION; XANTHOMONADIN; BACTERIAL	Although biosynthetic gene clusters (BGCs) have been discovered for hundreds of bacterial metabolites, our knowledge of their diversity remains limited. Here, we used a novel algorithm to systematically identify BGCs in the extensive extant microbial sequencing data. Network analysis of the predicted BGCs revealed large gene cluster families, the vast majority uncharacterized. We experimentally characterized the most prominent family, consisting of two subfamilies of hundreds of BGCs distributed throughout the Proteobacteria; their products are aryl polyenes, lipids with an aryl head group conjugated to a polyene tail. We identified a distant relationship to a third subfamily of aryl polyene BGCs, and together the three subfamilies represent the largest known family of biosynthetic gene clusters, with more than 1,000 members. Although these clusters are widely divergent in sequence, their small molecule products are remarkably conserved, indicating for the first time the important roles these compounds play in Gram-negative cell biology.	[Cimermancic, Peter; Claesen, Jan; Sali, Andrej; Fischbach, Michael A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Cimermancic, Peter; Claesen, Jan; Sali, Andrej; Fischbach, Michael A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Medema, Marnix H.; Takano, Eriko] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Microbial Physiol, NL-9747 AG Groningen, Netherlands; [Medema, Marnix H.] Univ Groningen, Groningen Bioinformat Ctr, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Kurita, Kenji; Linington, Roger G.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Brown, Laura C. Wieland] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Mavrommatis, Konstantinos; Pati, Amrita] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Godfrey, Paul A.; Koehrsen, Michael; Birren, Bruce W.] Broad Inst, Cambridge, MA 02142 USA; [Sali, Andrej] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Groningen; University of Groningen; University of California System; University of California Santa Cruz; Indiana University System; Indiana University Bloomington; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Fischbach, MA (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.	fischbach@fischbachgroup.org	Linington, Roger/ABD-5582-2021; Medema, Marnix H./AAR-3138-2021	Linington, Roger/0000-0003-1818-4971; Medema, Marnix H./0000-0002-2191-2821; Takano, Eriko/0000-0002-6791-3256; Claesen, Jan/0000-0002-0755-7974; Mavrommatis, Konstantinos/0000-0003-4549-385X; Fischbach, Michael/0000-0003-3079-8247	HHMI Predoctoral Fellowship; Boehringer Ingelheim Fonds; GenBiotics programme of the Dutch Technology Foundation STW [10463]; NIH [TW006634, OD007290, AI101018, AI101722, GM081879]; James and Eleanor Delfino Charitable Trust; Medical Research Program Grant from the W.M. Keck Foundation; David and Lucile Packard Foundation; DARPA [HR0011-12-C-0067]; National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services [HHSN272200900018C]; FOGARTY INTERNATIONAL CENTER [U01TW006634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101018, U19AI110818, R21AI101722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547, P50GM081879] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007290] Funding Source: NIH RePORTER	HHMI Predoctoral Fellowship(Howard Hughes Medical Institute); Boehringer Ingelheim Fonds(Boehringer Ingelheim); GenBiotics programme of the Dutch Technology Foundation STW; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Eleanor Delfino Charitable Trust; Medical Research Program Grant from the W.M. Keck Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Fischbach lab for helpful discussions and Rainer Breitling and an anonymous reviewer for constructive feedback on the manuscript. We thank Edward Ruby (University of Wisconsin) for providing us with V. fischeri ES114, Didier Mazel (Institut Pasteur) for plasmid pSW8197, and Mervyn Bibb (John Innes Centre) for plasmids pIJ773, pIJ790 and pIJ10257. This work was supported by an HHMI Predoctoral Fellowship (P.C.), a Boehringer Ingelheim Fonds travel grant (M.H.M.), Grant 10463 from the GenBiotics programme of the Dutch Technology Foundation STW to ET (M.H.M.), NIH grant TW006634 (R.G.L.), the James and Eleanor Delfino Charitable Trust (K.K.), a Medical Research Program Grant from the W.M. Keck Foundation (M.A.F.), a Fellowship for Science and Engineering from the David and Lucile Packard Foundation (M.A.F.), DARPA award HR0011-12-C-0067 (M.A.F.), and NIH grants OD007290, AI101018, AI101722, and GM081879 (M.A.F.). This project has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, under Contract No.: HHSN272200900018C. M.A.F. is on the scientific advisory board of Warp Drive Bio.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Barbe V, 2004, NUCLEIC ACIDS RES, V32, P5766, DOI 10.1093/nar/gkh910; Bergmann S, 2007, NAT CHEM BIOL, V3, P213, DOI 10.1038/nchembio869; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Challis GL, 2008, J MED CHEM, V51, P2618, DOI 10.1021/jm700948z; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; FAUTZ E, 1979, PHYTOCHEMISTRY, V18, P957, DOI 10.1016/S0031-9422(00)91457-2; Fischbach MA, 2008, P NATL ACAD SCI USA, V105, P4601, DOI 10.1073/pnas.0709132105; Flatt PM, 2007, NAT PROD REP, V24, P358, DOI 10.1039/b603816f; Franke J, 2012, ANGEW CHEM INT EDIT, V51, P11611, DOI 10.1002/anie.201205566; Frasch HJ, 2013, CURR OPIN BIOTECH, V24, P1144, DOI 10.1016/j.copbio.2013.03.006; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Fuchs SW, 2013, ANGEW CHEM INT EDIT, V52, P4108, DOI 10.1002/anie.201210116; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goel AK, 2002, J BACTERIOL, V184, P3539, DOI 10.1128/JB.184.13.3539-3548.2002; Gust B, 2004, ADV APPL MICROBIOL, V54, P107, DOI 10.1016/S0065-2164(04)54004-2; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; JENKINS CL, 1982, CURR MICROBIOL, V7, P195, DOI 10.1007/BF01568797; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kahne D, 2005, CHEM REV, V105, P425, DOI 10.1021/cr030103a; Kersten RD, 2013, P NATL ACAD SCI USA, V110, pE4407, DOI 10.1073/pnas.1315492110; Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Letzel AC, 2013, NAT PROD REP, V30, P392, DOI 10.1039/c2np20103h; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li MHT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-185; Lin K, 2006, BIOINFORMATICS, V22, P2081, DOI 10.1093/bioinformatics/btl366; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Lowry B, 2013, J AM CHEM SOC, V135, P16809, DOI 10.1021/ja409048k; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; Medema MH, 2013, MOL BIOL EVOL, V30, P1218, DOI 10.1093/molbev/mst025; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; Oliynyk M, 2007, NAT BIOTECHNOL, V25, P447, DOI 10.1038/nbt1297; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pelzer S, 1999, ANTIMICROB AGENTS CH, V43, P1565, DOI 10.1128/AAC.43.7.1565; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Poplawsky AR, 2000, APPL ENVIRON MICROB, V66, P5123, DOI 10.1128/AEM.66.12.5123-5127.2000; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Rajagopal L, 1997, FEBS LETT, V415, P125, DOI 10.1016/S0014-5793(97)01109-5; Rehm BHA, 2010, NAT REV MICROBIOL, V8, P578, DOI 10.1038/nrmicro2354; REICHENBACH H, 1980, ARCH MICROBIOL, V126, P291, DOI 10.1007/BF00409934; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Sattely ES, 2008, NAT PROD REP, V25, P757, DOI 10.1039/b801747f; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Starcevic A, 2008, NUCLEIC ACIDS RES, V36, P6882, DOI 10.1093/nar/gkn685; STARR MP, 1977, ARCH MICROBIOL, V113, P1, DOI 10.1007/BF00428572; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Walsh CT, 2010, J AM CHEM SOC, V132, P2469, DOI 10.1021/ja909118a; Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066633; Weber T, 2009, J BIOTECHNOL, V140, P13, DOI 10.1016/j.jbiotec.2009.01.007; Weitnauer G, 2001, CHEM BIOL, V8, P569, DOI 10.1016/S1074-5521(01)00040-0; Winter JM, 2011, CURR OPIN CHEM BIOL, V15, P22, DOI 10.1016/j.cbpa.2010.10.020	68	546	563	14	192	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					412	421		10.1016/j.cell.2014.06.034	http://dx.doi.org/10.1016/j.cell.2014.06.034			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036635	Green Accepted, Bronze			2022-12-28	WOS:000340943600019
J	Koh, HK; Gracia, JN; Alvarez, ME				Koh, Howard K.; Gracia, J. Nadine; Alvarez, Mayra E.			Culturally and Linguistically Appropriate Services - Advancing Health with CLAS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COMPETENCE; CARE		[Koh, Howard K.; Gracia, J. Nadine; Alvarez, Mayra E.] Dept Hlth & Human Serv, Off Assistant Secretary Hlth, Washington, DC 20201 USA		Koh, HK (corresponding author), Dept Hlth & Human Serv, Off Assistant Secretary Hlth, Washington, DC 20201 USA.							Department of Health and Human Services, GUID FED FIN ASS REC; LaVeist TA, 2008, J HEALTHC MANAG, V53, P257, DOI 10.1097/00115514-200807000-00008; Office of Minority Health Department of Health and Human Services, 2013, NAT STAND CULT LING; Weech-Maldonado R, 2012, MED CARE, V50, pS48, DOI 10.1097/MLR.0b013e3182610ad1; Wynia MK, 2010, AM J MED QUAL, V25, P436, DOI 10.1177/1062860610368428	5	46	46	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2014	371	3					198	201		10.1056/NEJMp1404321	http://dx.doi.org/10.1056/NEJMp1404321			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL3BK	25014685				2022-12-28	WOS:000338999800003
J	MacCallum, P; Bowles, L; Keeling, D				MacCallum, Peter; Bowles, Louise; Keeling, David			Diagnosis and management of heritable thrombophilias	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FACTOR-V-LEIDEN; RECURRENT VENOUS THROMBOEMBOLISM; MOLECULAR-WEIGHT HEPARIN; ORAL-CONTRACEPTIVE USERS; DEEP-VEIN THROMBOSIS; PROTEIN-C; RISK-FACTORS; FAMILY-HISTORY; INHERITED THROMBOPHILIA; HEREDITARY DEFICIENCIES		[MacCallum, Peter] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England; [MacCallum, Peter; Bowles, Louise] Barts Hlth NHS Trust, Dept Haematol, London, England; [Keeling, David] Oxford Univ Hosp, Oxford Haemophilia & Thrombosis Ctr, Oxford, England	University of London; Queen Mary University London; Barts Health NHS Trust	MacCallum, P (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England.	p.k.maccallum@qmul.ac.uk		Keeling, David/0000-0001-6779-6566	Boehringer Ingelheim; Bayer; Daiichi Sankyo; Leo Pharmaceuticals	Boehringer Ingelheim(Boehringer Ingelheim); Bayer(Bayer AG); Daiichi Sankyo(Daiichi Sankyo Company Limited); Leo Pharmaceuticals(LEO Pharma)	We have read and understood the BMJ policy on declaration of interests and declare the following interests: PM has received speaker fees from Boehringer Ingelheim and Bayer, advisory board fees from Daiichi Sankyo, and travel and accommodation costs for meetings from Leo Pharmaceuticals, Boehringer Ingelheim, and Daiichi Sankyo. LB has received travel and accommodation expenses for meetings from Leo Pharmaceuticals and Bayer. DK has received speaker fees from Boehringer Ingelheim, advisory board fees from Bayer and Daiichi Sankyo, and travel and accommodation costs from Bayer.	Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6; Baglin T, 2010, BRIT J HAEMATOL, V149, P209, DOI 10.1111/j.1365-2141.2009.08022.x; Bates Shannon M, 2012, Chest, V141, pe691S, DOI 10.1378/chest.11-2300; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bezemer ID, 2009, ARCH INTERN MED, V169, P610, DOI 10.1001/archinternmed.2008.589; Bouvier S, 2014, BLOOD, V123, P414, DOI 10.1182/blood-2013-09-525014; Brouwer JLP, 2009, THROMB HAEMOSTASIS, V101, P93, DOI 10.1160/TH08-06-0364; Bucciarelli P, 2012, J THROMB HAEMOST, V10, P1783, DOI 10.1111/j.1538-7836.2012.04858.x; Canonico M, 2008, BMJ-BRIT MED J, V336, P1227, DOI 10.1136/bmj.39555.441944.BE; Chinthammitr Y, 2006, J THROMB HAEMOST, V4, P2587, DOI 10.1111/j.1538-7836.2006.02257.x; Christiansen SC, 2005, JAMA-J AM MED ASSOC, V293, P2352, DOI 10.1001/jama.293.19.2352; Clark P, 2010, BLOOD, V115, P4162, DOI 10.1182/blood-2010-01-267252; Cohn DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007069.pub3; Cushman M, 2004, JAMA-J AM MED ASSOC, V292, P1573, DOI 10.1001/jama.292.13.1573; Dahlback B, 2008, BLOOD, V112, P19, DOI 10.1182/blood-2008-01-077909; de Moerloose P, 2000, BRIT J HAEMATOL, V110, P125, DOI 10.1046/j.1365-2141.2000.02039.x; De Stefano V, 2006, HAEMATOLOGICA, V91, P695; Di Minno MND, 2014, CIRCULATION, V129, P497, DOI 10.1161/CIRCULATIONAHA.113.003756; Douketis J, 2010, ANN INTERN MED, V153, P523, DOI 10.7326/0003-4819-153-8-201010190-00009; Eichinger S, 2010, CIRCULATION, V121, P1630, DOI 10.1161/CIRCULATIONAHA.109.925214; Einhaupl K, 2010, EUR J NEUROL, V17, P1229, DOI 10.1111/j.1468-1331.2010.03011.x; Emmerich J, 2001, THROMB HAEMOSTASIS, V86, P809; Franco RF, 2001, HUM GENET, V109, P369, DOI 10.1007/s004390100593; Gauthier K, 2013, J THROMB HAEMOST, V11, P200, DOI 10.1111/jth.12048; Gohil R, 2009, THROMB HAEMOSTASIS, V102, P360, DOI 10.1160/TH09-01-0013; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Heit JA, 2005, J THROMB HAEMOST, V3, P305, DOI 10.1111/j.1538-7836.2004.01117.x; Iorio A, 2010, ARCH INTERN MED, V170, P1710, DOI 10.1001/archinternmed.2010.367; Juul K, 2004, ANN INTERN MED, V140, P330, DOI 10.7326/0003-4819-140-5-200403020-00008; Kaandorp SP, 2010, NEW ENGL J MED, V362, P1586, DOI 10.1056/NEJMoa1000641; Keeling D, 2012, BRIT J HAEMATOL, V157, P47, DOI 10.1111/j.1365-2141.2012.09037.x; KOSTER T, 1995, BLOOD, V85, P2756, DOI 10.1182/blood.V85.10.2756.bloodjournal85102756; Lapner ST, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f757; Lijfering WM, 2010, BRIT J HAEMATOL, V149, P824, DOI 10.1111/j.1365-2141.2010.08206.x; Lijfering WM, 2010, CIRCULATION, V121, P1706, DOI 10.1161/CIRCULATIONAHA.109.906347; Lijfering WM, 2009, BLOOD, V113, P5314, DOI 10.1182/blood-2008-10-184879; Lind C, 2014, CIRCULATION, V129, P855, DOI 10.1161/CIRCULATIONAHA.113.004168; Mahmoodi BK, 2010, J THROMB HAEMOST, V8, P1193, DOI 10.1111/j.1538-7836.2010.03840.x; Medicines and Healthcare products Regulatory Agency, 2014, COMB HORM CONTR 2014; Medicines and Healthcare products Regulatory Agency, 2014, DRUG SAFETY UPDATE, V7; Middeldorp S, 2013, J THROMB HAEMOST, V11, P180, DOI 10.1111/jth.12266; Middeldorp S, 2011, HEMATOL-AM SOC HEMAT, P150, DOI 10.1182/asheducation-2011.1.150; MILETICH J, 1987, NEW ENGL J MED, V317, P991, DOI 10.1056/NEJM198710153171604; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Morris JG, 2010, STROKE, V41, P2985, DOI 10.1161/STROKEAHA.110.595199; National Institute for Health and Care Excellence, 2012, VEN THROMB DIS MAN V, VCG144; Pabinger I, 2012, J THROMB HAEMOST, V10, P217, DOI 10.1111/j.1538-7836.2011.04573.x; Pintao MC, 2013, BLOOD, V122, P3210, DOI 10.1182/blood-2013-04-499335; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Prandoni P, 2012, THROMB HAEMOSTASIS, V107, P1191, DOI 10.1160/TH11-12-0845; Rabinovich A, 2014, J THROMB HAEMOST, V12, P14, DOI 10.1111/jth.12447; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; Roach REJ, 2013, J THROMB HAEMOST, V11, P124, DOI 10.1111/jth.12060; Rodeghiero F, 1999, ANN INTERN MED, V130, P643, DOI 10.7326/0003-4819-130-8-199904200-00004; Rodger MA, 2014, BLOOD, V123, P822, DOI 10.1182/blood-2013-01-478958; Rodger MA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000292; Rossi E, 2011, THROMB HAEMOSTASIS, V106, P646, DOI 10.1160/TH11-02-0080; Royal College of Obstetricians and Gynaecologists, 2009, RED RISK THROMB EMB; Segal JB, 2009, JAMA-J AM MED ASSOC, V301, P2472, DOI 10.1001/jama.2009.853; Seligsohn U, 2001, NEW ENGL J MED, V344, P1222, DOI 10.1056/NEJM200104193441607; Simone B, 2013, EUR J EPIDEMIOL, V28, P621, DOI 10.1007/s10654-013-9825-8; Sweetland S, 2012, J THROMB HAEMOST, V10, P2277, DOI 10.1111/j.1538-7836.2012.04919.x; Tait C, 2012, BRIT J HAEMATOL, V159, P28, DOI 10.1111/j.1365-2141.2012.09249.x; Tosetto A, 2012, J THROMB HAEMOST, V10, P1019, DOI 10.1111/j.1538-7836.2012.04735.x; Vandenbroucke JP, 1996, BRIT MED J, V313, P1127, DOI 10.1136/bmj.313.7065.1127; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0; Verhovsek M, 2008, ANN INTERN MED, V149, P481, DOI 10.7326/0003-4819-149-7-200810070-00008; Wu O, 2005, BRIT J HAEMATOL, V131, P80, DOI 10.1111/j.1365-2141.2005.05715.x; Ye Z, 2006, LANCET, V367, P651, DOI 10.1016/S0140-6736(06)68263-9; Zoller B, 1996, THROMB RES, V83, P475; Zoller B, 2013, THROMB HAEMOSTASIS, V109, P458, DOI 10.1160/TH12-10-0743	72	31	33	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2014	349								g4387	10.1136/bmj.g4387	http://dx.doi.org/10.1136/bmj.g4387			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7PI	25035247				2022-12-28	WOS:000339326400004
J	Belknap, SM				Belknap, Steven M.			In adults, use of anxiolytic or hypnotic drugs was associated with increased risk for mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Belknap, SM (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.			Belknap, Steven/0000-0002-3670-7409				Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; SELLERS EM, 1983, CLIN PHARMACOL THER, V34, P822, DOI 10.1038/clpt.1983.256	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2							JC11	10.7326/0003-4819-161-2-201407150-02011	http://dx.doi.org/10.7326/0003-4819-161-2-201407150-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023265				2022-12-28	WOS:000339764600014
J	Hill, A; Cooke, G				Hill, Andrew; Cooke, Graham			Hepatitis C can be cured globally, but at what cost?	SCIENCE			English	Editorial Material							VIRAL-HEPATITIS; ACCESS; BURDEN		[Hill, Andrew] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England; [Cooke, Graham] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	University of Liverpool; Imperial College London	Hill, A (corresponding author), Univ Liverpool, Dept Pharmacol & Therapeut, POB 147, Liverpool L69 3BX, Merseyside, England.	microhaart@aol.com		Cooke, Graham/0000-0001-6475-5056	Medical Research Council [MR/K01532X/1] Funding Source: Medline; MRC [MR/K01532X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2013, FAIR PRICING COALITI; Cooke GS, 2013, J VIRAL HEPATITIS, V20, P600, DOI 10.1111/jvh.12123; Ford N, 2012, CLIN INFECT DIS, V54, P1465, DOI 10.1093/cid/cis227; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Medivir, 2012, MED 2012 ANN REP, P26; MSF Drug Access Team, 2012, UNT WEB ANT VIR PROC; Schwartlander B, 2006, LANCET, V368, P541, DOI 10.1016/S0140-6736(06)69164-2; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218	11	55	55	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					141	142		10.1126/science.1257737	http://dx.doi.org/10.1126/science.1257737			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8SS	25013048				2022-12-28	WOS:000339409900023
J	Medford, AJ; Wellendorff, J; Vojvodic, A; Studt, F; Abild-Pedersen, F; Jacobsen, KW; Bligaard, T; Norskov, JK				Medford, Andrew J.; Wellendorff, Jess; Vojvodic, Aleksandra; Studt, Felix; Abild-Pedersen, Frank; Jacobsen, Karsten W.; Bligaard, Thomas; Norskov, Jens K.			Assessing the reliability of calculated catalytic ammonia synthesis rates	SCIENCE			English	Article							1ST-PRINCIPLES CALCULATIONS; SINGLE-CRYSTAL; IDENTIFICATION; DESIGN; STEPS	introduce a general method for estimating the uncertainty in calculated materials properties based on density functional theory calculations. We illustrate the approach for a calculation of the catalytic rate of ammonia synthesis over a range of transition-metal catalysts. The correlation between errors in density functional theory calculations is shown to play an important role in reducing the predicted error on calculated rates. Uncertainties depend strongly on reaction conditions and catalyst material, and the relative rates between different catalysts are considerably better described than the absolute rates. We introduce an approach for incorporating uncertainty when searching for improved catalysts by evaluating the probability that a given catalyst is better than a known standard.	[Medford, Andrew J.; Wellendorff, Jess; Vojvodic, Aleksandra; Studt, Felix; Abild-Pedersen, Frank; Bligaard, Thomas; Norskov, Jens K.] SLAC Natl Accelerator Lab, SUNCAT Ctr Interface Sci & Catalysis, Menlo Pk, CA 94025 USA; [Medford, Andrew J.; Wellendorff, Jess; Norskov, Jens K.] Stanford Univ, Dept Chem Engn, SUNCAT Ctr Interface Sci & Catalysis, Stanford, CA 94305 USA; [Jacobsen, Karsten W.] Tech Univ Denmark, Dept Phys, Ctr Atom Scale Mat Design CAMD, DK-2800 Lyngby, Denmark	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Technical University of Denmark	Norskov, JK (corresponding author), SLAC Natl Accelerator Lab, SUNCAT Ctr Interface Sci & Catalysis, Menlo Pk, CA 94025 USA.	norskov@stanford.edu	Vojvodic, Aleksandra/C-3383-2014; Medford, Andrew/H-5405-2019; Studt, Felix/C-7874-2017; Bligaard, Thomas/A-6161-2011; Norskov, Jens K/D-2539-2017; Jacobsen, Karsten Wedel/B-3602-2009; Abild-Pedersen, Frank/C-3248-2014; Bligaard, Thomas/A-6161-2011	Vojvodic, Aleksandra/0000-0002-5584-6711; Studt, Felix/0000-0001-6841-4232; Bligaard, Thomas/0000-0003-0386-0201; Norskov, Jens K/0000-0002-4427-7728; Jacobsen, Karsten Wedel/0000-0002-1121-2979; Abild-Pedersen, Frank/0000-0002-1911-074X; Bligaard, Thomas/0000-0001-9834-9179; Medford, Andrew/0000-0001-8311-9581	U.S. Department of Energy Office of Basic Energy Science; U.S. Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program	U.S. Department of Energy Office of Basic Energy Science(United States Department of Energy (DOE)); U.S. Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program	Data reported herein are available in the supplementary materials. Support from the U.S. Department of Energy Office of Basic Energy Science to the SUNCAT Center for Interface Science and Catalysis is gratefully acknowledged. A.J.M. is grateful for support by the U.S. Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program.	Abild-Pedersen F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.016105; Aika K., 1981, CATALYSIS SCI TECHNO, V1; BARE SR, 1986, J PHYS CHEM-US, V90, P4726, DOI 10.1021/j100411a003; Burke K, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4704546; Ceder G, 1998, NATURE, V392, P694, DOI 10.1038/33647; Curtarolo S, 2013, NAT MATER, V12, P191, DOI [10.1038/nmat3568, 10.1038/NMAT3568]; Dahl S, 1998, J CATAL, V178, P679, DOI 10.1006/jcat.1998.2168; Dahl S, 1999, PHYS REV LETT, V83, P1814, DOI 10.1103/PhysRevLett.83.1814; Egeberg RC, 2001, SURF SCI, V491, P183, DOI 10.1016/S0039-6028(01)01397-8; ERTL G, 1980, CATAL REV, V21, P201, DOI 10.1080/03602458008067533; Frederiksen SL, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.165501; Honkala K, 2005, SCIENCE, V307, P555, DOI 10.1126/science.1106435; Liao PL, 2010, ACTA MATER, V58, P5912, DOI 10.1016/j.actamat.2010.07.007; Logadottir A, 2001, J CATAL, V197, P229, DOI 10.1006/jcat.2000.3087; Machta BB, 2013, SCIENCE, V342, P604, DOI 10.1126/science.1238723; Mortensen JJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.216401; Norskov JK, 2009, NAT CHEM, V1, P37, DOI [10.1038/nchem.121, 10.1038/NCHEM.121]; Reuter K., 2001, PHYS REV B, V2, P12; Schlogl R, 2003, ANGEW CHEM INT EDIT, V42, P2004, DOI 10.1002/anie.200301553; Ulissi Z, 2011, J CATAL, V281, P339, DOI 10.1016/j.jcat.2011.05.019; Vojvodic A, 2014, CHEM PHYS LETT, V598, P108, DOI 10.1016/j.cplett.2014.03.003; Wang S, 2011, PHYS CHEM CHEM PHYS, V13, P20760, DOI 10.1039/c1cp20547a; Wellendorff J, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.235149; Yu LP, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.068701	24	265	267	13	379	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					197	200		10.1126/science.1253486	http://dx.doi.org/10.1126/science.1253486			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013071				2022-12-28	WOS:000339409900049
J	Schemm, ER; Gannon, WJ; Wishne, CM; Halperin, WP; Kapitulnik, A				Schemm, E. R.; Gannon, W. J.; Wishne, C. M.; Halperin, W. P.; Kapitulnik, A.			Observation of broken time-reversal symmetry in the heavy-fermion superconductor UPt3	SCIENCE			English	Article							MUON SPIN RELAXATION; UNCONVENTIONAL SUPERCONDUCTIVITY; ORDER-PARAMETER; VORTEX LATTICE; PHASE-DIAGRAM; TRANSITION; SYSTEMS; STATE	Models of superconductivity in unconventional materials can be experimentally differentiated by the predictions they make for the symmetries of the superconducting order parameter. In the case of the heavy-fermion superconductor UPt3, a key question is whether its multiple superconducting phases preserve or break time-reversal symmetry (TRS). We tested for asymmetry in the phase shift between left and right circularly polarized light reflected from a single crystal of UPt3 at normal incidence and found that this so-called polar Kerr effect appears only below the lower of the two zero-field superconducting transition temperatures. Our results provide evidence for broken TRS in the low-temperature superconducting phase of UPt3, implying a complex two-component order parameter for superconductivity in this system.	[Schemm, E. R.; Kapitulnik, A.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Schemm, E. R.; Kapitulnik, A.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Schemm, E. R.; Kapitulnik, A.] SLAC Natl Accelerator Lab, SIMES, Menlo Pk, CA 94025 USA; [Gannon, W. J.; Wishne, C. M.; Halperin, W. P.] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA; [Kapitulnik, A.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Northwestern University; Stanford University	Schemm, ER (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	eschemm@stanford.edu		kapitulnik, aharon/0000-0002-2569-3582; Gannon, William/0000-0001-5635-2185	U.S. Department of Energy Office of Basic Energy Science, Division of Materials Science and Engineering at Stanford [DE-AC02-76SF00515]; U.S. Department of Energy Office of Basic Energy Science, Division of Materials Science and Engineering at Northwestern [DE-FG02-05ER46248]; Stanford Center for Probing the Nanoscale (NSF NSEC) [0425897]; Gabilan Stanford Graduate Fellowship; DARE Doctoral Fellowship Program	U.S. Department of Energy Office of Basic Energy Science, Division of Materials Science and Engineering at Stanford; U.S. Department of Energy Office of Basic Energy Science, Division of Materials Science and Engineering at Northwestern; Stanford Center for Probing the Nanoscale (NSF NSEC); Gabilan Stanford Graduate Fellowship; DARE Doctoral Fellowship Program	Stimulating discussions with S. Kivelson, A. Huxley, and D. Agterberg; sample characterization by K. Avers (Northwestern); and instrument design assistance from G. Burkhard (Stanford) are greatly appreciated. This work was supported by the U.S. Department of Energy Office of Basic Energy Science, Division of Materials Science and Engineering, at Stanford under contract DE-AC02-76SF00515 and at Northwestern under contract DE-FG02-05ER46248. Construction of the Sagnac apparatus was partially funded by the Stanford Center for Probing the Nanoscale (NSF NSEC 0425897). E.R.S. received additional support from a Gabilan Stanford Graduate Fellowship and the DARE Doctoral Fellowship Program.	ADENWALLA S, 1990, PHYS REV LETT, V65, P2298, DOI 10.1103/PhysRevLett.65.2298; AEPPLI G, 1987, PHYS REV LETT, V58, P808, DOI 10.1103/PhysRevLett.58.808; ARGYRES PN, 1955, PHYS REV, V97, P334, DOI 10.1103/PhysRev.97.334; BRISON JP, 1994, J LOW TEMP PHYS, V95, P145, DOI 10.1007/BF00754931; DEREOTIER PD, 1995, PHYS LETT A, V205, P239, DOI 10.1016/0375-9601(95)00548-H; FISHER RA, 1989, PHYS REV LETT, V62, P1411, DOI 10.1103/PhysRevLett.62.1411; Fujimoto S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.024515; Goryo J, 2010, MOD PHYS LETT B, V24, P2831, DOI 10.1142/S0217984910025115; HASSELBACH K, 1989, PHYS REV LETT, V63, P93, DOI 10.1103/PhysRevLett.63.93; Hosur P, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115116; Huxley A, 2000, NATURE, V406, P160, DOI 10.1038/35018020; JEANNERET B, 1989, APPL PHYS LETT, V55, P2336, DOI 10.1063/1.102053; Joynt R, 2002, REV MOD PHYS, V74, P235, DOI 10.1103/RevModPhys.74.235; Kapitulnik A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055060; KLEIMAN RN, 1992, PHYS REV LETT, V69, P3120, DOI 10.1103/PhysRevLett.69.3120; Landau LD., 1984, ELECTRODYNAMICS CONT; LUKE GM, 1993, PHYS REV LETT, V71, P1466, DOI 10.1103/PhysRevLett.71.1466; Lussier B, 1996, PHYS REV B, V53, P5145, DOI 10.1103/PhysRevB.53.5145; Lutchyn RM, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.104508; Machida Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.157002; Norman MR, 2011, SCIENCE, V332, P196, DOI 10.1126/science.1200181; SAULS JA, 1994, ADV PHYS, V43, P113, DOI 10.1080/00018739400101475; SIGNORE PJC, 1995, PHYS REV B, V52, P4446, DOI 10.1103/PhysRevB.52.4446; SPIELMAN S, 1992, PHYS REV LETT, V68, P3472, DOI 10.1103/PhysRevLett.68.3472; STEWART GR, 1984, PHYS REV LETT, V52, P679, DOI 10.1103/PhysRevLett.52.679; Strand JD, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.197002; SULEWSKI PE, 1988, PHYS REV B, V38, P5338, DOI 10.1103/PhysRevB.38.5338; Taylor E, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.157001; Xia J, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2336620; Xia J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.167002; Yakovenko VM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.087003; Yaron U, 1997, PHYS REV LETT, V78, P3185, DOI 10.1103/PhysRevLett.78.3185; YIP S, 1993, PHYS REV B, V48, P3304, DOI 10.1103/PhysRevB.48.3304	35	140	141	3	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					190	193		10.1126/science.1248552	http://dx.doi.org/10.1126/science.1248552			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013069	Green Submitted			2022-12-28	WOS:000339409900047
J	Sedgwick, P				Sedgwick, Philip			Understanding P values	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STATISTICAL QUESTION; TRIAL		Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P., 2010, BMJ, V340, pc2673, DOI [10.1136/bmj.c2673, DOI 10.1136/BMJ.C2673]; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4287; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3557; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2130; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6282; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1041; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4285; Walsh JM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5605	8	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 11	2014	349								g4550	10.1136/bmj.g4550	http://dx.doi.org/10.1136/bmj.g4550			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZH	25015369				2022-12-28	WOS:000338993900006
J	Brazil, R				Brazil, Rachel			FOOD SCIENCE Fat chance	NATURE			English	Editorial Material							KETOGENIC DIET; EPILEPSY; EFFICACY											Chang PS, 2013, NEUROPHARMACOLOGY, V69, P105, DOI 10.1016/j.neuropharm.2012.11.004; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Hallbook T, 2012, EPILEPSY RES, V100, P304, DOI 10.1016/j.eplepsyres.2011.04.017; Hughes SD, 2014, J NEUROCHEM, V129, P426, DOI 10.1111/jnc.12646; Kobow K, 2013, ACTA NEUROPATHOL, V126, P741, DOI 10.1007/s00401-013-1168-8; Kossoff EH, 2003, NEUROLOGY, V61, P1789, DOI 10.1212/01.WNL.0000098889.35155.72; Kossoff EH, 2009, EPILEPSIA, V50, P304, DOI 10.1111/j.1528-1167.2008.01765.x; Levy RG, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001903.pub2, 10.1002/14651858.CD001903.pub3]; McNally MA, 2012, J NEUROCHEM, V121, P28, DOI 10.1111/j.1471-4159.2012.07670.x; Muzykewicz DA, 2009, EPILEPSIA, V50, P1118, DOI 10.1111/j.1528-1167.2008.01959.x	10	1	1	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S14	S15		10.1038/511S14a	http://dx.doi.org/10.1038/511S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8AP	25019130				2022-12-28	WOS:000338649800007
J	Detry, MA; Lewis, RJ				Detry, Michelle A.; Lewis, Roger J.			The Intention-to-Treat Principle How to Assess the True Effect of Choosing a Medical Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NONINFERIORITY		[Detry, Michelle A.; Lewis, Roger J.] Berry Consultants LLC, Austin, TX USA; [Lewis, Roger J.] Harbor UCLA Med Ctr, Dept Emergency Med, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Lewis, Roger J.] UCLA, David Geffen Sch Med, Torrance, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lewis, RJ (corresponding author), Harbor UCLA Med Ctr, Dept Emergency, Bldg D9,1000 W Carson St, Torrance, CA 90509 USA.	roger@emedharbor.edu						Cook T, 2008, INTRO STAT METHODS C; Food and Drug Administration, 1998, GUID IND E9 STAT PRI; Le Henanff A, 2006, JAMA-J AM MED ASSOC, V295, P1147, DOI 10.1001/jama.295.10.1147; Montedori A, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-58; Mulla SM, 2012, JAMA-J AM MED ASSOC, V308, P2605, DOI 10.1001/2012.jama.11235; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232	8	76	77	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					85	86		10.1001/jama.2014.7523	http://dx.doi.org/10.1001/jama.2014.7523			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	25058221				2022-12-28	WOS:000338131100024
J	O'Meara, S; Richardson, R; Lipsky, BA				O'Meara, Susan; Richardson, Rachel; Lipsky, Benjamin A.			Topical and Systemic Antimicrobial Therapy for Venous Leg Ulcers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[O'Meara, Susan] Univ Leeds, Sch Healthcare, Leeds LS2 9JT, W Yorkshire, England; [Richardson, Rachel] Univ York, Dept Hlth Sci, Cochrane Wounds Grp, York YO10 5DD, N Yorkshire, England; [Lipsky, Benjamin A.] Univ Washington, Dept Med, Seattle, WA USA; [Lipsky, Benjamin A.] Univ Geneva, Dept Infect Dis, Geneva, Switzerland; [Lipsky, Benjamin A.] Univ Oxford, Green Templeton Coll, Oxford, England	University of Leeds; University of York - UK; University of Washington; University of Washington Seattle; University of Geneva; University of Oxford	O'Meara, S (corresponding author), Univ Leeds, Sch Healthcare, Leeds LS2 9JT, W Yorkshire, England.	s.m.omeara@leeds.ac.uk		Lipsky, Benjamin A./0000-0001-9886-5114				Howell-Jones RS, 2005, J ANTIMICROB CHEMOTH, V55, P143, DOI 10.1093/jac/dkh513; Lorimer Karen R, 2003, J Wound Ostomy Continence Nurs, V30, P132, DOI 10.1067/mjw.2003.122; Malas MB, CHRONIC VENOUS ULCER; O'Meara S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003557.pub5; Oien RF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003091; Scottish Intercollegiate Guidelines Network, MANAGEMENT OF CHRONI	6	15	15	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2534	2535		10.1001/jama.2014.4574	http://dx.doi.org/10.1001/jama.2014.4574			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	25058087				2022-12-28	WOS:000337757000027
J	Rusakova, M; Rakhmetova, A; Strathdee, SA				Rusakova, Maia; Rakhmetova, Aliya; Strathdee, Steffanie A.			Why are sex workers who use substances at risk for HIV?	LANCET			English	Editorial Material							BORDER CITIES; MALE PARTNERS; INJECT DRUGS; FEMALE; BEHAVIORS; RUSSIA		[Rusakova, Maia] NGO Stellit, St Petersburg, Russia; [Rakhmetova, Aliya] Sex Workers Rights Advocacy Network, Budapest, Hungary; [Strathdee, Steffanie A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Strathdee, SA (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	sstrathdee@ucsd.edu	Strathdee, Steffanie A/B-9042-2009	Strathdee, Steffanie/0000-0002-7724-691X; Rusakova, Mayya/0000-0003-1381-353X				Cottler LB, 2014, AM J PUBLIC HEALTH, V104, P338, DOI 10.2105/AJPH.2013.301513; Decker MR, 2014, AIDS BEHAV, V18, P562, DOI 10.1007/s10461-013-0577-y; Des Jarlais DC, 2012, DRUG ALCOHOL DEPEN, V124, P95, DOI 10.1016/j.drugalcdep.2011.12.020; Goldenberg SM, 2012, AIDS BEHAV, V16, P969, DOI 10.1007/s10461-011-0063-3; Rolon ML, 2013, J TROP PEDIATRICS, V59, P214, DOI 10.1093/tropej/fmt009; Odinokova V, 2014, INT J DRUG POLICY, V25, P96, DOI 10.1016/j.drugpo.2013.06.008; Open Society Institute, 2008, NOTH US US GREAT MEA; Patterson TL, 2012, JAIDS-J ACQ IMM DEF, V60, P414, DOI 10.1097/QAI.0b013e31825693f2; Platt L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002836; Robertson AM, 2013, SEX TRANSM DIS, V40, P801, DOI 10.1097/OLQ.0000000000000016; Shannon K., 2014, LANCET; Strathdee SA, 2008, DRUG ALCOHOL DEPEN, V92, P132, DOI 10.1016/j.drugalcdep.2007.07.001; Strathdee SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065812; UNAIDS, 2013, RUSS FED HIV AIDS ES; United Nations & AIDS (UNAIDS), 2012, WORLD AIDS DAY REP; Urada LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033282; World Health Organization, 2013, IMPL COMPR HIV STI P	17	16	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					211	212		10.1016/S0140-6736(14)61042-4	http://dx.doi.org/10.1016/S0140-6736(14)61042-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ2DL	25059944				2022-12-28	WOS:000348044800009
J	Koes, BW; Enthoven, WT				Koes, Bart W.; Enthoven, Wendy T.			Do patients with acute low-back pain need paracetamol?	LANCET			English	Editorial Material									[Koes, Bart W.; Enthoven, Wendy T.] Erasmus MC, Univ Med Ctr, Dept Gen Practice, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Koes, BW (corresponding author), Erasmus MC, Univ Med Ctr, Dept Gen Practice, NL-3000 CA Rotterdam, Netherlands.	b.koes@erasmusmc.nl	Koes, Bart w/K-4614-2016	Koes, Bart w/0000-0002-0450-9969				Chou D, 2013, COCHRANE DB SYST REV, V3; Hunt RH, 2007, CAN FAM PHYSICIAN, V53, P1177; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Roelofs PDDM, 2008, SPINE, V33, P1766, DOI 10.1097/BRS.0b013e31817e69d3; Toms L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004602.pub2; Williams CM, 2014, LANCET	6	4	4	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2014	384	9954					1556	1557		10.1016/S0140-6736(14)60978-8	http://dx.doi.org/10.1016/S0140-6736(14)60978-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9NK	25064595				2022-12-28	WOS:000343901700007
J	Suh, JM; Jonker, JW; Ahmadian, M; Goetz, R; Lackey, D; Osborn, O; Huang, ZF; Liu, WL; Yoshihara, E; van Dijk, TH; Havinga, R; Fan, WW; Yin, YQ; Yu, RT; Liddle, C; Atkins, AR; Olefsky, JM; Mohammadi, M; Downes, M; Evans, RM				Suh, Jae Myoung; Jonker, Johan W.; Ahmadian, Maryam; Goetz, Regina; Lackey, Denise; Osborn, Olivia; Huang, Zhifeng; Liu, Weilin; Yoshihara, Eiji; van Dijk, Theo H.; Havinga, Rick; Fan, Weiwei; Yin, Yun-Qiang; Yu, Ruth T.; Liddle, Christopher; Atkins, Annette R.; Olefsky, Jerrold M.; Mohammadi, Moosa; Downes, Michael; Evans, Ronald M.			Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer	NATURE			English	Article							GROWTH-FACTOR-I; PPAR-GAMMA-FGF1 AXIS; PPAR-GAMMA; FIBROBLAST; HOMEOSTASIS; MICE; SUPPRESSION; METABOLISM; RATS	Fibroblast growth factor 1 (FGF1) is an autocrine/paracrine regulator whose binding to heparan sulphate proteoglycans effectively precludes its circulation(1,2). Although FGF1 is known as a mitogenic factor, FGF1 knockout mice develop insulin resistance when stressed by a high-fat diet, suggesting a potential role in nutrient homeostasis(3,4). Here we show that parenteral delivery of a single dose of recombinant FGF1(rFGF1) results in potent, insulin-dependent lowering of glucose levels in diabetic mice that is dose-dependent but does not lead to hypoglycaemia. Chronic pharmacological treatment with rFGF1 increases insulin-dependent glucose uptake in skeletal muscle and suppresses the hepatic production of glucose to achieve whole-body insulin sensitization. The sustained glucose lowering and insulin sensitization attributed to rFGF1 are not accompanied by the side effects of weight gain, liver steatosis and bone loss associated with current insulin-sensitizing therapies. We also show that the glucose-lowering activity of FGF1 can be dissociated from its mitogenic activity and is mediated predominantly via FGF receptor 1 signalling. Thus we have uncovered an unexpected, neomorphic insulin-sensitizing action for exogenous non-mitogenic human FGF1 with therapeutic potential for the treatment of insulin resistance and type 2 diabetes.	[Suh, Jae Myoung; Ahmadian, Maryam; Yoshihara, Eiji; Fan, Weiwei; Yin, Yun-Qiang; Yu, Ruth T.; Atkins, Annette R.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Jonker, Johan W.; Liu, Weilin; van Dijk, Theo H.; Havinga, Rick] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, NL-9713 GZ Groningen, Netherlands; [Jonker, Johan W.; Liu, Weilin; van Dijk, Theo H.; Havinga, Rick] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Lab Med, NL-9713 GZ Groningen, Netherlands; [Goetz, Regina; Huang, Zhifeng; Mohammadi, Moosa] New York Univ Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Lackey, Denise; Osborn, Olivia; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Liddle, Christopher] Westmead Millennium Inst, Storr Liver Unit, Westmead, NSW 2145, Australia; [Liddle, Christopher] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; University of Groningen; University of Groningen; New York University; University of California System; University of California San Diego; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Howard Hughes Medical Institute; Salk Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	downes@salk.edu; evans@salk.edu	kasaei, fahime/T-7197-2018; Evans, Ronald/AAF-4001-2019; Mohammadi, Moosa/ABA-6745-2020; osborn, olivia/R-1460-2018; Suh, Jae Myoung/B-3268-2015; Jonker, Johan W./ABE-6853-2020; Goetz, Regina/M-2411-2019; Frank, Viki/GXZ-9902-2022	Evans, Ronald/0000-0002-9986-5965; Mohammadi, Moosa/0000-0003-2434-9437; osborn, olivia/0000-0003-0516-7937; Suh, Jae Myoung/0000-0001-8097-4662; Jonker, Johan W./0000-0002-3919-5437; Goetz, Regina/0000-0003-3681-4703; Yu, Ruth/0000-0002-9527-9627; Yoshihara, Eiji/0000-0001-6324-6495; Atkins, Annette/0000-0003-2558-7058	National Institutes of Health (NIH) [DK057978, DK090962, HL088093, HL105278, ES010337]; Glenn Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; Ipsen/Biomeasure; California Institute for Regenerative Medicine; The Ellison Medical Foundation; National Health and Medical Research Council [512354, 632886, 1043199]; European Research Council [IRG-277169]; Human Frontier Science Program [CDA00013/2011-C]; Netherlands Organisation for Scientific Research (VIDI grant) [016.126.338]; Dutch Digestive Foundation [WO 11-67]; Dutch Diabetes Foundation [2012.00.1537]; NIH [DK-033651, DK-074868, T32-DK-007494, DK-063491, P01-DK054441-14A1]; Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH [U54-HD-012303-25]; National Institute of Dental and Craniofacial Research [DE13686]; F32 Ruth L. Kirschstein National Research Service Award (National Institute of Diabetes and Digestive and Kidney Diseases); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088093, R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033651, T32DK007494, R37DK057978, R01DK033651, P01DK054441, P30DK063491, R24DK090962, P01DK074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; Ipsen/Biomeasure(Ipsen); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); The Ellison Medical Foundation(Lawrence Ellison Foundation); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); European Research Council(European Research Council (ERC)European Commission); Human Frontier Science Program(Human Frontier Science Program); Netherlands Organisation for Scientific Research (VIDI grant); Dutch Digestive Foundation; Dutch Diabetes Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); F32 Ruth L. Kirschstein National Research Service Award (National Institute of Diabetes and Digestive and Kidney Diseases); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank L. Chong, J. Alvarez, S. Kaufman, B. Collins, X. Zhao, S. Liu, A. Jurdzinski, A. Bleeker, K. Bijsterveld, D. Oh and G. Bandyopadhyay for technical assistance, and L. Ong and C. Brondos for administrative assistance. Computed tomography was performed at the Veterans Medical Research Foundation. R. M. E. is a Howard Hughes Medical Institute Investigator at the Salk Institute and March of Dimes Chair, and is supported by National Institutes of Health (NIH) grants (DK057978, DK090962, HL088093, HL105278 and ES010337), the Glenn Foundation for Medical Research, the Leona M. and Harry B. Helmsley Charitable Trust, Ipsen/Biomeasure, the California Institute for Regenerative Medicine and The Ellison Medical Foundation. C. L. and M. D. are funded by the National Health and Medical Research Council (grants 512354, 632886 and 1043199); J. W. J. by the European Research Council (grant IRG-277169), the Human Frontier Science Program (CDA00013/2011-C), the Netherlands Organisation for Scientific Research (VIDI grant 016.126.338), the Dutch Digestive Foundation (grant WO 11-67) and the Dutch Diabetes Foundation (grant 2012.00.1537); J.M.O. by NIH grants (DK-033651, DK-074868, T32-DK-007494, DK-063491 and P01-DK054441-14A1) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH through cooperative agreement of U54-HD-012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research; M. M. by the National Institute of Dental and Craniofacial Research grant (DE13686); and M.A. by an F32 Ruth L. Kirschstein National Research Service Award (National Institute of Diabetes and Digestive and Kidney Diseases).	Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Lee J, 2009, J MOL BIOL, V393, P113, DOI 10.1016/j.jmb.2009.08.026; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li AJ, 1998, NEUROSCI LETT, V255, P41, DOI 10.1016/S0304-3940(98)00701-0; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; SASAKI K, 1994, PHYSIOL BEHAV, V56, P211, DOI 10.1016/0031-9384(94)90186-4; Sun K, 2012, CELL RES, V22, P1416, DOI 10.1038/cr.2012.94; Suzuki S, 2001, EUR J NEUROSCI, V13, P2299, DOI 10.1046/j.0953-816x.2001.01606.x; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Zinn KR, 2000, NUCL MED BIOL, V27, P407, DOI 10.1016/S0969-8051(00)00090-1	18	157	188	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					436	+		10.1038/nature13540	http://dx.doi.org/10.1038/nature13540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043058	Green Accepted			2022-12-28	WOS:000341814900064
J	Pollux, BJA; Meredith, RW; Springer, MS; Garland, T; Reznick, DN				Pollux, B. J. A.; Meredith, R. W.; Springer, M. S.; Garland, T.; Reznick, D. N.			The evolution of the placenta drives a shift in sexual selection in livebearing fish	NATURE			English	Article							MOLECULAR PHYLOGENETIC-RELATIONSHIPS; PARENT-OFFSPRING CONFLICT; REPRODUCTIVE ISOLATION; SIZE DIMORPHISM; VIVIPARITY; POECILIA; CYPRINODONTIFORMES; COEVOLUTION; POLYTOMIES; PATTERNS	The evolution of the placenta from a non-placental ancestor causes a shift of maternal investment from pre- to post-fertilization, creating a venue for parent-offspring conflicts during pregnancy(1-4). Theory predicts that the rise of these conflicts should drive a shift from a reliance on pre-copulatory female mate choice to polyandry in conjunction with post-zygotic mechanisms of sexual selection(2). This hypothesis has not yet been empirically tested. Here we apply comparative methods to test a key prediction of this hypothesis, which is that the evolution of placentation is associated with reduced pre-copulatory female mate choice. We exploit a unique quality of the livebearing fish family Poeciliidae: placentas have repeatedly evolved or been lost, creating diversity among closely related lineages in the presence or absence of placentation(5,6). We show that post-zygotic maternal provisioning by means of a placenta is associated with the absence of bright coloration, courtship behaviour and exaggerated ornamental display traits in males. Furthermore, we found that males of placental species have smaller bodies and longer genitalia, which facilitate sneak or coercive mating and, hence, circumvents female choice. Moreover, we demonstrate that post-zygotic maternal provisioning correlates with superfetation, a female reproductive adaptation that may result in polyandry through the formation of temporally overlapping, mixed-paternity litters. Our results suggest that the emergence of prenatal conflict during the evolution of the placenta correlates with a suite of phenotypic and behavioural male traits that is associated with a reduced reliance on pre-copulatory female mate choice.	[Pollux, B. J. A.; Meredith, R. W.; Springer, M. S.; Garland, T.; Reznick, D. N.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Pollux, B. J. A.] Wageningen Univ, Expt Zool Grp, NL-6708 WD Wageningen, Netherlands; [Meredith, R. W.] Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ 07043 USA	University of California System; University of California Riverside; Wageningen University & Research; Montclair State University	Pollux, BJA (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	b.pollux@gmail.com; david.reznick@ucr.edu		Garland, Theodore/0000-0002-7916-3552; reznick, david/0000-0002-1144-0568	Netherlands Organisation for Scientific Research [825.07.017]; European Union [299048]; US National Science Foundation [DEB0416085]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); US National Science Foundation(National Science Foundation (NSF))	We thank all individuals and institutions who provided samples for this study (Rehoboth Aquatics, H. Bart Jr, R. Davis, D. Fromm, J. de Greef, H. Hieronimus, B. Hobbs, T. Hrbek, J. Johnson, B. Kohler, J. Langenhammer, C. Li, J. Lundberg, M. Mateos, A. Meyer, D. Nelson, L. Page, L. Parenti, M. Sabaj Perez, R. Robins, R. de Ruiter, S. Schaefer, M. Schartl, J. Sparks, M. Stiassny, J. Travis, J. Trexler and J. Williams); L. Rowe and A. Furness for discussions and reading the manuscript; and C. Oufiero and M. Banet for help in collecting part of the data. This study was supported by Rubicon grant 825.07.017 of the Netherlands Organisation for Scientific Research and Marie Curie - IIF grant 299048 of the European Union to B.J.A.P. and grant DEB0416085 of the US National Science Foundation to D.N.R. and M.S.S.	Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Banet AI, 2010, EVOLUTION, V64, P3172, DOI 10.1111/j.1558-5646.2010.01059.x; BISAZZA A, 1995, ETHOL ECOL EVOL, V7, P169, DOI 10.1080/08927014.1995.9522963; BISAZZA A, 1993, MAR BEHAV PHYSIOL, V23, P257, DOI 10.1080/10236249309378869; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; Breden F, 1999, MOL PHYLOGENET EVOL, V12, P95, DOI 10.1006/mpev.1998.0600; Bruggeman J, 2009, NUCLEIC ACIDS RES, V37, pW179, DOI 10.1093/nar/gkp370; Burnham KP., 2002, MODEL SELECTION MULT, V2, P70; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Coleman SW, 2009, AM NAT, V173, P291, DOI 10.1086/596542; Crespi B, 2004, AM NAT, V163, P635, DOI 10.1086/382734; Dugdale HL, 2007, MOL ECOL, V16, P5294, DOI 10.1111/j.1365-294X.2007.03571.x; EVANS J.P., 2011, ECOLOGY EVOLUTION PO; Evans JP, 2011, P ROY SOC B-BIOL SCI, V278, P2611, DOI 10.1098/rspb.2010.2453; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; Felsenstein J., 2004, INFERRING PHYLOGENIE; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; Garland T, 1999, SYST BIOL, V48, P547, DOI 10.1080/106351599260139; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAIG D, 1990, AM NAT, V136, P550, DOI 10.1086/285113; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kocher TD, 1995, MOL PHYLOGENET EVOL, V4, P420, DOI 10.1006/mpev.1995.1039; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Maddison W.P., MESQUITE MODULAR SYS; Meffe GK, 1989, ECOLOGY EVOLUTION LI; Meredith RW, 2011, MOL PHYLOGENET EVOL, V59, P148, DOI 10.1016/j.ympev.2011.01.014; Meredith RW, 2010, MOL PHYLOGENET EVOL, V55, P631, DOI 10.1016/j.ympev.2009.11.006; MEYER A, 1993, P ROY SOC B-BIOL SCI, V254, P153, DOI 10.1098/rspb.1993.0140; O'Neill MJ, 2007, P NATL ACAD SCI USA, V104, P12404, DOI 10.1073/pnas.0705048104; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M., 2013, USERS MANUAL BAYES T; Pilastro A, 1997, P ROY SOC B-BIOL SCI, V264, P1125, DOI 10.1098/rspb.1997.0155; Pollux BJA, 2009, ANNU REV ECOL EVOL S, V40, P271, DOI 10.1146/annurev.ecolsys.110308.120209; Pollux BJA, 2011, FUNCT ECOL, V25, P747, DOI 10.1111/j.1365-2435.2011.01831.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ptacek MB, 1998, J FISH BIOL, V53, P64, DOI 10.1006/jfbi.1998.0807; PURVIS A, 1993, SYST BIOL, V42, P569, DOI 10.2307/2992489; Rambaut A., SE AL SEQUENCE ALIGN; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Reznick DN, 2002, SCIENCE, V298, P1018, DOI 10.1126/science.1076018; SAS Institute, 2012, SAS ETS 12 1 US GUID, P1121; Schmidt TR, 1998, COPEIA, P14, DOI 10.2307/1447697; Schrader M, 2012, EVOLUTION, V66, P272, DOI 10.1111/j.1558-5646.2011.01422.x; Schrader M, 2008, AM NAT, V172, P806, DOI 10.1086/592999; SHACKELFORD RM, 1952, AM NAT, V86, P311, DOI 10.1086/281738; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Yamaguchi N, 2006, Q REV BIOL, V81, P33, DOI 10.1086/503923; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Zeh DW, 2000, BIOESSAYS, V22, P938, DOI 10.1002/1521-1878(200010)22:10<938::AID-BIES9>3.0.CO;2-9; Zeh JA, 2003, ETHOLOGY, V109, P929, DOI 10.1046/j.1439-0310.2003.00945.x	59	110	110	1	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					233	+		10.1038/nature13451	http://dx.doi.org/10.1038/nature13451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043015				2022-12-28	WOS:000341362800050
J	Duffy, JMN; Wilson, MJA; Khan, KS				Duffy, James M. N.; Wilson, Matthew J. A.; Khan, Khalid S.			What is the optimal pharmacological management of retained placenta?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NITROGLYCERIN		[Duffy, James M. N.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Wilson, Matthew J. A.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Khan, Khalid S.] Barts & London Queen Marys Sch Med & Dent, Womens Hlth Res Unit, Blizard Inst, London, England	University of Oxford; University of Sheffield; University of London; Queen Mary University London	Duffy, JMN (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England.	james.duffy@balliol.ox.ac.uk	Duffy, James M N/G-3762-2017; Khan, Khalid S/AAT-8824-2020	Duffy, James M N/0000-0001-6127-9859; Khan, Khalid S/0000-0001-5084-7312; Wilson, Matthew/0000-0002-9704-5189	Department of Health [DRF-2014-07-051] Funding Source: Medline; National Institute for Health Research [DRF-2014-07-051, ACF-2011-19-008] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Bullarbo M, 2005, INT J GYNECOL OBSTET, V91, P228, DOI 10.1016/j.ijgo.2005.08.020; Bullarbo M, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/321207; COMBS CA, 1991, OBSTET GYNECOL, V77, P77; Nardin JM, 2011, COCHRANE DB SYST REV, V5; National Institute for Health and Care Excellence, 2007, INTR CAR CG55; RCOG, 2011, PLAC PRAEV PLAC ACCR; van Stralen G, 2013, ACTA OBSTET GYN SCAN, V92, P398, DOI 10.1111/aogs.12065; Visalyaputra S, 2011, INT J GYNECOL OBSTET, V112, P103, DOI 10.1016/j.ijgo.2010.08.021; Weeks AD, 2008, BEST PRACT RES CL OB, V22, P1103, DOI 10.1016/j.bpobgyn.2008.07.005; Weeks AD, 2010, LANCET, V375, P141, DOI 10.1016/S0140-6736(09)61752-9; WHO Reproductive Health Library, 2012, UMB VEIN INJ MAN RET	11	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2014	349								g4778	10.1136/bmj.g4778	http://dx.doi.org/10.1136/bmj.g4778			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NA	25069774	Green Published			2022-12-28	WOS:000339905300002
J	Brashares, JS; Abrahms, B; Fiorella, KJ; Golden, CD; Hojnowski, CE; Marsh, RA; McCauley, DJ; Nunez, TA; Seto, K; Withey, L				Brashares, Justin S.; Abrahms, Briana; Fiorella, Kathryn J.; Golden, Christopher D.; Hojnowski, Cheryl E.; Marsh, Ryan A.; McCauley, Douglas J.; Nunez, Tristan A.; Seto, Katherine; Withey, Lauren			Wildlife decline and social conflict	SCIENCE			English	Editorial Material							CONSERVATION		[Brashares, Justin S.; Abrahms, Briana; Fiorella, Kathryn J.; Hojnowski, Cheryl E.; Marsh, Ryan A.; Nunez, Tristan A.; Seto, Katherine; Withey, Lauren] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Golden, Christopher D.] Wildlife Conservat Soc, Hlth & Ecosyst Anal Linkages HEAL Program, Bronx, NY 10460 USA; [McCauley, Douglas J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Berkeley; Wildlife Conservation Society; University of California System; University of California Santa Barbara	Brashares, JS (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	brashares@berkeley.edu	Abrahms, Briana/AEW-5094-2022	Abrahms, Briana/0000-0003-1987-5045; Golden, Christopher/0000-0002-0358-4625; Golden, Christopher/0000-0002-2258-7493				Bahadur J., 2011, PIRATES SOMALIA; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Douglas LR, 2014, BIOL CONSERV, V171, P270, DOI 10.1016/j.biocon.2014.01.031; Fa JE, 2005, BIOL CONSERV, V121, P167, DOI 10.1016/j.biocon.2004.04.016; Fisheries and Agriculture Department, 2012, STAT WORLD FISH AQ 2; Gore ML, 2011, CONSERV BIOL, V25, P659, DOI 10.1111/j.1523-1739.2011.01701.x; Namibian Association of Community-Based Natural Resource Management Support Organizations, 2013, STAT COMM CONS NAM A; Office of the President, 2014, NAT STRAT COMB WILDL; U. S. Department of Labor, 2012, FIND WORST FORMS CHI; UNODC, 2011, FOC TRAFF PERS SMUGG, P144; Vidal J., 2012, GUARDIAN; Weeks R, 2013, CONSERV BIOL, V27, P1234, DOI 10.1111/cobi.12153	12	79	81	3	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					376	378		10.1126/science.1256734	http://dx.doi.org/10.1126/science.1256734			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM2CB	25061187	Green Submitted			2022-12-28	WOS:000339655100014
J	Thwaites, T				Thwaites, Tim			RESEARCH METRICS Calling science to account	NATURE			English	Editorial Material																			0	4	4	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					S57	S60		10.1038/511S57a	http://dx.doi.org/10.1038/511S57a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL7SO	25054852	Bronze			2022-12-28	WOS:000339335700003
J	Heidari, S; Mofenson, LM; Bekker, LG				Heidari, Shirin; Mofenson, Lynne M.; Bekker, Linda-Gail			Realization of an AIDS-Free Generation Ensuring Sustainable Treatment for Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ANTIRETROVIRAL THERAPY		[Heidari, Shirin] Inforia, CH-1202 Geneva, Switzerland; [Mofenson, Lynne M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Cape Town	Heidari, S (corresponding author), Inforia, Rue Henri Veyrassat 3, CH-1202 Geneva, Switzerland.	shirin.heidari@inforia.org	Bekker, Linda-Gail/AAZ-8929-2020; Mofenson, Lynne/P-9631-2019	Mofenson, Lynne/0000-0002-2818-9808; Heidari, Shirin/0000-0002-6837-491X; BEKKER, LINDA-GAIL/0000-0002-0755-4386				Penazzato M, 2014, LANCET INFECT DIS, P20; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; UNAIDS, GLOB REP UNAIDS REP; United Nations Joint Programme on HIV/AIDS (UNAIDS), GLOB PLAN EL NEW HIV; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO, GLOB UPD HIV TREATM; World Health Organization, CONS GUID US ANT DRU; World Health Organization, MARCH 2014 SUPPL 201	8	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					339	340		10.1001/jama.2014.5806	http://dx.doi.org/10.1001/jama.2014.5806			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038347				2022-12-28	WOS:000339257800015
J	Ohno, H; Kato, S; Naito, Y; Kunitomo, H; Tomioka, M; Iino, Y				Ohno, Hayao; Kato, Shinya; Naito, Yasuki; Kunitomo, Hirofumi; Tomioka, Masahiro; Iino, Yuichi			Role of synaptic phosphatidylinositol 3-kinase in a behavioral learning response in C. elegans	SCIENCE			English	Article							INSULIN-RECEPTOR; PROTEIN; CHEMOTAXIS; PLASTICITY; COMPONENTS; KINESIN-1; CASY-1	The phosphatidylinositol 3-kinase (PI3K) pathway regulates many cellular functions, but its roles in the nervous system are still poorly understood. We found that a newly discovered insulin receptor isoform, DAF-2c, is translocated from the cell body to the synaptic region of the chemosensory neuron in Caenorhabditis elegans by a conditioning stimulus that induces taste avoidance learning. This translocation is essential for learning and is dependent on the mitogen-activated protein kinase-regulated interaction of CASY-1 (the calsyntenin ortholog) and kinesin-1. The PI3K pathway is required downstream of the receptor. Light-regulated activation of PI3K in the synaptic region, but not in other parts of the cell, switched taste-attractive behavior to taste avoidance, mimicking the effect of conditioning. Thus, synaptic PI3K is crucial for the behavioral switch caused by learning.	[Ohno, Hayao; Kato, Shinya; Naito, Yasuki; Kunitomo, Hirofumi; Iino, Yuichi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; [Ohno, Hayao; Iino, Yuichi] JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Naito, Yasuki; Tomioka, Masahiro; Iino, Yuichi] Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Tokyo 1130033, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Tomioka, M (corresponding author), Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Tokyo 1130033, Japan.	seidai@gen.s.u-tokyo.ac.jp; iino@bs.s.u-tokyo.ac.jp	TOMIOKA, MASAHIRO/G-4890-2014; KUNITOMO, HIROFUMI/G-4963-2014; IINO, YUICHI/G-4962-2014	TOMIOKA, MASAHIRO/0000-0002-7537-714X; KUNITOMO, HIROFUMI/0000-0001-7312-7051; Ohno, Hayao/0000-0003-2635-6964	Ministry of Education, Culture, Sports, Science and Technology of Japan [20115002, 25115010, 21370002, 23112704]; Grants-in-Aid for Scientific Research [25115010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Caenorhabditis Genetics Center (CGC), the National Bioresource Project, R. Iwata, O. Hobert, K. Matsumoto, M. Han, G. Ruvkun, M. Doi, and S. Oda for strains; N. Chronis for the design of the olfactory chip; K. D. Kimura and G. Ruvkun for daf-2a cDNA; and K. Shen, C. Bargmann, K. Takeo, and members of the Iino lab for thoughtful comments and discussions. The primary data of this study are archived in the Iino laboratory in the Department of Biological Sciences, University of Tokyo, and are available upon request. Y.I. was supported by a Grant-in-Aid for Innovative Areas "Systems molecular ethology" (20115002) and "Memory dynamism" (25115010) and for Scientific Research (B) (21370002), and M. T. was supported by a Grant-in-Aid for Innovative Areas "RNA regulation" (23112704), from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7; Cornils A, 2011, DEVELOPMENT, V138, P1183, DOI 10.1242/dev.060905; Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865; Hoerndli FJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004880; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Ikeda DD, 2008, P NATL ACAD SCI USA, V105, P5260, DOI 10.1073/pnas.0711894105; Kunitomo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3210; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Oda S, 2011, J NEUROPHYSIOL, V106, P301, DOI 10.1152/jn.01029.2010; Patel DS, 2008, GENETICS, V178, P931, DOI 10.1534/genetics.107.070813; Preuschhof C, 2010, NEUROPSYCHOLOGIA, V48, P402, DOI 10.1016/j.neuropsychologia.2009.09.031; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Samuel ADT, 2003, J NEUROSCI, V23, P373, DOI 10.1523/JNEUROSCI.23-02-00373.2003; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schioth HB, 2012, MOL NEUROBIOL, V46, P4, DOI 10.1007/s12035-011-8229-6; Tomida T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002983; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Vagnoni A, 2012, HUM MOL GENET, V21, P2845, DOI 10.1093/hmg/dds109; Vagnoni A, 2011, J CELL SCI, V124, P1032, DOI 10.1242/jcs.075168; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	24	54	57	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					313	317		10.1126/science.1250709	http://dx.doi.org/10.1126/science.1250709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035490				2022-12-28	WOS:000339400700048
J	Pratt, ST				Pratt, Stephen T.			Charge transfer goes the distance	SCIENCE			English	Editorial Material							DYNAMICS		Argonne Natl Lab, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory	Pratt, ST (corresponding author), Argonne Natl Lab, 9700 S Cass Ave, Argonne, IL 60439 USA.	stpratt@anl.gov						Bixner O, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4720492; Bostedt C, 2013, J PHYS B-AT MOL OPT, V46, DOI 10.1088/0953-4075/46/16/164003; Erk B, 2014, SCIENCE, V345, P288, DOI 10.1126/science.1253607; Eroms M, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3117902; Jonauskas V, 2003, J PHYS B-AT MOL OPT, V36, P4403, DOI 10.1088/0953-4075/36/22/003; NIEHAUS A, 1986, J PHYS B-AT MOL OPT, V19, P2925, DOI 10.1088/0022-3700/19/18/021; Popmintchev T, 2012, SCIENCE, V336, P1287, DOI 10.1126/science.1218497; Rose-Petruck C, 1999, NATURE, V398, P310, DOI 10.1038/18631; Schoenlein RW, 2000, SCIENCE, V287, P2237, DOI 10.1126/science.287.5461.2237; Stolow A, 2008, ADV CHEM PHYS, V139, P497, DOI 10.1002/9780470259498.ch6; Zewail A. H., 1993, NOBLE LECT CHEM 1996, P274; Zobeley J, 1999, J PHYS CHEM A, V103, P11145, DOI 10.1021/jp992677i	12	0	1	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					267	268		10.1126/science.1255943	http://dx.doi.org/10.1126/science.1255943			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035473				2022-12-28	WOS:000339400700027
J	Thompson, J; Lukin, MD				Thompson, Jeff; Lukin, Mikhail D.			Quantum systems under control	SCIENCE			English	Editorial Material							SINGLE ATOMS; TRAP		[Thompson, Jeff; Lukin, Mikhail D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University	Thompson, J (corresponding author), Harvard Univ, Dept Phys, 17 Oxford St, Cambridge, MA 02138 USA.	lukin@physics.harvard.edu		Thompson, Jeff/0000-0001-8673-052X				Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; Daley AJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.020505; Devoret MH, 2013, SCIENCE, V339, P1169, DOI 10.1126/science.1231930; Folling S, 2005, NATURE, V434, P481, DOI 10.1038/nature03500; Goban A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4808; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Kaufman AM, 2014, SCIENCE, V345, P306, DOI 10.1126/science.1250057; Kaufman AM, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041014; Monroe C, 2013, SCIENCE, V339, P1164, DOI 10.1126/science.1231298; MONROE C, 1995, PHYS REV LETT, V75, P4011, DOI 10.1103/PhysRevLett.75.4011; Schlosser N, 2001, NATURE, V411, P1024, DOI 10.1038/35082512; Serwane F, 2011, SCIENCE, V332, P336, DOI 10.1126/science.1201351; Thompson JD, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.133001; Tiecke TG, 2014, NATURE, V508, P241, DOI 10.1038/nature13188	14	6	6	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					272	273		10.1126/science.1256529	http://dx.doi.org/10.1126/science.1256529			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035477				2022-12-28	WOS:000339400700031
J	Ikeda, T; Ube, T				Ikeda, Tomiki; Ube, Toru			MATERIALS SCIENCE A superelastic organic crystal	NATURE			English	Editorial Material							ALLOYS		[Ikeda, Tomiki; Ube, Toru] Chuo Univ, Res & Dev Initiat, Bunkyo Ku, Tokyo 1128551, Japan	Chuo University	Ikeda, T (corresponding author), Chuo Univ, Res & Dev Initiat, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	tikeda@tamacc.chuo-u.ac.jp	Ube, Toru/AET-1798-2022					Jani JM, 2014, MATER DESIGN, V56, P1078, DOI 10.1016/j.matdes.2013.11.084; Kato T, 2006, ANGEW CHEM INT EDIT, V45, P38, DOI 10.1002/anie.200501384; Olander A, 1932, J AM CHEM SOC, V54, P3819, DOI 10.1021/ja01349a004; Otsuka K, 2005, PROG MATER SCI, V50, P511, DOI 10.1016/j.pmatsci.2004.10.001; Prins LJ, 2001, ANGEW CHEM INT EDIT, V40, P2382, DOI 10.1002/1521-3773(20010702)40:13<2382::AID-ANIE2382>3.0.CO;2-G; Takamizawa S, 2014, ANGEW CHEM INT EDIT, V53, P6970, DOI 10.1002/anie.201311014	6	5	5	3	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					300	301		10.1038/511300a	http://dx.doi.org/10.1038/511300a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030163				2022-12-28	WOS:000338992200024
J	McGary, RS; Evans, RL; Wannamaker, PE; Elsenbeck, J; Rondenay, S				McGary, R. Shane; Evans, Rob L.; Wannamaker, Philip E.; Elsenbeck, Jimmy; Rondenay, Stephane			Pathway from subducting slab to surface for melt and fluids beneath Mount Rainier	NATURE			English	Article							SOURCE REGION; ARC MAGMAS; ZONE; MANTLE; FLOW; DECOMPOSITION; WASHINGTON; ROCKS	Convergent margin volcanism originates with partial melting, primarily of the upper mantle, into which the subducting slab descends(1,2). Melting of this material can occur in one of two ways. The flow induced in the mantle by the slab can result in upwelling and melting through adiabatic decompression(1,3). Alternatively, fluids released from the descending slab through dehydration reactions can migrate into the hot mantle wedge, inducing melting by lowering the solidus temperature(2,4). The two mechanisms are not mutually exclusive(1). In either case, the buoyant melts make their way towards the surface to reside in the crust or to be extruded as lava. Here we use magnetotelluric data collected across the central state of Washington, USA, to image the complete pathway for the fluid-melt phase. By incorporating constraints from a collocated seismic study(5) into the magnetotelluric inversion process, we obtain superior constraints on the fluids and melt in a subduction setting. Specifically, we are able to identify and connect fluid release at or near the top of the slab, migration of fluids into the overlying mantle wedge, melting in the wedge, and transport of the melt/fluid phase to a reservoir in the crust beneath Mt Rainier.	[McGary, R. Shane; Evans, Rob L.; Elsenbeck, Jimmy] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Wannamaker, Philip E.] Univ Utah, Energy & Geosci Inst, Salt Lake City, UT 84108 USA; [Rondenay, Stephane] Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway	Woods Hole Oceanographic Institution; Utah System of Higher Education; University of Utah; University of Bergen	McGary, RS (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, MS 22,360 Woods Hole Rd, Woods Hole, MA 02543 USA.	mcgaryr@tcnj.edu	Rondenay, Stéphane/B-9764-2013	Rondenay, Stéphane/0000-0003-0805-249X; Evans, Robert/0000-0001-5585-0684; Wannamaker, Phil/0000-0001-5744-6474	US National Science Foundation through the Earthscope programme [EAR08-44041, EAR08-43725]; National Defense Science and Engineering Graduate (NDSEG) fellowship	US National Science Foundation through the Earthscope programme; National Defense Science and Engineering Graduate (NDSEG) fellowship	We thank V. Maris, M. Brown, A. Kelbert, and Quantec Geoscience, Inc. for their part in data acquisition. We also thank A. Pommier, D. Lizarralde, A. Malcolm, A. Shaw, H. Marschall and J. P. Canales for critical discussions and input on early versions of the manuscript. Finally, we thank P. van Keken for use of his thermal overlay in the magnetotelluric figure. This work was supported by US National Science Foundation grant EAR08-44041(Principal Investigator R. L. E.) and US National Science Foundation grant EAR08-43725 (Principal Investigator P. E. W.), both through the Earthscope programme. R. S. M. was supported by a National Defense Science and Engineering Graduate (NDSEG) fellowship.	Abers GA, 2009, GEOLOGY, V37, P1119, DOI 10.1130/G30143A.1; Caldwell TG, 2004, GEOPHYS J INT, V158, P457, DOI 10.1111/j.1365-246X.2004.02281.x; Chave AD, 2004, GEOPHYS J INT, V157, P988, DOI 10.1111/j.1365-246X.2004.02203.x; DAINES MJ, 1994, GEOPHYS RES LETT, V21, P145, DOI 10.1029/93GL03052; DAVIES JH, 1992, J GEOPHYS RES-SOL EA, V97, P2037, DOI 10.1029/91JB02571; DEFANT MJ, 1990, NATURE, V347, P662, DOI 10.1038/347662a0; Egbert GD, 1997, GEOPHYS J INT, V130, P475, DOI 10.1111/j.1365-246X.1997.tb05663.x; EGBERT GD, 1993, J GEOPHYS RES-SOL EA, V98, P15967, DOI 10.1029/93JB00778; Elsenbeck J., EARTH PLANE IN PRESS; England PC, 2010, NATURE, V467, P700, DOI 10.1038/nature09417; GROOM RW, 1989, J GEOPHYS RES-SOLID, V94, P1913, DOI 10.1029/JB094iB02p01913; Grove TL, 2009, NATURE, V460, P1044, DOI 10.1038/nature08312; Grove TL, 2006, EARTH PLANET SC LETT, V249, P74, DOI 10.1016/j.epsl.2006.06.043; Hall PS, 2001, SCIENCE, V292, P2472, DOI 10.1126/science.1060488; John T, 2003, CONTRIB MINERAL PETR, V146, P174, DOI 10.1007/s00410-003-0492-8; Marschall HR, 2012, NAT GEOSCI, V5, P862, DOI [10.1038/ngeo1634, 10.1038/NGEO1634]; Matsuno T, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003101; McCrory PA, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009407; McGary R.S, 2013, THESIS MIT; McNeice GW, 2001, GEOPHYSICS, V66, P158, DOI 10.1190/1.1444891; Meqbel N. M., EARTH PLANE IN PRESS; Mibe K, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001960; NAVON O, 1987, J GEOL, V95, P285, DOI 10.1086/629131; Ni HW, 2011, CONTRIB MINERAL PETR, V162, P637, DOI 10.1007/s00410-011-0617-4; Patro PK, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035326; PEARCE JA, 1995, ANNU REV EARTH PL SC, V23, P251, DOI 10.1146/annurev.ea.23.050195.001343; Rodi W, 2001, GEOPHYSICS, V66, P174, DOI 10.1190/1.1444893; Schurr B, 2003, EARTH PLANET SC LETT, V215, P105, DOI 10.1016/S0012-821X(03)00441-2; Simpson F., 2005, PRACTICAL MAGNETOTEL, P93; Soyer W, 2006, GEOLOGY, V34, P53, DOI 10.1130/G21951.1; Stern RJ, 2002, REV GEOPHYS, V40, DOI 10.1029/2001RG000108; Stockstill KR, 2003, J VOLCANOL GEOTH RES, V119, P275, DOI 10.1016/S0377-0273(02)00358-X; van Keken PE, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007922; WANNAMAKER PE, 1989, J GEOPHYS RES-SOLID, V94, P14127, DOI 10.1029/JB094iB10p14127; Worzewski T, 2011, NAT GEOSCI, V4, P108, DOI [10.1038/ngeo1041, 10.1038/NGEO1041]; Zhu WL, 2011, SCIENCE, V332, P88, DOI 10.1126/science.1202221	36	105	112	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					338	+		10.1038/nature13493	http://dx.doi.org/10.1038/nature13493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030172				2022-12-28	WOS:000338992200033
J	Rabar, S; Harker, M; O'Flynn, N; Wierzbicki, AS				Rabar, Silvia; Harker, Martin; O'Flynn, Norma; Wierzbicki, Anthony S.		Guideline Dev Grp	GUIDELINES Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHOLESTEROL; METAANALYSIS; THERAPY		[Rabar, Silvia; Harker, Martin; O'Flynn, Norma] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Wierzbicki, Anthony S.] Guys & St Thomas Hosp, London SE1 9RT, England	Royal College of Physicians; Guy's & St Thomas' NHS Foundation Trust	Rabar, S (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	silvia.rabar@rcplondon.ac.uk	Wierzbicki, Anthony/AAP-1735-2020	Wierzbicki, Anthony/0000-0003-2756-372X; Khan, Michael/0000-0002-8591-384X; Harker, Martin/0000-0001-6154-3517	Merck-Sharp-Dohme; Amgen; Pfizer; NICE	Merck-Sharp-Dohme(Merck & Company); Amgen(Amgen); Pfizer(Pfizer); NICE	We have read and understood BMJ policy on declaration of interests and declare the following interests: ASW declares contracts held by his institution and a role as principal site investigator for phase II and phase III studies on lipid lowering agents sponsored by Merck-Sharp-Dohme, Amgen, and Pfizer; these include phase III outcome studies that were sponsored by these companies but whose design and analysis are independent. These agents are not mentioned in the article because they are not licensed and are not likely to be licensed before the guideline is reviewed (2017). NICE did not consider these declared interests to be competing interests for this guideline. SR, MH, and NO'F are employed by the National Clinical Guideline Centre, which was funded by NICE to develop this guideline. The authors' statements can be viewed at www.bmj.com/content/bmj/349/bmj.g4356/related#datasupp.	[Anonymous], 2014, JBS3 RISK CALC; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Department of Health, 2013, NHS HLTH CHECK VASC; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; National Institue for Health and Care Excellence, 2013, DEV NICE CLIN GUID; National Institute for Health and Care Excellence, 2014, CLIN GUIDELINE; National Institute for Health and Clinical Excellence, 2006, CLIN GUIDELINE; National Institute for Health and Clinical Excellence, 2011, CLIN GUIDELINE; National Institute for Health and Clinical Excellence, 2008, CLIN GUIDELINE; National Institute for Health and Clinical Excellence, 2008, CLIN GUIDELINE	14	140	148	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2014	349								g4356	10.1136/bmj.g4356	http://dx.doi.org/10.1136/bmj.g4356			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7PI	25035388				2022-12-28	WOS:000339326400003
J	Lang, E				Lang, Eddy			In suspected PE, an age-adjusted D-dimer cutpoint improved ability to exclude PE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calgary, Calgary, AB, Canada	University of Calgary	Lang, E (corresponding author), Univ Calgary, Calgary, AB, Canada.		Lang, Eddy/AAS-2080-2020; Lang, Eddy/I-4759-2014	Lang, Eddy/0000-0003-0850-4337				Huckins DS, 2012, J EMERG MED, V43, P211, DOI 10.1016/j.jemermed.2011.05.036; Linkins LA, 2013, ANN INTERN MED, V158, P93, DOI 10.7326/0003-4819-158-2-201301150-00003; Pasha SM, 2010, THROMB RES, V125, pE123, DOI 10.1016/j.thromres.2009.11.009; Schouten HJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2492; Torres-Macho J, 2013, AM J EMERG MED, V31, P1646, DOI 10.1016/j.ajem.2013.08.037	5	1	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2							JC13	10.7326/0003-4819-161-2-201407150-02013	http://dx.doi.org/10.7326/0003-4819-161-2-201407150-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023267				2022-12-28	WOS:000339764600016
J	Morgan, D				Morgan, David			Bowel preparation with sodium picosulfate was linked to hyponatremia compared with polyethylene glycol	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Hamilton, ON, Canada	McMaster University	Morgan, D (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Rabeneck L, 2014, CANCER EPIDEM BIOMAR, V23, P508, DOI 10.1158/1055-9965.EPI-13-0956; Rahman A, 2012, CAN J GASTROENTEROL, V26, P424, DOI 10.1155/2012/757583	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2							JC12	10.7326/0003-4819-161-2-201407150-02012	http://dx.doi.org/10.7326/0003-4819-161-2-201407150-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023266				2022-12-28	WOS:000339764600015
J	Dijkstra, JM				Dijkstra, Johannes M.			T(H)2 and T-reg candidate genes in elephant shark	NATURE			English	Letter									Fujita Hlth Univ, Inst Comprehens Med Sci, Dengaku Gakubo 1-98, Toyoake, Aichi 4701192, Japan	Fujita Health University	Dijkstra, JM (corresponding author), Fujita Hlth Univ, Inst Comprehens Med Sci, Dengaku Gakubo 1-98, Toyoake, Aichi 4701192, Japan.	Dijkstra@fujita-hu.ac.jp						Andersen KG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00113; Dijkstra JM, 2014, IMMUNOGENETICS, V66, P93, DOI 10.1007/s00251-013-0747-0; Ohtani M, 2008, IMMUNOGENETICS, V60, P383, DOI 10.1007/s00251-008-0299-x; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Wen Y, 2011, CELL MOL LIFE SCI, V68, P2615, DOI 10.1007/s00018-010-0574-5	5	28	32	0	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					E7	E9		10.1038/nature13446	http://dx.doi.org/10.1038/nature13446			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SP	25008534				2022-12-28	WOS:000349549100001
J	Hauser, OP; Rand, DG; Peysakhovich, A; Nowak, MA				Hauser, Oliver P.; Rand, David G.; Peysakhovich, Alexander; Nowak, Martin A.			Cooperating with the future	NATURE			English	Article							PUBLIC-GOODS; COMMONS; TRAGEDY; CHOICE; GAME	Overexploitation of renewable resources today has a high cost on the welfare of future generations(1-5). Unlike in other public goods games(6-9), however, future generations cannot reciprocate actions made today. What mechanisms can maintain cooperation with the future? To answer this question, we devise a new experimental paradigm, the 'Intergenerational Goods Game'. A line-up of successive groups (generations) can each either extract a resource to exhaustion or leave something for the next group. Exhausting the resource maximizes the payoff for the present generation, but leaves all future generations empty-handed. Here we show that the resource is almost always destroyed if extraction decisions are made individually. This failure to cooperate with the future is driven primarily by a minority of individuals who extract far more than what is sustainable. In contrast, when extractions are democratically decided by vote, the resource is consistently sustained. Voting(10-15) is effective for two reasons. First, it allows a majority of cooperators to restrain defectors. Second, it reassures conditional cooperators(16) that their efforts are not futile. Voting, however, only promotes sustainability if it is binding for all involved. Our results have implications for policy interventions designed to sustain inter-generational public goods.	[Hauser, Oliver P.; Peysakhovich, Alexander; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Hauser, Oliver P.; Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Rand, David G.; Peysakhovich, Alexander] Yale Univ, Dept Psychol, New Haven, CT 06511 USA; [Rand, David G.] Yale Univ, Dept Econ, New Haven, CT 06511 USA; [Nowak, Martin A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA	Harvard University; Harvard University; Yale University; Yale University; Harvard University	Nowak, MA (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	martin_nowak@harvard.edu		Rand, David/0000-0001-8975-2783; Hauser, Oliver/0000-0002-9282-0801	Department of Organismic and Evolutionary Biology at Harvard; Harvard Office for Sustainability; John Templeton Foundation	Department of Organismic and Evolutionary Biology at Harvard; Harvard Office for Sustainability; John Templeton Foundation	We thank A. Dreber for discussion and three anonymous reviewers for helpful feedback. Financial support from the Department of Organismic and Evolutionary Biology at Harvard, the Harvard Office for Sustainability and the John Templeton Foundation is gratefully acknowledged.	Amir O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031461; Benkler Yochai, 2011, PENGUIN LEVIATHAN CO; Bernard M, 2013, J ECON BEHAV ORGAN, V91, P122, DOI 10.1016/j.jebo.2013.04.009; Cadsby CB, 1998, J ECON BEHAV ORGAN, V34, P603, DOI 10.1016/S0167-2681(97)00010-3; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; COASE RH, 1960, J LAW ECON, V3, P1, DOI 10.1086/466560; Ertan A, 2009, EUR ECON REV, V53, P495, DOI 10.1016/j.euroecorev.2008.09.007; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Haynes L., 2012, TEST LEARN ADAPT DEV; HOLCOMBE RG, 1989, PUBLIC CHOICE, V61, P115, DOI 10.1007/BF00115658; Jacquet J, 2013, NAT CLIM CHANGE, V3, P1025, DOI 10.1038/NCLIMATE2024; Levin S. A., 2000, FRAGILE DOMINION COM; Milinski M, 2006, P NATL ACAD SCI USA, V103, P3994, DOI 10.1073/pnas.0504902103; Milinski M, 2001, P ROY SOC B-BIOL SCI, V268, P2495, DOI 10.1098/rspb.2001.1809; Mueller Dennis C, 1979, PUBLIC CHOICE; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Ostrom E., 1990, GOVERNING COMMONS EV; Oullier O, 2013, NATURE, V501, P463, DOI 10.1038/501463a; Putterman L, 2011, J PUBLIC ECON, V95, P1213, DOI 10.1016/j.jpubeco.2011.05.001; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Tyran J.-R., 2014, EXP EC; Wade-Benzoni KA, 2009, PERS SOC PSYCHOL REV, V13, P165, DOI 10.1177/1088868309339317; Walker JM, 2000, ECON J, V110, P212, DOI 10.1111/1468-0297.00497; Wengstrom E, 2011, 201111 I FOOD RES EC; Williamson O. E., 1985, EC I CAPITALISM	30	182	184	7	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					220	+		10.1038/nature13530	http://dx.doi.org/10.1038/nature13530			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8AP	25008530	Green Accepted			2022-12-28	WOS:000338649800043
J	Hurley, R				Hurley, Richard			BMJ AWARDS INDIA The "Oscars of medicine" are coming to New Delhi: who will you nominate as a hero of Indian healthcare?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rhurley@bmj.com						BMJ Awards, 2011, PREV WINN 2011	1	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2014	349								g4540	10.1136/bmj.g4540	http://dx.doi.org/10.1136/bmj.g4540			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZF	25013214				2022-12-28	WOS:000338993700006
J	Rodger, MA; Hague, WM; Kingdom, J; Kahn, SR; Karovitch, A; Sermer, M; Clement, AM; Coat, S; Chan, WS; Said, J; Rey, E; Robinson, S; Khurana, R; Demers, C; Kovacs, MJ; Solymoss, S; Hinshaw, K; Dwyer, J; Smith, G; McDonald, S; Newstead-Angel, J; McLeod, A; Khandelwal, M; Silver, RM; Le Gal, G; Greer, IA; Keely, E; Rosene-Montella, K; Walker, M; Wells, PS				Rodger, Marc A.; Hague, William M.; Kingdom, John; Kahn, Susan R.; Karovitch, Alan; Sermer, Mathew; Clement, Anne Marie; Coat, Suzette; Chan, Wee Shian; Said, Joanne; Rey, Evelyne; Robinson, Sue; Khurana, Rshmi; Demers, Christine; Kovacs, Michael J.; Solymoss, Susan; Hinshaw, Kim; Dwyer, James; Smith, Graeme; McDonald, Sarah; Newstead-Angel, Jill; McLeod, Anne; Khandelwal, Meena; Silver, Robert M.; Le Gal, Gregoire; Greer, Ian A.; Keely, Erin; Rosene-Montella, Karen; Walker, Mark; Wells, Philip S.		TIPPS Investigators	Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial	LANCET			English	Article							MOLECULAR-WEIGHT HEPARIN; LOW-DOSE ASPIRIN; VENOUS THROMBOEMBOLISM; RECURRENT MISCARRIAGE; RISK-FACTORS; FETAL LOSS; PREECLAMPSIA; THROMBOPROPHYLAXIS; MULTICENTER; ENOXAPARIN	Background Thrombophilias are common disorders that increase the risk of pregnancy-associated venous thromboembolism and pregnancy loss and can also increase the risk of placenta-mediated pregnancy complications (severe pre-eclampsia, small-for-gestational-age infants, and placental abruption). We postulated that antepartum dalteparin would reduce these complications in pregnant women with thrombophilia. Methods In this open-label randomised trial undertaken in 36 tertiary care centres in five countries, we enrolled consenting pregnant women with thrombophilia at increased risk of venous thromboembolism or with previous placenta-mediated pregnancy complications. Eligible participants were randomly allocated in a 1: 1 ratio to either antepartum prophylactic dose dalteparin (5000 international units once daily up to 20 weeks' gestation, and twice daily thereafter until at least 37 weeks' gestation) or to no antepartum dalteparin (control group). Randomisation was done by a web-based randomisation system, and was stratified by country and gestational age at randomisation day with a permuted block design (block sizes 4 and 8). At randomisation, site pharmacists (or delegates) received a randomisation number and treatment allocation (by fax and/or e-mail) from the central web randomisation system and then dispensed study drug to the local coordinator. Patients and study personnel were not masked to treatment assignment, but the outcome adjudicators were masked. The primary composite outcome was independently adjudicated severe or early-onset pre-eclampsia, small-for-gestational-age infant (birthweight <10th percentile), pregnancy loss, or venous thromboembolism. We did intention-to-treat and on-treatment analyses. This trial is registered with ClinicalTrials. gov, number NCT00967382, and with Current Controlled Trials, number ISRCTN87441504. Findings Between Feb 28, 2000, and Sept 14, 2012, 292 women consented to participate and were randomly assigned to the two groups. Three women were excluded after randomisation because of ineligibility (two in the antepartum dalteparin group and one in the control group), leaving 146 women assigned to antepartum dalteparin and 143 assigned to no antepartum dalteparin. Some patients crossed over to the other group during treatment, and therefore for on-treatment and safety analysis there were 143 patients in the dalteparin group and 141 in the no dalteparin group. Dalteparin did not reduce the incidence of the primary composite outcome in both intention-to-treat analysis (dalteparin 25/146 [ 17.1%; 95% CI 11.4-24.2%] vs no dalteparin 27/143 [ 18.9%; 95% CI 12.8-26.3%]; risk difference -1.8% [ 95% CI -10.6% to 7.1%)) and on-treatment analysis (dalteparin 28/143 [ 19.6%] vs no dalteparin 24/141 [ 17.0%]; risk difference + 2.6% [ 95% CI -6.4 to 11.6%]). In safety analysis, the occurrence of major bleeding did not diff er between the two groups. However, minor bleeding was more common in the dalteparin group (28/143 [ 19.6%]) than in the no dalteparin group (13/141 [ 9.2%]; risk diff erence 10.4%, 95% CI 2.3-18.4; p= 0.01). Interpretation Antepartum prophylactic dalteparin does not reduce the occurrence of venous thromboembolism, pregnancy loss, or placenta-mediated pregnancy complications in pregnant women with thrombophilia at high risk of these complications and is associated with an increased risk of minor bleeding.	[Rodger, Marc A.] Univ Ottawa, Dept Med, Div Hematol, Thrombosis Program, Ottawa, ON, Canada; [Rodger, Marc A.; Clement, Anne Marie; Le Gal, Gregoire; Keely, Erin; Walker, Mark; Wells, Philip S.] Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Hague, William M.] Univ Adelaide, Robinson Inst, Womens & Childrens Hosp, Adelaide, SA, Australia; [Kingdom, John; Sermer, Mathew] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynecol, Div Maternal Fetal Med, Toronto, ON M5G 1X5, Canada; [Kahn, Susan R.] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; [Karovitch, Alan; Le Gal, Gregoire; Keely, Erin; Wells, Philip S.] Univ Ottawa, Dept Med, Ottawa Hosp, Ottawa, ON, Canada; [Coat, Suzette] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia; [Chan, Wee Shian] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Said, Joanne] Univ Melbourne, NorthWest Acad Ctr, Melbourne, Vic, Australia; [Rey, Evelyne] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Rey, Evelyne] Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ, Canada; [Rey, Evelyne] CHU St Justine Res Ctr, Montreal, PQ, Canada; [Robinson, Sue] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Khurana, Rshmi] Univ Alberta, Dept Med, Royal Alexandra Hosp, Edmonton, AB, Canada; [Khurana, Rshmi] Univ Alberta, Dept Obstet & Gynecol, Royal Alexandra Hosp, Edmonton, AB, Canada; [Demers, Christine] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Kovacs, Michael J.] Univ Western Ontario, Dept Med, London Hlth Sci Ctr, London, ON, Canada; [Solymoss, Susan] McGill Univ, Dept Med, St Marys Hosp Ctr, Montreal, PQ, Canada; [Hinshaw, Kim] Sunderland Royal Hosp, Dept Obstet, Sunderland, Tyne & Wear, England; [Dwyer, James] York Hosp, Dept Obstet & Gynaecol, York, N Yorkshire, England; [Smith, Graeme] Queens Univ, Dept Obstet & Gynecol, Kingston, ON, Canada; [McDonald, Sarah] McMaster Univ, Dept Radiol, Dept Obstet & Gynecol, Div Maternal Fetal Med, Hamilton, ON, Canada; [McDonald, Sarah] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Newstead-Angel, Jill] Univ Saskatchewan, Dept Med, Saskatoon, SK S7N 0W0, Canada; [McLeod, Anne] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada; [Khandelwal, Meena] Rowan Univ, Cooper Hosp, Cooper Med Sch, Dept Obstet & Gynecol, Camden, NJ USA; [Silver, Robert M.] Univ Utah, Hlth Sci Ctr, Dept Obstet & Gynecol, Salt Lake City, UT USA; [Greer, Ian A.] Univ Liverpool, Fac Hlth & Life Sci, Liverpool L69 3BX, Merseyside, England; [Rosene-Montella, Karen] Brown Univ, Dept Med, Warren Alpert Med Sch, Womens Med Collaborat, Providence, RI 02912 USA	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Robinson Research Institute; University of Adelaide; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; McGill University; University of Ottawa; Ottawa Hospital Research Institute; Robinson Research Institute; University of Adelaide; University of British Columbia; University of Melbourne; Universite de Montreal; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Dalhousie University; Royal Alexandra Hospital; University of Alberta; Royal Alexandra Hospital; University of Alberta; Laval University; London Health Sciences Centre; Western University (University of Western Ontario); McGill University; Sunderland Royal Hospital; Queens University - Canada; McMaster University; McMaster University; University of Saskatchewan; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Rowan University; Cooper Medical School of Rowan University; Utah System of Higher Education; University of Utah; University of Liverpool; Brown University	Rodger, MA (corresponding author), Ottawa Hosp, Gen Campus,501 Smyth Rd,Box 201A, Ottawa, ON K1H 8L6, Canada.	mrodger@ohri.ca	Smith, Graeme Neil/ABB-6863-2021; Coat, Suzette/AAB-4665-2020; Kovacs, Michael/G-3315-2011; Kingdom, John/AAF-2145-2020; Cushman, Mary/K-1157-2019; Kingdom, John/A-3247-2013; Said, Joanne M/AAC-8560-2020	Smith, Graeme Neil/0000-0002-3128-4523; Cushman, Mary/0000-0002-7871-6143; Hinshaw, Kim/0000-0003-0468-4326; Pasquier, Elisabeth/0000-0002-5849-0204; Rodger, Marc/0000-0001-8166-3487; von Dadelszen, Peter/0000-0003-4136-3070; Chan, Wee-Shian/0000-0002-2513-0480; Ramsay, Tim/0000-0001-8478-8170; Said, Joanne/0000-0001-6263-0030	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Pharmacia and UpJohn	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Pharmacia and UpJohn	Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, and Pharmacia and UpJohn.	Badawy AM, 2008, J OBSTET GYNAECOL, V28, P280, DOI 10.1080/01443610802042688; Bates SM, 2012, CHEST S, V141, pe691S; Brenner B, 2005, J THROMB HAEMOST, V3, P227, DOI 10.1111/j.1538-7836.2004.01090.x; Brenner B, 2003, J THROMB HAEMOST, V1, P2070, DOI 10.1046/j.1538-7836.2003.00504.x; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Clark P, 2010, BLOOD, V115, P4162, DOI 10.1182/blood-2010-01-267252; De Vries JIP, 2012, J THROMB HAEMOST, V10, P64, DOI 10.1111/j.1538-7836.2011.04553.x; Dolitzky M, 2006, FERTIL STERIL, V86, P362, DOI 10.1016/j.fertnstert.2005.12.068; Duhl AJ, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.022; Fawzy M, 2008, ARCH GYNECOL OBSTET, V278, P33, DOI 10.1007/s00404-007-0527-x; Friederich PW, 1996, ANN INTERN MED, V125, P955, DOI 10.7326/0003-4819-125-12-199612150-00003; Gerhardt A, 2000, NEW ENGL J MED, V342, P374, DOI 10.1056/NEJM200002103420602; Grandone E, 2002, FERTIL STERIL, V78, P371, DOI 10.1016/S0015-0282(02)03222-3; Greer IA, 2005, BLOOD, V106, P401, DOI 10.1182/blood-2005-02-0626; Gris JC, 2004, BLOOD, V103, P3695, DOI 10.1182/blood-2003-12-4250; Gris JC, 2011, THROMB HAEMOSTASIS, V106, P1053, DOI 10.1160/TH11-05-0340; Gris JC, 2010, THROMB HAEMOSTASIS, V104, P771, DOI 10.1160/TH10-03-0167; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Huhle G, 2000, GYNECOL OBSTET INVES, V49, P67, DOI 10.1159/000010216; Hunt BJ, 1997, THROMB HAEMOSTASIS, V77, P39; Jacobsen AF, 2008, J THROMB HAEMOST, V6, P905, DOI 10.1111/j.1538-7836.2008.02961.x; Kaandorp SP, 2010, NEW ENGL J MED, V362, P1586, DOI 10.1056/NEJMoa1000641; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Kupferminc MJ, 2001, HYPERTENS PREGNANCY, V20, P35, DOI 10.1081/PRG-100104170; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Laskin CA, 2009, J RHEUMATOL, V36, P279, DOI [10.3899/jrheum.080763), 10.3899/jrheum.080763]; Lepercq J, 2001, BRIT J OBSTET GYNAEC, V108, P1134, DOI 10.1111/j.1471-0528.2003.00272.x; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Lockwood CJ, 2002, OBSTET GYNECOL, V99, P333, DOI 10.1016/S0029-7844(01)01760-4; Lussana F, 2009, THROMB RES, V124, pE19, DOI [10.1016/j.thromres.2009.02.004, 10.1016/j.thromres.2009.06.031]; Martinelli I, 2012, BLOOD, V119, P3269, DOI 10.1182/blood-2011-11-391383; Mello G, 2005, HYPERTENSION, V45, P86, DOI 10.1161/01.HYP.0000149950.05182.a3; Pabinger I, 2001, ARTERIOSCL THROM VAS, V21, P874, DOI 10.1161/01.ATV.21.5.874; Rey E, 2003, LANCET, V361, P901, DOI 10.1016/S0140-6736(03)12771-7; Rey E, 2009, J THROMB HAEMOST, V7, P58, DOI 10.1111/j.1538-7836.2008.03230.x; Rodeghiero F, 1997, THROMB HAEMOSTASIS, V78, P636; Rodger MA, 2003, AM J PERINAT, V20, P69, DOI 10.1055/s-2003-38318; Rodger MA, 2014, BLOOD, V123, P822, DOI 10.1182/blood-2013-01-478958; Rodger MA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000292; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Sibai BM, 1997, AM J OBSTET GYNECOL, V177, P1003, DOI 10.1016/S0002-9378(97)70004-8; van Rijn BB, 2006, AM J OBSTET GYNECOL, V195, P723, DOI 10.1016/j.ajog.2006.06.044; van Walraven C, 2003, BRIT MED J, V326, P791, DOI 10.1136/bmj.326.7393.791; Visser J, 2011, THROMB HAEMOSTASIS, V105, P295, DOI 10.1160/TH10-05-0334	45	157	169	0	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1673	1683		10.1016/S0140-6736(14)60793-5	http://dx.doi.org/10.1016/S0140-6736(14)60793-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KU	25066248				2022-12-28	WOS:000345116200029
J	Srivastava, A; Yano, J; Hirozane, Y; Kefala, G; Gruswitz, F; Snell, G; Lane, W; Ivetac, A; Aertgeerts, K; Nguyen, J; Jennings, A; Okada, K				Srivastava, Ankita; Yano, Jason; Hirozane, Yoshihiko; Kefala, Georgia; Gruswitz, Franz; Snell, Gyorgy; Lane, Weston; Ivetac, Anthony; Aertgeerts, Kathleen; Nguyen, Jasmine; Jennings, Andy; Okada, Kengo			High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; FREE FATTY-ACIDS; CRYSTAL-STRUCTURE; ADRENERGIC-RECEPTOR; MOLECULAR-GRAPHICS; INSULIN-SECRETION; MEMBRANE-PROTEINS; OPIOID RECEPTOR; ACTIVATION; BINDING	Human GPR40 receptor (hGPR40), also known as free fatty-acid receptor 1 (FFAR1), is a G-protein-coupled receptor that binds long-chain free fatty acids to enhance glucose-dependent insulin secretion(1). Novel treatments for type-2 diabetes mellitus(2) are therefore possible by targeting hGPR40 with partial or full agonists. TAK-875, or fasiglifam, is an orally available, potent and selective partial agonist(3) of hGPR40 receptor, which reached phase III clinical trials for the potential treatment of type-2 diabetes mellitus(4). Data from clinical studies indicate that TAK-875, which is anago-allosteric modulator of hGPR40 (ref. 3), demonstrates improved glycaemic control and low hypoglycaemic risk in diabetic patients(5). Here we report the crystal structure of hGPR40 receptor bound to TAK-875 at 2.3 angstrom resolution. The co-complex structure reveals a unique binding mode of TAK-875 and suggests that entry to the non-canonical binding pocket most probably occurs via the lipid bilayer. The atomic details of the extensive charge network in the ligand binding pocket reveal additional interactions not identified in previous studies and contribute to a clear understanding of TAK-875 binding to the receptor. The hGPR40-TAK-875 structure also provides insights into the plausible binding of multiple ligands to the receptor, which has been observed in radioligand binding(6) and Ca2+ influx assay studies(3). Comparison of the transmembrane helix architecture with other G-protein-coupled receptors suggests that the crystallized TAK-875-bound hGPR40 complex is in an inactive-like state.	[Srivastava, Ankita; Yano, Jason; Kefala, Georgia; Gruswitz, Franz; Snell, Gyorgy; Lane, Weston; Ivetac, Anthony; Aertgeerts, Kathleen; Nguyen, Jasmine; Jennings, Andy] Takeda Calif, Dept Struct Biol & Core Sci & Technol, San Diego, CA 92121 USA; [Hirozane, Yoshihiko; Okada, Kengo] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Biomol Res Labs, Fujisawa, Kanagawa 2518555, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc; Takeda Pharmaceutical Company Ltd	Srivastava, A (corresponding author), Takeda Calif, Dept Struct Biol & Core Sci & Technol, 10410 Sci Ctr Dr, San Diego, CA 92121 USA.	ankita.srivastava@takeda.com		Yano, Jason/0000-0002-9774-2611; Gruswitz, Franz/0000-0002-9671-6788	National Institutes of Health and National Institute of General Medical Sciences; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-AC02-05CH11231, DE-AC02-06CH11357]	National Institutes of Health and National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE))	We thank K. P. Wilson, M. Hixon and K. Goodwill for review and feedback on the manuscript; T. Ho and S. Okubo for molecular cloning support; T. Sjoberg for membrane preparation; and C. Dillard for cell culture support. We also thank the staff of the Berkeley Center for Structural Biology, Lawrence Berkeley National Laboratory, which operates Advanced Light Source beamline 5.0.3, and the staff ofGM/CA, Argonne National Laboratory, which operates Advanced Photon Source beamline 23ID-D. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health and National Institute of General Medical Sciences. The GM/CA has been funded in whole or in part with Federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). The Advanced Light Source and Advanced Photon Source are supported by the Director, Office of Science, Office of Basic Energy Sciences of the US Department of Energy under contract numbers DE-AC02-05CH11231 and DE-AC02-06CH11357, respectively.	Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Choe HW, 2011, NEUROPHARMACOLOGY, V60, P52, DOI 10.1016/j.neuropharm.2010.07.018; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischetti RF, 2009, J SYNCHROTRON RADIAT, V16, P217, DOI 10.1107/S0909049508040612; Flodgren E, 2007, BIOCHEM BIOPH RES CO, V354, P240, DOI 10.1016/j.bbrc.2006.12.193; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Hirozane Y., MOL MEM BIO IN PRESS; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lin DCH, 2012, MOL PHARMACOL, V82, P843, DOI 10.1124/mol.112.079640; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mercier RW, 2010, CHEM BIOL, V17, P1132, DOI 10.1016/j.chembiol.2010.08.010; Negoro N, 2012, J MED CHEM, V55, P3960, DOI 10.1021/jm300170m; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yabuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076280; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	41	257	266	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					124	+		10.1038/nature13494	http://dx.doi.org/10.1038/nature13494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25043059				2022-12-28	WOS:000341174800043
J	Khan, MS; Coker, RJ				Khan, Mishal S.; Coker, Richard J.			How to hinder tuberculosis control: five easy steps	LANCET			English	Editorial Material							MULTIDRUG-RESISTANT TUBERCULOSIS; EXTENSIVELY DRUG-RESISTANT; PRIVATE PHARMACIES; RUSSIA; CHINA; TB		[Khan, Mishal S.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Communicable Dis Policy Res Grp, London WC1, England; Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore	University of London; London School of Hygiene & Tropical Medicine; National University of Singapore	Khan, MS (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Communicable Dis Policy Res Grp, London WC1, England.	mishal.khan@lshtm.ac.uk						Auer C, 2000, TROP MED INT HEALTH, V5, P648, DOI 10.1046/j.1365-3156.2000.00615.x; Bosman MCJ, 2000, INT J TUBERC LUNG D, V4, P606; Chuc NTK, 1999, EUR J CLIN PHARMACOL, V55, P325, DOI 10.1007/s002280050636; Coker R, 2000, EUR J PUBLIC HEALTH, V10, P148, DOI 10.1093/eurpub/10.2.148; Coker RJ, 2004, TROP MED INT HEALTH, V9, P25, DOI 10.1046/j.1365-3156.2003.01156.x; Dheda K, 2014, LANCET RESP MED, V2, P321, DOI 10.1016/S2213-2600(14)70031-1; Farmer PE, 2000, EUR J PUBLIC HEALTH, V10, P150, DOI 10.1093/eurpub/10.2.150; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Hazarika I, 2011, J GLOB INFECT DIS, V3, P19, DOI 10.4103/0974-777X.77291; Hu D, 2008, HEALTH POLICY PLANN, V23, P43, DOI 10.1093/heapol/czm038; Hurtig AK, 2000, INT J TUBERC LUNG D, V4, P730; Macfie N, 2014, MED AID GROUP MSF AL; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6; Reintjes R., 2008, HLTH SYSTEMS CHALLEN, P141; Shah S K, 2003, East Mediterr Health J, V9, P776; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Tesh S.N., 1988, HIDDEN ARGUMENTS POL; The Global Fund to Fight AIDS, 2014, PERF BAS FUND; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yadav A, 2012, Indian J Chest Dis Allied Sci, V54, P161	23	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					646	648		10.1016/S0140-6736(14)61175-2	http://dx.doi.org/10.1016/S0140-6736(14)61175-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5CJ	25064593				2022-12-28	WOS:000341359100010
J	Lingaraju, GM; Bunker, RD; Cavadini, S; Hess, D; Hassiepen, U; Renatus, M; Fischer, ES; Thoma, NH				Lingaraju, Gondichatnahalli M.; Bunker, Richard D.; Cavadini, Simone; Hess, Daniel; Hassiepen, Ulrich; Renatus, Martin; Fischer, Eric S.; Thomae, Nicolas H.			Crystal structure of the human COP9 signalosome	NATURE			English	Article							PCI DOMAIN; NEDD8 MODIFICATION; ARABIDOPSIS COP9; ARCHITECTURE; COMPLEX; INITIATION; SUBUNIT; PROTEIN; MODEL; ACTIVATION	Ubiquitination is a crucial cellular signalling process, and is controlled on multiple levels. Cullin-RINGE3 ubiquitin ligases (CRLs) are regulated by the eight-subunit COP9 signalosome (CSN). CSN inactivates CRLs by removing their covalently attached activator, NEDD8. NEDD8 cleavage by CSN is catalysed by CSN5, a Zn2+-dependent isopeptidase that is inactive in isolation. Here we present the crystal structure of the entire similar to 350-kDa human CSN holoenzyme at 3.8 angstrom resolution, detailing the molecular architecture of the complex. CSN has two organizational centres: a horseshoe-shaped ring created by its six proteasome lid-CSN-initiation factor 3 (PCI) domain proteins, and a large bundle formed by the carboxy-terminal a-helices of every subunit. CSN5 and its dimerization partner, CSN6, are intricately embedded at the core of the helical bundle. In the substrate-free holoenzyme, CSN5 is autoinhibited, which precludes access to the active site. We find that neddylated CRL binding to CSN is sensed by CSN4, and communicated to CSN5 with the assistance of CSN6, resulting in activation of the deneddylase.	[Lingaraju, Gondichatnahalli M.; Bunker, Richard D.; Cavadini, Simone; Hess, Daniel; Fischer, Eric S.; Thomae, Nicolas H.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Lingaraju, Gondichatnahalli M.; Bunker, Richard D.; Cavadini, Simone; Fischer, Eric S.; Thomae, Nicolas H.] Univ Basel, CH-4003 Basel, Switzerland; [Hassiepen, Ulrich; Renatus, Martin] Novartis Pharma AG, Inst Biomed Res, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel; Novartis; Universita della Svizzera Italiana	Thoma, NH (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	nicolas.thoma@fmi.ch		Thoma, Nicolas/0000-0003-2685-906X; Bunker, Richard/0000-0001-8866-5290; Fischer, Eric S./0000-0001-7337-6306	Novartis Research Foundation; Swiss National Science Foundation [31003A_144020]; European Research Council (MoBa-CS) [260481]; Novartis (NIBR)	Novartis Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (MoBa-CS); Novartis (NIBR)	This work was supported by the Novartis Research Foundation, the Swiss National Science Foundation (31003A_144020) and the European Research Council (MoBa-CS #260481). G. M. L. is the recipient of a Novartis (NIBR) presidential postdoctoral fellowship. Part of this work was performed at beamline X06DA and X10SA of the Swiss Light Source. We thank H. Wu for sharing the A. thaliana CSN1 coordinates before publication; H. Gut, J. Keusch and M. Jones for support; and C. Vonrhein and the BUSTER development group, R. Read, A. McCoy, T. Terwilliger, R. Nicholls, R. Kingston and K. Diederichs for technical advice. We are also grateful for the assistance of B. Martoglio, R. Assenberg, C. Logel and I. Bechtold in developing the PT22 CSN assays.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; Boehringer J, 2012, BIOCHEM J, V448, P55, DOI 10.1042/BJ20120542; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G., 2011, BUSTER VERSION 2 11; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Cronin CN, 2007, PROTEIN SCI, V16, P2023, DOI 10.1110/ps.072931407; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Dessau M, 2008, PLANT CELL, V20, P2815, DOI 10.1105/tpc.107.053801; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Echalier A, 2013, P NATL ACAD SCI USA, V110, P1273, DOI 10.1073/pnas.1209345110; Ellisdon Andrew M, 2012, Bioarchitecture, V2, P118, DOI 10.4161/bioa.21131; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Estrin E, 2013, STRUCTURE, V21, P1624, DOI 10.1016/j.str.2013.06.023; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Guevara T, 2010, J BIOL CHEM, V285, P13958, DOI 10.1074/jbc.M109.097436; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Khoshnevis S, 2014, NUCLEIC ACIDS RES, V42, P4123, DOI 10.1093/nar/gkt1369; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee JHW, 2013, J HYDRO-ENVIRON RES, V7, P227, DOI 10.1016/j.jher.2013.10.003; Lee M. H., 2011, CELL CYCLE, V10, P3057, DOI [DOI 10.4161/CC.10.18, 10.4161/cc.10.18.17320, DOI 10.4161/CC.10.18.17320]; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; Marks BD, 2005, ASSAY DRUG DEV TECHN, V3, P613, DOI 10.1089/adt.2005.3.613; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menon S, 2005, METHOD ENZYMOL, V398, P468, DOI 10.1016/S0076-6879(05)98038-5; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Pathare GR, 2012, P NATL ACAD SCI USA, V109, P149, DOI 10.1073/pnas.1117648108; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pick E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043980; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Querol-Audi J, 2013, STRUCTURE, V21, P920, DOI 10.1016/j.str.2013.04.002; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Tran HJTT, 2003, BIOCHEMISTRY-US, V42, P11460, DOI 10.1021/bi035033g; Tsuge T, 2001, J MOL BIOL, V305, P1, DOI 10.1006/jmbi.2000.4288; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Wei ZY, 2004, J BIOL CHEM, V279, P34983, DOI 10.1074/jbc.M405158200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Zhang H, 2012, FEBS LETT, V586, P1147, DOI 10.1016/j.febslet.2012.03.029; Zhao RY, 2011, J CLIN INVEST, V121, P851, DOI 10.1172/JCI44111; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	72	143	147	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					161	+		10.1038/nature13566	http://dx.doi.org/10.1038/nature13566			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043011				2022-12-28	WOS:000340200700024
J	Moltke, I; Grarup, N; Jorgensen, ME; Bjerregaard, P; Treebak, JT; Fumagalli, M; Korneliussen, TS; Andersen, MA; Nielsen, TS; Krarup, NT; Gjesing, AP; Zierath, JR; Linneberg, A; Wu, XL; Sun, GQ; Jin, X; Al-Aama, J; Wang, J; Borch-Johnsen, K; Pedersen, O; Nielsen, R; Albrechtsen, A; Hansen, T				Moltke, Ida; Grarup, Niels; Jorgensen, Marit E.; Bjerregaard, Peter; Treebak, Jonas T.; Fumagalli, Matteo; Korneliussen, Thorfinn S.; Andersen, Marianne A.; Nielsen, Thomas S.; Krarup, Nikolaj T.; Gjesing, Anette P.; Zierath, Juleen R.; Linneberg, Allan; Wu, Xueli; Sun, Guangqing; Jin, Xin; Al-Aama, Jumana; Wang, Jun; Borch-Johnsen, Knut; Pedersen, Oluf; Nielsen, Rasmus; Albrechtsen, Anders; Hansen, Torben			A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes	NATURE			English	Article							GLYCEMIC TRAITS; GLUCOSE; POPULATION; DISCOVERY; FRAMEWORK; MUTATION	The Greenlandic population, a small and historically isolated founder population comprising about 57,000 inhabitants, has experienced a dramatic increase in type 2 diabetes (T2D) prevalence during the past 25 years(1). Motivated by this, we performed association mapping of T2D-related quantitative traits in up to 2,575 Greenlandic individuals without known diabetes. Using array-based genotyping and exome sequencing, we discovered a nonsense p.Arg684Ter variant (in which arginine is replaced by a termination codon) in the gene TBC1D4 with an allele frequency of 17%. Here we show that homozygous carriers of this variant have markedly higher concentrations of plasma glucose(beta=3.8 mmol l(-1), P = 2.5 X 10(-35)) and serum insulin (beta = 165 pmol l(-1), P = 1.5 X 10(-20)) 2 hours after an oral glucose load compared with individuals with other genotypes (both non-carriers and heterozygous carriers). Furthermore, homozygous carriers have marginally lower concentrations of fasting plasma glucose (beta = -0.18 mmol l(-1), P = 1.1 X 10(-6)) and fasting serum insulin (beta = -8.3 pmol l(-1), P = 0.0014), and their T2D risk is markedly increased (odds ratio (OR) = 10.3, P = 1.6 X 10(-24)). Heterozygous carriers have a moderately higher plasma glucose concentration 2 hours after an oral glucose load than non-carriers (beta = 0.43 mmol l(-1), P = 5.3 X 10(-5)). Analyses of skeletal muscle biopsies showed lower messenger RNA and protein levels of the long isoform of TBC1D4, and lower muscle protein levels of the glucose transporter GLUT4, with increasing number of p.Arg684Ter alleles. These findings are concomitant with a severely decreased insulin-stimulated glucose uptake in muscle, leading to postprandial hyperglycaemia, impaired glucose tolerance and T2D. The observed effect sizes are several times larger than any previous findings in large-scale genome-wide association studies of these traits(2-4) and constitute further proof of the value of conducting genetic association studies outside the traditional setting of large homogeneous populations.	[Moltke, Ida; Albrechtsen, Anders] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Moltke, Ida] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Grarup, Niels; Krarup, Nikolaj T.; Gjesing, Anette P.; Wang, Jun; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, DK-2100 Copenhagen, Denmark; [Jorgensen, Marit E.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Bjerregaard, Peter] Univ Southern Denmark, Natl Inst Publ Hlth, DK-1353 Copenhagen, Denmark; [Treebak, Jonas T.; Andersen, Marianne A.; Nielsen, Thomas S.; Zierath, Juleen R.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth & Med Sci, Sect Integrat Physiol, DK-2200 Copenhagen, Denmark; [Fumagalli, Matteo; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Korneliussen, Thorfinn S.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Zierath, Juleen R.] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden; [Linneberg, Allan] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Wu, Xueli; Sun, Guangqing; Jin, Xin; Al-Aama, Jumana; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Al-Aama, Jumana; Wang, Jun] King Abdulaziz Univ, Fac Med, Dept Med Genet, Jeddah 21589, Saudi Arabia; [Al-Aama, Jumana; Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Albrahim Ctr Excellence Res H, Jeddah 21589, Saudi Arabia; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] Macau Univ Sci & Technol, Macau 999078, Peoples R China; [Borch-Johnsen, Knut] Holbaek Cent Hosp, DK-4300 Holbaek, Denmark; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, DK-5000 Odense, Denmark	University of Copenhagen; University of Chicago; Novo Nordisk Foundation; University of Copenhagen; Steno Diabetes Center; University of Southern Denmark; Novo Nordisk Foundation; University of Copenhagen; University of California System; University of California Berkeley; University of Copenhagen; Karolinska Institutet; University of Copenhagen; Beijing Genomics Institute (BGI); King Abdulaziz University; King Abdulaziz University; University of Copenhagen; Macau University of Science & Technology; Holbaek Hospital; University of California System; University of California Berkeley; University of Southern Denmark	Hansen, T (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, DK-2100 Copenhagen, Denmark.	albrecht@binf.ku.dk; torben.hansen@sund.ku.dk	Treebak, Jonas Thue/B-4521-2017; Pedersen, Oluf/AAG-8015-2020; Korneliussen, Thorfinn Sand/F-6421-2014; Gjesing, Anette/ACC-7521-2022; Jin, Xin/ABF-1329-2020; Al-aama, Jumana/AAA-8653-2021; Albrechtsen, Anders/K-4281-2013; Grarup, Niels/K-2807-2015; Bjerregaard, Peter/ABD-8894-2020; Korneliussen, Thorfinn Sand/ABB-7656-2021; Moltke, Ida/C-6158-2011; Pedersen, Oluf/Z-1731-2019; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016; Nielsen, Rasmus/D-4405-2009	Treebak, Jonas Thue/0000-0003-1488-7012; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Gjesing, Anette/0000-0003-4580-1576; Jin, Xin/0000-0001-7554-4975; Albrechtsen, Anders/0000-0001-7306-031X; Grarup, Niels/0000-0001-5526-1070; Bjerregaard, Peter/0000-0001-7153-8447; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Moltke, Ida/0000-0001-7052-8554; Pedersen, Oluf/0000-0002-3321-3972; Andersen, Marianne/0000-0002-4603-9504; Zierath, Juleen/0000-0001-6891-7497; Nielsen, Thomas Svava/0000-0002-9457-8000; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Hansen, Torben/0000-0001-8748-3831; Agerholm Jensen, Marianne/0000-0001-8687-1031; Jorgensen, Marit Eika/0000-0001-8356-5565; Krarup, Nikolaj Thure/0000-0001-6526-8663; Nielsen, Rasmus/0000-0003-0513-6591; Fumagalli, Matteo/0000-0002-4084-2953; Linneberg, Allan/0000-0002-0994-0184	Novo Nordisk Foundation; Danish Council for Independent Research (Medical Sciences); Steno Diabetes Center; Villum Foundation; Karen Elise Jensen's Foundation; NunaFonden; Medical Research Council of Denmark; Medical Research Council of Greenland; Commission for Scientific Research in Greenland; NNF Center for Basic Metabolic Research [Treebak Group] Funding Source: researchfish; Villum Fonden [00007171] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); Steno Diabetes Center; Villum Foundation(Villum Fonden); Karen Elise Jensen's Foundation; NunaFonden; Medical Research Council of Denmark; Medical Research Council of Greenland; Commission for Scientific Research in Greenland; NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Villum Fonden(Villum Fonden)	We thank I. Kleist, as well as all colleagues at the Physician's Clinic, Nuuk, Greenland. We also thank J. F. Wojtaszewski for comments and X. Zhou for discussions about GEMMA. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research centre at the University of Copenhagen and is partly funded by an unrestricted donation from the Novo Nordisk Foundation. This project was also funded by the Danish Council for Independent Research (Medical Sciences), the Steno Diabetes Center and the Villum Foundation. The IHIT study was supported by Karen Elise Jensen's Foundation, NunaFonden, the Medical Research Council of Denmark, the Medical Research Council of Greenland and the Commission for Scientific Research in Greenland. None of the funding agencies had any role in the study design or in the collection or interpretation of the data.	Albrechtsen A, 2013, DIABETOLOGIA, V56, P298, DOI 10.1007/s00125-012-2756-1; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baus D, 2008, CELL SIGNAL, V20, P2237, DOI 10.1016/j.cellsig.2008.08.010; Bjerregaard P., 2003, INT J CIRCUMPOL HEAL, V62, P3, DOI [10.3402/ijch.v62i0.18212, DOI 10.3402/IJCH.V62I0.18212]; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cederberg H, 2010, DIABETES CARE, V33, P2077, DOI 10.2337/dc10-0262; Dash S, 2009, P NATL ACAD SCI USA, V106, P9350, DOI 10.1073/pnas.0900909106; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Jorgensen ME, 2013, DIABETES CARE, V36, P2988, DOI 10.2337/dc12-2703; Jorgensen ME, 2002, DIABETES CARE, V25, P1766, DOI 10.2337/diacare.25.10.1766; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lohmueller KE, 2013, AM J HUM GENET, V93, P1072, DOI 10.1016/j.ajhg.2013.11.005; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moltke I, 2014, BIOINFORMATICS, V30, P1027, DOI 10.1093/bioinformatics/btt652; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Treebak JT, 2009, DIABETOLOGIA, V52, P891, DOI 10.1007/s00125-009-1294-y; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wang HY, 2013, BIOCHEM J, V449, P479, DOI 10.1042/BJ20120702; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	30	242	251	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					190	+		10.1038/nature13425	http://dx.doi.org/10.1038/nature13425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043022	Green Published			2022-12-28	WOS:000340200700031
J	Kulkarni, K				Kulkarni, Kunal			NHS leaders note: organisational culture is key	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Oxford Univ Hosp, Oxford OX3 9DU, England		Kulkarni, K (corresponding author), Oxford Univ Hosp, Headley Way, Oxford OX3 9DU, England.	kunalkulkarni@doctors.org.uk	Kulkarni, Kunal/GYI-9096-2022	Kulkarni, Kunal/0000-0002-9405-0273; /0000-0002-1236-1634				Black M., 2013, 5 THINGS YOU CAN LEA; Christensen C.M., 2011, HARVARD BUSINESS REV; Dixon-Woods M, 2013, BMJ QUAL SAF, V23, P1, DOI DOI 10.1136/BMJQA-1013-001947; Gould M., 2014, NHS STAFF HAPPIER TH; NHS Institute for Innovation and Improvement, BUILD NUTR IMPR CULT; NHS Institute for Innovation and Improvement, JOIN CAR CULT; NHS Institute for Innovation and Improvement, IMP ORG CULT; NHS Institute for Innovation and Improvement, CREAT CULT INN; Office for National Statistics, 2013, WHAT PERC MARR END D; Royal College of Physicians, 2014, IMPL NICE PUBL HLTH; Weber RA, 2003, MANAGE SCI, V49, P400, DOI 10.1287/mnsc.49.4.400.14430	11	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2014	349								g4814	10.1136/bmj.g4814	http://dx.doi.org/10.1136/bmj.g4814			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NA	25070073				2022-12-28	WOS:000339905300004
J	Darnell, JC				Darnell, Jennifer C.			Ribosome rescue and neurodegeneration	SCIENCE			English	Editorial Material							MESSENGER-RNAS; TRANSLATION; STALLS		Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10065 USA	Rockefeller University	Darnell, JC (corresponding author), Rockefeller Univ, Mol Neurooncol Lab, 1230 York Ave, New York, NY 10065 USA.	jennifer.darnell@rockefeller.edu			NICHD NIH HHS [R01 HD040647] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040647] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013	8	9	9	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					378	379		10.1126/science.1257193	http://dx.doi.org/10.1126/science.1257193			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061188				2022-12-28	WOS:000339655100015
J	Pawar, S				Pawar, Samraat			Why are plant-pollinator networks nested?	SCIENCE			English	Editorial Material							STABILITY		Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England	Imperial College London	Pawar, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Silwood Pk, Ascot SL5 7PY, Berks, England.	s.pawar@imperial.ac.uk	Pawar, Samraat/E-7388-2012	Pawar, Samraat/0000-0001-8375-5684				Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; Fukami T, 2004, POPUL ECOL, V46, P137, DOI 10.1007/s10144-004-0182-z; James A, 2012, NATURE, V487, P227, DOI 10.1038/nature11214; May R.M., 1974, STABILITY COMPLEXITY; Pawar S, 2012, NATURE, V486, P485, DOI 10.1038/nature11131; Pawar S, 2009, J THEOR BIOL, V259, P601, DOI 10.1016/j.jtbi.2009.04.006; Rohr RP, 2014, SCIENCE, V345, P416, DOI 10.1126/science.1253497; Staniczenko PPA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2422; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Tang S, 2014, ECOL LETT, V17, P1094, DOI 10.1111/ele.12312	13	11	12	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					383	383		10.1126/science.1256466	http://dx.doi.org/10.1126/science.1256466			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061191				2022-12-28	WOS:000339655100018
J	Carville, S; Wonderling, D; Stevens, P				Carville, Serena; Wonderling, David; Stevens, Paul		Guideline Dev Grp	GUIDELINES Early identification and management of chronic kidney disease in adults: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CKD-EPI EQUATION; RENAL-DISEASE; CYSTATIN C; PROGRESSION; ASSOCIATION; THRESHOLDS; CREATININE; MDRD		[Carville, Serena; Wonderling, David] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Stevens, Paul] East Kent Hosp Univ NHS Fdn Trust, Canterbury CT1 3NG, Kent, England	Royal College of Physicians	Stevens, P (corresponding author), East Kent Hosp Univ NHS Fdn Trust, Canterbury CT1 3NG, Kent, England.	pstevens@nhs.net		Wonderling, David/0000-0003-0315-6273				Conte G, 2014, NEPHROL DIAL TRANSPL, V29, P770, DOI 10.1093/ndt/gft324; Coresh J, 2014, JAMA; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Glassock RJ, 2014, NEPHROL DIAL TRANSPL, V29, P774, DOI 10.1093/ndt/gft306; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009; Matsushita K, 2012, AM J KIDNEY DIS, V60, P241, DOI 10.1053/j.ajkd.2012.03.016; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; National Clinical Guideline Centre, 2014, CHRON KIDN DIS NAT C; National Collaborating Centre for Chronic Conditions, 2008, CG73 ROY COLL PHYS; O'Hare AM, 2012, AM J KIDNEY DIS, V59, P513, DOI 10.1053/j.ajkd.2011.11.044; Peralta CA, 2011, JAMA-J AM MED ASSOC, V305, P1545, DOI 10.1001/jama.2011.468; Waheed S, 2013, CLIN J AM SOC NEPHRO, V8, P434, DOI 10.2215/CJN.04960512	13	36	38	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2014	349								g4507	10.1136/bmj.g4507	http://dx.doi.org/10.1136/bmj.g4507			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VS	25059691				2022-12-28	WOS:000339566200002
J	Levin, J; Hofstra, T				Levin, Jarad; Hofstra, Timothy			Recurrent Erythema Multiforme	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Levin, Jarad] Univ Texas Med Branch, Galveston, TX 77555 USA; [Hofstra, Timothy] Virginia Commonwealth Univ, Richmond, VA 23284 USA	University of Texas System; University of Texas Medical Branch Galveston; Virginia Commonwealth University	Levin, J (corresponding author), Univ Texas Med Branch, Off Internal Med, 301 Univ Blvd, Galveston, TX 77555 USA.	jilevin@utmb.edu						Aurelian L, 2003, Dermatol Online J, V9, P1; Kempf W, 2008, DERMATOPATHOLOGY, P57; Nasabzadeh TJ, 2010, J CUTAN PATHOL, V37, P1164, DOI 10.1111/j.1600-0560.2010.01607.x; Sen P, 2004, ANN ACAD MED SINGAP, V33, P793; Sokumbi O, 2012, INT J DERMATOL, V51, P889, DOI 10.1111/j.1365-4632.2011.05348.x; Wetter DA, 2010, J AM ACAD DERMATOL, V62, P45, DOI 10.1016/j.jaad.2009.06.046	6	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					426	427		10.1001/jama.2014.3611	http://dx.doi.org/10.1001/jama.2014.3611			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038360				2022-12-28	WOS:000339257800028
J	Pickard, CJ; Needs, RJ				Pickard, Chris J.; Needs, Richard J.			HIGH-PRESSURE PHYSICS Piling on the pressure	NATURE			English	Editorial Material									[Pickard, Chris J.] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Pickard, Chris J.] London Inst Math Sci, London, England; [Needs, Richard J.] Univ Cambridge, Cavendish Lab, Condensed Matter Theory Grp, Cambridge CB3 0HE, England	University of London; University College London; University of Cambridge	Pickard, CJ (corresponding author), UCL, Dept Phys & Astron, Mortimer St, London WC1E 6BT, England.	c.pickard@ucl.ac.uk	Pickard, Chris J/D-4704-2016	Pickard, Chris J/0000-0002-9684-5432	EPSRC [EP/F032773/1, EP/G007489/2, EP/K014560/1, EP/J017639/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G007489/2, EP/F032773/1, EP/J017639/1, EP/K014560/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Ball P., 2014, NATURE; Driver KP, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.115502; Jeanloz R, 2007, P NATL ACAD SCI USA, V104, P9172, DOI 10.1073/pnas.0608170104; Kobyakov D, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.112504; Martinez-Canales M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.045704; Pickard CJ, 2010, NAT MATER, V9, P624, DOI [10.1038/nmat2796, 10.1038/NMAT2796]; Rygg JR, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4766464; Smith RF, 2014, NATURE, V511, P330, DOI 10.1038/nature13526; Wagner FW, 2011, ICARUS, V214, P366, DOI 10.1016/j.icarus.2011.05.027	9	5	5	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					294	295		10.1038/511294a	http://dx.doi.org/10.1038/511294a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030158				2022-12-28	WOS:000338992200019
J	Briel, M				Briel, M.		DISCO Study Grp	Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS; CREDIBILITY	Objective To investigate the planning of subgroup analyses in protocols of randomised controlled trials and the agreement with corresponding full journal publications. Design Cohort of protocols of randomised controlled trial and subsequent full journal publications. Setting Six research ethics committees in Switzerland, Germany, and Canada. Data sources 894 protocols of randomised controlled trial involving patients approved by participating research ethics committees between 2000 and 2003 and 515 subsequent full journal publications. Results Of 894 protocols of randomised controlled trials, 252 (28.2%) included one or more planned subgroup analyses. Of those, 17 (6.7%) provided a clear hypothesis for at least one subgroup analysis, 10 (4.0%) anticipated the direction of a subgroup effect, and 87 (34.5%) planned a statistical test for interaction. Industry sponsored trials more often planned subgroup analyses compared with investigator sponsored trials (195/551 (35.4%) v 57/343 (16.6%), P<0.001). Of 515 identified journal publications, 246 (47.8%) reported at least one subgroup analysis. In 81 (32.9%) of the 246 publications reporting subgroup analyses, authors stated that subgroup analyses were prespecified, but this was not supported by 28 (34.6%) corresponding protocols. In 86 publications, authors claimed a subgroup effect, but only 36 (41.9%) corresponding protocols reported a planned subgroup analysis. Conclusions Subgroup analyses are insufficiently described in the protocols of randomised controlled trials submitted to research ethics committees, and investigators rarely specify the anticipated direction of subgroup effects. More than one third of statements in publications of randomised controlled trials about subgroup prespecification had no documentation in the corresponding protocols. Definitive judgments regarding credibility of claimed subgroup effects are not possible without access to protocols and analysis plans of randomised controlled trials.	[Briel, M.] Univ Basel Hosp, Dept Clin Res, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland	University of Basel	Briel, M (corresponding author), Univ Basel Hosp, Dept Clin Res, Basel Inst Clin Epidemiol & Biostat, Hebelstr 10, CH-4031 Basel, Switzerland.	Matthias.Briel@usb.ch	Meerpohl, Joerg J/J-4224-2013; Schandelmaier, Stefan/GLV-3722-2022; Moja, Pasquale Lorenzo/CAH-0318-2022; Walter, Martin A/B-5203-2017; Briel, Matthias/AAT-9284-2021; Hemkens, Lars G./AAB-2653-2020; Tikkinen, Kari/L-3632-2018	Meerpohl, Joerg J/0000-0002-1333-5403; Schandelmaier, Stefan/0000-0002-8429-0337; Moja, Pasquale Lorenzo/0000-0001-6680-6507; Walter, Martin A/0000-0001-6487-5349; Hemkens, Lars G./0000-0002-3444-1432; Blumle, Anette/0000-0003-2877-1029; von Elm, Erik/0000-0002-7412-0406; Tikkinen, Kari/0000-0002-1389-8214; Bassler, Dirk/0000-0003-2358-4419; Carrasco-Labra, Alonso/0000-0003-3546-3526; Busse, Jason/0000-0002-0178-8712; Schwenkglenks, Matthias/0000-0001-7217-1173; Briel, Matthias/0000-0002-2070-5230; Lamontagne, Francois/0000-0002-0360-3427	Swiss National Science Foundation [320030_133540/1]; German Research Foundation [EL 544/1-2]; Santesuisse; Gottfried and Julia Bangerter-Rhyner-Foundation; Sichuan University, China [2013SCU04A37]; Brocher Foundation; Canadian Institutes of Health Research; Canadian Chiropractic Research Foundation; Hamilton Health Sciences Foundation; Finnish Cultural Foundation; Finnish Medical Foundation; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation; Hamilton Health Sciences	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation(German Research Foundation (DFG)); Santesuisse; Gottfried and Julia Bangerter-Rhyner-Foundation; Sichuan University, China(Sichuan University); Brocher Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Chiropractic Research Foundation; Hamilton Health Sciences Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Medical Foundation; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Hamilton Health Sciences	This study was funded by the Swiss National Science Foundation (grant 320030_133540/1) and the German Research Foundation (grant EL 544/1-2). MB, AN, VG, HR, LGH, and HCB were supported by Santesuisse and the Gottfried and Julia Bangerter-Rhyner-Foundation. XS was supported by a young investigators award (2013SCU04A37) from Sichuan University, China. During study preparation, EvE was supported by the Brocher Foundation. JWB was funded by a new investigator award from the Canadian Institutes of Health Research and Canadian Chiropractic Research Foundation. DM was a recipient of a research early career award from Hamilton Health Sciences Foundation (Jack Hirsh Fellowship). KAOT was funded by unrestricted grants from the Finnish Cultural Foundation, Finnish Medical Foundation, Jane and Aatos Erkko Foundation, and Sigrid Juselius Foundation. JY was supported by a research early career award from Hamilton Health Sciences.	Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Bhandari M, 2006, CLIN ORTHOP RELAT R, P247, DOI 10.1097/01.blo.0000218736.23506.fe; Boonacker CWB, 2011, AM J EPIDEMIOL, V174, P219, DOI 10.1093/aje/kwr075; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Chan AW, 2006, BMJ-BRIT MED J, V332, P1086, DOI 10.1136/bmj.332.7549.1086; ClinicalTrials.gov, 2013, PROT DAT EL DEF; Gabler NB, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-43; Hernandez AV, 2006, AM HEART J, V151, P257, DOI 10.1016/j.ahj.2005.04.020; ICTRP, 2014, SEARCH PORTAL; ISRCTN, 2012, DAT SET; Kasenda B, 2014, JAMA-J AM MED ASSOC, V311, P1045, DOI 10.1001/jama.2014.1361; Kasenda B, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-131; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Sun X, 2014, JAMA-J AM MED ASSOC, V311, P405, DOI 10.1001/jama.2013.285063; Sun X, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1553; Sun X, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1569; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Szczech LA, 1998, ANN INTERN MED, V128, P817, DOI 10.7326/0003-4819-128-10-199805150-00004; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	28	61	62	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 16	2014	349								g4539	10.1136/bmj.g4539	http://dx.doi.org/10.1136/bmj.g4539			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7PE	25030633	hybrid, Green Published			2022-12-28	WOS:000339326000003
J	Schulman, M				Schulman, Marjorie			The M&M Game	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									NYU, Sch Med, Dept Populat Hlth, New York, NY 10012 USA	New York University	Schulman, M (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY 10012 USA.	schulmanm@mac.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					233	234		10.1001/jama.2014.6509	http://dx.doi.org/10.1001/jama.2014.6509			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	25027136				2022-12-28	WOS:000338940300017
J	Seltzer, SE; Lee, TH				Seltzer, Steven E.; Lee, Thomas H.			The Transformation of Diagnostic Radiology in the ACO Era	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Seltzer, Steven E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Lee, Thomas H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Seltzer, SE (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, 75 Francis St, Boston, MA 02115 USA.	sseltzer@partners.org						American College of Radiology, IM 3 0 TOOLK; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Iglehart JK, 2006, NEW ENGL J MED, V354, P2822, DOI 10.1056/NEJMhpr061219; Levin DC, 2011, AM J ROENTGENOL, V196, pW25, DOI 10.2214/AJR.10.4835; Miglioretti DL, 2011, AM FAM PHYSICIAN, V83, P1252; Radiological Society of North America, RAD CAR; Wong HJ, 2013, RADIOLOGY, V268, P779, DOI 10.1148/radiol.13130972	7	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					227	228		10.1001/jama.2014.6504	http://dx.doi.org/10.1001/jama.2014.6504			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	25027135				2022-12-28	WOS:000338940300014
J	Ma, H; Morey, R; O'Neil, RC; He, YP; Daughtry, B; Schultz, MD; Hariharan, M; Nery, JR; Castanon, R; Sabatini, K; Thiagarajan, RD; Tachibana, M; Kang, EJ; Tippner-Hedges, R; Ahmed, R; Gutierrez, NM; Van Dyken, C; Polat, A; Sugawara, A; Sparman, M; Gokhale, S; Amato, P; Wolf, DP; Ecker, JR; Laurent, LC; Mitalipov, S				Ma, Hong; Morey, Robert; O'Neil, Ryan C.; He, Yupeng; Daughtry, Brittany; Schultz, Matthew D.; Hariharan, Manoj; Nery, Joseph R.; Castanon, Rosa; Sabatini, Karen; Thiagarajan, Rathi D.; Tachibana, Masahito; Kang, Eunju; Tippner-Hedges, Rebecca; Ahmed, Riffat; Gutierrez, Nuria Marti; Van Dyken, Crystal; Polat, Alim; Sugawara, Atsushi; Sparman, Michelle; Gokhale, Sumita; Amato, Paula; Wolf, Don P.; Ecker, Joseph R.; Laurent, Louise C.; Mitalipov, Shoukhrat			Abnormalities in human pluripotent cells due to reprogramming mechanisms	NATURE			English	Article							EMBRYONIC STEM-CELLS; CODING MUTATIONS; DNA METHYLATION; DYNAMIC CHANGES; SOMATIC-CELLS; X-CHROMOSOME; COPY NUMBER; MEMORY; LINES; DIFFERENTIATION	Human pluripotent stem cells hold potential for regenerative medicine, but available cell types have significant limitations. Although embryonic stemcells (ES cells) from in vitro fertilized embryos (IVFES cells) represent the 'gold standard', they are allogeneic to patients. Autologous induced pluripotent stem cells (iPS cells) are prone to epigenetic and transcriptional aberrations. To determine whether such abnormalities are intrinsic to somatic cell reprogramming or secondary to the reprogramming method, genetically matched sets of human IVF ES cells, iPS cells and nuclear transfer ES cells (NT ES cells) derived by somatic cell nuclear transfer (SCNT) were subjected to genome-wide analyses. Both NT ES cells and iPS cells derived from the same somatic cells contained comparable numbers of de novo copy number variations. In contrast, DNA methylation and transcriptome profiles of NT ES cells corresponded closely to those of IVF ES cells, whereas iPS cells differed and retained residual DNA methylation patterns typical of parental somatic cells. Thus, human somatic cells can be faithfully reprogrammed to pluripotency by SCNT and are therefore ideal for cell replacement therapies.	[Ma, Hong; Daughtry, Brittany; Kang, Eunju; Tippner-Hedges, Rebecca; Ahmed, Riffat; Gutierrez, Nuria Marti; Van Dyken, Crystal; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, Portland, OR 97239 USA; [Ma, Hong; Daughtry, Brittany; Tachibana, Masahito; Kang, Eunju; Tippner-Hedges, Rebecca; Ahmed, Riffat; Gutierrez, Nuria Marti; Van Dyken, Crystal; Polat, Alim; Sugawara, Atsushi; Sparman, Michelle; Wolf, Don P.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR 97006 USA; [Morey, Robert; Sabatini, Karen; Thiagarajan, Rathi D.; Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [O'Neil, Ryan C.; He, Yupeng; Schultz, Matthew D.; Hariharan, Manoj; Nery, Joseph R.; Castanon, Rosa; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [O'Neil, Ryan C.; He, Yupeng] Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; [Gokhale, Sumita] Boston Univ, Sch Med, Roger Williams Med Ctr, Univ Pathologists LLC, Providence, RI 02918 USA; [Amato, Paula; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol, Portland, OR 97239 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; Boston University; Roger Williams Medical Center; Oregon Health & Science University; Howard Hughes Medical Institute; Salk Institute	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, 3303 Southwest Bond Ave, Portland, OR 97239 USA.	ecker@salk.edu; llaurent@ucsd.edu; mitalipo@ohsu.edu	Hariharan, Manoj/N-2855-2015; Ecker, Joseph R/B-9144-2008; Nery, Joseph/AAE-8422-2019	Hariharan, Manoj/0000-0002-1006-5372; Ecker, Joseph R/0000-0001-5799-5895; Nery, Joseph/0000-0003-0153-5659; Laurent, Louise/0000-0002-2095-7534	Leducq Foundation; OHSU; UCSD Department of Reproductive Medicine; Salk International Council Chair fund endowment; Mary K. Chapman Foundation; Swedish Research Council; Collins Medical Trust	Leducq Foundation(Leducq Foundation); OHSU; UCSD Department of Reproductive Medicine; Salk International Council Chair fund endowment; Mary K. Chapman Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Collins Medical Trust	The authors acknowledge the OHSU Embryonic Stem Cell Research Oversight Committee and the Institutional Review Board for providing oversight and guidance. We thank oocyte and sperm donors and the Women's Health Research Unit staff at the Center for Women's Health, University Fertility Consultants and the Reproductive Endocrinology and Infertility Division in the Department of Obstetrics and Gynecology of Oregon Health and Science University for their support and procurement of human gametes. We are grateful to C. Penedo for microsatellite analysis and W. Sanger and D. Zaleski for karyotyping services. We are also indebted to Y. Li, H. Sritanaudomchai and D. Melguizo Sanchis for their technical support. We thank the staff at the Institute for Genomic Medicine Genomics Facility at UCSD for running the Infinium HumanMethylation450 BeadChips and sequencing of the RNA-seq libraries. The authors acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin (http://www.tacc.utexas.edu) and the San Diego Supercomputing Center (through an allocation from the eXtreme Science and Engineering Discovery Environment (XSEDE)) for providing HPC resources that have contributed to the research results reported within this paper. SCNT and iPS cell studies were supported by grants from the Leducq Foundation and OHSU institutional funds. R. M., K. S., R. T. and L. C. L. were supported by the UCSD Department of Reproductive Medicine. Methylome studies were supported by the Salk International Council Chair fund endowment and the Mary K. Chapman Foundation to J.R.E. J.R.E. is an investigator of the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation (GMBF3034). A. P. received a fellowship fromthe Swedish Research Council, Vetenskapsra det. E. K. was partially funded by a fellowship from the Collins Medical Trust.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bancroft T, 2013, BIOMETRICS, V69, P1, DOI 10.1111/j.1541-0420.2012.01825.x; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Martin M, 2011, EMBNET J, V17; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Newman AM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-117; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Perkins W, 2011, APPL MATH COMPUT, V217, P9072, DOI 10.1016/j.amc.2011.03.124; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Price EM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-4; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Ruiz S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2381; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schultz MD, 2012, TRENDS GENET, V28, P583, DOI 10.1016/j.tig.2012.10.012; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Stelzer Y, 2013, STEM CELL REP, V1, P79, DOI 10.1016/j.stemcr.2013.03.005; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallot C, 2013, NAT GENET, V45, P239, DOI 10.1038/ng.2530; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	43	236	243	2	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					177	+		10.1038/nature13551	http://dx.doi.org/10.1038/nature13551			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008523	Green Published, Green Accepted			2022-12-28	WOS:000338649800035
J	Poteat, T; Wirtz, AL; Radix, A; Borquez, A; Silva-Santisteban, A; Deutsch, MB; Khan, SI; Winter, S; Operario, D				Poteat, Tonia; Wirtz, Andrea L.; Radix, Anita; Borquez, Annick; Silva-Santisteban, Alfonso; Deutsch, Madeline B.; Khan, Sharful Islam; Winter, Sam; Operario, Don			HIV risk and preventive interventions in transgender women sex workers	LANCET			English	Article							MENTAL-HEALTH; CONDOM USE; TRANSMITTED INFECTIONS; FEMALE; BEHAVIORS; CARE; GENDER; TRANSMISSION; PREVALENCE; VIOLENCE	Worldwide, transgender women who engage in sex work have a disproportionate risk for HIV compared with natal male and female sex workers. We reviewed recent epidemiological research on HIV in transgender women and show that transgender women sex workers (TSW) face unique structural, interpersonal, and individual vulnerabilities that contribute to risk for HIV. Only six studies of evidence-based prevention interventions were identified, none of which focused exclusively on TSW. We developed a deterministic model based on findings related to HIV risks and interventions. The model examines HIV prevention approaches in TSW in two settings (Lima, Peru and San Francisco, CA, USA) to identify which interventions would probably achieve the UN goal of 50% reduction in HIV incidence in 10 years. A combination of interventions that achieves small changes in behaviour and low coverage of biomedical interventions was promising in both settings, suggesting that the expansion of prevention services in TSW would be highly effective. However, this expansion needs appropriate sustainable interventions to tackle the upstream drivers of HIV risk and successfully reach this population. Case studies of six countries show context-specific issues that should inform development and implementation of key interventions across heterogeneous settings. We summarise the evidence and knowledge gaps that affect the HIV epidemic in TSW, and propose a research agenda to improve HIV services and policies for this population.	[Poteat, Tonia] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Wirtz, Andrea L.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Radix, Anita] Callen Lorde Community Hlth Ctr, New York, NY USA; [Borquez, Annick] Univ London Imperial Coll Sci Technol & Med, HIV Modelling Consortium, Dept Infect Dis Epidemiol, London, England; [Silva-Santisteban, Alfonso] Univ Peruana Cayetano Heredia, Unit Hlth Sexual & Human Dev, Lima, Peru; [Deutsch, Madeline B.] Univ Calif San Francisco, Dept Family & Community Med, Ctr Excellence Transgender Hlth, San Francisco, CA 94143 USA; [Khan, Sharful Islam] Icddr B, Ctr HIV & AIDS, Global Fund Project, Dhaka, Bangladesh; [Winter, Sam] Univ Hong Kong, Fac Educ, Div Policy & Social Studies Educ, Hong Kong, Hong Kong, Peoples R China; [Operario, Don] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Imperial College London; Universidad Peruana Cayetano Heredia; University of California System; University of California San Francisco; International Centre for Diarrhoeal Disease Research (ICDDR); University of Hong Kong; Brown University	Poteat, T (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	tpoteat@jhsph.edu	Radix, Asa/X-5189-2019	Radix, Asa/0000-0001-9611-4181; Poteat, Tonia/0000-0001-6541-3787; Khan, MBBS, MHSS, PhD, Sharful Islam/0000-0002-7319-1333; Silva-Santisteban, Alfonso/0000-0001-7225-3515; Radix, Asa/0000-0001-8594-1077	Johns Hopkins University Center for AIDS Research, an National Institutes of Health (NIH)-funded programme - NIH [1P30AI094189]; National Institute of Allergy and Infectious Diseases (NIAID); National Cancer Institute (NCI); National Institute for Child Health and Development (NICHD); National Heart, Lung, and Blood Institute (NHLBI); National Institute for Drug Abuse (NIDA); National Institute of Mental Health (NIMH); National Institute on Aging (NIA); Fogarty International Center (FIC); National Institute of General Medical Sciences (NIGMS); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Office of AIDS Research (OAR); Bill & Melinda Gates Foundation; UN Population Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Johns Hopkins University Center for AIDS Research, an National Institutes of Health (NIH)-funded programme - NIH; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute for Child Health and Development (NICHD); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of AIDS Research (OAR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UN Population Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Mike Pickles and Tim Hallett for their support with the modelling. This Review was made possible with help from the Johns Hopkins University Center for AIDS Research, an National Institutes of Health (NIH)-funded programme (1P30AI094189), which is supported by these NIH co-funding and participating institutes and centres: National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), National Institute for Child Health and Development (NICHD), National Heart, Lung, and Blood Institute (NHLBI), National Institute for Drug Abuse (NIDA), National Institute of Mental Health (NIMH), National Institute on Aging (NIA), Fogarty International Center (FIC), National Institute of General Medical Sciences (NIGMS), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and Office of AIDS Research (OAR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This Review and The Lancet Series on HIV and sex workers were supported by grants to the Center for Public Health and Human Rights at Johns Hopkins Bloomberg School of Public Health from the Bill & Melinda Gates Foundation and from the UN Population Fund. No authors have been paid to write this manuscript by a pharmaceutical company or other agency. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Abdullah MA, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-32; Altaf A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-279; Ayala G, 2011, ANAL MAJOR HIV DONOR; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baral S., 2011, 3 M TECHN ADV GROUP; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Bauer GR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-292; Bauer GR, 2009, J ASSOC NURSE AIDS C, V20, P348, DOI 10.1016/j.jana.2009.07.004; Beattie TSH, 2012, J EPIDEMIOL COMMUN H, V66, pII42, DOI 10.1136/jech-2011-200475; Beyrer C, 2005, AIDS, V19, P1535, DOI 10.1097/01.aids.0000183122.01583.c7; BMGF, 2010, BREAKING BARRIERS AV; Bockting W, 2007, ARCH SEX BEHAV, V36, P778, DOI 10.1007/s10508-006-9133-4; Bockting WO, 2013, AM J PUBLIC HEALTH, V103, P943, DOI 10.2105/AJPH.2013.301241; Bockting WO, 2005, AIDS CARE, V17, P289, DOI 10.1080/09540120412331299825; Bockting WO, 1998, AIDS CARE, V10, P505, DOI 10.1080/09540129850124028; Bockting WO, 1999, HEALTH EDUC RES, V14, P177, DOI 10.1093/her/14.2.177; BOLES J, 1994, SOC SCI MED, V39, P85, DOI 10.1016/0277-9536(94)90168-6; Boyce S, 2012, CULT HEALTH SEX, V14, P313, DOI 10.1080/13691058.2011.639393; Brennan J, 2012, AM J PUBLIC HEALTH, V102, P1751, DOI 10.2105/AJPH.2011.300433; Clements-Nolle K, 2001, AM J PUBLIC HEALTH, V91, P915, DOI 10.2105/AJPH.91.6.915; Clernents-Nolle K, 2008, SEX HEALTH, V5, P49, DOI 10.1071/SH07045; Cohan D, 2006, SEX TRANSM INFECT, V82, P418, DOI 10.1136/sti.2006.020628; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Coleman E, 2012, INT J TRANSGENDERISM, V13, P165, DOI 10.1080/15532739.2011.700873; Coulter RWS, 2014, AM J PUBLIC HEALTH, V104, pE105, DOI 10.2105/AJPH.2013.301501; Crago A-L., 2011, FEMALE MALE TRANSGEN; Decker MR, 2013, AM J REPROD IMMUNOL, V69, P122, DOI 10.1111/aji.12063; Dunham E, 2012, PHIL T HLTH C PHIL P; ELIFSON KW, 1993, AM J PUBLIC HEALTH, V83, P260, DOI 10.2105/AJPH.83.2.260; Erausquin JT, 2011, J INFECT DIS, V204, pS1223, DOI 10.1093/infdis/jir539; Fredriksen-Goldsen KI, 2014, GERONTOLOGIST, V54, P488, DOI 10.1093/geront/gnt021; Gertler P, 2005, J POLIT ECON, V113, P518, DOI 10.1086/429700; Gomez GB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001401; Gomez GB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001323; Goswami P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002183; Grant J.M., 2011, INJUSTICE EVERY TURN; Grant R, 2011, 6 IAS C HIV PATH TRE; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guadamuz TE, 2011, AIDS BEHAV, V15, P650, DOI 10.1007/s10461-010-9850-5; Gutierrez-Mock L., 2009, T SISTA RESOURCE GUI; Harawa NT, 2010, J HEALTH CARE POOR U, V21, P1071, DOI 10.1353/hpu.0.0349; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Herbst JH, 2008, AIDS BEHAV, V12, P1, DOI 10.1007/s10461-007-9299-3; Hill SC, 2011, INT J STD AIDS, V22, P686, DOI 10.1258/ijsa.2009.009491; Hotton AL, 2013, AIDS EDUC PREV, V25, P62, DOI 10.1521/aeap.2013.25.1.62; Hwahng Sel Julian, 2007, Sex Res Social Policy, V4, P36, DOI 10.1525/srsp.2007.4.4.36; Inciardi JA, 1999, INT J TRANSGENDERISM, V3, P1; International Woman's Rights Action Watch Asia Pacific (IWRAW), OCCASIONAL PAPERS SE, V7, P8; Jarolim L, 2009, J SEX MED, V6, P1635, DOI 10.1111/j.1743-6109.2009.01245.x; JENKINS C, 2005, KATOEY THAILAND HIV; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Lipsitz MC, 2014, INT J STD AIDS, V25, P325, DOI 10.1177/0956462413507443; Longfield K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-872; Mauk D, 2013, ARCH SEX BEHAV, V42, P793, DOI 10.1007/s10508-013-0079-z; Melendez RM, 2007, CULT HEALTH SEX, V9, P233, DOI 10.1080/13691050601065909; Melendez RM, 2006, AM J PUBLIC HEALTH, V96, P1034, DOI 10.2105/AJPH.2004.042010; Molano LF, 2012, 19 INT AIDS C; Nemoto T, 2005, AM J PUBLIC HEALTH, V95, P382, DOI 10.2105/AJPH.2004.040501; Nemoto T, 2004, AM J PUBLIC HEALTH, V94, P1193, DOI 10.2105/AJPH.94.7.1193; Nemoto T, 2004, AIDS CARE, V16, P724, DOI 10.1080/09540120413331269567; Nemoto T, 2014, AIDS CARE, V26, P434, DOI 10.1080/09540121.2013.841832; Nemoto T, 2012, AIDS CARE, V24, P210, DOI 10.1080/09540121.2011.597709; Nemoto T, 2011, AM J PUBLIC HEALTH, V101, P1980, DOI 10.2105/AJPH.2010.197285; Nuttbrock L, 2013, AM J PUBLIC HEALTH, V103, P300, DOI 10.2105/AJPH.2011.300568; Nuttbrock L, 2009, JAIDS-J ACQ IMM DEF, V52, P417, DOI 10.1097/QAI.0b013e3181ab6ed8; Opeiario D, 2008, JAIDS-J ACQ IMM DEF, V48, P97, DOI 10.1097/QAI.0b013e31816e3971; Open Society Foundation, 2012, LAWS POL AFF SEX WOR; Operario D, 2008, AIDS BEHAV, V12, P18, DOI 10.1007/s10461-007-9303-y; Operario D, 2011, ARCH SEX BEHAV, V40, P1255, DOI 10.1007/s10508-011-9781-x; Operario D, 2011, AIDS BEHAV, V15, P674, DOI 10.1007/s10461-010-9795-8; Operario D, 2010, JAIDS-J ACQ IMM DEF, V55, pS91, DOI 10.1097/QAI.0b013e3181fbc9ec; Pawa D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077113; Peinado Jesus, 2013, J Int Assoc Provid AIDS Care, V12, P278, DOI 10.1177/1545109712473650; Reback CJ, 2013, J SEX RES, V50, P151, DOI 10.1080/00224499.2011.632101; Reisner S, 2012, AIDS EDUC PREV, V24, P15, DOI 10.1521/aeap.2012.24.1.15; Rhodes T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a811; Sausa LA, 2007, ARCH SEX BEHAV, V36, P768, DOI 10.1007/s10508-007-9210-3; Sevelius JM, 2014, ANN BEHAV MED, V47, P5, DOI 10.1007/s12160-013-9565-8; Sevelius JM, 2013, SEX ROLES, V68, P675, DOI 10.1007/s11199-012-0216-5; Sevelius JM, 2010, J ASSOC NURSE AIDS C, V21, P256, DOI 10.1016/j.jana.2010.01.005; Shannon K., 2014, LANCET; Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858; Silva-Santisteban A, 2012, AIDS BEHAV, V16, P872, DOI 10.1007/s10461-011-0053-5; Stephens T, 1999, INT J STD AIDS, V10, P28, DOI 10.1258/0956462991913042; Subramanian T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-857; Taylor RD, 2011, AIDS EDUC PREV, V23, P469, DOI 10.1521/aeap.2011.23.5.469; TVT, 2012, LEG HEALTHC MAPP; UNAIDS, 2012, LOB REP UNAIDS REP G; Villayzan J., 2010, SITUACION POBLACION; Weinberg MS, 2010, J SEX RES, V47, P374, DOI 10.1080/00224490903050568; Winter S, 2011, GLOBAL PERSPECTIVES; Winter S., 2012, FOCUS, P69; Yang DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059020, 10.1371/journal.pone.0054495, 10.1371/journal.pone.0062329]; Yehia BR, 2013, CLIN INFECT DIS, V57, P774, DOI 10.1093/cid/cit363; Zaza S, 2000, AM J PREV MED, V18, P44, DOI 10.1016/S0749-3797(99)00122-1	95	241	244	4	58	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					274	286		10.1016/S0140-6736(14)60833-3	http://dx.doi.org/10.1016/S0140-6736(14)60833-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ2DL	25059941	Green Accepted			2022-12-28	WOS:000348044800031
J	Shipony, Z; Mukamel, Z; Cohen, NM; Landan, G; Chomsky, E; Zeliger, SR; Fried, YC; Ainbinder, E; Friedman, N; Tanay, A				Shipony, Zohar; Mukamel, Zohar; Cohen, Netta Mendelson; Landan, Gilad; Chomsky, Elad; Zeliger, Shlomit Reich; Fried, Yael Chagit; Ainbinder, Elena; Friedman, Nir; Tanay, Amos			Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells	NATURE			English	Article							DNA METHYLATION PATTERNS; STEM-CELLS; GENOME; PLASTICITY; CHROMATIN; ELEMENTS; DOMAINS; REGIONS	Stable maintenance of gene regulatory programs is essential for normal function in multicellular organisms. Epigenetic mechanisms, and DNA methylation in particular, are hypothesized to facilitate such maintenance by creating cellular memory(1-4) that can be written during embryonic development(5,6) and then guide cell-type-specific gene expression(7). Here we develop new methods for quantitative inference of DNA methylation turnover rates, and show that human embryonic stem cells preserve their epigenetic state by balancing antagonistic processes that add and remove methylation marks rather than by copying epigenetic information from mother to daughter cells. In contrast, somatic cells transmit considerable epigenetic information to progenies. Paradoxically, the persistence of the somatic epigenome makes it more vulnerable to noise, since random epimutations can accumulate to massively perturb the epigenomic ground state. The rate of epigenetic perturbation depends on the genomic context, and, in particular, DNA methylation loss is coupled to late DNA replication dynamics. Epigenetic perturbation is not observed in the pluripotent state, because the rapid turnover-based equilibrium continuously reinforces the canonical state. This dynamic epigenetic equilibrium also explains how the epigenome can be reprogrammed quickly(8) and to near perfection(9) after induced pluripotency.	[Shipony, Zohar; Mukamel, Zohar; Cohen, Netta Mendelson; Landan, Gilad; Chomsky, Elad; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Shipony, Zohar; Mukamel, Zohar; Cohen, Netta Mendelson; Landan, Gilad; Chomsky, Elad; Tanay, Amos] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Chomsky, Elad] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Zeliger, Shlomit Reich; Friedman, Nir] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Fried, Yael Chagit; Ainbinder, Elena] Weizmann Inst Sci, Dept Biol Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Tanay, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	amos.tanay@weizmann.ac.il			European Research Council (EVOEPIC); EU BLUEPRINT project; Israel Science Foundation [1050/12]; Israel Ministry of Science; Helen and Martin Kimmel Award	European Research Council (EVOEPIC); EU BLUEPRINT project; Israel Science Foundation(Israel Science Foundation); Israel Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Helen and Martin Kimmel Award	We thank E. Kenigsberg, E. Yaffe and the Tanay group for discussions. Research in the Tanay group was supported by the European Research Council (EVOEPIC), the EU BLUEPRINT project, the Israel Science Foundation (1050/12 and I-Core) the Israel Ministry of Science and the Helen and Martin Kimmel Award.	Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Halligan DL, 2009, ANNU REV ECOL EVOL S, V40, P151, DOI 10.1146/annurev.ecolsys.39.110707.173437; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Landan G, 2012, NAT GENET, V44, P1207, DOI 10.1038/ng.2442; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Milyavsky M, 2003, CANCER RES, V63, P7147; Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; STEIN R, 1982, P NATL ACAD SCI-BIOL, V79, P61, DOI 10.1073/pnas.79.1.61; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	36	93	100	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					115	+		10.1038/nature13458	http://dx.doi.org/10.1038/nature13458			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25043040				2022-12-28	WOS:000341174800041
J	Lu, PL; Bai, XC; Ma, D; Xie, T; Yan, CY; Sun, LF; Yang, GH; Zhao, YY; Zhou, R; Scheres, SHW; Shi, YG				Lu, Peilong; Bai, Xiao-chen; Ma, Dan; Xie, Tian; Yan, Chuangye; Sun, Linfeng; Yang, Guanghui; Zhao, Yanyu; Zhou, Rui; Scheres, Sjors H. W.; Shi, Yigong			Three-dimensional structure of human gamma-secretase	NATURE			English	Article							INTRAMEMBRANE PROTEOLYSIS; TRANSMEMBRANE DOMAIN-4; PRESENILIN; NICASTRIN; COMPLEX; BINDING; PROTEIN; RESOLUTION; APH-1; MODEL	The gamma-secretase complex, comprising presenilin 1 (PS1), PEN-2, APH-1 and nicastrin, is a membrane-embedded protease that controls a number of important cellular functions through substrate cleavage. Aberrant cleavage of the amyloid precursor protein (APP) results in aggregation of amyloid-beta, which accumulates in the brain and consequently causes Alzheimer's disease. Here we report the three-dimensional structure of an intact human gamma-secretase complex at 4.5 angstrom resolution, determined by cryo-electron-microscopy single-particle analysis. The gamma-secretase complex comprises a horseshoe-shaped transmembrane domain, which contains 19 transmembrane segments (TMs), and a large extracellular domain (ECD) from nicastrin, which sits immediately above the hollow space formed by the TM horseshoe. Intriguingly, nicastrin ECD is structurally similar to a large family of peptidases exemplified by the glutamate carboxypeptidase PSMA. This structure serves as an important basis for understanding the functional mechanisms of the gamma-secretase complex.	[Lu, Peilong; Ma, Dan; Xie, Tian; Sun, Linfeng; Zhao, Yanyu; Zhou, Rui; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Lu, Peilong; Ma, Dan; Xie, Tian; Yan, Chuangye; Sun, Linfeng; Yang, Guanghui; Zhao, Yanyu; Zhou, Rui; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Lu, Peilong; Ma, Dan; Xie, Tian; Yan, Chuangye; Sun, Linfeng; Yang, Guanghui; Zhao, Yanyu; Zhou, Rui; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China; [Bai, Xiao-chen; Scheres, Sjors H. W.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Yan, Chuangye; Yang, Guanghui] Tsinghua Univ, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; MRC Laboratory Molecular Biology; Tsinghua University	Scheres, SHW (corresponding author), MRC Lab Mol Biol, Cambridge Biomed Campus, Cambridge CB2 0QH, England.	scheres@mrc-lmb.cam.ac.uk; shi-lab@tsinghua.edu.cn	Scheres, Sjors H.W./AAY-2265-2021; Yan, Chuangye/AAJ-5832-2021; Bai, Xiao-chen/HGV-1244-2022	Scheres, Sjors H.W./0000-0002-0462-6540; Bai, Xiao-chen/0000-0002-4234-5686; Lu, Peilong/0000-0001-5894-9268; Yan, Chuangye/0000-0001-9338-8048; Shi, Yigong/0000-0003-2030-168X; Xie, Tian/0000-0002-5445-664X	Ministry of Science and Technology of China [2009CB918801]; National Natural Science Foundation of China [30888001, 31021002, 31130002]; European Union Marie Curie Fellowship; UK Medical Research Council [MC_UP_A025_1013]; Medical Research Council [MC_UP_A025_1013] Funding Source: researchfish; MRC [MC_UP_A025_1013] Funding Source: UKRI	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Union Marie Curie Fellowship(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Wolfeand D. Selkoe for support and encouragement, and S. Chen, C. Savva, J. Grimmett and T. Darling for technical support. This work was funded by the Ministry of Science and Technology of China (2009CB918801 to Y.S.), National Natural Science Foundation of China (projects 30888001, 31021002 and 31130002 to Y.S.), a European Union Marie Curie Fellowship (to X. C. B.), and the UK Medical Research Council (MC_UP_A025_1013, to S.H.W.S.).	Alexandrov A, 2004, MOL CELL PROTEOMICS, V3, P934, DOI 10.1074/mcp.T400008-MCP200; Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Bammens L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216978; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Elmlund H, 2013, STRUCTURE, V21, P1299, DOI 10.1016/j.str.2013.07.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fagan R, 2001, TRENDS BIOCHEM SCI, V26, P213, DOI 10.1016/S0968-0004(01)01789-3; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Li Y, 2014, STRUCTURE, V22, P125, DOI 10.1016/j.str.2013.09.018; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Ogura T, 2006, BIOCHEM BIOPH RES CO, V345, P543, DOI 10.1016/j.bbrc.2006.04.025; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Renzi F, 2011, J BIOL CHEM, V286, P21440, DOI 10.1074/jbc.M110.193326; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schedin-Weiss S, 2014, FEBS J, V281, P46, DOI 10.1111/febs.12590; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Steiner H, 2008, J BIOL CHEM, V283, P34677, DOI 10.1074/jbc.M709067200; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tang Ya-Ping, 2003, Dialogues Clin Neurosci, V5, P17; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wolfe MS, 2013, BBA-BIOMEMBRANES, V1828, P2886, DOI 10.1016/j.bbamem.2013.04.015; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Zhang AX, 2010, J AM CHEM SOC, V132, P12711, DOI 10.1021/ja104591m	60	253	268	8	296	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					166	+		10.1038/nature13567	http://dx.doi.org/10.1038/nature13567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043039	Green Accepted			2022-12-28	WOS:000340200700025
J	Telenti, A				Telenti, Amalio			HIV The mixed blessing of interferon	NATURE			English	Editorial Material							SIV INFECTION; ALPHA-2A; VIRUS		Univ Lausanne, Univ Lausanne Hosp, Inst Microbiol, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Telenti, A (corresponding author), Univ Lausanne, Univ Lausanne Hosp, Inst Microbiol, CH-1011 Lausanne, Switzerland.	amalio.telenti@chuv.ch	Telenti, Amalio/AAY-1674-2021					Asmuth DM, 2010, J INFECT DIS, V201, P1686, DOI 10.1086/652420; BORDEN EC, 1971, J IMMUNOL, V106, P134; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Fenton-May AE, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-146; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; LONGO DL, 1984, ANN NY ACAD SCI, V437, P421, DOI 10.1111/j.1749-6632.1984.tb37163.x; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Rausell Antonio, 2013, F1000Prime Rep, V5, P29, DOI 10.12703/P5-29; Rotger M, 2011, J CLIN INVEST, V121, P2391, DOI 10.1172/JCI45235; Rotger M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000781; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Schoggins JW, 2014, CURR OPIN VIROL, V6, P40, DOI 10.1016/j.coviro.2014.03.006; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842	14	8	8	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					537	538		10.1038/nature13517	http://dx.doi.org/10.1038/nature13517			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043060				2022-12-28	WOS:000339566300020
J	Hay, CM; Shepard, JAO; Hyle, EP; Duncan, LM				Hay, Christine M.; Shepard, Jo-Anne O.; Hyle, Emily P.; Duncan, Lyn M.			Case 23-2014: A 41-Year-Old Man with Fevers, Rash, Pancytopenia, and Abnormal Liver Function	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEASLES; INFECTION; HEPATITIS; FEATURES; RUBELLA; EUROPE		[Hay, Christine M.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Hay, Christine M.] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; [Shepard, Jo-Anne O.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Hyle, Emily P.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Duncan, Lyn M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Shepard, Jo-Anne O.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Hyle, Emily P.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Duncan, Lyn M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Rochester; University of Rochester; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Hay, CM (corresponding author), Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA.							Aronsson B, 2004, J CLIN LAB IMMUNOL, V53, P1; Blanco JR, 2002, CLIN MICROBIOL INFEC, V8, P763, DOI 10.1046/j.1469-0691.2002.00557.x; HELMS CM, 1979, ANN INTERN MED, V90, P543, DOI 10.7326/0003-4819-90-4-543; Hildebrandt A, 2013, INFECTION, V41, P1057, DOI 10.1007/s15010-013-0526-8; Lott JP, 2013, J AM ACAD DERMATOL, V69, P736, DOI 10.1016/j.jaad.2013.07.024; Muscat M, 2014, CLIN MICROBIOL INFEC, V20, P12, DOI 10.1111/1469-0691.12584; Muscat M, 2011, J INFECT DIS, V204, P1293, DOI 10.1093/infdis/jir519; RAOULT D, 1986, AM J TROP MED HYG, V35, P845, DOI 10.4269/ajtmh.1986.35.845; Rota JS, 2011, J INFECT DIS, V204, pS559, DOI 10.1093/infdis/jir098; SHALEVZIMELS H, 1988, HEPATOLOGY, V8, P1138, DOI 10.1002/hep.1840080529; TAMEDA Y, 1993, INTERNAL MED, V32, P580, DOI 10.2169/internalmedicine.32.580	11	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					358	366		10.1056/NEJMcpc1404140	http://dx.doi.org/10.1056/NEJMcpc1404140			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7TY	25054720				2022-12-28	WOS:000339339800013
J	Hotchkiss, RS; Moldawer, LL				Hotchkiss, Richard S.; Moldawer, Lyle L.			Parallels between Cancer and Infectious Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IMMUNOTHERAPY		[Hotchkiss, Richard S.] Washington Univ, Dept Anesthesiol, Sch Med, St Louis, MO 63130 USA; [Hotchkiss, Richard S.] Washington Univ, Dept Med, Sch Med, St Louis, MO 63130 USA; [Hotchkiss, Richard S.] Washington Univ, Dept Surg, Sch Med, St Louis, MO 63130 USA; [Moldawer, Lyle L.] Univ Florida, Coll Med, Dept Surg, Gainesville, FL USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); State University System of Florida; University of Florida	Hotchkiss, RS (corresponding author), Washington Univ, Dept Anesthesiol, Sch Med, St Louis, MO 63130 USA.			Moldawer, Lyle/0000-0002-9041-9838				Cheever MAM, 2008, IMMUNOL REV, V222, P357, DOI 10.1111/j.1600-065X.2008.00604.x; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Deloitte CIO Journal Editor, 2014, WALL STREET J; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patel A, 2010, J ANTIMICROB CHEMOTH, V65, P2697, DOI 10.1093/jac/dkq359	7	128	132	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					380	383		10.1056/NEJMcibr1404664	http://dx.doi.org/10.1056/NEJMcibr1404664			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7TY	25054723	Green Published			2022-12-28	WOS:000339339800017
J	Moon, IS; Lee, WS				Moon, In Seok; Lee, Won-Sang			Internal Carotid Artery in the Middle Ear	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Moon, In Seok; Lee, Won-Sang] Yonsei Univ, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System	Moon, IS (corresponding author), Yonsei Univ, Coll Med, Seoul, South Korea.	wsleemd@yuhs.ac		Moon, In Seok/0000-0002-3951-5074					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					E5	E5		10.1056/NEJMicm1312261	http://dx.doi.org/10.1056/NEJMicm1312261			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7TY	25054733				2022-12-28	WOS:000339339800001
J	Walz, S; Lorenzin, F; Morton, J; Wiese, KE; von Eyss, B; Herold, S; Rycak, L; Dumay-Odelot, H; Karim, S; Bartkuhn, M; Roels, F; Wustefeld, T; Fischer, M; Teichmann, M; Zender, L; Wei, CL; Sansom, O; Wolf, E; Eilers, M				Walz, Susanne; Lorenzin, Francesca; Morton, Jennifer; Wiese, Katrin E.; von Eyss, Bjoern; Herold, Steffi; Rycak, Lukas; Dumay-Odelot, Helene; Karim, Saadia; Bartkuhn, Marek; Roels, Frederik; Wuestefeld, Torsten; Fischer, Matthias; Teichmann, Martin; Zender, Lars; Wei, Chia-Lin; Sansom, Owen; Wolf, Elmar; Eilers, Martin			Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles	NATURE			English	Article							C-MYC; TRANSCRIPTION; PROMOTER; BINDING; GENOME; DNA; ASSOCIATION; INTEGRATION; INDUCTION; CELLS	In mammalian cells, the MYC oncoprotein binds to thousands of promoters(1-4). During mitogenic stimulation of primary lymphocytes, MYC promotes an increase in the expression of virtually all genes(1). In contrast, MYC-driven tumour cells differ from normal cells in the expression of specific sets of up-and downregulated genes that have considerable prognostic value(5-7). To understand this discrepancy, we studied the consequences of inducible expression and depletion of MYC in human cells and murine tumour models. Changes in MYC levels activate and repress specific sets of direct target genes that are characteristic of MYC-transformed tumour cells. Three factors account for this specificity. First, the magnitude of response parallels the change in occupancy by MYC at each promoter. Functionally distinct classes of target genes differ in the E-box sequence bound by MYC, suggesting that different cellular responses to physiological and oncogenic MYC levels are controlled by promoter affinity. Second, MYC both positively and negatively affects transcription initiation independent of its effect on transcriptional elongation(8). Third, complex formation with MIZ1 (also known as ZBTB17)(9) mediates repression of multiple target genes by MYC and the ratio of MYC and MIZ1 bound to each promoter correlates with the direction of response.	[Walz, Susanne; Lorenzin, Francesca; Wiese, Katrin E.; von Eyss, Bjoern; Herold, Steffi; Wolf, Elmar; Eilers, Martin] Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97074 Wurzburg, Germany; [Morton, Jennifer; Karim, Saadia; Sansom, Owen] CRUK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Rycak, Lukas] Inst Mol Biol & Tumor Res IMT, D-35033 Marburg, Germany; [Dumay-Odelot, Helene; Teichmann, Martin] Univ Bordeaux, IECB, ARNA Lab, Equipe Labellisee Canc, F-33600 Pessac, France; [Bartkuhn, Marek] Univ Giessen, Inst Genet, D-35390 Giessen, Germany; [Roels, Frederik; Fischer, Matthias] Univ Cologne, Univ Childrens Hosp Cologne, D-50924 Cologne, Germany; [Roels, Frederik; Fischer, Matthias] Univ Cologne, Cologne Ctr Mol Med CMMC, D-50924 Cologne, Germany; [Wuestefeld, Torsten; Zender, Lars] Univ Tubingen Hosp, Div Translat Gastrointestinal Oncol, Dept Internal Med 1, D-72076 Tubingen, Germany; [Zender, Lars] German Canc Res Ctr, German Ctr Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, D-69121 Heidelberg, Germany; [Wei, Chia-Lin] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Wolf, Elmar] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Eilers, Martin] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97080 Wurzburg, Germany	University of Wurzburg; Beatson Institute; UDICE-French Research Universities; Universite de Bordeaux; Justus Liebig University Giessen; University of Cologne; University of Cologne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); United States Department of Energy (DOE); German Research Foundation (DFG); University of Wurzburg; University of Wurzburg	Eilers, M (corresponding author), Univ Wurzburg, Bioctr, Theodor Boveri Inst, Hubland, D-97074 Wurzburg, Germany.	elmar.wolf@biozentrum.uni-wuerzburg.de; martin.eilers@biozentrum.uni-wuerzburg.de	Morton, Jennifer/AAJ-5113-2021; von Eyss, Bjoern/P-1077-2019; Wolf, Elmar/AAY-8493-2021; Morton, Jennifer P/E-1633-2011; DUMAY-ODELOT, Hélène/M-7751-2014; Teichmann, Martin/M-7407-2014	Morton, Jennifer/0000-0001-5766-9141; von Eyss, Bjoern/0000-0002-4731-6841; Wolf, Elmar/0000-0002-5299-6335; Morton, Jennifer P/0000-0001-5766-9141; DUMAY-ODELOT, Helene/0000-0002-7245-084X; Wiese, Katrin Evelyn/0000-0002-1603-2846; Teichmann, Martin/0000-0002-5257-0510; Bartkuhn, Marek/0000-0001-6872-9082; Sansom, Owen J./0000-0001-9540-3010; Eilers, Martin/0000-0002-0376-6533	Deutsche Forschungsgemeinschaft (DFG) [222/5-3, 222/12-1]; graduate college 1048 ("Molecular basis of organ development in vertebrates''); DFG Research Center for Experimental Biomedicine; Institut National Du Cancer (INCa); Ligue National Contre le Cancer (Equipe Labellisee); Cancer Research UK core grant; European Research Council investigator grant, "Coloncan''; Cancer Research UK [12481] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); graduate college 1048 ("Molecular basis of organ development in vertebrates''); DFG Research Center for Experimental Biomedicine(German Research Foundation (DFG)); Institut National Du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue National Contre le Cancer (Equipe Labellisee); Cancer Research UK core grant; European Research Council investigator grant, "Coloncan''; Cancer Research UK(Cancer Research UK)	This work was funded by the Deutsche Forschungsgemeinschaft (DFG) through grants 222/5-3 and 222/12-1 (to M.E.), by a stipend of the graduate college 1048 ("Molecular basis of organ development in vertebrates'' to S.W.) and through the DFG Research Center for Experimental Biomedicine (to E.W.). M. T. was supported by grants from the Institut National Du Cancer (INCa) and by the Ligue National Contre le Cancer (Equipe Labellisee). O.S. and J.M. are funded by a Cancer Research UK core grant and a European Research Council investigator grant, "Coloncan''. We thank Y. L. Lee and T. Poh for help with ChIP-sequencing, F. Finkernagel for help with the bioinformatic analysis, A. Au for help with mouse experiments, B. Luscher for critical reading of the manuscript and D. Levens for providing data before publication.	Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Boyd KE, 1997, MOL CELL BIOL, V17, P2529, DOI 10.1128/MCB.17.5.2529; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Horiuchi D, 2012, J EXP MED, V209, P679, DOI 10.1084/jem.20111512; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iraci N, 2011, CANCER RES, V71, P404, DOI 10.1158/0008-5472.CAN-10-2627; Kosan C, 2010, IMMUNITY, V33, P917, DOI 10.1016/j.immuni.2010.11.028; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; Wiese KE, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014290; Wolf E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3535; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Yustein JT, 2010, P NATL ACAD SCI USA, V107, P3534, DOI 10.1073/pnas.0901230107; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	38	305	312	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					483	+		10.1038/nature13473	http://dx.doi.org/10.1038/nature13473			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043018	Green Accepted			2022-12-28	WOS:000339335700050
J	Mei, AY; Li, X; Liu, LF; Ku, ZL; Liu, TF; Rong, YG; Xu, M; Hu, M; Chen, JZ; Yang, Y; Gratzel, M; Han, HW				Mei, Anyi; Li, Xiong; Liu, Linfeng; Ku, Zhiliang; Liu, Tongfa; Rong, Yaoguang; Xu, Mi; Hu, Min; Chen, Jiangzhao; Yang, Ying; Graetzel, Michael; Han, Hongwei			A hole-conductor-free, fully printable mesoscopic perovskite solar cell with high stability	SCIENCE			English	Article							CHARGE GENERATION; EFFICIENT; MOBILITIES; LENGTHS	We fabricated a perovskite solar cell that uses a double layer of mesoporous TiO2 and ZrO2 as a scaffold infiltrated with perovskite and does not require a hole-conducting layer. The perovskite was produced by drop-casting a solution of PbI2, methylammonium (MA) iodide, and 5-ammoniumvaleric acid (5-AVA) iodide through a porous carbon film. The 5-AVA templating created mixed-cation perovskite (5-AVA)(x)(MA)(1-x)PbI3 crystals with lower defect concentration and better pore filling as well as more complete contact with the TiO2 scaffold, resulting in a longer exciton lifetime and a higher quantum yield for photoinduced charge separation as compared to MAPbI(3). The cell achieved a certified power conversion efficiency of 12.8% and was stable for >1000 hours in ambient air under full sunlight.	[Mei, Anyi; Li, Xiong; Liu, Linfeng; Ku, Zhiliang; Liu, Tongfa; Rong, Yaoguang; Xu, Mi; Hu, Min; Chen, Jiangzhao; Yang, Ying; Han, Hongwei] Huazhong Univ Sci & Technol, Sch Optic & Elect Informat, Wuhan Natl Lab Optoelect, Michael Gratzel Ctr Mesoscop Solar Cells, Wuhan 430074, Hubei, Peoples R China; [Graetzel, Michael] Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Chem Sci & Engn, Lab Photon & Interfaces, CH-1015 Lausanne, Switzerland	Huazhong University of Science & Technology; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Han, HW (corresponding author), Huazhong Univ Sci & Technol, Sch Optic & Elect Informat, Wuhan Natl Lab Optoelect, Michael Gratzel Ctr Mesoscop Solar Cells, Wuhan 430074, Hubei, Peoples R China.	hongwei.han@mail.hust.edu.cn	Liu, Tongfa/M-2539-2016; Nazeeruddin, Mohammad K/B-1323-2008; Han, Hongwei/I-1057-2014; Ku, Zhiliang/W-1567-2017; Yang, Ying/V-5914-2019	Liu, Tongfa/0000-0001-6633-0502; Nazeeruddin, Mohammad K/0000-0001-5955-4786; Ku, Zhiliang/0000-0002-5363-378X; Li, Xiong/0000-0002-8932-6968; Yang, Ying/0000-0003-1815-4991	Ministry of Science and Technology of China (863 project) [SS2013AA50303]; National Natural Science Foundation of China [61106056]; Science and Technology Department of Hubei Province [2013BAA090]; Fundamental Research Funds for the Central Universities [HUSTNY022]; European Research Council [ARG 247404]	Ministry of Science and Technology of China (863 project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Hubei Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); European Research Council(European Research Council (ERC)European Commission)	The authors acknowledge financial support from the Ministry of Science and Technology of China (863 project, grant no. SS2013AA50303), the National Natural Science Foundation of China (grant no. 61106056), the Science and Technology Department of Hubei Province (grant no. 2013BAA090), and the Fundamental Research Funds for the Central Universities (grant no. HUSTNY022). We thank the Analytical and Testing Center of Huazhong University of Science and Technology for field emission SEM, TEM, and XRD testing. M. G. thanks the European Research Council for financial support under advanced research grant ARG 247404, "Mesolight."	Abrusci A, 2011, ADV FUNCT MATER, V21, P2571, DOI 10.1002/adfm.201100048; Aharon S, 2014, PHYS CHEM CHEM PHYS, V16, P10512, DOI 10.1039/c4cp00460d; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Cai H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-141; Eperon GE, 2014, ADV FUNCT MATER, V24, P151, DOI 10.1002/adfm.201302090; Etgar L, 2012, J AM CHEM SOC, V134, P17396, DOI 10.1021/ja307789s; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI [10.1038/NPHOTON.2013.80, 10.1038/nphoton.2013.80]; Hodes G, 2013, SCIENCE, V342, P317, DOI 10.1126/science.1245473; Kim HS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3242; Kim HS, 2013, NANO LETT, V13, P2412, DOI 10.1021/nl400286w; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Ku ZL, 2013, SCI REP-UK, V3, DOI 10.1038/srep03132; Laban W. A., 2013, ENERG ENVIRON SCI, V6, P3249, DOI DOI 10.1039/C3EE42282H; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Mercier N, 2005, CRYSTENGCOMM, V7, P429, DOI 10.1039/b504342e; Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Ogomi Y, 2014, J PHYS CHEM C, V118, P16651, DOI 10.1021/jp412627n; Ponseca CS, 2014, J AM CHEM SOC, V136, P5189, DOI 10.1021/ja412583t; Shi JJ, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4864638; Stoumpos CC, 2013, INORG CHEM, V52, P9019, DOI 10.1021/ic401215x; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Xing GC, 2013, SCIENCE, V342, P344, DOI 10.1126/science.1243167	23	2372	2455	84	2910	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					295	298		10.1126/science.1254763	http://dx.doi.org/10.1126/science.1254763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035487				2022-12-28	WOS:000339400700043
J	Gall, C; Hjorth, J; Watson, D; Dwek, E; Maund, JR; Fox, O; Leloudas, G; Malesani, D; Day-Jones, AC				Gall, Christa; Hjorth, Jens; Watson, Darach; Dwek, Eli; Maund, Justyn R.; Fox, Ori; Leloudas, Giorgos; Malesani, Daniele; Day-Jones, Avril C.			Rapid formation of large dust grains in the luminous supernova 2010j1	NATURE			English	Article							LARGE-MAGELLANIC-CLOUD; IIN SUPERNOVA; SN 2010JL; INFRARED-EMISSION; INTERSTELLAR DUST; SHOCK BREAKOUT; MASSIVE STARS; MILKY-WAY; RADIATION; HERSCHEL	The origin of dust in galaxies is still a mystery(1-4). The majority of the refractory elements are produced in supernova explosions, but it is unclear how and where dust grains condense and grow, and how they avoid destruction in the harsh environments of star-forming galaxies. The recent detection of 0.1 to 0.5 solar masses of dust in nearby supernova remnants(5-7) suggests in situ dust formation, while other observations reveal very little dust in supernovae in the first few years after explosion(1,8,10). Observations of the spectral evolution of the bright SN 2010j1 have been interpreted as pre-existing dust(11), dust formationlz(12,13) or no dust at all(14). Here we report the rapid (40 to 240 days) formation of dust in its dense circumstellar medium. The wavelength-dependent extinction of this dust reveals the presence of very large (exceeding one micrometre) grains, which resist destruction(15). At later times (500 to 900 days), the near-infrared thermal emission shows an accelerated growth in dust mass, marking the transition of the dust source from the circumstellar medium to the ejecta. This provides the link between the early and late dust mass evolution in supernovae with dense circumstellar media.	[Gall, Christa] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark; [Gall, Christa; Hjorth, Jens; Watson, Darach; Maund, Justyn R.; Leloudas, Giorgos; Malesani, Daniele] Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen O, Denmark; [Gall, Christa; Dwek, Eli] NASA, Observat Cosmol Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Maund, Justyn R.] Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland; [Fox, Ori] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Leloudas, Giorgos] Stockholm Univ, Dept Phys, Oskar Klein Ctr, Albanova Univ Ctr, S-10691 Stockholm, Sweden; [Day-Jones, Avril C.] Univ Chile, Dept Astron, Santiago, Chile	Aarhus University; University of Copenhagen; Niels Bohr Institute; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Queens University Belfast; University of California System; University of California Berkeley; Oskar Klein Centre; Stockholm University; Universidad de Chile	Gall, C (corresponding author), Aarhus Univ, Dept Phys & Astron, Ny Munkegade 120, DK-8000 Aarhus C, Denmark.	cgall@phys.au.dk	Gall, Christa/P-7630-2016; Hjorth, Jens/M-5787-2014; Watson, Darach/E-4521-2015; Leloudas, Giorgos/E-4470-2015	Gall, Christa/0000-0002-8526-3963; Hjorth, Jens/0000-0002-4571-2306; Watson, Darach/0000-0002-4465-8264; Maund, Justyn/0000-0003-0733-7215; Leloudas, Giorgos/0000-0002-8597-0756; Dwek, Eli/0000-0001-8033-1181	ESO Telescopes at the La Silla paranal Observatory [084.C-0315(D), 087.C-0456(A)]; NASA Postdoctoral Program (NPP); Danish Agency for Science and Technology and Innovation; Swedish Research Council [623-2011-7117]; Proyecto Basal [PB06]; Joint Committee ESO-Government Chile; Danish National Research Foundation	ESO Telescopes at the La Silla paranal Observatory; NASA Postdoctoral Program (NPP)(National Aeronautics & Space Administration (NASA)); Danish Agency for Science and Technology and Innovation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Proyecto Basal(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Joint Committee ESO-Government Chile; Danish National Research Foundation(Danmarks Grundforskningsfond)	We thank L. Christensen and T. Frederiksen for advice on data reduction with the X-shooter pipeline and M. Stritzinger and R. Arendt for discussions. RESEARCH This investigation is based on observations made with ESO Telescopes at the La Silla paranal Observatory under programme ID numbers 084.C-0315(D) and 087.C-0456(A). C.G. was supported from the NASA Postdoctoral Program (NPP) and acknowledges funding provided by the Danish Agency for Science and Technology and Innovation. G.L. is supported by the Swedish Research Council through grant number 623-2011-7117. A.C.D.-J. is supported by the Proyecto Basal PB06 (CATA), and partially supported by the Joint Committee ESO-Government Chile. The Dark Cosmology Centre is funded by the Danish National Research Foundation.	Andrews JE, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/2/45; Benetti S., 2010, CBET, V2536, P1; Blinnikov S, 2000, ASTROPHYS J, V532, P1132, DOI 10.1086/308588; Brandt TD, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/129; D'Odorico S., 2006, SPIE C SERIES, V6269; Draine BT, 2009, ASTR SOC P, V414, P453; Dunne L, 2011, MON NOT R ASTRON SOC, V417, P1510, DOI 10.1111/j.1365-2966.2011.19363.x; DWEK E, 1983, ASTROPHYS J, V274, P175, DOI 10.1086/161435; Dwek E, 2008, ASTROPHYS J, V685, P976, DOI 10.1086/589988; Fox O, 2009, ASTROPHYS J, V691, P650, DOI 10.1088/0004-637X/691/1/650; Fransson C., 2013, PREPRINT; Frisch PC, 1999, ASTROPHYS J, V525, P492, DOI 10.1086/307869; Gall C, 2011, ASTRON ASTROPHYS REV, V19, P1, DOI 10.1007/s00159-011-0043-7; Gallagher JS, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/109; Gomez HL, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/96; Gordon KD, 2003, ASTROPHYS J, V594, P279, DOI 10.1086/376774; HORNE K, 1986, PUBL ASTRON SOC PAC, V98, P609, DOI 10.1086/131801; Indebetouw R, 2014, ASTROPHYS J LETT, V782, DOI 10.1088/2041-8205/782/1/L2; Jones AP, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201014440; Li AG, 2001, ASTROPHYS J, V554, P778, DOI 10.1086/323147; LUCY LB, 1989, LECT NOTES PHYS, V350, P164; Maeda K, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/5; Malesani D, 2009, ASTROPHYS J LETT, V692, pL84, DOI 10.1088/0004-637X/692/2/L84; MATHIS JS, 1977, ASTROPHYS J, V217, P425, DOI 10.1086/155591; Matsuura M, 2011, SCIENCE, V333, P1258, DOI 10.1126/science.1205983; Matsuura M, 2009, MON NOT R ASTRON SOC, V396, P918, DOI 10.1111/j.1365-2966.2009.14743.x; Mauerhan J, 2012, MON NOT R ASTRON SOC, V424, P2659, DOI 10.1111/j.1365-2966.2012.21325.x; Modigliani A., 2010, SPIE C SERIES, V7737; Newton J., 2010, CBET, V2532, P1; Ofek EO, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/1/42; Otsuka M, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/26; Pozzo M, 2004, MON NOT R ASTRON SOC, V352, P457, DOI 10.1111/j.1365-2966.2004.07951.x; Rauscher T, 2002, ASTROPHYS J, V576, P323, DOI 10.1086/341728; ROULEAU F, 1991, ASTROPHYS J, V377, P526, DOI 10.1086/170382; Sarangi A, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/107; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Silvia DW, 2010, ASTROPHYS J, V715, P1575, DOI 10.1088/0004-637X/715/2/1575; Smith N, 2008, ASTROPHYS J, V680, P568, DOI 10.1086/587860; Smith N, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/1/17; Soderberg AM, 2008, NATURE, V453, P469, DOI 10.1038/nature06997; Stoll R, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/34; Stritzinger M, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/173; Tolstov AG, 2013, MON NOT R ASTRON SOC, V429, P3181, DOI 10.1093/mnras/sts577; Van Dyk SD, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/5/118; Vernet J, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201117752; Zhang TM, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/5/131; Zubko V, 2004, ASTROPHYS J SUPPL S, V152, P211, DOI 10.1086/382351	47	144	145	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					326	+		10.1038/nature13558	http://dx.doi.org/10.1038/nature13558			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030169	Green Submitted			2022-12-28	WOS:000338992200030
J	Jha, AK; Zaslavsky, AM				Jha, Ashish K.; Zaslavsky, Alan M.			Quality Reporting That Addresses Disparities in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Zaslavsky, Alan M.] Harvard Univ, Sch Med, Dept Healthcare Policy, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu						Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Medicare Payment Advisory Commission, 2013, REP C MED HTLH CAR D, P91; National Quality Forum, 2014, RISK ADJ SOC STAT OT; Smedley B. D., 2003, UNEQUAL TREATMENT CO	4	60	60	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					225	226		10.1001/jama.2014.7204	http://dx.doi.org/10.1001/jama.2014.7204			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	25027134				2022-12-28	WOS:000338940300013
J	Jorgensen, ME; Torp-Pedersen, C; Gislason, GH; Jensen, PF; Berger, SM; Christiansen, CB; Overgaard, C; Schmiegelow, MD; Andersson, C				Jorgensen, Mads E.; Torp-Pedersen, Christian; Gislason, Gunnar H.; Jensen, Per Foge; Berger, Siv Mari; Christiansen, Christine Benn; Overgaard, Charlotte; Schmiegelow, Michelle D.; Andersson, Charlotte			Time Elapsed After Ischemic Stroke and Risk of Adverse Cardiovascular Events and Mortality Following Elective Noncardiac Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERIOPERATIVE STROKE; CARDIAC RISK; MYOCARDIAL-INFARCTION; OUTCOMES; ASSOCIATION; VALIDATION; PREDICTORS; GUIDELINES; MANAGEMENT; VALIDITY	IMPORTANCE The timing of surgery in patients with recent ischemic stroke is an important and inadequately addressed issue. OBJECTIVE To assess the safety and importance of time elapsed between stroke and surgery in the risk of perioperative cardiovascular events and mortality. DESIGN, SETTING, AND PARTICIPANTS Danish nationwide cohort study (2005-2011) including all patients aged 20 years or older undergoing elective noncardiac surgeries (n = 481 183 surgeries). EXPOSURES Time elapsed between stroke and surgery in categories and as a continuous measure. MAIN OUTCOMES AND MEASURES Risk of major adverse cardiovascular events (MACE; including ischemic stroke, acutemyocardial infarction, and cardiovascular mortality) and all-cause mortality up to 30 days after surgery. Odds ratios (ORs) were calculated by multivariable logistic regression models. RESULTS Crude incidence rates ofMACE among patients with (n = 7137) and without (n = 474 046) prior stroke were 54.4 (95% CI, 49.1-59.9) vs 4.1 (95% CI, 3.9-4.2) per 1000 patients. Compared with patients without stroke, ORs forMACE were 14.23 (95% CI, 11.61-17.45) for stroke less than 3 months prior to surgery, 4.85 (95% CI, 3.32-7.08) for stroke 3 to less than 6 months prior, 3.04 (95% CI, 2.13-4.34) for stroke 6 to less than 12 months prior, and 2.47 (95% CI, 2.07-2.95) for stroke 12 months or more prior. MACE risks were at least as high for low-risk (OR, 9.96; 95% CI, 5.49-18.07 for stroke < 3 months) and intermediate-risk (OR, 17.12; 95% CI, 13.68-21.42 for stroke < 3 months) surgery compared with high-risk surgery (OR, 2.97; 95% CI, 0.98-9.01 for stroke < 3 months) (P =.003 for interaction). Similar patterns were found for 30-day mortality: ORs were 3.07 (95% CI, 2.30-4.09) for stroke less than 3 months prior, 1.97 (95% CI, 1.22-3.19) for stroke 3 to less than 6 months prior, 1.45 (95% CI, 0.95-2.20) for stroke 6 to less than 12 months prior, and 1.46 (95% CI, 1.21-1.77) for stroke 12 months or more prior to surgery compared with patients without stroke. Cubic regression splines performed on the stroke subgroup supported that risk leveled off after 9 months. CONCLUSIONS AND RELEVANCE A history of stroke was associated with adverse outcomes following surgery, in particular if time between stroke and surgery was less than 9 months. After 9 months, the associated risk appeared stable yet still increased compared with patients with no stroke. The time dependency of risk may warrant attention in future guidelines. Copyright 2014 American Medical Association. All rights reserved.	[Jorgensen, Mads E.; Gislason, Gunnar H.; Berger, Siv Mari; Christiansen, Christine Benn; Schmiegelow, Michelle D.; Andersson, Charlotte] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark; [Torp-Pedersen, Christian; Overgaard, Charlotte] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Gislason, Gunnar H.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Gislason, Gunnar H.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Jensen, Per Foge] Univ Copenhagen, Rigshosp, Dept Cardiothorac Anesthesia, DK-2100 Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Aalborg University; University of Copenhagen; University of Southern Denmark; Rigshospitalet; University of Copenhagen	Jorgensen, ME (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hjertemedicinsk Forskning 1, DK-2900 Hellerup, Denmark.	mads.emil.joergensen@regionh.dk	Andersson, Charlotte/P-4849-2014; Gislason, Gunnar/B-7561-2009; Overgaard, Charlotte/D-8083-2011; Overgaard, Charlotte/Q-2032-2019	Gislason, Gunnar/0000-0002-0548-402X; Overgaard, Charlotte/0000-0002-3370-2338; Overgaard, Charlotte/0000-0002-3370-2338	Danish Agency for Science, Technology and Innovation [FSS-11-120873]; Novo Nordisk Foundation; University of Copenhagen	Danish Agency for Science, Technology and Innovation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); University of Copenhagen	Dr Andersson was funded by an independent research grant from the Danish Agency for Science, Technology and Innovation (grant FSS-11-120873). Dr Gislason is supported by an independent research scholarship from the Novo Nordisk Foundation. Dr Schmiegelow was funded by an independent research grant from the University of Copenhagen.	Andersson C, 2014, JAMA INTERN MED, V174, P336, DOI 10.1001/jamainternmed.2013.11349; Andersson C, 2012, JAMA-J AM MED ASSOC, V308, P882, DOI 10.1001/2012.jama.10779; Andersson C, 2010, ESSENTIAL DURER, P12; Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Bateman BT, 2009, ANESTHESIOLOGY, V110, P231, DOI 10.1097/ALN.0b013e318194b5ff; Boersma E, 2005, AM J MED, V118, P1134, DOI 10.1016/j.amjmed.2005.01.064; Bottle A, 2013, ANESTHESIOLOGY, V118, P885, DOI 10.1097/ALN.0b013e3182815912; Brilakis ES, 2007, J AM COLL CARDIOL, V49, P2145, DOI 10.1016/j.jacc.2007.02.046; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Fleisher LA, 2007, CIRCULATION, V116, pE418, DOI 10.1161/CIRCULATIONAHA.107.185699; Gaist D, 1997, DAN MED BULL, V44, P445; Hawn MT, 2013, JAMA-J AM MED ASSOC, V310, P1462, DOI 10.1001/jama.2013.278787; Hogue CW, 1999, CIRCULATION, V100, P642, DOI 10.1161/01.CIR.100.6.642; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Livhits M, 2011, ANN SURG, V253, P857, DOI 10.1097/SLA.0b013e3182125196; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Mashour GA, 2013, ANESTHESIOLOGY, V119, P1340, DOI 10.1097/ALN.0b013e318295a25f; Mashour GA, 2011, ANESTHESIOLOGY, V114, P1289, DOI 10.1097/ALN.0b013e318216e7f4; Ng JLW, 2011, ANESTHESIOLOGY, V115, P879, DOI 10.1097/ALN.0b013e31822e9499; NOMESCO N., 2009, NOMESCO CLASSIFICATI; Noordzij PG, 2010, ANESTHESIOLOGY, V112, P1105, DOI 10.1097/ALN.0b013e3181d5f95c; Poldermans D, 2009, EUR HEART J, V30, P2769, DOI 10.1093/eurheartj/ehp337; Sanders RD, 2012, ANN SURG, V255, P901, DOI 10.1097/SLA.0b013e31824c438d; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Sharifpour M, 2013, ANESTH ANALG, V116, P424, DOI 10.1213/ANE.0b013e31826a1a32; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; van Kuijk JP, 2009, AM J CARDIOL, V104, P1229, DOI 10.1016/j.amjcard.2009.06.038; Vicenzi MN, 2006, BRIT J ANAESTH, V96, P686, DOI 10.1093/bja/ael083	30	90	97	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					269	277		10.1001/jama.2014.8165	http://dx.doi.org/10.1001/jama.2014.8165			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	25027142	Bronze			2022-12-28	WOS:000338940300024
J	Tateno, Y; Adachi, K				Tateno, Yuki; Adachi, Kensuke			Sudden knee pain in an underweight, older woman: obturator hernia	LANCET			English	Editorial Material									[Tateno, Yuki; Adachi, Kensuke] Tokyo Metropolitan Tama Med Ctr, Dept Surg, Tokyo, Japan		Adachi, K (corresponding author), Tokyo Metropolitan Tama Med Ctr, Dept Surg, 2-8-29 Musashidai, Fuchu, Tokyo 1838524, Japan.	kensuke_adachi@tmhp.jp						Burt Bryan M, 2010, Am J Surg, V199, pe75, DOI 10.1016/j.amjsurg.2009.06.027; Losanoff JE, 2002, J AM COLL SURGEONS, V194, P657, DOI 10.1016/S1072-7515(02)01137-7; Nasir BS, 2012, HERNIA, V16, P315, DOI 10.1007/s10029-011-0895-9; Yip AW, 1993, SURGERY, V119, P266; Yokoyama Y, 1999, WORLD J SURG, V23, P214, DOI 10.1007/PL00013176	5	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					206	206		10.1016/S0140-6736(14)60883-7	http://dx.doi.org/10.1016/S0140-6736(14)60883-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1YC	25016996				2022-12-28	WOS:000338921500039
J	Young, KD				Young, Kevin D.			A flipping cell wall ferry	SCIENCE			English	Editorial Material							ESCHERICHIA-COLI; MURJ MVIN; LIPID II; FTSW; IDENTIFICATION; TRANSLOCATION; BIOSYNTHESIS; PRECURSORS; MEMBRANE; FLIPPASE		Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Young, KD (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, 4301 West Markham St, Little Rock, AR 72205 USA.	kdyoung@uams.edu			NIGMS NIH HHS [R01 GM061019] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061019] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ehlert K, 1996, J BACTERIOL, V178, P6766, DOI 10.1128/jb.178.23.6766-6771.1996; Fay A, 2009, J BACTERIOL, V191, P6020, DOI 10.1128/JB.00605-09; Hong YQ, 2014, J BACTERIOL, V196, P1713, DOI 10.1128/JB.01323-13; Islam ST, 2013, ENVIRON MICROBIOL, V15, P1001, DOI 10.1111/j.1462-2920.2012.02890.x; Lara B, 2005, FEMS MICROBIOL LETT, V250, P195, DOI 10.1016/j.femsle.2005.07.005; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Mohamed YF, 2014, GLYCOBIOLOGY, V24, P564, DOI 10.1093/glycob/cwu025; Mohammadi T, 2014, J BIOL CHEM, V289, P14707, DOI 10.1074/jbc.M114.557371; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P15553, DOI 10.1073/pnas.0808352105; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545	13	11	11	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					139	140		10.1126/science.1256585	http://dx.doi.org/10.1126/science.1256585			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013047				2022-12-28	WOS:000339409900022
J	Robertson, CS; Hannay, HJ; Yamal, JM; Gopinath, S; Goodman, JC; Tilley, BC				Robertson, Claudia S.; Hannay, H. Julia; Yamal, Jose-Miguel; Gopinath, Shankar; Goodman, J. Clay; Tilley, Barbara C.		Epo Severe TBI Trial Investigators	Effect of Erythropoietin and Transfusion Threshold on Neurological Recovery After Traumatic Brain Injury A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLASGOW OUTCOME SCALE; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; HEAD-INJURY; COMA SCALE; SURVIVAL; CARE; CLASSIFICATION; REQUIREMENTS; OXYGENATION	IMPORTANCE There is limited information about the effect of erythropoietin or a high hemoglobin transfusion threshold after a traumatic brain injury. OBJECTIVE To compare the effects of erythropoietin and 2 hemoglobin transfusion thresholds (7 and 10 g/dL) on neurological recovery after traumatic brain injury. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial of 200 patients (erythropoietin, n = 102; placebo, n = 98) with closed head injury who were unable to follow commands and were enrolled within 6 hours of injury at neurosurgical intensive care units in 2 US level I trauma centers between May 2006 and August 2012. The study used a factorial design to test whether erythropoietin would fail to improve favorable outcomes by 20% and whether a hemoglobin transfusion threshold of greater than 10 g/dL would increase favorable outcomes without increasing complications. Erythropoietin or placebo was initially dosed daily for 3 days and then weekly for 2 more weeks (n = 74) and then the 24- and 48-hour doses were stopped for the remainder of the patients (n = 126). There were 99 patients assigned to a hemoglobin transfusion threshold of 7 g/dL and 101 patients assigned to 10 g/dL. INTERVENTIONS Intravenous erythropoietin (500 IU/kg per dose) or saline. Transfusion threshold maintained with packed red blood cells. MAIN OUTCOMES AND MEASURES Glasgow Outcome Scale score dichotomized as favorable (good recovery and moderate disability) or unfavorable (severe disability, vegetative, or dead) at 6 months postinjury. RESULTS There was no interaction between erythropoietin and hemoglobin transfusion threshold. Compared with placebo (favorable outcome rate: 34/89 [38.2%; 95% CI, 28.1% to 49.1%]), both erythropoietin groups were futile (first dosing regimen: 17/35 [48.6%; 95% CI, 31.4% to 66.0%], P=.13; second dosing regimen: 17/57 [29.8%; 95% CI, 18.4% to 43.4%], P<.001). Favorable outcome rates were 37/87 (42.5%) for the hemoglobin transfusion threshold of 7 g/dL and 31/94 (33.0%) for 10 g/dL (95% CI for the difference, -0.06 to 0.25, P=.28). There was a higher incidence of thromboembolic events for the transfusion threshold of 10 g/dL (22/101 [21.8%] vs 8/99 [8.1%] for the threshold of 7 g/dL, odds ratio, 0.32 [95% CI, 0.12 to 0.79], P=.009). CONCLUSIONS AND RELEVANCE In patients with closed head injury, neither the administration of erythropoietin nor maintaining hemoglobin concentration of greater than 10 g/dL resulted in improved neurological outcome at 6 months. The transfusion threshold of 10 g/dL was associated with a higher incidence of adverse events. These findings do not support either approach in this setting.	[Robertson, Claudia S.; Gopinath, Shankar] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Hannay, H. Julia] Univ Houston, Dept Psychol, Houston, TX USA; [Yamal, Jose-Miguel; Tilley, Barbara C.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Biostat, Houston, TX 77030 USA; [Goodman, J. Clay] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; University of Houston System; University of Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine	Robertson, CS (corresponding author), Baylor Coll Med, Dept Neurosurg, One Baylor Plaza, Houston, TX 77030 USA.	claudiar@bcm.edu	Rivera-Lara, Lucia/AAX-8233-2020	Rivera-Lara, Lucia/0000-0002-9053-2283; Hannay, H. Julia/0000-0001-7023-912X; Benoit, Julia/0000-0002-2734-5477	National Institute of Neurological Disorders and Stroke [P01-NS38660]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038660] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grant P01-NS38660 from the National Institute of Neurological Disorders and Stroke.	Abrishamkar S, 2012, J RES MED SCI, V17, P51; [Anonymous], 2007, J NEUROTRAUMA S1, V24, pS1; [Anonymous], 2008, J NEUROTRAUMA, V25, P276; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; Figaji AA, 2010, PEDIATR CRIT CARE ME, V11, P325, DOI 10.1097/PCC.0b013e3181b80a8e; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Napolitano LM, 2008, J TRAUMA, V65, P285, DOI 10.1097/TA.0b013e31817f2c6e; Nirula R, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/209848; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Talving P, 2012, ARCH SURG-CHICAGO, V147, P251, DOI 10.1001/archsurg.2011.1838; Talving P, 2010, ANN SURG, V251, P1, DOI 10.1097/SLA.0b013e3181b844fa; Tango HK, 2010, J TRAUMA, V68, P251; Tango HK, 2009, J TRAUMA, V66, P1748; Tango HK, 2009, J TRAUMA, V66, P720, DOI 10.1097/TA.0b013e3181719b35; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tilley BC, 2006, NEUROLOGY, V66, P628, DOI 10.1212/01.wnl.0000201251.33253.fb; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	36	314	317	3	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					36	47		10.1001/jama.2014.6490	http://dx.doi.org/10.1001/jama.2014.6490			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	25058216	Green Accepted, Bronze			2022-12-28	WOS:000338131100019
J	Friedewald, SM; Rafferty, EA; Rose, SL; Durand, MA; Plecha, DM; Greenberg, JS; Hayes, MK; Copit, DS; Carlson, KL; Cink, TM; Barke, LD; Greer, LN; Miller, DP; Conant, EF				Friedewald, Sarah M.; Rafferty, Elizabeth A.; Rose, Stephen L.; Durand, Melissa A.; Plecha, Donna M.; Greenberg, Julianne S.; Hayes, Mary K.; Copit, Debra S.; Carlson, Kara L.; Cink, Thomas M.; Barke, Lora D.; Greer, Linda N.; Miller, Dave P.; Conant, Emily F.			Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE; POPULATION; TRIAL	IMPORTANCE Mammography plays a key role in early breast cancer detection. Single-institution studies have shown that adding tomosynthesis to mammography increases cancer detection and reduces false-positive results. OBJECTIVE To determine if mammography combined with tomosynthesis is associated with better performance of breast screening programs in the United States. DESIGN, SETTING, AND PARTICIPANTS Retrospective analysis of screening performance metrics from 13 academic and nonacademic breast centers using mixed models adjusting for site as a random effect. EXPOSURES Period 1: digital mammography screening examinations 1 year before tomosynthesis implementation (start dates ranged from March 2010 to October 2011 through the date of tomosynthesis implementation); period 2: digital mammography plus tomosynthesis examinations from initiation of tomosynthesis screening (March 2011 to October 2012) through December 31, 2012. MAIN OUTCOMES AND MEASURES Recall rate for additional imaging, cancer detection rate, and positive predictive values for recall and for biopsy. RESULTS A total of 454 850 examinations (n = 281 187 digital mammography; n = 173 663 digital mammography + tomosynthesis) were evaluated. With digital mammography, 29 726 patients were recalled and 5056 biopsies resulted in cancer diagnosis in 1207 patients (n = 815 invasive; n = 392 in situ). With digital mammography + tomosynthesis, 15 541 patients were recalled and 3285 biopsies resulted in cancer diagnosis in 950 patients (n = 707 invasive; n = 243 in situ). Model-adjusted rates per 1000 screens were as follows: for recall rate, 107 (95% CI, 89-124) with digital mammography vs 91 (95% CI, 73-108) with digital mammography + tomosynthesis; difference, -16 (95% CI, -18 to -14; P < .001); for biopsies, 18.1 (95% CI, 15.4-20.8) with digital mammography vs 19.3 (95% CI, 16.6-22.1) with digital mammography + tomosynthesis; difference, 1.3 (95% CI, 0.4-2.1; P = .004); for cancer detection, 4.2 (95% CI, 3.8-4.7) with digital mammography vs 5.4 (95% CI, 4.9-6.0) with digital mammography + tomosynthesis; difference, 1.2 (95% CI, 0.8-1.6; P < .001); and for invasive cancer detection, 2.9 (95% CI, 2.5-3.2) with digital mammography vs 4.1 (95% CI, 3.7-4.5) with digital mammography + tomosynthesis; difference, 1.2 (95% CI, 0.8-1.6; P < .001). The in situ cancer detection rate was 1.4 (95% CI, 1.2-1.6) per 1000 screens with both methods. Adding tomosynthesis was associated with an increase in the positive predictive value for recall from 4.3% to 6.4%(difference, 2.1%; 95% CI, 1.7%-2.5%; P < .001) and for biopsy from 24.2% to 29.2%(difference, 5.0%; 95% CI, 3.0%-7.0%; P < .001). CONCLUSIONS AND RELEVANCE Addition of tomosynthesis to digital mammography was associated with a decrease in recall rate and an increase in cancer detection rate. Further studies are needed to assess the relationship to clinical outcomes.	[Friedewald, Sarah M.] Advocate Lutheran Gen Hosp, Ctr Adv Care, Caldwell Breast Ctr, Park Ridge, IL 60068 USA; [Rafferty, Elizabeth A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Rose, Stephen L.] TOPS Comprehens Breast Ctr, Houston, TX USA; [Rose, Stephen L.] Solis Womens Hlth, Dallas, TX USA; [Durand, Melissa A.] Yale Univ, Sch Med, Dept Diagnost Radiol, Breast Imaging Sect, New Haven, CT 06510 USA; [Plecha, Donna M.] Univ Hosp Case Med Ctr, Dept Radiol, Cleveland, OH USA; [Greenberg, Julianne S.] Washington Radiol Associates, Fairfax, VA USA; [Hayes, Mary K.] Radiol Associates Hollywood, Hollywood, FL USA; [Hayes, Mary K.] Mem Healthcare Syst, Hollywood, FL USA; [Copit, Debra S.] Albert Einstein Healthcare Network, Dept Diagnost Radiol, Philadelphia, PA USA; [Carlson, Kara L.] Evergreen Hlth Breast Ctr, Kirkland, WA USA; [Carlson, Kara L.] Radia Inc, Kirkland, WA USA; [Cink, Thomas M.] Edith Sanford Breast Hlth Inst, Sioux Falls, SD USA; [Barke, Lora D.] Invis Sally Jobe Breast Ctr, Denver, CO USA; [Barke, Lora D.] Radiol Imaging Associates, Denver, CO USA; [Greer, Linda N.] John C Lincoln Breast Hlth & Res Ctr, Phoenix, AZ USA; [Miller, Dave P.] ICON Clin Res, San Francisco, CA USA; [Conant, Emily F.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA	Harvard University; Massachusetts General Hospital; Yale University; Case Western Reserve University; Case Western Reserve University Hospital; Yeshiva University; ICON plc; University of Pennsylvania; Pennsylvania Medicine	Friedewald, SM (corresponding author), Advocate Lutheran Gen Hosp, Ctr Adv Care, Caldwell Breast Ctr, Third Floor,1700 Luther Ln, Park Ridge, IL 60068 USA.	sarah.friedewald@advocatehealth.com		Plecha, Donna/0000-0003-1714-4337; Miller, Dave/0000-0003-2947-152X	Hologic; National Cancer Institute [5U54CA163316-03]	Hologic; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Drs Friedewald, Rafferty, Rose, Durand, Plecha, Greenberg, Hayes, Copit, Carlson, Cink, Barke, and Greer received a research grant from Hologic. Dr Conant received research grant 5U54CA163316-03 from the National Cancer Institute.	Andersson I, 2008, EUR RADIOL, V18, P2817, DOI 10.1007/s00330-008-1076-9; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Carney PA, 2010, RADIOLOGY, V255, P354, DOI 10.1148/radiol.10091636; Ciatto S, 2013, LANCET ONCOL, V14, P583, DOI 10.1016/S1470-2045(13)70134-7; Gur D, 2009, AM J ROENTGENOL, V193, P586, DOI 10.2214/AJR.08.2031; Haas BM, 2013, RADIOLOGY, V269, P694, DOI 10.1148/radiol.13130307; Park JM, 2007, RADIOGRAPHICS, V27, pS231, DOI 10.1148/rg.27si075511; Pisano ED, 2005, RADIOLOGY, V234, P353, DOI 10.1148/radiol.2342030897; Rafferty EA, 2013, RADIOLOGY, V266, P104, DOI 10.1148/radiol.12120674; Rose SL, 2013, AM J ROENTGENOL, V200, P1401, DOI 10.2214/AJR.12.9672; Rosenberg RD, 2006, RADIOLOGY, V241, P55, DOI 10.1148/radiol.2411051504; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Skaane P, 2013, RADIOLOGY, V267, P47, DOI 10.1148/radiol.12121373; Tabar L, 2011, RADIOLOGY, V260, P658, DOI 10.1148/radiol.11110469; US Food and Drug Administration, SEL DIM 3D SYST P080; US Food and Drug Administration, SEL DIM 3D SYST P008; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635	18	558	565	4	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2499	2507		10.1001/jama.2014.6095	http://dx.doi.org/10.1001/jama.2014.6095			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	25058084	Bronze			2022-12-28	WOS:000337757000023
J	Praetorius, SK; Mix, AC				Praetorius, Summer K.; Mix, Alan C.			Synchronization of North Pacific and Greenland climates preceded abrupt deglacial warming	SCIENCE			English	Article							LAST DEGLACIATION; OCEAN CIRCULATION; SEA-ICE; ATLANTIC; ACCUMULATION; OSCILLATIONS; VARIABILITY; ANTARCTICA; TOPOGRAPHY; HOLOCENE	Some proposed mechanisms for transmission of major climate change events between the North Pacific and North Atlantic predict opposing patterns of variations; others suggest synchronization. Resolving this conflict has implications for regulation of poleward heat transport and global climate change. New multidecadal-resolution foraminiferal oxygen isotope records from the Gulf of Alaska (GOA) reveal sudden shifts between intervals of synchroneity and asynchroneity with the North Greenland Ice Core Project (NGRIP) delta O-18 record over the past 18,000 years. Synchronization of these regions occurred 15,500 to 11,000 years ago, just prior to and throughout the most abrupt climate transitions of the last 20,000 years, suggesting that dynamic coupling of North Pacific and North Atlantic climates may lead to critical transitions in Earth's climate system.	[Praetorius, Summer K.; Mix, Alan C.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University	Praetorius, SK (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	spraetor@coas.oregonstate.edu			NSF [AGS-0602395, OCE-1204204]; Division Of Ocean Sciences [0962077, 1204204] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank B. Jensen and D. Froese for the tephra analyses; J. Southon for assistance with radiocarbon samples; A. Ross, J. Padman, and J. McKay of the College of Earth, Ocean and Atmospheric Sciences Stable Isotope Lab; and five anonymous reviewers. This work was supported by NSF grants AGS-0602395 (Project PALEOVAR) and OCE-1204204 to A. C. M., and an NSF graduate research fellowship to S. K. P. The data can be found in the supplementary online materials and at the National Oceanic and Atmospheric Administration Paleoclimate Database.	ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; Asahi H, 2007, PROG OCEANOGR, V72, P343, DOI 10.1016/j.pocean.2006.03.021; Bakke J, 2009, NAT GEOSCI, V2, P202, DOI 10.1038/NGEO439; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Barron JA, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000768; Broecker W, 2012, QUATERNARY SCI REV, V57, P17, DOI 10.1016/j.quascirev.2012.09.024; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; BROECKER WS, 1985, NATURE, V315, P21, DOI 10.1038/315021a0; Caissie BE, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001671; Chang EKM, 2004, J CLIMATE, V17, P4230, DOI 10.1175/JCLI3195.1; Clark PU, 2001, SCIENCE, V293, P283, DOI 10.1126/science.1062517; Cronin TM, 2010, QUATERNARY SCI REV, V29, P3415, DOI 10.1016/j.quascirev.2010.05.024; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Davies MH, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002051; Davies-Walczak M, 2014, EARTH PLANET SC LETT, V397, P57, DOI 10.1016/j.epsl.2014.04.004; Dyke AS, 2004, DEV QUA SCI, V2, P373, DOI 10.1016/S1571-0866(04)80209-4; Gebhardt H, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001513; Justino F, 2005, J CLIMATE, V18, P2826, DOI 10.1175/JCLI3403.1; KENNETT JP, 1995, NATURE, V377, P510, DOI 10.1038/377510a0; Lemieux-Dudon B, 2010, QUATERNARY SCI REV, V29, P8, DOI 10.1016/j.quascirev.2009.11.010; Lenton TM, 2012, CLIM PAST, V8, P1127, DOI 10.5194/cp-8-1127-2012; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Li C, 2009, CLIM DYNAM, V32, P753, DOI 10.1007/s00382-009-0529-4; Livina VN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028672; Lund DC, 1998, PALEOCEANOGRAPHY, V13, P10, DOI 10.1029/97PA02984; Max L, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002292; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Mix AC, 1999, GEOPH MONOG SERIES, V112, P127; Monnin E, 2004, EARTH PLANET SC LETT, V224, P45, DOI 10.1016/j.epsl.2004.05.007; Okazaki Y, 2010, SCIENCE, V329, P200, DOI 10.1126/science.1190612; Okumura YM, 2009, J CLIMATE, V22, P1424, DOI 10.1175/2008JCLI2511.1; Pausata FSR, 2011, CLIM PAST, V7, P1089, DOI 10.5194/cp-7-1089-2011; Pedro JB, 2011, CLIM PAST, V7, P671, DOI 10.5194/cp-7-671-2011; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Saenko OA, 2004, J CLIMATE, V17, P2033, DOI 10.1175/1520-0442(2004)017<2033:TAS>2.0.CO;2; Sarnthein M, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000771; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; SHAFFER G, 1994, NATURE, V367, P354, DOI 10.1038/367354a0; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; Timmermann A, 2004, CLIM DYNAM, V23, P353, DOI 10.1007/s00382-004-0434-9; Ullman DJ, 2014, CLIM PAST, V10, P487, DOI 10.5194/cp-10-487-2014; Waelbroeck C, 2001, NATURE, V412, P724, DOI 10.1038/35089060; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002; Wu LX, 2005, J CLIMATE, V18, P331, DOI 10.1175/JCLI-3264.1	46	63	63	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					444	448		10.1126/science.1252000	http://dx.doi.org/10.1126/science.1252000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061208				2022-12-28	WOS:000339655100041
J	Rohr, RP; Saavedra, S; Bascompte, J				Rohr, Rudolf P.; Saavedra, Serguei; Bascompte, Jordi			On the structural stability of mutualistic systems	SCIENCE			English	Article							FACILITATE BIODIVERSITY MAINTENANCE; GENERALIZED VOLTERRA TYPE; COEVOLUTIONARY NETWORKS; GLOBAL STABILITY; DISENTANGLING NESTEDNESS; ECOLOGICAL-SYSTEMS; ECOSYSTEMS; MODEL; COMMUNITIES; COMPETITION	In theoretical ecology, traditional studies based on dynamical stability and numerical simulations have not found a unified answer to the effect of network architecture on community persistence. Here, we introduce a mathematical framework based on the concept of structural stability to explain such a disparity of results. We investigated the range of conditions necessary for the stable coexistence of all species in mutualistic systems. We show that the apparently contradictory conclusions reached by previous studies arise as a consequence of overseeing either the necessary conditions for persistence or its dependence on model parameterization. We show that observed network architectures maximize the range of conditions for species coexistence. We discuss the applicability of structural stability to study other types of interspecific interactions.	[Rohr, Rudolf P.; Saavedra, Serguei; Bascompte, Jordi] CSIC, EBD, Integrat Ecol Grp, E-41092 Seville, Spain; [Rohr, Rudolf P.] Univ Fribourg, Dept Biol, Unit Ecol & Evolut, CH-1700 Fribourg, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Fribourg	Bascompte, J (corresponding author), CSIC, EBD, Integrat Ecol Grp, Calle Americo Vespucio S-N, E-41092 Seville, Spain.	bascompte@ebd.csic.es	Bascompte, Jordi/B-7596-2008; Rohr, Rudolf Philippe/K-9232-2015	Bascompte, Jordi/0000-0002-0108-6411; Rohr, Rudolf Philippe/0000-0002-6440-2696	European Research Council; FP7-REGPOT-2010-1 program [264125 EcoGenes]	European Research Council(European Research Council (ERC)European Commission); FP7-REGPOT-2010-1 program	We thank U. Bastolla, L.-F. Bersier, V. Dakos, A. Ferrera, M. A. Fortuna, L. J. Gilarranz, S. Kefi, J. Lever, B. Luque, A. M. Neutel, A. Pascual-Garcia, D. B. Stouffer, and J. Tylianakis for insightful discussions. We thank S. Baigent for pointing out the counter-example in (53). Funding was provided by the European Research Council through an Advanced Grant (J. B.) and FP7-REGPOT-2010-1 program under project 264125 EcoGenes (R.P.R.). The data are publicly available at www.web-of-life.es.	ALBERCH P, 1985, EVOLUTION, V39, P8, DOI 10.1111/j.1558-5646.1985.tb04076.x; Alberch P., 1989, GEOBIOS, V12, P21, DOI DOI 10.1016/S0016-6995(89)80006-3; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Arnold V.I., 1988, GEOMETRICAL METHODS, V2nd; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bastolla U, 2005, J THEOR BIOL, V235, P521, DOI 10.1016/j.jtbi.2005.02.005; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Case T. J., 2000, AN ILLUSTRATED GUIDE; CASE TJ, 1990, P NATL ACAD SCI USA, V87, P9610, DOI 10.1073/pnas.87.24.9610; CASE TJ, 1979, AM NAT, V113, P705, DOI 10.1086/283427; GOH BS, 1979, AM NAT, V113, P261, DOI 10.1086/283384; GOH BS, 1977, AM NAT, V111, P135, DOI 10.1086/283144; Holland JN, 2006, SCIENCE, V313, P1887, DOI 10.1126/science.1129547; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; James A, 2012, NATURE, V487, P227, DOI 10.1038/nature11214; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kolmogorov A., 1936, GIORNALE ISTITUTO DE, V7, P74; Kuznetsov Yu. A., 2004, ELEMENTS OF APPLIED; Logofet D. O., 1992, MATRICES AND GRAPHS; Logofet DO, 2005, LINEAR ALGEBRA APPL, V398, P75, DOI 10.1016/j.laa.2003.04.001; MACARTHUR R, 1970, Theoretical Population Biology, V1, P1, DOI 10.1016/0040-5809(70)90039-0; Margalef R, 1968, PERSPECTIVES IN ECOL; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCullagh P. N., 1989, GENERALIZED LINEAR M; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; Ollerton J, 2003, ANN BOT-LONDON, V92, P807, DOI 10.1093/aob/mcg206; Pimm SL, 2002, FOOD WEBS; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; ROBERTS A, 1974, NATURE, V251, P607, DOI 10.1038/251607a0; Rohr R. P., 2013, ARXIV 1310 4633; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Saavedra S, 2013, NATURE, V500, pE1, DOI 10.1038/nature12380; Saavedra S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3350; SOLE RV, 1992, J THEOR BIOL, V155, P87, DOI 10.1016/S0022-5193(05)80550-8; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Svirezhev Y. M., 1982, STABILITY OF BIOLOGI; TAKEUCHI Y, 1980, J MATH BIOL, V10, P401, DOI 10.1007/BF00276098; TAKEUCHI Y, 1978, MATH BIOSCI, V42, P119, DOI 10.1016/0025-5564(78)90010-X; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thom R., 1994, STRUCTURAL STABILITY; Thompson D. A. W., 1992, ON GROWTH AND FORM; Thompson JN, 2005, THE GEOGRAPHIC MOSAI; Turchin P, 1997, AM NAT, V149, P842, DOI 10.1086/286027; VANDERMEER J H, 1970, American Naturalist, V104, P73, DOI 10.1086/282641; VANDERMEER JH, 1975, SCIENCE, V188, P253, DOI 10.1126/science.1118725; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; WRIGHT DH, 1989, AM NAT, V134, P664, DOI 10.1086/285003	52	294	300	14	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					416	+		10.1126/science.1253497	http://dx.doi.org/10.1126/science.1253497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7PY	25061214	Green Submitted			2022-12-28	WOS:000349821000001
J	Stanley, TL; Feldpausch, MN; Oh, J; Branch, KL; Lee, H; Torriani, M; Grinspoon, SK				Stanley, Takara L.; Feldpausch, Meghan N.; Oh, Jinhee; Branch, Karen L.; Lee, Hang; Torriani, Martin; Grinspoon, Steven K.			Effect of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients With Abdominal Fat Accumulation A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE-RELEASING-FACTOR; GROWTH-HORMONE; RESONANCE-SPECTROSCOPY; LIPID QUANTIFICATION; INSULIN SENSITIVITY; GH REPLACEMENT; FACTOR ANALOG; DISEASE; OBESITY; DEFICIENCY	IMPORTANCE Among patients infected with human immunodeficiency virus (HIV), visceral adiposity is associated with metabolic dysregulation and ectopic fat accumulation. Tesamorelin, a growth hormone-releasing hormone analog, specifically targets visceral fat reduction but its effects on liver fat are unknown. OBJECTIVE To investigate the effect of tesamorelin on visceral and liver fat. DESIGN, SETTING, AND PATIENTS Double-blind, randomized, placebo-controlled trial conducted among 50 antiretroviral-treated HIV-infected men and women with abdominal fat accumulation at Massachusetts General Hospital in Boston. The first patient was enrolled on January 10,2011; for the final patient, the 6-month study visit was completed on September 6, 2013. INTERVENTIONS Participants were randomized to receive tesamorelin, 2 mg (n=28), or placebo (n=22), subcutaneously daily for 6 months. MAIN OUTCOMES AND MEASURES Primary end points were changes in visceral adipose tissue and liver fat. Secondary end points included glucose levels and other metabolic end points. RESULTS Forty-eight patients received treatment with study drug. Tesamorelin significantly reduced visceral adipose tissue (mean change, -34 cm(2) [95% Cl, -53 to -15 cm(2)] with tesamorelin vs 8 cm(2) [95% Cl, -14 to 30 cm(2)] with placebo; treatment effect, -42 cm(2) [95% Cl, -71 to -14 cm(2)]; P = .005) and liver fat (median change in lipid to water percentage, -2.0% [interquartile range {IQR}, -6.4% to 0.1%] with tesamorelin vs 0.9% [IQR, -0.6% to 3.7%] with placebo; P = .003) over 6 months, for a net treatment effect of -2.9% in lipid to water percentage. Fasting glucose increased in the tesamorelin group at 2 weeks (mean change, 9 mg/dL [95% Cl, 5-13 mg/dL] vs 2 mg/dL [95% Cl, -3 to 8 mg/dL] in the placebo group; treatment effect, 7 mg/dL [95% Cl, 1-14 mg/dL]; P = .03), but changes at 6 months in fasting glucose (mean change, 4 mg/dL [95% Cl, -2 to 10 mg/dL] with tesamorelin vs 2 mg/dL [95% Cl, -4 to 7 mg/dL] with placebo; treatment effect, 2 mg/dL [95% Cl, -6 to 10 mg/dL]; P = .72 overall across time points) and 2-hour glucose (mean change, -1 mg/dL [95% Cl, -18 to 15 mg/dL] vs -8 mg/dL [95% Cl, -24 to 8 mg/dL], respectively; treatment effect, 7 mg/dL [95% Cl, -16 to 29 mg/dL]; P = .53 overall across time points) were not significant. CONCLUSIONS AND RELEVANCE In this preliminary study of HIV-infected patients with abdominal fat accumulation, tesamorelin administered for 6 months was associated with reductions in visceral fat and additionally with modest reductions in liver fat. Further studies are needed to determine the clinical importance and long-term consequences of these findings.	[Stanley, Takara L.; Feldpausch, Meghan N.; Oh, Jinhee; Grinspoon, Steven K.] Massachusetts Gen Hosp, Program Nutr Metab, Boston, MA 02114 USA; [Stanley, Takara L.; Feldpausch, Meghan N.; Oh, Jinhee; Grinspoon, Steven K.] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA; [Stanley, Takara L.; Feldpausch, Meghan N.; Oh, Jinhee; Branch, Karen L.; Lee, Hang; Torriani, Martin; Grinspoon, Steven K.] Harvard Univ, Sch Med, Boston, MA USA; [Branch, Karen L.] Massachusetts Gen Hosp, Clin Res Ctr, Boston, MA 02114 USA; [Lee, Hang] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Torriani, Martin] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Grinspoon, SK (corresponding author), Massachusetts Gen Hosp, Program Nutr Metab, LON5 207,55 Fruit St, Boston, MA 02114 USA.	sgrinspoon@partners.org	Stanley, Takara/GYV-4488-2022	Stanley, Takara/0000-0002-2336-2958	National Institutes of Health grants [K23DK089910, R01DK063639]; National Center for Research Resources [M01-RR-01066, 1 UL1 RR025758-01]; Nutrition Obesity Research Center, Harvard University (National Institutes of Health grant) [P30 DK40561]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066, UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063639, P30DK040561, K23DK089910] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Nutrition Obesity Research Center, Harvard University (National Institutes of Health grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding/Support: Funding was provided by National Institutes of Health grants K23DK089910 to Dr Stanley and R01DK063639 to Dr Grinspoon and by grants M01-RR-01066 and 1 UL1 RR025758-01 to the Harvard Clinical and Translational Science Center from the National Center for Research Resources. The study was also supported in part by the Nutrition Obesity Research Center, Harvard University (National Institutes of Health grant P30 DK40561). Study drug was provided by Theratechnologies Inc.	BORKAN GA, 1982, AM J CLIN NUTR, V36, P172, DOI 10.1093/ajcn/36.1.172; Bredella MA, 2010, J COMPUT ASSIST TOMO, V34, P372, DOI 10.1097/RCT.0b013e3181cefb89; Chan RC, 2000, COMPUT CARDIOL, V27, P37, DOI 10.1109/CIC.2000.898449; Crum-Cianflone NF, 2011, HIV MED, V12, P463, DOI 10.1111/j.1468-1293.2010.00904.x; Crum-Cianflone N, 2009, JAIDS-J ACQ IMM DEF, V50, P464, DOI 10.1097/QAI.0b013e318198a88a; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Falutz J, 2005, AIDS, V19, P1279, DOI 10.1097/01.aids.0000180099.35146.30; Falutz J, 2008, AIDS, V22, P1719, DOI 10.1097/QAD.0b013e32830a5058; Falutz J, 2007, NEW ENGL J MED, V357, P2359, DOI 10.1056/NEJMoa072375; Falutz J, 2010, J CLIN ENDOCR METAB, V95, P4291, DOI 10.1210/jc.2010-0490; Gardner CJ, 2012, EUR J ENDOCRINOL, V166, P993, DOI 10.1530/EJE-12-0002; Georgoff P, 2012, AM J ROENTGENOL, V199, P2, DOI 10.2214/AJR.11.7384; Glesby MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061160; GOODMAN HM, 1963, ENDOCRINOLOGY, V72, P95, DOI 10.1210/endo-72-1-95; Guaraldi G, 2008, CLIN INFECT DIS, V47, P250, DOI 10.1086/589294; Hadigan C, 2007, JAIDS-J ACQ IMM DEF, V46, P312, DOI 10.1097/QAI.0b013e3181568cc2; He Q, 2012, 14 INT WORKSH COM AD; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Koutkia P, 2004, JAMA-J AM MED ASSOC, V292, P210, DOI 10.1001/jama.292.2.210; KRISKA AM, 1990, DIABETES CARE, V13, P401, DOI 10.2337/diacare.13.4.401; Lemieux S, 1996, AM J CLIN NUTR, V64, P685, DOI 10.1093/ajcn/64.5.685; Lo J, 2008, JAMA-J AM MED ASSOC, V300, P509, DOI 10.1001/jama.300.5.509; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; Nielsen S, 2001, DIABETES, V50, P2301, DOI 10.2337/diabetes.50.10.2301; Nishizawa H, 2012, EUR J ENDOCRINOL, V167, P67, DOI 10.1530/EJE-12-0252; Perseghin G, 2011, DIABETES CARE, V34, pS367, DOI 10.2337/dc11-s249; Schwarz JM, 2002, J CLIN ENDOCR METAB, V87, P942, DOI 10.1210/jc.87.2.942; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, P150, DOI 10.1210/jc.2010-1587; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; THAETE FL, 1995, INT J OBESITY, V19, P464; Torriani M, 2005, RADIOLOGY, V236, P609, DOI 10.1148/radiol.2362041661	34	55	57	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					380	389		10.1001/jama.2014.8334	http://dx.doi.org/10.1001/jama.2014.8334			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038357	Green Accepted, Bronze			2022-12-28	WOS:000339257800025
J	Marston, L; Sedgwick, P				Marston, Louise; Sedgwick, Philip			Randomised controlled trials: missing data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Marston, Louise] UCL, Dept Primary Care & Populat Hlth, London NW3 2PF, England; [Sedgwick, Philip] Univ London, Ctr Med & Healthcare Educ, London, England	University of London; University College London; St Georges University London; University of London	Marston, L (corresponding author), UCL, Dept Primary Care & Populat Hlth, London NW3 2PF, England.	l.marston@ucl.ac.uk	Marston, Louise/A-8535-2012; Sedgwick, Philip/C-6997-2019	Marston, Louise/0000-0002-9973-1131; Sedgwick, Philip/0000-0001-8859-2175				Jolly K, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6500; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1742	2	12	13	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 18	2014	349								g4656	10.1136/bmj.g4656	http://dx.doi.org/10.1136/bmj.g4656			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7PJ	25038075				2022-12-28	WOS:000339326500002
J	Hickman, AB; Ewis, HE; Li, XH; Knapp, JA; Laver, T; Doss, AL; Tolun, G; Steven, AC; Grishaev, A; Bax, A; Atkinson, PW; Craig, NL; Dyda, F				Hickman, Alison B.; Ewis, Hosam E.; Li, Xianghong; Knapp, Joshua A.; Laver, Thomas; Doss, Anna-Louise; Tolun, Goekhan; Steven, Alasdair C.; Grishaev, Alexander; Bax, Ad; Atkinson, Peter W.; Craig, Nancy L.; Dyda, Fred			Structural Basis of hAT Transposon End Recognition by Hermes, an Octameric DNA Transposase from Musca domestica	CELL			English	Article							X-RAY-SCATTERING; BINDING DOMAIN; SUBTERMINAL SEQUENCES; PUTATIVE TRANSPOSASE; V(D)J RECOMBINATION; AC ELEMENT; HOBO; ARABIDOPSIS; DROSOPHILA; REVEALS	Hermes is a member of the hAT transposon superfamily that has active representatives, including McClintock's archetypal Ac mobile genetic element, in many eukaryotic species. The crystal structure of the Hermes transposase-DNA complex reveals that Hermes forms an octameric ring organized as a tetramer of dimers. Although isolated dimers are active in vitro for all the chemical steps of transposition, only octamers are active in vivo. The octamer can provide not only multiple specific DNA-binding domains to recognize repeated subterminal sequences within the transposon ends, which are important for activity, but also multiple nonspecific DNA binding surfaces for target capture. The unusual assembly explains the basis of bipartite DNA recognition at hAT transposon ends, provides a rationale for transposon end asymmetry, and suggests how the avidity provided by multiple sites of interaction could allow a transposase to locate its transposon ends amidst a sea of chromosomal DNA.	[Hickman, Alison B.; Dyda, Fred] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Ewis, Hosam E.; Li, Xianghong; Craig, Nancy L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Knapp, Joshua A.; Atkinson, Peter W.] Univ Calif Riverside, Grad Program Biochem & Mol Biol, Riverside, CA 92521 USA; [Laver, Thomas; Atkinson, Peter W.] Univ Calif Riverside, Grad Program Genet Genom & Bioinformat, Riverside, CA 92521 USA; [Doss, Anna-Louise; Atkinson, Peter W.] Univ Calif Riverside, Grad Program Cell Mol & Dev Biol, Riverside, CA 92521 USA; [Atkinson, Peter W.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Atkinson, Peter W.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Tolun, Goekhan; Steven, Alasdair C.] NIAMSD, Struct Biol Res Lab, NIH, Bethesda, MD 20892 USA; [Grishaev, Alexander; Bax, Ad] NIDDK, Phys Chem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Howard Hughes Medical Institute; Johns Hopkins University; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Dyda, F (corresponding author), NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	fred.dyda@nih.gov	Wilson, Matthew H/K-3193-2013; TOLUN, Gökhan/D-1971-2012; Tolun, Gokhan/AAG-9606-2021	TOLUN, Gökhan/0000-0001-6166-9451; Tolun, Gokhan/0000-0001-6166-9451; Grishaev, Alexander/0000-0002-9347-2327	NIH Intramural Programs of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Public Health Service (PHS) award [A1045741]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036153] Funding Source: NIH RePORTER	NIH Intramural Programs of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Public Health Service (PHS) award; US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially funded by the NIH Intramural Programs of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (F.D. and A.B.) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (A.C.S.). P.W.A. and N.L.C. were funded by Public Health Service (PHS) award A1045741. Crystallographic data were collected at the SER-CAT 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory (ANL). For the SAXS experiments, we gratefully acknowledge use of the shared scattering beamline 12-IDC resource allocated under the PUP-77 agreement between the National Cancer Institute and ANL and thank Soenke Seifert (ANL) for his support. Use of the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38. We thank Sriram Subramaniam and members of his laboratory for their preliminary EM efforts. We also thank Nadine Samara for critical reading of the manuscript, Primrose Musingarimi for help with Sf9-expressed Hermes, Robert Hice for assistance with EMSA and insect cell culture experiments, and Susan Chacko of the Helix systems group, CIT, NIH for advice and help with fuzznuc.	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Arensburger P, 2011, GENETICS, V188, P45, DOI 10.1534/genetics.111.126813; ATKINSON PW, 1993, P NATL ACAD SCI USA, V90, P9693, DOI 10.1073/pnas.90.20.9693; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Becker HA, 1997, MOL GEN GENET, V254, P219, DOI 10.1007/s004380050410; Biemont C, 2010, GENETICS, V186, P1085, DOI 10.1534/genetics.110.124180; BLACKMAN RK, 1989, EMBO J, V8, P211, DOI 10.1002/j.1460-2075.1989.tb03366.x; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Dawson A, 2003, MOL CELL, V11, P225, DOI 10.1016/S1097-2765(02)00798-0; Gangadharan S, 2010, P NATL ACAD SCI USA, V107, P21966, DOI 10.1073/pnas.1016382107; Gao J, 2006, INSECT MOL BIOL, V15, P835, DOI 10.1111/j.1365-2583.2006.00690.x; Grishaev A, 2010, J AM CHEM SOC, V132, P15484, DOI 10.1021/ja106173n; Grundy GJ, 2009, MOL CELL, V35, P217, DOI 10.1016/j.molcel.2009.06.022; HALLET B, 1994, MOL MICROBIOL, V14, P131, DOI 10.1111/j.1365-2958.1994.tb01273.x; Hashida SN, 2006, PLANT CELL, V18, P104, DOI 10.1105/tpc.105.037655; HEHL R, 1991, PLANT MOL BIOL, V16, P369, DOI 10.1007/BF00020572; Hickman AB, 2010, CRIT REV BIOCHEM MOL, V45, P50, DOI 10.3109/10409230903505596; Huang CRL, 2012, ANNU REV GENET, V46, P651, DOI 10.1146/annurev-genet-110711-155616; Kahlon AS, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-9; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kim YJ, 2011, GENETICA, V139, P985, DOI 10.1007/s10709-011-9600-2; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; KUNZE R, 1989, EMBO J, V8, P3177, DOI 10.1002/j.1460-2075.1989.tb08476.x; Kunze R., 2002, MOBILE DNA, P565, DOI DOI 10.1128/9781555817954.CH24; LAVOIE BD, 1991, EMBO J, V10, P3051, DOI 10.1002/j.1460-2075.1991.tb07856.x; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Liu D, 1998, GENETICS, V149, P693; Liu D, 2001, GENETICS, V157, P817; Mack AM, 2001, PLANT CELL, V13, P2319, DOI 10.1105/tpc.13.10.2319; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Montano SP, 2012, NATURE, V491, P413, DOI 10.1038/nature11602; Oh J, 2006, J VIROL, V80, P451, DOI 10.1128/JVI.80.1.451-459.2006; Pribil PA, 2003, J MOL BIOL, V330, P247, DOI 10.1016/S0022-2836(03)00588-6; Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Rubin E, 2001, GENETICS, V158, P949; Sarkar A, 1997, GENETICA, V99, P15, DOI 10.1023/A:1018349803656; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; STRECK RD, 1986, EMBO J, V5, P3615, DOI 10.1002/j.1460-2075.1986.tb04690.x; VandenDriessche T, 2009, BLOOD, V114, P1461, DOI 10.1182/blood-2009-04-210427; WARREN WD, 1994, GENET RES, V64, P87, DOI 10.1017/S0016672300032699; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157	52	47	52	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					353	367		10.1016/j.cell.2014.05.037	http://dx.doi.org/10.1016/j.cell.2014.05.037			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036632	Green Accepted, Bronze			2022-12-28	WOS:000340943600015
J	Paton, NI; Kityo, C; Hoppe, A; Reid, A; Kambugu, A; Lugemwa, A; van Oosterhout, JJ; Kiconco, M; Siika, A; Mwebaze, R; Abwola, M; Abongomera, G; Mweemba, A; Alima, H; Atwongyeire, D; Nyirenda, R; Boles, J; Thompson, J; Tumukunde, D; Chidziva, E; Mambule, I; Arribas, JR; Easterbrook, PJ; Hakim, J; Walker, AS; Mugyenyi, P				Paton, Nicholas I.; Kityo, Cissy; Hoppe, Anne; Reid, Andrew; Kambugu, Andrew; Lugemwa, Abbas; van Oosterhout, Joep J.; Kiconco, Mary; Siika, Abraham; Mwebaze, Raymond; Abwola, Mary; Abongomera, George; Mweemba, Aggrey; Alima, Hillary; Atwongyeire, Dickens; Nyirenda, Rose; Boles, Justine; Thompson, Jennifer; Tumukunde, Dinah; Chidziva, Ennie; Mambule, Ivan; Arribas, Jose R.; Easterbrook, Philippa J.; Hakim, James; Walker, A. Sarah; Mugyenyi, Peter		EARNEST Trial Team	Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOPINAVIR-RITONAVIR MONOTHERAPY; LOPINAVIR/RITONAVIR MONOTHERAPY; INFECTED PATIENTS; MULTIPLE IMPUTATION; DARUNAVIR/RITONAVIR; RALTEGRAVIR; TRIAL	Background The efficacy and toxic effects of nucleoside reverse-transcriptase inhibitors (NRTIs) are uncertain when these agents are used with a protease inhibitor in second-line therapy for human immunodeficiency virus (HIV) infection in resource-limited settings. Removing the NRTIs or replacing them with raltegravir may provide a benefit. Methods In this open-label trial in sub-Saharan Africa, we randomly assigned 1277 adults and adolescents with HIV infection and first-line treatment failure to receive a ritonavir-boosted protease inhibitor (lopinavir-ritonavir) plus clinician-selected NRTIs (NRTI group, 426 patients), a protease inhibitor plus raltegravir in a superiority comparison (raltegravir group, 433 patients), or protease-inhibitor monotherapy after 12 weeks of induction therapy with raltegravir in a noninferiority comparison (monotherapy group, 418 patients). The primary composite end point, good HIV disease control, was defined as survival with no new World Health Organization stage 4 events, a CD4+ count of more than 250 cells per cubic millimeter, and a viral load of less than 10,000 copies per milliliter or 10,000 copies or more with no protease resistance mutations at week 96 and was analyzed with the use of imputation of data (<= 4%). Results Good HIV disease control was achieved in 60% of the patients (mean, 255 patients) in the NRTI group, 64% of the patients (mean, 277) in the raltegravir group (P = 0.21 for the comparison with the NRTI group; superiority of raltegravir not shown), and 55% of the patients (mean, 232) in the monotherapy group (noninferiority of monotherapy not shown, based on a 10-percentage-point margin). There was no significant difference in rates of grade 3 or 4 adverse events among the three groups (P = 0.82). The viral load was less than 400 copies per milliliter in 86% of patients in the NRTI group, 86% in the raltegravir group (P = 0.97), and 61% in the monotherapy group (P<0.001). Conclusions When given with a protease inhibitor in second-line therapy, NRTIs retained substantial virologic activity without evidence of increased toxicity, and there was no advantage to replacing them with raltegravir. Virologic control was inferior with protease-inhibitor monotherapy. (Funded by European and Developing Countries Clinical Trials Partnership and others; EARNEST Current Controlled Trials number, ISRCTN 37737787, and ClinicalTrials.gov number, NCT00988039.)	[Paton, Nicholas I.; Hoppe, Anne; Boles, Justine; Thompson, Jennifer; Walker, A. Sarah] UCL, Med Res Council Clin Trials Unit, London, England; [Paton, Nicholas I.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Kityo, Cissy; Tumukunde, Dinah; Mugyenyi, Peter] St Francis Nsambya Hosp, Joint Clin Res Ctr, Kampala, Uganda; [Kambugu, Andrew; Mambule, Ivan; Easterbrook, Philippa J.] St Francis Nsambya Hosp, Infect Dis Inst, Kampala, Uganda; [Mwebaze, Raymond] St Francis Nsambya Hosp, Kampala, Uganda; [Lugemwa, Abbas] JCRC, Mbarara, Uganda; [Kiconco, Mary] JCRC, Ft Portal, Uganda; [Abwola, Mary] JCRC, Mbale, Uganda; [Abongomera, George] JCRC, Gulu, Uganda; [Alima, Hillary] JCRC, Kabale, Uganda; [Atwongyeire, Dickens] JCRC, Kakira, Uganda; [Reid, Andrew; Chidziva, Ennie; Hakim, James] Univ Zimbabwe, Clin Res Ctr, Harare, Zimbabwe; [van Oosterhout, Joep J.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [van Oosterhout, Joep J.] Dignitas Int, Zomba, Malawi; [Nyirenda, Rose] Mzuzu Cent Hosp, Mzuzu, Malawi; [Siika, Abraham] Moi Univ, Sch Med, Eldoret, Kenya; [Mweemba, Aggrey] Univ Teaching Hosp, Lusaka, Zambia; [Arribas, Jose R.] Hosp La Paz, Madrid, Spain	Medical Research Council Clinical Trials Unit; University of London; University College London; National University of Singapore; Joint Clinic Research Center - United Arab Emirates; University of Zimbabwe; University of Malawi; Moi University; University of Zambia; Hospital Universitario La Paz	Paton, NI (corresponding author), Yong Loo Lin Sch Med, Dept Med, NUHS Tower Block Level 10,1E Kent Ridge Rd, Singapore 119228, Singapore.	nick_paton@nuhs.edu.sg	Walker, Sarah/HDM-8717-2022; Floridia, Marco/Q-6571-2017; Giuliano, Marina/V-8991-2017; Arribas, Jose/A-1595-2015	Floridia, Marco/0000-0003-3971-0141; Giuliano, Marina/0000-0003-2789-7797; Mambule, Ivan Kiggundu/0000-0002-0888-8695; Arribas, Jose/0000-0002-7410-9450; Abongomera, George/0000-0001-8794-3674; Rinaldi, Eugenia/0000-0003-0343-6400; Heyderman, Robert/0000-0003-4573-449X; Easterbrook, Philippa/0000-0002-2603-5418; begumya, mary kiconco/0000-0002-5976-1862; Kudzala, Aubrey/0000-0003-0393-1321; Arenas-Pinto, Alejandro/0000-0002-3368-5005; Thompson, Jennifer/0000-0002-3068-3952; Kiweewa, Francis/0000-0003-4938-9558; Colebunders, Robert/0000-0002-1919-1340; Castle, Lyndsey/0000-0002-9756-6064; Thomason, Margaret/0000-0003-3590-0140	European and Developing Countries Clinical Trials Partnership; National Institute for Health Research [PDF-2012-05-305, CL-2009-18-014] Funding Source: researchfish	European and Developing Countries Clinical Trials Partnership; National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by European and Developing Countries Clinical Trials Partnership and others; EARNEST Current Controlled Trials number, ISRCTN 37737787, and ClinicalTrials.gov number, NCT00988039.	Ajose O, 2012, AIDS, V26, P929, DOI 10.1097/QAD.0b013e328351f5b2; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; Arribas JR, 2009, JAIDS-J ACQ IMM DEF, V51, P147, DOI 10.1097/QAI.0b013e3181a56de5; Bartlett JA, 2012, AIDS, V26, P1345, DOI 10.1097/QAD.0b013e328353b066; Boyd MA, 2013, LANCET, V381, P2091, DOI 10.1016/S0140-6736(13)61164-2; Bunupuradah T, 2012, ANTIVIR THER, V17, P1351, DOI 10.3851/IMP2443; Cameron DW, 2008, J INFECT DIS, V198, P234, DOI 10.1086/589622; Casotti JAS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-306; Clumeck N, 2011, J ANTIMICROB CHEMOTH, V66, P1878, DOI 10.1093/jac/dkr199; Cooper A, 2013, NATURE, V498, P376, DOI 10.1038/nature12274; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Deeks SG, 2005, J INFECT DIS, V192, P1537, DOI 10.1086/496892; Delfraissy JFO, 2008, AIDS, V22, P385, DOI 10.1097/QAD.0b013e3282f3f16d; Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research, 2013, GUID IND HUM IMM VIR; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gilks CF, 2012, ANTIVIR THER, V17, P1363, DOI 10.3851/IMP2253; Humphreys EH, 2010, COCHRANE DB SYST REV, V6; Idem, 2010, GUID IND NON CLIN TR; Lifson AR, 2010, HIV CLIN TRIALS, V11, P205, DOI 10.1310/hct1104-205; Manasa J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072152; Manosuthi Weerawat, 2009, AIDS Res Ther, V6, P30, DOI 10.1186/1742-6405-6-30; National Institutes of Health Division of AIDS, 2004, DIV AIDS TABL GRAD S; Negredo E, 2013, J ANTIMICROB CHEMOTH, V68, P2358, DOI 10.1093/jac/dkt183; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Reynes J, 2013, AIDS RES HUM RETROV, V29, P256, DOI [10.1089/aid.2011.0275, 10.1089/AID.2011.0275]; Valantin MA, 2012, J ANTIMICROB CHEMOTH, V67, P691, DOI 10.1093/jac/dkr504; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; WHO, 2010, ANT THER HIV INF AD; WHO, 2013, GLOB UPD HIV TREATM; World Health Organization, 2006, WHO CAS DEF HIV SURV; Zoufaly A, 2011, J INFECT DIS, V203, P364, DOI 10.1093/jinfdis/jiq055	32	151	158	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2014	371	3					234	247		10.1056/NEJMoa1311274	http://dx.doi.org/10.1056/NEJMoa1311274			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL3BK	25014688	Green Published, Green Accepted			2022-12-28	WOS:000338999800007
J	Shaw, RJ; McDuffie, JR; Hendrix, CC; Edie, A; Lindsey-Davis, L; Nagi, A; Kosinski, AS; Williams, JW				Shaw, Ryan J.; McDuffie, Jennifer R.; Hendrix, Cristina C.; Edie, Alison; Lindsey-Davis, Linda; Nagi, Avishek; Kosinski, Andrzej S.; Williams, John W., Jr.			Effects of Nurse-Managed Protocols in the Outpatient Management of Adults With Chronic Conditions A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							ENHANCED DIABETES CARE; HEART-FAILURE; GLYCEMIC CONTROL; SPECIALIST NURSE; META-REGRESSION; HYPERTENSION; INTERVENTION; GUIDELINES; EDUCATION; PEOPLE	Background: Changes in federal health policy are providing more access to medical care for persons with chronic disease. Providing quality care may require a team approach, which the American College of Physicians calls the "medical home." One new model may involve nurse-managed protocols. Purpose: To determine whether nurse-managed protocols are effective for outpatient management of adults with diabetes, hypertension, and hyperlipidemia. Data Sources: MEDLINE, Cochrane Central Register of Controlled Trials, EMBASE, and CINAHL from January 1980 through January 2014. Study Selection: Two reviewers used eligibility criteria to assess all titles, abstracts, and full texts and resolved disagreements by discussion or by consulting a third reviewer. Data Extraction: One reviewer did data abstractions and quality assessments, which were confirmed by a second reviewer. Data Synthesis: From 2954 studies, 18 were included. All studies used a registered nurse or equivalent who titrated medications by following a protocol. In a meta-analysis, hemoglobin A1c level decreased by 0.4% (95% CI, 0.1% to 0.7%) (n = 8); systolic and diastolic blood pressure decreased by 3.68 mm Hg (CI, 1.05 to 6.31 mm Hg) and 1.56 mm Hg (CI, 0.36 to 2.76 mm Hg), respectively (n = 12); total cholesterol level decreased by 0.24 mmol/L (9.37 mg/dL) (CI, 0.54-mmol/L decrease to 0.05-mmol/L increase [20.77-mg/dL decrease to 2.02-mg/dL increase]) (n = 9); and low-density-lipoprotein cholesterol level decreased by 0.31 mmol/L (12.07 mg/dL) (CI, 0.73-mmol/L decrease to 0.11-mmol/L increase [28.27-mg/dL decrease to 4.13-mg/dL increase]) (n = 6). Limitation: Studies had limited descriptions of the interventions and protocols used. Conclusion: A team approach that uses nurse-managed protocols may have positive effects on the outpatient management of adults with chronic conditions, such as diabetes, hypertension, and hyperlipidemia.	Durham Vet Affairs Ctr Hlth Serv Res Primary Care, Durham, NC USA; Durham Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Durham, NC 27701 USA; Duke Univ, Durham, NC 27701 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Shaw, RJ (corresponding author), Hlth Serv Res & Dev 152, 411 West Chapel Hill St,Suite 600, Durham, NC 27701 USA.	ryan.shaw@duke.edu	Williams, John/AAM-4572-2020; Davis, Linda Lindsey/T-7351-2019	Williams, John/0000-0002-5267-5558; 	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development (VA-ESP) [09-010]; Department of Veterans Affairs Health Services Research and Development Office of Academic Affiliations nursing postdoctoral research award [TPP-21-021]	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development (VA-ESP)(US Department of Veterans Affairs); Department of Veterans Affairs Health Services Research and Development Office of Academic Affiliations nursing postdoctoral research award(US Department of Veterans Affairs)	This report is based on research conducted by the Evidence-based Synthesis Program (ESP) Center located at the Durham Veterans Affairs Medical Center, Durham, North Carolina, which is funded by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development (VA-ESP Project 09-010; 2013). The first author, Dr. Ryan Shaw, was supported by a Department of Veterans Affairs Health Services Research and Development Office of Academic Affiliations nursing postdoctoral research award (TPP-21-021).	Agency for Healthcare Research and Quality, 2013, METHODS GUIDE FOR EF; Allen JK, 2010, J CARDIOVASC NURS, V25, P207, DOI 10.1097/JCN.0b013e3181cc79be; Allison TG, 1999, MAYO CLIN PROC, V74, P466; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Arnold M, 2011, J CARD FAIL, V17, pS109, DOI 10.1016/j.cardfail.2011.06.367; Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; Bebb C, 2007, BRIT J GEN PRACT, V57, P136; Bellary S, 2008, LANCET, V371, P1769, DOI 10.1016/S0140-6736(08)60764-3; Berra K, 2011, J CARDIOVASC NURS, V26, P145, DOI 10.1097/JCN.0b013e3181ec1337; BROWN SA, 1992, RES NURS HEALTH, V15, P409, DOI 10.1002/nur.4770150603; Chakeabarti S, 2010, J CARD FAIL, V16, pS53, DOI 10.1016/j.cardfail.2010.04.004; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clark CE, 2011, DIABETIC MED, V28, P250, DOI 10.1111/j.1464-5491.2010.03204.x; Clark CE, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3995; DEBUSK RF, 1994, ANN INTERN MED, V120, P721, DOI 10.7326/0003-4819-120-9-199405010-00001; Denver EA, 2003, DIABETES CARE, V26, P2256, DOI 10.2337/diacare.26.8.2256; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dorr DA, 2008, J AM GERIATR SOC, V56, P2195, DOI 10.1111/j.1532-5415.2008.02005.x; Driscoll A, 2012, COCHRANE DB SYST REV; Fahey T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub3; Fischer HH, 2012, AM J MANAG CARE, V18, P77; Gillespie C., 2011, Morbidity and Mortality Weekly Report, V60, P103; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Haskell William L, 2003, J Cardiovasc Nurs, V18, P245; Houweling ST, 2009, NETH J MED, V67, P279; Houweling ST, 2011, J CLIN NURS, V20, P1264, DOI 10.1111/j.1365-2702.2010.03562.x; Institute of Medicine, 2012, LIVING WELL WITH CHR; Jessup M, 2011, J CARD FAIL, V17, P349, DOI 10.1016/j.cardfail.2011.04.001; Joseph Philip, 2011, Curr Cardiol Rep, V13, P287, DOI 10.1007/s11886-011-0190-5; Klein S, 2011, THE VETERANS HEALTH; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Konstam V, 2011, J CARD FAIL, V17, P151, DOI 10.1016/j.cardfail.2010.08.012; Loveman E, 2003, Cochrane Database Syst Rev, pCD003286; Martinez AS, 2013, AM J HEALTH-SYST PH, V70, P1070, DOI 10.2146/ajhp120267; Meulepas MA, 2008, QUAL SAF HEALTH CARE, V17, P324, DOI 10.1136/qshc.2006.021204; New JP, 2004, DIABETIC MED, V21, P599, DOI 10.1111/j.1464-5491.2004.01213.x; New JP, 2003, DIABETES CARE, V26, P2250, DOI 10.2337/diacare.26.8.2250; Newhouse RR, 2011, NURS ECON, V29, P230; Nichol MB, 2010, J AM PHARM ASSOC, V50, P496, DOI 10.1331/JAPhA.2010.09123; O'Hare JP, 2004, DIABETIC MED, V21, P1357, DOI 10.1111/j.1464-5491.2004.01373.x; Philis-Tsimikas A, 2004, DIABETES CARE, V27, P110, DOI 10.2337/diacare.27.1.110; Rao A, 2007, INT J CARDIOL, V115, P196, DOI 10.1016/j.ijcard.2006.03.010; Rudd P, 2004, AM J HYPERTENS, V17, P921, DOI 10.1016/j.amjhyper.2004.06.006; Senaratne MPJ, 2001, AM HEART J, V142, P975, DOI 10.1067/mhj.2001.118739; Shafazand S, 2010, CLIN THER, V32, P1642, DOI 10.1016/j.clinthera.2010.08.002; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Smith SC, 2000, AM J CARDIOL, V86, p62L; Stanley JM, 2011, ADVANCED PRACTICE NU; Taylor CB, 2003, DIABETES CARE, V26, P1058, DOI 10.2337/diacare.26.4.1058; Tone JM, 2009, IRISH J MED SCI, V178, P179, DOI 10.1007/s11845-009-0316-6; Tshiananga JKT, 2012, DIABETES EDUCATOR, V38, P108, DOI 10.1177/0145721711423978; Varney S, 2001, EUR J HEART FAIL, V3, P365, DOI 10.1016/S1388-9842(01)00132-5; Wallymahmed ME, 2011, DIABETIC MED, V28, P373, DOI 10.1111/j.1464-5491.2010.03224.x; Welch G, 2010, DIABETES RES CLIN PR, V88, P1, DOI 10.1016/j.diabres.2009.12.026; Wilhelmsson Susan, 2007, Int J Nurs Pract, V13, P254, DOI 10.1111/j.1440-172X.2007.00635.x; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616	56	67	68	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2					113	+		10.7326/M13-2567	http://dx.doi.org/10.7326/M13-2567			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM3PJ	25023250				2022-12-28	WOS:000339764600020
J	Nandhagopal, R				Nandhagopal, R.			PICTURE QUIZ Focal neurological deficits after trauma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISSECTION; STROKE		Coll Med & Hlth Sci, Dept Neurol, SQU, Muscat 123, Oman		Nandhagopal, R (corresponding author), Coll Med & Hlth Sci, Dept Neurol, SQU, POB 35, Muscat 123, Oman.	rnandagopal@yahoo.com		Ramachandiran, Nandhagopal/0000-0002-2379-0055				Baumgartner RW, 2005, FRONT NEUROL NEUROSC, V20, P70, DOI 10.1159/000088151; DuBose J, 2008, J TRAUMA, V65, P1561, DOI 10.1097/TA.0b013e31817fd954; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Latchaw RE, 2009, STROKE, V40, P3646, DOI 10.1161/STROKEAHA.108.192616; Srinivasan A, 2006, RADIOGRAPHICS, V26, pS75, DOI 10.1148/rg.26si065501; Touze E, 2001, STROKE, V32, P418, DOI 10.1161/01.STR.32.2.418; Zinkstok SM, 2011, STROKE, V42, P2515, DOI 10.1161/STROKEAHA.111.617282	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2014	349								g4520	10.1136/bmj.g4520	http://dx.doi.org/10.1136/bmj.g4520			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7OP	25022348				2022-12-28	WOS:000339324300003
J	Kerrigan, D; Kennedy, CE; Morgan-Thomas, R; Reza-Paul, S; Mwangi, P; Win, KT; McFall, A; Fonner, VA; Butler, J				Kerrigan, Deanna; Kennedy, Caitlin E.; Morgan-Thomas, Ruth; Reza-Paul, Sushena; Mwangi, Peninah; Win, Kay Thi; McFall, Allison; Fonner, Virginia A.; Butler, Jennifer			A community empowerment approach to the HIV response among sex workers: effectiveness, challenges, and considerations for implementation and scale-up	LANCET			English	Article							TRANSMITTED INFECTIONS STIS; CONDOM USE; SOUTH-INDIA; PREVENTION PROJECT; ANDHRA-PRADESH; HIV/AIDS PREVENTION; KARNATAKA STATE; FEMALE; INTERVENTION; HEALTH	A community empowerment-based response to HIV is a process by which sex workers take collective ownership of programmes to achieve the most effective HIV outcomes and address social and structural barriers to their overall health and human rights. Community empowerment has increasingly gained recognition as a key approach for addressing HIV in sex workers, with its focus on addressing the broad context within which the heightened risk for infection takes places in these individuals. However, large-scale implementation of community empowerment-based approaches has been scarce. We undertook a comprehensive review of community empowerment approaches for addressing HIV in sex workers. Within this effort, we did a systematic review and meta-analysis of the effectiveness of community empowerment in sex workers in low-income and middle-income countries. We found that community empowerment-based approaches to addressing HIV among sex workers were significantly associated with reductions in HIV and other sexually transmitted infections, and with increases in consistent condom use with all clients. Despite the promise of a community-empowerment approach, we identified formidable structural barriers to implementation and scale-up at various levels. These barriers include regressive international discourses and funding constraints; national laws criminalising sex work; and intersecting social stigmas, discrimination, and violence. The evidence base for community empowerment in sex workers needs to be strengthened and diversified, including its role in aiding access to, and uptake of, combination interventions for HIV prevention. Furthermore, social and political change are needed regarding the recognition of sex work as work, both globally and locally, to encourage increased support for community empowerment responses to HIV.	[Kerrigan, Deanna; Kennedy, Caitlin E.; McFall, Allison; Fonner, Virginia A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Morgan-Thomas, Ruth] Global Network Sex Work Projects NSWP, Edinburgh, Midlothian, Scotland; [Reza-Paul, Sushena] Univ Manitoba, Winnipeg, MB, Canada; [Win, Kay Thi] Asia Pacific Network Sex Workers, Bangkok, Thailand; [Mwangi, Peninah] Bar Hostess Empowerment & Support Program, Nairobi, Kenya; [Butler, Jennifer] UN Populat Fund, New York, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Manitoba; United Nations Population Fund	Kerrigan, D (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	dkerrig1@jhu.edu		McFall, Allison/0000-0002-1157-2931; Fonner, Virginia/0000-0002-9005-3549	Center for Public Health and Human Rights (Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA) from The Bill & Melinda Gates Foundation; UN Population Fund; Johns Hopkins University Center for AIDS Research-a programme - National Institutes of Health (NIH) [1P30AI094189]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Center for Public Health and Human Rights (Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA) from The Bill & Melinda Gates Foundation; UN Population Fund; Johns Hopkins University Center for AIDS Research-a programme - National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all the sex workers who led and participated in the research and programmatic efforts which form the basis for this analysis; Gina Dallabetta for her assistance clarifying information about data from the Avahan project; Andrea Blanchard, Kim Blankenship, and Mandar Mainkar for providing additional information about their articles included in the systematic review; and the experts and members of the Network of Sex Work Projects (NSWP) listserv who responded to our requests for relevant articles and reports; Laura Murray for her help developing the Brazil case study; and the editorial and technical team of The Lancet Series on HIV and sex workers and the peer reviewers for their helpful comments and suggestions. This report and The Lancet Series on HIV and sex workers was supported by grants to the Center for Public Health and Human Rights (Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA) from The Bill & Melinda Gates Foundation, The UN Population Fund, and the Johns Hopkins University Center for AIDS Research-a programme funded by National Institutes of Health (NIH; 1P30AI094189), which is supported by the following NIH co-funding and participating institutes and centres: National Institutes of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), National Institute for Child Health and Development (NICHD), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Mental Health (NIMH), National Institute for Drug Abuse (NIDA), Fogarty International Center (FIC), and Office of AIDS Research (OAR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adhikary R, 2012, INDIAN J MED RES, V136, P5; Ahmed A, 2011, GLOB PUBLIC HEALTH, V6, pS357, DOI 10.1080/17441692.2011.623136; [Anonymous], 2013, RED RIBB AW; [Anonymous], 2012, 19 INT AIDS C WASH D; Argento E, 2011, AIDS CARE, V23, P69, DOI 10.1080/09540121.2010.498868; Arnott J, 2008, RIGHTS NOT RESCUE RE; Asthana S, 1996, SOC SCI MED, V43, P133, DOI 10.1016/0277-9536(95)00348-7; Bandewar SVS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-630; Bandyopadhyay N, 2004, ROLE COMMUNITY DEV A; Basu A, 2008, QUAL HEALTH RES, V18, P106, DOI 10.1177/1049732307309373; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; Beattie TSH, 2012, J EPIDEMIOL COMMUN H, V66, pII42, DOI 10.1136/jech-2011-200475; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Benzaken AS, 2007, REV SAUDE PUBL, V41; Beyrer C, 2011, JAIDS-J ACQ IMM DEF, V57, pS96, DOI 10.1097/QAI.0b013e31821db944; Bill & Melinda Gates Foundation, 2009, POW TACKL VIOL AV EX; Biradavolu MR, 2012, J EPIDEMIOL COMMUN H, V66, pII95, DOI 10.1136/jech-2011-200508; Biradavolu MR, 2009, SOC SCI MED, V68, P1541, DOI 10.1016/j.socscimed.2009.01.040; Bishakha D, 2009, AINT I WOMAN GLOBAL; Blanchard AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-234; Blankenship KA, 2008, AIDS, V22, pS109, DOI 10.1097/01.aids.0000343769.92949.dd; Blankenship KM, 2010, AIDS CARE, V22, P1629, DOI 10.1080/09540121.2010.516342; Boily MC, 2013, AIDS, V27, P1449, DOI 10.1097/QAD.0b013e32835fba81; Brown, 2021, PEOPLE MANAGEMENT; Busza J, 2001, REPROD HEALTH MATTER, V9, P72, DOI 10.1016/S0968-8080(01)90010-2; Campbell C, 2001, AM J PUBLIC HEALTH, V91, P1978, DOI 10.2105/AJPH.91.12.1978; Campbell C, 2012, AIDS BEHAV, V16, P847, DOI 10.1007/s10461-011-9966-2; Chakrapani V, 2009, AIDS PATIENT CARE ST, V23, P973, DOI 10.1089/apc.2009.0035; Chattopadhyay A, 2004, AIDS PATIENT CARE ST, V18, P159, DOI 10.1089/108729104322994847; Conecta Project, 2012, STRENGTH HIV STI INT; Cornish F, 2007, SOC SCI MED, V64, P496, DOI 10.1016/j.socscimed.2006.09.009; Cornish F, 2006, J COMMUNITY APPL SOC, V16, P301, DOI 10.1002/casp.866; Cornish F, 2012, HEALTH PLACE, V18, P468, DOI 10.1016/j.healthplace.2011.08.018; de Souza R, 2009, HEALTH COMMUN, V24, P692, DOI 10.1080/10410230903264006; Decker MR, 2012, SEX TRANSM INFECT, V88, P278, DOI 10.1136/sextrans-2011-050171; Decker MR, 2014, LANCET; Deering KN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S8; Diabate S, 2011, WORLD J AIDS, V1, P94, DOI [10.4236/wja.2011.13014, DOI 10.4236/WJA.2011.13014]; Ditmore MH, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17354; Dixon V, 2012, GLOB PUBLIC HEALTH, V7, P779, DOI 10.1080/17441692.2012.668918; Durbar Mahila Samanwaya Committee, MICR; Erausquin JT, 2012, J EPIDEMIOL COMMUN H, V66, pII49, DOI 10.1136/jech-2011-200511; Gangopadhyay DN, 2005, SEX TRANSM DIS, V32, P680, DOI 10.1097/01.olq.0000175399.43457.28; Ghimire L., 2009, GLOBAL J HLTH SCI, V1, P12, DOI DOI 10.5539/gjhs.v1n1p12; Greenall M, 2009, STRENGTHENING GLOBAL; Guha M, 2012, J EPIDEMIOL COMMUN H, V66, pII55, DOI 10.1136/jech-2011-200562; Gutierrez JB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-497; Halli SS, 2006, AIDS CARE, V18, P739, DOI 10.1080/09540120500466937; Huet C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-700; INDOORS, 2012, CAP BUILD AW RAIS EU; Jana S, 1998, AIDS, V12 Suppl B, pS101; Jeffreys Elena, 2011, INTERFACE, V3, P271; Jenkins Carol, 2000, FEMALE SEX WORKER HI; Karnataka Health Promotion Trust, 2008, COMM MOB FEM SEX WOR; Kennedy C., 2013, EXPLORING POSITIVE H; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; Kerrigan D, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9774-9; Kerrigan D, 2008, HEALTH EDUC RES, V23, P137, DOI 10.1093/her/cym011; Kerrigan DL, 2013, AIDS BEHAV, V17, P1926, DOI 10.1007/s10461-013-0458-4; Klein CH, 1998, SEXUALITIES, V1, P327; Laga M, 2010, SEX TRANSM INFECT, V86, pI6, DOI 10.1136/sti.2009.039255; Leuridan E, 2012, LANCET, V380, P1230, DOI 10.1016/S0140-6736(12)61716-4; Lippman SA, 2012, SEX TRANSM DIS, V39, P209, DOI 10.1097/OLQ.0b013e31823b1937; Lippman SA, 2010, SEX TRANSM DIS, V37, P512, DOI 10.1097/OLQ.0b013e3181d73feb; Lippman SA, 2010, AM J PUBLIC HEALTH, V100, pS216, DOI 10.2105/AJPH.2008.147462; Mainkar MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S2; Malaria TGFtFATa, 2011, GLOB FUND HIV INV SP; McLemore M., 2012, SEX WORKERS RISK CON; Michael E, 2011, SEX TRANSM INFECT, V87, pA235, DOI 10.1136/sextrans-2011-050108.318; Miller A, 2006, FOSTERING ENABLING L; Misra G, 2000, HEALTH HUM RIGHTS, V5, P89; Mtetwa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-698; Narayanan P, 2012, J EPIDEMIOL COMMUN H, V66, pII34, DOI 10.1136/jech-2012-201065; Newman PA, 2003, WOMENS STUDIES Q, V31, P168; O'Brien NC, 2007, MOVING PARADIGM PRAC; Park M, 2011, AM J EPIDEMIOL, V173, pS223; Pathfinder International Advocacy Programs, 2006, ANT LOYALT OATH UND; Pimenta C., 2010, SEXUALITY DEV BRAZIL; Rachakulla HK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S1; Ramakrishnan L, 2010, SEX TRANSM INFECT, V86, pI62, DOI 10.1136/sti.2009.038760; Ramesh BM, 2010, SEX TRANSM INFECT, V86, pI17, DOI 10.1136/sti.2009.038513; Reed E, 2010, PUBLIC HEALTH REP, V125, P81, DOI 10.1177/00333549101250S412; Reza-Paul S, 2008, AIDS, V22, pS91, DOI 10.1097/01.aids.0000343767.08197.18; Scambler G, 2008, SOC SCI MED, V66, P1848, DOI 10.1016/j.socscimed.2008.01.002; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Scorgie F, 2011, I EXPECT ABUSED I HA; Scorgie F, 2013, CULT HEALTH SEX, V15, P450, DOI 10.1080/13691058.2012.763187; Shannon K, 2005, J URBAN HEALTH, V82, P488, DOI 10.1093/jurban/jti076; Shinana A, 2012, 5 AFR C SEX HLTH RIG; Swain SN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-357; The Synergy Project University of Washington Center for Health Education and Research, 2003, ROOM CHANG PREV HIV; Thilakavathi S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S3; UNAIDS, 2012, UNAIDS GUID NOT HIV; UNDP/UNAIDS, 2012, UND ACT CRIT EN DEV; Wheeler T, 2012, J EPIDEMIOL COMMUN H, V66, pII16, DOI 10.1136/jech-2012-201081; Wirtz AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088047; World Health Organization, 2013, IMPL COMPR HIV STI P; Wurth MH, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18626	98	189	189	8	61	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2015	385	9963					172	185		10.1016/S0140-6736(14)60973-9	http://dx.doi.org/10.1016/S0140-6736(14)60973-9			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY7BI	25059938	Green Accepted			2022-12-28	WOS:000347715900025
J	Collet, JP; Silvain, J; Barthelemy, O; Range, G; Cayla, G; Van Belle, E; Cuisset, T; Elhadad, S; Schiele, F; Lhoest, N; Ohlmann, P; Carrie, D; Rousseau, H; Aubry, P; Monsegu, J; Sabouret, P; O'Connor, SA; Abtan, J; Kerneis, M; Saint-Etienne, C; Beygui, F; Vicaut, E; Montalescot, G				Collet, Jean-Philippe; Silvain, Johanne; Barthelemy, Olivier; Range, Gregoire; Cayla, Guillaume; Van Belle, Eric; Cuisset, Thomas; Elhadad, Simon; Schiele, Francois; Lhoest, Nicolas; Ohlmann, Patrick; Carrie, Didier; Rousseau, Helene; Aubry, Pierre; Monsegu, Jacques; Sabouret, Pierre; O'Connor, Stephen A.; Abtan, Jeremie; Kerneis, Mathieu; Saint-Etienne, Christophe; Beygui, Farzin; Vicaut, Eric; Montalescot, Gilles		ARCTIC Investigators	Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; BARE-METAL STENT; CLOPIDOGREL THERAPY; CLINICAL-OUTCOMES; EUROPEAN-SOCIETY; CARDIAC EVENTS; DOUBLE-BLIND; TASK-FORCE; THROMBOSIS; RATIONALE	Background Optimum duration of dual antiplatelet treatment (DAPT) after coronary stenting remains uncertain, with an unknown efficacy to safety ratio of extended treatment leading to discrepancies between international guidelines and clinical practice. We assessed whether DAPT continuation beyond 1 year after coronary stenting is beneficial. Methods This analysis was a planned extension of the previously published ARCTIC-Monitoring trial, in which we randomly allocated 2440 patients to a strategy of platelet function testing with antiplatelet treatment adjustment or a conventional strategy after coronary stenting with drug-eluting stent (DES). We recruited patients (aged 18 years or older) scheduled for planned DES implantation at 38 centres in France. After 1 year of follow-up, patients without contraindication to interruption of DAPT were eligible for a second randomisation to this second phase of the study (ARCTIC-Interruption). Using a computer-generated randomisation sequence (1: 1; stratified by centre), we allocated patients to a strategy of interruption of DAPT where the thienopyridine was interrupted and single aspirin antiplatelet treatment was maintained (interruption group) or a strategy of DAPT continuation for 6-18 months (continuation group). The primary endpoint was the composite of death, myocardial infarction, stent thrombosis, stroke, or urgent revascularisation, analysed by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00827411. Findings Between Jan 4, 2011, and March 3, 2012, 1259 eligible patients were randomly allocated to treatment in ARCTIC-Interruption: 624 to the interruption group and 635 to the continuation group. After a median follow-up of 17 months (IQR 15-18), the primary endpoint occurred in 27 (4%) patients in the interruption group and 24 (4%) patients in the continuation group (hazard ratio [HR] 1.17 [95% CI 0.68-2.03]; p= 0.58). STEEPLE major bleeding events occurred more often in the continuation group (seven [1%] patients) compared with the interruption group (one [<0.5%] patient; HR 0.15 [0.02-1.20]; p= 0.073). Major or minor bleedings were also more common in the continuation group compared with the interruption group (12 [2%] patients vs three [1%] patients; HR 0.26 [0.07-0.91]; p= 0.04). Interpretation Our finding suggests no apparent benefit but instead harm with extension of DAPT beyond 1 year after stenting with DES when no event has occurred within the first year after stenting. No conclusion can be drawn for high-risk patients who could not be randomised. The consistency between findings from all trials of such interruption suggests the need for a reappraisal of guidelines for DAPT after coronary stenting towards shorter duration of treatment.	[Collet, Jean-Philippe; Silvain, Johanne; Barthelemy, Olivier; Sabouret, Pierre; O'Connor, Stephen A.; Abtan, Jeremie; Kerneis, Mathieu; Montalescot, Gilles] Univ Paris 06, Hop Pitie Salpetriere, APHP, INSERM,Inst Cardiol,ACT Study Grp, Paris, France; [Range, Gregoire] Hop Chartres, Le Coudray, France; [Cayla, Guillaume] CHU Caremeau, ACT Study Grp, Nimes, France; [Van Belle, Eric; Rousseau, Helene] CHRU Lille, F-59037 Lille, France; [Cuisset, Thomas] CHU La Timone, Dept Cardiol, Marseille, France; [Elhadad, Simon] CH Lagny Marne la Vallee, Lagny Sur Marne, France; [Schiele, Francois] CHU Jean Minjoz, Besancon, France; [Lhoest, Nicolas] GH Ctr Alsace, Alsace, France; [Ohlmann, Patrick] CHR Strasbourg, Strasbourg, France; [Carrie, Didier] CHU Rangueil, F-31054 Toulouse, France; [Rousseau, Helene; Vicaut, Eric] Hop Lariboisiere, APHP, Unite Rech Clin, ACT Study Grp, F-75475 Paris, France; [Rousseau, Helene; Vicaut, Eric] Univ Paris 07, Paris, France; [Aubry, Pierre] Ctr Hosp Bichat, APHP, Paris, France; [Monsegu, Jacques] Inst Mutualiste Montsouris, Paris, France; [Saint-Etienne, Christophe] CHU Trousseau, Tours, France; [Beygui, Farzin] CHU Caen, ACT Study Grp, Caen, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; CHU de Nimes; Universite de Lille - ISITE; CHU Lille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Franche-Comte; CHU Besancon; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; CHU de Caen NORMANDIE; Universite de Caen Normandie	Montalescot, G (corresponding author), CHU Pitie Salpetriere, Inst Cardiol, Bur 2 236, 47 Blvd Hop, F-75013 Paris, France.	gilles.montalescot@psl.aphp.fr	Aubry, Pierre/ABF-1167-2021; Sabouret, Pierre/AAE-3459-2020; SILVAIN, Johanne/C-7521-2016	Sabouret, Pierre/0000-0002-0243-3673; O'Connor, Stephen/0000-0002-6539-0375; CARRIE, didier/0000-0003-2479-8144; VAN BELLE, ERIC/0000-0001-6509-443X; SILVAIN, Johanne/0000-0002-1901-2808; Kerneis, Mathieu/0000-0002-7141-5209	Allies in Cardiovascular Trials Initiatives and Organized Networks (ACTION Study Group); Fondation de France; Sanofi-Aventis; Cordis; Medtronic; Boston Scientific; Fondation SGAM	Allies in Cardiovascular Trials Initiatives and Organized Networks (ACTION Study Group); Fondation de France(Fondation de France); Sanofi-Aventis(Sanofi-Aventis); Cordis; Medtronic(Medtronic); Boston Scientific(Boston Scientific); Fondation SGAM	Allies in Cardiovascular Trials Initiatives and Organized Networks (ACTION Study Group), Fondation de France, Sanofi-Aventis, Cordis, Medtronic, Boston Scientific, Fondation SGAM.	Airoldi F, 2007, CIRCULATION, V116, P745, DOI 10.1161/CIRCULATIONAHA.106.686048; Aradi D, 2014, EUR HEART J, V35, P209, DOI 10.1093/eurheartj/eht375; Baber U, 2011, J AM COLL CARDIOL, V58, P1569, DOI 10.1016/j.jacc.2011.06.049; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bonaca MP, 2014, AM HEART J, V167, P437, DOI 10.1016/j.ahj.2013.12.020; Byrne RA, 2009, AM HEART J, V157, P620, DOI 10.1016/j.ahj.2008.12.019; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Collet JP, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.029; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Hahn JY, 2010, CIRC J, V74, P2314, DOI 10.1253/circj.CJ-10-0347; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Kandzari DE, 2011, JACC-CARDIOVASC INTE, V4, P1119, DOI 10.1016/j.jcin.2011.06.017; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Mauri L, 2010, AM HEART J, V160, P1035, DOI 10.1016/j.ahj.2010.07.038; Mehran R, 2013, LANCET, V382, P1714, DOI 10.1016/S0140-6736(13)61720-1; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Montalescot G, 2006, NEW ENGL J MED, V355, P1006, DOI 10.1056/NEJMoa052711; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Naidu SS, 2012, JACC-CARDIOVASC INTE, V5, P626, DOI 10.1016/j.jcin.2012.02.014; Neubauer H, 2013, NEW ENGL J MED, V368, P870, DOI 10.1056/NEJMc1300053; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Sarno G, 2012, EUR HEART J, V33, P606, DOI 10.1093/eurheartj/ehr479; Schulz S, 2009, EUR HEART J, V30, P2714, DOI 10.1093/eurheartj/ehp275; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589	33	248	261	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2014	384	9954					1577	1585		10.1016/S0140-6736(14)60612-7	http://dx.doi.org/10.1016/S0140-6736(14)60612-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9NK	25037988				2022-12-28	WOS:000343901700026
J	Iannaccone, A; Zarbin, MA				Iannaccone, Alessandro; Zarbin, Marco A.			A new era in medical therapy for retinal degenerative disease?	LANCET			English	Editorial Material							LEBER CONGENITAL AMAUROSIS; BARDET-BIEDL-SYNDROME; RPE65 MUTATIONS; RETINITIS-PIGMENTOSA; VARIABILITY; PHENOTYPE; PERIMETRY; GENE		[Iannaccone, Alessandro] Univ Tennessee, Ctr Hlth Sci, Retinal Degenerat & Ophthalm Genet Serv, Hamilton Eye Inst,Dept Ophthalmol, Memphis, TN 38163 USA; [Zarbin, Marco A.] Rutgers State Univ, Inst Ophthalmol & Visual Sci, Rutgers New Jersey Med Sch, Newark, NJ 07102 USA	University of Tennessee System; University of Tennessee Health Science Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Iannaccone, A (corresponding author), Univ Tennessee, Ctr Hlth Sci, Retinal Degenerat & Ophthalm Genet Serv, Hamilton Eye Inst,Dept Ophthalmol, Memphis, TN 38163 USA.	aiannacc@uthsc.edu		Iannaccone, Alessandro/0000-0001-5737-8424; Zarbin, Marco/0000-0002-7811-7132				Bittner AK, 2011, INVEST OPHTH VIS SCI, V52, P8042, DOI 10.1167/iovs.11-8321; Cox KF, 2012, VISION RES, V75, P77, DOI 10.1016/j.visres.2012.08.005; DAGNELIE G, 1990, CLIN VISION SCI, V5, P95; DevBorman A, 2012, INVEST OPHTH VIS SCI, V53, P3927; Iannaccone A, 1996, ACTA OPHTHALMOL SCAN, V74, P8; IANNACCONE A, 1995, DOC OPHTHALMOL, V90, P129, DOI 10.1007/BF01203333; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Jacobson SG, 2009, INVEST OPHTH VIS SCI, V50, P2368, DOI 10.1167/iovs.08-2696; Koenekoop RK, 2014, LANCET; Maeda T, 2009, HUM MOL GENET, V18, P2277, DOI 10.1093/hmg/ddp163; Mykytyn K, 2004, TRENDS MOL MED, V10, P106, DOI 10.1016/j.molmed.2004.01.003; Nowomiejska K, 2012, OPHTHALMOLOGICA, V227, P166, DOI 10.1159/000333821; Randhawa S, 2008, CURR OPIN OPHTHALMOL, V19, P445, DOI 10.1097/ICU.0b013e3283112d3e; Roman AJ, 2013, INVEST OPHTH VIS SCI, V54, P1378, DOI 10.1167/iovs.12-11341; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Weleber RG, 2011, INVEST OPHTH VIS SCI, V52, P292, DOI 10.1167/iovs.10-6106	16	3	3	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2014	384	9953					1482	1484		10.1016/S0140-6736(14)60956-9	http://dx.doi.org/10.1016/S0140-6736(14)60956-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9MO	25030841				2022-12-28	WOS:000343899600006
J	Liddle, AD; Judge, A; Pandit, H; Murray, DW				Liddle, Alexander D.; Judge, Andrew; Pandit, Hemant; Murray, David W.			Adverse outcomes after total and unicompartmental knee replacement in 101 330 matched patients: a study of data from the National Joint Registry for England and Wales	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; RETROSPECTIVE ANALYSIS; 90-DAY MORTALITY; PROPENSITY SCORE; TOTAL HIP; ARTHROPLASTY; REVISION; MORBIDITY	Background Total knee replacement (TKR) or unicompartmental knee replacement (UKR) are options for end-stage osteoarthritis. However, comparisons between the two procedures are confounded by differences in baseline characteristics of patients undergoing either procedure and by insufficient reporting of endpoints other than revision. We aimed to compare adverse outcomes for each procedure in matched patients. Methods With propensity score techniques, we compared matched patients undergoing TKR and UKR in the National Joint Registry for England and Wales. The National Joint Registry started collecting data in April 1, 2003, and is continuing. The last operation date in the extract of data used in our study was Aug 28, 2012. We linked data for multiple potential confounders from the National Health Service Hospital Episode Statistics database. We used regression models to compare outcomes including rates of revision, revision/reoperation, complications, readmission, mortality, and length of stay. Findings 25 334 UKRs were matched to 75 996 TKRs on the basis of propensity score. UKRs had worse implant survival both for revision (subhazard ratio [SHR] 2.12, 95% CI 1.99-2.26) and for revision/reoperation (1.38, 1.31-1.44) than TKRs at 8 years. Mortality was significantly higher for TKR at all timepoints than for UKR (30 day: hazard ratio 0.23, 95% CI 0.11-0.50; 8 year: 0.85, 0.79-0.92). Length of stay, complications (including thromboembolism, myocardial infarction, and stroke), and rate of readmission were all higher for TKR than for UKR. Interpretation In decisions about which procedure to off er, the higher revision/reoperation rate of UKR than of TKR should be balanced against a lower occurrence of complications, readmission, and mortality, together with known benefits for UKR in terms of postoperative function. If 100 patients receiving TKR received UKR instead, the result would be around one fewer death and three more reoperations in the first 4 years after surgery. Funding Royal College of Surgeons of England and Arthritis Research UK. Copyright (C) Liddle et al. Open Access article distributed under the terms of CC BY.	[Liddle, Alexander D.; Judge, Andrew; Pandit, Hemant; Murray, David W.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Judge, Andrew] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England	University of Oxford; University of Southampton	Murray, DW (corresponding author), Nuffield Orthopaed Ctr, Botnar Res Ctr, Oxford OX3 7LD, England.	david.murray@ndorms.ox.ac.uk	Liddle, Alex/AAA-3023-2021	Pandit, Hemant/0000-0001-7392-8561; Judge, Andrew/0000-0003-3015-0432; Liddle, Alexander/0000-0001-6135-1996	Royal College of Surgeons of England; Arthritis Research UK; Versus Arthritis [20499] Funding Source: researchfish	Royal College of Surgeons of England; Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)	Funding Royal College of Surgeons of England and Arthritis Research UK.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Amin AK, 2006, CLIN ORTHOP RELAT R, P101, DOI 10.1097/01.blo.0000224052.01873.20; Arno S, 2011, J ARTHROPLASTY, V26, P1396, DOI 10.1016/j.arth.2010.12.023; Australian Orthopaedic Association National Joint Replacement Registry, 2013, HIP KNEE ARTH ANN RE; Aylin P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2424; Baker P, 2013, J BONE JOINT SURG AM, V95A, P702, DOI 10.2106/JBJS.L.00520; Beard D, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-292; Brown NM, 2012, J ARTHROPLASTY, V27, P86, DOI 10.1016/j.arth.2012.03.022; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Costa Christopher R, 2011, J Knee Surg, V24, P273; Dahabreh IJ, 2012, EUR HEART J, V33, P1893, DOI 10.1093/eurheartj/ehs114; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Freemantle N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6409; Hunt LP, 2013, LANCET, V382, P1097, DOI 10.1016/S0140-6736(13)61749-3; Hunt LP, 2014, LANCET; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Lombardi AV, 2009, CLIN ORTHOP RELAT R, V467, P1450, DOI 10.1007/s11999-009-0731-z; Lyons MC, 2012, CLIN ORTHOP RELAT R, V470, P84, DOI 10.1007/s11999-011-2144-z; Manzotti A, 2007, INT ORTHOP, V31, P315, DOI 10.1007/s00264-006-0184-x; Morris MJ, 2013, KNEE, V20, P218, DOI 10.1016/j.knee.2012.10.019; National Joint Registry for England and Wales, 2010, 7 NAT JOINT REG ENGL; National Joint Registry for England Wales and Northern Ireland, 2013, 10 NAT JOINT REG ENG; Newman J, 2009, J BONE JOINT SURG BR, V91B, P52, DOI 10.1302/0301-620X.91B1.20899; NHS Information Centre, 2012, HOSP EP STAT FIN PAT; Niinimaki TT, 2011, KNEE, V18, P432, DOI 10.1016/j.knee.2010.08.004; Noble M, 2004, INDICES DEPRIVATION; Pearl J., 2009, UNDERSTANDING PROPEN, P348; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rothwell AG, 2010, J BONE JOINT SURG BR, V92B, P413, DOI 10.1302/0301-620X.92B3.22913; Saklad M., 1941, ANESTHESIOLOGY, V2, P281, DOI DOI 10.1097/00000542-194105000-00004; Scott CEH, 2010, J BONE JOINT SURG BR, V92B, P1253, DOI 10.1302/0301-620X.92B9.24394; Singh JA, 2012, J ARTHROPLASTY, V27, P1417, DOI 10.1016/j.arth.2012.03.008; Sun PF, 2012, KNEE, V19, P103, DOI 10.1016/j.knee.2011.01.006; The New Zealand Joint Registry, 2012, 13 YEAR REP; Willis-Owen CA, 2009, KNEE, V16, P473, DOI 10.1016/j.knee.2009.04.006; Wylde V, 2011, J BONE JOINT SURG BR, V93B, P569, DOI 10.1302/0301-620X.93B5.26687; Yang K. Y., 2003, SMJ Singapore Medical Journal, V44, P559; Zmistowski B, 2011, CLIN ORTHOP RELAT R, V469, P138, DOI 10.1007/s11999-010-1558-3	38	339	346	5	48	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2014	384	9952					1437	1445		10.1016/S0140-6736(14)60419-0	http://dx.doi.org/10.1016/S0140-6736(14)60419-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ8TV	25012116	Green Published			2022-12-28	WOS:000343107000024
J	Colegio, OR; Chu, NQ; Szabo, AL; Chu, T; Rhebergen, AM; Jairam, V; Cyrus, N; Brokowski, CE; Eisenbarth, SC; Phillips, GM; Cline, GW; Phillips, AJ; Medzhitov, R				Colegio, Oscar R.; Ngoc-Quynh Chu; Szabo, Alison L.; Chu, Thach; Rhebergen, Anne Marie; Jairam, Vikram; Cyrus, Nika; Brokowski, Carolyn E.; Eisenbarth, Stephanie C.; Phillips, Gillian M.; Cline, Gary W.; Phillips, Andrew J.; Medzhitov, Ruslan			Functional polarization of tumour-associated macrophages by tumour-derived lactic acid	NATURE			English	Article							ANGIOGENESIS; ACTIVATION; CELLS; INFLAMMATION; HYPOXIA; GROWTH	Macrophages have an important role in the maintenance of tissue homeostasis(1). To perform this function, macrophages must have the capacity to monitor the functional states of their 'client cells': namely, the parenchymal cells in the various tissues in which macrophages reside. Tumours exhibit many features of abnormally developed organs, including tissue architecture and cellular composition(2). Similarly to macrophages in normal tissues and organs, macrophages in tumours (tumour-associated macrophages) perform some key homeostatic functions that allow tumour maintenance and growth(3-5). However, the signals involved in communication between tumours and macrophages are poorly defined. Here we show that lactic acid produced by tumour cells, as a by-product of aerobic or anaerobic glycolysis, has a critical function in signalling, through inducing the expression of vascular endothelial growth factor and the M2-like polarization of tumour-associated macrophages. Furthermore, we demonstrate that this effect of lactic acid is mediated by hypoxia-inducible factor 1 alpha (HIF1 alpha). Finally, we show that the lactate-induced expression of arginase 1 by macrophages has an important role in tumour growth. Collectively, these findings identify a mechanism of communication between macrophages and their client cells, including tumour cells. This communication most probably evolved to promote homeostasis in normal tissues but can also be engaged in tumours to promote their growth.	[Colegio, Oscar R.; Ngoc-Quynh Chu; Szabo, Alison L.; Chu, Thach; Rhebergen, Anne Marie; Jairam, Vikram; Cyrus, Nika; Brokowski, Carolyn E.; Eisenbarth, Stephanie C.; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA; [Colegio, Oscar R.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; [Colegio, Oscar R.] Yale Univ, Sch Med, Yale New Haven Transplantat Ctr, New Haven, CT 06519 USA; [Colegio, Oscar R.; Medzhitov, Ruslan] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA; [Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Phillips, Gillian M.; Phillips, Andrew J.] Yale Univ, Sch Med, Dept Chem, New Haven, CT 06520 USA; [Cline, Gary W.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Medzhitov, Ruslan] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA.	ruslan.medzhitov@yale.edu		Eisenbarth, Stephanie/0000-0002-1244-208X; Colegio, Oscar/0000-0002-9524-6235; Colegio, Oscar/0000-0002-6519-3718; Cyrus, Nika/0000-0002-7511-8631	National Cancer Institute [1K08CA172580-01]; Yale Center for Clinical Investigation [5KL2RR024138]; Yale SPORE in Skin Cancer [1 P50 CA121974]; Damon Runyon Cancer Research Foundation [DRG 108-09]; Dermatology Foundation; Blavatnik Family Foundation; National Institutes of Health [AI046688, AI089771, CA157461]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA157461, P50CA121974, P30CA016359, K08CA172580] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046688, R37AI046688, R01AI089771] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Yale Center for Clinical Investigation; Yale SPORE in Skin Cancer; Damon Runyon Cancer Research Foundation; Dermatology Foundation; Blavatnik Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Medzhitov laboratory for discussions, L. Xu, C. Annicelli, S. Cronin and G. Tokmoulina for animal care and technical help, and N. Palm for critical feedback on the manuscript. O.R.C. is supported by the National Cancer Institute (1K08CA172580-01), the Yale Center for Clinical Investigation (5KL2RR024138), the Yale SPORE in Skin Cancer (1 P50 CA121974), the Damon Runyon Cancer Research Foundation (DRG 108-09) and the Dermatology Foundation. R.M.'s laboratory is supported by The Blavatnik Family Foundation, grants from the National Institutes of Health (AI046688, AI089771 and CA157461) and the Howard Hughes Medical Institute.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Chang CI, 2001, CANCER RES, V61, P1100; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354	23	1431	1480	31	402	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					559	+		10.1038/nature13490	http://dx.doi.org/10.1038/nature13490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25043024	Green Accepted			2022-12-28	WOS:000342075800043
J	Kir, S; White, JP; Kleiner, S; Kazak, L; Cohen, P; Baracos, VE; Spiegelman, BM				Kir, Serkan; White, James P.; Kleiner, Sandra; Kazak, Lawrence; Cohen, Paul; Baracos, Vickie E.; Spiegelman, Bruce M.			Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia	NATURE			English	Article							HORMONE-RELATED PROTEIN; SKELETAL-MUSCLE; MONOCLONAL-ANTIBODY; NUDE-MICE; MECHANISMS; CELL; THERMOGENESIS; ACTIVATION; SURVIVAL	Cachexia is a wasting disorder of adipose and skeletal muscle tissues that leads to profound weight loss and frailty. About half of all cancer patients suffer from cachexia, which impairs quality of life, limits cancer therapy and decreases survival. One key characteristic of cachexia is higher resting energy expenditure levels than in healthy individuals, which has been linked to greater thermogenesis by brown fat(1-6). How tumours induce brown fat activity is unknown. Here, using a Lewis lung carcinoma model of cancer cachexia, we show that tumour-derived parathyroid-hormone-related protein (PTHrP) has an important role in wasting, through driving the expression of genes involved in thermogenesis in adipose tissues. Neutralization of PTHrP in tumour-bearing mice blocked adipose tissue browning and the loss of muscle mass and strength. Our results demonstrate that PTHrP mediates energy wasting in fat tissues and contributes to the broader aspects of cancer cachexia. Thus, neutralization of PTHrP might hold promise for ameliorating cancer cachexia and improving patient survival.	[Kir, Serkan; White, James P.; Kleiner, Sandra; Kazak, Lawrence; Cohen, Paul; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Baracos, Vickie E.] Univ Alberta, Div Palliat Care Med, Dept Oncol, Edmonton, AB T6G 1Z2, Canada	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Alberta	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.	bruce_spiegelman@dfci.harvard.edu		Baracos, Vickie/0000-0002-9609-1001	American Cancer Society [PF-13-385-01-TBE]; National Institutes of Health [DK31405]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031405, R37DK031405] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Mourtzakis and C. Prado for their help with the human study. S. Kir is a Robert Black Fellow of the Damon Runyon Cancer Research Foundation (DRG-2153-13), and J.P.W. is supported by a postdoctoral fellowship from the American Cancer Society (PF-13-385-01-TBE). This work was supported by National Institutes of Health grant DK31405 to B.M.S.	BIANCHI A, 1989, HORM METAB RES, V21, P640, DOI 10.1055/s-2007-1009308; Bing C, 2000, CANCER RES, V60, P2405; BROOKS SL, 1981, BIOSCIENCE REP, V1, P509, DOI 10.1007/BF01121584; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Iguchi H, 2006, J BONE MINER METAB, V24, P16, DOI 10.1007/s00774-005-0640-5; Iguchi H, 2001, INT J CANCER, V94, P24, DOI 10.1002/ijc.1425; Lieffers JR, 2009, AM J CLIN NUTR, V89, P1173, DOI 10.3945/ajcn.2008.27273; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Mundy GR, 2008, J AM SOC NEPHROL, V19, P672, DOI 10.1681/ASN.2007090981; OVESEN L, 1993, J CLIN ONCOL, V11, P2043, DOI 10.1200/JCO.1993.11.10.2043; Penna F, 2010, EXPERT OPIN BIOL TH, V10, P1241, DOI 10.1517/14712598.2010.503773; Prado Carla M M, 2012, Can J Diet Pract Res, V73, pe298, DOI 10.3148/73.4.2012.e298; Roe S, 1996, METABOLISM, V45, P645, DOI 10.1016/S0026-0495(96)90037-2; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; SATO K, 1993, J BONE MINER RES, V8, P849; SHELLOCK FG, 1986, J CANCER RES CLIN, V111, P82, DOI 10.1007/BF00402783; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tsoli M, 2012, CANCER RES, V72, P4372, DOI 10.1158/0008-5472.CAN-11-3536; Vilardaga JP, 2011, CELL MOL LIFE SCI, V68, P1, DOI 10.1007/s00018-010-0465-9; White JP, 2013, MOL CELL ENDOCRINOL, V365, P174, DOI 10.1016/j.mce.2012.10.019; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	24	379	393	4	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					100	+		10.1038/nature13528	http://dx.doi.org/10.1038/nature13528			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25043053	Green Accepted			2022-12-28	WOS:000341174800038
J	Annas, GJ; Ruger, TW; Ruger, JP				Annas, George J.; Ruger, Theodore W.; Ruger, Jennifer Prah			Money, Sex, and Religion - The Supreme Court's ACA Sequel	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARE		[Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA; [Ruger, Theodore W.] Univ Penn, Sch Law, Philadelphia, PA 19104 USA; [Ruger, Jennifer Prah] Perelman Sch Med, Philadelphia, PA USA; [Ruger, Jennifer Prah] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	Boston University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.							Annas GJ, 2009, NEW ENGL J MED, V361, P2589, DOI 10.1056/NEJMp0911513; [Anonymous], 2014, NEW YORK TIMES, pA16; [Anonymous], 2011, COMMITTEE ON PREVENT, P102; [Anonymous], BIRTH CONTROL MEDICI; [Anonymous], 2014, WALL STREET JOURNAL, pA12; Cohen IG, 2014, NEW ENGL J MED, V371, P596, DOI 10.1056/NEJMp1407965; Long H., 2014, HOBBY LOBBY DOES INV; Mariner WK, 2012, NEW ENGL J MED, V367, P1154, DOI 10.1056/NEJMhle1208437; Mariner WK, 2014, HOBBY LOBBY PART 2 D; Ruger JP, 2012, NEW ENGL J MED, V366, P681, DOI 10.1056/NEJMp1200751; Ruger JP, 2009, HEALTH AND SOCIAL JU	11	8	8	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2014	371	9					862	866		10.1056/NEJMhle1408081	http://dx.doi.org/10.1056/NEJMhle1408081			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7ZN	25029337	Green Published, Green Submitted			2022-12-28	WOS:000340819800014
J	Behnia, R; Clark, DA; Carter, AG; Clandinin, TR; Desplan, C				Behnia, Rudy; Clark, Damon A.; Carter, Adam G.; Clandinin, Thomas R.; Desplan, Claude			Processing properties of ON and OFF pathways for Drosophila motion detection	NATURE			English	Article							VISUAL INTERNEURONS; OPTIC LOBE; WILD-TYPE; MELANOGASTER; PATTERNS; MEDULLA; CIRCUIT; LAMINA	The algorithms and neural circuits that process spatio-temporal changes in luminance to extract visual motion cues have been the focus of intense research. An influential model, the Hassenstein-Reichardt correlator(1), relies on differential temporal filtering of two spatially separated input channels, delaying one input signal with respect to the other. Motion in a particular direction causes these delayed and non-delayed luminance signals to arrive simultaneously at a subsequent processing step in the brain; these signals are then nonlinearly amplified to produce a direction-selective response. Recent work in Drosophila has identified two parallel pathways that selectively respond to either moving light or dark edges(2,3). Each of these pathways requires two critical processing steps to be applied to incoming signals: differential delay between the spatial input channels, and distinct processing of brightness increment and decrement signals. Here we demonstrate, using in vivo patch-clamp recordings, that four medulla neurons implement these two processing steps. The neurons Mi1 and Tm3 respond selectively to brightness increments, with the response of Mi1 delayed relative to Tm3. Conversely, Tm1 and Tm2 respond selectively to brightness decrements, with the response of Tm1 delayed compared with Tm2. Remarkably, constraining Hassenstein-Reichardt correlator models using these measurements produces outputs consistent with previously measured properties of motion detectors, including temporal frequency tuning and specificity for light versus dark edges. We propose that Mi1 and Tm3 perform critical processing of the delayed and non-delayed input channels of the correlator responsible for the detection of light edges, while Tm1 and Tm2 play analogous roles in the detection of moving dark edges. Our data show that specific medulla neurons possess response properties that allow them to implement the algorithmic steps that precede the correlative operation in the Hassenstein-Reichardt correlator, revealing elements of the long-sought neural substrates of motion detection in the fly.	[Behnia, Rudy; Desplan, Claude] NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA; [Clark, Damon A.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Clark, Damon A.; Clandinin, Thomas R.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Carter, Adam G.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Desplan, Claude] New York Univ Abu Dhabi Inst, Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates	New York University; Yale University; Stanford University; New York University	Behnia, R (corresponding author), NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA.	rb141@nyu.edu; damon.clark@yale.edu		Desplan, Claude/0000-0002-6914-1413; Clark, Damon/0000-0001-8487-700X; Behnia, Rudy/0000-0001-7258-1885	National Institutes of Health (NIH) [R01EY017916]; New York University Abu Dhabi Institute [G1205C]; EMBO; Human Frontier Science Program; NIH [R01EY022638, DP1 OD003530]; NIH; Jane Coffin Childs postdoctoral fellowship; McKnight Foundation; NATIONAL EYE INSTITUTE [R01EY017916, R01EY022638] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003530] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Abu Dhabi Institute; EMBO(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs postdoctoral fellowship; McKnight Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Turner for his initial help on whole-cell recordings; X. Li for providing the confocal image of the 686-Gal4 flip-out clone, and N. Vogt, J. Rister and members of the Clandin in laboratory, as well as H. S. Seung and S.A. Baccus, for reading of the manuscript. We also thank D. B. Chklovskii for suggesting recording from Tm3 and T. Erclick for identifying the Tm3 Gal4 line. This work was supported by a grant from the National Institutes of Health (NIH) (R01EY017916) and a grant from New York University Abu Dhabi Institute (G1205C) to C.D.; R.B. was supported by fellowships from EMBO and the Human Frontier Science Program. This work was also supported by grants from the NIH to T.R.C. (R01EY022638 and DP1 OD003530). D.A.C. was partly supported by an NIH T32 Vision Training Grant and a Jane Coffin Childs postdoctoral fellowship. A.G.C. was supported by a Scholar Award from The McKnight Foundation.	BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BAUSENWEIN B, 1992, CELL TISSUE RES, V270, P25, DOI 10.1007/BF00381876; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; BORST A, 1989, TRENDS NEUROSCI, V12, P297, DOI 10.1016/0166-2236(89)90010-6; BORST A, 1986, BIOL CYBERN, V55, P59, DOI 10.1007/BF00363978; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BUCHNER E, 1976, BIOL CYBERN, V24, P85, DOI 10.1007/BF00360648; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Franceschini N., 1989, FACETS VISION, P360; Freifeld L, 2013, NEURON, V78, P1075, DOI 10.1016/j.neuron.2013.04.024; Harris RA, 2000, NEURON, V28, P595, DOI 10.1016/S0896-6273(00)00136-7; Hasegawa E, 2011, DEVELOPMENT, V138, P983, DOI 10.1242/dev.058370; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; MARMARELIS PZ, 1973, KYBERNETIK, V12, P74, DOI 10.1007/BF00272463; Meier M., 2014, CURRENT BIOL; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Morante Javier, 2011, Cold Spring Harb Protoc, V2011, P652, DOI 10.1101/pdb.prot5629; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Schnell B, 2012, J COMP PHYSIOL A, V198, P389, DOI 10.1007/s00359-012-0716-3; Shinomiya K, 2014, CURR BIOL, V24, P1062, DOI 10.1016/j.cub.2014.03.051; Silies M, 2013, NEURON, V79, P111, DOI 10.1016/j.neuron.2013.04.029; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P189, DOI 10.1007/s00359-003-0390-6; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Tuthill JC, 2013, NEURON, V79, P128, DOI 10.1016/j.neuron.2013.05.024; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	38	135	135	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					427	U443		10.1038/nature13427	http://dx.doi.org/10.1038/nature13427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25043016	Green Accepted			2022-12-28	WOS:000340840600033
J	Gao, F; Bonsignori, M; Liao, HX; Kumar, A; Xia, SM; Lu, XZ; Cai, FP; Hwang, KK; Song, HS; Zhou, TQ; Lynch, RM; Alam, SM; Moody, MA; Ferrari, G; Berrong, M; Kelsoe, G; Shaw, GM; Hahn, BH; Montefiori, DC; Kamanga, G; Cohen, MS; Hraber, P; Kwong, PD; Korber, BT; Mascola, JR; Kepler, TB; Haynes, BF				Gao, Feng; Bonsignori, Mattia; Liao, Hua-Xin; Kumar, Amit; Xia, Shi-Mao; Lu, Xiaozhi; Cai, Fangping; Hwang, Kwan-Ki; Song, Hongshuo; Zhou, Tongqing; Lynch, Rebecca M.; Alam, S. Munir; Moody, M. Anthony; Ferrari, Guido; Berrong, Mark; Kelsoe, Garnett; Shaw, George M.; Hahn, Beatrice H.; Montefiori, David C.; Kamanga, Gift; Cohen, Myron S.; Hraber, Peter; Kwong, Peter D.; Korber, Bette T.; Mascola, John R.; Kepler, Thomas B.; Haynes, Barton F.			Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies	CELL			English	Article							CD4 BINDING-SITE; HIV-1-INFECTED INDIVIDUALS; CONFORMATIONAL EPITOPE; MONOCLONAL-ANTIBODIES; BROAD NEUTRALIZATION; IMMUNE-RESPONSES; GERMINAL-CENTERS; HIV-1 INFECTION; AFFINITY; MUTATIONS	Development of strategies for induction of HIV-1 broadly neutralizing antibodies (bnAbs) by vaccines is a priority. Determining the steps of bnAb induction in HIV-1-infected individuals who make bnAbs is a key strategy for immunogen design. Here, we study the B cell response in a bnAb-producing individual and report cooperation between two B cell lineages to drive bnAb development. We isolated a virus-neutralizing antibody lineage that targeted an envelope region (loop D) and selected virus escape mutants that resulted in both enhanced bnAb lineage envelope binding and escape mutant neutralization-traits associated with increased B cell antigen drive. Thus, in this individual, two B cell lineages cooperated to induce the development of bnAbs. Design of vaccine immunogens that simultaneously drive both helper and broadly neutralizing B cell lineages may be important for vaccine-induced recapitulation of events that transpire during the maturation of neutralizing antibodies in HIV-1-infected individuals.	[Gao, Feng; Bonsignori, Mattia; Liao, Hua-Xin; Kumar, Amit; Xia, Shi-Mao; Lu, Xiaozhi; Cai, Fangping; Hwang, Kwan-Ki; Song, Hongshuo; Alam, S. Munir; Moody, M. Anthony; Ferrari, Guido; Berrong, Mark; Kelsoe, Garnett; Montefiori, David C.; Haynes, Barton F.] Duke Univ, Sch Med, Human Vaccine Inst, Dept Med, Durham, NC 27710 USA; [Gao, Feng; Bonsignori, Mattia; Liao, Hua-Xin; Kumar, Amit; Xia, Shi-Mao; Lu, Xiaozhi; Cai, Fangping; Hwang, Kwan-Ki; Song, Hongshuo; Alam, S. Munir; Moody, M. Anthony; Ferrari, Guido; Berrong, Mark; Kelsoe, Garnett; Montefiori, David C.; Haynes, Barton F.] Duke Univ, Sch Med, Human Vaccine Inst, Dept Surg, Durham, NC 27710 USA; [Gao, Feng; Bonsignori, Mattia; Liao, Hua-Xin; Kumar, Amit; Xia, Shi-Mao; Lu, Xiaozhi; Cai, Fangping; Hwang, Kwan-Ki; Song, Hongshuo; Alam, S. Munir; Moody, M. Anthony; Ferrari, Guido; Berrong, Mark; Kelsoe, Garnett; Montefiori, David C.; Haynes, Barton F.] Duke Univ, Sch Med, Human Vaccine Inst, Dept Pediat & Immunol, Durham, NC 27710 USA; [Gao, Feng; Bonsignori, Mattia; Liao, Hua-Xin; Kumar, Amit; Xia, Shi-Mao; Lu, Xiaozhi; Cai, Fangping; Hwang, Kwan-Ki; Song, Hongshuo; Alam, S. Munir; Moody, M. Anthony; Ferrari, Guido; Berrong, Mark; Kelsoe, Garnett; Montefiori, David C.; Haynes, Barton F.] Duke Univ, Ctr HIV AIDS Vaccine Immunol Immunogen Discovery, Durham, NC 27710 USA; [Zhou, Tongqing; Lynch, Rebecca M.; Kwong, Peter D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Shaw, George M.; Hahn, Beatrice H.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Shaw, George M.; Hahn, Beatrice H.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Kamanga, Gift] UNC Project, Lilongwe, Malawi; [Kamanga, Gift] Univ N Carolina, Dept Hlth Policy, Chapel Hill, NC 27599 USA; [Kamanga, Gift] Univ N Carolina, Dept Management, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Hraber, Peter; Korber, Bette T.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87544 USA; [Kepler, Thomas B.] Boston Univ, Dept Microbiol, Boston, MA 02215 USA	Duke University; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); Los Alamos National Laboratory; Boston University	Gao, F (corresponding author), Duke Univ, Sch Med, Human Vaccine Inst, Dept Med, Durham, NC 27710 USA.	fgao@duke.edu; barton.haynes@duke.edu	Alam, S. Munir/AAC-6711-2019; Mascola, John/AAI-7193-2021; Moody, M/AAB-6947-2020; Ferrari, Guido/Z-2137-2019; Ferrari, Guido/A-6088-2015; Bonsignori, Mattia/AAE-7678-2019; Zhou, Tongqing/A-6880-2010	Moody, M/0000-0002-3890-5855; Ferrari, Guido/0000-0001-7747-3349; Bonsignori, Mattia/0000-0003-2973-2101; Zhou, Tongqing/0000-0002-3935-4637; Hraber, Peter/0000-0002-2920-4897; Korber, Bette/0000-0002-2026-5757; Kelsoe, Garnett/0000-0002-8770-040X; Hahn, Beatrice/0000-0002-9400-9887	Center For HIV/AIDS Vaccine Immunology-Immunogen Discovery grant (CHAVI-ID) [UM1 AI100645]; Duke University Center for AIDS Research (CFAR) [P30-AI-64518]; intramural research program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645, P30AI064518, P30AI050410, P30AI045008, ZIAAI005024] Funding Source: NIH RePORTER	Center For HIV/AIDS Vaccine Immunology-Immunogen Discovery grant (CHAVI-ID); Duke University Center for AIDS Research (CFAR); intramural research program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Center For HIV/AIDS Vaccine Immunology-Immunogen Discovery grant (CHAVI-ID; UM1 AI100645), the Duke University Center for AIDS Research (CFAR; P30-AI-64518), and the intramural research program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH. We thank Mark Hallen and Jiang Zhu for assistance and discussion on calculation of binding affinity and Daniel M Kozink, Abby Cooper, and Florence Perrin for technical assistance. Provisional patents have been filed by B. F. H., H.-X. L., R. M. L., T.Z., F. G., G. M. S., B. H. H., T. B. K., B. T. K., P. D. K., J.R.M., and P. H. M. S. C. served at Advisory Board of Roche Molecular Systems, Expert Advisory Panel of Gates Foundation, and Pipeline Advisory Board of Janssen Global Services.	Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Bonsignori M, 2014, J CLIN INVEST, V124, P1835, DOI 10.1172/JCI73441; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Cai FP, 2007, NAT METHODS, V4, P123, DOI 10.1038/nmeth995; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Cox JH, 2006, METHODS, V38, P274, DOI 10.1016/j.ymeth.2005.11.006; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; Dehouck Y, 2013, NUCLEIC ACIDS RES, V41, pW333, DOI 10.1093/nar/gkt450; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Fera D, 2014, P NATL ACAD SCI USA, V111, P10275, DOI 10.1073/pnas.1409954111; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Kepler Thomas B, 2013, F1000Res, V2, P103, DOI 10.12688/f1000research.2-103.v1; Kirchherr JL, 2007, J VIROL METHODS, V143, P104, DOI 10.1016/j.jviromet.2007.02.015; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liao HX, 2013, J VIROL, V87, P4185, DOI 10.1128/JVI.02297-12; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Montefiori D.C., 2004, CURRENT PROTOCOLS IM; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Moore PL, 2009, CURR OPIN HIV AIDS, V4, P358, DOI 10.1097/COH.0b013e32832ea7e8; Moretti R, 2013, PROTEINS, V81, P1980, DOI 10.1002/prot.24356; Mouquet H, 2012, CELL MOL LIFE SCI, V69, P1435, DOI 10.1007/s00018-011-0872-6; Sattentau Quentin J, 2010, F1000 Biol Rep, V2, P60, DOI 10.3410/B2-60; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Song HS, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-89; Stamatatos L, 2012, CURR OPIN IMMUNOL, V24, P316, DOI 10.1016/j.coi.2012.04.006; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Volpe JM, 2006, BIOINFORMATICS, V22, P438, DOI 10.1093/bioinformatics/btk004; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	51	198	211	0	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					481	491		10.1016/j.cell.2014.06.022	http://dx.doi.org/10.1016/j.cell.2014.06.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25065977	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000340944300004
J	Beck, JR; Muralidharan, V; Oksman, A; Goldberg, DE				Beck, Josh R.; Muralidharan, Vasant; Oksman, Anna; Goldberg, Daniel E.			PTEX component HSP101 mediates export of diverse malaria effectors into host erythrocytes	NATURE			English	Article							PLASMODIUM-FALCIPARUM PROTEIN; PLASMEPSIN V; FOOD VACUOLE; VIRULENCE; BIOSYNTHESIS; LOCALIZATION; TRANSLOCON; PARASITES; MEMBRANE; CELLS	To mediate its survival and virulence, the malaria parasite Plasmodium falciparum exports hundreds of proteins into the host erythrocyte(1). To enter the host cell, exported proteins must cross the parasitophorous vacuolar membrane (PVM) within which the parasite resides, but the mechanism remains unclear. A putative Plasmodium translocon of exported proteins (PTEX) has been suggested to be involved for at least one class of exported proteins; however, direct functional evidence for this has been elusive(2-4). Here we show that export across the PVM requires heat shock protein 101 (HSP101), a ClpB-likeAAA+ ATPase component of PTEX. Using a chaperone auto-inhibition strategy, we achieved rapid, reversible ablation of HSP101 function, resulting in a nearly complete block in export with substrates accumulating in the vacuole in both asexual and sexual parasites. Surprisingly, this block extended to all classes of exported proteins, revealing HSP101-dependent translocation across the PVM as a convergent step in the multi-pathway export process. Under export-blocked conditions, association between HSP101 and other components of the PTEX complex was lost, indicating that the integrity of the complex is required for efficient protein export. Our results demonstrate an essential and universal role for HSP101 in protein export and provide strong evidence for PTEX function in protein translocation into the host cell.	[Beck, Josh R.; Oksman, Anna; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Muralidharan, Vasant; Oksman, Anna; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Muralidharan, Vasant; Oksman, Anna; Goldberg, Daniel E.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Goldberg, DE (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	dgoldberg@wustl.edu		Muralidharan, Vasant/0000-0001-6367-6284	National Institutes of Health [AI047798, T32-AI007172, AI099156]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172, R01AI047798, K99AI099156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI047798 to D.E.G., T32-AI007172 to J.R.B. and AI099156 to V.M. We thank J. McBride, D. Cavanagh and EMRR for anti-EXP2 antibody, J. Adams and ATCC (MR4) for anti-BiP antibody, D. Taylor for anti-HRP2 antibody, R. Anders for anti-RESA antibody, C. Braun-Breton for anti-SBP1 antibody, K. Williamson for anti-PfGECO and anti-Pfs16 antibodies, T. Spielmann for anti-REX2, anti-REX3 and anti-MSRP6 antibodies, L. Tilley for anti-REX1 and anti-PfEMP1 antibodies, S. Desai for anti-CLAG3 antibody, A. Cowman for anti-KAHRP antibody, J. Przyborski and K. Lingelbach for anti-SERP antibody, W. Beatty for assistance with electron microscopy, B. Vaupel and T. Butler for technical assistance and P. Sigala and N. Spillman for suggestions.	Babbitt SE, 2012, P NATL ACAD SCI USA, V109, pE3278, DOI 10.1073/pnas.1209823109; Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Boddey JA, 2013, ANNU REV MICROBIOL, V67, P243, DOI 10.1146/annurev-micro-092412-155730; Boddey JA, 2013, TRAFFIC, V14, P532, DOI 10.1111/tra.12053; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Bullen HE, 2012, J BIOL CHEM, V287, P7871, DOI 10.1074/jbc.M111.328591; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; CULVENOR JG, 1991, INFECT IMMUN, V59, P1183, DOI 10.1128/IAI.59.3.1183-1187.1991; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Eksi S, 2005, MOL BIOCHEM PARASIT, V143, P90, DOI 10.1016/j.molbiopara.2005.05.010; Francis SE, 1997, J BIOL CHEM, V272, P14961, DOI 10.1074/jbc.272.23.14961; Frankland S, 2007, EUKARYOT CELL, V6, P1584, DOI 10.1128/EC.00063-07; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; Gruring C, 2012, CELL HOST MICROBE, V12, P717, DOI 10.1016/j.chom.2012.09.010; Hawthorne PL, 2004, MOL BIOCHEM PARASIT, V136, P181, DOI 10.1016/j.molbiopara.2004.03.013; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; KIRK K, 1994, J BIOL CHEM, V269, P3339; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Matthews K, 2013, MOL MICROBIOL, V89, P1167, DOI 10.1111/mmi.12334; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Morahan BJ, 2011, EUKARYOT CELL, V10, P1492, DOI 10.1128/EC.05155-11; Mundwiler-Pachlatko E, 2013, P NATL ACAD SCI USA, V110, P19987, DOI 10.1073/pnas.1309247110; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Riglar DT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2449; ROCK EP, 1987, PARASITOLOGY, V95, P209, DOI 10.1017/S0031182000057681; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Spielmann T, 2006, MOL BIOL CELL, V17, P3613, DOI 10.1091/mbc.E06-04-0291; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	40	159	159	0	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					592	+		10.1038/nature13574	http://dx.doi.org/10.1038/nature13574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043010	Green Accepted			2022-12-28	WOS:000339566300035
J	Dang, CV				Dang, Chi V.			GENE REGULATION Fine-tuned amplification in cells	NATURE			English	Editorial Material							C-MYC; EMBRYONIC STEM; CANCER; PROTEIN		Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Dang, CV (corresponding author), Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA.	dangvchi@exchange.upenn.edu	Dang, Chi/Y-3375-2019	Dang, Chi/0000-0002-4031-2522				Cunningham JT, 2014, CELL, V157, P1088, DOI 10.1016/j.cell.2014.03.052; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Elkon R, 2004, NUCLEIC ACIDS RES, V32, P4955, DOI 10.1093/nar/gkh816; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473	12	23	24	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					417	418		10.1038/nature13518	http://dx.doi.org/10.1038/nature13518			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043013				2022-12-28	WOS:000339335700035
J	Cohen, IG; Feigenbaum, J; Adashi, EY				Cohen, I. Glenn; Feigenbaum, Jeremy; Adashi, Eli Y.			Reconsideration of the Lifetime Ban on Blood Donation by Men Who Have Sex With Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cohen, I. Glenn; Feigenbaum, Jeremy] Harvard Univ, Sch Law, Cambridge, MA 02138 USA; [Cohen, I. Glenn] Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA USA; [Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA	Harvard University; Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	eli_adashi@brown.edu						American Medical Association, 2013, AMA OPPOSES LIFETIME; [Anonymous], 2013, COMMUNICATION, P2; [Anonymous], 2013, BLOOD DONATIONS FROM; Suligoil B, 2013, BLOOD TRANSFUS-ITALY, V11, P441, DOI 10.2450/2013.0162-12; US Department of Health and Human Services, 2013, FORTY FOURTH MEETING; US Department of Health and Human Services, 1992, REVISED RECOMMENDATI; US Department of Health and Human Services, 2010, ADVISORY COMMITTEE O	7	15	15	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					337	338		10.1001/jama.2014.8037	http://dx.doi.org/10.1001/jama.2014.8037			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038346				2022-12-28	WOS:000339257800014
J	Anderson, SJ; Cherutich, P; Kilonzo, N; Cremin, I; Fecht, D; Kimanga, D; Harper, M; Masha, RL; Ngongo, PB; Maina, W; Dybul, M; Hallett, TB				Anderson, Sarah-Jane; Cherutich, Peter; Kilonzo, Nduku; Cremin, Ide; Fecht, Daniela; Kimanga, Davies; Harper, Malayah; Masha, Ruth Laibon; Ngongo, Prince Bahati; Maina, William; Dybul, Mark; Hallett, Timothy B.			Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study	LANCET			English	Article							MALE CIRCUMCISION; EFFECTIVE RESPONSE; SPATIAL-ANALYSIS; HIGH-RISK; HIV/AIDS; INTERVENTIONS; INFECTION; IMPACT; STRATEGIES; MALARIA	Background Epidemiological data show substantial variation in the risk of HIV infection between communities within African countries. We hypothesised that focusing appropriate interventions on geographies and key populations at high risk of HIV infection could improve the effect of investments in the HIV response. Methods With use of Kenya as a case study, we developed a mathematical model that described the spatiotemporal evolution of the HIV epidemic and that incorporated the demographic, behavioural, and programmatic differences across subnational units. Modelled interventions (male circumcision, behaviour change communication, early antiretoviral therapy, and pre-exposure prophylaxis) could be provided to different population groups according to their risk behaviours or their location. For a given national budget, we compared the effect of a uniform intervention strategy, in which the same complement of interventions is provided across the country, with a focused strategy that tailors the set of interventions and amount of resources allocated to the local epidemiological conditions. Findings A uniformly distributed combination of HIV prevention interventions could reduce the total number of new HIV infections by 40% during a 15-year period. With no additional spending, this effect could be increased by 14% during the 15 years-almost 100 000 extra infections, and result in 33% fewer new HIV infections occurring every year by the end of the period if the focused approach is used to tailor resource allocation to reflect patterns in local epidemiology. The cumulative difference in new infections during the 15-year projection period depends on total budget and costs of interventions, and could be as great as 150 000 (a cumulative difference as great as 22%) under different assumptions about the unit costs of intervention. Interpretation The focused approach achieves greater effect than the uniform approach despite exactly the same investment. Through prioritisation of the people and locations at greatest risk of infection, and adaption of the interventions to reflect the local epidemiological context, the focused approach could substantially increase the efficiency and effectiveness of investments in HIV prevention.	[Anderson, Sarah-Jane; Cremin, Ide; Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [Fecht, Daniela] Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, SAHSU, London W2 1PG, England; [Cherutich, Peter; Kimanga, Davies; Maina, William] Natl AIDS & STI Control Programme NASCOP, Nairobi, Kenya; [Kilonzo, Nduku] Liverpool VCT Care & Treatment, Nairobi, Kenya; [Harper, Malayah; Masha, Ruth Laibon] UNAIDS, Nairobi, Kenya; [Ngongo, Prince Bahati] IAVI, Nairobi, Kenya; [Dybul, Mark] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland	Imperial College London; Imperial College London; International AIDS Vaccine Initiative	Anderson, SJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England.	sarah-jane.anderson@imperial.ac.uk	; Maina, William/L-6650-2017	Hallett, Timothy/0000-0002-9681-0424; Fecht, Daniela/0000-0002-0738-0013; Maina, William/0000-0002-3184-9854; Cremin, Ide/0000-0003-2560-6247	Bill & Melinda Gates Foundation; UNAIDS; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); UNAIDS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study was provided by the Bill & Melinda Gates Foundation and UNAIDS.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Beyrer C, 2012, LANCET; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cooke GS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-585; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Government of India Ministry of Health and Family Welfare, 1999, NAT OP GUID ART SER; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Halli SS, 2009, SEX TRANSM DIS, V36, P556, DOI 10.1097/OLQ.0b013e3181a8cdcf; Health Protection Agency, 2012, HIV UK 2012 REP; http://www.who.int/hiv/pub/surveillance/en/cds_edc_2000_5.pdf, 2000, GUID 2 GEN HIV SURV; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, S AFRICA; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, LOC LOC CONN PEOPL F; Jones A, 2014, LANCET; Kabatereine NB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-232; Kandala NB, 2012, HIV AIDS-RES PALLIAT, V4, P95, DOI 10.2147/HIV.S30537; Kenya National AIDS and STI Control Program (NASCOP), 2013, COUNT HIV SERV DEL P; Kenya National AIDS and STI Control Programme (NASCOP), 2011, SENT SURV HIV SYPH I; Kenya National AIDS and STI Control Programme (NASCOP) National AIDS Control Council (NACC), 2012, GEOGR MAPP MOST RISK; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2010, KEN DEM HLTH SURV 20; Lafort Y, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-144; Larmarange J, 2014, CYBERGEO EUROPEAN J; Law DCG, 2004, SEX TRANSM INFECT, V80, P294, DOI 10.1136/sti.2003.006700; Leydon NG, S AFR MED J, V100, P420; LowBeer D, 1997, NAT MED, V3, P553, DOI 10.1038/nm0597-553; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magalhaes RJS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001200; Meyer-Rath G, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001247; Mishra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032324; Moran D, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-22; Musenge E, 2013, GLOBAL HEALTH ACTION, V6, P38, DOI 10.3402/gha.v6i0.19266; Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67; Piot P, 2013, NEW ENGL J MED, V368, P2210, DOI 10.1056/NEJMra1201533; Qian HZ, 2006, AIDS CARE, V18, pS6, DOI 10.1080/09540120600839074; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Sgaier SK, 2012, SEX TRANSM INFECT, V88, P240, DOI 10.1136/sextrans-2011-050382; Shepard D, 1968, P 1968 ACM NAT C NEW; Shisana O, 2013, 6 SA AIDS C DURB S A; Sumartojo E, 1997, AIDS, V11, P1201, DOI 10.1097/00002030-199710000-00002; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; Tanzania Commission for HIV and AIDS, UNGASS REP 2010 TANZ; The Global Fund, 2013, NEW FUND MOD 2013; The United States President's Emergency Plan for AIDS Relief (PEPFAR), 2012, PEPFAR BLUEPR CREAT; US Centers for Disease Control and Prevention, 2013, HIV AIDS US GEOGR DI; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Verguet Stephane, 2013, Cost Eff Resour Alloc, V11, P1, DOI 10.1186/1478-7547-11-1; Weir SS, 2002, MEASURE EVALUATION B, V2002, P1; Williams BG, 2000, S AFR J SCI, V96, P297; Wilson DP, 2005, PLOS MED, V2, P132, DOI 10.1371/journal.pmed.0020050; World Health Organization, 2013, GUID 2 GEN HIV SURV; Yao J, 2013, SOC SCI MED, V96, P60, DOI [10.1016/j.socscimed.2013.07.025, 10.1016/j.socscimed.2012.11.005]	58	171	172	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					249	256		10.1016/S0140-6736(14)61053-9	http://dx.doi.org/10.1016/S0140-6736(14)61053-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL8JI	25042235	Green Submitted			2022-12-28	WOS:000339384100026
J	Smith, CJ; Ryom, L; Weber, R; Morlat, P; Pradier, C; Reiss, P; Kowalska, JD; de Wit, S; Law, M; el Sadr, W; Kirk, O; Friis-Moller, N; Monforte, AD; Phillips, AN; Sabin, CA; Lundgren, JD				Smith, Colette J.; Ryom, Lene; Weber, Rainer; Morlat, Philippe; Pradier, Christian; Reiss, Peter; Kowalska, Justyna D.; de Wit, Stephane; Law, Matthew; el Sadr, Wafaa; Kirk, Ole; Friis-Moller, Nina; Monforte, Antonella d'Arminio; Phillips, Andrew N.; Sabin, Caroline A.; Lundgren, Jens D.		D A D Study Grp	Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AIDS-DEFINING CANCERS; ANTIRETROVIRAL THERAPY; MYOCARDIAL-INFARCTION; DATA-COLLECTION; ADVERSE EVENTS; RISK-FACTORS; HEPATITIS-C; MORTALITY; INFECTION	Background With the advent of effective antiretroviral treatment, the life expectancy for people with HIV is now approaching that seen in the general population. Consequently, the relative importance of other traditionally non-AIDS-related morbidities has increased. We investigated trends over time in all-cause mortality and for specific causes of death in people with HIV from 1999 to 2011. Methods Individuals from the Data collection on Adverse events of anti-HIV Drugs (D: A: D) study were followed up from March, 1999, until death, loss to follow-up, or Feb 1, 2011, whichever occurred first. The D: A: D study is a collaboration of 11 cohort studies following HIV-1-positive individuals receiving care at 212 clinics in Europe, USA, and Australia. All fatal events were centrally validated at the D: A: D coordinating centre using coding causes of death in HIV (CoDe) methodology. We calculated relative rates using Poisson regression. Findings 3909 of the 49 731 D: A: D study participants died during the 308 719 person-years of follow-up (crude incidence mortality rate, 12 7 per 1000 person-years [95% CI 12.3-13.1]). Leading underlying causes were: AIDS-related (1123 [29%] deaths), non-AIDS-defining cancers (590 [15%] deaths), liver disease (515 [13%] deaths), and cardiovascular disease (436 [11%] deaths). Rates of all-cause death per 1000 person-years decreased from 17 5 in 1999-2000 to 9 1 in 2009-11; we saw similar decreases in death rates per 1000 person-years over the same period for AIDS-related deaths (5 9 to 2 0), deaths from liver disease (2 7 to 0 9), and cardiovascular disease deaths (1 8 to 0 9). However, non-AIDS cancers increased slightly from 1 6 per 1000 person-years in 1999-2000 to 2 1 in 2009-11 (p=0.58). After adjustment for factors that changed over time, including CD4 cell count, we detected no decreases in AIDS-related death rates (relative rate for 2009-11 vs 1999-2000: 0 92 [0.70-1.22]). However, all-cause (0 72 [0.61-0.83]), liver disease (0 48 [0.32-0.74]), and cardiovascular disease (0 33 [0.20-0.53) death rates still decreased over time. The percentage of all deaths that were AIDS-related (87/256 [34%] in 1999-2000 and 141/627 [22%] in 2009-11) and liver-related (40/256 [16%] in 1999-2000 and 64/627 [10%] in 2009-11) decreased over time, whereas non-AIDS cancers increased (24/256 [9%] in 1999-2000 to 142/627 [23%] in 2009-11). Interpretation Recent reductions in rates of AIDS-related deaths are linked with continued improvement in CD4 cell count. We hypothesise that the substantially reduced rates of liver disease and cardiovascular disease deaths over time could be explained by improved use of non-HIV-specific preventive interventions. Non-AIDS cancer is now the leading non-AIDS cause and without any evidence of improvement.	[Smith, Colette J.; Phillips, Andrew N.; Sabin, Caroline A.] UCL, Res Dept Infect & Populat Hlth, London NW3 2PF, England; [Ryom, Lene; Kirk, Ole; Lundgren, Jens D.] Univ Copenhagen, Rigshosp, CHIP, Dept Infect Dis 2100, DK-1168 Copenhagen, Denmark; [Weber, Rainer] Univ Zurich, Univ Zurich Hosp, Div Infect Dis, Zurich, Switzerland; [Morlat, Philippe] Univ Bordeaux Segalen, CHU Bordeaux, Serv Med Intern & Malad Infect, Bordeaux, France; [Pradier, Christian] Nice Univ Hosp, Dept Publ Hlth, Nice, France; [Reiss, Peter] Univ Amsterdam, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Reiss, Peter] Stichting HIV Monitoring, Amsterdam, Netherlands; [Kowalska, Justyna D.] Med Univ Warsaw, Dept Adults Infect Dis, Warsaw, Poland; [de Wit, Stephane] Hop Univ St Pierre, Dept Infect Dis, B-1000 Brussels, Belgium; [Law, Matthew] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [el Sadr, Wafaa] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Friis-Moller, Nina] Odense Univ Hosp, Dept Infect Dis, Odense, Denmark; [Monforte, Antonella d'Arminio] San Paolo Univ Hosp, Dept Hlth Sci, Milan, Italy	University of London; University College London; Rigshospitalet; University of Copenhagen; University of Zurich; University Zurich Hospital; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Nice; University of Amsterdam; Academic Medical Center Amsterdam; Medical University of Warsaw; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of New South Wales Sydney; Kirby Institute; Columbia University; University of Southern Denmark; Odense University Hospital	Smith, CJ (corresponding author), UCL, Res Dept Infect & Populat Hlth, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	c.smith@ucl.ac.uk	van der Ven, A.J.A.M./H-8102-2014; Phillips, Andrew N/B-4427-2008; Pradier, Christian/AFE-8255-2022; kirk, ole/ABB-4746-2021; Koopmans, Peter/O-9276-2015; Weber, Rainer/D-5175-2012; Lundgren, Jens/AAE-6876-2019; Ippolito, Giuseppe/J-7207-2017; Sabin, Caroline/C-2464-2008; VELLA, STEFANO/V-8440-2019; Vandekerckhove, Linos/J-6420-2013; Soriano, Vicente/O-5730-2018; Buonfrate, Dora/N-2965-2016; Harding, Richard/G-9729-2012; Ostergaard, Lars/AAA-3020-2020; Pradier, Christian/AAE-9669-2022; Pantaleo, Giuseppe/K-6163-2016; perno, carlo federico/O-1544-2016; Torres, Ferran/D-1296-2011	van der Ven, A.J.A.M./0000-0003-1833-3391; Phillips, Andrew N/0000-0003-2384-4807; Sabin, Caroline/0000-0001-5173-2760; VELLA, STEFANO/0000-0003-2347-5984; Vandekerckhove, Linos/0000-0002-8600-1631; Soriano, Vicente/0000-0002-4624-5199; Buonfrate, Dora/0000-0003-0108-6822; Ostergaard, Lars/0000-0003-2459-0511; Torres, Ferran/0000-0002-7355-7913; Ippolito, Giuseppe/0000-0002-1076-2979; COSTANTINI, ANDREA/0000-0003-1588-7030; McManus, Hamish/0000-0002-7264-8848; CAMANNI, GUIDO/0000-0003-0881-5426; Colebunders, Robert/0000-0002-1919-1340; Ristola, Matti/0000-0001-5115-2811; Smith, Colette/0000-0003-2847-3355; Katzenstein, Terese L/0000-0002-2233-500X; LIBOIS, Agnes/0000-0002-6078-878X; d'Arminio Monforte, Antonella/0000-0003-0073-1789; Lo Caputo, Sergio/0000-0002-4729-7548; CAUDA, Roberto/0000-0002-1498-4229; Rijnders, Bart/0000-0003-3343-9610; Law, Matthew/0000-0002-3540-8837; Leen, Clifford/0000-0001-8439-7719; Ostergaard, Lars/0000-0002-7619-605X; PERNO, CARLO FEDERICO/0000-0002-0825-5388; Lundgren, Jens/0000-0001-8901-7850	Oversight Committee for the Evaluation of Metabolic Complications of HAART; MRC [G0701639] Funding Source: UKRI; Medical Research Council [G0701639] Funding Source: researchfish	Oversight Committee for the Evaluation of Metabolic Complications of HAART; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Oversight Committee for the Evaluation of Metabolic Complications of HAART, with representatives from academia, patient community, US Food and Drug Administration, European Medicines Agency and consortium of AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, ViiV Healthcare, Merck, Pfizer, F Hoffmann-La Roche, and Janssen Pharmaceuticals.	[Anonymous], 2012, INT J EPIDEMIOL, V41, P433; Antiretroviral Therapy Cohort Collaboration, 1996, CLIN INFECT DIS, V50, P1387; Berenguer J, 2012, AIDS, V26, P2241, DOI 10.1097/QAD.0b013e3283574e94; Blanco F, 2011, J VIRAL HEPATITIS, V18, P11, DOI 10.1111/j.1365-2893.2009.01261.x; Bruyand M, 2013, 20 C RETR OPP INF CR; Buchacz K, 2013, ANTIVIR THER, V18, P65, DOI 10.3851/IMP2450; Conigliaro J, 2003, JAIDS-J ACQ IMM DEF, V33, P521, DOI 10.1097/00126334-200308010-00014; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Helleberg M, 2012, INFECTION, V40, P627, DOI 10.1007/s15010-012-0293-y; Hernando V, 2012, AIDS, V26, P1829, DOI 10.1097/QAD.0b013e328352ada4; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Horvath KJ, 2012, AM J PREV MED, V43, pS214, DOI 10.1016/j.amepre.2012.07.032; Kovari H, 2013, CLIN INFECT DIS, V56, P870, DOI 10.1093/cid/cis919; Kowalska JD, 2011, EPIDEMIOLOGY, V22, P516, DOI 10.1097/EDE.0b013e31821b5332; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Lundgren JD, 2012, 19 INT AIDS C WASH D; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Pinzone MR, 2012, EUR REV MED PHARMACO, V16, P1377; Sabin C, 2013, 20 C RETR OPP INF CR; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Scarborough P, 2010, CORONARY HEART DIS S; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simard EP, 2012, AIDS, V26, P1311, DOI 10.1097/QAD.0b013e328353f38e; Soriano V, 2012, INFECT DIS CLIN N AM, V26, P931, DOI 10.1016/j.idc.2012.08.004; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918; Worm SW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-471; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Worm SW, 2012, 19 C RETR OPP INF CR	33	620	657	1	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					241	248		10.1016/S0140-6736(14)60604-8	http://dx.doi.org/10.1016/S0140-6736(14)60604-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL8JI	25042234	Green Submitted			2022-12-28	WOS:000339384100025
J	Muindi, F				Muindi, Fanuel			Tell the negative committee to shut up	SCIENCE			English	Editorial Material									MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Muindi, F (corresponding author), MIT, Cambridge, MA 02139 USA.			/0000-0002-1998-1449					0	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					350	350		10.1126/science.345.6194.350	http://dx.doi.org/10.1126/science.345.6194.350			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8PG	25035495				2022-12-28	WOS:000339400700055
J	Goulson, D				Goulson, Dave			ECOLOGY Pesticides linked to bird declines	NATURE			English	Editorial Material							NEONICOTINOID INSECTICIDES; RISKS		Univ Sussex, Sch Life Sci, Falmer BN1 9QG, England	University of Sussex	Goulson, D (corresponding author), Univ Sussex, Sch Life Sci, Falmer BN1 9QG, England.	d.goulson@sussex.ac.uk	Goulson, David/A-2462-2010	Goulson, David/0000-0003-4421-2876				Carson Rachel, 1994, SILENT SPRING; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Sur Robin, 2003, Bulletin of Insectology, V56, P35; Tapparo A, 2012, ENVIRON SCI TECHNOL, V46, P2592, DOI 10.1021/es2035152; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; van der Sluijs JP, 2015, ENVIRON SCI POLLUT R, V22, P148, DOI 10.1007/s11356-014-3229-5; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374	8	81	86	5	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					295	296		10.1038/nature13642	http://dx.doi.org/10.1038/nature13642			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030159				2022-12-28	WOS:000338992200020
J	Levens, D; Larson, DR				Levens, David; Larson, Daniel R.			A New Twist on Transcriptional Bursting	CELL			English	Editorial Material							EXPRESSION; GENE	Transcriptional bursting has been observed across species and is one of the primary causes of variable gene expression in cells and tissue. In this issue, Chong et al. describe how DNA topology results in transcriptional bursting in E. coli.	[Levens, David; Larson, Daniel R.] NIH, Ctr Canc Res, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Larson, DR (corresponding author), NIH, Ctr Canc Res, Bldg 10, Bethesda, MD 20814 USA.	dan.larson@nih.gov	Larson, Daniel R/B-9829-2008; Levens, David/C-9216-2009	Larson, Daniel R/0000-0001-9253-3055; Levens, David/0000-0002-7616-922X	NATIONAL CANCER INSTITUTE [ZIABC011383] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CA999999] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Chong SS, 2014, CELL, V158, P314, DOI 10.1016/j.cell.2014.05.038; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Larson DR, 2013, ELIFE, V2, DOI 10.7554/eLife.00750; Larson DR, 2011, CURR OPIN GENET DEV, V21, P591, DOI 10.1016/j.gde.2011.07.010; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Ma J, 2013, SCIENCE, V340, P1580, DOI 10.1126/science.1235441; Sanchez A, 2013, SCIENCE, V342, P1188, DOI 10.1126/science.1242975; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817	10	5	5	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					241	242		10.1016/j.cell.2014.06.042	http://dx.doi.org/10.1016/j.cell.2014.06.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036624	Green Accepted, Bronze			2022-12-28	WOS:000340943600003
J	Orritt, R				Orritt, Rachel			PERSONAL VIEW Dog ownership has unknown risks but known health benefits: we need evidence based policy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BITES; ATTACKS		Lincoln Univ, Sch Psychol, Lincoln LN6 7TS, England	University of Lincoln	Orritt, R (corresponding author), Lincoln Univ, Sch Psychol, Lincoln LN6 7TS, England.	rorritt@lincoln.ac.uk		Orritt, Rachel/0000-0001-8396-7679				Besser R, 2007, BRIT MED J, V334, P425, DOI 10.1136/bmj.39129.471505.94; Christian HE, 2013, J PHYS ACT HEALTH, V10, P750, DOI 10.1123/jpah.10.5.750; Douglas K.S., 1999, LEGAL CRIMINOL PSYCH, V4, P149, DOI [https://doi.org/10.1348/135532599167824, DOI 10.1348/135532599167824]; Headey B, 1999, SOC INDIC RES, V47, P233, DOI 10.1023/A:1006892908532; HSCIC, 2012, HOSP STAT ADM PAT CA; Klaassen B, 1996, INJURY, V27, P89, DOI 10.1016/0020-1383(96)83411-5; McConnell AR, 2011, J PERS SOC PSYCHOL, V101, P1239, DOI 10.1037/a0024506; Morgan M, 2007, BMJ-BRIT MED J, V334, P413, DOI 10.1136/bmj.39105.659919.BE; THOMAS HF, 1990, J ROY SOC HEALTH, V110, P173, DOI 10.1177/146642409011000508; Wells DL, 2007, BRIT J HEALTH PSYCH, V12, P145, DOI 10.1348/135910706X103284	10	6	6	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2014	349								g4081	10.1136/bmj.g4081	http://dx.doi.org/10.1136/bmj.g4081			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL7PI	25034209	Green Submitted			2022-12-28	WOS:000339326400002
J	Preitner, N; Quan, J; Nowakowski, DW; Hancock, ML; Shi, JH; Tcherkezian, J; Young-Pearse, TL; Flanagan, JG				Preitner, Nicolas; Quan, Jie; Nowakowski, Dan W.; Hancock, Melissa L.; Shi, Jianhua; Tcherkezian, Joseph; Young-Pearse, Tracy L.; Flanagan, John G.			APC Is an RNA-Binding Protein, and Its Interactome Provides a Link to Neural Development and Microtubule Assembly	CELL			English	Article							TUMOR-SUPPRESSOR PROTEIN; POLYPOSIS-COLI PROTEIN; CANONICAL WNT PATHWAY; BETA-TUBULIN; CELL-MIGRATION; MESSENGER-RNAS; GENE; CYTOSKELETON; TRANSLATION; GROWTH	Adenomatous polyposis coli (APC) is a microtubule plus-end scaffolding protein important in biology and disease. APC is implicated in RNA localization, although the mechanisms and functional significance remain unclear. We show APC is an RNA-binding protein and identify an RNA interactome by HITS-CLIP. Targets were highly enriched for APC-related functions, including microtubule organization, cell motility, cancer, and neurologic disease. Among the targets is beta 2B-tubulin, known to be required in human neuron and axon migration. We show beta 2B-tubulin is synthesized in axons and localizes preferentially to dynamic microtubules in the growth cone periphery. APC binds the beta 2B-tubulin 3' UTR; experiments interfering with this interaction reduced beta 2B-tubulin mRNA axonal localization and expression, depleted dynamic microtubules and the growth cone periphery, and impaired neuron migration. These results identify APC as a platform binding functionally related protein and RNA networks, and suggest a self-organizing model for the microtubule to localize synthesis of its own subunits.	[Preitner, Nicolas; Quan, Jie; Nowakowski, Dan W.; Hancock, Melissa L.; Shi, Jianhua; Flanagan, John G.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Preitner, Nicolas; Quan, Jie; Nowakowski, Dan W.; Hancock, Melissa L.; Shi, Jianhua; Flanagan, John G.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Tcherkezian, Joseph] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Lab Therapeut Dev, Montreal, PQ H3G 1Y6, Canada; [Young-Pearse, Tracy L.] Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; McGill University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	flanagan@hms.harvard.edu	Flanagan, John/AAM-2995-2020; Shi, Jianhua/L-8463-2016	Shi, Jianhua/0000-0002-5351-406X; Young-Pearse, Tracy/0000-0001-7846-1542	NIH; Charles A. King Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD029417] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069913] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Kyoko Okada, Philippe Roux, David Van Vactor, Peter Park, Xinmin Li, Rebecca Meyer, Inke Nathke, Olivier Pertz, Antonina Andreeva, and Alexey Murzin for help, reagents, advice, and/or comments on the manuscript. We thank Jiangwen Zhang, Christian Daly, and the Bauer Center for Genomic Research for support with deep sequencing and Jennifer Waters, Josh Rosenberg, Lauren Piedmont, Lara Petrak, Gaudenz Danuser, Hunter Elliott, Yichao Xu, the Nikon Imaging Center, and the Image and Data Analysis Core at Harvard Medical School for imaging equipment and expertise. This work was supported by grants from the NIH and a fellowship from the Charles A. King Trust (to N.P.).	Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Bahi-Buisson N, 2014, BRAIN, V137, P1676, DOI 10.1093/brain/awu082; Barth AIM, 2008, SEMIN CELL DEV BIOL, V19, P245, DOI 10.1016/j.semcdb.2008.02.003; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Burgess AW, 2011, EXP CELL RES, V317, P2748, DOI 10.1016/j.yexcr.2011.08.010; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cederquist GY, 2012, HUM MOL GENET, V21, P5484, DOI 10.1093/hmg/dds393; Chang L, 2006, J CELL BIOL, V172, P747, DOI 10.1083/jcb.200511033; Chen YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024335; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Condeelis J, 2005, BIOL CELL, V97, P97; Cui DH, 2005, MOL PSYCHIATR, V10, P669, DOI 10.1038/sj.mp.4001653; Darnell RB, 2013, ANNU REV NEUROSCI, V36, P243, DOI 10.1146/annurev-neuro-062912-114322; Deka J, 1999, ONCOGENE, V18, P5654, DOI 10.1038/sj.onc.1202944; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Dyson HJ, 2012, MOL BIOSYST, V8, P97, DOI 10.1039/c1mb05258f; Eng H, 1999, J NEUROSCI, V19, P1; Gerdes JM, 2005, CELL MOL LIFE SCI, V62, P1556, DOI 10.1007/s00018-005-5007-5; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Hall KB, 2002, CURR OPIN STRUC BIOL, V12, P283, DOI 10.1016/S0959-440X(02)00323-8; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Jones KJ, 2008, GLIA, V56, P1401, DOI 10.1002/glia.20707; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Kalkman HO, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-10; Karkare S, 2006, APPL MICROBIOL BIOT, V71, P575, DOI 10.1007/s00253-006-0434-2; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006; Marin O, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001834; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Minde DP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-101; Myers KA, 2006, NEUROSCIENTIST, V12, P107, DOI 10.1177/1073858405283428; Nathke I, 2006, NAT REV CANCER, V6, P967, DOI 10.1038/nrc2010; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Pellegrini F, 2005, CANCER INVEST, V23, P264, DOI 10.1081/CNV-200055970; Qian J, 2008, GASTROENTEROLOGY, V135, P152, DOI 10.1053/j.gastro.2008.03.074; Romaniello R, 2012, DEV MED CHILD NEUROL, V54, P765, DOI 10.1111/j.1469-8749.2012.04316.x; Salinas PC, 2007, TRENDS CELL BIOL, V17, P333, DOI 10.1016/j.tcb.2007.07.003; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Tischfield MA, 2010, BIOSCIENCE REP, V30, P319, DOI 10.1042/BSR20100025; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j; Xing L, 2013, TRAFFIC, V14, P2, DOI 10.1111/tra.12004; Yasuda K, 2013, J CELL BIOL, V203, P737, DOI 10.1083/jcb.201306058; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	52	110	112	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					368	382		10.1016/j.cell.2014.05.042	http://dx.doi.org/10.1016/j.cell.2014.05.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036633	Green Accepted, Bronze			2022-12-28	WOS:000340943600016
J	Wolfe, MS; Selkoe, DJ				Wolfe, Michael S.; Selkoe, Dennis J.			gamma-Secretase: A Horseshoe Structure Brings Good Luck	CELL			English	Editorial Material							ALZHEIMERS-DISEASE	The intramembrane protease gamma-secretase is a key player in signaling and Alzheimer's disease, but its structural features have remained obscure. A structure reported recently reveals a horseshoe-shaped arrangement of 19 transmembrane helices and an extracellular domain positioned for substrate recognition. This advance bodes well for a finer resolution before long.	[Wolfe, Michael S.; Selkoe, Dennis J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wolfe, MS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	mswolfe@partners.org; dselkoe@partners.org						Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Chen AC, 2010, J BIOL CHEM, V285, P11378, DOI 10.1074/jbc.M109.088815; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Lu P, 2014, NATURE; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	10	5	7	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					247	249		10.1016/j.cell.2014.06.043	http://dx.doi.org/10.1016/j.cell.2014.06.043			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036627	Bronze			2022-12-28	WOS:000340943600006
J	Fletcher, RH				Fletcher, Robert H.			Review: Evidence for the effect of vitamin D supplementation on many patient outcomes was assessed	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Fletcher, RH (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Otten J.J., 2006, DIETARY REFERENCE IN, DOI DOI 10.17226/11537; Wood J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2215; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2							JC4	10.7326/0003-4819-161-2-201407150-02004	http://dx.doi.org/10.7326/0003-4819-161-2-201407150-02004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023270				2022-12-28	WOS:000339764600003
J	Beaglehole, R; Bonita, R; Ezzati, M; Alleyne, G; Dain, K; Kishore, SP; Horton, R				Beaglehole, Robert; Bonita, Ruth; Ezzati, Majid; Alleyne, George; Dain, Katie; Kishore, Sandeep P.; Horton, Richard			NCD Countdown 2025: accountability for the 25 x 25 NCD mortality reduction target	LANCET			English	Editorial Material							NONCOMMUNICABLE DISEASES		[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC,PHE Ctr Environm & Hlth, London, England; [Alleyne, George] Pan Amer Hlth Org, Washington, DC USA; [Dain, Katie] NCD Alliance, London, England; [Kishore, Sandeep P.] Young Profess Chron Dis Network, New Haven, CT USA; [Horton, Richard] The Lancet, London NW1 7BY, England	University of Auckland; Imperial College London; Pan American Health Organization	Beaglehole, R (corresponding author), 42 Albert Rd, Auckland 0624, New Zealand.	r.beaglehole@auckland.ac.nz			MRC [G0801056] Funding Source: UKRI; Medical Research Council [G0801056] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2014, LANCET; Beaglehole R, 2013, LANCET, V381, P602, DOI 10.1016/S0140-6736(13)60101-4; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Healthy Caribbean Coalition, 2014, RESP NCDS CAR COMM; Requejo JH, 2014, LANCET; Smith R, 2014, LANCET, V383, P1446, DOI 10.1016/S0140-6736(13)61808-5; The NCD Alliance, 2013, NONC DIS JOINT FIGHT; UN Secretary General, 2014, POST 2015 ACC SYST M; UNICEF, 2014, TRANSMONEE 2014 GUID; WHO, 2010, GLOB STAT REP NONC D; World Health Organization, 2013, GLOB ACT PLAN PREV C	11	42	45	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					105	107		10.1016/S0140-6736(14)61091-6	http://dx.doi.org/10.1016/S0140-6736(14)61091-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1YC	25012115				2022-12-28	WOS:000338921500008
J	Gardner, C				Gardner, Caleb			The burden of the mystery: the education of a physician	LANCET			English	Editorial Material									Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Gardner, C (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.	gardner.caleb@gmail.com						Keats John, 1994, COMPLETE POEMS	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					124	125		10.1016/S0140-6736(14)61152-1	http://dx.doi.org/10.1016/S0140-6736(14)61152-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1YC	25025103				2022-12-28	WOS:000338921500020
J	Hsieh, MM; Fitzhugh, CD; Weitzel, RP; Link, ME; Coles, WA; Zhao, XC; Rodgers, GP; Powell, JD; Tisdale, JF				Hsieh, Matthew M.; Fitzhugh, Courtney D.; Weitzel, R. Patrick; Link, Mary E.; Coles, Wynona A.; Zhao, Xiongce; Rodgers, Griffin P.; Powell, Jonathan D.; Tisdale, John F.			Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MARROW-TRANSPLANTATION; LONG-TERM; MIXED CHIMERISM; MAMMALIAN TARGET; DISEASE; ANEMIA; THALASSEMIA; SURVIVAL; FAILURE; INDIVIDUALS	IMPORTANCE Myeloablative allogeneic hematopoietic stem cell transplantation (HSCT) is curative for children with severe sickle cell disease, but toxicitymay be prohibitive for adults. Nonmyeloablative transplantation has been attempted with degrees of preparative regimen intensity, but graft rejection and graft-vs-host disease remain significant. OBJECTIVE To determine the efficacy, safety, and outcome on end-organ function with this low-intensity regimen for sickle cell phenotype with or without thalassemia. DESIGN, SETTING, AND PARTICIPANTS From July 16, 2004, to October 25, 2013, 30 patients aged 16-65 years with severe disease enrolled in this nonmyeloablative transplant study, consisting of alemtuzumab (1mg/kg in divided doses), total-body irradiation (300 cGy), sirolimus, and infusion of unmanipulated filgrastim mobilized peripheral blood stem cells (5.5-31.7 x 10(6) cells/kg) from human leukocyte antigen-matched siblings. MAIN OUTCOMES AND MEASURES The primary end point was treatment success at 1 year after the transplant, defined as a full donor-type hemoglobin for patients with sickle cell disease and transfusion independence for patients with thalassemia. The secondary end points were the level of donor leukocyte chimerism; incidence of acute and chronic graft-vs-host disease; and sickle cell-thalassemia disease-free survival, immunologic recovery, and changes in organ function, assessed by annual brain imaging, pulmonary function, echocardiographic image, and laboratory testing. RESULTS Twenty-nine patients survived a median 3.4 years (range, 1-8.6), with no nonrelapse mortality. One patient died from intracranial bleeding after relapse. As of October 25, 2013, 26 patients (87%) had long-term stable donor engraftment without acute or chronic graft-vs-host disease. The mean donor T-cell levelwas 48%(95% CI, 34%-62%); the myeloid chimerism levels, 86%(95% CI, 70%-100%). Fifteen engrafted patients discontinued immunosuppression medication with continued stable donor chimerism and no graft-vs-host disease. The normalized hemoglobin and resolution of hemolysis among engrafted patients were accompanied by stabilization in brain imaging, a reduction of echocardiographic estimates of pulmonary pressure, and allowed for phlebotomy to reduce hepatic iron. The mean annual hospitalization rate was 3.23 (95% CI, 1.83-4.63) the year before, 0.63 (95% CI, 0.26-1.01) the first year after, 0.19 (95% CI, 0-0.45) the second year after, and0.11 (95% CI, 0.04-0.19) the third year after transplant. For patients taking long-term narcotics, the mean use per week was 639 mg (95% CI, 220-1058) of intravenous morphine-equivalent dose the week of their transplants and 140 mg (95% CI, 56225) 6 months after transplant. There were 38 serious adverse events: pain and related management, infections, abdominal events, and sirolimus related toxic effects. CONCLUSIONS AND RELEVANCE Among 30 patients with sickle cell phenotype with or without thalassemia who underwent nonmyeloablative allogeneic HSCT, the rate of stable mixed-donor chimerism was high and allowed for complete replacement with circulating donor red blood cells among engrafted participants. Further accrual and follow-up are required to assess longer-term clinical outcomes, adverse events, and transplant tolerance.	[Hsieh, Matthew M.; Fitzhugh, Courtney D.; Weitzel, R. Patrick; Link, Mary E.; Coles, Wynona A.; Rodgers, Griffin P.; Tisdale, John F.] NIDDK, Mol & Clin Hematol Branch, Bethesda, MD USA; [Hsieh, Matthew M.; Fitzhugh, Courtney D.; Weitzel, R. Patrick; Link, Mary E.; Coles, Wynona A.; Rodgers, Griffin P.; Tisdale, John F.] NHLBI, Bethesda, MD 20892 USA; [Zhao, Xiongce] NIDDK, Off Clin Director, Bethesda, MD USA; [Powell, Jonathan D.] Johns Hopkins Med Inst, Sidney Kimmel Canc Ctr, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Johns Hopkins University; Johns Hopkins Medicine	Tisdale, JF (corresponding author), NIH, 9000 Rockville Pike,Bldg 10,9N 112, Bethesda, MD 20892 USA.	johntis@mail.nih.gov			intramural research program of the National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006191, ZIAHL006177, ZIAHL006007] Funding Source: NIH RePORTER	intramural research program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by the intramural research program of the National Institute of Diabetes and Digestive and Kidney Diseases and the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH).	Anasetti C, 2012, NEW ENGL J MED, V367, P1487, DOI 10.1056/NEJMoa1203517; Andreani M, 2000, BONE MARROW TRANSPL, V25, P401, DOI 10.1038/sj.bmt.1702151; Andreani M, 2011, HAEMATOL-HEMATOL J, V96, P128, DOI 10.3324/haematol.2010.031013; Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Anurathapan U, 2013, BIOL BLOOD MARROW TR, V19, P1259, DOI 10.1016/j.bbmt.2013.04.023; Bar M, 2013, BIOL BLOOD MARROW TR, V19, P949, DOI 10.1016/j.bbmt.2013.03.001; Bernaudin F, 2007, BLOOD, V110, P2749, DOI 10.1182/blood-2007-03-079665; Bolanos-Meade J, 2012, BLOOD, V120, P4285, DOI 10.1182/blood-2012-07-438408; Chalandon Y, 2010, BONE MARROW TRANSPL, V45, P558, DOI 10.1038/bmt.2009.177; Childs R, 1999, BLOOD, V94, P3234, DOI 10.1182/blood.V94.9.3234.421k16_3234_3241; Fitzhugh CD, 2013, BONE MARROW TRANSPL, V48, P1335, DOI 10.1038/bmt.2013.60; Fitzhugh CD, 2012, BLOOD, V119, P5671, DOI 10.1182/blood-2011-11-392654; Fitzhugh CD, 2009, CYTOTHERAPY, V11, P464, DOI 10.1080/14653240902849788; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Hsieh MM, 2011, BLOOD, V118, P1197, DOI 10.1182/blood-2011-01-332510; Hsieh MM, 2009, NEW ENGL J MED, V361, P2309, DOI 10.1056/NEJMoa0904971; Iannone R, 2003, BIOL BLOOD MARROW TR, V9, P519, DOI 10.1016/S1083-8791(03)00192-7; Kang EM, 2002, BLOOD, V99, P850, DOI 10.1182/blood.V99.3.850; Krishnamurti L, 2008, BIOL BLOOD MARROW TR, V14, P1270, DOI 10.1016/j.bbmt.2008.08.016; Marsh RA, 2010, BLOOD, V116, P5824, DOI 10.1182/blood-2010-04-282392; Nakamura R, 2002, BONE MARROW TRANSPL, V30, P235, DOI 10.1038/sj.bmt.1703648; Nollet F, 2001, BONE MARROW TRANSPL, V28, P511, DOI 10.1038/sj.bmt.1703162; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; POWARS DR, 1991, ANN INTERN MED, V115, P614, DOI 10.7326/0003-4819-115-8-614; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; Quinn CT, 2004, BLOOD, V103, P4023, DOI 10.1182/blood-2003-11-3758; Srinivasan R, 2006, BRIT J HAEMATOL, V133, P305, DOI 10.1111/j.1365-2141.2006.06019.x; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019; van Besien K, 2000, BONE MARROW TRANSPL, V26, P445, DOI 10.1038/sj.bmt.1702518; Vermylen C, 1998, BONE MARROW TRANSPL, V22, P1, DOI 10.1038/sj.bmt.1701291; Waickman AT, 2012, J IMMUNOL, V188, P4721, DOI 10.4049/jimmunol.1103143; Walters MC, 2001, BIOL BLOOD MARROW TR, V7, P665, DOI 10.1053/bbmt.2001.v7.pm11787529; Walters MC, 1996, NEW ENGL J MED, V335, P369, DOI 10.1056/NEJM199608083350601; Wierenga KJJ, 2001, LANCET, V357, P680, DOI 10.1016/S0140-6736(00)04132-5; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163	36	212	216	2	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					48	56		10.1001/jama.2014.7192	http://dx.doi.org/10.1001/jama.2014.7192			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	25058217	Green Accepted			2022-12-28	WOS:000338131100020
J	Das, P; Horton, R				Das, Pamela; Horton, Richard			Bringing sex workers to the centre of the HIV response	LANCET			English	Editorial Material																		Baral SD, 2014, LANCET; Beyrer C, 2014, LANCET; Decker MR, 2014, LANCET; Kerrigan D, 2014, LANCET; Overs S, 2014, LANCET; Poteat T, 2014, LANCET; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Shannon K., 2014, LANCET	8	20	20	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					3	4		10.1016/S0140-6736(14)61064-3	http://dx.doi.org/10.1016/S0140-6736(14)61064-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX8IW	25059937				2022-12-28	WOS:000347154200006
J	Amirthalingam, G; Andrews, N; Campbell, H; Ribeiro, S; Kara, E; Donegan, K; Fry, NK; Miller, E; Ramsay, M				Amirthalingam, Gayatri; Andrews, Nick; Campbell, Helen; Ribeiro, Sonia; Kara, Edna; Donegan, Katherine; Fry, Norman K.; Miller, Elizabeth; Ramsay, Mary			Effectiveness of maternal pertussis vaccination in England: an observational study	LANCET			English	Article							DIPHTHERIA; TETANUS; WOMEN; IMMUNIZATION; INFANTS	Background In October, 2012, a pertussis vaccination programme for pregnant women was introduced in response to an outbreak across England. We aimed to assess the vaccine effectiveness and the overall effect of the vaccine programme in preventing pertussis in infants. Methods We undertook an analysis of laboratory-confirmed cases and hospital admissions for pertussis in infants between Jan 1, 2008, and Sept 30, 2013, using data submitted to Public Health England as part of its enhanced surveillance of pertussis in England, to investigate the effect of the vaccination programme. We calculated vaccine effectiveness by comparing vaccination status for mothers in confirmed cases with estimates of vaccine coverage for the national population of pregnant women, based on data from the Clinical Practice Research Datalink. Findings The monthly total of confirmed cases peaked in October, 2012 (1565 cases), and subsequently fell across all age groups. For the first 9 months of 2013 compared with the same period in 2012, the greatest proportionate fall in confirmed cases (328 cases in 2012 vs 72 cases in 2013, -78%, 95% CI -72 to -83) and in hospitalisation admissions (440 admissions in 2012 vs 140 admissions in 2013, -68%, -61 to -74) occurred in infants younger than 3 months, although the incidence remained highest in this age group. Infants younger than 3 months were also the only age group in which there were fewer cases in 2013 than in 2011 (118 cases in 2011 vs 72 cases in 2013), before the resurgence. 26 684 women included in the Clinical Practice Research Datalink had a livebirth between Oct 1, 2012 and Sept 3, 2013; the average vaccine coverage before delivery based on this cohort was 64%. Vaccine effectiveness based on 82 confirmed cases in infants born from Oct 1, 2012, and younger than 3 months at onset was 91% (95% CI 84 to 95). Vaccine effectiveness was 90% (95% CI 82 to 95) when the analysis was restricted to cases in children younger than 2 months. Interpretation Our assessment of the programme of pertussis vaccination in pregnancy in England is consistent with high vaccine effectiveness. This effectiveness probably results from protection of infants by both passive antibodies and reduced maternal exposure, and will provide valuable information to international policy makers.	[Amirthalingam, Gayatri; Campbell, Helen; Ribeiro, Sonia; Kara, Edna; Miller, Elizabeth; Ramsay, Mary] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London NW9 5EQ, England; [Andrews, Nick] Publ Hlth England, Stat Modelling & Econ Dept, London NW9 5EQ, England; [Fry, Norman K.] Publ Hlth England, Resp & Vaccine Preventable Bacterial Reference Un, London NW9 5EQ, England; [Donegan, Katherine] Med & Healthcare Prod Regulatory Agcy, Vigilance & Risk Management Med, London, England	Public Health England; Public Health England; Public Health England; The Medicines & Healthcare Products Regulatory Agency	Campbell, H (corresponding author), Publ Hlth England, Immunisat Hepatitis & Blood Safety, London NW9 5EQ, England.	helen.campbell@phe.gov.uk	Datta, Samik/S-3822-2016	Donegan, Katherine/0000-0002-3488-9130	Public Health England	Public Health England	Public Health England.	Amirthalingam G, 2013, ARCH DIS CHILD, V98, P552, DOI 10.1136/archdischild-2012-302968; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P301; Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P1424; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P385; Burns DL, 2014, J INFECT DIS, V209, pS32, DOI 10.1093/infdis/jit491; Campbell H, 2012, EMERG INFECT DIS, V18, P38, DOI 10.3201/eid1801.110784; Campbell P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035874; Centers for Disease Control and Prevention, TDAP PREGN WOM INF P; Crowcroft NS, 2003, ARCH DIS CHILD, V88, P802, DOI 10.1136/adc.88.9.802; Dalhousie University, PERT MAT IMM STUD; Davies S.C., 2012, TEMPORARY PROGRAMME; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Donegan K, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4219; Douglas IJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1936; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; Fry NK, 2013, J MED MICROBIOL, V62, P1281, DOI 10.1099/jmm.0.062000-0; Halperin BA, 2011, CLIN INFECT DIS, V53, P885, DOI 10.1093/cid/cir538; Healy CM, 2013, CLIN INFECT DIS, V56, P539, DOI 10.1093/cid/cis923; Healy CM, 2004, J INFECT DIS, V190, P335, DOI 10.1086/421033; Leuridan E, 2011, PEDIATR INFECT DIS J, V30, P608, DOI 10.1097/INF.0b013e3182093814; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; National Institute of Allergy and Infectious Diseases, PERT VACC HLTH PREGN; Office For National Statistics, 2012, STAT B BIRTHS ENGL W; Public Health England, INFL VACC UPT GP PAT; Public Health England, 2012, PERT VACC PROGR PREG, V7; Warfel JM, 2012, INFECT IMMUN, V80, P1530, DOI 10.1128/IAI.06310-11; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; Wiley KE, 2013, VACCINE, V31, P618, DOI 10.1016/j.vaccine.2012.11.052	29	471	483	1	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2014	384	9953					1521	1528		10.1016/S0140-6736(14)60686-3	http://dx.doi.org/10.1016/S0140-6736(14)60686-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9MO	25037990				2022-12-28	WOS:000343899600026
J	Wilder-Smith, A				Wilder-Smith, Annelies			Dengue vaccines: dawning at last?	LANCET			English	Editorial Material							IMMUNOGENICITY; RECOMBINANT; SAFETY; TRIAL		[Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 308232, Singapore; [Wilder-Smith, Annelies] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Wilder-Smith, Annelies] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Ruprecht Karls University Heidelberg; Umea University	Wilder-Smith, A (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 308232, Singapore.	awilder-smith@ntu.edu.sg	Wilder-Smith, Annelies/F-8751-2015	Wilder-Smith, Annelies/0000-0003-0362-5375				Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Capeding MR, 2014, LANCET; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Gubler D, 2011, VACCINE COMPANION, V4, P1; Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003; Halstead SB, 2013, VACCINE, V31, P4501, DOI 10.1016/j.vaccine.2013.06.079; Lam SK, 2011, VACCINE, V29, P9417, DOI 10.1016/j.vaccine.2011.08.047; Leo YS, 2012, HUM VACC IMMUNOTHER, V8, P1259, DOI 10.4161/hv.21224; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Qiao M, 2011, AM J TROP MED HYG, V85, P724, DOI 10.4269/ajtmh.2011.10-0436; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Sirivichayakul C, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-48; Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888; Wilder-Smith A, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0404-2	14	32	32	2	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2014	384	9951					1327	1329		10.1016/S0140-6736(14)61142-9	http://dx.doi.org/10.1016/S0140-6736(14)61142-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NH	25018119	Green Accepted			2022-12-28	WOS:000343004000007
J	Fischer, ES; Bohm, K; Lydeard, JR; Yang, HD; Stadler, MB; Cavadini, S; Nagel, J; Serluca, F; Acker, V; Lingaraju, GM; Tichkule, RB; Schebesta, M; Forrester, WC; Schirle, M; Hassiepen, U; Ottl, J; Hild, M; Beckwith, REJ; Harper, JW; Jenkins, JL; Thoma, NH				Fischer, Eric S.; Boehm, Kerstin; Lydeard, John R.; Yang, Haidi; Stadler, Michael B.; Cavadini, Simone; Nagel, Jane; Serluca, Fabrizio; Acker, Vincent; Lingaraju, Gondichatnahalli M.; Tichkule, Ritesh B.; Schebesta, Michael; Forrester, William C.; Schirle, Markus; Hassiepen, Ulrich; Ottl, Johannes; Hild, Marc; Beckwith, Rohan E. J.; Harper, J. Wade; Jenkins, Jeremy L.; Thomae, Nicolas H.			Structure of the DDBI-CRBN E3 ubiquitin ligase in complex with thalidomide	NATURE			English	Article							MULTIPLE-MYELOMA; CONGENITAL ABNORMALITIES; MENTAL-RETARDATION; LENALIDOMIDE; POMALIDOMIDE; CEREBLON; PROTEIN; CELLS; RECOGNITION; CANCER	In the 1950s, the drug thalidomide, administered as a sedative to pregnant women, led to the birth of thousands of children with multiple defects. Despite the teratogenicity of thalidomide and its derivatives lenalidomide and pomalidomide, these immunomodulatory drugs (IMiDs) recently emerged as effective treatments for multiple myeloma and 5q-deletion-associated dysplasia. IMiDs target the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4(CRBN)) and promote the ubiquitination of the IKAROS family transcription factors IKZF1 and IKZF3 by CRL4(CRBN). Here we present crystal structures of the DDB1-CRBN complex bound to thalidomide, lenalidomide and pomalidomide. The structure establishes that CRBN is a substrate receptor within CRL4(CRBN) and enantioselectively binds IMiDs. Using an unbiased screen, we identified the homeobox transcription factor MEIS2 as an endogenous substrate of CRL4(CRBN). Our studies suggest that IMiDs block endogenous substrates (MEIS2) from binding to CRL4(CRBN) while the ligase complex is recruiting IKZF1 or IKZF3 for degradation. This dual activity implies that small molecules can modulate an E3 ubiquitin ligase and thereby upregulate or downregulate the ubiquitination of proteins.	[Fischer, Eric S.; Boehm, Kerstin; Stadler, Michael B.; Cavadini, Simone; Lingaraju, Gondichatnahalli M.; Thomae, Nicolas H.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Fischer, Eric S.; Boehm, Kerstin; Stadler, Michael B.; Cavadini, Simone; Lingaraju, Gondichatnahalli M.; Thomae, Nicolas H.] Univ Basel, CH-4003 Basel, Switzerland; [Lydeard, John R.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Yang, Haidi; Nagel, Jane; Serluca, Fabrizio; Tichkule, Ritesh B.; Schebesta, Michael; Forrester, William C.; Schirle, Markus; Hild, Marc; Beckwith, Rohan E. J.; Jenkins, Jeremy L.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Stadler, Michael B.] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland; [Acker, Vincent; Hassiepen, Ulrich; Ottl, Johannes] Novartis Pharma AG, Inst Biomed Res, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel; Harvard University; Harvard Medical School; Novartis; Swiss Institute of Bioinformatics; Novartis; Universita della Svizzera Italiana	Thoma, NH (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	nicolas.thoma@fmi.ch	高, 雨莉/HGU-8187-2022	Harper, Jeffrey/0000-0002-6944-7236; Fischer, Eric S./0000-0001-7337-6306; Thoma, Nicolas/0000-0003-2685-906X	Novartis Research Foundation; European Research Council [260481-MoBa-CS]; National Institutes of Health [AG011085]; Damon Runyon Postdoctoral Fellowship [DRG 2061-10]; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Novartis Research Foundation; European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Postdoctoral Fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Novartis Research Foundation and grants to N.H.T. from the European Research Council (ERC-2010-StG 260481-MoBa-CS) and to J.W.H. from the National Institutes of Health (AG011085). J.R.L. was supported by a Damon Runyon Postdoctoral Fellowship (DRG 2061-10). We acknowledge J. Reilly for performing immobilized artificial membrane (IAM) experiments. We thank J. Tallarico, J. Porter, W. Sellers, S. Cottens and M. Renatus for help and comments. D. Hess, R. Sack and J. Seebacher for the mass spectrometry analysis and J. Keusch and H. Gut for support. We thank W. Kaelin for kindly providing the IKZF1 reporter plasmid (pCMV-IRES-Renilla luciferase-IRES-Gateway-firefly luciferase). Part of this work was performed at the Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bartlett JB, 2004, NAT REV CANCER, V4, P314, DOI 10.1038/nrc1323; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Crowley MA, 2010, AM J MED GENET A, V152A, P1326, DOI 10.1002/ajmg.a.33375; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Hofmeister CC, 2011, J CLIN ONCOL, V29, P3427, DOI 10.1200/JCO.2010.32.4962; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Hur S, 2006, J BIOL CHEM, V281, P38969, DOI 10.1074/jbc.R600034200; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LENZ W, 1962, LANCET, V1, P45; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; MCBRIDE WG, 1961, LANCET, V2, P1358; Melchert M, 2007, INT J BIOCHEM CELL B, V39, P1489, DOI 10.1016/j.biocel.2007.01.022; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pan BQ, 2012, PHARMACOL THERAPEUT, V136, P56, DOI 10.1016/j.pharmthera.2012.07.004; Roche S, 2012, J CHROMATOGR B, V902, P16, DOI 10.1016/j.jchromb.2012.06.008; Ruchelman AL, 2013, BIOORG MED CHEM LETT, V23, P360, DOI 10.1016/j.bmcl.2012.10.071; Scrima A, 2011, FEBS LETT, V585, P2818, DOI 10.1016/j.febslet.2011.04.064; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; SHESKIN J, 1965, CLIN PHARMACOL THER, V6, P303; Shortt J, 2013, ONCOGENE, V32, P4191, DOI 10.1038/onc.2012.599; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Xu GQ, 2013, J BIOL CHEM, V288, P29573, DOI 10.1074/jbc.M113.472092; Zhang L, 2012, CELL CYCLE, V11, P4378, DOI 10.4161/cc.22688; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228; Zhou SF, 2005, EUR J DRUG METAB PH, V30, P49, DOI 10.1007/BF03226408; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	42	530	585	20	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					49	+		10.1038/nature13527	http://dx.doi.org/10.1038/nature13527			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043012	Green Accepted, Green Submitted			2022-12-28	WOS:000339908000028
J	Schlicht, KF; Mann, K; Jungmann, F; Kaes, J; Post, F; Munzel, T; Lieb, K				Schlicht, Konrad F.; Mann, Klaus; Jungmann, Florian; Kaes, Joachim; Post, Felix; Muenzel, Thomas; Lieb, Klaus			A 48-year-old woman with panic attacks	LANCET			English	Editorial Material							PULMONARY-EMBOLISM		[Schlicht, Konrad F.; Mann, Klaus; Lieb, Klaus] Univ Med Ctr Mainz, Dept Psychiat & Psychotherapy, D-55131 Mainz, Germany; [Jungmann, Florian] Univ Med Ctr Mainz, Dept Radiol, D-55131 Mainz, Germany; [Kaes, Joachim; Post, Felix; Muenzel, Thomas] Univ Med Ctr Mainz, Dept Cardiol & Angiol, D-55131 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Lieb, K (corresponding author), Univ Med Ctr Mainz, Dept Psychiat & Psychotherapy, Untere Zahlbacher Str 8, D-55131 Mainz, Germany.	klaus.lieb@unimedizin-mainz.de	Munzel, Thomas/A-2912-2014	Munzel, Thomas/0000-0001-5503-4150				Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Goldhaber SZ, 2012, LANCET, V379, P1835, DOI 10.1016/S0140-6736(11)61904-1; Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa1302097	3	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					280	280		10.1016/S0140-6736(14)60882-5	http://dx.doi.org/10.1016/S0140-6736(14)60882-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL8JI	25042236				2022-12-28	WOS:000339384100030
J	Deyo, RA; Jarvik, JG; Chou, R				Deyo, Richard A.; Jarvik, Jeffrey G.; Chou, Roger			RATIONAL IMAGING Low back pain in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; LUMBAR SPINE; RED FLAGS; METAANALYSIS; STRATEGIES; OUTCOMES; CANCER		[Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97239 USA; [Deyo, Richard A.; Chou, Roger] Oregon Hlth & Sci Univ, Dept Internal Med, Portland, OR 97239 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97239 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA; [Deyo, Richard A.; Jarvik, Jeffrey G.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Jarvik, Jeffrey G.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Jarvik, Jeffrey G.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Chou, Roger] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Oregon Health & Science University	Deyo, RA (corresponding author), Oregon Hlth & Sci Univ, Dept Family Med, Mail Code FM, Portland, OR 97239 USA.	deyor@ohsu.edu	Jarvik, Jeffrey/AAL-4292-2021	Chou, Roger/0000-0001-9889-8610				Ash LM, 2008, AM J NEURORADIOL, V29, P1098, DOI 10.3174/ajnr.A0999; Carragee Eugene, 2006, Spine J, V6, P624, DOI 10.1016/j.spinee.2006.03.005; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Downie A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7095; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Jarvik JG, 2002, ANN INTERN MED, V137, P586, DOI 10.7326/0003-4819-137-7-200210010-00010; Jarvik JG, 2003, JAMA-J AM MED ASSOC, V289, P2810, DOI 10.1001/jama.289.21.2810; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Joines JD, 2001, J GEN INTERN MED, V16, P14, DOI 10.1111/j.1525-1497.2001.00249.x; Kendrick D, 2001, BRIT MED J, V322, P400, DOI 10.1136/bmj.322.7283.400; Knopp-Sihota JA, 2012, OSTEOPOROSIS INT, V23, P17, DOI 10.1007/s00198-011-1676-0; Lurie JD, 2003, SPINE, V28, P616, DOI 10.1097/00007632-200303150-00018; McCullough BJ, 2012, RADIOLOGY, V262, P941, DOI 10.1148/radiol.11110618; National Institute for Health and Care Excellence (NICE, 2009, LOW BACK PAIN EARL M; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Underwood M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7432; Webster BS, 2010, J OCCUP ENVIRON MED, V52, P900, DOI 10.1097/JOM.0b013e3181ef7e53	19	18	21	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 16	2014	349								g4266	10.1136/bmj.g4266	http://dx.doi.org/10.1136/bmj.g4266			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7PE	25030632				2022-12-28	WOS:000339326000002
J	Li, AHT; Dixon, S; Prakash, V; Kim, SJ; Knoll, GA; Lam, NN; Garg, AX				Li, Alvin Ho-ting; Dixon, Stephanie; Prakash, Versha; Kim, S. Joseph; Knoll, Greg A.; Lam, Ngan N.; Garg, Amit X.			Physician Registration for Deceased Organ Donation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ATTITUDES		[Li, Alvin Ho-ting; Lam, Ngan N.] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Dixon, Stephanie; Kim, S. Joseph; Garg, Amit X.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Prakash, Versha] Trillium Gift Life Network, Toronto, ON, Canada; [Knoll, Greg A.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	Western University (University of Western Ontario); University of Toronto; University of Ottawa	Li, AHT (corresponding author), Victoria Hosp, London Hlth Sci Ctr, Kidney Clin Res Unit, Room ELL 101,Westminster Tower,800 Commissioners, London, ON N6A 4G5, Canada.	alvin.li@lhsc.on.ca	Lam, Ngan/AAX-3472-2020	Lam, Ngan/0000-0002-0129-7091; Knoll, Greg/0000-0001-5442-9310	Canadian Institutes of Health Research Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], REL PHYS INF BATCH F; Hobeika MJ, 2009, J TRAUMA, V67, P372, DOI 10.1097/TA.0b013e3181986ae6; Morgan SE, 2008, HEALTH COMMUN, V23, P23, DOI 10.1080/10410230701805158; Rosenblum AM, 2012, TRANSPL INT, V25, P801, DOI 10.1111/j.1432-2277.2012.01472.x; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Wakefield CE, 2010, PROG TRANSPLANT, V20, P380, DOI 10.7182/prtr.20.4.p54651601pg80183	6	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					291	293		10.1001/jama.2014.2934	http://dx.doi.org/10.1001/jama.2014.2934			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	25027146	Bronze			2022-12-28	WOS:000338940300028
J	Margolis, D; Bushman, F				Margolis, David; Bushman, Frederic			Persistence by proliferation?	SCIENCE			English	Editorial Material							CD4(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; HIV-1 INTEGRATION; RESERVOIR; VIREMIA		[Margolis, David] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Margolis, David] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Margolis, David] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Bushman, Frederic] Perelman Sch Med, Philadelphia, PA 19104 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Margolis, D (corresponding author), Univ N Carolina, Dept Med, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	dmargo@med.unc.edu; bushman@mail.med.upenn.edu	Margolis, David M./Y-2468-2019	Margolis, David M./0000-0001-5714-0002				Anderson JA, 2011, J VIROL, V85, P5220, DOI 10.1128/JVI.00284-11; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun T.-W., 1997, P NATL ACAD SCI US, V94, P13193; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Ikeda T, 2007, J INFECT DIS, V195, P716, DOI 10.1086/510915; Kearney MF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004010; Kuwahara M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4555; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291	15	9	11	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					143	144		10.1126/science.1257426	http://dx.doi.org/10.1126/science.1257426			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013050				2022-12-28	WOS:000339409900025
J	Hosseini, P; Wright, CD; Bhaskaran, H				Hosseini, Peiman; Wright, C. David; Bhaskaran, Harish			An optoelectronic framework enabled by low-dimensional phase-change films	NATURE			English	Article							MEMORY; NONVOLATILE	The development of materials whose refractive index can be optically transformed as desired, such as chalcogenide-based phase-change materials, has revolutionized the media and data storage industries by providing inexpensive, high-speed, portable and reliable platforms able to store vast quantities of data. Phase-change materials switch between two solid states-amorphous and crystalline-in response to a stimulus, such as heat, with an associated change in the physical properties of the material, including optical absorption, electrical conductance and Young's modulus(1-5). The initial applications of these materials(particularly the germanium antimony tellurium alloy Ge2Sb2Te5) exploited the reversible change in their optical properties in rewritable optical data storage technologies(6,7). More recently, the change in their electrical conductivity has also been extensively studied in the development of non-volatile phase-changememories(4,5). Here we show that by combining the optical and electronic property modulation of such materials, display and data visualization applications that go beyond data storage can be created. Using extremely thin phase-change materials and transparent conductors, we demonstrate electrically induced stable colour changes in both reflective and semi-transparent modes. Further, we show how a pixelated approach can be used in displays on both rigid and flexible films. This optoelectronic framework using low-dimensional phase-change materials has many likely applications, such as ultrafast, entirely solid-state displays with nanometre-scale pixels, semi-transparent 'smart' glasses, 'smart' contact lenses and artificial retina devices.	[Hosseini, Peiman; Bhaskaran, Harish] Univ Oxford, Dept Mat, Oxford OX1 3PH, England; [Wright, C. David] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England	University of Oxford; University of Exeter	Bhaskaran, H (corresponding author), Univ Oxford, Dept Mat, Parks Rd, Oxford OX1 3PH, England.	harish.bhaskaran@materials.ox.ac.uk	Bhaskaran, Harish/ABE-7858-2020; Bhaskaran, Harish/AAU-5844-2021	Bhaskaran, Harish/0000-0003-0774-8110	EPSRC [EP/J018783/1, EP/J018694/1, EP/J00541X/2]; OUP John Fell Fund; EPSRC [EP/J00541X/1, EP/M015173/1, EP/M015130/1, EP/L01730X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J00541X/2, EP/J00541X/1, EP/J018783/1, EP/J018694/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); OUP John Fell Fund; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank R. Taylor for scientific discussions related to optical spectroscopy measurements. We are grateful to M. Riede for discussions on the modelling aspects of our study. This research was supported by EPSRC via grant numbers EP/J018783/1, EP/J018694/1 and EP/J00541X/2 as well as the OUP John Fell Fund.	AFONSO CN, 1992, APPL PHYS LETT, V60, P3123, DOI 10.1063/1.106772; Bez R, 2013, 2013 5TH IEEE INTERNATIONAL MEMORY WORKSHOP (IMW), P13, DOI 10.1109/IMW.2013.6582084; Bhaskaran H, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3204449; Bichet O, 2004, J APPL PHYS, V95, P2360, DOI 10.1063/1.1644899; Burkhard GF, 2010, ADV MATER, V22, P3293, DOI 10.1002/adma.201000883; Caldwell MA, 2012, NANOSCALE, V4, P4382, DOI 10.1039/c2nr30541k; Chen Y. C., 2006, 2006 INT EL DEV M IE; Collings N, 2011, J DISP TECHNOL, V7, P112, DOI 10.1109/JDT.2010.2049337; Hamann HF, 2006, NAT MATER, V5, P383, DOI 10.1038/nmat1627; HEAVENS OS, 1991, OPTICAL PROPERTIES T, P46; Heikenfeld J, 2011, J SOC INF DISPLAY, V19, P129, DOI 10.1889/JSID19.2.129; Kats MA, 2013, NAT MATER, V12, P20, DOI [10.1038/NMAT3443, 10.1038/nmat3443]; Lankhorst MHR, 2005, NAT MATER, V4, P347, DOI 10.1038/nmat1350; Lee SH, 2007, NAT NANOTECHNOL, V2, P626, DOI 10.1038/nnano.2007.291; Lingley AR, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/12/125014; Llordes A, 2013, NATURE, V500, P323, DOI 10.1038/nature12398; Loke D, 2012, SCIENCE, V336, P1566, DOI 10.1126/science.1221561; Nam SW, 2012, SCIENCE, V336, P1561, DOI 10.1126/science.1220119; OHNO E, 1989, JPN J APPL PHYS 1, V28, P1235, DOI 10.1143/JJAP.28.1235; Oosthoek JLM, 2011, J APPL PHYS, V110, DOI 10.1063/1.3603025; Pettersson LAA, 1999, J APPL PHYS, V86, P487, DOI 10.1063/1.370757; Raoux S, 2008, IBM J RES DEV, V52, P465, DOI 10.1147/rd.524.0465; Redaelli A, 2008, J APPL PHYS, V103, DOI 10.1063/1.2931951; Satoh H, 2006, J APPL PHYS, V99, DOI 10.1063/1.2163010; Wang WJ, 2012, 2012 IEEE INTERNATIONAL ELECTRON DEVICES MEETING (IEDM), DOI 10.1109/IEDM.2012.6479143; Wuttig M, 2005, NAT MATER, V4, P265, DOI 10.1038/nmat1359; Wuttig M, 2007, NAT MATER, V6, P824, DOI 10.1038/nmat2009; Xiong F, 2011, SCIENCE, V332, P568, DOI 10.1126/science.1201938; Yamada N, 2000, J APPL PHYS, V88, P7020, DOI 10.1063/1.1314323; Zrenner E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007399	30	474	496	48	548	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					206	211		10.1038/nature13487	http://dx.doi.org/10.1038/nature13487			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008527	Green Submitted			2022-12-28	WOS:000338649800040
J	Zhao, L; Lee, X; Smith, RB; Oleson, K				Zhao, Lei; Lee, Xuhui; Smith, Ronald B.; Oleson, Keith			Strong contributions of local background climate to urban heat islands	NATURE			English	Article							CITIES; URBANIZATION; IMPACT; EXCHANGES; HEATWAVES; FORESTS; SYSTEM; MODEL	The urban heat island(UHI), a common phenomenon in which surface temperatures are higher in urban areas than in surrounding rural areas, represents one of the most significant human-induced changes to Earth's surface climate(1,2). Even though they are localized hotspots in the landscape, UHIs have a profound impact on the lives of urban residents, who comprise more than half of the world's population(3). A barrier to UHI mitigation is the lack of quantitative attribution of the various contributions to UHI intensity(4) (expressed as the temperature difference between urban and rural areas, Delta T). A common perception is that reduction in evaporative cooling in urban land is the dominant driver of DT (ref. 5). Here we use a climate model to show that, for cities across North America, geographic variations in daytime Delta T are largely explained by variations in the efficiency with which urban and rural areas convect heat to the lower atmosphere. If urban areas are aerodynamically smoother than surrounding rural areas, urban heat dissipation is relatively less efficient and urban warming occurs (and vice versa). This convection effect depends on the local background climate, increasing daytime Delta T by 3.06 +/- 0.3 kelvin (mean and standard error) in humid climates but decreasing Delta T by 1.5 +/- 0.2 kelvin in dry climates. In the humid eastern United States, there is evidence of higher Delta T in drier years. These relationship simply that UHIs will exacerbate heat wave stress on human health in wet climates where high temperature effects are already compounded by high air humidity(6,7) and in drier years when positive temperature anomalies may be reinforced by a precipitation temperature feedback(8). Our results support albedo management as a viable means of reducing Delta T on large scales(9,10).	[Zhao, Lei; Lee, Xuhui] Nanjing Univ Informat Sci & Technol, Yale NUIST Ctr Atmospher Environm, Nanjing 210044, Jiangsu, Peoples R China; [Zhao, Lei; Lee, Xuhui] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Smith, Ronald B.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; [Oleson, Keith] Natl Ctr Atmospher Res, Boulder, CO 80305 USA	Nanjing University of Information Science & Technology; Yale University; Yale University; National Center Atmospheric Research (NCAR) - USA	Lee, X (corresponding author), Nanjing Univ Informat Sci & Technol, Yale NUIST Ctr Atmospher Environm, Nanjing 210044, Jiangsu, Peoples R China.	xuhui.lee@yale.edu	Zhao, Lei/S-1855-2019; Oleson, Keith/A-9328-2008	Zhao, Lei/0000-0002-6481-3786; Oleson, Keith/0000-0002-0057-9900	Ministry of Education of China (grant PCSIRT); Yale Climate and Energy Institute; Yale Institute of Biospheric Studies; Yale University Graduate Fellowship; NASA [NNX10AK79G]; NCARWCIASP; US National Science Foundation	Ministry of Education of China (grant PCSIRT); Yale Climate and Energy Institute; Yale Institute of Biospheric Studies; Yale University Graduate Fellowship; NASA(National Aeronautics & Space Administration (NASA)); NCARWCIASP; US National Science Foundation(National Science Foundation (NSF))	This research was supported by the Ministry of Education of China (grant PCSIRT), the Yale Climate and Energy Institute, the Yale Institute of Biospheric Studies, and a Yale University Graduate Fellowship. K.O. acknowledges support from NASA grant NNX10AK79G (the SIMMER project) and the NCARWCIASP. NCAR is sponsored by the US National Science Foundation. The model simulations were supported by the Yale University Faculty of Arts and Sciences High Performance Computing Center.	Akbari H, 2009, CLIMATIC CHANGE, V94, P275, DOI 10.1007/s10584-008-9515-9; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Clinton N, 2013, REMOTE SENS ENVIRON, V134, P294, DOI 10.1016/j.rse.2013.03.008; Fischer EM, 2010, NAT GEOSCI, V3, P398, DOI 10.1038/NGEO866; Gallo KP, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002588; Garratt JR, 1994, ATMOSPHERIC BOUNDARY; Georgescu M, 2013, NAT CLIM CHANGE, V3, P37, DOI 10.1038/nclimate1656; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grimmond S, 2007, GEOGR J, V173, P83, DOI 10.1111/j.1475-4959.2007.232_3.x; Gu LH, 1999, J GEOPHYS RES-ATMOS, V104, P31421, DOI 10.1029/1999JD901068; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Hung T, 2006, INT J APPL EARTH OBS, V8, P34, DOI 10.1016/j.jag.2005.05.003; Hurrell JW, 2013, B AM METEOROL SOC, V94, P1339, DOI 10.1175/BAMS-D-12-00121.1; Imhoff ML, 2010, REMOTE SENS ENVIRON, V114, P504, DOI 10.1016/j.rse.2009.10.008; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Li D, 2013, J APPL METEOROL CLIM, V52, P2051, DOI 10.1175/JAMC-D-13-02.1; Mackey CW, 2012, BUILD ENVIRON, V49, P348, DOI 10.1016/j.buildenv.2011.08.004; Nichol JE, 2009, ATMOS RES, V94, P276, DOI 10.1016/j.atmosres.2009.06.011; OKE TR, 1982, Q J ROY METEOR SOC, V108, P1, DOI 10.1002/qj.49710845502; Oleson KW, 2008, J APPL METEOROL CLIM, V47, P1061, DOI 10.1175/2007JAMC1598.1; Oleson KW, 2011, INT J CLIMATOL, V31, P1848, DOI 10.1002/joc.2201; Oleson K. W., 2013, NCARTN478STR, DOI [10.5065/D6RR1W7M, DOI 10.5065/D6RR1W7M, DOI 10.5065/D6FB50WZ]; Oleson K, 2012, J CLIMATE, V25, P1390, DOI 10.1175/JCLI-D-11-00098.1; Peng SS, 2012, ENVIRON SCI TECHNOL, V46, P696, DOI 10.1021/es2030438; Qian TT, 2006, J HYDROMETEOROL, V7, P953, DOI 10.1175/JHM540.1; Rosenzweig C, 2009, B AM METEOROL SOC, V90, P1297, DOI 10.1175/2009BAMS2308.1; Rotenberg E, 2010, SCIENCE, V327, P451, DOI 10.1126/science.1179998; ROTH M, 1989, INT J REMOTE SENS, V10, P1699, DOI 10.1080/01431168908904002; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Smith TT, 2013, CLIMATIC CHANGE, V118, P811, DOI 10.1007/s10584-012-0659-2; Taha H, 1997, ENERG BUILDINGS, V25, P99, DOI 10.1016/S0378-7788(96)00999-1; Voogt JA, 2000, J APPL METEOROL, V39, P1679, DOI 10.1175/1520-0450-39.10.1679; Voogt JA, 2003, REMOTE SENS ENVIRON, V86, P370, DOI 10.1016/S0034-4257(03)00079-8; Zhou LM, 2004, P NATL ACAD SCI USA, V101, P9540, DOI 10.1073/pnas.0400357101	36	614	665	73	776	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					216	219		10.1038/nature13462	http://dx.doi.org/10.1038/nature13462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008529				2022-12-28	WOS:000338649800042
J	Martin, EG; Helbig, N; Shah, NR				Martin, Erika G.; Helbig, Natalie; Shah, Nirav R.			Liberating Data to Transform Health Care New York's Open Data Experience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Martin, Erika G.] SUNY Albany, Nelson A Rockfeller Inst Govt, Albany, NY 12222 USA; [Martin, Erika G.] SUNY Albany, Rockefeller Coll Publ Affairs & Policy, Albany, NY 12222 USA; [Helbig, Natalie] SUNY Albany, Ctr Technol Govt, Albany, NY 12222 USA; [Shah, Nirav R.] New York State Dept Hlth, Off Commissioner, Albany, NY 12237 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System	Shah, NR (corresponding author), Kaiser Permanente So Calif, 393 E Walnut St, Pasadena, CA 91188 USA.	nirav.r.shah@kp.org	Shah, Nirav R./B-6622-2008	Shah, Nirav R./0000-0003-2044-7865; Martin, Erika/0000-0003-2607-8933				[Anonymous], NEW YORK STATE OPEN; [Anonymous], 2014, CRAINS NEW YORK BUSI; Culter DM., 2010, NBER WORKING PAPER N; Cuomo AM, 2013, USING TECHNOLOGY TO; Hannan EL, 2012, J AM COLL CARDIOL, V59, P2309, DOI 10.1016/j.jacc.2011.12.051; Harrison TM, 2012, FUTURE INTERNET, V4, P900, DOI 10.3390/fi4040900; Manyika J, 2013, OPEN DATA UNLOCKING	7	15	15	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2481	2482		10.1001/jama.2014.4610	http://dx.doi.org/10.1001/jama.2014.4610			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	25058079				2022-12-28	WOS:000337757000018
J	Capeding, MR; Tran, NH; Hadinegoro, SRS; Ismail, HIHJM; Chotpitayasunondh, T; Chua, MN; Luong, CQ; Rusmil, K; Wirawan, DN; Nallusamy, R; Pitisuttithum, P; Thisyakorn, U; Yoon, IK; van der Vliet, D; Langevin, E; Laot, T; Hutagalung, Y; Frago, C; Boaz, M; Wartel, TA; Tornieporth, NG; Saville, M; Bouckenooghe, A				Capeding, Maria Rosario; Ngoc Huu Tran; Hadinegoro, Sri Rezeki S.; Ismail, Hussain Imam H. J. Muhammad; Chotpitayasunondh, Tawee; Chua, Mary Noreen; Chan Quang Luong; Rusmil, Kusnandi; Wirawan, Dewa Nyoman; Nallusamy, Revathy; Pitisuttithum, Punnee; Thisyakorn, Usa; Yoon, In-Kyu; van der Vliet, Diane; Langevin, Edith; Laot, Thelma; Hutagalung, Yanee; Frago, Carina; Boaz, Mark; Wartel, T. Anh; Tornieporth, Nadia G.; Saville, Melanie; Bouckenooghe, Alain		CYD14 Study Grp	Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial	LANCET			English	Article							IMMUNOGENICITY; RECOMBINANT; GUIDELINES	Background An estimated 100 million people have symptomatic dengue infection every year. This is the first report of a phase 3 vaccine efficacy trial of a candidate dengue vaccine. We aimed to assess the efficacy of the CYD dengue vaccine against symptomatic, virologically confirmed dengue in children. Methods We did an observer-masked, randomised controlled, multicentre, phase 3 trial in five countries in the Asia-Pacific region. Between June 3, and Dec 1, 2011, healthy children aged 2-14 years were randomly assigned (2: 1), by computer-generated permuted blocks of six with an interactive voice or web response system, to receive three injections of a recombinant, live, attenuated, tetravalent dengue vaccine (CYD-TDV), or placebo, at months 0, 6, and 12. Randomisation was stratified by age and site. Participants were followed up until month 25. Trial staff responsible for the preparation and administration of injections were unmasked to group allocation, but were not included in the follow-up of the participants; allocation was concealed from the study sponsor, investigators, and parents and guardians. Our primary objective was to assess protective efficacy against symptomatic, virologically confirmed dengue, irrespective of disease severity or serotype, that took place more than 28 days after the third injection. The primary endpoint was for the lower bound of the 95% CI of vaccine efficacy to be greater than 25%. Analysis was by intention to treat and per procotol. This trial is registered with ClinicalTrials.gov, number NCT01373281. Findings We randomly assigned 10 275 children to receive either vaccine (n=6851) or placebo (n=3424), of whom 6710 (98%) and 3350 (98%), respectively, were included in the primary analysis. 250 cases of virologically confirmed dengue took place more than 28 days after the third injection (117 [47%] in the vaccine group and 133 [53%] in the control group). The primary endpoint was achieved with 56.5% (95% CI 43.8-66.4) efficacy. We recorded 647 serious adverse events (402 [62%] in the vaccine group and 245 [38%] in the control group). 54(1%) children in the vaccine group and 33 (1%) of those in the control group had serious adverse events that happened within 28 days of vaccination. Serious adverse events were consistent with medical disorders in this age group and were mainly infections and injuries. Interpretation Our findings show that dengue vaccine is efficacious when given as three injections at months 0, 6, and 12 to children aged 2-14 years in endemic areas in Asia, and has a good safety profile. Vaccination could reduce the incidence of symptomatic infection and hospital admission and has the potential to provide an important public health benefit.	[Capeding, Maria Rosario] Res Inst Trop Med, Muntinlupa, Philippines; [Ngoc Huu Tran; Chan Quang Luong] Pasteur Inst Ho Chi Minh City, Ho Chi Minh City, Vietnam; [Hadinegoro, Sri Rezeki S.] Univ Indonesia, Cipto Mangunkusumo Hosp, Sch Med, Dept Child Hlth, Jakarta, Indonesia; [Ismail, Hussain Imam H. J. Muhammad] Kuala Lumpur Hosp, Inst Pediat, Kuala Lumpur, Malaysia; [Chotpitayasunondh, Tawee] Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand; [Chua, Mary Noreen] Chong Hua Hosp, Cebu City Guadalupe Hlth Ctr Annex, Cebu, Philippines; [Rusmil, Kusnandi] Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Dept Child Hlth, Bandung, Indonesia; [Wirawan, Dewa Nyoman] Udayana Univ, Sch Med, Dept Prevent Med, Denpasar, Bali, Indonesia; [Nallusamy, Revathy] Penang Hosp, Dept Paediat, Georgetown, Penang, Malaysia; [Pitisuttithum, Punnee] Mahidol Univ, Fac Trop Med, Vaccine Trial Ctr, Bangkok, Thailand; [Thisyakorn, Usa] Mahidol Univ, Fac Trop Med, Dengue Project Banpong Photharam, Bangkok, Thailand; [Yoon, In-Kyu] USAMC AFRIMS, Dept Virol, Bangkok, Thailand; [van der Vliet, Diane; Langevin, Edith; Tornieporth, Nadia G.] Sanofi Pasteur, Marcy Letoile, France; [Laot, Thelma] Sanofi Pasteur, Makati, Philippines; [Hutagalung, Yanee; Frago, Carina; Boaz, Mark; Wartel, T. Anh; Bouckenooghe, Alain] Sanofi Pasteur, Singapore, Singapore; [Boaz, Mark] Sanofi Pasteur, Swiftwater, PA USA; [Saville, Melanie] Sanofi Pasteur, Lyon, France	Research Institute for Tropical Medicine - Philippines; University of Indonesia; Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; Universitas Udayana; Mahidol University; Mahidol University; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Sanofi-Aventis; Sanofi-Aventis; Sanofi-Aventis	van der Vliet, D (corresponding author), Sanofi Pasteur, Marcy Letoile, France.	diane.vandervliet@sanofipasteur.com	Nallusamy, Revathy/V-3443-2019		Sanofi Pasteur	Sanofi Pasteur	Sanofi Pasteur.	Bhatia Rajesh, 2013, WHO South East Asia J Public Health, V2, P23, DOI 10.4103/2224-3151.115830; Breslow NE., 1987, STAT METHODS CANC RE, P81; Dayan GH, 2013, AM J TROP MED HYG, V89, P1058, DOI 10.4269/ajtmh.13-0304; Dayan GH, 2013, VACCINE, V31, P5047, DOI 10.1016/j.vaccine.2013.08.088; Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094; Hombach J, 2009, J CLIN VIROL, V46, pS7, DOI 10.1016/S1386-6532(09)70287-2; Hss AS, 2013, VACCINE, V31, P5814, DOI 10.1016/j.vaccine.2013.10.013; Huynh W, 2008, J CLIN NEUROSCI, V15, P1315, DOI 10.1016/j.jocn.2008.05.002; Lanata CF, 2012, VACCINE, V30, P5935, DOI 10.1016/j.vaccine.2012.07.043; Leo YS, 2012, HUM VACC IMMUNOTHER, V8, P1259, DOI 10.4161/hv.21224; Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011; Rodriguez-Barraquer I, 2014, AM J EPIDEMIOL, V179, P353, DOI 10.1093/aje/kwt256; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Sejvar JJ, 2007, VACCINE, V25, P5771, DOI 10.1016/j.vaccine.2007.04.060; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Timiryasova TM, 2013, AM J TROP MED HYG, V88, P962, DOI 10.4269/ajtmh.12-0461; Tran NH, 2012, J VACCINES VACCIN, V3, P162, DOI [10.4172/2157-7560.1000162, DOI 10.4172/2157-7560.1000162]; WHO, 1997, DENG HAEM FEV DIAGN; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2012, GLOB STRAT DENG PREV	20	674	700	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2014	384	9951					1358	1365		10.1016/S0140-6736(14)61060-6	http://dx.doi.org/10.1016/S0140-6736(14)61060-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NH	25018116				2022-12-28	WOS:000343004000025
J	Schiering, C; Krausgruber, T; Chomka, A; Frohlich, A; Adelmann, K; Wohlfert, EA; Pott, J; Griseri, T; Bollrath, J; Hegazy, AN; Harrison, OJ; Owens, BMJ; Lohning, M; Belkaid, Y; Fallon, PG; Powrie, F				Schiering, Chris; Krausgruber, Thomas; Chomka, Agnieszka; Froehlich, Anja; Adelmann, Krista; Wohlfert, Elizabeth A.; Pott, Johanna; Griseri, Thibault; Bollrath, Julia; Hegazy, Ahmed N.; Harrison, Oliver J.; Owens, Benjamin M. J.; Loehning, Max; Belkaid, Yasmine; Fallon, Padraic G.; Powrie, Fiona			The alarmin IL-33 promotes regulatory T-cell function in the intestine	NATURE			English	Article							AMELIORATES EXPERIMENTAL COLITIS; INFLAMMATORY-BOWEL-DISEASE; TRANSCRIPTION FACTOR FOXP3; ULCERATIVE-COLITIS; DEPENDENT COLITIS; SOLUBLE ST2; CYTOKINE; MICE; RESPONSES; COMPLEX	FOXP3+ regulatory T cells (T-reg cells) are abundant in the intestine, where they prevent dysregulated inflammatory responses to self and environmental stimuli. It is now appreciated that T-reg cells acquire tissue-specific adaptations that facilitate their survival and function(1); however, key host factors controlling theT(reg) response in the intestine are poorly understood. The interleukin (IL)-1 family member IL-33 is constitutively expressed in epithelial cells at barrier sites(2), where it functions as an endogenous danger signal, or alarmin, in response to tissue damage(3). Recent studies in humans have described high levels of IL-33 in inflamed lesions of inflammatory bowel disease patients(4-7), suggesting a role for this cytokine in disease pathogenesis. In the intestine, both protective and pathological roles for IL-33 have been described in murine models of acute colitis(8-11), but its contribution to chronic inflammation remains ill defined. Here we show in mice that the IL-33 receptor ST2 is preferentially expressed on colonic T-reg cells, where it promotes T-reg function and adaptation to the inflammatory environment. IL-33 signalling in T cells stimulates T-reg responses in several ways. First, it enhances transforming growth factor (TGF)-beta 1-mediated differentiation of T-reg cells and, second, it provides a necessary signal for T-reg-cell accumulation and maintenance in inflamed tissues. Strikingly, IL-23, a key pro-inflammatory cytokine in the pathogenesis of inflammatory bowel disease, restrained T-reg responses through inhibition of IL-33 responsiveness. These results demonstrate a hitherto unrecognized link between an endogenous mediator of tissue damage and a major anti-inflammatory pathway, and suggest that the balance between IL-33 and IL-23 may be a key controller of intestinal immune responses.	[Schiering, Chris; Krausgruber, Thomas; Chomka, Agnieszka; Adelmann, Krista; Griseri, Thibault; Bollrath, Julia; Hegazy, Ahmed N.; Owens, Benjamin M. J.; Powrie, Fiona] Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Nuffield Dept Clin Med,Expt Med Div, Oxford OX3 9DU, England; [Froehlich, Anja; Loehning, Max] Charite, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany; [Froehlich, Anja; Loehning, Max] German Rheumatism Res Ctr DRFZ, D-10117 Berlin, Germany; [Wohlfert, Elizabeth A.; Belkaid, Yasmine] NIAID, Program Barrier Immun & Repair, Mucosal Immunol Sect, Lab Parasit Dis,NIH, Bethesda, MD 20892 USA; [Pott, Johanna; Harrison, Oliver J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Fallon, Padraic G.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Dublin 2, Ireland	University of Oxford; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford; Trinity College Dublin	Powrie, F (corresponding author), Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Nuffield Dept Clin Med,Expt Med Div, Oxford OX3 9DU, England.	fiona.powrie@path.ox.ac.uk	wohlfert, beth/ABA-2255-2020; Krausgruber, Thomas/H-8490-2018; Löhning, Max/AAL-2967-2021; Fallon, Padraic/Y-2711-2019	Krausgruber, Thomas/0000-0002-1374-0329; Löhning, Max/0000-0001-6382-7281; Fallon, Padraic/0000-0002-8401-7293; Hegazy, Ahmed N./0000-0002-2946-8251; Stockenhuber, Krista/0000-0003-3608-064X; Harrison, Oliver/0000-0003-1515-9586; Pott, Johanna/0000-0003-4439-725X; Owens, Benjamin/0000-0003-4710-6841; Schiering, Chris/0000-0001-7902-6024; Belkaid, Yasmine/0000-0001-9962-3571	Wellcome Trust; Fondation Louis Jeantet; European Molecular Biology Organization long-term fellowship [ALTF 116-2012]; Science Foundation Ireland; Volkswagen Foundation (Lichtenberg Program); BMBF (e:Bio/T-Sys); Oxford-UCB Pharma Postdoctoral Fellowship; BBSRC [BB/I005609/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001132, ZIAAI001133] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I005609/1] Funding Source: researchfish; Wellcome Trust [095688/Z/11/Z] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Fondation Louis Jeantet; European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Volkswagen Foundation (Lichtenberg Program); BMBF (e:Bio/T-Sys)(Federal Ministry of Education & Research (BMBF)); Oxford-UCB Pharma Postdoctoral Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	C. S., K. A., A. C., O.J.H. and F. P. are supported by the Wellcome Trust. F. P. is also supported by the Fondation Louis Jeantet. A.N.H. is supported by a European Molecular Biology Organization long-term fellowship (ALTF 116-2012). P. G. F. is supported by Science Foundation Ireland. M. L. and A. F. are supported by the Volkswagen Foundation (Lichtenberg Program) and BMBF (e:Bio/T-Sys). B.M.J.O. is supported by an Oxford-UCB Pharma Postdoctoral Fellowship. We thank all members of the Oxford Translational Gastroenterology Unit for assistance and support. We are grateful to H. Ferry and K. Alford for essential flow cytometry support and the staff of the University of Oxford for animal care. We are also grateful to D. Baban for conducting microarray hybridizations.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Beltran CJ, 2010, INFLAMM BOWEL DIS, V16, P1097, DOI 10.1002/ibd.21175; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Diaz-Jimenez D, 2011, WORLD J GASTROENTERO, V17, P2181, DOI 10.3748/wjg.v17.i17.2181; Duan LH, 2012, MOL MED, V18, P753, DOI 10.2119/molmed.2011.00428; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Gross P, 2012, INFLAMM BOWEL DIS, V18, P1900, DOI 10.1002/ibd.22900; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Kobori A, 2010, J GASTROENTEROL, V45, P999, DOI 10.1007/s00535-010-0245-1; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sedhom MAK, 2013, GUT, V62, P1714, DOI 10.1136/gutjnl-2011-301785; Seidelin JB, 2010, IMMUNOL LETT, V128, P80, DOI 10.1016/j.imlet.2009.11.001; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wasserman A, 2012, ISR MED ASSOC J, V14, P620; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	36	637	651	6	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					564	+		10.1038/nature13577	http://dx.doi.org/10.1038/nature13577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25043027	Green Accepted			2022-12-28	WOS:000342075800044
J	Yach, D; Calitz, C				Yach, Derek; Calitz, Chris			New Opportunities in the Changing Landscape of Prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							US HEALTH		[Yach, Derek] Vital Grp LLC, Vital Inst, New York, NY USA; [Calitz, Chris] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Yach, D (corresponding author), Vital Inst, 3 Columbus Circle,Floor 15, New York, NY 10019 USA.	dyach@thevitalitygroup.com						Asch DA, 2012, NEW ENGL J MED, V367, P1, DOI 10.1056/NEJMp1203869; Bipartisan Policy Center, 2013, BIP RX PAT CENT CAR; Fineberg HV, 2013, JAMA-J AM MED ASSOC, V310, P85, DOI 10.1001/jama.2013.7518; Institute of Medicine of the National Academies, 2012, LIV WELL CHRON ILLN; Loewenstein G, 2013, HEALTH AFFAIR, V32, P1244, DOI 10.1377/hlthaff.2012.1163; Moses H, 2013, JAMA-J AM MED ASSOC, V310, P1947, DOI 10.1001/jama.2013.281425; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Vitality Institute Commission Report, 2014, INV PREV NAT IMP KEY; Woolf SH, 2013, JAMA-J AM MED ASSOC, V309, P771, DOI 10.1001/jama.2013.91	9	19	19	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2014	312	8					791	792		10.1001/jama.2014.8900	http://dx.doi.org/10.1001/jama.2014.8900			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7NX	25032720				2022-12-28	WOS:000340788500018
J	Hippisley-Cox, J; Coupland, C				Hippisley-Cox, Julia; Coupland, Carol			Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WALES PROSPECTIVE DERIVATION; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; EXTERNAL VALIDATION; ATRIAL-FIBRILLATION; UNITED-KINGDOM; CARDIOVASCULAR-DISEASE; OSTEOPOROTIC FRACTURE; 10-YEAR RISK; PRIMARY-CARE; MISSING DATA	Objective To develop and validate risk algorithms (QBleed) for estimating the absolute risk of upper gastrointestinal and intracranial bleed for patients with and without anticoagulation aged 21-99 years in primary care. Design Open cohort study using routinely collected data from general practice linked to hospital episode statistics data and mortality data during the five year study period between 1 January 2008 and 1 October 2013. Setting 565 general practices in England contributing to the national QResearch database to develop the algorithm and 188 different QResearch practices to validate the algorithm. All 753 general practices had data linked to hospital episode statistics and mortality data at individual patient level. Endpoint Gastrointestinal bleed and intracranial bleed recorded on either the linked mortality data or the linked hospital records. Participants We studied 4.4 million patients in the derivation cohort with 16.4 million person years of follow-up. During follow-up, 21 641 patients had an incident upper gastrointestinal bleed and 9040 had an intracranial bleed. For the validation cohort, we identified 1.4 million patients contributing over 4.9 million person years of follow-up. During follow-up, 6600 patients had an incident gastrointestinal bleed and 2820 had an intracranial bleed. We excluded patients without a valid Townsend score for deprivation and those prescribed anticoagulants in the 180 days before study entry. Risk factors Candidate variables recorded on the general practice computer system before entry to the cohort, including personal variables (age, sex, Townsend deprivation score, ethnicity), lifestyle variables (smoking, alcohol intake), chronic diseases, prescribed drugs, clinical values (body mass index, systolic blood pressure), and laboratory test results (haemoglobin, platelets). We also included previous bleed recorded before entry to the study. Results The final QBleed algorithms incorporated 21 variables. When applied to the validation cohort, the algorithms in women explained 40% of the variation for upper gastrointestinal bleed and 58% for intracranial bleed. The corresponding D statistics were 1.67 and 2.42. The receiver operating curve statistic values were 0.77 and 0.86. The sensitivity values for the top 10th of men and women at highest risk were 38% and 51%, respectively. There were similar results for men. Conclusion The QBleed algorithms provided valid measures of absolute risk of gastrointestinal and intracranial bleed in patients with and without anticoagulation as shown by the performance of the algorithms in a separate validation cohort. Further research is needed to evaluate the clinical outcomes and the cost effectiveness of using these algorithms in primary care.	[Hippisley-Cox, Julia; Coupland, Carol] Div Primary Care, Nottingham NG2 7RD, England		Hippisley-Cox, J (corresponding author), Div Primary Care, Univ Pk, Nottingham NG2 7RD, England.	Julia.hippisley-cox@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283				Apostolakis S, 2012, J AM COLL CARDIOL, V60, P861, DOI 10.1016/j.jacc.2012.06.019; Button LA, 2011, ALIMENT PHARM THER, V33, P64, DOI 10.1111/j.1365-2036.2010.04495.x; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Collins GS, 2011, DIABETIC MED, V28, P599, DOI 10.1111/j.1464-5491.2011.03237.x; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4181; Collins GS, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3651; Collins GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2442; Crooks CJ, 2012, GUT, V61, P514, DOI 10.1136/gutjnl-2011-300186; Donze J, 2012, AM J MED, V125, P1095, DOI 10.1016/j.amjmed.2012.04.005; Food and Drug Administration, 2013, PROT ASS DAB SEL SAF; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Health and Social Care Information Centre, 2013, QUAL OUTC FRAM; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley- Cox J., 2005, COMP KEY PRACTICE CH; Hippisley-Cox J, 2013, VALIDITY COMPLETENES, P14; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hippisley-Cox J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003482; Hippisley-Cox J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2573; Hippisley-Cox J, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3427; Hippisley-Cox J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4656; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; HOFFENBERG R, 1989, BRIT MED J, V298, P573; Johnson ES, 2013, PHARMACOEPIDEM DR S, V22, P1, DOI 10.1002/pds.3334; Lip GYH, 2012, NAT REV CARDIOL, V9, P71, DOI 10.1038/nrcardio.2011.203; Majeed Azeem, 2004, Health Stat Q, P5; Miller CS, 2012, AM J CARDIOL, V110, P453, DOI 10.1016/j.amjcard.2012.03.049; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; National Clinical Guideline Centre (UK), 2014, ATR FIBR MAN ATR FIB; National Institute for Health and Care Excellence, 2010, RED RISK VEN THROMB; Nilsson OG, 2000, J NEUROL NEUROSUR PS, V69, P601, DOI 10.1136/jnnp.69.5.601; Olesen JB, 2012, J AM COLL CARDIOL, V59, P194, DOI 10.1016/j.jacc.2011.08.071; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; ROCKALL TA, 1995, BRIT MED J, V311, P222, DOI 10.1136/bmj.311.6999.222; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; Tata LJ, 2005, ALIMENT PHARM THERAP, V22, P175, DOI 10.1111/j.1365-2036.2005.02543.x; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0	46	54	54	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2014	349								g4606	10.1136/bmj.g4606	http://dx.doi.org/10.1136/bmj.g4606			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NA	25069704	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000339905300001
J	Besnier, PA				Astudillo Besnier, Pablo			Chile needs better science governance and support	NATURE			English	Editorial Material									[Astudillo Besnier, Pablo] Becas Chile Programme, Santiago, Chile; [Astudillo Besnier, Pablo] More Sci Fdn, Santiago, Chile		Besnier, PA (corresponding author), Becas Chile Programme, Santiago, Chile.	pastudillo@fmasciencia.cl						2014, NATURE, V510, P204	1	4	4	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					385	385		10.1038/511385a	http://dx.doi.org/10.1038/511385a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL7SO	25056028	Bronze			2022-12-28	WOS:000339335700013
J	Bochner, BH; Sjoberg, DD; Laudone, VP				Bochner, Bernard H.; Sjoberg, Daniel D.; Laudone, Vincent P.			A Randomized Trial of Robot-Assisted Laparoscopic Radical Cystectomy	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Bochner, Bernard H.; Sjoberg, Daniel D.; Laudone, Vincent P.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Bochner, BH (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.			Sjoberg, Daniel/0000-0003-0862-2018; Bochner, Bernard/0000-0003-0846-0848				Chavan S, 2014, EUR UROL, V66, P59, DOI 10.1016/j.eururo.2013.10.001; Johar RS, 2013, EUR UROL, V64, P52, DOI 10.1016/j.eururo.2013.01.010; Shabsigh A, 2009, EUR UROL, V55, P164, DOI 10.1016/j.eururo.2008.07.031; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138	4	67	70	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					389	390		10.1056/NEJMc1405213	http://dx.doi.org/10.1056/NEJMc1405213			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7TY	25054732				2022-12-28	WOS:000339339800027
J	Gragert, L; Eapen, M; Williams, E; Freeman, J; Spellman, S; Baitty, R; Hartzman, R; Rizzo, JD; Horowitz, M; Confer, D; Maiers, M				Gragert, Loren; Eapen, Mary; Williams, Eric; Freeman, John; Spellman, Stephen; Baitty, Robert; Hartzman, Robert; Rizzo, J. Douglas; Horowitz, Mary; Confer, Dennis; Maiers, Martin			HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORD BLOOD TRANSPLANTATION; UNRELATED DONOR; RETROSPECTIVE ANALYSIS; HAPLOTYPE FREQUENCIES; ACUTE-LEUKEMIA; BONE-MARROW; NATIONAL REGISTRY; OUTCOMES; IMPACT; ADULTS	BACKGROUND Hematopoietic stem-cell transplantation (HSCT) is a potentially lifesaving therapy for several blood cancers and other diseases. For patients without a suitable related HLA-matched donor, unrelated-donor registries of adult volunteers and banked umbilical cord-blood units, such as the Be the Match Registry operated by the National Marrow Donor Program (NMDP), provide potential sources of donors. Our goal in the present study was to measure the likelihood of finding a suitable donor in the U. S. registry. METHODS Using human HLA data from the NMDP donor and cord-blood-unit registry, we built population-based genetic models for 21 U. S. racial and ethnic groups to predict the likelihood of identifying a suitable donor (either an adult donor or a cord-blood unit) for patients in each group. The models incorporated the degree of HLA matching, adult-donor availability (i.e., ability to donate), and cord-blood-unit cell dose. RESULTS Our models indicated that most candidates for HSCT will have a suitable (HLA-matched or minimally mismatched) adult donor. However, many patients will not have an optimal adult donor - that is, a donor who is matched at high resolution at HLA-A, HLA-B, HLA-C, and HLA-DRB1. The likelihood of finding an optimal donor varies among racial and ethnic groups, with the highest probability among whites of European descent, at 75%, and the lowest probability among blacks of South or Central American descent, at 16%. Likelihoods for other groups are intermediate. Few patients will have an optimal cord-blood unit - that is, one matched at the antigen level at HLA-A and HLA-B and matched at high resolution at HLA-DRB1. However, cord-blood units mismatched at one or two HLA loci are available for almost all patients younger than 20 years of age and for more than 80% of patients 20 years of age or older, regardless of racial and ethnic background. CONCLUSIONS Most patients likely to benefit from HSCT will have a donor. Public investment in donor recruitment and cord-blood banks has expanded access to HSCT.	[Gragert, Loren; Williams, Eric; Freeman, John; Confer, Dennis; Maiers, Martin] Natl Marrow Donor Program Be Match, Minneapolis, MN 55413 USA; [Eapen, Mary; Spellman, Stephen; Rizzo, J. Douglas; Horowitz, Mary] Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI USA; [Eapen, Mary; Spellman, Stephen; Rizzo, J. Douglas; Horowitz, Mary] Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA; [Baitty, Robert] Hlth Resources & Serv Adm, Blood Stem Cell Transplantat Program, Div Transplantat, Washington, DC USA; [Hartzman, Robert] Dept Navy, CW Bill Young Marrow Donor Recruitment & Res Pro, Dept Def Marrow Donor Recruitment, Washington, DC USA; [Hartzman, Robert] Dept Navy, Res Program, Bone Marrow Res Directorate, Naval Med Res Ctr, Washington, DC USA	National Marrow Donor Program; Center for International Blood & Marrow Transplant Research; Center for International Blood & Marrow Transplant Research; United States Health Resources & Service Administration (HRSA); Naval Medical Research Center (NMRC)	Gragert, L (corresponding author), Natl Marrow Donor Program Be Match, 3001 Broadway St NE,Suite 100, Minneapolis, MN 55413 USA.	lgragert@nmdp.org	horowitz, Mary/ABH-2173-2021	Eapen, Mary/0000-0001-6193-4243; Maiers, Martin/0000-0002-0198-2064	Office of Naval Research, Department of the Navy; Health Resources and Services Administration, Department of Health and Human Services	Office of Naval Research, Department of the Navy; Health Resources and Services Administration, Department of Health and Human Services(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	Funded by the Office of Naval Research, Department of the Navy, and the Health Resources and Services Administration, Department of Health and Human Services.	Atsuta Y, 2009, BLOOD, V113, P1631, DOI 10.1182/blood-2008-03-147041; Beatty PG, 2000, HUM IMMUNOL, V61, P834, DOI 10.1016/S0198-8859(00)00138-5; BEATTY PG, 1995, TRANSPLANTATION, V60, P778, DOI 10.1097/00007890-199510270-00003; Brunstein CG, 2007, BLOOD, V110, P3064, DOI 10.1182/blood-2007-04-067215; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Eapen M, 2007, LANCET, V369, P1947, DOI 10.1016/S0140-6736(07)60915-5; Eapen M, 2014, BLOOD, V123, P133, DOI 10.1182/blood-2013-05-506253; Eapen M, 2011, LANCET ONCOL, V12, P1214, DOI 10.1016/S1470-2045(11)70260-1; Eapen M, 2010, LANCET ONCOL, V11, P653, DOI 10.1016/S1470-2045(10)70127-3; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Flomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803; Furst D, 2013, BLOOD, V122, P3220, DOI 10.1182/blood-2013-02-482547; Gluckman E, 2004, EXP HEMATOL, V32, P397, DOI 10.1016/j.exphem.2004.01.002; Gragert L, 2013, HUM IMMUNOL, V74, P1313, DOI 10.1016/j.humimm.2013.06.025; Gratwohl A, 2009, CANCER-AM CANCER SOC, V115, P4715, DOI 10.1002/cncr.24531; Horan J, 2012, BLOOD, V120, P2918, DOI 10.1182/blood-2012-03-417758; Howard DH, 2008, MED DECIS MAKING, V28, P243, DOI 10.1177/0272989X07308750; Humes KR, 2011, OVERVIEW RACE HISPAN; Kollman C, 2004, TRANSPLANTATION, V78, P89, DOI 10.1097/01.TP.0000132327.40702.97; Kollman C, 2007, HUM IMMUNOL, V68, P950, DOI 10.1016/j.humimm.2007.10.009; Kurtzberg J, 1996, NEW ENGL J MED, V335, P157, DOI 10.1056/NEJM199607183350303; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Mori M, 1996, Biol Blood Marrow Transplant, V2, P134; Pidala J, 2013, BONE MARROW TRANSPL, V48, P346, DOI 10.1038/bmt.2012.150; Rocha V, 2009, BRIT J HAEMATOL, V147, P262, DOI 10.1111/j.1365-2141.2009.07883.x; Scaradavou A, 2013, BLOOD, V121, P752, DOI 10.1182/blood-2012-08-449108; Schmidt AH, 2007, BONE MARROW TRANSPL, V40, P823, DOI 10.1038/sj.bmt.1705832; Spellman SR, 2012, BLOOD, V120, P259, DOI 10.1182/blood-2012-03-379032; Woolfrey A, 2011, BIOL BLOOD MARROW TR, V17, P885, DOI 10.1016/j.bbmt.2010.09.012	30	581	585	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					339	348		10.1056/NEJMsa1311707	http://dx.doi.org/10.1056/NEJMsa1311707			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7TY	25054717	Green Accepted			2022-12-28	WOS:000339339800010
J	Miller, PE; Houston, BA				Miller, P. Elliott; Houston, Brian A.			Dahl's Sign	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Miller, P. Elliott; Houston, Brian A.] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Miller, PE (corresponding author), Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA.	elliottmiller@jhmi.edu	Miller, Elliott/AAM-5774-2021						0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					357	357		10.1056/NEJMicm1309904	http://dx.doi.org/10.1056/NEJMicm1309904			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7TY	25054719				2022-12-28	WOS:000339339800012
J	Sheil, M				Sheil, Margaret			PERSPECTIVE On the verge of a new ERA	NATURE			English	Editorial Material									Univ Melbourne, Melbourne, Vic 3010, Australia	University of Melbourne	Sheil, M (corresponding author), Univ Melbourne, Melbourne, Vic 3010, Australia.	provost@unimelb.edu.au	Sheil, Margaret/F-2949-2015						0	6	6	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					S67	S67		10.1038/511S67a	http://dx.doi.org/10.1038/511S67a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL7SO	25054854	Bronze			2022-12-28	WOS:000339335700005
J	Tadhunter, C; Morganti, R; Rose, M; Oonk, JBR; Oosterloo, T				Tadhunter, C.; Morganti, R.; Rose, M.; Oonk, J. B. R.; Oosterloo, T.			Jet acceleration of the fast molecular outflows in the Seyfert galaxy IC 5063	NATURE			English	Article							RADIO GALAXIES; STAR-FORMATION; BLACK-HOLES; COLD GAS; FEEDBACK; EMISSION; QUASARS; NUCLEUS; GROWTH; WARM	Massive outflows driven by active galactic nuclei are widely recognized to have a key role in the evolution of galaxies(1-4), by heating the ambient gas, expelling it from the nuclear regions, and thereby affecting the star-formation histories of the galaxy bulges. It has been proposed that the powerful jets of relativistic particles (such as electrons) launched by some active nuclei can both accelerate(5-7) and heat(8) the molecular gas, which often dominates the mass budgets of the outflows(5,9). Clear evidence for this mechanism, in the form of detailed associations between the molecular gas kinematics and features in the radio-emitting jets, has however been lacking. Here we report that the warm molecular hydrogen gas in the western radio lobe of the Seyfert galaxy IC 5063 is moving at high velocities-up to about 600 kilometres per second-relative to the galaxy disk. This suggests that the molecules have been accelerated by fast shocks driven into the interstellar medium by the expanding radio jets. These results demonstrate the general feasibility of accelerating molecular outflows in fast shocks driven by active nuclei.	[Tadhunter, C.] Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England; [Morganti, R.; Oonk, J. B. R.; Oosterloo, T.] Netherlands Inst Radio Astron, ASTRON, NL-7990 AA Dwingeloo, Netherlands; [Morganti, R.; Oosterloo, T.] Univ Groningen, Kapteyn Astron Inst, NL-9700 AV Groningen, Netherlands; [Rose, M.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	University of Sheffield; University of Groningen; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Tadhunter, C (corresponding author), Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England.	c.tadhunter@sheffield.ac.uk	Oosterloo, Tom/GVU-4543-2022; Morganti, Raffaella/GVU-5894-2022	Oosterloo, Tom/0000-0002-0616-6971; Morganti, Raffaella/0000-0002-9482-6844	European Southern Observatory, Chile [290.B-5162]; UK Science and Technology Research Council; European Research Council under the European Union [RADIOLIFE-320745]; Science and Technology Facilities Council [ST/J001589/1] Funding Source: researchfish; STFC [ST/J001589/1] Funding Source: UKRI	European Southern Observatory, Chile; UK Science and Technology Research Council; European Research Council under the European Union(European Research Council (ERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work is based on observations collected at the European Southern Observatory, Chile (programme 290.B-5162). C.T. and M.R. acknowledge financial support from the UK Science and Technology Research Council. R.M. acknowledges support from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Advanced Grant RADIOLIFE-320745.	Alatalo K, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/88; ALIGHIERI SD, 1989, NATURE, V341, P307, DOI 10.1038/341307a0; Crockett RM, 2012, MON NOT R ASTRON SOC, V421, P1603, DOI 10.1111/j.1365-2966.2012.20418.x; Croft S, 2006, ASTROPHYS J, V647, P1040, DOI 10.1086/505526; Dasyra KM, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201219229; Di Matteo T, 2005, NATURE, V433, P604, DOI 10.1038/nature03335; DICKSON R, 1995, MON NOT R ASTRON SOC, V273, pL29, DOI 10.1093/mnras/273.1.L29; Fabian AC, 2012, ANNU REV ASTRON ASTR, V50, P455, DOI 10.1146/annurev-astro-081811-125521; Fabian AC, 1999, MON NOT R ASTRON SOC, V308, pL39, DOI 10.1046/j.1365-8711.1999.03017.x; Gaibler V, 2012, MON NOT R ASTRON SOC, V425, P438, DOI 10.1111/j.1365-2966.2012.21479.x; GRIERSMITH D, 1982, ASTRON J, V87, P1106, DOI 10.1086/113195; Guillard P, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/95; HOLLENBACH D, 1979, ASTROPHYS J SUPPL S, V41, P555, DOI 10.1086/190631; Kulkarni VP, 1998, ASTROPHYS J, V492, pL121, DOI 10.1086/311104; MCCARTHY PJ, 1987, ASTROPHYS J, V321, pL29, DOI 10.1086/185000; Mellema G, 2002, ASTRON ASTROPHYS, V395, pL13, DOI 10.1051/0004-6361:20021408; Morganti R, 2007, ASTRON ASTROPHYS, V476, P735, DOI 10.1051/0004-6361:20077888; Morganti R, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220734; Morganti R, 1998, ASTRON J, V115, P915, DOI 10.1086/300236; Morganti R, 2013, SCIENCE, V341, P1082, DOI 10.1126/science.1240436; Oonk JBR, 2010, MON NOT R ASTRON SOC, V405, P898, DOI 10.1111/j.1365-2966.2010.16535.x; Oosterloo TA, 2000, ASTRON J, V119, P2085, DOI 10.1086/301358; REES MJ, 1989, MON NOT R ASTRON SOC, V239, pP1, DOI 10.1093/mnras/239.1.1P; Riffel RA, 2013, MON NOT R ASTRON SOC, V430, P2249, DOI 10.1093/mnras/stt045; Schmitt HR, 2003, ASTROPHYS J SUPPL S, V148, P327, DOI 10.1086/377440; Silk J, 1998, ASTRON ASTROPHYS, V331, pL1; Veilleux S, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/27; Wagner AY, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/136; Zubovas K, 2014, MON NOT R ASTRON SOC, V439, P400, DOI 10.1093/mnras/stt2472	30	97	97	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					440	443		10.1038/nature13520	http://dx.doi.org/10.1038/nature13520			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043049	Green Submitted			2022-12-28	WOS:000339335700040
J	Wasmuth, EV; Januszyk, K; Lima, CD				Wasmuth, Elizabeth V.; Januszyk, Kurt; Lima, Christopher D.			Structure of an Rrp6-RNA exosome complex bound to poly(A) RNA	NATURE			English	Article							CRYSTAL-STRUCTURE; DEGRADATION; RRP6P; CORE; RECONSTITUTION; EXONUCLEASE; COFACTOR; BINDING	The eukaryotic RNA exosome processes and degrades RNA by directing substrates to the distributive or processive 3' to 5' exoribonuclease activities of Rrp6 or Rrp44, respectively. The non-catalytic nine-subunit exosome core (Exo9) features a prominent central channel. Although RNA can pass through the channel to engage Rrp44, it is not clear how RNA is directed to Rrp6 or whether Rrp6 uses the central channel. Here we report a 3.3 angstrom crystal structure of a ten-subunit RNA exosome complex from Saccharomyces cerevisiae composed of the Exo9 core and Rrp6 bound to single-stranded poly(A) RNA. The Rrp6 catalytic domain rests on top of the Exo9 S1/KH ring above the central channel, the RNA 3' end is anchored in the Rrp6 active site, and the remaining RNA traverses the S1/KH ring in an opposite orientation to that observed in a structure of a Rrp44-containing exosome complex. Solution studies with human and yeast RNA exosome complexes suggest that the RNA path to Rrp6 is conserved and dependent on the integrity of the S1/KH ring. Although path selection to Rrp6 or Rrp44 is stochastic in vitro, the fate of a particular RNA may be determined in vivo by the manner in which cofactors present RNA to the RNA exosome.	[Wasmuth, Elizabeth V.; Januszyk, Kurt; Lima, Christopher D.] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA; [Wasmuth, Elizabeth V.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Louis Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Lima, Christopher D.] Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Lima, CD (corresponding author), Sloan Kettering Inst, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.	limac@mskcc.org		Lima, Christopher/0000-0002-9163-6092; Wasmuth, Elizabeth/0000-0003-1474-4935	US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; National Institute of General Medical Sciences of the National Institutes of Health [F31GM097910, R01GM079196]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408, P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473, P41GM111244, F31GM097910, R01GM079196, P41GM103403] Funding Source: NIH RePORTER	US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank NE-CAT beamlines (Advanced Photon Source) supported by P41GM103403 (NIH NIGMS). APS is supported by the US Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Beamline X29 (National Synchrotron Light Source) supported by the US Department of Energy, the Office of Basic Energy Sciences and P41RR012408 (NIH NCRR) and P41GM103473 (NIH NIGMS). Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award numbers F31GM097910 (E.V.W.) and R01GM079196 (C.D.L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. C.D.L. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Assenholt J, 2008, RNA, V14, P2305, DOI 10.1261/rna.1108008; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Cha SS, 2010, EMBO J, V29, P3520, DOI 10.1038/emboj.2010.226; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Drazkowska K, 2013, NUCLEIC ACIDS RES, V41, P3845, DOI 10.1093/nar/gkt060; Effantin G, 2010, J BIOL CHEM, V285, P14834, DOI 10.1074/jbc.M109.090498; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Greimann JC, 2008, METHOD ENZYMOL, V448, P185, DOI 10.1016/S0076-6879(08)02610-4; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Januszyk K, 2011, RNA, V17, P1566, DOI 10.1261/rna.2763111; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Liu JJ, 2014, NAT STRUCT MOL BIOL, V21, P95, DOI 10.1038/nsmb.2736; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Makino DL, 2013, NAT REV MOL CELL BIO, V14, P654, DOI 10.1038/nrm3657; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Wasmuth EV, 2012, ENZYMES, V31, P53, DOI 10.1016/B978-0-12-404740-2.00003-3; Wasmuth EV, 2012, MOL CELL, V48, P133, DOI 10.1016/j.molcel.2012.07.012; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	36	103	104	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					435	+		10.1038/nature13406	http://dx.doi.org/10.1038/nature13406			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043052	Green Accepted			2022-12-28	WOS:000339335700039
J	[Anonymous]				[Anonymous]			HIV: science and stigma	LANCET			English	Editorial Material																			0	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					207	207						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL8JI	25042217				2022-12-28	WOS:000339384100001
J	Allan, V				Allan, Viki			One, two, three, cytoplasmic dynein is go!	SCIENCE			English	Editorial Material							MICROTUBULE-BINDING; DYNACTIN INCREASES; PROCESSIVITY; MOTOR; TRANSPORT		Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Allan, V (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester M13 9PT, Lancs, England.	viki.allan@manchester.ac.uk		Allan, Victoria/0000-0003-4583-0836				Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Carter AP, 2013, J CELL SCI, V126, P705, DOI 10.1242/jcs.120725; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Kim H, 2007, J CELL BIOL, V176, P641, DOI 10.1083/jcb.200608128; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; McKenney RJ, 2011, J BIOL CHEM, V286, P39615, DOI 10.1074/jbc.M111.289017; Moughamian AJ, 2012, NEURON, V74, P331, DOI 10.1016/j.neuron.2012.02.025; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; Schiavo G, 2013, TRENDS NEUROSCI, V36, P641, DOI 10.1016/j.tins.2013.08.001; Schlager MA, 2014, EMBO J; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Soundararajan HC, 2014, ELIFE, V3, DOI 10.7554/eLife.01596; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210	16	7	7	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					271	272		10.1126/science.1257245	http://dx.doi.org/10.1126/science.1257245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035476				2022-12-28	WOS:000339400700030
J	Collins, FS; Wilder, EL; Zerhouni, E				Collins, Francis S.; Wilder, Elizabeth L.; Zerhouni, Elias			NIH Roadmap/Common Fund at 10 years	SCIENCE			English	Editorial Material							FUTURE		[Collins, Francis S.; Wilder, Elizabeth L.; Zerhouni, Elias] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Collins, FS (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	francis.collins@nih.gov						[Anonymous], 2011, INT RES CONS IN EV E; Berg JM, 2012, J AM MED INFORM ASSN, V19, P151, DOI 10.1136/amiajnl-2011-000800; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Lal B, 2012, OUTCOME EVALUATION N; Reiner A, 2013, TRENDS NEUROSCI, V36, P557, DOI 10.1016/j.tins.2013.08.005; White S., 2014, MEMBRANE PROTEINS KN; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867; Zerhouni EA, 2005, NEW ENGL J MED, V353, P1621, DOI 10.1056/NEJMsb053723	10	23	23	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					274	276		10.1126/science.1255860	http://dx.doi.org/10.1126/science.1255860			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8PG	25035478	Green Published			2022-12-28	WOS:000339400700032
J	Lin, DM; Fan, PY; Hasman, E; Brongersma, ML				Lin, Dianmin; Fan, Pengyu; Hasman, Erez; Brongersma, Mark L.			Dielectric gradient metasurface optical elements	SCIENCE			English	Article							SUBWAVELENGTH GRATINGS; LIGHT; PHASE; PROPAGATION; REFLECTION; LENS	Gradient metasurfaces are two-dimensional optical elements capable of manipulating light by imparting local, space-variant phase changes on an incident electromagnetic wave. These surfaces have thus far been constructed from nanometallic optical antennas, and high diffraction efficiencies have been limited to operation in reflection mode. We describe the experimental realization and operation of dielectric gradient metasurface optical elements capable of also achieving high efficiencies in transmission mode in the visible spectrum. Ultrathin gratings, lenses, and axicons have been realized by patterning a 100-nanometer-thick Si layer into a dense arrangement of Si nanobeam antennas. The use of semiconductors can broaden the general applicability of gradient metasurfaces, as they offer facile integration with electronics and can be realized by mature semiconductor fabrication technologies.	[Lin, Dianmin; Fan, Pengyu; Brongersma, Mark L.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Hasman, Erez] Technion Israel Inst Technol, Fac Mech Engn, Micro & Nanoopt Lab, IL-32000 Haifa, Israel; [Hasman, Erez] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel	Stanford University; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Brongersma, ML (corresponding author), Stanford Univ, Geballe Lab Adv Mat, 476 Lomita Mall, Stanford, CA 94305 USA.	brongersma@stanford.edu	Brongersma, Mark L/R-6099-2016	Brongersma, Mark L/0000-0003-1777-8970; Lin, Dianmin/0000-0001-8343-9120	Global Climate and Energy Project; Stanford Graduate Fellowship	Global Climate and Energy Project; Stanford Graduate Fellowship(Stanford University)	We acknowledge funding support from the Global Climate and Energy Project. P. F. acknowledges support from the Stanford Graduate Fellowship. We also thank P. Landreman for his assistance with the optical measurements.	Afshinmanesh F, 2012, NANOPHOTONICS-BERLIN, V1, P125, DOI 10.1515/nanoph-2012-0004; BERRY MV, 1987, J MOD OPTIC, V34, P1401, DOI 10.1080/09500348714551321; Bomzon Z, 2002, OPT LETT, V27, P1141, DOI 10.1364/OL.27.001141; Bomzon Z, 2002, OPT LETT, V27, P285, DOI 10.1364/OL.27.000285; Cao LY, 2010, NANO LETT, V10, P2649, DOI 10.1021/nl1013794; Cao LY, 2010, NANO LETT, V10, P439, DOI 10.1021/nl9036627; Cao LY, 2009, NAT MATER, V8, P643, DOI [10.1038/NMAT2477, 10.1038/nmat2477]; Chang-Hasnain CJ, 2011, SEMICOND SCI TECH, V26, DOI 10.1088/0268-1242/26/1/014043; Engheta N, 2007, SCIENCE, V317, P1698, DOI 10.1126/science.1133268; Fattal D, 2010, NAT PHOTONICS, V4, P466, DOI [10.1038/nphoton.2010.116, 10.1038/NPHOTON.2010.116]; Hasman E, 2003, APPL PHYS LETT, V82, P328, DOI 10.1063/1.1539300; Kildishev AV, 2013, SCIENCE, V339, DOI 10.1126/science.1232009; Mongia RK, 1997, IEEE T ANTENN PROPAG, V45, P1348, DOI 10.1109/8.623123; Ni XJ, 2012, SCIENCE, V335, P427, DOI 10.1126/science.1214686; Niv A, 2005, OPT COMMUN, V251, P306, DOI 10.1016/j.optcom.2005.03.002; Niv A, 2004, OPT LETT, V29, P238, DOI 10.1364/OL.29.000238; PANCHARATNAM S, 1956, P INDIAN ACAD SCI A, V44, P247, DOI DOI 10.1007/BF03046050; Pors A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02155; Rogers ETF, 2012, NAT MATER, V11, P432, DOI [10.1038/NMAT3280, 10.1038/nmat3280]; Spinelli P, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1691; Sun SL, 2012, NANO LETT, V12, P6223, DOI 10.1021/nl3032668; Verslegers L, 2009, NANO LETT, V9, P235, DOI 10.1021/nl802830y; Yang YM, 2014, NANO LETT, V14, P1394, DOI 10.1021/nl4044482; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713	24	1567	1638	116	1544	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					298	302		10.1126/science.1253213	http://dx.doi.org/10.1126/science.1253213			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035488				2022-12-28	WOS:000339400700044
J	Bhutta, ZA				Bhutta, Zulfiqar Ahmed			Polio eradication hinges on child health in Pakistan	NATURE			English	Editorial Material									[Bhutta, Zulfiqar Ahmed] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Bhutta, Zulfiqar Ahmed] Sick Kids Ctr Global Child Hlth, Toronto, ON, Canada	Aga Khan University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Bhutta, ZA (corresponding author), Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan.	zulfiqar.bhutta@aku.edu						Bhutta ZA, 2013, LANCET, V381, P2207, DOI 10.1016/S0140-6736(12)61999-0; Bhutta ZA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f280; Blake I. M., 2014, P NATL ACAD SCI US; Independent Monitoring Board of the Global Polio Eradication Initiative, 2014, 9 GLOB POL ER IN IND; Mayer BT, 2013, AM J EPIDEMIOL, V177, P1236, DOI 10.1093/aje/kws378; National Institute of Population Studies, 2013, PAK DEM HLTH SURV 20; Rutter PD, 2014, LANCET, V383, P1695, DOI 10.1016/S0140-6736(14)60756-X	7	13	13	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					285	287		10.1038/511285a	http://dx.doi.org/10.1038/511285a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL2YR	25030151	Bronze, Green Published			2022-12-28	WOS:000338992200012
J	Caplin, ME; Pavel, M; Cwikla, JB; Phan, AT; Raderer, M; Sedlackova, E; Cadiot, G; Wolin, EM; Capdevila, J; Wall, L; Rindi, G; Langley, A; Martinez, S; Blumberg, J; Ruszniewski, P				Caplin, Martyn E.; Pavel, Marianne; Cwikla, Jaroslaw B.; Phan, Alexandria T.; Raderer, Markus; Sedlackova, Eva; Cadiot, Guillaume; Wolin, Edward M.; Capdevila, Jaume; Wall, Lucy; Rindi, Guido; Langley, Alison; Martinez, Severine; Blumberg, Joelle; Ruszniewski, Philippe		CLARINET Investigators	Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOMATOSTATIN ANALOGS; CARCINOID-SYNDROME; GUIDELINES; STREPTOZOCIN; FLUOROURACIL; DOXORUBICIN; EVEROLIMUS; EFFICACY	Background Somatostatin analogues are commonly used to treat symptoms associated with hormone hypersecretion in neuroendocrine tumors; however, data on their antitumor effects are limited. Methods We conducted a randomized, double-blind, placebo-controlled, multinational study of the somatostatin analogue lanreotide in patients with advanced, well-differentiated or moderately differentiated, nonfunctioning, somatostatin receptor-positive neuroendocrine tumors of grade 1 or 2 (a tumor proliferation index [on staining for the Ki-67 antigen] of < 10%) and documented disease-progression status. The tumors originated in the pancreas, midgut, or hindgut or were of unknown origin. Patients were randomly assigned to receive an extended-release aqueous-gel formulation of lanreotide (Autogel [known in the United States as Depot], Ipsen) at a dose of 120 mg (101 patients) or placebo (103 patients) once every 28 days for 96 weeks. The primary end point was progression-free survival, defined as the time to disease progression (according to the Response Evaluation Criteria in Solid Tumors, version 1.0) or death. Secondary end points included overall survival, quality of life (assessed with the European Organization for Research and Treatment of Cancer questionnaires QLQ-C30 and QLQ-GI. NET21), and safety. Results Most patients (96%) had no tumor progression in the 3 to 6 months before randomization, and 33% had hepatic tumor volumes greater than 25%. Lanreotide, as compared with placebo, was associated with significantly prolonged progression-free survival (median not reached vs. median of 18.0 months, P<0.001 by the stratified log-rank test; hazard ratio for progression or death, 0.47; 95% confidence interval [CI], 0.30 to 0.73). The estimated rates of progression-free survival at 24 months were 65.1% (95% CI, 54.0 to 74.1) in the lanreotide group and 33.0% (95% CI, 23.0 to 43.3) in the placebo group. The therapeutic effect in predefined subgroups was generally consistent with that in the overall population, with the exception of small subgroups in which confidence intervals were wide. There were no significant between-group differences in quality of life or overall survival. The most common treatment-related adverse event was diarrhea (in 26% of the patients in the lanreotide group and 9% of those in the placebo group). Conclusions Lanreotide was associated with significantly prolonged progression-free survival among patients with metastatic enteropancreatic neuroendocrine tumors of grade 1 or 2 (Ki-67 < 10%). (Funded by Ipsen; CLARINET ClinicalTrials.gov number, NCT00353496; EudraCT 2005-004904-35.)	[Caplin, Martyn E.] Royal Free Hosp, London NW3 2QG, England; [Pavel, Marianne] Charite, D-13353 Berlin, Germany; [Cwikla, Jaroslaw B.] Univ Warmia & Mazury, Olsztyn, Poland; [Phan, Alexandria T.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Raderer, Markus] Univ Hosp Vienna, Vienna, Austria; [Sedlackova, Eva] Fac Med 1, Dept Oncol, Prague, Czech Republic; [Sedlackova, Eva] Gen Teaching Hosp, Prague, Czech Republic; [Cadiot, Guillaume] Robert Debre Hosp, Reims, France; [Langley, Alison; Martinez, Severine; Blumberg, Joelle] Ipsen, Les Ulis, France; [Ruszniewski, Philippe] Beaujon Hosp, Clichy, France; [Ruszniewski, Philippe] Paris Diderot Univ, Paris, France; [Wolin, Edward M.] Cedars Sinai Med Ctr, Samuel Oschin Canc Ctr, Los Angeles, CA 90048 USA; [Capdevila, Jaume] Vall dHebron Univ Hosp, Barcelona, Spain; [Wall, Lucy] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Rindi, Guido] Univ Cattolica Sacro Cuore, Rome, Italy	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Warmia & Mazury; University of Texas System; UTMD Anderson Cancer Center; University Hospital Vienna; Charles University Prague; General University Hospital Prague; CHU de Reims; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Cedars Sinai Medical Center; Hospital Universitari Vall d'Hebron; University of Edinburgh; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Caplin, ME (corresponding author), Royal Free Hosp, Dept Gastroenterol, Pond St, London NW3 2QG, England.	m.caplin@ucl.ac.uk	Sedlackova, Eva/B-9959-2017; Tabernero, Josep/AAG-5026-2019; Cannizzaro, Renato/V-3804-2018; Ramage, John/ABG-4603-2020; Gronbaek, Henning/AAJ-3202-2020	Sedlackova, Eva/0000-0002-0089-1611; Tabernero, Josep/0000-0002-2495-8139; Cannizzaro, Renato/0000-0002-2020-222X; Ramage, John/0000-0003-4824-6600; Gronbaek, Henning/0000-0001-8998-7910; Borbath, Ivan/0000-0001-7598-214X; RINDI, Guido/0000-0003-2996-4404; Aithal, Guruprasad/0000-0003-3924-4830; Cwikla, Jaroslaw B./0000-0001-5147-4167	Ipsen; Novo Nordisk Fonden [NNF10OC1013267] Funding Source: researchfish	Ipsen(Ipsen); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funded by Ipsen; CLARINET ClinicalTrials.gov number, NCT00353496; EudraCT 2005-004904-35.	Bajetta E, 2005, ANN ONCOL, V16, P1374, DOI 10.1093/annonc/mdi258; Food and Drug Administration, 2007, GUID IND CLIN TRIAL; Grozinsky-Glasberg S, 2008, ENDOCR-RELAT CANCER, V15, P701, DOI 10.1677/ERC-07-0288; Khan MS, 2011, ALIMENT PHARM THER, V34, P235, DOI 10.1111/j.1365-2036.2011.04693.x; Kouvaraki MA, 2004, J CLIN ONCOL, V22, P4762, DOI 10.1200/JCO.2004.04.024; Kouvaraki MA, 2005, J CLIN ONCOL, V23, P248; Krenning Eric P., 1995, V1995, P1; Kulke MH, 2012, J NATL COMPR CANC NE, V10, P724, DOI 10.6004/jnccn.2012.0075; Kulke MH, 2011, J CLIN ONCOL, V29, P934, DOI 10.1200/JCO.2010.33.2056; Martin-Richard M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-427; Oberg K, 2012, ANN ONCOL S7, V23; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Palazzo M, 2013, EUR J GASTROEN HEPAT, V25, P232, DOI 10.1097/MEG.0b013e328359d1a6; Pavel M, 2012, NEUROENDOCRINOLOGY, V95, P157, DOI 10.1159/000335597; Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Rindi G, 2010, WHO CLASSIFICATION T, V4, P13; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; Sideris L, 2012, ONCOLOGIST, V17, P747, DOI 10.1634/theoncologist.2011-0458; Sun WJ, 2005, J CLIN ONCOL, V23, P4897, DOI 10.1200/JCO.2005.03.616; Susini C, 2006, ANN ONCOL, V17, P1733, DOI 10.1093/annonc/mdl105; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Toumpanakis C, 2013, SEMIN ONCOL, V40, P56, DOI 10.1053/j.seminoncol.2012.11.006; van der Zwan JM, 2013, EUR J CANCER, V49, P2565, DOI 10.1016/j.ejca.2013.02.029; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290	26	1060	1104	2	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2014	371	3					224	233		10.1056/NEJMoa1316158	http://dx.doi.org/10.1056/NEJMoa1316158			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL3BK	25014687				2022-12-28	WOS:000338999800006
J	Clenet, H; Jutzi, M; Barrat, JA; Asphaug, EI; Benz, W; Gillet, P				Clenet, Harold; Jutzi, Martin; Barrat, Jean-Alix; Asphaug, Erik I.; Benz, Willy; Gillet, Philippe			A deep crust-mantle boundary in the asteroid 4 Vesta	NATURE			English	Article							MODIFIED GAUSSIAN MODEL; PARENT BODY; PYROXENE MIXTURES; HED METEORITES; MAGMA OCEAN; OLIVINE; DIOGENITES; DAWN; REFLECTANCE; SPECTROSCOPY	The asteroid 4 Vesta was recently found to have two large impact craters near its south pole, exposing subsurface material. Modelling suggested that surface material in the northern hemisphere of Vesta came from a depth of about 20 kilometres, whereas the exposed southern material comes from a depth of 60 to 100 kilometres. Large amounts of olivine from the mantle were not seen, suggesting that the outer 100 kilometres or so is mainly igneous crust. Here we analyse the data on Vesta and conclude that the crust-mantle boundary (or Moho) is deeper than 80 kilometres.	[Clenet, Harold; Gillet, Philippe] Ecole Polytech Fed Lausanne, Inst Condensed Matter Phys, EPSL, Stn 3, CH-1015 Lausanne, Switzerland; [Jutzi, Martin; Benz, Willy] Univ Bern, Inst Phys, Ctr Space & Habitabil, CH-3012 Bern, Switzerland; [Barrat, Jean-Alix] Univ Bretagne Occidentale, Inst Univ Europeen Mer, CNRS, UMR 6538, F-29280 Plouzane, France; [Asphaug, Erik I.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Bern; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Arizona State University; Arizona State University-Tempe	Clenet, H (corresponding author), Ecole Polytech Fed Lausanne, Inst Condensed Matter Phys, EPSL, Stn 3, CH-1015 Lausanne, Switzerland.	harold.clenet@epfl.ch	Asphaug, Erik/AAC-9455-2020; Clenet, Harold/B-7621-2016; Barrat, Jean-Alix/C-8416-2017	Clenet, Harold/0000-0002-6743-7798; Barrat, Jean-Alix/0000-0003-3158-3109; Jutzi, Martin/0000-0002-1800-2974	Swiss National Science Foundation through the Ambizione program; INSU Programme National de Planetologie; NASA Planetary Geology and Geophysics Program	Swiss National Science Foundation through the Ambizione program; INSU Programme National de Planetologie; NASA Planetary Geology and Geophysics Program(National Aeronautics & Space Administration (NASA))	M.J. acknowledges support from the Swiss National Science Foundation through the Ambizione program. J.-A.B. acknowledges support from the INSU Programme National de Planetologie. E. I. A. was sponsored by the NASA Planetary Geology and Geophysics Program.	ADAMS JB, 1974, J GEOPHYS RES, V79, P4829, DOI 10.1029/JB079i032p04829; Ammannito E, 2013, NATURE, V504, P122, DOI 10.1038/nature12665; Ammannito E, 2013, METEORIT PLANET SCI, V48, P2185, DOI 10.1111/maps.12192; Anderson J., 2011, AGU FALL M; Barrat JA, 2010, GEOCHIM COSMOCHIM AC, V74, P6218, DOI 10.1016/j.gca.2010.07.028; Beck AW, 2013, METEORIT PLANET SCI, V48, P2155, DOI 10.1111/maps.12160; Beck AW, 2010, METEORIT PLANET SCI, V45, P850, DOI 10.1111/j.1945-5100.2010.01061.x; Beck P, 2011, ICARUS, V216, P560, DOI 10.1016/j.icarus.2011.09.015; BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; Buratti BJ, 2013, J GEOPHYS RES-PLANET, V118, P1991, DOI 10.1002/jgre.20152; Bus S. J., 2013, 8 WORKSH CAT DISR SO; Clenet H., 2009, THESIS U TOULOUSE; Clenet H, 2013, J GEOPHYS RES-PLANET, V118, P1632, DOI 10.1002/jgre.20112; Clenet H, 2011, ICARUS, V213, P404, DOI 10.1016/j.icarus.2011.03.002; CLOUTIS EA, 1991, EARTH MOON PLANETS, V53, P11, DOI 10.1007/BF00116217; De Sanctis MC, 2012, SCIENCE, V336, P697, DOI 10.1126/science.1219270; De Sanctis MC, 2011, SPACE SCI REV, V163, P329, DOI 10.1007/s11214-010-9668-5; De Sanctis MC, 2013, METEORIT PLANET SCI, V48, P2166, DOI 10.1111/maps.12138; Gillet P., 2014, LUNAR PLANET SCI C, P1822; Greenwood RC, 2014, EARTH PLANET SC LETT, V390, P165, DOI 10.1016/j.epsl.2013.12.011; Hans U, 2013, EARTH PLANET SC LETT, V374, P204, DOI 10.1016/j.epsl.2013.05.029; Ivanov BA, 2013, J GEOPHYS RES-PLANET, V118, P1545, DOI 10.1002/jgre.20108; Jutzi M, 2013, NATURE, V494, P207, DOI 10.1038/nature11892; Kanner LC, 2007, ICARUS, V187, P442, DOI 10.1016/j.icarus.2006.10.025; Li J.-Y., 2012, AST COM MET C; Mandler BE, 2013, METEORIT PLANET SCI, V48, P2333, DOI 10.1111/maps.12135; Mayne RG, 2011, ICARUS, V214, P147, DOI 10.1016/j.icarus.2011.04.013; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; McSween H. Y., 2013, J GEOPHYS RES, V118, P1; McSween HY, 2013, METEORIT PLANET SCI, V48, P2090, DOI 10.1111/maps.12108; Nesvorny D, 2008, ICARUS, V193, P85, DOI 10.1016/j.icarus.2007.08.034; Park R. S., ICARUS IN PRESS; Reddy V, 2012, SCIENCE, V336, P700, DOI 10.1126/science.1219088; Reddy V, 2011, ICARUS, V212, P175, DOI 10.1016/j.icarus.2010.11.032; Righter K, 1997, METEORIT PLANET SCI, V32, P929, DOI 10.1111/j.1945-5100.1997.tb01582.x; Russell CT, 2012, SCIENCE, V336, P684, DOI 10.1126/science.1219381; Ruzicka A, 1997, METEORIT PLANET SCI, V32, P825, DOI 10.1111/j.1945-5100.1997.tb01573.x; Schenk P, 2012, SCIENCE, V336, P694, DOI 10.1126/science.1223272; SINGER RB, 1981, J GEOPHYS RES, V86, P7967, DOI 10.1029/JB086iB09p07967; SUNSHINE JM, 1993, J GEOPHYS RES-PLANET, V98, P9075, DOI 10.1029/93JE00677; Sunshine JM, 1998, J GEOPHYS RES-PLANET, V103, P13675, DOI 10.1029/98JE01217; SUNSHINE JM, 1990, J GEOPHYS RES-SOLID, V95, P6955, DOI 10.1029/JB095iB05p06955; Tera F., 1970, GEOCHIM COSMOCHIM AC, V2, P1637; Toplis M. J., 2013, METEORIT PLANET SCI, V16, P1, DOI DOI 10.1111/MAPS.12195; Yamaguchi A, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003753	45	46	46	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					303	+		10.1038/nature13499	http://dx.doi.org/10.1038/nature13499			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030166				2022-12-28	WOS:000338992200026
J	Koonin, EV				Koonin, Eugene V.			Calorie Restriction a Lamarck	CELL			English	Editorial Material							INHERITANCE; MECHANISMS; ARGONAUTE; EVOLUTION; RNAS; DNA	Epigenetic inheritance of resistance to exogenous nucleic acids via small interfering (si) RNA is well established in animal models. Rechavi et al. demonstrate epigenetic inheritance of a starvation-induced pattern of gene silencing caused by endogenous siRNAs and resulting in an increased longevity in the third generation progeny. Combined with recent findings in prokaryotes, these results suggest that Lamarckian-type inheritance of acquired traits is a major evolutionary phenomenon.	NIH, Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Koonin, EV (corresponding author), NIH, Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA.	koonin@ncbi.nlm.nih.gov			Intramural NIH HHS [Z01 LM000061-15] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [ZIALM000061] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Grishok A, 2013, ADV GENET, V83, P1, DOI 10.1016/B978-0-12-407675-4.00001-8; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Koonin EV, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-27; Koonin EV, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-42; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Rechavi O, 2014, CELL, V158, P277, DOI 10.1016/j.cell.2014.06.020; Rechavi O, 2014, TRENDS CELL BIOL, V24, P212, DOI 10.1016/j.tcb.2013.10.003; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971	10	15	15	1	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					237	238		10.1016/j.cell.2014.07.004	http://dx.doi.org/10.1016/j.cell.2014.07.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036622	Bronze, Green Accepted			2022-12-28	WOS:000340943600001
J	Ksander, BR; Kolovou, PE; Wilson, BJ; Saab, KR; Guo, Q; Ma, J; McGuire, SP; Gregory, MS; Vincent, WJB; Perez, VL; Cruz-Guilloty, F; Kao, WWY; Call, MK; Tucker, BA; Zhan, Q; Murphy, GF; Lathrop, KL; Alt, C; Mortensen, LJ; Lin, CP; Zieske, JD; Frank, MH; Frank, NY				Ksander, Bruce R.; Kolovou, Paraskevi E.; Wilson, Brian J.; Saab, Karim R.; Guo, Qin; Ma, Jie; McGuire, Sean P.; Gregory, Meredith S.; Vincent, William J. B.; Perez, Victor L.; Cruz-Guilloty, Fernando; Kao, Winston W. Y.; Call, Mindy K.; Tucker, Budd A.; Zhan, Qian; Murphy, George F.; Lathrop, Kira L.; Alt, Clemens; Mortensen, Luke J.; Lin, Charles P.; Zieske, James D.; Frank, Markus H.; Frank, Natasha Y.			ABCB5 is a limbal stem cell gene required for corneal development and repair	NATURE			English	Article							OCULAR SURFACE; CHEMORESISTANCE; MELANOMA; MICE; POPULATION; DEFICIENCY; MICROSCOPY; PHENOTYPE; THERAPY	Corneal epithelial homeostasis and regeneration are sustained by limbal stem cells (LSCs)(1-3), and LSC deficiency is a major cause of blindness worldwide(4). Transplantation is often the only therapeutic option available to patients with LSC deficiency. However, while transplant success depends foremost on LSC frequency within grafts(5), a gene allowing for prospective LSC enrichment has not been identified so far(5). Here we show that ATP-binding cassette, sub-family B, member(5) (ABCB5)(6,7) marks LSCs and is required for LSC maintenance, corneal development and repair. Furthermore, we demonstrate that prospectively isolated humanor murine ABCB5-positive LSCs possess the exclusive capacity to fully restore the cornea upon grafting to LSC-deficient mice in xenogeneic or syngeneic transplantation models. ABCB5 is preferentially expressed on label-retaining LSCs2 in mice and p63 alpha-positive LSCs8 in humans. Consistent with these findings, ABCB5-positive LSC frequency is reduced in LSC-deficient patients. Abcb5 loss of function in Abcb5 knockout mice causes depletion of quiescent LSCs due to enhanced proliferation and apoptosis, and results in defective corneal differentiation and wound healing. Our results from gene knockout studies, LSC tracing and transplantation models, as well as phenotypic and functional analyses of human biopsy specimens, provide converging lines of evidence that ABCB5 identifies mammalian LSCs. Identification and prospective isolation of molecularly defined LSCs with essential functions in corneal development and repair has important implications for the treatment of corneal disease, particularly corneal blindness due to LSC deficiency.	[Ksander, Bruce R.; Kolovou, Paraskevi E.; McGuire, Sean P.; Gregory, Meredith S.; Vincent, William J. B.; Zieske, James D.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02114 USA; [Ksander, Bruce R.; Kolovou, Paraskevi E.; McGuire, Sean P.; Gregory, Meredith S.; Vincent, William J. B.; Alt, Clemens; Mortensen, Luke J.; Lin, Charles P.; Zieske, James D.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Wilson, Brian J.; Saab, Karim R.; Guo, Qin; Ma, Jie; Frank, Markus H.; Frank, Natasha Y.] Boston Childrens Hosp, Div Nephrol, Transplant Res Program, Boston, MA 02115 USA; [Wilson, Brian J.; Saab, Karim R.; Guo, Qin; Ma, Jie; Frank, Markus H.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Wilson, Brian J.; Guo, Qin; Frank, Natasha Y.] VA Boston Healthcare Syst, Dept Med, Boston, MA 02130 USA; [Perez, Victor L.; Cruz-Guilloty, Fernando] Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Perez, Victor L.; Cruz-Guilloty, Fernando] Univ Miami, Miller Sch Med, Dept Ophthalmol, Miami, FL 33136 USA; [Kao, Winston W. Y.; Call, Mindy K.] Univ Cincinnati, Med Ctr, Dept Ophthalmol, Cincinnati, OH 45229 USA; [Tucker, Budd A.] Univ Iowa, Stephen A Wynn Inst Vis Res, Carver Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Zhan, Qian; Murphy, George F.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lathrop, Kira L.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA; [Lathrop, Kira L.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15213 USA; [Alt, Clemens; Mortensen, Luke J.; Lin, Charles P.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Alt, Clemens; Mortensen, Luke J.; Lin, Charles P.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Frank, Markus H.; Frank, Natasha Y.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02138 USA; [Frank, Natasha Y.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Bascom Palmer Eye Institute; University of Miami; University System of Ohio; University of Cincinnati; University of Iowa; Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Frank, NY (corresponding author), Boston Childrens Hosp, Div Nephrol, Transplant Res Program, Boston, MA 02115 USA.	markus.frank@childrens.harvard.edu; nfrank@partners.org	Perez, Victor L./AAY-8633-2020; Gregory-Ksander, Meredith/AAG-1413-2019; Mortensen, Luke/N-2640-2018; Frank, Markus/O-1625-2014	Gregory-Ksander, Meredith/0000-0002-7193-0032; Mortensen, Luke/0000-0002-4331-4099; Tucker, Budd/0000-0003-2178-1742; Zieske, James/0000-0002-3730-6180; Frank, Markus/0000-0002-1312-0488	National Institutes of Health (NIH)/National Institutes of Neurological Disorders and Stroke [K08NS051349]; VA BLRD [1I01BX000516]; VA RRD [1I01RX000989]; Harvard Stem Cell Institute; NIH/National Cancer Institute [R01CA113796, R01CA158467, R01CA138231]; Department of Defense [PR0332453]; NIH [R01CA138231, R01EY018624, P30EY014801, R01EY021768, DP2OD007483, R01 EB017274, U01HL100402, P41EB015903]; Corley Research Foundation; Western Pennsylvania Medical Eye Bank Core Grant for Vision Research [EY08098]; NATIONAL CANCER INSTITUTE [R01CA138231, R01CA113796, R01CA158467] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021768, P30EY014801, R01EY018624, P30EY003790, P30EY008098] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017274, P41EB015903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS051349] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007483] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000989, I01BX000516] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institutes of Neurological Disorders and Stroke; VA BLRD; VA RRD; Harvard Stem Cell Institute; NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Corley Research Foundation; Western Pennsylvania Medical Eye Bank Core Grant for Vision Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	We thank R. Maas for critical reading of the manuscript. We also thank P. Mallen for assistance with graphic illustrations; the Heartland Lions Eye Bank for providing clinical specimens; G. Berg for assistance with mouse colony maintenance; D. Dombkowski, F. Preffer and R. Huang for their assistance with cell sorting and viability studies. This work was supported by National Institutes of Health (NIH)/National Institutes of Neurological Disorders and Stroke grant K08NS051349, VA BLR&D 1I01BX000516 and VA RR&D 1I01RX000989 Merit Review Awards, and a Harvard Stem Cell Institute grant to N.Y.F., NIH/National Cancer Institute grants R01CA113796, R01CA158467 and R01CA138231 to M. H. F., Department of Defense grant PR0332453 to B. R. K., NIH R01EY018624 and P30EY014801 grants to V. L. P., NIH grant R01EY021768 to W. W. K., NIH New Innovator Award DP2OD007483 and a Corley Research Foundation grant to B. A. T., NIH R01CA138231 to G. F. M., Western Pennsylvania Medical Eye Bank Core Grant for Vision Research (EY08098) to K. L. L., and NIH grants R01 EB017274, U01HL100402 and P41EB015903 to C. P. L. F. C. G. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation.	Cheung ST, 2011, GASTROENTEROLOGY, V140, P344, DOI 10.1053/j.gastro.2010.07.049; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Dua HS, 2003, EYE, V17, P877, DOI 10.1038/sj.eye.6700573; Frank NY, 2011, CANCER RES, V71, P1474, DOI 10.1158/0008-5472.CAN-10-1660; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; Hutcheon AEK, 2007, EXP EYE RES, V84, P32, DOI 10.1016/j.exer.2006.08.011; Hutcheson DA, 2009, CELL CYCLE, V8, P3675, DOI 10.4161/cc.8.22.9992; Kao WWY, 1996, INVEST OPHTH VIS SCI, V37, P2572; Klocke J, 2011, INVEST OPHTH VIS SCI, V52, P256, DOI 10.1167/iovs.10-5566; Krulova M, 2008, INVEST OPHTH VIS SCI, V49, P3903, DOI 10.1167/iovs.08-1987; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lathrop KL, 2012, INVEST OPHTH VIS SCI, V53, P1381, DOI 10.1167/iovs.11-8524; Lin JY, 2013, BIOCHEM BIOPH RES CO, V436, P536, DOI 10.1016/j.bbrc.2013.06.006; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Luo YC, 2012, J INVEST DERMATOL, V132, P2440, DOI 10.1038/jid.2012.161; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Meyer-Blazejewska EA, 2011, STEM CELLS, V29, P57, DOI 10.1002/stem.550; Meyer-Blazejewska EA, 2010, INVEST OPHTH VIS SCI, V51, P765, DOI 10.1167/iovs.09-4109; Notara M, 2008, CELL TISSUE RES, V331, P135, DOI 10.1007/s00441-007-0458-7; Pal-Ghosh S, 2008, EXP EYE RES, V87, P478, DOI 10.1016/j.exer.2008.08.013; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Rocco A, 2012, LAB INVEST, V92, P1407, DOI 10.1038/labinvest.2012.100; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; Wang K, 2012, BIOMED OPT EXPRESS, V3, P1972, DOI 10.1364/BOE.3.001972; Wilson BJ, 2011, CANCER RES, V71, P5307, DOI 10.1158/0008-5472.CAN-11-0221	32	167	176	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					353	+		10.1038/nature13426	http://dx.doi.org/10.1038/nature13426			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030174	Green Accepted			2022-12-28	WOS:000338992200037
J	Levine, M				Levine, Michael			The Contraction of Time and Space in Remote Chromosomal Interactions	CELL			English	Editorial Material							IGH LOCUS; GENE; ELEMENTS; DNA	Lucas et al. report the visualization of V(D)J recombination of the immunoglobulin heavy-chain gene (Igh) in living pro-B cells. Despite the huge distances separating V coding sequences from D-J sequences (similar to 2 Mb), the authors document an astonishingly rapid rate of remote associations. The key to speed is contraction of the Igh chromosomal domain. These findings provide a foundation for understanding long-range regulatory interactions in a variety of developmental processes, including the patterning of vertebrate limbs.	Univ Calif Berkeley, Ctr Integrat Gen, Dept Mol & Cell Biol, Div Genet Gen & Dev, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Levine, M (corresponding author), Univ Calif Berkeley, Ctr Integrat Gen, Dept Mol & Cell Biol, Div Genet Gen & Dev, Berkeley, CA 94720 USA.	mlevine@berkeley.edu		Levine, Michael/0000-0001-7629-0081	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034431, R01GM046638, R37GM046638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076542] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM046638, R37 GM046638, R01 GM034431] Funding Source: Medline; NINDS NIH HHS [R01 NS076542] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Lucas JS, 2014, CELL, V158, P339, DOI 10.1016/j.cell.2014.05.036; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; Perlot T, 2008, ADV IMMUNOL, V99, P1, DOI 10.1016/S0065-2776(08)00601-9; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279	9	3	4	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					243	244		10.1016/j.cell.2014.06.039	http://dx.doi.org/10.1016/j.cell.2014.06.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036625	Green Accepted, Bronze			2022-12-28	WOS:000340943600004
J	Robinette, ML; Colonna, M				Robinette, Michelle L.; Colonna, Marco			GI Motility: Microbiota and Macrophages Join Forces	CELL			English	Editorial Material							ENTERIC NERVOUS-SYSTEM	Gastrointestinal motility causes movement of food during digestion through contractions of the gut smooth muscle. The enteric nervous system regulates these events, and Muller et al. now find that its interaction with the immune system, in concert with gut microbiota, provides an additional layer of regulation to this complex task.	[Robinette, Michelle L.; Colonna, Marco] Washington Univ, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.	mcolonna@pathology.wustl.edu		Colonna, Marco/0000-0001-5222-4987				Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Kunze WAA, 1999, ANNU REV PHYSIOL, V61, P117, DOI 10.1146/annurev.physiol.61.1.117; Matteoli G, 2014, GUT, V63, P938, DOI 10.1136/gutjnl-2013-304676; Mikkelsen HB, 2010, J CELL MOL MED, V14, P818, DOI 10.1111/j.1582-4934.2010.01025.x; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Olofsson PS, 2012, IMMUNOL REV, V248, P188, DOI 10.1111/j.1600-065X.2012.01138.x; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Sasselli V, 2012, DEV BIOL, V366, P64, DOI 10.1016/j.ydbio.2012.01.012; Talley N.J., 2008, MOTIL, V20, P121; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	10	8	8	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					239	240		10.1016/j.cell.2014.06.040	http://dx.doi.org/10.1016/j.cell.2014.06.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036623	Bronze			2022-12-28	WOS:000340943600002
J	Cole, TB				Cole, Thomas B.			The Smiths W. Blair Bruce	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					214	215		10.1001/jama.2013.279615	http://dx.doi.org/10.1001/jama.2013.279615			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	25027122				2022-12-28	WOS:000338940300001
J	Morris, AM				Morris, Andrew M.			Review: Voriconazole for prevention or treatment of invasive fungal infections in cancer with neutropenia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LIPOSOMAL AMPHOTERICIN-B; PERSISTENT FEVER; THERAPY		[Morris, Andrew M.] Mt Sinai Hosp, Univ Hlth Network, Toronto, ON M5G 1X5, Canada; [Morris, Andrew M.] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto; University of Toronto	Morris, AM (corresponding author), Mt Sinai Hosp, Univ Hlth Network, Toronto, ON M5G 1X5, Canada.							Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Johnson LB, 2003, CLIN INFECT DIS, V36, P630, DOI 10.1086/367933; Powers JH, 2002, NEW ENGL J MED, V346, P289, DOI 10.1056/NEJM200201243460414; Walsh TJ, 2002, NEW ENGL J MED, V346, P225, DOI 10.1056/NEJM200201243460403	4	3	3	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2							JC8	10.7326/0003-4819-161-2-201407150-02008	http://dx.doi.org/10.7326/0003-4819-161-2-201407150-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023274				2022-12-28	WOS:000339764600011
J	Barouch, DH; Deeks, SG				Barouch, Dan H.; Deeks, Steven G.			Immunologic strategies for HIV-1 remission and eradication	SCIENCE			English	Review							CD4(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; INTERFERON-STIMULATED GENES; PERSISTENT LCMV INFECTION; PLACEBO-CONTROLLED TRIAL; HIGHLY PATHOGENIC SIV; IN-VIVO; NEUTRALIZING ANTIBODIES; ANTIVIRAL THERAPY; RHESUS-MONKEYS	Antiretroviral therapy (ART) is able to suppress HIV-1 replication indefinitely in individuals who have access to these medications, are able to tolerate these drugs, and are motivated to take them daily for life. However, ART is not curative. HIV-1 persists indefinitely during ART as quiescent integrated DNA within memory CD4(+) T cells and perhaps other long-lived cellular reservoirs. In this Review, we discuss the role of the immune system in the establishment and maintenance of the latent HIV-1 reservoir. A detailed understanding of how the host immune system shapes the size and distribution of the viral reservoir should lead to the development of a new generation of immune-based therapeutics, which may eventually contribute to a curative intervention.	[Barouch, Dan H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Barouch, Dan H.] MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02139 USA; [Barouch, Dan H.] Harvard Univ, Cambridge, MA 02139 USA; [Deeks, Steven G.] Univ Calif San Francisco, San Francisco, CA 94110 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; University of California System; University of California San Francisco	Barouch, DH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu; sdeeks@php.ucsf.edu	Barouch, Dan/Y-3918-2019		NIH [AI078526, AI084794, AI095985, AI096040, AI096109, AI100663, OD011170]; Bill and Melinda Gates Foundation [OPP1033091, OPP1040741, OPP1083689]; Ragon Institute of MGH, MIT, and Harvard; Henry M. Jackson Foundation; American Foundation for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084794, U19AI096040, U19AI095985, UM1AI100663, U19AI078526, U19AI096109] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011170] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ragon Institute of MGH, MIT, and Harvard; Henry M. Jackson Foundation; American Foundation for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank B. Walker, N. Michael, J. Kim, M. Robb, R. Geleziunas, M. McCune, R. Sekaly, N. Chomont, and S. Lewin for helpful discussions. The authors acknowledge support from the NIH [AI078526, AI084794, AI095985, AI096040, AI096109 (Delaney AIDS Research Enterprise), AI100663, and OD011170]; the Bill and Melinda Gates Foundation (OPP1033091, OPP1040741, and OPP1083689); the Ragon Institute of MGH, MIT, and Harvard; the Henry M. Jackson Foundation; and the American Foundation for AIDS Research. D. H. B. is a co-inventor on Ad26 vector, mosaic antigen, and Env immunogen patents. S. G. D. has served as an ad hoc consultant for Bristol-Myers Squib, GlaxoSmithKline, and Janssen on HIV cure-related activities.	Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Angel JB, 2011, AIDS, V25, P731, DOI 10.1097/QAD.0b013e328344cea5; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2012, P NATL ACAD SCI USA, V109, P9523, DOI 10.1073/pnas.1120248109; Autran B, 2008, AIDS, V22, P1313, DOI 10.1097/QAD.0b013e3282fdce94; Azzoni L, 2013, J INFECT DIS, V207, P213, DOI 10.1093/infdis/jis663; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Blazkova J, 2012, J INFECT DIS, V206, P765, DOI 10.1093/infdis/jis412; Bosque A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002288; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Cannon PM, 2014, NAT BIOTECHNOL, V32, P314, DOI 10.1038/nbt.2868; Casazza JP, 2013, J INFECT DIS, V207, P1829, DOI 10.1093/infdis/jit098; Chevalier MF, 2013, BLOOD, V121, P29, DOI 10.1182/blood-2012-07-409755; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Cillo AR, 2014, P NATL ACAD SCI USA, V111, P7078, DOI 10.1073/pnas.1402873111; Cohen J, 2014, SCIENCE, V343, P1188, DOI 10.1126/science.343.6176.1188; Dahirel V, 2011, P NATL ACAD SCI USA, V108, P11530, DOI 10.1073/pnas.1105315108; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Evans VA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003799; Favre D, 2011, BLOOD, V117, P2189, DOI 10.1182/blood-2010-06-288035; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Fernandez S, 2011, J INFECT DIS, V204, P1927, DOI 10.1093/infdis/jir659; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Gandhi RT, 2009, VACCINE, V27, P6088, DOI 10.1016/j.vaccine.2009.05.016; Garcia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004682; Gardiner D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063818; Gavegnano C, 2014, ANTIMICROB AGENTS CH, V58, P1977, DOI 10.1128/AAC.02496-13; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hatano H, 2013, J INFECT DIS, V208, P1436, DOI 10.1093/infdis/jit453; Hatano H, 2013, J INFECT DIS, V208, P50, DOI 10.1093/infdis/jis630; Henrich TJ, 2013, J INFECT DIS, V207, P1694, DOI 10.1093/infdis/jit086; Heredia A, 2003, P NATL ACAD SCI USA, V100, P10411, DOI 10.1073/pnas.1834278100; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Kilby JM, 2006, J INFECT DIS, V194, P1672, DOI 10.1086/509508; Klatt NR, 2013, IMMUNOL REV, V254, P326, DOI 10.1111/imr.12065; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kulkosky J, 2002, J INFECT DIS, V186, P1403, DOI 10.1086/344357; Le Saout C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003976; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978; Luzuriaga K, 2014, J INFECT DIS; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Murray JM, 2014, J VIROL, V88, P3516, DOI 10.1128/JVI.03331-13; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Persaud D, 2003, J VIROL, V77, P1659, DOI 10.1128/JVI.77.3.1659-1665.2003; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Pillai SK, 2012, P NATL ACAD SCI USA, V109, P3035, DOI 10.1073/pnas.1111573109; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; Rosenberg ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010555; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Schooley RT, 2010, J INFECT DIS, V202, P705, DOI 10.1086/655468; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Siliciano RF, 2014, NAT MED, V20, P484, DOI 10.1038/nm.3550; Spivak AM, 2014, CLIN INFECT DIS, V58, P883, DOI 10.1093/cid/cit813; Stock PG, 2014, AM J TRANSPLANT, V14, P1136, DOI 10.1111/ajt.12699; Stoddart CA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000766; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Vandergeeten C, 2013, BLOOD, V121, P4321, DOI 10.1182/blood-2012-11-465625; Wang FX, 2005, J CLIN INVEST, V115, P128, DOI 10.1172/JCI200522574; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Younan PM, 2013, BLOOD, V122, P179, DOI 10.1182/blood-2013-01-482224; Yukl SA, 2013, J INFECT DIS, V208, P1212, DOI 10.1093/infdis/jit308; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437	95	167	175	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					169	174		10.1126/science.1255512	http://dx.doi.org/10.1126/science.1255512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013067	Green Accepted			2022-12-28	WOS:000339409900041
J	van der Marel, D; Sawatzky, GA				van der Marel, Dirk; Sawatzky, George Albert			An optical twist for triplet superconductors	SCIENCE			English	Editorial Material							SPIN FLUCTUATIONS; UPT3		[van der Marel, Dirk] Univ Geneva, Dept Phys Mat Condensee, Ecole Phys, CH-1211 Geneva, Switzerland; [Sawatzky, George Albert] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada	University of Geneva; University of British Columbia	van der Marel, D (corresponding author), Univ Geneva, Dept Phys Mat Condensee, Ecole Phys, Quai Ernest Ansermet 24, CH-1211 Geneva, Switzerland.	dirk.vandermarel@unige.ch; sawatzky@physics.ubc.ca	van der Marel, Dirk/G-4618-2012	van der Marel, Dirk/0000-0001-5266-9847				ANDERSON PW, 1984, PHYS REV B, V30, P1549, DOI 10.1103/PhysRevB.30.1549; DEVISSER A, 1984, PHYSICA B & C, V127, P442, DOI 10.1016/S0378-4363(84)80072-8; Han JE, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.054513; HIRSCH JE, 1985, PHYS REV LETT, V54, P1317, DOI 10.1103/PhysRevLett.54.1317; Keizer RS, 2006, NATURE, V439, P825, DOI 10.1038/nature04499; Klejnberg A, 1999, J PHYS-CONDENS MAT, V11, P6553, DOI 10.1088/0953-8984/11/34/307; MEUL HW, 1984, PHYS REV LETT, V53, P497, DOI 10.1103/PhysRevLett.53.497; NORMAN MR, 1994, PHYS REV LETT, V72, P2077, DOI 10.1103/PhysRevLett.72.2077; Schemm ER, 2014, SCIENCE, V345, P190, DOI 10.1126/science.1248552; STEWART GR, 1984, PHYS REV LETT, V52, P679, DOI 10.1103/PhysRevLett.52.679; VANDERMAREL D, 1985, SOLID STATE COMMUN, V55, P937, DOI 10.1016/0038-1098(85)90562-9; Varma C. M., 1985, Comments on Solid State Physics, V11, P221	12	0	0	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					138	139		10.1126/science.1255925	http://dx.doi.org/10.1126/science.1255925			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013046				2022-12-28	WOS:000339409900021
J	Gostin, LO				Gostin, Lawrence O.			Healthy living needs global governance	NATURE			English	Editorial Material							TOBACCO CONTROL		Georgetown Univ, World Hlth Org Collaborating Ctr Publ Hlth Law &, Washington, DC 20057 USA	Georgetown University; World Health Organization	Gostin, LO (corresponding author), Georgetown Univ, World Hlth Org Collaborating Ctr Publ Hlth Law &, Washington, DC 20057 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Alleyne G, 2013, LANCET, V381, P566, DOI 10.1016/S0140-6736(12)61806-6; Dieleman JL, 2014, HEALTH AFFAIR, V33, P878, DOI 10.1377/hlthaff.2013.1432; Gostin L.O., 2014, GLOBAL HLTH LAW; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; Holford TR, 2014, JAMA-J AM MED ASSOC, V311, P164, DOI 10.1001/jama.2013.285112; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Matsudo Sandra Mahecha, 2003, Rev Panam Salud Publica, V14, P265, DOI 10.1590/S1020-49892003000900007; Muggli M. E., 2013, TOB CONTROL; Ng M., 2014, LANCET; Yach D, 2014, LANCET, V383, P1771, DOI 10.1016/S0140-6736(13)62155-8	10	26	28	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					147	149		10.1038/511147a	http://dx.doi.org/10.1038/511147a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8AP	25013878	Bronze			2022-12-28	WOS:000338649800021
J	Lane, R				Lane, Richard			Profile Steff anie Strathdee: "called" to HIV prevention	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					20	20		10.1016/S0140-6736(14)61048-5	http://dx.doi.org/10.1016/S0140-6736(14)61048-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX8IW	25059940				2022-12-28	WOS:000347154200014
J	Shannon, K; Strathdee, SA; Goldenberg, SM; Duff, P; Mwangi, P; Rusakova, M; Reza-Paul, S; Lau, J; Deering, K; Pickles, MR; Boily, MC				Shannon, Kate; Strathdee, Steffanie A.; Goldenberg, Shira M.; Duff, Putu; Mwangi, Peninah; Rusakova, Maia; Reza-Paul, Sushena; Lau, Joseph; Deering, Kathleen; Pickles, Michael R.; Boily, Marie-Claude			Global epidemiology of HIV among female sex workers: influence of structural determinants	LANCET			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; CONSISTENT CONDOM USE; CROSS-SECTIONAL SURVEYS; INJECTION-DRUG USERS; COMMERCIAL SEX; RISK BEHAVIORS; ANDHRA-PRADESH; PREVENTION PROGRAM; MULTILEVEL ANALYSIS; KARNATAKA STATE	Female sex workers (FSWs) bear a disproportionately large burden of HIV infection worldwide. Despite decades of research and programme activity, the epidemiology of HIV and the role that structural determinants have in mitigating or potentiating HIV epidemics and access to care for FSWs is poorly understood. We reviewed available published data for HIV prevalence and incidence, condom use, and structural determinants among this group. Only 87 (43%) of 204 unique studies reviewed explicitly examined structural determinants of HIV. Most studies were from Asia, with few from areas with a heavy burden of HIV such as sub-Saharan Africa, Russia, and eastern Europe. To further explore the potential effect of structural determinants on the course of epidemics, we used a deterministic transmission model to simulate potential HIV infections averted through structural changes in regions with concentrated and generalised epidemics, and high HIV prevalence among FSWs. This modelling suggested that elimination of sexual violence alone could avert 17% of HIV infections in Kenya (95% uncertainty interval [UI] 1-31) and 20% in Canada (95% UI 3-39) through its immediate and sustained effect on non-condom use) among FSWs and their clients in the next decade. In Kenya, scaling up of access to antiretroviral therapy among FSWs and their clients to meet WHO eligibility of a CD4 cell count of less than 500 cells per mu L could avert 34% (95% UI 25-42) of infections and even modest coverage of sex worker-led outreach could avert 20% (95% UI 8-36) of infections in the next decade. Decriminalisation of sex work would have the greatest effect on the course of HIV epidemics across all settings, averting 33-46% of HIV infections in the next decade. Multipronged structural and community-led interventions are crucial to increase access to prevention and treatment and to promote human rights for FSWs worldwide.	[Shannon, Kate; Goldenberg, Shira M.; Duff, Putu; Deering, Kathleen] Univ British Columbia, Gender & Sexual Hlth Initiat, BC Ctr Excellence HIV AIDS, Vancouver, BC V5N 1P7, Canada; [Strathdee, Steffanie A.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Mwangi, Peninah] African Sex Workers Alliance, Bar Hostesses Empowerment & Support Program, Nairobi, Kenya; [Rusakova, Maia] Stellit NGO, St Petersburg, Russia; [Reza-Paul, Sushena] Ashodaya Samathi Collect, Mysore, Karnataka, India; [Lau, Joseph] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Pickles, Michael R.; Boily, Marie-Claude] Univ London Imperial Coll Sci Technol & Med, London, England	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of California System; University of California San Diego; Chinese University of Hong Kong; Imperial College London	Shannon, K (corresponding author), Univ British Columbia, Gender & Sexual Hlth Initiat, BC Ctr Excellence HIV AIDS, 1081 Burrard St, Vancouver, BC V5N 1P7, Canada.	kshannon@cfenet.ubc.ca	Strathdee, Steffanie A/B-9042-2009; Goldenberg, Shira/C-9627-2009	Goldenberg, Shira/0000-0003-1633-9749; Rusakova, Mayya/0000-0003-1381-353X; Boily, Marie-Claude/0000-0003-3919-006X; Strathdee, Steffanie/0000-0002-7724-691X; Pickles, Michael/0000-0002-6754-3945	US National Institutes of Health [R01DA028648]; Bill & Melinda Gates Foundation; United Nations Population Fund; Canada Research Chair in Global Sexual Health and HIV/AIDS; NIDA merit award [R37 DA019829]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033147, R37DA019829, R01DA028648] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); United Nations Population Fund; Canada Research Chair in Global Sexual Health and HIV/AIDS; NIDA merit award; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This Review was partly supported by the US National Institutes of Health (R01DA028648), the Bill & Melinda Gates Foundation, and the United Nations Population Fund. KS is partially supported by a Canada Research Chair in Global Sexual Health and HIV/AIDS. SAS is partially supported by a NIDA merit award (R37 DA019829). For assistance with the report, we thank Jinghua Li, Nancy Stimson, Ursula Ellis, and Katherine Miller.	Ang A, 2012, AIDS BEHAV, V16, P934, DOI 10.1007/s10461-011-9925-y; Argento E, 2011, AIDS CARE, V23, P69, DOI 10.1080/09540121.2010.498868; Baral SD, 2014, LANCET; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Bharat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068043; Blanchard AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-234; Blanchard JF, 2010, SEX TRANSM INFECT, V86, P4, DOI 10.1136/sti.2010.046037; Blankenship KA, 2008, AIDS, V22, pS109, DOI 10.1097/01.aids.0000343769.92949.dd; Blankenship KM, 2000, AIDS, V14, pS11, DOI 10.1097/00002030-200006001-00003; Boily MC, 2013, AIDS, V27, P1449, DOI 10.1097/QAD.0b013e32835fba81; Bradley J, 2013, AIDS BEHAV, V17, P559, DOI 10.1007/s10461-012-0192-3; Bradley J, 2012, SEX TRANSM INFECT, V88, P163, DOI 10.1136/sextrans-2011-050283; Bradley J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S14; Braunstein Sarah L, 2012, Open AIDS J, V6, P112, DOI 10.2174/1874613601206010112; Braunstein SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024321; British Columbia Centre for Disease Control, 2012, HIV BRIT COL ANN SUR; Chen YY, 2013, ADDICT BEHAV, V38, P2888, DOI 10.1016/j.addbeh.2013.08.019; Chen YY, 2013, AIDS CARE, V25, P1114, DOI 10.1080/09540121.2012.750709; Chersich MF, 2007, INT J STD AIDS, V18, P764, DOI 10.1258/095646207782212342; Chiao C, 2009, AIDS BEHAV, V13, P892, DOI 10.1007/s10461-008-9418-9; Choi SYP, 2008, SEX TRANSM DIS, V35, P141, DOI 10.1097/OLQ.0b013e31815407c3; Choi SYP, 2011, SOCIOL HEALTH ILL, V33, P33, DOI 10.1111/j.1467-9566.2010.01265.x; Cohen J, 2004, SCIENCE, V304, P506, DOI 10.1126/science.304.5670.506; Damacena GN, 2011, JAIDS-J ACQ IMM DEF, V57, pS144, DOI 10.1097/QAI.0b013e31821e9bf6; Decker MR, 2014, AIDS BEHAV, V18, P562, DOI 10.1007/s10461-013-0577-y; Decker MR, 2012, SEX TRANSM INFECT, V88, P278, DOI 10.1136/sextrans-2011-050171; Decker MR, 2011, J EPIDEMIOL COMMUN H, V65, P334, DOI 10.1136/jech.2009.096834; Deering KN, 2014, AM J PUBLIC HEALTH, V104, pE42, DOI 10.2105/AJPH.2014.301909; Deering KN, 2013, JAIDS-J ACQ IMM DEF, V63, P522, DOI 10.1097/QAI.0b013e3182968d39; Deering KN, 2013, SEX TRANSM DIS, V40, P168, DOI 10.1097/OLQ.0b013e31827df174; Deering KN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S8; Department of AIDS Control National AIDS Control Organization, 2011, AN TI PROGR PERF APR; Department of AIDS Control National AIDS Control Organization, 2011, ANN REP 2011 12 NAT; Deschamps MM, 2013, REV PANAM SALUD PUBL, V34, P92; Erausquin JT, 2012, J EPIDEMIOL COMMUN H, V66, pII49, DOI 10.1136/jech-2011-200511; Erausquin JT, 2011, J INFECT DIS, V204, pS1223, DOI 10.1093/infdis/jir539; Gaines TL, 2013, J URBAN HEALTH, V90, P915, DOI 10.1007/s11524-012-9735-1; Goldenberg SM, 2014, JAIDS-J ACQ IMM DEF, V65, P122, DOI 10.1097/QAI.0b013e3182a98ee6; Gu J, 2010, WOMEN HEALTH, V50, P20, DOI 10.1080/03630241003601137; Gu J, 2009, AIDS CARE, V21, P967, DOI 10.1080/09540120802657548; Gutierrez JB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-497; Hao XiaoGang, 2012, Disease Surveillance, V27, P300; Hemalatha R, 2011, Indian J Med Res, V134, P470; Hong Y, 2008, SEX TRANSM DIS, V35, P662, DOI 10.1097/OLQ.0b013e31816b322c; India Health Action Trust, 2010, HIV AIDS SIT RESP KA; Jain AK, 2012, J HIV-AIDS SOC SERV, V11, P169, DOI 10.1080/15381501.2012.678136; Jayaraman GC, 2013, SEX TRANSM INFECT, V89, P635, DOI 10.1136/sextrans-2013-051203; Jung M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066867; Kang DM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-717; Kayembe PK, 2008, SEX TRANSM INFECT, V84, P202, DOI 10.1136/sti.2007.028324; Kerrigan D, 2008, HEALTH EDUC RES, V23, P137, DOI 10.1093/her/cym011; Kimani J, 2008, AIDS, V22, P131, DOI 10.1097/QAD.0b013e3282f27035; Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1; Krusi A, 2012, AM J PUBLIC HEALTH, V102, P1154, DOI 10.2105/AJPH.2011.300638; Larios SE, 2009, AIDS CARE, V21, P1335, DOI 10.1080/09540120902803190; Lau JTF, 2008, SEX TRANSM INFECT, V84, P212, DOI 10.1136/sti.2007.029256; Lau JTF, 2012, SEX HEALTH, V9, P368, DOI 10.1071/SH11108; Liao M, 2012, INT J STD AIDS, V23, pE23, DOI 10.1258/ijsa.2009.009449; Lippman SA, 2010, AM J PUBLIC HEALTH, V100, pS216, DOI 10.2105/AJPH.2008.147462; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; Mainkar MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S2; McClelland RS, 2010, AIDS, V24, P891, DOI 10.1097/QAD.0b013e32833616c7; Mishra S, 2013, SEX TRANSM INFECT, V89, P34, DOI 10.1136/sextrans-2012-050776; Morisky DE, 2010, AIDS EDUC PREV, V22, P371, DOI 10.1521/aeap.2010.22.4.371; Morris CN, 2009, AIDS BEHAV, V13, P860, DOI 10.1007/s10461-008-9431-z; Munoz FA, 2010, AIDS EDUC PREV, V22, P455, DOI 10.1521/aeap.2010.22.5.455; Muraguri N, 2010, NATL GUIDELINES HIV; National AIDS Control Council and National AIDS and STIs Control Programme, 2011, KEN AIDS EP UPD 2011; Ngugi E, 2012, CULT HEALTH SEX, V14, P17, DOI 10.1080/13691058.2011.608436; Nguyen T, 2009, AIDS BEHAV, V13, P873, DOI 10.1007/s10461-008-9499-5; Okal J, 2011, AIDS CARE, V23, P612, DOI 10.1080/09540121.2010.525605; Open Society Foundations, 2012, CRIM COND POL PRACT; Overs C., 2002, SEX WORKERS PART SOL; Pando MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054147; Papo JK, 2011, AIDS, V25, P247, DOI 10.1097/QAD.0b013e328341b9b8; Pickles M, 2013, LANCET GLOB HEALTH, V1, pE289, DOI 10.1016/S2214-109X(13)70083-4; Poteat T, 2014, LANCET; Rachakulla HK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S1; Ramakrishnan L, 2010, SEX TRANSM INFECT, V86, pI62, DOI 10.1136/sti.2009.038760; Ramesh BM, 2010, SEX TRANSM INFECT, V86, pI17, DOI 10.1136/sti.2009.038513; Ramesh BA, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000343762.54831.5c; Ramesh S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-764; Reed E, 2013, AIDS BEHAV, V17, P543, DOI 10.1007/s10461-012-0249-3; Reed E, 2012, Int J STD AIDS, V23, pe7, DOI 10.1258/ijsa.2009.009421; Reed E, 2011, SOC SCI MED, V72, P710, DOI 10.1016/j.socscimed.2010.12.009; Reed E, 2010, PUBLIC HEALTH REP, V125, P81, DOI 10.1177/00333549101250S412; Reza-Paul S, 2008, AIDS, V22, pS91, DOI 10.1097/01.aids.0000343767.08197.18; Reza-Paul S, 2012, INDIAN J MED RES, V135, P98, DOI 10.4103/0971-5916.93431; Rhodes T, 2002, INT J DRUG POLICY, V13, P8594; Rhodes T, 2012, RETHINKING SOCIAL EPIDEMIOLOGY: TOWARDS A SCIENCE OF CHANGE, P205, DOI 10.1007/978-94-007-2138-8_10; Roux AVD, 2005, J INFECT DIS, V191, pS25, DOI 10.1086/425288; Saggurti N, 2012, AIDS BEHAV, V16, P952, DOI 10.1007/s10461-011-9937-7; Saggurti N, 2011, J BIOSOC SCI, V43, P535, DOI 10.1017/S0021932011000277; Sarkar K, 2008, J HEALTH POPUL NUTR, V26, P223; SCHECHTER MT, 1986, CAN MED ASSOC J, V135, P1355; Scorgie F, 2013, CULT HEALTH SEX, V15, P450, DOI 10.1080/13691058.2012.763187; Shahmanesh M, 2009, SEX TRANSM INFECT, V85, P50, DOI 10.1136/sti.2008.030767; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Shahmanesh M, 2009, JAIDS-J ACQ IMM DEF, V52, P253, DOI 10.1097/QAI.0b013e3181ab6d75; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Shannon K, 2007, CAN J PUBLIC HEALTH, V98, P465, DOI 10.1007/BF03405440; Shannon K, 2014, CURR OPIN HIV AIDS, V9, P174, DOI 10.1097/COH.0000000000000042; Shannon K, 2012, LANCET INFECT DIS, V12, P500, DOI 10.1016/S1473-3099(12)70065-8; Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090; Shannon K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2939; Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858; Shi YH, 2013, INT J INFECT DIS, V17, pE59, DOI 10.1016/j.ijid.2012.09.003; Sobela F, 2009, JAIDS-J ACQ IMM DEF, V51, P216, DOI 10.1097/QAI.0b013e31819c170f; Strathdee SA, 2003, J URBAN HEALTH, V80, P7; Strathdee SA, 1997, AIDS, V11, pF59, DOI 10.1097/00002030-199708000-00001; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Strathdee SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065812; Strathdee SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019048; The UN General Assembly Special Session on Drugs, 2010, COUNTR PROGR REP UNG; Thilakavathi S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S3; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Tyndall MW, 2002, SEX TRANSM INFECT, V78, pI170, DOI 10.1136/sti.78.suppl_1.i170; Ulibarri MD, 2011, AIDS BEHAV, V15, P179, DOI 10.1007/s10461-009-9595-1; Urada LA, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/812635; Urada LA, 2013, AIDS BEHAV, V17, P523, DOI 10.1007/s10461-011-0113-x; Urada LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033282; Uuskula A, 2008, SEX TRANSM INFECT, V84, P189, DOI 10.1136/sti.2007.027664; Vandepitte J, 2011, SEX TRANSM DIS, V38, P316, DOI 10.1097/OLQ.0b013e3182099545; Verma R, 2010, SEX TRANSM INFECT, V86, pI76, DOI 10.1136/sti.2009.039115; Wang B, 2010, SEX TRANSM DIS, V37, P629, DOI 10.1097/OLQ.0b013e3181e2118a; Wang B, 2009, SEX TRANSM DIS, V36, P134, DOI 10.1097/OLQ.0b013e318191721a; Wang XT, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/560361; WHO, 2012, GUID PREV TREATM HIV; Wirth KE, 2013, AM J EPIDEMIOL, V177, P232, DOI 10.1093/aje/kws338; Wood E, 2007, ADDICT RES THEORY, V15, P321, DOI 10.1080/16066350701254258; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; Yang X, 2013, INT J STD AIDS, V24, P555, DOI 10.1177/0956462412473959; Ye XX, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-599; Yi HS, 2012, GLOB PUBLIC HEALTH, V7, P840, DOI 10.1080/17441692.2012.662991; Zhang C, 2013, AIDS CARE, V25, P503, DOI 10.1080/09540121.2012.726345; Zhang H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-113	137	494	500	5	93	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					55	71		10.1016/S0140-6736(14)60931-4	http://dx.doi.org/10.1016/S0140-6736(14)60931-4			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX8IW	25059947	Green Accepted			2022-12-28	WOS:000347154200028
J	Dail, M; Wong, J; Lawrence, J; O'Connor, D; Nakitandwe, J; Chen, SC; Xu, J; Lee, LB; Akagi, K; Li, Q; Aster, JC; Pear, WS; Downing, JR; Sampath, D; Shannon, K				Dail, Monique; Wong, Jason; Lawrence, Jessica; O'Connor, Daniel; Nakitandwe, Joy; Chen, Shann-Ching; Xu, Jin; Lee, Leslie B.; Akagi, Keiko; Li, Qing; Aster, Jon C.; Pear, Warren S.; Downing, James R.; Sampath, Deepak; Shannon, Kevin			Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PTEN; MUTATIONS; FREQUENCY	Mutations that deregulate Notch1 and Ras/phosphoinositide 3 kinase (PI3K)/Akt signalling are prevalent in T-cell acute lymphoblastic leukaemia (T-ALL), and often coexist. Here we show that the PI3K inhibitor GDC-0941 is active against primary T-ALLs from wild-type and Kras(G12D) mice, and addition of the MEK inhibitor PD0325901 increases its efficacy. Mice invariably relapsed after treatment with drug-resistant clones, most of which unexpectedly had reduced levels of activated Notch1 protein, downregulated many Notch1 target genes, and exhibited cross-resistance to gamma-secretase inhibitors. Multiple resistant primary T-ALLs that emerged in vivo did not contain somatic Notch1 mutations present in the parental leukaemia. Importantly, resistant clones upregulated PI3K signalling. Consistent with these data, inhibiting Notch1 activated the PI3K pathway, providing a likely mechanism for selection against oncogenic Notch1 signalling. These studies validate PI3K as a therapeutic target in T-ALL and raise the unexpected possibility that dual inhibition of PI3K and Notch1 signalling could promote drug resistance in T-ALL.	[Dail, Monique; Wong, Jason; Lawrence, Jessica; O'Connor, Daniel; Xu, Jin; Shannon, Kevin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Dail, Monique; Wong, Jason; Lawrence, Jessica; O'Connor, Daniel; Xu, Jin; Shannon, Kevin] Univ Calif San Francisco, Benniof Childrens Hosp, San Francisco, CA 94143 USA; [Nakitandwe, Joy; Chen, Shann-Ching; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Lee, Leslie B.; Sampath, Deepak] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Akagi, Keiko] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Li, Qing] Univ Michigan, Dept Med, Div Haematol Oncol, Ann Arbor, MI 48109 USA; [Aster, Jon C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Pear, Warren S.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Pear, Warren S.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; St Jude Children's Research Hospital; Roche Holding; Genentech; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Shannon, K (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	shannonk@peds.ucsf.edu	Downing, James R./N-8102-2018		William Lawrence and Blanche Hughes Foundation; Specialized Center of Research (SCOR) from the Leukaemia and Lymphoma Society of America [7019, 7703]; National Institutes of Health [R37 CA72614, R01 CA180037, K99 CA157950, K08 CA134649, P01 CA119070]; ALSAC of St. Jude Children's Research Hospital; Ohio Supercomputer Center [PAS0425]; Ohio Cancer Research Associate [GRT00024299]; American Cancer Society (ACS); NATIONAL CANCER INSTITUTE [K99CA157950, K08CA134649, R01CA180037, R37CA072614, U01CA084221, T32CA128583, P01CA119070, P30CA021765] Funding Source: NIH RePORTER	William Lawrence and Blanche Hughes Foundation; Specialized Center of Research (SCOR) from the Leukaemia and Lymphoma Society of America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Ohio Supercomputer Center; Ohio Cancer Research Associate; American Cancer Society (ACS)(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the William Lawrence and Blanche Hughes Foundation to J.C.A. and K. S.; by Specialized Center of Research (SCOR) awards 7019 and 7703 from the Leukaemia and Lymphoma Society of America; by National Institutes of Health grants R37 CA72614 and R01 CA180037 (to K. S.), K99 CA157950 (to M. D.), K08 CA134649 (to Q. L.) and P01 CA119070 (to J.C.A. and W. S. P.), and by the ALSAC of St. Jude Children's Research Hospital (J.R.D.). K. A. is supported by the Ohio Supercomputer Center (#PAS0425) and is an Ohio Cancer Research Associate (#GRT00024299); and J.X received a Research Fellowship from the American Cancer Society (ACS). K. S. is an ACS Research Professor. We are grateful to T. Jacks and D. Tuveson for Kras<SUP>G12D</SUP> mice; to L. Wolff for the MOL4070 virus; and to D. Largaespada and G. Narla for sharing their advice and expertise.	Aster JC, 1997, J BIOL CHEM, V272, P11336; Aster JC, 2012, J CLIN ONCOL, V30, P2418, DOI 10.1200/JCO.2012.42.0992; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Blackburn JS, 2014, CANCER CELL, V25, P366, DOI 10.1016/j.ccr.2014.01.032; Brown AP, 2007, CANCER CHEMOTH PHARM, V59, P671, DOI 10.1007/s00280-006-0323-5; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Corcoran RB, 2011, ONCOTARGET, V2, P336; Dail M, 2010, P NATL ACAD SCI USA, V107, P5106, DOI 10.1073/pnas.1001064107; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gutierrez A, 2007, CANCER CELL, V12, P411, DOI 10.1016/j.ccr.2007.10.027; Gutierrez A, 2011, J EXP MED, V208, P1595, DOI 10.1084/jem.20101691; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Hales EC, 2013, J BIOL CHEM, V288, P22836, DOI 10.1074/jbc.M113.451625; HAWLEY RG, 1994, GENE THER, V1, P136; Jotta PY, 2010, LEUKEMIA, V24, P239, DOI 10.1038/leu.2009.209; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lauchle JO, 2009, NATURE, V461, P411, DOI 10.1038/nature08279; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Mansour MR, 2007, CLIN CANCER RES, V13, P6964, DOI 10.1158/1078-0432.CCR-07-1474; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Shieh A., 2013, BLOOD; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Tosello V, 2013, THER ADV HEMATOL, V4, P199, DOI 10.1177/2040620712471368; Trinquand A, 2013, J CLIN ONCOL, V31, P4333, DOI 10.1200/JCO.2012.48.5292; Tzoneva G, 2013, NAT MED, V19, P368, DOI 10.1038/nm.3078; Wendorff AA, 2010, IMMUNITY, V33, P671, DOI 10.1016/j.immuni.2010.11.014; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zuber J, 2011, GENE DEV, V25, P1628, DOI 10.1101/gad.17269211	33	47	49	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					512	+		10.1038/nature13495	http://dx.doi.org/10.1038/nature13495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25043004	Green Accepted			2022-12-28	WOS:000342075800032
J	Zhang, B; Wang, J; Wang, X; Zhu, J; Liu, Q; Shi, Z; Chambers, MC; Zimmerman, LJ; Shaddox, KF; Kim, S; Davies, SR; Wang, S; Wang, P; Kinsinger, CR; Rivers, RC; Rodriguez, H; Townsend, RR; Ellis, MJC; Carr, SA; Tabb, DL; Coffey, RJ; Slebos, RJC; Liebler, DC				Zhang, Bing; Wang, Jing; Wang, Xiaojing; Zhu, Jing; Liu, Qi; Shi, Zhiao; Chambers, Matthew C.; Zimmerman, Lisa J.; Shaddox, Kent F.; Kim, Sangtae; Davies, Sherri R.; Wang, Sean; Wang, Pei; Kinsinger, Christopher R.; Rivers, Robert C.; Rodriguez, Henry; Townsend, R. Reid; Ellis, Matthew J. C.; Carr, Steven A.; Tabb, David L.; Coffey, Robert J.; Slebos, Robbert J. C.; Liebler, Daniel C.		NCI CPTAC	Proteogenomic characterization of human colon and rectal cancer	NATURE			English	Article							RNA-SEQ DATA; PROTEIN EXPRESSION; COLORECTAL-CANCER; PEPTIDE IDENTIFICATION; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; ANALYSIS REVEALS; GENE; ABUNDANCE; HNF4-ALPHA	Extensive genomic characterization of human cancers presents the problem of inference from genomic abnormalities to cancer phenotypes. To address this problem, we analysed proteomes of colon and rectal tumours characterized previously by The Cancer Genome Atlas (TCGA) and perform integrated proteogenomic analyses. Somatic variants displayed reduced protein abundance compared to germline variants. Messenger RNA transcript abundance did not reliably predict protein abundance differences between tumours. Proteomics identified five proteomic subtypes in the TCGA cohort, two of which overlapped with the TCGA 'microsatellite instability/CpG island methylation phenotype' transcriptomic subtype, but had distinct mutation, methylation and protein expression patterns associated with different clinical outcomes. Although copy number alterations showed strong cis- and trans-effects on mRNA abundance, relatively few of these extend to the protein level. Thus, proteomics data enabled prioritization of candidate driver genes. The chromosome 20q amplicon was associated with the largest global changes at both mRNA and protein levels; proteomics data highlighted potential 20q candidates, including HNF4A(hepatocyte nuclear factor 4, alpha), TOMM34 (translocase of outer mitochondrial membrane 34) and SRC (SRC proto-oncogene, non-receptor tyrosine kinase). Integrated proteogenomic analysis provides functional context to interpret genomic abnormalities and affords a new paradigm for understanding cancer biology.	[Zhang, Bing; Wang, Jing; Wang, Xiaojing; Zhu, Jing; Liu, Qi; Chambers, Matthew C.; Tabb, David L.] Vanderbilt Univ Sch Med, Dept Biomed Informat, Nashville, TN 37232 USA; [Zhang, Bing; Slebos, Robbert J. C.] Vanderbilt Univ Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Shi, Zhiao] Vanderbilt Univ, Adv Comp Ctr Res & Educ, Nashville, TN 37232 USA; [Shi, Zhiao] Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37232 USA; [Zimmerman, Lisa J.; Liebler, Daniel C.] Vanderbilt Univ Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Zimmerman, Lisa J.; Shaddox, Kent F.; Slebos, Robbert J. C.; Liebler, Daniel C.] Vanderbilt Ingram Canc Ctr, Jim Ayers Inst Precanc Detect & Diag, Nashville, TN 37232 USA; [Kim, Sangtae] Pacific NW Natl Lab, Directorate Fundamental & Computat Sci, Richland, WA 99352 USA; [Davies, Sherri R.; Townsend, R. Reid; Ellis, Matthew J. C.] Washington Univ Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Wang, Sean] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Wang, Pei] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kinsinger, Christopher R.; Rivers, Robert C.; Rodriguez, Henry] NCI, Off Canc Clin Prote Res, Bethesda, MD 20892 USA; [Carr, Steven A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Coffey, Robert J.] Vanderbilt Univ Sch Med, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Washington University (WUSTL); Fred Hutchinson Cancer Center; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Vanderbilt University	Liebler, DC (corresponding author), Vanderbilt Univ Sch Med, Dept Biochem, Nashville, TN 37232 USA.	daniel.liebler@vanderbilt.edu	Smith, Richard D/J-3664-2012; Carr, Steven A./AAH-8366-2019	Smith, Richard D/0000-0002-2381-2349; McGarvey, Peter/0000-0002-8312-6017; White, Forest/0000-0002-1545-1651; Levine, Douglas/0000-0003-1038-8232; Liebler, Daniel/0000-0002-7873-3031; Fenyo, David/0000-0001-5049-3825; Davies, Sherri/0000-0002-7141-8354; Wang, Pei/0000-0002-6890-6453; McDermott, Jason/0000-0003-2961-2572; Tabb, David/0000-0001-7223-578X; Payne, Samuel/0000-0002-8351-1994; Mani, D. R./0000-0003-3914-133X	National Cancer Institute (NCI) CPTAC awards [U24CA159988, U24CA160035, U24CA160034]; NCI SPORE award [P50CA095103]; NCI Cancer Center Support Grant [P30CA068485]; National Institutes of Health [GM088822]; Leidos Biomedical Research, Inc. [13XS029]; NATIONAL CANCER INSTITUTE [P30CA068485, U24CA159988, U24CA160034, U24CA160019, U24CA160035, R01CA046413, P50CA095103] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088822] Funding Source: NIH RePORTER	National Cancer Institute (NCI) CPTAC awards; NCI SPORE award; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leidos Biomedical Research, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Cancer Institute (NCI) CPTAC awards U24CA159988, U24CA160035, and U24CA160034; by NCI SPORE award P50CA095103 and NCI Cancer Center Support Grant P30CA068485; by National Institutes of Health grant GM088822; and by contract 13XS029 from Leidos Biomedical Research, Inc. Genomics data for this study were generated by The Cancer Genome Atlas pilot project established by the NCI and the National Human Genome Research Institute. Information about TCGA and the investigators and institutions comprising the TCGA research network can be found at http://cancergenome.nih.gov/.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cancer Genome Atlas Res. Netw, 2012, NATURE, V490, P292; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chellappa K, 2012, BIOMARK MED, V6, P297, DOI [10.2217/BMM.12.23, 10.2217/bmm.12.23]; Chellappa K, 2012, P NATL ACAD SCI USA, V109, P2302, DOI 10.1073/pnas.1106799109; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Darsigny M, 2010, CANCER RES, V70, P9423, DOI 10.1158/0008-5472.CAN-10-1697; Dasari S, 2012, J PROTEOME RES, V11, P1686, DOI 10.1021/pr200874e; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Foss EJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001144; Fu J, 2009, NAT GENET, V41, P166, DOI 10.1038/ng.308; Gallien S, 2012, MOL CELL PROTEOMICS, V11, P1709, DOI 10.1074/mcp.O112.019802; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Geiger T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001574; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Halvey PJ, 2014, CANCER RES, V74, P387, DOI 10.1158/0008-5472.CAN-13-2488; Halvey PJ, 2012, J PROTEOME RES, V11, P1184, DOI 10.1021/pr2009109; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Kiemer AK, 2001, ONCOGENE, V20, P6679, DOI 10.1038/sj.onc.1204872; Kim S, 2010, MOL CELL PROTEOMICS, V9, P2840, DOI 10.1074/mcp.M110.003731; Kim WK, 2013, CLIN CANCER RES, V19, P3369, DOI 10.1158/1078-0432.CCR-13-0684; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li M, 2010, J PROTEOME RES, V9, P4295, DOI 10.1021/pr100527g; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Licklider LJ, 2002, ANAL CHEM, V74, P3076, DOI 10.1021/ac025529o; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu Q, 2013, MOL CELL PROTEOMICS, V12, P1900, DOI 10.1074/mcp.M112.025783; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Ma ZQ, 2011, BIOINFORMATICS, V27, P3214, DOI 10.1093/bioinformatics/btr544; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ning K, 2012, J PROTEOME RES, V11, P2261, DOI 10.1021/pr201052x; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Peng J, 2010, ANN APPL STAT, V4, P53, DOI 10.1214/09-AOAS271; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Saandi T, 2013, ONCOGENE, V32, P3782, DOI 10.1038/onc.2012.401; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwartz B, 2009, INT J CANCER, V124, P1081, DOI 10.1002/ijc.24041; Shi ZA, 2013, NAT METHODS, V10, P597, DOI 10.1038/nmeth.2517; Shimokawa T, 2006, INT J ONCOL, V29, P381; Slebos RJC, 2013, INT J CANCER, V132, P568, DOI 10.1002/ijc.27699; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turner B, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq023; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang J, 2012, BRIEF BIOINFORM, V13, P216, DOI 10.1093/bib/bbr041; Wang P., 2010, STAT METHODS CGH ARR; Wang XJ, 2013, BIOINFORMATICS, V29, P3235, DOI 10.1093/bioinformatics/btt543; Wang XJ, 2012, J PROTEOME RES, V11, P1009, DOI 10.1021/pr200766z; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273; Zhou JY, 2010, J PROTEOME RES, V9, P5698, DOI 10.1021/pr100508p; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	82	905	922	11	310	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					382	+		10.1038/nature13438	http://dx.doi.org/10.1038/nature13438			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043054	Green Accepted, Green Submitted			2022-12-28	WOS:000341814900052
J	Zhang, YN; Nicholatos, J; Dreier, JR; Ricoult, SJH; Widenmaier, SB; Hotamisligil, GS; Kwiatkowski, DJ; Manning, BD				Zhang, Yinan; Nicholatos, Justin; Dreier, John R.; Ricoult, Stephane J. H.; Widenmaier, Scott B.; Hotamisligil, Goekhan S.; Kwiatkowski, David J.; Manning, Brendan D.			Coordinated regulation of protein synthesis and degradation by mTORC1	NATURE			English	Article							ACTIVATION; HOMEOSTASIS; AUTOPHAGY; SREBP-1A; PATHWAY; COMPLEX; TARGET; GENES	Eukaryotic cells coordinately control anabolic and catabolic processes to maintain cell and tissue homeostasis. Mechanistic target of rapamycin complex 1 (mTORC1) promotes nutrient-consuming anabolic processes, such as protein synthesis(1). Here we show that as well as increasing protein synthesis, mTORC1 activation in mouse and human cells also promotes an increased capacity for protein degradation. Cells with activated mTORC1 exhibited elevated levels of intact and active proteasomes through a global increase in the expression of genes encoding proteasome subunits. The increase in proteasome gene expression, cellular proteasome content, and rates of protein turnover downstream of mTORC1 were all dependent on induction of the transcription factor nuclear factor erythroid-derived 2-related factor 1 (NRF1; also known as NFE2L1). Genetic activation of mTORC1 through loss of the tuberous sclerosis complex tumour suppressors, TSC1 or TSC2, or physiological activation of mTORC1 in response to growth factors or feeding resulted in increased NRF1 expression in cells and tissues. We find that this NRF1-dependent elevation in proteasome levels serves to increase the intracellular pool of amino acids, which thereby influences rates of new protein synthesis. Therefore, mTORC1 signalling increases the efficiency of proteasome-mediated protein degradation for both quality control and as a mechanism to supply substrate for sustained protein synthesis.	[Zhang, Yinan; Nicholatos, Justin; Ricoult, Stephane J. H.; Widenmaier, Scott B.; Hotamisligil, Goekhan S.; Manning, Brendan D.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Dreier, John R.; Kwiatkowski, David J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Translat Med Div,Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Manning, BD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	bmanning@hsph.harvard.edu	Manning, Brendan/ABD-6528-2021; Zhang, Yinan/N-6432-2014	Manning, Brendan/0000-0003-3895-5956; Zhang, Yinan/0000-0002-3471-6598; Widenmaier, Scott/0000-0001-5684-2707; Nicholatos, Justin/0000-0002-5433-3041	Department of Defense Tuberous Sclerosis Complex Research Program [W81XWH-10-1-0861]; National Institutes of Health [CA122617, CA120964]; Ellison Medical Foundation; National Science Foundation [DGE-1144152]; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [P01CA120964, R01CA122617] Funding Source: NIH RePORTER	Department of Defense Tuberous Sclerosis Complex Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Science Foundation(National Science Foundation (NSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank I. Ben-Sahra and L. Yang for technical assistance. This work was supported in part by Department of Defense Tuberous Sclerosis Complex Research Program grant W81XWH-10-1-0861 (B. D. M.), National Institutes of Health grants CA122617 (B. D. M.) and CA120964 (B. D. M. and D.J.K.), the Ellison Medical Foundation (B. D. M.), National Science Foundation fellowship DGE-1144152 (S.J.H.R.), and a Canadian Institutes of Health Research fellowship (S.B.W.).	Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; El-Hashemite N, 2003, LANCET, V361, P1348, DOI 10.1016/S0140-6736(03)13044-9; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CS, 2013, FEBS J, V280, P3609, DOI 10.1111/febs.12350; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Radhakrishnan SK, 2014, ELIFE, V3, DOI [10.7554/elife.01856, 10.7554/eLife.01856]; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yuan E, 2012, HUM MOL GENET, V21, P4286, DOI 10.1093/hmg/dds262; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1350, DOI 10.1016/j.bbalip.2012.07.006; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	27	208	212	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					440	+		10.1038/nature13492	http://dx.doi.org/10.1038/nature13492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043031	Green Accepted			2022-12-28	WOS:000341814900065
J	Ruiz, S; Metois, M; Fuenzalida, A; Ruiz, J; Leyton, F; Grandin, R; Vigny, C; Madariaga, R; Campos, J				Ruiz, S.; Metois, M.; Fuenzalida, A.; Ruiz, J.; Leyton, F.; Grandin, R.; Vigny, C.; Madariaga, R.; Campos, J.			Intense foreshocks and a slow slip event preceded the 2014 Iquique M-w 8.1 earthquake	SCIENCE			English	Article							CHILE; AFTERSHOCKS; NUCLEATION	The subduction zone in northern Chile is a well-identified seismic gap that last ruptured in 1877. The moment magnitude (M-w) 8.1 Iquique earthquake of 1 April 2014 broke a highly coupled portion of this gap. To understand the seismicity preceding this event, we studied the location and mechanisms of the foreshocks and computed Global Positioning System (GPS) time series at stations located on shore. Seismicity off the coast of Iquique started to increase in January 2014. After 16 March, several M-w > 6 events occurred near the low-coupled zone. These events migrated northward for similar to 50 kilometers until the 1 April earthquake occurred. On 16 March, on-shore continuous GPS stations detected a westward motion that we model as a slow slip event situated in the same area where the mainshock occurred.	[Ruiz, S.; Ruiz, J.; Campos, J.] Univ Chile, Fac Ciencias Fis & Matemat, Dept Geofis, Santiago, Chile; [Metois, M.] Ctr Nazl Terremoti, Ist Nazl Geofis & Vulcanol, Rome, Italy; [Fuenzalida, A.] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England; [Leyton, F.] Univ Chile, Fac Ciencias Fis & Matemat, Ctr Sismol Nacl, Santiago, Chile; [Grandin, R.] Univ Paris Diderot, Inst Phys Globe Paris, Sorbonne Paris Cite, CNRS,UMR 7154, Paris, France; [Vigny, C.; Madariaga, R.] Ecole Normale Super, CNRS, Geol Lab, UMR 8538, Paris, France	Universidad de Chile; Istituto Nazionale Geofisica e Vulcanologia (INGV); University of Liverpool; Universidad de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Ruiz, S (corresponding author), Univ Chile, Fac Ciencias Fis & Matemat, Dept Geofis, Santiago, Chile.	sruiz@dgf.uchile.cl	Grandin, Raphael/K-4031-2012; Madariaga, Raul/D-5304-2011; Ruiz, Javier/I-6304-2016; Grandin, Raphael/V-8784-2019; Ruiz, Sergio/D-6688-2013; Leyton, Felipe/B-4482-2018; CAMPOS, Jaime/K-7358-2014; Métois, Marianne/D-7019-2017	Grandin, Raphael/0000-0002-1837-011X; Ruiz, Javier/0000-0003-2073-3319; Grandin, Raphael/0000-0002-1837-011X; Ruiz, Sergio/0000-0003-1758-0788; Leyton, Felipe/0000-0002-6438-4045; CAMPOS, Jaime/0000-0002-5924-9009; Métois, Marianne/0000-0002-1489-0513	Chilean National Science Foundation project FONDECYT [1130636]; French Agence Nationale de la Recherche [ANR-2011-BS56-017, ANR-2012-BS06-004]; project FONDECYT [11130230]	Chilean National Science Foundation project FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); French Agence Nationale de la Recherche(French National Research Agency (ANR)); project FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	We thank J. C. Ruegg for his initiative to study northern Chile with GPS, followed by J. B. De Chabalier, A. Socquet, D. Carrizo, and others after him. S. R., J. R., R. M., and J. C. acknowledge the support of the Chilean National Science Foundation project FONDECYT no. 1130636 and S. R. of project FONDECYT no.11130230. This work received partial support from ANR-2011-BS56-017 and ANR-2012-BS06-004 of the French Agence Nationale de la Recherche. This is Institut de Physique du Globe de Paris contribution no. 3551. We thank Incorporated Research Institutions for Seismology Data Management Center (www.iris.edu/data/), International Plate Boundary Observatory Chile (http://geofon.gfz-potsdam.de/waveform/), Centro Sismologico Nacional (www.sismologia.cl), and International Associated Laboratory Montessus de Ballore for making raw data available to us.	Bejar-Pizarro M, 2013, NAT GEOSCI, V6, P462, DOI [10.1038/ngeo1802, 10.1038/NGEO1802]; Chlieh M, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008166; Comte D., 1991, Natural Hazards, V4, P23, DOI 10.1007/BF00126557; COMTE D, 1986, SCIENCE, V233, P449, DOI 10.1126/science.233.4762.449; Contreras-Reyes E, 2012, NAT GEOSCI, V5, P342, DOI [10.1038/ngeo1447, 10.1038/NGEO1447]; de Ballore F. Montessus, 1916, HIST SISMICA ANDES M; ELLSWORTH WL, 1995, SCIENCE, V268, P851, DOI 10.1126/science.268.5212.851; Engdahl E. R., 2002, INT HDB EARTHQUAKE A; Fuenzalida A, 2013, GEOPHYS J INT, V194, P1216, DOI 10.1093/gji/ggt163; Hayes GP, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008524; Kato A, 2012, SCIENCE, V335, P705, DOI 10.1126/science.1215141; Kausel E., 1986, B ACAD CHILENA CIENC, V3, P8; KIKUCHI M, 1991, B SEISMOL SOC AM, V81, P2335; Latour S, 2013, GEOPHYS RES LETT, V40, P5064, DOI 10.1002/grl.50974; Lay T, 2014, GEOPHYS RES LETT, V41, P3818, DOI 10.1002/2014GL060238; Lomnitz C, 1971, GEOFIS PANAMERICANA, V1, P151; Madariaga R, 2010, SCIENCE, V328, P181, DOI 10.1126/science.1189197; MALGRANGE M, 1983, GEOPHYS J ROY ASTR S, V73, P489, DOI 10.1111/j.1365-246X.1983.tb03326.x; Metois M, 2013, GEOPHYS J INT, V194, P1283, DOI 10.1093/gji/ggt183; Ozawa S, 2007, EARTH PLANETS SPACE, V59, P1241, DOI 10.1186/BF03352072; Pasyanos ME, 1996, B SEISMOL SOC AM, V86, P1255; Peyrat S, 2010, GEOPHYS J INT, V182, P1411, DOI 10.1111/j.1365-246X.2010.04685.x; Ruegg J. C., 2001, SEISMOL RES LETT, V72, P673, DOI DOI 10.1785/GSSRL.72.6.673; Yagi Y, 2014, GEOPHYS RES LETT, V41, P4201, DOI 10.1002/2014GL060274	24	232	237	1	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1165	1169		10.1126/science.1256074	http://dx.doi.org/10.1126/science.1256074			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25061132				2022-12-28	WOS:000341179800043
J	Shukla, AK; Westfield, GH; Xiao, KH; Reis, RI; Huang, LY; Tripathi-Shukla, P; Qian, J; Li, S; Blanc, A; Oleskie, AN; Dosey, AM; Su, M; Liang, CR; Gu, LL; Shan, JM; Chen, X; Hanna, R; Choi, MJ; Yao, XJ; Klink, BU; Kahsai, AW; Sidhu, SS; Koide, S; Penczek, PA; Kossiakoff, AA; Woods, VL; Kobilka, BK; Skiniotis, G; Lefkowitz, RJ				Shukla, Arun K.; Westfield, Gerwin H.; Xiao, Kunhong; Reis, Rosana I.; Huang, Li-Yin; Tripathi-Shukla, Prachi; Qian, Jiang; Li, Sheng; Blanc, Adi; Oleskie, Austin N.; Dosey, Anne M.; Su, Min; Liang, Cui-Rong; Gu, Ling-Ling; Shan, Jin-Ming; Chen, Xin; Hanna, Rachel; Choi, Minjung; Yao, Xiao Jie; Klink, Bjoern U.; Kahsai, Alem W.; Sidhu, Sachdev S.; Koide, Shohei; Penczek, Pawel A.; Kossiakoff, Anthony A.; Woods, Virgil L., Jr.; Kobilka, Brian K.; Skiniotis, Georgios; Lefkowitz, Robert J.			Visualization of arrestin recruitment by a G-protein-coupled receptor	NATURE			English	Article							BETA(2) ADRENERGIC-RECEPTOR; CONFORMATIONAL-CHANGES; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; VISUAL ARRESTIN; ACTIVATION; COMPLEX; BETA-ARRESTIN1; IMAGES; DOMAIN	G-protein-coupled receptors (GPCRs) are critically regulated by beta-arrestins, which not only desensitize G-protein signalling but also initiate a G-protein-independent wave of signalling(1-5). A recent surge of structural data on a number of GPCRs, including the beta(2) adrenergic receptor (beta(2)AR)-G-proteincomplex, has provided novel insights into the structural basis of receptor activation(6-11). However, complementary information has been lacking on the recruitment of beta-arrestins to activated GPCRs, primarily owing to challenges in obtaining stable receptor-beta-arrestin complexes for structural studies. Here we devised a strategy for forming and purifying a functional human beta(2)AR-beta-arrestin-1 complex that allowed us to visualize its architecture by single-particle negative-stain electron microscopy and to characterize the interactions between beta(2)AR and beta-arrestin 1 using hydrogen-deuterium exchange mass spectrometry (HDX-MS) and chemical crosslinking. Electron microscopy two-dimensional averages and three dimensional reconstructions reveal bimodal binding of beta-arrestin 1 to the beta(2)AR, involving two separate sets of interactions, one with the phosphorylated carboxy terminus of the receptor and the other with its seven-transmembrane core. Areas of reduced HDX together with identification of crosslinked residues suggest engagement of the finger loop of beta-arrestin 1 with the seven-transmembrane core of the receptor. In contrast, focal areas of raised HDX levels indicate regions of increased dynamics in both the N and C domains of beta-arrestin 1 when coupled to the beta(2)AR. A molecular model of the beta(2)AR-beta-arrestin signalling complex was made by docking activated beta-arrestin 1 and beta(2)AR crystal structures into the electron microscopymap densities with constraints provided by HDX-MS and crosslinking, allowing us to obtain valuable insights into the overall architecture of a receptor-arrestin complex. The dynamic and structural information presented here provides a framework for better understanding the basis of GPCR regulation by arrestins.	[Shukla, Arun K.; Xiao, Kunhong; Reis, Rosana I.; Huang, Li-Yin; Tripathi-Shukla, Prachi; Qian, Jiang; Blanc, Adi; Yao, Xiao Jie; Klink, Bjoern U.; Kahsai, Alem W.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Westfield, Gerwin H.; Oleskie, Austin N.; Dosey, Anne M.; Su, Min; Skiniotis, Georgios] Univ Michigan, Sch Med, Life Sci Inst, Ann Arbor, MI 48109 USA; [Westfield, Gerwin H.; Oleskie, Austin N.; Dosey, Anne M.; Su, Min; Skiniotis, Georgios] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; [Liang, Cui-Rong; Gu, Ling-Ling; Shan, Jin-Ming; Chen, Xin] Changzhou Univ, Sch Pharmaceut & Life Sci, Changzhou 213164, Jiangsu, Peoples R China; [Hanna, Rachel; Sidhu, Sachdev S.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Choi, Minjung; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Koide, Shohei; Kossiakoff, Anthony A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Penczek, Pawel A.] Univ Texas Houston, Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77054 USA; [Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Changzhou University; University of Toronto; Duke University; University of Chicago; University of Texas System; University of Texas Health Science Center Houston; Stanford University; Duke University; Howard Hughes Medical Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	kobilka@stanford.edu; skinioti@umich.edu; lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021; Xiao, Kunhong/AAG-4275-2020; dos Reis, Rosana Maria/E-3346-2012	Xiao, Kunhong/0000-0002-1069-1226; shukla, arun/0000-0003-2910-8288; Westfield, Gerwin/0000-0001-9634-2336; Koide, Shohei/0000-0001-5473-4358; Skiniotis, Georgios/0000-0003-0238-7846; dos Reis, Rosana Maria/0000-0001-9631-4167; Reis, Rosana/0000-0002-0465-8331; Kobilka, Brian/0000-0001-5958-3990; Choi, Minjung/0000-0002-2601-107X	National Institutes of Health [DK090165, NS028471, GM072688, GM087519, HL075443, HL16037, HL70631]; Mathers Foundation [GM60635]; Pew Scholars Program in Biomedical Sciences; Canadian Institutes of Health Research [MOP-93725]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, P01HL075443, R01HL070631, R37HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072688, U54GM087519, R01GM060635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Pew Scholars Program in Biomedical Sciences; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Capel for technical assistance, V. Ronk, D. Addison and Q. Lennon for administrative support, R. K. Sunahara for stimulating discussions and Alex R. B. Thomsen for critical reading of the manuscript. We acknowledge support from the National Institutes of Health Grants DK090165 (G. S.), NS028471 (B. K. K.), GM072688 and GM087519 (A. A. K. and S. K.), HL075443 (K. X.), HL16037 and HL70631 (R.J.L.), from the Mathers Foundation (B. K. K.), GM60635 (P. A. P.) and from the Pew Scholars Program in Biomedical Sciences (G. S.). R. H. and S. S. S. were supported by a research grant from the Canadian Institutes of Health Research (MOP-93725). R. I. R is supported by a postdoctoral fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. R.J.L. is an investigator with the Howard Hughes Medical Institute.	Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gimenez LE, 2012, J BIOL CHEM, V287, P29495, DOI 10.1074/jbc.M112.366674; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Gurevich VV, 2013, PROG MOL BIOL TRANSL, V118, P57, DOI 10.1016/B978-0-12-394440-5.00003-6; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Kang DS, 2009, J BIOL CHEM, V284, P29860, DOI 10.1074/jbc.M109.023366; Kim KM, 2008, BIOCHEM BIOPH RES CO, V366, P42, DOI 10.1016/j.bbrc.2007.11.055; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lohse Martin J, 2014, Handb Exp Pharmacol, V219, P15, DOI 10.1007/978-3-642-41199-1_2; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nobles KN, 2007, J BIOL CHEM, V282, P21370, DOI 10.1074/jbc.M611483200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110	36	341	345	9	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					218	+		10.1038/nature13430	http://dx.doi.org/10.1038/nature13430			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043026	Green Submitted, Green Accepted			2022-12-28	WOS:000340200700037
J	Parmar, MKB; Carpenter, J; Sydes, MR				Parmar, Mahesh K. B.; Carpenter, James; Sydes, Matthew R.			More multiarm randomised trials of superiority are needed	LANCET			English	Editorial Material							CLINICAL-TRIALS		[Parmar, Mahesh K. B.; Carpenter, James; Sydes, Matthew R.] UCL, MRC Clin Trials Unit, London WC2B 6NH, England; [Carpenter, James] London Sch Hyg & Trop Med, London WC1, England	Medical Research Council Clinical Trials Unit; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Sydes, MR (corresponding author), UCL, MRC Clin Trials Unit, London WC2B 6NH, England.	m.sydes@ucl.ac.uk	Sydes, Matthew/C-3373-2008; Hemingway, Harry/C-1219-2009	Sydes, Matthew/0000-0002-9323-1371; Carpenter, James/0000-0003-3890-6206; Hemingway, Harry/0000-0003-2279-0624	Economic and Social Research Council [ES/G026300/1] Funding Source: researchfish; ESRC [ES/G026300/1] Funding Source: UKRI; MRC [MC_EX_G0800814, MC_U122861326, MC_UU_12023/4, G0701770, MC_U122861383, MC_U122861325, MC_U122861330] Funding Source: UKRI; Cancer Research UK [12127] Funding Source: Medline; Medical Research Council [MR/K006584/1, MC_UU_12023/4, MC_U122861383, MC_EX_G0800814, MC_U122861325, MC_U122861326, MC_U122861330, MC_PC_13041, G0701770] Funding Source: Medline	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Campbell MK, 2007, HEALTH TECHNOL ASSES, V11, piii; Campbell MK, 2007, HEALTH TECHNOL ASSES, V11, pix; Clark T, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1135; Cross J, 2002, PHARMACOEPIDEM DR S, V11, P439, DOI 10.1002/pds.744; Djulbegovic B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058711; Djulbegovic B, 2008, ARCH INTERN MED, V168, P632, DOI 10.1001/archinte.168.6.632; Freidlin B, 2008, CLIN CANCER RES, V14, P4368, DOI 10.1158/1078-0432.CCR-08-0325; Gan HK, 2012, J NATL CANCER I, V104, P590, DOI 10.1093/jnci/djs141; Hearn J, 2011, TRIALS, V12, pA6, DOI [10.1186/1745-6215-12-S1-A6, DOI 10.1186/1745-6215-12-S1-A6]; Lisovskaja V, 2013, STAT MED, V32, P1661, DOI 10.1002/sim.5632; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Proschan MA, 2000, CONTROL CLIN TRIALS, V21, P527, DOI 10.1016/S0197-2456(00)00106-9; Royston P, 2003, STAT MED, V22, P2239, DOI 10.1002/sim.1430; Sydes M.R., 2011, TRIALS, Vvol. 12, pA3; Sydes MR, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-39	15	87	87	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2014	384	9940					283	284		10.1016/S0140-6736(14)61122-3	http://dx.doi.org/10.1016/S0140-6736(14)61122-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM3AE	25066148				2022-12-28	WOS:000339722400004
J	Rao, JN; Madasu, Y; Dominguez, R				Rao, Jampani Nageswara; Madasu, Yadaiah; Dominguez, Roberto			Mechanism of actin filament pointed-end capping by tropomodulin	SCIENCE			English	Article							BACTERIAL EFFECTOR VOPL; TROPOMYOSIN BINDING; THIN-FILAMENTS; F-ACTIN; MUSCLE; DOMAIN; CELLS; NUCLEATION; MODEL	Proteins that cap the ends of the actin filament are essential regulators of cytoskeleton dynamics. Whereas several proteins cap the rapidly growing barbed end, tropomodulin (Tmod) is the only protein known to cap the slowly growing pointed end. The lack of structural information severely limits our understanding of Tmod's capping mechanism. We describe crystal structures of actin complexes with the unstructured amino-terminal and the leucine-rich repeat carboxy-terminal domains of Tmod. The structures and biochemical analysis of structure-inspired mutants showed that one Tmod molecule interacts with three actin subunits at the pointed end, while also contacting two tropomyosin molecules on each side of the filament. We found that Tmod achieves high-affinity binding through several discrete low-affinity interactions, which suggests a mechanism for controlled subunit exchange at the pointed end.	[Rao, Jampani Nageswara; Madasu, Yadaiah; Dominguez, Roberto] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Dominguez, R (corresponding author), Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	droberto@mail.med.upenn.edu		Dominguez, Roberto/0000-0003-3186-5229	NIH [R01 GM073791, GM-0080]; U.S. Department of Energy [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073791] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant R01 GM073791. X-ray data collection at beamline X6A of the National Synchrotron Light Source was supported by NIH grant GM-0080 and U.S. Department of Energy contract DE-AC02-98CH10886. We thank G. Rebowski for the preparation of actin and TM for this study and W. Lehman and M. Orzechowski for providing the TM models. The structures have been deposited in the Protein Data Bank under codes 4PKG, 4PKH, and 4PKI.	Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Fowler VM, 2003, J BIOL CHEM, V278, P40000, DOI 10.1074/jbc.M306895200; FOWLER VM, 1993, J CELL BIOL, V120, P411, DOI 10.1083/jcb.120.2.411; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Greenfield NJ, 2005, BIOPHYS J, V88, P372, DOI 10.1529/biophysj.104.051128; Kostyukova AS, 2006, BIOCHEMISTRY-US, V45, P12068, DOI 10.1021/bi060899i; Kostyukova AS, 2005, BIOCHEMISTRY-US, V44, P4905, DOI 10.1021/bi047468p; Krieger I, 2002, BIOPHYS J, V83, P2716, DOI 10.1016/S0006-3495(02)75281-8; Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; Moyer JD, 2010, BLOOD, V116, P2590, DOI 10.1182/blood-2010-02-268458; Nag S, 2013, CYTOSKELETON, V70, P360, DOI 10.1002/cm.21117; Namgoong S, 2011, NAT STRUCT MOL BIOL, V18, P1060, DOI 10.1038/nsmb.2109; Tsukada T, 2011, J BIOL CHEM, V286, P2194, DOI 10.1074/jbc.M110.186924; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Weber A, 1999, J BIOL CHEM, V274, P34637, DOI 10.1074/jbc.274.49.34637; WEBER A, 1994, J CELL BIOL, V127, P1627, DOI 10.1083/jcb.127.6.1627; Yamashiro S, 2012, CYTOSKELETON, V69, P337, DOI 10.1002/cm.21031; Yamashiro S, 2010, J BIOL CHEM, V285, P33265, DOI 10.1074/jbc.M110.144873; Yao WJ, 2010, J BIOL CHEM, V285, P31408, DOI 10.1074/jbc.M110.130278; Yu BK, 2011, NAT STRUCT MOL BIOL, V18, P1068, DOI 10.1038/nsmb.2110; Zahm JA, 2013, CELL, V155, P423, DOI 10.1016/j.cell.2013.09.019	27	69	70	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					463	467		10.1126/science.1256159	http://dx.doi.org/10.1126/science.1256159			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061212	Green Accepted			2022-12-28	WOS:000339655100046
J	Ripke, S; Neale, BM; Corvin, A; Walters, JTR; Farh, KH; Holmans, PA; Lee, P; Bulik-Sullivan, B; Collier, DA; Huang, HL; Pers, TH; Agartz, I; Agerbo, E; Albus, M; Alexander, M; Amin, F; Bacanu, SA; Begemann, M; Belliveau, RA; Bene, J; Bergen, SE; Bevilacqua, E; Bigdeli, TB; Black, DW; Bruggeman, R; Buccola, NG; Buckner, RL; Byerley, W; Cahn, W; Cai, GQ; Campion, D; Cantor, RM; Carr, VJ; Carrera, N; Catts, SV; Chambert, KD; Chan, RCK; Chen, RYL; Chen, EYH; Cheng, W; Cheung, EFC; Chong, SA; Cloninger, CR; Cohen, D; Cohen, N; Cormican, P; Craddock, N; Crowley, JJ; Curtis, D; Davidson, M; Davis, KL; Degenhardt, F; Del Favero, J; Demontis, D; Dikeos, D; Dinan, T; Djurovic, S; Donohoe, G; Drapeau, E; Duan, J; Dudbridge, F; Durmishi, N; Eichhammer, P; Eriksson, J; Escott-Price, V; Essioux, L; Fanous, AH; Farrell, MS; Frank, J; Franke, L; Freedman, R; Freimer, NB; Friedl, M; Friedman, JI; Fromer, M; Genovese, G; Georgieva, L; Giegling, I; Giusti-Rodriguez, P; Godard, S; Goldstein, JI; Golimbet, V; Gopal, S; Gratten, J; de Haan, L; Hammer, C; Hamshere, ML; Hansen, M; Hansen, T; Haroutunian, V; Hartmann, AM; Henskens, FA; Herms, S; Hirschhorn, JN; Hoffmann, P; Hofman, A; Hollegaard, MV; Hougaard, DM; Ikeda, M; Joa, I; Julia, A; Kahn, RS; Kalaydjieva, L; Karachanak-Yankova, S; Karjalainen, J; Kavanagh, D; Keller, MC; Kennedy, JL; Khrunin, A; Kim, Y; Klovins, J; Knowles, JA; Konte, B; Kucinskas, V; Kucinskiene, ZA; Kuzelova-Ptackova, H; Kahler, AK; Laurent, C; Keong, JLC; Lee, SH; Legge, SE; Lerer, B; Li, MX; Li, T; Liang, KY; Lieberman, J; Limborska, S; Loughland, CM; Lubinski, J; Lonnqvist, J; Macek, M; Magnusson, PKE; Maher, BS; Maier, W; Mallet, J; Marsal, S; Mattheisen, M; Mattingsdal, M; McCarley, RW; McDonald, C; McIntosh, AM; Meier, S; Meijer, CJ; Melegh, B; Melle, I; Mesholam-Gately, RI; Metspalu, A; Michie, PT; Milani, L; Milanova, V; Mokrab, Y; Morris, DW; Mors, O; Murphy, KC; Murray, RM; Myin-Germeys, I; Muller-Myhsok, B; Nelis, M; Nenadic, I; Nertney, DA; Nestadt, G; Nicodemus, KK; Nikitina-Zake, L; Nisenbaum, L; Nordin, A; O'Callaghan, E; O'Dushlaine, C; O'Neill, FA; Oh, SY; Olincy, A; Olsen, L; Van Os, J; Pantelis, C; Papadimitriou, GN; Papiol, S; Parkhomenko, E; Pato, MT; Paunio, T; Pejovic-Milovancevic, M; Perkins, DO; Pietilainen, O; Pimm, J; Pocklington, AJ; Powell, J; Price, A; Pulver, AE; Purcell, SM; Quested, D; Rasmussen, HB; Reichenberg, A; Reimers, MA; Richards, AL; Roffman, JL; Roussos, P; Ruderfer, DM; Salomaa, V; Sanders, AR; Schall, U; Schubert, CR; Schulze, TG; Schwab, SG; Scolnick, EM; Scott, RJ; Seidman, LJ; Shi, JX; Sigurdsson, E; Silagadze, T; Silverman, JM; Sim, K; Slominsky, P; Smoller, JW; So, HC; Spencer, CCA; Stahl, EA; Stefansson, H; Steinberg, S; Stogmann, E; Straub, RE; Strengman, E; Strohmaier, J; Stroup, TS; Subramaniam, M; Suvisaari, J; Svrakic, DM; Szatkiewicz, JP; Soderman, E; Thirumalai, S; Toncheva, D; Tosato, S; Veijola, J; Waddington, J; Walsh, D; Wang, D; Wang, Q; Webb, BT; Weiser, M; Wildenauer, DB; Williams, NM; Williams, S; Witt, SH; Wolen, AR; Wong, EHM; Wormley, BK; Xi, HS; Zai, CC; Zheng, XB; Zimprich, F; Wray, NR; Stefansson, K; Visscher, PM; Adolfsson, R; Andreassen, OA; Blackwood, DHR; Bramon, E; Buxbaum, JD; Borglum, AD; Cichon, S; Darvasi, A; Domenici, E; Ehrenreich, H; Esko, T; Gejman, PV; Gill, M; Gurling, H; Hultman, CM; Iwata, N; Jablensky, AV; Jonsson, EG; Kendler, KS; Kirov, G; Knight, J; Lencz, T; Levinson, DF; Li, QQS; Liu, JJ; Malhotra, AK; McCarroll, SA; McQuillin, A; Moran, JL; Mortensen, PB; Mowry, BJ; Nothen, MM; Ophoff, RA; Owen, MJ; Palotie, A; Pato, CN; Petryshen, TL; Posthuma, D; Rietschel, M; Riley, BP; Rujescu, D; Sham, PC; Sklar, P; St Clair, D; Weinberger, DR; Wendland, JR; Werge, T; Daly, MJ; Sullivan, PF; O'Donovan, MC				Ripke, Stephan; Neale, Benjamin M.; Corvin, Aiden; Walters, James T. R.; Farh, Kai-How; Holmans, Peter A.; Lee, Phil; Bulik-Sullivan, Brendan; Collier, David A.; Huang, Hailiang; Pers, Tune H.; Agartz, Ingrid; Agerbo, Esben; Albus, Margot; Alexander, Madeline; Amin, Farooq; Bacanu, Silviu A.; Begemann, Martin; Belliveau, Richard A., Jr.; Bene, Judit; Bergen, Sarah E.; Bevilacqua, Elizabeth; Bigdeli, Tim B.; Black, Donald W.; Bruggeman, Richard; Buccola, Nancy G.; Buckner, Randy L.; Byerley, William; Cahn, Wiepke; Cai, Guiqing; Campion, Dominique; Cantor, Rita M.; Carr, Vaughan J.; Carrera, Noa; Catts, Stanley V.; Chambert, Kimberly D.; Chan, Raymond C. K.; Chen, Ronald Y. L.; Chen, Eric Y. H.; Cheng, Wei; Cheung, Eric F. C.; Chong, Siow Ann; Cloninger, C. Robert; Cohen, David; Cohen, Nadine; Cormican, Paul; Craddock, Nick; Crowley, James J.; Curtis, David; Davidson, Michael; Davis, Kenneth L.; Degenhardt, Franziska; Del Favero, Jurgen; Demontis, Ditte; Dikeos, Dimitris; Dinan, Timothy; Djurovic, Srdjan; Donohoe, Gary; Drapeau, Elodie; Duan, Jubao; Dudbridge, Frank; Durmishi, Naser; Eichhammer, Peter; Eriksson, Johan; Escott-Price, Valentina; Essioux, Laurent; Fanous, Ayman H.; Farrell, Martilias S.; Frank, Josef; Franke, Lude; Freedman, Robert; Freimer, Nelson B.; Friedl, Marion; Friedman, Joseph I.; Fromer, Menachem; Genovese, Giulio; Georgieva, Lyudmila; Giegling, Ina; Giusti-Rodriguez, Paola; Godard, Stephanie; Goldstein, Jacqueline I.; Golimbet, Vera; Gopal, Srihari; Gratten, Jacob; de Haan, Lieuwe; Hammer, Christian; Hamshere, Marian L.; Hansen, Mark; Hansen, Thomas; Haroutunian, Vahram; Hartmann, Annette M.; Henskens, Frans A.; Herms, Stefan; Hirschhorn, Joel N.; Hoffmann, Per; Hofman, Andrea; Hollegaard, Mads V.; Hougaard, David M.; Ikeda, Masashi; Joa, Inge; Julia, Antonio; Kahn, Rene S.; Kalaydjieva, Luba; Karachanak-Yankova, Sena; Karjalainen, Juha; Kavanagh, David; Keller, Matthew C.; Kennedy, James L.; Khrunin, Andrey; Kim, Yunjung; Klovins, Janis; Knowles, James A.; Konte, Bettina; Kucinskas, Vaidutis; Kucinskiene, Zita Ausrele; Kuzelova-Ptackova, Hana; Kahler, Anna K.; Laurent, Claudine; Keong, Jimmy Lee Chee; Lee, S. Hong; Legge, Sophie E.; Lerer, Bernard; Li, Miaoxin; Li, Tao; Liang, Kung-Yee; Lieberman, Jeffrey; Limborska, Svetlana; Loughland, Carmel M.; Lubinski, Jan; Lonnqvist, Jouko; Macek, Milan, Jr.; Magnusson, Patrik K. E.; Maher, Brion S.; Maier, Wolfgang; Mallet, Jacques; Marsal, Sara; Mattheisen, Manuel; Mattingsdal, Morten; McCarley, Robert W.; McDonald, Colm; McIntosh, Andrew M.; Meier, Sandra; Meijer, Carin J.; Melegh, Bela; Melle, Ingrid; Mesholam-Gately, Raquelle I.; Metspalu, Andres; Michie, Patricia T.; Milani, Lili; Milanova, Vihra; Mokrab, Younes; Morris, Derek W.; Mors, Ole; Murphy, Kieran C.; Murray, Robin M.; Myin-Germeys, Inez; Mueller-Myhsok, Bertram; Nelis, Mari; Nenadic, Igor; Nertney, Deborah A.; Nestadt, Gerald; Nicodemus, Kristin K.; Nikitina-Zake, Liene; Nisenbaum, Laura; Nordin, Annelie; O'Callaghan, Eadbhard; O'Dushlaine, Colm; O'Neill, F. Anthony; Oh, Sang-Yun; Olincy, Ann; Olsen, Line; Van Os, Jim; Pantelis, Christos; Papadimitriou, George N.; Papiol, Sergi; Parkhomenko, Elena; Pato, Michele T.; Paunio, Tiina; Pejovic-Milovancevic, Milica; Perkins, Diana O.; Pietilainen, Olli; Pimm, Jonathan; Pocklington, Andrew J.; Powell, John; Price, Alkes; Pulver, Ann E.; Purcell, Shaun M.; Quested, Digby; Rasmussen, Henrik B.; Reichenberg, Abraham; Reimers, Mark A.; Richards, Alexander L.; Roffman, Joshua L.; Roussos, Panos; Ruderfer, Douglas M.; Salomaa, Veikko; Sanders, Alan R.; Schall, Ulrich; Schubert, Christian R.; Schulze, Thomas G.; Schwab, Sibylle G.; Scolnick, Edward M.; Scott, Rodney J.; Seidman, Larry J.; Shi, Jianxin; Sigurdsson, Engilbert; Silagadze, Teimuraz; Silverman, Jeremy M.; Sim, Kang; Slominsky, Petr; Smoller, Jordan W.; So, Hon-Cheong; Spencer, Chris C. A.; Stahl, Eli A.; Stefansson, Hreinn; Steinberg, Stacy; Stogmann, Elisabeth; Straub, Richard E.; Strengman, Eric; Strohmaier, Jana; Stroup, T. Scott; Subramaniam, Mythily; Suvisaari, Jaana; Svrakic, Dragan M.; Szatkiewicz, Jin P.; Soderman, Erik; Thirumalai, Srinivas; Toncheva, Draga; Tosato, Sarah; Veijola, Juha; Waddington, John; Walsh, Dermot; Wang, Dai; Wang, Qiang; Webb, Bradley T.; Weiser, Mark; Wildenauer, Dieter B.; Williams, Nigel M.; Williams, Stephanie; Witt, Stephanie H.; Wolen, Aaron R.; Wong, Emily H. M.; Wormley, Brandon K.; Xi, Hualin Simon; Zai, Clement C.; Zheng, Xuebin; Zimprich, Fritz; Wray, Naomi R.; Stefansson, Kari; Visscher, Peter M.; Adolfsson, Rolf; Andreassen, Ole A.; Blackwood, Douglas H. R.; Bramon, Elvira; Buxbaum, Joseph D.; Borglum, Anders D.; Cichon, Sven; Darvasi, Ariel; Domenici, Enrico; Ehrenreich, Hannelore; Esko, Tonu; Gejman, Pablo V.; Gill, Michael; Gurling, Hugh; Hultman, Christina M.; Iwata, Nakao; Jablensky, Assen V.; Jonsson, Erik G.; Kendler, Kenneth S.; Kirov, George; Knight, Jo; Lencz, Todd; Levinson, Douglas F.; Li, Qingqin S.; Liu, Jianjun; Malhotra, Anil K.; McCarroll, Steven A.; McQuillin, Andrew; Moran, Jennifer L.; Mortensen, Preben B.; Mowry, Bryan J.; Noethen, Markus M.; Ophoff, Roel A.; Owen, Michael J.; Palotie, Aarno; Pato, Carlos N.; Petryshen, Tracey L.; Posthuma, Danielle; Rietschel, Marcella; Riley, Brien P.; Rujescu, Dan; Sham, Pak C.; Sklar, Pamela; St Clair, David; Weinberger, Daniel R.; Wendland, Jens R.; Werge, Thomas; Daly, Mark J.; Sullivan, Patrick F.; O'Donovan, Michael C.		Psychiat Genomics Consortium; Psychosis Endophenotypes Int Conso; Wellcome Trust Case-Control Consor	Biological insights from 108 schizophrenia-associated genetic loci	NATURE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; CONFERRING RISK; MUTATIONS	Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of alleles, including common alleles of small effect that might be detected by genome-wide association studies. Here we report a multi-stage schizophrenia genome-wide association study of up to 36,989 cases and 113,075 controls. We identify 128 independent associations spanning 108 conservatively defined loci that meet genome-wide significance, 83 of which have not been previously reported. Associations were enriched among genes expressed in brain, providing biological plausibility for the findings. Many findings have the potential to provide entirely new insights into aetiology, but associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses. Independent of genes expressed in brain, associations were enriched among genes expressed in tissues that have important roles in immunity, providing support for the speculated link between the immune system and schizophrenia.	[Ripke, Stephan; Neale, Benjamin M.; Farh, Kai-How; Lee, Phil; Bulik-Sullivan, Brendan; Huang, Hailiang; Fromer, Menachem; Goldstein, Jacqueline I.; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ripke, Stephan; Neale, Benjamin M.; Lee, Phil; Bulik-Sullivan, Brendan; Belliveau, Richard A., Jr.; Bergen, Sarah E.; Bevilacqua, Elizabeth; Chambert, Kimberly D.; Fromer, Menachem; Genovese, Giulio; O'Dushlaine, Colm; Scolnick, Edward M.; Smoller, Jordan W.; McCarroll, Steven A.; Moran, Jennifer L.; Palotie, Aarno; Petryshen, Tracey L.; Daly, Mark J.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Neale, Benjamin M.; Huang, Hailiang; Pers, Tune H.; Goldstein, Jacqueline I.; Hirschhorn, Joel N.; Price, Alkes; Stahl, Eli A.; Esko, Tonu; Daly, Mark J.] Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA 02142 USA; [Neale, Benjamin M.; Lee, Phil; Fromer, Menachem; Smoller, Jordan W.; Palotie, Aarno] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Corvin, Aiden; Cormican, Paul; Donohoe, Gary; Morris, Derek W.; Gill, Michael] Univ Ireland Trinity Coll, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin 8, Ireland; [Walters, James T. R.; Holmans, Peter A.; Carrera, Noa; Craddock, Nick; Escott-Price, Valentina; Georgieva, Lyudmila; Hamshere, Marian L.; Kavanagh, David; Legge, Sophie E.; Pocklington, Andrew J.; Richards, Alexander L.; Ruderfer, Douglas M.; Williams, Nigel M.; Kirov, George; Owen, Michael J.; O'Donovan, Michael C.] Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Inst Psychol Med & Clin Neurosci, Cardiff CF24 4HQ, S Glam, Wales; [Holmans, Peter A.; Craddock, Nick; Owen, Michael J.; O'Donovan, Michael C.] Cardiff Univ, Natl Ctr Mental Hlth, Cardiff CF24 4HQ, S Glam, Wales; [Collier, David A.; Mokrab, Younes] Eli Lilly & Co Ltd, Erl Wood Manor, Windlesham GU20 6PH, Surrey, England; [Collier, David A.] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AF, England; [Pers, Tune H.] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Pers, Tune H.; Hirschhorn, Joel N.; Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Pers, Tune H.; Hirschhorn, Joel N.; Esko, Tonu] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Agartz, Ingrid; Soderman, Erik; Jonsson, Erik G.] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat, N-0319 Oslo, Norway; [Agartz, Ingrid; Djurovic, Srdjan; Mattingsdal, Morten; Melle, Ingrid; Andreassen, Ole A.; Jonsson, Erik G.] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, N-0424 Oslo, Norway; [Agerbo, Esben; Mortensen, Preben B.] Aarhus Univ, CIRRAU, Ctr Integrat Register Based Res, DK-8210 Aarhus, Denmark; [Agerbo, Esben; Mortensen, Preben B.] Aarhus Univ, Natl Ctr Register Based Res, DK-8210 Aarhus, Denmark; [Agerbo, Esben; Demontis, Ditte; Hansen, Thomas; Mattheisen, Manuel; Mors, Ole; Olsen, Line; Rasmussen, Henrik B.; Borglum, Anders D.; Mortensen, Preben B.; Werge, Thomas] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark; [Albus, Margot] State Mental Hosp, D-85540 Haar, Germany; [Alexander, Madeline; Laurent, Claudine; Levinson, Douglas F.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Amin, Farooq] Atlanta Vet Affairs Med Ctr, Dept Psychiat & Behav Sci, Atlanta, GA 30033 USA; [Amin, Farooq] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Bacanu, Silviu A.; Bigdeli, Tim B.; Webb, Bradley T.; Wormley, Brandon K.] Virginia Commonwealth Univ, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA; [Begemann, Martin; Hammer, Christian; Papiol, Sergi; Ehrenreich, Hannelore] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Bene, Judit; Melegh, Bela] Univ Pecs, Dept Med Genet, H-7624 Pecs, Hungary; [Bene, Judit; Melegh, Bela] Univ Pecs, Szentagothai Res Ctr, H-7624 Pecs, Hungary; [Bergen, Sarah E.; Kahler, Anna K.; Magnusson, Patrik K. E.; Hultman, Christina M.; Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Black, Donald W.] Univ Iowa, Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Bruggeman, Richard] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9700 RB Groningen, Netherlands; [Buccola, Nancy G.] Louisiana State Univ, Hlth Sci Ctr, Sch Nursing, New Orleans, LA 70112 USA; [Buckner, Randy L.; Roffman, Joshua L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr, Boston, MA 02129 USA; [Buckner, Randy L.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Buckner, Randy L.; Roffman, Joshua L.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Byerley, William] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Cahn, Wiepke; Kahn, Rene S.; Strengman, Eric; Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, NL-3584 Utrecht, Netherlands; [Cai, Guiqing; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Human Genet, New York, NY 10029 USA; [Cai, Guiqing; Davis, Kenneth L.; Drapeau, Elodie; Friedman, Joseph I.; Haroutunian, Vahram; Parkhomenko, Elena; Reichenberg, Abraham; Silverman, Jeremy M.; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Campion, Dominique] Ctr Hosp Rouvray, F-76301 Rouen, France; [Campion, Dominique] INSERM, U1079, Fac Med, F-76301 Rouen, France; [Cantor, Rita M.; Ophoff, Roel A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Carr, Vaughan J.; Catts, Stanley V.; Henskens, Frans A.; Loughland, Carmel M.; Michie, Patricia T.; Pantelis, Christos; Schall, Ulrich; Scott, Rodney J.; Jablensky, Assen V.] Schizophrenia Res Inst, Sydney, NSW 2010, Australia; [Carr, Vaughan J.] Univ New S Wales, Sch Psychiat, Sydney, NSW 2031, Australia; [Catts, Stanley V.] Univ Queensland, Royal Brisbane & Womens Hosp, St Lucia, Qld 4072, Australia; [Chan, Raymond C. K.] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Chen, Ronald Y. L.; Chen, Eric Y. H.; Li, Miaoxin; So, Hon-Cheong; Wong, Emily H. M.; Sham, Pak C.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Chen, Eric Y. H.; Li, Miaoxin; Sham, Pak C.] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Cheng, Wei] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27514 USA; [Cheung, Eric F. C.] Castle Peak Hosp, Hong Kong, Hong Kong, Peoples R China; [Chong, Siow Ann; Keong, Jimmy Lee Chee; Sim, Kang; Subramaniam, Mythily] Inst Mental Hlth, Singapore 539747, Singapore; [Cloninger, C. Robert; Svrakic, Dragan M.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Cohen, David] Assistance Publ Hop Paris, Dept Child & Adolescent Psychiat, Pierre & Marie Curie Fac Med, F-75013 Paris, France; [Cohen, David] Inst Intelligent Syst & Robot, F-75013 Paris, France; [Cohen, Nadine] Blue Note Biosci, Princeton, NJ 08540 USA; [Crowley, James J.; Farrell, Martilias S.; Giusti-Rodriguez, Paola; Kim, Yunjung; Szatkiewicz, Jin P.; Williams, Stephanie; Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Curtis, David] Queen Mary Univ London, Dept Psychol Med, London E1 1BB, England; [Curtis, David; Pimm, Jonathan; Gurling, Hugh; McQuillin, Andrew] UCL, Mol Psychiat Lab, Div Psychiat, London WC1E 6JJ, England; [Davidson, Michael; Weiser, Mark] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Degenhardt, Franziska; Herms, Stefan; Hoffmann, Per; Hofman, Andrea; Cichon, Sven; Noethen, Markus M.] Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Degenhardt, Franziska; Herms, Stefan; Hoffmann, Per; Hofman, Andrea; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Del Favero, Jurgen] Univ Antwerp VIB, Dept Mol Genet, Appl Mol Genom Unit, B-2610 Antwerp, Belgium; [Demontis, Ditte; Mattheisen, Manuel; Mors, Ole; Borglum, Anders D.] Aarhus Univ, iSEQ, Ctr Integrat Sequencing, DK-8000 Aarhus C, Denmark; [Demontis, Ditte; Mattheisen, Manuel; Borglum, Anders D.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Dikeos, Dimitris; Papadimitriou, George N.] Univ Athens, Sch Med, Dept Psychiat 1, Athens 11528, Greece; [Dinan, Timothy] Univ Coll Cork, Dept Psychiat, Cork, Ireland; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, N-0424 Oslo, Norway; [Donohoe, Gary; Morris, Derek W.] Natl Univ Ireland Galway, Cognit Genet & Therapy Grp, Sch Psychol, Galway, Ireland; [Donohoe, Gary; Morris, Derek W.] Natl Univ Ireland Galway, Discipline Biochem, Galway, Ireland; [Duan, Jubao; Sanders, Alan R.; Gejman, Pablo V.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Duan, Jubao; Sanders, Alan R.; Gejman, Pablo V.] NorthShore Univ HealthSyst, Dept Psychiat & Biobehav Sci, Evanston, IL 60201 USA; [Dudbridge, Frank] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Durmishi, Naser] Univ Clin Psychiat, Dept Child & Adolescent Psychiat, Skopje 1000, North Macedonia; [Eichhammer, Peter] Univ Regensburg, Dept Psychiat, D-93053 Regensburg, Germany; [Eriksson, Johan] Univ Helsinki, Cent Hosp, Dept Gen Practice, FI-00014 Helsinki, Finland; [Eriksson, Johan] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan] Biomedicum Helsinki 1, FI-00290 Helsinki, Finland; [Eriksson, Johan; Salomaa, Veikko] Natl Inst Hlth & Welf, FI-00271 Helsinki, Finland; [Essioux, Laurent] F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Translat Technol & Bioinformat, CH-4070 Basel, Switzerland; [Fanous, Ayman H.] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC 20057 USA; [Fanous, Ayman H.] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [Fanous, Ayman H.] Virginia Commonwealth Univ, Sch Med, Dept Psychiat, Richmond, VA 23298 USA; [Fanous, Ayman H.] Washington VA Med Ctr, Washington, DC 20422 USA; [Frank, Josef; Meier, Sandra; Schulze, Thomas G.; Strohmaier, Jana; Witt, Stephanie H.; Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-68159 Mannheim, Germany; [Franke, Lude; Karjalainen, Juha] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Freedman, Robert; Olincy, Ann] Univ Colorado Denver, Dept Psychiat, Aurora, CO 80045 USA; [Freimer, Nelson B.; Ophoff, Roel A.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Friedl, Marion; Giegling, Ina; Hartmann, Annette M.; Konte, Bettina; Rujescu, Dan] Univ Halle Wittenberg, Dept Psychiat, D-06112 Halle, Germany; [Fromer, Menachem; Purcell, Shaun M.; Roussos, Panos; Ruderfer, Douglas M.; Stahl, Eli A.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, New York, NY USA; [Giegling, Ina; Rujescu, Dan] Univ Munich, Dept Psychiat, D-80336 Munich, Germany; [Godard, Stephanie] Hop La Pitie Salpetriere, Dept Psychiat, INSERM, Inst Myol, F-75013 Paris, France; [Godard, Stephanie] Hop La Pitie Salpetriere, Dept Human & Mol Genet, INSERM, Inst Myol, F-75013 Paris, France; [Golimbet, Vera] Russian Acad Med Sci, Mental Hlth Res Ctr, Moscow 115522, Russia; [Gopal, Srihari; Wang, Dai; Li, Qingqin S.] Janssen Res & Dev, Neurosci Therapeut Area, Raritan, NJ 08869 USA; [Gratten, Jacob; Lee, S. Hong; Wray, Naomi R.; Visscher, Peter M.; Mowry, Bryan J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [de Haan, Lieuwe; Meijer, Carin J.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Hansen, Mark] Illumina, La Jolla, CA 92122 USA; [Hansen, Thomas; Olsen, Line; Rasmussen, Henrik B.; Werge, Thomas] Mental Hlth Serv Copenhagen, Mental Hlth Ctr Sct Hans, Inst Biol Psychiat, DK-4000 Roskilde, Denmark; [Haroutunian, Vahram; Buxbaum, Joseph D.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Haroutunian, Vahram] JJ Peters VA Med Ctr, Bronx, NY 10468 USA; [Henskens, Frans A.] Univ Newcastle, Prior Res Ctr Hlth Behav, Newcastle, NSW 2308, Australia; [Henskens, Frans A.] Univ Newcastle, Sch Elect Engn & Comp Sci, Newcastle, NSW 2308, Australia; [Herms, Stefan; Hoffmann, Per; Cichon, Sven] Univ Basel, Dept Biomed, Div Med Genet, CH-4058 Basel, Switzerland; [Hirschhorn, Joel N.; Esko, Tonu; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Hollegaard, Mads V.; Hougaard, David M.] Statens Serum Inst, Dept Clin Biochem Immunol & Genet, Sect Neonatal Screening & Hormones, DK-2300 Copenhagen, Denmark; [Ikeda, Masashi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 4701192, Japan; [Joa, Inge] Stavanger Univ Hosp, Dept Psychiat, Reg Ctr Clin Res Psychosis, N-4011 Stavanger, Norway; [Julia, Antonio; Marsal, Sara] Vall dHebron Res Inst, Rheumatol Res Grp, Barcelona 08035, Spain; [Kalaydjieva, Luba] Univ Western Australia, Ctr Med Res, Perth, WA 6009, Australia; [Kalaydjieva, Luba; Jablensky, Assen V.] Univ Western Australia, Perkins Inst Med Res, Perth, WA 6009, Australia; [Karachanak-Yankova, Sena; Toncheva, Draga] Med Univ, Dept Med Genet, Sofia 1431, Bulgaria; [Keller, Matthew C.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Kennedy, James L.; Zai, Clement C.; Knight, Jo] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON M5T 1R8, Canada; [Kennedy, James L.; Zai, Clement C.; Knight, Jo] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; [Kennedy, James L.; Knight, Jo] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Khrunin, Andrey; Limborska, Svetlana; Slominsky, Petr] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; [Klovins, Janis; Nikitina-Zake, Liene] Latvian Biomed Res & Study Ctr, LV-1067 Riga, Latvia; [Knowles, James A.; Pato, Michele T.; Pato, Carlos N.] Univ So Calif, Dept Psychiat, Los Angeles, CA 90089 USA; [Knowles, James A.; Pato, Michele T.; Pato, Carlos N.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Kucinskas, Vaidutis; Kucinskiene, Zita Ausrele] Vilnius State Univ, Fac Med, LT-01513 Vilnius, Lithuania; [Kuzelova-Ptackova, Hana; Macek, Milan, Jr.] 2nd Fac Med, Dept Biol & Med Genet, Prague 15006, Czech Republic; [Kuzelova-Ptackova, Hana; Macek, Milan, Jr.] Univ Hosp Motol, Prague 15006, Czech Republic; [Laurent, Claudine] Pierre & Marie Curie Fac Med, Dept Child & Adolescent Psychiat, F-75013 Paris, France; [Keong, Jimmy Lee Chee] Duke NUS Grad Med Sch, Singapore 169857, Singapore; [Lerer, Bernard] Hadassah Hebrew Univ, Med Ctr, Dept Psychiat, IL-91120 Jerusalem, Israel; [Li, Miaoxin; Sham, Pak C.] Univ Hong Kong, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China; [Li, Tao; Wang, Qiang] Sichuan Univ, Mental Hlth Ctr, Chengdu 610041, Sichuan, Peoples R China; [Li, Tao; Wang, Qiang] Sichuan Univ, West China Hosp, Psychiat Lab, Chengdu 610041, Sichuan, Peoples R China; [Liang, Kung-Yee] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Lieberman, Jeffrey; Stroup, T. Scott] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Loughland, Carmel M.; Schall, Ulrich] Univ Newcastle, Prior Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW 2300, Australia; [Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, PL-70453 Szczecin, Poland; [Lonnqvist, Jouko; Suvisaari, Jaana] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, FI-00271 Helsinki, Finland; [Maher, Brion S.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA; [Maier, Wolfgang] Univ Bonn, Dept Psychiat, D-53127 Bonn, Germany; [Mallet, Jacques] Hop La Pitie Salpetriere, CNRS, Lab Genet Mol Neurotransmiss & Proc Neurodegenera, F-75013 Paris, France; [Mattheisen, Manuel] Univ Bonn, Dept Genom Math, D-53127 Bonn, Germany; [Mattingsdal, Morten] Sorlandet Hosp, Res Unit, N-4604 Kristiansand, Norway; [McCarley, Robert W.; Mesholam-Gately, Raquelle I.; Seidman, Larry J.; Petryshen, Tracey L.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [McCarley, Robert W.] VA Boston Hlth Care Syst, Brockton, MA 02301 USA; [McDonald, Colm] Natl Univ Ireland Galway, Dept Psychiat, Galway, Ireland; [McIntosh, Andrew M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH16 4SB, Midlothian, Scotland; [McIntosh, Andrew M.; Blackwood, Douglas H. R.] Univ Edinburgh, Div Psychiat, Edinburgh EH16 4SB, Midlothian, Scotland; [Melle, Ingrid; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, N-0424 Oslo, Norway; [Mesholam-Gately, Raquelle I.; Seidman, Larry J.] Beth Israel Deaconess Med Ctr, Publ Psychiat Div, Massachusetts Mental Hlth Ctr, Boston, MA 02114 USA; [Metspalu, Andres; Milani, Lili; Nelis, Mari; Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Michie, Patricia T.] Univ Newcastle, Sch Psychol, Callaghan, NSW 2308, Australia; [Milanova, Vihra] Med Univ, Psychiat Clin 1, Sofia 1431, Bulgaria; [Mors, Ole; Borglum, Anders D.] Aarhus Univ Hosp, Dept P, DK-8240 Risskov, Denmark; [Murphy, Kieran C.] Royal Coll Surgeons Ireland, Dept Psychiat, Dublin 2, Ireland; [Murray, Robin M.; Powell, John] Kings Coll London, London SE5 8AF, England; [Myin-Germeys, Inez; Van Os, Jim] Maastricht Univ, Med Ctr, South Limburg Mental Hlth Res & Teaching Network, EURON, NL-6229 HX Maastricht, Netherlands; [Mueller-Myhsok, Bertram] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80336 Munich, Germany; [Mueller-Myhsok, Bertram] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany; [Nenadic, Igor] Jena Univ Hosp, Dept Psychiat & Psychotherapy, D-07743 Jena, Germany; [Nertney, Deborah A.] Univ Queensland, Queensland Brain Inst, Dept Psychiat, St Lucia, Qld 4072, Australia; [Nertney, Deborah A.] Univ Queensland, Queensland Ctr Mental Hlth Res, St Lucia, Qld 4072, Australia; [Nestadt, Gerald; Pulver, Ann E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Nicodemus, Kristin K.] Univ Dublin Trinity Coll, Dept Psychiat, Dublin 2, Ireland; [Nisenbaum, Laura] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Nordin, Annelie; Adolfsson, Rolf] Umea Univ, Dept Clin Sci, SE-90187 Umea, Sweden; [O'Callaghan, Eadbhard] DETECT Early Intervent Serv Psychosis, Blackrock, Dublin, Ireland; [O'Neill, F. Anthony] Queens Univ Belfast, Inst Clin Sci, Ctr Publ Hlth, Belfast BT12 6AB, Antrim, North Ireland; [Oh, Sang-Yun] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Van Os, Jim] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Pantelis, Christos] Univ Melbourne, Melbourne Neuropsychiat Ctr, Melbourne, Vic 3053, Australia; [Pantelis, Christos] Melbourne Hlth, Melbourne, Vic 3053, Australia; [Paunio, Tiina] Univ Helsinki, Dept Psychiat, FI-00029 Helsinki, Finland; [Paunio, Tiina; Pietilainen, Olli] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, FI-00271 Helsinki, Finland; [Pejovic-Milovancevic, Milica] Univ Belgrade, Fac Med, Belgrade 11000, Serbia; [Perkins, Diana O.; Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Pietilainen, Olli; Palotie, Aarno] Univ Helsinki, FIMM, FI-00014 Helsinki, Finland; [Price, Alkes] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Quested, Digby] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Reimers, Mark A.; Wolen, Aaron R.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA; [Roussos, Panos; Sklar, Pamela] Icahn Sch Med Mt Sinai, Inst Multiscale Biol, New York, NY 10029 USA; [Schubert, Christian R.; Wendland, Jens R.] Pfizer Worldwide Res & Dev, Pharma Therapeut Clin Res, Cambridge, MA 02139 USA; [Schulze, Thomas G.] Univ Gottingen, Dept Psychiat & Psychotherapy, D-37073 Gottingen, Germany; [Schwab, Sibylle G.] Univ Erlangen Nurnberg, Psychiat & Psychotherapy Clin, D-91054 Erlangen, Germany; [Scott, Rodney J.] Hunter New England Hlth Serv, Newcastle, NSW 2308, Australia; [Scott, Rodney J.] Univ Newcastle, Sch Biomed Sci, Newcastle, NSW 2308, Australia; [Shi, Jianxin] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Sigurdsson, Engilbert] Univ Iceland, Natl Univ Hosp, Landspitali, IS-101 Reykjavik, Iceland; [Silagadze, Teimuraz] Tbilisi State Med Univ TSMU, Dept Psychiat & Drug Addict, GE-0177 Tbilisi, Georgia; [Silverman, Jeremy M.] Bronx Vet Affairs Med Ctr, New York, NY 10468 USA; [Spencer, Chris C. A.] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Stefansson, Hreinn; Steinberg, Stacy; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Stogmann, Elisabeth; Zimprich, Fritz] Med Univ Vienna, Dept Clin Neurol, A-1090 Vienna, Austria; [Straub, Richard E.; Weinberger, Daniel R.] Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Strengman, Eric] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CG Utrecht, Netherlands; [Thirumalai, Srinivas] Berkshire Healthcare NHS Fdn Trust, Bracknell RG12 1BQ, Berks, England; [Tosato, Sarah] Univ Verona, Sect Psychiat, I-37134 Verona, Italy; [Veijola, Juha] Univ Oulu, Dept Psychiat, Oulu 90014, Finland; [Veijola, Juha] Univ Hosp Oulu, Oys 90029, Finland; [Waddington, John] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Walsh, Dermot] Hlth Res Board, Dublin 2, Ireland; [Wildenauer, Dieter B.; Jablensky, Assen V.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Xi, Hualin Simon] Pfizer Worldwide Res & Dev, Computat Sci CoE, Cambridge, MA 02139 USA; [Zheng, Xuebin; Liu, Jianjun] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Bramon, Elvira] UCL, London WC1E 6BT, England; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM 1, D-52428 Julich, Germany; [Darvasi, Ariel] Hebrew Univ Jerusalem, Dept Genet, IL-91905 Jerusalem, Israel; [Domenici, Enrico] F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Neurosci Discovery & Translat Area, CH-4070 Basel, Switzerland; [Jablensky, Assen V.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Ctr Clin Res Neuropsychiat, Perth, WA 6000, Australia; [Kendler, Kenneth S.; Riley, Brien P.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA 23298 USA; [Kendler, Kenneth S.; Riley, Brien P.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Lencz, Todd; Malhotra, Anil K.] Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Lencz, Todd; Malhotra, Anil K.] Hofstra NS LIJ Sch Med, Hempstead, NY 11549 USA; [Lencz, Todd; Malhotra, Anil K.] Zucker Hillside Hosp, Glen Oaks, NY 11004 USA; [Liu, Jianjun] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Mowry, Bryan J.] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld 4076, Australia; [Petryshen, Tracey L.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Petryshen, Tracey L.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Posthuma, Danielle] Erasmus Univ, Med Ctr, Dept Child & Adolescent Psychiat, NL-3000 Rotterdam, Netherlands; [Posthuma, Danielle] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Complex Trait Genet, NL-1081 Amsterdam, Netherlands; [Posthuma, Danielle] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, NL-1081 Amsterdam, Netherlands; [St Clair, David] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Werge, Thomas] Univ Copenhagen, Dept Clin Med, DK-2200 Copenhagen, Denmark	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Trinity College Dublin; Cardiff University; Cardiff University; Eli Lilly; University of London; King's College London; Technical University of Denmark; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Karolinska Institutet; Diakonhjemmet Hospital; University of Oslo; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Virginia Commonwealth University; Max Planck Society; University of Pecs; University of Pecs; Karolinska Institutet; University of Iowa; University of Groningen; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; Utrecht University; Utrecht University Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of New South Wales Sydney; Royal Brisbane & Women's Hospital; University of Queensland; Chinese Academy of Sciences; Institute of Psychology, CAS; University of Hong Kong; University of Hong Kong; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of North Carolina; University of North Carolina Chapel Hill; University of London; Queen Mary University London; University of London; University College London; Chaim Sheba Medical Center; University of Bonn; University of Bonn; Flanders Institute for Biotechnology (VIB); University of Antwerp; Aarhus University; Aarhus University; Athens Medical School; National & Kapodistrian University of Athens; University College Cork; University of Oslo; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; University of Chicago; NorthShore University Health System; University of London; London School of Hygiene & Tropical Medicine; University of Regensburg; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Finland National Institute for Health & Welfare; Roche Holding; Georgetown University; University of Southern California; Virginia Commonwealth University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Groningen; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles; Martin Luther University Halle Wittenberg; Icahn School of Medicine at Mount Sinai; University of Munich; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Russian Academy of Medical Sciences; Johnson & Johnson; Janssen Pharmaceuticals; University of Queensland; University of Amsterdam; Academic Medical Center Amsterdam; Illumina; Icahn School of Medicine at Mount Sinai; University of Newcastle; University of Newcastle; University of Basel; Harvard University; Harvard Medical School; Statens Serum Institut; Fujita Health University; Stavanger University Hospital; University of Western Australia; University of Western Australia; Medical University Sofia; University of Colorado System; University of Colorado Boulder; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; Russian Academy of Sciences; Latvian Biomedical Research & Study Centre; University of Southern California; University of Southern California; Vilnius University; Charles University Prague; Motol University Hospital; UDICE-French Research Universities; Sorbonne Universite; National University of Singapore; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Hong Kong; Sichuan University; Sichuan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Columbia University; University of Newcastle; Pomeranian Medical University; Finland National Institute for Health & Welfare; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Bonn; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Bonn; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Ollscoil na Gaillimhe-University of Galway; University of Edinburgh; University of Edinburgh; University of Oslo; Harvard University; Beth Israel Deaconess Medical Center; University of Tartu; University of Newcastle; Medical University Sofia; Aarhus University; Royal College of Surgeons - Ireland; University of London; King's College London; Maastricht University; University of Liverpool; Max Planck Society; University of Munich; Friedrich Schiller University of Jena; University of Queensland; Queensland Centre for Mental Health Research; University of Queensland; Johns Hopkins University; Trinity College Dublin; Eli Lilly; Umea University; Queens University Belfast; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of London; King's College London; University of Melbourne; University of Helsinki; Finland National Institute for Health & Welfare; University of Belgrade; University of North Carolina; University of North Carolina Chapel Hill; University of Helsinki; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Virginia Commonwealth University; Icahn School of Medicine at Mount Sinai; Pfizer; University of Gottingen; University of Erlangen Nuremberg; University of Newcastle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Iceland; Tbilisi State Medical University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Oxford; Wellcome Centre for Human Genetics; Medical University of Vienna; Utrecht University; Utrecht University Medical Center; University of Verona; University of Oulu; Royal College of Surgeons - Ireland; Health Research Board - Ireland; University of Western Australia; Pfizer; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of London; University College London; Icahn School of Medicine at Mount Sinai; Helmholtz Association; Research Center Julich; Hebrew University of Jerusalem; Roche Holding; University of Western Australia; Virginia Commonwealth University; Virginia Commonwealth University; Northwell Health; Hofstra University; Northwell Health; National University of Singapore; Queensland Centre for Mental Health Research; University of Queensland; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Aberdeen; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Copenhagen	O'Donovan, MC (corresponding author), Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Inst Psychol Med & Clin Neurosci, Cardiff CF24 4HQ, S Glam, Wales.	odonovanmc@cardiff.ac.uk	Webb, Bradley T/B-1459-2009; St Clair, David/AAN-2412-2021; Karjalainen, Juha/P-8624-2016; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Andreassen, Ole A./AAY-7531-2020; Nelis, Mari/ABG-7775-2020; Donohoe, Gary/J-6481-2013; Gratten, Jacob/G-1485-2011; Golimbet, V/E-2328-2016; Mattheisen, Manuel/S-3725-2019; Silverman, Jeremy M./AAO-4268-2020; McQuillin, Andrew/C-1623-2008; Fanous, Ayman H/O-1263-2017; Mortensen, Preben B/D-2358-2015; Reichenberg, Abraham/GQB-1227-2022; Powell, John F/G-4412-2011; Meier, Sandra/AAB-1242-2021; Hansen, Thomas Folkmann/O-5965-2014; Zimprich, Fritz/O-1406-2019; Lee, Jimmy/ABB-2919-2020; Bergen, Sarah/I-8313-2012; Limborska, Svetlana/A-5633-2016; Hartmann, Annette/AAS-6331-2021; Buxbaum, Joseph D/G-6001-2010; O'Neill, Francis A/C-5582-2008; Herms, Stefan/J-1949-2014; Hougaard, David/AAD-6368-2019; Pantelis, Christos/H-7722-2014; Walters, James/HCH-8835-2022; McCarley, Robert W/N-5562-2014; Lee, Sang Hong/A-2569-2011; Giegling, Ina/ABA-3677-2021; Petryshen, Tracey/X-5850-2019; Zai, Clement C/G-7379-2015; Ripke, Stephan/AAK-5486-2021; Magnusson, Patrik KE/C-4458-2017; Degenhardt, Franziska/H-4169-2017; McDonald, Colm/C-1430-2009; Rujescu, Dan/GRS-3875-2022; Stefansson, Kari/AAE-7187-2019; Myin Germeys, Inez/HIR-3364-2022; Jablensky, Assen/H-5116-2014; Bramon, Elvira/A-9463-2011; Zimprich, Fritz/W-1738-2017; McIntosh, Andrew M/B-9379-2008; Sigurdsson, Engilbert/D-2486-2014; Wang, Qiang/AAV-7131-2021; Konte, Bettina/AAT-1142-2021; Holmans, Peter/F-4518-2015; Klovins, Janis/C-5695-2011; Bigdeli, Tim B./AAX-7761-2020; O'Donovan, Michael C/P-7005-2018; Shenton, Martha/V-8780-2019; Stroup, Thomas/AAB-7780-2019; Dinan, Timothy/ABA-8284-2020; KUČINSKAS, Vaidutis/A-4798-2013; Daly, Mark J/B-2453-2017; Karachanak-Yankova, Sena/AAL-2721-2021; So, Hon-Cheong/I-1100-2016; Franke, Lude/P-7036-2016; van Os, Jim/V-8884-2019; Slominsky, Petr/AAO-1852-2020; Tosato, Sarah/E-6045-2010; Collier, David A/D-1649-2011; Chan, Raymond CK/B-6717-2009; Wray, Naomi/C-8639-2015; Lencz, Todd/J-3418-2014; Knight, Jo/F-4946-2011; Agerbo, Esben/A-2645-2012; Liu, Jianjun/AAK-4989-2020; SCHALL, ULRICH ANDREAS/G-7452-2013; Domenici, Enrico/K-8194-2016; Curtis, David/HGB-3921-2022; blackwood, douglas/AIB-8874-2022; Kendler, Kenneth/AAF-2876-2019; Ruderfer, Douglas M/M-5795-2016; Lieberman, Jeffrey/AAY-8239-2020; Zai, Clement C/AAA-5431-2022; Visscher, Peter/ABB-6151-2020; van Os, Jim/C-2113-2014; Bramon, Elvira/HHC-3809-2022; Roffman, Joshua/G-8228-2012; Hoffmann, Per/A-5149-2010; Myin-Germeys, Inez/L-5106-2014; Cloninger, Claude/F-5357-2012; Limborska, Svetlana/S-2961-2019; Kennedy, James Lowery/AAZ-6947-2020; Mattingsdal, Morten/Q-9367-2016; Morris, Derek/AAW-8343-2021; Melle, Ingrid S/B-4858-2011; Milani, Lili/N-1097-2019; Slominsky, Petr A/B-4640-2016; Perkins, Diana O/F-5213-2013; Catts, Stanley V/G-6917-2013; Mattheisen, Manuel/B-4949-2012; Mortensen, Preben/F-6758-2015; Hammer, Christian/C-5827-2014; Cichon, Sven/B-9618-2014; Scott, Rodney/B-2827-2013; murray, robin/F-8658-2012; Ptackova, Hana/M-9763-2017; Mowry, Bryan/G-5046-2010	Webb, Bradley T/0000-0002-0576-5366; Nelis, Mari/0000-0001-9748-1020; Donohoe, Gary/0000-0003-3037-7426; Gratten, Jacob/0000-0003-1293-409X; Golimbet, V/0000-0002-9960-7114; Mattheisen, Manuel/0000-0002-8442-493X; McQuillin, Andrew/0000-0003-1567-2240; Mortensen, Preben B/0000-0002-5230-9865; Powell, John F/0000-0001-6124-439X; Hansen, Thomas Folkmann/0000-0001-6703-7762; Zimprich, Fritz/0000-0002-6998-5480; Lee, Jimmy/0000-0002-7724-7445; Bergen, Sarah/0000-0002-5888-0034; O'Neill, Francis A/0000-0002-7531-7657; Herms, Stefan/0000-0002-2786-8200; Pantelis, Christos/0000-0002-9565-0238; McCarley, Robert W/0000-0001-5705-7495; Lee, Sang Hong/0000-0001-9701-2718; Petryshen, Tracey/0000-0002-7972-4612; Magnusson, Patrik KE/0000-0002-7315-7899; McDonald, Colm/0000-0003-1661-5192; Myin Germeys, Inez/0000-0002-3731-4930; Jablensky, Assen/0000-0003-0602-6810; Zimprich, Fritz/0000-0002-6998-5480; McIntosh, Andrew M/0000-0002-0198-4588; Sigurdsson, Engilbert/0000-0001-9404-7982; Konte, Bettina/0000-0001-5287-308X; Holmans, Peter/0000-0003-0870-9412; Bigdeli, Tim B./0000-0003-2215-5946; O'Donovan, Michael C/0000-0001-7073-2379; Stroup, Thomas/0000-0002-3123-0672; Daly, Mark J/0000-0002-0949-8752; Karachanak-Yankova, Sena/0000-0001-6441-629X; Franke, Lude/0000-0002-5159-8802; van Os, Jim/0000-0002-7245-1586; Slominsky, Petr/0000-0003-3530-0655; Tosato, Sarah/0000-0002-9665-7538; Collier, David A/0000-0003-4087-1559; Chan, Raymond CK/0000-0002-3414-450X; Wray, Naomi/0000-0001-7421-3357; Lencz, Todd/0000-0001-8586-338X; Agerbo, Esben/0000-0002-2849-524X; Liu, Jianjun/0000-0002-3255-3019; SCHALL, ULRICH ANDREAS/0000-0001-9041-4562; Domenici, Enrico/0000-0001-7436-6919; Curtis, David/0000-0002-4089-9183; Ruderfer, Douglas M/0000-0002-2365-386X; Zai, Clement C/0000-0003-0496-7262; Visscher, Peter/0000-0002-2143-8760; Bramon, Elvira/0000-0003-1369-5983; Roffman, Joshua/0000-0003-4073-532X; Hoffmann, Per/0000-0002-6573-983X; Cloninger, Claude/0000-0003-3096-4807; Limborska, Svetlana/0000-0002-1697-6820; Kennedy, James Lowery/0000-0002-8733-3806; Mattingsdal, Morten/0000-0003-4440-0324; Morris, Derek/0000-0002-3413-570X; Melle, Ingrid S/0000-0002-9783-548X; Milani, Lili/0000-0002-5323-3102; Slominsky, Petr A/0000-0003-3530-0655; Mattheisen, Manuel/0000-0002-8442-493X; Mortensen, Preben/0000-0002-4782-1450; Hammer, Christian/0000-0003-4548-7548; Suvisaari, Jaana/0000-0001-7167-0990; Huang, Hailiang/0000-0003-1461-5762; Legge, Sophie/0000-0001-6617-0289; Escott-Price, Valentina/0000-0003-1784-5483; Posthuma, Danielle/0000-0001-7582-2365; Milovancevic, Milos/0000-0002-7891-1010; ripke, stephan/0000-0003-3622-835X; Julia Cano, Antonio/0000-0001-6064-3620; Nothen, Markus/0000-0002-8770-2464; Golimbet, Vera/0000-0002-0114-4300; Bruggeman, Richard/0000-0002-3238-8471; Stefansson, Hreinn/0000-0002-9331-6666; Klovins, Janis/0000-0001-8362-5505; Esko, Tonu/0000-0003-1982-6569; Borglum, Anders/0000-0001-8627-7219; Kirov, George/0000-0002-3427-3950; McCarroll, Steven/0000-0002-6954-8184; Pejovic Milovancevic, Milica/0000-0001-8902-2668; Lubinski, Jan/0000-0003-2931-3003; Giusti-Rodriguez, Paola/0000-0002-1921-1305; Joa, Inge/0000-0002-5516-2336; IWATA, Nakao/0000-0003-3189-6076; Stogmann, Elisabeth/0000-0003-4688-8482; Demontis, Ditte/0000-0001-9124-2766; Murphy, Kieran/0000-0003-2930-4465; Powell, Joseph/0000-0002-5070-4124; Knight, Joanne/0000-0002-7148-1660; Freedman, Robert/0000-0002-2181-2898; Eriksson, Johan/0000-0002-2516-2060; Cichon, Sven/0000-0002-9475-086X; Crowley, James/0000-0001-9051-1557; Palotie, Aarno/0000-0002-2527-5874; Chen, Eric/0000-0002-5247-3593; Scott, Rodney/0000-0001-7724-3404; Buccola, Nancy/0000-0003-1378-4636; Toncheva, Draga/0000-0002-7451-6363; Gill, Michael/0000-0003-0206-5337; marsal, sara/0000-0001-5515-3854; Hollegaard, Mads Vilhelm/0000-0003-1061-0091; Sim, Kang/0000-0003-3209-9626; Agartz, Ingrid/0000-0002-9839-5391; Corvin, Aiden/0000-0001-6717-4089; Quested, Digby/0000-0001-6155-3336; Ehrenreich, Hannelore/0000-0001-8371-5711; Adolfsson, Rolf/0000-0001-9785-8473; Black, Donald/0000-0001-8038-1971; Goldstein, Jacqueline/0000-0003-1902-6916; murray, robin/0000-0003-0829-0519; Ptackova, Hana/0000-0002-5694-3695; Pers, Tune/0000-0003-0207-4831; Henskens, Frans/0000-0003-2358-5630; Mowry, Bryan/0000-0002-4115-5645; Walters, James/0000-0002-6980-4053; Papiol, Sergi/0000-0001-9366-8728; Pocklington, Andrew/0000-0002-2137-0452; Jonsson, Erik/0000-0001-8368-6332; Andreassen, Ole A./0000-0002-4461-3568; Buxbaum, Joseph/0000-0001-8898-8313; Djurovic, Srdjan/0000-0002-8140-8061; /0000-0002-8114-7615; Gopal, Srihari/0000-0001-5254-2192; Dinan, Timothy/0000-0002-2316-7220; So, Hon-Cheong/0000-0002-7102-833X; Mors, Ole/0000-0002-5660-0393; Oh, Sang-Yun/0000-0002-0364-5109; Perkins, Diana/0000-0001-9396-2206; Bacanu, Silviu-Alin/0000-0002-4364-1583; Moran, Jennifer/0000-0002-5664-4716	US National Institute of Mental Health [U01 MH094421]; MRC [G0800509, G1100583, G0801418, G1000718, G0901310, G0601635] Funding Source: UKRI; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [G0800509, MR/L010305/1, G0801418, 1247950, G0601635, G1100583, G0901310, G1000718] Funding Source: researchfish; National Institute for Health Research [PDA/02/06/016] Funding Source: researchfish; Chief Scientist Office [SCD/12] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH096296, R01MH077139, R01MH100141, T32MH020030, R01MH040799, K99MH101367, U01MH094432, U01MH094421] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002395, I01BX001356] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	Core funding for the Psychiatric Genomics Consortium is from the US National Institute of Mental Health (U01 MH094421). We thank T. Lehner (NIMH). The work of the contributing groups was supported by numerous grants from governmental and charitable bodies as well as philanthropic donation. Details are provided in the Supplementary Notes. Membership of the Wellcome Trust Case Control Consortium and of the Psychosis Endophenotype International Consortium are provided in the Supplementary Notes.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], PREPRINT; [Anonymous], 2012, NATURE GENET; Begum F, 2012, NUCLEIC ACIDS RES, V40, P3777, DOI 10.1093/nar/gkr1255; Benros ME, 2012, ANN NY ACAD SCI, V1262, P56, DOI 10.1111/j.1749-6632.2012.06638.x; CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140; Cichon S, 2009, MOL PSYCHIATR, V14, P10, DOI 10.1038/mp.2008.126; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Knapp M, 2004, SCHIZOPHRENIA BULL, V30, P279, DOI 10.1093/oxfordjournals.schbul.a007078; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Lee SH, 2012, GENET EPIDEMIOL, V36, P214, DOI 10.1002/gepi.21614; Lencz T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3739; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lichtenstein P, 2006, PSYCHOL MED, V36, P1417, DOI 10.1017/S0033291706008385; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lips ES, 2012, MOL PSYCHIATR, V17, P996, DOI 10.1038/mp.2011.117; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Richards AL, 2012, MOL PSYCHIATR, V17, P193, DOI 10.1038/mp.2011.11; Rietschel M, 2012, MOL PSYCHIATR, V17, P906, DOI 10.1038/mp.2011.80; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2011, HUM MOL GENET, V20, P4076, DOI 10.1093/hmg/ddr325; Strange A, 2012, BIOL PSYCHIAT, V72, P620, DOI 10.1016/j.biopsych.2012.05.035; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; VANROSSUM JM, 1966, ARCH INT PHARMACOD T, V160, P492; World Health Organization, 2008, The global burden of disease: 2004 update; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979	50	4866	4926	42	902	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					421	+		10.1038/nature13595	http://dx.doi.org/10.1038/nature13595			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25056061	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-28	WOS:000339335700037
J	Sulkowski, MS; Naggie, S; Lalezari, J; Fessel, WJ; Mounzer, K; Shuhart, M; Luetkemeyer, AF; Asmuth, D; Gaggar, A; Ni, LY; Svarovskaia, E; Brainard, DM; Symonds, WT; Subramanian, GM; McHutchison, JG; Rodriguez-Torres, M; Dieterich, D				Sulkowski, Mark S.; Naggie, Susanna; Lalezari, Jacob; Fessel, Walford Jeffrey; Mounzer, Karam; Shuhart, Margaret; Luetkemeyer, Anne F.; Asmuth, David; Gaggar, Anuj; Ni, Liyun; Svarovskaia, Evguenia; Brainard, Diana M.; Symonds, William T.; Subramanian, G. Mani; McHutchison, John G.; Rodriguez-Torres, Maribel; Dieterich, Douglas		PHOTON-1 Investigators	Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROTEASE INHIBITORS; GENOTYPE 1; VIRUS; ATAZANAVIR; THERAPY; INFECTION; BILIRUBIN	IMPORTANCE Treatment of hepatitis C virus (HCV) infection in patients also infected with human immunodeficiency virus (HIV) has been limited due to drug interactions with antiretroviral therapies (ARTs) and the need to use interferon. OBJECTIVE To determine the rates of HCV eradication (sustained virologic response [SVR]) and adverse events in patients with HCV-HIV coinfection receiving sofosbuvir and ribavirin treatment. DESIGN, SETTING, AND PARTICIPANTS Open-label, nonrandomized, uncontrolled phase 3 trial conducted at 34 treatment centers in the United States and Puerto Rico (August 2012-November 2013) evaluating treatment with sofosbuvir and ribavirin among patients with HCV genotypes 1, 2, or 3 and concurrent HIV. Patients were required to be receiving ART with HIV RNA values of 50 copies/mL or less and a CD4 T-cell count of more than 200 cells/mu L or to have untreated HIV infection with a CD4 T-cell count of more than 500 cells/mu L. Of the treatment-naive patients, 114 had HCV genotype 1 and 68 had HCV genotype 2 or 3, and 41 treatment experienced participants who had been treated with peginterferon-ribavirin had HCV genotype 2 or 3, for a total of 223 participants. INTERVENTIONS Treatment-naive patients with HCV genotype 2 or 3 received 400 mg of sofosbuvir and weight-based ribavirin for 12 weeks and treatment-naive patients with HCV genotype 1 and treatment-experienced patients with HCV genotype 2 or 3 received the same treatment for 24 weeks. MAIN OUTCOMES AND MEASURES The primary study outcome was the proportion of patients with SVR (serum HCV <25 copies/mL) 12 weeks (SVR12) after cessation of HCV therapy. RESULTS Among treatment-naive participants, 87 patients (76%) of 114(95% Cl, 67%-84%) with genotype 1, 23 patients (88%) of 26 with genotype 2(95% Cl, 70%-985), and 28 patients (67%) of 42 with genotype 3 (95% Cl, 51%-80%) achieved SVR12. Among treatment-experienced participants, 22 patients (92%) of 24 with genotype 2 (95% Cl, 73%-99%) and 16 patients (94%) of 17(95% Cl, 71%-100%) achieved SVR12. The most common adverse events were fatigue, insomnia, headache, and nausea. Seven patients (3%) discontinued HCV treatment due to adverse events. No adverse effect on HIV disease or its treatment was observed. CONCLUSIONS AND RELEVANCE In this open-label, nonrandomized, uncontrolled study, patients with HIV who were coinfected with HCV genotype 1, 2, or 3 who received the oral, interferon-free combination of sofosbuvir and ribavirin for 12 or 24 weeks had high rates of SVR12. Further studies of this oral regimen in diverse populations of coinfected patients are warranted.	[Sulkowski, Mark S.] Johns Hopkins Univ, Viral Hepatitis Ctr, Baltimore, MD 21287 USA; [Naggie, Susanna] Duke Univ, Duke Infect Dis, Durham, NC USA; [Lalezari, Jacob] Quest Clin Res, Clin Res, San Francisco, CA USA; [Fessel, Walford Jeffrey] Kaiser Permanente, Internal Med, San Francisco, CA USA; [Mounzer, Karam] Philadelphia FIGHT, Philadelphia, PA USA; [Shuhart, Margaret] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; [Luetkemeyer, Anne F.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA; [Asmuth, David] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Gaggar, Anuj; Ni, Liyun; Svarovskaia, Evguenia; Brainard, Diana M.; Symonds, William T.; Subramanian, G. Mani; McHutchison, John G.] Gilead Sci Inc, Liver Dis Therapeut Area, Foster City, CA 94404 USA; [Rodriguez-Torres, Maribel] Fdn Invest San Juan, San Juan, PR USA; [Dieterich, Douglas] Mt Sinai Sch Med, Dept Med Liver Dis, New York, NY USA	Johns Hopkins University; Duke University; Kaiser Permanente; Harborview Medical Center; University of Washington; University of Washington Seattle; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California Davis; Gilead Sciences; Icahn School of Medicine at Mount Sinai	Sulkowski, MS (corresponding author), Johns Hopkins Univ, Sch Med, 600 N Wolfe St,1830 Bldg,Room 445, Baltimore, MD 21287 USA.	msulkowski@jhmi.edu		Asmuth, David/0000-0003-0916-7950	Gilead Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007641, K23AI096913] Funding Source: NIH RePORTER	Gilead Sciences(Gilead Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding/Support: This trial was funded by Gilead Sciences.	American Association for the Study of Liver Diseases and the Infectious Diseases Society of America, REC TEST MAN TREAT C; [Anonymous], 2013, PEG PEG ALF 2A INJ S; Hulskotte EGJ, 2013, CLIN INFECT DIS, V56, P718, DOI 10.1093/cid/cis968; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Kirby B, 2012, HEPATOLOGY, V56, p1067A; Lam AM, 2010, ANTIMICROB AGENTS CH, V54, P3187, DOI 10.1128/AAC.00399-10; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Limketkai BN, 2012, JAMA-J AM MED ASSOC, V308, P370, DOI 10.1001/jama.2012.7844; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P1987, DOI 10.1001/jama.2013.281319; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Rodriguez-Novoa S, 2008, AIDS, V22, P2535, DOI 10.1097/QAD.0b013e3283177f38; Rodriguez-Torres M, 2013, INFECTIOUS DIS WEEK; Soriano V, 2010, ANTIVIR RES, V85, P303, DOI 10.1016/j.antiviral.2009.10.021; Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; Sulkowski MS, 2013, J INFECT DIS, V207, pS26, DOI 10.1093/infdis/jis764; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Zhang DL, 2005, DRUG METAB DISPOS, V33, P1729, DOI 10.1124/dmd.105.005447	19	211	218	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					353	361		10.1001/jama.2014.7734	http://dx.doi.org/10.1001/jama.2014.7734			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038354	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000339257800022
J	Gandhi, M; Gandhi, RT				Gandhi, Monica; Gandhi, Rajesh T.			Single-Pill Combination Regimens for Treatment of HIV-1 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NON-INFERIORITY TRIAL; RILPIVIRINE/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE; ANTIRETROVIRAL-NAIVE ADULTS; ONCE-DAILY DOLUTEGRAVIR; CO-FORMULATED ELVITEGRAVIR; BOOSTED PROTEASE INHIBITOR; DOUBLE-BLIND; INITIAL TREATMENT; TABLET REGIMEN; OPEN-LABEL	A 52-year-old man with a history of homelessness, depression, and polysubstance use received a diagnosis of human immunodeficiency virus type 1 (HIV-1) infection in 2005 but has declined antiretroviral therapy (ART) in the past. His CD4+ T-cell count is now 257 per cubic millimeter, and his plasma HIV-1 RNA level is 17,000 copies per milliliter. The patient was prescribed a multipill antiretroviral regimen 2 months ago but has not followed this regimen regularly because "taking out lots of pills in the shelter just announces to the world that I have AIDS [the acquired immunodeficiency syndrome]." The patient desires to keep his HIV status private and states that he would take medications regularly if he could take just "one pill once a day." The patient is not taking any other medications; his renal function is normal. How should he be evaluated and treated?	[Gandhi, Monica] Univ Calif San Francisco, Div HIV AIDS, San Francisco, CA 94110 USA; [Gandhi, Monica] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Gandhi, Rajesh T.] MIT, Ragon Inst MGH, Cambridge, MA 02139 USA; [Gandhi, Rajesh T.] Harvard Univ, Cambridge, MA 02138 USA	University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Gandhi, M (corresponding author), Univ Calif San Francisco, 995 Potrero Ave,4th Fl, San Francisco, CA 94110 USA.	monica.gandhi@ucsf.edu; rgandhi@partners.org			ViiV Healthcare; Abbott Laboratories; Janssen Pharmaceuticals	ViiV Healthcare; Abbott Laboratories(Abbott Laboratories); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Dr. Rajesh Gandhi reports receiving grant support through his institution from ViiV Healthcare, Abbott Laboratories, and Janssen Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Airoldi M, 2010, PATIENT PREFER ADHER, V4, P115; Al-Dakkak I, 2013, AIDS CARE, V25, P400, DOI 10.1080/09540121.2012.712667; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; Antinori A, 2012, J INT AIDS SOC S4, V15, P8098; Applebaum AJ, 2009, AIDS PATIENT CARE ST, V23, P455, DOI 10.1089/apc.2008.0181; Arribas JR, 2014, LANCET INFECT DIS, V14, P581, DOI 10.1016/S1473-3099(14)70782-0; Bangsberg DR, 2013, ANTIVIR THER, V18, P25, DOI 10.3851/IMP2536; Bangsberg DR, 2010, AIDS, V24, P2835, DOI 10.1097/QAD.0b013e328340a209; Bedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192ae; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Byakika-Tusiime J, 2009, AIDS BEHAV, V13, pS82, DOI 10.1007/s10461-009-9546-x; Cahn P, 2014, LANCET, V383, P30; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Castagna A, 2014, J INFECT DIS; Clotet B, 2014, LANCET, V383, P2222, DOI 10.1016/S0140-6736(14)60084-2; Cohen C, 2014, AIDS, V28, P989, DOI 10.1097/QAD.0000000000000169; Cohen CJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003028; Cohen CJ, 2013, AIDS, V27, P939, DOI 10.1097/QAD.0b013e32835cee6e; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohn SE, 2011, AIDS CARE, V23, P775, DOI 10.1080/09540121.2010.525617; Custodio JM, 2014, J CLIN PHARMACOL, V54, P378, DOI 10.1002/jcph.210; DeJesus E, 2012, LANCET, V379, P2429, DOI 10.1016/S0140-6736(12)60918-0; DeJesus E, 2009, JAIDS-J ACQ IMM DEF, V51, P163, DOI 10.1097/QAI.0b013e3181a572cf; Ding X, 2012, JAIDS-J ACQ IMM DEF, V61, P441, DOI 10.1097/QAI.0b013e31826f993c; Earnshaw VA, 2013, AIDS BEHAV, V17, P1785, DOI 10.1007/s10461-013-0437-9; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Engsig F, 2013, 20 C RETR OPP INF AT; Eron JJ, 2011, LANCET INFECT DIS, V11, P895, DOI 10.1016/S1473-3099(11)70286-9; Eron JJ, 2013, J INFECT DIS, V207, P740, DOI 10.1093/infdis/jis750; Ford N, 2012, PEDIATR INFECT DIS J, V31, P999, DOI 10.1097/INF.0b013e31825c36fc; Ford N, 2011, AIDS, V25, P2301, DOI 10.1097/QAD.0b013e32834cdb71; Ford N, 2010, AIDS, V24, P1461, DOI 10.1097/QAD.0b013e32833a2a14; Gallant JE, 2013, J INFECT DIS, V208, P32, DOI 10.1093/infdis/jit122; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; Gardner EM, 2010, AIDS, V24, P395, DOI 10.1097/QAD.0b013e328335cd8a; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hatano H, 2011, J INFECT DIS, V203, P960, DOI 10.1093/infdis/jiq138; Havlir D, 2012, NEW ENGL J MED, V367, P685, DOI 10.1056/NEJMp1207138; Hodder SL, 2010, AIDS PATIENT CARE ST, V24, P87, DOI 10.1089/apc.2009.0259; Horne R, 2007, JAIDS-J ACQ IMM DEF, V45, P334; Kakuda TN, 2014, J CLIN PHARM; Kong MC, 2012, J GEN INTERN MED, V27, P1159, DOI 10.1007/s11606-012-2043-3; Liu HH, 2006, JAIDS-J ACQ IMM DEF, V41, P315, DOI 10.1097/01.qai.0000197071.77482.6e; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; May M., 2014, AIDS; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Nachega JB, 2014, CLIN INFECT DIS, V58, P1297, DOI 10.1093/cid/ciu046; O'Connor JL, 2013, J INFECT DIS, V208, P40, DOI 10.1093/infdis/jis731; OCEBM Levels of Evidence Working Group, 2011, OXF LEV EV 2; Palella FJ, 2014, AIDS, V28, P335, DOI 10.1097/QAD.0000000000000087; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2014, GUIDELINES USE ANTIR; Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, 2014, REC US ANT DRUGS PRE; Phillips EJ, 2006, CLIN INFECT DIS, V43, P103, DOI 10.1086/504878; Post FA, 2010, JAIDS-J ACQ IMM DEF, V55, P49, DOI 10.1097/QAI.0b013e3181dd911e; Pozniak A, 2014, LANCET INFECT DIS, V14, P590, DOI 10.1016/S1473-3099(14)70796-0; Raffi F, 2013, LANCET INFECT DIS, V13, P927, DOI 10.1016/S1473-3099(13)70257-3; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Rao G, 2013, 53 INT C ANT AG CHEM; Rockstroh JK, 2013, JAIDS-J ACQ IMM DEF, V63, P77, DOI 10.1097/QAI.0b013e31828ace69; Sax PE, 2012, LANCET, V380, P730; Sax PE, 2012, LANCET, V379, P2439, DOI 10.1016/S0140-6736(12)60917-9; Sax PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031591; Sax PE, 2011, J INFECT DIS, V204, P1191, DOI 10.1093/infdis/jir505; Sax PE, 2014, J ACQUIR IMMUNE DEFI, V27; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Simoni JM, 2012, JAIDS-J ACQ IMM DEF, V60, P466, DOI 10.1097/QAI.0b013e31825db0bd; Smith KY, 2009, AIDS, V23, P1547, DOI 10.1097/QAD.0b013e32832cbcc2; Sullivan PS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000552; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Walensky RP, 2013, ANN INTERN MED, V158, P84, DOI 10.7326/0003-4819-158-2-201301150-00002; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541; Weller S, 2014, JAIDS-J ACQ IMM DEF, V66, P393, DOI 10.1097/QAI.0000000000000193; Williams I, 2014, HIV MED, V15, P1, DOI 10.1111/hiv.12119; Wohl DA, 2014, JAIDS-J ACQ IMM DEF, V65, pE118, DOI 10.1097/QAI.0000000000000057; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Young J, 2012, AIDS, V26, P567, DOI 10.1097/QAD.0b013e32834f337c; Zolopa A, 2013, JAIDS-J ACQ IMM DEF, V63, P96, DOI 10.1097/QAI.0b013e318289545c; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	82	38	38	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2014	371	3					248	259		10.1056/NEJMct1215532	http://dx.doi.org/10.1056/NEJMct1215532			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL3BK	25014689				2022-12-28	WOS:000338999800008
J	Major, JD; Treharne, RE; Phillips, LJ; Durose, K				Major, J. D.; Treharne, R. E.; Phillips, L. J.; Durose, K.			A low-cost non-toxic post-growth activation step for CdTe solar cells	NATURE			English	Article							BACK-CONTACT; FILM; RECRYSTALLIZATION	Cadmium telluride, CdTe, is now firmly established as the basis for the market-leading thin-film solar-cell technology. With laboratory efficiencies approaching 20 per cent(1), the research and development targets for CdTe are to reduce the cost of power generation further to less than half a US dollar per watt (ref. 2) and to minimize the environmental impact. A central part of the manufacturing process involves doping the polycrystalline thin-film CdTe with CdCl2. This acts to form the photovoltaic junction at the CdTe/CdS interface(3,4) and to passivate the grain boundaries(5), making it essential in achieving high device efficiencies. However, although such doping has been almost ubiquitous since the development of this processing route over 25 years ago(6), CdCl2 has two severe disadvantages; it is both expensive (about 30 cents per gram) and a water-soluble source of toxic cadmium ions, presenting a risk to both operators and the environment during manufacture. Here we demonstrate that solar cells prepared using MgCl2, which is non-toxic and costs less than a cent per gram, have efficiencies (around 13%) identical to those of a CdCl2-processed control group. They have similar hole densities in the active layer (9x10(14)cm(-3)) and comparable impurity profiles for Cl and O, these elements being important p-type dopants for CdTe thin films. Contrary to expectation, CdCl2-processed and MgCl2-processed solar cells contain similar concentrations of Mg; this is because ofMgout-diffusion from the soda-lime glass substrates and is not disadvantageous to device performance. However, treatment with other low-cost chlorides such as NaCl, KCl and MnCl2 leads to the introduction of electrically active impurities that do compromise device performance. Our results demonstrate that CdCl2 may simply be replaced directly with MgCl2 in the existing fabrication process, thus both minimizing the environmental risk and reducing the cost of CdTe solar-cell production.	[Major, J. D.; Treharne, R. E.; Phillips, L. J.; Durose, K.] Univ Liverpool, Sch Phys Sci, Stephenson Inst Renewable Energy, Liverpool L69 7ZF, Merseyside, England; [Major, J. D.; Treharne, R. E.; Phillips, L. J.; Durose, K.] Univ Liverpool, Sch Phys Sci, Dept Phys, Liverpool L69 7ZF, Merseyside, England	University of Liverpool; University of Liverpool	Major, JD (corresponding author), Univ Liverpool, Sch Phys Sci, Stephenson Inst Renewable Energy, Chadwick Bldg, Liverpool L69 7ZF, Merseyside, England.	jon.major@liverpool.ac.uk		Phillips, Laurie/0000-0001-5181-1565; Major, Jonathan/0000-0002-5554-1985	Engineering and Physical Sciences Research Council	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank T. Veal for assistance in manuscript preparation and the Engineering and Physical Sciences Research Council for funding support.	BALAREW C, 1993, PURE APPL CHEM, V65, P213, DOI 10.1351/pac199365020213; Barth KL, 2005, IEEE PHOT SPEC CONF, P323, DOI 10.1109/PVSC.2005.1488134; BASOL BM, 1985, J APPL PHYS, V58, P3803; Batzner DL, 2000, THIN SOLID FILMS, V361, P288, DOI 10.1016/S0040-6090(99)00862-7; Blood P., 1992, ELECT CHARACTERIZATI, P220; Burgelman M, 1999, APPL PHYS A-MATER, V69, P149, DOI 10.1007/s003390050985; Demtsu SH, 2006, THIN SOLID FILMS, V510, P320, DOI 10.1016/j.tsf.2006.01.004; Drayton J., 2013, P 2013 MRS SPRING M, V1538, P269; Edwards PR, 2000, THIN SOLID FILMS, V372, P284, DOI 10.1016/S0040-6090(00)00963-9; Fahrenbruch AL, 2007, MATER RES SOC SYMP P, V1012, P283; Fthenakis VM, 2007, THIN SOLID FILMS, V515, P5961, DOI 10.1016/j.tsf.2006.12.138; Green MA, 2015, PROG PHOTOVOLTAICS, V23, P1, DOI 10.1002/pip.2573; Hsiao KJ, 2012, PROG PHOTOVOLTAICS, V20, P486, DOI 10.1002/pip.1143; Kobyakov P. S., 2012, 2012 IEEE 38th Photovoltaic Specialists Conference (PVSC), P000160, DOI 10.1109/PVSC.2012.6317591; Kosyachenko L, 2014, SOL ENERG MAT SOL C, V120, P512, DOI 10.1016/j.solmat.2013.09.032; Li JV, 2012, SOL ENERG MAT SOL C, V100, P126, DOI 10.1016/j.solmat.2012.01.003; Liu ZS, 2008, J FOOD PROCESS PRES, V32, P39, DOI 10.1111/j.1745-4549.2007.00163.x; Major JD, 2013, PROG PHOTOVOLTAICS, V21, P436, DOI 10.1002/pip.1196; Mazzamuto S, 2008, THIN SOLID FILMS, V516, P7079, DOI 10.1016/j.tsf.2007.12.124; McCandless BE, 1997, PROG PHOTOVOLTAICS, V5, P249, DOI 10.1002/(SICI)1099-159X(199707/08)5:4<249::AID-PIP178>3.0.CO;2-S; Moutinho HR, 1997, IEEE PHOT SPEC CONF, P431, DOI 10.1109/PVSC.1997.654120; Proskuryakov YY, 2009, SOL ENERG MAT SOL C, V93, P1572, DOI 10.1016/j.solmat.2009.04.010; Tyan Y.-S., 1984, Conference Record of the Seventeenth IEEE Photovoltaic Specialists Conference - 1984 (Cat. No. 84CH2019-8), P840; Waters D., 1995, P 2 WORLD C EXH PHOT, P1031; Wu X, 2004, PHYS STATUS SOLIDI C, V1, P1062, DOI 10.1002/pssc.200304217; Zweibel K, 2010, SCIENCE, V328, P699, DOI 10.1126/science.1189690	26	211	215	6	263	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					334	+		10.1038/nature13435	http://dx.doi.org/10.1038/nature13435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030171				2022-12-28	WOS:000338992200032
J	Gottenberg, JE; Ravaud, P; Puechal, X; Le Guern, V; Sibilia, J; Goeb, V; Larroche, C; Dubost, JJ; Rist, S; Saraux, A; Devauchelle-Pensec, V; Morel, J; Hayem, G; Hatron, P; Perdriger, A; Sene, D; Zarnitsky, C; Batouche, D; Furlan, V; Benessiano, J; Perrodeau, E; Seror, R; Mariette, X				Gottenberg, Jacques-Eric; Ravaud, Philippe; Puechal, Xavier; Le Guern, Veronique; Sibilia, Jean; Goeb, Vincent; Larroche, Claire; Dubost, Jean-Jacques; Rist, Stephanie; Saraux, Alain; Devauchelle-Pensec, Valerie; Morel, Jacques; Hayem, Gilles; Hatron, Pierre; Perdriger, Aleth; Sene, Damien; Zarnitsky, Charles; Batouche, Djilali; Furlan, Valerie; Benessiano, Joelle; Perrodeau, Elodie; Seror, Raphaele; Mariette, Xavier			Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjogren Syndrome The JOQUER Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RITUXIMAB TREATMENT; INFLIXIMAB; BLOOD	IMPORTANCE Primary Sjogren syndrome is a systemic autoimmune disease characterized by mouth and eye dryness, pain, and fatigue. Hydroxychloroquine is the most frequently prescribed immunosuppressant for the syndrome. However, evidence regarding its efficacy is limited. OBJECTIVE To evaluate the efficacy of hydroxychloroquine for the main symptoms of primary Sjogren syndrome: dryness, pain, and fatigue. DESIGN, SETTING, AND PARTICIPANTS From April 2008 to May 2011, 120 patients with primary Sjogren syndrome according to American-European Consensus Group Criteria from 15 university hospitals in France were randomized in a double-blind, parallel-group, placebo-controlled trial. Participants were assessed at baseline, week 12, week 24 (primary outcome), and week 48. The last follow-up date for the last patient was May 15, 2012. INTERVENTIONS Patients were randomized (1: 1) to receive hydroxychloroquine (400mg/d) or placebo until week 24. All patients were prescribed hydroxychloroquine between weeks 24 and 48. MAIN OUTCOMES AND MEASURES The primary end point was the proportion of patients with a 30% or greater reduction between weeks 0 and 24 in scores on 2 of 3 numeric analog scales (from 0 [best] to 10 [worst]) evaluating dryness, pain, and fatigue. RESULTS At 24 weeks, the proportion of patients meeting the primary end point was 17.9% (10/56) in the hydroxychloroquine group and 17.2%(11/64) in the placebo group (odds ratio, 1.01; 95% CI, 0.37-2.78; P = .98). Between weeks 0 and 24, the mean (SD) numeric analog scale score for dryness changed from 6.38 (2.14) to 5.85 (2.57) in the placebo group and 6.53 (1.97) to 6.22 (1.87) in the hydroxychloroquine group. The mean (SD) numeric analog scale score for pain changed from 4.92 (2.94) to 5.08 (2.48) in the placebo group and 5.09 (3.06) to 4.59 (2.90) in the hydroxychloroquine group. The mean (SD) numeric analog scale for fatigue changed from 6.26 (2.27) to 5.72 (2.38) in the placebo group and 6.00 (2.52) to 5.94 (2.40) in the hydroxychloroquine group. All but 1 patient in the hydroxychloroquine group had detectable blood levels of the drug. Hydroxychloroquine had no efficacy in patients with anti-SSA autoantibodies, high IgG levels, or systemic involvement. During the first 24 weeks, there were 2 serious adverse events in the hydroxychloroquine group and 3 in the placebo group; in the last 24 weeks, there were 3 serious adverse events in the hydroxychloroquine group and 4 in the placebo group. CONCLUSIONS AND RELEVANCE Among patients with primary Sjogren syndrome, the use of hydroxychloroquine compared with placebo did not improve symptoms during 24 weeks of treatment. Further studies are needed to evaluate longer-term outcomes. Copyright 2014 American Medical Association. All rights reserved.	[Gottenberg, Jacques-Eric; Sibilia, Jean] Univ Strasbourg, Hop Univ Strasbourg, Serv Rhumatol,Dept Rheumatol, Ctr Reference Natl Malad Autoimmunes Syst Rares, F-67000 Strasbourg, France; [Ravaud, Philippe; Perrodeau, Elodie] Hop Hotel Dieu, AP HP, Dept Epidemiol & Publ Hlth, Paris, France; [Puechal, Xavier; Le Guern, Veronique] Cochin Hosp, AP HP, Dept Internal Med, Paris, France; [Goeb, Vincent] Amiens Univ Hosp, Dept Rheumatol, Amiens, France; [Larroche, Claire] Avicenne Hosp, AP HP, Dept Internal Med, Bobigny, France; [Dubost, Jean-Jacques] Clermont Ferrand Univ Hosp, Dept Rheumatol, Clermont Ferrand, France; [Rist, Stephanie] Orlaans Hosp, Dept Rheumatol, Orleans, France; [Saraux, Alain; Devauchelle-Pensec, Valerie] Brest Univ Hosp, Dept Rheumatol, Brest, France; [Morel, Jacques] Montpellier Univ Hosp, Dept Rheumatol, Montpellier, France; [Hayem, Gilles] Hop Bichat Claude Bernard, AP HP, Dept Rheumatol, F-75877 Paris, France; [Hatron, Pierre] Lille Univ Hosp, Dept Internal Med, Lille, France; [Perdriger, Aleth] Rennes Univ Hosp, Dept Rheumatol, Rennes, France; [Sene, Damien] Lariboisee Hosp, AP HP, Dept Internal Med, Paris, France; [Zarnitsky, Charles] Le Havre Hosp, Dept Rheumatol, Le Havre, France; [Batouche, Djilali; Seror, Raphaele; Mariette, Xavier] Univ Paris 11, Hop Univ Paris Sud, AP HP, INSERM,Dept Rheumatol,U1012, Le Kremlin Bicetre, France; [Furlan, Valerie] Hop Univ Paris Sud, AP HP, Dept Pharm, Le Kremlin Bicetre, France; [Benessiano, Joelle] Hop Xavier Bichat, AP HP, Dept Ctr Ressources Biol, Paris, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; CHU Clermont Ferrand; Centre Hospitalier Regional d'Orleans; CHU Brest; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; CHU Rennes; Universite de Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Gottenberg, JE (corresponding author), Univ Strasbourg, Hop Univ Strasbourg, Serv Rhumatol, Ctr Reference Natl Malad Autoimmunes Syst Rares, 1 Ave Moliere, F-67000 Strasbourg, France.	jacques-eric.gottenberg@chru-strasbourg.fr; xavier.mariette@bct.aphp.fr	ravaud, philippe/C-1694-2009; sene, damien/R-3970-2017; Puéchal, Xavier/P-1555-2017; SEROR, Raphaele/E-2283-2017	sene, damien/0000-0001-8640-4580; Puéchal, Xavier/0000-0003-3573-9203; SEROR, Raphaele/0000-0002-5523-1856; Ravaud, Philippe/0000-0001-8264-9206; Sibilia, Jean/0000-0002-1601-4795; Goeb, Vincent/0000-0002-3807-545X	Assistance Publique-Hopitaux de Paris; French Ministry of Research (Programme Hospitalier de Recherche Clinique National) [2007 P070125]	Assistance Publique-Hopitaux de Paris; French Ministry of Research (Programme Hospitalier de Recherche Clinique National)	The study was sponsored by Assistance Publique-Hopitaux de Paris, with a grant from the French Ministry of Research (Programme Hospitalier de Recherche Clinique National 2007 P070125). sanofi-aventis provided hydroxychloroquine and placebo.	Bijlsma JWJ, 2012, SJOGRENS SYNDROME LY, P594; Bowman SJ, 2009, RHEUMATOLOGY, V48, P140, DOI 10.1093/rheumatology/ken426; Costedoat-Chalumeau N, 2007, ANN RHEUM DIS, V66, P821, DOI 10.1136/ard.2006.067835; Devauchelle-Pensec V, 2007, ARTHRIT RHEUM-ARTHR, V57, P310, DOI 10.1002/art.22536; Devauchelle-Pensec V, 2014, ANN INTERN MED, V160, P233, DOI 10.7326/M13-1085; ESDAILE J, 1991, NEW ENGL J MED, V324, P150; Fox RI, 1996, LUPUS, V5, pS31, DOI 10.1177/096120339600500108; FOX RI, 1988, AM J MED, V85, P62, DOI 10.1016/0002-9343(88)90365-8; Garcia-Carrasco M, 2002, MEDICINE, V81, P270, DOI 10.1097/00005792-200207000-00003; Gottenberg JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059868; Gottenberg JE, 2013, ANN RHEUM DIS, V72, P1026, DOI 10.1136/annrheumdis-2012-202293; KRUIZE AA, 1993, ANN RHEUM DIS, V52, P360, DOI 10.1136/ard.52.5.360; Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702; Mariette X, 2004, ARTHRITIS RHEUM, V50, P1270, DOI 10.1002/art.20146; Mariette X, 2015, ANN RHEUM DIS, V74, P526, DOI 10.1136/annrheumdis-2013-203991; Mariette X, 2010, CURR OPIN RHEUMATOL, V22, P471, DOI 10.1097/BOR.0b013e32833c36c5; Meijer JM, 2010, ARTHRITIS RHEUM-US, V62, P960, DOI 10.1002/art.27314; Olsen NJ, 2013, SEMIN ARTHRITIS RHEU, V43, P264, DOI 10.1016/j.semarthrit.2013.01.001; Pijpe J, 2005, ARTHRITIS RHEUM-US, V52, P2740, DOI 10.1002/art.21260; Ramos-Casals M, 2012, BMJ-BRIT MED J, V344, DOI [10.1136/bmj.e3821, 10.1024/1661-8157/a001133]; Ramos-Casals M, 2012, NAT REV RHEUMATOL, V8, P399, DOI 10.1038/nrrheum.2012.53; Ramos-Casals M, 2010, JAMA-J AM MED ASSOC, V304, P452, DOI 10.1001/jama.2010.1014; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; TETT SE, 1985, J CHROMATOGR, V344, P241, DOI 10.1016/S0378-4347(00)82024-1; Tishler M, 1999, ANN RHEUM DIS, V58, P253, DOI 10.1136/ard.58.4.253; Tubach F, 2007, J RHEUMATOL, V34, P1188; van Vollenhoven RF, 2009, LANCET, V374, P459, DOI 10.1016/S0140-6736(09)60944-2; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	29	180	191	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					249	258		10.1001/jama.2014.7682	http://dx.doi.org/10.1001/jama.2014.7682			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	25027140	Bronze			2022-12-28	WOS:000338940300022
J	Joseph, SB; Swanstrom, R				Joseph, Sarah B.; Swanstrom, Ronald			A fitness bottleneck in HIV-1 transmission	SCIENCE			English	Editorial Material							CCR5 UTILIZATION; INFECTION		[Joseph, Sarah B.; Swanstrom, Ronald] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Swanstrom, Ronald] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Swanstrom, Ronald] Univ N Carolina, UNC Ctr AIDS Res, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Joseph, SB (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	sbjoseph@email.unc.edu; ron_swanstrom@med.unc.edu						Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Carlson JM, 2014, SCIENCE, V345, DOI 10.1126/science.1254031; Fenton-May AE, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-146; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Isaacman-Beck J, 2009, J VIROL, V83, P8208, DOI 10.1128/JVI.00296-09; Joseph SB, 2014, J VIROL, V88, P1858, DOI 10.1128/JVI.02477-13; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Parrish NF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002686; Ping LH, 2013, J VIROL, V87, P7218, DOI 10.1128/JVI.03577-12; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10	12	10	10	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					136	137		10.1126/science.1257425	http://dx.doi.org/10.1126/science.1257425			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013044				2022-12-28	WOS:000339409900019
J	Dolgin, E				Dolgin, Elie			TECHNOLOGY Dressed to detect	NATURE			English	Editorial Material																		Poh MZ, 2012, NEUROLOGY, V78, P1868, DOI 10.1212/WNL.0b013e318258f7f1; Poh MZ, 2012, EPILEPSIA, V53, pe93, DOI 10.1111/j.1528-1167.2012.03444.x	2	16	16	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S16	S17		10.1038/511S16a	http://dx.doi.org/10.1038/511S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25019131	Bronze			2022-12-28	WOS:000338649800008
J	Holmes, MV; Dale, CE; Zuccolo, L; Silverwood, RJ; Guo, Y; Ye, Z; Prieto-Merino, D; Dehghan, A; Trompet, S; Wong, A; Cavadino, A; Drogan, D; Padmanabhan, S; Li, S; Yesupriya, A; Leusink, M; Sundstrom, J; Hubacek, JA; Pikhart, H; Swerdlow, DI; Panayiotou, AG; Borinskaya, SA; Finan, C; Shah, S; Kuchenbaecker, KB; Shah, T; Engmann, J; Folkersen, L; Eriksson, P; Ricceri, F; Melander, O; Sacerdote, C; Gamble, DM; Rayaprolu, S; Ross, OA; McLachlan, S; Vikhireva, O; Sluijs, I; Scott, RA; Adamkova, V; Flicker, L; Van Bockxmeer, FM; Power, C; Marques-Vidal, P; Meade, T; Marmot, MG; Ferro, JM; Paulos-Pinheiro, S; Humphries, SE; Talmud, PJ; Leach, IM; Verweij, N; Linneberg, A; Skaaby, T; Doevendans, PA; Cramer, MJ; Van der Harst, P; Klungel, OH; Dowling, NF; Dominiczak, AF; Kumari, M; Nicolaides, AN; Weikert, C; Boeing, H; Ebrahim, S; Gaunt, TR; Price, JF; Lannfelt, L; Peasey, A; Kubinova, R; Pajak, A; Malyutina, S; Voevoda, MI; Tamosiunas, A; Maitland-van der Zee, AH; Norman, PE; Hankey, GJ; Bergmann, MM; Hofman, A; Franco, OH; Cooper, J; Palmen, J; Spiering, W; de Jong, PA; Kuh, D; Hardy, R; Uitterlinden, AG; Ikram, MA; Ford, I; Hyppoenen, E; Almeida, OP; Wareham, NJ; Khaw, KT; Hamsten, A; Husemoen, LLN; Tjonneland, A; Tolstrup, JS; Rimm, E; Beulens, JWJ; Verschuren, WMM; Onland-Moret, NC; Hofker, MH; Wannamethee, SG; Whincup, PH; Morris, R; Vicente, AM; Watkins, H; Farrall, M; Jukema, JW; Meschia, J; Cupples, LA; Sharp, SJ; Fornage, M; Kooperberg, C; LaCroix, AZ; Dai, JY; Lanktree, MB; Siscovick, DS; Jorgenson, E; Spring, B; Coresh, J; Li, YR; Buxbaum, SG; Schreiner, PJ; Ellison, RC; Tsai, MY; Patel, SR; Redline, S; Johnson, AD; Hoogeveen, RC; Rotter, JI; Boerwinkle, E; de Bakker, PIW; Kivimaki, M; Asselbergs, FW; Sattar, N; Lawlor, DA; Whittaker, J; Smith, GD; Mukamal, K; Psaty, BM; Wilson, JG; Lange, LA; Hamidovic, A; Hingorani, AD; Nordestgaard, BG; Bobak, M; Leon, DA; Langenberg, C; Palmer, TM; Reiner, AP; Keating, BJ; Dudbridge, F; Casas, JP				Holmes, Michael V.; Dale, Caroline E.; Zuccolo, Luisa; Silverwood, Richard J.; Guo, Yiran; Ye, Zheng; Prieto-Merino, David; Dehghan, Abbas; Trompet, Stella; Wong, Andrew; Cavadino, Alana; Drogan, Dagmar; Padmanabhan, Sandosh; Li, Shanshan; Yesupriya, Ajay; Leusink, Maarten; Sundstrom, Johan; Hubacek, Jaroslav A.; Pikhart, Hynek; Swerdlow, Daniel I.; Panayiotou, Andrie G.; Borinskaya, Svetlana A.; Finan, Chris; Shah, Sonia; Kuchenbaecker, Karoline B.; Shah, Tina; Engmann, Jorgen; Folkersen, Lasse; Eriksson, Per; Ricceri, Fulvio; Melander, Olle; Sacerdote, Carlotta; Gamble, Dale M.; Rayaprolu, Sruti; Ross, Owen A.; McLachlan, Stela; Vikhireva, Olga; Sluijs, Ivonne; Scott, Robert A.; Adamkova, Vera; Flicker, Leon; Van Bockxmeer, Frank M.; Power, Christine; Marques-Vidal, Pedro; Meade, Tom; Marmot, Michael G.; Ferro, Jose M.; Paulos-Pinheiro, Sofia; Humphries, Steve E.; Talmud, Philippa J.; Leach, Irene Mateo; Verweij, Niek; Linneberg, Allan; Skaaby, Tea; Doevendans, Pieter A.; Cramer, Maarten J.; Van der Harst, Pim; Klungel, Olaf H.; Dowling, Nicole F.; Dominiczak, Anna F.; Kumari, Meena; Nicolaides, Andrew N.; Weikert, Cornelia; Boeing, Heiner; Ebrahim, Shah; Gaunt, Tom R.; Price, Jackie F.; Lannfelt, Lars; Peasey, Anne; Kubinova, Ruzena; Pajak, Andrzej; Malyutina, Sofia; Voevoda, Mikhail I.; Tamosiunas, Abdonas; Maitland-van der Zee, Anke H.; Norman, Paul E.; Hankey, Graeme J.; Bergmann, Manuela M.; Hofman, Albert; Franco, Oscar H.; Cooper, Jackie; Palmen, Jutta; Spiering, Wilko; de Jong, Pim A.; Kuh, Diana; Hardy, Rebecca; Uitterlinden, Andre G.; Ikram, M. Arfan; Ford, Ian; Hyppoenen, Elina; Almeida, Osvaldo P.; Wareham, Nicholas J.; Khaw, Kay-Tee; Hamsten, Anders; Husemoen, Lise Lotte N.; Tjonneland, Anne; Tolstrup, Janne S.; Rimm, Eric; Beulens, Joline W. J.; Verschuren, W. M. Monique; Onland-Moret, N. Charlotte; Hofker, Marten H.; Wannamethee, S. Goya; Whincup, Peter H.; Morris, Richard; Vicente, Astrid M.; Watkins, Hugh; Farrall, Martin; Jukema, J. Wouter; Meschia, James; Cupples, L. Adrienne; Sharp, Stephen J.; Fornage, Myriam; Kooperberg, Charles; LaCroix, Andrea Z.; Dai, James Y.; Lanktree, Matthew B.; Siscovick, David S.; Jorgenson, Eric; Spring, Bonnie; Coresh, Josef; Li, Yun R.; Buxbaum, Sarah G.; Schreiner, Pamela J.; Ellison, R. Curtis; Tsai, Michael Y.; Patel, Sanjay R.; Redline, Susan; Johnson, Andrew D.; Hoogeveen, Ron C.; Rotter, Jerome I.; Boerwinkle, Eric; de Bakker, Paul I. W.; Kivimaki, Mika; Asselbergs, Folkert W.; Sattar, Naveed; Lawlor, Debbie A.; Whittaker, John; Smith, George Davey; Mukamal, Kenneth; Psaty, Bruce M.; Wilson, James G.; Lange, Leslie A.; Hamidovic, Ajna; Hingorani, Aroon D.; Nordestgaard, Borge G.; Bobak, Martin; Leon, David A.; Langenberg, Claudia; Palmer, Tom M.; Reiner, Alex P.; Keating, Brendan J.; Dudbridge, Frank; Casas, Juan P.		IMPROVE Study Grp; InterAct Consortium	Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; CONSUMPTION; HEALTH; DEHYDROGENASE; DEPENDENCE; MORTALITY; DESIGN; BURDEN; COHORT	Objective To use the rs1229984 variant in the alcohol dehydrogenase 1B gene (ADH1B) as an instrument to investigate the causal role of alcohol in cardiovascular disease. Design Mendelian randomisation meta-analysis of 56 epidemiological studies. Participants 261 991 individuals of European descent, including 20 259 coronary heart disease cases and 10 164 stroke events. Data were available on ADH1B rs1229984 variant, alcohol phenotypes, and cardiovascular biomarkers. Main outcome measures Odds ratio for coronary heart disease and stroke associated with the ADH1B variant in all individuals and by categories of alcohol consumption. Results Carriers of the A-allele of ADH1B rs1229984 consumed 17.2% fewer units of alcohol per week (95% confidence interval 15.6% to 18.9%), had a lower prevalence of binge drinking (odds ratio 0.78 (95% CI 0.73 to 0.84)), and had higher abstention (odds ratio 1.27 (1.21 to 1.34)) than non-carriers. Rs1229984 A-allele carriers had lower systolic blood pressure (-0.88 (-1.19 to -0.56) mm Hg), interleukin-6 levels (-5.2% (-7.8 to -2.4%)), waist circumference (-0.3 (-0.6 to -0.1) cm), and body mass index (-0.17 (-0.24 to -0.10) kg/m(2)). Rs1229984 A-allele carriers had lower odds of coronary heart disease (odds ratio 0.90 (0.84 to 0.96)). The protective association of the ADH1B rs1229984 A-allele variant remained the same across all categories of alcohol consumption (P= 0.83 for heterogeneity). Although no association of rs1229984 was identified with the combined subtypes of stroke, carriers of the A-allele had lower odds of ischaemic stroke (odds ratio 0.83 (0.72 to 0.95)). Conclusions Individuals with a genetic variant associated with non-drinking and lower alcohol consumption had a more favourable cardiovascular profile and a reduced risk of coronary heart disease than those without the genetic variant. This suggests that reduction of alcohol consumption, even for light to moderate drinkers, is beneficial for cardiovascular health.	[Holmes, Michael V.; Swerdlow, Daniel I.; Finan, Chris; Shah, Tina; Engmann, Jorgen; Kumari, Meena; Hingorani, Aroon D.; Casas, Juan P.] UCL, Dept Epidemiol & Publ Hlth, Inst Cardiovasc Sci, Genet Epidemiol Grp, London WC1E 6BT, England; [Holmes, Michael V.; Keating, Brendan J.] Univ Penn, Perelman Sch Med, Penn Transplant Inst, Dept Surg, Philadelphia, PA 19104 USA; [Holmes, Michael V.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Dale, Caroline E.; Silverwood, Richard J.; Prieto-Merino, David; Meade, Tom; Ebrahim, Shah; Whittaker, John; Leon, David A.; Dudbridge, Frank; Casas, Juan P.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, London WC1E 7HT, England; [Zuccolo, Luisa; Gaunt, Tom R.; Lawlor, Debbie A.; Smith, George Davey] Univ Bristol, MRC Integrat Epidemiol Unit IEU, Bristol BS8 2BN, Avon, England; [Silverwood, Richard J.] Univ London London Sch Hyg & Trop Med, Ctr Stat Methodol, London WC1E 7HT, England; [Guo, Yiran; Li, Yun R.; Keating, Brendan J.] Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Guo, Yiran] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Ye, Zheng; Scott, Robert A.; Wareham, Nicholas J.; Sharp, Stephen J.; Langenberg, Claudia] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Dehghan, Abbas; Hofman, Albert; Uitterlinden, Andre G.; Ikram, M. Arfan] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RA Leiden, Netherlands; [Wong, Andrew; Kuh, Diana; Hardy, Rebecca] UCL, MRC Unit Lifelong Hlth & Ageing, London, England; [Cavadino, Alana; Power, Christine; Hyppoenen, Elina] UCL Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; [Drogan, Dagmar; Weikert, Cornelia; Boeing, Heiner; Bergmann, Manuela M.] German Inst Human Nutr Potsdam Rehbrucke, D-14558 Nuthetal, Germany; [Padmanabhan, Sandosh; Dominiczak, Anna F.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland; [Li, Shanshan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Yesupriya, Ajay; Dowling, Nicole F.] Ctr Dis Control & Prevent, Off Epidemiol Surveillance & Lab Serv, Off Publ Hlth Genom, Atlanta, GA 30333 USA; [Leusink, Maarten; Klungel, Olaf H.; Maitland-van der Zee, Anke H.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Sundstrom, Johan] Uppsala Univ, Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden; [Hubacek, Jaroslav A.] Inst Clin & Expt Med, Ctr Med Expt, Prague 14021 4, Czech Republic; [Pikhart, Hynek; Vikhireva, Olga; Peasey, Anne; Kivimaki, Mika; Bobak, Martin] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Panayiotou, Andrie G.] Cyprus Univ Technol, Cyprus Int Inst Environm & Publ Hlth Assoc Harvar, CY-3603 Limassol, Cyprus; [Borinskaya, Svetlana A.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Shah, Sonia] UCL Genet Inst, Dept Genet Environm & Evolut, London WC1E 6BT, England; [Kuchenbaecker, Karoline B.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Folkersen, Lasse; Eriksson, Per; Hamsten, Anders] Karolinska Inst, Dept Med, Ctr Mol Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Ricceri, Fulvio; Sacerdote, Carlotta] San Giovanni Battista Hosp, Unit Canc Epidemiol, I-10129 Turin, Italy; [Ricceri, Fulvio; Sacerdote, Carlotta] Ctr Canc Prevent CPO Piemonte, I-10129 Turin, Italy; [Gamble, Dale M.; Meschia, James] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Rayaprolu, Sruti; Ross, Owen A.] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL USA; [McLachlan, Stela; Price, Jackie F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Sluijs, Ivonne; Beulens, Joline W. J.; Onland-Moret, N. Charlotte; de Bakker, Paul I. W.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Adamkova, Vera] Inst Clin & Expt Med, Dept Prevent Cardiol, Prague 14021 4, Czech Republic; [Flicker, Leon; Almeida, Osvaldo P.] Univ Western Australia, Med Res Ctr, Western Australian Ctr Hlth & Ageing, Perth, WA 6009, Australia; [Van Bockxmeer, Frank M.] Royal Perth Hosp, Dept Clin Biochem, Perth, WA, Australia; [Van Bockxmeer, Frank M.] Univ Western Australia, Sch Surg, Nedlands, WA 6009, Australia; [Marques-Vidal, Pedro] CHU Vaudois, Dept Internal Med, Lausanne, Switzerland; [Marmot, Michael G.] UCL Inst Hlth Equ, Dept Epidemiol & Publ Hlth, London WC1E 7HB, England; [Ferro, Jose M.] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Ferro, Jose M.] Hosp Santa Maria, Serv Neurol, P-1649035 Lisbon, Portugal; [Paulos-Pinheiro, Sofia; Vicente, Astrid M.] Inst Nacl Saude Doutor Ricardo Jorge, P-1649016 Lisbon, Portugal; [Paulos-Pinheiro, Sofia] Univ Lisbon, Fac Ciencias, P-1749016 Lisbon, Portugal; [Talmud, Philippa J.; Palmen, Jutta] UCL, Inst Cardiovasc Sci, Ctr Cardiovascular Genet, London, England; [Leach, Irene Mateo; Verweij, Niek; Van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9713 AV Groningen, Netherlands; [Linneberg, Allan; Skaaby, Tea; Husemoen, Lise Lotte N.] Glostrup Univ Hosp, Capital Region Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Doevendans, Pieter A.; Cramer, Maarten J.; Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [Van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Van der Harst, Pim; Asselbergs, Folkert W.] ICIN Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands; [Nicolaides, Andrew N.] Ayios Dometios, Vasc Screening & Diagnost Ctr, Nicosia, Cyprus; [Nicolaides, Andrew N.] Univ London Imperial Coll Sci Technol & Med, Dept Vasc Surg, London SW7 2BX, England; [Nicolaides, Andrew N.] Cyprus Cardiovasc Dis Educ & Res Trust, Nicosia, Cyprus; [Lannfelt, Lars] Uppsala Univ, Univ Uppsala Hosp, Dept Publ Hlth & Caring Sci, SE-75185 Uppsala, Sweden; [Kubinova, Ruzena] Natl Inst Publ Hlth, Ctr Hlth Monitoring, Prague 10042, Czech Republic; [Pajak, Andrzej] Jagiellonian Univ, Coll Med, Inst Publ Hlth, Dept Epidemiol & Populat Studies, PL-31531 Krakow, Poland; [Malyutina, Sofia; Voevoda, Mikhail I.] Russian Acad Med Sci, Siberian Branch, Inst Internal & Preventat Med, Novosibirsk 630089, Russia; [Malyutina, Sofia] Novosibirsk State Med Univ, Dept Internal Med, Novosibirsk 630091, Russia; [Voevoda, Mikhail I.] Novosibirsk State Univ, Fac Med, Novosibirsk 630090, Russia; [Tamosiunas, Abdonas] Lithuanian Univ Hlth Sci, Inst Cardiol, Dept Populat Studies, LT-50161 Kaunas, Lithuania; [Norman, Paul E.] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia; [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Cooper, Jackie] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London WC1E 6JF, England; [Spiering, Wilko] Univ Med Ctr Utrecht, Dept Vasc Med, Utrecht, Netherlands; [de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Hyppoenen, Elina] Univ S Australia, Sch Populat Hlth, Adelaide, SA 5000, Australia; [Hyppoenen, Elina] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5000, Australia; [Hyppoenen, Elina] South Australian Hlth & Med Res Inst, Adelaide, SA 5000, Australia; [Almeida, Osvaldo P.] Univ Western Australia, Sch Psychiat & Clin Neurosci M573, Perth, WA 6009, Australia; [Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA 6001, Australia; [Khaw, Kay-Tee] Univ Cambridge, Dept Primary Care & Publ Hlth & Primary C, Cambridge, England; [Hamsten, Anders] Karolinska Univ Hosp Solna, Ctr Mol Med, Stockholm, Sweden; [Tjonneland, Anne] Danish Canc Soc, Copenhagen, Denmark; [Tolstrup, Janne S.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Rimm, Eric] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rimm, Eric] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Rimm, Eric] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Rimm, Eric] Harvard Univ, Sch Med, Boston, MA USA; [Verschuren, W. M. Monique] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Hofker, Marten H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Med Biol Div, NL-9713 AV Groningen, Netherlands; [Hofker, Marten H.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Wannamethee, S. Goya; Morris, Richard] UCL, Dept Primary Care & Populat Hlth, London, England; [Whincup, Peter H.] Univ London, Populat Hlth Res Inst, London, England; [Vicente, Astrid M.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Vicente, Astrid M.] FCUL, Biofig Ctr Biodivers Funct & Integrat Genom, P-1749016 Lisbon, Portugal; [Watkins, Hugh; Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Watkins, Hugh; Farrall, Martin] Univ Oxford, Dept Cardiovasc Med, Oxford, England; [Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Johnson, Andrew D.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Kooperberg, Charles; LaCroix, Andrea Z.; Dai, James Y.; Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Lanktree, Matthew B.] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada; [Siscovick, David S.] New York Acad Med, New York, NY 10021 USA; [Jorgenson, Eric] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Spring, Bonnie] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Coresh, Josef] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Jackson State Univ, Sch Hlth Sci, Jackson, MS USA; [Schreiner, Pamela J.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Ellison, R. Curtis] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; [Tsai, Michael Y.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Patel, Sanjay R.; Redline, Susan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Sleep & Circadian Disorders, Boston, MA 02115 USA; [Hoogeveen, Ron C.] Baylor Coll Med, Dept Med, Div Atherosclerosis & Vasc Med, Houston, TX 77030 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, Los Angeles BioMed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90509 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol, Houston, TX 77030 USA; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, Utrecht, Netherlands; [Asselbergs, Folkert W.] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London, England; [Sattar, Naveed] Univ Glasgow, British Heart Fdn Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Whittaker, John] GlaxoSmithKline, Genet, R&D, Stevenage, Herts, England; [Patel, Sanjay R.; Mukamal, Kenneth] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol & Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Lange, Leslie A.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27514 USA; [Hamidovic, Ajna] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA; [Nordestgaard, Borge G.] Herlev Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth Sci, Copenhagen, Denmark; [Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Palmer, Tom M.] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England	University of London; University College London; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Beijing Genomics Institute (BGI); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London; University of London; University College London; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Glasgow; Harvard University; Harvard T.H. Chan School of Public Health; Centers for Disease Control & Prevention - USA; Utrecht University; Uppsala University; Uppsala University Hospital; Institute for Clinical & Experimental Medicine (IKEM); University of London; University College London; Cyprus International Institute for Environmental & Public Health; Cyprus University of Technology; Russian Academy of Sciences; Vavilov Institute of General Genetics; University of London; University College London; University of Cambridge; Karolinska Institutet; Lund University; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Mayo Clinic; Mayo Clinic; University of Edinburgh; Utrecht University; Utrecht University Medical Center; Institute for Clinical & Experimental Medicine (IKEM); University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of London; University College London; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa; University of London; University College London; University of Groningen; University of Copenhagen; Utrecht University; Utrecht University Medical Center; University of Groningen; Imperial College London; Uppsala University; Uppsala University Hospital; National Institute of Public Health (SZU) - Czech Republic; Jagiellonian University; Collegium Medicum Jagiellonian University; Russian Academy of Medical Sciences; Russian Academy of Sciences; Novosibirsk State Medical University; Novosibirsk State University; Lithuanian University of Health Sciences; University of Western Australia; University of Western Australia; University of Western Australia; University of London; University College London; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Glasgow; University of South Australia; University of South Australia; South Australian Health & Medical Research Institute (SAHMRI); University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Cambridge; Karolinska Institutet; Karolinska University Hospital; Danish Cancer Society; University of Southern Denmark; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Netherlands National Institute for Public Health & the Environment; University of Groningen; University of Groningen; University of London; University College London; University of London; Instituto Gulbenkian de Ciencia; Universidade de Lisboa; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Health Science Center Houston; Fred Hutchinson Cancer Center; McMaster University; New York Academy of Medicine; Kaiser Permanente; Northwestern University; Feinberg School of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Jackson State University; University of Minnesota System; University of Minnesota Twin Cities; Boston University; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Baylor College of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Utrecht University; Utrecht University Medical Center; University of London; University College London; University of Glasgow; GlaxoSmithKline; Harvard University; Beth Israel Deaconess Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Mississippi; University of Mississippi Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of New Mexico; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Warwick	Casas, JP (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, Keppel St, London WC1E 7HT, England.	Juan-P.Casas@lshtm.ac.uk	LaCroix, Andrea/N-9880-2018; Marmot, M G/Y-3920-2019; Sundstrom, Johan/R-2139-2019; de Jong, Pim A/G-7220-2014; Lanktree, Matthew Bruce/I-9790-2019; Gaunt, Tom R/O-3918-2014; Sundström, Johan/A-6286-2009; Hankey, Graeme J/H-4968-2014; Dai, Jiyan/I-7098-2013; Wong, Andrew/AAE-6995-2019; Tamosiunas, Abdonas/AAD-4274-2021; Swerdlow, Daniel/A-3497-2009; Johnson, Andrew D/G-6520-2013; Rotter, Jerome/AAY-6598-2021; Leon, David A/G-2195-2010; Li, Shanshan/N-2593-2019; Ford, Ian/ABE-6145-2020; Panayiotou, Andrie/AAE-8664-2020; Buxbaum, Sarah G./E-1970-2013; Franco, Óscar H/ABE-2305-2020; Amato, Mauro/J-3289-2016; Wong, Andrew/M-8899-2016; de Bakker, Paul IW/B-8730-2009; Guo, Yiran/H-4120-2011; Hubacek, Jaroslav Alois/AAN-6134-2021; Jukema, J. Wouter/ABD-6503-2021; Verweij, Niek/A-4499-2017; Hardy, Rebecca/AFR-1989-2022; Nordestgaard, Borge Gronne/ABF-1310-2020; Davey Smith, George/A-7407-2013; Almeida, Osvaldo P./A-4925-2008; Khaw, Kay-Tee/AAZ-3209-2021; Asselbergs, Folkert W./ABD-6752-2021; Whittaker, John C/B-8609-2012; Hypponen, Elina/B-2596-2014; Marques-Vidal, Pedro M/C-9449-2009; Mukamal, Kenneth/GVR-7978-2022; Kivimaki, Mika/B-3607-2012; Cavadino, Alana/CAG-8915-2022; Dehghan, Abbas/ABE-7377-2020; Ricceri, Fulvio/I-9910-2018; Pikhart, Hynek/E-3074-2010; Langenberg, Claudia/ABG-9067-2021; Ikram, M. Arfan/AAM-5225-2021; Silverwood, Richard/A-1249-2014; Palmer, Tom Michael/X-6807-2019; Shah, Sonia/N-7547-2013; Dominiczak, Anna F/P-9390-2017; Flicker, Leon/AAE-1530-2022; Meschia, James/GPP-1636-2022; Verweij, Niek/ABC-6249-2021; Holmes, Michael/AAA-2208-2021; Malyutina, Sofia/J-1651-2018; Kuh, Diana/L-6019-2014; Onland-Moret, N. Charlotte/G-9185-2011; Ferro, José/ABA-1779-2021; Padmanabhan, Sandosh/S-3963-2016; Vicente, Astrid/F-8692-2014; Voevoda, Mikhail/N-6713-2015; Maitland-van der Zee, Anke/I-9572-2016; Dehghan, Abbas/B-9896-2008	LaCroix, Andrea/0000-0002-9532-976X; Marmot, M G/0000-0002-2431-6419; Sundstrom, Johan/0000-0003-2247-8454; de Jong, Pim A/0000-0003-4840-6854; Lanktree, Matthew Bruce/0000-0002-5750-6286; Gaunt, Tom R/0000-0003-0924-3247; Sundström, Johan/0000-0003-2247-8454; Hankey, Graeme J/0000-0002-6044-7328; Dai, Jiyan/0000-0002-7720-8032; Wong, Andrew/0000-0003-2079-4779; Swerdlow, Daniel/0000-0002-7946-3459; Johnson, Andrew D/0000-0001-6369-5178; Leon, David A/0000-0001-9747-1762; Li, Shanshan/0000-0001-6268-125X; Buxbaum, Sarah G./0000-0002-4886-3564; Franco, Óscar H/0000-0002-4606-4929; Amato, Mauro/0000-0002-0118-5719; Wong, Andrew/0000-0003-2079-4779; de Bakker, Paul IW/0000-0001-7735-7858; Hubacek, Jaroslav Alois/0000-0001-6537-1353; Jukema, J. Wouter/0000-0002-3246-8359; Davey Smith, George/0000-0002-1407-8314; Almeida, Osvaldo P./0000-0002-8689-6199; Asselbergs, Folkert W./0000-0002-1692-8669; Whittaker, John C/0000-0002-3529-2379; Hypponen, Elina/0000-0003-3670-9399; Marques-Vidal, Pedro M/0000-0002-4548-8500; Kivimaki, Mika/0000-0002-4699-5627; Cavadino, Alana/0000-0002-5709-367X; Ricceri, Fulvio/0000-0001-8749-9737; Pikhart, Hynek/0000-0001-5277-4049; Langenberg, Claudia/0000-0002-5017-7344; Silverwood, Richard/0000-0002-2744-1194; Palmer, Tom Michael/0000-0003-4655-4511; Shah, Sonia/0000-0001-5860-4526; Dominiczak, Anna F/0000-0003-4913-3608; Flicker, Leon/0000-0002-3650-0475; Meschia, James/0000-0002-4475-8142; Verweij, Niek/0000-0002-4303-7685; Malyutina, Sofia/0000-0001-6539-0466; Kuh, Diana/0000-0001-7386-2857; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Vicente, Astrid/0000-0001-7134-8037; Voevoda, Mikhail/0000-0001-9425-413X; Engmann, Jorgen/0000-0001-7015-7773; Finan, Chris/0000-0002-3319-1937; Hingorani, Aroon/0000-0001-8365-0081; Beulens, Joline/0000-0002-4181-0937; Rayaprolu, Sruti/0000-0002-5212-3745; Ross, Owen/0000-0003-4813-756X; Whincup, Peter/0000-0002-5589-4107; Padmanabhan, Sandosh/0000-0003-3869-5808; Li, Yun Rose/0000-0002-8077-4975; Zuccolo, Luisa/0000-0002-7049-3037; Sacerdote, Carlotta/0000-0002-8008-5096; Watkins, Hugh/0000-0002-5287-9016; Patel, Sanjay/0000-0002-9142-5172; Prieto-Merino, David/0000-0001-5001-0061; Peasey, Anne/0000-0001-7434-2079; Talmud, Philippa/0000-0002-5560-1933; Cupples, L. Adrienne/0000-0003-0273-7965; Eriksson, Per/0000-0002-5635-2692; Dale, Caroline/0000-0002-3889-8974; s, hema/0000-0002-3440-9475; Nordestgaard, Borge/0000-0002-1954-7220; Maitland-van der Zee, Anke/0000-0002-0414-3442; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Hoogeveen, Ron/0000-0003-2399-4653; Humphries, Stephen E/0000-0002-8221-6547; Lawlor, Debbie A/0000-0002-6793-2262; Folkersen, Lasse/0000-0003-0708-9530; Skaaby, Tea/0000-0003-0031-5726; Tsai, Michael/0000-0001-7553-3408; Price, Jackie/0000-0003-3251-3970; Dehghan, Abbas/0000-0001-6403-016X; Spring, Bonnie/0000-0003-0692-9868; Melander, Olle/0000-0002-2581-484X; Tjonneland, Anne/0000-0003-4385-2097; Tolstrup, Janne/0000-0002-9796-3967; Hardy, Rebecca/0000-0001-9949-0799; Linneberg, Allan/0000-0002-0994-0184; Kumari, Meena/0000-0001-9716-1035; Schreiner, Pamela/0000-0002-9920-6257; Bobak, Martin/0000-0002-2633-6851; Morris, Richard/0000-0001-7240-4563	UK Medical Research Council (MRC) population health scientist fellowship [G0802432]; NWO [916.12.154]; EUR Fellowship; Mayo Foundation for Medical Education and Research; Medical Research Council; British Heart Foundation; Economic and Social Research Council; National Heart Lung and Blood Institute [NHLBI: HL36310, HL 114901]; National Institute on Aging [AG13196]; US, NIH; Netherlands Heart Foundation [2001 D 032, 2014T001]; James and Ester King Foundation; Florida State Department of Health; American Heart Association; Myron and Jane Hanley Award in Stroke research; Medical Research Council Professorship; Swedish Heart-Lung Foundation [20041151]; Swedish Research Council [2007-5942, 8691, 0593]; NIH National Heart Lung and Blood Institute [HHSN268200900009C]; MRC [G1000718]; UCL MBPhD; MH CZ - DRO ("Institute for Clinical and Experimental Medicine - IKEM) [IN 00023001]; UK Economic and Social Research Council (NCRM) [ES/I025561/2]; British Heart Foundation [PG/2008/008]; Medical Research Council [MC_UU_12019/1, MRC G0601653, G0000934]; National Institute of Health Research University College London Hospitals Biomedical Research Centre; National Institute on Alcohol Abuse and Alcoholism [NIAAA: AA021223-01]; MD Scientist Fellowship in Genetic Medicine (Northwestern Memorial Foundation); National Research Service Award (NIH/NIDA) [F32DA024920]; NIH [HL075451]; BHF [RG/10/12/28456]; UK Medical Research Council [MC_UU_12013/1, MC_UU_12013/5, 092731]; National Institute on Minority Health and Health Disparities of the National Institutes of Health [P20MD006899]; Wellcome Trust [092731, WT088806, WT087997MA]; National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C, UL1RR025005]; NIH Roadmap for Medical Research; British Heart Foundation (BHF) [PG/09/022, PG/07/131/24254, RG/08/013/25942, RG/98002, RG2008/014, RG/07/005/23633]; UK Department of Health Policy Research Programme (England) [0090049]; National Heart, Lung and Blood Institute; NHLBI [HHSN268200960009C]; National Heart, Lung, and Blood Institute/National Institutes of Health [N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-95095]; National Heart, Lung, and Blood Institute (NHLBI) [HL46380, HHSN268201200036C, HHSN268200800007C, N01 HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, N01HC65226, HL080295]; Herlev Hospital; Copenhagen University Hospital; Copenhagen County Research Fund; Danish Medical Research Council; National Institute on Aging (NIA) [AG023629]; Cyprus Cardiovascular Disease Educational and Research Trust (CCDERT); Joint Cyprus Research Promotion Foundation, Ministry of Health; Cyprus Heart Foundation [41/5PE]; Research Promotion Foundation [PENEK 05/04, YGEIA 04/06]; National Institute on Ageing (NIA) [AG1764406S1]; European Union of the European Community [LSHM-CT-2006-037197]; European Commission: Public Health and Consumer Protection Directorate; Dutch Ministry of Public Health, Welfare and Sports; Netherlands Cancer Registry; LK Research Funds; Dutch Prevention Funds; Dutch Zorg Onderzoek Nederland; World Cancer Research Fund (The Netherlands); 'Europe against Cancer' Programme of the European Commission (SANCO); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); Dutch Cancer Society; ZonMW the Netherlands Organisation for Health Research and Development; World Cancer Research Fund (WCRF) (The Netherlands); IOP Genomics grant from Agentschap NL [IGE05012]; Cancer Research UK; Federal Ministry of Science, Germany [01 EA 9401]; European Union [SOC 95201408 05F02]; German Cancer Aid [70-2488-Ha I]; European Community [SOC 98200769 05F02]; Federal Ministry of Education and Research [0312750B]; German Research Federal Ministry (BMBF); Heisenberg-Professorship [SP716/1-1]; German Research Foundation (DFG) [KFO192/1, 218/1]; graduate school of the DFG [GK1208]; Associazione Italiana per le Ricerche sul Cancro, Italy; Compagnia di San Paolo, Turin, Italy; Wellcome Trust 'Determinants of Cardiovascular Diseases in Eastern Europe: A multi-centre cohort study' [064947/Z/01/Z, 081081/Z/06/Z]; MacArthur Foundation 'MacArthur Initiative on Social Upheaval and Health' [712058]; National Institute on Ageing 'Health disparities and aging in societies in transition (the HAPIEE study)' [1R01 AG23522]; Ministry of Health, Czech Republic [00023001]; National Health and Medical Research Council (NHMRC) [279408, 379600, 403963, 513823, 634492]; National Institute of Health, Bethesda; M. D [HL35464, CA55075, CA87969, AA11181, HL34594]; European Commission [QLG1-CT-2002-00896]; Ministero della Salute Ricerca Corrente, Italy; Swedish Heart-Lung Foundation; Foundation for Strategic Research; Stockholm County Council [562183]; Academy of Finland [110413, 12926]; Danish Centre for Evaluation and Health Technology Assessment; Copenhagen County; Danish Heart Foundation; Danish Pharmaceutical Association; Health Insurance Foundation; Augustinus Foundation; Ib Henriksens foundation; Beckett Foundation; Danish Diabetes Association [32]; Health Insurance Foundation [2010 B 131]; ISGS/SWISS: ISGS - National Institute of Neurological Disorders and Stroke (US) [R01 42733]; SWISS - National Institute of Neurological Disorders and Stroke (US) [R01 NS39987]; UK Wellcome Trust [078557]; Swedish Medical Research Council; Swedish Heart and Lung Foundation; Medical Faculty of Lund University, Malmo University Hospital; Albert Pahlsson Research Foundation; Crafoord foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation; Lennart Hanssons Memorial Fund; Marianne and Marcus Wallenberg Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation International (JDRF); MRC; British Medical Research Council; US National Institutes of Health [NHLBI 33014]; Du Pont Pharma, Wilmington, Delaware; Dutch Kidney Foundation [E033]; Netherlands organisation for health research and development (ZonMw) [90.700.441]; Dutch Inter University Cardiology Institute Netherlands (ICIN); EU FP7 Program [LSHM-CT-2007-037273]; AstraZeneca; Oxford BHF Centre of Research Excellence; Wellcome Trust core award [090532/Z/09/Z]; Swedish Research Council; Knut and Alice Wallenberg Foundation; Torsten and Ragnar Soderberg Foundation; Strategic Cardiovascular Program of Karolinska Institutet; Stockholm County Council; Bristol-Myers Squibb; Interuniversity Cardiology Institute of the Netherlands (ICIN); Netherlands Royal Academy of Arts and Sciences (KNAW); Netherlands Heart Foundation; Center for Medical Systems Biology (CMSB); Netherlands Genomics Initiative (Netherlands Consortium for Healthy Aging) [050-060-810]; Erasmus Medical Center; Erasmus University Rotterdam; Netherlands Organization for Scientific Research (NWO); Netherlands Organization for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry of Health Welfare and Sports; European Commission; Municipality of Rotterdam; Netherlands Organisation of Scientific Research NWO Investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015, RIDE2]; Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Aging (NCHA) [050-060-810]; BBMRI-NL; Dutch government (NWO) [184.021.007]; Bayer Corporation; Veni grant Organization for Scientific Research (NWO) [2001.064]; Netherlands Heart Foundation (NHS); TI Pharma [T6-101]; Netherlands Organisation for Health Research and Development (ZonMW); Dutch Health Care Insurance Board (CVZ); Royal Dutch Pharmacists Association (KNMP); Top Institute Pharma; EU Innovative Medicines Initiative (IMI); EU 7th Framework Program (FP7); Dutch Medicines Evaluation Board; Dutch Ministry of Health and industry (GlaxoSmithKline); Dutch Ministry of Health and industry (Pfizer); National Heart Lung and Blood Institute (NHLBI) [HL36310]; National Heart, Lung, and Blood Institute, National Institutes of Health, U. S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C];  [R01HL087641];  [R01HL59367];  [R01HL086694];  [U01 DK062418]; British Heart Foundation [RG/08/013/25942, RG/13/16/30528, PG/13/66/30442, RG/10/12/28456, RG/07/008/23674, RG/08/008/25291] Funding Source: researchfish; Cancer Research UK [14136] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1, ES/F02679X/1, ES/I025561/2, ES/I025561/1, ES/I025561/3] Funding Source: researchfish; Medical Research Council [G1000143, G8802774, MC_UU_12015/1, G19/35, G0902144, MR/K013351/1, G0902037, G0701830, G1000718, G0600580, G1001799, G0100222, MR/K006584/1, G0601647, G0701863, MC_PC_15018, MC_UU_12013/5, MC_U106179471, MC_UU_12013/1, G0802432, MC_UU_12013/8, G1000616, G0401527] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135, NF-SI-0512-10114] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0009819, NNF13OC0005339] Funding Source: researchfish; ESRC [ES/F02679X/1, ES/J023299/1, ES/I025561/1, ES/I025561/3, ES/I025561/2] Funding Source: UKRI; MRC [MC_UU_12019/1, G0000934, MR/K013351/1, G0802432, G1001799, MC_UU_12013/1, G0600580, G0902037, G0902144, G0601647, MC_UU_12013/8, G0701863, MC_UU_12013/5, G1000616, G0701830, MC_UU_12015/1] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055222, N01HC085083, N01HC048049, N01HC085086, N01HC048048, N01HC085081, N01HC085079, N01HC048047, N01HC085082, N01HC048050, N01HC095095, N01HC085080] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA015704, P01CA087969] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006170, R01HL075451, R01HL036310, R01HL034594, R01HL114901, R01HL086694, R01HL046380, R01HL035464, R01HL080295, U01HL080295, R01HL059367, R01HL087641] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, U01DK062418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, R01AG017644, R01AG023629, R37AG013196, R01AG023522, R56AG023629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA021223, R01AA011181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA024920] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	UK Medical Research Council (MRC) population health scientist fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NWO(Netherlands Organization for Scientific Research (NWO)); EUR Fellowship; Mayo Foundation for Medical Education and Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Heart Foundation(Netherlands Heart Foundation); James and Ester King Foundation; Florida State Department of Health; American Heart Association(American Heart Association); Myron and Jane Hanley Award in Stroke research; Medical Research Council Professorship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); NIH National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCL MBPhD; MH CZ - DRO ("Institute for Clinical and Experimental Medicine - IKEM); UK Economic and Social Research Council (NCRM); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research University College London Hospitals Biomedical Research Centre; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); MD Scientist Fellowship in Genetic Medicine (Northwestern Memorial Foundation); National Research Service Award (NIH/NIDA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BHF(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute on Minority Health and Health Disparities of the National Institutes of Health; Wellcome Trust(Wellcome Trust); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation (BHF)(British Heart Foundation); UK Department of Health Policy Research Programme (England); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Herlev Hospital; Copenhagen University Hospital; Copenhagen County Research Fund; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cyprus Cardiovascular Disease Educational and Research Trust (CCDERT); Joint Cyprus Research Promotion Foundation, Ministry of Health; Cyprus Heart Foundation; Research Promotion Foundation; National Institute on Ageing (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); European Union of the European Community; European Commission: Public Health and Consumer Protection Directorate(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Public Health, Welfare and Sports; Netherlands Cancer Registry; LK Research Funds; Dutch Prevention Funds; Dutch Zorg Onderzoek Nederland(Netherlands Organization for Scientific Research (NWO)); World Cancer Research Fund (The Netherlands)(Netherlands Government); 'Europe against Cancer' Programme of the European Commission (SANCO)(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); Dutch Cancer Society(KWF Kankerbestrijding); ZonMW the Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); World Cancer Research Fund (WCRF) (The Netherlands)(Netherlands GovernmentWorld Cancer Research Fund International (WCRF)); IOP Genomics grant from Agentschap NL; Cancer Research UK(Cancer Research UK); Federal Ministry of Science, Germany; European Union(European Commission); German Cancer Aid(Deutsche Krebshilfe); European Community(European Commission); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Federal Ministry (BMBF)(Federal Ministry of Education & Research (BMBF)); Heisenberg-Professorship(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); graduate school of the DFG(German Research Foundation (DFG)); Associazione Italiana per le Ricerche sul Cancro, Italy(Fondazione AIRC per la ricerca sul cancro); Compagnia di San Paolo, Turin, Italy(Compagnia di San Paolo); Wellcome Trust 'Determinants of Cardiovascular Diseases in Eastern Europe: A multi-centre cohort study'(Wellcome Trust); MacArthur Foundation 'MacArthur Initiative on Social Upheaval and Health'; National Institute on Ageing 'Health disparities and aging in societies in transition (the HAPIEE study)'; Ministry of Health, Czech Republic(Ministry of Health, Czech RepublicCzech Republic Government); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Health, Bethesda; M. D(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); Ministero della Salute Ricerca Corrente, Italy(Ministry of Health, Italy); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Foundation for Strategic Research; Stockholm County Council(Stockholm County Council); Academy of Finland(Academy of Finland); Danish Centre for Evaluation and Health Technology Assessment; Copenhagen County; Danish Heart Foundation; Danish Pharmaceutical Association; Health Insurance Foundation; Augustinus Foundation; Ib Henriksens foundation; Beckett Foundation; Danish Diabetes Association; Health Insurance Foundation; ISGS/SWISS: ISGS - National Institute of Neurological Disorders and Stroke (US); SWISS - National Institute of Neurological Disorders and Stroke (US); UK Wellcome Trust(Wellcome Trust); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty of Lund University, Malmo University Hospital; Albert Pahlsson Research Foundation; Crafoord foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation; Lennart Hanssons Memorial Fund; Marianne and Marcus Wallenberg Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Du Pont Pharma, Wilmington, Delaware; Dutch Kidney Foundation; Netherlands organisation for health research and development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Inter University Cardiology Institute Netherlands (ICIN); EU FP7 Program(European Commission); AstraZeneca(AstraZeneca); Oxford BHF Centre of Research Excellence; Wellcome Trust core award(Wellcome Trust); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Torsten and Ragnar Soderberg Foundation; Strategic Cardiovascular Program of Karolinska Institutet; Stockholm County Council(Stockholm County Council); Bristol-Myers Squibb(Bristol-Myers Squibb); Interuniversity Cardiology Institute of the Netherlands (ICIN); Netherlands Royal Academy of Arts and Sciences (KNAW); Netherlands Heart Foundation(Netherlands Heart Foundation); Center for Medical Systems Biology (CMSB); Netherlands Genomics Initiative (Netherlands Consortium for Healthy Aging); Erasmus Medical Center; Erasmus University Rotterdam; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health Welfare and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Netherlands Organisation of Scientific Research NWO Investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Aging (NCHA); BBMRI-NL; Dutch government (NWO); Bayer Corporation(Bayer AG); Veni grant Organization for Scientific Research (NWO); Netherlands Heart Foundation (NHS)(Netherlands Heart Foundation); TI Pharma; Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Dutch Health Care Insurance Board (CVZ); Royal Dutch Pharmacists Association (KNMP); Top Institute Pharma; EU Innovative Medicines Initiative (IMI); EU 7th Framework Program (FP7); Dutch Medicines Evaluation Board; Dutch Ministry of Health and industry (GlaxoSmithKline); Dutch Ministry of Health and industry (Pfizer); National Heart Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute, National Institutes of Health, U. S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Dr Michael V. Holmes is funded by a UK Medical Research Council (MRC) population health scientist fellowship (G0802432). Dr Abbas Dehghan is supported by NWO grant (veni, 916.12.154) and the EUR Fellowship. Dr James Meschia receives support from a Clinical Investigator grant from the Mayo Foundation for Medical Education and Research. Prof Mika Kivimaki was supported by the Medical Research Council; the British Heart Foundation; the Economic and Social Research Council; the National Heart Lung and Blood Institute (NHLBI: HL36310); and the National Institute on Aging (AG13196), US, NIH. Prof. Dr. J. W. Jukema is an Established Clinical Investigator of the Netherlands Heart Foundation (grant 2001 D 032). Dr Owen Ross is funded by the James and Ester King Foundation and the Florida State Department of Health, the American Heart Association and the Myron and Jane Hanley Award in Stroke research. Prof Sir Michael Marmot is supported by a Medical Research Council Professorship. Dr Johan Sundstrom is supported by the Swedish Heart-Lung Foundation (grant 20041151), the Swedish Research Council (grant 2007-5942). Dr. Alex Reiner was supported by a contract HHSN268200900009C from the NIH National Heart Lung and Blood Institute. Dr James Y. Dai was supported by a R01 grant from the National Heart Lung and Blood Institute (HL 114901). Prof Hugh Watkins and Prof Martin Farrall are members of the Oxford British Heart Foundation (BHF) Centre of Research Excellence. Dr Daniel Swerdlow was supported by a MRC doctoral training award, and acknowledges support of the UCL MBPhD programme. Prof Frank Dudbridge is supported by a MRC grant (G1000718). Dr Jaroslav Hubacek was supported by MH CZ - DRO ("Institute for Clinical and Experimental Medicine - IKEM, IN 00023001"). Dr Richard Silverwood is supported by the UK Economic and Social Research Council (NCRM Pathways node, ES/I025561/2). Professor Steve E. Humphries is supported by the British Heart Foundation (PG/2008/008). Prof Kuh, Prof Hardy and Dr Wong were supported by the Medical Research Council (MC_UU_12019/1). Dr Folkert W. Asselbergs is supported by National Institute of Health Research University College London Hospitals Biomedical Research Centre and Netherlands Heart Foundation (2014T001). Dr. Jorgenson is supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA: AA021223-01). Ajna Hamidovic was funded by MD Scientist Fellowship in Genetic Medicine (Northwestern Memorial Foundation) and the National Research Service Award F32DA024920 (NIH/NIDA; Ajna Hamidovic). Dr. Spring's work is supported by NIH HL075451. This work was supported in part by BHF Programme Grant RG/10/12/28456. Professors Lawlor and Davey Smith and Dr Zuccolo work in a research unit that receives funding from the UK Medical Research Council (MC_UU_12013/1 and MC_UU_12013/5). Dr. Buxbaum's research is supported in part by P20MD006899 awarded by the National Institute on Minority Health and Health Disparities of the National Institutes of Health. Professors Aroon D. Hingorani and Juan P Casas are supported by the National Institute of Health Research University College London Hospitals Biomedical Research Centre.; ALSPAC: We are extremely grateful to all of the families who took part in this study, the midwives for recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The research leading to the specific results from ALSPAC in this paper received funding from the Wellcome Trust (WT088806 and WT087997MA). The UK Medical Research Council and Wellcome Trust (092731), together with the University of Bristol, provide core support for the ALSPAC study. ARIC: The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. The authors thank the staff and participants of the ARIC study for their important contributions. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research; BWHHS: The British Women's Heart and Health Study has been supported by funding from the British Heart Foundation (BHF) (grant PG/09/022) and the UK Department of Health Policy Research Programme (England) (grant 0090049). The BWHHS HumanCVD data were funded by the BHF (PG/07/131/24254); We thank all BWHHS participants, the general practitioners and their staff who have supported data collection since the study inception; BRHS: The British Regional Heart Study has been supported by programme grant funding from the British Heart Foundation (RG/08/013/25942); CARe: wishes to acknowledge the support of the National Heart, Lung and Blood Institute and the contributions of the research institutions, study investigators, field staff, and study participants in creating this resource for biomedical research (NHLBI contract number HHSN268200960009C); CARDIA: CARDIA is supported by contracts N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050 and N01-HC-95095 from the National Heart, Lung, and Blood Institute/National Institutes of Health; CFS: The Cleveland Family Study (CFS) was supported by grant HL46380 from the National Heart, Lung, and Blood Institute (NHLBI); CGPS: This study was supported by Herlev Hospital, Copenhagen University Hospital, The Copenhagen County Research Fund, and The Danish Medical Research Council; CHS: This research was supported by contracts HHSN268201200036C, HHSN268200800007C, N01 HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, N01HC65226, and grant HL080295 from the National Heart, Lung, and Blood Institute (NHLBI), with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided by AG023629 from the National Institute on Aging (NIA). A full list of principal CHS investigators and institutions can be found at CHS-NHLBI.; org; Cyprus: The Cyprus Study has been supported by the Cyprus Cardiovascular Disease Educational and Research Trust (CCDERT) and Joint Cyprus Research Promotion Foundation, Ministry of Health and Cyprus Heart Foundation grant No 41/5PE as well as Research Promotion Foundation grants (PENEK 05/04 and YGEIA 04/06); EAS: The EAS was funded by the British Heart Foundation (Programme Grant RG/98002); ELSA: Samples from the English Longitudinal Study of Ageing (ELSA) DNA Repository (EDNAR), received support under a grant (AG1764406S1) awarded by the National Institute on Ageing (NIA). ELSA was developed by a team of researchers based at the National Centre for Social Research, University College London and the Institute of Fiscal Studies. The data were collected by the National Centre for Social Research.; EPIC InterAct: We thank all EPIC participants and staff for their contribution to the study. We thank staff from the Technical, Field Epidemiology and Data Functional Group Teams of the MRC Epidemiology Unit in Cambridge, UK, for carrying out sample preparation, DNA provision and quality control, genotyping and data-handling work. The InterAct study received funding from the European Union (Integrated Project LSHM-CT-2006-037197 in the Framework Programme 6 of the European Community); EPIC Netherlands: We thank Statistics Netherlands and Netherlands Cancer Registry (NKR) for follow-up data on cancer, cardiovascular disease, vital status and causes of death. Supported by the European Commission: Public Health and Consumer Protection Directorate 1993-2004; Research Directorate-General 2005; Dutch Ministry of Public Health, Welfare and Sports; Netherlands Cancer Registry; LK Research Funds; Dutch Prevention Funds; Dutch Zorg Onderzoek Nederland; and World Cancer Research Fund (The Netherlands) (to the European Prospective Investigation into Cancer and Nutrition-Netherlands study). The EPIC-NL study was funded by 'Europe against Cancer' Programme of the European Commission (SANCO), Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch Cancer Society; ZonMW the Netherlands Organisation for Health Research and Development, World Cancer Research Fund (WCRF) (The Netherlands). Genotyping was funded by IOP Genomics grant IGE05012 from Agentschap NL; EPIC Norfolk: We thank all study participants and the general practitioners and the EPIC-Norfolk study team for their helpful input. The EPIC-Norfolk study is supported by programme grants from the Medical Research Council and Cancer Research UK; EPIC Potsdam: The recruitment phase of the EPIC-Potsdam Study was supported by the Federal Ministry of Science, Germany (01 EA 9401), and the European Union (SOC 95201408 05F02). The follow-up was supported by the German Cancer Aid (70-2488-Ha I) and the European Community (SOC 98200769 05F02). The present study was supported by the Federal Ministry of Education and Research (0312750B). Mercodia provided the oxLDL kits free of charge. JS and AFHP were supported by German Research Federal Ministry (BMBF), JS was supported by a Heisenberg-Professorship (SP716/1-1) and clinical research groups of the German Research Foundation (DFG; KFO192/1 and 218/1).; JS, AFHP and MM were also supported by a graduate school of the DFG (GK1208); EPIC Turin: The EPIC Turin study is funded by grants from the Associazione Italiana per le Ricerche sul Cancro, Italy and grants from the Compagnia di San Paolo, Turin, Italy; FHS: The Framingham Heart Study began in 1948 with the recruitment of an original cohort of 5,209 men and women (mean age 44 years; 55 percent women). In 1971 a second generation of study participants was enrolled; this cohort consisted of 5,124 children and spouses of children of the original cohort. The mean age of the offspring cohort was 37 years; 52 percent were women. A third generation cohort of 4,095 children of offspring cohort participants (mean age 40 years; 53 percent women) was enrolled beginning in 2002. At each clinic visit, a medical history was obtained with a focus on cardiovascular content, and participants underwent a physical examination including measurement of height and weight from which BMI was calculated; HAPIEE: This study was supported by Wellcome Trust 'Determinants of Cardiovascular Diseases in Eastern Europe: A multi-centre cohort study' [grants 064947/Z/01/Z; and 081081/Z/06/Z]; the MacArthur Foundation 'MacArthur Initiative on Social Upheaval and Health' [grant 712058]; the National Institute on Ageing 'Health disparities and aging in societies in transition (the HAPIEE study)' [grant 1R01 AG23522]; and a project from the Ministry of Health, Czech Republic, for the development of the research organization No. 00023001 (IKEM, Prague, Czech Republic). We would like to thank researchers, interviewers and participants in Novosibirsk, Krakow, Kaunas, Havriov/Karvina, Jihlava, Usti nad Labem, Liberec, Hradec Kralove, and Kromeriz.; HIMS: National Health and Medical Research Council (NHMRC) project grants 279408, 379600, 403963, 513823 and 634492; HPFS/NHS: We would like to thank Hardeep Ranu and Pati Soule from the DF/HCC Genotyping Core for genotyping and data management. This study was supported by research grants HL35464, CA55075, CA87969, AA11181, and HL34594 from the National Institute of Health, Bethesda; M. D; IMPROVE: This study was supported by the European Commission (Contract number: QLG1-CT-2002-00896), Ministero della Salute Ricerca Corrente, Italy, the Swedish Heart-Lung Foundation, the Swedish Research Council (projects 8691 and 0593), the Foundation for Strategic Research, the Stockholm County Council (project 562183), the Foundation for Strategic Research, the Academy of Finland (Grant #110413) and the British Heart Foundation (RG2008/014). None of the aforementioned funding organizations or sponsors has had a specific role in design or conduct of the study, collection, management, analysis, or interpretation of the data, or preparation, review, or approval of the manuscript; Inter99: The Inter99 study was supported by the Danish Medical Research Council, the Danish Centre for Evaluation and Health Technology Assessment, Copenhagen County, the Danish Heart Foundation, the Danish Pharmaceutical Association, the Health Insurance Foundation, the Augustinus Foundation, the Ib Henriksens foundation and the Beckett Foundation. The present study was further supported by the Danish Diabetes Association (grant No. 32, December 2005) and the Health Insurance Foundation (grant No.; 2010 B 131); ISGS/SWISS: ISGS (Grant Number R01 42733) and SWISS (R01 NS39987) were funded by grants from the National Institute of Neurological Disorders and Stroke (US); Izhevsk: The Izhevsk Family Studies was funded by a UK Wellcome Trust programme grant (078557); MDC: This work was supported by the Swedish Medical Research Council; by the Swedish Heart and Lung Foundation; by the Medical Faculty of Lund University, Malmo University Hospital; by the Albert Pahlsson Research Foundation; by the Crafoord foundation; by the Ernhold Lundstroms Research Foundation, the Region Skane; by the Hulda and Conrad Mossfelt Foundation; by the King Gustaf V and Queen Victoria Foundation; by the Lennart Hanssons Memorial Fund; and by the Marianne and Marcus Wallenberg Foundation. Genotyping was supported by the British Heart Foundation (grant number CH/98001 to A. F. D., RG/07/005/23633 to A. F. D., S. P.); MESA: The Multi-Ethnic Study of Atherosclerosis Study (MESA) is a multicenter prospective cohort study initiated to study the development of subclinical cardiovascular disease. A total of 6814 women and men between the age of 45 and 84 year were recruited for the first examination between 2000 and 2002. Participants were recruited in six US cities (Baltimore, MD; Chicago, IL; Forsyth County, NC; Los Angeles County, CA; Northern Manhattan, NY; and St. Paul, MN). This study was approved by the institutional review boards of each study site, and written informed consent was obtained from all participants. This cohort was genotyped as part of the National Heart Lung and Blood Institute's (NHLBI) Candidate Gene Association Resource (CARe) (Musunuru, K., Lettre, G., Young, T., Farlow, D. N., Pirruccello, J. P., Ejebe, K. G., Keating, B. J., Yang, Q., Chen, M. H., Lapchyk, N. et al. Candidate gene association resource (CARe): design, methods, and proof of concept. Circ. Cardiovasc. Genet, 3, 267-275.); MRC 1958BC: Dr Sue Ring and Dr Wendy McArdle (University of Bristol) and Mr Jon Johnson (Centre for Longitudinal Studies, Institute of Education, London) are thanked for help with data linkage. The study was supported by the Academy of Finland (12926) and the Medical Research Council (MRC G0601653 and SALVE/PrevMedsyn). The Medical Research Council funded the 2002-2004 clinical follow-up of the 1958 birth cohort (grant G0000934). This research used resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, National Institute of Child Health and Human Development, and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418. This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of investigators who contributed to generation of the data is available from the Wellcome Trust Case-Control Consortium website(www.wtccc.org.uk). Funding for the project was provided by the Wellcome Trust under award 076113. Work at the Centre for Paediatric Epidemiology and Biostatistics benefits from funding support from the MRC in its capacity as the MRC Centre of Epidemiology for Child Health. Research at the University College London Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust benefits from R&D funding received from the NHS Executive; MRC NSHD: Supported by Medical Research Council - MC_UU_12019/1.; We are very grateful to the members of this birth cohort for their continuing interest and participation in the study. We would like to acknowledge the Swallow group, UCL, who performed the DNA extractions; NHANES III: The findings and conclusions in this report are those of the author(s) and do not necessarily represent the views of the Centers for Disease Control and Prevention; NORDIL: This work was supported by the British Heart Foundation (grant number CH/98001 to A. F. D., RG/07/005/23633 to A. F. D., S. P.) and a Special Project, for genotyping of the Swedish extremes from the NORDIL and MDC cohorts; and by Pharmacia. We thank Professor Thomas Hedner (Department of Clinical Pharmacology, Sahlgrenska Academy, Gotheburg, Sweden) and Professor Sverre Kjeldsen (Ullevaal University Hospital, University of Oslo, Oslo, Norway), who are investigators of the NORDIL study. Professor Kjeldsen is also an investigator of the ASCOT trial; NPHS II: NPHS-II was supported by the British Medical Research Council, the US National Institutes of Health (grant NHLBI 33014), and Du Pont Pharma, Wilmington, Delaware; Portuguese stroke: Instituto Nacional de Saude Doutor Ricardo Jorge; PREVEND: PREVEND genetics is supported by the Dutch Kidney Foundation (Grant E033), The Netherlands organisation for health research and development (ZonMw grant 90.700.441), and the Dutch Inter University Cardiology Institute Netherlands (ICIN); PROCARDIS: PROCARDIS was supported by the EU FP7 Program (LSHM-CT-2007-037273), AstraZeneca, the British Heart Foundation, the Oxford BHF Centre of Research Excellence, the Wellcome Trust core award (090532/Z/09/Z), the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Swedish Heart-Lung Foundation, the Torsten and Ragnar Soderberg Foundation, the Strategic Cardiovascular Program of Karolinska Institutet and Stockholm County Council, the Foundation for Strategic Research and the Stockholm County Council (560283); PROSPER: The PROSPER study was supported by an investigator initiated grant obtained from Bristol-Myers Squibb and by grants from the Interuniversity Cardiology Institute of the Netherlands (ICIN) and the Durrer Center for Cardiogenetic Research both Institutes of the Netherlands Royal Academy of Arts and Sciences (KNAW), the Netherlands Heart Foundation, the Center for Medical Systems Biology (CMSB), a center of excellence approved by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NWO), the Netherlands Consortium for Healthy Ageing (NCHA). The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no HEALTH-F2-2009-223004 and by the Netherlands Genomics Initiative (Netherlands Consortium for Healthy Aging grant 050-060-810); Rotterdam: The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University Rotterdam; the Netherlands Organization for Scientific Research (NWO); the Netherlands Organization for Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Netherlands Heart Foundation; the Ministry of Education, Culture and Science; the Ministry of Health Welfare and Sports; the European Commission; and the Municipality of Rotterdam. Support for genotyping was provided by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.; 011, 911-03-012), the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Aging (NCHA) project nr. 050-060-810; SMART: SMART GENETICS was financially supported by BBMRI-NL, a Research Infrastructure financed by the Dutch government (NWO 184.021.007); TPT: TPT was funded by the Medical Research Council, the British Heart Foundation, DuPont Pharma and Bayer Corporation; UCP: The UCP study was funded by Veni grant Organization for Scientific Research (NWO), Grant no. 2001.064 Netherlands Heart Foundation (NHS), and TI Pharma Grant T6-101 Mondriaan. The department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, has received unrestricted research funding from the Netherlands Organisation for Health Research and Development (ZonMW), the Dutch Health Care Insurance Board (CVZ), the Royal Dutch Pharmacists Association (KNMP), the private-public funded Top Institute Pharma (www.tipharma.nl, includes co-funding from universities, government, and industry), the EU Innovative Medicines Initiative (IMI), EU 7th Framework Program (FP7), the Dutch Medicines Evaluation Board, the Dutch Ministry of Health and industry (including GlaxoSmithKline, Pfizer, and others); Whitehall II: The Whitehall II study and Mika Kivimaki were supported by the Medical Research Council; the British Heart Foundation; the Economic and Social Research Council; the National Heart Lung and Blood Institute (NHLBI: HL36310); and the National Institute on Aging (AG13196), US, NIH; WHI: The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U. S. Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C. A listing of WHI investigators can be found at https://cleo.whi.org/researchers/Documents%20%20Write%20a%20Paper/WHI%20Investigator%20Short%20List.pdf.	Bierut LJ, 2012, MOL PSYCHIATR, V17, P445, DOI 10.1038/mp.2011.124; Boffetta P, 1990, Epidemiology, V1, P342, DOI 10.1097/00001648-199009000-00003; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; Drogan D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032176; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Freiberg MS, 2005, CIRCULATION, V112, P1379, DOI 10.1161/CIRCULATIONAHA.105.568030; Glymour MM, 2012, AM J EPIDEMIOL, V175, P332, DOI 10.1093/aje/kwr323; Hansel B, 2010, EUR J CLIN NUTR, V64, P561, DOI 10.1038/ejcn.2010.61; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hindorff LA, CATALOG PUBLISHED GE; Hingorani A, 2005, LANCET, V366, P1906, DOI 10.1016/S0140-6736(05)67767-7; Husemoen LLN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011735; Jackson R, 2005, LANCET, V366, P1911, DOI 10.1016/S0140-6736(05)67770-7; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Langenberg C, 2011, DIABETOLOGIA, V54, P2272, DOI 10.1007/s00125-011-2182-9; Lawlor DA, 2013, EUR HEART J, V34, P2519, DOI 10.1093/eurheartj/eht081; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Macgregor S, 2009, HUM MOL GENET, V18, P580, DOI 10.1093/hmg/ddn372; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Quertemont E, 2006, ALCOHOL RES HEALTH, V29, P258; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Room R, 2004, BIOMED PHARMACOTHER, V58, P111, DOI 10.1016/j.biopha.2003.12.003; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; SHAPER AG, 1988, LANCET, V2, P1267; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Tolstrup JS, 2009, CIRC-CARDIOVASC GENE, V2, P507, DOI 10.1161/CIRCGENETICS.109.873604; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Yokoyama A, 2014, ALCOHOL ALCOHOLISM, V49, P31, DOI 10.1093/alcalc/agt136	35	400	415	5	131	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2014	349								g4164	10.1136/bmj.g4164	http://dx.doi.org/10.1136/bmj.g4164			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZF	25011450	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000338993700001
J	Strathdee, SA; Crago, AL; Butler, J; Bekker, LG; Beyrer, C				Strathdee, Steffanie A.; Crago, Anna-Louise; Butler, Jenny; Bekker, Linda-Gail; Beyrer, Chris			Dispelling myths about sex workers and HIV	LANCET			English	Editorial Material							CONDOM USE; RISK; INTERVENTION		[Strathdee, Steffanie A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Crago, Anna-Louise] Univ Toronto, Toronto, ON, Canada; [Butler, Jenny] United Nations Populat Fund, New York, NY USA; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Res Ctr, ZA-7925 Cape Town, South Africa; [Beyrer, Chris] Johns Hopkins Univ, Ctr Publ Hlth & Human Rights, Baltimore, MD USA	University of California System; University of California San Diego; University of Toronto; United Nations Population Fund; University of Cape Town; Johns Hopkins University	Strathdee, SA (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	sstrathdee@ucsd.edu	Strathdee, Steffanie A/B-9042-2009; Bekker, Linda-Gail/AAZ-8929-2020	Strathdee, Steffanie/0000-0002-7724-691X; BEKKER, LINDA-GAIL/0000-0002-0755-4386	NIAID NIH HHS [P30 AI094189] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; [Anonymous], 2010, REC HIV AIDS WORLD W; [Anonymous], 2001, 42914044992001 ALM R; Baral S, 2013, EXAMINING PREVALENCE; Baral SD, 2014, LANCET; Beckham S. W., 2013, ANY OTHER WOMAN PREG; DODILLET SUSANNE, 2011, INT WORKSHOP DECRIMI; Ghose T, 2011, QUAL HEALTH RES, V21, P587, DOI 10.1177/1049732310395328; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; International Labor Organization, 2012, 21 MILL PEOPL AR NOW; International Labour Organization, 2012, ILO 2012 GLOB EST FO; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; Kerrigan DL, 2013, AIDS BEHAV, V17, P1926, DOI 10.1007/s10461-013-0458-4; Nemoto T, 1999, AIDS CARE, V11, P297, DOI 10.1080/09540129947938; Patterson TL, 2008, AM J PUBLIC HEALTH, V98, P2051, DOI 10.2105/AJPH.2007.130096; Poteat T, 2014, LANCET; RFSL,, 2011, OS SYNL AKT HBT PERS; *SOC, 2000, KANN PROST 1998 1999; Stachowiak JA, 2005, SIECUS REPORT, V22, P18; Steinfatt T. M., 2008, MEASURING EXTENT SEX; Strathdee SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065812; Stridbeck U., 2004, PURCHASING SEXUAL SE; The Global Alliance Against Traffic in Women, 2011, MOV SUPPL DEM CATCHP; Ulibarri MD, 2012, INT J STD AIDS, V23, P229, DOI 10.1258/ijsa.2011.011184; *UN, PROT PREV SUPPR PUN; UNAIDS, 2012, UNAIDS GUID NOT HIV; United Nations Office on Drugs and Crime, 2014, UN CONV TRANSN ORG C; Wagner Jamie., 2013, WEBCOMIC HOMESTUCK G	28	16	16	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					4	7		10.1016/S0140-6736(14)60980-6	http://dx.doi.org/10.1016/S0140-6736(14)60980-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX8IW	25059948				2022-12-28	WOS:000347154200007
J	Singh, G; Chan, H; Baskin, A; Gelman, E; Repnin, N; Kral, P; Klajn, R				Singh, Gurvinder; Chan, Henry; Baskin, Artem; Gelman, Elijah; Repnin, Nikita; Kral, Petr; Klajn, Rafal			Self-assembly of magnetite nanocubes into helical superstructures	SCIENCE			English	Article							BINARY NANOPARTICLE SUPERLATTICES; COLLOIDAL SUPERPARTICLES; MAGNETOTACTIC BACTERIA; SHAPE; CRYSTALLIZATION; NANOCRYSTALS; CDTE	Organizing inorganic nanocrystals into complex architectures is challenging and typically relies on preexisting templates, such as properly folded DNA or polypeptide chains. We found that under carefully controlled conditions, cubic nanocrystals of magnetite self-assemble into arrays of helical superstructures in a template-free manner with >99% yield. Computer simulations revealed that the formation of helices is determined by the interplay of van der Waals and magnetic dipole-dipole interactions, Zeeman coupling, and entropic forces and can be attributed to spontaneous formation of chiral nanocube clusters. Neighboring helices within their densely packed ensembles tended to adopt the same handedness in order to maximize packing, thus revealing a novel mechanism of symmetry breaking and chirality amplification.	[Singh, Gurvinder; Gelman, Elijah; Klajn, Rafal] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; [Chan, Henry; Baskin, Artem; Repnin, Nikita; Kral, Petr] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Kral, Petr] Univ Illinois, Dept Phys, Chicago, IL 60607 USA	Weizmann Institute of Science; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Klajn, R (corresponding author), Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel.	pkral@uic.edu; rafal.klajn@weizmann.ac.il	Singh, Gurvinder/D-4417-2009; Liu, Xin/I-7709-2015	Singh, Gurvinder/0000-0001-9700-3344; 	Israel Science Foundation [1463/11]; G. M. J. Schmidt-Minerva Center for Supramolecular Architectures; Minerva Foundation; NSF Division of Materials Research [1309765]; American Chemical Society Petroleum Research Fund [53062-ND6]; Federal German Ministry for Education and Research	Israel Science Foundation(Israel Science Foundation); G. M. J. Schmidt-Minerva Center for Supramolecular Architectures; Minerva Foundation; NSF Division of Materials Research(National Science Foundation (NSF)); American Chemical Society Petroleum Research Fund(American Chemical Society); Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	Supported by Israel Science Foundation grant 1463/11, the G. M. J. Schmidt-Minerva Center for Supramolecular Architectures, and the Minerva Foundation with funding from the Federal German Ministry for Education and Research (R. K.) and by NSF Division of Materials Research grant 1309765 and American Chemical Society Petroleum Research Fund grant 53062-ND6 (P.K.).	Aleksandrovic V, 2008, ACS NANO, V2, P1123, DOI 10.1021/nn800147a; Auyeung E, 2014, NATURE, V505, P73, DOI 10.1038/nature12739; Baranov D, 2010, NANO LETT, V10, P743, DOI 10.1021/nl903946n; Bishop KJM, 2009, SMALL, V5, P1600, DOI 10.1002/smll.200900358; Brooks S, 2011, CH CRC HANDB MOD STA, pXIX; Chen ZY, 2007, J AM CHEM SOC, V129, P15702, DOI 10.1021/ja076698z; Cui HG, 2010, SCIENCE, V327, P555, DOI 10.1126/science.1182340; Das S, 2013, ADV MATER, V25, P422, DOI 10.1002/adma.201201734; Dong AG, 2011, NANO LETT, V11, P841, DOI 10.1021/nl104208x; Dong AG, 2010, NATURE, V466, P474, DOI 10.1038/nature09188; Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Hasan SA, 2009, CHEM COMMUN, P3723, DOI 10.1039/b902622c; KAKOL Z, 1989, SOLID STATE COMMUN, V69, P793, DOI 10.1016/0038-1098(89)90833-8; Kalsin AM, 2006, SCIENCE, V312, P420, DOI 10.1126/science.1125124; Kim D, 2009, J AM CHEM SOC, V131, P454, DOI 10.1021/ja8086906; Kostiainen MA, 2013, NAT NANOTECHNOL, V8, P52, DOI [10.1038/nnano.2012.220, 10.1038/NNANO.2012.220]; Kovalenko MV, 2007, J AM CHEM SOC, V129, P6352, DOI 10.1021/ja0692478; Miszta K, 2011, NAT MATER, V10, P872, DOI [10.1038/NMAT3121, 10.1038/nmat3121]; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Ozgur U, 2009, J MATER SCI-MATER EL, V20, P789, DOI 10.1007/s10854-009-9923-2; Shevchenko EV, 2005, J AM CHEM SOC, V127, P8741, DOI 10.1021/ja050510z; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Srivastava S, 2010, SCIENCE, V327, P1355, DOI 10.1126/science.1177218; Szyndler MW, 2012, J PHYS CHEM LETT, V3, P2320, DOI 10.1021/jz300931s; Tang ZY, 2006, SCIENCE, V314, P274, DOI 10.1126/science.1128045; Timonen JVI, 2013, SCIENCE, V341, P253, DOI 10.1126/science.1233775; Wang T, 2012, J AM CHEM SOC, V134, P18225, DOI 10.1021/ja308962w; Wang T, 2012, SCIENCE, V338, P358, DOI 10.1126/science.1224221; Ye XC, 2013, NAT CHEM, V5, P466, DOI [10.1038/NCHEM.1651, 10.1038/nchem.1651]; Ye XC, 2011, J AM CHEM SOC, V133, P2613, DOI 10.1021/ja108708v	31	351	353	17	841	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1149	1153		10.1126/science.1254132	http://dx.doi.org/10.1126/science.1254132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25061133				2022-12-28	WOS:000341179800039
J	Ibata, NG; Ibata, RA; Famaey, B; Lewis, GF				Ibata, Neil G.; Ibata, Rodrigo A.; Famaey, Benoit; Lewis, Geraint F.			Velocity anti-correlation of diametrically opposed galaxy satellites in the low-redshift Universe	NATURE			English	Article							DIGITAL SKY SURVEY; MILKY-WAY; LOCAL GROUP; DWARF GALAXIES; THIN PLANE; ANDROMEDA; M31; SIMULATION; DENSITY; SYSTEM	Recent work has shown that the Milky Way and the Andromeda galaxies both possess the unexpected property that their dwarf satellite galaxies are aligned in thin and kinematically coherent planar structures(1-7). It is interesting to evaluate the incidence of such planar structures in the larger galactic population, because the Local Group may not be a representative environment. Here we report measurements of the velocities of pairs of diametrically opposed satellite galaxies. In the local Universe (redshift z<0.05), we find that satellite pairs out to a distance of 150 kiloparsecs from the galactic centre are preferentially anti-correlated in their velocities (99.994 per cent confidence level), and that the distribution of galaxies in the larger-scale environment (out to distances of about 2 megaparsecs) is strongly clumped along the axis joining the inner satellite pair ( >7 sigma confidence). This may indicate that planes of co-rotating satellites, similar to those seen around the Andromeda galaxy, are ubiquitous, and their coherent motion suggests that they represent a substantial repository of angular momentum on scales of about 100 kiloparsecs.	[Ibata, Neil G.] Lycee Int Pontonniers, F-67000 Strasbourg, France; [Ibata, Rodrigo A.; Famaey, Benoit] Univ Strasbourg, CNRS, UMR 7550, Observ Astron Strasbourg, F-67000 Strasbourg, France; [Lewis, Geraint F.] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Sydney	Ibata, NG (corresponding author), Lycee Int Pontonniers, 1 Rue Pontonniers, F-67000 Strasbourg, France.	neil.ibata@gmail.com	Lewis, Geraint/F-9069-2015	Lewis, Geraint/0000-0003-3081-9319; Ibata, Rodrigo/0000-0002-3292-9709; Famaey, Benoit/0000-0003-3180-9825	Alfred P. Sloan Foundation; National Science Foundation; US Department of Energy; National Aeronautics and Space Administration; Japanese Monbukagakusho; Max Planck Society; Higher Education Funding Council for England	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Japanese Monbukagakusho(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE))	Funding for the SDSS and SDSS-II has been provided by the Alfred P. Sloan Foundation, the Participating Institutions, the National Science Foundation, the US Department of Energy, the National Aeronautics and Space Administration, the Japanese Monbukagakusho, the Max Planck Society and the Higher Education Funding Council for England. The Millennium-II simulation databases used in this paper and the web application providing online access to them were constructed as part of the activities of the German Astrophysical Virtual Observatory.	Ade P. A. R., 2013, PREPRINT; Adelman-McCarthy JK, 2006, ASTROPHYS J SUPPL S, V162, P38, DOI 10.1086/497917; Bahl H, 2014, MON NOT R ASTRON SOC, V438, P2916, DOI 10.1093/mnras/stt2399; Bellazzini M, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201322744; Blanton MR, 2005, ASTRON J, V129, P2562, DOI 10.1086/429803; Boylan-Kolchin M, 2009, MON NOT R ASTRON SOC, V398, P1150, DOI 10.1111/j.1365-2966.2009.15191.x; Chiboucas K, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/5/126; Collins MLM, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/172; Conn AR, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/120; Conn AR, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/11; Guo Q, 2013, MON NOT R ASTRON SOC, V428, P1351, DOI 10.1093/mnras/sts115; Hammer F, 2013, MON NOT R ASTRON SOC, V431, P3543, DOI 10.1093/mnras/stt435; Ibata RA, 2014, ASTROPHYS J LETT, V784, DOI 10.1088/2041-8205/784/1/L6; Ibata RA, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/128; Ibata RA, 2013, NATURE, V493, P62, DOI 10.1038/nature11717; Komatsu E, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/18; Kroupa P, 2005, ASTRON ASTROPHYS, V431, P517, DOI 10.1051/0004-6361:20041122; Li YS, 2008, MON NOT R ASTRON SOC, V384, P1459, DOI 10.1111/j.1365-2966.2007.12748.x; LYNDENBELL D, 1976, MON NOT R ASTRON SOC, V174, P695, DOI 10.1093/mnras/174.3.695; McConnachie AW, 2009, NATURE, V461, P66, DOI 10.1038/nature08327; McMillan PJ, 2011, MON NOT R ASTRON SOC, V414, P2446, DOI 10.1111/j.1365-2966.2011.18564.x; Metz M, 2008, ASTROPHYS J, V680, P287, DOI 10.1086/587833; Metz M, 2007, MON NOT R ASTRON SOC, V374, P1125, DOI 10.1111/j.1365-2966.2006.11228.x; Metz M, 2009, MON NOT R ASTRON SOC, V394, P2223, DOI 10.1111/j.1365-2966.2009.14489.x; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Pawlowski MS, 2012, MON NOT R ASTRON SOC, V423, P1109, DOI 10.1111/j.1365-2966.2012.20937.x; Pawlowski MS, 2013, MON NOT R ASTRON SOC, V435, P2116, DOI 10.1093/mnras/stt1429; Pawlowski MS, 2013, MON NOT R ASTRON SOC, V435, P1928, DOI 10.1093/mnras/stt1384; Shaya EJ, 2013, MON NOT R ASTRON SOC, V436, P2096, DOI 10.1093/mnras/stt1714; Strauss MA, 2002, ASTRON J, V124, P1810, DOI 10.1086/342343; Tollerud EJ, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/45; Walker M., 2013, PLANETS STARS STELLA, V5, P1039	32	69	69	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					563	+		10.1038/nature13481	http://dx.doi.org/10.1038/nature13481			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043008	Green Submitted			2022-12-28	WOS:000339566300028
J	Cohen, D				Cohen, Deborah			ANTICOAGULANTS Dabigatran: how the drug company withheld important analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ATRIAL-FIBRILLATION					dcohen@bmj.com						[Anonymous], 2014, J AM COLL CARDIOL; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Cohen D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4747; Committee for Medicinal Products for Human Use (CHMP), 2011, EMACHMP2034682011; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Heneghan C, 2014, BMJ-BRIT MED J, V349, pg4560; Moore T. J., 2012, QUARTERWATCH; Moore TJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4517; Moore TJ, 2012, JAMA-J AM MED ASSOC, V308, P869, DOI 10.1001/jama.2012.9658; NICE Implementation Collaborative, CONS SUPP LOCAL IMPL; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Reilly PA, 2014, J AM COLL CARDIOL, V63, P2885, DOI 10.1016/j.jacc.2014.04.012; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Skanes AC, 2012, CAN J CARDIOL, V28, P125, DOI 10.1016/j.cjca.2012.01.021; Stangier J, 2012, BLOOD COAGUL FIBRIN, V23, P138, DOI 10.1097/MBC.0b013e32834f1b0c; Staton T, 2012, PRADAXA HITS BLOCKBU	16	91	93	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2014	349								g4670	10.1136/bmj.g4670	http://dx.doi.org/10.1136/bmj.g4670			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VP	25055829	Green Published, hybrid			2022-12-28	WOS:000339565900003
J	Couzin-Frankel, J				Couzin-Frankel, Jennifer			The elusive heart fix	SCIENCE			English	Editorial Material																			0	10	10	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					252	257		10.1126/science.345.6194.252	http://dx.doi.org/10.1126/science.345.6194.252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035469				2022-12-28	WOS:000339400700015
J	Mayer, KFX; Rogers, J; Dolezel, J; Pozniak, C; Eversole, K; Feuillet, C; Gill, B; Friebe, B; Lukaszewski, AJ; Sourdille, P; Endo, TR; Dolezel, J; Kubalakova, M; Cihalikova, J; Dubska, Z; Vrana, J; Sperkova, R; Simkova, H; Rogers, J; Febrer, M; Clissold, L; McLay, K; Singh, K; Chhuneja, P; Singh, NK; Khurana, J; Akhunov, E; Choulet, F; Sourdille, P; Feuillet, C; Alberti, A; Barbe, V; Wincker, P; Kanamori, H; Kobayashi, F; Itoh, T; Matsumoto, T; Sakai, H; Tanaka, T; Wu, JZ; Ogihara, Y; Handa, H; Pozniak, C; Maclachlan, PR; Sharpe, A; Klassen, D; Edwards, D; Batley, J; Olsen, OA; Sandve, SR; Lien, S; Steuernagel, B; Wulff, B; Caccamo, M; Ayling, S; Ramirez-Gonzalez, RH; Clavijo, BJ; Steuernagel, B; Wright, J; Pfeifer, M; Spannagl, M; Mayer, KFX; Martis, MM; Akhunov, E; Choulet, F; Mayer, KFX; Mascher, M; Chapman, J; Poland, JA; Scholz, U; Barry, K; Waugh, R; Rokhsar, DS; Muehlbauer, GJ; Stein, N; Gundlach, H; Zytnicki, M; Jamilloux, V; Quesneville, H; Wicker, T; Mayer, KFX; Faccioli, P; Colaiacovo, M; Pfeifer, M; Stanca, AM; Budak, H; Cattivelli, L; Glover, N; Martis, MM; Choulet, F; Feuillet, C; Mayer, KFX; Pfeifer, M; Pingault, L; Mayer, KFX; Paux, E; Spannagl, M; Sharma, S; Mayer, KFX; Pozniak, C; Appels, R; Bellgard, M; Chapman, B; Pfeifer, M; Pfeifer, M; Sandve, SR; Nussbaumer, T; Bader, KC; Choulet, F; Feuillet, C; Mayer, KFX; Akhunov, E; Paux, E; Rimbert, H; Wang, SC; Poland, JA; Knox, R; Kilian, A; Pozniak, C; Alaux, M; Alfama, F; Couderc, L; Jamilloux, V; Guilhot, N; Viseux, C; Loaec, M; Quesneville, H; Rogers, J; Dolezel, J; Eversole, K; Feuillet, C; Keller, B; Mayer, KFX; Olsen, OA; Praud, S				Mayer, Klaus F. X.; Rogers, Jane; Dolezel, Jaroslav; Pozniak, Curtis; Eversole, Kellye; Feuillet, Catherine; Gill, Bikram; Friebe, Bernd; Lukaszewski, Adam J.; Sourdille, Pierre; Endo, Takashi R.; Dolezel, Jaroslav; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana; Rogers, Jane; Febrer, Melanie; Clissold, Leah; McLay, Kirsten; Singh, Kuldeep; Chhuneja, Parveen; Singh, Nagendra K.; Khurana, Jitendra; Akhunov, Eduard; Choulet, Frederic; Sourdille, Pierre; Feuillet, Catherine; Alberti, Adriana; Barbe, Valerie; Wincker, Patrick; Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Ogihara, Yasunari; Handa, Hirokazu; Pozniak, Curtis; Maclachlan, P. Ron; Sharpe, Andrew; Klassen, Darrin; Edwards, David; Batley, Jacqueline; Olsen, Odd-Arne; Sandve, Simen Rod; Lien, Sigbjorn; Steuernagel, Burkhard; Wulff, Brande; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Steuernagel, Burkhard; Wright, Jonathan; Pfeifer, Matthias; Spannagl, Manuel; Mayer, Klaus F. X.; Martis, Mihaela M.; Akhunov, Eduard; Choulet, Frederic; Mayer, Klaus F. X.; Mascher, Martin; Chapman, Jarrod; Poland, Jesse A.; Scholz, Uwe; Barry, Kerrie; Waugh, Robbie; Rokhsar, Daniel S.; Muehlbauer, Gary J.; Stein, Nils; Gundlach, Heidrun; Zytnicki, Matthias; Jamilloux, Veronique; Quesneville, Hadi; Wicker, Thomas; Mayer, Klaus F. X.; Faccioli, Primetta; Colaiacovo, Moreno; Pfeifer, Matthias; Stanca, Antonio Michele; Budak, Hikmet; Cattivelli, Luigi; Glover, Natasha; Martis, Mihaela M.; Choulet, Frederic; Feuillet, Catherine; Mayer, Klaus F. X.; Pfeifer, Matthias; Pingault, Lise; Mayer, Klaus F. X.; Paux, Etienne; Spannagl, Manuel; Sharma, Sapna; Mayer, Klaus F. X.; Pozniak, Curtis; Appels, Rudi; Bellgard, Matthew; Chapman, Brett; Pfeifer, Matthias; Pfeifer, Matthias; Sandve, Simen Rod; Nussbaumer, Thomas; Bader, Kai Christian; Choulet, Frederic; Feuillet, Catherine; Mayer, Klaus F. X.; Akhunov, Eduard; Paux, Etienne; Rimbert, Helene; Wang, Shichen; Poland, Jesse A.; Knox, Ron; Kilian, Andrzej; Pozniak, Curtis; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Jamilloux, Veronique; Guilhot, Nicolas; Viseux, Claire; Loaec, Mikael; Quesneville, Hadi; Rogers, Jane; Dolezel, Jaroslav; Eversole, Kellye; Feuillet, Catherine; Keller, Beat; Mayer, Klaus F. X.; Olsen, Odd-Arne; Praud, Sebastien		IWGSC	A chromosome-based draft sequence of the hexaploid bread wheat (Triticum aestivum) genome	SCIENCE			English	Article							GENE-EXPRESSION; AEGILOPS-TAUSCHII; A-GENOME; EVOLUTION; REVEALS; TRANSCRIPTOME; ANNOTATION; DOMINANCE; RICE; POLYPLOIDIZATION	An ordered draft sequence of the 17-gigabase hexaploid bread wheat (Triticum aestivum) genome has been produced by sequencing isolated chromosome arms. We have annotated 124,201 gene loci distributed nearly evenly across the homeologous chromosomes and subgenomes. Comparative gene analysis of wheat subgenomes and extant diploid and tetraploid wheat relatives showed that high sequence similarity and structural conservation are retained, with limited gene loss, after polyploidization. However, across the genomes there was evidence of dynamic gene gain, loss, and duplication since the divergence of the wheat lineages. A high degree of transcriptional autonomy and no global dominance was found for the subgenomes. These insights into the genome biology of a polyploid crop provide a springboard for faster gene isolation, rapid genetic marker development, and precise breeding to meet the needs of increasing food demand worldwide.	[Mayer, Klaus F. X.; Pfeifer, Matthias; Spannagl, Manuel; Martis, Mihaela M.; Gundlach, Heidrun; Sharma, Sapna; Nussbaumer, Thomas; Bader, Kai Christian] Helmholtz Zentrum Munich, D-85764 Neuherberg, Germany; [Rogers, Jane; Eversole, Kellye] Eversole Associates, IWGSC, Bethesda, MD 20816 USA; [Dolezel, Jaroslav; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana] Ctr Plant Struct & Funct Genom, Inst Expt Bot, Olomouc 78371, Czech Republic; [Pozniak, Curtis; Maclachlan, P. Ron] Univ Saskatchewan, Ctr Crop Dev, Dept Plant Sci, Coll Agr & Bioresources, Saskatoon, SK S7N 0W0, Canada; [Feuillet, Catherine] Bayer Crop Sci, Morrisville, NC 27560 USA; [Gill, Bikram; Friebe, Bernd; Akhunov, Eduard; Wang, Shichen] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Lukaszewski, Adam J.] Univ Calif Riverside, Coll Nat & Agr Sci Bot & Plant Sci, Riverside, CA 92521 USA; [Endo, Takashi R.] Kyoto Univ, Grad Sch Agr, Lab Plant Genet, Kyoto 6068502, Japan; [Febrer, Melanie] Univ Dundee, Genom Sequencing Unit, Dundee DD1 5EH, Scotland; [Clissold, Leah; McLay, Kirsten; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Wright, Jonathan] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Singh, Kuldeep; Chhuneja, Parveen] Punjab Agr Univ, Sch Agrictural Biotechnol, Ludhiana 141004, Punjab, India; [Singh, Nagendra K.] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Khurana, Jitendra] Univ Delhi, Interdisciplinary Ctr Plant Genom, New Delhi 110021, India; [Khurana, Jitendra] Univ Delhi, Dept Plant Mol Biol, New Delhi 110021, India; [Sourdille, Pierre; Choulet, Frederic; Glover, Natasha; Pingault, Lise; Paux, Etienne; Guilhot, Nicolas] Univ Blaise Pascal, INRA, Genet Divers & Ecophysiol Cereals UMR1095, F-63039 Clermont Ferrand, France; [Alberti, Adriana; Barbe, Valerie; Wincker, Patrick] Commissariat Energie Atom Genoscope, Ctr Natl Sequencage, F-91057 Evry, France; [Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Handa, Hirokazu] Natl Inst Agrobiol Sci, Plant Genome Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Ogihara, Yasunari] Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; [Sharpe, Andrew; Klassen, Darrin] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada; [Edwards, David; Batley, Jacqueline] Univ Queensland, Australian Ctr Plant Funct Genom, Sch Agr & Food Sci, St Lucia, Qld 4072, Australia; [Edwards, David; Batley, Jacqueline] Univ Western Australia, Sch Plant Biol, Nedlands, WA 6009, Australia; [Olsen, Odd-Arne; Sandve, Simen Rod] Norwegian Univ Life Sci, Dept Plant Sci, Ctr Integrat Genet CIGENE, N-1432 As, Norway; [Olsen, Odd-Arne] Hedmark Univ Coll, Dept Nat Sci & Technol, N-2318 Elverum, Norway; [Steuernagel, Burkhard; Wulff, Brande] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Mascher, Martin; Scholz, Uwe] Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Seeland Ot Gatersleben, Germany; [Chapman, Jarrod; Barry, Kerrie; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Poland, Jesse A.] Kansas State Univ, USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS 66506 USA; [Poland, Jesse A.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Waugh, Robbie] James Hutton Inst, Dundee DD2 5DA, Scotland; [Muehlbauer, Gary J.] Univ Minnesota, Dept Plant Biol, Dept Agron & Plant Genet, St Paul, MN 55108 USA; [Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Seeland Ot Gatersleben, Germany; [Zytnicki, Matthias; Jamilloux, Veronique; Quesneville, Hadi; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Viseux, Claire; Loaec, Mikael] INRA, URGI Res Unit Genom Info UR1164, F-78026 Versailles, France; [Wicker, Thomas; Keller, Beat] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Faccioli, Primetta; Colaiacovo, Moreno; Stanca, Antonio Michele; Cattivelli, Luigi] Genom Res Ctr, Consiglio Ric & Sperimentaz Agr, I-29017 Fiorenzuola Darda, Italy; [Budak, Hikmet] Sabanci Univ, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey; [Appels, Rudi; Bellgard, Matthew; Chapman, Brett] Murdoch Univ, Ctr Comparat Genom, Perth, WA 6150, Australia; [Knox, Ron] Semiarid Prairie Agr Res Ctr, Swift Current, SK S9H 3X2, Canada; [Kilian, Andrzej] Divers Arrays Technol Pty Ltd, Yarralumla, ACT 2600, Australia; [Rimbert, Helene; Praud, Sebastien] Biogemma, Ctr Rech Chappes, F-63720 Chappes, France; [Lien, Sigbjorn] Norwegian Univ Life Sci, CIGENE, Dept Anim & Aquicultural Sci, N-1432 As, Norway	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Saskatchewan; Bayer AG; Bayer CropScience; Kansas State University; University of California System; University of California Riverside; Kyoto University; University of Dundee; The Genome Analysis Centre (TGAC); Punjab Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); University of Delhi; University of Delhi; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Clermont Auvergne (UCA); UDICE-French Research Universities; Universite Paris Saclay; National Institute of Agrobiological Sciences - Japan; Yokohama City University; National Research Council Canada; University of Queensland; University of Western Australia; Norwegian University of Life Sciences; Inland Norway University of Applied Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Kansas State University; United States Department of Agriculture (USDA); Kansas State University; James Hutton Institute; University of Minnesota System; University of Minnesota Twin Cities; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Zurich; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Sabanci University; Murdoch University; Norwegian University of Life Sciences	Mayer, KFX (corresponding author), Helmholtz Zentrum Munich, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	k.mayer@helmholtz-muenchen.de; janerogersh@gmail.com; dolezel@ueb.cas.cz; curtis.pozniak@usask.ca; eversole@eversoleassociates.com; catherine.feuillet@bayer.com	Batley, Jacqueline/A-5723-2008; Edwards, David/H-3710-2015; Sharma, Sapna/N-6357-2017; cattivelli, luigi/AAE-7046-2020; Budak, Hikmet/F-4708-2010; Keller, Beat/K-3093-2019; Simkova, Hana/F-7734-2014; , 叮当๑/AAZ-9709-2020; Mayer, Klaus FX/M-7941-2015; Wulff, Brande B/N-4273-2013; Wulff, Brande BH/C-7465-2013; Kubaláková, Marie/F-8269-2014; Quesneville, Hadi/AAG-1048-2020; Eversole, Kellye/AAN-6141-2020; Dolezel, Jaroslav/B-7716-2008; Pfeifer, Matthias/GRJ-4579-2022; Wicker, Thomas/Z-1978-2019; Singh, Nouratan/N-9377-2017; Budak, Hikmet/U-8517-2019; HANDA, Hirokazu/C-9781-2009; SAB, Parveen Chhuneja -/H-5456-2019; Barry, Kerrie Whitelaw/AAA-5500-2020; Ramírez, Ricardo/H-4808-2019; Sourdille, Pierre/CAF-2780-2022; Wu, Jian/AAU-5221-2020; Stein, Nils/F-7507-2017; Pingault, Lise/AAQ-8602-2020; Vrana, Jan/F-7306-2014; Budak, Hikmet/S-5835-2017; Wang, Shichen/E-6213-2012; Wu, Jian/AAU-5221-2020	Batley, Jacqueline/0000-0002-5391-5824; Edwards, David/0000-0001-7599-6760; cattivelli, luigi/0000-0002-6067-4600; Budak, Hikmet/0000-0002-2556-2478; Keller, Beat/0000-0003-2379-9225; Simkova, Hana/0000-0003-4159-7619; Mayer, Klaus FX/0000-0001-6484-1077; Wulff, Brande BH/0000-0003-4044-4346; Quesneville, Hadi/0000-0003-3001-4908; Eversole, Kellye/0000-0002-8784-4913; Dolezel, Jaroslav/0000-0002-6263-0492; Singh, Nouratan/0000-0002-8063-8375; Budak, Hikmet/0000-0002-2556-2478; HANDA, Hirokazu/0000-0003-2985-2883; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Ramírez, Ricardo/0000-0001-5745-7085; Wu, Jian/0000-0001-9933-7364; Stein, Nils/0000-0003-3011-8731; Pingault, Lise/0000-0002-6149-1267; Vrana, Jan/0000-0001-6171-8516; Budak, Hikmet/0000-0002-2556-2478; Wang, Shichen/0000-0003-1441-2252; Singh, Kuldeep/0000-0001-5239-6586; Alaux, Michael/0000-0001-9356-4072; Martis, Mihaela-Maria/0000-0001-7509-2446; Bellgard, Matthew/0000-0002-6303-9469; Itoh, Takeshi/0000-0002-6291-4233; Gundlach, Heidrun/0000-0002-6757-0943; Poland, Jesse/0000-0002-7856-1399; Clavijo, Bernardo J./0000-0002-7597-2774; Tanaka, Tsuyoshi/0000-0003-3740-6832; Colaiacovo, Moreno/0000-0003-1320-0506; Scholz, Uwe/0000-0001-6113-3518; Kilian, Andrzej/0000-0002-2730-7462; Sourdille, Pierre/0000-0002-1027-2224; Paux, Etienne/0000-0002-3094-7129; Jamilloux, Veronique/0000-0002-6898-4910; Choulet, Frederic/0000-0003-1788-7288; Rokhsar, Daniel/0000-0002-8704-2224; , Thomas/0000-0002-6777-7135; Knox, Ron/0000-0002-2030-3899; Wu, Jian/0000-0002-3394-1507; Dyer, Sarah/0000-0001-5690-9633; Wright, Jonathan/0000-0001-6471-8749; Mascher, Martin/0000-0001-6373-6013; Spannagl, Manuel/0000-0003-0701-7035; Steuernagel, Burkhard/0000-0002-8284-7728	Institut National de la Recherche Agronomique (INRA); International Center for Agricultural Research in the Dry Areas; Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/IWGSC/03/TF/2008]; Biotechnology and Biological Sciences Research Council (BBSRC UK); 3A-U.S. Department of Agriculture Agriculture and Food Research Initiative (USDA AFRI) Triticeae-CAP [2011-68002-30029]; Kansas Wheat Commission; French National Research Agency [ANR-09-GENM-025 3BSEQ]; France Agrimer; Ministry of Agriculture, Forestry and Fisheries of Japan [KGS-1003,1004, NGB-1003]; Nisshin Flour Milling Incorporated; Genome Canada; Genome Prairie; University of Saskatchewan Ministry of Agriculture, Western Grains Research Foundation; Norwegian Research Council [199387]; Graminor AS; Czech Science foundation [P501/12/G090, P501/12/2554]; BBSRC (UK); German Ministry for Education and Research (BMBF) Plant2030; TRITEX; Deutsche Forschungsgemeinschaft (DFG) [SFB 924]; EC Transplant; IWGSC; Arcadia Biosciences; Australian Centre for Plant Functional Genomics; Biogemma; Bayer CropScience; Commonwealth Science and Industrial Research Organisation; Centro Internacional de Mejoramiento de Maiz y Trigo; Cereales Vallee; Dow AgroSciences; Dupont; Evogene; Florimond Desprez; Grains Research and Development Corporation; Graminor; Heartland Plant Innovation; INRA; KWS; Limagrain; Monsanto; RAGT; Syngenta; European Commission Marie Curie Actions (FP7-MC-IIF-Noncollinear Genes); Division Of Computer and Network Systems [1126709] Funding Source: National Science Foundation; BBSRC [BB/I026030/1, BBS/E/T/000PR5885, BBS/E/T/000PR6193, BB/J003743/1, BB/J003166/1, BB/I00663X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR5885, BB/I00663X/1, BB/J003743/1, BB/I026030/1, BBS/E/T/000PR6193, BB/J003166/1] Funding Source: researchfish	Institut National de la Recherche Agronomique (INRA); International Center for Agricultural Research in the Dry Areas; Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Biotechnology and Biological Sciences Research Council (BBSRC UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); 3A-U.S. Department of Agriculture Agriculture and Food Research Initiative (USDA AFRI) Triticeae-CAP; Kansas Wheat Commission; French National Research Agency(French National Research Agency (ANR)); France Agrimer; Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Nisshin Flour Milling Incorporated; Genome Canada(Genome Canada); Genome Prairie; University of Saskatchewan Ministry of Agriculture, Western Grains Research Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); Graminor AS; Czech Science foundation(Grant Agency of the Czech Republic); BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German Ministry for Education and Research (BMBF) Plant2030(Federal Ministry of Education & Research (BMBF)); TRITEX; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EC Transplant; IWGSC; Arcadia Biosciences; Australian Centre for Plant Functional Genomics; Biogemma; Bayer CropScience(Bayer AG); Commonwealth Science and Industrial Research Organisation; Centro Internacional de Mejoramiento de Maiz y Trigo; Cereales Vallee; Dow AgroSciences; Dupont; Evogene; Florimond Desprez; Grains Research and Development Corporation(Grains R&D Corp); Graminor; Heartland Plant Innovation; INRA; KWS; Limagrain; Monsanto; RAGT; Syngenta(Syngenta); European Commission Marie Curie Actions (FP7-MC-IIF-Noncollinear Genes); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to thank Graminor AS; Biogemma; Institut National de la Recherche Agronomique (INRA); International Center for Agricultural Research in the Dry Areas; Department of Biotechnology, Ministry of Science and Technology, Government of India (chr. 2A; grant no. BT/IWGSC/03/TF/2008); and the Biotechnology and Biological Sciences Research Council (BBSRC UK) for funding the chromosome sequencing at the Genome Analysis Centre. Chromosome sequencing at other centers was funded by the following: chr. 3A-U.S. Department of Agriculture Agriculture and Food Research Initiative (USDA AFRI) Triticeae-CAP (2011-68002-30029) and the Kansas Wheat Commission; chr. 3B-grants from the French National Research Agency (ANR-09-GENM-025 3BSEQ) and France Agrimer; chr. 6B-grants from the Ministry of Agriculture, Forestry and Fisheries of Japan "Genomics for agricultural innovation KGS-1003,1004", "Genomics based technology for agricultural improvement, NGB-1003," and Nisshin Flour Milling Incorporated; chr. 6D and Triticum durum cv. Strongfield-grants from Genome Canada, Genome Prairie, University of Saskatchewan Ministry of Agriculture, Western Grains Research Foundation; chr. 7B-grant no. 199387 from the Norwegian Research Council and from Graminor AS; chr. 7A and 7D sequence reads were provided by D. E.. Chromosome flow sorting and DNA preparation was supported through grants P501/12/G090 and P501/12/2554 from the Czech Science foundation. Chromosome sequence assembly was supported by the BBSRC (UK). K. F. X. M. acknowledges grants from the German Ministry for Education and Research (BMBF) Plant2030, TRITEX, Deutsche Forschungsgemeinschaft (DFG) SFB 924, and EC Transplant. K. E. and J.R. are supported by sponsors of the IWGSC, which include Arcadia Biosciences, Australian Centre for Plant Functional Genomics, Biogemma, Bayer CropScience, Commonwealth Science and Industrial Research Organisation, Centro Internacional de Mejoramiento de Maiz y Trigo, Cereales Vallee, Dow AgroSciences, Dupont, Evogene, Florimond Desprez, Grains Research and Development Corporation, Graminor, Heartland Plant Innovation, INRA, KWS, Kansas Wheat Commission, Limagrain, Monsanto, RAGT, and Syngenta. N. G. is supported by European Commission Marie Curie Actions (FP7-MC-IIF-Noncollinear Genes). T. W. is supported by the Swiss National Foundation and P. F., M. C., A. M. S., and L. C. are supported by the Italian Ministry of Agriculture special project "MAPPA-5A." H. B. acknowledges funding from Sabanci University and the Scientific and Technological Research Council of Turkey. B. W. and B. S. were funded by the Gatsby Charitable Foundation and the BBSRC (UK) Grant BB/J003166/1. R. W. is a Trustee Director of TGAC, Norwich, UK, and A. K. is a shareholder of Diversity Arrays Technology Pty Ltd. The POPSeq analysis carried out by the U. S. Department of Energy Joint Genome Institute was supported by the Office of Science of the U. S. Department of Energy under contract no. DE-AC02-05CH11231. Additional support for the work was funded from the Triticeae-CAP, USDA AFRI (2011-68002-30029) to G.J.M.; the Scottish Government Rural and Environment Science and Analytical Services Division Research Programme to R. W.; and the German Ministry of Research and Education (BMBF TRITEX 0315954) to N.S. Sequence reads and assembled sequences are available at European Molecular Biology Laboratory/GenBank/DNA Data Bank of Japan short read archives and sequence repositories, respectively (PRJEB3955-whole-genome sequences of T. aestivum 'Chinese Spring,' T. urartu, Ae. speltoides, Ae.; tauschii, T. turgidum; SRP004490.3-whole-genome sequencing of T. monococcum; SRP004490-whole-genome sequencing of Ae. tauschii; PRJEB4849 -whole-genome sequences of Ae. sharonensis; PRJEB4750-T. aestivum RNA-seq data; SRP037990-T. aestivum SynOpDH mapping population; SRP037781-T. aestivum synthetic opata M85; SRP037994-T. aestivum synthetic W7984). All data can be accessed via the IWGSC repository at Unite de Rercherche Genomique Info: http://wheat-urgi.versailles.inra.fr/Seq-Repository/.	Adams KL, 2007, J HERED, V98, P136, DOI 10.1093/jhered/esl061; Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Akhunov ED, 2013, PLANT PHYSIOL, V161, P252, DOI 10.1104/pp.112.205161; Allen AM, 2013, PLANT BIOTECHNOL J, V11, P279, DOI 10.1111/pbi.12009; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Berkman PJ, 2012, THEOR APPL GENET, V124, P423, DOI 10.1007/s00122-011-1717-2; Berkman PJ, 2011, PLANT BIOTECHNOL J, V9, P768, DOI 10.1111/j.1467-7652.2010.00587.x; Bernardo AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-251; Borchert Glen M, 2011, Mob Genet Elements, V1, P8; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Buggs RJA, 2012, CURR BIOL, V22, P248, DOI 10.1016/j.cub.2011.12.027; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chaudhary B, 2009, GENETICS, V182, P503, DOI 10.1534/genetics.109.102608; Chelaifa H, 2013, NEW PHYTOL, V197, P730, DOI 10.1111/nph.12108; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Cheng F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036442; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Civan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081955; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Coram TE, 2008, THEOR APPL GENET, V117, P401, DOI 10.1007/s00122-008-0784-5; Diaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033234; Eilam T, 2007, GENOME, V50, P1029, DOI 10.1139/G07-083; Escobar JS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-181; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food and Agriculture Organization (FAO) of the United Nations, 2013, FAO CER SUPPL DEM BR; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Griffiths S, 2006, NATURE, V439, P749, DOI 10.1038/nature04434; Hernandez P, 2012, PLANT J, V69, P377, DOI 10.1111/j.1365-313X.2011.04808.x; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; KANTAR M, 2012, GENOMICS, V12, P465, DOI DOI 10.1007/S10142-012-0285-0; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Knox RE, 2009, GENOME, V52, P741, DOI [10.1139/G09-042, 10.1139/g09-042]; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Krasileva KV, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r66; Kurtz S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-517; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Lucas SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040859; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; Ma J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079329; Marcussen T, 2014, SCIENCE, V345, DOI 10.1126/science.1250092; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Martinez-Perez E, 2001, NATURE, V411, P204, DOI 10.1038/35075597; Martis MM, 2013, PLANT CELL, V25, P3685, DOI 10.1105/tpc.113.114553; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Mayer KFX, 2009, PLANT PHYSIOL, V151, P496, DOI 10.1104/pp.109.142612; Mochida K, 2009, PLANT PHYSIOL, V150, P1135, DOI 10.1104/pp.109.138214; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; Nesbitt M., HULLED WHEATS PROMOT, P41; OECD/Food and Agriculture Organization of the United Nations, 2013, OECD FAO AGR OUTL 20, DOI [10.1787/agr_outlook-2013-en, DOI 10.1787/AGR_OUTLOOK-2013-EN]; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Pfeifer M, 2014, SCIENCE, V345, DOI 10.1126/science.1250091; Pumphrey M, 2009, GENETICS, V181, P1147, DOI 10.1534/genetics.108.096941; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Rapp RA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-18; Safar J, 2010, CYTOGENET GENOME RES, V129, P211, DOI 10.1159/000313072; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sears E. R., 1978, Proceedings of the fifth international wheat genetics symposium. Volume 1. Session IV. Cytogenetics., P389; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sorrells ME, 2011, GENOME, V54, P875, DOI [10.1139/G11-054, 10.1139/g11-054]; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Tanaka T, 2014, DNA RES, V21, P103, DOI 10.1093/dnares/dst041; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang JL, 2004, GENETICS, V167, P1961, DOI 10.1534/genetics.104.027896; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Wiebe K, 2010, THEOR APPL GENET, V121, P1047, DOI 10.1007/s00122-010-1370-1; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	86	1118	1138	30	440	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194			SI				1251788	10.1126/science.1251788	http://dx.doi.org/10.1126/science.1251788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR2MB	25035500				2022-12-28	WOS:000343420300004
J	Zhan, ZW; Helmberger, DV; Kanamori, H; Shearer, PM				Zhan, Zhongwen; Helmberger, Donald V.; Kanamori, Hiroo; Shearer, Peter M.			Supershear rupture in a M-w 6.7 aftershock of the 2013 Sea of Okhotsk earthquake	SCIENCE			English	Article							DEEP EARTHQUAKES; DYNAMIC RUPTURE; SHEAR CRACKS; WAVE-FORMS; TRANSITION; MECHANISM; FAULT; 3-D	Earthquake rupture speeds exceeding the shear-wave velocity have been reported for several shallow strike-slip events. Whether supershear rupture also can occur in deep earthquakes is unclear, because of their enigmatic faulting mechanism. Using empirical Green's functions in both regional and teleseismic waveforms, we observed supershear rupture during the 2013 moment magnitude (M-w) 6.7 deep earthquake beneath the Sea of Okhotsk, an aftershock of the large deep earthquake (M-w 8.3). The M-w 6.7 event ruptured downward along a steeply dipping fault plane at an average speed of 8 kilometers per second, suggesting efficient seismic energy generation. Comparing it to the highly dissipative 1994 M-w 8.3 Bolivia earthquake, the two events represent end members of deep earthquakes in terms of energy partitioning and imply that there is more than one rupture mechanism for deep earthquakes.	[Zhan, Zhongwen; Shearer, Peter M.] Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA; [Zhan, Zhongwen; Helmberger, Donald V.; Kanamori, Hiroo] CALTECH, Seismol Lab, Pasadena, CA 91125 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; California Institute of Technology	Zhan, ZW (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA.	zwzhan@ucsd.edu	; Shearer, Peter/K-5247-2012	Zhan, Zhongwen/0000-0002-5586-2607; Shearer, Peter/0000-0002-2992-7630	NSF [EAR-1142020, EAR-1111111]; Directorate For Geosciences [1111111] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank two anonymous reviewers for their helpful comments. The Incorporated Research Institutions for Seismology (IRIS) provided the seismic data. This work was supported by NSF (grants EAR-1142020 and EAR-1111111). All data used are available from the IRIS data center at www.iris.edu.	Ammon CJ, 2005, SCIENCE, V308, P1133, DOI 10.1126/science.1112260; ANDREWS DJ, 1976, J GEOPHYS RES, V81, P5679, DOI 10.1029/JB081i032p05679; ARCHULETA RJ, 1984, J GEOPHYS RES, V89, P4559, DOI 10.1029/JB089iB06p04559; Bouchon M, 2003, SCIENCE, V301, P824, DOI 10.1126/science.1086832; Bouchon M, 2001, GEOPHYS RES LETT, V28, P2723, DOI 10.1029/2001GL013112; Bouchon M, 2010, TECTONOPHYSICS, V493, P244, DOI 10.1016/j.tecto.2010.06.011; BURRIDGE R, 1973, GEOPHYS J ROY ASTR S, V35, P439, DOI 10.1111/j.1365-246X.1973.tb00608.x; Dunham EM, 2004, B SEISMOL SOC AM, V94, pS256, DOI 10.1785/0120040616; Frohlich C, 2006, DEEP EARTHQUAKES, P1, DOI 10.2277/ 0521828694; Hayes GP, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008524; Houston H., 2007, TREATISE SEISMOLOGY, P321, DOI DOI 10.1016/B978-044452748-6.00071-7; Kanamori H, 1998, SCIENCE, V279, P839, DOI 10.1126/science.279.5352.839; Kaneko Y, 2010, TECTONOPHYSICS, V493, P272, DOI 10.1016/j.tecto.2010.06.015; KUGE K, 1994, J GEOPHYS RES-SOL EA, V99, P2671, DOI 10.1029/93JB02992; Madariaga R, 2000, PURE APPL GEOPHYS, V157, P1981, DOI 10.1007/PL00001071; Park SC, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005434; Persh SE, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002762; Suzuki M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046807; Tibi R, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001948; Tocheport A, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004534; Vallee M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050725; Walker KT, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005738; Wang D, 2012, B SEISMOL SOC AM, V102, P301, DOI 10.1785/0120110034; Wiens DA, 2001, PHYS EARTH PLANET IN, V127, P145, DOI 10.1016/S0031-9201(01)00225-4; Xia KW, 2004, SCIENCE, V303, P1859, DOI 10.1126/science.1094022; Ye LL, 2013, SCIENCE, V341, P1380, DOI 10.1126/science.1242032; Yue H, 2013, J GEOPHYS RES-SOL EA, V118, P5903, DOI 10.1002/2013JB010594; Zhan ZW, 2014, PHYS EARTH PLANET IN, V232, P30, DOI 10.1016/j.pepi.2014.03.008; Zhan ZW, 2014, EARTH PLANET SC LETT, V385, P89, DOI 10.1016/j.epsl.2013.10.028; Zhang HM, 2006, GEOPHYS J INT, V167, P917, DOI 10.1111/j.1365-246X.2006.03102.x	30	43	44	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					204	207		10.1126/science.1252717	http://dx.doi.org/10.1126/science.1252717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013073				2022-12-28	WOS:000339409900051
J	Sibbing, D; Massberg, S				Sibbing, Dirk; Massberg, Steffen			Dual antiplatelet treatment after stenting: is longer better?	LANCET			English	Editorial Material							DRUG-ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; CONTROLLED-TRIAL; DOUBLE-BLIND; THERAPY; IMPLANTATION; DURATION; MULTICENTER; THROMBOSIS; RATIONALE		[Sibbing, Dirk] Univ Munich, Klinikum Univ Munchen, Med Klin & Poliklin 1, D-81377 Munich, Germany; DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany	University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Sibbing, D (corresponding author), Univ Munich, Klinikum Univ Munchen, Med Klin & Poliklin 1, Marchioninistr 15, D-81377 Munich, Germany.	dirk@sibbing.net	Massberg, Steffen/AAN-6054-2021					Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Byrne RA, 2009, AM HEART J, V157, P620, DOI 10.1016/j.ahj.2008.12.019; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Collet JP, 2014, LANCET, VS0140-6736, P60612; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Lee CW, 2014, CIRCULATION, V129, P304, DOI 10.1161/CIRCULATIONAHA.113.003303; Mauri L, 2010, AM HEART J, V160, P1035, DOI 10.1016/j.ahj.2010.07.038; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Sibbing D, 2010, THROMB HAEMOSTASIS, V103, P151, DOI 10.1160/TH09-05-0284; Stone GW, 2013, LANCET, V382, P614, DOI 10.1016/S0140-6736(13)61170-8; Valgimigli M, 2013, EUR HEART J, V34, P909, DOI 10.1093/eurheartj/ehs460	14	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2014	384	9954					1553	1555		10.1016/S0140-6736(14)60768-6	http://dx.doi.org/10.1016/S0140-6736(14)60768-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9NK	25037991				2022-12-28	WOS:000343901700006
J	Scheen, AJ				Scheen, Andre J.			Which incretin-based therapy for type 2 diabetes?	LANCET			English	Editorial Material							GLP-1 RECEPTOR AGONISTS; OPEN-LABEL; NON-INFERIORITY; EXENATIDE; LIRAGLUTIDE; INHIBITORS; TWICE		[Scheen, Andre J.] Univ Liege, CHU Sart Tilman, Dept Med, Div Diabet Nutr & Metab Disorders, B-4000 Liege, Belgium; [Scheen, Andre J.] Univ Liege, CHU Sart Tilman, Dept Med, Clin Pharmacol Unit, B-4000 Liege, Belgium	University of Liege; University of Liege	Scheen, AJ (corresponding author), Univ Liege, CHU Sart Tilman, Dept Med, Div Diabet Nutr & Metab Disorders, B-4000 Liege, Belgium.	andre.scheen@chu.ulg.ac.be						Blevins T, 2011, J CLIN ENDOCR METAB, V96, P1301, DOI 10.1210/jc.2010-2081; Buse JB, 2013, LANCET, V381, P117, DOI 10.1016/S0140-6736(12)61267-7; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Dungan KM, 2014, LANCET; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Owens DR, 2013, DIABETES METAB, V39, P485, DOI 10.1016/j.diabet.2013.09.004; Pratley RE, 2014, LANCET DIABETES ENDO, V2, P289, DOI 10.1016/S2213-8587(13)70214-6; Scheen AJ, 2008, LANCET, V372, P1197, DOI 10.1016/S0140-6736(08)61207-6; Scheen AJ, 2013, ANN ENDOCRINOL-PARIS, V74, P515, DOI 10.1016/j.ando.2012.06.002; Scheen AJ, 2010, LANCET, V375, P1410, DOI 10.1016/S0140-6736(10)60399-6; Wysham C, 2014, DIABETES CARE, V37, P2159, DOI [10.2337/dc13-2760, 10.2337/dc15-er07b]	13	9	9	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2014	384	9951					1325	1327		10.1016/S0140-6736(14)61097-7	http://dx.doi.org/10.1016/S0140-6736(14)61097-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NH	25018117	Green Submitted			2022-12-28	WOS:000343004000006
J	Ghosh, R; Wang, L; Wang, ES; Perera, BGK; Igbaria, A; Morita, S; Prado, K; Thamsen, M; Caswell, D; Macias, H; Weiberth, KF; Gliedt, MJ; Alavi, MV; Hari, SB; Mitra, AK; Bhhatarai, B; Schurer, SC; Snapp, EL; Gould, DB; German, MS; Backes, BJ; Maly, DJ; Oakes, SA; Papa, FR				Ghosh, Rajarshi; Wang, Likun; Wang, Eric S.; Perera, B. Gayani K.; Igbaria, Aeid; Morita, Shuhei; Prado, Kris; Thamsen, Maike; Caswell, Deborah; Macias, Hector; Weiberth, Kurt F.; Gliedt, Micah J.; Alavi, Marcel V.; Hari, Sanjay B.; Mitra, Arinjay K.; Bhhatarai, Barun; Schuerer, Stephan C.; Snapp, Erik L.; Gould, Douglas B.; German, Michael S.; Backes, Bradley J.; Maly, Dustin J.; Oakes, Scott A.; Papa, Feroz R.			Allosteric Inhibition of the IRE1 alpha RNase Preserves Cell Viability and Function during Endoplasmic Reticulum Stress	CELL			English	Article							UNFOLDED PROTEIN RESPONSE; ER STRESS; TRANSCRIPTION FACTOR; MAMMALIAN-CELLS; NLRP3 INFLAMMASOME; MESSENGER-RNAS; IRE1; KINASE; DEATH; TRANSLATION	Depending on endoplasmic reticulum (ER) stress levels, the ER transmembrane multidomain protein IRE1 alpha promotes either adaptation or apoptosis. Unfolded ER proteins cause IRE1a lumenal domain homo-oligomerization, inducing trans autophosphorylation that further drives homo-oligomerization of its cytosolic kinase/endoribonuclease (RNase) domains to activatem RNA splicing of adaptive XBP1 transcription factor. However, under high/chronic ER stress, IRE1a surpasses an oligomerization threshold that expands RNase substrate repertoire to many ER-localized mRNAs, leading to apoptosis. To modulate these effects, we developed ATP-competitive IRE1a Kinase-Inhibiting RNase Attenuators-KIRAs-that allosterically inhibit IRE1 alpha's RNase by breaking oligomers. One optimized KIRA, KIRA6, inhibits IRE1a in vivo and promotes cell survival under ER stress. Intravitreally, KIRA6 preserves photoreceptor functional viability in rat models of ER stress-induced retinal degeneration. Systemically, KIRA6 preserves pancreatic beta cells, increases insulin, and reduces hyperglycemia in Akita diabetic mice. Thus, IRE1a powerfully controls cell fate but can itself be controlled with small molecules to reduce cell degeneration.	[Ghosh, Rajarshi; Wang, Likun; Igbaria, Aeid; Morita, Shuhei; Prado, Kris; Thamsen, Maike; Macias, Hector; Weiberth, Kurt F.; Gliedt, Micah J.; German, Michael S.; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Ghosh, Rajarshi; Wang, Eric S.; Caswell, Deborah; Oakes, Scott A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Alavi, Marcel V.; Gould, Douglas B.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Gould, Douglas B.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Ghosh, Rajarshi; Wang, Likun; Igbaria, Aeid; Morita, Shuhei; Prado, Kris; Thamsen, Maike; Macias, Hector; Weiberth, Kurt F.; German, Michael S.; Oakes, Scott A.; Papa, Feroz R.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Ghosh, Rajarshi; Wang, Likun; Igbaria, Aeid; Morita, Shuhei; Prado, Kris; Thamsen, Maike; Weiberth, Kurt F.; Gliedt, Micah J.; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [Ghosh, Rajarshi; Wang, Likun; Igbaria, Aeid; Morita, Shuhei; Prado, Kris; Thamsen, Maike; Weiberth, Kurt F.; Papa, Feroz R.] Univ Calif San Francisco, California Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Perera, B. Gayani K.; Hari, Sanjay B.; Mitra, Arinjay K.; Maly, Dustin J.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Schuerer, Stephan C.] Univ Miami, Miller Sch Med, Ctr Computat Sci, Miami, FL 33136 USA; [Bhhatarai, Barun; Schuerer, Stephan C.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Snapp, Erik L.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of Miami; University of Miami; Yeshiva University; Albert Einstein College of Medicine	Oakes, SA (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	scott.oakes@ucsf.edu; frpapa@medicine.ucsf.edu	Igbaria, Aeid/S-6871-2019	Alavi, Marcel/0000-0002-1319-3062; Maly, Dustin/0000-0003-0094-0177; Igbaria, Aeid/0000-0003-3940-1824; /0000-0003-0606-9896; Ghosh, Rajarshi/0000-0002-5780-8241; Snapp, Erik/0000-0001-9482-2272; Papa, Feroz/0000-0002-3684-9108; Bhhatarai, Barun/0000-0002-0109-7487	National Institutes of Health [DP2OD001925, RO1 CA136577, RO1 DK080955, RO1 DK095306, RO1 DK100623, PO1 HL108794, P30 DK063720, UO1 DK089541, RO1 DK021344, RO1 GM086858, R21 CA177402, EY019504, EY01919, EY06842, F31-NS083323]; HHMI Physician-Scientist Early Career Award; American Cancer Society Research Scholar Award; Burroughs Wellcome Foundation; Juvenile Diabetes Research Foundation; Harrington Discovery Institute Scholar-Innovator Award; Alfred P. Sloan Foundation; Camille and Henry Dreyfus Foundation; National Science Foundation; American Diabetes Association [ADA-7-07-MN-22]; NATIONAL CANCER INSTITUTE [R21CA177402, R01CA136577] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY001919, F32EY006842, R37EY001919, R01EY006842] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021344, R01DK095306, U01DK089541, P30DK063720, R01DK080955, R01DK100623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS083323] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI Physician-Scientist Early Career Award(Howard Hughes Medical Institute); American Cancer Society Research Scholar Award(American Cancer Society); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Harrington Discovery Institute Scholar-Innovator Award; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Camille and Henry Dreyfus Foundation; National Science Foundation(National Science Foundation (NSF)); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Michael Matthes and Doug Yasumura for technical assistance with rat models, Vinh Nguyen for islet isolation, and Oakes and Papa lab members for discussions. The work was supported by National Institutes of Health grants DP2OD001925 (F. R. P.), RO1 CA136577 (S. A. O.), RO1 DK080955 (F. R. P.), RO1 DK095306 (S. A. O. and F. R. P.), RO1 DK100623 (D.J.M. and F. R. P.), PO1 HL108794 (F. R. P.), P30 DK063720 (F. R. P. and M. S. G.), UO1 DK089541 (F. R. P. and M. S. G.), RO1 DK021344 (M. S. G.), RO1 GM086858 (D.J.M.), R21 CA177402 (D.J.M.), EY019504 (D. B. G.), EY01919 (D. B. G.), EY06842 (D. B. G.), and F31-NS083323 (E. S. W.); HHMI Physician-Scientist Early Career Award (S. A. O.); American Cancer Society Research Scholar Award (S. A. O.); Burroughs Wellcome Foundation (F. R. P.); Juvenile Diabetes Research Foundation (F. R. P. and S. A. O.); Harrington Discovery Institute Scholar-Innovator Award (S. A. O. and F. R. P.); Alfred P. Sloan Foundation (D.J.M.); Camille and Henry Dreyfus Foundation (D.J.M.); National Science Foundation (E. S. W.); and American Diabetes Association ADA-7-07-MN-22 (H. M. S.).	Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dan H, 2008, BIOCHEM BIOPH RES CO, V365, P777, DOI 10.1016/j.bbrc.2007.11.040; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Kohno K, 2007, ANTIOXID REDOX SIGN, V9, P2295, DOI 10.1089/ars.2007.1819; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Pennesi ME, 2008, EXP EYE RES, V87, P561, DOI 10.1016/j.exer.2008.09.004; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Shimazawa M, 2007, MOL VIS, V13, P578; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Szot Gregory L, 2007, J Vis Exp, P255, DOI 10.3791/255; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang LK, 2012, NAT CHEM BIOL, V8, P982, DOI [10.1038/NCHEMBIO.1094, 10.1038/nchembio.1094]; Xue Z, 2011, J BIOL CHEM, V286, P30859, DOI 10.1074/jbc.M111.273714; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhang SX, 2014, EXP EYE RES, V125, P30, DOI 10.1016/j.exer.2014.04.015; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	38	309	322	2	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					534	548		10.1016/j.cell.2014.07.002	http://dx.doi.org/10.1016/j.cell.2014.07.002			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25018104	Bronze, Green Accepted			2022-12-28	WOS:000340944300008
J	Yaqub, F				Yaqub, Farhat			Rana Dajani: stem-cell research and ethics in the Middle East	LANCET			English	Biographical-Item																			0	1	1	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2014	384	9940					299	299		10.1016/S0140-6736(14)61250-2	http://dx.doi.org/10.1016/S0140-6736(14)61250-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3AE	25066151				2022-12-28	WOS:000339722400014
J	Dirzo, R; Young, HS; Galetti, M; Ceballos, G; Isaac, NJB; Collen, B				Dirzo, Rodolfo; Young, Hillary S.; Galetti, Mauro; Ceballos, Gerardo; Isaac, Nick J. B.; Collen, Ben			Defaunation in the Anthropocene	SCIENCE			English	Review							EXTINCTION RISK; FUNCTIONAL EXTINCTION; SPECIES EXTINCTION; BIODIVERSITY LOSS; CONSERVATION; DIVERSITY; DECLINES; IMPACTS; DISEASE; VULNERABILITY	We live amid a global wave of anthropogenically driven biodiversity loss: species and population extirpations and, critically, declines in local species abundance. Particularly, human impacts on animal biodiversity are an under-recognized form of global environmental change. Among terrestrial vertebrates, 322 species have become extinct since 1500, and populations of the remaining species show 25% average decline in abundance. Invertebrate patterns are equally dire: 67% of monitored populations show 45% mean abundance decline. Such animal declines will cascade onto ecosystem functioning and human well-being. Much remains unknown about this "Anthropocene defaunation"; these knowledge gaps hinder our capacity to predict and limit defaunation impacts. Clearly, however, defaunation is both a pervasive component of the planet's sixth mass extinction and also a major driver of global ecological change.	[Dirzo, Rodolfo] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Young, Hillary S.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Galetti, Mauro] Univ Estadual Paulista, Dept Ecol, BR-13506900 Rio Claro, SP, Brazil; [Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Isaac, Nick J. B.] NERC, Ctr Ecol & Hydrol, Crowmarsh Gifford OX10 8BB, Oxon, England; [Collen, Ben] UCL, Dept Genet Evolut & Environm, Ctr Biodivers & Environm Res, London WC1E 6BT, England	Stanford University; University of California System; University of California Santa Barbara; Universidade Estadual Paulista; Universidad Nacional Autonoma de Mexico; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of London; University College London	Dirzo, R (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	rdirzo@stanford.edu	Young, Hillary/S-1514-2017; Isaac, Nick/C-2716-2011; Galetti, Mauro/M-8751-2013; Lobo, Diele/I-9106-2012; Galetti, Mauro/C-5275-2008; Collen, Ben/F-2543-2016	Isaac, Nick/0000-0002-4869-8052; Galetti, Mauro/0000-0002-8187-8696; Galetti, Mauro/0000-0002-8187-8696; Collen, Ben/0000-0003-2564-4243	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao para o Desenvolvimento do Unesp; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; NERC; Joint Nature Conservation Committee; Universidad Nacional Autonoma de Mexico; NSF; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao para o Desenvolvimento do Unesp; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Joint Nature Conservation Committee; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); NSF(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	D. Orr, L. Gillespie, B. Rossman, R. Pringle, C. Bello, T. August, G. Powney, F. Pedrosa, and M. Pires helped in providing or analyzing data and producing figures. P. Ehrlich, T. Young, S. Vignieri, and two anonymous reviewers read a previous draft and offered constructive comments. Butterfly Conservation, the British Dragonfly Society, Bees Wasps and Ants Recording Society, the Ground Beetle Recording Scheme, and Bird Life International provided access to unpublished data. We thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao para o Desenvolvimento do Unesp, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, NERC, Joint Nature Conservation Committee, NSF, and Universidad Nacional Autonoma de Mexico for financial support. Vector images are courtesy of University of Maryland Center for Environmental Science.	Anderson SH, 2011, SCIENCE, V331, P1068, DOI 10.1126/science.1199092; Atwood TB, 2013, NAT GEOSCI, V6, P191, DOI 10.1038/ngeo1734; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Cardillo M, 2012, TRENDS ECOL EVOL, V27, P167, DOI 10.1016/j.tree.2011.09.013; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Ceballos G., 2010, J COSMOL, V8, P1821; Collen B., 2012, SPINELESS STATUS TRE; Collen B, 2010, SCIENCE, V329, P140, DOI 10.1126/science.329.5988.140-a; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Cowlishaw G, 2009, P R SOC B, V276, P63, DOI 10.1098/rspb.2008.0767; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; Di Marco M, 2014, CONSERV BIOL, V28, P1109, DOI 10.1111/cobi.12249; Dirzo R, 2001, ECOL STU AN, V152, P251; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Doughty CE, 2013, NAT GEOSCI, V6, P761, DOI 10.1038/NGEO1895; Estes JA, 2013, AM NAT, V181, pS76, DOI 10.1086/668120; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Fox R, 2014, J APPL ECOL, V51, P949, DOI 10.1111/1365-2664.12256; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Galetti M, 2008, BIOTROPICA, V40, P386, DOI 10.1111/j.1744-7429.2007.00378.x; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Golden CD, 2011, P NATL ACAD SCI USA, V108, P19653, DOI 10.1073/pnas.1112586108; Hawlena D, 2012, SCIENCE, V336, P1434, DOI 10.1126/science.1220097; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; IUCN, 2013, IUCN RED LIST THREAT; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Karp DS, 2013, ECOL LETT, V16, P1339, DOI 10.1111/ele.12173; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; McCauley DJ, 2012, ECOL APPL, V22, P1711, DOI 10.1890/11-1653.1; Mooers AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003700; Mora C., 2013, SCIENCE, V443, P295; Myers SS, 2013, P NATL ACAD SCI USA, V110, P18753, DOI 10.1073/pnas.1218656110; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pocock MJO, 2011, P ROY SOC B-BIOL SCI, V278, P1532, DOI 10.1098/rspb.2010.1971; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roels SAB, 2011, EVOLUTION, V65, P2541, DOI 10.1111/j.1558-5646.2011.01326.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Saterberg T, 2013, NATURE, V499, P468, DOI 10.1038/nature12277; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Whiles MR, 2013, ECOSYSTEMS, V16, P146, DOI 10.1007/s10021-012-9602-7; Wood CL, 2014, ECOLOGY, V95, P817, DOI 10.1890/13-1041.1; World Wildlife Fund (WWF), 2012, LIV PLAN REP 2012 BI; Wright JP, 2002, OECOLOGIA, V132, P96, DOI 10.1007/s00442-002-0929-1; Young HS, 2014, P NATL ACAD SCI USA, V111, P7036, DOI 10.1073/pnas.1404958111; Young HS, 2010, P NATL ACAD SCI USA, V107, P2072, DOI 10.1073/pnas.0914169107	78	1961	2032	87	1868	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					401	406		10.1126/science.1251817	http://dx.doi.org/10.1126/science.1251817			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061202	Green Submitted			2022-12-28	WOS:000339655100031
J	Johnson, AS; Hall, HI; Hu, XH; Lansky, A; Holtgrave, DR; Mermin, J				Johnson, Anna Satcher; Hall, H. Irene; Hu, Xiaohong; Lansky, Amy; Holtgrave, David R.; Mermin, Jonathan			Trends in Diagnoses of HIV Infection in the United States. 2002-2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Johnson, Anna Satcher; Hall, H. Irene; Hu, Xiaohong; Lansky, Amy] Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Atlanta, GA USA; [Holtgrave, David R.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Mermin, Jonathan] CDC, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA	Johnson, AS (corresponding author), CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, 1600 Clifton Rd NE, Atlanta, GA 30329 USA.	ats5@cdc.gov		Holtgrave, David/0000-0002-4321-7395	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Centers for Disease Control and Prevention, MONITORING SELECTED; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Paz-Bailey G, 2013, MMWR-MORBID MORTAL W, V62, P958; Ries LAG, 2002, SEER CANCER STATISTI; Whitmore Suzanne K., 2012, Morbidity and Mortality Weekly Report, V61, P971	6	110	110	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					432	434		10.1001/jama.2014.8534	http://dx.doi.org/10.1001/jama.2014.8534			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038362	Green Accepted, Bronze			2022-12-28	WOS:000339257800030
J	MacPherson, P; Lalloo, DG; Webb, EL; Maheswaran, H; Choko, AT; Makombe, SD; Butterworth, AE; van Oosterhout, JJ; Desmond, N; Thindwa, D; Squire, SB; Hayes, RJ; Corbett, EL				MacPherson, Peter; Lalloo, David G.; Webb, Emily L.; Maheswaran, Hendramoorthy; Choko, Augustine T.; Makombe, Simon D.; Butterworth, Anthony E.; van Oosterhout, Joep J.; Desmond, Nicola; Thindwa, Deus; Squire, Stephen Bertel; Hayes, Richard J.; Corbett, Elizabeth L.			Effect of Optional Home Initiation of HIV Care Following HIV Self-testing on Antiretroviral Therapy Initiation Among Adults in Malawi A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUB-SAHARAN AFRICA; INFECTION; RISK	IMPORTANCE Self-testing for HIV infection may contribute to early diagnosis of without necessarily increasing antiretroviral therapy (ART) initiation. OBJECTIVE To investigate whether offering optional home initiation of HIV care after HIV self-testing might increase demand for ART initiation, compared with HIV self-testing accompanied by facility-based services only. DESIGN, SETTING, AND PARTICIPANTS Cluster randomized trial conducted in Blantyre, Malawi, between January 30 and November 5, 2012, using restricted 1.1 randomization of 14 community health worker catchment areas. Participants were all adult (16 years) residents (n = 16 660) who received access to home HIV self-testing through resident volunteers. This was a second-stage randomization of clusters allocated to the HIV self-testing group of a parent trial. INTERVENTIONS Clusters were randomly allocated to facility-based care or optional home.. initiation of HIV care (including 2 weeks of ART if eligible) for participants reporting positive HIV self-test results. MAIN OUTCOMES AND MEASURES The PrePlanned Primary outcome compared between groups the proportion of all adult residents who initiated ART within the first 6 months of HIV self-testing availability. Secondary outcomes were uptake of HIV self-testing, reporting of positive HIV self-test results, and rates of loss from ART at 6 months. RESULTS A significantly greater proportion of adults in the home group initiated ART (181/8194, 2.2%) compared with the facility group (63/8466, 0.7%; risk ratio [RR], 2.94, 95% Cl, 2.10-4.12; P < .001). Uptake of HIV self-testing was high in both the home (5287/8194, 64.9%) and facility groups (4433/8466, 52.7%; RR, 1.23; 95% Cl, 0.96-1.58; P = .10). Significantly more adults reported positive HIV self-test results in the home group (490/8194 [6.0%] vs the facility group, 278/8466 [3.3%]; RR, 1.86; 95% Cl, 1.16-2.97; P = .006). After 6 months, 52 of 181 ART initiators (28.7%) and 15 of 63 ART initiators (23.8%) in the home and facility groups, respectively, were lost from ART (adjusted incidence rate ratio, 1.18; 95% Cl, 0.62-2.25, P = .57). CONCLUSIONS AND RELEVANCE Among Malawian adults offered HIV self-testing, optional home initiation of care compared with standard HIV care resulted in a significant increase in the proportion of adults initiating ART.	[MacPherson, Peter; Lalloo, David G.; Desmond, Nicola; Squire, Stephen Bertel] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [MacPherson, Peter; Maheswaran, Hendramoorthy; Choko, Augustine T.; Desmond, Nicola; Thindwa, Deus; Corbett, Elizabeth L.] Malawi Liverpool Wellcome Trust Clin Res Programm, TB & HIV Grp, Blantyre, Malawi; [Webb, Emily L.; Hayes, Richard J.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1, England; [Maheswaran, Hendramoorthy] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Warwick, England; [Makombe, Simon D.] Minist Hlth, HIV Dept, Lilongwe, Malawi; [Butterworth, Anthony E.; Corbett, Elizabeth L.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [van Oosterhout, Joep J.] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [van Oosterhout, Joep J.] Dignitas Int, Zomba, Malawi	Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of London; London School of Hygiene & Tropical Medicine; University of Warwick; University of London; London School of Hygiene & Tropical Medicine; University of Malawi	MacPherson, P (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	petermacp@gmail.com	Desmond, Nicola/GYQ-8574-2022; Desmond, Nicola/ABA-6504-2020; MacPherson, Peter/AHD-2477-2022	Desmond, Nicola/0000-0002-2874-8569; MacPherson, Peter/0000-0002-0329-9613; Webb, Emily/0000-0002-4019-7456; Maheswaran, Hendramoorthy/0000-0002-7375-4845; Hayes, Richard/0000-0002-1729-9892; Squire, Stephen/0000-0001-7173-9038; Thindwa, Deus/0000-0003-4845-7862; Corbett, Elizabeth/0000-0002-3552-3181; Lalloo, David/0000-0001-7680-2200	Wellcome Trust [WT089673, WT097973]; Wellcome Trust Senior Research Fellowship in Clinical Science [WT091769]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding/Support: This work was supported in part by grants from the Wellcome Trust (WT089673, P.M. and WT097973, H.M.) and a Wellcome Trust Senior Research Fellowship in Clinical Science (WT091769, E.L.C.).	[Anonymous], REP 1 INT S SELFT HI; [Anonymous], TEST HIV; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Corbett E., INTENSIFIED HIV TB P; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hayes RJ, 2009, INTERD STAT, P3; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Kalibala S, KNOW MYS 1 FEAS SELF; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Leisegang R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000189; MacPherson P, 2013, AM J EPIDEMIOL, V177, P1143, DOI 10.1093/aje/kws376; MacPherson P, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.18020; MacPherson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044794; Mavedzenge SN, 2013, CLIN INFECT DIS, V57, P126, DOI 10.1093/cid/cit156; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Ministry of Health, 2012, INT HIV PROGR REP OC; Ministry of Health Government of Malawi, 2011, CLIN MAN HIV CHILDR; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Reynolds NR, 2007, JAIDS-J ACQ IMM DEF, V46, P402, DOI 10.1097/QAI.0b013e318158a44f; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Staveteig S, 2013, DEMOGRAPHIC PATTERNS, V30; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; WHO, 2011, RET HIV PROGR DEF CH	33	135	135	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					372	379		10.1001/jama.2014.6493	http://dx.doi.org/10.1001/jama.2014.6493			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038356	Green Accepted, Bronze			2022-12-28	WOS:000339257800024
J	Belcheva, A; Irrazabal, T; Robertson, SJ; Streutker, C; Maughan, H; Rubino, S; Moriyama, EH; Copeland, JK; Kumar, S; Green, B; Geddes, K; Pezo, RC; Navarre, WW; Milosevic, M; Wilson, BC; Girardin, SE; Wolever, TMS; Edelmann, W; Guttman, DS; Philpott, DJ; Martin, A				Belcheva, Antoaneta; Irrazabal, Thergiory; Robertson, Susan J.; Streutker, Catherine; Maughan, Heather; Rubino, Stephen; Moriyama, Eduardo H.; Copeland, Julia K.; Kumar, Sachin; Green, Blerta; Geddes, Kaoru; Pezo, Rossanna C.; Navarre, William W.; Milosevic, Michael; Wilson, Brian C.; Girardin, Stephen E.; Wolever, Thomas M. S.; Edelmann, Winfried; Guttman, David S.; Philpott, Dana J.; Martin, Alberto			Gut Microbial Metabolism Drives Transformation of Msh2-Deficient Colon Epithelial Cells	CELL			English	Article							MULTIPLE INTESTINAL NEOPLASIA; DIETARY GLYCEMIC LOAD; COLORECTAL-CANCER; MISMATCH-REPAIR; DNA-DAMAGE; BUTYRATE; TUMORIGENESIS; INFLAMMATION; DEFICIENCY; ACTIVATION	The etiology of colorectal cancer (CRC) has been linked to deficiencies in mismatch repair and adenomatous polyposis coli (APC) proteins, diet, inflammatory processes, and gut microbiota. However, the mechanism through which the microbiota synergizes with these etiologic factors to promote CRC is not clear. We report that altering the microbiota composition reduces CRC in APC(Min/+) MSH2(-/-) mice, and that a diet reduced in carbohydrates phenocopies this effect. Gut microbes did not induce CRC in these mice through an inflammatory response or the production of DNA mutagens but rather by providing carbohydrate-derived metabolites such as butyrate that fuel hyperproliferation of MSH2(-/-) colon epithelial cells. Further, we provide evidence that the mismatch repair pathway has a role in regulating beta-catenin activity and modulating the differentiation of transit-amplifying cells in the colon. These data thereby provide an explanation for the interaction between microbiota, diet, and mismatch repair deficiency in CRC induction.	[Belcheva, Antoaneta; Irrazabal, Thergiory; Robertson, Susan J.; Kumar, Sachin; Green, Blerta; Geddes, Kaoru; Philpott, Dana J.; Martin, Alberto] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Streutker, Catherine] St Michaels Hosp, Dept Lab Med, Toronto, ON M5S 1W8, Canada; [Maughan, Heather] Ronin Inst, Montclair, NJ 07043 USA; [Rubino, Stephen; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON M5S 1A8, Canada; [Moriyama, Eduardo H.; Wilson, Brian C.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Copeland, Julia K.; Guttman, David S.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON M5S 3B2, Canada; [Pezo, Rossanna C.] Univ Toronto, Dept Med Oncol, Toronto, ON M5S 1A8, Canada; [Navarre, William W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Milosevic, Michael] Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada; [Wolever, Thomas M. S.] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada; [Edelmann, Winfried] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Yeshiva University; Albert Einstein College of Medicine	Martin, A (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.	alberto.martin@utoronto.ca	Wolever, Thomas/AAC-8066-2022	Navarre, William/0000-0002-9293-9220; Martin, Alberto/0000-0002-0795-0418; Wilson, Brian C./0000-0001-5543-666X; Kumar, Sachin/0000-0002-4853-3864; Milosevic, Michael/0000-0002-9620-6876; Irrazabal, Thergiory/0000-0003-0388-131X; Belcheva, Antoaneta/0000-0001-5061-7533	Becas Chile; DFATD Canada; CIHR [MOP-86683, MSH-87729]; Cancer Research Society [MOP66965]; Lotte & John Hecht Memorial Foundation grant of the Canadian Cancer Society [702027]; Canada Research Chair award	Becas Chile; DFATD Canada; CIHR(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; Lotte & John Hecht Memorial Foundation grant of the Canadian Cancer Society; Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	We are thankful to Drs. M. Shulman, M. Ohh, J. Mogridge, J. Danska, J. Carlyle, J. Gommerman, R. Bruce, and the Martin laboratory for helpful discussions and for reading the manuscript. We thank Maribel Berru and Kervan Rivera-Rufner for technical help. We acknowledge Becas Chile and DFATD Canada for sponsoring T.I. This research is supported by a CIHR grant to D.S.G. and to W.W.N. (MOP-86683, MSH-87729) and by a Cancer Research Society grant (MOP66965) and the Lotte & John Hecht Memorial Foundation grant of the Canadian Cancer Society (#702027) to A.M., who is supported by a Canada Research Chair award.	Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Arthur JC, 2011, INFLAMM BOWEL DIS, V17, P396, DOI 10.1002/ibd.21354; BARTHOLD SW, 1977, CANCER RES, V37, P4352; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chen GY, 2008, CANCER RES, V68, P10060, DOI 10.1158/0008-5472.CAN-08-2061; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Donohoe DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046589; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Dove WF, 1997, CANCER RES, V57, P812; Fernandes J, 2011, EUR J CLIN NUTR, V65, P1279, DOI 10.1038/ejcn.2011.116; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Franceschi S, 2001, ANN ONCOL, V12, P173, DOI 10.1023/A:1008304128577; FREEMAN HJ, 1986, GASTROENTEROLOGY, V91, P596, DOI 10.1016/0016-5085(86)90628-1; Gnagnarella P, 2008, AM J CLIN NUTR, V87, P1793, DOI 10.1093/ajcn/87.6.1793; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Heijmans J, 2013, CELL REP, V3, P1128, DOI 10.1016/j.celrep.2013.02.031; HERR R, 1990, AM J HEMATOL, V34, P1, DOI 10.1002/ajh.2830340102; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; KLEIN RS, 1977, NEW ENGL J MED, V297, P800, DOI 10.1056/NEJM197710132971503; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kucherlapati MH, 2010, GASTROENTEROLOGY, V138, P993, DOI 10.1053/j.gastro.2009.11.009; Lazarova DL, 2004, INT J CANCER, V110, P523, DOI 10.1002/ijc.20152; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Lupton JR, 2004, J NUTR, V134, P479, DOI 10.1093/jn/134.2.479; Magalhaes B, 2012, EUR J CANCER PREV, V21, P15, DOI 10.1097/CEJ.0b013e3283472241; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Meyerhardt JA, 2012, JNCI-J NATL CANCER I, V104, P1702, DOI 10.1093/jnci/djs399; Miller PE, 2010, NUTR CANCER, V62, P413, DOI 10.1080/01635580903407114; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Olive PL, 2005, CYTOM PART A, V66A, P1, DOI 10.1002/cyto.a.20154; Peters AC, 2003, DNA REPAIR, V2, P427, DOI 10.1016/S1568-7864(03)00003-X; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Reitmair AH, 1996, CANCER RES, V56, P2922; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; Roy Claude C, 2006, Nutr Clin Pract, V21, P351, DOI 10.1177/0115426506021004351; Senda T, 2007, MED MOL MORPHOL, V40, P68, DOI 10.1007/s00795-006-0352-5; Shoemaker AR, 2000, ONCOGENE, V19, P2774, DOI 10.1038/sj.onc.1203574; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Sohn KJ, 2003, CARCINOGENESIS, V24, P217, DOI 10.1093/carcin/24.2.217; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van den Abbeele P, 2013, ISME J, V7, P949, DOI 10.1038/ismej.2012.158; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015	54	275	285	0	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					288	299		10.1016/j.cell.2014.04.051	http://dx.doi.org/10.1016/j.cell.2014.04.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036629	Bronze			2022-12-28	WOS:000340943600010
J	Gomez, H				Gomez, Haley			ASTROPHYSICS Survival of the largest	NATURE			English	Editorial Material							HIGH-REDSHIFT; DUST BUDGET; HERSCHEL; GALAXIES; EXTINCTION; EVOLUTION; SHOCKS; STARS		Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3AA, S Glam, Wales	Cardiff University	Gomez, H (corresponding author), Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3AA, S Glam, Wales.	haley.gomez@astro.cf.ac.uk		Gomez, Haley/0000-0003-3398-0052	STFC [ST/K000926/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/K000926/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		BARLOW MJ, 1977, ASTROPHYS J, V211, pL83, DOI 10.1086/182346; Dunne L, 2011, MON NOT R ASTRON SOC, V417, P1510, DOI 10.1111/j.1365-2966.2011.19363.x; Gall C, 2011, ASTRON ASTROPHYS REV, V19, P1, DOI 10.1007/s00159-011-0043-7; Gall C, 2014, NATURE, V511, P326, DOI 10.1038/nature13558; Gomez HL, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/96; Gomez H. L., 2014, P SCI; GRUN E, 1993, NATURE, V362, P428, DOI 10.1038/362428a0; Indebetouw R, 2014, ASTROPHYS J LETT, V782, DOI 10.1088/2041-8205/782/1/L2; JONES AP, 1994, ASTROPHYS J, V433, P797, DOI 10.1086/174689; Li Y, 2008, ASTROPHYS J, V678, P1136, DOI 10.1086/528734; Matsuura M, 2011, SCIENCE, V333, P1258, DOI 10.1126/science.1205983; Matsuura M, 2009, MON NOT R ASTRON SOC, V396, P918, DOI 10.1111/j.1365-2966.2009.14743.x; Meisel DD, 2002, ASTROPHYS J, V579, P895, DOI 10.1086/342919; Morgan HL, 2003, MON NOT R ASTRON SOC, V343, P427, DOI 10.1046/j.1365-8711.2003.06681.x; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Rowlands K, 2014, MON NOT R ASTRON SOC, V441, P1040, DOI 10.1093/mnras/stu605; Zubko V, 2004, ASTROPHYS J SUPPL S, V152, P211, DOI 10.1086/382351	17	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					296	297		10.1038/nature13640	http://dx.doi.org/10.1038/nature13640			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030160				2022-12-28	WOS:000338992200021
J	Brown, RA; Lip, GYH				Brown, Richard A.; Lip, Gregory Y. H.			An "unlikely" Wells rule score (<= 1) plus a negative D-dimer result excluded DVT in noncancer patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DEEP-VEIN THROMBOSIS		[Brown, Richard A.; Lip, Gregory Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, Birmingham, England	University of Birmingham	Brown, RA (corresponding author), Univ Birmingham, Ctr Cardiovasc Sci, Birmingham, England.							Galanaud JP, 2014, J THROMB HAEMOST, V12, P436, DOI 10.1111/jth.12512; Goodacre S, 2006, QJM-INT J MED, V99, P377, DOI 10.1093/qjmed/hcl051; Kilroy DA, 2003, EMERG MED J, V20, P29, DOI 10.1136/emj.20.1.29; Runyon MS, 2008, EMERG MED J, V25, P70, DOI 10.1136/emj.2007.048918	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2							JC9	10.7326/0003-4819-161-2-201407150-02009	http://dx.doi.org/10.7326/0003-4819-161-2-201407150-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023275				2022-12-28	WOS:000339764600012
J	Chou, R				Chou, Roger			Low Back Pain	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; SOCIETY/AMERICAN COLLEGE; AMERICAN-COLLEGE; EXERCISE THERAPY; MANAGEMENT; PHYSICIANS; OUTCOMES; CARE; REHABILITATION; METAANALYSIS							Chou, Roger/0000-0001-9889-8610				*AM COLL SPORTS ME, 2005, ACSMS GUID EX TEST P; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Calonge N, 2005, AM FAM PHYSICIAN, V71, P2337; Choi BKL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006555.pub2; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Chou R, 2009, J PAIN, V10, P131, DOI 10.1016/j.jpain.2008.10.009; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Cramer H, 2013, CLIN J PAIN, V29, P450, DOI 10.1097/AJP.0b013e31825e1492; Davis Patricia C, 2009, J Am Coll Radiol, V6, P401, DOI 10.1016/j.jacr.2009.02.008; Deshpande A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004959.pub3; DEYO RA, 1992, JAMA-J AM MED ASSOC, V268, P760, DOI 10.1001/jama.268.6.760; Fairbank J C, 1980, Physiotherapy, V66, P271; Furlan AD, 2009, SPINE, V34, P1669, DOI 10.1097/BRS.0b013e3181ad7bd6; Gagnier JJ, 2007, SPINE, V32, P82, DOI 10.1097/01.brs.0000249525.70011.fe; Guzman J, 2001, BMJ-BRIT MED J, V322, P1511, DOI 10.1136/bmj.322.7301.1511; Hagen KB, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001254.PUB2; Hayden JA, 2005, ANN INTERN MED, V142, P765, DOI 10.7326/0003-4819-142-9-200505030-00013; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Henschke N, 2007, EUR SPINE J, V16, P1673, DOI 10.1007/s00586-007-0412-0; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Ijzelenberg H, 2007, SPINE, V32, P711, DOI 10.1097/01.brs.0000259072.14859.d9; Karjalainen K, 2001, SPINE, V26, P262, DOI 10.1097/00007632-200102010-00011; KEEFE FJ, 1989, PAIN, V37, P51, DOI 10.1016/0304-3959(89)90152-8; Lam M, 2013, SPINE, V38, P2124, DOI 10.1097/01.brs.0000435025.65564.b7; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Mirza SK, 2007, SPINE, V32, P816, DOI 10.1097/01.brs.0000259225.37454.38; National Center for Health Statistics, 2011, NAT AMB MED CAR SURV; Ostelo RWJG, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub2; Ostelo RWJG, 2005, BEST PRACT RES CL RH, V19, P593, DOI 10.1016/j.berh.2005.03.003; Pinto RZ, 2012, ANN INTERN MED, V157, P865, DOI 10.7326/0003-4819-157-12-201212180-00564; Roelofs PD, 2008, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000396.PUB3; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Rubinstein SM, 2011, SPINE, V36, pE825, DOI 10.1097/BRS.0b013e3182197fe1; Salerno SM, 2002, ARCH INTERN MED, V162, P19, DOI 10.1001/archinte.162.1.19; Skljarevski V, 2009, EUR J NEUROL, V16, P1041, DOI 10.1111/j.1468-1331.2009.02648.x; Skljarevski V, 2010, J PAIN, V11, P1282, DOI 10.1016/j.jpain.2010.03.002; Skljarevski V, 2010, SPINE, V35, pE578, DOI 10.1097/BRS.0b013e3181d3cef6; Sodha R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001167; Staiger TO, 2003, SPINE, V28, P2540, DOI 10.1097/01.BRS.0000092372.73527.BA; Urquhart DM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001703.pub3; Van Duijvenbode ICD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001823.pub3; van Tulder M W, 2003, Cochrane Database Syst Rev, pCD004252; van Tulder MW, 2004, SPINE, V29, pE357, DOI 10.1097/01.brs.0000137056.64166.51; Verbeek JH, 2012, WORK, V41, P2299, DOI 10.3233/WOR-2012-0455-2299; VonKorff M, 1996, SPINE, V21, P2833, DOI 10.1097/00007632-199612150-00004; WADDELL G, 1980, SPINE, V5, P117, DOI 10.1097/00007632-198003000-00005; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2451, DOI 10.1001/jama.296.20.2451	52	36	38	6	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2014	160	11							ITC5	10.7326/0003-4819-160-11-201406030-01006	http://dx.doi.org/10.7326/0003-4819-160-11-201406030-01006			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QW	25009837				2022-12-28	WOS:000364907800001
J	Cassel, CK; Saunders, RS				Cassel, Christine K.; Saunders, Robert S.			Engineering a Better Health Care System A Report From the President's Council of Advisors on Science and Technology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cassel, Christine K.; Saunders, Robert S.] Natl Qual Forum, Washington, DC 20005 USA		Saunders, RS (corresponding author), Natl Qual Forum, 1030 15th St NW,Ste 800, Washington, DC 20005 USA.	rsaunders@qualityforum.org						Blackmore CC, 2011, HEALTH AFFAIR, V30, P1680, DOI 10.1377/hlthaff.2011.0291; Bloom Jr FJ, IMPROVED PATIENT OUT; Cortese DA, 2013, JAMA-J AM MED ASSOC, V310, P1937, DOI 10.1001/jama.2013.281856; CRAWFORD B, 2012, CRIT CARE, V16, P12, DOI DOI 10.1186/CC11699; Eggleston EM, 2014, JAMA-J AM MED ASSOC, V311, P797, DOI 10.1001/jama.2014.163; Gabow PA., 2012, PROMISE LEAN PROCESS; President's Council of Advisors on Science and Technology, 2014, REP PRES BETT HLTH C; President's Council of Advisors on Science and Technology, 2010, REP PRES REAL FULL P	8	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2014	312	8					787	788		10.1001/jama.2014.8906	http://dx.doi.org/10.1001/jama.2014.8906			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7NX	25022260				2022-12-28	WOS:000340788500016
J	Harman, SM; Black, DM; Naftolin, F; Brinton, EA; Budoff, MJ; Cedars, MI; Hopkins, PN; Lobo, RA; Manson, JE; Merriam, GR; Miller, VM; Neal-Perry, G; Santoro, N; Taylor, HS; Vittinghoff, E; Yan, M; Hodis, HN				Harman, S. Mitchell; Black, Dennis M.; Naftolin, Frederick; Brinton, Eliot A.; Budoff, Matthew J.; Cedars, Marcelle I.; Hopkins, Paul N.; Lobo, Rogerio A.; Manson, Joann E.; Merriam, George R.; Miller, Virginia M.; Neal-Perry, Genevieve; Santoro, Nanette; Taylor, Hugh S.; Vittinghoff, Eric; Yan, Mingzhu; Hodis, Howard N.			Arterial Imaging Outcomes and Cardiovascular Risk Factors in Recently Menopausal Women A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							INTIMA-MEDIA THICKNESS; HORMONE REPLACEMENT THERAPY; CORONARY-HEART-DISEASE; ESTROGEN PLUS PROGESTIN; NORMOTENSIVE POSTMENOPAUSAL WOMEN; BEAM COMPUTED-TOMOGRAPHY; RENIN-ANGIOTENSIN SYSTEM; BLOOD-PRESSURE; FOLLOW-UP; CAROTID ATHEROSCLEROSIS	Background: Whether menopausal hormone therapy (MHT) protects against cardiovascular disease (CVD) remains unclear. Objective: To assess atherosclerosis progression and CVD risk factors after MHT initiated in early menopause. Design: Randomized, controlled trial. (ClinicalTrials.gov: NCT00154180) Setting: Nine U.S. academic centers. Participants: Healthy menopausal women aged 42 to 58 years between 6 and 36 months from last menses without prior CVD events who had a coronary artery calcium (CAC) score less than 50 Agatston units and had not received estrogen or lipid-lowering therapy for at least 90 days. Intervention: Oral conjugated equine estrogens (o-CEE), 0.45 mg/d, or transdermal 17 beta-estradiol (t-E-2), 50 mcg/d, each with 200 mg of oral progesterone for 12 days per month, or placebo for 48 months. Measurements: Primary end point was annual change in carotid artery intima-media thickness (CIMT). Secondary end points included changes in markers of CVD risk. Results: Of 727 randomly assigned women, 89.3% had at least 1 follow-up CIMT and 79.8% had CIMT at 48 months. Mean CIMT increases of 0.007 mm/y were similar across groups. The percentages of participants in whom CAC score increased did not differ significantly across groups. No changes in blood pressure were observed with o-CEE or t-E-2. Low-and high-density lipoprotein cholesterol levels improved and levels of C-reactive protein and sex hormone-binding globulin but not interleukin-6 increased with o-CEE. Insulin resistance decreased with t-E-2. Serious adverse events did not differ by treatment. Limitation: Power to compare clinical events was insufficient. Conclusion: Four years of early MHT did not affect progression of atherosclerosis despite improving some markers of CVD risk.	[Harman, S. Mitchell] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ 85012 USA; [Black, Dennis M.; Vittinghoff, Eric] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Naftolin, Frederick] NYU, Sch Med, New York, NY 10016 USA; [Brinton, Eliot A.; Hopkins, Paul N.] Univ Utah, Coll Med, Metab Sect, Salt Lake City, UT 84108 USA; [Budoff, Matthew J.] Harbor Univ Calif, Med Ctr, St Johns Cardiovasc Res Ctr, Torrance, CA 90502 USA; [Cedars, Marcelle I.] Univ Calif San Francisco, UCSF Ctr Reprod Hlth, San Francisco, CA 94115 USA; [Lobo, Rogerio A.] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Manson, Joann E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02215 USA; [Miller, Virginia M.] Mayo Clin, Rochester, MN 55905 USA; [Neal-Perry, Genevieve] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, Bronx, NY 10461 USA; [Santoro, Nanette] Univ Colorado Denver, Aurora, CO 80045 USA; [Taylor, Hugh S.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Yan, Mingzhu; Hodis, Howard N.] Univ So Calif, Sch Med, Div Cardiovasc Med, Atherosclerosis Res Unit, Los Angeles, CA 90033 USA	University of California System; University of California San Francisco; New York University; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California San Francisco; Columbia University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Mayo Clinic; Yeshiva University; Albert Einstein College of Medicine; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Yale University; University of Southern California	Harman, SM (corresponding author), Phoenix Vet Affairs Hlth Care Syst, Mailstop 111E,650 East Indian Sch Rd, Phoenix, AZ 85012 USA.	sherman.harman@va.gov	Budoff, Matthew/ABD-5175-2021	Budoff, Matthew/0000-0002-9616-1946	Aurora Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139, UL1RR024131, UL1RR024150] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090639] Funding Source: NIH RePORTER	Aurora Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Aurora Foundation.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; [Anonymous], 2005, CARDIOVASC J S AFR, V16, P61; Arad Y, 1996, CIRCULATION, V93, P1951, DOI 10.1161/01.CIR.93.11.1951; Brinton EA, 2008, TRENDS ENDOCRIN MET, V19, P206, DOI 10.1016/j.tem.2008.03.002; BUSH TL, 1983, JAMA-J AM MED ASSOC, V249, P903, DOI 10.1001/jama.249.7.903; Clarkson TB, 2007, MENOPAUSE, V14, P373, DOI 10.1097/GME.0b013e31803c764d; Crouse JR, 2007, CURR MED RES OPIN, V23, P641, DOI 10.1185/030079907X178711; ESPELAND MA, 1995, AM J EPIDEMIOL, V142, P1011, DOI 10.1093/oxfordjournals.aje.a117553; Ettinger B, 1996, OBSTET GYNECOL, V87, P6, DOI 10.1016/0029-7844(95)00358-4; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; Futterman L G, 2001, Am J Crit Care, V10, P63; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Grodstein F, 2003, NEW ENGL J MED, V348, P645, DOI 10.1056/NEJMsb022365; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Guzic-Salobir B, 2001, J INTERN MED, V250, P508, DOI 10.1046/j.1365-2796.2001.00910.x; Harman SM, 2005, CLIMACTERIC, V8, P3, DOI 10.1080/13697130500042417; Harman SM, 2009, MENOPAUSAL MED, V17, pS5; Harvey PJ, 1999, J HYPERTENS, V17, P405, DOI 10.1097/00004872-199917030-00014; Herrington DM, 1999, J AM COLL CARDIOL, V33, P2030, DOI 10.1016/S0735-1097(99)00128-X; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Houslay ES, 2006, HEART, V92, P1207, DOI 10.1136/hrt.2005.080929; Hsia J, 2004, CIRCULATION, V109, P620, DOI 10.1161/01.CIR.0000115309.63979.92; Hsia J, 2006, ARCH INTERN MED, V166, P357, DOI 10.1001/archinte.166.3.357; Ichikawa J, 2006, AM J HYPERTENS, V19, P744, DOI 10.1016/j.amjhyper.2005.10.006; Kawecka-Jaszcz K, 2002, J HUM HYPERTENS, V16, P509, DOI 10.1038/sj.jhh.1001431; Kennedy J, 1998, AM HEART J, V135, P696, DOI 10.1016/S0002-8703(98)70288-1; LIEBERMAN EH, 1994, ANN INTERN MED, V121, P936, DOI 10.7326/0003-4819-121-12-199412150-00005; Liebson Philip R, 2010, Prev Cardiol, V13, P141, DOI 10.1111/j.1751-7141.2010.00069.x; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; MacMahon S, 1998, CIRCULATION, V97, P1784, DOI 10.1161/01.CIR.97.18.1784; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Manson JE, 2007, NEW ENGL J MED, V356, P2591, DOI 10.1056/NEJMoa071513; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Mercuri M, 1996, AM J MED, V101, P627, DOI 10.1016/S0002-9343(96)00333-6; Moreau KL, 2003, CARDIOVASC RES, V57, P861, DOI 10.1016/S0008-6363(02)00777-0; Naftolin F, 2004, FERTIL STERIL, V81, P1498, DOI 10.1016/j.fertnstert.2004.02.095; Nasir K, 2004, AM J CARDIOL, V93, P1146, DOI 10.1016/j.amjcard.2004.01.043; Ostberg JE, 2007, CLIN ENDOCRINOL, V66, P557, DOI 10.1111/j.1365-2265.2007.02772.x; Raggi P, 2004, ARTERIOSCL THROM VAS, V24, P1272, DOI 10.1161/01.ATV.0000127024.40516.ef; Raggi P, 2003, AM J CARDIOL, V92, P827, DOI 10.1016/S0002-9149(03)00892-0; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; RUMBERGER JA, 1994, AM J CARDIOL, V73, P1169, DOI 10.1016/0002-9149(94)90176-7; Scuteri A, 2001, ANN INTERN MED, V135, P229, DOI 10.7326/0003-4819-135-4-200108210-00007; SELZER RH, 1994, ATHEROSCLEROSIS, V111, P1, DOI 10.1016/0021-9150(94)90186-4; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; Stanczyk FZ, 2010, CANCER EPIDEM BIOMAR, V19, P903, DOI 10.1158/1055-9965.EPI-10-0081; Steiner AZ, 2005, MENOPAUSE, V12, P728, DOI 10.1097/01.gme.0000184426.81190.01; Stork S, 2002, ATHEROSCLEROSIS, V165, P301, DOI 10.1016/S0021-9150(02)00242-3; Utian WH, 2007, MENOPAUSE, V14, P168, DOI 10.1097/gme.0b013e31803167ab; Vehkavaara S, 2000, CIRCULATION, V102, P2687, DOI 10.1161/01.CIR.102.22.2687; Wakatsuki A, 2001, CIRCULATION, V104, P1773, DOI 10.1161/hc4001.097035; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; 1995, JAMA, V273, P199	59	216	226	2	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4					249	+		10.7326/M14-0353	http://dx.doi.org/10.7326/M14-0353			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	25069991				2022-12-28	WOS:000342347300015
J	Whelan, R; Watts, R; Orr, CA; Althoff, RR; Artiges, E; Banaschewski, T; Barker, GJ; Bokde, ALW; Buchel, C; Carvalho, FM; Conrod, PJ; Flor, H; Fauth-Buhler, M; Frouin, V; Gallinat, J; Gan, G; Gowland, P; Heinz, A; Ittermann, B; Lawrence, C; Mann, K; Martinot, JL; Nees, F; Ortiz, N; Paillere-Martinot, ML; Paus, T; Pausova, Z; Rietschel, M; Robbins, TW; Smolka, MN; Strohle, A; Schumann, G; Garavan, H				Whelan, Robert; Watts, Richard; Orr, Catherine A.; Althoff, Robert R.; Artiges, Eric; Banaschewski, Tobias; Barker, Gareth J.; Bokde, Arun L. W.; Buechel, Christian; Carvalho, Fabiana M.; Conrod, Patricia J.; Flor, Herta; Fauth-Buehler, Mira; Frouin, Vincent; Gallinat, Juergen; Gan, Gabriela; Gowland, Penny; Heinz, Andreas; Ittermann, Bernd; Lawrence, Claire; Mann, Karl; Martinot, Jean-Luc; Nees, Frauke; Ortiz, Nick; Paillere-Martinot, Marie-Laure; Paus, Tomas; Pausova, Zdenka; Rietschel, Marcella; Robbins, Trevor W.; Smolka, Michael N.; Stroehle, Andreas; Schumann, Gunter; Garavan, Hugh		IMAGEN Consortium	Neuropsychosocial profiles of current and future adolescent alcohol misusers	NATURE			English	Article							SUBSTANCE USE; BRAIN; RISK; REINFORCEMENT; ENDOPHENOTYPES; RELIABILITY; IMPULSIVITY; DYSFUNCTION; INHIBITION; DEPENDENCE	A comprehensive account of the causes of alcohol misuse must accommodate individual differences in biology, psychology and environment, and must disentangle cause and effect. Animal models(1) can demonstrate the effects of neurotoxic substances; however, they provide limited insight into the psycho-social and higher cognitive factors involved in the initiation of substance use and progression to misuse. One can search for pre-existing risk factors by testing for endophenotypic biomarkers(2) in non-using relatives; however, these relatives may have personality or neural resilience factors that protect them from developing dependence(3). A longitudinal study has potential to identify predictors of adolescent substance misuse, particularly if it can incorporate a wide range of potential causal factors, both proximal and distal, and their influence on numerous social, psychological and biological mechanisms(4). Here we apply machine learning to a wide range of data from a large sample of adolescents (n = 692) to generate models of current and future adolescent alcohol misuse that incorporate brain structure and function, individual personality and cognitive differences, environmental factors (including gestational cigarette and alcohol exposure), life experiences, and candidate genes. These models were accurate and generalized to novel data, and point to life experiences, neurobiological differences and personality as important antecedents of binge drinking. By identifying the vulnerability factors underlying individual differences in alcohol misuse, these models shed light on the aetiology of alcohol misuse and suggest targets for prevention.	[Whelan, Robert; Ortiz, Nick; Garavan, Hugh] Univ Vermont, Dept Psychiat, Burlington, VT 05401 USA; [Whelan, Robert] Natl Univ Ireland Univ Coll Dublin, Dept Psychol, Dublin 4, Ireland; [Watts, Richard] Univ Vermont, Dept Radiol, Burlington, VT 05401 USA; [Orr, Catherine A.] Univ Vermont, Vermont Ctr Children Youth & Families, Burlington, VT 05401 USA; [Althoff, Robert R.] Univ Vermont, Dept Pediat, Burlington, VT 05401 USA; [Althoff, Robert R.; Garavan, Hugh] Univ Vermont, Dept Psychol, Burlington, VT 05401 USA; [Artiges, Eric; Martinot, Jean-Luc] Univ Paris 11, CEA, INSERM, Imaging & Psychiat U1000, F-91400 Orsay, France; [Artiges, Eric] Orsay Hosp, Dept Psychiat, F-91400 Orsay, France; [Banaschewski, Tobias; Flor, Herta; Fauth-Buehler, Mira; Mann, Karl; Nees, Frauke; Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, D-68159 Mannheim, Germany; [Barker, Gareth J.; Carvalho, Fabiana M.; Conrod, Patricia J.; Schumann, Gunter] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Bokde, Arun L. W.; Garavan, Hugh] Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland; [Buechel, Christian; Gallinat, Juergen] Univ Klinikum Hamburg Eppendorf, Dept Syst Neurosci, D-20246 Hamburg, Germany; [Buechel, Christian] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Conrod, Patricia J.] Univ Montreal, CHU Ste Justine Hosp, Dept Psychiat, Montreal, PQ H3T 1C5, Canada; [Fauth-Buehler, Mira] Heidelberg Univ, Dept Addict Behav & Addict Med, D-68159 Mannheim, Germany; [Frouin, Vincent] 14 CEA, DSV, I2BM, F-91191 Gif Sur Yvette, France; [Gallinat, Juergen; Heinz, Andreas; Paillere-Martinot, Marie-Laure; Stroehle, Andreas] Charite, Dept Psychiat & Psychotherapy, D-10117 Berlin, Germany; [Gan, Gabriela; Smolka, Michael N.] Tech Univ Dresden, Dept Psychiat, D-01062 Dresden, Germany; [Gan, Gabriela; Smolka, Michael N.] Tech Univ Dresden, Neuroimaging Ctr, D-01062 Dresden, Germany; [Gowland, Penny] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Ittermann, Bernd] Phys Tech Bundesanstalt PTB, D-10587 Berlin, Germany; [Lawrence, Claire] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Martinot, Jean-Luc; Paillere-Martinot, Marie-Laure] Univ Paris 05, AP HP, Dept Adolescent Psychopathol & Med, F-75006 Paris, France; [Ortiz, Nick] Univ Vermont, Neurosci Grad Program, Burlington, VT 05401 USA; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON M5R 0A3, Canada; [Paus, Tomas] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 0A4, Canada; [Robbins, Trevor W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 1TN, England; [Robbins, Trevor W.] Univ Cambridge, Dept Psychol, Cambridge CB2 1TN, England; [Schumann, Gunter] MRC Social Genet & Dev Psychiat SGDP Ctr, London WC2R 2LS, England	University of Vermont; University College Dublin; University of Vermont; University of Vermont; University of Vermont; University of Vermont; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of London; King's College London; Trinity College Dublin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Stanford University; Universite de Montreal; Ruprecht Karls University Heidelberg; CEA; UDICE-French Research Universities; Universite Paris Saclay; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; Technische Universitat Dresden; University of Nottingham; Physikalisch-Technische Bundesanstalt (PTB); University of Nottingham; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; University of Vermont; University of Toronto; University Toronto Affiliates; Baycrest; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Cambridge; University of Cambridge	Whelan, R (corresponding author), Univ Vermont, Dept Psychiat, Burlington, VT 05401 USA.	Robert.whelan@ucd.ie; Hugh.garavan@uvm.edu	Rapp, Michael/ABB-7573-2020; Heinz, Andreas/ABB-7736-2020; Lawrence, Claire/P-1058-2018; Vollstädt-Klein, Sabine/C-6744-2012; Williams, Steve C/D-6979-2011; Banaschewski, Tobias/ABE-5985-2020; Smolka, Michael/B-4865-2011; Stacey, David/AFX-6013-2022; Barker, Gareth J/C-9616-2009; Poustka, Luise/D-9299-2017; Artiges, Eric/C-2815-2019; Conrod, Patricia J/P-4187-2018; Robbins, Trevor W/A-7551-2008; Gowland, Penny A./I-9016-2012; Whelan, Robert/E-5365-2010; Nees, Frauke/AAZ-2150-2020; Martinot, Jean-Luc/N-3704-2018; Ströhle, Andreas/E-4286-2012; Artiges, Eric/AAT-7219-2021; Jia, Tianye/AAC-3925-2019	Rapp, Michael/0000-0003-0106-966X; Heinz, Andreas/0000-0001-5405-9065; Lawrence, Claire/0000-0001-6787-9716; Vollstädt-Klein, Sabine/0000-0002-6210-672X; Williams, Steve C/0000-0003-4299-1941; Banaschewski, Tobias/0000-0003-4595-1144; Smolka, Michael/0000-0001-5398-5569; Stacey, David/0000-0002-9392-9235; Barker, Gareth J/0000-0002-5214-7421; Artiges, Eric/0000-0003-4461-7646; Gowland, Penny A./0000-0002-4900-4817; Whelan, Robert/0000-0002-2790-7281; Artiges, Eric/0000-0003-4461-7646; Jia, Tianye/0000-0001-5399-2953; Bokde, Arun/0000-0003-0114-4914; Flor, Herta/0000-0003-4809-5398; Nees, Frauke/0000-0002-7796-8234; Robbins, Trevor/0000-0003-0642-5977; Gan, Gabriela/0000-0001-6589-6168; MIRANDA, RUBEN/0000-0002-9445-7348	European Union [LSHM-CT- 2007-037286]; FP7 projects IMAGEMEND [602450]; MATRICS [603016]; Innovative Medicine Initiative Project EU-AIMS [115300-2]; Medical Research Council Programme Grant "Developmental pathways into adolescent substance abuse" [93558]; Swedish funding agency FORMAS; Medical Research Council; Wellcome Trust (Behavioural and Clinical Neuroscience Institute, University of Cambridge); National Institute for Health Research (NIHR) Biomedical Research Centre at South London; Maudsley NHS Foundation Trust; King's College London; Bundesministerium fur Bildung und Forschung (BMBF) [01GS08152, 01EV0711, eMED SysAlc 01ZX1311A]; Deutsche Forschungsgemeinschaft (DFG) [SP 383/5-1, SM 80/7-1, SFB 940/1, FOR 1617]; French MILDT (Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie); CENIR (Centre de NeuroImagerie de Recherche) within the ICM institute; National Institute of Mental Health [MH082116]; National Institutes of Health Center of Biomedical Research Excellence award from the National Institute of General Medical Sciences [P20GM103644]; Tobacco Centers of Regulatory Science award [P50DA036114]; NASA at University of Vermont [NNX 06AC88G]; MRC [G0901858] Funding Source: UKRI; Medical Research Council [G1000183B, G0901858, G0001354B, G0001354] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH082116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA036114] Funding Source: NIH RePORTER	European Union(European Commission); FP7 projects IMAGEMEND; MATRICS; Innovative Medicine Initiative Project EU-AIMS; Medical Research Council Programme Grant "Developmental pathways into adolescent substance abuse"(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish funding agency FORMAS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (Behavioural and Clinical Neuroscience Institute, University of Cambridge); National Institute for Health Research (NIHR) Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; King's College London(General Electric); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); French MILDT (Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie); CENIR (Centre de NeuroImagerie de Recherche) within the ICM institute; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health Center of Biomedical Research Excellence award from the National Institute of General Medical Sciences; Tobacco Centers of Regulatory Science award; NASA at University of Vermont; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work received support from the following sources: the European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behaviour in normal brain function and psychopathology) (LSHM-CT- 2007-037286), the FP7 projects IMAGEMEND(602450; IMAging GEnetics for MENtal Disorders) and MATRICS (603016), the Innovative Medicine Initiative Project EU-AIMS (115300-2), a Medical Research Council Programme Grant "Developmental pathways into adolescent substance abuse" (93558), the Swedish funding agency FORMAS, the Medical Research Council and the Wellcome Trust (Behavioural and Clinical Neuroscience Institute, University of Cambridge), the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, the Bundesministerium fur Bildung und Forschung (BMBF grants 01GS08152; 01EV0711; eMED SysAlc 01ZX1311A; Forschungsnetz AERIAL), the Deutsche Forschungsgemeinschaft (DFG): Reinhart-Koselleck Award SP 383/5-1 and grants SM 80/7-1, SFB 940/1, FOR 1617), the French MILDT (Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie), the CENIR (Centre de NeuroImagerie de Recherche, Pr. S. Lehericy) within the ICM institute, the National Institute of Mental Health(MH082116), a National Institutes of Health Center of Biomedical Research Excellence award P20GM103644 from the National Institute of General Medical Sciences and the Tobacco Centers of Regulatory Science award P50DA036114. The authors acknowledge the Vermont Advanced Computing Core which is supported by NASA (NNX 06AC88G), at the University of Vermont for providing high performance computing resources that have contributed to the research results reported within this paper.	Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Castellanos-Ryan N, 2013, ALCOHOL CLIN EXP RES, V37, pE281, DOI 10.1111/j.1530-0277.2012.01931.x; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cloninger CR., 1999, TEMPERAMENT CHARACTE; Conrod PJ, 2008, J CHILD PSYCHOL PSYC, V49, P181, DOI [10.1111/j-1469-7610.2007.01826.x, 10.1111/j.1469-7610.2007.01826.x]; COSTA PT, 1995, J PERS ASSESS, V64, P21, DOI 10.1207/s15327752jpa6401_2; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Dube S. R., 2006, Journal of Adolescent Health, V38, DOI 10.1016/j.jadohealth.2005.06.006; Ersche KD, 2012, AM J PSYCHIAT, V169, P926, DOI 10.1176/appi.ajp.2012.11091421; Ersche KD, 2012, SCIENCE, V335, P601, DOI 10.1126/science.1214463; Ghahremani DG, 2013, J ADOLESCENT HEALTH, V53, P139, DOI 10.1016/j.jadohealth.2013.02.010; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Gottfredson Denise C, 2003, Prev Sci, V4, P27, DOI 10.1023/A:1021782710278; Grant BF, 2001, J SUBST ABUSE, V13, P493, DOI 10.1016/S0899-3289(01)00096-7; Grant JD, 2006, PSYCHOL MED, V36, P109, DOI 10.1017/S0033291705006045; Grosbras MH, 2006, CEREB CORTEX, V16, P1087; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hibell B, 1997, 1995 ESPAD REPORT AL; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; NEWCOMB MD, 1981, J HEALTH SOC BEHAV, V22, P400, DOI 10.2307/2136681; Nigg JT, 2006, J AM ACAD CHILD PSY, V45, P468, DOI 10.1097/01.chi.0000199028.76452.a9; Norman AL, 2011, DRUG ALCOHOL DEPEN, V119, P216, DOI 10.1016/j.drugalcdep.2011.06.019; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Pausova Z, 2007, HUM BRAIN MAPP, V28, P502, DOI 10.1002/hbm.20402; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Rietschel M, 2013, ANN NY ACAD SCI, V1282, P39, DOI 10.1111/j.1749-6632.2012.06794.x; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Schumann G, 2010, MOL PSYCHIATR, V15, P1128, DOI 10.1038/mp.2010.4; Stacey D, 2012, P NATL ACAD SCI USA, V109, P21128, DOI 10.1073/pnas.1211844110; Swendsen J, 2012, ARCH GEN PSYCHIAT, V69, P390, DOI 10.1001/archgenpsychiatry.2011.1503; Tyndale RF, 2003, ANN MED, V35, P94, DOI 10.1080/07853890310010014; Volkow ND, 2006, ARCH GEN PSYCHIAT, V63, P999, DOI 10.1001/archpsyc.63.9.999; Wechsler D, 1974, WECHSLER INTELLIGENC; Whelan R, 2014, BIOL PSYCHIAT, V75, P746, DOI 10.1016/j.biopsych.2013.05.014; Whelan R, 2012, NAT NEUROSCI, V15, P920, DOI 10.1038/nn.3092; Woicik PA, 2009, ADDICT BEHAV, V34, P1042, DOI 10.1016/j.addbeh.2009.07.001; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	43	286	292	10	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					185	+		10.1038/nature13402	http://dx.doi.org/10.1038/nature13402			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM9KO	25043041	Green Accepted, Green Submitted			2022-12-28	WOS:000340200700030
J	Liu, Y; Jesus, AA; Marrero, B; Yang, D; Ramsey, SE; Sanchez, GAM; Tenbrock, K; Wittkowski, H; Jones, OY; Kuehn, HS; Lee, CCR; DiMattia, MA; Cowen, EW; Gonzalez, B; Palmer, I; DiGiovanna, JJ; Biancotto, A; Kim, H; Tsai, WL; Trier, AM; Huang, Y; Stone, DL; Hill, S; Kim, HJ; St Hilaire, C; Gurprasad, S; Plass, N; Chapelle, D; Horkayne-Szakaly, I; Foell, D; Barysenka, A; Candotti, F; Holland, SM; Hughes, JD; Mehmet, H; Issekutz, AC; Raffeld, M; McElwee, J; Fontana, JR; Minniti, CP; Moir, S; Kastner, DL; Gadina, M; Steven, AC; Wingfield, PT; Brooks, SR; Rosenzweig, SD; Fleisher, TA; Deng, Z; Boehm, M; Paller, AS; Goldbach-Mansky, R				Liu, Y.; Jesus, A. A.; Marrero, B.; Yang, D.; Ramsey, S. E.; Sanchez, G. A. Montealegre; Tenbrock, K.; Wittkowski, H.; Jones, O. Y.; Kuehn, H. S.; Lee, C. -C. R.; DiMattia, M. A.; Cowen, E. W.; Gonzalez, B.; Palmer, I.; DiGiovanna, J. J.; Biancotto, A.; Kim, H.; Tsai, W. L.; Trier, A. M.; Huang, Y.; Stone, D. L.; Hill, S.; Kim, H. J.; St Hilaire, C.; Gurprasad, S.; Plass, N.; Chapelle, D.; Horkayne-Szakaly, I.; Foell, D.; Barysenka, A.; Candotti, F.; Holland, S. M.; Hughes, J. D.; Mehmet, H.; Issekutz, A. C.; Raffeld, M.; McElwee, J.; Fontana, J. R.; Minniti, C. P.; Moir, S.; Kastner, D. L.; Gadina, M.; Steven, A. C.; Wingfield, P. T.; Brooks, S. R.; Rosenzweig, S. D.; Fleisher, T. A.; Deng, Z.; Boehm, M.; Paller, A. S.; Goldbach-Mansky, R.			Activated STING in a Vascular and Pulmonary Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOGENIC AUTOINFLAMMATORY DISEASES; FAMILIAL CHILBLAIN LUPUS; CYCLIC GMP-AMP; I INTERFERON; PROTEASOME SUBUNIT; INBORN-ERRORS; DNA; SENSOR; LIPODYSTROPHY; EXPRESSION	BACKGROUND The study of autoinflammatory diseases has uncovered mechanisms underlying cytokine dysregulation and inflammation. METHODS We analyzed the DNA of an index patient with early-onset systemic inflammation, cutaneous vasculopathy, and pulmonary inflammation. We sequenced a candidate gene, TMEM173, encoding the stimulator of interferon genes (STING), in this patient and in five unrelated children with similar clinical phenotypes. Four children were evaluated clinically and immunologically. With the STING ligand cyclic guanosine monophosphate-adenosine monophosphate (cGAMP), we stimulated peripheral-blood mononuclear cells and fibroblasts from patients and controls, as well as commercially obtained endothelial cells, and then assayed transcription of IFNB1, the gene encoding interferon-beta, in the stimulated cells. We analyzed IFNB1 reporter levels in HEK293T cells cotransfected with mutant or nonmutant STING constructs. Mutant STING leads to increased phosphorylation of signal transducer and activator of transcription 1 (STAT1), so we tested the effect of Janus kinase (JAK) inhibitors on STAT1 phosphorylation in lymphocytes from the affected children and controls. RESULTS We identified three mutations in exon 5 of TMEM173 in the six patients. Elevated transcription of IFNB1 and other gene targets of STING in peripheral-blood mononuclear cells from the patients indicated constitutive activation of the pathway that cannot be further up-regulated with stimulation. On stimulation with cGAMP, fibroblasts from the patients showed increased transcription of IFNB1 but not of the genes encoding interleukin-1 (IL1), interleukin-6 (IL6), or tumor necrosis factor (TNF). HEK293T cells transfected with mutant constructs show elevated IFNB1 reporter levels. STING is expressed in endothelial cells, and exposure of these cells to cGAMP resulted in endothelial activation and apoptosis. Constitutive up-regulation of phosphorylated STAT1 in patients' lymphocytes was reduced by JAK inhibitors. CONCLUSIONS STING-associated vasculopathy with onset in infancy (SAVI) is an autoinflammatory disease caused by gain-of-function mutations in TMEM173.	[Liu, Y.; Jesus, A. A.; Marrero, B.; Sanchez, G. A. Montealegre; DiMattia, M. A.; Palmer, I.; Kim, H.; Tsai, W. L.; Trier, A. M.; Huang, Y.; Plass, N.; Chapelle, D.; Gadina, M.; Steven, A. C.; Wingfield, P. T.; Brooks, S. R.; Deng, Z.; Goldbach-Mansky, R.] NIAMSD, NIH, Bethesda, MD 20892 USA; [Lee, C. -C. R.; Cowen, E. W.; DiGiovanna, J. J.; Raffeld, M.] NCI, NIH, Bethesda, MD 20892 USA; [Yang, D.; Biancotto, A.; St Hilaire, C.; Fontana, J. R.; Minniti, C. P.; Boehm, M.] NHLBI, NIH, Bethesda, MD 20892 USA; [Kuehn, H. S.; Gurprasad, S.; Rosenzweig, S. D.; Fleisher, T. A.] NIH, Dept Lab Med, Bethesda, MD 20892 USA; [Stone, D. L.; Candotti, F.; Kastner, D. L.] NHGRI, NIH, Bethesda, MD 20892 USA; [Hill, S.] NIH, Dept Radiol & Imaging Serv, Bethesda, MD 20892 USA; [Kim, H. J.] Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD USA; [Holland, S. M.; Moir, S.] NIAID, NIH, Bethesda, MD 20892 USA; [Jones, O. Y.; Horkayne-Szakaly, I.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Ramsey, S. E.; Issekutz, A. C.] Dalhousie Univ, Halifax, NS, Canada; [Tenbrock, K.] Rhein Westfal TH Aachen, D-52062 Aachen, Germany; [Wittkowski, H.; Foell, D.; Barysenka, A.] Univ Hosp Muenster, Munster, Germany; [Gonzalez, B.] Hosp Ninos Luis Calvo Mackenna, Santiago, Chile; [Hughes, J. D.; Mehmet, H.; McElwee, J.] Merck Res Labs, Boston, MA USA; [Paller, A. S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Walter Reed National Military Medical Center; Dalhousie University; RWTH Aachen University; University of Munster; Universidad de Chile; Merck & Company; Northwestern University; Feinberg School of Medicine	Goldbach-Mansky, R (corresponding author), NIAMSD, NIH Bldg 10,Rm 6D-47B,10 Ctr Dr, Bethesda, MD 20892 USA.	goldbacr@mail.nih.gov	Gadina, Massimo/R-4195-2019; biancotto, angelique/C-4632-2011; Goldbach-Mansky, Raphaela/N-5917-2017; Moir, Susan/AAC-3676-2020; St. Hilaire, Cynthia/R-8205-2017; Lee, Chyi-Chia Richard/AAO-1149-2020; Minniti, Caterina/AAX-3187-2021; Lee, Chyi-Chia/I-1938-2013	biancotto, angelique/0000-0003-2271-009X; St. Hilaire, Cynthia/0000-0003-1871-6915; Kim, Hanna/0000-0002-0595-6533; Trier, Anna/0000-0001-7957-2180; Wingfield, Paul/0000-0002-9515-4752; Lee, Chyi-Chia/0000-0002-5306-7781; Paller, Amy/0000-0001-6187-6549; Candotti, Fabio/0000-0001-6399-6042; DiGiovanna, John J./0000-0002-2750-2313	National Institute of Arthritis and Musculoskeletal and Skin Diseases; NATIONAL CANCER INSTITUTE [ZICBC011087, ZIDBC011317] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006077, ZIAHL006079] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000825, ZIAAI001122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIDAR041180, ZIHAR041173, ZICAR041181, ZIAAR041138, ZIAAR027015] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases.	Agarwal AK, 2010, AM J HUM GENET, V87, P866, DOI 10.1016/j.ajhg.2010.10.031; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Arima K, 2011, P NATL ACAD SCI USA, V108, P14914, DOI 10.1073/pnas.1106015108; Beuthien W, 2005, CLIN RHEUMATOL, V24, P507, DOI 10.1007/s10067-005-1093-x; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Clark JD, 2014, J MED CHEM; Crow YJ, 2013, HAND CLINIC, V113, P1629, DOI 10.1016/B978-0-444-59565-2.00031-9; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Goldbach-Mansky R, 2012, CLIN EXP IMMUNOL, V167, P391, DOI 10.1111/j.1365-2249.2011.04533.x; GOODWIN JN, 1974, ARCH SURG-CHICAGO, V108, P780; Graf J, 2013, CURR OPIN RHEUMATOL, V25, P50, DOI 10.1097/BOR.0b013e32835b4449; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414; Kondo T, 2013, P NATL ACAD SCI USA, V110, P2969, DOI 10.1073/pnas.1222694110; Lee-Kirsch MA, 2006, AM J HUM GENET, V79, P731, DOI 10.1086/507848; Liu Y, 2012, ARTHRITIS RHEUM-US, V64, P895, DOI 10.1002/art.33368; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; O'Shea JJ, 2013, NEW ENGL J MED, V368, P161, DOI 10.1056/NEJMra1202117; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Rani MRS, 2007, J LEUKOCYTE BIOL, V82, P1353, DOI 10.1189/jlb.0507273; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rongioletti F, 1999, BRIT J DERMATOL, V140, P948, DOI 10.1046/j.1365-2133.1999.02833.x; Rosengren S, 2012, ANN RHEUM DIS, V71, P440, DOI 10.1136/ard.2011.150284; Ruiz-Irastorza G, 2010, LANCET, V376, P1498, DOI 10.1016/S0140-6736(10)60709-X; Sanchez GAM, 2013, RHEUM DIS CLIN N AM, V39, P701, DOI 10.1016/j.rdc.2013.08.001; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Szilasiova J, 2009, CLIN NEUROPHARMACOL, V32, P301, DOI 10.1097/WNF.0b013e3181a2b5fd; Thornsberry LA, 2013, J AM ACAD DERMATOL, V69, P450, DOI 10.1016/j.jaad.2013.01.043; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; van Boxel-Dezaire AHH, 2010, J IMMUNOL, V185, P5888, DOI 10.4049/jimmunol.0902314; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	42	730	767	8	131	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					507	518		10.1056/NEJMoa1312625	http://dx.doi.org/10.1056/NEJMoa1312625			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5LE	25029335	Green Accepted			2022-12-28	WOS:000339899100005
J	Sandler, NG; Bosinger, SE; Estes, JD; Zhu, RTR; Tharp, GK; Boritz, E; Levin, D; Wijeyesinghe, S; Makamdop, KN; del Prete, GQ; Hill, BJ; Timmer, JK; Reiss, E; Yarden, G; Darko, S; Contijoch, E; Todd, JP; Silvestri, G; Nason, M; Norgren, RB; Keele, BF; Rao, S; Langer, JA; Lifson, JD; Schreiber, G; Douek, DC				Sandler, Netanya G.; Bosinger, Steven E.; Estes, Jacob D.; Zhu, Richard T. R.; Tharp, Gregory K.; Boritz, Eli; Levin, Doron; Wijeyesinghe, Sathi; Makamdop, Krystelle Nganou; del Prete, Gregory Q.; Hill, Brenna J.; Timmer, J. Katherina; Reiss, Emma; Yarden, Ganit; Darko, Samuel; Contijoch, Eduardo; Todd, John Paul; Silvestri, Guido; Nason, Martha; Norgren, Robert B., Jr.; Keele, Brandon F.; Rao, Srinivas; Langer, Jerome A.; Lifson, Jeffrey D.; Schreiber, Gideon; Douek, Daniel C.			Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression	NATURE			English	Article							PERSISTENT LCMV INFECTION; CD4(+) T-CELLS; HIV-1 INFECTION; ALPHA; REPLICATION; ACQUISITION; ACTIVATION; BLOCKADE; THERAPY; GENES	Inflammation in HIV infection is predictive of non-AIDS morbidity and death(1), higher set point plasma virus load(2) and virus acquisition3; thus, therapeutic agents are in development to reduce its causes and consequences. However, inflammation may simultaneously confer both detrimental and beneficial effects. This dichotomy is particularly applicable to type I interferons (IFN-I) which, while contributing to innate control of infection(4-10), also provide target cells for the virus during acute infection, impair CD4 T-cell recovery, and are associated with disease progression(6,11-19). Here we manipulated IFN-I signalling in rhesus macaques (Macaca mulatta) during simian immunodeficiency virus (Sly) transmission and acute infection with two complementary in vivo interventions. We show that blockade of the IFN-I receptor caused reduced antiviral gene expression, increased SIV reservoir size and accelerated CD4 T-cell depletion with progression to AIDS despite decreased T-cell activation. In contrast, IFN-a2a administration initially upreg-ulated expression of antiviral genes and prevented systemic infection. However, continued IFN-a2a treatment induced IFN-I desensitization and decreased antiviral gene expression, enabling infection with increased SIV reservoir size and accelerated CD4 T-cell loss. Thus, the timing of IFN-induced innate responses in acute SIV infection profoundly affects overall disease course and outweighs the detrimental consequences of increased immune activation. Yet, the clinical consequences of manipulation of IFN signalling are difficult to predict in vivo and therapeutic interventions in human studies should be approached with caution.	[Sandler, Netanya G.; Zhu, Richard T. R.; Boritz, Eli; Wijeyesinghe, Sathi; Makamdop, Krystelle Nganou; Hill, Brenna J.; Timmer, J. Katherina; Reiss, Emma; Darko, Samuel; Contijoch, Eduardo; Douek, Daniel C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Bosinger, Steven E.; Tharp, Gregory K.; Silvestri, Guido] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Div Microbiol & Immunol, Atlanta, GA 30322 USA; [Bosinger, Steven E.; Tharp, Gregory K.] Emory Univ, Robert W Woodruff Hlth Sci Ctr, Yerkes Natl Primate Res Ctr, Nonhuman Primate Genom Core, Atlanta, GA 30322 USA; [Estes, Jacob D.; del Prete, Gregory Q.; Keele, Brandon F.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab, Frederick, MD 21702 USA; [Levin, Doron; Yarden, Ganit; Schreiber, Gideon] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Todd, John Paul; Rao, Srinivas] NIAID, Lab Anim Med, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Nason, Martha] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA; [Norgren, Robert B., Jr.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Langer, Jerome A.] Rutgers Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Nebraska System; University of Nebraska Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Douek, DC (corresponding author), NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ddouek@mail.nih.gov		Wijeyesinghe, Sathi/0000-0002-8819-2654; Utay, Netanya/0000-0002-6407-8670; Norgren, Robert/0000-0002-0021-5875; Contijoch, Eduardo/0000-0002-2873-6808; Langer, Jerome/0000-0002-4617-3260	NIH Intramural Funding; NCI/NIH [HHSN261200800001E]; NIH [R24 RR017444, AI-076174]; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation grant [1775/12]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI076174] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	NIH Intramural Funding; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation grant(Israel Science Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to acknowledge A. Zimin for his work in creating the MuSuRCA rhesus assembly, C. Miller for the gift of 6 rhesus macaques and Y. Peleg and S. Albeck at the Israel Structure Proteomic Center and G. Jona from Weizmann Institute Biological services for helping with protein production and purification; A. Roque and N. Haining for initial work on the pilot study; N. Modi, D. Ambrozak, R. Koup, M. Ghosh, I. Srivastava, R. Schwartz, F. Villinger, K. Zoon, J. Bekisz, K. Ghneim, A. Filali, R. Sekaly, L. Mach and L. Shen for their assistance on the current project; and A. Somasunderam for additional support This project was supported by NIH Intramural Funding, federal funds from NCI/NIH Contract HHSN261200800001E, NIH R24 RR017444, NIH AI-076174, I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation grant No. 1775/12.	Abel K, 2002, J VIROL, V76, P8433, DOI 10.1128/JVI.76.16.8433-8445.2002; Asmuth DM, 2008, J MED PRIMATOL, V37, P26, DOI 10.1111/j.1600-0684.2007.00221.x; Azzoni L, 2013, J INFECT DIS, V207, P213, DOI 10.1093/infdis/jis663; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Brenchley JM, 2012, BLOOD, V120, P4172, DOI 10.1182/blood-2012-06-437608; Carrington M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007070; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Fenton-May AE, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-146; Fernandez S, 2011, J INFECT DIS, V204, P1927, DOI 10.1093/infdis/jir659; Fraietta JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003658; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Haas DW, 2000, AIDS RES HUM RETROV, V16, P183, DOI 10.1089/088922200309278; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hunt PW, 2014, J INFECT DIS; LANE HC, 1988, LANCET, V2, P1218; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Manion M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030306; McElrath MJ, 2013, JAIDS-J ACQ IMM DEF, V63, P263, DOI 10.1097/QAI.0b013e3182898392; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Roberts L, 2012, J INFECT DIS, V205, P194, DOI 10.1093/infdis/jir715; Schellekens H, 1996, ANTIVIR RES, V32, P1, DOI 10.1016/0166-3542(95)00955-8; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vanderford TH, 2012, BLOOD, V119, P5750, DOI 10.1182/blood-2012-02-411496; Waggoner SN, 2014, J VIROL, V88, P1953, DOI 10.1128/JVI.03002-13; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208	34	332	337	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					601	+		10.1038/nature13554	http://dx.doi.org/10.1038/nature13554			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043006	Green Accepted, Green Published			2022-12-28	WOS:000339566300037
J	Zhang, LR; Wang, SX; Yin, S; Hong, S; Kim, KP; Kleckner, N				Zhang, Liangran; Wang, Shunxin; Yin, Shen; Hong, Soogil; Kim, Keun P.; Kleckner, Nancy			Topoisomerase II mediates meiotic crossover interference	NATURE			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; CROSSING-OVER; CHROMOSOME SYNAPSIS; MITOTIC CHROMOSOMES; CHIASMA FORMATION; YEAST MEIOSIS; RECOMBINATION; PROTEIN	Spatial patterning is a ubiquitous feature of biological systems. Meiotic crossovers provide an interesting example, defined by the classic phenomenon of crossover interference. Here we identify a molecular pathway for interference by analysing crossover patterns in budding yeast. Topoisomerase II plays a central role, thus identifying a new function for this critical molecule. SUMOylation (of topoisomerase II and axis component Red1) and ubiquitin-mediated removal of SUMOylated proteins are also required. The findings support the hypothesis that crossover interference involves accumulation, relief and redistribution of mechanical stress along the protein/ DNA meshwork of meiotic chromosome axes, with topoisomerase II required to adjust spatial relationships among DNA segments.	[Zhang, Liangran; Wang, Shunxin; Yin, Shen; Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Hong, Soogil; Kim, Keun P.] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea	Harvard University; Chung Ang University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu		Kim, Keun/0000-0002-5973-8259; zhang, liangran/0000-0002-8550-6742	National Institutes of Health [RO1 GM044794]; National Research Foundation of Korea - Ministry of Science, ICT and Future Planning [2012-M3A9C6050367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea - Ministry of Science, ICT and Future Planning; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Hochstrasser, J. Bachant, S. Jentsch, L. Pillus and M. Weinreich for plasmids, J. Fung for Zip2 focus data, D. Zickler for the image in Fig. 6a, and members of the Kleckner laboratory and D. Zickler for advice and discussions. This research, L.Z., S. W., S.Y. and N.K. were supported by a grant to N.K. from the National Institutes of Health (RO1 GM044794); S. H. and K. P. K. were supported by the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning (2012-M3A9C6050367).	Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Agostinho M, 2008, CANCER RES, V68, P2409, DOI 10.1158/0008-5472.CAN-07-2092; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Baldwin M, 2009, METHODS MOL BIOL, V582, P209, DOI 10.1007/978-1-60761-340-4_16; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Charles DR, 1938, J GENET, V36, P103, DOI 10.1007/BF02982376; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; Darst RP, 2008, MOL CELL BIOL, V28, P1361, DOI 10.1128/MCB.01291-07; de los Santos T, 2003, GENETICS, V164, P81; Deryshire MK, 1996, YEAST, V12, P631; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; Drouaud J, 2007, PLOS GENET, V3, P1096, DOI 10.1371/journal.pgen.0030106; Eichinger CS, 2010, P NATL ACAD SCI USA, V107, P11370, DOI 10.1073/pnas.1004248107; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Henderson KA, 2005, BIOESSAYS, V27, P995, DOI 10.1002/bies.20310; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hong S, 2013, MOL CELL, V51, P440, DOI 10.1016/j.molcel.2013.08.008; Hooker GW, 2006, CURR BIOL, V16, P1238, DOI 10.1016/j.cub.2006.04.045; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Jones GH, 2006, CELL, V126, P246, DOI 10.1016/j.cell.2006.07.010; Kauppi L, 2013, GENE DEV, V27, P873, DOI 10.1101/gad.213652.113; Kawamura R, 2010, J CELL BIOL, V188, P653, DOI 10.1083/jcb.200910085; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; KING JS, 1990, GENETICS, V126, P1127; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kleckner N., 2011, GENOME ORG FUNCTION, P487; Kleckner N, 2013, SCIENCE, V342, P940, DOI 10.1126/science.1247514; KLEIN F, 1992, J CELL BIOL, V117, P935, DOI 10.1083/jcb.117.5.935; Koszul R, 2009, TRENDS CELL BIOL, V19, P716, DOI 10.1016/j.tcb.2009.09.007; Lee MT, 2009, DNA REPAIR, V8, P557, DOI 10.1016/j.dnarep.2009.01.004; Libuda DE, 2013, NATURE, V502, P703, DOI 10.1038/nature12577; Loidl J, 1998, METHOD CELL BIOL, V53, P257; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; MOENS PB, 1989, CHROMOSOMA, V98, P317, DOI 10.1007/BF00292383; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Nagai S, 2011, CELL RES, V21, P474, DOI 10.1038/cr.2011.31; Nishant KT, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001109; Novak I, 2008, J CELL BIOL, V180, P83, DOI 10.1083/jcb.200706136; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Petkolv PM, 2007, TRENDS GENET, V23, P539, DOI 10.1016/j.tig.2007.08.015; Pope LH, 2006, MOL BIOL CELL, V17, P104, DOI 10.1091/mbc.e05-04-0321; ROSE D, 1993, MOL CELL BIOL, V13, P3445, DOI 10.1128/MCB.13.6.3445; Serrentino ME, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003416; Shinohara M, 2008, NAT GENET, V40, P299, DOI 10.1038/ng.83; Storlazzi A, 2010, CELL, V141, P94, DOI 10.1016/j.cell.2010.02.041; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Vecchiarelli AG, 2013, P NATL ACAD SCI USA, V110, pE1390, DOI 10.1073/pnas.1302745110; Warsi T. H., 2009, THESIS U CALIF; Wu CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002000; Zhang LR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004042; Zhang LR, 2011, P NATL ACAD SCI USA, V108, P20036, DOI 10.1073/pnas.1117937108; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	67	109	109	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					551	+		10.1038/nature13442	http://dx.doi.org/10.1038/nature13442			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043020	Green Accepted			2022-12-28	WOS:000339566300026
J	Smith, JM				Smith, Jeanette M.			HIV/AIDS: Gaining Ground and Forging Forward	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									JAMA, Chicago, IL 60611 USA		Smith, JM (corresponding author), JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA.	Jeanette.Smith@jamanetwork.org						[Anonymous], 2014, JAMA, V312, P428, DOI 10.1001/jama.2014.8406; Bender GA, 1965, GREAT MOMENTS MED ST, P60; Chi BH, 2014, JAMA-J AM MED ASSOC, V312, P341, DOI 10.1001/jama.2014.6929; Cohen IG, 2014, JAMA-J AM MED ASSOC, V312, P337, DOI 10.1001/jama.2014.8037; Fauci AS, 2014, JAMA-J AM MED ASSOC, V312, P335, DOI 10.1001/jama.2014.4754; Folkers GK, 2010, JAMA-J AM MED ASSOC, V304, P350, DOI 10.1001/jama.2010.957; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Heidari S, 2014, JAMA-J AM MED ASSOC, V312, P339, DOI 10.1001/jama.2014.5806; Jin Jill, 2014, JAMA, V312, P452, DOI 10.1001/jama.2014.8191; Johnson AS, 2014, JAMA-J AM MED ASSOC, V312, P432, DOI 10.1001/jama.2014.8534; MacPherson P, 2014, JAMA-J AM MED ASSOC, V312, P372, DOI 10.1001/jama.2014.6493; Marrazzo JM, 2014, JAMA-J AM MED ASSOC, V312, P390, DOI 10.1001/jama.2014.7999; Mathers BM, 2014, JAMA-J AM MED ASSOC, V312, P349, DOI 10.1001/jama.2014.8606; Mugo NR, 2014, JAMA-J AM MED ASSOC, V312, P362, DOI 10.1001/jama.2014.8735; Saag MS, 2014, JAMA-J AM MED ASSOC, V312, P347, DOI 10.1001/jama.2014.7735; Stanley TL, 2014, JAMA-J AM MED ASSOC, V312, P380, DOI 10.1001/jama.2014.8334; Sulkowski MS, 2014, JAMA-J AM MED ASSOC, V312, P353, DOI 10.1001/jama.2014.7734; US Public Health Service, PREEXP PROPH PREV HI	18	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					351	352		10.1001/jama.2014.9145	http://dx.doi.org/10.1001/jama.2014.9145			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038353				2022-12-28	WOS:000339257800021
J	Wise, S				Wise, Sarah			The art of medicine A tale of whistle-blowing and the English lunacy laws	LANCET			English	Editorial Material												blackeststreets@googlemail.com						HERVEY N, 1986, MED HIST, V30, P245, DOI 10.1017/S0025727300045701; Mitford J., 1825, MADHOUSE SYSTEM; Mitford J., 1823, MADHOUSE SYSTEM; Paternoster R, 1841, MADHOUSE SYSTEM; Wise Sarah., 2013, INCONVENIENT PEOPLE	5	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					226	227		10.1016/S0140-6736(14)61201-0	http://dx.doi.org/10.1016/S0140-6736(14)61201-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	AL8JI	25050440				2022-12-28	WOS:000339384100013
J	Qin, H; Diaz, A; Blouin, L; Lebbink, RJ; Patena, W; Tanbun, P; LeProust, EM; McManus, MT; Song, JS; Ramalho-Santos, M				Qin, Han; Diaz, Aaron; Blouin, Laure; Lebbink, Robert Jan; Patena, Weronika; Tanbun, Priscilia; LeProust, Emily M.; McManus, Michael T.; Song, Jun S.; Ramalho-Santos, Miguel			Systematic Identification of Barriers to Human iPSC Generation	CELL			English	Article							PLURIPOTENT STEM-CELLS; SOMATIC-CELLS; REVEALS; PATHWAY; DISTINCT	Reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) holds enormous promise for regenerative medicine. To elucidate endogenous barriers limiting this process, we systematically dissected human cellular reprogramming by combining a genome-wide RNAi screen, innovative computational methods, extensive single-hit validation, and mechanistic investigation of relevant pathways and networks. We identify reprogramming barriers, including genes involved in transcription, chromatin regulation, ubiquitination, dephosphorylation, vesicular transport, and cell adhesion. Specific a disintegrin and metalloproteinase (ADAM) proteins inhibit reprogramming, and the disintegrin domain of ADAM29 is necessary and sufficient for this function. Clathrin-mediated endocytosis can be targeted with small molecules and opposes reprogramming by positively regulating TGF-beta signaling. Genetic interaction studies of endocytosis or ubiquitination reveal that barrier pathways can act in linear, parallel, or feedforward loop architectures to antagonize reprogramming. These results provide a global view of barriers to human cellular reprogramming.	[Qin, Han; Diaz, Aaron; Blouin, Laure; Lebbink, Robert Jan; Patena, Weronika; Tanbun, Priscilia; McManus, Michael T.; Song, Jun S.; Ramalho-Santos, Miguel] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Qin, Han; Blouin, Laure; Tanbun, Priscilia; Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Reprod Sci, Dept Ob Gyn, San Francisco, CA 94143 USA; [Qin, Han; Blouin, Laure; Tanbun, Priscilia; Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Reprod Sci, Dept Pathol, San Francisco, CA 94143 USA; [Qin, Han; Blouin, Laure; Tanbun, Priscilia; Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Diaz, Aaron; Song, Jun S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Lebbink, Robert Jan; Patena, Weronika; McManus, Michael T.] Univ Calif San Francisco, Ctr Diabet, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Lebbink, Robert Jan; Patena, Weronika; McManus, Michael T.] Univ Calif San Francisco, WM Keck Ctr Noncoding RNAs, San Francisco, CA 94143 USA; [Song, Jun S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Song, Jun S.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [LeProust, Emily M.] Agilent Technol, Genom Solut Unit, Santa Clara, CA 95051 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Agilent Technologies	Song, JS (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	songj@illinois.edu; miguel.ramalho-santos@ucsf.edu	Ramalho-Santos, Miguel/L-9092-2018; Song, Jun S/E-2526-2016; Lebbink, Robert Jan/GNH-5209-2022; Patena, Weronika/AAZ-3275-2020; mcmanus, michael/AAB-1239-2020	Ramalho-Santos, Miguel/0000-0003-0177-5556; Song, Jun S/0000-0002-0422-2175; Patena, Weronika/0000-0002-8388-1303; mcmanus, michael/0000-0003-3013-6569; Lebbink, Robert Jan/0000-0002-1981-0420	NWO Rubicon [825.06.030]; NWO Veni [916.10.138]; UCSF Program for Breakthrough Biomedical Research; NIH [1U01CA168370, R01 GM80783, R01CA163336, DP2OD4698]; Sontag Foundation Distinguished Scientist Award; CIRM [RB4-06028]; NATIONAL CANCER INSTITUTE [R01CA163336, U01CA168370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080783] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004698] Funding Source: NIH RePORTER	NWO Rubicon(Netherlands Organization for Scientific Research (NWO)); NWO Veni(Netherlands Organization for Scientific Research (NWO)); UCSF Program for Breakthrough Biomedical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sontag Foundation Distinguished Scientist Award; CIRM(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Robert Blelloch, Keith Mostov, and Zena Werb for critical reading of the manuscript, Jonathan Weissman, Martin Kampann, and Michael Bassick for discussions and help with library generation, Nikki Shariat for input on the experiment design, Xiaoyin Wang for virus production, Fong Ming Koh for providing the pGAMA vector, Charles Nicolet and Henriette O'Geen for support on NGS, and Tara Rambaldo and Michael Kissner for support with FACS. This work was supported by NWO Rubicon grant 825.06.030 and Veni grant 916.10.138 to R.J.L.; the UCSF Program for Breakthrough Biomedical Research and NIH grants 1U01CA168370 and R01 GM80783 to M.T.M.; NIH R01CA163336 and Sontag Foundation Distinguished Scientist Award to J.S.S.; and CIRM grant RB4-06028 and NIH Director's New Innovator Award DP2OD4698 to M.R.-S.E.M.L. is an employee of Agilent Technologies.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bassik MC, 2009, NAT METHODS, V6, P443, DOI [10.1038/NMETH.1330, 10.1038/nmeth.1330]; Buckley SM, 2012, CELL STEM CELL, V11, P783, DOI 10.1016/j.stem.2012.09.011; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Daley GQ, 2008, COLD SH Q B, V73, P171, DOI 10.1101/sqb.2008.73.041; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Handl J, 2007, IEEE ACM T COMPUT BI, V4, P279, DOI 10.1109/TCBB.2007.070203; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Igarashi T, 2007, FEBS LETT, V581, P2416, DOI 10.1016/j.febslet.2007.04.057; Karpiuk O, 2012, MOL CELL, V46, P705, DOI 10.1016/j.molcel.2012.05.022; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Qin H, 2012, HUM MOL GENET, V21, P2054, DOI 10.1093/hmg/dds023; Ramalho-Santos M, 2009, CELL, V138, P616, DOI 10.1016/j.cell.2009.08.012; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan TZ, 2013, EMBO MOL MED, V5, P1051, DOI 10.1002/emmm.201201823; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wei XM, 2011, HUM MUTAT, V32, pE2148, DOI 10.1002/humu.21477; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	38	62	62	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					449	461		10.1016/j.cell.2014.05.040	http://dx.doi.org/10.1016/j.cell.2014.05.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036638	Bronze, Green Accepted			2022-12-28	WOS:000340943600022
J	Wolfe, BE; Button, JE; Santarelli, M; Dutton, RJ				Wolfe, Benjamin E.; Button, Julie E.; Santarelli, Marcela; Dutton, Rachel J.			Cheese Rind Communities Provide Tractable Systems for In Situ and In Vitro Studies of Microbial Diversity	CELL			English	Article							FUNCTIONAL-ANALYSIS; BACTERIAL; IDENTIFICATION; SURFACE; PATTERNS; GENOME; COLD	Tractable microbial communities are needed to bridge the gap between observations of patterns of microbial diversity and mechanisms that can explain these patterns. We developed cheese rinds as model microbial communities by characterizing in situ patterns of diversity and by developing an in vitro system for community reconstruction. Sequencing of 137 different rind communities across 10 countries revealed 24 widely distributed and culturable genera of bacteria and fungi as dominant community members. Reproducible community types formed independent of geographic location of production. Intensive temporal sampling demonstrated that assembly of these communities is highly reproducible. Patterns of community composition and succession observed in situ can be recapitulated in a simple in vitro system. Widespread positive and negative interactions were identified between bacterial and fungal community members. Cheese rind microbial communities represent an experimentally tractable system for defining mechanisms that influence microbial community assembly and function.	[Wolfe, Benjamin E.; Button, Julie E.; Santarelli, Marcela; Dutton, Rachel J.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University	Dutton, RJ (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	rdutton@cgr.harvard.edu			National Institutes of Health [P50 GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Andrew Murray, Bodo Stern, Peter Turnbaugh, the Turnbaugh lab, Lawrence David, Miriam Shiffman, Jon Calarco, Lauren O'Connell, Mike Laub, and Kevin Verstrepen for helpful comments and discussions; Noah Fierer for fungal ITS primers; Christian Daly, Michele Clamp, Claire Reardon, and Noelani Kamelamela for technical support; Mateo and Andy Kehler, Vince Razionale, Jasper Hill Farm, the Cellars at Jasper Hill, Bronwen Percival, Sister Noella Marcellino, Catherine Donnelly, Eric Meredith, Brian Ralph, Ihsan Gurdal, and the many members of the artisan cheese community who made collection of samples possible. This work was supported by the National Institutes of Health (P50 GM068763).	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Amarita F, 2004, APPL ENVIRON MICROB, V70, P7348, DOI 10.1128/AEM.70.12.7348-7354.2004; Beresford TP, 2001, INT DAIRY J, V11, P259, DOI 10.1016/S0958-6946(01)00056-5; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P5214, DOI 10.1128/AEM.00934-13; Brennan NM, 2002, APPL ENVIRON MICROB, V68, P820, DOI 10.1128/AEM.68.2.820-830.2002; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cheeseman K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3876; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; de Pascale D, 2010, POLAR SCI, V4, P285, DOI 10.1016/j.polar.2010.03.009; de Pascale D, 2008, EXTREMOPHILES, V12, P311, DOI 10.1007/s00792-008-0163-9; Engel AS, 2010, GEOMICROBIOLOGY: MOLECULAR AND ENVIRONMENTAL PERSPECTIVE, P219, DOI 10.1007/978-90-481-9204-5_10; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Feligini M, 2012, J FOOD SCI, V77, pM609, DOI 10.1111/j.1750-3841.2012.02932.x; Fierer N, 2012, ANNU REV ECOL EVOL S, V43, P137, DOI 10.1146/annurev-ecolsys-110411-160307; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Fox P.F., 2004, CHEESE CHEM PHYS MIC, V1, DOI DOI 10.1016/S1874-558X(04)80060-5; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kuck U, 2010, APPL MICROBIOL BIOT, V86, P51, DOI 10.1007/s00253-009-2416-7; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; MARCELLINO N, 1992, APPL ENVIRON MICROB, V58, P3448, DOI 10.1128/AEM.58.11.3448-3454.1992; Marsh AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069371; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Meersman E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081559; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Minhas A, 2009, FEMS YEAST RES, V9, P95, DOI 10.1111/j.1567-1364.2008.00457.x; Monnet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015489; Mounier J, 2009, INT J FOOD MICROBIOL, V133, P31, DOI 10.1016/j.ijfoodmicro.2009.04.020; Mounier J, 2008, APPL ENVIRON MICROB, V74, P172, DOI 10.1128/AEM.01338-07; Na Jong-Min, 2011, Korean Journal of Microbiology and Biotechnology, V39, P133; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; Passerini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015306; Prax M, 2013, MICROBIOL-SGM, V159, P421, DOI 10.1099/mic.0.061705-0; Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030; Quigley L, 2012, APPL ENVIRON MICROB, V78, P5717, DOI 10.1128/AEM.00918-12; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Reen FJ, 2006, NAT REV MICROBIOL, V4, P697, DOI 10.1038/nrmicro1476; Schroder J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-545; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Sieuwerts S, 2008, APPL ENVIRON MICROB, V74, P4997, DOI 10.1128/AEM.00113-08; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Verdier-Metz I, 2012, APPL ENVIRON MICROB, V78, P326, DOI 10.1128/AEM.06229-11; White T.J., 1990, PCR PROTOCOLS GUIDE, P315	50	326	354	24	236	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					422	433		10.1016/j.cell.2014.05.041	http://dx.doi.org/10.1016/j.cell.2014.05.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036636	Bronze, Green Accepted			2022-12-28	WOS:000340943600020
J	Kinnier, CV; Barnard, C; Bilimoria, KY				Kinnier, Christine V.; Barnard, Cindy; Bilimoria, Karl Y.			The Need to Revisit VTE Quality Measures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VENOUS THROMBOEMBOLISM; PROPHYLAXIS; THROMBOSIS; SURGERY; CANCER	Object: To prospectively determine the incidence of venous thromboembolism (VTE) following major head and neck surgery. At the midpoint of enrollment, an interim analysis was performed to determine if it was ethical to continue this study as an observational study without routine anticoagulation. DESIGN Prospective, observational cohort study. SETTING Academic surgical center. The interim analysis comprised 47 subjects. MAIN OUTCOME MEASURE The total number of new cases of VIE aVid deep) identified within 30 days of surgery and confirmed on diagnostic imaging. These cases were further categorized as clinically relevant and nonclinically relevant. Clinically relevant VTEs were those requiring more than 6 weeks of anticoagulation or were associated with any negative impact on clinical course. On postoperative day 2 or 3, subjects were clinically examined and received duplex ultrasonography. Subjects with negative findings from examination and ultrasonography were followed up clinically; subjects with evidence of deep venous thrombus or pulmonary embolism were given therapeutic anticoagulation. Subjects with superficial VIE received repeated ultrasonography on postoperative days 4 to 6. Subjects were monitored for 30 days after surgery. RESULTS Three subjects (6%) were identified as having clinically significant VIE; 2 cases of deep venous thrombus and 1 case of pulmonary embolism. Two additional subjects had lower extremity superficial VIE without clinical findings, which were detected by ultrasonography alone. No statistically significant differences were seen between patients with VIE and those without VIE. CONCLUSIONS: This interim analysis of the first prospective study 5..f the incidence of VIE in patients with head and neck cancer showed a VIE rate slightly higher than previously estimated in retrospective studies. There have been no unexpected serious adverse events and no rationale for early termination of the study.	[Kinnier, Christine V.; Bilimoria, Karl Y.] Northwestern Univ, Feinberg Sch Med, Surg Outcomes & Qual Improvement Ctr, Dept Surg, Chicago, IL 60611 USA; [Kinnier, Christine V.; Bilimoria, Karl Y.] NW Mem Hosp, Chicago, IL 60611 USA; [Kinnier, Christine V.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Barnard, Cindy; Bilimoria, Karl Y.] NW Mem Hosp, Dept Qual Strategies, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern Memorial Hospital; Harvard University; Massachusetts General Hospital; Northwestern Memorial Hospital	Bilimoria, KY (corresponding author), NW Mem Hosp, Surg Outcomes & Qual Improvement Ctr, Dept Surg, Feinberg Sch Med, 676 St Clair St,Arkes Pavil Ste 6-650, Chicago, IL 60611 USA.	k-bilimoria@northwestern.edu						[Anonymous], 2014, SURG CAR IMPR PROJ V; [Anonymous], POST PULM EMB DVT RA; Bergqvist D, 2002, NEW ENGL J MED, V346, P975, DOI 10.1056/NEJMoa012385; Bilimoria KY, 2013, JAMA-J AM MED ASSOC, V310, P1482, DOI 10.1001/jama.2013.280048; Clayburgh D, 2013, JAMA OTOLARYNGOL, V139, P161, DOI 10.1001/jamaoto.2013.1372; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Haut ER, 2012, ARCH SURG-CHICAGO, V147, P901, DOI 10.1001/archsurg.2012.2024; Hull RD, 2001, ANN INTERN MED, V135, P858, DOI 10.7326/0003-4819-135-10-200111200-00006; Raslan AM, 2010, NEUROCRIT CARE, V12, P297, DOI 10.1007/s12028-009-9316-7	9	7	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					286	287		10.1001/jama.2014.1841	http://dx.doi.org/10.1001/jama.2014.1841			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	25027144				2022-12-28	WOS:000338940300026
J	Lansdorp-Vogelaar, I; Gulati, R; Mariotto, AB; Schechter, CB; de Carvalho, TM; Knudsen, AB; van Ravesteyn, NT; Heijnsdijk, EAM; Pabiniak, C; van Ballegooijen, M; Rutter, CM; Kuntz, KM; Feuer, EJ; Etzioni, R; de Koning, HJ; Zauber, AG; Mandelblatt, JS				Lansdorp-Vogelaar, Iris; Gulati, Roman; Mariotto, Angela B.; Schechter, Clyde B.; de Carvalho, Tiago M.; Knudsen, Amy B.; van Ravesteyn, Nicolien T.; Heijnsdijk, Eveline A. M.; Pabiniak, Chester; van Ballegooijen, Marjolein; Rutter, Carolyn M.; Kuntz, Karen M.; Feuer, Eric J.; Etzioni, Ruth; de Koning, Harry J.; Zauber, Ann G.; Mandelblatt, Jeanne S.			Personalizing Age of Cancer Screening Cessation Based on Comorbid Conditions: Model Estimates of Harms and Benefits	ANNALS OF INTERNAL MEDICINE			English	Article							SERVICES TASK-FORCE; COLORECTAL-CANCER; PROSTATE-CANCER; LIFE-STYLE; RECOMMENDATION STATEMENT; POTENTIAL BENEFITS; COST-EFFECTIVENESS; DECISION-ANALYSIS; ELDERLY-PATIENTS; BREAST	Background: Harms and benefits of cancer screening depend on age and comorbid conditions, but reliable estimates are lacking. Objective: To estimate the harms and benefits of cancer screening by age and comorbid conditions to inform decisions about screening cessation. Design: Collaborative modeling with 7 cancer simulation models and common data on average and comorbid condition level-specific life expectancy. Setting: U. S. population. Patients: U. S. cohorts aged 66 to 90 years in 2010 with average health or 1 of 4 comorbid condition levels: none, mild, moderate, or severe. Intervention: Mammography, prostate-specific antigen testing, or fecal immunochemical testing. Measurements: Lifetime cancer deaths prevented and life-years gained (benefits); false-positive test results and overdiagnosed cancer cases (harms). For each comorbid condition level, the age at which harms and benefits of screening were similar to that for persons with average health having screening at age 74 years. Results: Screening 1000 women with average life expectancy at age 74 years for breast cancer resulted in 79 to 96 (range across models) false-positive results, 0.5 to 0.8 overdiagnosed cancer cases, and 0.7 to 0.9 prevented cancer deaths. Although absolute numbers of harms and benefits differed across cancer sites, the ages at which to cease screening were consistent across models and cancer sites. For persons with no, mild, moderate, and severe comorbid conditions, screening until ages 76, 74, 72, and 66 years, respectively, resulted in harms and benefits similar to average-health persons. Limitation: Comorbid conditions influenced only life expectancy. Conclusion: Comorbid conditions are an important determinant of harms and benefits of screening. Estimates of screening benefits and harms by comorbid condition can inform discussions between providers and patients about personalizing screening cessation decisions.	Erasmus Univ, Med Ctr, NL-3000 CA Rotterdam, Netherlands; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Grp Hlth Res Inst, Seattle, WA 98101 USA; NCI, Bethesda, MD 20892 USA; Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Minnesota, Minneapolis, MN 55455 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; Georgetown Univ, Washington, DC 20007 USA	Erasmus University Rotterdam; Erasmus MC; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; Harvard University; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities; Memorial Sloan Kettering Cancer Center; Georgetown University	Lansdorp-Vogelaar, I (corresponding author), Erasmus Univ, Med Ctr, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	i.vogelaar@erasmusmc.nl	Gulati, Roman/AAE-4298-2019; de+Koning, Harry/AAF-9062-2019; Rutter, Carolyn/AAZ-3677-2021	Gulati, Roman/0000-0002-7592-6567; de+Koning, Harry/0000-0003-4682-3646; 	National Cancer Institute at the National Institutes of Health; Centers for Disease Control and Prevention [U01CA097426, U01CA115953, U01CA152959, U01CA157224, U01CA088283, U01CA152958]; National Cancer Institute at the National Institutes of Health [KO5CA96940, P01CA154292, U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, HHSN261201100031C]; Dutch Cancer Society [94-869, 98-1657, 2002-277, 2006-3518]; Netherlands Organisation for Health Research and Development [002822820, 22000106, 50-50110-98-311]; NATIONAL CANCER INSTITUTE [UM1CA182883, U01CA115953, U01CA086082, U01CA070040, K05CA096940, U01CA152958, U01CA070013, U01CA097426, U01CA086076, P30CA008748, U01CA088283, U01CA063736, U01CA152959, U01CA063731, U01CA069976, U01CA063740, U01CA157224, P01CA154292] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute at the National Institutes of Health and the Centers for Disease Control and Prevention (grants U01CA097426, U01CA115953, U01CA152959, U01CA157224, U01CA088283, and U01CA152958) and in part by the National Cancer Institute at the National Institutes of Health (grants KO5CA96940 to Dr. Mandelblatt and P01CA154292 to Drs. Mandelblatt, Schechter, van Ravesteyn, Heijnsdijk, and de Koning), the Dutch Cancer Society (grants 94-869, 98-1657, 2002-277, and 2006-3518 to Drs. Heijnsdijk and de Koning), and the Netherlands Organisation for Health Research and Development (grants 002822820, 22000106, and 50-50110-98-311 to Drs. Heijnsdijk and de Koning). Breast Cancer Surveillance Consortium data collection and sharing used in some variables for modeling breast cancer screening was supported by the National Cancer Institute at the National Institutes of Health (grants U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, and HHSN261201100031C).	Begg CB, 2010, ANN INTERN MED, V152, P540, DOI 10.7326/0003-4819-152-8-201004200-00203; Braithwaite RS, 2010, ANN INTERN MED, V152, P539, DOI 10.7326/0003-4819-152-8-201004200-00201; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Chang YJ, 2012, BREAST CANCER RES TR, V136, P823, DOI 10.1007/s10549-012-2274-3; Cho H, 2013, ANN INTERN MED, V159, P667, DOI 10.7326/0003-4819-159-10-201311190-00005; Col NF, 2010, ANN INTERN MED, V152, P542, DOI 10.7326/0003-4819-152-8-201004200-00206; Dinh TA, 2012, J GEN INTERN MED, V27, P730, DOI 10.1007/s11606-011-1972-6; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Gong ZH, 2006, CANCER EPIDEM BIOMAR, V15, P1977, DOI 10.1158/1055-9965.EPI-06-0477; Greene KL, 2009, J UROLOGY, V182, P2232, DOI 10.1016/j.juro.2009.07.093; Gulati R, 2013, ANN INTERN MED, V158, P145, DOI 10.7326/0003-4819-158-3-201302050-00003; Gulati R, 2011, CANCER EPIDEM BIOMAR, V20, P740, DOI 10.1158/1055-9965.EPI-10-0718; Gulati R, 2010, BIOSTATISTICS, V11, P707, DOI 10.1093/biostatistics/kxq036; Harewood GC, 2006, J GASTROEN HEPATOL, V21, P1021, DOI 10.1111/j.1440-1746.2006.04218.x; Harris R, 2011, EPIDEMIOL REV, V33, P20, DOI 10.1093/epirev/mxr005; Heijnsdijk EAM, 2012, NEW ENGL J MED, V367, P595, DOI 10.1056/NEJMoa1201637; Ho A, 2010, ANN INTERN MED, V152, P542, DOI 10.7326/0003-4819-152-8-201004200-00207; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Kawachi Mark H, 2007, J Natl Compr Canc Netw, V5, P714; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Klijs B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-378; Ko CW, 2005, GASTROENTEROLOGY, V129, P1163, DOI 10.1053/j.gastro.2005.07.027; Lee SJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8441; Loeve F, 1999, COMPUT BIOMED RES, V32, P13, DOI 10.1006/cbmr.1998.1498; Maheshwari S, 2008, J AGING HEALTH, V20, P126, DOI 10.1177/0898264307309939; Mandelblatt Jeanne, 2006, J Natl Cancer Inst Monogr, P47, DOI 10.1093/jncimonographs/lgj008; Mandelblatt JS, 2013, JAMA INTERN MED, V173, P227, DOI 10.1001/jamainternmed.2013.2127; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Mandelblatt JS, 2005, J GEN INTERN MED, V20, P487, DOI 10.1111/j.1525-1497.2005.0116.x; MANDELBLATT JS, 1992, ANN INTERN MED, V116, P722, DOI 10.7326/0003-4819-116-9-722; Nelson NJ, 2012, J NATL CANCER I, V104, P574, DOI 10.1093/jnci/djs213; Qaseem A, 2013, ANN INTERN MED, V158, P761, DOI 10.7326/0003-4819-158-10-201305210-00633; Rich J S, 2000, Eff Clin Pract, V3, P78; Rutter CM, 2010, CANCER EPIDEM BIOMAR, V19, P1992, DOI 10.1158/1055-9965.EPI-09-0954; Schonberg MA, 2011, J AM GERIATR SOC, V59, P1444, DOI 10.1111/j.1532-5415.2011.03523.x; Schonberg MA, 2009, J GEN INTERN MED, V24, P1115, DOI 10.1007/s11606-009-1073-y; Smith RA, 2012, CA CANCER J CLIN; Stevens T, 2003, AM J GASTROENTEROL, V98, P1881, DOI 10.1016/S0002-9270(03)00425-8; Tan Sita Y G L, 2006, J Natl Cancer Inst Monogr, P56, DOI 10.1093/jncimonographs/lgj009; U.S. Census Bureau, 2013, 2012 NATIONAL POPULA; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Wolk A, 2005, ACTA ONCOL, V44, P277, DOI 10.1080/02841860510029572; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	50	91	92	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2					104	+		10.7326/M13-2867	http://dx.doi.org/10.7326/M13-2867			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023249	Green Accepted			2022-12-28	WOS:000339764600019
J	Thompson, BT				Thompson, B. Taylor			In patients with severe sepsis, adding albumin to crystalloid solution did not reduce 28-or 90-day mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RESUSCITATION; SALINE; FLUID		Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Thompson, BT (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							Delaney AP, 2011, CRIT CARE MED, V39, P386, DOI 10.1097/CCM.0b013e3181ffe217; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2011, INTENS CARE MED, V37, P86, DOI 10.1007/s00134-010-2039-6; Russell JA, 2014, NEW ENGL J MED, V370, P1649, DOI 10.1056/NEJMe1402066	5	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2							JC6	10.7326/0003-4819-161-2-201407150-02006	http://dx.doi.org/10.7326/0003-4819-161-2-201407150-02006			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023272				2022-12-28	WOS:000339764600007
J	Cully, M				Cully, Megan			DRUG DEVELOPMENT Illuminated targets	NATURE			English	Editorial Material							DRAVET SYNDROME; BRIVARACETAM; ADULTS							Cully, Megan/0000-0003-4726-134X				Baraban SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3410; Chiron C, 2011, EPILEPSIA, V52, P72, DOI 10.1111/j.1528-1167.2011.03007.x; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; MEUNIER H, 1963, Therapie, V18, P435; Mula M, 2014, EXPERT REV NEUROTHER, V14, P361, DOI 10.1586/14737175.2014.896200; Rogawski MA, 2011, EPILEPSY CURR, V11, P56, DOI 10.5698/1535-7511-11.2.56; Van Paesschen W, 2013, EPILEPSIA, V54, P89, DOI 10.1111/j.1528-1167.2012.03598.x	8	6	6	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S12	S13		10.1038/511S12a	http://dx.doi.org/10.1038/511S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25019129	Bronze			2022-12-28	WOS:000338649800006
J	Cole, TB				Cole, Thomas B.			The Statue of Liberty in Frederic-Auguste Bartholdi's Studio, Paris Paul-Joseph-Victor Dargaud	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					8	9		10.1001/jama.2013.279587	http://dx.doi.org/10.1001/jama.2013.279587			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	25058200				2022-12-28	WOS:000338131100001
J	Gibson, PS; Nerenberg, KA				Gibson, Paul S.; Nerenberg, Kara A.			TIPPing practice away from anticoagulation in pregnancy	LANCET			English	Editorial Material							MOLECULAR-WEIGHT HEPARIN; LOW-DOSE ASPIRIN; WOMEN; THROMBOPHILIA; COMPLICATIONS; MULTICENTER		[Gibson, Paul S.] Univ Calgary, Dept Med, Calgary, AB T3L 2Y3, Canada; [Gibson, Paul S.] Univ Calgary, Dept Obstet & Gynecol, Calgary, AB T3L 2Y3, Canada; [Nerenberg, Kara A.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Calgary; University of Calgary; University of Ottawa; Ottawa Hospital Research Institute	Gibson, PS (corresponding author), Univ Calgary, Dept Med, Calgary, AB T3L 2Y3, Canada.	gibsonp@ucalgary.ca						Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Bates SA, 2004, CHEST, V126, p627S, DOI 10.1378/chest.126.3_suppl.627S; Bates Shannon M, 2012, Chest, V141, pe691S, DOI 10.1378/chest.11-2300; Brenner B, 2005, J THROMB HAEMOST, V3, P227, DOI 10.1111/j.1538-7836.2004.01090.x; Clark P, 2010, BLOOD, V115, P4162, DOI 10.1182/blood-2010-01-267252; De Vries JIP, 2012, J THROMB HAEMOST, V10, P64, DOI 10.1111/j.1538-7836.2011.04553.x; Gris JC, 2004, BLOOD, V103, P3695, DOI 10.1182/blood-2003-12-4250; Kaandorp SP, 2010, NEW ENGL J MED, V362, P1586, DOI 10.1056/NEJMoa1000641; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Martinelli I, 2012, BLOOD, V119, P3269, DOI 10.1182/blood-2011-11-391383; Rey E, 2003, LANCET, V361, P901, DOI 10.1016/S0140-6736(03)12771-7; Rodger MA, 2014, LANCET; Rodger MA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000292	13	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1648	1649		10.1016/S0140-6736(14)60850-3	http://dx.doi.org/10.1016/S0140-6736(14)60850-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KU	25066247				2022-12-28	WOS:000345116200008
J	Koenekoop, RK; Sui, RF; Sallum, J; van den Born, LI; Ajlan, R; Khan, A; den Hollander, AI; Cremers, FPM; Mendola, JD; Bittner, AK; Dagnelie, G; Schuchard, RA; Saperstein, DA				Koenekoop, Robert K.; Sui, Ruifang; Sallum, Juliana; van den Born, L. Ingeborgh; Ajlan, Radwan; Khan, Ayesha; den Hollander, Anneke I.; Cremers, Frans P. M.; Mendola, Janine D.; Bittner, Ava K.; Dagnelie, Gislin; Schuchard, Ronald A.; Saperstein, David A.			Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial	LANCET			English	Article							GENE-THERAPY; RETINITIS-PIGMENTOSA; MOUSE MODEL; VISUAL FUNCTIONS; DYSTROPHY; VISION; ACYLTRANSFERASE; IMPROVEMENT; CYCLE	Background Leber congenital amaurosis, caused by mutations in RPE65 and LRAT, is a severe form of inherited retinal degeneration leading to blindness. We aimed to assess replacement of the missing chromophore 11-cis retinal with oral QLT091001 (synthetic 9-cis-retinyl acetate) in these patients. Methods In our open-label, prospective, phase 1b trial, we enrolled patients (aged >= 6 years) with Leber congenital amaurosis and RPE65 or LRAT mutations at McGill University's Montreal Children's Hospital. Patients received 7 days of oral QLT091001 (10-40 mg/m(2) per day). We assessed patients at baseline and days 7, 9, 14, and 30, and then 2 months and every 2 months thereafter for up to 2.2 years for safety outcomes and visual function endpoints including Goldmann visual fields (GVF), visual acuity, and functional MRI assessment. We regarded patients as having an improvement in vision if we noted at least a 20% improvement in retinal area on GVF compared with baseline or a visual acuity improvement of five or more letters compared with baseline in two consecutive study visits (or any improvement from no vision at baseline). This study is registered with ClinicalTrials.gov, numberNCT01014052. Findings Between December, 2009, and June, 2011, we enrolled and treated 14 patients aged 6-38 years who were followed up until March, 2012. Ten (71%) of 14 patients had an improvement in GVF areas (mean increase in retinal area of 28-683%). Six (43%) patients had an improvement in visual acuity (mean increase of 2-30 letters). Self-reported or parent-reported improvements in activities of daily living supported these findings. After 2 years, 11 (79%) patients had returned to their baseline GVF retinal area and ten (71%) had returned to baseline visual acuity letter values. Thus, three (21%) patients had a sustained GVF response and four (30%) had a sustained visual acuity response. Four patients had functional MRI scans, which correlated with visual response or absence of response to treatment. No serious adverse events occurred, although we noted transient headaches (11 patients), photophobia (11 patients), reduction in serum HDL concentrations (four patients), and increases in serum triglycerides (eight patients) and aspartate aminotransferase concentrations (two patients). Interpretation Non-invasive oral QLT091001 therapy is well tolerated, and can rapidly improve visual function in some patients with Leber congenital amaurosis and RPE65 and LRAT mutations.	[Koenekoop, Robert K.; Ajlan, Radwan; Khan, Ayesha] McGill Univ, Ctr Hlth, McGill Ocular Genet Lab, Montreal, PQ H3H 1P3, Canada; [Koenekoop, Robert K.; Ajlan, Radwan; Khan, Ayesha] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Paediat Surg, Montreal, PQ H3H 1P3, Canada; [Koenekoop, Robert K.; Ajlan, Radwan; Khan, Ayesha] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Human Genet, Montreal, PQ H3H 1P3, Canada; [Koenekoop, Robert K.; Ajlan, Radwan; Khan, Ayesha] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Ophthalmol, Montreal, PQ H3H 1P3, Canada; [Sui, Ruifang] Beijing Union Med Coll Hosp, Beijing, Peoples R China; [Sallum, Juliana] Univ Fed Sao Paulo, Sao Paulo, Brazil; [van den Born, L. Ingeborgh] Rotterdam Eye Hosp, Rotterdam, Netherlands; [den Hollander, Anneke I.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [den Hollander, Anneke I.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Mendola, Janine D.] McGill Univ, Ctr Hlth, McGill Vis Res Unit, Montreal, PQ H3H 1P3, Canada; [Mendola, Janine D.] McGill Univ, Ctr Hlth, Dept Ophthalmol, Montreal, PQ H3H 1P3, Canada; [Bittner, Ava K.; Dagnelie, Gislin] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA; [Schuchard, Ronald A.] Stanford Univ, Stanford, CA 94305 USA; [Saperstein, David A.] Vitreoretinal Associates Washington, Seattle, WA USA	McGill University; McGill University; McGill University; McGill University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Universidade Federal de Sao Paulo (UNIFESP); Rotterdam Eye Hospital; Radboud University Nijmegen; Radboud University Nijmegen; McGill University; McGill University; Johns Hopkins University; Johns Hopkins Medicine; Stanford University	Koenekoop, RK (corresponding author), McGill Univ, Montreal Childrens Hosp, Dept Paediat Surg Human Genet & Ophthalmol, Ctr Hlth, 2300 Tupper, Montreal, PQ H3H 1P3, Canada.	robert.koenekoop@mcgill.ca	Hollander, Anneke den/N-4911-2014; Koenekoop, Robert/AAT-6676-2021; Sallum, Juliana Maria Ferraz/AAL-4000-2020; Cremers, Frans/A-5625-2014; Bittner, Ava/AAK-8778-2021	Sallum, Juliana Maria Ferraz/0000-0002-7206-4447; Cremers, Frans/0000-0002-4954-5592; Bittner, Ava/0000-0002-9498-2230	QLT; Foundation Fighting Blindness Canada; CIHR; FRSQ; Reseau Vision	QLT; Foundation Fighting Blindness Canada; CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); Reseau Vision	QLT, Foundation Fighting Blindness Canada, CIHR, FRSQ, Reseau Vision.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Bittner AK, 2011, INVEST OPHTH VIS SCI, V52, P8042, DOI 10.1167/iovs.11-8321; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; DAGNELIE G, 1990, CLIN VISION SCI, V5, P95; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Gearhart PM, 2010, ARCH OPHTHALMOL-CHIC, V128, P1442, DOI 10.1001/archophthalmol.2010.210; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Jacobson SG, 2009, INVEST OPHTH VIS SCI, V50, P2368, DOI 10.1167/iovs.08-2696; Koenekoop RK, 2004, SURV OPHTHALMOL, V49, P379, DOI 10.1016/j.survophthal.2004.04.003; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Narfstrom K, 2009, ASS RES VIS OPHTH 20; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Palczewski K, 2010, TRENDS PHARMACOL SCI, V31, P284, DOI 10.1016/j.tips.2010.03.001; Paunescu K, 2005, GRAEF ARCH CLIN EXP, V243, P417, DOI 10.1007/s00417-004-1020-x; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; RODIECK RW, 1979, ANNU REV NEUROSCI, V2, P193, DOI 10.1146/annurev.ne.02.030179.001205; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Thompson DA, 2001, NAT GENET, V28, P123, DOI 10.1038/88828; Turano KA, 1999, INVEST OPHTH VIS SCI, V40, P865; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246	31	67	67	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2014	384	9953					1513	1520		10.1016/S0140-6736(14)60153-7	http://dx.doi.org/10.1016/S0140-6736(14)60153-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9MO	25030840				2022-12-28	WOS:000343899600025
J	Ferrier-Barbut, I; Delehaye, M; Laurent, S; Grier, AT; Pierce, M; Rem, BS; Chevy, F; Salomon, C				Ferrier-Barbut, I.; Delehaye, M.; Laurent, S.; Grier, A. T.; Pierce, M.; Rem, B. S.; Chevy, F.; Salomon, C.			A mixture of Bose and Fermi superfluids	SCIENCE			English	Article							COLLECTIVE OSCILLATIONS; EINSTEIN CONDENSATION; NOBEL LECTURE; GAS; TRANSITION	Superconductivity and superfluidity of fermionic and bosonic systems are remarkable many-body quantum phenomena. In liquid helium and dilute gases, Bose and Fermi superfluidity has been observed separately, but producing a mixture in which both the fermionic and the bosonic components are superfluid is challenging. Here we report on the observation of such a mixture with dilute gases of two lithium isotopes, lithium-6 and lithium-7. We probe the collective dynamics of this system by exciting center-of-mass oscillations that exhibit extremely low damping below a certain critical velocity. Using high-precision spectroscopy of these modes, we observe coherent energy exchange and measure the coupling between the two superfluids. Our observations can be captured theoretically using a sum-rule approach that we interpret in terms of two coupled oscillators.	[Ferrier-Barbut, I.] Ecole Normale Super, CNRS, Coll France, Lab Kastler Brossel, F-75005 Paris, France; UPMC, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Ferrier-Barbut, I (corresponding author), Ecole Normale Super, CNRS, Coll France, Lab Kastler Brossel, 24 Rue Lhomond, F-75005 Paris, France.	iferrier@lkb.ens.fr	Ferrier-Barbut, Igor/J-8759-2016; Delehaye, Marion/M-1528-2018; Salomon, Carlos F/L-2167-2013; Grier, Andrew/K-5894-2013	Ferrier-Barbut, Igor/0000-0002-4707-0474; Salomon, Carlos F/0000-0003-4474-0046; Grier, Andrew/0000-0002-0088-2184; Delehaye, Marion/0000-0002-3809-2524	European Research Council Ferlodim and Thermodynamix; Ile de France Nano-K; Institut de France Louis D. Prize	European Research Council Ferlodim and Thermodynamix; Ile de France Nano-K; Institut de France Louis D. Prize	We thank S. Stringari and Y. Castin for fruitful discussions and S. Balibar, J. Dalibard, F. Gerbier, S. Nascimbene, C. Cohen-Tannoudji, and M. Schleier-Smith for critical reading of the manuscript. We acknowledge support from the European Research Council Ferlodim and Thermodynamix, the Ile de France Nano-K (contract Atomix), and Institut de France Louis D. Prize.	Banerjee A, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.023611; Cornell EA, 2002, REV MOD PHYS, V74, P875, DOI 10.1142/S0217979202014681; De Silva TN, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.051602; Ferlaino F, 2003, J OPT B-QUANTUM S O, V5, pS3, DOI 10.1088/1464-4266/5/2/351; Hadzibabic Z, 2006, NATURE, V441, P1118, DOI 10.1038/nature04851; Hall DS, 1998, PHYS REV LETT, V81, P1539, DOI 10.1103/PhysRevLett.81.1539; Hou YH, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.043630; Ketterle W, 2002, REV MOD PHYS, V74, P1131, DOI [10.1103/RevModPhys.74.1131, 10.1142/S0217979202014668]; Kinoshita T, 2006, NATURE, V440, P900, DOI 10.1038/nature04693; Ku MJH, 2012, SCIENCE, V335, P563, DOI 10.1126/science.1214987; Kuklov AB, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.100401; Lobo C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.200403; Maddaloni P, 2000, PHYS REV LETT, V85, P2413, DOI 10.1103/PhysRevLett.85.2413; Miyakawa T, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.063613; Molmer K, 1998, PHYS REV LETT, V80, P1804, DOI 10.1103/PhysRevLett.80.1804; Navon N, 2010, SCIENCE, V328, P729, DOI 10.1126/science.1187582; Rysti J, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.134529; Schreck F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.080403; Sommer A, 2011, NATURE, V472, P201, DOI 10.1038/nature09989; Stringari S, 2004, J PHYS IV, V116, P47, DOI 10.1051/jp4:2004116002; Tey MK, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.055303; Truscott AG, 2001, SCIENCE, V291, P2570, DOI 10.1126/science.1059318; Tuoriniemi J, 2002, J LOW TEMP PHYS, V129, P531, DOI 10.1023/A:1021468614550; VOLOVIK GE, 1975, ZH EKSP TEOR FIZ+, V69, P675; Zurn G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.135301; Zwerger W., 2012, LECT NOTES PHYS, V836	27	190	191	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1035	1038		10.1126/science.1255380	http://dx.doi.org/10.1126/science.1255380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25035409	Green Submitted			2022-12-28	WOS:000340870900035
J	Gonzalez-Munoz, E; Arboleda-Estudillo, Y; Otu, HH; Cibelli, JB				Gonzalez-Munoz, Elena; Arboleda-Estudillo, Yohanna; Otu, Hasan H.; Cibelli, Jose B.			Histone chaperone ASF1A is required for maintenance of pluripotency and cellular reprogramming	SCIENCE			English	Article							ACETYLATION; H3; OOCYTES	Unfertilized oocytes have the intrinsic capacity to remodel sperm and the nuclei of somatic cells. The discoveries that cells can change their phenotype from differentiated to embryonic state using oocytes or specific transcription factors have been recognized as two major breakthroughs in the biomedical field. Here, we show that ASF1A, a histone-remodeling chaperone specifically enriched in the metaphase II human oocyte, is necessary for reprogramming of human adult dermal fibroblasts (hADFs) into undifferentiated induced pluripotent stem cell. We also show that overexpression of just ASF1A and OCT4 in hADFs exposed to the oocyte-specific paracrine growth factor GDF9 can reprogram hADFs into pluripotent cells. Our Report underscores the importance of studying the unfertilized MII oocyte as a means to understand the molecular pathways governing somatic cell reprogramming.	[Gonzalez-Munoz, Elena; Arboleda-Estudillo, Yohanna; Cibelli, Jose B.] Ctr Andaluz Nanomed & Biotecnol Andalucia, BIONAND, LARCEL, Lab Andaluz Reprogramac Celular, Seville 29590, Spain; [Otu, Hasan H.] Istanbul Bilgi Univ, Dept Genet & Bioengn, TR-34060 Istanbul, Turkey; [Otu, Hasan H.] Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA; [Cibelli, Jose B.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Cibelli, Jose B.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	Istanbul Bilgi University; University of Nebraska System; University of Nebraska Lincoln; Michigan State University; Michigan State University	Cibelli, JB (corresponding author), Ctr Andaluz Nanomed & Biotecnol Andalucia, BIONAND, LARCEL, Lab Andaluz Reprogramac Celular, Seville 29590, Spain.	cibelli@msu.edu	Gonzalez-Munoz, Elena/AAY-4658-2020	Gonzalez-Munoz, Elena/0000-0001-8291-1518; Otu, Hasan/0000-0002-9253-8152; Cibelli, Jose/0000-0002-2176-3854	Fundacion Progreso y Salud, Sevilla, Andalucia, Spain; Michigan State University AgBioResearch, East Lansing, Michigan, USA; Naylor Family Foundation, York, Pennsylvania, USA	Fundacion Progreso y Salud, Sevilla, Andalucia, Spain; Michigan State University AgBioResearch, East Lansing, Michigan, USA; Naylor Family Foundation, York, Pennsylvania, USA	We thank members of LARCEL laboratory for comments and support, A. Wittgreen and N. Lopez Corrales for intellectual input and discussion, and Biobanco del Sistema Sanitario Publico de Andalucia for karyotyping and teratoma assay service. This work was supported by Fundacion Progreso y Salud, Sevilla, Andalucia, Spain; Michigan State University AgBioResearch, East Lansing, Michigan, USA; and the Naylor Family Foundation, York, Pennsylvania, USA. The Gene Expression Omnibus (GEO) accession number for the oocyte transcriptome is GSE12034. E. G.-M. and J.B.C. are listed as inventors on a patent application filed by Fundacion Progreso y Salud, Sevilla, Andalucia, Spain, and Michigan State University, East Lansing, Michigan, USA.	Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Awe JP, 2013, CELL REPROGRAM, V15, P126, DOI 10.1089/cell.2012.0060; Battu A, 2011, NUCLEIC ACIDS RES, V39, P7931, DOI 10.1093/nar/gkr523; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; GURDON JB, 1967, SCI PROG, V55, P259; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Houlard M, 2006, PLOS GENET, V2, P1686, DOI 10.1371/journal.pgen.0020181; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Miyamoto K, 2013, SCIENCE, V341, P1002, DOI 10.1126/science.1240376; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Mousson F, 2007, CHROMOSOMA, V116, P79, DOI 10.1007/s00412-006-0087-z; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan YL, 2013, P NATL ACAD SCI USA, V110, P11493, DOI 10.1073/pnas.1309914110; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620	20	54	57	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					822	825		10.1126/science.1254745	http://dx.doi.org/10.1126/science.1254745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25035411				2022-12-28	WOS:000340593100047
J	Xue, MS; Atallah, BV; Scanziani, M				Xue, Mingshan; Atallah, Bassam V.; Scanziani, Massimo			Equalizing excitation-inhibition ratios across visual cortical neurons	NATURE			English	Article							RECTIFYING POTASSIUM CHANNELS; IN-VIVO ELECTROPORATION; NETWORK ACTIVITY; GENE-TRANSFER; CORTEX; MOUSE; CHANNELRHODOPSIN-2; CONNECTIVITY; INTERNEURONS; MODULATION	The relationship between synaptic excitation and inhibition (E/I ratio), two opposing forces in the mammalian cerebral cortex, affects many cortical functions such as feature selectivity and gain(1,2). Individual pyramidal cells show stable E/I ratios in time despite fluctuating cortical activity levels. This is because when excitation increases, inhibition increases proportionally through the increased recruitment of inhibitory neurons, a phenomenon referred to as excitation-inhibition balance(3-9). However, little is known about the distribution of E/I ratios across pyramidal cells. Through their highly divergent axons, inhibitory neurons indiscriminately contact most neighbouring pyramidal cells(10,11). Is inhibition homogeneously distributed(12) or is it individually matched to the different amounts of excitation received by distinct pyramidal cells? Here we discover that pyramidal cells in layer 2/3 of mouse primary visual cortex each receive inhibition in a similar proportion to their excitation. As a consequence, E/I ratios are equalized across pyramidal cells. This matched inhibition is mediated by parvalbumin-expressing but not somatostatin-expressing inhibitory cells and results from the independent adjustment of synapses originating from individual parvalbumin-expressing cells targeting different pyramidal cells. Furthermore, this match is activity-dependent as it is disrupted by perturbing pyramidal cell activity. Thus, the equalization of E/I ratios across pyramidal cells reveals an unexpected degree of order in the spatial distribution of synaptic strengths and indicates that the relationship between the cortex's two opposing forces is stabilized not only in time but also in space.	[Xue, Mingshan; Scanziani, Massimo] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Xue, Mingshan; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Atallah, Bassam V.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal; [Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Fundacao Champalimaud; Howard Hughes Medical Institute; University of California System; University of California San Diego	Xue, MS (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	mingshanxue@gmail.com; massimo@ucsd.edu		Atallah, Bassam/0000-0003-2315-7126; Xue, Mingshan/0000-0003-1463-8884	Jane Coffin Childs Memorial Fund for Medical Research; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Chan, J. Evora, A. Linder and P. Abelkop for technical assistance; M. S. Caudill and S. R. Olsen for help with the in vivo physiology recording programme; E. Kim and A. Ghosh for pCAG-Kir2.1-T2A-tdTomato plasmid; J. Isaacson and H. Y. Zoghbi for comments on earlier versions of the manuscript; D. N. Hill, G. I. Allen, E. Arias-Castro and M. Wang for advice on statistical analysis; the members of the Scanziani and Isaacson laboratories for suggestions; and the University of California, San Diego Neuroscience Microscopy Facility (P30 N5047101) for imaging equipment. M.X. was supported by a fellowship from Jane Coffin Childs Memorial Fund for Medical Research. M.S. is an investigator of the Howard Hughes Medical Institute. This work was also supported by the Gatsby Charitable Foundation.	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Benedetti BL, 2013, CEREB CORTEX, V23, P2690, DOI 10.1093/cercor/bhs257; Bloodgood BL, 2013, NATURE, V503, P121, DOI 10.1038/nature12743; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Manent JB, 2009, NAT MED, V15, P84, DOI 10.1038/nm.1897; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Peng YR, 2010, J NEUROSCI, V30, P16220, DOI 10.1523/JNEUROSCI.3085-10.2010; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Sim SY, 2013, J NEUROSCI, V33, P7928, DOI 10.1523/JNEUROSCI.1571-12.2013; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; Tong YH, 2001, J GEN PHYSIOL, V117, P103, DOI 10.1085/jgp.117.2.103; Turan S, 2010, J MOL BIOL, V402, P52, DOI 10.1016/j.jmb.2010.07.015; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699	50	384	387	4	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					596	+		10.1038/nature13321	http://dx.doi.org/10.1038/nature13321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043046	Green Accepted			2022-12-28	WOS:000339566300036
J	Sedgwick, P; Hooper, C				Sedgwick, Philip; Hooper, Carwyn			What are randomised consent designs?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIAL		[Sedgwick, Philip; Hooper, Carwyn] Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019; Hooper, Carwyn/AAM-1819-2021	Sedgwick, Philip/0000-0001-8859-2175; Hooper, Carwyn/0000-0001-5147-3842				Crotty M, 2005, BMJ-BRIT MED J, V331, P1110, DOI 10.1136/bmj.38638.441933.63; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5970; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3662	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 25	2014	349								g4727	10.1136/bmj.g4727	http://dx.doi.org/10.1136/bmj.g4727			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VU	25063074				2022-12-28	WOS:000339566400002
J	Li, J; Yi, X; Lee, H; Diddams, SA; Vahala, KJ				Li, Jiang; Yi, Xu; Lee, Hansuek; Diddams, Scott A.; Vahala, Kerry J.			Electro-optical frequency division and stable microwave synthesis	SCIENCE			English	Article							BRILLOUIN-FIBER-LASER; MACH-ZEHNDER MODULATOR; PHASE-NOISE; GENERATION; SILICON; CHIP; GHZ; STABILIZATION; RESONATOR; PHOTONICS	Optical frequency division by using frequency combs has revolutionized time keeping and the generation of stable microwave signals. We demonstrate optical frequency division and microwave generation by using a tunable electrical oscillator to create dual combs through phase modulation of two optical signals that have a stable difference frequency. Phase-locked control of the electrical oscillator by means of optical frequency division produces stable microwaves. Our approach transposes the oscillator and frequency reference of a conventional microwave frequency synthesizer. In this way, the oscillator experiences large phase noise reduction relative to the frequency reference. The electro-optical approach additionally relaxes the need for highly linear photodetection of the comb mode spacing. As well as simplicity, the technique is also tunable and scalable to higher division ratios.	[Li, Jiang; Yi, Xu; Lee, Hansuek; Vahala, Kerry J.] CALTECH, Thomas J Watson Lab Appl Phys, Pasadena, CA 91125 USA; [Diddams, Scott A.] NIST, Time & Frequency Div, Boulder, CO 80305 USA	California Institute of Technology; National Institute of Standards & Technology (NIST) - USA	Vahala, KJ (corresponding author), CALTECH, Thomas J Watson Lab Appl Phys, Pasadena, CA 91125 USA.	vahala@caltech.edu	Lee, Hansuek/HDL-6447-2022; Diddams, Scott A/L-2819-2013; Lee, Hansuek/G-2007-2015	Diddams, Scott A/0000-0002-2144-0764; Lee, Hansuek/0000-0002-0748-7662; Yi, Xu/0000-0002-2485-1104	Defense Advanced Research Projects Agency ORCHID program; Defense Advanced Research Projects Agency PULSE program; California Institute of Technology Institute for Quantum Information and Matter, an NSF Physics Frontiers Center; Gordon and Betty Moore Foundation; Kavli NanoScience Institute at the California Institute of Technology; Gordon and Betty Moore Foundation as a Moore Scholar at Caltech; Direct For Mathematical & Physical Scien [1125565] Funding Source: National Science Foundation	Defense Advanced Research Projects Agency ORCHID program; Defense Advanced Research Projects Agency PULSE program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); California Institute of Technology Institute for Quantum Information and Matter, an NSF Physics Frontiers Center; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Kavli NanoScience Institute at the California Institute of Technology; Gordon and Betty Moore Foundation as a Moore Scholar at Caltech; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was sponsored by the Defense Advanced Research Projects Agency ORCHID and PULSE programs and the California Institute of Technology Institute for Quantum Information and Matter, an NSF Physics Frontiers Center with support of the Gordon and Betty Moore Foundation. The authors also acknowledge support from the Kavli NanoScience Institute at the California Institute of Technology. S. A. D. acknowledges the support from the Gordon and Betty Moore Foundation as a Moore Scholar at Caltech.	Callahan PT, 2011, IEEE J QUANTUM ELECT, V47, P1142, DOI 10.1109/JQE.2011.2160047; Carpintero G, 2012, OPT LETT, V37, P3657, DOI 10.1364/OL.37.003657; DREVER RWP, 1983, APPL PHYS B-PHOTO, V31, P97, DOI 10.1007/BF00702605; Fortier TM, 2011, NAT PHOTONICS, V5, P425, DOI [10.1038/NPHOTON.2011.121, 10.1038/nphoton.2011.121]; Fujiwara M, 2001, ELECTRON LETT, V37, P967, DOI 10.1049/el:20010612; Geng JH, 2008, OPT LETT, V33, P16, DOI 10.1364/OL.33.000016; Gross MC, 2010, OPT EXPRESS, V18, P13321, DOI 10.1364/OE.18.013321; Huang CB, 2008, OPT EXPRESS, V16, P2520, DOI 10.1364/OE.16.002520; Ishizawa A, 2013, OPT EXPRESS, V21, P29186, DOI 10.1364/OE.21.029186; Ivanov EN, 2005, IEEE T ULTRASON FERR, V52, P1068, DOI 10.1109/TUFFC.2005.1503992; Kessler T, 2012, NAT PHOTONICS, V6, P687, DOI [10.1038/NPHOTON.2012.217, 10.1038/nphoton.2012.217]; Lee H, 2012, NAT PHOTONICS, V6, P369, DOI [10.1038/nphoton.2012.109, 10.1038/NPHOTON.2012.109]; Li J, 2014, OPT LETT, V39, P287, DOI 10.1364/OL.39.000287; Li J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3097; Li J, 2012, OPT EXPRESS, V20, P26337, DOI 10.1364/OE.20.026337; Li J, 2012, OPT EXPRESS, V20, P20170, DOI 10.1364/OE.20.020170; Metcalf AJ, 2013, IEEE J SEL TOP QUANT, V19, DOI 10.1109/JSTQE.2013.2268384; Morohashi I, 2009, OPT LETT, V34, P2297, DOI 10.1364/OL.34.002297; Murata H, 2000, IEEE J SEL TOP QUANT, V6, P1325, DOI 10.1109/2944.902186; Pan SL, 2009, OPT EXPRESS, V17, P5414, DOI 10.1364/OE.17.005414; Papp S. B., 2013, ARXIV13093525; Pillet G, 2008, J LIGHTWAVE TECHNOL, V26, P2764, DOI 10.1109/JLT.2008.927209; Rohde U. L., 1997, MICROWAVE WIRELESS S; Rolland A, 2011, OPT EXPRESS, V19, P17944, DOI 10.1364/OE.19.017944; Sakamoto T, 2007, OPT LETT, V32, P1515, DOI 10.1364/OL.32.001515; Schneider GJ, 2013, NAT PHOTONICS, V7, P118, DOI [10.1038/NPHOTON.2012.339, 10.1038/nphoton.2012.339]; Seeds AJ, 2006, J LIGHTWAVE TECHNOL, V24, P4628, DOI 10.1109/JLT.2006.885787; Suzuki S., 2013, NONL OPT C OPT SOC A; Swann WC, 2011, OPT EXPRESS, V19, P24387, DOI 10.1364/OE.19.024387; Taylor J, 2011, IEEE PHOTONICS J, V3, P140, DOI 10.1109/JPHOT.2011.2109703; Yao JP, 2009, J LIGHTWAVE TECHNOL, V27, P314, DOI 10.1109/JLT.2008.2009551; Young BC, 1999, PHYS REV LETT, V82, P3799, DOI 10.1103/PhysRevLett.82.3799	32	91	100	6	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					309	313		10.1126/science.1252909	http://dx.doi.org/10.1126/science.1252909			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035489	Green Accepted			2022-12-28	WOS:000339400700047
J	Landray, MJ; Haynes, R; Hopewell, JC; Parish, S; Aung, T; Tomson, J; Wallendszus, K; Craig, M; Jiang, LX; Collins, R; Armitage, J				Landray, Martin J.; Haynes, Richard; Hopewell, Jemma C.; Parish, Sarah; Aung, Theingi; Tomson, Joseph; Wallendszus, Karl; Craig, Martin; Jiang, Lixin; Collins, Rory; Armitage, Jane		HPS2-THRIVE Collaborative Grp	Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; MYOCARDIAL-INFARCTION; NICOTINIC-ACID; METABOLIC SYNDROME; RANDOMIZED-TRIALS; LDL CHOLESTEROL; NIACIN/LAROPIPRANT; DYSLIPIDEMIA; EFFICACY; SAFETY	BACKGROUND Patients with evidence of vascular disease are at increased risk for subsequent vascular events despite effective use of statins to lower the low-density lipoprotein (LDL) cholesterol level. Niacin lowers the LDL cholesterol level and raises the high-density lipoprotein (HDL) cholesterol level, but its clinical efficacy and safety are uncertain. METHODS After a prerandomization run-in phase to standardize the background statin-based LDL cholesterol-lowering therapy and to establish participants' ability to take extended-release niacin without clinically significant adverse effects, we randomly assigned 25,673 adults with vascular disease to receive 2 g of extended-release niacin and 40 mg of laropiprant or a matching placebo daily. The primary outcome was the first major vascular event (nonfatal myocardial infarction, death from coronary causes, stroke, or arterial revascularization). RESULTS During a median follow-up period of 3.9 years, participants who were assigned to extended-release niacin-laropiprant had an LDL cholesterol level that was an average of 10 mg per deciliter (0.25 mmol per liter as measured in the central laboratory) lower and an HDL cholesterol level that was an average of 6 mg per deciliter (0.16 mmol per liter) higher than the levels in those assigned to placebo. Assignment to niacin-laropiprant, as compared with assignment to placebo, had no significant effect on the incidence of major vascular events (13.2% and 13.7% of participants with an event, respectively; rate ratio, 0.96; 95% confidence interval [ CI], 0.90 to 1.03; P = 0.29). Niacin-laropiprant was associated with an increased incidence of disturbances in diabetes control that were considered to be serious (absolute excess as compared with placebo, 3.7 percentage points; P<0.001) and with an increased incidence of diabetes diagnoses (absolute excess, 1.3 percentage points; P<0.001), as well as increases in serious adverse events associated with the gastro-intestinal system (absolute excess, 1.0 percentage point; P<0.001), musculoskeletal system (absolute excess, 0.7 percentage points; P<0.001), skin (absolute excess, 0.3 percentage points; P = 0.003), and unexpectedly, infection (absolute excess, 1.4 percentage points; P<0.001) and bleeding (absolute excess, 0.7 percentage points; P<0.001). CONCLUSIONS Among participants with atherosclerotic vascular disease, the addition of extended-release niacin-laropiprant to statin-based LDL cholesterol-lowering therapy did not significantly reduce the risk of major vascular events but did increase the risk of serious adverse events. (Funded by Merck and others; HPS2-THRIVE ClinicalTrials.gov number, NCT00461630.)	[Landray, Martin J.; Haynes, Richard; Hopewell, Jemma C.; Parish, Sarah; Aung, Theingi; Tomson, Joseph; Wallendszus, Karl; Craig, Martin; Collins, Rory; Armitage, Jane] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Jiang, Lixin] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [Jiang, Lixin] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China	University of Oxford; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Armitage, J (corresponding author), Univ Oxford, Clin Trial Serv Unit, Nuffield Dept Populat Hlth, Richard Doll Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7LF, England.	jane.armitage@ctsu.ox.ac.uk	Chattopadhyay, Sudipta/AAM-1617-2020; Collins, Rory/ABA-8487-2020; Rahimi, Kazem/Q-1279-2015	Chattopadhyay, Sudipta/0000-0002-6421-6762; Rahimi, Kazem/0000-0002-4807-4610; Lakka, Timo/0000-0002-9199-2871; Schmidt, Erik Berg/0000-0002-0623-5666; Townend, Jonathan/0000-0002-5881-5806; Landray, Martin/0000-0001-6646-827X; Klemsdal, Tor Ole/0000-0001-5442-9134; Vadmann, Henrik/0000-0001-8551-9271; Craig, Martin/0000-0003-4956-4512; Hopewell, Jemma/0000-0002-3870-8018; Wickman, Magnus/0000-0003-2710-8620; Willmer, Katherine/0000-0003-2454-6182; Dunachie, Susanna/0000-0001-5665-6293; Wallendszus, Karl/0000-0003-0971-3026; Haynes, Richard/0000-0002-1179-0023	Merck; MRC [MC_EX_G0801669, MC_U137686853] Funding Source: UKRI; Medical Research Council [MC_U137686853, MC_EX_G0801669] Funding Source: researchfish; National Institute for Health Research [CDF-2013-06-012] Funding Source: researchfish	Merck(Merck & Company); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by Merck and others; HPS2-THRIVE ClinicalTrials.gov number, NCT00461630.	Anderson TJ, 2014, NEW ENGL J MED, V371, P288, DOI 10.1056/NEJMc1311039; [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bays HE, 2009, CLIN THER, V31, P115, DOI 10.1016/j.clinthera.2009.01.010; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; Chesney CM, 2000, AM HEART J, V140, P631, DOI 10.1067/mhj.2000.109648; Dallob A, 2011, PLATELETS, V22, P495, DOI 10.3109/09537104.2011.565433; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; Fazio S, 2010, DIABETES OBES METAB, V12, P983, DOI 10.1111/j.1463-1326.2010.01289.x; Goldberg RB, 2008, MAYO CLIN PROC, V83, P470, DOI 10.4065/83.4.470; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guyton JR, 2007, AM J CARDIOL, V99, p22C, DOI 10.1016/j.amjcard.2006.11.018; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; Jackevicius CA, 2013, JAMA INTERN MED, V173, P1379, DOI 10.1001/jamainternmed.2013.6489; Kwiterovich PO, 1998, AM J CARDIOL, V82, p39U, DOI 10.1016/S0002-9149(98)00958-8; Lai E, 2007, CLIN PHARMACOL THER, V81, P849, DOI 10.1038/sj.clpt.6100180; Lai E, 2010, PLATELETS, V21, P191, DOI 10.3109/09537100903521611; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lauring B, 2009, J CLIN PHARMACOL, V49, P1426, DOI 10.1177/0091270009339593; Maccubbin D, 2008, INT J CLIN PRACT, V62, P1959, DOI 10.1111/j.1742-1241.2008.01938.x; Morgan JM, 1998, AM J CARDIOL, V82, p29U, DOI 10.1016/S0002-9149(98)00732-2; NAGAKAWA Y, 1985, THROMB RES, V40, P543, DOI 10.1016/0049-3848(85)90291-9; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Philipose S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040222; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Serebruany V, 2010, THROMB HAEMOSTASIS, V104, P311, DOI 10.1160/TH10-01-0015; Shepherd J, 2005, CURR MED RES OPIN, V21, P665, DOI 10.1185/030079905X43677; Stone NJ, 2013, CIRCULATION; Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine ( SEARCH) Collaborative Group, 2011, LANCET, V377, P126; Voight BF, 2012, LANCET, V380, P564; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	37	1051	1116	2	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2014	371	3					203	212		10.1056/NEJMoa1300955	http://dx.doi.org/10.1056/NEJMoa1300955			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL3BK	25014686	Green Submitted, Green Published			2022-12-28	WOS:000338999800004
J	Zhou, W; Yuan, JY				Zhou, Wen; Yuan, Junying			SnapShot: Necroptosis	CELL			English	Editorial Material									[Zhou, Wen; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Zhou, W (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.							Christofferson DE, 2014, ANNU REV PHYSIOL, V76, P129, DOI 10.1146/annurev-physiol-021113-170259; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Zhou ZR, 2012, PROTEIN CELL, V3, P811, DOI 10.1007/s13238-012-2083-9	3	48	51	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					464	U262		10.1016/j.cell.2014.06.041	http://dx.doi.org/10.1016/j.cell.2014.06.041			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036639	Bronze			2022-12-28	WOS:000340943600025
J	Soroldoni, D; Jorg, DJ; Morelli, LG; Richmond, DL; Schindelin, J; Julicher, F; Oates, AC				Soroldoni, Daniele; Joerg, David J.; Morelli, Luis G.; Richmond, David L.; Schindelin, Johannes; Juelicher, Frank; Oates, Andrew C.			A Doppler effect in embryonic pattern formation	SCIENCE			English	Article							SEGMENTATION CLOCK; VERTEBRATE SEGMENTATION; DYNAMICS; SOMITOGENESIS	During embryonic development, temporal and spatial cues are coordinated to generate a segmented body axis. In sequentially segmenting animals, the rhythm of segmentation is reported to be controlled by the time scale of genetic oscillations that periodically trigger new segment formation. However, we present real-time measurements of genetic oscillations in zebrafish embryos showing that their time scale is not sufficient to explain the temporal period of segmentation. A second time scale, the rate of tissue shortening, contributes to the period of segmentation through a Doppler effect. This contribution is modulated by a gradual change in the oscillation profile across the tissue. We conclude that the rhythm of segmentation is an emergent property controlled by the time scale of genetic oscillations, the change of oscillation profile, and tissue shortening.	[Soroldoni, Daniele; Morelli, Luis G.; Richmond, David L.; Schindelin, Johannes; Oates, Andrew C.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Soroldoni, Daniele; Oates, Andrew C.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Soroldoni, Daniele; Oates, Andrew C.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Joerg, David J.; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Morelli, Luis G.] Univ Buenos Aires, Dept Fis, Fac Ciencias Exactas & Nat, RA-1428 Buenos Aires, DF, Argentina; [Morelli, Luis G.] Consejo Nacl Invest Cient & Tecn, Inst Fis Buenos Aires, RA-1428 Buenos Aires, DF, Argentina; [Schindelin, Johannes] Univ Wisconsin, Lab Opt & Computat Instrumentat, Madison, WI 53706 USA	Max Planck Society; MRC National Institute for Medical Research; University of London; University College London; Max Planck Society; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Wisconsin System; University of Wisconsin Madison	Oates, AC (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	aoates@nimr.mrc.ac.uk	Jörg, David/I-3905-2012; Julicher, Frank/B-1828-2009; Zebrafish, UCL/A-3125-2009; Morelli, Luis G/A-6345-2009	Jörg, David/0000-0001-5960-0260; Julicher, Frank/0000-0003-4731-9185; Morelli, Luis G/0000-0001-5614-073X; Oates, Andrew/0000-0002-3015-3978	Max Planck Society; Medical Research Council [MC_UP_1202/3]; European Research Council (ERC) under European Communities 7th Framework Programme [207634]; European Molecular Biology Organization fellowship [ALTF1402-2011]; Wellcome Trust [WT098025MA]; MRC [MC_UP_1202/3] Funding Source: UKRI	Max Planck Society(Max Planck SocietyFoundation CELLEX); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council (ERC) under European Communities 7th Framework Programme(European Research Council (ERC)); European Molecular Biology Organization fellowship(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Wetzel, L. Rohde, C. Poulet, C. Eugster, M. Gonzales-Gaitan, and J. Firmino, for comments on the manuscript; D. Hasselhoff for mental support; and the fish and light microscopy facilities of the Max Planck Institute of Molecular Cell Biology and Genetics. This work was supported by the Max Planck Society and the Medical Research Council (MC_UP_1202/3); D. S., L. G. M., and A.C.O. by the European Research Council (ERC) under the European Communities 7th Framework Programme (FP7/2007-2013)/(ERC grant 207634); D. L. R. by a European Molecular Biology Organization fellowship [ALTF1402-2011]; and A.C.O. and D. S. by the Wellcome Trust (WT098025MA). The original time-lapse recordings in this study are available for anonymous download via the Web site www.nimr.mrc.ac.uk/supplementary/oaties. The ROI and LOI are available as plugins via the Fiji website www.fiji.sc/Fiji. D. S., D. J. J., L. G. M., and A.C.O. designed experiments; D. S. performed experiments; J. S. developed analysis tools; D. S., D. J. J., L. G. M., F. J., and A.C.O. analyzed data; D. S., D. J. J., D. L. R., L. G. M., F. J., and A.C.O. developed the concepts and wrote the paper.	Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Benazeraf B, 2013, ANNU REV CELL DEV BI, V29, P1, DOI 10.1146/annurev-cellbio-101011-155703; Delaune EA, 2012, DEV CELL, V23, P995, DOI 10.1016/j.devcel.2012.09.009; Giudicelli F, 2007, PLOS BIOL, V5, P1309, DOI 10.1371/journal.pbio.0050150; Lauschke VM, 2013, NATURE, V493, P101, DOI 10.1038/nature11804; Mara A, 2007, NAT CELL BIOL, V9, P523, DOI 10.1038/ncb1578; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Morelli LG, 2009, HFSP J, V3, P55, DOI 10.2976/1.3027088; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Sarrazin AF, 2012, SCIENCE, V336, P338, DOI 10.1126/science.1218256; Schroter C, 2008, DEV DYNAM, V237, P545, DOI 10.1002/dvdy.21458; Soroldoni D, 2011, CURR OPIN GENET DEV, V21, P600, DOI 10.1016/j.gde.2011.09.006	13	75	75	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					222	225		10.1126/science.1253089	http://dx.doi.org/10.1126/science.1253089			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013078	Green Accepted			2022-12-28	WOS:000339409900056
J	Richerme, P; Gong, ZX; Lee, A; Senko, C; Smith, J; Foss-Feig, M; Michalakis, S; Gorshkov, AV; Monroe, C				Richerme, Philip; Gong, Zhe-Xuan; Lee, Aaron; Senko, Crystal; Smith, Jacob; Foss-Feig, Michael; Michalakis, Spyridon; Gorshkov, Alexey V.; Monroe, Christopher			Non-local propagation of correlations in quantum systems with long-range interactions	NATURE			English	Article							TRAPPED IONS; ENTANGLEMENT; DYNAMICS		[Richerme, Philip; Gong, Zhe-Xuan; Lee, Aaron; Senko, Crystal; Smith, Jacob; Foss-Feig, Michael; Gorshkov, Alexey V.; Monroe, Christopher] Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA; [Richerme, Philip; Gong, Zhe-Xuan; Lee, Aaron; Senko, Crystal; Smith, Jacob; Foss-Feig, Michael; Gorshkov, Alexey V.; Monroe, Christopher] NIST, College Pk, MD 20742 USA; [Michalakis, Spyridon] CALTECH, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA	University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA; California Institute of Technology	Richerme, P (corresponding author), Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA.	richerme@umd.edu	Monroe, Christopher R/G-8105-2011; Gorshkov, Alexey V/A-9848-2008; Gong, Zhexuan/G-4348-2016	Gorshkov, Alexey V/0000-0003-0509-3421; 	US Army Research Office (ARO) [W911NF0710576]; DARPA Optical Lattice Emulator Program; ARO [W911NF0410234]; IARPA MQCO Program; USNSF Physics Frontier Center at JQI; NRC; Institute for Quantum Information and Matter, an NSF Physics Frontier Center; Gordon and Betty Moore Foundation [GBMF1250]; Division Of Physics [0822671, 1430094] Funding Source: National Science Foundation	US Army Research Office (ARO); DARPA Optical Lattice Emulator Program; ARO; IARPA MQCO Program; USNSF Physics Frontier Center at JQI; NRC(National Research Centre (NRC)); Institute for Quantum Information and Matter, an NSF Physics Frontier Center; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank J. Preskill, A. M. Rey, K. Hazzard, A. Daley, J. Schachenmayer, M. Kastner, S. Manmana and L.-M. Duan for discussions. This work is supported by the US Army Research Office (ARO) Award W911NF0710576 with funds from the DARPA Optical Lattice Emulator Program, ARO award W911NF0410234 with funds from the IARPA MQCO Program, and the USNSF Physics Frontier Center at JQI. M.F.-F. thanks the NRC for support. S. M. acknowledges funding provided by the Institute for Quantum Information and Matter, an NSF Physics Frontier Center with the support of the Gordon and Betty Moore Foundation (through grant GBMF1250).	Bose S, 2007, CONTEMP PHYS, V48, P13, DOI 10.1080/00107510701342313; Bravyi S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050401; Cheneau M, 2012, NATURE, V481, P484, DOI 10.1038/nature10748; Eisert J, 2010, REV MOD PHYS, V82, P277, DOI 10.1103/RevModPhys.82.277; Foss-Feig M, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.042101; Gong Z.-X., 2014, PERSISTENCE LOCALITY; Gong ZX, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/11/113051; Hastings MB, 2006, COMMUN MATH PHYS, V265, P781, DOI 10.1007/s00220-006-0030-4; Hauke P, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.207202; Hazzard KRA, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.075301; Islam R, 2013, SCIENCE, V340, P583, DOI 10.1126/science.1232296; James DFV, 1998, APPL PHYS B-LASERS O, V66, P181, DOI 10.1007/s003400050373; Junemann J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.230404; Kim K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.120502; LIEB EH, 1972, COMMUN MATH PHYS, V28, P251, DOI 10.1007/BF01645779; Michalakis S., 2012, STABILITY AREA LAW E; Molmer K, 1999, PHYS REV LETT, V82, P1835, DOI 10.1103/PhysRevLett.82.1835; Nachtergaele B, 2006, J STAT PHYS, V124, P1, DOI 10.1007/s10955-006-9143-6; Nachtergaele B, 2006, COMMUN MATH PHYS, V265, P119, DOI 10.1007/s00220-006-1556-1; Olmschenk S, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.052314; Porras D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207901; Richerme P, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.100506; Rigol M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.050405; Schachenmayer J, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.031015; Shen C, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/053053; van den Worm M, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/083007; Wang CCJ, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032329	30	492	493	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					198	+		10.1038/nature13450	http://dx.doi.org/10.1038/nature13450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008525	Green Submitted			2022-12-28	WOS:000338649800038
J	Kirschner, NM; Sulmasy, LS; Kesselheim, AS				Kirschner, Neil M.; Sulmasy, Lois Snyder; Kesselheim, Aaron S.			Health Policy Basics: The Physician Payment Sunshine Act and the Open Payments Program	ANNALS OF INTERNAL MEDICINE			English	Article							INDUSTRY RELATIONS	The Open Payments program is a government initiative through which financial relationships between applicable industries and covered physicians or teaching hospitals are publicly reported. The program does not assess these relationships but rather facilitates transparency and allows stakeholders to use this information in making informed decisions. This article outlines the program and its goals, reviews its requirements and when they go into effect, examines the implications for physicians and their patients, and makes recommendations to help physicians and teaching hospitals prepare for its implementation.	Amer Coll Physicians, Philadelphia, PA 19106 USA; [Kirschner, Neil M.] Amer Coll Physicians, Washington, DC 20001 USA; Brigham & Womens Hosp, Boston, MA 02120 USA	American College of Physicians; American College of Physicians; Harvard University; Brigham & Women's Hospital	Kirschner, NM (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	nkirschner@acponline.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Agrawal S, 2013, NEW ENGL J MED, V368, P2054, DOI 10.1056/NEJMp1303523; American College of Physicians, 2010, HEALTHC TRANSP FOC P; [Anonymous], 2012, US PHARM PROMOTION S; Coyle SL, 2002, ANN INTERN MED, V136, P396, DOI 10.7326/0003-4819-136-5-200203050-00014; Coyle SL, 2002, ANN INTERN MED, V136, P403, DOI 10.7326/0003-4819-136-5-200203050-00015; Kesselheim AS, 2013, NEW ENGL J MED, V368, P2049, DOI 10.1056/NEJMp1302723; Licurse A, 2010, ARCH INTERN MED, V170, P675, DOI 10.1001/archinternmed.2010.39; Manchanda Puneet, 2005, Yale J Health Policy Law Ethics, V5, P785; Pearson SD, 2006, ARCH INTERN MED, V166, P623, DOI 10.1001/archinte.166.6.623; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001	10	62	62	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2014	161	7					519	+		10.7326/M14-1303	http://dx.doi.org/10.7326/M14-1303			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LU	25069795				2022-12-28	WOS:000343896700011
J	Horton, DK; Mehta, P; Antao, VC				Horton, D. Kevin; Mehta, Paul; Antao, Vinicius C.			Quantifying a Nonnotifiable Disease in the United States The National Amyotrophic Lateral Sclerosis Registry Model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Horton, D. Kevin; Mehta, Paul; Antao, Vinicius C.] Agcy Tox Subst & Dis Registry, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Horton, DK (corresponding author), Agcy Tox Subst & Dis Registry, 4770 Buford Hwy,Mailstop F-58, Atlanta, GA 30341 USA.	dhorton@cdc.gov	Mehta, Paul/ABH-6582-2020	Mehta, Paul/0000-0002-0796-8861; Horton, D. Kevin/0000-0001-6214-6687	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Buehler James W, 2012, MMWR Suppl, V61, P1; Kaye WE, 2014, AMYOTROPH LAT SCL FR, V15, P433, DOI 10.3109/21678421.2014.887119; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; Mehta P, 2014, MMWR SURVEILL SUMM, V63, P1; Mitsumoto H., 1998, AMYOTROPHIC LATERAL	5	20	20	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2014	312	11					1097	1098		10.1001/jama.2014.9799	http://dx.doi.org/10.1001/jama.2014.9799			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO8SN	25057819	Green Accepted			2022-12-28	WOS:000341624700016
J	Lu, KF; Psakhye, I; Jentsch, S				Lu, Kefeng; Psakhye, Ivan; Jentsch, Stefan			Autophagic Clearance of PolyQ Proteins Mediated by Ubiquitin-Atg8 Adaptors of the Conserved CUET Protein Family	CELL			English	Article							SELECTIVE AUTOPHAGY; MISFOLDED PROTEINS; PROTEASOME SYSTEM; DEGRADATION; BINDING; DOMAIN; TOLLIP; RECOGNITION; DISEASE; AGGREGATION	Selective ubiquitin-dependent autophagy plays a pivotal role in the elimination of protein aggregates, assemblies, or organelles and counteracts the cytotoxicity of proteins linked to neurodegenerative diseases. Following substrate ubiquitylation, the cargo is delivered to autophagosomes involving adaptors like human p62 that bind ubiquitin and the autophagosomal ubiquitin-like protein Atg8/LC3; however, whether similar pathways exist in lower eukaryotes remained unclear. Here, we identify by a screen in yeast a new class of ubiquitin-Atg8 adaptors termed CUET proteins, comprising the ubiquitin-binding CUE-domain protein Cue5 from yeast and its human homolog Tollip. Cue5 collaborates with Rsp5 ubiquitin ligase, and the corresponding yeast mutants accumulate aggregation-prone proteins and are vulnerable to polyQ protein expression. Similarly, Tollip depletion causes cytotoxicity toward polyQ proteins, whereas Tollip overexpression clears human cells from Huntington's disease-linked polyQ proteins by autophagy. We thus propose that CUET proteins play a critical and ancient role in autophagic clearance of cytotoxic protein aggregates.	[Lu, Kefeng; Psakhye, Ivan; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de		Lu, Kefeng/0000-0001-8200-9380; Psakhye, Ivan/0000-0003-3877-133X	Max Planck Society; Deutsche Forschungsgemeinschaft; Center for Integrated Protein Science Munich; ERC Advanced Grant; Louis-Jeantet Foundation	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; ERC Advanced Grant; Louis-Jeantet Foundation	We thank F. den Brave, F. Paasch, and F. Wilfling for comments on the manuscript; U. Hartl and E. Lemichez for materials; C. Boulegue for mass spectrometry analysis; B. Habermann for help with bioinformatic analysis; T. Ammon for help with mammalian cell culture techniques; and A. Strasser for technical assistance. S.J. is supported by Max Planck Society, Deutsche Forschungsgemeinschaft, Center for Integrated Protein Science Munich, ERC Advanced Grant, and the Louis-Jeantet Foundation.	Ankem G, 2011, BIOCHEM J, V435, P597, DOI 10.1042/BJ20102160; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bagola K, 2013, MOL CELL, V50, P528, DOI 10.1016/j.molcel.2013.04.005; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Capelluto DGS, 2012, MICROBES INFECT, V14, P140, DOI 10.1016/j.micinf.2011.08.018; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Katoh Y, 2006, BIOCHEM BIOPH RES CO, V341, P143, DOI 10.1016/j.bbrc.2005.12.156; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mitra S, 2013, J BIOL CHEM, V288, P25780, DOI 10.1074/jbc.M113.484170; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Moreno-Borchart AC, 2001, EMBO J, V20, P6946, DOI 10.1093/emboj/20.24.6946; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Oguro A, 2011, NEUROSCI LETT, V503, P234, DOI 10.1016/j.neulet.2011.08.043; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Visvikis O, 2011, TRAFFIC, V12, P579, DOI 10.1111/j.1600-0854.2011.01174.x	47	224	230	2	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					549	563		10.1016/j.cell.2014.05.048	http://dx.doi.org/10.1016/j.cell.2014.05.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25042851	Bronze			2022-12-28	WOS:000340944300009
J	Schattner, A; Gotler, J				Schattner, Ami; Gotler, Jacob			Fever, night sweats, and abnormal liver enzymes	LANCET			English	Editorial Material									[Schattner, Ami] Kaplan Med Ctr, Dept Med, IL-76100 Rehovot, Israel; [Gotler, Jacob] Kaplan Med Ctr, Dept Radiol, IL-76100 Rehovot, Israel; [Schattner, Ami] Hebrew Univ Jerusalem, Jerusalem, Israel; [Schattner, Ami] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Schattner, A (corresponding author), Kaplan Med Ctr, Dept Med, POB 1, IL-76100 Rehovot, Israel.	amiMD@clalit.org.il	Schattner, Ami/ABI-1894-2020	Schattner, Ami/0000-0002-1413-8858				Fox JM, 2010, SLEISENGER FORDTRANS, P2073; Kasper DL, 2005, NEW ENGL J MED, V353, P713, DOI 10.1056/NEJMcpc059020; Mohsen AH, 2002, QJM, V95, P707; PLEMMONS RM, 1995, CLIN INFECT DIS, V21, P1114, DOI 10.1093/clinids/21.5.1114; WALLACK MK, 1976, ANN SURG, V184, P241, DOI 10.1097/00000658-197608000-00018	5	4	4	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2014	384	9940					376	376		10.1016/S0140-6736(14)61180-6	http://dx.doi.org/10.1016/S0140-6736(14)61180-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3AE	25066159				2022-12-28	WOS:000339722400034
J	Griffin, D; Parsons, N; Shaw, E; Kulikov, Y; Hutchinson, C; Thorogood, M; Lamb, SE				Griffin, Damian; Parsons, Nick; Shaw, Ewart; Kulikov, Yuri; Hutchinson, Charles; Thorogood, Margaret; Lamb, Sarah E.		UK Heel Fracture Trial UK HeFT	Operative versus non-operative treatment for closed, displaced, intra-articular fractures of the calcaneus: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONTROLLED MULTICENTER TRIAL; INTERNAL-FIXATION; MANAGEMENT; SF-36; ANKLE	Objective To investigate whether surgery by open reduction and internal fixation provides benefit compared with non-operative treatment for displaced, intra-articular calcaneal fractures. Design Pragmatic, multicentre, two arm, parallel group, assessor blinded randomised controlled trial (UK Heel Fracture Trial). Setting 22 tertiary referral hospitals, United Kingdom. Participants 151 patients with acute displaced intra-articular calcaneal fractures randomly allocated to operative (n=73) or non-operative (n=78) treatment. Main outcome measures The primary outcome measure was patient reported Kerr-Atkins score for pain and function (scale 0-100, 100 being the best possible score) at two years after injury. Secondary outcomes were complications; hindfoot pain and function (American Orthopaedic Foot and Ankle Society score); general health (SF-36); quality of life (EQ-5D); clinical examination; walking speed; and gait symmetry. Analysis was by intention to treat. Results 95% follow-up was achieved for the primary outcome (69 in operative group and 74 in non-operative group), and a complete set of secondary outcomes were available for 75% of participants. There was no significant difference in the primary outcome (mean Kerr-Atkins score 69.8 in operative group v 65.7 in non-operative group; adjusted 95% confidence interval of difference -7.1 to 7.0) or in any of the secondary outcomes between treatment groups. Complications and reoperations were more common in those who received operative care (estimated odds ratio 7.5, 95% confidence interval 2.0 to 41.8). Conclusions Operative treatment compared with non-operative care showed no symptomatic or functional advantage after two years in patients with typical displaced intra-articular fractures of the calcaneus, and the risk of complications was higher after surgery. Based on these findings, operative treatment by open reduction and internal fixation is not recommended for these fractures.	Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England; Univ Hosp Coventry & Warwickshire NHS Trust, Coventry, W Midlands, England	University of Warwick; University of Warwick; University of Warwick	Griffin, D (corresponding author), Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England.	damian.griffin@warwick.ac.uk	Parsons, Nick/AAA-8713-2019; Hart, Alister/I-2948-2014	Achten, Juul/0000-0002-8857-5743; Lamb, Sarah/0000-0003-4349-7195; Blom, Ashley/0000-0002-9940-1095; Hart, Alister/0000-0003-1281-6886; Parsons, Nick/0000-0001-9975-888X; Platt, Simon/0000-0002-2391-7749	British Trauma Society; Versus Arthritis [15964] Funding Source: researchfish	British Trauma Society; Versus Arthritis(Versus Arthritis)	We thank Bernard Meggitt and David Johns who stimulated our interest in calcaneal fractures; Sarah Meredith, Richard Lilford, Richard Buckley, and Roger Atkins who influenced the design of the trial; the scientific committees of the British Orthopaedic Foot and Ankle Society and the British Trauma Society who supported the trial; and the participants who agreed to take part.	Agency for Healthcare Research and Quality, 2010, HCUP NAT INP SAMPL; Agren PH, 2013, J BONE JOINT SURG AM, V95A, P1351, DOI 10.2106/JBJS.L.00759; Bajammal S, 2005, J ORTHOP TRAUMA, V19, P360; Brookes S T, 2001, Health Technol Assess, V5, P1; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Bruce J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008628.pub2; Buckley R, 2002, J BONE JOINT SURG AM, V84A, P1733, DOI 10.2106/00004623-200210000-00001; Charnley J, 2003, CLOSED TREATMENT COM, V4th; Cotton F. J., 1916, J BONE JOINT SURG, V2, P290; CROSBY LA, 1993, CLIN ORTHOP RELAT R, P47; Dhillon MS, 2012, J POSTGRAD MED EDU R, V46, P144; EASTWOOD DM, 1993, J BONE JOINT SURG BR, V75, P189, DOI 10.1302/0301-620X.75B2.8444935; Epstein N, 2012, FOOT ANKLE INT, V33, P79, DOI 10.3113/FAI.2012.0079; ESSEXLOPRESTI P, 1952, BRIT J SURG, V39, P395, DOI 10.1002/bjs.18003915704; Folk JW, 1999, J ORTHOP TRAUMA, V13, P369, DOI 10.1097/00005131-199906000-00008; Gougoulias N, 2009, BRIT MED BULL, V92, P153, DOI 10.1093/bmb/ldp030; Holecek T, 2002, EUR J TRAUMA S1, V28, P84; Ibrahim T, 2007, INJURY, V38, P848, DOI 10.1016/j.injury.2007.01.003; Jain S, 2013, CHIN J TRAUMATOL, V16, P355, DOI 10.3760/cma.j.issn.1008-1275.2013.06.008; Jenkinson C, 1999, J EPIDEMIOL COMMUN H, V53, P46, DOI 10.1136/jech.53.1.46; Jiang N, 2012, INT ORTHOP, V36, P1615, DOI 10.1007/s00264-012-1563-0; Kerr PS, 1996, INJURY, V27, P35, DOI 10.1016/0020-1383(95)00165-4; KITAOKA HB, 1994, FOOT ANKLE INT, V15, P349, DOI 10.1177/107110079401500701; Menadue C, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-60; Mitchell M J, 2009, Foot (Edinb), V19, P197, DOI 10.1016/j.foot.2009.05.001; NHS Information Centre, HOSP EP STAT 2000 20; OFARRELL DA, 1993, INJURY, V24, P263, DOI 10.1016/0020-1383(93)90183-7; POZO JL, 1984, J BONE JOINT SURG BR, V66, P386, DOI 10.1302/0301-620X.66B3.6725350; ROBINSON RO, 1987, J MANIP PHYSIOL THER, V10, P172; SANDERS R, 1993, CLIN ORTHOP RELAT R, P87; Schepers T, 2008, INT ORTHOP, V32, P711, DOI 10.1007/s00264-007-0385-y; Tadros AMA, 2010, INJURY, V41, P137, DOI 10.1016/j.injury.2009.05.031; Tennent TD, 2001, INJURY, V32, P491, DOI 10.1016/S0020-1383(01)00024-9; Thordarson DB, 1996, FOOT ANKLE INT, V17, P2, DOI 10.1177/107110079601700102; Thornes BS, 2002, IRISH J MED SCI, V171, P155, DOI 10.1007/BF03170505; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; ZELEN M, 1979, NEW ENGL J MED, V300, P1242, DOI 10.1056/NEJM197905313002203	37	146	158	2	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2014	349								g4483	10.1136/bmj.g4483	http://dx.doi.org/10.1136/bmj.g4483			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VS	25059747	Green Published, hybrid			2022-12-28	WOS:000339566200001
J	Watts, G				Watts, Geoff			Ciro de Quadros Obituary	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					228	228		10.1016/S0140-6736(14)61202-2	http://dx.doi.org/10.1016/S0140-6736(14)61202-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL8JI	25050441				2022-12-28	WOS:000339384100014
J	Kessler, DA				Kessler, David A.			Toward More Comprehensive Food Labeling	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kessler, David A.] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Kessler, David A.] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kessler, DA (corresponding author), Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA.							Food and Drug Administration Silver Spring, PROP CHANG NUTR FACT; Food Marketing Institute, SUP FACTS IND OV 201; Kessler D.A, 2003, HARVARD HLTH POLICY, V4, P13; Nestle M, 2011, IOM RELEASES TOUGH R; Todd J. E, 2008, DECLINE CONSUMER USE	5	19	19	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2014	371	3					193	195		10.1056/NEJMp1402971	http://dx.doi.org/10.1056/NEJMp1402971			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL3BK	25014683				2022-12-28	WOS:000338999800001
J	Sylvetsky, AC; Dietz, WH				Sylvetsky, Allison C.; Dietz, William H.			Nutrient-Content Claims - Guidance or Cause for Confusion?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FOODS		[Sylvetsky, Allison C.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Exercise & Nutr Sci, Washington, DC 20052 USA; [Dietz, William H.] George Washington Univ, Milken Inst Sch Publ Hlth, Sumner M Redstone Global Ctr Prevent & Wellness, Washington, DC USA	George Washington University; George Washington University	Sylvetsky, AC (corresponding author), George Washington Univ, Milken Inst Sch Publ Hlth, Dept Exercise & Nutr Sci, Washington, DC 20052 USA.							[Anonymous], 2011, GUID FOOD LAB ADV; Colby SE, 2010, J NUTR EDUC BEHAV, V42, P92, DOI 10.1016/j.jneb.2008.11.002; LeGault L, 2004, J AM DIET ASSOC, V104, P952, DOI 10.1016/j.jada.2004.03.024; Sylvetsky AC, 2013, FASEB J, V27; Williams P, 2005, NUTR REV, V63, P256, DOI [10.1301/nr.2005.jul.256-264, 10.1111/j.1753-4887.2005.tb00382.x]	5	39	40	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2014	371	3					195	198		10.1056/NEJMp1404899	http://dx.doi.org/10.1056/NEJMp1404899			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL3BK	25014684				2022-12-28	WOS:000338999800002
J	Turrigiano, G				Turrigiano, Gina			NEUROBIOLOGY Keeping a lid on it	NATURE			English	Editorial Material							NERVOUS-SYSTEM; NPAS4		[Turrigiano, Gina] Brandeis Univ, Dept Biol, Ctr Complex Syst, Waltham, MA 02454 USA; [Turrigiano, Gina] Brandeis Univ, Ctr Behav Genom, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Turrigiano, G (corresponding author), Brandeis Univ, Dept Biol, Ctr Complex Syst, Waltham, MA 02454 USA.	turrigiano@brandeis.edu			NINDS NIH HHS [R37 NS092635] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS092635] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Hangya B, 2014, CURR OPIN NEUROBIOL, V26, P117, DOI 10.1016/j.conb.2014.01.007; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Lyons MR, 2011, PROG NEUROBIOL, V94, P259, DOI 10.1016/j.pneurobio.2011.05.003; Maya-Vetencourt JF, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/683909; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736	8	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					297	298		10.1038/nature13641	http://dx.doi.org/10.1038/nature13641			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030161				2022-12-28	WOS:000338992200022
J	Gulde, M; Schweda, S; Storeck, G; Maiti, M; Yu, HK; Wodtke, AM; Schafer, S; Ropers, C				Gulde, Max; Schweda, Simon; Storeck, Gero; Maiti, Manisankar; Yu, Hak Ki; Wodtke, Alec M.; Schaefer, Sascha; Ropers, Claus			Ultrafast low-energy electron diffraction in transmission resolves polymer/graphene superstructure dynamics	SCIENCE			English	Article							PICOSECOND; SURFACE; POLYMER; VISUALIZATION	Two-dimensional systems such as surfaces and molecular monolayers exhibit a multitude of intriguing phases and complex transitions. Ultrafast structural probing of such systems offers direct time-domain information on internal interactions and couplings to a substrate or bulk support. We have developed ultrafast low-energy electron diffraction and investigate in transmission the structural relaxation in a polymer/graphene bilayer system excited out of equilibrium. The laser-pump/electron-probe scheme resolves the ultrafast melting of a polymer superstructure consisting of folded-chain crystals registered to a free-standing graphene substrate. We extract the time scales of energy transfer across the bilayer interface, the loss of superstructure order, and the appearance of an amorphous phase with short-range correlations. The high surface sensitivity makes this experimental approach suitable for numerous problems in ultrafast surface science.	[Gulde, Max; Schweda, Simon; Storeck, Gero; Maiti, Manisankar; Schaefer, Sascha; Ropers, Claus] Univ Gottingen, Phys Inst 4, D-37077 Gottingen, Germany; [Yu, Hak Ki; Wodtke, Alec M.] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Wodtke, Alec M.] Univ Gottingen, Inst Phys Chem, D-37077 Gottingen, Germany	University of Gottingen; Max Planck Society; University of Gottingen	Ropers, C (corresponding author), Univ Gottingen, Phys Inst 4, D-37077 Gottingen, Germany.	cropers@gwdg.de	SchÃfer, Sascha/AAV-3086-2021; Ropers, Claus/D-4843-2015; Wodtke, Alec M/I-4848-2012; Yu, Hak Ki/AFS-9489-2022	Ropers, Claus/0000-0002-9539-3817; Yu, Hak Ki/0000-0003-4970-7018; Schafer, Sascha/0000-0003-1908-8316; Wodtke, Alec/0000-0002-6509-2183	Deutsche Forschungsgemeinschaft [DFG-ZuK 45/1, DFG-SFB 1073]; German National Academic Foundation; Alexander von Humboldt Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German National Academic Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank M. Muller for helpful discussions on polymer dynamics. Supporting sample characterizations by H. Schuhmann, M. Seibt, S. Strauch, H. Stark (TEM imaging), S. Dechert, and M. Sivis (Raman spectroscopy), as well as James E. Evans and Nigel D. Browning (high-resolution TEM, Pacific Northwest National Laboratory), are gratefully acknowledged. This work was partially funded by the Deutsche Forschungsgemeinschaft (DFG-ZuK 45/1 and DFG-SFB 1073). M. G. was financially supported by the German National Academic Foundation. A. M. W. and H.K.Y. gratefully acknowledge support from the Alexander von Humboldt Foundation.	Baum P, 2007, SCIENCE, V318, P788, DOI 10.1126/science.1147724; BECKER RS, 1984, PHYS REV LETT, V52, P307, DOI 10.1103/PhysRevLett.52.307; Braun O. M., 2004, TEXT MONOGR; Carbone F, 2009, SCIENCE, V325, P181, DOI 10.1126/science.1175005; Chaikin P. M., 2000, PRINCIPLES CONDENSED; Chergui M, 2010, ACTA CRYSTALLOGR A, V66, P229, DOI 10.1107/S010876730904968X; Cirelli C, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/17010; Eichberger M, 2010, NATURE, V468, P799, DOI 10.1038/nature09539; Forrest JA, 2001, ADV COLLOID INTERFAC, V94, P167, DOI 10.1016/S0001-8686(01)00060-4; Fritz DM, 2007, SCIENCE, V315, P633, DOI 10.1126/science.1135009; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; HA JS, 1994, J VAC SCI TECHNOL B, V12, P1977, DOI 10.1116/1.587683; Hanisch-Blicharski A, 2013, ULTRAMICROSCOPY, V127, P2, DOI 10.1016/j.ultramic.2012.07.017; Herink G, 2012, NATURE, V483, P190, DOI 10.1038/nature10878; Hove M.A., 1986, LOW ENERGY ELECT DIF; Juve V, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.217401; Karrer R, 2001, REV SCI INSTRUM, V72, P4404, DOI 10.1063/1.1419219; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; Kruger M, 2011, NATURE, V475, P78, DOI 10.1038/nature10196; Kumaki J, 2005, J AM CHEM SOC, V127, P5788, DOI 10.1021/ja050457e; LaGrange T, 2008, ULTRAMICROSCOPY, V108, P1441, DOI 10.1016/j.ultramic.2008.03.013; Lin YC, 2012, NANO LETT, V12, P414, DOI 10.1021/nl203733r; Mohammed OF, 2011, J AM CHEM SOC, V133, P7708, DOI 10.1021/ja2031322; Paarmann A, 2012, J APPL PHYS, V112, DOI 10.1063/1.4768204; Park H, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3157270; Quinonez E, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4827035; Raman RK, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3259779; Rissanou AN, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1589-2; Schafer S, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3663963; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; Spence JCH, 2010, PHILOS MAG, V90, P4691, DOI 10.1080/14786431003630868; Tress M, 2013, SCIENCE, V341, P1371, DOI 10.1126/science.1238950; Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135	34	148	153	2	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					200	204		10.1126/science.1250658	http://dx.doi.org/10.1126/science.1250658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013072				2022-12-28	WOS:000339409900050
J	Lotko, W; Smith, RH; Zhang, BZ; Ouellette, JE; Brambles, OJ; Lyon, JG				Lotko, William; Smith, Ryan H.; Zhang, Binzheng; Ouellette, Jeremy E.; Brambles, Oliver J.; Lyon, John G.			Ionospheric control of magnetotail reconnection	SCIENCE			English	Article							MAGNETIC RECONNECTION; POTENTIAL PATTERN; MAGNETOSPHERE; OUTFLOW; FLOWS; SHEET; FIELD	Observed distributions of high-speed plasma flows at distances of 10 to 30 Earth radii (RE) in Earth's magnetotail neutral sheet are highly skewed toward the premidnight sector. The flows are a product of the magnetic reconnection process that converts magnetic energy stored in the magnetotail into plasma kinetic and thermal energy. We show, using global numerical simulations, that the electrodynamic interaction between Earth's magnetosphere and ionosphere produces an asymmetry consistent with observed distributions in nightside reconnection and plasmasheet flows and in accompanying ionospheric convection. The primary causal agent is the meridional gradient in the ionospheric Hall conductance which, through the Cowling effect, regulates the distribution of electrical currents flowing within and between the ionosphere and magnetotail.	[Lotko, William; Smith, Ryan H.; Zhang, Binzheng; Ouellette, Jeremy E.; Brambles, Oliver J.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Lotko, William] Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA; [Ouellette, Jeremy E.] Vermont Tech Coll, Dept Comp & Informat Syst, Randolph, VT USA; [Lyon, John G.] Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA	Dartmouth College; National Center Atmospheric Research (NCAR) - USA; Dartmouth College	Lotko, W (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.	wlotko@dartmouth.edu		Lotko, William/0000-0002-3859-1593; Zhang, Binzheng/0000-0002-1555-6023	NASA HTP Program [NNX11AO59G]; NASA Geospace SR Program [NNX11AJ10G]; NSF NSWP [AGS-1023346]; Computational and Information Systems Laboratory of the National Center for Atmospheric Research [36761008, 2761009]	NASA HTP Program; NASA Geospace SR Program; NSF NSWP; Computational and Information Systems Laboratory of the National Center for Atmospheric Research	G. Haerendel provided helpful suggestions on the research. Support was provided by the NASA HTP Program (grant NNX11AO59G), NASA Geospace SR Program (grant NNX11AJ10G), and NSF NSWP (grant AGS-1023346). Computing resources were provided by the Computational and Information Systems Laboratory of the National Center for Atmospheric Research (grants 36761008 and 2761009). Simulation data are available from W. Lotko.	ANGELOPOULOS V, 1994, J GEOPHYS RES-SPACE, V99, P21257, DOI 10.1029/94JA01263; BARBOSA DD, 1984, J GEOPHYS RES-SPACE, V89, P2881, DOI 10.1029/JA089iA05p02881; Brambles OJ, 2011, SCIENCE, V332, P1183, DOI 10.1126/science.1202869; Haerendel G, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014138; HONES EW, 1979, J GEOPHYS RES-SPACE, V84, P7155, DOI 10.1029/JA084iA12p07155; Israelevich PL, 2001, J GEOPHYS RES-SPACE, V106, P25919, DOI 10.1029/2000JA900165; Juusola L, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016479; KAMIDE Y, 1981, J GEOPHYS RES-SPACE, V86, P3665, DOI 10.1029/JA086iA05p03665; Lennartsson OW, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2004JA010690; Lyon JG, 2004, J ATMOS SOL-TERR PHY, V66, P1333, DOI 10.1016/j.jastp.2004.03.020; Lyon JG, 2000, SCIENCE, V288, P1987, DOI 10.1126/science.288.5473.1987; LYSAK RL, 1990, SPACE SCI REV, V52, P33, DOI 10.1007/BF00704239; McPherron RL, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA015923; Nagai T, 2013, J GEOPHYS RES-SPACE, V118, P1667, DOI 10.1002/jgra.50247; Nagai T, 1998, GEOPH MONOG SERIES, V105, P211; NAKAMURA M, 1991, J GEOPHYS RES-SPACE, V96, P5631, DOI 10.1029/90JA02495; Nakamura TKM, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017006; Ouellette JE, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014886; Raj A, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA007547; Ridley AJ, 2004, ANN GEOPHYS-GERMANY, V22, P567, DOI 10.5194/angeo-22-567-2004; Russell C. T., 1971, Cosmic Electrodynamics, V2, P184; Shay MA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.175001; Weimer DR, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010884; Wiltberger M, 2004, J ATMOS SOL-TERR PHY, V66, P1411, DOI 10.1016/j.jastp.2004.03.026; YASUHARA F, 1983, J GEOPHYS RES-SPACE, V88, P5773, DOI 10.1029/JA088iA07p05773; Zhang B, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017680	26	59	59	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					184	187		10.1126/science.1252907	http://dx.doi.org/10.1126/science.1252907			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013068				2022-12-28	WOS:000339409900045
J	McMahon, TA; Sears, BF; Venesky, MD; Bessler, SM; Brown, JM; Deutsch, K; Halstead, NT; Lentz, G; Tenouri, N; Young, S; Civitello, DJ; Ortega, N; Fites, JS; Reinert, LK; Rollins-Smith, LA; Raffel, TR; Rohr, JR				McMahon, Taegan A.; Sears, Brittany F.; Venesky, Matthew D.; Bessler, Scott M.; Brown, Jenise M.; Deutsch, Kaitlin; Halstead, Neal T.; Lentz, Garrett; Tenouri, Nadia; Young, Suzanne; Civitello, David J.; Ortega, Nicole; Fites, J. Scott; Reinert, Laura K.; Rollins-Smith, Louise A.; Raffel, Thomas R.; Rohr, Jason R.			Amphibians acquire resistance to live and dead fungus overcoming fungal immunosuppression	NATURE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; CHYTRID FUNGUS; IMMUNE DEFENSES; INFECTION; CHYTRIDIOMYCOSIS; FROG; PATHOGEN; DECLINES; HOSTS; PLANT	Emerging fungal pathogens pose a greater threat to biodiversity than any other parasitic group(1), causing declines of many taxa, including bats, corals, bees, snakes and amphibians(1-4). Currently, there is little evidence that wild animals can acquire resistance to these pathogens(5). Batrachochytrium dendrobatidis is a pathogenic fungus implicated in the recent global decline of amphibians(6). Here we demonstrate that three species of amphibians can acquire behavioural or immunological resistance to B. dendrobatidis. Frogs learned to avoid the fungus after just one B. dendrobatidis exposure and temperature-induced clearance. In subsequent experiments in which B. dendrobatidis avoidance was prevented, the number of previous exposures was a negative predictor of B. dendrobatidis burden on frogs and B. dendrobatidis-induced mortality, and was a positive predictor of lymphocyte abundance and proliferation. These results suggest that amphibians can acquire immunity to B. dendrobatidis that overcomes pathogen-induced immunosuppression(7-9) and increases their survival. Importantly, exposure to dead fungus induced a similar magnitude of acquired resistance as exposure to live fungus. Exposure of frogs to B. dendrobatidis antigens might offer a practical way to protect pathogen-naive amphibians and facilitate the reintroduction of amphibians to locations in the wild where B. dendrobatidis persists. Moreover, given the conserved nature of vertebrate immune responses to fungi(5) and the fact that many animals are capable of learning to avoid natural enemies(10), these results offer hope that other wild animal taxa threatened by invasive fungi might be rescued by management approaches based on herd immunity.	[McMahon, Taegan A.; Sears, Brittany F.; Bessler, Scott M.; Brown, Jenise M.; Deutsch, Kaitlin; Halstead, Neal T.; Lentz, Garrett; Tenouri, Nadia; Young, Suzanne; Civitello, David J.; Ortega, Nicole; Rohr, Jason R.] Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA; [McMahon, Taegan A.] Univ Tampa, Dept Biol, Tampa, FL 33606 USA; [Venesky, Matthew D.] Allegheny Coll, Dept Biol, Meadville, PA 16335 USA; [Fites, J. Scott; Rollins-Smith, Louise A.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Reinert, Laura K.; Rollins-Smith, Louise A.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; [Reinert, Laura K.; Rollins-Smith, Louise A.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Reinert, Laura K.; Rollins-Smith, Louise A.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Raffel, Thomas R.] Oakland Univ, Dept Biol, Rochester, MI 48309 USA	State University System of Florida; University of South Florida; University of Tampa; Allegheny College; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Oakland University	McMahon, TA (corresponding author), Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA.	taeganmcmahon@gmail.com; jasonrohr@gmail.com	Rohr, Jason R./AAJ-5856-2021; Bessler, Scott/ABG-5280-2021	Lentz, Garrett/0000-0003-1588-8148; Sears, Brittany/0000-0002-8515-8573; Deutsch, Kaitlin/0000-0002-6492-366X	National Science Foundation [DEB 0516227, EF-1241889, IOS-1121758]; National Institutes of Health [R01GM109499]; US Department of Agriculture [NRI 2006-01370, 2009-35102-0543]; US Environmental Protection Agency [STAR R83-3835, CAREER 83518801]; NSF RCN "Refining and Diversifying Ecoimmunology"; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109499] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Agriculture(United States Department of Agriculture (USDA)); US Environmental Protection Agency(United States Environmental Protection Agency); NSF RCN "Refining and Diversifying Ecoimmunology"(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Holden and J. Pask for their assistance with the immunological assays, J. Cohen for comments on the manuscript, and our undergraduate assistants H. Folse, S. Lopez, L. Soto, S. Hekkanen and E. Creasey. We also thank V. Vasquez and J. Longcore for providing the Bd isolates used in these experiments. Funds were provided by grants from the National Science Foundation (DEB 0516227 and EF-1241889 to J. R. R. and IOS-1121758 to L.A.R.-S.), the National Institutes of Health (R01GM109499 to J. R. R.), the US Department of Agriculture (NRI 2006-01370 and 2009-35102-0543 to J. R. R.), the US Environmental Protection Agency grant (STAR R83-3835 and CAREER 83518801 to J. R. R.), and the NSF RCN "Refining and Diversifying Ecoimmunology". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender MC, 2011, EMERG INFECT DIS, V17, P2383, DOI 10.3201/eid1712.110240; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cashins SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056747; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fites JS, 2013, SCIENCE, V342, P366, DOI 10.1126/science.1243316; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Kiesecker JM, 1999, P NATL ACAD SCI USA, V96, P9165, DOI 10.1073/pnas.96.16.9165; McMahon TA, 2013, P NATL ACAD SCI USA, V110, P210, DOI 10.1073/pnas.1200592110; Murphy PJ, 2011, DIS AQUAT ORGAN, V95, P31, DOI 10.3354/dao02336; PAWELEC G, 1991, INT J IMMUNOPHARMACO, V13, P299, DOI 10.1016/0192-0561(91)90111-J; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Richmond JQ, 2009, BIOSCIENCE, V59, P311, DOI 10.1525/bio.2009.59.4.9; Rohr JR, 2009, OECOLOGIA, V159, P447, DOI 10.1007/s00442-008-1208-6; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Rollins-Smith Louise A, 2009, Front Biosci (Schol Ed), V1, P68; ROLLINSSMITH LA, 1984, IMMUNOLOGY, V52, P491; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Sexton AC, 2006, EUKARYOT CELL, V5, P1941, DOI 10.1128/EC.00277-06; Shaw SD, 2010, DIS AQUAT ORGAN, V92, P159, DOI 10.3354/dao02227; Stice MJ, 2010, J WILDLIFE DIS, V46, P70, DOI 10.7589/0090-3558-46.1.70; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Venesky MD, 2014, BIOL REV, V89, P477, DOI 10.1111/brv.12064; Venesky MD, 2012, CONSERV BIOL, V26, P586, DOI 10.1111/j.1523-1739.2012.01854.x; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	30	153	156	2	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					224	+		10.1038/nature13491	http://dx.doi.org/10.1038/nature13491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008531	Green Accepted			2022-12-28	WOS:000338649800044
J	Herr, NR; Williams, JW; Benjamin, S; McDuffie, J				Herr, Nathaniel R.; Williams, John W., Jr.; Benjamin, Sophiya; McDuffie, Jennifer			Does This Patient Have Generalized Anxiety or Panic Disorder? The Rational Clinical Examination Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PRIMARY-CARE; MENTAL-DISORDERS; DIAGNOSTIC-ACCURACY; SEARCH STRATEGIES; PREVALENCE; DEPRESSION; COMORBIDITY; IMPAIRMENT; UTILITY; BURDEN	IMPORTANCE In primary care settings, generalized anxiety disorder (GAD) and panic disorder are common but underrecognized illnesses. Identifying accurate and feasible screening instruments for GAD and panic disorder has the potential to improve detection and facilitate treatment. OBJECTIVE To systematically review the accuracy of self-report screening instruments in diagnosing GAD and panic disorder in adults. DATA SOURCES We searched MEDLINE, PsycINFO, and the Cochrane Library for relevant articles published from 1980 through April 2014. STUDY SELECTION Prospective studies of diagnostic accuracy that compared a self-report screening instrument for GAD or panic disorder with the diagnosis made by a trained clinician using Diagnostic and Statistical Manual of Mental Disorders or International Classification of Diseases criteria. RESULTS We screened 3605 titles, excluded 3529, and performed a more detailed review of 76 articles. We identified 9 screening instruments based on 13 articles from 10 unique studies for the detection of GAD and panic disorder in primary care patients Across all studies, diagnostic interviews determined that 257 of 2785 patients assessed had a diagnosis of GAD while 224 of 2637 patients assessed had a diagnosis of panic disorder. The best-performing test for GAD was the Generalized Anxiety Disorder Scale 7 Item (GAD-7), with a positive likelihood ratio of 5.1 (95% CI, 4.3-6.0) and a negative likelihood ratio of 0.13 (95% CI, 0.07-0.25). The best-performing test for panic disorder was the Patient Health Questionnaire, with a positive likelihood ratio of 78 (95% CI, 29-210) and a negative likelihood ratio of 0.20 (95% CI, 0.11-0.37). CONCLUSIONS AND RELEVANCE Two screening instruments, the GAD-7 for GAD and the Patient Health Questionnaire for panic disorder, have good performance characteristics and are feasible for use in primary care. However, further validation of these instruments is needed because neither instrument was replicated in more than 1 primary care population.	[Herr, Nathaniel R.] Amer Univ, Dept Psychol, Washington, DC 20016 USA; [Williams, John W., Jr.; McDuffie, Jennifer] Durham Vet Affairs Evidence Based Synth Program E, Durham, NC USA; [Williams, John W., Jr.; McDuffie, Jennifer] Duke Univ, Dept Med, Durham, NC USA; [Benjamin, Sophiya] Grand River Hosp, Kitchener, ON, Canada; [Benjamin, Sophiya] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada	American University; Duke University; McMaster University	Williams, JW (corresponding author), 411 W Chapel Hill St,Ste 500, Durham, NC 27701 USA.	jw.williams@duke.edu	Benjamin, Sophiya/AAA-6643-2021		Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development (VA-ESP Project) [09-010]	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development (VA-ESP Project)(US Department of Veterans Affairs)	This report is based on research conducted by the Evidence-based Synthesis Program (ESP) Center, located at the Durham VA Medical Center, and funded by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development (VA-ESP Project 09-010).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; APFELDORF WJ, 1994, J ANXIETY DISORD, V8, P71, DOI 10.1016/0887-6185(94)90024-8; Barsky AJ, 1997, ARCH FAM MED, V6, P241, DOI 10.1001/archfami.6.3.241; Beck AT, 1997, ASSESSMENT, V4, P211, DOI 10.1177/107319119700400301; Benjamin S, PERFORMANCE CHARACTE; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Broadhead W E, 1995, Arch Fam Med, V4, P211, DOI 10.1001/archfami.4.3.211; Haynes RB, 2004, BMJ-BRIT MED J, V328, P1040, DOI 10.1136/bmj.38068.557998.EE; Hoffman DL, 2008, DEPRESS ANXIETY, V25, P72, DOI 10.1002/da.20257; Johnson MR, 2007, ETHNIC HEALTH, V12, P283, DOI 10.1080/13557850701235069; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Krasucki C, 1999, INT J GERIATR PSYCH, V14, P60, DOI 10.1002/(SICI)1099-1166(199901)14:1<60::AID-GPS893>3.0.CO;2-G; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Leon AC, 1996, J GEN INTERN MED, V11, P426, DOI 10.1007/BF02600191; LINDESAY J, 1989, BRIT J PSYCHIAT, V155, P317, DOI 10.1192/bjp.155.3.317; Means-Christensen AJ, 2006, GEN HOSP PSYCHIAT, V28, P108, DOI 10.1016/j.genhosppsych.2005.08.010; Moore MT, 2014, J ANXIETY DISORD, V28, P25, DOI 10.1016/j.janxdis.2013.10.009; Schonfeld WH, 1997, J AFFECT DISORDERS, V43, P105, DOI 10.1016/S0165-0327(96)01416-4; Simel DL., 2009, RATIONAL CLIN EXAMIN, V2 ed, P9; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tatsioni A, 2005, ANN INTERN MED, V142, P1048, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00004; Wilczynski NL, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-7; Williams JW, 2002, JAMA-J AM MED ASSOC, V287, P1160, DOI 10.1001/jama.287.9.1160; Wittchen HU, 2002, DEPRESS ANXIETY, V16, P162, DOI 10.1002/da.10065; Woltmann E, 2012, AM J PSYCHIAT, V169, P790, DOI 10.1176/appi.ajp.2012.11111616; Zaroukian MH, 2012, COMPLETE PATIENT HIS; Zaubler TS, 1998, J PSYCHOSOM RES, V44, P25, DOI 10.1016/S0022-3999(97)00134-7	29	30	32	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					78	84		10.1001/jama.2014.5950	http://dx.doi.org/10.1001/jama.2014.5950			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK0UK	25058220				2022-12-28	WOS:000338131100023
J	Gewin, V				Gewin, Virginia			Science and politics: Hello, Governor	NATURE			English	News Item							TIPPING POINTS; BIOSPHERE											Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Barrett S, 2014, NAT CLIM CHANGE, V4, P36, DOI [10.1038/nclimate2059, 10.1038/NCLIMATE2059]; Brook BW, 2013, TRENDS ECOL EVOL, V28, P396, DOI 10.1016/j.tree.2013.01.016	3	11	11	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					402	404		10.1038/511402a	http://dx.doi.org/10.1038/511402a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25061649	Bronze			2022-12-28	WOS:000339335700020
J	Savage, N				Savage, Neil			LOGISTICS Keeping cool	NATURE			English	Editorial Material																			0	30	31	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S8	S9		10.1038/507S8a	http://dx.doi.org/10.1038/507S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611169	Bronze			2022-12-28	WOS:000332224400004
